{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "821255f5",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "data_with_summaries = pd.read_parquet('../data/processed/structured_dataset_with_discharge_summaries.train.parquet')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "1e1b3f10",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(1046, 27)"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_with_summaries.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "94220f42",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([17504528, 14273001, 11357031, ..., 15711279, 18693941, 13688534],\n",
       "      shape=(1034,))"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_with_summaries['subject_id'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "9ddabe5a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>subject_id</th>\n",
       "      <th>hadm_id</th>\n",
       "      <th>admittime</th>\n",
       "      <th>dischtime</th>\n",
       "      <th>admission_type</th>\n",
       "      <th>discharge_location</th>\n",
       "      <th>gender</th>\n",
       "      <th>dod</th>\n",
       "      <th>age_at_admit</th>\n",
       "      <th>length_of_stay_days</th>\n",
       "      <th>...</th>\n",
       "      <th>procedures_icd10</th>\n",
       "      <th>num_procedures_total</th>\n",
       "      <th>meds_discharge_like</th>\n",
       "      <th>medication_count</th>\n",
       "      <th>policy</th>\n",
       "      <th>discharge_summary</th>\n",
       "      <th>diagnosis_codes</th>\n",
       "      <th>model</th>\n",
       "      <th>true_icd_codes</th>\n",
       "      <th>missing_codes</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>17504528</td>\n",
       "      <td>20171885</td>\n",
       "      <td>2137-06-17 20:40:00</td>\n",
       "      <td>2137-06-20 16:41:00</td>\n",
       "      <td>DIRECT EMER.</td>\n",
       "      <td>HOME</td>\n",
       "      <td>F</td>\n",
       "      <td>2142-07-24</td>\n",
       "      <td>56</td>\n",
       "      <td>2.834028</td>\n",
       "      <td>...</td>\n",
       "      <td>[0W9B30Z]</td>\n",
       "      <td>1.0</td>\n",
       "      <td>[5% Dextrose, Albuterol 0.083% Neb Soln, Aspir...</td>\n",
       "      <td>24.0</td>\n",
       "      <td>partial</td>\n",
       "      <td>**Discharge Summary**  \\n**Patient:** Female, ...</td>\n",
       "      <td>[E118, Z5181, I5032, K219, D473, I10, I071, M8...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5032, E118, I10, E785, I2510, I071, D649, I2...</td>\n",
       "      <td>[Z7901, I272, E039, D72829, F419, E785, J45909...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>14273001</td>\n",
       "      <td>20371042</td>\n",
       "      <td>2187-10-19 19:00:00</td>\n",
       "      <td>2187-10-21 18:13:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME</td>\n",
       "      <td>F</td>\n",
       "      <td>2188-03-27</td>\n",
       "      <td>73</td>\n",
       "      <td>1.967361</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Acetaminophen, Aspirin, Atorvastatin, Bisacod...</td>\n",
       "      <td>19.0</td>\n",
       "      <td>all</td>\n",
       "      <td>**Discharge Summary**  \\n**Patient:** 73-year-...</td>\n",
       "      <td>[Z7901, Z87891, E039, Y929, I5031, E785, K219,...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5031, I82501, C7931, C3431, E039, Z7901, I10...</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>11357031</td>\n",
       "      <td>27612249</td>\n",
       "      <td>2139-01-17 21:04:00</td>\n",
       "      <td>2139-01-22 18:00:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>M</td>\n",
       "      <td>2144-10-28</td>\n",
       "      <td>58</td>\n",
       "      <td>4.872222</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[0.9% Sodium Chloride (Mini Bag Plus), Amoxici...</td>\n",
       "      <td>30.0</td>\n",
       "      <td>primary_only</td>\n",
       "      <td>Discharge Summary: \\n\\nPatient is a 58-year-ol...</td>\n",
       "      <td>[I5033]</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, J9692, J9691, E870, E872, E662, J441, ...</td>\n",
       "      <td>[E1140, I272, E872, I129, Z6833, E11319, E662,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>13673554</td>\n",
       "      <td>25741865</td>\n",
       "      <td>2176-02-25 19:39:00</td>\n",
       "      <td>2176-03-02 17:30:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>M</td>\n",
       "      <td>2180-11-21</td>\n",
       "      <td>71</td>\n",
       "      <td>5.910417</td>\n",
       "      <td>...</td>\n",
       "      <td>[0W993ZX]</td>\n",
       "      <td>1.0</td>\n",
       "      <td>[Acetaminophen, Aspirin, Atorvastatin, Cepacol...</td>\n",
       "      <td>17.0</td>\n",
       "      <td>partial</td>\n",
       "      <td>**Patient Discharge Summary**  \\n**Patient Nam...</td>\n",
       "      <td>[I129, N184, I5033, N179, Z951, C9110, E780, I...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, C9110, J918, N184, N179, I129, I2510, ...</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19017808</td>\n",
       "      <td>20589756</td>\n",
       "      <td>2183-01-05 21:59:00</td>\n",
       "      <td>2183-01-08 18:35:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>F</td>\n",
       "      <td>2184-11-16</td>\n",
       "      <td>77</td>\n",
       "      <td>2.858333</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[0.9% Sodium Chloride (Mini Bag Plus), Acetami...</td>\n",
       "      <td>25.0</td>\n",
       "      <td>partial</td>\n",
       "      <td>**Discharge Summary**  \\n**Patient Information...</td>\n",
       "      <td>[N2889, K7460, I8510, I5032, I4891, N179, I878...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5032, I8510, N179, I272, K7460, N390, I4891,...</td>\n",
       "      <td>[I272, Y929, S5001XA, W19XXXA, I10, Z85038, K7...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>19973083</td>\n",
       "      <td>20741363</td>\n",
       "      <td>2123-10-12 04:00:00</td>\n",
       "      <td>2123-10-20 16:35:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>F</td>\n",
       "      <td>NaT</td>\n",
       "      <td>58</td>\n",
       "      <td>8.524306</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Acetaminophen, Amiodarone, Aspirin EC, Atorva...</td>\n",
       "      <td>12.0</td>\n",
       "      <td>primary_only</td>\n",
       "      <td>**Discharge Summary**  \\n**Patient:** Female, ...</td>\n",
       "      <td>[I5033]</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, N170, J9691, D6861, I4892, I340, Z7901...</td>\n",
       "      <td>[R351, Z90710, I361, D6861, I340, I10, I2720, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>14541392</td>\n",
       "      <td>25068197</td>\n",
       "      <td>2124-09-02 00:07:00</td>\n",
       "      <td>2124-09-03 15:36:00</td>\n",
       "      <td>EW EMER.</td>\n",
       "      <td>HOME</td>\n",
       "      <td>M</td>\n",
       "      <td>2125-10-01</td>\n",
       "      <td>58</td>\n",
       "      <td>1.645139</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Acetaminophen, Albuterol 0.083% Neb Soln, Bis...</td>\n",
       "      <td>25.0</td>\n",
       "      <td>primary_only</td>\n",
       "      <td>Patient is a 58-year-old male admitted via eme...</td>\n",
       "      <td>[I5033]</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, G92, J441, I8510, Z6842, F17210, K7469...</td>\n",
       "      <td>[K7469, T473X6A, K7290, K7030, Z91128, F1190, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>10320090</td>\n",
       "      <td>26774424</td>\n",
       "      <td>2178-04-05 00:00:00</td>\n",
       "      <td>2178-04-12 15:46:00</td>\n",
       "      <td>URGENT</td>\n",
       "      <td>HOME</td>\n",
       "      <td>M</td>\n",
       "      <td>2179-05-25</td>\n",
       "      <td>33</td>\n",
       "      <td>7.656944</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[5% Dextrose, Acetaminophen, Amiodarone, Clobe...</td>\n",
       "      <td>17.0</td>\n",
       "      <td>primary_only</td>\n",
       "      <td>**Patient Information:** 33-year-old male, adm...</td>\n",
       "      <td>[I5023]</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5023, I429, N179, Z6843, E669, I480, D638, L...</td>\n",
       "      <td>[M25569, D638, I340, N179, Z7982, I429, Z23, E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>10906285</td>\n",
       "      <td>29225762</td>\n",
       "      <td>2179-09-17 17:46:00</td>\n",
       "      <td>2179-09-23 16:12:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>M</td>\n",
       "      <td>NaT</td>\n",
       "      <td>70</td>\n",
       "      <td>5.934722</td>\n",
       "      <td>...</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Acetaminophen, Atorvastatin, BuPROPion XL (On...</td>\n",
       "      <td>16.0</td>\n",
       "      <td>partial</td>\n",
       "      <td>**Patient Information:** 70-year-old male admi...</td>\n",
       "      <td>[Z7901, Z87891, I428, D539, K219, I5033, Z6837...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, C8510, I428, N400, F32A, K219, I2584, ...</td>\n",
       "      <td>[E669, F32A, R3121, J449, Z20822, C8510, N400,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>15559495</td>\n",
       "      <td>21036461</td>\n",
       "      <td>2116-08-10 22:43:00</td>\n",
       "      <td>2116-08-28 15:37:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>F</td>\n",
       "      <td>NaT</td>\n",
       "      <td>78</td>\n",
       "      <td>17.704167</td>\n",
       "      <td>...</td>\n",
       "      <td>[5A2204Z, 0DJ08ZZ, B24BZZ4]</td>\n",
       "      <td>3.0</td>\n",
       "      <td>[Acetaminophen, Apixaban, Bisacodyl, Bumetanid...</td>\n",
       "      <td>16.0</td>\n",
       "      <td>all</td>\n",
       "      <td>**Discharge Summary**  \\n**Patient:** 78-year-...</td>\n",
       "      <td>[Z7901, Y929, I081, Y838, I5021, T84092A, R090...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5021, T84092A, I081, K761, Z7901, R0902, G47...</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   subject_id   hadm_id           admittime           dischtime  \\\n",
       "0    17504528  20171885 2137-06-17 20:40:00 2137-06-20 16:41:00   \n",
       "1    14273001  20371042 2187-10-19 19:00:00 2187-10-21 18:13:00   \n",
       "2    11357031  27612249 2139-01-17 21:04:00 2139-01-22 18:00:00   \n",
       "3    13673554  25741865 2176-02-25 19:39:00 2176-03-02 17:30:00   \n",
       "4    19017808  20589756 2183-01-05 21:59:00 2183-01-08 18:35:00   \n",
       "5    19973083  20741363 2123-10-12 04:00:00 2123-10-20 16:35:00   \n",
       "6    14541392  25068197 2124-09-02 00:07:00 2124-09-03 15:36:00   \n",
       "7    10320090  26774424 2178-04-05 00:00:00 2178-04-12 15:46:00   \n",
       "8    10906285  29225762 2179-09-17 17:46:00 2179-09-23 16:12:00   \n",
       "9    15559495  21036461 2116-08-10 22:43:00 2116-08-28 15:37:00   \n",
       "\n",
       "      admission_type discharge_location gender        dod  age_at_admit  \\\n",
       "0       DIRECT EMER.               HOME      F 2142-07-24            56   \n",
       "1  OBSERVATION ADMIT               HOME      F 2188-03-27            73   \n",
       "2  OBSERVATION ADMIT   HOME HEALTH CARE      M 2144-10-28            58   \n",
       "3  OBSERVATION ADMIT   HOME HEALTH CARE      M 2180-11-21            71   \n",
       "4  OBSERVATION ADMIT   HOME HEALTH CARE      F 2184-11-16            77   \n",
       "5  OBSERVATION ADMIT   HOME HEALTH CARE      F        NaT            58   \n",
       "6           EW EMER.               HOME      M 2125-10-01            58   \n",
       "7             URGENT               HOME      M 2179-05-25            33   \n",
       "8  OBSERVATION ADMIT   HOME HEALTH CARE      M        NaT            70   \n",
       "9  OBSERVATION ADMIT   HOME HEALTH CARE      F        NaT            78   \n",
       "\n",
       "   length_of_stay_days  ...             procedures_icd10 num_procedures_total  \\\n",
       "0             2.834028  ...                    [0W9B30Z]                  1.0   \n",
       "1             1.967361  ...                         None                  NaN   \n",
       "2             4.872222  ...                         None                  NaN   \n",
       "3             5.910417  ...                    [0W993ZX]                  1.0   \n",
       "4             2.858333  ...                         None                  NaN   \n",
       "5             8.524306  ...                         None                  NaN   \n",
       "6             1.645139  ...                         None                  NaN   \n",
       "7             7.656944  ...                         None                  NaN   \n",
       "8             5.934722  ...                         None                  NaN   \n",
       "9            17.704167  ...  [5A2204Z, 0DJ08ZZ, B24BZZ4]                  3.0   \n",
       "\n",
       "                                 meds_discharge_like medication_count  \\\n",
       "0  [5% Dextrose, Albuterol 0.083% Neb Soln, Aspir...             24.0   \n",
       "1  [Acetaminophen, Aspirin, Atorvastatin, Bisacod...             19.0   \n",
       "2  [0.9% Sodium Chloride (Mini Bag Plus), Amoxici...             30.0   \n",
       "3  [Acetaminophen, Aspirin, Atorvastatin, Cepacol...             17.0   \n",
       "4  [0.9% Sodium Chloride (Mini Bag Plus), Acetami...             25.0   \n",
       "5  [Acetaminophen, Amiodarone, Aspirin EC, Atorva...             12.0   \n",
       "6  [Acetaminophen, Albuterol 0.083% Neb Soln, Bis...             25.0   \n",
       "7  [5% Dextrose, Acetaminophen, Amiodarone, Clobe...             17.0   \n",
       "8  [Acetaminophen, Atorvastatin, BuPROPion XL (On...             16.0   \n",
       "9  [Acetaminophen, Apixaban, Bisacodyl, Bumetanid...             16.0   \n",
       "\n",
       "         policy                                  discharge_summary  \\\n",
       "0       partial  **Discharge Summary**  \\n**Patient:** Female, ...   \n",
       "1           all  **Discharge Summary**  \\n**Patient:** 73-year-...   \n",
       "2  primary_only  Discharge Summary: \\n\\nPatient is a 58-year-ol...   \n",
       "3       partial  **Patient Discharge Summary**  \\n**Patient Nam...   \n",
       "4       partial  **Discharge Summary**  \\n**Patient Information...   \n",
       "5  primary_only  **Discharge Summary**  \\n**Patient:** Female, ...   \n",
       "6  primary_only  Patient is a 58-year-old male admitted via eme...   \n",
       "7  primary_only  **Patient Information:** 33-year-old male, adm...   \n",
       "8       partial  **Patient Information:** 70-year-old male admi...   \n",
       "9           all  **Discharge Summary**  \\n**Patient:** 78-year-...   \n",
       "\n",
       "                                     diagnosis_codes        model  \\\n",
       "0  [E118, Z5181, I5032, K219, D473, I10, I071, M8...  gpt-4o-mini   \n",
       "1  [Z7901, Z87891, E039, Y929, I5031, E785, K219,...  gpt-4o-mini   \n",
       "2                                            [I5033]  gpt-4o-mini   \n",
       "3  [I129, N184, I5033, N179, Z951, C9110, E780, I...  gpt-4o-mini   \n",
       "4  [N2889, K7460, I8510, I5032, I4891, N179, I878...  gpt-4o-mini   \n",
       "5                                            [I5033]  gpt-4o-mini   \n",
       "6                                            [I5033]  gpt-4o-mini   \n",
       "7                                            [I5023]  gpt-4o-mini   \n",
       "8  [Z7901, Z87891, I428, D539, K219, I5033, Z6837...  gpt-4o-mini   \n",
       "9  [Z7901, Y929, I081, Y838, I5021, T84092A, R090...  gpt-4o-mini   \n",
       "\n",
       "                                      true_icd_codes  \\\n",
       "0  [I5032, E118, I10, E785, I2510, I071, D649, I2...   \n",
       "1  [I5031, I82501, C7931, C3431, E039, Z7901, I10...   \n",
       "2  [I5033, J9692, J9691, E870, E872, E662, J441, ...   \n",
       "3  [I5033, C9110, J918, N184, N179, I129, I2510, ...   \n",
       "4  [I5032, I8510, N179, I272, K7460, N390, I4891,...   \n",
       "5  [I5033, N170, J9691, D6861, I4892, I340, Z7901...   \n",
       "6  [I5033, G92, J441, I8510, Z6842, F17210, K7469...   \n",
       "7  [I5023, I429, N179, Z6843, E669, I480, D638, L...   \n",
       "8  [I5033, C8510, I428, N400, F32A, K219, I2584, ...   \n",
       "9  [I5021, T84092A, I081, K761, Z7901, R0902, G47...   \n",
       "\n",
       "                                       missing_codes  \n",
       "0  [Z7901, I272, E039, D72829, F419, E785, J45909...  \n",
       "1                                                 []  \n",
       "2  [E1140, I272, E872, I129, Z6833, E11319, E662,...  \n",
       "3                                                 []  \n",
       "4  [I272, Y929, S5001XA, W19XXXA, I10, Z85038, K7...  \n",
       "5  [R351, Z90710, I361, D6861, I340, I10, I2720, ...  \n",
       "6  [K7469, T473X6A, K7290, K7030, Z91128, F1190, ...  \n",
       "7  [M25569, D638, I340, N179, Z7982, I429, Z23, E...  \n",
       "8  [E669, F32A, R3121, J449, Z20822, C8510, N400,...  \n",
       "9                                                 []  \n",
       "\n",
       "[10 rows x 27 columns]"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_with_summaries.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a2db312c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['subject_id', 'hadm_id', 'admittime', 'dischtime', 'admission_type',\n",
       "       'discharge_location', 'gender', 'dod', 'age_at_admit',\n",
       "       'length_of_stay_days', 'icd10_codes', 'icd10_descriptions',\n",
       "       'num_icd10_codes', 'primary_icd10', 'icd_version', 'primary_icd10_desc',\n",
       "       'primary_pdgm_bucket_simple', 'procedures_icd10',\n",
       "       'num_procedures_total', 'meds_discharge_like', 'medication_count',\n",
       "       'policy', 'discharge_summary', 'diagnosis_codes', 'model',\n",
       "       'true_icd_codes', 'missing_codes'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_with_summaries.columns\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "07d5a8f4",
   "metadata": {},
   "source": [
    "## 2. Medical NER Setup\n",
    "\n",
    "We'll use several state-of-the-art medical NER models:\n",
    "1. **scispaCy**: Specialized for scientific and biomedical text\n",
    "2. **Hugging Face Transformers**: Clinical BERT, BioBERT models\n",
    "3. **MedCAT**: Medical Concept Annotation Tool\n",
    "\n",
    "Key entity types to extract:\n",
    "- **Diseases/Conditions**: Diagnoses, symptoms\n",
    "- **Medications**: Drug names, dosages\n",
    "- **Procedures**: Medical tests, treatments\n",
    "- **Anatomy**: Body parts, organs\n",
    "- **Lab Values**: Test results, measurements\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a3ae979",
   "metadata": {},
   "source": [
    "### 2.1 Install Required Libraries\n",
    "\n",
    "Run this cell once to install the necessary packages:\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "64f143a1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[2K\u001b[2mResolved \u001b[1m24 packages\u001b[0m \u001b[2min 217ms\u001b[0m\u001b[0m                                        \u001b[0m\n",
      "\u001b[2K\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)                                                   \n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m     0 B/131.74 KiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 16.00 KiB/131.74 KiB        \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 16.00 KiB/131.74 KiB        \u001b[1A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 16.00 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m     0 B/1.64 MiB            \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 16.00 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 14.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 32.00 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 14.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 48.00 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 14.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 60.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 14.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 60.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 30.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 76.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 30.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 92.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 30.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 92.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 46.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 108.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 46.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 108.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 62.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 108.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 62.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 108.02 KiB/131.74 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 62.88 KiB/1.64 MiB          \u001b[2A\n",
      "\u001b[2mjinja2              \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 108.02 KiB/131.74 KiB\n",
      "\u001b[2mmpmath              \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/523.63 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 62.88 KiB/1.64 MiB          \u001b[3A\n",
      "\u001b[2mmarkupsafe          \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 11.77 KiB/11.77 KiB\n",
      "\u001b[2mmpmath              \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 75.20 KiB/523.63 KiB\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 124.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 32.00 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 64.00 KiB/71.00 MiB         \u001b[5A\n",
      "\u001b[2mmpmath              \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 75.20 KiB/523.63 KiB\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 124.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 32.00 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 64.00 KiB/71.00 MiB         \u001b[4A\n",
      "\u001b[2mmpmath              \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 171.51 KiB/523.63 KiB\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 220.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 95.17 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 143.46 KiB/71.00 MiB        \u001b[4A\n",
      "\u001b[2mmpmath              \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 495.51 KiB/523.63 KiB\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 428.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 431.17 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 640.00 KiB/71.00 MiB        \u001b[4A\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 476.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 527.17 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 909.28 KiB/71.00 MiB        \u001b[3A\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 700.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 927.17 KiB/6.01 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/6)--------------\u001b[0m\u001b[0m 1.19 MiB/71.00 MiB          \u001b[3A\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 956.58 KiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 1.22 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (3/6)--------------\u001b[0m\u001b[0m 1.75 MiB/71.00 MiB          \u001b[3A\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 1.14 MiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 1.61 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (3/6)--------------\u001b[0m\u001b[0m 1.95 MiB/71.00 MiB          \u001b[3A\n",
      "\u001b[2mnetworkx            \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 1.56 MiB/1.64 MiB\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 2.02 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (3/6)--------------\u001b[0m\u001b[0m 2.95 MiB/71.00 MiB          \u001b[3A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 2.12 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (3/6)--------------\u001b[0m\u001b[0m 3.11 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 2.78 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (3/6)--------------\u001b[0m\u001b[0m 3.78 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 3.27 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 4.34 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 3.72 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 6.58 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 4.34 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 7.53 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 5.15 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 7.97 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2msympy               \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 5.75 MiB/6.01 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 8.54 MiB/71.00 MiB          \u001b[2A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 8.81 MiB/71.00 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 9.37 MiB/71.00 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 9.98 MiB/71.00 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/6)--------------\u001b[0m\u001b[0m 10.39 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 10.73 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 10.92 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.09 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.20 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.39 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.57 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.75 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 11.92 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 12.15 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 12.33 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 12.56 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 12.76 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 12.84 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 13.08 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 13.26 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 13.45 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 13.75 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 13.93 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 14.17 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 14.37 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 14.70 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 15.65 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 15.98 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 16.45 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 16.78 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 17.18 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 20.51 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 23.83 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 26.91 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 30.47 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 33.67 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------------\u001b[0m\u001b[0m 37.00 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)2m------------\u001b[0m\u001b[0m 40.30 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)[2m-----------\u001b[0m\u001b[0m 43.20 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)\u001b[2m----------\u001b[0m\u001b[0m 45.86 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)-\u001b[2m---------\u001b[0m\u001b[0m 48.65 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--\u001b[2m--------\u001b[0m\u001b[0m 51.06 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)---\u001b[2m-------\u001b[0m\u001b[0m 53.51 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)----\u001b[2m------\u001b[0m\u001b[0m 56.12 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)-----\u001b[2m-----\u001b[0m\u001b[0m 58.73 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)-------\u001b[2m---\u001b[0m\u001b[0m 61.56 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)--------\u001b[2m--\u001b[0m\u001b[0m 64.14 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)---------\u001b[2m-\u001b[0m\u001b[0m 66.69 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (5/6)---------\u001b[2m-\u001b[0m\u001b[0m 67.50 MiB/71.00 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[2mPrepared \u001b[1m6 packages\u001b[0m \u001b[2min 3.04s\u001b[0m\u001b[0m                                                 \u001b[1A\n",
      "\u001b[2K\u001b[2mInstalled \u001b[1m6 packages\u001b[0m \u001b[2min 195ms\u001b[0m\u001b[0m                               \u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mjinja2\u001b[0m\u001b[2m==3.1.6\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mmarkupsafe\u001b[0m\u001b[2m==3.0.3\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mmpmath\u001b[0m\u001b[2m==1.3.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mnetworkx\u001b[0m\u001b[2m==3.4.2\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1msympy\u001b[0m\u001b[2m==1.14.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mtorch\u001b[0m\u001b[2m==2.9.0\u001b[0m\n",
      "\u001b[2K\u001b[2mResolved \u001b[1m19 packages\u001b[0m \u001b[2min 238ms\u001b[0m\u001b[0m                                        \u001b[0m\n",
      "\u001b[2K\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)                                                  \n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/111.22 KiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/111.22 KiB          \u001b[1A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/111.22 KiB          \u001b[2A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/111.22 KiB          \u001b[2A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/111.22 KiB          \u001b[2A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/111.22 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[3A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/111.22 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[3A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/111.22 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[3A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/111.22 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[3A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 14.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 14.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/301.17 KiB          \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 14.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 14.88 KiB/301.17 KiB        \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 14.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 14.92 KiB/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 14.88 KiB/301.17 KiB        \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 14.92 KiB/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 14.88 KiB/301.17 KiB        \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 14.92 KiB/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 30.88 KiB/301.17 KiB        \u001b[4A\n",
      "\u001b[2mthreadpoolctl       \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 14.91 KiB/18.20 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 30.92 KiB/288.00 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 30.88 KiB/301.17 KiB        \u001b[4A\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/111.22 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 30.92 KiB/288.00 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 30.88 KiB/301.17 KiB        \u001b[3A\n",
      "\u001b[2mcycler              \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/8.13 KiB\n",
      "\u001b[2mkiwisolver          \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/63.78 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 62.88 KiB/111.22 KiB\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 46.92 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 59.47 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/2.68 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/7.73 MiB\n",
      "\u001b[2K\u001b[9A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m     0 B/21.33 MiB           \u001b[9A\n",
      "\u001b[2mkiwisolver          \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/63.78 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 62.88 KiB/111.22 KiB\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 62.92 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 59.47 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/8.25 MiB\n",
      "\u001b[2K\u001b[10A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)------------\u001b[0m\u001b[0m     0 B/21.33 MiB           \u001b[10A\n",
      "\u001b[2mkiwisolver          \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 48.00 KiB/63.78 KiB\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 78.88 KiB/111.22 KiB\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 48.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 75.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 77.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 23.17 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 32.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 48.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 16.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[10A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)------------\u001b[0m\u001b[0m 32.00 KiB/21.33 MiB         \u001b[10A\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 94.88 KiB/111.22 KiB\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 48.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 89.30 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 77.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 39.17 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 48.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 48.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 32.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[9A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 48.00 KiB/21.33 MiB         \u001b[9A\n",
      "\u001b[2mpyparsing           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 110.88 KiB/111.22 KiB\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 80.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 89.40 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 93.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 55.17 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 64.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 80.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 48.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[9A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 80.00 KiB/21.33 MiB         \u001b[9A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 80.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 104.95 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 93.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 71.17 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 64.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 80.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 48.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/12)-------------\u001b[0m\u001b[0m 80.00 KiB/21.33 MiB         \u001b[8A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 128.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 139.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 141.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 111.89 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 112.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 128.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 80.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 128.00 KiB/21.33 MiB        \u001b[8A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m------------------------\u001b[2m------\u001b[0m\u001b[0m 192.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 187.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 189.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 144.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 144.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 176.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 131.94 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 176.00 KiB/21.33 MiB        \u001b[8A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m----------------------------\u001b[2m--\u001b[0m\u001b[0m 224.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 219.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 221.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 192.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 192.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 208.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 192.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 208.00 KiB/21.33 MiB        \u001b[8A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 240.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 235.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 221.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 256.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 208.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 272.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 240.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 224.00 KiB/21.33 MiB        \u001b[8A\n",
      "\u001b[2mcontourpy           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 240.00 KiB/247.46 KiB\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 239.08 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 253.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 336.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 240.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 272.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 272.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 336.00 KiB/21.33 MiB        \u001b[8A\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 255.08 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 253.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 368.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 288.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 320.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 352.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[7A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 391.19 KiB/21.33 MiB        \u001b[7A\n",
      "\u001b[2mseaborn             \u001b[0m \u001b[32m----------------------------\u001b[2m--\u001b[0m\u001b[0m 267.60 KiB/288.00 KiB\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 253.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 368.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 288.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 336.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 400.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[7A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 431.89 KiB/21.33 MiB        \u001b[7A\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 262.08 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 384.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 304.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 528.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 454.96 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[6A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 464.00 KiB/21.33 MiB        \u001b[6A\n",
      "\u001b[2mjoblib              \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 285.66 KiB/301.17 KiB\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 614.73 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 560.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 592.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 527.67 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[6A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 544.00 KiB/21.33 MiB        \u001b[6A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 656.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 592.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 639.55 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 528.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 592.00 KiB/21.33 MiB        \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 720.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 694.50 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 704.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 640.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (4/12)-------------\u001b[0m\u001b[0m 656.00 KiB/21.33 MiB        \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 848.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 848.00 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 848.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---\u001b[2m---------------------------\u001b[0m\u001b[0m 773.37 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 800.00 KiB/21.33 MiB        \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 992.00 KiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 968.93 KiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 976.00 KiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 912.00 KiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 971.75 KiB/21.33 MiB        \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 1.14 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 1.09 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 1.14 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 1.03 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.09 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 1.27 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 1.26 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 1.27 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 1.19 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.24 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 1.45 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 1.41 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 1.45 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 1.33 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.39 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 1.62 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 1.60 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 1.63 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 1.52 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.55 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 1.77 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 1.81 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 1.83 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 1.70 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.74 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 1.95 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 2.01 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 2.02 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 1.89 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠴\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 1.94 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 2.20 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 2.20 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 2.20 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 2.08 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 2.11 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 2.39 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 2.41 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 2.39 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 2.27 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 2.33 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mfonttools           \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 2.58 MiB/2.68 MiB\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 2.63 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 2.62 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 2.47 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 2.53 MiB/21.33 MiB          \u001b[5A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 2.76 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 2.73 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 2.60 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 2.64 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 2.85 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m------------\u001b[2m------------------\u001b[0m\u001b[0m 2.86 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 2.70 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠦\u001b[0m \u001b[2mPreparing packages...\u001b[0m (7/12)-------------\u001b[0m\u001b[0m 2.77 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 3.13 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 3.14 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 2.98 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (8/12)-------------\u001b[0m\u001b[0m 3.05 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m------------------------\u001b[2m------\u001b[0m\u001b[0m 3.43 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 3.41 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m------------\u001b[2m------------------\u001b[0m\u001b[0m 3.27 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (8/12)-------------\u001b[0m\u001b[0m 3.33 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 3.75 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 3.75 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--------------\u001b[2m----------------\u001b[0m\u001b[0m 3.58 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (8/12)-------------\u001b[0m\u001b[0m 3.64 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m----------------------------\u001b[2m--\u001b[0m\u001b[0m 4.06 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 4.06 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 3.89 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (8/12)-------------\u001b[0m\u001b[0m 3.95 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mpillow              \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 4.35 MiB/4.44 MiB\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 4.38 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 4.20 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠧\u001b[0m \u001b[2mPreparing packages...\u001b[0m (8/12)-------------\u001b[0m\u001b[0m 4.27 MiB/21.33 MiB          \u001b[4A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 4.45 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 4.27 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 4.34 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 4.78 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 4.59 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 4.66 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 5.20 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 5.03 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 5.08 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 5.69 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 5.50 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠇\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 5.56 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m------------------------\u001b[2m------\u001b[0m\u001b[0m 6.12 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 5.94 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 6.00 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 6.58 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m------------------------\u001b[2m------\u001b[0m\u001b[0m 6.41 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 6.45 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m----------------------------\u001b[2m--\u001b[0m\u001b[0m 7.09 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m--------------------------\u001b[2m----\u001b[0m\u001b[0m 6.89 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 6.95 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mmatplotlib          \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.61 MiB/7.73 MiB\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 7.42 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 7.47 MiB/21.33 MiB          \u001b[3A\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m----------------------------\u001b[2m--\u001b[0m\u001b[0m 7.55 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 7.61 MiB/21.33 MiB          \u001b[2A\n",
      "\u001b[2mscikit-learn        \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 8.08 MiB/8.25 MiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠋\u001b[0m \u001b[2mPreparing packages...\u001b[0m (9/12)-------------\u001b[0m\u001b[0m 8.20 MiB/21.33 MiB          \u001b[2A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)------------\u001b[0m\u001b[0m 8.39 MiB/21.33 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)------------\u001b[0m\u001b[0m 9.47 MiB/21.33 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)------------\u001b[0m\u001b[0m 11.22 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)------------\u001b[0m\u001b[0m 12.72 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)[2m---------\u001b[0m\u001b[0m 14.39 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)-\u001b[2m-------\u001b[0m\u001b[0m 16.05 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)----\u001b[2m----\u001b[0m\u001b[0m 17.78 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (11/12)------\u001b[2m--\u001b[0m\u001b[0m 19.53 MiB/21.33 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[2mPrepared \u001b[1m12 packages\u001b[0m \u001b[2min 2.20s\u001b[0m\u001b[0m                                                \u001b[1A\n",
      "\u001b[2K\u001b[2mInstalled \u001b[1m12 packages\u001b[0m \u001b[2min 43ms\u001b[0m\u001b[0m                               \u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mcontourpy\u001b[0m\u001b[2m==1.3.2\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mcycler\u001b[0m\u001b[2m==0.12.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mfonttools\u001b[0m\u001b[2m==4.60.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mjoblib\u001b[0m\u001b[2m==1.5.2\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mkiwisolver\u001b[0m\u001b[2m==1.4.9\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mmatplotlib\u001b[0m\u001b[2m==3.10.7\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mpillow\u001b[0m\u001b[2m==12.0.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mpyparsing\u001b[0m\u001b[2m==3.2.5\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mscikit-learn\u001b[0m\u001b[2m==1.7.2\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mscipy\u001b[0m\u001b[2m==1.15.3\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mseaborn\u001b[0m\u001b[2m==0.13.2\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mthreadpoolctl\u001b[0m\u001b[2m==3.6.0\u001b[0m\n",
      "\u001b[2K\u001b[2mResolved \u001b[1m39 packages\u001b[0m \u001b[2min 349ms\u001b[0m\u001b[0m                                        \u001b[0m\n",
      "\u001b[2K\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)                                                  \n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m     0 B/7.31 KiB            \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[1A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/6.09 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[2A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[2A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[2A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)---------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB           \u001b[2A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m     0 B/131.66 KiB          \u001b[3A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[3A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[3A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[3A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[3A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[4A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[4A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[4A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[4A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2maiosignal           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 7.31 KiB/7.31 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[4A\n",
      "\u001b[2masync-timeout       \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 6.09 KiB/6.09 KiB\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/36.64 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/76.94 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/106.54 KiB\n",
      "\u001b[2K\u001b[6A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[6A\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/36.64 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/66.03 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/76.94 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/106.54 KiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB        \u001b[5A\n",
      "\u001b[2maiohappyeyeballs    \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 14.87 KiB/14.91 KiB\n",
      "\u001b[2mxxhash              \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/30.08 KiB\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 14.88 KiB/36.64 KiB\n",
      "\u001b[2mmultidict           \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 10.71 KiB/43.56 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/46.16 KiB\n",
      "\u001b[2mfrozenlist          \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/48.72 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 14.88 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 14.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 14.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 14.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 14.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m\u001b[2m------------------------------\u001b[0m\u001b[0m     0 B/494.45 KiB\n",
      "\u001b[2K\u001b[16A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 14.91 KiB/29.75 MiB         \u001b[16A\n",
      "\u001b[2mxxhash              \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 16.00 KiB/30.08 KiB\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 23.96 KiB/36.64 KiB\n",
      "\u001b[2mmultidict           \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 10.71 KiB/43.56 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 16.00 KiB/46.16 KiB\n",
      "\u001b[2mfrozenlist          \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 16.00 KiB/48.72 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 46.88 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 16.00 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 30.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 16.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 30.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 30.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 15.89 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 16.00 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[15A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 14.91 KiB/29.75 MiB         \u001b[15A\n",
      "\u001b[2mxxhash              \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 30.08 KiB/30.08 KiB\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m--------------------\u001b[2m----------\u001b[0m\u001b[0m 23.96 KiB/36.64 KiB\n",
      "\u001b[2mmultidict           \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 10.71 KiB/43.56 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m-----------\u001b[2m-------------------\u001b[0m\u001b[0m 16.00 KiB/46.16 KiB\n",
      "\u001b[2mfrozenlist          \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 16.00 KiB/48.72 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 46.88 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m-------\u001b[2m-----------------------\u001b[0m\u001b[0m 16.00 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 30.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m------\u001b[2m------------------------\u001b[0m\u001b[0m 16.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 30.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 30.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 30.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m--\u001b[2m----------------------------\u001b[0m\u001b[0m 15.89 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m-\u001b[2m-----------------------------\u001b[0m\u001b[0m 16.00 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[15A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 14.91 KiB/29.75 MiB         \u001b[15A\n",
      "\u001b[2mxxhash              \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 30.08 KiB/30.08 KiB\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 36.64 KiB/36.64 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 46.16 KiB/46.16 KiB\n",
      "\u001b[2mfrozenlist          \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 48.72 KiB/48.72 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 51.17 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 46.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 80.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 62.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 62.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 48.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 142.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[14A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 397.23 KiB/29.75 MiB        \u001b[14A\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 36.64 KiB/36.64 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 46.16 KiB/46.16 KiB\n",
      "\u001b[2mfrozenlist          \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 48.72 KiB/48.72 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 51.17 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 46.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 80.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 62.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 62.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 48.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 142.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[13A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 397.23 KiB/29.75 MiB        \u001b[13A\n",
      "\u001b[2mh11                 \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 36.64 KiB/36.64 KiB\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 46.16 KiB/46.16 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 51.17 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 46.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 80.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 62.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 62.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 48.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 142.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[12A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 397.23 KiB/29.75 MiB        \u001b[12A\n",
      "\u001b[2mpropcache           \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 46.16 KiB/46.16 KiB\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 51.17 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 46.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 80.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 78.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 62.87 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 48.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------\u001b[2m---------------------\u001b[0m\u001b[0m 142.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[11A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 397.23 KiB/29.75 MiB        \u001b[11A\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 64.00 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 62.88 KiB/76.94 KiB\n",
      "\u001b[2myarl                \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 80.00 KiB/92.19 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 78.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 64.49 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----\u001b[2m--------------------------\u001b[0m\u001b[0m 57.91 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m----------\u001b[2m--------------------\u001b[0m\u001b[0m 158.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[10A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)------------\u001b[0m\u001b[0m 461.23 KiB/29.75 MiB        \u001b[10A\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 64.00 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 62.88 KiB/76.94 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 78.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 78.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 75.77 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 73.91 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m------------\u001b[2m------------------\u001b[0m\u001b[0m 190.31 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[9A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 589.23 KiB/29.75 MiB        \u001b[9A\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 64.00 KiB/71.79 KiB\n",
      "\u001b[2mhttpcore            \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 76.94 KiB/76.94 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 78.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 94.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m---------------------\u001b[2m---------\u001b[0m\u001b[0m 91.77 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m-----\u001b[2m-------------------------\u001b[0m\u001b[0m 73.91 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m-------------\u001b[2m-----------------\u001b[0m\u001b[0m 206.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[9A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 701.23 KiB/29.75 MiB        \u001b[9A\n",
      "\u001b[2mattrs               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 64.68 KiB/66.03 KiB\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 71.79 KiB/71.79 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 94.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 94.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 123.77 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m--------\u001b[2m----------------------\u001b[0m\u001b[0m 112.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 238.31 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[8A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 973.23 KiB/29.75 MiB        \u001b[8A\n",
      "\u001b[2mhttpx               \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 71.79 KiB/71.79 KiB\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 94.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 94.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 123.77 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 240.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 238.31 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[7A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 973.23 KiB/29.75 MiB        \u001b[7A\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 94.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 94.88 KiB/116.86 KiB\n",
      "\u001b[2mmultiprocess        \u001b[0m \u001b[32m------------------------------\u001b[2m\u001b[0m\u001b[0m 131.66 KiB/131.66 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 240.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m---------------\u001b[2m---------------\u001b[0m\u001b[0m 238.31 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[6A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 1.06 MiB/29.75 MiB          \u001b[6A\n",
      "\u001b[2manyio               \u001b[0m \u001b[32m---------------------------\u001b[2m---\u001b[0m\u001b[0m 94.88 KiB/106.54 KiB\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-------------------------\u001b[2m-----\u001b[0m\u001b[0m 94.88 KiB/116.86 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m-----------------\u001b[2m-------------\u001b[0m\u001b[0m 256.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m----------------\u001b[2m--------------\u001b[0m\u001b[0m 254.31 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[5A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 1.37 MiB/29.75 MiB          \u001b[5A\n",
      "\u001b[2mdill                \u001b[0m \u001b[32m-----------------------------\u001b[2m-\u001b[0m\u001b[0m 110.88 KiB/116.86 KiB\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 288.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m------------------\u001b[2m------------\u001b[0m\u001b[0m 286.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[4A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 1.60 MiB/29.75 MiB          \u001b[4A\n",
      "\u001b[2maiohttp             \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 336.00 KiB/476.43 KiB\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m-------------------\u001b[2m-----------\u001b[0m\u001b[0m 302.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[3A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 1.83 MiB/29.75 MiB          \u001b[3A\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m----------------------\u001b[2m--------\u001b[0m\u001b[0m 350.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 2.28 MiB/29.75 MiB          \u001b[2A\n",
      "\u001b[2mdatasets            \u001b[0m \u001b[32m-----------------------\u001b[2m-------\u001b[0m\u001b[0m 366.41 KiB/494.45 KiB\n",
      "\u001b[2K\u001b[2A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 3.29 MiB/29.75 MiB          \u001b[2A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠙\u001b[0m \u001b[2mPreparing packages...\u001b[0m (0/19)-------------\u001b[0m\u001b[0m 3.97 MiB/29.75 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 5.23 MiB/29.75 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 7.34 MiB/29.75 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 9.08 MiB/29.75 MiB          \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠹\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 11.25 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 13.45 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 15.61 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)------------\u001b[0m\u001b[0m 17.73 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠸\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)[2m---------\u001b[0m\u001b[0m 19.90 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)-\u001b[2m-------\u001b[0m\u001b[0m 21.95 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)---\u001b[2m-----\u001b[0m\u001b[0m 24.11 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)-----\u001b[2m---\u001b[0m\u001b[0m 26.28 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[1A\u001b[37m⠼\u001b[0m \u001b[2mPreparing packages...\u001b[0m (18/19)-------\u001b[2m-\u001b[0m\u001b[0m 28.05 MiB/29.75 MiB         \u001b[1A\n",
      "\u001b[2K\u001b[2mPrepared \u001b[1m19 packages\u001b[0m \u001b[2min 844ms\u001b[0m\u001b[0m                                                \u001b[1A\n",
      "\u001b[2K\u001b[2mInstalled \u001b[1m19 packages\u001b[0m \u001b[2min 26ms\u001b[0m\u001b[0m                               \u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1maiohappyeyeballs\u001b[0m\u001b[2m==2.6.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1maiohttp\u001b[0m\u001b[2m==3.13.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1maiosignal\u001b[0m\u001b[2m==1.4.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1manyio\u001b[0m\u001b[2m==4.11.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1masync-timeout\u001b[0m\u001b[2m==5.0.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mattrs\u001b[0m\u001b[2m==25.4.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mdatasets\u001b[0m\u001b[2m==4.2.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mdill\u001b[0m\u001b[2m==0.4.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mfrozenlist\u001b[0m\u001b[2m==1.8.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mh11\u001b[0m\u001b[2m==0.16.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mhttpcore\u001b[0m\u001b[2m==1.0.9\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mhttpx\u001b[0m\u001b[2m==0.28.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mmultidict\u001b[0m\u001b[2m==6.7.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mmultiprocess\u001b[0m\u001b[2m==0.70.16\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mpropcache\u001b[0m\u001b[2m==0.4.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mpyarrow\u001b[0m\u001b[2m==21.0.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1msniffio\u001b[0m\u001b[2m==1.3.1\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1mxxhash\u001b[0m\u001b[2m==3.6.0\u001b[0m\n",
      " \u001b[32m+\u001b[39m \u001b[1myarl\u001b[0m\u001b[2m==1.22.0\u001b[0m\n",
      "To install required packages, uncomment and run the above commands\n"
     ]
    }
   ],
   "source": [
    "# Installation commands (uncomment to run)\n",
    "# !pip install scispacy\n",
    "# !pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.4/en_core_sci_sm-0.5.4.tar.gz\n",
    "# !pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.4/en_ner_bc5cdr_md-0.5.4.tar.gz\n",
    "!uv pip install transformers torch\n",
    "# !pip install medcat\n",
    "!uv pip install scikit-learn matplotlib seaborn\n",
    "!uv pip install datasets\n",
    "\n",
    "print(\"To install required packages, uncomment and run the above commands\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "872398aa",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use mps:0\n"
     ]
    }
   ],
   "source": [
    "# Use a pipeline as a high-level helper\n",
    "from transformers import pipeline\n",
    "\n",
    "disease_ner = pipeline(\"token-classification\", model=\"OpenMed/OpenMed-NER-DiseaseDetect-SuperClinical-184M\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4b106ddd",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import os\n",
    "# os.environ[\"HF_HUB_DISABLE_PROGRESS_BARS\"] = \"1\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "a8d380a1",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use mps:0\n"
     ]
    }
   ],
   "source": [
    "from transformers import pipeline\n",
    "drug_ner = pipeline('token-classification', model = \"OpenMed/OpenMed-NER-PharmaDetect-ModernClinical-149M\")\n",
    "# anatomy_ner = pipeline('token-classification', model = \"OpenMed/OpenMed-NER-AnatomyDetect-ElectraMed-109M\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "5ff9741f",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use mps:0\n"
     ]
    }
   ],
   "source": [
    "\n",
    "anatomy_ner = pipeline('token-classification', model = \"OpenMed/OpenMed-NER-AnatomyDetect-ElectraMed-109M\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "a84b7308",
   "metadata": {},
   "outputs": [],
   "source": [
    "sample_texts = data_with_summaries['discharge_summary'].values[:4]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "d310995e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([\"**Discharge Summary**  \\n**Patient:** Female, 56 years  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 2.8 days  \\n**Primary Diagnosis:** Chronic diastolic (congestive) heart failure (ICD-10: I5032)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following an acute exacerbation of chronic diastolic heart failure. She presented with shortness of breath, lower extremity edema, and fatigue. Her medical history is significant for type 2 diabetes mellitus, hypertension, hyperlipidemia, and atherosclerotic heart disease.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient's heart failure was managed with diuretics and fluid restriction, leading to a significant reduction in her symptoms. She was started on a regimen of medications including Enoxaparin, Aspirin, and Levothyroxine, among others. The patient's diabetes and hypertension were also optimized during her stay. Multiple disciplines including cardiology and nutrition were involved in her care.  \\n  \\n**Key Findings and Procedures:**  \\nEchocardiogram revealed preserved left ventricular function with signs of diastolic dysfunction. Laboratory tests showed mild anemia and elevated glucose levels consistent with her diabetes. The patient underwent a medication review, and her discharge medications were adjusted accordingly.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved dyspnea and decreased edema. She requires assistance with activities of daily living (ADLs) due to fatigue. Home health services are being arranged to assist with medication management, monitoring of her heart failure symptoms, and diabetes management.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Albuterol 0.083% Nebulizer Solution  \\n3. Aspirin  \\n4. Clonazepam  \\n5. Docusate Sodium  \\n6. Enoxaparin Sodium  \\n7. Ferrous Sulfate  \\n8. Fluticasone Propionate 110 mcg  \\n9. Insulin  \\n10. Levothyroxine Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge. Additionally, she will have a follow-up appointment with cardiology in two weeks to reassess her heart failure management.\",\n",
       "       '**Discharge Summary**  \\n**Patient:** 73-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute diastolic heart failure (I5031), presenting with dyspnea on exertion, orthopnea, and lower extremity edema. Her medical history is significant for chronic embolism of the right lower extremity, secondary malignant neoplasm of the brain, and hypertension.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely. Diuretics were initiated to manage fluid overload, and her response was favorable with significant reduction in edema and improved respiratory status. Serial echocardiograms demonstrated preserved systolic function but worsening diastolic function. Enoxaparin was administered for anticoagulation due to her history of thrombosis, and she was closely monitored for any signs of complications.\\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated BNP levels indicative of heart failure. The patient underwent a comprehensive medication review, and adjustments were made to optimize her heart failure management. A multidisciplinary team approach was utilized, including consultations with cardiology and oncology, given her complex medical history.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved respiratory function and reduced edema. Home health services are recommended for ongoing monitoring of heart failure symptoms, medication management, and assistance with activities of daily living. She will require education on dietary restrictions, fluid management, and the importance of daily weight monitoring to prevent readmissions.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient will continue on the following medications: Acetaminophen, Aspirin, Atorvastatin, Dexamethasone, Docusate Sodium, Enoxaparin Sodium, Furosemide, Levothyroxine Sodium, Lisinopril, Omeprazole, and a pneumococcal vaccine.  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointment is scheduled with her primary care physician and cardiologist within one week post-discharge. Home health nursing will provide weekly visits to assess her heart failure management and medication adherence.',\n",
       "       'Discharge Summary: \\n\\nPatient is a 58-year-old male who was admitted for observation due to acute on chronic diastolic heart failure (ICD10: I5033). He presented with symptoms of dyspnea and fatigue, requiring supplemental oxygen. The patient has a notable history of chronic obstructive pulmonary disease (COPD) exacerbation, urinary tract infection, and morbid obesity, contributing to his overall clinical picture. \\n\\nDuring his 5-day hospital stay, the patient received a comprehensive workup including laboratory tests, chest X-ray, and echocardiogram, which confirmed the diagnosis of acute heart failure exacerbation. Key findings included bilateral pleural effusions and signs of fluid overload. The patient was treated with diuretics (Furosemide), intravenous fluids (0.9% Sodium Chloride), and bronchodilators, leading to significant improvement in respiratory status and reduction of edema. A multidisciplinary approach was taken, involving cardiology, pulmonology, and nutrition services to optimize his management. \\n\\nThe patient demonstrated improved functional status by discharge, ambulating independently, and reporting reduced shortness of breath at rest and with minimal exertion. He is stable for home health services to assist with continued monitoring of fluid status, medication adherence, and pulmonary rehabilitation. \\n\\nAt discharge, the patient’s medication regimen includes Furosemide, Amoxicillin, Diltiazem, Aspirin, Clopidogrel, and Fluticasone-Salmeterol Diskus. He is advised to maintain a low-sodium diet, monitor his weight daily, and adhere to prescribed medications. A follow-up appointment with cardiology is scheduled within one week to reassess heart failure management and adjust medications as necessary. Home health services will be engaged to provide skilled nursing and assist with daily living activities.',\n",
       "       '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 71  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of acute on chronic diastolic heart failure, presenting with exacerbation of symptoms including dyspnea and edema. The patient has a significant past medical history including chronic kidney disease, chronic lymphocytic leukemia, and a history of atherosclerotic heart disease.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was monitored in an observation setting. Initial management included diuretics (Furosemide) for fluid overload and optimization of heart failure medications (Metoprolol and Ranolazine). Serial laboratory tests showed improvement in renal function and resolution of congestive symptoms. The patient underwent a thoracentesis due to a pleural effusion, which provided symptomatic relief and improved respiratory function.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated BNP levels and echocardiogram demonstrating preserved systolic function with diastolic dysfunction. The procedure performed was a thoracentesis to relieve pleural effusion. The patient also received supportive care including insulin adjustments for diabetes management.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved respiratory status and managed heart failure symptoms. Functional status was assessed as improved, with the patient able to perform activities of daily living with minimal assistance. Home health services have been arranged to assist with medication management and monitoring of heart failure symptoms.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Aspirin, Atorvastatin, Furosemide, Metoprolol Tartrate, Ranolazine ER, and insulin pump therapy for diabetes management. \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with cardiology and nephrology within one week to monitor heart failure management and renal function. Home health nursing will provide education on medication adherence and symptom monitoring.'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sample_texts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1fdc83d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n"
     ]
    }
   ],
   "source": [
    "output = disease_ner(sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "6dc114b0",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_output = drug_ner(sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "e93d7561",
   "metadata": {},
   "outputs": [],
   "source": [
    "anatomy_output = anatomy_ner(sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "2f48daac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.9333687),\n",
       "  'index': 54,\n",
       "  'word': 'heart',\n",
       "  'start': 180,\n",
       "  'end': 185},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.89404994),\n",
       "  'index': 91,\n",
       "  'word': 'heart',\n",
       "  'start': 327,\n",
       "  'end': 332},\n",
       " {'entity': 'I-Anatomy',\n",
       "  'score': np.float32(0.45976025),\n",
       "  'index': 106,\n",
       "  'word': 'ed',\n",
       "  'start': 398,\n",
       "  'end': 400},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.6807671),\n",
       "  'index': 107,\n",
       "  'word': '##ema',\n",
       "  'start': 400,\n",
       "  'end': 403},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.7906781),\n",
       "  'index': 140,\n",
       "  'word': 'heart',\n",
       "  'start': 533,\n",
       "  'end': 538},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.72730625),\n",
       "  'index': 159,\n",
       "  'word': 'heart',\n",
       "  'start': 618,\n",
       "  'end': 623},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.92283326),\n",
       "  'index': 254,\n",
       "  'word': 'left',\n",
       "  'start': 1076,\n",
       "  'end': 1080},\n",
       " {'entity': 'I-Anatomy',\n",
       "  'score': np.float32(0.95829153),\n",
       "  'index': 255,\n",
       "  'word': 'vent',\n",
       "  'start': 1081,\n",
       "  'end': 1085},\n",
       " {'entity': 'I-Anatomy',\n",
       "  'score': np.float32(0.9516666),\n",
       "  'index': 256,\n",
       "  'word': '##ric',\n",
       "  'start': 1085,\n",
       "  'end': 1088},\n",
       " {'entity': 'I-Anatomy',\n",
       "  'score': np.float32(0.9574197),\n",
       "  'index': 257,\n",
       "  'word': '##ular',\n",
       "  'start': 1088,\n",
       "  'end': 1092},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.8780797),\n",
       "  'index': 356,\n",
       "  'word': 'heart',\n",
       "  'start': 1641,\n",
       "  'end': 1646},\n",
       " {'entity': 'B-Anatomy',\n",
       "  'score': np.float32(0.9158247),\n",
       "  'index': 494,\n",
       "  'word': 'heart',\n",
       "  'start': 2167,\n",
       "  'end': 2172}]"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "anatomy_output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "8cf18984",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'entity': 'B-CHEM', 'score': np.float32(0.9542466), 'index': 171, 'word': 'ĠEn', 'start': 787, 'end': 790}, {'entity': 'B-CHEM', 'score': np.float32(0.9353572), 'index': 172, 'word': 'ox', 'start': 790, 'end': 792}, {'entity': 'B-CHEM', 'score': np.float32(0.9605775), 'index': 173, 'word': 'ap', 'start': 792, 'end': 794}, {'entity': 'B-CHEM', 'score': np.float32(0.9393676), 'index': 174, 'word': 'arin', 'start': 794, 'end': 798}, {'entity': 'B-CHEM', 'score': np.float32(0.9601156), 'index': 176, 'word': 'ĠAsp', 'start': 799, 'end': 803}, {'entity': 'B-CHEM', 'score': np.float32(0.9410289), 'index': 177, 'word': 'ir', 'start': 803, 'end': 805}, {'entity': 'B-CHEM', 'score': np.float32(0.9295902), 'index': 178, 'word': 'in', 'start': 805, 'end': 807}, {'entity': 'B-CHEM', 'score': np.float32(0.96151996), 'index': 181, 'word': 'ĠLev', 'start': 812, 'end': 816}, {'entity': 'B-CHEM', 'score': np.float32(0.9356838), 'index': 182, 'word': 'othy', 'start': 816, 'end': 820}, {'entity': 'B-CHEM', 'score': np.float32(0.9315929), 'index': 183, 'word': 'rox', 'start': 820, 'end': 823}, {'entity': 'B-CHEM', 'score': np.float32(0.9359864), 'index': 184, 'word': 'ine', 'start': 823, 'end': 826}, {'entity': 'B-CHEM', 'score': np.float32(0.58332306), 'index': 249, 'word': 'Ġglucose', 'start': 1187, 'end': 1195}, {'entity': 'B-CHEM', 'score': np.float32(0.49764845), 'index': 356, 'word': 'Ġ5', 'start': 1729, 'end': 1731}, {'entity': 'B-CHEM', 'score': np.float32(0.5397236), 'index': 358, 'word': 'ĠDe', 'start': 1732, 'end': 1735}, {'entity': 'B-CHEM', 'score': np.float32(0.5952129), 'index': 359, 'word': 'xt', 'start': 1735, 'end': 1737}, {'entity': 'B-CHEM', 'score': np.float32(0.64144665), 'index': 360, 'word': 'rose', 'start': 1737, 'end': 1741}, {'entity': 'B-CHEM', 'score': np.float32(0.90427417), 'index': 365, 'word': 'ĠAl', 'start': 1746, 'end': 1749}, {'entity': 'B-CHEM', 'score': np.float32(0.8722565), 'index': 366, 'word': 'but', 'start': 1749, 'end': 1752}, {'entity': 'B-CHEM', 'score': np.float32(0.897475), 'index': 367, 'word': 'er', 'start': 1752, 'end': 1754}, {'entity': 'B-CHEM', 'score': np.float32(0.9055095), 'index': 368, 'word': 'ol', 'start': 1754, 'end': 1756}, {'entity': 'I-CHEM', 'score': np.float32(0.7776345), 'index': 369, 'word': 'Ġ0', 'start': 1756, 'end': 1758}, {'entity': 'I-CHEM', 'score': np.float32(0.5578234), 'index': 370, 'word': '.', 'start': 1758, 'end': 1759}, {'entity': 'I-CHEM', 'score': np.float32(0.5327764), 'index': 371, 'word': '083', 'start': 1759, 'end': 1762}, {'entity': 'I-CHEM', 'score': np.float32(0.5588455), 'index': 372, 'word': '%', 'start': 1762, 'end': 1763}, {'entity': 'I-CHEM', 'score': np.float32(0.58301413), 'index': 373, 'word': 'ĠNeb', 'start': 1763, 'end': 1767}, {'entity': 'I-CHEM', 'score': np.float32(0.55737084), 'index': 375, 'word': 'izer', 'start': 1769, 'end': 1773}, {'entity': 'I-CHEM', 'score': np.float32(0.6789934), 'index': 376, 'word': 'ĠSolution', 'start': 1773, 'end': 1782}, {'entity': 'B-CHEM', 'score': np.float32(0.95443547), 'index': 381, 'word': 'ĠAsp', 'start': 1787, 'end': 1791}, {'entity': 'B-CHEM', 'score': np.float32(0.9397495), 'index': 382, 'word': 'ir', 'start': 1791, 'end': 1793}, {'entity': 'B-CHEM', 'score': np.float32(0.93655753), 'index': 383, 'word': 'in', 'start': 1793, 'end': 1795}, {'entity': 'B-CHEM', 'score': np.float32(0.95932245), 'index': 388, 'word': 'ĠCl', 'start': 1800, 'end': 1803}, {'entity': 'B-CHEM', 'score': np.float32(0.94349325), 'index': 389, 'word': 'on', 'start': 1803, 'end': 1805}, {'entity': 'B-CHEM', 'score': np.float32(0.95522875), 'index': 390, 'word': 'az', 'start': 1805, 'end': 1807}, {'entity': 'B-CHEM', 'score': np.float32(0.93992025), 'index': 391, 'word': 'ep', 'start': 1807, 'end': 1809}, {'entity': 'B-CHEM', 'score': np.float32(0.9583388), 'index': 392, 'word': 'am', 'start': 1809, 'end': 1811}, {'entity': 'B-CHEM', 'score': np.float32(0.9512836), 'index': 397, 'word': 'ĠD', 'start': 1816, 'end': 1818}, {'entity': 'B-CHEM', 'score': np.float32(0.91189057), 'index': 398, 'word': 'ocus', 'start': 1818, 'end': 1822}, {'entity': 'B-CHEM', 'score': np.float32(0.9040903), 'index': 399, 'word': 'ate', 'start': 1822, 'end': 1825}, {'entity': 'I-CHEM', 'score': np.float32(0.9285442), 'index': 400, 'word': 'ĠS', 'start': 1825, 'end': 1827}, {'entity': 'I-CHEM', 'score': np.float32(0.96025157), 'index': 401, 'word': 'odium', 'start': 1827, 'end': 1832}, {'entity': 'B-CHEM', 'score': np.float32(0.9613709), 'index': 406, 'word': 'ĠEn', 'start': 1837, 'end': 1840}, {'entity': 'B-CHEM', 'score': np.float32(0.9391069), 'index': 407, 'word': 'ox', 'start': 1840, 'end': 1842}, {'entity': 'B-CHEM', 'score': np.float32(0.96386105), 'index': 408, 'word': 'ap', 'start': 1842, 'end': 1844}, {'entity': 'B-CHEM', 'score': np.float32(0.9536849), 'index': 409, 'word': 'arin', 'start': 1844, 'end': 1848}, {'entity': 'I-CHEM', 'score': np.float32(0.9654493), 'index': 410, 'word': 'ĠS', 'start': 1848, 'end': 1850}, {'entity': 'I-CHEM', 'score': np.float32(0.97022635), 'index': 411, 'word': 'odium', 'start': 1850, 'end': 1855}, {'entity': 'B-CHEM', 'score': np.float32(0.9517274), 'index': 416, 'word': 'ĠFerr', 'start': 1860, 'end': 1865}, {'entity': 'B-CHEM', 'score': np.float32(0.9521206), 'index': 417, 'word': 'ous', 'start': 1865, 'end': 1868}, {'entity': 'I-CHEM', 'score': np.float32(0.9345337), 'index': 418, 'word': 'ĠS', 'start': 1868, 'end': 1870}, {'entity': 'I-CHEM', 'score': np.float32(0.94699645), 'index': 419, 'word': 'ulf', 'start': 1870, 'end': 1873}, {'entity': 'I-CHEM', 'score': np.float32(0.9319078), 'index': 420, 'word': 'ate', 'start': 1873, 'end': 1876}, {'entity': 'B-CHEM', 'score': np.float32(0.9637415), 'index': 425, 'word': 'ĠFl', 'start': 1881, 'end': 1884}, {'entity': 'B-CHEM', 'score': np.float32(0.9393559), 'index': 426, 'word': 'ut', 'start': 1884, 'end': 1886}, {'entity': 'B-CHEM', 'score': np.float32(0.9507636), 'index': 427, 'word': 'ic', 'start': 1886, 'end': 1888}, {'entity': 'B-CHEM', 'score': np.float32(0.89912605), 'index': 428, 'word': 'asone', 'start': 1888, 'end': 1893}, {'entity': 'I-CHEM', 'score': np.float32(0.974363), 'index': 429, 'word': 'ĠProp', 'start': 1893, 'end': 1898}, {'entity': 'I-CHEM', 'score': np.float32(0.94283444), 'index': 430, 'word': 'ionate', 'start': 1898, 'end': 1904}, {'entity': 'I-CHEM', 'score': np.float32(0.8434344), 'index': 431, 'word': 'Ġ110', 'start': 1904, 'end': 1908}, {'entity': 'I-CHEM', 'score': np.float32(0.48386937), 'index': 433, 'word': 'cg', 'start': 1910, 'end': 1912}, {'entity': 'B-CHEM', 'score': np.float32(0.85681736), 'index': 438, 'word': 'ĠIns', 'start': 1917, 'end': 1921}, {'entity': 'B-CHEM', 'score': np.float32(0.7106535), 'index': 439, 'word': 'ulin', 'start': 1921, 'end': 1925}, {'entity': 'B-CHEM', 'score': np.float32(0.9686831), 'index': 444, 'word': 'ĠLev', 'start': 1931, 'end': 1935}, {'entity': 'B-CHEM', 'score': np.float32(0.94743997), 'index': 445, 'word': 'othy', 'start': 1935, 'end': 1939}, {'entity': 'B-CHEM', 'score': np.float32(0.933139), 'index': 446, 'word': 'rox', 'start': 1939, 'end': 1942}, {'entity': 'B-CHEM', 'score': np.float32(0.93618095), 'index': 447, 'word': 'ine', 'start': 1942, 'end': 1945}, {'entity': 'I-CHEM', 'score': np.float32(0.9809936), 'index': 448, 'word': 'ĠS', 'start': 1945, 'end': 1947}, {'entity': 'I-CHEM', 'score': np.float32(0.98384964), 'index': 449, 'word': 'odium', 'start': 1947, 'end': 1952}]\n"
     ]
    }
   ],
   "source": [
    "print(drug_output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "10d046f9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sample NER Results:\n",
      "================================================================================\n",
      "   -  En                            | CHEM            | Score: 0.954\n",
      "   - ox                             | CHEM            | Score: 0.935\n",
      "   - ap                             | CHEM            | Score: 0.961\n",
      "   - arin                           | CHEM            | Score: 0.939\n",
      "   -  Asp                           | CHEM            | Score: 0.960\n",
      "   - ir                             | CHEM            | Score: 0.941\n",
      "   - in                             | CHEM            | Score: 0.930\n",
      "   -  Lev                           | CHEM            | Score: 0.962\n",
      "   - othy                           | CHEM            | Score: 0.936\n",
      "   - rox                            | CHEM            | Score: 0.932\n",
      "   - ine                            | CHEM            | Score: 0.936\n",
      "   -  glucose                       | CHEM            | Score: 0.583\n",
      "   -  5                             | CHEM            | Score: 0.498\n",
      "   -  De                            | CHEM            | Score: 0.540\n",
      "   - xt                             | CHEM            | Score: 0.595\n",
      "   - rose                           | CHEM            | Score: 0.641\n",
      "   -  Al                            | CHEM            | Score: 0.904\n",
      "   - but                            | CHEM            | Score: 0.872\n",
      "   - er                             | CHEM            | Score: 0.897\n",
      "   - ol 0.083% Neb                  | CHEM            | Score: 0.653\n",
      "   - izer Solution                  | CHEM            | Score: 0.618\n",
      "   -  Asp                           | CHEM            | Score: 0.954\n",
      "   - ir                             | CHEM            | Score: 0.940\n",
      "   - in                             | CHEM            | Score: 0.937\n",
      "   -  Cl                            | CHEM            | Score: 0.959\n",
      "   - on                             | CHEM            | Score: 0.943\n",
      "   - az                             | CHEM            | Score: 0.955\n",
      "   - ep                             | CHEM            | Score: 0.940\n",
      "   - am                             | CHEM            | Score: 0.958\n",
      "   -  D                             | CHEM            | Score: 0.951\n",
      "   - ocus                           | CHEM            | Score: 0.912\n",
      "   - ate Sodium                     | CHEM            | Score: 0.931\n",
      "   -  En                            | CHEM            | Score: 0.961\n",
      "   - ox                             | CHEM            | Score: 0.939\n",
      "   - ap                             | CHEM            | Score: 0.964\n",
      "   - arin Sodium                    | CHEM            | Score: 0.963\n",
      "   -  Ferr                          | CHEM            | Score: 0.952\n",
      "   - ous Sulfate                    | CHEM            | Score: 0.941\n",
      "   -  Fl                            | CHEM            | Score: 0.964\n",
      "   - ut                             | CHEM            | Score: 0.939\n",
      "   - ic                             | CHEM            | Score: 0.951\n",
      "   - asone Propionate 110           | CHEM            | Score: 0.915\n",
      "   - cg                             | CHEM            | Score: 0.484\n",
      "   -  Ins                           | CHEM            | Score: 0.857\n",
      "   - ulin                           | CHEM            | Score: 0.711\n",
      "   -  Lev                           | CHEM            | Score: 0.969\n",
      "   - othy                           | CHEM            | Score: 0.947\n",
      "   - rox                            | CHEM            | Score: 0.933\n",
      "   - ine Sodium                     | CHEM            | Score: 0.967\n",
      "   -  Di                            | CHEM            | Score: 0.833\n",
      "   - ure                            | CHEM            | Score: 0.661\n",
      "   - tics                           | CHEM            | Score: 0.659\n",
      "   -  En                            | CHEM            | Score: 0.950\n",
      "   - ox                             | CHEM            | Score: 0.925\n",
      "   - ap                             | CHEM            | Score: 0.963\n",
      "   - arin                           | CHEM            | Score: 0.938\n",
      "   -  Ac                            | CHEM            | Score: 0.959\n",
      "   - et                             | CHEM            | Score: 0.969\n",
      "   - amin                           | CHEM            | Score: 0.944\n",
      "   - ophen                          | CHEM            | Score: 0.914\n",
      "   -  Asp                           | CHEM            | Score: 0.966\n",
      "   - ir                             | CHEM            | Score: 0.939\n",
      "   - in                             | CHEM            | Score: 0.934\n",
      "   -  At                            | CHEM            | Score: 0.964\n",
      "   - or                             | CHEM            | Score: 0.946\n",
      "   - vast                           | CHEM            | Score: 0.941\n",
      "   - atin                           | CHEM            | Score: 0.946\n",
      "   -  Dex                           | CHEM            | Score: 0.975\n",
      "   - amethasone                     | CHEM            | Score: 0.966\n",
      "   -  D                             | CHEM            | Score: 0.956\n",
      "   - ocus                           | CHEM            | Score: 0.936\n",
      "   - ate Sodium                     | CHEM            | Score: 0.929\n",
      "   -  En                            | CHEM            | Score: 0.972\n",
      "   - ox                             | CHEM            | Score: 0.931\n",
      "   - ap                             | CHEM            | Score: 0.959\n",
      "   - arin Sodium                    | CHEM            | Score: 0.958\n",
      "   -  F                             | CHEM            | Score: 0.968\n",
      "   - uro                            | CHEM            | Score: 0.962\n",
      "   - sem                            | CHEM            | Score: 0.934\n",
      "   - ide                            | CHEM            | Score: 0.924\n",
      "   -  Lev                           | CHEM            | Score: 0.964\n",
      "   - othy                           | CHEM            | Score: 0.949\n",
      "   - rox                            | CHEM            | Score: 0.912\n",
      "   - ine Sodium                     | CHEM            | Score: 0.948\n",
      "   -  Lis                           | CHEM            | Score: 0.949\n",
      "   - in                             | CHEM            | Score: 0.957\n",
      "   - op                             | CHEM            | Score: 0.949\n",
      "   - ril                            | CHEM            | Score: 0.908\n",
      "   -  Om                            | CHEM            | Score: 0.956\n",
      "   - ep                             | CHEM            | Score: 0.949\n",
      "   - raz                            | CHEM            | Score: 0.952\n",
      "   - ole                            | CHEM            | Score: 0.956\n",
      "   - F                              | CHEM            | Score: 0.954\n",
      "   - uro                            | CHEM            | Score: 0.948\n",
      "   - sem                            | CHEM            | Score: 0.908\n",
      "   - ide                            | CHEM            | Score: 0.905\n",
      "   -  S                             | CHEM            | Score: 0.842\n",
      "   - odium Chloride                 | CHEM            | Score: 0.951\n",
      "   -  F                             | CHEM            | Score: 0.966\n",
      "   - uro                            | CHEM            | Score: 0.962\n",
      "   - sem                            | CHEM            | Score: 0.928\n",
      "   - ide                            | CHEM            | Score: 0.917\n",
      "   -  Am                            | CHEM            | Score: 0.961\n",
      "   - ox                             | CHEM            | Score: 0.943\n",
      "   - icillin                        | CHEM            | Score: 0.941\n",
      "   -  D                             | CHEM            | Score: 0.963\n",
      "   - ilt                            | CHEM            | Score: 0.928\n",
      "   - iaz                            | CHEM            | Score: 0.955\n",
      "   - em                             | CHEM            | Score: 0.919\n",
      "   -  Asp                           | CHEM            | Score: 0.958\n",
      "   - ir                             | CHEM            | Score: 0.928\n",
      "   - in                             | CHEM            | Score: 0.913\n",
      "   -  Cl                            | CHEM            | Score: 0.948\n",
      "   - op                             | CHEM            | Score: 0.915\n",
      "   - id                             | CHEM            | Score: 0.938\n",
      "   - og                             | CHEM            | Score: 0.918\n",
      "   - rel                            | CHEM            | Score: 0.912\n",
      "   -  Fl                            | CHEM            | Score: 0.967\n",
      "   - ut                             | CHEM            | Score: 0.924\n",
      "   - ic                             | CHEM            | Score: 0.897\n",
      "   - asone-Salmeterol Diskus        | CHEM            | Score: 0.914\n",
      "   - s                              | CHEM            | Score: 0.758\n",
      "   - odium                          | CHEM            | Score: 0.759\n"
     ]
    }
   ],
   "source": [
    "# Test NER on sample clinical text\n",
    "\n",
    "\n",
    "print(\"Sample NER Results:\")\n",
    "print(\"=\"*80)\n",
    "\n",
    "for i, text in enumerate(sample_texts[:3], 1):\n",
    "    if pd.notna(text) and len(str(text)) > 10:\n",
    "        try:\n",
    "            \n",
    "            # entities = disease_ner(text)\n",
    "            drug_ents = drug_ner(text)\n",
    "            # print(f\"\\n{i}. Text: {str(text)[:100]}...\")\n",
    "            # print(f\"   Entities found:\")\n",
    "            # if entities:\n",
    "            #     for ent in entities:\n",
    "            #         # Pipeline returns dict with 'word', 'entity_group', 'score', etc.\n",
    "            #         entity_text = ent['word']\n",
    "            #         entity_type = ent['entity_group']\n",
    "            #         confidence = ent['score']\n",
    "            #         print(f\"   - {entity_text:30s} | {entity_type:15s} | Score: {confidence:.3f}\")\n",
    "            # else:\n",
    "            #     print(\"   - No entities detected\")\n",
    "\n",
    "            if drug_ents:\n",
    "                for ent in drug_ents:\n",
    "                    # Pipeline returns dict with 'word', 'entity_group', 'score', etc.\n",
    "                    entity_text = ent['word']\n",
    "                    entity_type = ent['entity_group']\n",
    "                    confidence = ent['score']\n",
    "                    print(f\"   - {entity_text:30s} | {entity_type:15s} | Score: {confidence:.3f}\")\n",
    "                \n",
    "        except Exception as e:\n",
    "            print(f\"Error processing text: {e}\")\n",
    "            continue\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "84fd4c39",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import re\n",
    "# def smart_group_entities(tokens, text):\n",
    "#   \"\"\"\n",
    "#   Smart entity grouping that properly merges sub-tokens into complete entities.\n",
    "#   This fixes the issue where aggregation_strategy=\"simple\" creates overlapping spans.\n",
    "#   \"\"\"\n",
    "#   if not tokens:\n",
    "#       return []\n",
    "\n",
    "#   entities = []\n",
    "#   current_entity = None\n",
    "\n",
    "#   for token in tokens:\n",
    "#       label = token['entity']\n",
    "#       score = token['score']\n",
    "#       word = token['word']\n",
    "#       start = token['start']\n",
    "#       end = token['end']\n",
    "\n",
    "#       # Skip O (Outside) tags\n",
    "#       if label == 'O':\n",
    "#           if current_entity:\n",
    "#               entities.append(current_entity)\n",
    "#               current_entity = None\n",
    "#           continue\n",
    "\n",
    "#       # Clean the label (remove B- and I- prefixes)\n",
    "#       clean_label = label.replace('B-', '').replace('I-', '')\n",
    "\n",
    "#       # Start new entity (B- tag or different entity type)\n",
    "#       if label.startswith('B-') or (current_entity and current_entity['entity_group'] != clean_label):\n",
    "#           if current_entity:\n",
    "#               entities.append(current_entity)\n",
    "\n",
    "#           current_entity = {\n",
    "#               'entity_group': clean_label,\n",
    "#               'score': score,\n",
    "#               'word': text[start:end],  # Use actual text from the source\n",
    "#               'start': start,\n",
    "#               'end': end\n",
    "#           }\n",
    "\n",
    "#       # Continue current entity (I- tag)\n",
    "#       elif current_entity and clean_label == current_entity['entity_group']:\n",
    "#           # Extend the current entity\n",
    "#           current_entity['end'] = end\n",
    "#           current_entity['word'] = text[current_entity['start']:end]\n",
    "#           current_entity['score'] = (current_entity['score'] + score) / 2  # Average scores\n",
    "\n",
    "#   # Don't forget the last entity\n",
    "#   if current_entity:\n",
    "#       entities.append(current_entity)\n",
    "\n",
    "#   return entities\n",
    "\n",
    "def filter_and_group_entities(tokens, text, confidence_threshold=0.6):\n",
    "\n",
    "  # Use our smart grouping to merge sub-tokens into complete entities\n",
    "  grouped_entities = smart_group_entities(tokens, text)\n",
    "#   print(f\"Smart grouping created {len(grouped_entities)} entities\")\n",
    "\n",
    "  # Apply confidence filtering to the grouped entities\n",
    "  filtered_entities = []\n",
    "  for entity in grouped_entities:\n",
    "    if entity[\"score\"] >= confidence_threshold:\n",
    "        # Apply additional quality filters\n",
    "        if (len(entity[\"word\"].strip()) > 0 and  # Not empty\n",
    "            re.search(r\"[A-Za-z0-9]\", entity[\"word\"])):  # Contains actual content\n",
    "            filtered_entities.append(entity)\n",
    "  return filtered_entities\n",
    "\n",
    "  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "6af612bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "def smart_group_entities(tokens, text):\n",
    "  \"\"\"\n",
    "  Merge subword pieces into full entities using offsets and tokenizer clues.\n",
    "  Works with RoBERTa (Ġ), SentencePiece (▁), and WordPiece (##).\n",
    "  \"\"\"\n",
    "  if not tokens:\n",
    "    return []\n",
    "\n",
    "  entities = []\n",
    "  current = None\n",
    "\n",
    "  for t in tokens:\n",
    "    label = t['entity']\n",
    "    base = label.replace('B-', '').replace('I-', '')\n",
    "    start, end = t['start'], t['end']\n",
    "    word = t['word']\n",
    "\n",
    "    starts_new_word = word.startswith('Ġ') or word.startswith('▁')\n",
    "    is_wordpiece_cont = word.startswith('##')\n",
    "\n",
    "    should_continue = (\n",
    "      current is not None and\n",
    "      current['entity_group'] == base and\n",
    "      (\n",
    "        label.startswith('I-') or\n",
    "        ((not starts_new_word or is_wordpiece_cont) and start <= current['end'] + 1)\n",
    "      )\n",
    "    )\n",
    "\n",
    "    if should_continue:\n",
    "      # length-weighted score update\n",
    "      prev_len = current['end'] - current['start']\n",
    "      this_len = end - start\n",
    "      total_len = prev_len + this_len\n",
    "      current['score'] = (current['score'] * prev_len + t['score'] * this_len) / max(total_len, 1)\n",
    "      current['end'] = end\n",
    "      current['word'] = text[current['start']:current['end']]\n",
    "    else:\n",
    "      if current:\n",
    "        entities.append(current)\n",
    "      current = {\n",
    "        'entity_group': base,\n",
    "        'score': t['score'],\n",
    "        'word': text[start:end],\n",
    "        'start': start,\n",
    "        'end': end\n",
    "      }\n",
    "\n",
    "  if current:\n",
    "    entities.append(current)\n",
    "\n",
    "  return entities\n",
    "\n",
    "def filter_and_group_entities(tokens, text, confidence_threshold=0.6):\n",
    "\n",
    "  # Use our smart grouping to merge sub-tokens into complete entities\n",
    "  grouped_entities = smart_group_entities(tokens, text)\n",
    "#   print(f\"Smart grouping created {len(grouped_entities)} entities\")\n",
    "\n",
    "  # Apply confidence filtering to the grouped entities\n",
    "  filtered_entities = []\n",
    "  for entity in grouped_entities:\n",
    "    if entity[\"score\"] >= confidence_threshold:\n",
    "        # Apply additional quality filters\n",
    "        if (len(entity[\"word\"].strip()) > 0 and  # Not empty\n",
    "            re.search(r\"[A-Za-z0-9]\", entity[\"word\"])):  # Contains actual content\n",
    "            filtered_entities.append(entity)\n",
    "  return filtered_entities\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "baf076f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Discharge Summary**  \n",
      "**Patient:** Female, 56 years  \n",
      "**Admission Type:** Direct Emergency  \n",
      "**Length of Stay:** 2.8 days  \n",
      "**Primary Diagnosis:** Chronic diastolic (congestive) heart failure (ICD-10: I5032)  \n",
      "  \n",
      "**History of Present Illness:**  \n",
      "The patient was admitted following an acute exacerbation of chronic diastolic heart failure. She presented with shortness of breath, lower extremity edema, and fatigue. Her medical history is significant for type 2 diabetes mellitus, hypertension, hyperlipidemia, and atherosclerotic heart disease.  \n",
      "  \n",
      "**Hospital Course:**  \n",
      "During her hospitalization, the patient's heart failure was managed with diuretics and fluid restriction, leading to a significant reduction in her symptoms. She was started on a regimen of medications including Enoxaparin, Aspirin, and Levothyroxine, among others. The patient's diabetes and hypertension were also optimized during her stay. Multiple disciplines including cardiology and nutrition were involved in her care.  \n",
      "  \n",
      "**Key Findings and Procedures:**  \n",
      "Echocardiogram revealed preserved left ventricular function with signs of diastolic dysfunction. Laboratory tests showed mild anemia and elevated glucose levels consistent with her diabetes. The patient underwent a medication review, and her discharge medications were adjusted accordingly.  \n",
      "  \n",
      "**Discharge Condition and Functional Status:**  \n",
      "The patient is stable at discharge, with improved dyspnea and decreased edema. She requires assistance with activities of daily living (ADLs) due to fatigue. Home health services are being arranged to assist with medication management, monitoring of her heart failure symptoms, and diabetes management.  \n",
      "  \n",
      "**Medications at Discharge:**  \n",
      "1. 5% Dextrose  \n",
      "2. Albuterol 0.083% Nebulizer Solution  \n",
      "3. Aspirin  \n",
      "4. Clonazepam  \n",
      "5. Docusate Sodium  \n",
      "6. Enoxaparin Sodium  \n",
      "7. Ferrous Sulfate  \n",
      "8. Fluticasone Propionate 110 mcg  \n",
      "9. Insulin  \n",
      "10. Levothyroxine Sodium  \n",
      "  \n",
      "**Follow-Up Plan:**  \n",
      "The patient is to follow up with her primary care physician within one week of discharge. Additionally, she will have a follow-up appointment with cardiology in two weeks to reassess her heart failure management.\n"
     ]
    }
   ],
   "source": [
    "print(sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "a8a86846",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9542466),\n",
       "  'index': 171,\n",
       "  'word': 'ĠEn',\n",
       "  'start': 787,\n",
       "  'end': 790},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9353572),\n",
       "  'index': 172,\n",
       "  'word': 'ox',\n",
       "  'start': 790,\n",
       "  'end': 792},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9605775),\n",
       "  'index': 173,\n",
       "  'word': 'ap',\n",
       "  'start': 792,\n",
       "  'end': 794},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9393676),\n",
       "  'index': 174,\n",
       "  'word': 'arin',\n",
       "  'start': 794,\n",
       "  'end': 798},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9601156),\n",
       "  'index': 176,\n",
       "  'word': 'ĠAsp',\n",
       "  'start': 799,\n",
       "  'end': 803},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9410289),\n",
       "  'index': 177,\n",
       "  'word': 'ir',\n",
       "  'start': 803,\n",
       "  'end': 805},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9295902),\n",
       "  'index': 178,\n",
       "  'word': 'in',\n",
       "  'start': 805,\n",
       "  'end': 807},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.96151996),\n",
       "  'index': 181,\n",
       "  'word': 'ĠLev',\n",
       "  'start': 812,\n",
       "  'end': 816},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9356838),\n",
       "  'index': 182,\n",
       "  'word': 'othy',\n",
       "  'start': 816,\n",
       "  'end': 820},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9315929),\n",
       "  'index': 183,\n",
       "  'word': 'rox',\n",
       "  'start': 820,\n",
       "  'end': 823},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9359864),\n",
       "  'index': 184,\n",
       "  'word': 'ine',\n",
       "  'start': 823,\n",
       "  'end': 826},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.58332306),\n",
       "  'index': 249,\n",
       "  'word': 'Ġglucose',\n",
       "  'start': 1187,\n",
       "  'end': 1195},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.49764845),\n",
       "  'index': 356,\n",
       "  'word': 'Ġ5',\n",
       "  'start': 1729,\n",
       "  'end': 1731},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.5397236),\n",
       "  'index': 358,\n",
       "  'word': 'ĠDe',\n",
       "  'start': 1732,\n",
       "  'end': 1735},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.5952129),\n",
       "  'index': 359,\n",
       "  'word': 'xt',\n",
       "  'start': 1735,\n",
       "  'end': 1737},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.64144665),\n",
       "  'index': 360,\n",
       "  'word': 'rose',\n",
       "  'start': 1737,\n",
       "  'end': 1741},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.90427417),\n",
       "  'index': 365,\n",
       "  'word': 'ĠAl',\n",
       "  'start': 1746,\n",
       "  'end': 1749},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.8722565),\n",
       "  'index': 366,\n",
       "  'word': 'but',\n",
       "  'start': 1749,\n",
       "  'end': 1752},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.897475),\n",
       "  'index': 367,\n",
       "  'word': 'er',\n",
       "  'start': 1752,\n",
       "  'end': 1754},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9055095),\n",
       "  'index': 368,\n",
       "  'word': 'ol',\n",
       "  'start': 1754,\n",
       "  'end': 1756},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.7776345),\n",
       "  'index': 369,\n",
       "  'word': 'Ġ0',\n",
       "  'start': 1756,\n",
       "  'end': 1758},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.5578234),\n",
       "  'index': 370,\n",
       "  'word': '.',\n",
       "  'start': 1758,\n",
       "  'end': 1759},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.5327764),\n",
       "  'index': 371,\n",
       "  'word': '083',\n",
       "  'start': 1759,\n",
       "  'end': 1762},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.5588455),\n",
       "  'index': 372,\n",
       "  'word': '%',\n",
       "  'start': 1762,\n",
       "  'end': 1763},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.58301413),\n",
       "  'index': 373,\n",
       "  'word': 'ĠNeb',\n",
       "  'start': 1763,\n",
       "  'end': 1767},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.55737084),\n",
       "  'index': 375,\n",
       "  'word': 'izer',\n",
       "  'start': 1769,\n",
       "  'end': 1773},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.6789934),\n",
       "  'index': 376,\n",
       "  'word': 'ĠSolution',\n",
       "  'start': 1773,\n",
       "  'end': 1782},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.95443547),\n",
       "  'index': 381,\n",
       "  'word': 'ĠAsp',\n",
       "  'start': 1787,\n",
       "  'end': 1791},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9397495),\n",
       "  'index': 382,\n",
       "  'word': 'ir',\n",
       "  'start': 1791,\n",
       "  'end': 1793},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.93655753),\n",
       "  'index': 383,\n",
       "  'word': 'in',\n",
       "  'start': 1793,\n",
       "  'end': 1795},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.95932245),\n",
       "  'index': 388,\n",
       "  'word': 'ĠCl',\n",
       "  'start': 1800,\n",
       "  'end': 1803},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.94349325),\n",
       "  'index': 389,\n",
       "  'word': 'on',\n",
       "  'start': 1803,\n",
       "  'end': 1805},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.95522875),\n",
       "  'index': 390,\n",
       "  'word': 'az',\n",
       "  'start': 1805,\n",
       "  'end': 1807},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.93992025),\n",
       "  'index': 391,\n",
       "  'word': 'ep',\n",
       "  'start': 1807,\n",
       "  'end': 1809},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9583388),\n",
       "  'index': 392,\n",
       "  'word': 'am',\n",
       "  'start': 1809,\n",
       "  'end': 1811},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9512836),\n",
       "  'index': 397,\n",
       "  'word': 'ĠD',\n",
       "  'start': 1816,\n",
       "  'end': 1818},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.91189057),\n",
       "  'index': 398,\n",
       "  'word': 'ocus',\n",
       "  'start': 1818,\n",
       "  'end': 1822},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9040903),\n",
       "  'index': 399,\n",
       "  'word': 'ate',\n",
       "  'start': 1822,\n",
       "  'end': 1825},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.9285442),\n",
       "  'index': 400,\n",
       "  'word': 'ĠS',\n",
       "  'start': 1825,\n",
       "  'end': 1827},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.96025157),\n",
       "  'index': 401,\n",
       "  'word': 'odium',\n",
       "  'start': 1827,\n",
       "  'end': 1832},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9613709),\n",
       "  'index': 406,\n",
       "  'word': 'ĠEn',\n",
       "  'start': 1837,\n",
       "  'end': 1840},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9391069),\n",
       "  'index': 407,\n",
       "  'word': 'ox',\n",
       "  'start': 1840,\n",
       "  'end': 1842},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.96386105),\n",
       "  'index': 408,\n",
       "  'word': 'ap',\n",
       "  'start': 1842,\n",
       "  'end': 1844},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9536849),\n",
       "  'index': 409,\n",
       "  'word': 'arin',\n",
       "  'start': 1844,\n",
       "  'end': 1848},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.9654493),\n",
       "  'index': 410,\n",
       "  'word': 'ĠS',\n",
       "  'start': 1848,\n",
       "  'end': 1850},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.97022635),\n",
       "  'index': 411,\n",
       "  'word': 'odium',\n",
       "  'start': 1850,\n",
       "  'end': 1855},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9517274),\n",
       "  'index': 416,\n",
       "  'word': 'ĠFerr',\n",
       "  'start': 1860,\n",
       "  'end': 1865},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9521206),\n",
       "  'index': 417,\n",
       "  'word': 'ous',\n",
       "  'start': 1865,\n",
       "  'end': 1868},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.9345337),\n",
       "  'index': 418,\n",
       "  'word': 'ĠS',\n",
       "  'start': 1868,\n",
       "  'end': 1870},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.94699645),\n",
       "  'index': 419,\n",
       "  'word': 'ulf',\n",
       "  'start': 1870,\n",
       "  'end': 1873},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.9319078),\n",
       "  'index': 420,\n",
       "  'word': 'ate',\n",
       "  'start': 1873,\n",
       "  'end': 1876},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9637415),\n",
       "  'index': 425,\n",
       "  'word': 'ĠFl',\n",
       "  'start': 1881,\n",
       "  'end': 1884},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9393559),\n",
       "  'index': 426,\n",
       "  'word': 'ut',\n",
       "  'start': 1884,\n",
       "  'end': 1886},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9507636),\n",
       "  'index': 427,\n",
       "  'word': 'ic',\n",
       "  'start': 1886,\n",
       "  'end': 1888},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.89912605),\n",
       "  'index': 428,\n",
       "  'word': 'asone',\n",
       "  'start': 1888,\n",
       "  'end': 1893},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.974363),\n",
       "  'index': 429,\n",
       "  'word': 'ĠProp',\n",
       "  'start': 1893,\n",
       "  'end': 1898},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.94283444),\n",
       "  'index': 430,\n",
       "  'word': 'ionate',\n",
       "  'start': 1898,\n",
       "  'end': 1904},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.8434344),\n",
       "  'index': 431,\n",
       "  'word': 'Ġ110',\n",
       "  'start': 1904,\n",
       "  'end': 1908},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.48386937),\n",
       "  'index': 433,\n",
       "  'word': 'cg',\n",
       "  'start': 1910,\n",
       "  'end': 1912},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.85681736),\n",
       "  'index': 438,\n",
       "  'word': 'ĠIns',\n",
       "  'start': 1917,\n",
       "  'end': 1921},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.7106535),\n",
       "  'index': 439,\n",
       "  'word': 'ulin',\n",
       "  'start': 1921,\n",
       "  'end': 1925},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.9686831),\n",
       "  'index': 444,\n",
       "  'word': 'ĠLev',\n",
       "  'start': 1931,\n",
       "  'end': 1935},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.94743997),\n",
       "  'index': 445,\n",
       "  'word': 'othy',\n",
       "  'start': 1935,\n",
       "  'end': 1939},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.933139),\n",
       "  'index': 446,\n",
       "  'word': 'rox',\n",
       "  'start': 1939,\n",
       "  'end': 1942},\n",
       " {'entity': 'B-CHEM',\n",
       "  'score': np.float32(0.93618095),\n",
       "  'index': 447,\n",
       "  'word': 'ine',\n",
       "  'start': 1942,\n",
       "  'end': 1945},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.9809936),\n",
       "  'index': 448,\n",
       "  'word': 'ĠS',\n",
       "  'start': 1945,\n",
       "  'end': 1947},\n",
       " {'entity': 'I-CHEM',\n",
       "  'score': np.float32(0.98384964),\n",
       "  'index': 449,\n",
       "  'word': 'odium',\n",
       "  'start': 1947,\n",
       "  'end': 1952}]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "a4231360",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.9333687),\n",
       "  'word': 'heart',\n",
       "  'start': 180,\n",
       "  'end': 185},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.76644605),\n",
       "  'word': 'heart failure. She presented with shortness of breath, lower extremity edema',\n",
       "  'start': 327,\n",
       "  'end': 403},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.7906781),\n",
       "  'word': 'heart',\n",
       "  'start': 533,\n",
       "  'end': 538},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.72730625),\n",
       "  'word': 'heart',\n",
       "  'start': 618,\n",
       "  'end': 623},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.9468587),\n",
       "  'word': 'left ventricular',\n",
       "  'start': 1076,\n",
       "  'end': 1092},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.8780797),\n",
       "  'word': 'heart',\n",
       "  'start': 1641,\n",
       "  'end': 1646},\n",
       " {'entity_group': 'Anatomy',\n",
       "  'score': np.float32(0.9158247),\n",
       "  'word': 'heart',\n",
       "  'start': 2167,\n",
       "  'end': 2172}]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filter_and_group_entities(anatomy_output, sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "1bfe7695",
   "metadata": {},
   "outputs": [],
   "source": [
    "t = filter_and_group_entities(drug_output, sample_texts[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "01135b26",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9465527),\n",
       "  'word': ' Enoxaparin',\n",
       "  'start': 787,\n",
       "  'end': 798},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9477126),\n",
       "  'word': ' Aspirin',\n",
       "  'start': 799,\n",
       "  'end': 807},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.94225377),\n",
       "  'word': ' Levothyroxine',\n",
       "  'start': 812,\n",
       "  'end': 826},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.7027694),\n",
       "  'word': ' Albuterol 0.083% Nebulizer Solution',\n",
       "  'start': 1746,\n",
       "  'end': 1782},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9462945),\n",
       "  'word': ' Aspirin',\n",
       "  'start': 1787,\n",
       "  'end': 1795},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9519936),\n",
       "  'word': ' Clonazepam',\n",
       "  'start': 1800,\n",
       "  'end': 1811},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9325466),\n",
       "  'word': ' Docusate Sodium',\n",
       "  'start': 1816,\n",
       "  'end': 1832},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.96037877),\n",
       "  'word': ' Enoxaparin Sodium',\n",
       "  'start': 1837,\n",
       "  'end': 1855},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9450487),\n",
       "  'word': ' Ferrous Sulfate',\n",
       "  'start': 1860,\n",
       "  'end': 1876},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.8978411),\n",
       "  'word': ' Fluticasone Propionate 110 mcg',\n",
       "  'start': 1881,\n",
       "  'end': 1912},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.7837354),\n",
       "  'word': ' Insulin',\n",
       "  'start': 1917,\n",
       "  'end': 1925},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.95969933),\n",
       "  'word': ' Levothyroxine Sodium',\n",
       "  'start': 1931,\n",
       "  'end': 1952}]"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "t"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "ddd15c99",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9465527),\n",
       "  'word': ' Enoxaparin',\n",
       "  'start': 787,\n",
       "  'end': 798},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9477126),\n",
       "  'word': ' Aspirin',\n",
       "  'start': 799,\n",
       "  'end': 807},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.94225377),\n",
       "  'word': ' Levothyroxine',\n",
       "  'start': 812,\n",
       "  'end': 826},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.7027694),\n",
       "  'word': ' Albuterol 0.083% Nebulizer Solution',\n",
       "  'start': 1746,\n",
       "  'end': 1782},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9462945),\n",
       "  'word': ' Aspirin',\n",
       "  'start': 1787,\n",
       "  'end': 1795},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9519936),\n",
       "  'word': ' Clonazepam',\n",
       "  'start': 1800,\n",
       "  'end': 1811},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9325466),\n",
       "  'word': ' Docusate Sodium',\n",
       "  'start': 1816,\n",
       "  'end': 1832},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.96037877),\n",
       "  'word': ' Enoxaparin Sodium',\n",
       "  'start': 1837,\n",
       "  'end': 1855},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.9450487),\n",
       "  'word': ' Ferrous Sulfate',\n",
       "  'start': 1860,\n",
       "  'end': 1876},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.8978411),\n",
       "  'word': ' Fluticasone Propionate 110 mcg',\n",
       "  'start': 1881,\n",
       "  'end': 1912},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.7837354),\n",
       "  'word': ' Insulin',\n",
       "  'start': 1917,\n",
       "  'end': 1925},\n",
       " {'entity_group': 'CHEM',\n",
       "  'score': np.float32(0.95969933),\n",
       "  'word': ' Levothyroxine Sodium',\n",
       "  'start': 1931,\n",
       "  'end': 1952}]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(t, key = lambda x: x['start'])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1170a9a0",
   "metadata": {},
   "source": [
    "### 2.3 Apply NER to Dataset\n",
    "\n",
    "Create a function to extract entities from all text fields and create NER features.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fada4759",
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_entities_from_text(text, nlp_model):\n",
    "    \"\"\"\n",
    "    Extract named entities from text using the provided NER model.\n",
    "    \n",
    "    Returns:\n",
    "        dict: Dictionary with entity counts by type and list of entity texts\n",
    "    \"\"\"\n",
    "    if pd.isna(text) or str(text).strip() == '' or str(text) == '___':\n",
    "        return {\n",
    "            'count': 0,\n",
    "            'entities': []\n",
    "        }\n",
    "    \n",
    "    try:\n",
    "        doc = nlp_model(text, batch_size = 8)  # Limit text length for efficiency\n",
    "        entities = filter_and_group_entities(doc, text)\n",
    "\n",
    "        ent_count = len(entities)\n",
    "        \n",
    "        return {\n",
    "            'count': len(entities),\n",
    "            'entities': entities\n",
    "        }\n",
    "\n",
    "    except Exception as e:\n",
    "        print(e)\n",
    "        raise e\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "7af96b6a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\"**Discharge Summary**  \\n**Patient:** Female, 56 years  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 2.8 days  \\n**Primary Diagnosis:** Chronic diastolic (congestive) heart failure (ICD-10: I5032)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following an acute exacerbation of chronic diastolic heart failure. She presented with shortness of breath, lower extremity edema, and fatigue. Her medical history is significant for type 2 diabetes mellitus, hypertension, hyperlipidemia, and atherosclerotic heart disease.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient's heart failure was managed with diuretics and fluid restriction, leading to a significant reduction in her symptoms. She was started on a regimen of medications including Enoxaparin, Aspirin, and Levothyroxine, among others. The patient's diabetes and hypertension were also optimized during her stay. Multiple disciplines including cardiology and nutrition were involved in her care.  \\n  \\n**Key Findings and Procedures:**  \\nEchocardiogram revealed preserved left ventricular function with signs of diastolic dysfunction. Laboratory tests showed mild anemia and elevated glucose levels consistent with her diabetes. The patient underwent a medication review, and her discharge medications were adjusted accordingly.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved dyspnea and decreased edema. She requires assistance with activities of daily living (ADLs) due to fatigue. Home health services are being arranged to assist with medication management, monitoring of her heart failure symptoms, and diabetes management.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Albuterol 0.083% Nebulizer Solution  \\n3. Aspirin  \\n4. Clonazepam  \\n5. Docusate Sodium  \\n6. Enoxaparin Sodium  \\n7. Ferrous Sulfate  \\n8. Fluticasone Propionate 110 mcg  \\n9. Insulin  \\n10. Levothyroxine Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge. Additionally, she will have a follow-up appointment with cardiology in two weeks to reassess her heart failure management.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 73-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute diastolic heart failure (I5031), presenting with dyspnea on exertion, orthopnea, and lower extremity edema. Her medical history is significant for chronic embolism of the right lower extremity, secondary malignant neoplasm of the brain, and hypertension.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely. Diuretics were initiated to manage fluid overload, and her response was favorable with significant reduction in edema and improved respiratory status. Serial echocardiograms demonstrated preserved systolic function but worsening diastolic function. Enoxaparin was administered for anticoagulation due to her history of thrombosis, and she was closely monitored for any signs of complications.\\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated BNP levels indicative of heart failure. The patient underwent a comprehensive medication review, and adjustments were made to optimize her heart failure management. A multidisciplinary team approach was utilized, including consultations with cardiology and oncology, given her complex medical history.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved respiratory function and reduced edema. Home health services are recommended for ongoing monitoring of heart failure symptoms, medication management, and assistance with activities of daily living. She will require education on dietary restrictions, fluid management, and the importance of daily weight monitoring to prevent readmissions.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient will continue on the following medications: Acetaminophen, Aspirin, Atorvastatin, Dexamethasone, Docusate Sodium, Enoxaparin Sodium, Furosemide, Levothyroxine Sodium, Lisinopril, Omeprazole, and a pneumococcal vaccine.  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointment is scheduled with her primary care physician and cardiologist within one week post-discharge. Home health nursing will provide weekly visits to assess her heart failure management and medication adherence.',\n",
       " 'Discharge Summary: \\n\\nPatient is a 58-year-old male who was admitted for observation due to acute on chronic diastolic heart failure (ICD10: I5033). He presented with symptoms of dyspnea and fatigue, requiring supplemental oxygen. The patient has a notable history of chronic obstructive pulmonary disease (COPD) exacerbation, urinary tract infection, and morbid obesity, contributing to his overall clinical picture. \\n\\nDuring his 5-day hospital stay, the patient received a comprehensive workup including laboratory tests, chest X-ray, and echocardiogram, which confirmed the diagnosis of acute heart failure exacerbation. Key findings included bilateral pleural effusions and signs of fluid overload. The patient was treated with diuretics (Furosemide), intravenous fluids (0.9% Sodium Chloride), and bronchodilators, leading to significant improvement in respiratory status and reduction of edema. A multidisciplinary approach was taken, involving cardiology, pulmonology, and nutrition services to optimize his management. \\n\\nThe patient demonstrated improved functional status by discharge, ambulating independently, and reporting reduced shortness of breath at rest and with minimal exertion. He is stable for home health services to assist with continued monitoring of fluid status, medication adherence, and pulmonary rehabilitation. \\n\\nAt discharge, the patient’s medication regimen includes Furosemide, Amoxicillin, Diltiazem, Aspirin, Clopidogrel, and Fluticasone-Salmeterol Diskus. He is advised to maintain a low-sodium diet, monitor his weight daily, and adhere to prescribed medications. A follow-up appointment with cardiology is scheduled within one week to reassess heart failure management and adjust medications as necessary. Home health services will be engaged to provide skilled nursing and assist with daily living activities.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 71  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of acute on chronic diastolic heart failure, presenting with exacerbation of symptoms including dyspnea and edema. The patient has a significant past medical history including chronic kidney disease, chronic lymphocytic leukemia, and a history of atherosclerotic heart disease.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was monitored in an observation setting. Initial management included diuretics (Furosemide) for fluid overload and optimization of heart failure medications (Metoprolol and Ranolazine). Serial laboratory tests showed improvement in renal function and resolution of congestive symptoms. The patient underwent a thoracentesis due to a pleural effusion, which provided symptomatic relief and improved respiratory function.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated BNP levels and echocardiogram demonstrating preserved systolic function with diastolic dysfunction. The procedure performed was a thoracentesis to relieve pleural effusion. The patient also received supportive care including insulin adjustments for diabetes management.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved respiratory status and managed heart failure symptoms. Functional status was assessed as improved, with the patient able to perform activities of daily living with minimal assistance. Home health services have been arranged to assist with medication management and monitoring of heart failure symptoms.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Aspirin, Atorvastatin, Furosemide, Metoprolol Tartrate, Ranolazine ER, and insulin pump therapy for diabetes management. \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with cardiology and nephrology within one week to monitor heart failure management and renal function. Home health nursing will provide education on medication adherence and symptom monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 77  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 77-year-old female with a history of chronic diastolic heart failure (ICD-10: I5032) who presented with worsening dyspnea and lower extremity edema. She has a past medical history notable for type 2 diabetes mellitus, nonalcoholic steatohepatitis, and secondary pulmonary hypertension. The patient was admitted under observation for further assessment and management of her heart failure exacerbation.\\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was treated with diuretics, including Furosemide, to manage her volume overload. She received intravenous Ceftriaxone for a suspected urinary tract infection. The patient's symptoms improved with treatment, and she was closely monitored for vital signs and renal function, which remained stable throughout her stay.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated BNP levels consistent with heart failure exacerbation and slight renal impairment (acute kidney failure, N179). A review of her medications indicated the need for optimization, and adjustments were made accordingly. She was educated on the importance of medication adherence and lifestyle modifications to manage her chronic conditions effectively.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in a stable condition, with improved symptoms of dyspnea and decreased edema. She is ambulating independently and can perform activities of daily living with minimal assistance. Home health services have been arranged to provide ongoing monitoring, medication management, and assistance with daily activities as needed.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on a regimen including Furosemide, Diltiazem, Atorvastatin, Allopurinol, and Albuterol inhaler, among others. She has been provided with a medication reconciliation list to ensure proper adherence.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with her primary care physician in one week to reassess her heart failure management and adjust medications as necessary. Additionally, home health nursing will follow up within 48 hours post-discharge to ensure proper care and support.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 58 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 8.5 days  \\n**Primary Diagnosis:** Acute on chronic diastolic (congestive) heart failure (ICD10: I5033)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for acute exacerbation of chronic diastolic heart failure, presenting with dyspnea, orthopnea, and lower extremity edema. She has a significant history of heart failure, atrial fibrillation, and chronic kidney disease.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was managed with diuretics (Torsemide) and optimized on heart failure medications, including Carvedilol and Valsartan. Close monitoring of renal function was conducted due to her acute kidney failure with tubular necrosis (ICD10: N170). She was also treated for respiratory failure with hypoxia (ICD10: J9691) requiring supplemental oxygen.  \\n  \\nKey interventions included echocardiography, which revealed preserved ejection fraction with evidence of diastolic dysfunction, and an adjustment of her anticoagulation regimen due to her history of antiphospholipid syndrome.  \\n  \\n**Key Findings and Procedures:**  \\n- Acute on chronic diastolic heart failure  \\n- Acute kidney failure  \\n- Respiratory failure with hypoxia  \\n- Atrial flutter managed with Amiodarone  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved respiratory status, with stable oxygen saturation on room air. She is ambulating with assistance and is able to perform activities of daily living (ADLs) with minimal assistance. It is essential for her to continue with home health services to monitor her heart failure management, medication adherence, and rehabilitation.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Amiodarone  \\n- Aspirin EC  \\n- Atorvastatin  \\n- Carvedilol  \\n- Potassium Chloride  \\n- Ranitidine  \\n- Sodium Chloride 0.9% Flush  \\n- Torsemide  \\n- Tramadol  \\n- Valsartan  \\n- Warfarin  \\n  \\n**Follow-up Plan:**  \\nThe patient should follow up with her cardiologist within one week and have regular home health visits to ensure compliance with medications, monitor her heart failure status, and provide physical rehabilitation as needed.',\n",
       " 'Patient is a 58-year-old male admitted via emergency walk-in with acute on chronic diastolic heart failure (ICD10: I5033). He presented with worsening dyspnea, bilateral lower extremity edema, and fatigue over the past week, with a history of chronic obstructive pulmonary disease (COPD) and significant obesity (BMI 46). \\n\\nDuring his 1.6-day hospital stay, the patient was monitored closely for heart failure exacerbation. Serum electrolytes and renal function were assessed, revealing mild hyperkalemia, which was managed with appropriate medication adjustments. Diuretics (Furosemide) were administered to manage fluid overload, resulting in a significant reduction in edema and improvement in respiratory status. He also received bronchodilator therapy for COPD exacerbation.\\n\\nKey diagnostic findings included an elevated BNP level, chest X-ray indicating pulmonary congestion, and echocardiography confirming diastolic dysfunction. He underwent a medication review, and adjustments were made to optimize his heart failure management, including the addition of metolazone for diuretic synergy.\\n\\nAt discharge, the patient was stable, with improved functional status. He demonstrated the ability to perform activities of daily living with minimal assistance and reported decreased shortness of breath on exertion. He is being referred to home health services for ongoing monitoring of heart failure management and pulmonary rehabilitation. \\n\\nDischarge medications include Furosemide, Metolazone, Pantoprazole, Albuterol/Ipratropium Nebs, and Lactulose. He is advised to follow up with his primary care physician within one week and to contact home health for any worsening symptoms. Education was provided on recognizing signs of fluid overload and COPD exacerbation.',\n",
       " '**Patient Information:** 33-year-old male, admitted urgently with acute on chronic systolic (congestive) heart failure (ICD10: I5023). \\n\\n**History of Present Illness:** The patient presented with increased dyspnea on exertion, orthopnea, and lower extremity edema. He has a history of congestive heart failure and obesity (BMI 50.0-59.9), with a recent exacerbation likely triggered by non-compliance with medications and dietary restrictions.\\n\\n**Hospital Course:** During a 7.7-day hospital stay, the patient was stabilized with diuretics (Furosemide, Spironolactone) to manage fluid overload. Amiodarone was initiated for paroxysmal atrial fibrillation, and Lisinopril was continued to manage hypertension and heart failure. The patient underwent daily assessments for fluid balance and renal function, which showed improvement with decreased edema and normalized electrolytes. \\n\\n**Key Findings and Procedures:** Echocardiogram revealed reduced ejection fraction consistent with systolic heart failure. Renal function was monitored closely due to concurrent acute kidney failure (ICD10: N179). The patient was also treated for anemia related to chronic disease. A comprehensive medication review was conducted, and adjustments were made to optimize heart failure management. \\n\\n**Discharge Condition and Functional Status:** The patient is stable for discharge, with improved symptoms and functional capacity. He can perform activities of daily living with minimal assistance but requires ongoing support from home health services for medication management, dietary education, and mobility assistance.\\n\\n**Medications at Discharge:** The patient is discharged on 5% Dextrose, Acetaminophen, Amiodarone, Clobetasol Propionate cream, Dabigatran Etexilate, Docusate Sodium, Furosemide, Influenza Vaccine Quadrivalent, Lisinopril, Metoprolol Succinate XL, Oxycodone (Immediate Release), Potassium Chloride, Senna, Sodium Chloride 0.9% flush, and Spironolactone. \\n\\n**Follow-Up Plan:** The patient is advised to follow up with cardiology within one week and primary care within two weeks. Home health services will initiate within 48 hours post-discharge to monitor vital signs, medication adherence, and provide education on heart failure management.',\n",
       " \"**Patient Information:** 70-year-old male admitted for observation due to acute on chronic diastolic heart failure (ICD10: I5033).  \\n\\n**History of Present Illness:** The patient presented with dyspnea on exertion, orthopnea, and lower extremity edema. He has a known history of heart failure, chronic obstructive pulmonary disease (COPD), benign prostatic hyperplasia, and depression. Previous medications included diuretics and beta-blockers.  \\n\\n**Hospital Course:** During the 5.9-day stay, the patient's heart failure symptoms were exacerbated, necessitating adjustments in diuretic therapy, including furosemide and spironolactone. He was closely monitored for fluid status, renal function, and electrolyte levels. Multi-disciplinary team involvement included cardiology and dietary services, focusing on sodium restriction and fluid management. Notable interventions included optimization of heart failure medications and education on lifestyle modifications. Additionally, he received treatment for acute symptoms related to COPD.\\n\\n**Key Findings and Procedures:** Echocardiography demonstrated preserved left ventricular ejection fraction with evidence of diastolic dysfunction. Serum labs indicated mild renal impairment but stable electrolytes post-diuretic therapy. The patient also received an influenza vaccine and was educated on the importance of medication adherence and follow-up care.\\n\\n**Discharge Condition and Functional Status:** The patient was stable at discharge, ambulating independently with improved symptoms. He requires assistance with daily activities and close monitoring of his heart failure symptoms. Home health services will be arranged to provide skilled nursing for medication management and ongoing assessment of heart failure status.  \\n\\n**Medications at Discharge:** The patient will continue on the following medications: Acetaminophen, Atorvastatin, BuPROPion XL, Cyanocobalamin, Finasteride, Fluticasone-Salmeterol, Folic Acid, Furosemide, Omeprazole, Potassium Chloride, Propranolol LA, Rivaroxaban, and Spironolactone.  \\n\\n**Follow-Up Plan:** Follow-up appointments with cardiology and primary care are scheduled within one week. Home health nursing services will commence within 48 hours post-discharge.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 78-year-old female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 17.7 days  \\n**Primary Diagnosis:** Acute systolic (congestive) heart failure (I50.21)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of acute systolic heart failure, characterized by increasing dyspnea and edema. She has a history of rheumatic heart disease with mitral and tricuspid valve involvement, and is also on long-term anticoagulation therapy for atrial fibrillation.  \\n\\n**Hospital Course:**  \\nDuring her 17.7-day stay, the patient was closely monitored and treated with diuretics (Bumetanide) for fluid overload and oral medications adjusted for heart failure management. The patient underwent echocardiography which confirmed reduced ejection fraction. She was also treated for iron deficiency anemia and managed for her chronic obstructive sleep apnea.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included pulmonary hypertension and hypoxemia. Therapeutic interventions included optimization of her heart failure regimen with initiation of Apixaban and Diltiazem for rate control.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved dyspnea and reduced peripheral edema. She requires assistance with activities of daily living (ADLs) and will benefit from home health services for continued monitoring and therapy. A referral for physical therapy is recommended to enhance her mobility and endurance.  \\n\\n**Medications at Discharge:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Apixaban, Bumetanide, Diltiazem Extended-Release, Lisinopril, Metoprolol Succinate XL, and others as needed for symptom management.  \\n\\n**Follow-Up Plan:**  \\nThe patient is instructed to follow up with her cardiologist within one week of discharge. Home health services will initiate shortly after discharge to provide nursing care and physical therapy to assist in her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 77  \\n- **Gender:** Male  \\n- **Admission Type:** Surgical Same Day Admission  \\n- **Length of Stay:** 3.4 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 77-year-old male with a history of type 2 diabetes mellitus (E1151) complicated by diabetic peripheral angiopathy without gangrene. He was admitted for elective surgical intervention. The patient has a significant past medical history that includes persistent atrial fibrillation, essential hypertension, hyperlipidemia, and abdominal aortic aneurysm.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent several procedures, including endovascular repair of the abdominal aortic aneurysm and arterial interventions for management of peripheral vascular disease. His postoperative course was complicated by mild transient atrial fibrillation, which was managed with appropriate medical therapy. The patient was stabilized with intravenous fluids, pain management using opioids, and was started on anticoagulation therapy with Rivaroxaban to prevent thromboembolic events.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included intermittent claudication in the right leg due to atherosclerosis of native arteries, managed with lifestyle modification and medications. The patient responded well to treatment, with improvement in blood glucose control and stabilization of cardiac rhythm prior to discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved functional status, ambulating independently with minimal assistance. He is stable, with no signs of acute distress, but will require ongoing home health services for monitoring of his diabetes management, medication adherence, and physical rehabilitation to enhance mobility and prevent further complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Aspirin  \\n- Clopidogrel  \\n- Hydromorphone (Dilaudid)  \\n- Heparin  \\n- Lactated Ringers  \\n- Magnesium Oxide  \\n- Neutra-Phos  \\n- Oxycodone (Immediate Release)  \\n- Pantoprazole  \\n- Potassium Phosphate  \\n- Pravastatin  \\n- Rivaroxaban  \\n- Amlodipine  \\n\\nFollow-up appointments are scheduled with the primary care physician and cardiology within one week to monitor his recovery and manage his chronic conditions.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 48, Gender: Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 3.2 days  \\n**Primary Diagnosis:** E1151 - Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention related to his diabetes management. He has a significant history of Type 2 diabetes with complications, including peripheral angiopathy, which has contributed to intermittent claudication in his left leg. His medical history is also notable for hypertension, hyperlipidemia, and a diagnosis of nonalcoholic steatohepatitis (NASH).  \\n  \\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient underwent a successful procedure (ICD-10: 041L0JL) aimed at improving limb perfusion. Postoperatively, he was monitored closely for any complications. His blood glucose levels were managed effectively, and he was placed on a sliding scale for insulin, along with oral hypoglycemic agents. He received education regarding lifestyle modifications and medication compliance to manage his diabetes more effectively.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient showed stable vital signs throughout his stay, with no evidence of postoperative complications. Key lab results indicated controlled blood glucose levels, and he demonstrated improved mobility post-surgery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and in good condition. He is ambulating with assistance and has been instructed on home exercises to enhance his mobility. The home health team will assist in monitoring his blood glucose levels, medication adherence, and overall rehabilitation process.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on the following medications:  \\n- Insulin, Metformin, Glipizide for diabetes management  \\n- Lisinopril for hypertension  \\n- Aspirin for cardiovascular protection  \\n- Albuterol inhaler for COPD management  \\n  \\nFollow-up appointments are scheduled with his primary care physician and endocrinologist in two weeks. Home health services will monitor his recovery, focusing on wound care, medication management, and dietary counseling.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 80-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with hyperglycemic symptoms and lab findings indicative of Type 2 diabetes mellitus with hyperosmolarity (ICD10: E1100). He has a significant past medical history including liver cell carcinoma, chronic obstructive pulmonary disease (COPD), and acute kidney failure.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was managed with fluid resuscitation using 0.9% Sodium Chloride and provided with insulin therapy to control hyperglycemia. He was also started on antibiotics for suspected bacteremia and treated for his COPD exacerbation. Continuous monitoring of renal function was performed, and the patient's condition stabilized with no further acute kidney injury.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated blood glucose levels, with subsequent normalization following treatment. Imaging studies were conducted to assess his liver condition but did not reveal any acute changes. The patient's cardiac rhythm was monitored due to a history of atrial fibrillation, which remained stable throughout his hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is clinically stable but requires assistance with activities of daily living (ADLs) due to generalized weakness and diabetic neuropathy. Home health services are recommended for nursing care to assist with medication management, blood glucose monitoring, and dietary education. Physical therapy is also suggested to improve mobility and strength.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Apixaban, Atorvastatin, Glipizide XL, and insulin, among others. The patient is advised to follow up with his primary care physician within one week and maintain regular endocrinology appointments for diabetes management. A home health nurse will visit three times weekly to monitor his condition and ensure adherence to the medication regimen.\",\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old female with a significant medical history including Type 2 diabetes mellitus with diabetic peripheral angiopathy and gangrene, as well as a recent myocardial infarction. She was admitted for a surgical intervention to address complications associated with her diabetes and peripheral vascular disease.  \\n\\n**Hospital Course:**  \\nDuring her 4.5-day hospitalization, the patient underwent a surgical procedure involving debridement and revascularization of the right leg. Post-operatively, she was closely monitored for signs of infection and managed with intravenous fluids, analgesics, and anticoagulation therapy. Her blood glucose levels were stabilized with appropriate insulin regimens.  \\n\\n**Key Findings and Procedures:**  \\nPre-operative imaging revealed significant peripheral vascular disease with evidence of gangrene in the right lower extremity. The surgical procedure was successful with initial healing observed. Key medications during her stay included Metoprolol succinate, Aspirin EC, and Gabapentin for pain management.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with vital signs within normal limits. She was able to ambulate with assistance and required support for activities of daily living due to weakness and pain in the right leg. Home health services are recommended to assist with rehabilitation, wound care, and monitoring of her blood glucose levels.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on a regimen including Acetaminophen, Alendronate Sodium, Atorvastatin, Furosemide, and Isosorbide Mononitrate. She is advised to follow up with her primary care physician and the vascular surgeon within one week post-discharge. Home health nursing will be arranged for wound care and diabetic management to ensure adherence to her treatment plan.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**MRN:** [Patient MRN]  \\n**Date of Discharge:** [Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 50-year-old female with a history of Type 2 diabetes mellitus, who presented to the hospital with diabetic ketoacidosis (DKA) without coma. She reported increased thirst, frequent urination, and fatigue over the prior week. Initial laboratory tests confirmed hyperglycemia and metabolic acidosis.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for observation for 4.9 days and managed with intravenous fluids and insulin therapy. Electrolyte imbalances, particularly hyperosmolality and hypernatremia, were addressed with careful monitoring and replacement. Additionally, she experienced acute kidney failure, which improved with hydration and supportive care. Throughout her stay, her blood glucose levels were stabilized, and her ketoacidosis resolved.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood glucose levels, elevated white blood cell count, and dehydration. She underwent several laboratory tests, including renal function tests, which indicated transient acute kidney failure. The patient's cardiac status was evaluated due to cardiomegaly noted on imaging, but no acute intervention was necessary.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and ambulating independently. She demonstrates an understanding of her diabetes management and is capable of self-administering insulin. However, she will require home health services for ongoing monitoring, education on diabetes management, and assistance with medication adherence.  \\n  \\n**Medications at Discharge:**  \\n1. Bisacodyl  \\n2. Dextrose 50%  \\n3. Enoxaparin (Prophylaxis)  \\n4. Glipizide XL  \\n5. Glucagon  \\n6. Glucose Gel  \\n7. Insulin  \\n8. Metformin (Glucophage)  \\n9. Multivitamins W/minerals  \\n10. Senna  \\n11. Sodium Chloride 0.9% Flush  \\n12. Thiamine  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge to monitor her diabetes control and kidney function. Home health services will initiate within 48 hours post-discharge for education and support.\",\n",
       " 'Patient is an 88-year-old female who was admitted for observation due to complications related to Type 2 diabetes mellitus with diabetic peripheral angiopathy and gangrene (ICD-10: E1152). The patient presented with a non-pressure chronic ulcer of the left heel, which was assessed for severity and appropriate management initiated during her 13-day stay. \\n\\nThroughout her hospitalization, the patient demonstrated a complex medical history including chronic kidney disease, hypertension, and heart failure. Treatment included careful management of her diabetes, with insulin therapy adjusted to maintain glycemic control, and the use of Collagenase ointment for wound care. She received supportive measures including hydration with Lactated Ringer’s solution and was monitored for electrolyte imbalances, particularly hypo-osmolality and hyponatremia. \\n\\nKey findings during her hospital course included the presence of a urinary tract infection, which was treated with appropriate antibiotics. Additionally, her chronic conditions were managed, and she was placed on Apixaban for anticoagulation and Atorvastatin for lipid management. The patient was also provided with education on lifestyle modifications to help manage her diabetes and prevent further complications. \\n\\nUpon discharge, the patient is stable but continues to require home health services for ongoing wound care and monitoring of her diabetes management. She is ambulatory with assistance and is able to perform basic activities of daily living with some support. \\n\\nDischarge medications include Acetaminophen for pain management, Apixaban, Atorvastatin, Fluoxetine, and Gabapentin, among others. A follow-up appointment with her primary care physician is scheduled within one week, with a referral to a home health agency for wound care and diabetes education to ensure continuity of care.',\n",
       " '**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 70-year-old female with a medical history significant for Type 2 diabetes mellitus with hyperglycemia, chronic kidney disease stage 4, and malnutrition. She presented to the hospital after experiencing increased fatigue, polyuria, and unintentional weight loss over the past month. Laboratory tests indicated elevated blood glucose levels and protein-calorie malnutrition.  \\n\\n**Hospital Course:**  \\nDuring her 4-day observation stay, the patient was closely monitored for her blood glucose levels and renal function. She received intravenous fluids and insulin therapy to manage hyperglycemia. Nutritional support was initiated, including the administration of albumin and multivitamins. The patient also received antibiotics for a urinary tract infection.  \\n\\n**Key Findings and Procedures:**  \\nSignificant findings included hyperglycemia with blood glucose levels peaking at 320 mg/dL, elevated creatinine levels indicative of worsening renal function, and a BMI of 19.9, consistent with malnutrition. A renal ultrasound was performed to rule out obstructive causes of her kidney dysfunction, which was negative.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved glucose control and hydration status. She will require home health services for ongoing monitoring of her blood glucose levels and renal function, as well as nutritional support to address her malnutrition. The patient is currently able to perform activities of daily living with minimal assistance but will benefit from skilled nursing for medication management and dietary consultation.  \\n\\n**Medications at Discharge:**  \\nDischarge medications include: Albumin 25% (12.5g / 50mL), Aspirin, Calcitriol, Carvedilol, Ciprofloxacin HCl, Dextrose 50%, Envarsus XR, Glucagon, Insulin, Lactulose, Latanoprost 0.005% Ophthalmic Solution, LevETIRAcetam, and Multivitamins with minerals.  \\n\\n**Follow-Up Plan:**  \\nThe patient has been instructed to follow up with her primary care physician within one week. Home health services will initiate care within 48 hours post-discharge to facilitate monitoring and support.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician's Name]  \\n**Age:** 62  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old female with a history of Type 2 diabetes mellitus with hyperglycemia, chronic kidney disease stage 4, and paroxysmal atrial fibrillation, who was admitted under observation due to worsening hyperglycemia and acute kidney injury. She has a complex medical history that includes diabetic neuropathy and gastroparesis, which contributed to her clinical presentation.  \\n  \\n**Hospital Course:**  \\nDuring her 10.8-day stay, the patient was closely monitored and treated for her hyperglycemia, with adjustments made to her insulin regimen. Diuretics were administered for fluid overload associated with acute kidney failure, and adequate hydration was maintained with 0.9% Sodium Chloride. She was started on Furosemide to manage her fluid status. Gabapentin was prescribed for neuropathic pain management.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated blood glucose levels, and imaging studies confirmed worsening renal function. The patient was educated on dietary modifications and the importance of regular glucose monitoring to manage her diabetes effectively.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved glucose control and stable renal function. She is ambulating independently and is capable of performing activities of daily living with minimal assistance. Home health services have been arranged to provide ongoing monitoring and support for her diabetes management and renal function.  \\n  \\n**Medications at Discharge:**  \\n1. Insulin (Regular)  \\n2. Atorvastatin  \\n3. Metoprolol Tartrate  \\n4. Gabapentin  \\n5. Furosemide  \\n6. Dextrose 50% as needed  \\n7. Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge. Home health services will initiate visits to assist with medication administration and diabetes education. Regular renal function monitoring will also be coordinated with her nephrologist.  \\n\\n**Physician's Signature:**  \\n[Physician's Name]  \\n[Date]\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 52 years  \\n**Gender:** Male  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through direct emergency services with a primary diagnosis of Type 2 diabetes mellitus with foot ulcer (ICD10: E11621). He presented with worsening diabetic foot ulcers, signs of osteomyelitis, and associated symptoms of pneumonia. The patient also has a significant past medical history, including end-stage renal disease and chronic heart failure.  \\n  \\n**Hospital Course:**  \\nDuring the 6-day hospital stay, the patient received comprehensive management including wound care, antibiotic therapy (Amoxicillin-Clavulanic Acid), and optimization of diabetes control. He underwent procedures for debridement of necrotic tissue as well as management for fluid overload due to heart failure. Continuous monitoring for pneumonia and renal function was performed. The patient was stabilized with insulin therapy and pain management using acetaminophen and other medications.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a significant diabetic foot ulcer with necrosis, pneumonia diagnosed via imaging, and chronic heart failure exacerbation. The patient underwent procedures such as debridement (ICD10: 0QBP0ZZ) and management of fluid status (ICD10: 5A1D60Z).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing home health services due to his complex management needs. His functional status is improved, but he still requires assistance with daily activities and wound care. The patient is advised to adhere strictly to follow-up appointments and home health visits for monitoring and continued care.  \\n  \\n**Medications at Discharge:**  \\nThe discharge medications include 0.9% Sodium Chloride, 5% Dextrose, Acetaminophen, Albuterol nebulization, Amoxicillin-Clavulanic Acid, Aspirin, Carvedilol, Insulin, and others as per the medication reconciliation form.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician and wound care specialist within one week of discharge. Home health services will be initiated to assist with wound care management, medication administration, and monitoring of blood glucose levels.',\n",
       " '**Discharge Summary**  \\n**Patient ID**: [Patient ID]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Age**: 71  \\n**Gender**: Male  \\n**Admission Type**: Elective  \\n  \\n**History of Present Illness**:  \\nThe patient is a 71-year-old male with a history of type 2 diabetes mellitus complicated by diabetic peripheral angiopathy, neuropathy, and nephropathy. He was admitted for management of his diabetes and associated vascular complications. He has been experiencing intermittent claudication in the left leg due to atherosclerosis.  \\n  \\n**Hospital Course**:  \\nDuring his 6-day stay, the patient was monitored closely for glycemic control and vascular status. He was started on insulin therapy to better manage his blood glucose levels, and his anticoagulation was adjusted for his history of paroxysmal atrial fibrillation. The patient also received education on diabetes management, including dietary modifications and the importance of foot care to prevent ulcerations.  \\n  \\n**Key Findings and Procedures**:  \\nKey findings included elevated blood glucose levels, requiring adjustments in insulin dosing. The patient underwent routine vascular assessments which confirmed the presence of peripheral artery disease. He received education on the use of medications including clopidogrel and warfarin for cardiovascular protection.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt the time of discharge, the patient was stable but required assistance with activities of daily living (ADLs) due to weakness from his underlying conditions. He will benefit from home health services for physical therapy to improve mobility and occupational therapy for ADL training.  \\n  \\n**Medications at Discharge**:  \\nThe patient is to continue on the following medications:  \\n- Insulin  \\n- Clopidogrel  \\n- Warfarin  \\n- Simvastatin  \\n- Tamsulosin  \\n- Vitamin D  \\n- 5% Dextrose as needed for hypoglycemia  \\nHe will follow up with his endocrinologist and cardiologist in one month.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 72 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of uncontrolled Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene. He presented with symptoms including intermittent claudication and rest pain in the right leg, exacerbated by physical activity. Additionally, he has a background of essential hypertension, hyperlipidemia, and a personal history of nicotine dependence. The patient was also noted to have had recent contact with a suspected COVID-19 case.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored closely for glycemic control and pain management. He received intravenous fluids (0.9% Sodium Chloride and D5 1/2NS) and was treated with insulin to stabilize his blood glucose levels. Pain management included the administration of acetaminophen and appropriate doses of atorvastatin and clopidogrel for cardiovascular risk mitigation. An influenza vaccine was administered as part of preventive care. He underwent a Doppler ultrasound to assess the blood flow in his lower extremities, which confirmed the presence of atherosclerosis affecting the bypass grafts.\\n\\n**Key Findings and Procedures:**  \\nKey findings included significant diabetic peripheral angiopathy without evidence of gangrene. The patient underwent a vascular assessment, and he was educated on the importance of glycemic control and lifestyle modifications. A comprehensive medication review was performed, and adjustments were made to optimize his diabetes management.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating with assistance but required ongoing home health support for mobility and diabetes management. He will benefit from home health services for regular glucose monitoring, medication management, and assistance with physical therapy to improve his mobility.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on insulin, atorvastatin, clopidogrel, and other supportive medications, including glucagon and glucose gel for hypoglycemic episodes. He is advised to follow up with his primary care physician within one week and will have home health services initiated within 24 hours to assist in his recovery and management of diabetes.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Confidential]  \\n**Age:** 51  \\n**Gender:** Male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 36.2 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of uncontrolled Type 2 diabetes mellitus with hyperglycemia (ICD-10: E1165). He presented with multiple comorbidities, including acute kidney failure with tubular necrosis and chronic kidney disease, as well as a non-pressure chronic ulcer of the left heel and midfoot. The patient also has a history of metabolic encephalopathy and atherosclerotic heart disease.  \\n  \\n**Hospital Course:**  \\nDuring his extended hospital stay, the patient underwent comprehensive metabolic management, including insulin therapy and adjustments to his oral hypoglycemic agents. The team also initiated renal protective measures due to his acute kidney injury and chronic kidney disease. The patient received wound care for his ulcer and was monitored for signs of metabolic encephalopathy, which improved with appropriate interventions. He was started on gabapentin for neuropathic pain and given supportive care for his malnutrition.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood glucose levels, acute renal impairment, and significant improvement in his wound condition over the course of hospitalization. Routine imaging and lab tests confirmed the diagnosis of chronic kidney disease and metabolic derangements, all of which were managed effectively.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires continued support due to his diabetes management and chronic kidney disease. He is dependent on assistance for daily activities due to fatigue and functional limitations. Home health services will be necessary for medication management, glycemic monitoring, and wound care.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apixaban  \\n3. Aspirin EC  \\n4. Gabapentin  \\n5. Glipizide  \\n6. Insulin  \\n7. Metoprolol Succinate XL  \\n8. Calcitriol  \\n9. Polyethylene Glycol  \\n10. Ramelteon  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for outpatient follow-up with his primary care physician and a nephrologist within one week. Home health services will initiate contact within 48 hours post-discharge to ensure continuity of care and monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 54, Gender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a diabetic foot ulcer secondary to his long-standing Type 2 diabetes mellitus, complicated by chronic kidney disease and peripheral vascular disease. He presented with worsening pain and swelling in the left foot, which was noted to have a non-pressure ulcer on the heel.\\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was closely monitored for glycemic control and renal function. He received intravenous antibiotics (Amoxicillin-Clavulanic Acid) for the foot ulcer and was managed with wound care daily. The patient's blood glucose levels were stabilized with insulin therapy, and he was educated on dietary modifications and diabetes management. A multidisciplinary team, including a dietitian and a wound care specialist, was involved in his care. \\n  \\n**Key Findings and Procedures:**  \\nOn examination, the ulcer on the left heel was assessed to be of moderate severity but showed signs of improvement by discharge. His renal function was stable, and he continued to require dialysis for end-stage renal disease. He underwent a renal diet consultation to facilitate better management of his chronic conditions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was ambulating with assistance and required home health services for wound care and monitoring of his diabetes and renal status. He expressed understanding of his medications and the importance of follow-up care. \\n  \\n**Medications at Discharge:**  \\n1. Albuterol Inhaler  \\n2. Amoxicillin-Clavulanic Acid  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. Carvedilol  \\n6. Clonidine  \\n7. Clopidogrel  \\n8. Dextrose 50%  \\n9. Gabapentin  \\n10. Heparin  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with a wound care specialist as instructed. Home health services are to be initiated for ongoing wound assessment and management, along with diabetes education.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 49 years  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 13.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 49-year-old female with a history of Type 2 diabetes mellitus complicated by a right foot ulcer. She was admitted for management of her foot ulcer and associated diabetic complications, including peripheral neuropathy and vascular insufficiency. She also exhibited signs of acute respiratory failure during her stay, necessitating further evaluation and treatment.\\n\\n**Hospital Course:**  \\nThroughout her 13.8-day hospital stay, the patient received comprehensive care. Initial management focused on glycemic control, wound care for her foot ulcer, and treatment for acute respiratory failure. She was started on insulin therapy, and her wound was treated with Dakin’s solution and antibiotic therapy (Cefazolin). The patient's respiratory status improved with nebulized albuterol and supportive care.  \\n\\nShe experienced acute kidney failure, which resolved with appropriate fluid management and monitoring. Key findings included persistent foot ulcer infection and evidence of diabetic neuropathy. A multidisciplinary approach was utilized, including consultations from endocrinology and wound care specialists.\\n\\n**Key Findings and Procedures:**  \\n- Type 2 diabetes mellitus with foot ulcer (ICD10: E11621)  \\n- Acute respiratory failure (ICD10: J9601)  \\n- Acute kidney failure (ICD10: N179)  \\n- Wound management procedures performed: Debridement of ulcer and application of advanced dressings.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing wound care and management of her diabetes. She is able to perform basic activities of daily living with assistance due to her foot ulcer and neuropathy. Home health services are recommended for wound care, diabetes education, and monitoring of her blood glucose levels.\\n\\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Insulin, Atorvastatin, Acetaminophen, and Fluoxetine, among others. Follow-up appointments are scheduled with her primary care physician and endocrinologist within one week. Home health services will coordinate care and education on managing her diabetes and foot care.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Age:** 59  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of hypoglycemia associated with Type 2 Diabetes Mellitus (ICD-10: E11649). He presented with episodes of low blood sugar during home monitoring, requiring urgent care.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was closely monitored for blood glucose levels and received intravenous dextrose as needed. His diabetes management was adjusted, and he was started on insulin therapy alongside his usual medications. The patient also demonstrated signs of chronic kidney disease and has a history of liver transplant rejection, which necessitated coordination with nephrology and transplant specialists.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vitals, improved glycemic control with adjustments to insulin dosages, and no evidence of acute rejection of the transplanted liver. Laboratory results indicated chronic kidney disease progression but stable renal function during admission. The patient was educated on dietary modifications and glucose monitoring.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented, capable of performing activities of daily living with minimal assistance. He requires home health services for ongoing diabetes management and monitoring of renal function. A follow-up with his endocrinologist and nephrologist is essential to ensure continuity of care.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Citalopram, Creon 12, Dextrose 50%, Gabapentin, Glucagon, Glucose Gel, Heparin, Insulin, Magnesium Oxide, Mycophenolate Mofetil, Nicotine Patch, OxyCODONE (Immediate Release), Sodium Chloride 0.9% Flush, Tacrolimus, and Vitamin D. He is instructed to continue home glucose monitoring, dietary management, and to report any symptoms of hypoglycemia immediately. A follow-up appointment is scheduled in one week with his primary care physician and endocrinologist.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient:** Male, 54 years old  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of sepsis, unspecified organism, following a 2-day history of fever, chills, and worsening back pain. He has a known history of morbid obesity (BMI 40.0-44.9) and cervical spinal stenosis. The patient reported no prior history of significant infections or recent travel.  \\n\\n**Hospital Course:**  \\nDuring his 1.5-day stay, the patient was started on broad-spectrum IV antibiotics, including Ceftriaxone, Levofloxacin, and Metronidazole, due to the suspected source of infection. The patient's condition stabilized with aggressive hydration and antibiotics. He was also managed for atelectasis and underwent a CT scan, revealing no acute changes. Multivitamins were administered to address nutritional status, and Apixaban was continued for his documented venous thromboembolism history.  \\n\\n**Key Findings and Procedures:**  \\nClinical examination revealed elevated WBC count with left shift and a C-reactive protein that indicated significant inflammation. The patient’s lumbar spine MRI confirmed pre-existing osteomyelitis. No surgical intervention was required during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved vital signs and reduced fever. He is ambulating independently, but due to his spinal stenosis and history of falls, he will require home health services for physical therapy and monitoring of his mobility. Assistance with activities of daily living may also be necessary given his obesity and recent infection.  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient’s medication regimen includes Apixaban, Ceftriaxone (transition to oral as outpatient), Levofloxacin, MetroNIDAZOLE, Simvastatin, and a 0.9% Sodium Chloride flush. He is advised to follow up with his primary care physician and infectious disease specialist within one week. Home health services are arranged to ensure continuity of care and support.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** 81-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of biliary acute pancreatitis without necrosis or infection (ICD-10: K8510). She presented with severe abdominal pain, nausea, and vomiting. A detailed history revealed that the patient has a history of type 2 diabetes mellitus, hypertension, and hyperlipidemia. \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely for signs of complications associated with acute pancreatitis. She was placed on NPO status initially and received supportive care including IV fluids (Lactated Ringer's), pain management with Hydromorphone, and management of her diabetes with insulin. Her condition improved gradually with a reduction in abdominal pain and normalization of laboratory values, including amylase and lipase. \\n\\n**Key Findings and Procedures:**  \\nImaging studies showed no evidence of biliary obstruction or necrosis. The patient underwent a routine abdominal ultrasound which confirmed the diagnosis of biliary pancreatitis. There were no procedural interventions required during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with no abdominal pain and was able to tolerate a regular diet. Her functional status has returned to baseline; she is independent in activities of daily living but will require home health services for monitoring of her glucose levels and medication management due to her diabetes and recent hospitalization.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications: Acetaminophen, Cilostazol, Clopidogrel, Diltiazem Extended-Release, Furosemide, Insulin, Lisinopril, and Magnesium Sulfate.  \\n\\n**Follow-Up Plan:**  \\nFollow-up with her primary care physician and a diabetes educator within one week is recommended. Home health services will initiate monitoring of her blood glucose, medication adherence, and assist with any additional needs as she transitions back to her home.\",\n",
       " '**Discharge Summary**  \\n**Patient Details:**  \\n- **Age:** 48  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 7.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of osteomyelitis of the thoracic vertebrae, presenting with significant back pain, fever, and elevated inflammatory markers. Notable past medical history includes type 2 diabetes mellitus with chronic kidney disease and hypertension.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was stabilized with intravenous antibiotics, including Ceftriaxone, and received supportive care. Pain management was achieved with Acetaminophen and Dexamethasone. A multidisciplinary approach was taken, involving physical therapy to address mobility issues secondary to pain and weakness.  \\n  \\n**Key Findings and Procedures:**  \\nMRI imaging confirmed the diagnosis of osteomyelitis. The patient underwent a minimally invasive procedure for catheter placement for drainage, which was successful without complications. Blood glucose levels were closely monitored, and insulin regimen was adjusted accordingly due to her diabetes management needs.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved pain control and mobility. She is able to ambulate with assistance and requires continued support for activities of daily living. Home health services will be initiated to provide nursing care for wound management and medication administration, as well as physical therapy to enhance her strength and mobility.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Ceftriaxone  \\n- DULoxetine  \\n- Insulin (adjusted dosage)  \\n- HydrOXYzine  \\n- Acetaminophen  \\n- Bisacodyl  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician and orthopedic specialist within one week of discharge. Home health services will continue to monitor her recovery, manage her medications, and provide necessary rehabilitation support.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Attending Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 72-year-old female admitted through the emergency department with exacerbation of hypertensive heart disease and chronic kidney disease (CKD). She presented with dyspnea, fatigue, and symptoms of heart failure. Initial workup revealed elevated blood pressure, elevated creatinine levels, and signs of congestive heart failure.\\n\\n**Hospital Course:**  \\nDuring her 34-day hospital stay, the patient was stabilized with diuretics and antihypertensive medications. She received treatment for acute on chronic diastolic heart failure and was managed for urinary tract infection. Renal function was monitored closely, and nephrology was consulted due to her stage 4 CKD. The patient underwent a cystostomy for urinary retention and was treated for secondary infections related to the catheter. \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent proteinuria, worsening renal function, and significant heart failure symptoms. Procedures performed included cystostomy placement and multiple imaging studies to assess renal and cardiac status. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing management for her heart and kidney conditions. She is capable of performing activities of daily living with assistance and will benefit from home health services for physical therapy and skilled nursing to monitor her medication regimen and vital signs. The patient demonstrates understanding of her conditions and agrees to adhere to follow-up appointments. \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Albuterol Nebulizer, Aspirin, Atorvastatin, Carvedilol, Clopidogrel, and Insulin. She is advised to follow up with her primary care physician within one week and continue follow-ups with nephrology and cardiology. Home health services will initiate contact within 48 hours of discharge to provide necessary support.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**MRN:** [MRN]  \\n**DOB:** [DOB]  \\n**Age:** 34  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for maternal care due to a low transverse scar from a previous cesarean delivery (ICD-10: O34211) at 39 weeks gestation. She presented with contractions and reported decreased fetal movement.  \\n\\n**Hospital Course:**  \\nDuring her 3-day stay, the patient was monitored closely for labor progression and fetal well-being. The patient received routine medications including 0.9% Sodium Chloride for hydration, Acetaminophen for pain management, and Enoxaparin Sodium for thromboprophylaxis. Additionally, she was given Oxytocin to augment labor and Naloxone as a precautionary measure due to opioid use in labor.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent a successful vaginal delivery with labor complicated by a cord around the neck, without compression. A single live birth was achieved, and the newborn was stable post-delivery. She remained afebrile and hemodynamically stable throughout her hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with good functional status. She is capable of ambulating independently and has been instructed on proper self-care and newborn care at home. Home health services will be initiated to provide postpartum support and monitor recovery, particularly focusing on incision care from her previous cesarean delivery and managing any pain post-delivery.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue with the following medications:  \\n- Ibuprofen for pain management  \\n- Docusate Sodium to prevent constipation  \\n- Ondansetron for nausea if needed  \\n- OxyCODONE (Immediate Release) for breakthrough pain relief as necessary  \\n- Calcium Carbonate for calcium supplementation  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with her obstetrician in one week. Home health services will follow up to assess her recovery, monitor vital signs, and assist with the care of her newborn.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 31 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 5.6 days  \\n**Diagnosis:** Severe pre-eclampsia complicating childbirth (ICD10: O1414)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to severe pre-eclampsia at 36 weeks gestation. She presented with elevated blood pressure, proteinuria, and significant edema. The decision was made for an expedited delivery due to concerns for both maternal and fetal well-being.\\n\\n**Hospital Course:**  \\nThe patient underwent an urgent cesarean section, which was uncomplicated. Postoperatively, she was monitored in the maternal-fetal unit. Her blood pressure was stabilized using labetalol and nifedipine, and her symptoms of pre-eclampsia gradually improved. Throughout her stay, she was managed for anxiety, and sertraline was initiated for her mental health needs. Additionally, she received supportive care, including pain management with acetaminophen and ibuprofen, as well as gastrointestinal support with docusate sodium and simethicone.  \\n\\n**Key Findings and Procedures:**  \\n- Cesarean delivery performed without complications.  \\n- Blood pressure stabilized within normal limits post-treatment.  \\n- No signs of additional infection or complications were observed during her stay.  \\n- Comprehensive discharge education was provided regarding signs of worsening symptoms related to pre-eclampsia and mental health.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with no acute issues. She is ambulating independently and able to perform activities of daily living with minimal assistance. Home health services will be beneficial for ongoing monitoring of her blood pressure, medication management, and support for her mental health as she transitions to postpartum care.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Dermoplast Spray  \\n- Diphenhydramine  \\n- Docusate Sodium  \\n- Ibuprofen  \\n- Labetalol  \\n- Nifedipine (Extended Release)  \\n- Sertraline  \\n- Simethicone  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nFollow-up with obstetrics within one week post-discharge and with mental health services for support. Home health nursing will be arranged to assess vital signs and medication adherence.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Age:** 54  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of gastrointestinal complications associated with a prosthetic device. He presented with abdominal discomfort and signs of malnutrition, including fatigue and weight loss. His past medical history is notable for alcoholic cirrhosis and hepatic failure.\\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent several diagnostic tests, including imaging studies which confirmed the presence of complications related to his gastrointestinal prosthetic devices. He received intravenous albumin for malnutrition, along with lactulose to manage hepatic encephalopathy. The patient was monitored closely for signs of portal hypertension and ascites. He demonstrated improved nutritional status and stability in his liver function tests by the time of discharge.\\n\\n**Key Findings and Procedures:**  \\nThe primary diagnosis was identified as an other mechanical complication of gastrointestinal prosthetic devices (ICD-10: T85598A). Additional findings included severe protein-calorie malnutrition (E43) and alcoholic cirrhosis (K7031). Interventions included administration of heparin for thromboprophylaxis and supportive care measures. The patient was also started on rifaximin to manage hepatic encephalopathy symptoms.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing home health services for management of his nutritional needs and medication regimen. He has been advised on dietary modifications to support liver health and maintain protein intake. The patient is capable of ambulating with minimal assistance but will benefit from home health nursing visits to monitor his clinical status and ensure adherence to his medication plan.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include albumin 25%, midodrine, rifaximin, lactulose, and sertraline, among others. The patient is scheduled for follow-up with his primary care physician within one week of discharge, and home health services will be initiated to assist with medication management and nutritional support.\",\n",
       " '**Patient Name:** [Redacted]  \\n**Age:** 41  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.5 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of acute onset abdominal pain, diarrhea, and vomiting lasting for 48 hours. Initial evaluation suggested infectious gastroenteritis (ICD-10: A09). The patient has a past medical history of essential hypertension, bipolar disorder, asthma, and gastroparesis.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was treated symptomatically with IV fluids including D5LR, electrolytes, and medications to control nausea and abdominal cramping (Dicyclomine and Ondansetron). She was monitored closely in the observation unit for rehydration and symptom improvement. The patient was also evaluated for coexisting conditions, including her bipolar disorder and asthma, which were managed with appropriate medications (e.g., Albuterol inhaler, Fluticasone). \\n\\n**Key Findings and Procedures:**  \\nKey findings included mild dehydration and elevated potassium levels, which were corrected during hospitalization. An ultrasound of the abdomen was performed to rule out any complications related to her abdominal symptoms, showing no acute findings. The patient was provided with education on dietary modifications due to her gastroparesis and advised on managing her gastrointestinal symptoms at home.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with resolved gastrointestinal symptoms and improved hydration status. She is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services will be initiated to assist with medication management, monitor her electrolyte levels, and provide education on dietary adjustments.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue medications including Losartan, Pantoprazole, and Magnesium Sulfate. A follow-up appointment with her primary care physician is recommended within one week to reassess her overall health and medication regimen. Home health services should ensure regular monitoring and provide support as needed.',\n",
       " '**Discharge Summary**  \\n**Patient Information**: 72-year-old male  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 1.9 days  \\n  \\n**History of Present Illness**: The patient was admitted for evaluation and management of biliary obstruction characterized by abdominal pain and jaundice. Initial imaging confirmed obstruction of the bile duct (ICD10: K831). The patient also has a complex medical history including portal vein thrombosis and chronic kidney disease, complicating his care.  \\n  \\n**Hospital Course**: During his stay, the patient was monitored closely for any signs of deterioration. He received intravenous fluids (D5 1/2NS, Lactated Ringers) and was started on analgesics for pain management. A multidisciplinary team was involved in his care, including consultations from gastroenterology and nephrology.  \\n  \\n**Key Findings and Procedures**: Imaging studies showed no acute complications, though the bile duct obstruction was confirmed. Procedures performed included endoscopic retrograde cholangiopancreatography (ERCP) to relieve the obstruction. The patient responded well to treatment with resolution of jaundice and improvement in abdominal pain.  \\n  \\n**Discharge Condition and Functional Status**: The patient is being discharged in stable condition with improved functional status. He is able to perform activities of daily living with minimal assistance. Home health services will be initiated for ongoing monitoring of his condition and assistance with medication management.  \\n  \\n**Medications at Discharge**: The patient is being discharged on the following medications: Artificial Tears Preservative-Free, Atenolol, Dextrose 50%, Fluoxetine, Gabapentin, Glucagon, Heparin, Insulin, Lorazepam, Levothyroxine Sodium, Lisinopril, and Omeprazole.  \\n  \\n**Follow-Up Plan**: The patient is advised to follow up with his primary care physician within one week and to maintain close communication with home health services. Monitoring of vital signs and blood glucose levels will be essential due to his diabetes and chronic kidney disease.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 29 years  \\n- **Gender:** Female  \\n- **Admission Type:** Surgical same-day admission  \\n- **Length of Stay:** 3.8 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with clonic hemifacial spasm, left side, requiring surgical intervention. The patient reported episodes of involuntary muscle contractions affecting the left side of her face, which had become progressively more frequent and bothersome. She also has a history of gastro-esophageal reflux disease, vitamin D deficiency, and migraine headaches.  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful surgical procedure (ICD-10: 00NM0ZZ) aimed at addressing her hemifacial spasm. Post-operatively, she was monitored in the recovery unit and subsequently transferred to a surgical ward. During her hospital stay, she received symptomatic treatment for pain and discomfort, including acetaminophen and dexamethasone. The patient tolerated the procedure well with no immediate complications.  \\n\\n**Key Findings and Procedures:**  \\n- Clonic hemifacial spasm confirmed; surgical intervention performed.  \\n- Discharge medications included acetaminophen, cyclobenzaprine for muscle relaxation, and escitalopram for anxiety management.  \\n- Patient's vitamin D levels were monitored, and she was prescribed calcium carbonate and cyanocobalamin to address deficiencies.  \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient demonstrated improved facial muscle control and reduced spasm frequency. She exhibited stable vital signs and was able to ambulate independently with mild fatigue. She requires home health services for post-operative monitoring and physical therapy to enhance recovery and ensure optimal functional status.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue with prescribed medications:  \\n- Acetaminophen for pain management  \\n- Cyclobenzaprine for muscle spasms  \\n- Escitalopram for mood stabilization  \\nFollow-up with her primary care physician and neurologist is recommended in 1 week to reassess her condition and make any necessary adjustments to her treatment plan.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Patient DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 52-year-old male who presented with symptoms consistent with malignant neoplasm of the head of the pancreas (ICD-10: C250). He exhibited signs of weight loss, jaundice, and abdominal pain. His past medical history is significant for type 2 diabetes mellitus with diabetic neuropathy, chronic systolic heart failure, and atrial fibrillation.\\n\\n**Hospital Course:**  \\nDuring an 11.9-day observation admission, the patient underwent extensive workup including imaging studies that confirmed the malignancy. He was started on supportive care, including pain management and nutritional support. The patient was monitored for complications such as hypokalemia and heart failure exacerbations. Throughout his stay, he received appropriate interventions for symptomatic relief and management of his chronic conditions.\\n\\n**Key Findings and Procedures:**  \\nKey findings included a significant increase in jaundice levels and the presence of a pancreatic mass on imaging. The patient was treated with medications including Bumetanide for fluid retention and Enoxaparin for DVT prophylaxis. He demonstrated improvement with symptom management and stabilization of his heart failure parameters. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required ongoing support due to his complex medical needs. He is being referred to home health services for assistance with medication management, monitoring of his diabetes, and support with activities of daily living due to weakness and fatigue. The patient can ambulate with assistance but will benefit from home health physical therapy to improve mobility.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Albuterol Inhaler, Amitriptyline, Atorvastatin, Clopidogrel, Creon 12, and Eplerenone, among others. He is scheduled for follow-up with oncology and primary care within the next two weeks to reassess his condition and adjust his treatment plan as necessary. The importance of adhering to the medication regimen and attending follow-up appointments was emphasized.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 29  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with abnormal fetal heart rate and rhythm complicating labor and delivery (ICD-10 O76). The labor was complicated by a cord around the neck without compression. The patient was at 40 weeks gestation and delivered a single live birth.  \\n  \\n**Hospital Course:**  \\nThe patient was monitored closely in the labor and delivery unit. Fetal heart rate abnormalities were assessed, and continuous fetal monitoring was employed. A first-degree perineal laceration occurred during delivery, which was repaired without complications. Pain management was initiated with acetaminophen and ibuprofen, and the patient was provided with supportive care and hydration through Lactated Ringer's solution.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a stable maternal condition post-delivery, with normal vital signs and appropriate uterine involution. The perineal laceration was appropriately managed. Medications administered during hospitalization included ondansetron for nausea and docusate sodium for stool softening.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently. She demonstrated adequate understanding of postpartum care, including perineal hygiene, pain management, and signs of potential complications. The patient will benefit from home health services to assist with ongoing monitoring of physical recovery and education on infant care.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Ibuprofen, Oxycodone (Immediate Release) for pain, Bisacodyl, Calcium Carbonate, Docusate Sodium, Milk of Magnesia, Simethicone, and sodium chloride 0.9% flush. She has been advised to follow up with her obstetrician within one week postpartum. Home health services have been arranged to provide further support.\",\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 69  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a postprocedural hemorrhage of the digestive system following a recent gastroenterological procedure. She presented with abdominal pain, weakness, and signs suggestive of significant blood loss, necessitating close monitoring and intervention. \\n\\n**Hospital Course:**  \\nDuring her 3.3-day stay, the patient received supportive care including IV fluids and blood transfusions to address acute posthemorrhagic anemia. The surgical team was consulted, and she underwent endoscopic intervention to address the source of hemorrhage. Her condition stabilized after the procedure, and she showed improvement in hemoglobin levels and overall clinical status. \\n\\n**Key Findings and Procedures:**  \\nKey findings included a significant drop in hemoglobin levels attributed to the postprocedural hemorrhage, confirmed via laboratory tests. The patient underwent two primary procedures: 0W3P8ZZ (Endoscopic intervention for hemorrhage control) and 0DJ08ZZ (Bowel anastomosis), which successfully managed the complications. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and reports mild abdominal discomfort, manageable with prescribed medications. She is ambulating independently and demonstrates the ability to perform activities of daily living with minimal assistance. Home health services will be engaged to provide continued monitoring and assistance with medication management, as well as to ensure dietary compliance related to her Type 2 diabetes and post-surgical recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Chlorthalidone, Dextrose 5%, Entecavir, Lisinopril, MoviPrep, Pantoprazole, and Insulin. A follow-up appointment with her primary care physician and a gastroenterologist is scheduled within one week to monitor her recovery and manage any ongoing treatment related to her diabetes and gastrointestinal health. Home health nursing will support medication administration and assess her overall progress.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 52 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of hypertensive heart disease complicated by chronic kidney disease and acute on chronic diastolic heart failure. He presented with worsening dyspnea, fatigue, and edema. His past medical history includes chronic kidney disease, paroxysmal atrial fibrillation, hypothyroidism, and hyperlipidemia.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was closely monitored and managed. He received diuretics to alleviate fluid overload, and his heart failure symptoms improved significantly. Renal function was assessed with regular laboratory tests, indicating mild acute kidney injury, likely secondary to dehydration. Electrolytes were corrected, and he was stabilized.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, elevated BUN and creatinine levels, and an echocardiogram revealing left ventricular hypertrophy. The patient was treated with intravenous diuretics and started on a regimen of oral antihypertensives, including Lisinopril and Metoprolol.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved functional capacity, with notable reduction in dyspnea and edema. He was able to ambulate independently and reported minimal fatigue.  Home health services have been arranged to assist with medication management, monitoring vital signs, and daily activities to ensure continued stability and support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Atorvastatin, Chlorthalidone, Heparin, Ipratropium Bromide Nebulizer, Lorazepam, Levothyroxine, Lisinopril, Metoprolol Succinate XL, Metoprolol Tartrate, Omeprazole, OxyCODONE (Immediate Release), and Spironolactone. A follow-up appointment with a cardiologist and nephrologist is scheduled in one week to monitor his heart and kidney function.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 45  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with signs of acute kidney failure, characterized by elevated creatinine levels and oliguria. She has a significant medical history, including chronic kidney disease and a history of a kidney transplant. The patient reported recent episodes of disorientation and fatigue. \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was closely monitored for renal function and fluid balance. Initial labs confirmed acute kidney failure (ICD10: N179). She was treated with intravenous 0.9% sodium chloride for hydration, alongside supportive care. A variety of medications were adjusted, including antihypertensives and antiplatelet agents due to her history of cardiovascular disease. \\n\\nKey findings included persistent elevation of serum creatinine, requiring nephrology consultation. An ultrasound ruled out obstructive uropathy. The patient received education regarding her medication regimen and dietary restrictions pertinent to her renal status. She was also evaluated by physical therapy to address her functional mobility, which had been compromised during the hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required ongoing monitoring of her kidney function and medication adherence. She demonstrated improved mobility with assistance and was deemed safe for discharge with recommendations for home health services to assist with medication management and physical rehabilitation. The patient was alert and oriented, but will need continued support to manage her chronic conditions effectively. \\n\\n**Medications at Discharge:**  \\nThe patient is to continue the following medications: Acetaminophen, Amlodipine, Aspirin, Atorvastatin, Calcitriol, Citalopram, Clopidogrel, Docusate Sodium, and Febuxostat. Follow-up appointments with nephrology and her primary care physician are scheduled within one week of discharge to reassess her renal function and adjust her treatment plan as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 53  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 7.4 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of secondary malignant neoplasm of the small intestine, initially presenting with abdominal discomfort and weight loss. Imaging studies and laboratory tests were performed to assess her condition, revealing complications of malignancy including intestinal obstruction and malignant pleural effusion.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient underwent careful monitoring and management of her symptoms. She received supportive care, including pain management with Morphine Sulfate and antiemetics such as Ondansetron. Dexamethasone was administered to manage inflammation associated with her malignant condition. The patient also received Liposomal Doxorubicin as part of her cancer treatment regimen.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included evidence of intestinal obstruction (ICD10 K5669) and a significant pleural effusion (ICD10 J910) which were managed conservatively. The patient tolerated interventions well, and her symptoms improved with treatment.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved abdominal symptoms and effective control of her malignant pleural effusion. She demonstrated the ability to perform activities of daily living with minimal assistance. Home health services have been arranged to provide follow-up care, including nursing visits for wound care and medication management.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Dextrose 5%, Docusate Sodium, Heparin flushes, and ongoing management with Dexamethasone and Morphine. A follow-up appointment with oncology is scheduled in one week to reassess her condition and adjust treatment as necessary. Home health services will coordinate with the oncology team to ensure continuity of care.  \\n  \\n**Plan for Home Health Services:**  \\nHome health nursing will assist with medication administration, monitor for any complications, and provide education regarding symptom management related to her ongoing treatment.',\n",
       " 'Patient is a 47-year-old female admitted for surgical intervention due to lumbar spinal stenosis with neurogenic claudication (ICD-10: M48062). The patient presented with worsening lower back pain radiating to both legs, accompanied by intermittent claudication, significantly impairing mobility. Surgical intervention involved decompression laminectomy and fusion (ICD-10: 0SG0071, 01NB0ZZ) to alleviate nerve compression and improve functional capacity.\\n\\nDuring her 2.6-day hospital stay, the patient was monitored closely in a post-anesthesia care unit, where she was stabilized and transitioned to the orthopedic ward. Post-operative recovery was uneventful, with gradual improvement in pain control managed with intravenous and oral analgesics including Hydromorphone, Oxycodone, and Acetaminophen. The patient also received Gabapentin for neuropathic pain and Diazepam to manage muscle spasms. Her vital signs remained stable throughout the hospitalization, and she was mobilized with physical therapy assistance.\\n\\nKey findings included the successful relief of lumbar nerve root compression, confirmed by post-operative imaging, and a reduction of pain levels from 8/10 to 3/10 by discharge. The patient demonstrated improved ambulation with the use of a walker and was able to perform activities of daily living with minimal assistance.\\n\\nAt the time of discharge, the patient is stable with a functional status that allows for home health services to assist with physical therapy and medication management. She was educated on the importance of continued rehabilitation and pain management strategies at home. Discharge medications include Acetaminophen, Atorvastatin, Bisacodyl, CeFAZolin, Diazepam, Docusate Sodium, Gabapentin, Hydrochlorothiazide, and appropriate bowel regimen medications.\\n\\nFollow-up appointment is scheduled with orthopedic surgery in one week to assess recovery and adjust treatment as necessary. Home health services will monitor her progress and assist with physical therapy to enhance mobility and function.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Age:** 51  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for sepsis, unspecified organism, following a presentation of fever, chills, and altered mental status. He has a history of diabetes mellitus, hypertension, and acute kidney failure. Initial laboratory workup indicated elevated white blood cell count and positive blood cultures, reinforcing the diagnosis of sepsis. \\n\\n**Hospital Course:**  \\nUpon admission, the patient was started on broad-spectrum intravenous antibiotics and underwent aggressive fluid resuscitation. He was monitored closely in a step-down unit, where he received supportive care for his diabetes and kidney function. The patient’s blood glucose levels were managed with insulin therapy, and he was stabilized over the course of his hospital stay. The urinary tract infection was treated accordingly, and a urology consult was obtained for follow-up on urinary function. \\n\\n**Key Findings and Procedures:**  \\nNotable findings included severe sepsis without septic shock, acute kidney failure, and a urinary tract infection. The patient underwent daily labs to monitor kidney function and electrolytes. He responded well to treatment, with improvement in clinical status and laboratory parameters. \\n\\n**Discharge Condition and Functional Status:**  \\nAt time of discharge, the patient is stable and ambulating independently. He requires assistance with activities of daily living (ADLs) and will benefit from home health services for medication management, monitoring of blood glucose, and continued assessment of kidney function.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride (IV fluids as needed)  \\n- Acetaminophen  \\n- Atenolol  \\n- Atorvastatin  \\n- Insulin  \\n- Bisacodyl  \\n- Calcium Gluconate  \\n- Dextrose 50% (for hypoglycemia management)  \\n- Glucagon  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with nephrology for ongoing management of his renal status. Home health services have been arranged to assist with medication adherence and monitoring of his overall health status.',\n",
       " \"**Patient Summary:**  \\n**Name:** [Patient Name]  \\n**Age:** 66 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to recurrent episodes of orthostatic hypotension, which led to several falls at home. She has a significant past medical history including major depressive disorder, hypothyroidism, and attention-deficit hyperactivity disorder. During her stay, the patient experienced persistent dizziness and hypotensive episodes, particularly while transitioning from sitting to standing.\\n\\n**Hospital Course:**  \\nThe patient's hospital stay lasted 9.9 days, during which she received comprehensive evaluations, including orthostatic vital signs monitoring and medication adjustments. A multidisciplinary approach was employed, involving physical therapy to address mobility and balance concerns, and psychiatric support for her depressive symptoms. \\n\\n**Key Findings and Procedures:**  \\nSignificant laboratory findings included an elevated TSH, confirming hypothyroidism, which was managed with Levothyroxine. An echocardiogram was performed to rule out cardiac causes of syncope, which returned normal results. The patient was started on Fludrocortisone and Midodrine to manage her hypotensive episodes.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required assistance with activities of daily living due to her history of falls and ongoing dizziness. She demonstrated improved ambulation with a walker and was able to follow basic instructions. Home health services are recommended for ongoing physical therapy and nursing support to monitor her medication regimen and manage her hypotension. \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. BuPROPion (Sustained Release)  \\n4. Enoxaparin (Prophylaxis)  \\n5. Fludrocortisone Acetate  \\n6. Levothyroxine Sodium  \\n7. Midodrine  \\n8. Polyethylene Glycol  \\n9. Ramelteon  \\n10. Simethicone  \\n11. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge and will have regular assessments by home health services to monitor her blood pressure and medication adherence. She has been educated on fall precautions and the importance of hydration.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 65 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of infection and inflammatory reaction due to internal prosthetic devices, with a primary diagnosis of T8579XA. He presented with fever, chills, and abdominal discomfort. Initial labs indicated an elevated white blood cell count and signs of sepsis.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient received intravenous antibiotics, including Ceftriaxone, and supportive care for sepsis. He was monitored closely for signs of acute kidney failure and cholangitis; renal function stabilized with fluid management and diuretics (Furosemide). He also received antipyretics (Acetaminophen) and antacids as needed.  \\n  \\nMultiple imaging studies were performed, confirming malignant ascites and obstruction of the bile duct. The patient underwent a biliary drain placement (0FC98ZZ) to relieve cholestasis. Additionally, he received supportive care for anemia resulting from chemotherapy (D6481).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s condition improved with treatment, and he showed significant recovery. Key findings included resolution of fever and stabilization of renal function. He demonstrated improved functional status, ambulating independently and participating in activities of daily living with minimal assistance.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and tolerating diet; he requires ongoing home health services for management of his biliary drain and monitoring for infection. He will benefit from physical therapy to strengthen endurance and mobility.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Ceftriaxone  \\n- Furosemide  \\n- Allopurinol  \\n- Enoxaparin Sodium  \\n- Lorazepam  \\n- Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his oncologist and primary care physician within one week of discharge. Home health services will initiate within 48 hours to ensure continuity of care.',\n",
       " \"**Patient Name:** [REDACTED]  \\n**Age:** 42 years  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 6.3 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of abdominal pain and nausea. She was diagnosed with other appendicitis (ICD-10: K36) after imaging studies confirmed the diagnosis. The patient also presented with acute kidney failure (ICD-10: N179), requiring careful monitoring and management of her renal function during her stay.  \\n\\n**Hospital Course:**  \\nThroughout her 6-day hospitalization, the patient was treated with intravenous fluids, antibiotics (Ciprofloxacin HCl), and pain management (Hydromorphone). She was closely monitored for renal function and underwent daily laboratory evaluations. The patient's renal function improved, and she gradually progressed to a regular diet.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine levels initially suggestive of acute kidney failure, which improved with hydration and cessation of nephrotoxic agents. The patient was also found to have hypertension (ICD-10: I10) and iron deficiency anemia (ICD-10: D509), which were addressed through medication adjustments and supplementation. No surgical intervention was necessary for appendicitis as her condition stabilized.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with an improved functional status. She demonstrated the ability to ambulate independently and manage activities of daily living with minimal assistance. However, she requires home health services for continued monitoring of her renal function and medication management, especially considering her complex medical history.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atenolol  \\n3. Calcium Carbonate  \\n4. Ciprofloxacin HCl  \\n5. Docusate Sodium  \\n6. Emtricitabine-Tenofovir (Truvada)  \\n7. Ferrous Sulfate  \\n8. Hydrochlorothiazide  \\n9. Lorazepam  \\n10. Omeprazole  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week of discharge for comprehensive evaluation and monitoring. Home health services will be arranged to assist with medication management and renal function monitoring, ensuring a seamless transition to home care.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 54  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute postprocedural respiratory failure following a recent surgical intervention. His medical history is significant for portal vein thrombosis, portal hypertension with secondary esophageal varices, and hepatic fibrosis. He experienced acute respiratory distress, which was addressed promptly with supplemental oxygen and respiratory support.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored closely in the ICU. He received multiple interventions, including the administration of 0.9% sodium chloride, 5% dextrose, and medications such as enoxaparin sodium, pantoprazole, and nadolol. The patient's respiratory status improved with treatment, and he was gradually weaned off respiratory support.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent several procedures, including the insertion of a central venous catheter and interventions to manage his thrombosis. Imaging studies confirmed the presence of portal vein thrombosis but showed no acute changes in his liver. He tolerated all procedures well and showed improvement in his clinical status by discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated stable respiratory function with adequate oxygenation levels. He is alert, oriented, and able to perform basic activities of daily living with minimal assistance. He will benefit from home health services for ongoing monitoring of his respiratory status and management of his complex medical needs.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed acetaminophen, pravastatin, and bisacodyl for symptomatic management. He is advised to continue enoxaparin sodium and nadolol as directed. A follow-up appointment with his primary care physician and a hepatologist is scheduled within one week to assess his recovery and manage any complications related to his underlying conditions. Home health services will also assist with medication management and daily monitoring.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 49  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted under observation for management of a non-ST elevation myocardial infarction (NSTEMI) diagnosed during an emergency evaluation following complaints of chest pain. His past medical history is significant for essential hypertension, nicotine dependence, and a previous myocardial infarction.  \\n\\n**Hospital Course:**  \\nDuring his 2.7-day stay, the patient was monitored closely for cardiac rhythm and vital signs. He was started on aspirin, atorvastatin, and carvedilol to manage his cardiac condition and optimize heart function. He also received intravenous heparin for anticoagulation. His pain was managed with nitroglycerin and acetaminophen. Cardiac biomarkers showed a gradual normalization, and he remained hemodynamically stable throughout his stay.  \\n\\n**Key Findings and Procedures:**  \\nElectrocardiogram (ECG) showed no new ischemic changes, and echocardiogram indicated preserved left ventricular function. Laboratory tests revealed mild anemia and decreased white blood cell count, which were monitored without significant intervention. A nicotine patch was initiated to assist with smoking cessation.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with no chest pain and a satisfactory functional status. He demonstrated an understanding of his discharge medications and the importance of adhering to lifestyle modifications. He will benefit from home health services for ongoing monitoring of his blood pressure, medication adherence, and smoking cessation support.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 5% dextrose, aspirin, atorvastatin, carvedilol, gabapentin, heparin, hydralazine, lorazepam, magnesium sulfate, nicotine patch, and nitroglycerin sublingual. A follow-up appointment is scheduled with his cardiologist in one week to assess recovery and adjust medications as necessary. The patient is advised to contact his healthcare provider for any worsening symptoms or concerns.',\n",
       " \"Patient is a 24-year-old female who presented urgently with a Streptococcus B carrier state complicating childbirth. She was admitted for observation and management after delivery of a single live birth at 37 weeks gestation. The delivery was uncomplicated, but the presence of the Streptococcus B carrier status necessitated monitoring and treatment to prevent neonatal transmission.\\n\\nDuring her 2.5-day hospital stay, the patient was started on intravenous fluids and received prophylactic antibiotics to mitigate the risk of infection. A multidisciplinary team, including obstetrics and neonatology, was involved in her care. Key findings included stable vital signs, appropriate uterine involution, and the absence of any signs of infection. The patient was treated with pain management including Acetaminophen and Ibuprofen, and she received lactated Ringer's solution for hydration. Other supportive treatments included Bisacodyl and Docusate Sodium for bowel regularity, and she was administered the Influenza Vaccine Quadrivalent as part of her discharge immunization plan.\\n\\nUpon discharge, the patient is stable, with a functional status that allows her to care for herself and her newborn at home. She has been educated on signs of infection and the importance of follow-up care. Home health services have been arranged to provide additional support, including a nursing visit to monitor her recovery and assist with newborn care.\\n\\nDischarge medications include 0.9% Sodium Chloride for hydration, Hydrocortisone (Rectal) 2.5% Cream for any perineal discomfort, and Milk of Magnesia as needed for constipation. The patient is advised to follow up with her obstetrician within one week and to seek immediate medical attention if any concerning symptoms arise. Overall, the patient is well-prepared for home care with adequate resources in place.\",\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Patient Name:** [Insert Patient Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 54-year-old male with a notable history of Type 2 diabetes mellitus and other comorbidities who was admitted for observation due to a suspected cerebral infarction. He presented with dysarthria, facial weakness, and difficulty swallowing. Initial imaging confirmed other cerebral infarction (ICD-10: I638).  \\n\\n**Hospital Course:**  \\nDuring his 13-day stay, the patient was managed with supportive care, including nutritional support for moderate protein-calorie malnutrition. He received treatment with acetaminophen for pain, ampicillin-sulbactam for potential infection, and insulin for glycemic control. His condition improved progressively, with a reduction in dysarthria and facial weakness.  \\n\\n**Key Findings and Procedures:**  \\nNeurological examination revealed residual dysphagia and mild anarthria. The patient underwent swallow studies which indicated a need for a modified diet. He was also given a quadrivalent influenza vaccine, and his lipid levels were managed with atorvastatin. The patient's renal function was monitored due to his diabetic nephropathy, and appropriate adjustments to his medications were made.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but continued to require assistance with activities of daily living (ADLs) due to dysphagia and anarthria. Home health services will be needed for ongoing speech therapy and assistance with nutrition. The patient has been referred for home health nursing for medication management and monitoring of blood glucose levels.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications:  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Acetaminophen  \\n- Ampicillin-Sulbactam  \\n- Aspirin  \\n- Atorvastatin  \\n- Bisacodyl  \\n- Docusate Sodium  \\n- Insulin  \\n\\nA follow-up appointment is scheduled with his primary care physician in one week, and a referral to a speech therapist has been made for outpatient therapy. The patient is advised to monitor his blood sugar closely and report any concerns immediately.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Male, 74 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 5.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a primary diagnosis of angiodysplasia of the colon with hemorrhage (ICD-10: K5521). He presented with significant rectal bleeding and associated symptoms of weakness and fatigue. His medical history is notable for chronic kidney disease, type 2 diabetes mellitus, and hypertension.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care, including IV fluids and blood transfusions due to acute posthemorrhagic anemia. He underwent endoscopy, which identified and treated the angiodysplastic lesions, controlling the source of the hemorrhage. The patient was closely monitored for renal function, which remained stable throughout his stay.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, improvement in hemoglobin levels post-transfusion, and successful intervention during endoscopy. The following procedures were performed:  \\n1. Endoscopic intervention for angiodysplasia (ICD-10: 0DJ07ZZ)  \\n2. Blood transfusion (ICD-10: 0DJD8ZZ)  \\n3. Fluid management (ICD-10: 0DJ08ZZ)  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved energy levels and no active bleeding. His functional status has improved, allowing for ambulation with minimal assistance. He will require home health services for medication management, monitoring of blood pressure, and assistance with activities of daily living, considering his chronic conditions.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Aspirin EC  \\n- Docusate Sodium  \\n- Gabapentin  \\n- Heparin Sodium  \\n- Hydralazine  \\n- Levothyroxine Sodium  \\n- Metoprolol Succinate XL  \\n- Pantoprazole  \\n- Rosuvastatin Calcium  \\n- Polyethylene Glycol  \\n- Senna  \\n  \\nA follow-up appointment is scheduled with his primary care physician in one week to reassess his renal function and overall health status. Home health services will initiate within 48 hours post-discharge to ensure continuity of care.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name**: [Patient's Name]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Attending Physician**: [Physician's Name]  \\n\\n**Brief History of Present Illness**:  \\nThe patient is a 78-year-old male who presented to the emergency department with signs of confusion, weakness, and altered mental status. Laboratory tests revealed hypo-osmolality and significant hyponatremia (ICD10: E871). The patient has a past medical history of chronic systolic heart failure, atrial flutter, and multiple malignancies, contributing to his complex clinical picture.  \\n\\n**Hospital Course**:  \\nDuring the 4.8-day hospitalization, the patient was closely monitored and treated with intravenous fluids (D5NS) and electrolyte replacements to correct his sodium levels. His renal function remained stable, and he received supportive care for dehydration and hypo-osmolality. Other issues addressed included pain management with morphine sulfate and constipation, which was managed with bisacodyl and polyethylene glycol.  \\n\\n**Key Findings and Procedures**:  \\nKey laboratory findings showed gradual improvement in serum sodium levels from 120 to 134 mEq/L. The patient underwent daily monitoring of electrolytes and cardiac status due to his history of atrial flutter and heart failure. Additionally, he was assessed by a dietitian to ensure adequate nutritional intake.  \\n\\n**Discharge Condition and Functional Status**:  \\nAt discharge, the patient is stable with improved cognitive function and is able to perform activities of daily living with moderate assistance. He will require home health services to assist with medication management, further electrolyte monitoring, and general support in daily activities.  \\n\\n**Medications and Follow-up Plan**:  \\nThe patient will be discharged on the following medications: Acetaminophen, Apixaban, Aspirin, Bisacodyl, D5NS, Docusate Sodium, Ferrous Sulfate, Morphine Sulfate IR, Multivitamins, Neutra-Phos, Omeprazole, Phosphorus, Polyethylene Glycol, Senna, and Simvastatin. A follow-up appointment with his primary care physician is scheduled in one week, and home health services will initiate care within 48 hours post-discharge. Further lab work will be necessitated to monitor electrolyte levels and renal function.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 23  \\n**Gender:** Male  \\n**Admission Type:** Observation  \\n\\n**History of Present Illness:**  \\nThe patient is a 23-year-old male who presented with signs and symptoms suggestive of sepsis. Upon admission, he exhibited fever, tachycardia, and elevated inflammatory markers. The primary diagnosis was sepsis due to an unspecified organism (ICD10: A419).  \\n\\n**Hospital Course:**  \\nDuring his 4.9-day stay, the patient was treated with intravenous antibiotics, including Ceftriaxone, and supportive care. His clinical condition improved after aggressive fluid resuscitation and the initiation of broad-spectrum antibiotics. The patient also experienced acute kidney failure with tubular necrosis (ICD10: N170), which was managed with careful monitoring of renal function and hydration.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver transaminases (ICD10: R7401) and signs of disseminated intravascular coagulation (ICD10: D65). The patient underwent monitoring for potential complications associated with sepsis and received symptomatic treatment for headache and insomnia. No invasive procedures were performed.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was afebrile, hemodynamically stable, and reported significant improvement in symptoms. Functional status is stable, with the ability to ambulate independently and perform activities of daily living with minimal assistance. Home health services have been arranged to monitor recovery and manage medications.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Ceftriaxone  \\n3. Heparin  \\n4. Ondansetron  \\n5. Pantoprazole  \\n6. Prochlorperazine  \\n7. Ramelteon  \\n8. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge and to monitor for any signs of recurrent infection or complications. Home health nursing services will visit to assess ongoing needs and ensure adherence to the medication regimen.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n**Attending Physician:** [Redacted]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old male who presented with acute onset of right eye ptosis and diplopia. He was diagnosed with third oculomotor nerve palsy. The onset of symptoms was sudden, causing significant distress and functional impairment. On admission, the patient reported associated symptoms of dizziness and difficulty with balance.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for observation due to the risk of associated complications from his medical history, including chronic obstructive pulmonary disease (COPD) and atrial fibrillation. During his stay, a comprehensive neurological assessment was performed, confirming the diagnosis of third nerve palsy with no evidence of intracranial hemorrhage on CT imaging. The patient was managed with appropriate symptomatic treatment, including acetaminophen for pain control and bronchodilators for COPD exacerbation.  \\n  \\n**Key Findings and Procedures:**  \\nNeurological examination revealed decreased pupillary reaction in the right eye with preserved extraocular movements in the left eye. Cardiac monitoring was initiated to manage the atrial fibrillation. The patient was also assessed for his diabetes management, and adjustments to his insulin regimen were made.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with a significant reduction in pain and improved understanding of his condition. He is able to ambulate with assistance but requires continued support for activities of daily living (ADLs) due to his visual impairment and underlying medical conditions. Home health services will be initiated to assist with medication management and monitoring for potential complications.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Acetaminophen, Albuterol Inhaler, Aspirin, Atorvastatin, Dextrose 50%, Digoxin, Docusate Sodium, Fluticasone-Salmeterol Diskus, Gabapentin, Glucagon, Glucose Gel, Insulin, Levothyroxine Sodium, Metoprolol Succinate XL, and Midodrine. A follow-up appointment with neurology and primary care is scheduled within one week to reassess his neurological status and manage chronic conditions.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 78  \\n**Gender:** Female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptomatic unspecified atrial fibrillation (ICD-10 I4891). She presented with palpitations and mild dyspnea. A review of her medical history revealed long-term use of anticoagulants and a history of essential hypertension and hyperlipidemia.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient's heart rate was monitored closely, and anticoagulation therapy was adjusted as needed. She received intravenous fluids for dehydration and was treated for acidosis. Laboratory tests indicated elevated white blood cell count, and she was managed for bacteriuria.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent atrial fibrillation with a rapid ventricular response, and imaging revealed a solitary pulmonary nodule. The patient underwent a comprehensive evaluation, including echocardiography and chest imaging, which were discussed with the patient and her family.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improvement in symptoms. She is able to perform activities of daily living with moderate assistance and requires ongoing monitoring at home. Home health services will be initiated to assist with medication management and monitoring of her cardiovascular status.  \\n  \\n**Medications:**  \\nUpon discharge, the patient is prescribed the following medications:  \\n- Metoprolol Succinate XL  \\n- Lisinopril  \\n- Calcium Gluconate  \\n- Magnesium Oxide  \\n- Docusate Sodium  \\n- Acetaminophen as needed  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week for reevaluation of her atrial fibrillation and management of her comorbidities. Home health services will provide support for medication adherence and monitor her clinical status. \",\n",
       " '**Discharge Summary**  \\n**Patient Information**: 58-year-old male  \\n**Admission Type**: Observation admit  \\n**Length of Stay**: 33.4 days  \\n  \\n**History of Present Illness**: The patient was admitted with a diagnosis of alcoholic cirrhosis of the liver with ascites (ICD10: K7031). He presented with worsening abdominal distension, jaundice, and fatigue. His history includes chronic alcohol use and multiple prior hospitalizations for similar issues.  \\n  \\n**Hospital Course**: During his stay, the patient underwent extensive medical management, including paracentesis to relieve ascites and management of his nutritional deficiencies, evidenced by severe protein-calorie malnutrition (ICD10: E43). He received diuretics (Furosemide), electrolyte replacement, and treatment for Clostridium difficile enterocolitis. His condition fluctuated, showing signs of acute kidney failure (ICD10: N179) and hepatic failure without coma (ICD10: K7200), necessitating close monitoring and adjustment of his medications.  \\n  \\n**Key Findings and Procedures**: Significant findings included persistent ascites and elevated liver function tests. The patient had successful paracentesis and received IV fluids and electrolyte management. His other comorbidities, including esophageal varices (ICD10: I8510), were managed appropriately.  \\n  \\n**Discharge Condition and Functional Status**: Upon discharge, the patient is stable but requires continued home health services for monitoring of his ascites and nutritional support. He is ambulatory but exhibits signs of weakness and fatigue, indicating a need for assistance with daily activities. A follow-up with a gastroenterologist is essential to monitor his liver function and manage his dietary needs.  \\n  \\n**Medications at Discharge**: The patient will continue on several medications, including Furosemide, Everolimus, and nutritional supplements. A comprehensive medication list was provided, including acutely needed medications like Acetaminophen and Albuterol inhaler.  \\n  \\n**Follow-Up Plan**: Follow up with home health services within the next week, and outpatient gastroenterology within 2 weeks. Monitor for signs of infection, worsening ascites, and adherence to dietary recommendations.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name], **Age:** 24, **Gender:** Female  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 24-year-old female who presented urgently with a Streptococcus B carrier state complicating childbirth. She was in labor at 39 weeks of gestation and was found to be a carrier of Group B Streptococcus. The patient was assessed for potential complications and was monitored closely throughout her labor.  \\n\\n**Hospital Course:**  \\nDuring her 1.5-day stay, the patient underwent continuous fetal monitoring and was managed with appropriate intravenous fluids, including Lactated Ringer's solution, and medications to support her comfort and labor progression. Oxytocin was administered to augment labor, and the patient received postpartum analgesia with Acetaminophen and Ibuprofen. She was educated on breastfeeding and appropriate newborn care.  \\n\\n**Key Findings and Procedures:**  \\nThe patient delivered a single live birth without complications. Post-delivery, she was observed for signs of infection given her carrier status. Vital signs remained stable, and the patient displayed no signs of infection or other complications. The patient received a postpartum care plan including Bisacodyl and Docusate Sodium for constipation prophylaxis, and Dermoplast Spray for perineal care.  \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was in stable condition. She was ambulating independently and demonstrated adequate understanding of self-care regarding her postpartum needs. The patient will benefit from home health services for continued monitoring of her recovery, education on infant care, and assistance with lactation support.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications: 0.9% Sodium Chloride flushes, Calcium Carbonate, Senna, and Simethicone as needed. She is advised to follow up with her obstetrician within one week post-discharge. Home health services will initiate contact to schedule visits for support and assessment.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 58 years old  \\n**Admit Type:** Observation  \\n**Length of Stay:** 2.8 days  \\n**Primary Diagnosis:** Acute embolism and thrombosis of femoral vein, bilateral (ICD-10: I82413)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of acute bilateral femoral vein thrombosis, presenting with unilateral leg swelling and discomfort. A Doppler ultrasound confirmed the diagnosis of acute embolism and thrombosis of the femoral vein bilaterally. The patient has a significant past medical history, including obesity (BMI 45.0-49.9), essential hypertension, hypothyroidism, and a personal history of nicotine dependence.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was initiated on anticoagulation therapy with Rivaroxaban and received Heparin during the initial management phase. Pain management was addressed with Acetaminophen, and hypertension was managed with Lisinopril and Hydrochlorothiazide. A comprehensive evaluation was conducted to rule out associated complications, including pulmonary embolism, which was not observed. The patient was educated on lifestyle modifications and the importance of adherence to anticoagulation therapy.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated D-dimer levels and imaging confirming the presence of thrombus in the bilateral femoral veins. No significant pulmonary embolism was detected. The patient received vaccinations, including the influenza vaccine, and was counseled on his chronic conditions.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating with assistance. He demonstrated understanding of his medication regimen and the importance of follow-up care. Home health services have been arranged for nursing visits to monitor INR levels and overall health status, as well as physical therapy to enhance mobility and prevent further thromboembolic events.\\n\\n**Medications at Discharge:**  \\n1. Rivaroxaban  \\n2. Heparin (as needed)  \\n3. Lisinopril  \\n4. Hydrochlorothiazide  \\n5. Levothyroxine Sodium  \\n6. Prednisone  \\n7. Calcium Carbonate  \\n8. Vitamin D  \\n9. 5% Dextrose and Sodium Chloride 0.9% flush (as needed)  \\n10. Acetaminophen (for pain management)  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and to maintain regular appointments with cardiology and endocrinology for ongoing management of his chronic conditions. Home health services will ensure compliance with anticoagulation therapy and assist in mobility rehabilitation.',\n",
       " \"**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Date of Admission**: [Date of Admission]  \\n**Date of Discharge**: [Date of Discharge]  \\n**Age**: 35 years  \\n**Gender**: Female  \\n\\n**History of Present Illness**:  \\nThe patient is a 35-year-old female admitted for observation due to acute posthemorrhagic anemia secondary to excessive bleeding, noted during her premenopausal period. The patient reported a history of heavy menstrual bleeding and presented with fatigue, dizziness, and pallor.  \\n\\n**Hospital Course**:  \\nDuring her brief hospital stay of less than 24 hours, the patient was monitored closely. Initial laboratory evaluations confirmed a hemoglobin level of 8.5 g/dL, indicating significant anemia. IV fluids (Sodium Chloride 0.9%) were administered to maintain hydration and support blood volume. The patient was also started on Atenolol to manage mild hypertension observed during admission.  \\n\\n**Key Findings and Procedures**:  \\nComplete blood count (CBC) revealed leukocytosis and thrombocytopenia, likely secondary to acute blood loss. The gynecology team was consulted for evaluation of the underlying cause of menorrhagia, and a pelvic ultrasound was performed, revealing the presence of leiomyoma (fibroids) of the uterus. The patient's condition stabilized with supportive care, and she was educated on the importance of follow-up regarding her menstrual health.  \\n\\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient was alert, oriented, and demonstrated improved energy levels. She was advised to refrain from heavy physical activity until her follow-up appointment. The patient expressed understanding of her condition and the need for subsequent care. Home health services were arranged to assist with monitoring her recovery and managing medication compliance.  \\n\\n**Medications and Follow-Up Plan**:  \\nThe patient is to continue taking Atenolol as prescribed and utilize Sodium Chloride 0.9% flush for hydration. Follow-up with her primary care physician and gynecologist is recommended within one week to reassess her anemia and discuss treatment options for the uterine leiomyoma. Home health services will monitor her vital signs and assist with medication administration.\",\n",
       " 'Patient is a 66-year-old female who was admitted for surgical intervention related to an arteriovenous malformation (AVM) of the cerebral vessels, coded as Q282. The patient presented with a history of hypertension (I10), hyperlipidemia (E785), and a personal history of transient ischemic attack (TIA), complicating her case. The surgical procedure performed was a craniotomy with resection of the AVM, coded as 03LG3DZ. \\n\\nDuring her 1.5-day hospital stay, the patient was monitored closely for neurological function and hemodynamic stability. Postoperatively, she experienced mild headache and nausea, which were managed effectively with acetaminophen and ondansetron, respectively. Neurological exams showed no deficits, and she remained stable throughout her course. \\n\\nKey findings included resolution of initial symptoms and no signs of rebleeding or complications from the procedure. The patient was educated on the importance of medication adherence and lifestyle modifications to manage her hypertension and hyperlipidemia, aiming to prevent further cerebrovascular events. \\n\\nAt discharge, the patient was alert and oriented, with functional independence in activities of daily living. She requires home health services for ongoing monitoring of her blood pressure and medication management. A follow-up appointment with her neurologist is scheduled in one week, along with a referral to a dietitian to address her hyperlipidemia. \\n\\nDischarge medications include Atenolol for hypertension, Atorvastatin for hyperlipidemia, and LevETIRAcetam for seizure prophylaxis. The patient is also prescribed Albuterol Inhaler for bronchospasm management, along with stool softeners and laxatives to prevent constipation. Overall, she is discharged in stable condition with a comprehensive plan for home health support to facilitate her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 25 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with exacerbation of symptoms consistent with chronic bronchitis, including persistent cough, wheezing, and increased sputum production. Her history is notable for unspecified chronic bronchitis (ICD-10: J42) and she has a history of bronchopulmonary dysplasia, congenital tracheomalacia, and gastro-esophageal reflux disease.  \\n  \\n**Hospital Course:**  \\nDuring her brief hospitalization, the patient received supportive care, including nebulized Ipratropium-Albuterol, systemic corticosteroids, and antibiotics (Ciprofloxacin) due to a suspected secondary infection. She was monitored closely for respiratory distress and was started on pain management with Hydromorphone and Gabapentin, assisting her with discomfort. Her respiratory status improved significantly with treatment, and she was able to demonstrate effective coughing and clear audible wheezing by day two.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a chest X-ray that revealed no acute changes from her baseline. Her vital signs stabilized, and she showed improvement in peak flow measurements. No invasive procedures were necessary during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was in stable condition, with improved respiratory function, although she required continued assistance with activities of daily living (ADLs) due to her baseline respiratory issues. It is recommended that she engage home health services for ongoing respiratory therapy and medication management.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Ibuprofen Suspension, Fluoxetine, Guaifenesin, Heparin (for flushing), Loratadine, and Ipratropium-Albuterol Nebulizer. The patient is advised to follow up with her primary care physician and a pulmonologist within one week to reassess her chronic bronchitis management and discuss further treatment options. Home health nursing will assist with medication administration and monitoring her respiratory status.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 55  \\nGender: Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 3.4 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 55-year-old male with a known history of a nonruptured cerebral aneurysm (ICD-10: I671). He presented for elective surgical intervention to address the aneurysm. Prior to admission, the patient reported intermittent headaches and dizziness but no acute neurological deficits.\\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a successful endovascular coiling procedure to address the cerebral aneurysm. The procedure was well-tolerated, and post-operative monitoring revealed stable vital signs and no immediate complications. Throughout the hospital stay, the patient was managed for essential hypertension (ICD-10: I10), anxiety disorder (ICD-10: F419), and other comorbidities, including chronic obstructive pulmonary disease and migraines. A multidisciplinary team was involved in the patient’s care, including neurology, psychiatry, and physical therapy.\\n\\n**Key Findings and Procedures:**  \\nNeuroimaging revealed successful occlusion of the aneurysm with no signs of hemorrhage. The patient was started on a regimen of anticoagulation therapy and was monitored closely for any signs of neurological deterioration. Discharge instructions included activity restrictions and the importance of follow-up imaging.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, alert, and oriented, with a Glasgow Coma Scale score of 15. Functional status was assessed as independent with activities of daily living, although some assistance with mobility may be required initially due to dizziness. Home health services are recommended for continued monitoring of blood pressure, medication compliance, and physical therapy to enhance recovery.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Alprazolam, Acetaminophen, Clopidogrel, and Hydrochlorothiazide among others. The patient is advised to follow up with neurology in one week for assessment and further management of his aneurysm and comorbid conditions. Home health will coordinate follow-up visits to ensure adherence to the treatment plan and monitor progress.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 53  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for acute management of worsening symptoms related to Bipolar II disorder, characterized by severe mood swings and suicidal ideations. The patient reported significant anxiety and chronic pain, which exacerbated her psychiatric symptoms.  \\n  \\n**Hospital Course:**  \\nDuring her 6-day hospitalization, the patient underwent psychiatric evaluation and was stabilized with pharmacotherapy, including adjustments to her mood stabilizers and anxiolytics. She was closely monitored for suicidal ideations and experienced a gradual improvement in her symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nPsychiatric evaluation indicated persistent symptoms of anxiety disorder and PTSD, contributing to her overall instability. A comprehensive pain management plan was instituted to address her chronic pain syndrome, and her blood pressure was monitored closely due to her essential hypertension. The patient was prescribed a combination of medications, including Lithium Carbonate, DULoxetine, and QUEtiapine Fumarate, among others, to manage her mood and anxiety.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged with improved mood stability and diminished suicidal ideations. She is deemed stable for home health services, with a need for ongoing psychiatric support and monitoring of her medications. Functional status has improved; however, she requires assistance with activities of daily living due to residual anxiety and chronic pain. Home health nursing will focus on medication management and mental health support.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. DULoxetine  \\n4. Fluticasone Propionate NASAL  \\n5. LORazepam  \\n6. Lithium Carbonate  \\n7. Milk of Magnesia  \\n8. NIFEdipine (Extended Release)  \\n9. OxyCODONE SR (OxyconTIN)  \\n10. QUEtiapine Fumarate  \\n11. Tizanidine  \\n12. Topiramate (Topamax)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her psychiatrist within one week of discharge. Home health services will initiate visits to assist with medication compliance and monitor her mental health status.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 71 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 19.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to embolism and thrombosis of the iliac artery (ICD-10: I745). She presented with acute limb ischemia, characterized by pain and pallor in the lower extremities. Her past medical history includes myocardial infarction (type 2), chronic heart failure, and paroxysmal atrial fibrillation, which contributed to her complex clinical picture.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent several diagnostic procedures including vascular imaging which confirmed the diagnosis of iliac artery thrombosis. She was started on anticoagulation therapy with Enoxaparin and underwent a successful endovascular procedure to restore perfusion. Her heart failure was managed with diuretics (Furosemide) and her atrial fibrillation was controlled with rate and rhythm management.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated troponin levels indicative of myocardial stress and evidence of chronic heart failure on echocardiogram. Procedures performed included endovascular thrombectomy and optimization of heart failure management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires assistance with activities of daily living (ADLs) due to residual weakness in her lower extremities. She is oriented and capable of participating in her care plan but will benefit from home health services for physical therapy and nursing management of her anticoagulation therapy.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Acetaminophen, Aspirin, Atorvastatin, Furosemide, and Enoxaparin. She will also continue with her inhalers (Albuterol and Ipratropium) for respiratory management. A follow-up appointment with her cardiologist and primary care physician is scheduled within one week to monitor her recovery and adjust her treatment plan as necessary. Home health services have been arranged to assist with medication management and rehabilitation.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 64  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 64-year-old female with a history of hypertensive heart disease and chronic kidney disease who presented for observation due to exacerbation of heart failure, likely related to fluid overload. She reported increased shortness of breath and lower extremity edema for several days prior to admission.  \\n  \\n**Hospital Course:**  \\nDuring her 7.9-day stay, the patient was stabilized with diuretics and fluid management. She responded well to treatment, with gradual improvement noted in her respiratory status and a decrease in edema. In addition to diuretics, she received antihypertensive therapy to manage her blood pressure, which remained within acceptable ranges.  \\nKey findings included elevated B-type natriuretic peptide (BNP) levels and renal function tests indicating stage 3 chronic kidney disease. The patient was monitored closely for any signs of acute kidney injury, which did not manifest.  \\n  \\n**Key Findings and Procedures:**  \\nEchocardiography was performed, revealing preserved left ventricular function with diastolic dysfunction, consistent with her known cardiac history. She was also screened for obstructive sleep apnea, which was confirmed, and appropriate management strategies were discussed.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved respiratory symptoms. She is able to perform activities of daily living with minimal assistance but will require continued support at home through home health services for medication management and monitoring of her heart failure status.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Allopurinol, Aspirin EC, Atorvastatin, Bisacodyl, Docusate Sodium, Fluticasone Propionate NASAL, Insulin, Labetalol, and Heparin as needed.  \\n  \\n**Follow-Up Plan:**  \\nShe is advised to follow up with her primary care physician within one week and with cardiology within two weeks. Home health services will be initiated to assist with medication management and monitor her fluid status. A referral for dietary counseling regarding diabetes and heart failure management has also been made.',\n",
       " 'Patient is a 63-year-old female who was admitted for surgical management of a malignant carcinoid tumor of the bronchus and lung (ICD-10: C7A090). The patient presented with complaints of persistent cough, shortness of breath, and recent weight loss, which prompted further investigation and subsequent surgical intervention. \\n\\nDuring her 3.5-day hospital stay, the patient underwent a right thoracotomy with resection of the tumor, where intraoperative findings revealed significant atelectasis and a pleural effusion (ICD-10: J9811, J90). Postoperatively, she received adequate pain management, including acetaminophen and ketorolac, as well as respiratory support with albuterol nebulizations to improve her lung function. \\n\\nKey findings during the hospitalization included the resolution of pleural effusion on imaging and stabilization of blood glucose levels, as she has a history of Type 2 diabetes mellitus (ICD-10: E119). She was also treated for hyperlipidemia and nonalcoholic steatohepatitis (ICD-10: K7581, E785). The patient was closely monitored for any signs of postprocedural complications, and she exhibited improvement in her respiratory status and overall condition.\\n\\nOn discharge, the patient is in stable condition, ambulating independently, and demonstrates adequate understanding of her discharge medications and follow-up care. She requires home health services for continued monitoring of her recovery, particularly to assist with respiratory therapy and diabetes management. \\n\\nMedications at discharge include Albuterol nebulizer solution, MetFORMIN (Glucophage), Docusate Sodium, and Ondansetron. The patient is advised to follow up with oncology within one week post-discharge for further evaluation of her malignancy and postoperative care. She is also instructed to monitor her blood glucose levels regularly and report any abnormal readings. Home health services will assist in medication management and ensure adherence to the follow-up plan.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 51 years  \\nGender: Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 4.9 days  \\n**Primary Diagnosis:** Agranulocytosis secondary to cancer chemotherapy (ICD-10 D701)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with severe neutropenia following chemotherapy for leukemia. She presented with fever and signs of infection, necessitating immediate intervention. Laboratory findings confirmed agranulocytosis, prompting initiation of broad-spectrum antibiotics and supportive care.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored closely for signs of infection and received several blood transfusions due to anemia. She was treated with Acyclovir for suspected viral infection and received supportive medications including intravenous fluids and electrolytes. The patient responded positively, with gradual improvement in her white blood cell count.  \\n\\n**Key Findings and Procedures:**  \\nBlood cultures were negative, and repeat CBC showed resolution of agranulocytosis. She underwent a supportive care regimen that included nutritional support and pain management. The patient was educated about her condition and the importance of monitoring for any signs of infection upon discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved blood counts and no signs of active infection. She is able to perform activities of daily living with some assistance and will require home health services for continued monitoring of her blood counts and medication management. Family members have been instructed on recognizing signs of infection and the importance of adherence to follow-up care.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on Sorafenib, Acyclovir, and other supportive medications including Atovaquone Suspension, Budesonide, and Clobetasol Propionate Cream. Follow-up appointments are scheduled with oncology and primary care to monitor her recovery.  \\n\\n**Follow-Up Plan:**  \\nShe is to follow up with her oncologist within one week and home health services will be arranged to assist with medication administration and daily care needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 77  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 77-year-old female who presented with respiratory distress and fever, subsequently diagnosed with pneumonia, unspecified organism (ICD10: J189). The patient has a significant medical history including chronic atrial fibrillation, acute kidney failure, and moderate protein-calorie malnutrition.  \\n  \\n**Hospital Course:**  \\nDuring her 5-day hospital stay, the patient was started on broad-spectrum antibiotics and received supportive care, including oxygen therapy for hypoxemia. Continuous monitoring of vital signs revealed stable parameters post-initial deterioration. The patient was treated for acute kidney failure with fluid management and diuretics.  \\n  \\n**Key Findings and Procedures:**  \\nChest X-ray indicated bilateral infiltrates consistent with pneumonia. Laboratory tests demonstrated elevated inflammatory markers. The patient underwent a therapeutic procedure for fluid management and received a total of three medications via IV during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient showed clinical improvement. She is currently stable, with oxygen saturation levels within normal limits on room air and improved respiratory effort. The patient requires assistance with activities of daily living due to musculoskeletal weakness and is being referred to home health services for continued monitoring and rehabilitation support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: 0.9% Sodium Chloride, Acetaminophen (Liquid), Albuterol Inhaler, Aspirin, Atorvastatin, Carbamazepine Chewable Tabs, Carvedilol, Docusate Sodium, Enoxaparin Sodium, Multivitamins, Neutra-Phos, Omeprazole, Potassium Chloride, and Senna.  \\nA follow-up appointment is scheduled with her primary care physician in one week to monitor her recovery and medication management. In addition, home health services will initiate care to assist with her rehabilitation and ensure proper medication adherence.',\n",
       " '**Patient Information:** 52-year-old female admitted for observation with a primary diagnosis of alcohol dependence with withdrawal (ICD10: F10239).  \\n\\n**History of Present Illness:** The patient presented with symptoms of acute alcohol withdrawal, including tremors, anxiety, and diaphoresis. There was a notable history of heavy alcohol use, with recent cessation leading to withdrawal symptoms. She also exhibited signs of sepsis with a pending workup for the source of infection.  \\n\\n**Hospital Course:** During her 8-day stay, the patient was monitored closely for withdrawal symptoms and started on a tapering regimen of lorazepam. Antibiotic therapy with nafcillin was initiated for suspected sepsis. Additionally, supportive care was provided for acute kidney failure (ICD10: N179) and other secondary issues related to her condition. The patient also received treatment for thrombosis related to a central venous catheter (ICD10: T80211A) and was managed for acute embolism of the right upper extremity (ICD10: I82621).  \\n\\n**Key Findings and Procedures:** Key laboratory results indicated acute kidney injury, which improved with hydration and supportive management. Imaging studies ruled out significant embolic events beyond the upper extremity, and blood cultures confirmed methicillin-sensitive Staphylococcus aureus. The patient received multiple medications including gabapentin for neuropathic pain, famotidine for gastrointestinal protection, and pantoprazole for acid suppression.  \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable but required continued monitoring at home for ongoing alcohol dependence and potential withdrawal symptoms. She demonstrated the ability to perform activities of daily living with minimal assistance but will benefit from home health services for medication management and education on alcohol cessation.  \\n\\n**Medications at Discharge:** The patient’s discharge medications include: 0.9% Sodium Chloride, Acetaminophen, aluminum-magnesium hydroxide-simethicone, famotidine, folic acid, gabapentin, lorazepam, multivitamins, nafcillin, pantoprazole, quetiapine extended-release, rivaroxaban, and trazodone.  \\n\\n**Follow-Up Plan:** The patient is advised to follow up with her primary care physician within one week of discharge and engage with home health services for ongoing support and monitoring of her alcohol dependence and overall health.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 77  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 77-year-old female with a history of secondary malignant neoplasm of the brain, presenting for observation due to worsening neurological symptoms. She has a complex medical history including cerebral edema, lung malignancy, atrial fibrillation, hypertension, and type 2 diabetes mellitus.  \\n  \\n**Hospital Course:**  \\nDuring the 3.7-day hospital stay, the patient was closely monitored for neurological status and symptoms of increased intracranial pressure. She received dexamethasone for cerebral edema and was managed for her diabetes and hypertension. Multiple imaging studies confirmed the presence of secondary malignancies and significant cerebral edema.  \\n  \\n**Key Findings and Procedures:**  \\nThe primary diagnosis was confirmed as a secondary malignant neoplasm of the brain (ICD-10: C7931). The patient underwent supportive care, including adjustments in her anticoagulation therapy due to her atrial fibrillation. A comprehensive medication review was conducted, and she was stabilized for discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with activities of daily living (ADLs) due to her neurological condition. She demonstrated the ability to participate in her care plan but will need home health assistance for medication management, mobility support, and monitoring of her neurological status.  \\n  \\n**Medications at Discharge:**  \\nThe patient is being discharged on the following medications: Atorvastatin, Dexamethasone, Diltiazem Extended-Release, Metoprolol Succinate XL, Insulin, Omeprazole, and a Pneumococcal vaccine. Additionally, she will receive D5NS and glucose gel for her diabetes management.  \\n  \\n**Follow-Up Plan:**  \\nOutpatient follow-up is scheduled with oncology and neurology specialists within one week of discharge. Home health services will initiate within 48 hours to assist with monitoring her condition and ensuring adherence to her medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 72  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 3.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of worsening respiratory symptoms, specifically dyspnea and cough, attributed to an underlying diagnosis of other specified diseases of the upper respiratory tract (ICD-10 J398). She has a history of essential hypertension and gastro-esophageal reflux disease, which were considered during her management.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was treated with nebulized bronchodilators (Albuterol and Ipratropium bromide) to alleviate respiratory distress. She received supportive care including intravenous fluids (0.9% Sodium Chloride) and was monitored for any signs of respiratory or gastrointestinal complications. The patient demonstrated improvement in her respiratory status with a decrease in dyspnea and was able to tolerate oral intake better towards the end of her stay.  \\n  \\n**Key Findings and Procedures:**  \\n- Notable improvement in respiratory function; oxygen saturation levels improved to >92% on room air.  \\n- No significant gastrointestinal issues noted, despite her history of irritable bowel syndrome and gastro-esophageal reflux.  \\n- Chest X-ray performed showed no acute abnormalities.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable and reported feeling better with improved functional capacity. She is able to perform activities of daily living with minimal assistance but requires ongoing monitoring due to her respiratory condition. Home health services are recommended for continued respiratory therapy and medication management, with an emphasis on monitoring her symptoms and adherence to her medication regimen.  \\n  \\n**Medications at Discharge:**  \\n- Albuterol 0.083% Nebulized Solution  \\n- Ipratropium Bromide Neb  \\n- Acetaminophen  \\n- Docusate Sodium  \\n- GuaiFENesin  \\n- Calcium Carbonate  \\n- Lorazepam  \\nFollow-up with her primary care physician is advised within one week of discharge to reassess her respiratory condition and adjust medications as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 25  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 6.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following an urgent assessment for exacerbation of bipolar disorder, presenting with a current manic episode without psychotic features. She exhibited elevated mood, increased energy, and decreased need for sleep, which had persisted for several days prior to admission. The patient also reported heightened anxiety and compulsive behaviors during this period.  \\n  \\n**Hospital Course:**  \\nDuring her 6-day hospitalization, the patient was stabilized on a regimen including Lithium Carbonate, Lamotrigine, and Risperidone to manage her manic symptoms effectively. She also received Diazepam to address acute anxiety episodes. The patient was monitored closely for side effects of medications, with regular lithium level checks performed due to her history of bipolar disorder.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient was assessed by psychiatry and underwent psychiatric evaluations, which confirmed the diagnosis of Bipolar Disorder, current episode manic (F3110). Additional evaluations revealed comorbid anxiety and obsessive-compulsive disorder, which were managed concurrently. Sleep studies indicated mild obstructive sleep apnea, which will require follow-up.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in a stable condition, with significant improvement in manic symptoms and overall mood. However, she requires ongoing support to manage her mental health, particularly with regards to anxiety and sleep disturbances. A referral to home health services has been initiated to provide ongoing psychiatric support and medication management.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Diazepam  \\n3. Lamotrigine  \\n4. Lithium Carbonate  \\n5. Propranolol  \\n6. Risperidone  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her psychiatrist within one week of discharge for medication adjustment and monitoring. Additionally, home health services will assist in ensuring compliance with medications and provide support for her mental health regimen. Recommendations for lifestyle modifications, including sleep hygiene practices, were discussed.',\n",
       " '**Patient Information:**  \\nAge: 50, Gender: Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted electively for the management of acute myeloblastic leukemia (ICD10: C9200) not having achieved remission. He presented with significant fatigue, weight loss, and recurrent infections. Initial workup revealed leukocytosis and abnormal bone marrow findings consistent with the diagnosis.  \\n\\n**Hospital Course:**  \\nThe patient underwent intensive chemotherapy but continued to experience complications, including acute graft-versus-host disease (GVHD), which necessitated the initiation of immunosuppressive therapy. A stem cell transplant was performed to address the malignancy, followed by close monitoring for transplant-related complications. Throughout his 30.7-day hospitalization, he received supportive care, including transfusions and antibiotics, to manage his symptoms and prevent infections.  \\n\\n**Key Findings and Procedures:**  \\nKey procedures included stem cell transplant (ICD10: 0JH63XZ) and supportive measures to manage GVHD. The patient had episodes of hemorrhage related to vascular prosthetic devices, necessitating interventions. Cardiac evaluations indicated atherosclerotic heart disease without angina (ICD10: I2510).  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing monitoring and support. He is advised to engage with home health services for assistance with daily activities, medication management, and monitoring for infection or GVHD symptoms. His functional status indicates partial independence but requires assistance with personal care and mobility.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Acyclovir, Fluconazole, Enoxaparin Sodium, and Bisacodyl among others. The patient is scheduled for follow-up with oncology in one week to evaluate response to treatment and adjust medications as necessary. Education on signs of infection and GVHD management was provided to the patient and family.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 61 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4 days  \\n**Primary Diagnosis:** Viral intestinal infection, unspecified (ICD10: A084)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a viral intestinal infection, presenting with diarrhea, abdominal cramping, and dehydration. Initial evaluation revealed significant electrolyte imbalances, including hypokalemia and hypomagnesemia. The patient has a history of obesity and type 2 diabetes, which contributed to her overall clinical picture.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was treated with intravenous fluids (0.9% Sodium Chloride and Lactated Ringer's solution) to manage dehydration. Electrolyte replacement was initiated with Neutra-Phos and potassium supplements. She was monitored closely for improvement in her symptoms, which gradually resolved over the course of her admission. Antiemetics (Ondansetron) were administered to manage nausea, and pain control was achieved with Morphine Sulfate and Acetaminophen. The patient's blood glucose levels were stabilized with Insulin therapy, and her diabetes was closely monitored.\\n\\n**Key Findings and Procedures:**  \\nThe patient underwent daily laboratory evaluations to monitor electrolyte levels and renal function. Key findings included normalization of electrolytes by the time of discharge. A psychological assessment was also conducted, noting a history of major depressive disorder, for which Mirtazapine was prescribed.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with resolution of acute symptoms. She is ambulatory and able to perform activities of daily living with minimal assistance. Home health services will be arranged to assist with medication management, monitor her diabetes, and provide support for mobility and dietary needs.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Apixaban, Atorvastatin, CloNIDine, Dextrose 50%, Glucagon, LORazepam, and Mirtazapine. A follow-up appointment with her primary care physician is scheduled within one week. Home health services will continue to monitor her condition and provide necessary support.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 66  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency ward with symptoms related to biliary tract disease, specifically diagnosed with \"Other specified diseases of biliary tract\" (ICD-10: K838). He presented with abdominal pain and jaundice, prompting further evaluation.\\n\\n**Hospital Course:**  \\nDuring his 1.7-day stay, the patient underwent laboratory tests and imaging studies to assess the biliary system. He was treated with intravenous fluids, antibiotics (Ciprofloxacin and Metronidazole), and supportive care. The patient received Lactated Ringer\\'s solution and Magnesium Sulfate for electrolyte management due to mild dehydration. He was monitored closely for any signs of acute kidney failure (ICD-10: N179), which was ruled out during the hospitalization.\\n\\n**Key Findings and Procedures:**  \\nThe patient\\'s primary diagnosis was confirmed through imaging, and he underwent supportive treatment. No surgical intervention was required at this time. Other significant comorbidities included essential hypertension (ICD-10: I10) and benign prostatic hyperplasia. The patient was evaluated by the gastroenterology team and was stable for discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improvement in his symptoms. He was ambulating independently and exhibited stable vital signs. He will require home health services for continued monitoring of his biliary condition and management of his medications, especially due to his history of alcohol dependence (in remission) and recent dehydration.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient was discharged on the following medications: Omeprazole, Ciprofloxacin HCl, Metronidazole, Finasteride, and Sodium Chloride 0.9%. He received vaccinations for influenza and pneumococcus. The patient is advised to follow up with his primary care physician in one week and the gastroenterology clinic within two weeks for further evaluation of his biliary tract condition. Home health nursing services will be initiated to assist with medication management and ensure adherence to follow-up appointments.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nMr. [Patient's Name], a 74-year-old male, was admitted for observation due to dehydration, secondary to end-stage renal disease and poorly controlled diabetes, presenting with nausea and vomiting. His medical history includes chronic diastolic heart failure and hypertension.\\n\\n**Hospital Course:**  \\nDuring his 1.7-day stay, the patient received intravenous fluids (Lactated Ringer's) to correct his hypovolemia, along with electrolyte monitoring. His blood glucose levels were managed with insulin (U-500), and he received appropriate care for his underlying conditions. The patient was closely monitored for signs of heart failure exacerbation, and furosemide was administered to manage fluid overload.\\n\\n**Key Findings and Procedures:**  \\nLab results indicated significant dehydration and electrolyte imbalances, necessitating rapid rehydration. The patient's renal function was assessed, and he was evaluated for his diabetic management. He did not exhibit any acute complications during his hospital stay, and there were no procedural interventions required other than IV fluid administration.\\n\\n**Discharge Condition and Functional Status:**  \\nMr. [Patient's Name] is stable at discharge, with improved hydration status and a better tolerance for oral intake. He is ambulating with assistance and can perform basic activities of daily living but will benefit from home health services for ongoing monitoring of his renal status, blood glucose levels, and medication management. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Acetaminophen, Aspirin, Calcitriol, Dextrose 50%, Docusate Sodium, Furosemide, and Insulin. He is advised to follow up with his nephrologist and primary care physician within one week to ensure continuity of care and management of his chronic conditions. Home health services will provide nursing support for medication administration and ongoing assessment of his condition.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 54  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 54-year-old male with a history of mild intermittent asthma who presented with an acute exacerbation characterized by increased wheezing, shortness of breath, and a productive cough. He also has a medical history of type 2 diabetes, essential hypertension, and a recent episode of acute kidney failure. The exacerbation was likely precipitated by a viral upper respiratory infection.  \\n  \\n**Hospital Course:**  \\nDuring his 3-day stay, the patient was monitored closely in the observation unit. He received nebulized albuterol and ipratropium treatments every 4-6 hours, along with systemic corticosteroids. Antibiotics were initiated to cover for a possible infection. His acute kidney failure improved with hydration and electrolyte management. The patient's blood glucose levels were stabilized with insulin therapy, and he was educated on proper glucose monitoring and management.  \\n  \\n**Key Findings and Procedures:**  \\nOn examination, the patient demonstrated improved respiratory effort, with a reduction in wheezing. Peak flow readings improved from 200 L/min to 350 L/min by discharge. Laboratory tests showed normalization of renal function parameters.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was clinically stable with improved respiratory status and understanding of his asthma action plan. He was able to ambulate independently and demonstrate proper inhaler techniques. Home health services have been arranged for follow-up assessments, medication management, and education on diabetes care.  \\n  \\n**Medications at Discharge:**  \\n1. Albuterol 0.083% Nebulized Solution  \\n2. Fluticasone-Salmeterol Diskus (100/50)  \\n3. Azithromycin  \\n4. Insulin  \\n5. Labetalol  \\n6. Magnesium Oxide  \\n7. Acetaminophen  \\n8. Nicotine Patch  \\n9. Dextrose 50% (for hypoglycemia)  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with primary care physician within one week, and an appointment with a pulmonologist to reassess asthma management. Home health nurse to visit within 48 hours for initial assessment and continued education.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 69 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of dysuria and increased urinary frequency. A urinalysis revealed bacteriuria, leading to further evaluation for potential urinary tract infection and associated complications. The patient has a history of end-stage renal disease requiring dialysis, which complicates his clinical picture.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored, and supportive care was initiated. He was started on intravenous fluids and antibiotics after urine cultures were obtained. Dialysis was performed as scheduled. The patient was also managed for hypertension and chronic kidney disease. He received symptomatic treatment for respiratory distress, and his oxygen saturation improved with bronchodilator therapy.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent bacteriuria, elevated blood pressure, and chronic respiratory failure. The patient underwent two dialysis sessions during the admission without complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for medication management and monitoring of vital signs. He is able to perform activities of daily living with some assistance and will benefit from physical therapy to improve strength and mobility.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications: Acetaminophen, Albuterol Inhaler, Allopurinol, Atorvastatin, Calcium Acetate, Finasteride, Folic Acid, Lorazepam, Levothyroxine Sodium, Lidocaine Jelly 2%, Magnesium Oxide, Ondansetron, Oxycodone (Immediate Release), and Oxybutynin.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with nephrology within one week and to engage home health services for medication compliance, dialysis support, and physical rehabilitation. Patients are also encouraged to contact the office for any signs of infection or respiratory distress.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 60 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of urinary tract infection (UTI) and exhibited acute symptoms including fever, dysuria, and increased urinary frequency. He has a significant past medical history, including chronic kidney disease stage 4, hypertensive heart disease, and atrial fibrillation. Notably, he has been on long-term anticoagulant therapy due to his atrial fibrillation.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was treated with intravenous antibiotics (CefTAZidime) for the UTI. His renal function was monitored closely due to underlying chronic kidney disease, and adjustments were made to his medications accordingly. He experienced transient hemiparesis post-stroke, which required physical therapy consultation.  \\n\\n**Key Findings and Procedures:**  \\nInitial labs confirmed the diagnosis of UTI, and imaging ruled out complications such as renal abscess. The patient required supportive therapies for his heart failure and was managed on diuretics and beta-blockers. He received physical therapy and occupational therapy to address mobility issues secondary to his hemiplegia. The patient improved progressively, demonstrating increased strength and independence in activities of daily living (ADLs).  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with improved urinary symptoms and has a functional mobility level sufficient for home health services. He will require assistance with daily activities and mobility support, given his recent hemiparesis.  \\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Albuterol Inhaler  \\n- Amiodarone  \\n- Apixaban  \\n- Atorvastatin  \\n- Bisacodyl  \\n- CARVedilol  \\n- CefTAZidime  \\n- Gabapentin  \\n- Isosorbide Mononitrate (Extended Release)  \\n- Levothyroxine Sodium  \\n- Mirtazapine  \\n\\n**Follow-Up Plan:**  \\nHe is advised to follow up with his primary care physician within one week. Home health services will be coordinated to provide nursing care for medication management and physical therapy for rehabilitation.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 64 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 12.7 days  \\n**Primary Diagnosis:** Diffuse large B-cell lymphoma, extranodal and solid organ sites (ICD-10: C8339)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted via the Emergency department with significant fatigue, weight loss, and night sweats. A thorough workup revealed diffuse large B-cell lymphoma involving extranodal sites.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent several diagnostic procedures, including imaging studies and a biopsy, which confirmed the diagnosis. She was initiated on chemotherapy comprising Cyclophosphamide, Doxorubicin, and Etoposide. The treatment was well-tolerated, and she received supportive care including hydration with 0.9% Sodium Chloride and nutritional support with 5% Dextrose. Her atrial fibrillation was managed appropriately with Dexamethasone and necessary monitoring.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s initial laboratory findings indicated elevated lactate dehydrogenase (LDH) and a significant reduction in hemoglobin levels, indicative of her underlying condition. During her stay, she received blood transfusions to manage anemia. Imaging revealed lymphadenopathy consistent with lymphoma. She was also treated for obstructive sleep apnea with appropriate interventions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrates improved strength and stability compared to admission. She is independent in activities of daily living but requires assistance with mobility. Due to her ongoing treatment and functional status, home health services are recommended for nursing care and rehabilitation support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Acyclovir, Allopurinol, Atorvastatin, and supportive chemotherapy agents. A follow-up appointment is scheduled with hematology within one week for ongoing evaluation and management. Home health services will monitor her vital signs, manage medications, and provide assistance with daily activities.',\n",
       " '**Discharge Summary**  \\n**Patient:** 83-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with symptoms suggestive of a non-ST elevation myocardial infarction (NSTEMI). He reported chest discomfort and dyspnea, prompting an urgent evaluation. His past medical history includes type 2 diabetes mellitus, essential hypertension, atherosclerotic heart disease, and benign prostatic hyperplasia.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent cardiac monitoring and laboratory evaluations, which confirmed NSTEMI. He received dual antiplatelet therapy with aspirin and clopidogrel, alongside atorvastatin for cholesterol management. He was treated for acute diastolic heart failure with furosemide and monitored closely for fluid status.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated troponin levels and evidence of heart failure on echocardiogram, which demonstrated diastolic dysfunction. The patient underwent a coronary angiogram, which revealed significant stenosis but no immediate intervention was performed.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved respiratory status and is ambulating independently. He demonstrates an understanding of his condition and medication regimen, which is crucial for his home health management. A follow-up with cardiology is recommended within one week post-discharge to assess ongoing cardiac care.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Clopidogrel  \\n- Docusate Sodium  \\n- Finasteride  \\n- Furosemide  \\n- Heparin Sodium  \\n- Metoprolol Tartrate  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Ticagrelor  \\n  \\n**Follow-Up Plan:**  \\nThe patient is referred to home health services for medication management, monitoring of vital signs, and assistance with activities of daily living as needed. He will require a home health nurse to ensure adherence to the treatment plan and address any emerging health issues.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 32  \\n- **Gender:** Female  \\n- **Admission Date:** [Admission Date]  \\n- **Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with a diagnosis of endometritis following delivery (ICD-10 O8612). She presented with fever, abdominal pain, and vaginal discharge, consistent with a postpartum infection.  \\n\\n**Hospital Course:**  \\nDuring her 1.8-day hospital stay, the patient was started on intravenous antibiotics, including Ampicillin and Clindamycin, to manage her endometritis. She received supportive care including analgesics (Acetaminophen and Ibuprofen) for pain management, and intravenous fluids (Lactated Ringer's and 0.9% Sodium Chloride) for hydration. The patient's respiratory status was monitored due to her history of asthma (ICD-10 J45909), but she remained stable throughout her stay.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed leukocytosis, consistent with infection. The patient's vital signs were closely monitored, and imaging studies were not necessary. The patient's condition improved significantly with treatment, and she was afebrile by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and afebrile, with a significant reduction in abdominal pain. She is able to perform activities of daily living with assistance and has been educated on signs of potential complications, such as increased pain, fever, or changes in discharge that would necessitate immediate medical attention.  \\n\\n**Medications at Discharge:**  \\n- Ampicillin Sodium  \\n- Clindamycin  \\n- Ibuprofen  \\n- Docusate Sodium  \\n- Simethicone  \\n- Calcium Carbonate  \\n- 0.9% Sodium Chloride Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is referred to home health services for continued monitoring and support with wound care and medication management. A follow-up appointment with her obstetrician is scheduled in one week to assess recovery and further management of her postpartum condition.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 43 years old  \\n**Admission Date:** [Insert Admission Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n**Length of Stay:** 13.7 days  \\n**Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of alcoholic cirrhosis of the liver with ascites (ICD10: K7031) after presenting with abdominal distension, ascitic fluid accumulation, and signs of spontaneous bacterial peritonitis (ICD10: K652). The patient has a significant history of alcohol use disorder, contributing to hepatic dysfunction and portal hypertension.  \\n\\n**Hospital Course:**  \\nDuring the hospitalization, the patient received supportive care including intravenous fluids, diuretics (Furosemide), and antibiotics (Ciprofloxacin) for the management of spontaneous bacterial peritonitis. The patient was also placed on lactulose to manage hepatic encephalopathy symptoms. Serial abdominal ultrasounds confirmed the presence of ascites, and paracentesis was performed to relieve abdominal pressure and analyze ascitic fluid, which showed no signs of malignancy.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included hypo-osmolality and hyponatremia, anemia, and thrombocytopenia. Two procedures (ICD10: 0W9G3ZZ, 0W9G3ZX) were performed to manage the ascitic fluid.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved abdominal girth and resolved symptoms of infection. However, he requires ongoing monitoring for liver function, fluid management, and nutritional support. Functional status is limited; the patient will need assistance with activities of daily living and close follow-up with home health services for medication management and monitoring of liver disease progression.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Baclofen  \\n3. BuPROPion (Sustained Release)  \\n4. Ciprofloxacin HCl  \\n5. Furosemide  \\n6. Lactulose  \\n7. Multivitamins  \\n8. Ondansetron  \\n9. Pantoprazole  \\n10. Pregabalin  \\n11. HydrOXYzine  \\n   \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with a gastroenterologist within one week of discharge and engage in regular home health visits for medication adherence and monitoring of vital signs, fluid balance, and nutritional intake.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 28  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 4.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 28-year-old female with a history of Crohn's disease affecting both the small and large intestines, complicated by the presence of a fistula. She presented for surgical intervention to address her condition and was admitted for a same-day surgical procedure.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent a successful surgical procedure (ICD-10: 0DTH4ZZ, 0D1B4Z4) to manage her Crohn's disease and associated complications. Post-operatively, she was monitored closely for signs of infection and fistula output. The patient demonstrated an appropriate recovery trajectory, with gradual improvement in gastrointestinal function and pain management.  \\n  \\n**Key Findings:**  \\nUpon initial assessment, the patient's vital signs remained stable, with no acute distress. Laboratory tests revealed mild electrolyte imbalances, which were corrected with potassium chloride and phosphate supplementation. Pain was managed effectively with a regimen of acetaminophen and ketorolac, transitioning to oxycodone for breakthrough pain. The patient also received pre-operative and post-operative education regarding her condition and home care needs.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved functional status. She demonstrates the ability to perform activities of daily living with minimal assistance. Recommendations for home health services include monitoring of her surgical site, medication management, and dietary counseling to accommodate her Crohn's disease.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Enoxaparin Sodium  \\n4. Ketorolac  \\n5. Loperamide  \\n6. Metoclopramide  \\n7. Oxycodone (Immediate Release)  \\n8. Potassium Chloride  \\n9. Potassium Phosphate  \\n10. Prednisone  \\n11. Psyllium Wafer  \\n12. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with the gastroenterology team to assess her recovery and ongoing management of Crohn's disease. Home health services will commence immediately to ensure continuity of care.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 32  \\nGender: Female  \\n\\n**Admitting Diagnosis:** Neutropenia due to infection (ICD-10: D703)  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 32-year-old female who was admitted to the hospital with neutropenia secondary to an infection. She presented with fever and fatigue, prompting further investigation and subsequent admission for observation. The patient has a complex medical history involving lymphoblastic lymphoma and has been on multiple medications, including immunosuppressants.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was evaluated by hematology and oncology. Blood cultures were obtained, and broad-spectrum antibiotics were initiated. Her neutrophil count was monitored closely, and supportive care was provided, including hydration and transfusions as necessary. Notably, she was treated with GammaGARD for immunoglobulin support and managed with symptomatic relief medications such as acetaminophen for fever and ondansetron for nausea. The patient's condition stabilized, and she was discharged in a medically improved state.  \\n\\n**Key Findings and Procedures:**  \\n- Neutropenia resolved, with blood counts returning to baseline levels.  \\n- No active infections were identified upon discharge.  \\n- The patient received education on signs of infection and the importance of follow-up care.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and alert, with no acute distress. She can perform activities of daily living with minimal assistance and demonstrates an understanding of her medication management and follow-up needs. Home health services will assist with medication administration and monitoring for any signs of infection.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Acyclovir  \\n- Apixaban  \\n- CefePIME  \\n- DiphenhydrAMINE  \\n- GammaGARD Liquid  \\n- Pantoprazole  \\n- OxyCODONE (Immediate Release)  \\n- Ondansetron ODT  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician and hematology-oncology within 1 week. Additionally, home health services will be initiated to provide ongoing nursing care, medication management, and education to ensure a smooth recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 60  \\n- **Gender:** Male  \\n- **Length of Stay:** 5.8 days  \\n- **Admission Type:** Emergency  \\n  \\n**History of Present Illness:**  \\nThe patient presented with exacerbation of rheumatoid arthritis, characterized by severe joint pain and swelling, and was admitted for management of associated symptoms. He has a significant past medical history including acute kidney failure with tubular necrosis, which was closely monitored during the hospitalization.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was treated with intravenous acetaminophen for pain control, alongside hydroxychloroquine for his rheumatoid arthritis. He received supportive care, including docusate sodium for constipation and ondansetron for nausea. A multidisciplinary approach was utilized to address his nutritional needs, and he was started on Neutra-Phos supplementation. His renal function improved during the hospital stay, and he was stabilized without the need for dialysis.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated inflammatory markers consistent with rheumatoid arthritis flare, and improvement noted in renal function tests by discharge. Procedures performed included close monitoring of renal function and medication adjustments.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved joint mobility but continues to require assistance with activities of daily living due to ongoing symptoms of rheumatoid arthritis. He is advised to engage home health services for physical therapy to enhance mobility and for nursing support to manage medication administration.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen IV  \\n- Hydroxychloroquine Sulfate  \\n- PredniSONE  \\n- Levothyroxine Sodium  \\n- Tamsulosin  \\n- Neutra-Phos  \\n- Nystatin Oral Suspension  \\n- Ondansetron  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician in one week and is referred to rheumatology for ongoing management of rheumatoid arthritis. Home health services have been arranged to facilitate a smooth transition and ensure adherence to the medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 79 years old  \\n**Admit Type:** Observation Admit  \\n**Length of Stay:** 6.6 days  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n\\n**History of Present Illness:**  \\nThe patient presented to the hospital with an infection following a recent procedure. His past medical history is significant for type 2 diabetes mellitus, chronic obstructive pulmonary disease (COPD), and protein-calorie malnutrition. He demonstrated signs of infection with fever, elevated white blood cell count, and localized tenderness at the surgical site.\\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was monitored closely in the observation unit, receiving intravenous antibiotics and supportive care for his infection. He was also assessed for his malnutrition and given nutritional supplementation. Pulmonary function was monitored due to his COPD, and he received nebulized bronchodilators as needed. The patient underwent imaging studies, which revealed no complications related to the procedure itself. \\n\\n**Key Findings and Procedures:**  \\nThe patient was treated with IV antibiotics for the infection and received supportive measures for his nutritional status. A comprehensive geriatric assessment was performed, which highlighted the need for continued nutritional support and pulmonary rehabilitation.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, afebrile, and reported improvement in symptoms. He demonstrated the ability to perform activities of daily living with assistance and was able to ambulate short distances. Home health services are recommended to assist with medication management, nutritional support, and pulmonary care, including nebulizer treatments.\\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Allopurinol  \\n- Creon 12  \\n- Dextrose 50%  \\n- Diphenhydramine  \\n- Fluticasone-Salmeterol Diskus (250/50)  \\n- Glucagon  \\n- Glucose Gel  \\n- Hydromorphone (Dilaudid)  \\n- Heparin and Heparin Flush  \\n- Insulin  \\n- Lidocaine 1%  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge for reassessment of his infection and management of chronic conditions. Home health services will initiate within 48 hours post-discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, Age 32  \\n**Admit Date:** [Date of Admission]  \\n**Discharge Date:** [Date of Discharge]  \\n**Length of Stay:** 4.8 days  \\n**Admission Type:** Direct Emergency  \\n**Primary Diagnosis:** Crohn's disease of small intestine with abscess (ICD10: K50014)  \\n**Secondary Diagnoses:** Nicotine dependence (ICD10: F17210), Crohn's disease with fistula (ICD10: K50013), Unspecified asthma (ICD10: J45909), Encounter for immunization (ICD10: Z23)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with severe abdominal pain and signs of intestinal obstruction due to Crohn's disease complicated by an abscess. The patient reported a history of intermittent abdominal pain, weight loss, and fatigue over the past few months, exacerbated by smoking and poor dietary habits.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent imaging studies that confirmed the presence of an abscess. He received intravenous hydration, nutritional support, and broad-spectrum antibiotics. Surgical evaluation was performed, and the decision was made to manage the abscess conservatively.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was monitored for signs of perforation and bowel obstruction. Daily labs were conducted revealing leukocytosis consistent with infection. Vital signs stabilized with treatment, and the patient responded well to medical management.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and has been educated on signs of potential complications such as fever, worsening abdominal pain, or changes in bowel habits. He is ambulatory and able to perform activities of daily living independently. Home health services have been arranged to assist with medication management and nutritional counseling.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Hydromorphone (Dilaudid)  \\n4. Heparin  \\n5. Influenza Vaccine Quadrivalent  \\n6. Metoclopramide  \\n7. Oxycodone (Immediate Release)  \\n8. Potassium Chloride 20 mEq in D5 1/2 NS  \\n9. Sodium Chloride 0.9% flush  \\n\\n**Follow-Up Plan:**  \\nFollow-up with a gastroenterologist in one week to monitor Crohn's disease management and adjust medications as needed. The patient is also referred to a smoking cessation program to address nicotine dependence.\",\n",
       " '**Patient Summary:**  \\nThe patient is a 66-year-old male who was admitted for observation after sustaining an unspecified fracture of the shaft of the right tibia due to a fall. The patient has a history of essential hypertension, obesity (BMI 35.0-35.9), and attention-deficit hyperactivity disorder.  \\n\\n**History of Present Illness:**  \\nThe patient presented with moderate pain and swelling in the right leg following a slip and fall incident at home. Initial imaging confirmed a closed fracture of the right tibia and fibula.  \\n\\n**Hospital Course:**  \\nDuring the 5-day stay, the patient was managed conservatively with pain control using acetaminophen and gabapentin, and appropriate hydration with IV fluids including 0.9% Sodium Chloride and Lactated Ringer’s solution. Antibiotic prophylaxis was initiated with Cefazolin, and he received enoxaparin for DVT prophylaxis. His acute kidney failure was monitored and improved during hospitalization.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent repeat imaging which showed stable fracture alignment. He was also evaluated for any potential complications related to his obesity and hypertension, which were managed with metoprolol and lifestyle modifications discussed. He was started on a bowel regimen with docusate sodium and bisacodyl to prevent constipation related to immobility and medication use.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating with a walker and demonstrating an ability to perform activities of daily living (ADLs) with assistance. Home health services are recommended for physical therapy to aid recovery and improve mobility. The patient will require follow-up for medication management and monitoring of his renal function.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Gabapentin  \\n4. Metoprolol Tartrate  \\n5. Enoxaparin Sodium  \\n6. Docusate Sodium  \\n7. Bisacodyl  \\n8. Antibiotics as prescribed (Cefazolin, Ceftriaxone)  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the orthopedic clinic in one week to assess fracture healing. Home health services will initiate within 48 hours post-discharge for physical therapy and nursing care.',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**MRN**: [Medical Record Number]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Age**: 32 years  \\n**Gender**: Female  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted for observation following a cerebral infarction due to embolism of other cerebral artery (ICD10: I6349). Initial symptoms included sudden onset hemiplegia affecting the right side, dysphagia, and expressive aphasia. The patient was also noted to have a NIHSS score of 5 at admission, indicating mild neurologic impairment.  \\n  \\n**Hospital Course**:  \\nDuring her 18-day hospital stay, the patient was closely monitored and underwent several diagnostic tests and treatments. She was started on anticoagulation therapy with Enoxaparin and later transitioned to Warfarin. A multidisciplinary team was involved in her care, addressing her needs related to hemiplegia and dysphagia. The patient received speech therapy and physical therapy, which significantly improved her functional status, allowing her to participate in activities of daily living with assistance.  \\n  \\n**Key Findings and Procedures**:  \\nImaging studies confirmed the cerebral infarction, and her condition was managed with supportive care. She was treated for iron deficiency anemia with Ferrous Sulfate and managed for hypertension with Hydralazine. The patient was discharged with a stable condition, having made progress in her rehabilitation.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt discharge, the patient was alert and oriented, requiring moderate assistance for mobility and ADLs. She displayed improved verbal communication skills but continued to have some dysphagia. Home health services are recommended to provide support with physical therapy and speech therapy.  \\n  \\n**Medications at Discharge**:  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Enoxaparin (Treatment)  \\n- Ferrous Sulfate  \\n- Hydralazine  \\n- Lorazepam  \\n- Lansoprazole Oral Disintegrating Tab  \\n- Polyethylene Glycol  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Warfarin  \\n  \\n**Follow-Up Plan**:  \\nThe patient is to follow up with her primary care physician within one week of discharge and continue home health services for rehabilitation support. Monitoring of INR levels is necessary due to Warfarin therapy.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 72-year-old male who presented to the emergency department with accidental poisoning due to medications. He was admitted for observation and supportive care. The patient's medical history is significant for chronic heart failure, chronic kidney disease, and a malignant neoplasm of the rectum.  \\n\\n**Hospital Course:**  \\nDuring his 5.8-day stay, the patient was closely monitored and treated for complications resulting from his poisoning, including toxic encephalopathy. He received intravenous fluids and medications to manage his acute symptoms. The patient's heart failure was managed with diuretics and monitoring of his renal function. He was assessed by a multidisciplinary team that included cardiology and nephrology.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated creatinine levels consistent with acute on chronic kidney disease and signs of heart failure. Imaging studies did not reveal any acute abnormalities beyond the known malignancy. The patient was stabilized and demonstrated improvement in cognitive function and renal parameters before discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert and oriented, with improved mental status and stable vital signs. He exhibits moderate functional limitations and requires assistance with activities of daily living, particularly with mobility and medication management. Home health services will be essential for ongoing monitoring and support.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue medications including Acetaminophen, Allopurinol, Furosemide, and Digoxin. A follow-up appointment is scheduled with his primary care physician in one week, along with referrals to cardiology and nephrology for ongoing management of his chronic conditions. Home health will initiate visits to assist with medication adherence and monitor his heart failure symptoms.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Female, 30 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with polyhydramnios in the third trimester of pregnancy, presenting with increased abdominal girth and discomfort. She is 39 weeks gestation and has a history of obesity, BMI 45.0-49.9, complicating her pregnancy. She reported no significant contractions or rupture of membranes at the time of admission.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent careful monitoring of fetal heart rate and maternal vitals. An ultrasound confirmed the diagnosis of polyhydramnios, and she was assessed for potential complications. The patient received education on potential risks associated with her condition. She also received supportive care for her obesity-related challenges, including nutritional counseling and medication management.\\n\\n**Key Findings and Procedures:**  \\nThe primary diagnosis was confirmed as polyhydramnios (ICD-10: O403XX0). The patient's condition was stable throughout her hospital stay, with no acute complications noted. Procedures performed included amnioreduction to alleviate discomfort and prevent further complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, demonstrating good functional mobility and understanding of her discharge instructions. She requires home health services for ongoing monitoring of her condition, including maternal and fetal health checks. She will benefit from assistance with activities of daily living due to her obesity and postpartum recovery. \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Ibuprofen, Levothyroxine Sodium, Calcitriol, Calcium Carbonate, Docusate Sodium, Bisacodyl, Milk of Magnesia, Dermoplast Spray, Simethicone, and Misoprostol.  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her obstetrician within one week post-discharge and will have home health services initiated to monitor her recovery and support her needs. She is advised to contact her healthcare provider for any concerning symptoms.\",\n",
       " '**Patient Information:** 65-year-old male admitted for observation due to Non-ST elevation myocardial infarction (NSTEMI).  \\n\\n**History of Present Illness:** The patient presented with chest pain and dyspnea, leading to further diagnostics confirming NSTEMI. He has a notable history of hyperlipidemia and a family history of ischemic heart disease. During hospitalization, he developed acute posthemorrhagic anemia, likely secondary to blood loss associated with interventions.  \\n\\n**Hospital Course:** The patient was managed with aggressive medical therapy including aspirin, atorvastatin, and supportive care with intravenous fluids. He underwent several diagnostic procedures, including cardiac catheterization, which revealed atherosclerotic changes in the coronary arteries. The patient was closely monitored for potential complications, including postprocedural air leak and right bundle-branch block, which were addressed accordingly. His hemoglobin levels stabilized with appropriate transfusions and monitoring.  \\n\\n**Key Findings and Procedures:** Key findings included evidence of NSTEMI and postprocedural complications. Procedures performed included cardiac catheterization and subsequent interventions for anemia management.  \\n\\n**Discharge Condition and Functional Status:** The patient demonstrates significant improvement with stable vital signs and resolution of acute symptoms. He is ambulatory with assistance and meets criteria for home health services to facilitate his recovery. He will require nursing services for medication management and monitoring of cardiovascular status at home.  \\n\\n**Medications and Follow-Up Plan:** Upon discharge, the patient will continue on a regimen of 0.9% Sodium Chloride, Aspirin EC, Atorvastatin, and Furosemide, among others. He is advised to follow up with cardiology within one week of discharge for ongoing management of his cardiovascular health and to ensure adherence to his medication plan. Home health services will initiate within 48 hours post-discharge to provide necessary support.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 77  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a nontraumatic intracerebral hemorrhage (ICD10: I618), presenting with acute aphasia and altered mental status. Initial CT imaging confirmed the intracerebral bleed, prompting a neurology consult. The patient has a history of chronic diastolic heart failure, hypertension, and COPD, which complicated her clinical picture.  \\n\\n**Hospital Course:**  \\nDuring her 11.8-day hospital stay, the patient was stabilized with intravenous fluids, antihypertensive medications, and managed for her pulmonary conditions. Neurology monitored her progress, and speech therapy was initiated upon improvement in her mental status. The patient exhibited gradual improvement in her communication abilities and was able to participate in basic activities of daily living with assistance.  \\n\\n**Key Findings and Procedures:**  \\n- Neurology assessment indicated partial recovery of speech but persistent mild aphasia.  \\n- Cardiology evaluated her heart failure status, recommending continued monitoring and adjustments to her medication regimen.  \\n- The patient required supplemental oxygen during hospitalization due to exacerbation of COPD.  \\n- The patient received an influenza vaccination prior to discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved cognitive function but ongoing mild aphasia. She requires assistance with daily activities and supervision for safety concerns. Home health services have been arranged to provide physical and speech therapy to facilitate her recovery.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Nebulizer Solution  \\n- Aspirin  \\n- Furosemide  \\n- Hydralazine  \\n- Labetalol  \\n- Fluticasone-Salmeterol Diskus  \\n- Docusate Sodium  \\n- Bisacodyl  \\n- Heparin  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and continue home health services as initiated. She will also be monitored for her heart failure and respiratory conditions. Regular communication with her home health team is essential to adjust her care plan as needed.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 28  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to toxic liver disease with hepatic necrosis (ICD-10: K7110). He presented with symptoms of jaundice, fatigue, and abdominal pain following a recent medication regimen that included barbiturates and iminostilbenes.  \\n  \\n**Hospital Course:**  \\nDuring the 10.6-day hospital stay, the patient was closely monitored for liver function and renal status. Initial lab results indicated elevated liver enzymes and bilirubin, along with signs of acute kidney failure with tubular necrosis (ICD-10: N170). Supportive care was initiated, including intravenous fluids, heparin for DVT prophylaxis, and medications to manage symptoms such as nausea and pain.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed hepatic necrosis, and the patient received multiple consultations from hepatology and nephrology. A liver biopsy was performed, which corroborated the diagnosis. The patient’s coagulation profile was monitored due to acquired coagulation factor deficiency (ICD-10: D684). He showed gradual improvement in liver function tests and was stabilized before discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient exhibited improved liver function with a decrease in jaundice and abdominal pain. He is able to perform activities of daily living independently but requires home health services for ongoing monitoring of liver function and medication management, especially in adjusting his medications including Lacosamide and Amlodipine. The patient has been advised to maintain a high level of hydration and to report any signs of recurrence of symptoms immediately.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 5% dextrose, clindamycin, ondansetron, sevelamer carbonate, and a flush of sodium chloride 0.9%. The patient is scheduled for a follow-up appointment with his primary care physician in one week to reassess liver function and renal status. Home health services will provide a nurse for medication administration and monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 63  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 63-year-old male with a history of peripheral vascular disease (ICD-10: I739) who was admitted for surgical intervention related to his condition. He has a complex medical history including type 2 diabetes mellitus, hypertension, Barrett's esophagus, and obstructive sleep apnea. He was evaluated for worsening claudication and underwent a surgical procedure (ICD-10: 041J0JB) on admission day.  \\n  \\n**Hospital Course:**  \\nDuring his 4-day hospital stay, the patient was closely monitored for post-operative complications. He received appropriate pain management with hydromorphone and was started on anticoagulation therapy with heparin. His diabetes was managed with metformin and glipizide. The patient demonstrated improvement in ambulation and wound healing during his stay, although he required assistance due to limited mobility from his prior leg amputation.  \\n  \\n**Key Findings and Procedures:**  \\nPre-operative assessments showed significant peripheral vascular disease, and the surgical procedure aimed to improve blood flow. Post-surgery, the patient was stable with no signs of infection or complications. He was educated on lifestyle modifications, including tobacco cessation, and the importance of medication adherence.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved functional status but required assistance for activities of daily living (ADLs) due to decreased mobility. Home health services will be initiated for physical therapy to enhance ambulation and for nursing visits to manage medication adherence and monitor his diabetes.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: 5% Dextrose, Clopidogrel, Gabapentin, Lisinopril, Metoprolol Succinate XL, Metformin, and Docusate Sodium. He is advised to follow up with his primary care physician within one week and to monitor his blood glucose levels regularly. Home health services will contact him within 48 hours to initiate therapy.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 41-year-old male with known primary sclerosing cholangitis (ICD-10 K8301), who presented for observation due to worsening abdominal discomfort and pruritus. The symptoms began approximately two weeks prior to admission and were associated with fatigue and nonspecific gastrointestinal complaints.  \\n\\n**Hospital Course:**  \\nDuring his 1.9-day stay, the patient underwent a comprehensive evaluation, including laboratory tests that revealed elevated transaminases and alkaline phosphatase levels. Imaging studies were performed, which confirmed the diagnosis of bile duct obstruction (ICD-10 K831). The patient was treated with intravenous fluids (Lactated Ringers), magnesium sulfate, and analgesics including hydromorphone and acetaminophen for symptom relief. Ondansetron was administered for nausea.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was assessed by gastroenterology, and a biliary intervention was considered but deferred due to risks. He received supportive care, including Sarna lotion for pruritus management. Psychosocial evaluation noted mild anxiety (ICD-10 F419) that was addressed with a plan for outpatient follow-up and prescription of venlafaxine XR.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved abdominal discomfort and manageable pruritus. He demonstrated adequate understanding of his condition and the need for follow-up care. Home health services are recommended to assist with medication management and monitoring of liver function. The patient is advised to maintain hydration and report any worsening symptoms immediately.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Clonazepam  \\n3. Hydromorphone (Dilaudid)  \\n4. Lactated Ringers (for home health assistance)  \\n5. Magnesium Sulfate (as needed)  \\n6. Ondansetron (as needed)  \\n7. Sarna Lotion  \\n8. Venlafaxine XR  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with gastroenterology in one week and will have his liver function tests monitored closely. Home health services will be initiated to support his recovery and ensure adherence to the medication regimen.',\n",
       " '**Patient Information:**  \\n- **Age:** 65  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old female admitted via emergency with exacerbation of hypertensive heart disease complicated by heart failure. She presented with increasing dyspnea, edema, and fatigue. Her medical history is significant for chronic kidney disease, COPD, and common variable immunodeficiency.\\n\\n**Hospital Course:**  \\nDuring her 5-day stay, the patient was stabilized with diuretics and antihypertensives. Serial echocardiograms confirmed worsening diastolic dysfunction. Renal function was monitored closely due to acute kidney failure, and nephrology was consulted. The patient was treated with supplemental oxygen and bronchodilators for her COPD. She was closely monitored for fluid status, and her medications were adjusted accordingly.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, increased jugular venous distention, and bilateral crackles on auscultation. She underwent a renal ultrasound to evaluate her kidneys, which showed no obstructive pathology. A comprehensive review of her medication regimen was performed, and adjustments made to optimize her heart failure management.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved dyspnea and stable vital signs. She is functional with assistance, requiring help with activities of daily living due to weakness and fatigue. Her family is engaged and prepared to assist with her care at home. Home health services will be initiated to provide nursing care and physical therapy to enhance her recovery and independence.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aspirin, Bisacodyl, Calcium Carbonate, Diazepam, and Fluticasone Propionate nasal spray among others. The patient is advised to follow up with her primary care physician in one week and with cardiology in two weeks to monitor her heart failure management. Home health nursing will conduct regular assessments and medication management.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\nAge: 80  \\nGender: Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is an 80-year-old male who presented with acute onset of syncope and was diagnosed with a complete atrioventricular block. He has a notable history of chronic kidney disease, hyperlipidemia, and atherosclerotic heart disease.  \\n  \\n**Hospital Course:**  \\nUpon admission, the patient underwent telemetry monitoring which confirmed the diagnosis of complete AV block. He received intravenous magnesium sulfate and was stabilized with the initiation of heparin therapy due to a background of old myocardial infarction. A cardiology consult was obtained, and the patient was advised for potential pacemaker placement, which will be further evaluated in the outpatient setting.  \\n  \\n**Key Findings and Procedures:**  \\nDuring hospitalization, the patient exhibited transient episodes of bradycardia, which resolved with medical management. Laboratory tests revealed hyperlipidemia and mild acidosis, which were managed accordingly. Significant procedures included telemetry monitoring and fluid management for acute kidney failure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable, alert, and oriented, with no acute distress. He is ambulating independently with assistance and is able to perform activities of daily living with some support. Home health services have been arranged for continued monitoring of cardiac status and assistance with daily activities.  \\n  \\n**Medications and Follow-up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Aspirin, Atorvastatin, AmLODIPine, Fluticasone Propionate nasal spray, Heparin, Magnesium Sulfate, Polyethylene Glycol, Ramelteon, and Sodium Chloride 0.9% flush. He is advised to follow up with cardiology in one week and with his primary care physician in two weeks. Home health services will monitor his medication adherence and assist with daily living activities.  \\n',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Patient ID**: [Patient ID]  \\n**Date of Admission**: [Date]  \\n**Date of Discharge**: [Date]  \\n**Admitting Physician**: [Physician Name]  \\n**Discharge Physician**: [Physician Name]  \\n\\n**History of Present Illness**:  \\nThe patient is a 63-year-old female who presented to the emergency department with jaundice and abdominal discomfort. Initial evaluation indicated elevated bilirubin levels, prompting further investigation for underlying liver dysfunction. The patient has a history of essential hypertension, generalized anxiety disorder, and major depressive disorder, which were considered in her management.  \\n\\n**Hospital Course**:  \\nDuring her 1.5-day admission, the patient was monitored closely for liver function and metabolic status. She received intravenous fluids and electrolyte management, specifically for hyperkalemia. Liver function tests showed elevated transaminases, and a hepatology consult was obtained. The patient was initiated on supportive care, including Prednisone for inflammatory symptoms associated with giant cell arteritis.  \\n\\n**Key Findings and Procedures**:  \\nKey laboratory findings included significant elevations in bilirubin and liver transaminases, consistent with her diagnosis of other disorders of bilirubin metabolism (ICD10: E806). An abdominal ultrasound was performed, revealing no acute pathology.  \\n\\n**Discharge Condition and Functional Status**:  \\nThe patient is stable at discharge, ambulating independently with no acute distress. She has been educated on dietary modifications and the importance of regular follow-up for her liver function and overall health. Home health services will be arranged to assist with medication management and monitoring her mental health status.  \\n\\n**Medications and Follow-Up Plan**:  \\nAt discharge, the patient will continue on the following medications: Cetirizine, Gabapentin, Heparin, Lidocaine 5% Patch, Metoprolol Succinate XL, Omeprazole, Prednisone, Sarna Lotion, Sodium Chloride 0.9% Flush, Sodium Polystyrene Sulfonate, Trazodone, Triamcinolone Acetonide 0.1% Cream, Venlafaxine XR, and Amlodipine.  \\nFollow-up appointments are scheduled with her primary care physician and hepatology in one week. Home health services will initiate contact within 48 hours post-discharge.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 58-year-old male who presented with symptoms consistent with infective pericarditis, including chest pain and dyspnea. He has a past medical history significant for essential hypertension, hypothyroidism, gastro-esophageal reflux disease, and nicotine dependence.  \\n\\n**Hospital Course:**  \\nThe patient was admitted under observation for further evaluation and management of his condition. During the hospitalization, he underwent comprehensive cardiac evaluation, including echocardiography, which confirmed the presence of pericardial effusion. Laboratory tests indicated elevated inflammatory markers consistent with an infectious process. The patient was started on intravenous antibiotics and anti-inflammatory medication. His symptoms improved with treatment, and he was transitioned to oral medications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included echocardiographic evidence of pericardial effusion and elevated CRP levels. The patient's renal function remained stable throughout his hospitalization. No invasive procedures such as pericardiocentesis were required as the effusion was managed medically.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was clinically stable with resolution of acute symptoms. He is able to perform activities of daily living with some assistance as needed. A home health referral has been initiated to assist with medication management and monitoring of his vital signs, particularly blood pressure and signs of potential recurrence of pericarditis.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Colchicine, Heparin, Levothyroxine Sodium, Omeprazole, and Sodium Chloride 0.9% flush. He is scheduled for a follow-up appointment with his primary care physician in one week to reassess his condition and medication regimen. Education was provided regarding the importance of medication adherence and monitoring for any symptoms of recurrent pericarditis.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 26  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for a post-term pregnancy (ICD-10: O480). Upon admission, she presented with signs of labor complications, including abnormal fetal heart rate and rhythm (ICD-10: O76). The pregnancy was complicated by mental health issues, specifically major depressive disorder, which required careful management throughout her stay.  \\n\\n**Hospital Course:**  \\nDuring her 4.8-day hospitalization, the patient underwent an emergency cesarean section (ICD-10: 10D00Z1) due to a uterine rupture during labor (ICD-10: O711). Post-operatively, she was monitored in the labor and delivery unit for both maternal and neonatal well-being. Pain management was initiated with intravenous and oral analgesics, including Acetaminophen and Oxycodone. The patient also received lactated Ringer's solution to maintain hydration.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a single live birth without immediate complications. The patient exhibited stable vital signs post-operatively, although she experienced moderate pain, managed effectively with prescribed medications. Comprehensive mental health support was initiated due to her depressive symptoms, and she was provided with Lorazepam for anxiety management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with no immediate complications noted. She is able to care for her newborn with assistance and has been advised to avoid heavy lifting and strenuous activities. Home health services will be arranged to support her postpartum recovery and mental health needs, ensuring she has access to counseling and follow-up care.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, Ibuprofen, Lactulose, and Ondansetron for symptomatic management. She is to follow up with her OB-GYN within one week and maintain contact with her mental health provider for ongoing support. Home health nursing services will visit twice a week for the first month to monitor her recovery and provide assistance as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient’s Name]  \\n- **Age:** 41  \\n- **Gender:** Female  \\n\\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute onset of right upper quadrant pain, jaundice, and nausea. Imaging confirmed the presence of a calculus of the bile duct without associated cholangitis or cholecystitis, leading to obstruction.  \\n\\n**Hospital Course:**  \\nDuring her 2.4-day hospitalization, the patient underwent endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and stone extraction, followed by a laparoscopic cholecystectomy. Post-procedure, she was monitored for pain management and potential complications. Her pain was managed effectively with Morphine Sulfate and Acetaminophen. She also received supportive medications including Ondansetron for nausea, Docusate Sodium, and Bisacodyl for constipation management.  \\n\\n**Key Findings and Procedures:**  \\nUpon examination, the patient displayed stable vital signs post-ERCP. She experienced significant relief of her abdominal pain and was able to tolerate a regular diet. Labs indicated normalization of liver function tests prior to discharge, and no signs of infection were noted.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulatory, and able to perform activities of daily living with minimal assistance. Home health services are being arranged to assist with wound care and monitoring, as well as to address any potential complications related to her recent procedures. She has been educated on signs and symptoms to report, ensuring proactive management of her recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, Bisacodyl, Docusate Sodium, and a Nicotine Patch for smoking cessation. A follow-up appointment with her primary care physician and gastroenterologist is scheduled within one week. Home health services will provide ongoing assessment and support during her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date:** [Insert Date]  \\n**Attending Physician:** [Insert Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 34-year-old male who presented with symptoms consistent with acute cholecystitis, including abdominal pain and nausea. The patient reported onset of symptoms approximately 24 hours prior to admission, with increasing severity leading to the decision for hospital evaluation.\\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a thorough evaluation, including laboratory tests and imaging studies, which confirmed the diagnosis of acute cholecystitis (ICD-10 K810). He was admitted as an observation case due to the severity of the symptoms. The patient was initiated on IV fluids (Lactated Ringers), antibiotics (Ceftriaxone and Metronidazole), and pain management (Morphine Sulfate and Oxycodone). He also received supportive care, including antiemetics (Ondansetron) and stool softeners (Docusate Sodium and Senna).\\n\\n**Key Findings and Procedures:**  \\nDuring his stay, the patient showed signs of improvement, with significant reduction in abdominal pain and stabilization of vitals. No surgical intervention was required during the observation period. The patient was also monitored for any signs of complications related to his cholecystitis. The decision was made to discharge the patient after 1.6 days of observation, with stable vitals and satisfactory symptom control.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was clinically stable, ambulating independently, and able to perform activities of daily living with minimal assistance. He was advised to follow up with a gastroenterologist for ongoing management of his irritable bowel syndrome (ICD-10 K589) and to monitor any changes in his condition.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed the following medications: Acetaminophen, Ciprofloxacin HCl, Heparin, and continued use of stool softeners. A follow-up appointment is scheduled for one week post-discharge to assess recovery and medication efficacy. Home health services have been arranged for nursing support and medication management to ensure a safe recovery at home.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Age:** 56  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 5.6 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 56-year-old female diagnosed with a malignant neoplasm of the unspecified ovary (ICD-10: C569). She presented for surgical intervention and was admitted for same-day surgery. Preoperative evaluation indicated a need for comprehensive management of her associated comorbidities, including secondary malignant neoplasm of other urinary organs (C7919), hypertension (I10), and obesity (Z6831).\\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent multiple procedures including laparoscopic staging and debulking surgery. Postoperatively, she was closely monitored in the surgical unit for any complications such as bleeding or infection. The patient experienced acute posthemorrhagic anemia (D62) necessitating blood transfusions. She was also treated for hyperlipidemia (E785) and managed for symptoms of gastro-esophageal reflux disease (K219).\\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs post-surgery, and the patient was mobilized on postoperative day one. She received analgesics, including acetaminophen and oxycodone, for pain management. Postoperative imaging confirmed no immediate complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is currently stable for discharge with improved functional status. She can ambulate independently and perform activities of daily living with minimal assistance. Home health services will be arranged to assist with ongoing wound care and medication management.\\n\\n**Medications at Discharge:**  \\nThe patient will continue the following medications: Acetaminophen, Atorvastatin, Docusate Sodium, Enoxaparin (prophylaxis), Hydromorphone (Dilaudid), Ibuprofen, Ondansetron, Oxycodone (immediate release), Senna, Simethicone, Sodium Chloride 0.9% flush, Venlafaxine XR, and Amlodipine.  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments with oncology and primary care are scheduled within the next week. Home health services will be initiated to monitor her recovery and manage her medications.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 41  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 16.1 days  \\n**Primary Diagnosis:** Other specified sepsis (ICD-10: A4189)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with signs of sepsis, complicated by COVID-19 and acute respiratory distress syndrome (ARDS). He presented with fever, tachycardia, and altered mental status, requiring immediate intervention.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was treated with broad-spectrum antibiotics, including CefTAZidime, along with supportive care. He received dexmedetomidine for sedation and was placed on ventilatory support due to ARDS. His condition fluctuated, with episodes of shock managed with IV fluids and vasopressors. A total of 16 days were spent in the hospital, where he stabilized following aggressive management of his sepsis and respiratory failure. He was also treated for delirium secondary to his critical illness.  \\n\\n**Key Findings and Procedures:**  \\nKey investigations revealed acute respiratory distress, toxic encephalopathy, and acquired coagulopathy. The patient underwent procedures for ventilator management and was monitored closely in the ICU.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing assistance with activities of daily living (ADLs) due to residual weakness and cognitive effects from his illness. He will benefit from home health services for rehabilitation and monitoring.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Bisacodyl  \\n4. CefTAZidime  \\n5. Dexmedetomidine  \\n6. Enoxaparin (Prophylaxis)  \\n7. GuaiFENesin  \\n8. Methadone  \\n9. OxyCODONE (Immediate Release)  \\n10. Polyethylene Glycol  \\n11. Potassium Chloride  \\n12. Senna  \\n13. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with primary care and pulmonary specialists in one week. Home health services will commence immediately to assist with rehabilitation and medication management.',\n",
       " 'Patient is a 28-year-old male admitted for observation due to symptoms consistent with nonpyogenic meningitis, as indicated by ICD-10 code G030. The patient presented with severe headache, nausea, and vomiting, and reported a history of tobacco use. Upon admission, a lumbar puncture was performed to analyze cerebrospinal fluid (CSF), which confirmed the diagnosis of nonpyogenic meningitis. Throughout the 7.6-day hospital stay, the patient was treated with intravenous fluids, analgesics, and antiemetics to manage symptoms. Notably, the patient experienced constipation, which was addressed with bisacodyl and polyethylene glycol. He required pain management with opioids, including morphine sulfate and oxycodone, due to significant discomfort.\\n\\nThe patient showed gradual improvement, with a resolution of acute symptoms by the time of discharge. Key findings during the hospital course included elevated white blood cell count in CSF, but cultures remained negative for bacterial infection. The patient was able to tolerate oral intake and manage daily activities with minimal assistance by discharge. \\n\\nOn discharge, the patient’s condition was stable, and he was alert and oriented. His functional status had improved, allowing him to resume basic self-care tasks with the assistance of home health services. The discharge plan includes follow-up with neurology and primary care in one week, as well as continuation of medications including acetaminophen, ibuprofen, and a regimen for constipation. The patient will require ongoing monitoring for headache management and potential need for further symptom control. Home health services will assist with medication management and monitoring for any recurrence of symptoms.',\n",
       " '**Discharge Summary**  \\n**Patient:** 26-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.8 days  \\n**Primary Diagnosis:** Post-term pregnancy (ICD10: O480)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of post-term pregnancy at 41 weeks gestation. She presented with increased fetal monitoring due to concerns of fetal well-being and potential complications of prolonged gestation.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent continuous fetal heart rate monitoring, which demonstrated reassuring patterns. Given her post-term status, she was counseled on the risks of continued pregnancy, including potential for fetal macrosomia and increased likelihood of cesarean delivery. After a thorough discussion, the decision was made to induce labor. The induction was initiated, and she received oxytocin and epidural analgesia to manage labor pain.  \\n\\n**Key Findings and Procedures:**  \\nThe patient successfully delivered a healthy infant via spontaneous vaginal delivery. She experienced a shoulder dystocia, which was promptly managed, and there were no lasting complications for either mother or infant. After delivery, she was monitored for postpartum complications, and her vital signs remained stable. The patient received education on postpartum care, breastfeeding, and infant care. Procedures included induction of labor (ICD10: 3E0P7GC) and continuous fetal monitoring (ICD10: 10E0XZZ).  \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was stable, ambulating independently, and demonstrated an understanding of her discharge instructions. She expressed confidence in managing her postpartum recovery and infant care. Home health services have been arranged to provide assistance with breastfeeding support and postpartum monitoring, ensuring a smooth transition to home care.  \\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include Acetaminophen, Ibuprofen for pain management, Docusate Sodium, and Milk of Magnesia for constipation prophylaxis, as well as a flu vaccine. The patient is advised to follow up with her obstetrician within one week to assess recovery and address any concerns. Home health services will initiate their visit within 48 hours post-discharge.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Male, 58 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of rectal bleeding and discomfort associated with diagnosed hemorrhoids (ICD10 K648). He has a medical history significant for alcohol dependence, chronic pancreatitis, and iron deficiency anemia secondary to chronic blood loss.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent conservative management for his hemorrhoidal condition, including pain control with topical diclofenac and oral medications. He was also monitored for complications related to his chronic conditions, particularly in the context of his alcohol use and anemia.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant improvement in the patient's rectal discomfort and resolution of acute bleeding episodes. Laboratory tests confirmed iron deficiency anemia, which was managed with appropriate supplementation. The patient was assessed for his opioid dependence and provided referrals for outpatient support services.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulatory, and able to perform activities of daily living with minimal assistance. He demonstrated understanding of his discharge instructions, particularly regarding medication management and dietary modifications to prevent further complications. Due to his history of chronic pain and potential medication-related side effects, home health services have been arranged to assist in medication management and to provide support for his ongoing rehabilitation.  \\n\\n**Medications at Discharge:**  \\nThe following medications were prescribed at discharge: Creon 12, Diclofenac Topical Gel 1%, Docusate Sodium, Enoxaparin (treatment), Famotidine, Folic Acid, Gabapentin, Influenza Vaccine Quadrivalent, Lidocaine 1% for PICC/Midline insertions, Lisinopril, Morphine SR (MS Contin), MoviPrep, Multivitamins, Nitroglycerin SL, and Omeprazole.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with his primary care physician and will have home health nursing visits to monitor his recovery and adherence to the prescribed medication regimen. The patient was educated on signs of potential complications, including worsening anemia or gastrointestinal distress, and encouraged to seek immediate medical attention if these occur.\",\n",
       " 'Patient is a 91-year-old male who was admitted for observation due to pleural effusion (ICD-10: J90), accompanied by acute respiratory distress. The patient presented with increased shortness of breath, hypoxemia, and altered mental status. Initial assessment revealed decreased breath sounds on the right, leading to the suspicion of a significant pleural effusion. \\n\\nDuring the hospital course, the patient underwent a thoracentesis, which confirmed the presence of a right-sided pleural effusion. Approximately 1.5 liters of fluid were drained, resulting in marked improvement in respiratory status. The patient was monitored closely for any complications during the procedure and remained stable throughout his stay. Additional assessments indicated essential hypertension (I10) and a history of transient ischemic attacks (Z8673), requiring careful management of his cardiovascular status.\\n\\nKey findings included resolution of hypoxemia post-thoracentesis, although the patient continued to exhibit mild confusion, attributed to possible dehydration and age-related cognitive decline. His functional status at discharge was improved, with the ability to perform activities of daily living with minimal assistance. Home health services are recommended to provide ongoing respiratory support, medication management, and monitoring of mental status.\\n\\nAt discharge, the patient was prescribed Acetaminophen, Aspirin EC, Docusate Sodium, Furosemide, Influenza Vaccine Quadrivalent, Ipratropium-Albuterol Nebulizer, Metoprolol Succinate XL, Ramelteon, Senna, and Sodium Chloride 0.9% Flush. A follow-up appointment with the primary care physician is scheduled for one week post-discharge to reassess respiratory status and medication adherence. Additionally, home health nursing will monitor vital signs and assist with respiratory treatments.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 72  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient presented with symptoms consistent with hydronephrosis, primarily characterized by flank pain and difficulty urinating. A history of renal calculi was noted, and upon examination, she exhibited signs of acute kidney failure. The patient has a background of essential hypertension and hyperlipidemia, alongside a personal history of nicotine dependence and age-related osteoporosis.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted under observation for a length of stay of one day. During her stay, she underwent imaging studies confirming hydronephrosis due to renal and ureteral calculous obstruction (ICD10: N132). She was started on IV fluids (Lactated Ringers) and supportive care, alongside medications to manage her pain and control her blood pressure (Lisinopril). The patient received broad-spectrum antibiotics (Amoxicillin-Clavulanic Acid) to address potential urinary tract infections due to obstruction.  \\n  \\n**Key Findings and Procedures:**  \\nThe imaging results showed significant dilation of the renal pelvis and calyces due to obstruction. A urinary catheter was placed to relieve the obstruction temporarily. The patient was monitored closely for renal function, which showed gradual improvement throughout her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs and improvement in renal function, though she will need ongoing monitoring of her kidney health. She is alert and oriented, capable of performing her activities of daily living with assistance needed for mobility due to her age and osteoporosis. Home health services will be arranged to monitor her condition and assist with rehabilitation as necessary.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, OxyCODONE (Immediate Release), MethylPREDNISolone Sodium Succ, Ondansetron, Tamsulosin, Lisinopril, and Vitamin D3. She is advised to follow up with her primary care physician within one week and a nephrologist for further evaluation of her renal status. Home health nursing will assist with medication management and monitoring for any signs of complications.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 75-year-old female  \\n**Admission Type:** Observation  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to exacerbation of hypertensive heart disease with heart failure (ICD-10: I110). Upon admission, she presented with acute respiratory distress, hypoxia, and signs of pneumonia. The patient has a significant medical history, including acute kidney failure, hemiplegia following cerebral infarction, and chronic heart failure.\\n\\n**Hospital Course:**  \\nDuring her 6-day stay, the patient underwent a comprehensive evaluation and management plan, including intravenous antibiotics (Cefepime) for pneumonia and management of heart failure symptoms. She received diuretics for fluid overload and was monitored closely for respiratory status. Nebulization with Albuterol was initiated to alleviate bronchospasm. The patient's respiratory status improved, and she was weaned off supplemental oxygen.  \\n\\n**Key Findings and Procedures:**  \\nChest imaging revealed bilateral infiltrates consistent with pneumonia, and laboratory tests indicated acute kidney injury, which improved with hydration and medication adjustments. The patient was stabilized, and her heart failure was managed with diuretics and an ACE inhibitor.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improved respiratory function and resolution of acute distress. She is alert and oriented, but requires assistance with activities of daily living (ADLs) due to her hemiplegia. Home health services have been arranged to assist with physical therapy and monitoring of her medications and heart failure management.  \\n\\n**Medications at Discharge:**  \\nThe patient will be prescribed Acetaminophen, Albuterol (inhaler and nebulizer solution), Atorvastatin, Azithromycin, Gabapentin, and Dabigatran Etexilate, among others.  \\n\\n**Follow-up Plan:**  \\nA follow-up appointment is scheduled with her primary care physician within one week of discharge to monitor her heart failure and overall health status.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 31  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following an emergency visit due to an infection at a superficial incisional surgical site (ICD10: T8141XA) that developed post-operatively. The infection was characterized by local tenderness, erythema, and purulent discharge at the site. The patient has a history of recent abdominal surgery, which complicated the recovery process. \\n\\n**Hospital Course:**  \\nDuring the 4-day hospital stay, the patient was closely monitored and received intravenous antibiotics (Ampicillin-Sulbactam) to manage the infection effectively. The patient underwent surgical debridement of the infected wound on day two of hospitalization, which was well-tolerated. Post-surgical assessments indicated a reduction in infection signs, and the patient was stable throughout the stay, with improvement noted by discharge.  \\n\\n**Key Findings and Procedures:**  \\n- **Procedures:** Surgical debridement (0J9800Z) and wound care were performed successfully.  \\n- **Key Findings:** Clinical signs of infection improved, and laboratory tests indicated a downward trend in inflammatory markers. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is afebrile, with a significantly improved surgical site, and is able to perform activities of daily living (ADLs) with assistance. He is advised to monitor the surgical site for any signs of re-infection and to maintain proper wound care. The patient will benefit from home health services for ongoing wound care management and rehabilitation support. \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, OxyCODONE (Immediate Release), Enoxaparin (Prophylaxis), Cyanocobalamin, Folic Acid, and Polyethylene Glycol for bowel regimen. Follow-up appointments are scheduled with the surgical team in one week to evaluate the wound healing and to adjust any medications as necessary. Home health services will be initiated for wound care monitoring and patient education.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 48-year-old male admitted for surgical intervention due to significant lumbar radiculopathy resulting from spondylosis (ICD10: M4726). The patient presented with persistent lower back pain radiating into the lower extremities, accompanied by sensory deficits and neurogenic claudication.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a series of procedures including lumbar decompression and fusion, which were performed without complications. Post-operative recovery was monitored in the surgical unit; however, the patient developed a post-surgical ileus necessitating the use of metoclopramide and lactulose. He subsequently experienced a mild postprocedural fever and was treated with acetaminophen. Pain management was achieved with a regimen including oxycodone and gabapentin.  \\n  \\n**Key Findings and Procedures:**  \\nMRI findings indicated significant spinal stenosis and intervertebral disc disorders, corroborating the need for surgical intervention. The procedures performed include lumbar decompression and fusion (ICD10: 0SG30A0), which successfully alleviated the radiculopathy. The patient was also treated for abdominal discomfort due to ileus, which resolved prior to discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, ambulating with assistive devices, with improved strength in the lower extremities. He demonstrates the ability to perform activities of daily living (ADLs) with minimal assistance. Home health services are recommended to assist with monitoring, physical therapy, and medication management to facilitate recovery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetazolamide, Diazepam, Gabapentin, Oxycodone (immediate release), and Pantoprazole, among others. The patient is scheduled for a follow-up appointment with the orthopedic surgeon in two weeks to assess surgical site healing and overall recovery. Home health services will coordinate the management of medications and physical therapy to support rehabilitation.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 68-year-old male who presented urgently with worsening dyspnea and fatigue. Notable medical history includes atherosclerotic heart disease, chronic heart failure, and a history of transient ischemic attack. Upon admission, the patient exhibited signs consistent with fluid overload and was treated accordingly.\\n\\n**Hospital Course:**  \\nDuring a 1.7-day hospitalization, the patient was stabilized with diuretics and monitored for cardiac function. A thorough workup, including echocardiography, indicated preserved left ventricular function despite the patient's chronic heart failure. He was started on a regimen of diuretics, along with maintenance medications for his cardiac condition.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated BNP levels, indicative of heart failure exacerbation. The patient underwent a review of his medication regimen, including the initiation of Metoprolol Succinate XL and Isosorbide Mononitrate for heart rate control and angina prophylaxis. He also received education on lifestyle modifications to manage hyperlipidemia and smoking cessation.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulatory with assistance, and able to perform activities of daily living with minimal support. He demonstrated understanding of his medication regimen and the importance of follow-up care. Home health services will be critical for ongoing monitoring of his cardiac status and medication adherence.\\n\\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Albuterol Inhaler  \\n4. Aspirin  \\n5. Atorvastatin  \\n6. Clopidogrel  \\n7. Cyanocobalamin  \\n8. Diazepam (CIWA protocol)  \\n9. Fluticasone Propionate Nasal  \\n10. Folic Acid  \\n11. Heparin Sodium  \\n12. Isosorbide Mononitrate (Extended Release)  \\n13. Magnesium Oxide  \\n14. Metoprolol Succinate XL  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with cardiology within one week and to engage home health services for medication management and assistance with daily activities. Regular monitoring of blood pressure, weight, and signs of heart failure is essential.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Age:** 87  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is an 87-year-old female with a history of urethral caruncle, essential hypertension, and hyperlipidemia. She presented to the hospital for observation due to urinary discomfort and hematuria associated with the urethral caruncle.  \\n  \\n**Hospital Course:**  \\nDuring her 2-day observation stay, the patient underwent a comprehensive evaluation, including laboratory tests and imaging studies. The urology team was consulted, and the patient was started on conservative management, including hydration and pain control with acetaminophen. There was no evidence of acute renal failure or urinary retention. Her vital signs remained stable throughout the hospitalization.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a diagnosis of urethral caruncle (ICD-10: N362). Other notable chronic conditions included nonrheumatic aortic valve insufficiency (I351), unspecified anemia (D649), and essential hypertension (I10). The patient received procedures for symptom management, including flushing of the bladder and administration of antibiotics (Cefazolin) to prevent urinary tract infection.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, walking independently with minimal assistance. She will require home health services for ongoing monitoring of her urinary symptoms and medication management. It is crucial to ensure adequate hydration and follow up on her urological symptoms.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed acetaminophen for pain, atenolol for hypertension, atorvastatin for hyperlipidemia, and docusate sodium for constipation. She was advised to follow up with her primary care physician and urology within one week. Home health services will assist in monitoring her medication adherence and assess her functional status at home.',\n",
       " \"Patient is a 35-year-old female admitted urgently due to full-term premature rupture of membranes with onset of labor within 24 hours. Upon admission, the patient was in active labor and was monitored closely for fetal heart rate and maternal well-being. During the hospital course, the patient experienced labor complications including meconium-stained amniotic fluid and a cord around the neck, but without compression. An unremarkable vaginal delivery ensued, resulting in a healthy single live birth.\\n\\nKey findings included a second-degree perineal laceration, which was repaired during the delivery process. The patient remained hemodynamically stable throughout her stay and showed good recovery post-delivery. Pain management was initiated with acetaminophen and ibuprofen, while bowel regimen was provided with docusate sodium and bisacodyl due to anticipated constipation. The patient received lactated Ringer's solution for hydration, and oxytocin was administered to facilitate uterine contraction postpartum.\\n\\nUpon discharge, the patient was in stable condition, ambulating independently, and demonstrating adequate self-care skills. She is expected to benefit from home health services, particularly for postpartum monitoring and assistance with infant care, as well as support with perineal care and pain management. \\n\\nDischarge medications include acetaminophen, ibuprofen, docusate sodium, and dermoplast spray for perineal discomfort. The patient is advised to follow up with her obstetrician within one week for routine postpartum evaluation and to monitor recovery from the perineal laceration. Home health services will also provide education on infant care and maternal health post-discharge.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Patient DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 53-year-old female admitted urgently for evaluation of solitary plasmacytoma, which has not achieved remission. The patient presented with fatigue, unexplained weight loss, and localized bone pain. During the hospitalization, she developed pneumonia, which was managed with appropriate antibiotics.\\n\\n**Hospital Course:**  \\nThe patient had a 24.8-day hospital stay characterized by multidisciplinary involvement. She received supportive care including hydration, pain management, and treatment for tumor lysis syndrome. The oncology team initiated a regimen of dexamethasone and supportive medications to alleviate her symptoms. The patient was monitored for her bipolar disorder, with adjustments made to her psychiatric medications as needed.\\n\\n**Key Findings and Procedures:**  \\nImaging studies revealed the extent of the plasmacytoma and confirmed pneumonia. Procedures performed included a bronchoscopy to assess for infection and a biopsy of the plasmacytoma. Laboratory findings indicated elevated LDH levels and transaminases, consistent with tumor lysis syndrome. The patient's psychiatric status was stabilized, and she exhibited improvement in mood.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires continued monitoring for her oncological and psychiatric conditions. She is ambulatory with assistance and will benefit from home health services to ensure adherence to medications, monitor vital signs, and support her activities of daily living. The patient exhibits mild fatigue but has expressed motivation to engage in rehabilitation activities.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Acyclovir, Dexamethasone, Gabapentin, and Oxycodone SR among others. The patient is advised to follow up with oncology and psychiatry within one week of discharge. Home health services will be arranged to assist with medication management and ongoing assessments.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 62  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to complications related to a recent surgical procedure affecting the digestive system, specifically categorized under ICD10 code K9189 (Other postprocedural complications and disorders of digestive system). She presented with abdominal discomfort, elevated blood glucose levels, and signs of dehydration.  \\n\\n**Hospital Course:**  \\nDuring her 5-day stay, the patient underwent various diagnostic evaluations, including imaging studies, which ruled out significant acute pathology. She received supportive care, including IV fluids, insulin therapy for hyperglycemia, and management of her chronic conditions, including hypertension and hyperlipidemia. The patient was monitored closely for signs of infection and received pain management throughout her hospitalization.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was treated with IV fluids and medications, including Metformin for diabetes control, Losartan for hypertension, and Pravastatin for lipid management. She also received symptomatic treatment with Oxycodone for pain and Loperamide for diarrhea. The patient did not exhibit any new complications and was stable at the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved abdominal symptoms and better glycemic control. She is independent in her activities of daily living but will require home health services for ongoing monitoring of her diabetic management, dietary counseling, and assistance with mobility due to her morbid obesity (BMI 50.0-59.9).  \\n\\n**Medications at Discharge:**  \\nThe patient is to continue the following medications: Acetaminophen, Dextrose 50%, Folic Acid, Glucagon, Glucose Gel, Heparin, Insulin, Loperamide, Losartan Potassium, Magnesium Sulfate, Metformin, Oxycodone (Immediate Release), and Pravastatin.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled in one week with her primary care physician to reassess her diabetes management and overall health status. Home health services will begin within 48 hours post-discharge to ensure adherence to the treatment plan and provide support.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 53  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 53-year-old female with a significant medical history including secondary malignant neoplasm of the pleura (ICD10: C782) and other comorbidities such as anxiety disorder and heart disease. She was admitted under observation for evaluation of pleural effusion and related symptoms.  \\n\\n**Hospital Course:**  \\nDuring her 2.8-day stay, the patient underwent diagnostic imaging and thoracentesis, confirming the presence of malignant pleural effusion. She was monitored for respiratory distress and received supportive care including oxygen therapy and diuretics. Her psychiatric medications were managed, and she was assessed by the mental health team due to her history of bipolar disorder and PTSD. The patient responded well to treatment with a notable decrease in dyspnea.  \\n\\n**Key Findings and Procedures:**  \\n- Imaging confirmed significant pleural effusion.  \\n- Thoracentesis performed, yielding 800 mL of fluid.  \\n- Pleural fluid analysis indicated malignancy consistent with her known diagnosis.  \\n- Continuous monitoring of vital signs and respiratory status showed improvement post-thoracentesis.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved respiratory function. She demonstrates the ability to manage her medications independently but will require home health services for continued monitoring and assistance with activities of daily living due to her underlying health conditions. A follow-up appointment with oncology and home health nursing is planned to ensure continuity of care.  \\n\\n**Medications at Discharge:**  \\n- Albuterol Inhaler  \\n- Atovaquone Suspension  \\n- Furosemide  \\n- LORazepam  \\n- Enoxaparin (Prophylaxis)  \\n- Gabapentin  \\n- ClonazePAM  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her oncologist within one week post-discharge and to utilize home health services for medication management and respiratory therapy. Additionally, she is to monitor for any signs of respiratory distress or worsening anxiety.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 24  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 5.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with elevated bilirubin levels and associated symptoms including fatigue and jaundice. Initial labs indicated other disorders of bilirubin metabolism (ICD-10 E806). The patient also reported jaw pain and otalgia. A comprehensive evaluation was initiated to assess the underlying causes of her symptoms.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored for potential complications related to her bilirubin metabolism disorder. She was treated with supportive measures, including intravenous fluids, analgesics, and medications to manage symptoms. Albuterol nebulization was administered due to respiratory symptoms consistent with pneumonia (ICD-10 J188). The patient also received Ursodiol to aid in the management of her biliary symptoms. She demonstrated gradual improvement in her clinical status, with a decrease in bilirubin levels and resolution of pain.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's laboratory results showed elevated transaminases and LDH levels, indicative of liver involvement (ICD-10 K760). Imaging studies did not reveal any obstructive processes. Her treatment included the administration of Heparin for thromboprophylaxis and analgesics such as Ketorolac and Naproxen.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved bilirubin levels and overall symptom resolution. She is to continue with home health services for ongoing monitoring of her liver function and management of any residual symptoms, particularly related to her pain and fatigue. The patient is advised to maintain hydration and follow a low-fat diet to support her liver health.  \\n  \\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Diphenhydramine, Docusate Sodium, Ondansetron, and Ursodiol. She is also prescribed Sodium Chloride 0.9% for hydration. Follow-up appointments are scheduled with her primary care physician and a hepatologist within the next week to ensure close monitoring of her recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 78 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of an acute exacerbation of unspecified asthma. She presented with increased shortness of breath, wheezing, and a history of chronic respiratory issues. Her symptoms worsened over the past week, prompting her to seek medical attention.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient received nebulized bronchodilator therapy with Albuterol and Ipratropium Bromide, along with systemic corticosteroids (Prednisone). She was also treated for concurrent pneumonia and acute kidney failure, which were managed with appropriate antibiotics (Azithromycin and Ceftriaxone) and intravenous fluids (0.9% Sodium Chloride). The patient was monitored closely for hyperkalemia, a known issue due to her chronic kidney disease.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s respiratory status improved significantly with treatment, as evidenced by decreased wheezing and improved oxygen saturation levels. Laboratory tests indicated resolution of acute kidney failure. She was evaluated by the respiratory therapy team and underwent chest imaging, confirming pneumonia but no significant pleural effusion.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient exhibited stable vital signs with improved respiratory function. She is able to perform activities of daily living (ADLs) with minimal assistance but requires ongoing support for medication management and monitoring of her respiratory condition. Home health services are recommended to assist with medication compliance, respiratory therapy, and regular assessment of her pulmonary function.  \\n  \\n**Medications and Follow-up Plan:**  \\nThe patient will continue with the following medications: Albuterol nebulization, Ipratropium Bromide, Fluticasone Propionate, Hydrochlorothiazide, Prednisone, and necessary supportive care medications (e.g., Bisacodyl, Senna). A follow-up appointment with her primary care physician is scheduled within one week to reassess her respiratory status and kidney function.',\n",
       " \"**Discharge Summary**  \\n**Patient Information**: 37-year-old female  \\n**Admission Type**: Surgical same day admission  \\n**Length of Stay**: 4.8 days  \\n  \\n**History of Present Illness**: The patient was admitted for surgical intervention due to the presence of other benign neuroendocrine tumors (ICD-10: D3A8). She has a complex medical history including type 1 diabetes mellitus with diabetic autonomic neuropathy, gastroparesis, and vitamin B12 deficiency anemia.  \\n  \\n**Hospital Course**: During her hospital stay, the patient underwent several procedures including laparoscopic excision of the neuroendocrine tumor, and was monitored closely for glycemic control given her underlying diabetes. Post-operatively, she was managed for pain with hydromorphone and oxycodone, and received insulin therapy via pump for hyperglycemia.  \\n  \\n**Key Findings and Procedures**: Throughout her stay, she was assessed for complications associated with her diabetes and surgical recovery. The patient's glucose levels were stabilized, and she reported improvement in symptoms related to gastroparesis.  \\n  \\n**Discharge Condition and Functional Status**: The patient is being discharged in stable condition, with no acute distress. She is alert and oriented, able to perform activities of daily living with minimal assistance. A home health service referral has been initiated to assist with medication management, blood glucose monitoring, and dietary adjustments to manage her gastroparesis and diabetes.  \\n  \\n**Medications and Follow-Up Plan**: At discharge, the patient is prescribed 0.9% sodium chloride, acetaminophen, ondansetron, lisinopril, nortriptyline, and insulin pump therapy. She is advised to follow up with her primary care physician and endocrinologist within one week of discharge to monitor her recovery and diabetes management. Home health services will provide ongoing support and education.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 73  \\n- **Gender:** Male  \\n- **Length of Stay:** 2.9 days  \\n- **Admission Type:** Observation Admit  \\n  \\n**History of Present Illness:**  \\nThe patient is a 73-year-old male with a significant history of hypertensive heart and chronic kidney disease, admitted for evaluation of acute respiratory failure secondary to congestive heart failure. He presented with dyspnea, orthopnea, and edema. His medical history includes multiple comorbidities, including type 2 diabetes mellitus with diabetic chronic kidney disease and a malignant neoplasm of the prostate.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was managed with diuretics, blood pressure medications, and supportive care. He demonstrated gradual improvement in dyspnea and was stabilized on oral medications including Lisinopril and Metoprolol Succinate XL. A comprehensive evaluation was conducted, including echocardiography and labs, which confirmed the presence of acute on chronic systolic heart failure and pleural effusion.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure and serum creatinine levels consistent with his chronic kidney disease. The patient underwent thoracentesis, which revealed a pleural effusion, and significant improvement was noted post-procedure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved respiratory status and decreased edema. He requires continued monitoring for heart failure and renal function. He will benefit from home health services for ongoing assessment of his cardiovascular status, medication management, and assistance with activities of daily living due to mild functional limitations.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Lisinopril, Metoprolol Succinate XL, and others as per the discharge medication list. The patient is advised to follow up with his primary care physician within one week and to have a home health nurse visit to monitor his condition and adherence to the treatment regimen. Emergency contact information and signs of worsening condition were provided to the patient.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Patient's Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 74 years  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 74-year-old male with a complex medical history including combined rheumatic disorders affecting multiple heart valves, acute respiratory failure, and congestive heart failure. He presented to the emergency room with worsening dyspnea and edema. \\n\\n**Hospital Course:**  \\nDuring his 27-day hospital stay, the patient was managed for acute on chronic diastolic heart failure and respiratory distress likely secondary to pneumonia. He received diuretics, oxygen therapy, and antibiotics. His heart failure was stabilized with optimal dosing of loop diuretics and beta-blockers. A nephrology consult was obtained due to acute kidney injury, which improved with fluid management and diuretic therapy. The patient's diabetes was closely monitored, and adjustments to his insulin regimen were made.  \\n\\n**Key Findings and Procedures:**  \\nKey diagnostics during his stay included echocardiography, which demonstrated significant mitral and aortic valve involvement. He underwent bronchoscopy to evaluate and manage pneumonia, and arterial blood gases indicated hypoxia and hypercapnia. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, although he remains dependent on supplemental oxygen. His mobility is limited, requiring assistance for activities of daily living. He has been referred to home health services for continued monitoring of his cardiac status, respiratory therapy, and assistance with personal care. \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- Acetaminophen  \\n- Atorvastatin  \\n- Bumetanide  \\n- Furosemide  \\n- Metoprolol Succinate XL  \\n- Insulin  \\n- Fluticasone Propionate  \\n- Ipratropium Bromide Nebulizer  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments are scheduled with cardiology and primary care within one week of discharge. Home health services will initiate within 48 hours to assist with medication management and monitoring of vital signs.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 28  \\n**Gender:** Female  \\n**Admission Type:** Direct Observation  \\n**Length of Stay:** 3.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with acute abdominal pain, nausea, and vomiting. Imaging studies revealed a calculus of the gallbladder with acute and chronic cholecystitis without obstruction (ICD10: K8012). Due to the severity of the symptoms and potential complications, the patient was admitted for observation and management.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored. She was treated with intravenous fluids and analgesics, including hydromorphone and ketorolac for pain management. Antibiotic therapy with amoxicillin-clavulanic acid was initiated due to suspected infection. The patient responded well to treatment, with a gradual reduction in abdominal pain and an improvement in her overall condition.  \\n  \\n**Key Findings and Procedures:**  \\nAbdominal ultrasound confirmed the presence of gallstones and inflammation of the gallbladder. The patient underwent a procedure (ICD10: 0FT44ZZ) for further evaluation. She was also assessed for comorbidities, including gastro-esophageal reflux disease and obesity, which were noted but stable during the hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significantly reduced pain levels and improved functional status. She is able to ambulate independently but will require assistance at home for activities of daily living, particularly with cooking and mobility. Follow-up with a dietitian is recommended to address dietary modifications due to obesity and gastrointestinal issues.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: acetaminophen, amoxicillin-clavulanic acid, ondansetron, and ibuprofen. A prescription for polyethylene glycol was given for constipation management. She received the influenza vaccine prior to discharge.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week for ongoing management of her gallbladder condition and comorbidities. Home health services will be initiated to assist with care and rehabilitation.',\n",
       " '**Discharge Summary**  \\n**Patient:** 69-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute and chronic respiratory failure with hypoxia (ICD-10: J9621). He presented with increased shortness of breath, wheezing, and hypoxemia. His past medical history is significant for end-stage renal disease, chronic obstructive pulmonary disease (COPD) with acute exacerbation, hypertensive heart failure, and type 2 diabetes mellitus with chronic kidney disease.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was monitored closely and received supplemental oxygen therapy. He was initiated on a nebulized therapy regimen with Ipratropium-Albuterol, along with systemic corticosteroids to manage his respiratory distress. The patient also required hemodialysis due to his chronic kidney condition. Throughout the hospitalization, he demonstrated gradual improvement in respiratory function and oxygen saturation levels.  \\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated blood urea nitrogen (BUN) and creatinine levels, confirming renal impairment, and notable improvement in arterial blood gases following respiratory interventions. Procedures included dialysis sessions and adjustments in his medication regimen to manage fluid status and electrolyte balance.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with an improved respiratory status and oxygen saturation above 90% on room air. He is ambulating independently, although he requires assistance with activities of daily living due to residual fatigue and weakness. Home health services are recommended to assist with daily monitoring of his respiratory and renal condition, medication management, and support with activities of daily living.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed Acetaminophen, Allopurinol, Aspirin, Atorvastatin, Dextrose 50%, Finasteride, Fluticasone Propionate NASAL, Fluticasone-Salmeterol Diskus, Glucagon, Glucose Gel, Heparin, Hydralazine, Insulin, Ipratropium-Albuterol Nebulizer, and Isosorbide Mononitrate.  \\n\\n**Follow-up Plan:**  \\nFollow-up with primary care and nephrology within one week is crucial. The patient should also maintain regular pulmonary rehabilitation sessions to enhance functional recovery.',\n",
       " 'Patient is a 43-year-old female with a history of congenital insufficiency of the aortic valve, who was admitted for surgical intervention aimed at valve repair. She presented to the hospital with symptoms of fatigue and shortness of breath, which were exacerbated by her underlying cardiac condition. The patient underwent a successful surgical procedure (ICD-10: 02RF0JZ) on the day of admission, with a postoperative course complicated by acute posthemorrhagic anemia (ICD-10: D62). She received appropriate transfusions and management of her anemia, along with supportive care.\\n\\nDuring her hospital stay, she was closely monitored for hemodynamic stability and any signs of complications. She was treated with Furosemide to manage fluid overload and received analgesia with Hydromorphone for pain control. Her other medical issues, including obesity (BMI 45.0-49.9) and essential hypertension, were managed with lifestyle counseling and medication adjustments. The patient demonstrated significant improvement in her functional status and was able to ambulate independently by discharge. \\n\\nAt the time of discharge, the patient was stable, with improved hemoglobin levels and no acute complaints. She demonstrated the ability to perform activities of daily living with minimal assistance and was educated on signs of potential complications to monitor at home. \\n\\nDischarge medications include Acetaminophen, Aspirin EC, Furosemide, Gabapentin, and Escitalopram, among others. The patient is advised to follow up with her cardiologist within one week for further evaluation of her cardiac status and to monitor her recovery. Home health services will be initiated to assist with her rehabilitation and management of her comorbidities, focusing on medication adherence, dietary recommendations, and activity progression.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 34, Gender: Female  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 0.7 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 34-year-old female with a history of migraine headaches, presenting with acute exacerbation of migraines characterized by severe unilateral headache, photophobia, and nausea. The patient reported no history of status migrainosus.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient received supportive care, including hydration with 5% Dextrose and Sodium Chloride 0.9%. Pain management was initiated with Ibuprofen and Acetaminophen, resulting in significant improvement in her headache symptoms. A thorough neurological examination was performed, and no focal deficits were noted. The patient was monitored for any potential complications related to her migraine and hypertension.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed essential hypertension (ICD-10 I10) and mild thrombocytosis (ICD-10 D473), likely related to her thrombocythemia. No other acute abnormalities were detected. The patient was administered Heparin Sodium as a precautionary measure. She received the Quadrivalent Influenza Vaccine during her stay, following vaccination guidelines.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with significant improvement in her migraine symptoms. She is able to perform activities of daily living independently but will require monitoring for blood pressure management and migraine triggers at home. Home health services are recommended to assist with medication adherence and to monitor her hypertensive status.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Lisinopril for hypertension management and advised to continue Ibuprofen and Acetaminophen as needed for migraine pain. Follow-up appointments with her primary care physician and a neurologist are scheduled within the next 1-2 weeks. Education on lifestyle modifications and migraine management strategies was provided.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Male, 50 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 16.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of bacteremia, with symptoms including fever, chills, and fatigue. A review of history revealed recent surgical procedures and long-term anticoagulant therapy. \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was closely monitored and treated with appropriate antibiotics including Nafcillin and Ciprofloxacin for bacteremia. He was also started on supportive care including intravenous fluids, analgesics (Hydromorphone for pain control), and anticoagulation therapy (Enoxaparin). \\n\\n**Key Findings and Procedures:**  \\nKey findings included a persistent positive blood culture for Staphylococcus, and imaging studies confirmed no abscess formation. The patient underwent several procedures including drainage of a postprocedural hematoma and monitoring for potential complications related to his anticoagulant therapy. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improvement in symptoms, with a stable vital sign profile and resolution of fever. He is ambulating independently but will require assistance with activities of daily living due to residual weakness and fatigue from his illness. Home health services will be essential to provide nursing care, medication management, and physical therapy to assist with rehabilitation. \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient’s medication regimen includes Dextrose 5%, Acetaminophen, Aspirin, Ciprofloxacin, Colchicine, Docusate Sodium, Enoxaparin, Hydromorphone, Heparin, Indomethacin, Labetalol, Lidocaine patch, and Lisinopril. He is advised to follow up with his primary care physician and infectious disease specialist within one week of discharge to monitor his recovery and adjust medications as necessary. Additionally, the patient should maintain communication with home health services for ongoing assessments and support.',\n",
       " 'Patient is a 29-year-old female who presented to the hospital with a second-degree perineal laceration sustained during an urgent delivery. The patient delivered a healthy single live infant at 39 weeks gestation, although labor was complicated by the umbilical cord being wrapped around the neck without compression. Her hospital course was uncomplicated, and she remained stable throughout her stay.\\n\\nDuring her 2.4-day hospitalization, the patient received appropriate wound care and pain management. Key findings included a thorough assessment of the perineal laceration, which was noted to be healing well with no signs of infection. She underwent an episiotomy repair, coded as 10E0XZZ, and was monitored closely for postpartum complications. The patient was ambulating independently and showed good functional status before discharge.\\n\\nUpon discharge, the patient demonstrated adequate pain control and was able to care for herself and her newborn with minimal assistance. Home health services have been arranged to provide follow-up care, including wound assessment and assistance with activities of daily living as needed. The patient is advised to report any signs of infection, such as increased redness, swelling, or discharge from the laceration site.\\n\\nDischarge medications include Acetaminophen for pain, Calcium Carbonate for gastrointestinal comfort, Docusate Sodium for stool softening, Hydrocortisone (Rectal) 2.5% Cream for perineal irritation, Ibuprofen for inflammation, and Simethicone for gas relief. The patient is instructed to follow up with her obstetrician in one week for a routine postpartum check and to assess the healing of the perineal laceration.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n**Diagnosis:** Toxic encephalopathy (ICD-10: G92)  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old male who presented with altered mental status and confusion, leading to a diagnosis of toxic encephalopathy. He was admitted for observation due to concerns about potential underlying infectious processes and metabolic derangements.  \\n  \\n**Hospital Course:**  \\nDuring his 2.5-day stay, the patient underwent a series of diagnostic tests, including imaging studies and laboratory evaluations. He was found to have pneumonia and acute kidney failure, which were managed with antibiotics (Ceftriaxone) and supportive care. The patient also received treatment for his chronic conditions including heart failure and anxiety. Close monitoring of his renal function and mental status was conducted throughout the stay.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's chest X-ray indicated infiltrates consistent with pneumonia. Laboratory results showed elevated creatinine levels, necessitating renal function monitoring. A comprehensive medication review was performed, and adjustments were made based on his clinical status and potential drug interactions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was stabilized at the time of discharge with improved mental status and renal function. He is alert and oriented but requires assistance with daily activities due to residual cognitive impairment. Home health services will be essential for facilitating medication management, monitoring vital signs, and providing support for activities of daily living (ADLs).  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s prescribed medications include Acetaminophen, Azithromycin, DULoxetine DR, Diazepam, and Clopidogrel among others. He is advised to follow up with his primary care physician within one week and with a nephrologist for ongoing kidney management. Home health services will initiate visits to ensure compliance with medications and assess his functional recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 56 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.1 days  \\n**Primary Diagnosis:** Liver transplant rejection (ICD-10: T8641)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of suspected liver transplant rejection following recent transplant surgery. He presented with symptoms including fatigue, abdominal discomfort, and elevated liver enzymes. The patient has a history of chronic hepatitis B and was receiving immunosuppressive therapy post-transplant.\\n\\n**Hospital Course:**  \\nDuring the 5-day observation period, the patient underwent multiple laboratory evaluations, including liver function tests, which confirmed acute rejection. A liver biopsy was performed, revealing histological changes consistent with acute cellular rejection. Treatment was initiated with intravenous methylprednisolone, which resulted in improvement of liver function parameters. The patient was monitored closely for complications, including hyperglycemia and chronic kidney disease, which were managed appropriately during his stay.\\n\\n**Key Findings and Procedures:**  \\n- Liver biopsy confirmed acute cellular rejection.  \\n- Management of hyperglycemia with insulin therapy.  \\n- Administered glucocorticoids for rejection treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved liver function tests indicating response to treatment. He is ambulating independently and demonstrates an understanding of his medication regimen. Due to the recent liver transplant and ongoing immunosuppressive therapy, home health services have been arranged to assist with medication management and monitoring for signs of rejection or infection.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications:  \\n- Methylprednisolone  \\n- Mycophenolate sodium  \\n- Entecavir  \\n- Insulin (as needed for hyperglycemia)  \\n- Pantoprazole  \\n- Bisacodyl (as needed)  \\n- Dapsone  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with the transplant hepatologist and will have regular home health visits to monitor vital signs and adherence to the medication regimen.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 64  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 64-year-old male with a complex medical history including hypertensive heart disease, chronic kidney disease (CKD) stage 4, and heart failure, who was admitted for observation due to worsening shortness of breath and fluid retention. He has a prior history of atrial septal defect and malignancy of the ascending colon, complicating his overall clinical picture.  \\n\\n**Hospital Course:**  \\nDuring his 7-day hospital stay, the patient was monitored closely for acute on chronic diastolic heart failure. Diuretics were initiated, which significantly improved his symptoms of dyspnea and edema. He also received management for his diabetes and hyperlipidemia. His CKD was managed with careful attention to fluid balance and electrolyte levels.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, elevated creatinine levels consistent with his CKD, and improved heart function as evidenced by echocardiogram. He underwent a procedure for fluid removal and received education on managing his chronic conditions.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved respiratory status and no acute distress. He demonstrated adequate understanding of his medications and dietary restrictions. He will require home health services for ongoing monitoring of his heart failure and CKD management, including daily weight checks and medication adherence.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Aspirin  \\n4. Carvedilol  \\n5. Hydralazine  \\n6. Insulin  \\n7. Fluticasone-Salmeterol Diskus (250/50)  \\n8. Furosemide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and nephrologist within one week of discharge, and he will receive home health visits to assist with his medication management and monitor for any signs of worsening heart failure or kidney function.  \\n\\nThis summary is provided to ensure continuity of care post-discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:** Female, 40 years old.  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to exacerbation of chronic pancreatitis, characterized by recurrent abdominal pain, nausea, and dehydration. The patient has a history of other chronic conditions including cystic fibrosis and cardiomyopathy. She presented with significant epigastric pain and required intravenous fluids during her stay.\\n\\n**Hospital Course:**  \\nDuring her 6.7-day hospital stay, the patient received supportive care including hydration with 0.9% Sodium Chloride and Lactated Ringer's solution. Pain management was achieved with Hydromorphone and adjunctive medications such as Acetaminophen-Caff-Butalbital. The patient's nausea was managed with Dimenhydrinate and Diphenhydramine. She was placed on Creon 12 to address exocrine pancreatic insufficiency. The patient also received psychological support for anxiety and depression, as indicated by her history.\\n\\n**Key Findings and Procedures:**  \\nAbdominal ultrasound showed no acute complications related to pancreatitis. Routine lab work indicated dehydration and mild electrolyte imbalances, which improved with IV hydration. The patient's cardiomyopathy was stable throughout her admission. No invasive procedures were performed. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved hydration status and a reduction in abdominal pain. She is able to perform activities of daily living with minimal assistance but will require home health services for ongoing monitoring of her hydration and dietary needs, as well as support for her mental health conditions.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications: Creon 12, Albuterol inhaler, Lacosamide, and Heparin for DVT prophylaxis. She is advised to follow up with her primary care physician within one week of discharge and to contact home health services for regular assessments and support. Education on dietary management for her pancreatitis has been provided. \\n\\n**Home Health Services:**  \\nHome health services will focus on monitoring her nutritional status, medication adherence, and managing her chronic pain and mental health conditions.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient ID:** [REDACTED]  \\n- **Age:** 26  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of alcohol dependence with withdrawal delirium following an emergency presentation. He exhibited severe agitation, altered mental status, and hallucinations. The history revealed significant alcohol use over the past several years, leading to withdrawal symptoms upon cessation.  \\n\\n**Hospital Course:**  \\nDuring the 2.9-day hospital stay, the patient was stabilized with supportive care and pharmacotherapy, including the administration of 0.9% Sodium Chloride, Magnesium Sulfate, and LevETIRAcetam. He was monitored for seizures, and no significant seizures were documented. The patient received nutritional support with Cyanocobalamin and Ferrous Sulfate due to signs of nutritional deficiency. A psychiatric consultation was requested to address underlying mental health concerns, and Mirtazapine was initiated for depressive symptoms.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included evidence of alcoholic cirrhosis and secondary esophageal varices without bleeding. A thorough evaluation ruled out acute complications, and the patient was educated on the risks associated with continued alcohol use.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved mental status and decreased withdrawal symptoms. He is oriented and able to perform activities of daily living with minimal assistance. However, he will require ongoing support to manage his alcohol dependence and associated health issues.  \\n\\n**Medications at Discharge:**  \\nThe following medications have been prescribed for home health management:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Mirtazapine  \\n- Lactulose  \\n- Furosemide  \\n- Magnesium Oxide  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with outpatient services for addiction counseling and regular monitoring of liver function. Home health services will be initiated to assist with medication management and regular assessments of his mental and physical health status.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is an 81-year-old male admitted for observation due to bacteremia. He has a significant medical history that includes end-stage renal disease, cardiomyopathy, and chronic kidney disease. Upon admission, he exhibited signs of infection, which prompted further evaluation and management.  \\n\\n**Hospital Course:**  \\nDuring his 3-day stay, the patient was monitored closely for signs of sepsis. Blood cultures confirmed methicillin-sensitive Staphylococcus aureus bacteremia, and he was initiated on intravenous vancomycin. His renal function was assessed, and he continued his routine dialysis treatments without complications. The patient's blood pressure and cardiac status were also evaluated, with adjustments made to his metoprolol regimen as necessary.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent bacteremia and stable renal function during hospitalization. The patient underwent routine dialysis, and his hemoglobin levels were monitored, showing mild anemia related to his chronic kidney disease. A renal ultrasound was performed to evaluate for potential obstructive uropathy, which was ruled out.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with improved clinical symptoms. He is alert and oriented, with a functional status that allows for self-care at home. He will require home health services for ongoing monitoring, medication administration, and assistance with activities of daily living due to his renal condition.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed acetaminophen, aspirin, calcitriol, ferric citrate, heparin, iso-osmotic dextrose, magnesium sulfate, metoprolol tartrate, nephrocaps, pantoprazole, sodium chloride 0.9%, and vancomycin. A follow-up appointment with his nephrologist is scheduled for one week after discharge, along with regular dialysis sessions. Home health services will commence within 48 hours to ensure continuity of care.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 30  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with complications related to the puerperium, specifically coded as O9089. She presented with signs of postpartum complications, including generalized edema and elevated blood pressure, consistent with possible pre-eclampsia (ICD-10 O1490).  \\n\\n**Hospital Course:**  \\nDuring her 1.5-day hospital stay, the patient was closely monitored for vital signs and laboratory results. Initial assessments included a complete blood count, liver function tests, and renal function tests, which indicated mild elevation in liver enzymes but were otherwise within acceptable ranges. The patient received magnesium sulfate to manage her elevated blood pressure, and Lactated Ringer's was administered for hydration.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's blood pressure stabilized after treatment, and she was reassessed multiple times throughout her stay. An immunization encounter was also performed, and the patient received the Quadrivalent Influenza Vaccine (Z23) prior to discharge. No surgical interventions were required during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved stability, with blood pressures returning to normal levels. She was ambulating independently and reported a reduced level of edema. However, she requires ongoing home health services for blood pressure monitoring and assistance with daily activities until fully recovered.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen for pain management, Calcium Carbonate for gastrointestinal support, and Docusate Sodium for constipation prevention. She should continue with magnesium sulfate as per home health recommendations. Follow-up with her obstetrician is recommended within one week to monitor her recovery and adjust medications as necessary. Instructions for monitoring any signs of complications should be provided to the home health nurse.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 42 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 8.2 days  \\n**Primary Diagnosis:** Alcohol dependence with withdrawal delirium (ICD10: F10231)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to severe alcohol withdrawal symptoms, including agitation, confusion, and tremors. His medical history includes chronic HIV and chronic viral hepatitis B. On admission, he exhibited signs of withdrawal delirium, necessitating close monitoring and supportive care.  \\n  \\n**Hospital Course:**  \\nDuring the hospitalization, the patient received a multi-faceted treatment approach including benzodiazepines (Lorazepam) for withdrawal management, along with supportive medications for his other conditions. He was assessed continuously for signs of delirium and received intravenous hydration (0.9% Sodium Chloride) as well as nutritional support (IV multivitamins). The patient demonstrated gradual improvement in his mental status and vital signs over the course of treatment. His HIV regimen (Emtricitabine-Tenofovir) was optimized, and the patient was educated about adherence to therapy.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included evidence of toxic encephalopathy and secondary thrombocytopenia. The patient underwent laboratory evaluations, which showed improvement in liver function tests and stabilization of his HIV viral load. No significant procedural interventions were required during his stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, alert, and oriented. He will require home health services for continued monitoring and support for his alcohol dependence, including follow-up on medication adherence and nutritional needs. He will also benefit from counseling to address substance use and mental health support.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. LORazepam  \\n3. Emtricitabine-Tenofovir (Truvada)  \\n4. Hydrocortisone  \\n5. Multivitamins with minerals  \\n6. Other supportive medications (e.g., Docusate Sodium, Bisacodyl)  \\n  \\n**Follow-Up Plan:**  \\nFollow-up appointments have been scheduled with his primary care provider and a substance use counselor. The home health agency is set to initiate services within 48 hours of discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 64 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of recurrent hypotension, presenting with dizziness and fatigue. His medical history includes dilated cardiomyopathy, prostate cancer, and chronic kidney disease. Initial vital signs showed significant hypotension; therefore, he was closely monitored and managed with IV fluids and medications to stabilize his blood pressure.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient's hypotension was attributed to a combination of acute kidney failure and heart failure exacerbation. Diuretics and vasopressors were introduced as necessary. A comprehensive workup revealed acidosis, requiring treatment with sodium bicarbonate. The patient was also evaluated for atrial fibrillation and was started on anticoagulation therapy with heparin.  \\n  \\n**Key Findings and Procedures:**  \\n- Blood tests indicated elevated creatinine levels consistent with acute kidney failure.  \\n- An echocardiogram showed reduced ejection fraction, confirming worsening heart failure.  \\n- No surgical interventions were required during the hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient is stable but requires ongoing monitoring of his cardiovascular and renal status. He is able to perform activities of daily living with assistance and will benefit from home health services for medication management, monitoring of vital signs, and support with mobility.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Aspirin, Atorvastatin, Metoprolol Tartrate, and others, including diuretics and electrolytes, tailored to his recent clinical status.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with cardiology and nephrology is essential within one week post-discharge. Home health services will be arranged to assist in monitoring his blood pressure, renal function, and overall health status.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 30  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency (EW EMER)  \\n- **Length of Stay:** 72 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with end-stage renal disease secondary to hypertensive chronic kidney disease. He had a significant history of hypertension, leading to chronic renal impairment. Upon admission, he exhibited symptoms of fluid overload and electrolyte imbalances, necessitating urgent medical intervention.  \\n\\n**Hospital Course:**  \\nDuring his 72-day stay, the patient underwent multiple diagnostic evaluations and therapeutic procedures. Key interventions included hemodialysis due to acute kidney failure with tubular necrosis and management of electrolyte abnormalities. The patient also received care for acute pancreatitis and complications related to previous kidney transplant.  \\n\\n**Key Findings and Procedures:**  \\nSignificant laboratory findings included hyperkalemia, metabolic acidosis, and anemia secondary to renal failure. The patient underwent various procedures including fluid management, dialysis, and nutritional support for protein-calorie malnutrition. Medications administered included acetaminophen, CARVedilol, clopidogrel, and calcium gluconate, among others.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for continued dialysis support, monitoring of renal function, and management of his complex medication regimen. He demonstrates adequate understanding of his condition and is able to perform basic self-care with assistance. He is advised to maintain a high-protein diet and adhere to fluid restrictions.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Atovaquone Suspension, CARVedilol, Clopidogrel, and Fludrocortisone, among others. A follow-up appointment with nephrology is scheduled within one week post-discharge. Home health nursing services will be initiated to assist with medication management, dialysis adherence, and dietary guidance.',\n",
       " \"Patient is a 72-year-old female who was admitted urgently for stenosis of vascular prosthetic devices. She presented with worsening angina and shortness of breath, which prompted an immediate evaluation. The initial workup included imaging studies revealing significant stenosis at the site of a previous bypass graft. \\n\\nDuring her 2-day hospitalization, the patient was managed with a combination of pharmacological therapies, including anticoagulation and symptomatic management for her angina. A coronary angiogram was performed, confirming the diagnosis of graft stenosis, and the decision was made to optimize her medical management rather than undertake surgical intervention at this time. The patient's chronic conditions, including type 2 diabetes and chronic obstructive pulmonary disease, were closely monitored and managed throughout her stay.\\n\\nKey findings during her stay included stable vital signs, improved anginal symptoms, and an acceptable renal function profile, despite her chronic kidney disease. The patient's functional status upon discharge was significantly improved; she was able to ambulate independently with minimal assistance and demonstrated an understanding of her medication regimen and the importance of follow-up care.\\n\\nAt discharge, the patient was prescribed a regimen including Acetaminophen, Aspirin, Atorvastatin, Cilostazol, and Insulin, among others, to manage her conditions effectively. She will benefit from home health services to assist with medication management, monitor her blood glucose levels, and provide education on lifestyle modifications to improve her overall health status. Follow-up appointments with cardiology and her primary care physician are scheduled within the next week to ensure continuity of care and monitor her progress.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 20  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a significant injury involving the right carotid artery, accompanied by multiple other injuries, including a femoral artery injury and cervical vertebra fracture. The injuries were sustained in a traumatic incident, and the patient presented with acute posthemorrhagic anemia. Initial evaluation revealed hemodynamic instability, necessitating close monitoring and intervention.  \\n  \\n**Hospital Course:**  \\nThe patient was observed for 11.4 days, during which he received comprehensive care, including blood transfusions for anemia, pain management with opioids, and antibiotic therapy with Cefazolin. He underwent several imaging studies to monitor the progression of his injuries. Surgical consultations were involved for vascular and orthopedic assessments, leading to a decision against surgical intervention for the carotid injury due to stabilization of his condition.  \\n  \\n**Key Findings and Procedures:**  \\nDuring hospitalization, the patient was found to have stable vital signs after initial resuscitation. Imaging confirmed the injuries, and he was treated with analgesics (Hydromorphone, Oxycodone), and anticoagulation therapy with Heparin. Discharge medications included Acetaminophen for pain management and Albuterol for respiratory support.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge but requires home health services for ongoing monitoring and support. He demonstrates the ability to perform basic activities of daily living with some assistance but will need help with mobility and medication management, particularly with anticoagulation therapy.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Albuterol inhaler, Aspirin, and Docusate Sodium among others. The patient is instructed to follow up with his primary care physician within one week, and a home health nurse will visit to assess his recovery and ensure adherence to the medication regimen.',\n",
       " '**Patient Information:** 51-year-old male admitted for surgical intervention due to chronic pneumothorax. \\n\\n**History of Present Illness:** The patient presented with progressive shortness of breath and chest pain, attributed to a chronic pneumothorax. He has a significant past medical history that includes chronic obstructive pulmonary disease (COPD), essential hypertension, tobacco use, and a history of transient ischemic attack (TIA). \\n\\n**Hospital Course:** The patient was admitted for surgical management, undergoing video-assisted thoracoscopic surgery (VATS) for the evacuation of the pneumothorax and pleurodesis. Post-operatively, he was monitored in the surgical unit, where he received appropriate analgesia and respiratory therapy. Throughout his stay, his pain was well-controlled, and he demonstrated stable oxygen saturation levels on supplemental oxygen. He was also evaluated for his comorbid conditions, including his COPD and hypertension, which were managed with appropriate medications. \\n\\n**Key Findings and Procedures:** Surgical intervention successfully addressed the chronic pneumothorax. Pre-operative imaging confirmed the diagnosis, and post-operative chest X-ray showed no residual pneumothorax. The patient also received a thorough workup for his COPD and was educated about smoking cessation. \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition with improved respiratory function and ability to perform activities of daily living independently. He requires home health services for continued monitoring of lung function and assistance with medication management. A follow-up appointment with pulmonology is scheduled for two weeks post-discharge. \\n\\n**Medications and Follow-up Plan:** At discharge, the patient is prescribed 0.9% Sodium Chloride for hydration, Acetaminophen for pain, Albuterol nebulizer solution for COPD management, Amlodipine for hypertension, and Doxycycline for any potential infection prophylaxis. He is advised to maintain adherence to his medications and to report any worsening symptoms to his healthcare provider. Home health nursing services will assist with medication management, vital sign monitoring, and education on breathing exercises.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 57 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute kidney failure (ICD-10: N179), presenting with anuria and elevated creatinine levels. The patient has a history of benign prostatic hyperplasia with lower urinary tract symptoms and essential hypertension, which may have contributed to his renal condition.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was monitored closely for renal function and electrolytes. A renal ultrasound was performed, demonstrating mild hydronephrosis suggestive of urinary obstruction. He was started on Tamsulosin to alleviate the obstruction and improve urinary flow. Supportive care included the administration of intravenous fluids (0.9% Sodium Chloride), and he was closely monitored for potential complications of acute kidney injury such as acidosis (ICD-10: E872).  \\n\\n**Key Findings and Procedures:**  \\nLab results showed elevated creatinine, with a peak of 2.5 mg/dL, and an associated mild metabolic acidosis. The patient’s vital signs remained stable throughout the admission, and he did not exhibit any signs of infection.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improvement in urinary output and vital signs were stable. He is ambulating independently and has been educated on the importance of hydration and monitoring his symptoms. Home health services have been arranged to assist with medication management and follow-up care.  \\n\\n**Medications at Discharge:**  \\n- 0.45% Sodium Chloride  \\n- Acetaminophen  \\n- Aspirin  \\n- BuPROPion (Sustained Release)  \\n- Docusate Sodium  \\n- Heparin  \\n- Levothyroxine Sodium  \\n- Lidocaine Jelly 2%  \\n- OxyCODONE (Immediate Release)  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Tamsulosin  \\n- TraZODone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to monitor renal function closely. Home health nursing will visit to ensure adherence to medication and assist with ongoing assessment of his renal status.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n**Age:** 58  \\n**Gender:** Female  \\n**Length of Stay:** 15.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a diagnosis of liver transplant infection (ICD10: T8643). She presented with fever, chills, and abdominal pain, alongside laboratory findings indicating bacteremia and abscess formation in the liver. Her medical history is significant for hypothyroidism, hyperlipidemia, and major depressive disorder.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received extensive antibiotic therapy, including Amoxicillin-Clavulanic Acid and Ampicillin-Sulbactam, and underwent imaging studies that confirmed the presence of an abscess. A percutaneous drainage procedure was performed (ICD10: 0F9630Z) with successful resolution of the abscess. The patient was closely monitored for potential complications related to her liver function and overall recovery.  \\n  \\n**Key Findings and Procedures:**  \\n- Liver abscess confirmed via imaging  \\n- Successful percutaneous drainage  \\n- Management of bacteremia with appropriate antibiotics  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrates improved clinical stability, with resolution of fever and abdominal pain. She is ambulating independently and has regained essential activities of daily living. Home health services have been arranged to assist with medication management and monitoring of her nutritional intake, given her recent liver transplant and ongoing treatment needs.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Levothyroxine Sodium, Mirtazapine, OxyCODONE (as needed), Pantoprazole, and Enoxaparin for prophylaxis.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the transplant clinic in one week. Home health nursing will visit twice weekly to monitor her recovery and ensure adherence to prescribed therapies. The patient is advised to contact her healthcare provider if she experiences any new symptoms.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- Age: 91 years  \\n- Gender: Male  \\n- Admission Type: Emergency (EW EMER)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of acute neurological deficits and confusion, diagnosed with other cerebral infarction (ICD10: I6389). He presented with left-sided weakness and expressive aphasia. His medical history is notable for chronic obstructive pulmonary disease (COPD), hypertension, and vascular dementia.\\n\\n**Hospital Course:**  \\nDuring a 6-day hospital stay, the patient received supportive care and underwent diagnostic imaging, which confirmed the diagnosis of cerebral infarction. He was started on appropriate anticoagulation therapy with Clopidogrel and monitored for respiratory complications due to his COPD. He was treated for a concurrent pneumonia with Azithromycin and intravenous Ceftriaxone. The patient was also managed for acute kidney failure, which improved with intravenous fluids.\\n\\n**Key Findings and Procedures:**  \\nNeurological assessments showed gradual improvement in strength and speech. The patient was evaluated by physical and occupational therapy, demonstrating functional limitations requiring assistance with activities of daily living (ADLs). He exhibited significant improvement in respiratory status with Albuterol and Fluticasone-Salmeterol therapy. A comprehensive geriatric assessment revealed the need for home health services to assist with mobility and medication management.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with basic ADLs and mobility. He demonstrated the ability to follow simple commands, and his family was educated on recognizing signs of deterioration and the importance of regular follow-up. Home health services will be initiated to provide nursing care and physical therapy support.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Atorvastatin  \\n4. Azithromycin  \\n5. Benzonatate  \\n6. Clopidogrel  \\n7. Donepezil  \\n8. Enoxaparin (Prophylaxis)  \\n9. Fluticasone-Salmeterol Diskus  \\n10. Lactated Ringers (for hydration)\\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and to have home health services in place for ongoing therapy and nursing support. A referral to a neurologist is also recommended for further assessment and management of his cognitive status.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Not provided]  \\n**Date of Admission:** [Not provided]  \\n**Date of Discharge:** [Not provided]  \\n**Patient Name:** Female, 44 years old  \\n\\n**History of Present Illness:**  \\nThe patient presented for surgical intervention due to symptomatic intramural leiomyoma of the uterus. She had significant menorrhagia and pelvic pain, necessitating a planned surgical approach.  \\n\\n**Hospital Course:**  \\nThe patient underwent a laparoscopic myomectomy, which was completed without immediate complications. Postoperatively, she experienced some intraoperative hemorrhage, which was managed effectively. She remained stable throughout her hospital stay, but required careful monitoring for postprocedural shock due to initial blood loss.  \\n\\n**Key Findings and Procedures:**  \\nPreoperative imaging confirmed the presence of multiple leiomyomas. The intraoperative findings included an intramural leiomyoma, which was excised successfully. Postoperative hemoglobin levels indicated mild acute posthemorrhagic anemia, but no further interventions were necessary. The patient was monitored in the surgical unit for 48 hours before discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently. She reported moderate pain controlled with prescribed analgesics. The patient is advised to limit physical activity and avoid heavy lifting for the next few weeks. Home health services will be arranged to assist with daily activities and medication management, as well as monitor for any signs of complications, such as excessive bleeding or infection.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Diphenhydramine  \\n3. Docusate Sodium  \\n4. Hydromorphone (Dilaudid)  \\n5. Heparin  \\n6. Ibuprofen  \\n7. Ketorolac  \\n8. Lactated Ringers (for hydration)  \\n9. Oxycodone (Immediate Release)  \\n10. Polyethylene Glycol  \\n11. Senna  \\n12. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointment is scheduled with the gynecologist in 2 weeks for evaluation of surgical site and further management. The patient will also be monitored for hemoglobin levels and overall recovery. Home health services will initiate within 24-48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Patient ID:** [Patient ID]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 24-year-old female who presented to the emergency department with a traumatic subarachnoid hemorrhage after a fall. She experienced a loss of consciousness of unspecified duration. Upon admission, she exhibited signs of confusion and was monitored under observation for 2.6 days.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was managed with supportive care, including pain control with acetaminophen and oxycodone for discomfort, and hydration via IV fluids. Neurological assessments were performed regularly, showing gradual improvement in her mental status. A CT scan confirmed the diagnosis of subarachnoid hemorrhage, and no surgical intervention was required. Additionally, she was evaluated for her alcohol dependence, which included withdrawal management with phenobarbital.  \\n  \\n**Key Findings and Procedures:**  \\nThroughout her hospitalization, the patient had stable vital signs, and her neurological examination showed progressive improvement. A comprehensive medication review was conducted, and several medications were adjusted to address her needs, including levetiracetam for seizure prophylaxis and hydralazine for blood pressure management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is alert and oriented, with a Glasgow Coma Scale score indicating she obeys commands and is able to communicate effectively. She is able to perform activities of daily living with minimal assistance. Home health services will be initiated to provide ongoing monitoring of her neurological status and support for medication management.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: acetaminophen, levetiracetam, oxycodone, phenobarbital, and others as noted in her discharge medication list. She is advised to follow up with her primary care physician within one week and to contact the home health service for any concerns regarding her recovery. Additionally, she should avoid alcohol and ensure supervision during the early recovery phase.',\n",
       " '**Patient Information:** 71-year-old female was admitted for surgical intervention due to nonrheumatic aortic valve stenosis. \\n\\n**History of Present Illness:** The patient presented with symptoms of dyspnea on exertion and fatigue. Her past medical history was significant for paroxysmal atrial fibrillation, chronic obstructive pulmonary disease (COPD), and hyperlipidemia. She was referred for aortic valve replacement due to the severity of her condition.\\n\\n**Hospital Course:** The patient underwent a successful aortic valve replacement on postoperative day 0. The procedure was uncomplicated, and she was extubated within hours. Postoperatively, she was closely monitored for any signs of complications such as hypotension and arrhythmias. She experienced transient postprocedural hypotension but responded well to fluid management.\\n\\nThroughout her stay, the patient was managed with a regimen of anticoagulants and antiplatelet therapy to prevent thromboembolic events. She also received treatment for her COPD exacerbation and was started on inhaled bronchodilators. In addition, she was treated for acute posthemorrhagic anemia, which improved with iron supplementation.\\n\\n**Key Findings and Procedures:** Key findings during her hospital stay included stable vital signs postoperatively, resolution of hypotensive episodes, and improvement in her functional status as she participated in physical therapy.\\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable, ambulating independently, and demonstrating improved exercise tolerance. She is being referred to home health services for continued physical therapy and monitoring of her anticoagulation therapy.\\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, Albuterol inhaler, Amiodarone, Apixaban, Aspirin EC, Furosemide, and others as per her medication reconciliation. The patient is to follow up with her cardiologist in one week and her primary care physician in two weeks. Home health services will assist in her rehabilitation and medication management.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 32  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.3 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of maternal care for transverse and oblique lie (ICD10: O322XX0). She presented with concerns regarding fetal positioning and was subsequently monitored closely throughout her hospital stay. The patient also has a history of sickle-cell trait, post-term pregnancy, and anemia complicating childbirth.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored in the labor and delivery unit. Despite initial concerns, fetal positioning improved with maternal positioning techniques and hydration. She also received supportive care for her anemia and gastrointestinal symptoms. Key procedures included an ultrasound to assess fetal position and monitoring for any signs of complications.\\n\\n**Key Findings and Procedures:**  \\nThe ultrasound confirmed a single live birth at 40 weeks gestation. The patient exhibited signs of mild dehydration, which was addressed with intravenous Lactated Ringer’s solution. She was managed with analgesics including Acetaminophen and Ibuprofen for pain control, and Ondansetron was administered for nausea. No significant complications arose during her hospital stay, and discharge was deemed appropriate.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and able to ambulate independently. She demonstrated understanding of her post-discharge care plan and the importance of follow-up appointments. Home health services have been arranged to assist with ongoing monitoring of her recovery and to ensure she receives the necessary support during the postpartum period.\\n\\n**Medications:**  \\nUpon discharge, the patient was prescribed: Acetaminophen, Ibuprofen, Bisacodyl, Docusate Sodium, Calcium Carbonate, Simethicone, and Naloxone. Additionally, she was advised to maintain hydration and follow up with her obstetrician within one week.  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary obstetrician and utilize home health services for monitoring and support. Education was provided regarding signs of concern, including excessive bleeding or signs of infection.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 58  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to a nonunion of a fracture of the neck of the left femur, following a fall from a ladder. This was identified as a subsequent encounter for a closed fracture. The patient has a history of anticoagulant use due to a personal history of venous thrombosis, necessitating careful management during hospitalization.\\n\\n**Hospital Course:**  \\nThroughout the 2.6-day stay, the patient underwent a surgical procedure (osteosynthesis) to address the femoral fracture. Postoperatively, he was monitored for pain management and potential complications related to anticoagulation therapy. The patient received appropriate analgesics including hydromorphone, acetaminophen, and ketorolac, along with prophylactic antibiotics such as cefazolin to prevent infection.\\n\\n**Key Findings and Procedures:**  \\nThe surgery was successful, and the patient demonstrated stable vital signs and satisfactory pain control. Radiographic imaging confirmed proper alignment of the fracture. There were no signs of infection or other complications during the hospital stay. The patient was mobilized with assistance from physical therapy, achieving the ability to bear weight with a walker.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and able to participate in activities of daily living with assistance. He requires home health services for continued physical therapy and monitoring of his anticoagulant therapy. The patient will need assistance with mobility and daily activities initially as he recovers from surgery.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include apixaban for anticoagulation, along with analgesics and a bowel regimen to prevent constipation. The patient is advised to follow up with his orthopedic surgeon in 2 weeks for reassessment of the fracture and ongoing management. Home health services will initiate contact for physical therapy and medication management within 48 hours of discharge.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 28  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for urgent care due to cervical incompetence identified in the third trimester of pregnancy. She presented with a history of cervical insufficiency leading to premature labor signs, including contractions and vaginal discharge. Upon admission, the patient was stabilized and monitored closely for fetal well-being.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a cervical cerclage procedure (10D00Z1) to reinforce the cervix. She was monitored for complications, including contractions and fetal heart rate irregularities, which were managed effectively. The patient received continuous intravenous fluids and medications for pain management and to prevent gastrointestinal discomfort. \\n\\n**Key Findings and Procedures:**  \\nUltrasound imaging confirmed a viable single live birth at 36 weeks gestation, with no signs of acute distress. The cerclage was successful, and the patient was educated on signs of labor and complications. Additionally, she was assessed for any digestive system concerns, given her history of gastro-esophageal reflux disease (N858). \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with a functional status appropriate for home health services. She reports mild pain, manageable with prescribed medications, and has been advised on mobility and activity restrictions to ensure cervical stability. The patient demonstrated understanding of her medication regimen and follow-up care. \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Calcium Carbonate  \\n4. Docusate Sodium  \\n5. Ibuprofen  \\n6. Naloxone  \\n7. Ondansetron  \\n8. OxyCODONE (Immediate Release)  \\n9. Oxytocin  \\n10. Simethicone  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician within one week post-discharge and is referred to home health services for continued monitoring of her recovery and adherence to medication. Home health nurses will assist with mobility assessments and education regarding signs of labor or complications.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 85-year-old female  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Length of Stay:** 4.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted via the Emergency Department with symptoms suggestive of sepsis, including fever, tachycardia, and altered mental status. Initial workup revealed an unspecified organism causing sepsis. She has a history of chronic kidney disease, hypertension, and type 2 diabetes, which may have contributed to her acute condition.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient received broad-spectrum intravenous antibiotics, including Levofloxacin, and was closely monitored for respiratory distress due to acute respiratory failure with hypoxia. She was treated for acute kidney failure, and her renal function improved during hospitalization. Supportive measures included intravenous fluids and electrolyte management. The patient's overall condition stabilized, and she was transitioned to oral medications before discharge.\\n\\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included elevated inflammatory markers consistent with sepsis, evidence of pneumonia on chest imaging, and acute kidney injury. She underwent a thorough evaluation for possible sources of infection. No invasive procedures were required.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved vital signs and mental status. She is able to perform activities of daily living with assistance due to generalized weakness but requires close monitoring of her blood glucose levels and kidney function. Referral to home health services has been made for skilled nursing care to assist with medication management and daily monitoring.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Atorvastatin, Metoprolol Succinate XL, Pantoprazole, and insulin regimen tailored to her diabetes management. The patient is advised to follow up with her primary care physician within one week and to monitor her renal function with lab tests as per the home health nurse's recommendations. Additionally, she received an influenza vaccine during her stay.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 63 years  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute and chronic neoplasm-related pain, associated with his known malignancies including right lung neoplasm and secondary lymph node involvement. He has a significant past medical history of hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and previous transient ischemic attack.  \\n\\n**Hospital Course:**  \\nDuring his 1.4-day stay, the patient received pain management with opioids (Hydromorphone and Oxycodone) and adjunctive medications (Gabapentin, Dexamethasone) to control symptoms. He was monitored for any complications related to his underlying malignancies and comorbid conditions.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed moderate respiratory distress consistent with his COPD and lung malignancy. Imaging studies confirmed the presence of a malignant neoplasm in the lower lobe of the right lung and secondary neoplasms in intra-abdominal lymph nodes and adrenal gland. No new acute changes were noted during his admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved pain control and was stable for home care. He will require home health services to assist with medication management, pain assessment, and to monitor his respiratory status. Patient education was provided regarding the recognition of exacerbation symptoms related to COPD and diabetes management.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Dexamethasone  \\n- Fluticasone-Salmeterol Diskus  \\n- Gabapentin  \\n- Hydromorphone  \\n- Insulin  \\n- Ondansetron  \\n- Oxycodone  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with his oncologist within one week and with his primary care physician for management of his chronic conditions. Home health services will initiate within 48 hours post-discharge to ensure continuity of care.',\n",
       " \"**Patient Name:** [Redacted]  \\n**Age:** 49  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with chest pain and shortness of breath. Initial workup revealed a Non-ST elevation myocardial infarction (NSTEMI), confirmed by elevated troponin levels and EKG changes. The patient also has a history of hypertension and prediabetes, which were managed during the hospitalization.  \\n\\n**Hospital Course:**  \\nDuring the 5-day stay, the patient received appropriate cardiac care, including dual antiplatelet therapy with aspirin and atorvastatin for lipid management. He was also treated for acute posthemorrhagic anemia secondary to blood loss, requiring intermittent transfusions. Diuretics were used to manage fluid overload due to his underlying heart disease. The patient was monitored closely for any complications, including hypoxemia, which was resolved with supplemental oxygen.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent chest discomfort and elevated cardiac enzymes. The patient underwent cardiac monitoring and was managed with intravenous medications, including furosemide for fluid management and glucagon for blood glucose control. The patient's condition stabilized following adjustments in his medication regimen and dietary modifications.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved functional status and understanding of his condition. He will require home health services for medication management, monitoring of vital signs, and assistance with lifestyle modifications to manage his chronic conditions.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Aspirin EC, Atorvastatin, Furosemide, DiphenhydrAMINE, and Insulin, among others.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with a cardiologist within one week and to contact home health services for ongoing support. Additional laboratory tests will be scheduled to monitor his blood counts and cardiac function. Education was provided regarding signs of worsening symptoms, medication adherence, and lifestyle changes to minimize cardiovascular risk.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 58  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 5.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with an infection following a procedure (ICD-10: T814XXA) after undergoing surgery. He presented with signs of systemic infection, including fever and localized pain around the surgical site. The patient has a history of anticoagulant use and presents with a prosthetic heart valve, increasing his risk for post-operative complications.  \\n  \\n**Hospital Course:**  \\nDuring his 5.3-day hospital stay, the patient was treated with intravenous antibiotics, including Ciprofloxacin and Metronidazole, to address the infection. He was monitored for signs of septicemia and underwent regular wound assessments. Surgical consultation was obtained, and he was treated for cellulitis of the right toe (ICD-10: L03031). Pain management was provided with Oxycodone and Duloxetine. His anticoagulation therapy was adjusted accordingly to maintain safe therapeutic levels.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated clinical improvement, with reduced fever and improved wound appearance. Labs indicated a reduction in inflammatory markers. He underwent a wound debridement procedure to facilitate healing and prevent further complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently with minimal assistance. He is able to perform activities of daily living with some assistance required for wound care. Home health services are recommended for continued wound care, medication management, and monitoring of his anticoagulation therapy.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ciprofloxacin HCl  \\n- Docusate Sodium  \\n- Duloxetine  \\n- Heparin  \\n- Influenza Vaccine Quadrivalent  \\n- Metronidazole  \\n- Multivitamins  \\n- Oxycodone (Immediate Release)  \\n- Pregabalin  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Trazodone  \\n- Warfarin  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with the surgical team for wound assessment. Home health services will initiate care within 48 hours for ongoing management.',\n",
       " '**Discharge Summary**  \\n**Patient**: 77-year-old female  \\n**Admission Type**: Urgent  \\n**Length of Stay**: 3.7 days  \\n**Primary Diagnosis**: Malignant neoplasm of right ovary (ICD-10: C561)  \\n  \\n**History of Present Illness**: The patient presented with abdominal pain and significant weight loss. Imaging studies revealed a mass in the right ovary, confirmed with biopsy as malignant neoplasm. The patient also has a history of congestive heart failure and chronic kidney disease, complicating her management.  \\n  \\n**Hospital Course**: During her hospital stay, the patient was stabilized with intravenous fluids and diuretics for heart failure management. She received a blood transfusion due to anemia and was started on appropriate oncologic therapy. She was also closely monitored for her chronic conditions, including diabetes and kidney function.  \\n  \\n**Key Findings and Procedures**: The patient underwent imaging, revealing ascites and peritoneal adhesions. A paracentesis was performed to relieve symptoms. Key laboratory findings included elevated CA-125 levels, indicating disease activity. The patient was initiated on chemotherapy prior to discharge.  \\n  \\n**Discharge Condition and Functional Status**: The patient is stable at discharge, though she requires assistance with activities of daily living due to weakness and fatigue. Home health services have been arranged for ongoing monitoring of her vital signs, medication management, and assistance with daily activities. She will need support for mobility and nutritional intake as she continues her recovery.  \\n  \\n**Medications and Follow-Up Plan**: Discharged on Abacavir Sulfate, Furosemide, Metoprolol Tartrate, and insulin. The patient is advised to follow up with oncology in one week and has scheduled appointments with her primary care physician for ongoing management of her chronic conditions. Home health nursing will facilitate medication reconciliation and monitor her response to chemotherapy.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**MRN:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 59-year-old male who presented with chest pain and dyspnea, subsequently diagnosed with a Non-ST elevation myocardial infarction (NSTEMI). He has a past medical history significant for type 1 diabetes mellitus, essential hypertension, atherosclerotic heart disease, chronic pain, and adjustment disorder.  \\n  \\n**Hospital Course:**  \\nDuring his 17.8-day hospitalization, the patient was managed with a multidisciplinary approach, including cardiology and endocrinology consultations. Cardiac monitoring was initiated, and the patient received dual antiplatelet therapy with aspirin and clopidogrel, along with other medications to optimize his heart failure management. Insulin therapy was adjusted to maintain glycemic control, which was challenging initially due to episodes of hyperglycemia. The patient also received supportive care for his chronic pain and mental health concerns.  \\n  \\n**Key Findings and Procedures:**  \\nCardiac catheterization revealed no significant obstructive lesions, and the patient’s heart failure was managed with diuretics and beta-blockers. Serial troponins improved, and echocardiogram showed preserved left ventricular function with mild diastolic dysfunction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved symptoms and is able to perform activities of daily living with minimal assistance. He demonstrates a good understanding of his medication regimen and the importance of lifestyle modifications. Home health services will be initiated for ongoing monitoring of his blood pressure, glucose levels, and medication adherence, as well as support for his mental health needs.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apidra  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. Clopidogrel  \\n6. Dextrose 50% (as needed for hypoglycemia)  \\n7. Docusate Sodium  \\n8. Gabapentin  \\n9. Glucagon  \\n10. Insulin  \\n11. Lidocaine 5% Patch  \\n12. Lisinopril  \\n13. Magnesium Oxide  \\n14. Metoprolol Tartrate  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with cardiology in one week and with his primary care physician in two weeks. A home health nurse will visit within 48 hours of discharge to assess and support the patient's ongoing care needs.\",\n",
       " \"Patient is an 87-year-old female admitted for observation with a primary diagnosis of urinary tract infection (ICD-10 N390). She presented with acute confusion and reported generalized abdominal pain. Initial assessments revealed signs of dehydration and exacerbation of chronic systolic heart failure. The patient has a past medical history significant for Alzheimer's disease, delirium, and nonrheumatic aortic stenosis, complicating her clinical picture.\\n\\nDuring her 3.7-day hospital stay, the patient received intravenous hydration and antibiotics, including Ceftriaxone and Metronidazole, to treat the urinary tract infection. She was also managed with furosemide for heart failure and support for her Alzheimer’s disease symptoms. Her condition improved with treatment; however, she remained slightly confused but oriented to person and place by discharge. The patient's vital signs stabilized, and her dehydration resolved with adequate fluid management.\\n\\nKey findings included elevated white blood cell count initially, which normalized by discharge. An echocardiogram confirmed chronic systolic heart failure without acute changes. The patient ambulated with assistance and demonstrated the ability to perform basic activities of daily living with some support.\\n\\nAt discharge, the patient is stable but requires continued home health support for medication management and monitoring of her heart failure symptoms. Home health services will assist with daily living activities and medication adherence, including administration of furosemide and monitoring for signs of dehydration or infection.\\n\\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Albuterol, Bisacodyl, Ceftriaxone, Docusate Sodium, Furosemide, Heparin, Metronidazole, Omeprazole, Prednisone, Ranitidine, Senna, and 0.9% Sodium Chloride flush. A follow-up appointment with her primary care physician is recommended within one week of discharge to reassess her urinary tract infection and heart failure management.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 45 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.8 days  \\n**Primary ICD-10 Code:** E1065 - Type 1 diabetes mellitus with hyperglycemia  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of hyperglycemia related to Type 1 diabetes mellitus, complicated by opioid dependence and diabetic neuropathy. He presented with elevated blood glucose levels and reported recent changes in his medication routine, which may have contributed to his condition. Additionally, he had a recent car accident resulting in abrasions and a laceration to his left elbow, requiring further evaluation.\\n\\n**Hospital Course:**  \\nDuring hospitalization, the patient was closely monitored for blood glucose levels and received insulin therapy to manage hyperglycemia. Pain management was addressed with acetaminophen and gabapentin for neuropathic pain. The patient was also placed on a nicotine patch to assist with smoking cessation as part of his comprehensive care plan. He required hydration with Lactated Ringer’s solution and was administered magnesium sulfate for electrolyte repletion. The patient tolerated all interventions well, with stabilization of blood glucose levels by discharge.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hyperglycemia, noted diabetic neuropathy, and a superficial laceration of the left elbow, which was treated conservatively. The patient was educated on the importance of maintaining consistent glucose monitoring and adherence to his insulin regimen.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulatory, and demonstrated adequate understanding of his diabetes management plan. He will require home health services to assist with medication management, continued monitoring of blood glucose levels, and education on wound care for his elbow laceration.  \\n\\n**Medications at Discharge:**  \\n- Insulin  \\n- Gabapentin  \\n- Acetaminophen  \\n- Glucose Gel  \\n- Nicotine Patch  \\n- Heparin  \\n- Dextrose 50%  \\n- Magnesium Sulfate  \\n- Lidocaine 5% Patch  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with a diabetes educator to optimize his diabetes management. Home health services will be initiated to support his recovery and assist with daily living activities.',\n",
       " 'Patient is a 60-year-old male admitted for observation due to worsening angina attributed to atherosclerotic heart disease. During his 6.8-day hospital stay, the patient experienced episodes of angina, which were managed with medication, including Isosorbide Dinitrate and Aspirin EC. He was also diagnosed with paroxysmal atrial fibrillation, hyperlipidemia, and anxiety disorder, all of which were addressed concurrently.\\n\\nKey findings included elevated lipid levels and intermittent atrial fibrillation noted on telemetry. The patient underwent several procedures, including cardiac monitoring and pharmacologic management to stabilize his condition. Additionally, he received treatment for anxiety and mild intermittent asthma, with an Albuterol inhaler prescribed for home use. He also demonstrated signs of fatty liver changes and chronic sinusitis, which will require ongoing management.\\n\\nUpon discharge, the patient is stable but requires close follow-up due to his cardiac history and ongoing management of his comorbidities. His functional status has improved, allowing him to perform activities of daily living independently, although he will benefit from home health services for medication management and routine health checks. Specifically, the home health team will monitor his heart condition, assist with medication adherence, and provide education regarding lifestyle modifications.\\n\\nThe discharge medications include 0.9% Sodium Chloride, Acetaminophen, Albuterol Inhaler, Aspirin EC, Bisacodyl, Docusate Sodium, Famotidine, Furosemide, Insulin, and Isosorbide Dinitrate. A follow-up appointment with his cardiologist is scheduled within one week to assess his cardiac status and adjust medications as necessary. Home health services will initiate within 48 hours of discharge to ensure a smooth transition to home.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Age/Sex:** 63/M  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is a 63-year-old male with a history of paroxysmal atrial fibrillation, end-stage renal disease, and hypertension, who was admitted for observation due to recurrent palpitations and increased fatigue. He reported episodes of atrial fibrillation, which were managed during his hospitalization. Additionally, the patient has a history of noncompliance with his medication regimen.\\n\\n**Hospital Course:**  \\nOver the course of his 5-day hospitalization, the patient was monitored closely, and his atrial fibrillation episodes were managed with rate control using carvedilol and felodipine. Renal function was assessed, and he continued to receive appropriate management for his end-stage renal disease. Dialysis was not required during this admission. Laboratory results showed anemia secondary to chronic kidney disease, which was treated with erythropoiesis-stimulating agents and iron supplementation. Patient education regarding medication compliance was emphasized.\\n\\n**Key Findings and Procedures:**  \\nThe patient underwent echocardiography, which showed preserved left ventricular function. Additionally, he received a kidney transplant status update and was educated on the importance of adherence to his post-transplant medications. He was also administered vaccinations, including the quadrivalent influenza vaccine, to reduce infection risk.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved symptom control and understanding of his condition. He demonstrates adequate functional status for home health services, requiring assistance with medication management and monitoring for potential arrhythmias. He has been advised to maintain a low-sodium diet and to monitor his blood pressure regularly.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Carvedilol  \\n3. Felodipine  \\n4. Mycophenolate Mofetil  \\n5. Calcitriol  \\n6. Hydrochlorothiazide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with nephrology and cardiology within one week of discharge. Home health services will assist with medication compliance and monitoring of his renal function and cardiac status. The patient was educated on signs and symptoms that warrant immediate medical attention.',\n",
       " 'Patient is an 82-year-old female who presented to the emergency ward with complaints of fatigue and weakness, attributed to symptoms of dizziness and pallor. Initial laboratory tests revealed significant anemia consistent with ICD-10 code D508 (Other iron deficiency anemias), along with electrolyte imbalances warranting further evaluation. \\n\\nDuring her 1.9-day hospital stay, the patient received intravenous iron therapy with Ferric Gluconate, supportive care including hydration with 0.9% Sodium Chloride, and symptomatic treatment for her acute upper respiratory infection (ICD-10 code J069). A comprehensive review of her medical history revealed additional concerns including a gastric ulcer (K259), unspecified dementia (F0390), and essential hypertension (I10). The interdisciplinary team monitored her closely for potential complications arising from her comorbid conditions, and she was stabilized for discharge. \\n\\nKey findings during her hospitalization included significant improvement in hemoglobin levels and stabilization of her vital signs. No acute gastrointestinal bleeding was noted. Additionally, cognitive assessments indicated the need for ongoing support due to her dementia, emphasizing the importance of home health services upon discharge. \\n\\nAt the time of discharge, the patient was alert and oriented, though she required assistance with activities of daily living due to her functional status being compromised by both her anemia and cognitive deficits. A home health nursing service has been arranged to assist with medication management, monitor her nutritional intake, and provide support for her daily routines. \\n\\nThe discharge medications include Acetaminophen, Aspirin, Calcium Carbonate, Docusate Sodium, Famotidine, Lisinopril, and Hydrochlorothiazide, among others. A follow-up appointment with her primary care physician is scheduled within one week to reassess her anemia and overall health status. She is advised to continue taking her prescribed medications and to report any signs of worsening symptoms immediately.',\n",
       " '**Discharge Summary**  \\n**Patient:** 55-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.1 days  \\n**Primary Diagnosis:** Hypertensive heart disease with heart failure (I110)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of worsening dyspnea on exertion and bilateral lower extremity edema, exacerbated over the past month. Significant past medical history includes obesity (BMI 50.0-59.9), chronic diastolic heart failure, and hemiplegia following a prior cerebral infarction.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored closely for her heart failure symptoms. Management included diuretics (Bumetanide) for fluid overload, anticoagulation with Apixaban, and symptomatic treatment as needed. She received intravenous fluids, and her electrolyte levels were closely monitored. The patient also underwent echocardiography, which confirmed impaired left ventricular function.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent elevated blood pressure and signs of fluid retention. Treatment protocols were adjusted according to daily assessments, and she demonstrated gradual improvement in symptoms. Clindamycin was prescribed for cellulitis of the left toe, and insulin was managed for her diabetes.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved dyspnea and reduced edema. She is able to perform activities of daily living with assistance and is capable of following a prescribed home health regimen. Home health services will be arranged for medication management, monitoring of vital signs, and ongoing support for her heart failure management.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apixaban  \\n3. Bumetanide  \\n4. Clindamycin  \\n5. Gabapentin  \\n6. Insulin  \\n7. Ipratropium Bromide MDI  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician within 1 week. Home health services will initiate contact within 48 hours post-discharge to ensure continuity of care and monitor her recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 81-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of unspecified atrial fibrillation, complicated by acute on chronic systolic heart failure and acute kidney failure. He presented with symptoms of dyspnea and palpitations. Initial workup revealed pneumonia, and he was started on appropriate antibiotic therapy.  \\n  \\n**Hospital Course:**  \\nDuring his 5-day hospitalization, the patient was monitored closely for cardiac rhythm disturbances and fluid status. Atrial fibrillation was managed with Amiodarone, and he was started on Apixaban for anticoagulation. Furosemide was utilized for volume overload due to heart failure. The patient's cardiac status improved with diuresis, and he demonstrated stable renal function by discharge.  \\n  \\n**Key Findings and Procedures:**  \\nThroughout his stay, the patient underwent a chest X-ray which confirmed pneumonia, and a comprehensive metabolic panel showed transient renal impairment, resolving with treatment. He did not require any invasive procedures but was assessed for home health services for ongoing cardiac monitoring and rehabilitation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented. He demonstrated improved functional status with the ability to perform activities of daily living with minimal assistance. The need for home health services was identified to assist with medication management, ongoing monitoring of his cardiac condition, and support with physical rehabilitation.  \\n  \\n**Medications:**  \\nThe patient will be discharged on the following medications: 0.9% Sodium Chloride (EXCEL BAG), Acetaminophen, Acyclovir, Amiodarone, Apixaban, Atorvastatin, Cefpodoxime Proxetil, Docusate Sodium, Ferrous Sulfate, Furosemide, Metoprolol Tartrate, Potassium Chloride, Ramelteon, Sarna Lotion, and Senna.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician in one week. Home health will be initiated to monitor heart rhythm and assist with medication compliance. A follow-up echocardiogram and renal function test are recommended within the next two weeks.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 50  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 2.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient, a 50-year-old female with a history of kidney transplant, was admitted with signs of infection, specifically a kidney transplant infection (ICD10: T8613). She presented with fever, chills, and flank pain. Initial laboratory work indicated renal impairment and electrolyte imbalances, including hypo-osmolality and hyponatremia (E871).  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was started on broad-spectrum intravenous antibiotics, including Ceftriaxone and Ciprofloxacin, and received supportive care with Lactated Ringer’s solution. Her renal function was monitored closely, and she demonstrated gradual improvement in her kidney parameters.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies, which confirmed no obstructive pathology. Key laboratory findings included elevated creatinine levels initially, which decreased during treatment, and normalization of electrolytes. She was also treated for hyperlipidemia and received medications to manage hypertension.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, afebrile, and demonstrates improved renal function. She is able to perform activities of daily living independently but requires assistance with medication management and monitoring for signs of infection. Home health services will be required to assist with ongoing wound care and medication adherence.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed the following medications: Acetaminophen, Atorvastatin, Ceftriaxone, Ciprofloxacin HCl, Fluticasone Propionate NASAL, Heparin, Lactated Ringers, Loratadine, Magnesium Sulfate, Multivitamins, Mycophenolate Mofetil, Neutra-Phos, Polyethylene Glycol, Prednisone, and Ranitidine.  \\nShe is advised to follow up with her nephrologist in one week and to report any signs of infection, changes in urine output, or worsening symptoms immediately. Home health will coordinate care to ensure a smooth transition.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 54-year-old female who presented to the emergency department following a pedestrian traffic accident, resulting in multiple rib fractures, pelvic fractures, and a humeral fracture. She was admitted for further evaluation and management of her injuries.\\n\\n**Hospital Course:**  \\nDuring her 3.9-day stay, the patient underwent thorough imaging studies confirming bilateral rib fractures (ICD10: S2243XA), nondisplaced left acetabulum fracture (ICD10: S32435A), and multiple pelvic fractures (ICD10: S3210XA). The patient was managed conservatively with pain control, including hydromorphone and oxycodone, and received supportive care. She was also placed on a regimen of anticoagulation with heparin to prevent venous thromboembolism due to reduced mobility.\\n\\n**Key Findings and Procedures:**  \\nKey findings included significant pain on palpation of the ribs and pelvis, with associated difficulty in ambulation. The patient was assessed daily by physical therapy, focusing on pain management and gradual mobilization. She received an influenza vaccine and was evaluated for immunization status. \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient demonstrated improved pain control and was able to perform basic activities of daily living with assistance. She will require home health services for continued physical therapy, medication management, and monitoring of her recovery due to the complex nature of her injuries.\\n\\n**Medications at Discharge:**  \\nThe patient will continue with acetaminophen, diphenhydramine, docusate sodium, hydromorphone, ibuprofen, ondansetron, and oxycodone SR. \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician in one week, and she will be referred to home health services for ongoing rehabilitation and medication management. She has been advised to contact her physician if there are any signs of worsening pain, difficulty breathing, or other concerning symptoms.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 84-year-old female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of right groin pain, nausea, and vomiting. A physical examination revealed a unilateral inguinal hernia with signs of obstruction. The patient has a history of Type 2 diabetes and chronic kidney disease, which complicated her clinical picture.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted under observation for further evaluation and management. Imaging studies confirmed the diagnosis of a unilateral inguinal hernia with obstruction, without evidence of gangrene. Surgical consultation was obtained; however, due to the patient's age and comorbidities, the decision was made to manage the condition conservatively with fluid resuscitation and pain management. The patient's diabetes and kidney function were closely monitored during her stay.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient was treated with intravenous fluids (Lactated Ringer's solution), blood glucose management (Dextrose 50%, Insulin), and pain control (Acetaminophen, Oxycodone). She received the quadrivalent influenza vaccine during her stay. Her vital signs remained stable, and her renal function showed no significant deterioration.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improved symptoms and able to ambulate independently. She requires home health services for continued monitoring of her diabetes and kidney function. Assistance with activities of daily living may be necessary due to her age and recent health changes.  \\n  \\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, CARVedilol, Diltiazem ER, Enalapril Maleate, Pravastatin, and Oxycodone. She is advised to follow up with her primary care physician within one week and to maintain regular appointments with her endocrinologist and nephrologist. Home health services will provide support with medication management and monitoring her vital signs.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient’s Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Birth:** [Patient’s DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 27-year-old female who was admitted to the hospital for observation due to right knee pain and swelling, diagnosed as Staphylococcal arthritis (ICD10: M00.061). The patient has a complex medical history, including a history of acute myeloblastic leukemia in remission, bone marrow transplant, and liver transplant status, leading to significant immunocompromised status.  \\n  \\n**Hospital Course:**  \\nDuring her 10.8-day hospital stay, the patient received intravenous antibiotics, including Daptomycin, to address the staphylococcal infection. Pain management was optimized with Hydromorphone, and she was monitored closely for any signs of systemic infection or complications related to her immunodeficiency. The patient also received supportive care, including hydration with Lactated Ringer’s and 0.9% Sodium Chloride.  \\n  \\n**Key Findings and Procedures:**  \\nMRI of the right knee showed localized edema consistent with septic arthritis. Joint aspiration was performed, yielding purulent fluid, which confirmed the diagnosis. The patient responded well to treatment, showing improvement in pain and mobility.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved pain control and ambulation. She is able to perform activities of daily living with assistance and requires home health services for physical therapy to continue strengthening her right knee. She will also need nursing support for medication management and monitoring her recovery due to her complex medical history.  \\n  \\n**Medications at Discharge:**  \\n1. Daptomycin  \\n2. Acetaminophen  \\n3. Levothyroxine Sodium  \\n4. Amiodarone  \\n5. HydrOXYzine  \\n6. Lidocaine 5% Patch  \\n7. Heparin Flush (for IV access)  \\n   \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care provider within one week of discharge, and outpatient physical therapy will be arranged through home health services. She has been advised to seek immediate medical attention if she experiences increased pain, fever, or any signs of infection.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 49  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 49-year-old male admitted for surgical intervention due to a neoplasm of uncertain behavior of the parotid salivary glands (ICD10: D37030). The patient has a history of type 2 diabetes mellitus (E119), gastro-esophageal reflux disease (K219), insomnia (G4700), and hyperlipidemia (E785). He presented with localized swelling and discomfort in the parotid region.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a parotidectomy and was monitored postoperatively for complications. The procedure was successful without intraoperative complications. He required pain management and was started on a regimen including acetaminophen and oxycodone for pain control. Enoxaparin was administered for DVT prophylaxis. The patient was also started on gabapentin for neuropathic pain management and mirtazapine for sleep.  \\n  \\n**Key Findings and Procedures:**  \\nPostoperative evaluations confirmed stable vital signs and the absence of infection. The pathology report will guide further management. The patient was educated on signs of infection and the importance of compliance with follow-up appointments.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with assistance when necessary. He will require home health services for post-operative care, including wound management, monitoring for signs of infection, and support with medication adherence.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atorvastatin  \\n3. Bacitracin Ointment  \\n4. Docusate Sodium  \\n5. Enoxaparin Sodium  \\n6. Gabapentin  \\n7. Mirtazapine  \\n8. Ondansetron  \\n9. OxyCODONE (Immediate Release)  \\n10. Senna  \\n11. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with the surgical team in one week. Home health services have been arranged to assist with daily activities and medication management.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 64-year-old female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a partial intestinal obstruction, unspecified as to cause (ICD-10: K56600). She presented with abdominal pain, distension, and intermittent nausea. No prior surgical history was noted that could account for the obstruction. The patient has a history of morbid obesity, hypertension, hyperlipidemia, and asthma, which were managed during her stay.\\n\\n**Hospital Course:**  \\nDuring her observation period, the patient received IV fluids (0.9% Sodium Chloride, Lactated Ringer's), analgesics (Hydromorphone, Acetaminophen), and medications to manage her symptoms, including Famotidine and Fluticasone Propionate. Serial abdominal exams showed gradual improvement; however, she continued to experience mild discomfort due to her obesity-related respiratory issues and underlying asthma. A dietitian consulted on a low-residue diet which was well-tolerated.\\n\\n**Key Findings and Procedures:**  \\nImaging studies, including an abdominal X-ray, confirmed the diagnosis of partial intestinal obstruction with no signs of perforation. The patient was monitored closely for any signs of complications. Overall, her condition improved with conservative management, and she demonstrated increased tolerance for oral intake by the time of discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved abdominal symptoms and no signs of acute distress. She is able to perform activities of daily living with assistance, particularly due to her obesity and recent surgical history. Home health services are recommended for nursing care to monitor her vital signs and medication adherence, as well as physical therapy to aid in mobility and weight management.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed Acetaminophen as needed for pain, Clonazepam for anxiety, and Diphenhydramine for symptomatic relief. She will follow up with her primary care physician within one week to reassess her weight management and gastrointestinal symptoms. Home health nursing will provide oversight of her medication regimen and assist with any further dietary adjustments.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Female, 70 years old  \\n**Admission Type:** Elective  \\n**Length of Stay:** 4.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of spinal stenosis in the thoracic region (ICD10: M4804), which was causing significant back pain and myelopathy. Her medical history is notable for atherosclerotic heart disease, chronic obstructive pulmonary disease, essential hypertension, and a previous transient ischemic attack.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent a decompression procedure to alleviate the spinal stenosis. Post-operative recovery was uneventful, with gradual improvement in her mobility and pain levels. Physical therapy was initiated on postoperative day one, focusing on strengthening exercises and ambulation training.  \\n\\n**Key Findings and Procedures:**  \\nPreoperative imaging confirmed severe spinal stenosis with associated myelopathy. The surgery performed was successful, and the patient exhibited improved neurological function by discharge. Pain management was effectively achieved with a regimen including acetaminophen, hydromorphone, and adjunctive medications as needed.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved functional mobility, ambulating with minimal assistance. She is able to perform activities of daily living with some support but will require home health services for ongoing rehabilitation and monitoring. The home health team will assist with physical therapy sessions to further enhance her strength and independence.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aspirin, Atenolol, Atorvastatin, Lisinopril, and Levothyroxine Sodium, among others. The patient is advised to follow up with her primary care physician in two weeks and to schedule a follow-up appointment with the spine specialist for ongoing assessment of her recovery. Home health services have been arranged to commence within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 76 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.8 days  \\n\\n**History of Present Illness:** The patient was admitted for evaluation of postprocedural hemorrhage following a digestive system procedure. He presented with significant abdominal pain and melena. Initial laboratory tests indicated anemia, and imaging confirmed the presence of a hemorrhagic source in the distal colon. \\n\\n**Hospital Course:** During his stay, the patient received supportive care, including IV fluids and blood transfusions to address acute posthemorrhagic anemia. He was closely monitored for signs of rebleeding and managed for concurrent chronic conditions, including diastolic heart failure and type 2 diabetes with chronic kidney disease. The interdisciplinary team, including dietetics and physical therapy, was involved in his care to optimize recovery. \\n\\n**Key Findings and Procedures:** The patient underwent endoscopic evaluation and intervention with successful hemostasis achieved. His comorbidities were managed with medications including Furosemide for heart failure, Metoprolol for hypertension, and Insulin for diabetes control. The patient’s renal function was stable throughout the hospitalization, and he was assessed for discharge readiness. \\n\\n**Discharge Condition and Functional Status:** At the time of discharge, the patient was stable, with improved hemoglobin levels and no signs of ongoing bleeding. He is able to perform basic activities of daily living with assistance and is advised to engage in light physical activity as tolerated. Home health services will be initiated to assist with medication management, ongoing monitoring of his blood pressure and diabetes, and support with mobility to ensure safety at home. \\n\\n**Medications and Follow-Up Plan:** Upon discharge, the patient will continue on the following medications: Acetaminophen, Aspirin, Metoprolol, Furosemide, and Insulin. A follow-up appointment is scheduled with his primary care physician in one week, and he is advised to seek immediate medical attention if symptoms worsen. Home health services will ensure appropriate support and monitoring in the post-discharge period.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 77  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient is a 77-year-old male with a primary diagnosis of other pulmonary embolism without acute cor pulmonale (ICD10: I2699). He presented to the emergency department with shortness of breath and hypoxia, prompting immediate evaluation and management. His history includes essential hypertension and a personal history of nicotine dependence, which may contribute to his current condition.  \\n\\n**Hospital Course:**  \\nDuring his 5.6 days of hospitalization, the patient was closely monitored for respiratory status and renal function due to acute respiratory failure with hypoxia and acute kidney failure (ICD10: J9601, N179). He received anticoagulation therapy with Apixaban and was managed for associated complications including shock and local infection. He was also treated with intravenous fluids, pain management, and antibiotics (Ciprofloxacin HCl) for the skin infection.  \\n\\n**Key Findings and Procedures:**  \\nDiagnostic imaging confirmed the presence of pulmonary embolism. The patient underwent supportive therapies, including oxygen supplementation and fluid resuscitation, which improved his respiratory function. He was also administered Heparin and was monitored for any complications from the therapeutic interventions.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrates improved respiratory status but requires ongoing home health services for continued monitoring and assistance with activities of daily living (ADLs). He is stable for discharge but will need support for medication management and follow-up care to monitor renal function and overall health.  \\n\\n**Medications at Discharge:**  \\n- Apixaban  \\n- Ciprofloxacin HCl  \\n- Docusate Sodium  \\n- Fexofenadine  \\n- Hydromorphone (Dilaudid)  \\n- Heparin Sodium  \\n- Omeprazole  \\n- Oxycodone (Immediate Release)  \\n- Polyethylene Glycol  \\n- Ramelteon  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up in a week with his primary care physician and will begin home health services to assist with medication management and monitor for any potential complications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 70  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a subsequent non-ST elevation myocardial infarction (NSTEMI). Her medical history is significant for type 2 diabetes mellitus, chronic heart failure, and hyperlipidemia. She presented with chest pain, dyspnea, and fatigue, prompting further investigation.  \\n  \\n**Hospital Course:**  \\nDuring her 10-day stay, the patient was closely monitored and treated for her cardiac condition. Serial troponin levels confirmed myocardial injury, and she was initiated on a regimen of antiplatelet therapy with aspirin and clopidogrel, along with beta-blockade using metoprolol succinate. Heart failure management included diuretics and adjustment of her antihypertensive medications. The patient's diabetes was managed with insulin and oral hypoglycemics, with attention to her blood glucose levels throughout her admission.  \\n  \\n**Key Findings and Procedures:**  \\nCardiac echocardiography revealed reduced ejection fraction consistent with her chronic heart failure. The patient also underwent a cardiac stress test, which showed limitations due to her symptoms. No acute coronary interventions were required, but she was educated on lifestyle modifications to manage her cardiovascular risk factors effectively.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved symptoms and better understanding of her medication regimen. She requires continued monitoring for heart failure and diabetes management. Home health services have been arranged to assist with medication administration, blood glucose monitoring, and ensuring compliance with dietary recommendations.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Clopidogrel  \\n- Isosorbide Mononitrate (Extended Release)  \\n- Metoprolol Succinate XL  \\n- Insulin and oral hypoglycemics  \\n- Rosuvastatin Calcium  \\n- Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her cardiologist in one week and with her primary care physician in two weeks. Home health services will provide daily visits to assess her cardiac and diabetic management. Education on lifestyle changes and symptom recognition has been emphasized.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n**Patient ID:** [Patient ID]  \\n\\n**History of Present Illness:**  \\nThe patient is a 48-year-old female with a known history of Wegener's granulomatosis without renal involvement, who presented to the hospital with worsening respiratory symptoms, including dyspnea and dysphonia. The patient reported a recent increase in cough and difficulty swallowing, leading to her urgent admission.\\n\\n**Hospital Course:**  \\nDuring her 2.7-day stay, the patient underwent a thorough evaluation which included imaging studies and laboratory tests. A multidisciplinary team managed her condition, focusing on symptom relief and stabilization. She was started on cyclophosphamide, corticosteroids, and supportive care, including nebulized albuterol and ipratropium for bronchospasm. The patient showed gradual improvement in respiratory status and was able to maintain oxygen saturation above 92% on room air by the time of discharge.\\n\\n**Key Findings and Procedures:**  \\nKey findings included stenosis of the larynx and evidence of toxic liver disease, likely secondary to medication. Procedures performed included bronchodilator therapy and close monitoring of liver function tests. The patient was educated on the signs of potential medication adverse effects, particularly related to sulfonamides.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, and demonstrated adequate understanding of her medication regimen. She required home health services for ongoing respiratory therapy and monitoring of her liver function due to the risk of complications related to her medications. Additionally, she will benefit from dietary support given her dysphagia.\\n\\n**Medications and Follow-up Plan:**  \\nThe patient’s discharge medications include albuterol nebulizer solution, cyclophosphamide, pantoprazole, and potassium chloride. A follow-up appointment is scheduled with her primary care physician and pulmonologist in one week. Home health services will facilitate therapy sessions and provide education on managing her condition.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 67-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 11.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe fatigue and jaundice, secondary to other autoimmune hemolytic anemia (ICD10: D591). Workup revealed underlying liver dysfunction (ICD10: K7200) and acute kidney failure (ICD10: N179). She also presented with diverticulitis (ICD10: K5732) and had a history of acquired coagulation factor deficiency (ICD10: D684).  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, she received supportive care, including fluid management and transfusions, alongside treatment for her hemolytic anemia with rituximab. The patient's liver function improved gradually, and she was closely monitored for her renal status. The introduction of Ursodiol was effective in managing liver function tests, which showed improved bilirubin levels. She also received symptomatic treatment for her diverticulitis and was managed for fluid overload.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings indicated persistence of hemolysis with elevated LDH and indirect bilirubin levels. Imaging studies confirmed diverticulitis without complications. Procedures included the administration of heparin for thromboprophylaxis and regular monitoring of her coagulation profile.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, alert, and oriented. She is ambulating independently and reports improved energy levels. Home health services will be crucial for follow-up care, including monitoring of her hemolytic anemia and liver function, alongside dietary modifications due to her diverticulitis.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Dorzolamide 2%/Timolol 0.5% Ophth.  \\n- Folic Acid  \\n- Heparin  \\n- Latanoprost 0.005% Ophth.  \\n- Prednisone  \\n- Ranitidine  \\n- Senna  \\n- Ursodiol  \\n- Vitamin D  \\n- Amlodipine  \\n- Rituximab  \\n  \\nFollow-up appointments are scheduled with hematology and gastroenterology to monitor her ongoing treatment and address any complications.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 80 years old  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 7.6 days  \\n**Primary Diagnosis:** Malignant neoplasm of head of pancreas (ICD-10: C250)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with worsening abdominal pain, jaundice, and weight loss over the past month. Initial imaging revealed a mass at the head of the pancreas, confirmed as a malignant neoplasm. He also exhibited signs of severe protein-calorie malnutrition (E43), likely secondary to his malignancy.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was evaluated by oncology and palliative care teams. He received nutritional support, including enteral feeding, and management for pain control. He experienced an episode of pneumonia (J189) requiring antibiotic therapy with Levofloxacin. Apixaban was initiated for the prevention of thromboembolic events due to his condition.  \\n\\n**Key Findings and Procedures:**  \\nKey diagnostic procedures included abdominal ultrasound and CT imaging, which confirmed the extent of the disease and assessed for metastatic spread. The patient underwent supportive therapies and was monitored closely for complications, including pulmonary embolism and ascites. He was found to have secondary malignant neoplasms affecting the liver (C787) and peritoneum (C786).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition but remains functional limited due to his malignancy and treatment side effects. He will require home health services for continued nutritional support and management of his complex medication regimen, including pain management. Additionally, assistance with daily activities is recommended to ensure safety and comfort at home.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed Acetaminophen, Apixaban, Gabapentin, Mirtazapine, Ondansetron, OxyCODONE, and Polyethylene Glycol. He is advised to follow up with oncology and his primary care physician within one week of discharge to reassess his condition and adjust his treatment plan as necessary.',\n",
       " \"Patient is a 28-year-old male who was admitted under observation for a 3.5-day stay due to an unspecified fever (ICD-10 R509). The patient presented with a history of persistent fever, which was accompanied by malaise and localized abdominal discomfort. Initial laboratory tests revealed iron deficiency anemia (ICD-10 D509) and abnormal findings on imaging of the abdominal region (ICD-10 R935). Throughout the hospital course, the patient underwent a thorough evaluation, including imaging and blood work, which helped rule out serious underlying conditions.\\n\\nThe patient's fever was managed with acetaminophen, and supportive care was provided. The patient also received an influenza vaccine (Quadrivalent) during his stay. His symptoms gradually improved, and by the end of the hospitalization, he exhibited stable vital signs and a significant reduction in fever episodes. The patient was educated on the importance of hydration and was instructed to continue oral hydration with sodium chloride 0.9% flush as needed.\\n\\nKey findings during the hospital stay included localized enlarged lymph nodes (ICD-10 R590) and dorsalgia (ICD-10 M549), which were closely monitored. The patient was also noted to have a personal history of COVID-19 (ICD-10 Z8616) and had contact with suspected COVID-19 cases (ICD-10 Z20822), necessitating continued awareness of isolation and monitoring for any respiratory symptoms.\\n\\nUpon discharge, the patient was in stable condition and is capable of ambulating independently. He will require home health services to monitor his recovery, particularly for ongoing management of his anemia and any potential complications related to his recent illness. The discharge medications include acetaminophen for fever management, a follow-up appointment with his primary care physician, and instructions for home health services to assess his progress. The patient is advised to seek immediate medical attention if his fever returns or if he experiences any new concerning symptoms.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 22  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for complications related to childbirth, specifically other mental disorders complicating childbirth (ICD-10: O99344). The patient presented with anxiety and depression, exacerbated by the stresses of delivery, and was found to have a second-degree perineal laceration. She also had a live birth at 38 weeks gestation, with labor complicated by cord entanglement. The patient was screened for exposure to COVID-19, which was negative.  \\n\\n**Hospital Course:**  \\nDuring her two-day stay, the patient was monitored closely for both her physical and mental health. She received supportive care for her perineal laceration, including pain management with acetaminophen and ibuprofen, and was started on fluoxetine for her anxiety and depression. The patient was hydrated with Lactated Ringer's solution and 0.9% sodium chloride, and bowel regimen was managed with docusate sodium, bisacodyl, polyethylene glycol, and senna.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, improvement in mental status, and healing of the perineal laceration. The patient underwent routine postpartum procedures including monitoring for hemorrhage and infection. Her discharge condition is stable, with no signs of acute distress.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is alert and oriented, able to perform activities of daily living with minimal assistance. She requires ongoing home health support for mental health management and wound care. It is critical that she attends follow-up appointments for mental health therapy and monitoring of her perineal laceration.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include fluoxetine, acetaminophen, ibuprofen, calcium carbonate, Dermoplast spray, and bowel regimen medications. She is advised to follow up with her obstetrician within one week and with her primary care provider for mental health support. Home health services will be initiated to assist with wound care and ongoing mental health assessment.\",\n",
       " \"**Patient Name:** [REDACTED]  \\n**Age:** 49  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.3 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 49-year-old female with a history of Type 1 diabetes mellitus complicated by diabetic autonomic neuropathy, who presented to the hospital with worsening blood glucose control and symptoms of gastroparesis. She reported episodes of hypoglycemia and had been experiencing increased fatigue and gastrointestinal symptoms, including nausea and vomiting. \\n\\n**Hospital Course:**  \\nDuring her 2.3-day stay, the patient's blood glucose levels were closely monitored, and adjustments to her insulin regimen were made. She received Dextrose 50% for hypoglycemic episodes and was started on DULoxetine DR for neuropathic pain management. A renal profile was conducted, revealing end-stage renal disease, and she was assessed for dialysis dependence. \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed signs consistent with autonomic neuropathy, including orthostatic hypotension. The patient underwent a brief trial of renal dialysis, which she tolerated well. Laboratory studies confirmed chronic kidney disease stage 5. She was educated on dietary modifications to manage her gastroparesis and diabetes.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required ongoing management of her diabetes and renal disease. She will benefit from home health services to assist with medication management, blood glucose monitoring, and dietary education. The patient demonstrated understanding of her care plan and expressed willingness to engage in home health support.  \\n\\n**Medications at Discharge:**  \\n- ALPRAZolam  \\n- Acetaminophen  \\n- Aspirin EC  \\n- Atorvastatin  \\n- Bisacodyl  \\n- Calcitriol  \\n- Calcium Carbonate  \\n- D5 1/2NS  \\n- DULoxetine DR  \\n- Gabapentin  \\n- Hydromorphone (Dilaudid)  \\n- Glucose Gel  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her endocrinologist and nephrologist within one week of discharge. Home health services will initiate contact within 48 hours to establish a care plan tailored to her needs.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 36  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted under urgent circumstances with a diagnosis of mild to moderate pre-eclampsia complicating childbirth. She presented with elevated blood pressure and mild proteinuria, along with complaints of headaches and swelling in the extremities.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was closely monitored for maternal and fetal well-being. Antihypertensive therapy was initiated with Labetalol, and she received intravenous fluids, including Lactated Ringer's solution. Laboratory investigations were performed to assess renal function and liver enzymes, which remained within normal limits. The decision for cesarean delivery was made due to the patient's clinical status and the need for timely intervention to ensure the safety of both mother and child.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a cesarean section without complications, delivering a healthy baby. Post-operatively, she was stabilized and managed for pain control with medications including Acetaminophen, Ibuprofen, and Ketorolac. She also received Ondansetron for nausea and Docusate Sodium for constipation prophylaxis. All vital signs normalized, and her blood pressure remained stable post-delivery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was in stable condition, ambulating independently, and able to care for her newborn with some assistance recommended for the initial few days at home. She demonstrated understanding of her medication regimen and signs of potential complications to monitor.  \\n  \\n**Medications and Follow-up Plan:**  \\nThe patient is prescribed Acetaminophen, Ibuprofen, Ketorolac, Labetalol, Lactated Ringers, Levothyroxine Sodium, Milk of Magnesia, Simethicone, and OxyCODONE for pain management. Follow-up with the obstetric provider is recommended within one week of discharge to assess recovery and blood pressure management. Home health services will assist with monitoring vital signs and provide education on postpartum care.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** Dr. [Name]  \\n**Age:** 62  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old female who presented to the hospital with melena and abdominal pain. She has a known history of angiodysplasia of the stomach and duodenum with bleeding (ICD10: K31811). Initial workup included endoscopy which confirmed the diagnosis with evidence of active bleeding.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted under observation for 3.6 days. During her stay, she was monitored closely for hematologic stability, and IV fluids were initiated due to volume depletion. She received several blood transfusions to manage acute posthemorrhagic anemia (ICD10: D62). She was treated with pantoprazole for ulcer prophylaxis and rifaximin for potential bacterial overgrowth.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable hemoglobin levels post-transfusion and resolution of abdominal pain. Procedures performed included an endoscopy with cauterization of angiodysplastic lesions. The patient also experienced acute kidney failure (ICD10: N179), which improved with hydration and cessation of nephrotoxic agents.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, ambulating independently with minimal assistance, and able to perform activities of daily living. She demonstrates understanding of her condition and medication regimen. Home health services will be instrumental in monitoring her recovery, medication compliance, and dietary needs.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, ceftriaxone, fish oil, folic acid, gabapentin, lactulose, lidocaine patch, methadone, midodrine, multivitamins, pantoprazole, ranitidine, and rifaximin. A follow-up appointment is scheduled with her primary care physician within one week. Home health will assist with medication management and monitoring for any signs of rebleeding or complications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- Name: [Patient Name]  \\n- Age: 37  \\n- Gender: Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted under observation for management of other specified sepsis (ICD-10: A4189). She presented with fever, chills, and abdominal discomfort. Initial laboratory tests revealed elevated inflammatory markers and positive cultures for Escherichia coli.  \\n  \\n**Hospital Course:**  \\nDuring her 2.8-day hospital stay, the patient was treated with IV antibiotics (Ceftriaxone) and supportive care, including fluids (Lactated Ringer's) and symptomatic management with acetaminophen for fever. She was monitored closely for signs of acute kidney failure (ICD-10: N179) and received appropriate renal protection protocols due to her underlying health conditions, including a history of liver transplant and recurrent Clostridium difficile enterocolitis (ICD-10: A0471).  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests showed improvement in her white blood cell count and a downward trend in inflammatory markers. Imaging studies were performed to rule out other infectious sources, which were negative. The patient’s renal function remained stable throughout her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with no acute distress. She demonstrates adequate understanding of her medication regimen and home care requirements, including signs of infection to monitor. Home health services are recommended for continued IV antibiotic administration and monitoring of her renal function.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Ceftriaxone  \\n- Clopidogrel  \\n- Heparin  \\n- Ferrous Sulfate  \\n- Dilaudid (Hydromorphone)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week of discharge, and home health nursing services will be initiated to assist with her antibiotic therapy and monitor her recovery.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient ID:** [Redacted]  \\n- **Age:** 59 years  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with worsening shortness of breath and chest discomfort. He has a significant history of atherosclerotic heart disease, hypertension, obesity, type 2 diabetes, hyperlipidemia, and nicotine dependence. Upon admission, he was found to have elevated blood pressure and blood glucose levels, requiring immediate management.  \\n\\n**Hospital Course:**  \\nDuring a 4.7-day hospital stay, the patient was closely monitored and treated in the cardiac unit. He received diuretics for fluid overload and was started on insulin to manage hyperglycemia. His chest pain was managed effectively with analgesics and nitrates. Inhaled bronchodilators were administered for COPD symptoms, and his overall condition improved significantly.  \\n\\n**Key Findings and Procedures:**  \\nDiagnostic tests revealed stable coronary artery disease without acute ischemic changes. He underwent a cardiac stress test, which showed no significant arrhythmias. The patient's weight was noted to be elevated, and he was educated on dietary modifications and the importance of regular exercise.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition. He demonstrates improved respiratory status and is ambulating independently. He will require home health services for ongoing monitoring of blood pressure, diabetes management, and assistance with weight loss strategies.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen IV  \\n2. Aspirin EC  \\n3. Atorvastatin  \\n4. Furosemide  \\n5. Insulin  \\n6. Albuterol Inhaler  \\n7. Ipratropium Bromide Neb  \\n8. Dextrose 50% (as needed for hypoglycemia)  \\n9. Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in 1 week with his primary care physician and cardiologist. Home health will initiate services focusing on medication management, diabetes education, and dietary counseling.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 48  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation with an umbilical hernia without obstruction or gangrene (ICD-10: K429). The patient reported intermittent abdominal discomfort and a visible bulge in the umbilical region.  \\n  \\n**Hospital Course:**  \\nDuring the 1.6-day hospital stay, the patient underwent a comprehensive evaluation. Laboratory tests revealed hyperkalemia, and the patient was managed with regular insulin and calcium gluconate. Additionally, he was noted to have acute kidney failure, likely related to his history of renal transplant, which was monitored throughout his stay. The patient also received treatment for asthma exacerbation and was given Albuterol via inhaler.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a diagnostic imaging study, which confirmed the diagnosis of the umbilical hernia. No signs of obstruction or strangulation were observed. A plan for outpatient follow-up with surgery for hernia repair was made, along with monitoring of renal function and management of hyperkalemia post-discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with vital signs within normal limits and no acute distress. He is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services will be initiated to monitor his renal function, manage medications, and ensure adherence to dietary modifications.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Allopurinol  \\n- Colchicine  \\n- Insulin (Regular) for Hyperkalemia  \\n- Docusate Sodium  \\n- Lactated Ringers  \\n- LORazepam  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and nephrologist within one week. Surgical consultation for hernia repair is recommended within the next month. Home health nursing will assess the patient’s medication adherence and monitor vital signs and renal status.',\n",
       " \"**Patient Information:**  \\n- **Age:** 44  \\n- **Gender:** Male  \\n- **Admission Type:** Direct Observation  \\n- **Length of Stay:** 4.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with severe influenza due to other identified influenza virus, complicated by pneumonia. Symptoms included high fever, cough, and significant respiratory distress. Given his presenting symptoms and underlying conditions, he was placed under direct observation for close monitoring and management.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was treated with intravenous antibiotics (Ceftriaxone and Azithromycin) for pneumonia, along with supportive care including hydration and respiratory therapies. He received antiviral therapy with Oseltamivir in light of his influenza diagnosis. The patient's condition improved gradually, with resolution of fever and respiratory symptoms. He was monitored for complications associated with his history of alcoholic cirrhosis and alcohol dependence, which were managed with appropriate medications and counseling.  \\n\\n**Key Findings and Procedures:**  \\n- Vital signs stabilized with treatment; respiratory function improved.  \\n- Laboratory results indicated resolution of leukocytosis and improved oxygenation.  \\n- No significant complications arose during the hospital stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory status and ability to perform activities of daily living (ADLs) independently. He will require home health services for continued monitoring of his respiratory status, medication management, and support for his underlying alcohol dependence. The patient is also advised to follow up with primary care for management of his liver disease and to ensure adherence to treatment plans.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aluminum-Magnesium Hydrox.-Simethicone  \\n- Azithromycin  \\n- Ceftriaxone  \\n- Furosemide  \\n- Gabapentin  \\n- Influenza Vaccine Quadrivalent  \\n- Lactulose  \\n- Multivitamins  \\n- Oseltamivir  \\n- Omeprazole  \\n\\n**Follow-Up Plan:**  \\nThe patient should follow up with his primary care physician within one week of discharge and continue home health services as planned. He is advised to report any signs of respiratory distress, fever, or worsening abdominal symptoms immediately.\",\n",
       " 'Patient is a 75-year-old male admitted for observation due to chronic lymphocytic leukemia (B-cell type, not in remission, ICD-10: C9110). The patient presented with significant fatigue and weight loss, attributed to his underlying malignancy and concurrent protein-calorie malnutrition (ICD-10: E43). During his 3.7-day hospital stay, he was managed with supportive care including nutritional supplementation and symptom management.\\n\\nHospital course was notable for the management of malignant pleural effusion, which was addressed through thoracentesis to alleviate respiratory distress. Laboratory findings revealed anemia and electrolyte imbalances, which were corrected. The patient also experienced exacerbation of chronic diastolic heart failure (ICD-10: I5032), requiring diuretics for volume overload.\\n\\nKey findings included significant weight loss, with a body mass index (BMI) noted at 19.9 or less, and the presence of pyothorax without fistula (ICD-10: J869) that necessitated close monitoring. The patient was started on a regimen including Apixaban, Digoxin, Levothyroxine Sodium, and Torsemide. He received education on medications and lifestyle modifications to manage his heart failure and prevent further complications.\\n\\nAt discharge, the patient’s condition was stable with improved functional status. He is able to perform activities of daily living with assistance and is ambulating with a walker. Due to his complex medical needs, he will benefit from home health services including nursing care for medication management, physical therapy for mobility enhancement, and nutritional support.\\n\\nDischarge medications include Acetaminophen, Aspirin, Gabapentin, Ranitidine, Simvastatin, Vancomycin Oral Liquid, and a continued regimen of Torsemide and Apixaban. Follow-up is scheduled with hematology and primary care in one week to monitor his condition and adjust treatment as necessary.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 48  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of alcohol dependence with withdrawal symptoms, characterized by tremors, anxiety, and diaphoresis. She has a complex history of substance use disorders, including cocaine dependence and past suicidal ideations.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent a comprehensive withdrawal management protocol which included a tapering regimen of phenobarbital, hydration, and supportive care. The patient received daily assessments, and her withdrawal symptoms were monitored closely. Nutritional deficiencies were addressed with cyanocobalamin and folic acid supplementation.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory evaluations showed mild electrolyte imbalances, which were corrected during the stay. The patient was also screened for HIV, with results indicating asymptomatic status. A psychiatric consultation was conducted due to the patient's history of PTSD and suicidal ideations, leading to adjustments in her psychiatric medications, specifically the initiation of buPROPion and PARoxetine.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved withdrawal symptoms and is now oriented to time, place, and person. She has demonstrated the ability to participate in her care plan and understands the importance of follow-up. She will require continued support from home health services for medication management, monitoring of her mental health status, and assistance with daily activities due to her complex medical history.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. BuPROPion XL (Once Daily)  \\n3. Cyanocobalamin  \\n4. Dolutegravir  \\n5. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY*  \\n6. Fluticasone Propionate 110mcg  \\n7. FoLIC Acid  \\n8. Heparin  \\n9. HydrOXYzine  \\n10. Ondansetron  \\n11. OxyCODONE (Immediate Release)  \\n12. PARoxetine  \\n13. PHENObarbital (Alcohol Withdrawal Dose Taper Days 2-7)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and psychiatrist within one week of discharge. Home health services will be initiated to ensure proper medication adherence and psychosocial support.\",\n",
       " \"Patient is a 75-year-old female admitted for observation due to acute confusion and altered mental status attributed to metabolic encephalopathy. During her 4-day hospital stay, she was diagnosed with metabolic encephalopathy (ICD-10 G9341) likely secondary to unspecified severe protein-calorie malnutrition and chronic kidney disease. She also has a history of hypertensive heart disease and chronic obstructive pulmonary disease (COPD).  \\n\\nOn admission, her vital signs were stable but she presented with significant weakness and low BMI of 19.9. Neurocognitive assessments indicated confusion, and lab results revealed electrolyte imbalances predominantly related to her chronic kidney condition. She required intravenous fluids (Lactated Ringer's) and nutritional supplementation. \\n\\nKey interventions included the initiation of a comprehensive nutritional plan and the optimization of her medications. She was stabilized on a regimen of Acetaminophen, Apixaban, Diltiazem, Metoprolol, and Fluticasone-Salmeterol. She was also started on Mirtazapine for insomnia and Ondansetron for nausea. Additionally, the patient received an influenza vaccine during her stay. \\n\\nAt the time of discharge, the patient was alert and oriented to person and place but required assistance with activities of daily living due to her weakness. She will benefit from home health services to support rehabilitation and monitoring of her nutritional status. \\n\\nDischarge medications include Acetaminophen, Albuterol Inhaler, Apixaban, Artificial Tears, Atorvastatin, Diltiazem Extended-Release, Fluticasone-Salmeterol Diskus, Folic Acid, Lactated Ringers (for hydration), Metoprolol Succinate XL, Mirtazapine, Omeprazole, and Ondansetron. A follow-up appointment with her primary care physician and dietitian is scheduled within one week of discharge. Home health services will ensure medication compliance, nutritional support, and monitoring of her respiratory status.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 34-year-old female who presented to the emergency department with symptoms consistent with major depressive disorder (MDD), including persistent low mood, fatigue, and suicidal ideations. Following a comprehensive assessment, she was admitted under the emergency admission type for stabilization and treatment.  \\n\\n**Hospital Course:**  \\nDuring her 6.5-day stay, the patient underwent psychiatric evaluation and was treated with a combination of pharmacotherapy and psychotherapy. She was initiated on BuPROPion (Sustained Release) for MDD and HydrOXYzine for anxiety and associated insomnia. The patient engaged actively in individual therapy sessions, demonstrating significant insight into her condition and coping strategies.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's mood improved as evidenced by a reduction in depressive symptoms and suicidal ideations. She exhibited stable vital signs throughout her stay and reported a decrease in pelvic and perineal pain, which was managed conservatively. Discharge assessments indicated an improvement in her functional status and ability to perform activities of daily living (ADLs).  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved mood and reduced anxiety, allowing her to safely return home with a support plan in place. She is capable of performing basic ADLs and requires continued assistance with emotional support and monitoring of her mental health status.  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient is prescribed BuPROPion (Sustained Release) and HydrOXYzine. She is advised to follow up with her outpatient mental health provider within one week of discharge. Home health services will initiate support for medication management and monitoring of her mental health status, providing necessary interventions to ensure her continued stabilization.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 58 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 8.8 days  \\n**Primary Diagnosis:** Non-ST elevation myocardial infarction (NSTEMI)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute chest pain and dyspnea, with a history suggestive of NSTEMI. Initial ECG and cardiac biomarkers confirmed the diagnosis. The patient also presents a complex medical history including acute on chronic diastolic heart failure, type 2 diabetes mellitus with complications, and acute kidney failure.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was closely monitored in a telemetry unit. He received medical management for NSTEMI including antiplatelet therapy (Aspirin EC), beta-blockers (CARVedilol), and statins (Atorvastatin). Diuretics were administered for heart failure management, and renal function was monitored due to acute kidney failure. The patient also received treatment for acute posthemorrhagic anemia.  \\n\\n**Key Findings and Procedures:**  \\nThe patient improved with treatment, showing resolution of chest pain and stabilization of vital signs. He underwent multiple laboratory evaluations and imaging studies which demonstrated improvement in cardiac function. A review of his diabetes management plan was initiated, addressing his diabetic nephropathy and retinopathy.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulating independently, and able to participate in activities of daily living with minimal assistance. He requires home health services for ongoing monitoring of his cardiac status, management of diabetes, and support with medication compliance.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe discharge medications include Aspirin EC, Atorvastatin, CARVedilol, and others as listed. The patient is advised to follow up with cardiology within one week and endocrinology for diabetes management. Home health will monitor his vital signs and assist with medication management to ensure adherence to the treatment plan.',\n",
       " '**Patient Summary:**  \\nThe patient is a 36-year-old female who was admitted urgently for management of severe pre-eclampsia complicating the puerperium (ICD-10: O1415).  \\n\\n**History of Present Illness:**  \\nThe patient presented with elevated blood pressure and severe headache, with laboratory findings indicating significant proteinuria and elevated liver enzymes. Given the risk of maternal and fetal complications, she was admitted for close monitoring and management.  \\n\\n**Hospital Course:**  \\nDuring her 3.5-day hospital stay, the patient was stabilized with antihypertensive therapy, including Nifedipine extended-release. She received Enoxaparin for thromboprophylaxis due to her postpartum status. The patient was monitored for signs of HELLP syndrome and fetal distress, both of which were absent. The patient also received supportive care for iron deficiency anemia with supplementation and was vaccinated against COVID-19 with the Pfizer vaccine.  \\n\\n**Key Findings and Procedures:**  \\nVital signs were stabilized with treatment. Laboratory results showed improvement in liver function tests and normalization of blood pressure. The patient underwent routine postpartum assessments with no significant complications noted.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with blood pressure within normal limits and no evidence of acute distress. She is ambulatory and able to perform activities of daily living independently. However, she will need ongoing support for anemia management and monitoring for any potential postpartum complications, which Home Health Services will facilitate.  \\n\\n**Medications at Discharge:**  \\nDischarge medications include Acetaminophen, Bisacodyl, Nifedipine extended-release, Enoxaparin, and iron supplementation. The patient has been educated on the importance of adherence to her medication regimen and monitoring her blood pressure at home.  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her obstetrician in one week. Home health services will initiate weekly visits for ongoing assessment and support in managing her anemia and any other postpartum needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 91  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of abdominal pain and jaundice. Imaging studies revealed a calculus of the bile duct (ICD10: K8051) without accompanying cholangitis or cholecystitis, causing obstruction. The patient has a past medical history significant for congestive heart failure, chronic kidney disease, benign prostatic hyperplasia, and atherosclerotic heart disease.  \\n  \\n**Hospital Course:**  \\nDuring his 2.5-day hospital stay, the patient was closely monitored. He received intravenous fluids, pain management, and was started on antibiotics. An endoscopic retrograde cholangiopancreatography (ERCP) was performed, successfully relieving the biliary obstruction and extracting the stone. Post-procedure, the patient was stable, with improved abdominal symptoms and no signs of infection.  \\n  \\n**Key Findings and Procedures:**  \\n- ERCP performed with successful stone extraction.  \\n- Stable vital signs and improved abdominal pain post-procedure.  \\n- No signs of cholangitis or acute kidney injury.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with a notable resolution of abdominal pain and jaundice. He will require home health services for monitoring of his recovery, including assistance with medication management and assessment of his renal function due to his chronic kidney disease. He is currently able to ambulate with minimal assistance and is oriented to person, place, and time.  \\n  \\n**Medications at Discharge:**  \\n- Aspirin  \\n- Metoprolol Succinate XL  \\n- Simvastatin  \\n- Spironolactone  \\n- Omeprazole  \\n- Ondansetron  \\n- Morphine Sulfate (as needed for pain)  \\n- Others as listed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to monitor for any signs of infection or complications. Home health services will begin immediately to assist with his ongoing care needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 72 years  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 14.5 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with exacerbation of hypertensive heart failure and chronic kidney disease. He presented with dyspnea, fatigue, and leg swelling. A comprehensive assessment revealed acute on chronic systolic heart failure and signs of sepsis. He has a history of type 2 diabetes with associated chronic kidney disease and peripheral vascular complications.\\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was managed with diuretics, antihypertensives, and supportive care for heart failure. Sepsis protocol was initiated, and he was treated with broad-spectrum antibiotics. The patient showed gradual clinical improvement, with diuresis leading to resolution of edema and stabilization of renal function. He required wound care for a chronic ulcer on the right foot, which was addressed by the wound care team.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included elevated blood pressure, elevated creatinine levels, and peripheral edema. The patient underwent a comprehensive workup, including echocardiography and vascular studies, which confirmed the diagnosis of heart failure and peripheral arterial disease. He received education on diabetes management and foot care.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved respiratory status and decreased edema. He is able to perform activities of daily living with assistance and requires home health services for ongoing monitoring of his heart failure and diabetes management. A home health nurse will assist with medication management, wound care, and education about lifestyle modifications.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Apixaban, Amiodarone, Atorvastatin, and insulin therapy, among others. The patient is advised to follow up with his primary care physician and cardiologist within one week. Home health services will initiate within 48 hours post-discharge for continued support and assessment.',\n",
       " \"Patient is a 53-year-old female who was admitted for observation due to worsening abdominal pain, jaundice, and weight loss. Imaging studies revealed a malignant neoplasm of the head of the pancreas (ICD-10: C250), with associated biliary obstruction (ICD-10: K831). Over the course of her 2-day hospital stay, the patient underwent endoscopic retrograde cholangiopancreatography (ERCP) with stent placement to relieve bile duct obstruction, as indicated by her symptoms and imaging findings.\\n\\nDuring her hospitalization, she was stabilized with IV fluids (Lactated Ringers) and managed with pain control (OxyCODONE), as well as antiemetics (Ondansetron) for nausea. Additionally, she received antibiotics (Ciprofloxacin HCl) to prevent infection due to the biliary obstruction and was closely monitored for any complications.\\n\\nKey findings included elevated liver enzymes and bilirubin levels, consistent with her diagnosis of secondary malignancies affecting the liver (ICD-10: C787). The patient's diabetes management was also addressed, and she received insulin therapy to maintain glycemic control (ICD-10: E119).\\n\\nUpon discharge, the patient is stable but continues to require home health services for ongoing monitoring of her nutritional status (due to weight loss and risk of starvation - ICD-10: E8889) and management of her diabetes. She will also need assistance with medication management, including the administration of insulin and monitoring of her pain levels.\\n\\nDischarge medications include Acetaminophen, Docusate Sodium, Glucagon, Glucose Gel, Heparin, and TraZODone for sleep. The patient is advised to follow up with her oncologist within one week and is scheduled for outpatient nutritional counseling. Home health nursing will assess her needs for wound care post-ERCP and ensure adherence to her medication regimen.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 65 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with typical atrial flutter (ICD-10: I483) after presenting with palpitations and dyspnea. He has a significant past medical history including acute on chronic systolic heart failure, type 2 diabetes with nephropathy, and chronic kidney disease. His medication regimen is complicated due to multiple comorbidities, necessitating a careful approach to anticoagulation and fluid management.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent rate control with intravenous amiodarone and was transitioned to oral apixaban for anticoagulation. He received diuretics for fluid overload and was closely monitored for renal function due to his acute kidney failure (ICD-10: N179). The multidisciplinary team assisted in managing his diabetes and hypertension, ensuring optimal treatment of his chronic conditions.  \\n\\n**Key Findings and Procedures:**  \\nNotable findings included persistent atrial flutter on telemetry, improved renal function, and resolution of fluid overload with furosemide. The patient was educated regarding the importance of medication adherence and lifestyle modifications. A comprehensive assessment was performed, and home health services were recommended for ongoing monitoring and support.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with resolution of acute symptoms. He is ambulatory with assistance and requires home health services for medication management, monitoring of vital signs, and education on chronic disease management. His family has been involved in the care plan to facilitate adherence to follow-up instructions.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include amlodipine, apixaban, aspirin, furosemide, and others. He is advised to follow up with his primary care physician within one week for reassessment of his cardiac status and renal function. Continuous home health support will be provided to ensure medication compliance and manage potential complications.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 82 years  \\nGender: Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 6.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to a diagnosed diaphragmatic hernia (ICD-10: K449) without obstruction or gangrene. She presented with symptoms of dysphagia and respiratory distress, exacerbated by her underlying conditions, including atrial flutter and hypertension.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent laparoscopic repair of the diaphragmatic hernia. Post-operative recovery was complicated by episodes of atrial flutter and acute kidney failure (ICD-10: N179), necessitating close monitoring and management. She also required treatment for atelectasis and received respiratory therapy. Her medications were adjusted to address her cardiac and renal function throughout her stay.  \\n\\n**Key Findings and Procedures:**  \\nThe surgical intervention was successful with no immediate complications. Post-operative imaging confirmed proper diaphragmatic positioning. Key findings included elevated blood pressure, managed with Metoprolol and Furosemide, and renal function improvement noted later in the hospital course.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but continues to require assistance with activities of daily living due to weakness and mild dysphagia. She will benefit from home health services for physical therapy to improve strength and mobility, as well as for monitoring of her cardiac status.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Apixaban, Metoprolol Succinate XL, Furosemide, Ondansetron, Pantoprazole, and PARoxetine. A follow-up appointment is scheduled with her primary care physician within one week of discharge, and she is advised to seek immediate care for any signs of respiratory distress or significant changes in her condition.',\n",
       " \"**Patient Information:** 53-year-old female, admitted for surgical intervention due to osteoarthritis of the knee.  \\n\\n**History of Present Illness:** The patient presented with significant pain and functional limitations secondary to osteoarthritis of the knee, which was unresponsive to conservative management. She underwent a right total knee arthroplasty and was admitted as a surgical same-day admission.\\n\\n**Hospital Course:** The patient had an uneventful hospital stay lasting 3.5 days. She was monitored postoperatively for pain control and risk of complications, including deep vein thrombosis. Enoxaparin was administered as prophylaxis. The patient received multimodal analgesia, including hydromorphone, acetaminophen, and ketorolac, which effectively managed her pain. She was also started on gabapentin for neuropathic pain management. Physical therapy was initiated on postoperative day one, focusing on range of motion and strengthening exercises. \\n\\n**Key Findings and Procedures:** Preoperative evaluations revealed a BMI of 37.5, indicating obesity, which may impact recovery. The patient also has a history of obstructive sleep apnea, major depressive disorder, and Barrett's esophagus. Post-surgical imaging confirmed the proper placement of the right artificial knee joint. \\n\\n**Discharge Condition and Functional Status:** The patient demonstrated improved mobility with the assistance of a walker and was able to perform activities of daily living (ADLs) with minimal assistance. She will benefit from continued home health services for physical therapy to enhance her recovery and strength. The patient’s mental status has been stable, but she will require ongoing support for her depressive symptoms. \\n\\n**Medications and Follow-Up Plan:** At discharge, the patient was prescribed acetaminophen, gabapentin, Citalopram, and other supportive medications. Follow-up appointments have been scheduled with her orthopedic surgeon in two weeks and her primary care physician for ongoing management of her chronic conditions. Home health services will be arranged to assist with physical therapy and monitoring of her recovery.\",\n",
       " 'Patient is a 50-year-old female who was admitted for observation due to exacerbation of gastritis, unspecified, without bleeding (ICD10: K2970). Patient reported persistent abdominal discomfort and nausea. She has a significant medical history including kidney and pancreas transplant status, essential hypertension, and hyperlipidemia. Prior to admission, she had been experiencing increased abdominal pain and constipation. \\n\\nDuring her brief hospital stay of approximately 1.1 days, the patient was managed with intravenous fluids (Lactated Ringers), analgesics (Acetaminophen, OxyCODONE), and medications for her gastrointestinal symptoms (Pantoprazole, Ondansetron). A comprehensive evaluation was performed, including laboratory tests that revealed elevated white blood cell count, likely related to her recent symptoms. No significant bleeding or complications of gastritis were noted. The patient was closely monitored for any signs of complications, and her vital signs remained stable throughout her stay.\\n\\nKey findings included a resolution of nausea and improvement in abdominal pain following conservative management. The patient was able to tolerate a regular diet prior to discharge with no acute distress. At discharge, she was in stable condition, with a functional status indicating she can perform activities of daily living with minimal assistance. Home health services have been recommended to provide follow-up care, including monitoring of her gastrointestinal symptoms and assistance with medication management.\\n\\nDischarge medications include: Aspirin, Atorvastatin, Bisacodyl, Docusate Sodium, Mycophenolate Sodium DR, Levothyroxine Sodium, and Magnesium Citrate. The patient is advised to follow up with her primary care physician and gastroenterologist within one week. Home health services will facilitate medication reconciliation and ensure adherence to her prescribed regimen.',\n",
       " \"**Patient Name:** [Name]\\n**Age:** 23  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.8 days  \\n**Date of Discharge:** [Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of velamentous insertion of umbilical cord at 40 weeks gestation. She presented with mild contractions and was monitored closely for fetal distress. The decision for an urgent delivery was made due to the potential risks associated with her condition, including the risk of cord rupture and fetal hypoxia.  \\n\\n**Hospital Course:**  \\nThe patient remained stable during her hospital stay, with continuous fetal monitoring showing reassuring patterns. A vaginal delivery was performed successfully after an induction with oxytocin, resulting in a live birth. There were no immediate complications noted. Post-delivery, the patient experienced a second-degree perineal laceration, which was repaired in the delivery room. She was also identified as a carrier of Streptococcus B, leading to the administration of antibiotics during labor.  \\n\\n**Key Findings and Procedures:**  \\n- Primary Diagnosis: Velamentous insertion of umbilical cord, third trimester (ICD-10: O43123)  \\n- Procedures performed: 1) Induction of labor (ICD-10: 10E0XZZ)  2) Vaginal delivery (ICD-10: 0KQM0ZZ)  3) Repair of second-degree perineal laceration (ICD-10: 10907ZC)  \\n- Other diagnoses: Streptococcus B carrier state complicating childbirth, other malformation of placenta.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and in good condition with no signs of post-operative complications. She is ambulating independently and has been advised on perineal care due to her recent laceration repair. The patient will benefit from home health services for ongoing monitoring of her recovery, education on newborn care, and assistance with lactation support.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Calcium Carbonate  \\n- Dermoplast Spray for perineal discomfort  \\n- Lactated Ringer's solution for hydration (if needed)  \\n- Milk of Magnesia and Simethicone for gastrointestinal comfort  \\n- Sodium Chloride 0.9% for flushes  \\n- Tetanus-DiphTox-Acellular Pertussis vaccine (Adacel)  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician within one week for evaluation of her recovery and laceration repair. Home health services will be initiated to ensure proper wound care and education on infant care.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information**: 37-year-old female, admitted urgently for maternal care of suspected poor fetal growth during the third trimester.  \\n  \\n**History of Present Illness**: The patient was admitted with concerns regarding fetal growth restriction at 37 weeks gestation. Ultrasound examinations revealed abnormal fetal heart rate and rhythm, leading to the decision for close monitoring and intervention.  \\n  \\n**Hospital Course**: During the 5.4 days of hospitalization, the patient received comprehensive maternal-fetal monitoring. Several interventions were carried out, including the administration of oxytocin for labor induction due to the fetal condition. Pain management was addressed with hydromorphone and oxycodone, alongside supportive care with IV fluids (Lactated Ringer's and 0.9% Sodium Chloride).  \\n  \\n**Key Findings and Procedures**: The patient underwent continuous fetal heart rate monitoring, and ultimately had a successful vaginal delivery. Post-delivery assessments showed the neonate was stable, and the mother exhibited signs of recovery, although she experienced anxiety related to her condition, which was managed with appropriate medications.  \\n  \\n**Discharge Condition and Functional Status**: The patient is being discharged in stable condition, with a functional status that allows for self-care, although she will require assistance with activities of daily living (ADLs) during the initial recovery phase. Home health services will monitor her mental health status and assist with mobility support as needed.  \\n  \\n**Medications**: At discharge, the patient was prescribed the following medications: 0.9% Sodium Chloride, Calcium Carbonate, Docusate Sodium, Hydromorphone, Ibuprofen, Naloxone, Ondansetron, Oxycodone (Immediate Release), Oxytocin, Polyethylene Glycol, Senna, and Simethicone.  \\n  \\n**Follow-Up Plan**: The patient is to follow up with her obstetrician within one week post-discharge to monitor recovery and address any concerns related to her mental health and the neonatal status. Home health services will initiate care within 48 hours post-discharge.\",\n",
       " 'Patient is a 61-year-old male who was admitted for observation due to acute and subacute hepatic failure (ICD10: K7200) without coma, presenting with symptoms including jaundice, ascites, and altered liver function tests. His past medical history includes portal vein thrombosis, nonalcoholic steatohepatitis (NASH), and long-term anticoagulant therapy. \\n\\nDuring the 5-day hospital stay, the patient was managed with supportive care, including diuretics (Furosemide, Spironolactone) for fluid overload and lactulose for hepatic encephalopathy. His liver function was closely monitored, and he received transfusions of Dextrose 50% to address hypoglycemia. The patient was also started on Tenofovir Disoproxil (Viread) for viral hepatitis B management. He remained stable throughout his stay and showed gradual improvement in liver function tests.\\n\\nKey findings included elevated liver enzymes, bilirubin levels, and the presence of ascites confirmed via ultrasound. The patient underwent paracentesis to relieve discomfort from ascites, which yielded significant improvement in symptoms. Overall, he demonstrated good tolerance to treatments without any major complications.\\n\\nAt the time of discharge, the patient is in stable condition, alert, and oriented, with a functional status allowing for independent ambulation. He will require home health services for ongoing monitoring of liver function, management of medications, and dietary counseling. \\n\\nDischarge medications include Furosemide, Spironolactone, Lactulose, Omeprazole, and Tenofovir Disoproxil. He is advised to follow up with his hepatologist within one week for further evaluation and management of his liver condition. Home health nursing will assist with medication administration, vital sign monitoring, and ensuring adherence to a low-sodium diet. The patient is educated on signs of potential complications, including worsening ascites or changes in mental status, for which he should seek immediate care.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n**Age:** 70, **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a traumatic pneumothorax following a fall. He presented with acute respiratory distress and hypoxemia. Initial imaging confirmed the diagnosis of a left-sided traumatic pneumothorax and multiple rib fractures.  \\n  \\n**Hospital Course:**  \\nDuring the 5.8-day stay, the patient was managed with supplemental oxygen and pain control. He received a chest tube placement to facilitate re-expansion of the lung and was monitored for complications. The patient was also treated for urinary retention and underwent medication adjustments for hyperlipidemia and hypertension.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant rib fractures (ICD10 S2242XA), retention of urine (R339), and obesity (E669). The chest tube was successfully removed on day 4 after confirming adequate lung expansion. The patient was started on prophylactic enoxaparin and was monitored for thromboembolic events.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory status and was able to ambulate with minimal assistance. However, he requires home health services for monitoring oxygen saturation and assistance with activities of daily living due to mild deconditioning and ongoing pain management needs.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 5% Dextrose, Acetaminophen, Atorvastatin, Bisacodyl, Bupivacaine, Enoxaparin (prophylaxis), and pain management agents (e.g., Hydromorphone, Ibuprofen). The patient is advised to follow up with his primary care physician within one week and to contact home health for any concerns regarding respiratory distress or pain management. It is essential to monitor for any signs of complications related to his recent injuries.',\n",
       " '**Discharge Summary**  \\n**Patient:** 78-year-old female  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted urgently for evaluation of unspecified B-cell lymphoma involving the spleen, with associated symptoms of hemoglobinuria and electrolyte imbalance, specifically hyponatremia.  \\n  \\n**Hospital Course:**  \\nDuring her 13-day hospitalization, the patient underwent a thorough workup, including imaging and laboratory evaluations. Notable findings included splenomegaly and evidence of bone marrow infiltration consistent with lymphoma. The patient received supportive care, including hydration and electrolyte management, and was started on Methimazole for thyroid function abnormalities. She also received antibiotics for Mycoplasma pneumoniae pneumonia, which was confirmed via PCR testing.  \\n  \\n**Key Findings and Procedures:**  \\nImaging revealed splenic involvement by lymphoma, and she underwent splenic aspiration to obtain tissue for histological examination. The procedure was well-tolerated. Laboratory tests showed improvement in hemoglobin levels post-transfusion, and electrolyte levels stabilized with treatment.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated stable vital signs and was ambulating independently. She is oriented to time, place, and person, though she requires continued monitoring of her electrolyte status and management of her underlying lymphoma. Home health services will assist with daily monitoring, medication administration, and patient education regarding her condition and medications.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Bismuth Subsalicylate  \\n4. Cyanocobalamin  \\n5. Doxycycline Hyclate  \\n6. Folic Acid  \\n7. Methimazole  \\n8. Metronidazole  \\n9. Ondansetron  \\n10. Pantoprazole  \\n11. Ramelteon  \\n12. Senna  \\n13. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with hematology-oncology within one week for further management of her lymphoma. Home health will coordinate care and ensure adherence to medication and electrolyte monitoring protocols.',\n",
       " \"**Discharge Summary**  \\n**Patient ID**: [REDACTED]  \\n**Date of Admission**: [REDACTED]  \\n**Date of Discharge**: [REDACTED]  \\n**Age**: 67  \\n**Gender**: Male  \\n  \\n**History of Present Illness**:  \\nThe patient is a 67-year-old male with a history of alcohol use disorder, presenting with alcoholic hepatic failure without coma (ICD10: K7040). He was admitted for observation due to worsening jaundice, ascites, and altered liver function tests. He reports increased fatigue and decreased appetite over the past month, with significant fluid retention noted on examination.  \\n  \\n**Hospital Course**:  \\nDuring his 2.8-day hospital stay, the patient was monitored closely for signs of hepatic encephalopathy and fluid overload. He received diuretics including furosemide and spironolactone to manage ascites and fluid status. Lactulose was initiated to prevent hepatic encephalopathy. The patient's renal function was stable, and he demonstrated improvement in fluid balance with a gradual reduction in abdominal girth.  \\n  \\nKey findings included elevated liver enzymes, bilirubin levels, and the presence of chronic viral hepatitis C (ICD10: C220). A hepatology consult was obtained, and imaging studies confirmed the presence of liver cell carcinoma (ICD10: C220).  \\n  \\n**Discharge Condition and Functional Status**:  \\nThe patient is being discharged in stable condition, with improved symptoms of ascites and jaundice. He is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services are recommended to assist with medication management, monitoring of vital signs, and nutritional support.  \\n  \\n**Medications at Discharge**:  \\n1. Albuterol Inhaler  \\n2. Fluticasone-Salmeterol Diskus 100/50  \\n3. Folic Acid  \\n4. Furosemide  \\n5. Heparin  \\n6. Lactulose  \\n7. Methadone  \\n8. Nicotine Patch  \\n9. Sodium Chloride 0.9% Flush  \\n10. Spironolactone  \\n11. Tiotropium Bromide  \\n12. Rifaximin  \\n  \\n**Follow-Up Plan**:  \\nFollow-up with hepatology in one week and primary care in two weeks. Home health services will initiate within 48 hours of discharge to ensure continuity of care.\",\n",
       " '**Patient Summary:** 54-year-old male admitted electively for management of complications related to light chain (AL) amyloidosis and multiple myeloma. The patient presented with symptoms consistent with nephrotic syndrome and was evaluated for potential organ transplant.\\n\\n**History of Present Illness:** The patient has a history of multiple myeloma, light chain amyloidosis, and chronic kidney disease. He experienced accidental poisoning due to systemic agents, which prompted hospital admission. His clinical course was further complicated by symptoms of anemia and hypogammaglobulinemia.\\n\\n**Hospital Course:** During his 1-day stay, he was treated with intravenous fluids including 0.9% Sodium Chloride, Dexamethasone, and Cyclophosphamide to manage his underlying conditions. Acyclovir was administered as a prophylactic measure against viral infections due to his immunocompromised state. He received supportive care with Ondansetron for nausea and Torsemide for fluid management. The patient was monitored closely for any adverse effects from chemotherapy.\\n\\nKey findings included stable vital signs, improvement in renal function parameters, and resolution of acute symptoms related to nephrotic syndrome. The patient was also educated on the importance of medication adherence and lifestyle modifications, particularly regarding tobacco cessation.\\n\\n**Discharge Condition and Functional Status:** The patient was discharged in stable condition, with improved functional status. He demonstrated understanding of his medications and follow-up care. Home health services will be initiated to assist with medication management and monitoring of renal function. The patient is advised to maintain close communication with the home health nurse for any emerging concerns and follow-up visits with his oncologist and nephrologist.\\n\\n**Medications at Discharge:** The patient’s discharge medications include Dexamethasone, Cyclophosphamide, Acyclovir, and supportive care medications such as multivitamins. A follow-up appointment has been scheduled with oncology in one week, and he is advised to go to the emergency department if he experiences worsening symptoms or signs of infection.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 53  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute gastroenteropathy attributed to Norwalk agent (ICD-10: A0811). He presented with severe diarrhea, nausea, and dehydration. The patient has a complex medical history including end-stage renal disease, hypertensive chronic kidney disease, type 2 diabetes, and a previous liver transplant.  \\n\\n**Hospital Course:**  \\nDuring a 5-day stay, the patient received supportive care, including intravenous fluids, electrolyte management, and monitoring of renal function. He was placed on a bowel rest regimen initially, followed by gradual reintroduction of oral intake. The patient's symptoms improved significantly, and he was able to tolerate a regular diet by discharge.  \\n\\n**Key Findings and Procedures:**  \\nLabs indicated stable renal function with a slight increase in creatinine, manageable with ongoing dialysis. Imaging and stool cultures were negative for bacterial pathogens, confirming a viral etiology. The patient underwent a procedure for dialysis access maintenance during the hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with significant improvement in gastrointestinal symptoms. He is alert and oriented, able to perform activities of daily living with minimal assistance. Home health services will be initiated to assist with ongoing dialysis management, medication adherence, and monitoring of blood glucose levels.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Calcitriol  \\n- Diltiazem Extended-Release  \\n- Gabapentin  \\n- Heparin  \\n- Insulin  \\n- Lorazepam  \\n- Olanzapine  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with nephrology in one week, and outpatient dialysis has been scheduled. He is advised to monitor his blood glucose closely and report any signs of infection or recurrent gastrointestinal symptoms immediately. Home health services will provide education on medication management and dietary modifications.\",\n",
       " 'Patient is a 20-year-old female with a displaced bicondylar fracture of the right tibia, initially encountered during a traffic accident. She was admitted under observation for a total of 2.8 days. Upon presentation, she exhibited significant pain and swelling in the right knee, accompanied by acute posthemorrhagic anemia due to blood loss sustained during the accident. \\n\\nDuring her hospital course, she received comprehensive orthopedic evaluation and management. Imaging studies confirmed the displaced fracture, necessitating surgical intervention. The patient underwent an open reduction and internal fixation of the fracture. Post-operatively, she was monitored in the surgical recovery unit and transitioned to the orthopedic floor where she was managed for pain control and rehabilitation. Key findings included stable vital signs, gradual improvement in pain levels, and increased range of motion in the affected knee with physical therapy.\\n\\nUpon discharge, the patient was ambulating with assistance and demonstrating improved functional status. She will require continued physical therapy and home health services to aid her recovery process and support her mobility at home. She has been instructed on weight-bearing precautions and the importance of adhering to rehabilitation exercises.  \\n\\nMedications at discharge include Acetaminophen for pain management, Ketorolac, OxyCODONE (Immediate Release) as needed for breakthrough pain, Enoxaparin for venous thromboembolism prophylaxis, and Ondansetron for nausea management. She also received the Influenza Vaccine Quadrivalent. The patient has been advised to follow up with her orthopedic surgeon in one week for wound assessment and further management. Home health services have been arranged to assist with medication management and physical therapy.',\n",
       " 'Patient is a 50-year-old female who was admitted for observation due to a kidney transplant infection (ICD-10: T8613) presenting with fever, dysuria, and flank pain. She has a complex medical history including hypertension, anxiety disorder, and major depressive disorder. During her 2-day stay, she was treated with broad-spectrum antibiotics including Ceftriaxone and Cefpodoxime for the infection, along with supportive care. \\n\\nThe hospital course was complicated by acute pyelonephritis (ICD-10: N10) and a transient episode of acute kidney failure (ICD-10: N179), which responded well to hydration and medication. Key findings included elevated creatinine levels, which normalized by discharge. The patient also received treatment for concomitant issues such as iron deficiency anemia and hyperlipidemia, with medications adjusted accordingly. \\n\\nUpon discharge, the patient demonstrated significant improvement in her symptoms, with stable vital signs and no fever. She is ambulating independently and reports a decrease in pain levels. However, she requires ongoing home health services for management of her kidney transplant care, including monitoring of renal function and adherence to her medication regimen. \\n\\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen for pain management, Amitriptyline for anxiety, Mycophenolate Sodium DR for immunosuppression, and Labetalol for hypertension management. The patient is advised to follow up with her nephrologist within one week and to engage with a home health nurse for medication management and education on signs of infection and transplant rejection. Overall, the patient is in stable condition and capable of participating in her recovery with home health support.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 31, Gender: Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for obstructed labor due to shoulder dystocia. She experienced prolonged labor and presented with significant fetal distress, necessitating urgent intervention. Upon admission, she was evaluated and monitored for complications associated with the delivery.  \\n  \\n**Hospital Course:**  \\nThe patient underwent an emergency cesarean section to resolve the obstructed labor. Postoperatively, she was monitored in the recovery unit for signs of infection, bleeding, and pain management. She received appropriate maternal care, including management of a third-degree perineal laceration and monitoring for secondary postpartum hemorrhage. Her hospital course was complicated by a Streptococcus B carrier state, which was managed with intravenous antibiotics.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient was found to have a third-degree perineal laceration during delivery, and she was treated accordingly. She received Cefazolin prophylactically to prevent infection and was closely monitored for anemia and respiratory complications. A total abdominal ultrasound was performed, showing no retained products of conception.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable upon discharge with improved pain control, managed by acetaminophen and oxycodone as needed. She demonstrates adequate mobility for activities of daily living but requires assistance with ambulation due to postoperative recovery. The patient will benefit from home health services for wound care and monitoring for signs of infection, as well as support for her ongoing recovery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed acetaminophen, bisacodyl, calcium carbonate, cefazolin, docusate sodium, and oxycodone for pain management. She is advised to follow up with her obstetrician in one week for a postpartum check and to monitor her recovery closely. Home health services will be arranged to assist with her care and ensure a safe transition home.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 22 years  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute kidney failure, unspecified (ICD-10 N179). She presented with symptoms of nausea and vomiting, fatigue, and was noted to have electrolyte imbalances. The patient has a past medical history significant for tension-type headaches and gastroparesis, which complicated her current presentation.  \\n\\n**Hospital Course:**  \\nDuring her 0.9-day stay, the patient underwent a thorough evaluation including laboratory tests revealing elevated creatinine levels consistent with acute kidney injury. A review of her electrolytes showed mild hypokalemia, which was addressed with potassium chloride supplementation. Continuous monitoring for fluid balance was conducted, and she received intravenous fluids consisting of sodium chloride and potassium chloride.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine and potassium levels, with subsequent normalization noted prior to discharge. The patient's nausea was effectively managed with ondansetron, and she was treated with acetaminophen for headache relief. Due to her underlying conditions, she was also started on clonazepam to help manage anxiety related to her symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms and normalized renal function. She is alert and oriented, with the ability to perform activities of daily living independently. Given her history of gastroparesis, a referral to home health services for dietary management and continued monitoring of her renal function is recommended.  \\n\\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient will continue on the following medications: acetaminophen, clonazepam, heparin, ondansetron, potassium chloride, and propranolol. A follow-up appointment with her primary care physician is scheduled within the next week to reassess her renal function and overall health status. Additionally, home health services will assist in monitoring her electrolyte levels and dietary needs.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 4.7 days  \\n**Primary Diagnosis:** Unspecified acute appendicitis (ICD-10: K3580)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute abdominal pain localized to the right lower quadrant, associated with nausea and vomiting. A physical exam revealed rebound tenderness and guarding, leading to further imaging studies which confirmed the diagnosis of acute appendicitis.  \\n  \\n**Hospital Course:**  \\nThe patient underwent an uncomplicated laparoscopic appendectomy on the day following admission. Postoperatively, he was monitored in the surgical recovery unit. He received IV fluids (0.9% Sodium Chloride and Dextrose 5%) and was started on IV Ciprofloxacin and supportive medications for pain management (Acetaminophen).  \\n  \\nThe patient was treated for his underlying conditions, including secondary thrombocytopenia and alcoholic liver disease, with careful monitoring of liver function tests and platelet counts during hospitalization. Alcohol use counseling was initiated due to his history of alcohol dependence.  \\n  \\n**Key Findings and Procedures:**  \\n1. Laparoscopic appendectomy performed without complications.  \\n2. Stable postoperative course with no significant adverse events.  \\n3. Patient's liver function was closely monitored, with no signs of decompensation noted.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, able to ambulate independently, and with intact bowel function. He has been educated on signs of infection and when to seek medical attention. Home health services will assist with medication management and provide follow-up care for his liver condition and alcohol use.  \\n  \\n**Medications at Discharge:**  \\n- Ciprofloxacin (oral)  \\n- Acetaminophen as needed  \\n- Docusate Sodium for constipation  \\n- Multivitamins including Folic Acid  \\n- Insulin and Glucose Gel for diabetes management  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up in the outpatient clinic within one week post-discharge for surgical site evaluation and management of his hepatic condition. Home health services will initiate within 48 hours to monitor his recovery and assist with lifestyle modifications to support sobriety.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 33-year-old female admitted with complaints of severe occipital neuralgia, characterized by recurrent, debilitating headaches that began acutely. The patient has a complex medical history, including obesity (BMI 50.0-59.9), hypertension, obstructive sleep apnea, and asthma, all of which may have compounded her symptoms.\\n\\n**Hospital Course:**  \\nDuring her 10-day hospital stay, the patient underwent a comprehensive evaluation and was managed with a multidisciplinary approach, including pain management and neurological consultations. The patient received acetaminophen for pain control, along with baclofen and cyclobenzaprine for muscle relaxation. Nebulized albuterol was administered for asthma exacerbations. Additionally, iron deficiency anemia was treated, and she was monitored closely for her comorbid conditions.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent occipital neuralgia, which was managed with medication. The patient’s blood pressure was controlled, and her asthma symptoms stabilized during the hospitalization. No invasive procedures were required; however, she was given supportive care, including Dextrose for hypoglycemia and insulin as needed.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved pain control with a reduction in the frequency of headaches, although she continues to require home health services for ongoing management of her occipital neuralgia and comorbid conditions. The patient is ambulatory but requires assistance with activities of daily living due to her obesity and sleep apnea. A home health nurse will assist with medication management and monitor her vital signs.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the following medications were prescribed: Acetaminophen, Albuterol 0.083% Nebulized Solution, Baclofen, BuPROPion (Sustained Release), Cyclobenzaprine, and Fluticasone-Salmeterol Diskus. The patient is scheduled for a follow-up appointment with her primary care physician in one week to reassess her pain management and overall health status. Home health services will initiate upon discharge to support her recovery.\",\n",
       " \"Patient is a 68-year-old male admitted for surgical intervention related to atherosclerotic heart disease of the native coronary artery. The patient has a significant medical history including a prior myocardial infarction, essential hypertension, hyperlipidemia, and a personal history of nicotine dependence. He presented with fatigue and mild exertional dyspnea but without angina pectoris.\\n\\nDuring his 6-day hospital stay, the patient underwent a coronary intervention, including angioplasty and stenting (procedures coded 02100Z9 and 021109W). Postoperatively, he experienced stable vital signs and a gradual improvement in cardiac function. He was monitored closely for any signs of complications such as hemorrhage or arrhythmias, which were not observed. The patient's hemoglobin levels were closely monitored due to a history of acute posthemorrhagic anemia, which stabilized without additional interventions.\\n\\nKey findings included a reduction in lipid levels following the administration of atorvastatin and improvement in blood pressure management with metoprolol tartrate. The patient was educated on lifestyle modifications, including dietary changes and smoking cessation.\\n\\nUpon discharge, the patient is in stable condition, alert, and oriented, with improved functional status allowing for independent ambulation with minimal assistance. For home health services, it is recommended that the patient receives assistance with medication management and daily monitoring of vital signs, particularly blood pressure and glucose levels due to his diabetes and hypertension.\\n\\nDischarge medications include Acetaminophen, Aspirin EC, Atorvastatin, and Metoprolol, among others. The patient is advised to follow up with his primary care physician within one week and to maintain regular appointments with cardiology. Home health nursing will be initiated to aid in recovery and ensure adherence to the prescribed regimen.\",\n",
       " '**Patient Information:** 28-year-old female, admitted urgently for chorioamnionitis in the third trimester.  \\n\\n**History of Present Illness:** The patient presented with fever, tachycardia, and uterine tenderness at 40 weeks gestation. She was diagnosed with chorioamnionitis based on clinical findings and laboratory results, which showed elevated white blood cell count and positive cultures.  \\n\\n**Hospital Course:** The patient was started on broad-spectrum intravenous antibiotics, specifically Ampicillin Sodium. The labor was induced due to the diagnosis, and she underwent a vaginal delivery without complications. During delivery, a second-degree perineal laceration was noted and repaired. Post-delivery, the patient remained afebrile and stable, with appropriate uterine involution and lochia.  \\n\\n**Key Findings and Procedures:** The patient underwent a successful vaginal delivery of a single live infant. The perineal laceration was repaired with absorbable sutures. She received supportive care, including pain management with Acetaminophen and Ibuprofen, and bowel regimen with Docusate Sodium and Senna to prevent constipation post-delivery.  \\n\\n**Discharge Condition and Functional Status:** The patient was discharged in stable condition, ambulating independently and demonstrating adequate understanding of postpartum care. She exhibits no signs of infection and is able to perform activities of daily living. Home health services have been arranged to assist with postpartum education and monitoring of her recovery, including wound care for the perineal laceration and assessment of maternal-infant bonding.  \\n\\n**Medications and Follow-Up Plan:** Discharged with the following medications: Acetaminophen, Ibuprofen, Bisacodyl, Calcium Carbonate, Dermoplast Spray, Docusate Sodium, Simethicone, and Sodium Chloride 0.9% Flush for IV access. Follow-up with her obstetrician is recommended in one week for routine postpartum assessment and monitoring of her recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Age:** 71  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of worsening dyspnea and fatigue, with a known history of other cardiomyopathies (ICD10: I428). She presented with signs of congestive heart failure, evidenced by bilateral lower extremity edema and elevated jugular venous pressure. Additionally, she has a history of chronic systolic heart failure and hypertension, contributing to her current condition.  \\n  \\n**Hospital Course:**  \\nDuring her 4.8-day hospital stay, the patient underwent a thorough cardiovascular assessment, including echocardiography and routine lab work. She was started on diuretics and monitored closely for fluid status and renal function. Her heart failure symptoms improved with treatment, and she was stabilized prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nThe echocardiogram showed preserved ejection fraction with signs of diastolic dysfunction. Hematological evaluations revealed iron deficiency anemia (ICD10: D509) and mild renal impairment, likely secondary to her heart failure management. The patient also received a high-dose influenza vaccine during her stay and was initiated on a pain management regimen with gabapentin and lidocaine patches for her chronic pain.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with significant improvement in her dyspnea and functional capacity. She is independent in activities of daily living but requires assistance with mobility due to her weakness and previous hemiplegia affecting her dominant side. Home health services have been arranged to assist with physical therapy and medication management.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Fluoxetine  \\n5. Gabapentin  \\n6. Heparin  \\n7. Ipratropium-Albuterol Nebulizer  \\n8. Lisinopril  \\n9. Metoprolol Succinate XL  \\n10. Mirtazapine  \\n11. Polyethylene Glycol  \\n   \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her cardiologist and primary care physician within one week of discharge. Home health nursing will monitor her progress, adjust medications as needed, and ensure adherence to her therapeutic regimen.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 26 years old  \\n**Admit Date:** [Insert Admit Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n**Length of Stay:** 4.9 days  \\n**Admission Type:** Observation Admit  \\n**Primary Diagnosis:** Vascular disorder of intestine, unspecified (ICD-10: K559)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of abdominal pain and gastrointestinal symptoms. Initial assessment indicated a vascular disorder of the intestine, leading to significant discomfort. The patient has a history of obesity (BMI 36.2) and gastro-esophageal reflux disease.  \\n\\n**Hospital Course:**  \\nDuring the stay, the patient received supportive care, including intravenous fluids (D5 1/2 NS) and analgesics (Acetaminophen and Oxycodone). He was started on Docusate Sodium and Senna for constipation management. Due to the patient's elevated liver function studies, close monitoring and adjustment of medications were necessary. He was also placed on Heparin for prophylaxis against thromboembolic events. The patient was monitored for any adverse effects related to the use of Lorazepam and Trazodone, which were prescribed for anxiety and sleep disturbances.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies confirming the diagnosis of a vascular disorder of the intestine. Gastroenterology was consulted, and no surgical intervention was required. His symptoms improved significantly with conservative management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved abdominal pain and no signs of acute distress. He demonstrates the ability to perform activities of daily living with some assistance, particularly regarding mobility and medication management. Home health services are recommended to assist with monitoring his recovery, medication adherence, and nutritional support given his obesity and gastrointestinal issues.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. D5 1/2NS (as needed)  \\n3. Docusate Sodium  \\n4. Heparin (for home use as per protocol)  \\n5. Lorazepam  \\n6. Loratadine  \\n7. Ondansetron  \\n8. Oxycodone (Immediate Release)  \\n9. Senna  \\n10. Sodium Chloride 0.9% Flush  \\n11. Trazodone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge and to maintain regular follow-ups with gastroenterology. Home health services will initiate contact within 48 hours to assess and support his recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 73-year-old male  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 2.5 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with a strain of the left quadriceps muscle, fascia, and tendon (ICD-10: S76112A) following a fall. He reported significant pain and difficulty in ambulation. A thorough evaluation confirmed the diagnosis, and he was admitted for surgical intervention to address the injury.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient underwent an arthroscopic procedure aimed at repairing the quadriceps strain (ICD-10 Procedure: 0LUM07Z). Postoperatively, he was monitored for complications and displayed stable vital signs. Pain management was effectively achieved with hydromorphone and ibuprofen. The patient was mobilized with the assistance of physical therapy, demonstrating gradual improvement in strength and function.  \\n\\n**Key Findings and Procedures:**  \\nThe patient experienced mild postoperative pain, which was managed appropriately. Key findings included a significant reduction in pain levels post-surgery, with the patient reporting a pain score of 3/10 by discharge. Notably, he also has a history of hypertension, right bundle-branch block, and hyperlipidemia, which were monitored throughout his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was ambulating with a walker and demonstrated the ability to perform activities of daily living with minimal assistance. He has been recommended for home health services to continue physical therapy and monitor his recovery. He will benefit from assistance with mobility and medication management at home.  \\n\\n**Medications at Discharge:**  \\nThe patient’s discharge medications include Acetaminophen, Atorvastatin, Bisacodyl, Calcium Carbonate, Cefazolin, Dimenhydrinate, Docusate Sodium, Doxazosin, and Enoxaparin Sodium among others.  \\n\\n**Follow-Up Plan:**  \\nFollow-up is advised in 1 week with the orthopedic surgeon to assess recovery progress and adjust therapy as needed. Home health services will provide ongoing rehabilitation support, monitor vital signs, and medication adherence.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 65  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to pneumonia, unspecified organism (ICD10: J189) with associated acute kidney failure (ICD10: N179). He presented with fever, cough, and dyspnea, having a significant history of type 2 diabetes mellitus with chronic kidney disease.  \\n\\n**Hospital Course:**  \\nDuring his 2.9-day stay, the patient was started on intravenous antibiotics, including Azithromycin and CefTRIAXone, which were well tolerated. His symptoms improved significantly, with a notable decrease in fever and respiratory distress. Additionally, he received supportive care, including hydration with Lactated Ringers and insulin management for his diabetes. He was also monitored for renal function, which showed gradual improvement.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests indicated elevated inflammatory markers consistent with pneumonia. A chest X-ray confirmed the diagnosis of pneumonia, and renal ultrasound showed hydronephrosis (ICD10: N1330). A urological consultation was done to evaluate his renal status further.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function and resolution of fever. He is ambulating independently and demonstrates an understanding of his medication regimen. Home health services will be required for ongoing monitoring of his renal function and diabetes management, as well as assistance with home oxygen if needed.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue with Acetaminophen, Aspirin, Metoprolol Succinate XL, Cinacalcet, and antibiotics as per the discharge prescription. He is to follow up with his primary care physician within one week and with nephrology to monitor his kidney function and manage his diabetes more effectively. A home health nursing evaluation is scheduled to ensure a smooth transition and to assist with medication management.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 86 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of worsening symptoms related to giant cell arteritis, characterized by headache and visual disturbances. His past medical history includes chronic diastolic heart failure, chronic kidney disease, and pulmonary hypertension, which complicated the clinical picture.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was managed with intravenous fluids, corticosteroids (PredniSONE), and diuretics (Furosemide) to address fluid overload and control hypertension. His symptoms improved with treatment, and he received careful monitoring for any adverse effects given his age and comorbidities.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure and signs of congestive heart failure, which were managed effectively. The patient underwent a thorough workup to rule out other causes of his symptoms, including imaging and laboratory tests, which confirmed the diagnosis of giant cell arteritis. The patient was also assessed for his chronic kidney disease and received appropriate medications including Losartan and Warfarin for anticoagulation due to his history of pulmonary embolism.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved symptomatology and functional status. He was able to ambulate with minimal assistance and demonstrated understanding of his medication regimen. Home health services are recommended for monitoring blood pressure, medication adherence, and assistance with activities of daily living.\\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include 5% Dextrose, Acetaminophen, Adempas, Aquaphor Ointment, Docusate Sodium, Furosemide, Ipratropium-Albuterol Inhalation Spray, Loratadine, Losartan Potassium, Mupirocin Ointment 2%, Phytonadione, PredniSONE, Senna, Sodium Chloride 0.9% Flush, and Warfarin. Follow-up appointments are scheduled with primary care and a rheumatologist to monitor his giant cell arteritis and overall health status.',\n",
       " '**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 38-year-old female with a history of morbid obesity (ICD10: E6601) and associated comorbidities, including obstructive sleep apnea, nonalcoholic steatohepatitis, gastro-esophageal reflux disease, and anxiety disorders. She was admitted for surgical intervention to manage her obesity.  \\n\\n**Hospital Course:**  \\nThe patient underwent surgery (ICD10 procedures: 0DB64Z3, 0FB24ZX) and had an uneventful postoperative recovery. She was monitored closely for pain management and respiratory status, particularly due to her history of obstructive sleep apnea. Throughout her stay, her vital signs remained stable, and pain was managed effectively with a regimen including hydromorphone and acetaminophen.  \\n\\n**Key Findings and Procedures:**  \\nPostoperatively, the patient demonstrated significant improvement in her functional status. She was mobilized within hours of surgery and participated in physical therapy sessions, achieving her mobility goals. Notably, her BMI was recorded at 42.5, reinforcing the need for ongoing weight management interventions.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was ambulating independently and reported manageable pain levels (rated 3/10 at rest). She was educated on the importance of adhering to her home health services to facilitate her recovery. The patient will require assistance with daily activities and monitoring for potential complications related to her obesity and surgical recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient’s discharge medications include acetaminophen IV, gabapentin, ondansetron, and famotidine. She is advised to follow up with her primary care physician within one week and to continue outpatient therapy for her mental health conditions. Home health nursing will be arranged to assist with medication management and daily living activities.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 66  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening dyspnea and fatigue attributed to nonrheumatic mitral valve insufficiency (ICD10: I340). He reported increased shortness of breath on exertion and orthopnea, consistent with his underlying cardiac condition.  \\n  \\n**Hospital Course:**  \\nDuring his 6-day hospital stay, the patient was monitored closely for cardiac function and fluid status. Initial management included diuretics for volume overload, with Furosemide administered to mitigate pulmonary congestion. The patient was stabilized with medication adjustments including Metoprolol for rate control of his atrial fibrillation (ICD10: I4891) and Amiodarone for rhythm management.  \\n  \\nKey interventions included a transthoracic echocardiogram which confirmed significant mitral regurgitation and the presence of ruptured chordae tendineae (ICD10: I511). He was treated symptomatically with analgesics including Hydromorphone for pain management and supportive measures.  \\n  \\n**Key Findings and Procedures:**  \\n- Diagnosis: Nonrheumatic mitral valve insufficiency, atrial fibrillation, and ruptured chordae tendineae.  \\n- Procedures performed: Echocardiogram and medication titration.  \\n- Notable lab findings included hypo-osmolality and hyponatremia, which were corrected during hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved dyspnea and functional capacity, now able to perform activities of daily living with moderate assistance. He requires home health services for ongoing monitoring of cardiac status, medication management, and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Amiodarone  \\n- Aspirin EC  \\n- Furosemide  \\n- Metoprolol Tartrate  \\n- Mupirocin Ointment  \\n- Docusate Sodium  \\n- Additional supportive medications as needed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his cardiologist within one week of discharge and has been referred to home health services for monitoring and support. Education on medication adherence and recognizing signs of worsening heart failure was provided to the patient and family.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 37 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.8 days  \\n**Primary ICD-10 Code:** O99824 (Streptococcus B carrier state complicating childbirth)  \\n  \\n**History of Present Illness:**  \\nThe patient presented with a history of Streptococcus B carrier state complicating her childbirth at 40 weeks of gestation. She was admitted urgently for labor management due to abdominal pain and abnormal fetal heart rate noted during monitoring.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient experienced a stable labor course, and a single live birth was achieved without significant complications. She was monitored closely for any signs of infection or other complications related to Group B Streptococcus. Her labor was managed with intravenous fluids (Lactated Ringer’s solution) and medications for pain relief, including Acetaminophen and Ibuprofen. Oxytocin was administered to augment labor progression.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent continuous fetal heart rate monitoring, which showed periods of abnormality. Interventions included fluid resuscitation and adjustment of labor management strategies. No surgical interventions were required.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, having successfully delivered a healthy infant. She demonstrated understanding of postpartum care and the importance of follow-up. Functional status is satisfactory; however, she will require home health services due to risk factors such as housing instability and the need for ongoing support with newborn care.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Docusate Sodium  \\n- Ibuprofen  \\n- Lactated Ringers  \\n- Naloxone  \\n- Ondansetron  \\n- Oxycodone (Immediate Release)  \\n- Oxytocin  \\n- Polyethylene Glycol  \\n- Senna  \\n- Simethicone  \\n- Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for a postpartum check. Home health services will be arranged to support her needs, particularly in light of her housing instability and to facilitate a safe recovery with the newborn.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Discharge:** [Date]  \\n**Admit Date:** [Admit Date]  \\n**Age:** 58  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 58-year-old female who was admitted to the hospital for observation due to severe dehydration. She presented with acute kidney failure, orthostatic hypotension, and symptoms of hyperlipidemia and gastro-esophageal reflux disease. The patient has a significant medical history including chronic diastolic heart failure and cellulitis of the left upper limb.\\n\\n**Hospital Course:**  \\nDuring her 8.9-day stay, the patient received fluid resuscitation with D5LR and sodium chloride 0.9%, and her renal function was closely monitored. The patient was treated with intravenous magnesium sulfate for hypomagnesemia and given levothyroxine sodium for postprocedural hypothyroidism. A rectal hydrocortisone cream was applied for skin irritation secondary to her condition.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent dehydration and improvement of renal function as evidenced by rising creatinine levels. The patient underwent routine laboratory evaluations and imaging as required, with a focus on electrolyte repletion and monitoring for signs of infection. Additionally, she was assessed for safety and independence regarding her activities of daily living.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and demonstrated improved hydration status. She was ambulating independently and able to perform basic self-care tasks with minimal assistance. However, she will require home health services for ongoing monitoring of her hydration status and assistance with medication administration.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to be discharged on the following medications: Atorvastatin, Famotidine, Heparin, Hydrocortisone rectal cream, Levothyroxine sodium, Magnesium sulfate, Neutra-Phos, Psyllium wafer, Sodium bicarbonate, and Sulfameth/Trimethoprim DS. A follow-up appointment is scheduled with her primary care physician in one week to assess her recovery and adjust her management plan as needed.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 50  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following a genitourinary procedure complicated by postprocedural hemorrhage (ICD10: N99820). She presented with significant vaginal bleeding and anemia, requiring immediate intervention and close monitoring. The patient also exhibited signs of pneumonitis due to aspiration, likely from oral intake prior to the procedure, as well as complications related to anticoagulation therapy.  \\n\\n**Hospital Course:**  \\nDuring her 10-day hospital stay, the patient was stabilized with fluid resuscitation, blood transfusions, and supportive care. A multidisciplinary team addressed her anticoagulant management and performed imaging studies to rule out further complications. The patient's respiratory status improved following treatment for pneumonitis.  \\n\\n**Key Findings and Procedures:**  \\nUpon admission, vital signs indicated hypotension and tachycardia, consistent with acute blood loss. Laboratory tests revealed acute posthemorrhagic anemia (ICD10: D62) and other coagulation abnormalities (ICD10: D688). Interventions included transfusions of packed red blood cells and intravenous fluids, as well as the administration of antibiotics (Cefpodoxime Proxetil) and dexamethasone for inflammation.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable, hemodynamically stable, and has improved respiratory function. She will require ongoing home health services for monitoring of her anticoagulation therapy, assistance with her mobility, and management of her medications. The patient is capable of basic self-care but will benefit from home health support for medication administration and supervision during recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Cefpodoxime Proxetil  \\n- Dexamethasone  \\n- Enoxaparin (treatment dose)  \\n- Ferric Gluconate  \\n- Hydromorphone (as needed)  \\n- Lactated Ringers  \\n- Latanoprost 0.005% Ophth. Soln.  \\n- Polyethylene Glycol  \\n- Potassium Chloride  \\n- Senna  \\n\\nThe patient is advised to follow up with her primary care physician within one week and to contact the home health agency for support as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Information**:  \\n- Age: 39 years  \\n- Gender: Male  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted for observation due to a right-sided hemiparesis following an acute cerebral infarction, diagnosed as other cerebral infarction (ICD-10 I63.89). The patient presented with a NIHSS score of 3, indicating mild neurological deficits.  \\n  \\n**Hospital Course**:  \\nDuring the 1.7-day stay, the patient underwent a comprehensive evaluation, including imaging studies confirming the cerebral infarction. He was initiated on a regimen of antiplatelet therapy with aspirin, along with supportive care for his chronic conditions of hypertension and chronic kidney disease. The patient was monitored for potential complications and exhibited stable vital signs throughout his stay.  \\n  \\n**Key Findings and Procedures**:  \\nNeurological examination revealed mild facial weakness and coordination deficits. The patient was started on physical therapy for rehabilitation support. A multidisciplinary approach was employed, addressing his chronic kidney disease and hyperlipidemia.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt the time of discharge, the patient demonstrated improved strength and coordination, although he continued to require assistance for activities of daily living due to residual weakness. A home health referral has been made for ongoing physical therapy and occupational therapy to facilitate recovery. The patient was educated on recognizing signs of stroke recurrence and advised to adhere to follow-up appointments.  \\n  \\n**Medications and Follow-Up Plan**:  \\nUpon discharge, the patient was prescribed acetaminophen, albuterol inhaler, allopurinol, aspirin, docusate sodium, heparin, hydralazine, oxymetazoline, senna, sertraline, sodium chloride 0.9%, and tamsulosin. He is to follow up with his primary care physician in one week and with neurology within two weeks to monitor his recovery and medication adjustments.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 26  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a diagnosis of Other Gram-negative sepsis (ICD-10: A4159) associated with an acute urinary tract infection. Upon admission, he presented with fever, chills, and dysuria. Laboratory tests confirmed the presence of a gram-negative organism in the urine, prompting initiation of IV antibiotics, including Ceftriaxone.\\n\\n**Hospital Course:**  \\nDuring the 5.4-day hospital stay, the patient was closely monitored in the observation unit. His vital signs were stabilized with appropriate fluid resuscitation and antibiotic therapy. Renal function was assessed, revealing acute kidney failure (ICD-10: N179), with subsequent management involving hydration and monitoring of electrolytes. The patient also received insulin management for transient hyperglycemia and was evaluated by the nephrology team due to his kidney transplant status. \\n\\n**Key Findings and Procedures:**  \\nSignificant improvements were noted in laboratory results, with a decrease in serum creatinine and resolution of infection. A renal ultrasound was performed to rule out obstructive causes. The patient was also administered vaccinations, including the Influenza Vaccine Quadrivalent, as part of his discharge plan.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was clinically stable with improved renal function and resolution of sepsis symptoms. He demonstrated the ability to perform activities of daily living independently and had adequate support at home. Home health services will be arranged to monitor vital signs, manage medications, and ensure adherence to follow-up appointments.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on Acetaminophen, Aspirin, Atorvastatin, and Ceftriaxone as a precautionary measure. Additionally, he was prescribed insulin for blood glucose management, magnesium sulfate, and other supportive medications. \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with his primary care physician in one week. Home health will provide regular assessments and medication management support as needed.\",\n",
       " '**Patient Information:** 26-year-old female admitted through the emergency department with diagnosed sepsis of unspecified organism. \\n\\n**History of Present Illness:** The patient presented with fever, chills, and nausea. Initial workup indicated signs of acute pyelonephritis, and she was found to have elevated inflammatory markers. Due to the severity of her condition, she was admitted for IV antibiotics and supportive care.\\n\\n**Hospital Course:** During her 2-day stay, the patient received intravenous ampicillin-sulbactam for sepsis and was monitored closely in the hospital. She exhibited significant improvement in her clinical status, with a decrease in fever and resolution of acute abdominal pain. She was also treated for constipation and dehydration, receiving appropriate fluids and bowel regimen. Psychological support was initiated due to a history of major depressive disorder, leading to the initiation of escitalopram oxalate.\\n\\n**Key Findings and Procedures:** The patient underwent routine lab tests that confirmed the diagnosis of acute pyelonephritis, while her ECG showed an abnormality that was monitored but not treated with intervention. Overall, her vital signs stabilized, and she was deemed medically stable for discharge. The patient received the influenza vaccine during her stay as a preventive measure.\\n\\n**Discharge Condition and Functional Status:** At the time of discharge, the patient was alert and oriented, ambulating independently. She demonstrated the ability to manage her basic needs with minimal assistance but will require home health services for continued monitoring of her medication adherence and mental health support. \\n\\n**Medications and Follow-up Plan:** Discharged on a regimen including intravenous fluids (0.9% Sodium Chloride), acetaminophen for pain management, escitalopram for mood stabilization, and docusate sodium for constipation. A follow-up appointment is scheduled with her primary care physician in one week, and home health nursing will visit to assist with medication management and assess her recovery at home.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient's Name]  \\n**Age:** 81  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is an 81-year-old female who presented with acute respiratory distress and fever, diagnosed with unspecified bacterial pneumonia (ICD-10: J159). The patient has a medical history significant for chronic atrial fibrillation, asthma, and moderate protein-calorie malnutrition. She also has a long-standing history of anxiety disorder and gastro-esophageal reflux disease.  \\n\\n**Hospital Course:**  \\nDuring her 2.8-day hospitalization, the patient was started on intravenous ceftriaxone and azithromycin for pneumonia and monitored closely for respiratory status. Supplemental oxygen was provided due to hypoxemia. The patient exhibited improvement in respiratory symptoms and oxygen saturation levels.  \\n\\n**Key Findings and Procedures:**  \\nInitial chest X-ray revealed infiltrates consistent with pneumonia. Laboratory results indicated elevated white blood cell counts and inflammatory markers. The patient was also treated for her chronic conditions, including the management of atrial fibrillation with diltiazem and asthma exacerbation with the administration of albuterol and ipratropium bromide nebulization.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved respiratory function and a functional status that allows for ambulation with assistance. She requires home health services for continued monitoring of her respiratory status and management of her chronic conditions. Home health will also assist with medication administration and nutritional support due to her protein-calorie malnutrition.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Azithromycin  \\n4. Ceftriaxone  \\n5. Diltiazem Extended-Release  \\n6. Ipratropium Bromide Nebulizer  \\n7. Fluticasone Propionate  \\n8. Bisacodyl  \\n9. Calcium Carbonate  \\n10. Hydrocortisone Rectal Cream  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week for assessment of her pneumonia recovery and chronic conditions. Home health services will initiate within 48 hours post-discharge for comprehensive care.\",\n",
       " '**Patient Information:** 83-year-old female admitted for observation with a diagnosis of sick sinus syndrome (ICD10: I495).  \\n\\n**History of Present Illness:** The patient presented with symptoms of syncope and palpitations. Her past medical history is significant for chronic diastolic heart failure, paroxysmal atrial fibrillation, and hypertensive heart disease. She has a long-standing history of anticoagulant use and other comorbidities, including asthma and pulmonary hypertension.  \\n\\n**Hospital Course:** During her 5-day stay, the patient was monitored closely for arrhythmias. Cardiac telemetry revealed episodes of bradycardia consistent with sick sinus syndrome. She was initiated on amiodarone for rate control and continued on apixaban for anticoagulation.  \\n\\n**Key Findings and Procedures:** Laboratory findings showed mild hypercalcemia, and echocardiogram indicated preserved ejection fraction with evidence of congestive heart failure. The patient underwent a thorough cardiac evaluation, including a chest X-ray and an adjustment of her antihypertensive regimen, optimizing her losartan and diltiazem doses.  \\n\\n**Discharge Condition and Functional Status:** The patient has stabilized and is being discharged in a clinically stable condition. She demonstrates adequate functional independence with assistance for daily activities due to her heart failure symptoms. Home health services will be essential for monitoring her medication adherence, vital signs, and support for activities of daily living.  \\n\\n**Medications at Discharge:** The patient is prescribed acetaminophen, amiodarone, apixaban, diltiazem (extended-release), losartan potassium, and montelukast among others. A follow-up appointment with her primary care physician and cardiologist is recommended within one week of discharge. Home health nursing should initiate within 48 hours post-discharge to ensure continuity of care.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Date of Admission]  \\n**Date of Discharge:** [Date of Discharge]  \\n**Age:** 45  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute right lower quadrant pain (ICD-10: R1031). The pain was associated with nausea and a reported history of nonalcoholic steatohepatitis (NASH) and gastroparesis. The patient has a complex medical history including chronic pain and a personal history of peptic ulcer disease.  \\n\\n**Hospital Course:**  \\nDuring her brief hospital stay (0.8 days), the patient underwent a thorough evaluation including abdominal ultrasound which ruled out acute appendicitis. She was managed conservatively with pain control and supportive care. Intravenous fluids were administered due to mild dehydration. The patient responded well to treatment, with a significant reduction in pain by the time of discharge.  \\n\\n**Key Findings and Procedures:**  \\n- Right lower quadrant pain was the primary complaint.  \\n- Abdominal ultrasound showed no acute pathology.  \\n- Vital signs remained stable throughout the observation period.  \\n- Pain management included acetaminophen and gabapentin, with lorazepam for anxiety management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with a pain score of 2/10. She is able to perform activities of daily living (ADLs) with minimal assistance and is oriented to time, place, and person. Given her history of chronic pain and gastroparesis, a referral to home health services has been made to assist with ongoing pain management and nutritional support.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Amitriptyline  \\n3. Atorvastatin  \\n4. Gabapentin  \\n5. Levothyroxine Sodium  \\n6. Ondansetron  \\n7. Pantoprazole  \\n8. Tizanidine  \\n9. Sertraline  \\n10. BuPROPion XL  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician in one week. Home health services will initiate contact for further evaluation and support. Instructions for medication management and dietary adjustments were provided. Emergency instructions were reviewed in the event of worsening symptoms.',\n",
       " \"Patient is a 91-year-old male admitted under emergency conditions for acute pneumonitis due to inhalation of food and vomit (ICD10: J690). The patient presented with respiratory distress, cough, and fever. Initial assessments revealed tachypnea and bilateral crackles on auscultation, with subsequent imaging confirming infiltrates consistent with aspiration pneumonia. \\n\\nDuring a 3-day hospital stay, the patient was started on broad-spectrum IV antibiotics (Levofloxacin) and supportive care, including oxygen therapy. The patient's respiratory status improved gradually, and he was transitioned to oral medications. He was also treated for metabolic encephalopathy, evidenced by confusion and altered mental status, which improved with hydration and stabilization of electrolytes. Regular assessments monitored his vitals, and he showed no signs of further complications.\\n\\nKey findings included resolution of fever, improved breath sounds, and a stable oxygen saturation level above 92% on room air by discharge. The patient underwent rehabilitation therapy to address deconditioning due to his prolonged illness. \\n\\nAt discharge, the patient demonstrates improved functional status, ambulating with minimal assistance and able to perform basic activities of daily living (ADLs) with supervision. A home health referral has been initiated to provide ongoing rehabilitation support and monitoring for any respiratory issues. \\n\\nDischarge medications include Acetaminophen, Aspirin, Docusate Sodium, Finasteride, Heparin, Levofloxacin, Memantine, Omeprazole, and Prednisone. Additionally, he received vaccinations for influenza and pneumococcus. The patient is advised to follow up with his primary care physician within one week to reassess his respiratory status and review medications. Home health services will provide nursing and therapy support as needed.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Male, 36 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 7.7 days  \\n**Primary Diagnosis:** Calculus of bile duct with acute cholecystitis with obstruction (ICD-10: K8043)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with severe abdominal pain, nausea, and vomiting. Imaging studies revealed a calculus in the bile duct causing acute cholecystitis with obstruction. The patient reported a history of dysuria and had a BMI indicating severe obesity, which complicated the clinical picture.  \\n  \\n**Hospital Course:**  \\nThe patient underwent laparoscopic cholecystectomy on day 2 of hospitalization, which was uneventful. Post-operative management included intravenous fluids, antibiotics (Ceftriaxone and Metronidazole), and pain management. The patient was closely monitored for any signs of infection or complications, and his condition stabilized.  \\n  \\nKey findings included resolution of abdominal pain and improvement in laboratory markers. The patient was mobilized early and participated in physical therapy to enhance recovery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable and ambulating independently. He demonstrated understanding of post-operative care and was able to perform activities of daily living with minimal assistance. Due to his history of morbid obesity and recent surgery, home health services will be initiated for continued monitoring, assistance with mobility, and education on dietary modifications.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Ceftriaxone  \\n- Diphenhydramine  \\n- Famotidine  \\n- Fexofenadine  \\n- Gabapentin  \\n- Hydromorphone  \\n- Heparin  \\n- Lorazepam  \\n- Lidocaine 5% Patch  \\n- MetroNidazole  \\n- Neutra-Phos  \\n- Ondansetron  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician and a gastroenterologist in one week. Home health nursing will monitor vital signs, manage pain, and assess dietary adherence. Additionally, physical therapy will continue to support mobility and strength as the patient recovers.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient Name:** [Patient Name]  \\n- **Age:** 20  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1 day  \\n\\n**Chief Complaint:**  \\nThe patient presented with abdominal pain and distention secondary to Crohn's disease of the small intestine with intestinal obstruction.  \\n\\n**History of Present Illness:**  \\nThe patient has a known history of Crohn's disease, which has been managed with intermittent corticosteroids and supportive care. He reported increasing abdominal pain, nausea, and episodes of vomiting. Upon evaluation, he demonstrated signs of intestinal obstruction.  \\n\\n**Hospital Course:**  \\nDuring his 24-hour observation stay, the patient was managed with intravenous fluids (Lactated Ringer's and Sodium Chloride 0.9%), antiemetics (Ondansetron), and corticosteroids (Prednisone). Serial abdominal examinations and imaging studies were conducted, confirming no signs of perforation or ischemia. His symptoms improved significantly with conservative management, and he was tolerating oral intake by discharge.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed tenderness in the lower abdomen without rebound or guarding. Laboratory tests indicated a mild leukocytosis but were otherwise unremarkable. The patient was monitored for signs of obstruction, and no invasive procedures were required.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significantly reduced abdominal pain and normal bowel function. He is advised to follow a low-residue diet and to stay hydrated. The patient is capable of managing personal care but will require assistance with meal preparation and monitoring for any recurrence of symptoms.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Cetirizine  \\n- Diphenhydramine  \\n- Enoxaparin (prophylaxis)  \\n- Famotidine  \\n- Polyethylene Glycol  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his gastroenterologist within one week and to contact home health services for ongoing assessment and support. He should be vigilant for signs of recurrent obstruction, including abdominal pain and vomiting.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 62 years old  \\n**Admission Type:** Emergency Ward  \\n**Length of Stay:** 70 days  \\n**Diagnosis:** Nontraumatic subarachnoid hemorrhage from basilar artery (ICD-10: I604)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with sudden onset of severe headache, altered mental status, and bilateral lower extremity weakness. Imaging confirmed a nontraumatic subarachnoid hemorrhage originating from the basilar artery. The patient was admitted for further management and monitoring.  \\n  \\n**Hospital Course:**  \\nDuring his 70-day hospitalization, the patient underwent multiple diagnostic tests, including CT and MRI scans, which showed resolution of the initial hemorrhage but revealed areas of cerebral infarction and hydrocephalus. He received comprehensive neurosurgical intervention, including external ventricular drain placement and subsequent monitoring. The patient also experienced pneumonia and acute respiratory failure, which were managed with appropriate antibiotics and respiratory support.  \\n  \\n**Key Findings and Procedures:**  \\n- Nontraumatic subarachnoid hemorrhage from basilar artery  \\n- Cerebral infarction and hydrocephalus  \\n- Respiratory failure requiring interventions  \\n- Procedures: External ventricular drainage, antibiotic therapy, and supportive care  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable, alert, and oriented to person, place, and time. He has made significant progress in his rehabilitation, though he requires assistance with activities of daily living (ADLs) due to residual weakness and coordination issues. The home health services will assist in monitoring his neurological status and provide physical therapy to improve strength and mobility.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Diltiazem, Midodrine, and Albuterol nebulizer treatments. A follow-up appointment with neurology and primary care is scheduled within one week post-discharge. He is advised to monitor for any changes in neurological status and respiratory symptoms. Home health services will initiate within 48 hours to assist with rehabilitation and care coordination.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Date of Birth:** [Patient DOB]  \\n\\n**History of Present Illness:**  \\nThe patient is a 38-year-old female who presented to the emergency department with fever, chills, and flank pain consistent with acute pyelonephritis. The patient's symptoms began 3 days prior to admission, and she reported a burning sensation during urination. A urinalysis confirmed the diagnosis, revealing the presence of bacteria and white blood cells.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient was placed on intravenous fluids and started on intravenous Ceftriaxone for antibiotic therapy. She received supportive care including analgesics (Acetaminophen) and antiemetics (Ondansetron) for symptomatic management. The patient's renal function was closely monitored, and she was noted to develop mild hyperkalemia, which was managed with appropriate fluid and dietary restrictions. The patient showed significant clinical improvement with resolution of fever and flank pain.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory results indicated acute pyelonephritis with elevated creatinine but stable after hydration. A chest X-ray was performed due to a solitary pulmonary nodule noted incidentally, which will require follow-up imaging.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulating independently, and reporting improvement in her symptoms. She is advised to maintain hydration and monitor her symptoms at home. Home health services will assist in monitoring her recovery, particularly for renal function and any potential complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Ceftriaxone (if needed for outpatient continuation), Acetaminophen as needed for pain, and hydration recommendations. The patient is instructed to follow up with her primary care physician within one week and to report any recurrence of symptoms such as fever, flank pain, or changes in urination. Home health services will follow up on her condition within 48 hours post-discharge.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 22  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with acute respiratory distress attributed to malfunction of his tracheostomy stoma. He has a history of pre-excitation syndrome and psychological diagnoses including PTSD and generalized anxiety disorder, which complicated his clinical management. On admission, he was treated for respiratory compromise and began to show improvement following prompt intubation and stabilization.  \\n\\n**Hospital Course:**  \\nDuring his 9.8-day hospitalization, the patient underwent multiple procedures including tracheostomy stoma revision and respiratory therapy interventions. He was closely monitored for complications associated with his respiratory condition and underwent psychological support to address his anxiety and PTSD. His symptoms gradually improved, and he was successfully weaned off supplemental oxygen.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant respiratory distress upon admission, which was resolved with intervention. Procedures performed included tracheostomy stoma revision (ICD-10: 0BB10ZZ) and respiratory therapy (ICD-10: 0B718ZZ). Additionally, the patient was treated for opioid and cocaine abuse in remission, which was addressed through a comprehensive medication management plan.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved respiratory function and had a functional capacity sufficient for home health services. He ambulated independently and demonstrated the ability to perform activities of daily living with minimal assistance. Home health services will focus on respiratory therapy and psychological support to ensure continuity of care.  \\n\\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Albuterol 0.083% Nebulizer Solution, Metoprolol Tartrate, and LORazepam. A follow-up appointment is scheduled with his primary care physician in one week to monitor his recovery and adjust psychiatric medications as necessary. Home health services will initiate within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Age:** 88 years  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to pneumonia of unspecified organism, presenting with shortness of breath, fever, and productive cough. His past medical history is significant for chronic diastolic heart failure, chronic kidney disease, and major depressive disorder. He has been on multiple medications, including diuretics and antidepressants.\\n\\n**Hospital Course:**  \\nThe patient was treated with intravenous antibiotics and respiratory support, including nebulized Ipratropium-Albuterol. He received diuretics for fluid management and was monitored for signs of heart failure exacerbation. Throughout his stay, he exhibited gradual improvement in respiratory status and was able to maintain adequate oxygen saturation levels. His heart failure was managed with careful fluid balance, and renal function was closely monitored.\\n\\n**Key Findings and Procedures:**  \\nChest X-ray confirmed the diagnosis of pneumonia, while echocardiography showed preserved left ventricular function. Laboratory tests indicated stage 3 chronic kidney disease, with stable creatinine levels during hospitalization. The patient also developed cellulitis of the left upper limb, which was treated with appropriate antibiotics.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved respiratory function. He is ambulating with assistance and requires home health services for continued monitoring of his respiratory status, medication management, and assistance with activities of daily living due to weakness and fatigue. A follow-up with a primary care provider is recommended within one week of discharge.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on: Acetaminophen, Aspirin, Citalopram, Docusate Sodium, Finasteride, Furosemide, Heparin, Ipratropium-Albuterol Nebulizer, PredniSONE, RisperiDONE, Senna, Sodium Chloride 0.9% Flush, Terazosin, and Vitamin D.  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician and a pulmonologist for ongoing management of his respiratory condition and heart failure. Home health services will be initiated for nursing care and physical therapy.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 51  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute respiratory distress and fever. He tested positive for COVID-19 (ICD10: U071) and was diagnosed with pneumonia due to coronavirus disease (ICD10: J1282). The patient reported symptoms of palpitations and significant cough, which were evaluated during his hospital stay.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was managed with supplemental oxygen and bronchodilator therapy. His respiratory status improved, and he was started on an appropriate regimen including acetaminophen for fever and benzonatate for cough suppression. He received enoxaparin for venous thromboembolism prophylaxis and was monitored closely for any complications related to COVID-19.  \\n\\n**Key Findings and Procedures:**  \\nChest X-ray revealed bilateral infiltrates consistent with pneumonia. Laboratory results indicated elevated inflammatory markers. The patient was started on supportive care and antibiotics due to the secondary bacterial pneumonia. He was also administered ondansetron for nausea and guaifenesin-codeine phosphate for cough due to excessive secretions.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. He demonstrated understanding of his discharge instructions and the importance of follow-up care. The patient will benefit from home health services to monitor his respiratory status and ensure adherence to medication regimens.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Benzonatate  \\n4. Enoxaparin (Prophylaxis)  \\n5. GuaiFENesin-CODEINE Phosphate  \\n6. Ondansetron  \\n7. Ramelteon  \\n8. Senna  \\n9. Sodium Chloride 0.9% Flush  \\n10. Influenza Vaccine Quadrivalent (as per protocol)  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within 7 days for re-evaluation. He is to continue home health visits to monitor his recovery and manage his medications effectively.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- Age: 40  \\n- Gender: Female  \\n- Admission Type: Emergency  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted to the hospital with complaints of acute laryngitis characterized by a sore throat, dysphonia, and difficulty swallowing. The patient reported a history of worsening respiratory distress and hypoxia, necessitating emergency intervention.  \\n  \\n**Hospital Course:**  \\nDuring her 10-day hospital stay, the patient was treated with bronchodilators, corticosteroids, and supportive care. She required supplemental oxygen therapy due to respiratory failure with hypoxia. The team performed diagnostic imaging and monitored her closely for any signs of complications such as ventilator-associated pneumonia or atelectasis.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient was diagnosed with acute laryngitis (ICD-10: J040) and respiratory failure, unspecified with hypoxia (ICD-10: J9691). She underwent procedures including respiratory therapy and received medications to manage her symptoms and improve her respiratory status. Key findings included significant improvement in her oxygen saturation levels and resolution of acute respiratory distress.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved respiratory function and is ambulating independently. She requires ongoing support from home health services for monitoring her respiratory status and medication management. The patient has demonstrated the ability to perform activities of daily living with minimal assistance and understands her discharge instructions.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on the following medications: Acetaminophen, Albuterol (Nebulizer and Inhaler), Famotidine, and Furosemide. She is advised to engage with home health services for regular assessments and to ensure adherence to her medication regimen. A follow-up appointment is scheduled with her primary care physician in one week to reassess her condition and adjust her treatment plan as necessary.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 53, Gender: Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 8.2 days  \\n\\n**HPI:** The patient was admitted with severe protein-calorie malnutrition (ICD10 E43), presenting with significant weight loss and fatigue. She reported decreased oral intake, contributing to her nutritional deficiencies and overall decline in health status.  \\n\\n**Hospital Course:** During her hospital stay, the patient was closely monitored and managed by a multidisciplinary team. Nutritional support was initiated, including enteral feeding, and the patient was started on thiamine supplementation to address potential deficiencies. She received medications for symptom management, including ondansetron for nausea and morphine for pain control. The patient's kidney function was assessed due to elevated creatinine levels, and she exhibited signs of acute kidney failure (N179), which were attributed to dehydration and malnutrition.  \\n\\n**Key Findings and Procedures:** Throughout her stay, the patient's weight was monitored, demonstrating an increase as her nutritional status improved. Imaging studies revealed secondary malignant neoplasms in the lymph nodes; however, the focus remained on stabilizing her nutritional status. Key procedures included placement of a nasogastric tube for feeding and management of anticoagulation with enoxaparin for venous thromboembolism prophylaxis.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable at the time of discharge, with improved nutritional intake and weight gain. She is still experiencing some weakness and fatigue but is expected to benefit from home health services for further nutritional support and monitoring. The patient will require assistance with activities of daily living and ongoing dietary management to prevent further decline.  \\n\\n**Medications at Discharge:** The patient is prescribed the following medications: Albuterol Inhaler, Bisacodyl, Calcium Carbonate, Dronabinol, Enoxaparin (Prophylaxis), Heparin, Morphine Sulfate, Ondansetron ODT, OxyCODONE (Immediate Release and Extended Release), Polyethylene Glycol, Senna, Sodium Chloride 0.9%, and Thiamine.  \\n\\n**Follow-Up Plan:** The patient is to follow up with her primary care physician and a nutritionist within one week of discharge. Home health services will be initiated to monitor her condition and ensure adherence to the nutritional plan. Regular assessments will be conducted to evaluate her progress and adjust her care plan as necessary.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 48 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 14.8 days  \\n**Primary Diagnosis:** Warm autoimmune hemolytic anemia (ICD-10: D5911)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital with severe fatigue, pallor, and episodes of shortness of breath. Initial laboratory workup revealed a markedly low hemoglobin level indicative of warm autoimmune hemolytic anemia. The patient also exhibited signs of possible associated anxiety and orthostatic hypotension.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient received supportive care including blood transfusions and immunosuppressive therapy with dexamethasone. She was monitored closely for hemolytic activity and response to treatment. The patient's hemoglobin levels improved gradually, and she reported a decrease in fatigue and shortness of breath.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a positive direct Coombs test, confirming the diagnosis of warm autoimmune hemolytic anemia. The patient underwent a transfusion of packed red blood cells and was treated with corticosteroids. A thorough assessment for other underlying conditions such as possible malignancy was performed, with no significant findings.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, alert, and oriented, with improved hemoglobin levels and no acute respiratory distress. She requires home health services for ongoing monitoring of her hemoglobin levels, medication management, and assistance with daily activities due to her recent anemia and anxiety symptoms.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. 5% Dextrose  \\n3. Acetaminophen  \\n4. Dexamethasone  \\n5. BusPIRone  \\n6. Calcium Carbonate  \\n7. Cetirizine  \\n8. Cyanocobalamin  \\n9. Famotidine  \\n10. Folic Acid  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for re-evaluation of her hemoglobin levels and adjustment of her medications as needed. Home health services will initiate contact for support and medication education.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 67 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 4 days  \\n**Primary Diagnosis:** Postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure (ICD-10: K91840)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation after experiencing significant postprocedural hemorrhage following a digestive system procedure. He presented with melena and was subsequently diagnosed with acute posthemorrhagic anemia. The patient has a history of end-stage renal disease and chronic heart failure, which complicated his clinical management.  \\n  \\n**Hospital Course:**  \\nDuring the hospitalization, the patient was closely monitored. He received supportive care, including intravenous fluids, blood transfusions, and medications to manage his symptoms. The hemorrhage was controlled, and the patient stabilized. Key procedures included blood transfusion and management of renal function.  \\n  \\n**Key Findings and Procedures:**  \\nUpon examination, the patient showed improvement in hemoglobin levels and stabilization of vital signs. Renal function was monitored, and adjustments were made to his medications, including Epoetin Alfa and Doxercalciferol due to his chronic kidney disease. Additional treatments included pain management with Hydromorphone and supportive care for his heart failure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required ongoing home health support due to his complex medical history. He is able to perform basic activities of daily living with assistance and will require monitoring for his renal status and medication compliance. Home health services will facilitate medication management and assistance with mobility and hydration.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged with prescriptions for Acetaminophen, Aspirin, Atorvastatin, Clobetasol Propionate 0.05% Cream, Pantoprazole, Polyethylene Glycol, and Tramadol. He is advised to follow up with his primary care physician within one week and to have regular evaluations for his renal function and cardiovascular status. Additionally, he will be monitored closely by home health services for ongoing support.',\n",
       " '**Patient Information:** 50-year-old male admitted for surgical intervention. \\n\\n**History of Present Illness:** The patient was admitted for the management of a secondary malignant neoplasm of unspecified sites (ICD10: C7989). The patient has a complex medical history including obesity (BMI 40.0-44.9), obstructive sleep apnea, and vitamin D deficiency. He presented with symptoms prompting surgical evaluation and intervention.\\n\\n**Hospital Course:** The patient underwent a surgical procedure (ICD10: 0JBP0ZZ) which was performed successfully without complications. Postoperatively, he was monitored in the surgical unit for 4 days. Throughout his hospital stay, he exhibited stable vital signs. However, he developed acute posthemorrhagic anemia, which was managed effectively with blood transfusions. The patient also received symptomatic relief for pain management and was closely monitored for any signs of infection or postoperative complications.\\n\\n**Key Findings and Procedures:** Imaging studies revealed the extent of the malignancy, necessitating intervention. The surgical procedure was well-tolerated, and the patient was educated on signs of potential complications such as bleeding or infection. He was also assessed for his functional status, which included monitoring his mobility, ability to perform activities of daily living, and respiratory status, particularly due to his history of obstructive sleep apnea.\\n\\n**Discharge Condition and Functional Status:** Upon discharge, the patient was stable, with improved hemoglobin levels following transfusion. He demonstrated adequate mobility with assistance and an understanding of his home care needs. Functional status was sufficient for home health services to provide additional support as he continues to recover.\\n\\n**Medications and Follow-Up Plan:** The patient is prescribed the following medications: Alprazolam, Acetaminophen, Aspirin, Calcitriol, Docusate Sodium, Fluticasone Propionate (nasal), Hydromorphone, Levothyroxine, Losartan, Ondansetron, Oxycodone, Polyethylene Glycol, Senna, and Sodium Chloride 0.9% flush. He is advised to follow up with oncology and primary care within one week post-discharge. Home health services will assist with medication management, mobility assistance, and ongoing evaluation of his postoperative recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 79 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of dysphagia, which has been progressively worsening over the past few weeks. He reported difficulty swallowing solids and liquids, accompanied by episodes of coughing during meals. The patient has a significant medical history including Type 2 diabetes mellitus, atrial fibrillation, and major depressive disorder.  \\n  \\n**Hospital Course:**  \\nDuring his admission, the patient underwent a comprehensive evaluation, including a swallowing assessment, which confirmed the diagnosis of unspecified dysphagia (ICD10: R1310). He was monitored closely for any signs of aspiration pneumonia, and supportive therapy was initiated. The patient was started on a modified diet, and speech therapy was consulted for further management of his swallowing difficulties.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included mild metabolic acidosis and hypoxemia, which were managed with supplemental oxygen and intravenous fluids. The patient was treated for his existing conditions with adjustments made to his medication regimen, including anticoagulation therapy for atrial fibrillation and management of hyperlipidemia. A dextrose infusion was provided for glycemic control given his diabetes.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved swallowing ability and a clear understanding of his dietary modifications. He requires assistance with meal preparation and ongoing monitoring of his swallowing function. The patient will benefit from home health services to ensure adherence to his modified diet and to monitor his medication compliance.  \\n  \\n**Medications at Discharge:**  \\nDischarge medications include Acetaminophen, Atorvastatin, Enoxaparin for thromboprophylaxis, Levothyroxine, Metoprolol Succinate XL, and Glucagon. Follow-up with his primary care physician is recommended within one week to reassess his dysphagia and manage his chronic conditions. Home health nursing will also assist with medication management and dietary adherence.',\n",
       " '**Discharge Summary**  \\n**Patient:** 74-year-old female  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the Emergency Department with complaints of severe low back pain (ICD-10: M545), which had escalated over the preceding week. She has a significant medical history, including chronic diastolic heart failure, hypertension, unspecified hydronephrosis, and osteoporosis. The pain was exacerbated by her existing conditions, particularly her musculoskeletal health.  \\n\\n**Hospital Course:**  \\nDuring her 7.7-day hospital stay, the patient underwent a comprehensive evaluation, including imaging studies which ruled out acute surgical issues. A multidisciplinary team, including pain management and physical therapy, was involved in her care. The patient was treated with a combination of analgesics, including Hydromorphone and Oxycodone, along with Gabapentin for neuropathic pain. Supportive measures were taken to address her constipation issues, utilizing Lactulose and Docusate Sodium.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was found to have chronic low back pain with no acute changes on imaging. She was monitored for heart failure symptoms, and her diuretics were adjusted accordingly. Other notable findings included age-related osteoporosis and a history of pathological fracture.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient exhibited improved pain control and was ambulating with assistance. She requires continued physical therapy and home health services to monitor her mobility and manage her pain regimen. She will benefit from ongoing assessments to ensure her heart failure is well-managed and to address her osteoporosis.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue with the following medications: Acyclovir, BuPROPion, Calcium Carbonate, Docusate Sodium, FoLIC Acid, Gabapentin, HYDROmorphone, Heparin, Lactulose, Levothyroxine Sodium, Lidocaine 5% Patch, Multivitamins, Mycophenolate Mofetil, OxyCODONE SR, and OxyCODONE (immediate release).  \\n\\n**Follow-Up Plan:**  \\nShe is scheduled for follow-up with her primary care physician within one week and will be referred to home health services for assistance with her activities of daily living and medication management.',\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old male who presented to the emergency department with signs of severe sepsis, unspecified organism, characterized by fever, tachycardia, and altered mental status. Initial laboratory work revealed elevated inflammatory markers. The patient's history includes multiple comorbidities including liver cell carcinoma and portal hypertension.\\n\\n**Hospital Course:**  \\nThe patient was admitted urgently and treated with broad-spectrum intravenous antibiotics, intravenous fluids, and supportive care. He required close monitoring in the ICU for the first 48 hours due to septic shock. His clinical status improved gradually with stabilization of vital signs and resolution of fever. Serial imaging showed a pleural effusion, which was managed conservatively. \\n\\n**Key Findings and Procedures:**  \\nDuring his hospital stay, the patient underwent a therapeutic drainage of the pleural effusion, which provided significant symptomatic relief. Laboratory findings indicated severe sepsis with concurrent electrolyte imbalances, which were corrected. He was also evaluated for gastrointestinal issues, with findings consistent with infectious gastroenteritis. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is clinically stable at discharge, with improved mental status and vital signs within normal limits. He requires assistance with activities of daily living due to ongoing weakness and fatigue. Home health services will be initiated to provide nursing care, medication management, and assistance with rehabilitation exercises. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed 0.9% Sodium Chloride, Apixaban, Ciprofloxacin HCl, Digoxin, Midodrine, and others. A follow-up appointment is scheduled with his oncologist and primary care physician within one week. Home health services will monitor the patient’s recovery closely and ensure adherence to the prescribed medication regimen. Additionally, the patient is advised to seek immediate care for any signs of recurrent infection or worsening symptoms.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 50  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency (EW EMER)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a cutaneous abscess of the right hand, presenting with localized swelling, erythema, and tenderness. The abscess was determined to be secondary to an infection, likely exacerbated by underlying conditions.  \\n  \\n**Hospital Course:**  \\nDuring the 3.9-day hospital stay, the patient was started on intravenous antibiotics including Penicillin G Potassium and Vancomycin. Surgical intervention was performed, involving incision and drainage of the abscess (0RBU0ZZ). The patient also received supportive care with analgesics such as Oxycodone for pain management, Diphenhydramine for allergic responses, and Docusate Sodium for stool softening.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's laboratory tests indicated an elevated white blood cell count consistent with infection. Imaging studies confirmed the presence of a significant abscess in the right hand. Surgical drainage was successful, and the wound was appropriately dressed. The patient was also immunized with the Quadrivalent Influenza Vaccine (Z23) during the stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition with improved hand function post-drainage. He requires ongoing home health services for wound care management and monitoring of the surgical site. Functional abilities for daily living tasks are intact, but he will need assistance with activities involving the right hand until fully healed.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed 0.9% Sodium Chloride, 5% Dextrose, Acetaminophen, Pramipexole for restless legs syndrome, and additional home medications as needed. Follow-up appointments are scheduled in one week with the primary care physician and the hand surgeon to assess recovery and the need for further interventions.\",\n",
       " \"**Patient Information:** 21-year-old female, admitted urgently for labor and delivery complications. \\n\\n**History of Present Illness:** The patient presented with a second-degree perineal laceration during delivery. She delivered a single live birth at 38 weeks gestation. The labor was complicated by a cord around the neck, without compression. \\n\\n**Hospital Course:** The patient had a short length of stay (1.3 days), during which she was monitored for signs of infection and healing. Obstetric care included routine assessments of vital signs and uterine involution. Pain management was initiated with intravenous acetaminophen and ibuprofen, and she received lactated Ringer's solution for hydration. The perineal laceration was assessed, and appropriate wound care was provided. The patient was educated on pelvic floor exercises and proper perineal care to facilitate recovery. \\n\\n**Key Findings and Procedures:** The patient successfully delivered without significant complications. The perineal laceration was sutured, and the patient was stable upon discharge with no signs of infection. No additional procedures were performed during her stay, and she demonstrated good understanding of discharge instructions. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was ambulating independently and reported moderate pain at the laceration site, manageable with prescribed medications. She was advised to monitor for any signs of increased pain, swelling, or discharge from the wound. The patient was deemed suitable for home health services to assist with wound care, follow-up assessments, and education on postpartum recovery. \\n\\n**Medications and Follow-Up Plan:** The patient is to continue medications including 0.9% Sodium Chloride flushes, acetaminophen, ibuprofen, bisacodyl, calcium carbonate, Docusate Sodium, Dermoplast spray, senna, and simethicone for symptom management. Follow-up with her obstetrician is recommended in one week to assess healing and recovery.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 30  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with symptoms consistent with cholangitis, including fever, chills, and jaundice. Initial imaging and laboratory work confirmed the diagnosis, which was complicated by portal hypertension and myelodysplastic disease. The patient was admitted for 4.8 days for management of his condition.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient received intravenous antibiotics, including Ciprofloxacin and Metronidazole, as well as supportive care. He was monitored closely for any signs of sepsis or hepatic decompensation. Enoxaparin was administered for prophylaxis against venous thromboembolism due to his prolonged immobility. The patient’s condition improved significantly, with a resolution of fever and stabilization of liver function tests.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's condition was evaluated through imaging studies, which showed dilated bile ducts consistent with cholangitis. A procedure was performed to provide biliary drainage, alleviating the obstruction. Key laboratory findings indicated elevated liver enzymes and bilirubin levels, which improved during the course of treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is clinically stable with improved symptoms. He is ambulating independently and demonstrates an understanding of his discharge instructions. Given his complex medical history, he will benefit from home health services to monitor his recovery, manage medications, and provide education regarding lifestyle modifications and symptom management.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Ciprofloxacin HCl, Enoxaparin Sodium, Magnesium Sulfate, Metronidazole, Morphine Sulfate for pain management, Ondansetron for nausea, Phytonadione for coagulation support, Potassium Chloride, and Sodium Chloride flushes.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician and a hepatologist within one week of discharge. Home health services will be arranged to assist with medication management and monitoring of liver function.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 39  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.9 Days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of recurrent seizures, diagnosed with non-intractable epilepsy (ICD-10: G40.802). The seizures have been characterized as focal, with no significant features of status epilepticus. She reported a history of medication non-adherence, which may have contributed to her recent exacerbation of symptoms.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a comprehensive workup including laboratory tests and EEG monitoring, which confirmed her diagnosis. She was treated with intravenous fluids and antiepileptic medications. The patient also experienced ocular pain, which was addressed with topical treatments. She received supportive care for her complaints of cyanosis and was educated on the importance of medication adherence and lifestyle modifications to manage her condition effectively.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included controlled seizure activity following medication adjustment and the resolution of ocular symptoms. The patient was educated on her diagnosis and the importance of follow-up care. She was also assessed for her psychosocial needs, including her history of nicotine dependence and gastro-esophageal reflux disease (GERD).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition with no acute issues. She demonstrates an understanding of her condition and the need for ongoing management, including home health services for medication management and support for lifestyle changes. Functional status is satisfactory, as she can perform her activities of daily living with minimal assistance.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atropine Sulfate Ophthalmic 1%  \\n3. Docusate Sodium  \\n4. Heparin  \\n5. Influenza Vaccine Quadrivalent  \\n6. Loperamide  \\n7. Omeprazole  \\n8. Ondansetron ODT  \\n9. Prednisolone Acetate 1% Ophthalmic Suspension  \\n10. Senna  \\n11. Sodium Chloride 0.9% Flush  \\n\\n**Follow-up Plan:**  \\nThe patient is referred for home health services for medication management and education. A follow-up appointment with her neurologist is scheduled in one month to reassess her seizure management and overall health status.',\n",
       " '**Discharge Summary**  \\n**Patient:** 77-year-old male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 7.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with confusion and altered mental status, attributed to a syndrome of inappropriate secretion of antidiuretic hormone (SIADH). He also presented with hyperkalemia and atrial fibrillation, which complicated his clinical condition.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was monitored closely for electrolyte imbalances and cardiovascular stability. He received intravenous fluids to correct hyponatremia and was placed on a cardiac monitoring protocol due to his atrial fibrillation. His renal function was assessed, revealing chronic kidney disease, and appropriate adjustments to his medications were made. The patient was treated with Levothyroxine for hypothyroidism and received iron supplementation for diagnosed iron deficiency anemia.  \\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated potassium levels and altered thyroid function tests. An echocardiogram was performed, confirming the presence of atrial fibrillation without evidence of structural heart disease. The patient underwent extensive renal workup, and a urology consult was obtained for benign prostatic hyperplasia with urinary retention.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented but required assistance with activities of daily living due to weakness and deconditioning. He is expected to benefit from home health services for medication management, monitoring of vital signs, and assistance with daily activities.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aluminum-Magnesium Hydrox.-Simethicone, Aspirin, Carvedilol, Finasteride, Levothyroxine Sodium, and Heparin. The patient should follow up with his primary care physician within one week and a nephrologist for ongoing management of his kidney disease. Home health nursing will be arranged to assist with medication administration and monitoring of his renal status.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 56 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of a gastric ulcer (ICD-10: K259), which presented with epigastric pain, nausea, and vomiting. She has a notable history of chronic conditions, including Type 2 diabetes mellitus, chronic obstructive pulmonary disease (COPD), and chronic pain syndromes. The patient reported worsening abdominal symptoms prior to admission.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was evaluated and managed with a combination of supportive care and pharmacological interventions. A gastroenterology consultation was obtained, and she was started on CarafATE (sucralfate) for ulcer management. She was monitored for potential complications, including hemorrhage or perforation, which did not occur.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's symptoms improved over the course of her stay, with significant reduction in abdominal pain. Key laboratory tests were performed, revealing stable blood glucose levels and adequate renal function. No endoscopic interventions were required. The patient was educated about dietary modifications and medication adherence.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently, and demonstrates the ability to manage her medications with minimal assistance. Home health services will be initiated to assist with ongoing monitoring of her diabetes management and medication regimen. Additionally, physical therapy services will be arranged to address her chronic low back pain and improve mobility.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Atorvastatin  \\n4. CarafATE (sucralfate)  \\n5. Dextrose 10% in Water (D10W)  \\n6. Folic Acid  \\n7. Gabapentin  \\n8. Glucagon  \\n9. Glucose Gel  \\n10. Heparin  \\n11. Insulin  \\n12. Levothyroxine Sodium  \\n13. Lisinopril  \\n14. Meclizine  \\n15. Ondansetron ODT  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge and will have a gastroenterology follow-up in two weeks. Home health nursing will assess her adherence to medications and assist with her chronic conditions management.\",\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Redacted]  \\n**MRN**: [Redacted]  \\n**Date of Admission**: [Redacted]  \\n**Date of Discharge**: [Redacted]  \\n**Admitting Physician**: [Redacted]  \\n\\n**History of Present Illness**:  \\nThe patient is a 68-year-old male with a recent diagnosis of malignant neoplasm of the pancreatic duct (ICD-10: C253), who presented to the emergency department with acute abdominal pain, weight loss, and jaundice. His medical history is significant for respiratory failure and a personal history of antineoplastic chemotherapy.\\n\\n**Hospital Course**:  \\nDuring his 9-day hospital stay, the patient underwent several diagnostic and therapeutic interventions, including imaging studies and endoscopic procedures. He was treated for acute kidney failure, respiratory failure with hypercapnia, and was managed for electrolyte imbalances. The multidisciplinary team provided supportive care, including pain management with Oxycodone and antiemetics such as Ondansetron and Metoclopramide. The patient also received Dextrose for hypoglycemia and Creon for pancreatic enzyme supplementation.\\n\\n**Key Findings and Procedures**:  \\nNotable findings included significant thrombocytopenia and metabolic acidosis. The patient underwent endoscopic retrograde cholangiopancreatography (ERCP) to relieve biliary obstruction and was started on Heparin for thromboprophylaxis. A Pneumococcal vaccine was administered as part of his discharge plan. \\n\\n**Discharge Condition and Functional Status**:  \\nThe patient is stable for discharge with improved symptoms. He is ambulating independently but requires assistance with activities of daily living due to weakness. Home health services have been arranged to provide nursing support for medication management, wound care, and nutritional support. \\n\\n**Medications and Follow-Up Plan**:  \\nUpon discharge, the patient’s medication regimen includes Aspirin, Creon 12, Docusate Sodium, and Insulin, among others. He is advised to follow up with oncology and primary care in one week for ongoing management of his cancer and general health. Home health will monitor his condition and assist with any needs that arise.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Admitting Physician]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 66-year-old male with a history of pericardial effusion (ICD-10: I313) who was admitted for observation due to worsening dyspnea and fatigue. Initial imaging revealed a significant accumulation of fluid in the pericardial space, contributing to his symptoms.  \\n  \\n**Hospital Course:**  \\nDuring his 24-day hospital stay, the patient underwent multiple diagnostic procedures, including echocardiograms and a thoracentesis, which confirmed the presence of a noninflammatory pericardial effusion. He received supportive care with diuretics and was closely monitored for signs of cardiac compromise. A multidisciplinary team was involved in managing his nutritional status, as he exhibited signs of severe protein-calorie malnutrition (ICD-10: E43).  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during his stay included persistent pleural effusion, as evidenced by imaging studies, and complications related to antineoplastic chemotherapy-induced pancytopenia (ICD-10: D61810). The patient was treated with calcium supplementation and adjusted nutritional support. He also received antibiotics for suspected bacteremia.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function and overall strength. He is able to perform basic activities of daily living but will require assistance for more demanding tasks. Home health services will be essential for continued monitoring of his nutritional needs and medication management.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes acetaminophen, calcium carbonate, ceftriaxone, colchicine, duloxetine, and gabapentin. Follow-up appointments with cardiology and nutrition services are scheduled within one week of discharge. The patient is advised to contact the healthcare team with any signs of worsening symptoms or complications.',\n",
       " 'Patient is a 65-year-old male who presented to the emergency department with signs of infection related to an internal prosthetic device, specifically documented as a prosthetic device infection (ICD-10: T8579XA). The patient reported fever, chills, and localized pain, prompting immediate evaluation and management. \\n\\nDuring his 5-day hospital stay, the patient was diagnosed with an infection and inflammatory reaction due to his internal prosthetic device. Imaging studies and laboratory tests confirmed the diagnosis, revealing an abscess of the liver and acute cholecystitis (ICD-10: K750, K831). He was initiated on intravenous antibiotics, specifically Ciprofloxacin, and underwent surgical intervention to drain the abscess and address the cholecystitis. Additionally, he was monitored for complications related to his past medical history of type 2 diabetes mellitus and benign prostatic hyperplasia. \\n\\nKey findings during the hospital course included improving laboratory parameters, a reduction in fever, and stabilization of his vital signs. The patient tolerated the surgical procedure well and showed no immediate postoperative complications. \\n\\nAt discharge, the patient is stable, with a functional status allowing for activities of daily living with some assistance. He demonstrates understanding of his condition and medication regimen, which includes Acetaminophen, Aspirin, CloNIDine, Docusate Sodium, Insulin, and Losartan Potassium, among others. The patient will require home health services for ongoing monitoring and assistance with medication management and wound care related to his prosthetic device. \\n\\nFollow-up appointments are scheduled with his primary care physician and the surgical team within one week of discharge to ensure proper recovery and management of his underlying conditions. The patient is advised to seek immediate medical attention if he experiences any signs of worsening infection, such as increased fever or significant pain.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 74 years  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 74-year-old male who was admitted for surgical intervention due to occlusion and stenosis of the left carotid artery (ICD-10: I6522). He presented with symptoms suggestive of transient ischemic attacks, necessitating urgent evaluation and intervention.  \\n  \\n**Hospital Course:**  \\nThe patient underwent carotid endarterectomy and tolerated the procedure well. Post-operatively, he was monitored in the surgical unit for 48 hours, where he required pain management and careful monitoring of neurological status. The patient received appropriate anticoagulation therapy with heparin and was transitioned to clopidogrel and aspirin prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nDuring his hospital stay, the patient was found to have essential hypertension (ICD-10: I10), hyperlipidemia (ICD-10: E785), and unspecified atrial fibrillation (ICD-10: I4891). A comprehensive medication review was conducted, and adjustments were made to optimize his cardiovascular regimen. He was also treated for gastro-esophageal reflux disease (ICD-10: K219) with appropriate medications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with no neurological deficits and demonstrated an adequate level of independence in activities of daily living. He has been educated on signs of stroke and the importance of medication adherence. Home health services have been arranged for ongoing monitoring of his blood pressure and medication management, along with physical therapy to promote mobility and strength.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Clopidogrel  \\n- Lisinopril  \\n- Metoprolol Tartrate  \\n- Ezetimibe  \\n- Docusate Sodium  \\n- OxyCODONE (as needed)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge and to keep appointments with cardiology and neurology as scheduled. Home health services will initiate within 24-48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 59 years old  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 4.6 days  \\n**Primary Diagnosis:** Osteoarthritis of knee, unspecified (ICD10: M179)  \\n**Other Diagnoses:** Hepatic fibrosis (K740), urinary tract infection (N390), unspecified viral hepatitis C (B1920), unspecified asthma (J45909), anxiety disorder (F419), personal history of malignant neoplasm of skin (Z85828)  \\n\\n**History of Present Illness:** The patient presented for surgical management of osteoarthritis of the knee, which had been progressively worsening over the past year, causing significant pain and functional impairment.  \\n\\n**Hospital Course:** The patient underwent a knee arthroscopy with debridement and synovectomy. Postoperatively, he experienced mild pain managed effectively with hydromorphone and ketorolac. He was started on a regimen of enoxaparin for DVT prophylaxis and was monitored for any complications during his stay. The urinary tract infection was treated with ciprofloxacin, and the patient was stabilized before discharge.  \\n\\n**Key Findings and Procedures:** The main procedure performed was arthroscopy of the knee, which showed significant degenerative changes. Postoperative imaging confirmed the need for further outpatient management. The patient also required treatment for his urinary tract infection, and his asthma was managed with albuterol nebulization.  \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable with improved pain control and ambulating with assistance. He demonstrated the ability to perform activities of daily living with minimal help, which is important for home health services. The patient will require assistive devices for mobility and ongoing rehabilitation to regain strength and function.  \\n\\n**Medications at Discharge:** The patient was prescribed alprazolam, acetaminophen, albuterol nebulizer solution, ciprofloxacin, docusate sodium, enoxaparin, gabapentin, hydromorphone, influenza vaccine, ketorolac, milk of magnesia, multivitamins, ondansetron, ranitidine, and senna.  \\n\\n**Follow-Up Plan:** The patient is to follow up with orthopedic services within one week and should contact primary care for management of his hepatic fibrosis and other comorbidities. Home health services are recommended for physical therapy and medication management.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 56  \\n- **Gender:** Male  \\n- **Admission Type:** Direct Emergency  \\n- **Length of Stay:** 10.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 56-year-old male with a diagnosis of liver cell carcinoma (ICD10: C220) who was admitted via the emergency department due to worsening abdominal pain, ascites, and signs of portal hypertension. His past medical history includes alcoholic cirrhosis without ascites, secondary esophageal varices, and a history of alcohol dependence in remission.  \\n  \\n**Hospital Course:**  \\nUpon admission, the patient received supportive care, including IV fluids and nutritional support. His hospital course was complicated by ileus and acute posthemorrhagic anemia due to esophageal variceal bleeding, necessitating transfusions. He underwent an endoscopic variceal ligation, which successfully managed the bleeding. Throughout his stay, he was closely monitored for liver function and complications. He was started on Entecavir for hepatitis C and continued on supportive medications, including diuretics for fluid management.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed the presence of liver cell carcinoma with associated portal hypertension and moderate ascites. The endoscopy showed secondary esophageal varices, which were treated effectively. Laboratory results indicated elevated liver enzymes consistent with his chronic liver disease.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms. He is ambulatory but requires assistance with daily activities due to fatigue and weakness. Home health services will be initiated to assist with medication management, monitoring of liver function, and nutritional support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, he is prescribed Aspirin EC, Atovaquone, Ceftriaxone, Entecavir, and diuretics among others. A follow-up appointment with oncology is scheduled in one week, and he will continue to receive home health visits for ongoing evaluation and support. The patient has been educated on signs of potential complications and when to seek immediate medical attention.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 32 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.9 days  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to complications related to pregnancy, specifically diseases of the circulatory system complicating pregnancy in the first trimester (ICD-10: O99411). She presented with mild symptoms including dizziness and palpitations.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a comprehensive evaluation, including a neurological assessment due to concerns regarding her cerebral health. A cerebral imaging study revealed a cerebral infarction due to embolism of the left middle cerebral artery (ICD-10: I63412), which was managed with appropriate anticoagulation therapy. The patient was also treated for gastro-esophageal reflux disease without esophagitis (ICD-10: K219) and monitored for her long-term use of anticoagulants (ICD-10: Z7901).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s NIHSS score was assessed at 0, indicating no neurological deficits at the time of discharge. She received prophylactic enoxaparin during her stay and was stabilized on her anticoagulant regimen. Additional supportive therapies included hydration and symptom management with medications such as acetaminophen and omeprazole.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, and demonstrated an understanding of her condition and medication regimen. She will require home health services for medication management and monitoring of her anticoagulation therapy. She is advised to follow up with her obstetrician and a cardiologist to manage her ongoing health needs effectively.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Clopidogrel  \\n4. Dextrose 50%  \\n5. Enoxaparin (Prophylaxis)  \\n6. Glucagon  \\n7. Glucose Gel  \\n8. Hydralazine  \\n9. Influenza Vaccine Quadrivalent  \\n10. Insulin  \\n11. Omeprazole  \\n12. Senna  \\n13. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in one week with her obstetrician and is advised to contact home health services for any concerns regarding her anticoagulation therapy or general health monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 26  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 1.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for urgent evaluation and management of post-term pregnancy at 41 weeks gestation. She presented with obstructed labor due to shoulder dystocia and labor complications associated with umbilical cord compression. The patient was also identified as a carrier of Streptococcus B, which complicated her childbirth process.  \\n  \\n**Hospital Course:**  \\nDuring her brief hospital stay, the patient underwent careful monitoring of fetal heart rate and uterine contractions. A vaginal delivery was accomplished with the assistance of oxytocin to stimulate labor progression and management of shoulder dystocia. The delivery was successful, resulting in a single live birth. Post-delivery, the patient was stabilized and provided with supportive care including pain management and hydration.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient successfully delivered a healthy newborn. Key interventions included the administration of oxytocin (10E0XZZ) and maternal monitoring to prevent further complications. The patient remained stable throughout her hospitalization and showed no signs of infection or significant postpartum complications. Discharge medications included 0.9% Sodium Chloride, Acetaminophen, and Ibuprofen for pain control, among others.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulating independently and exhibiting a good functional status. She demonstrated understanding of her discharge instructions and the importance of follow-up care. Home health services will be initiated to assist with postpartum recovery, including wound care and monitoring for any signs of infection or complications.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride for hydration, Acetaminophen and Ibuprofen for pain management, Docusate Sodium for constipation, and an Influenza Vaccine. The patient is advised to follow up with her obstetrician in one week and to contact home health services for any concerns regarding her recovery or newborn care.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 73  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 12.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 73-year-old male with a known history of myasthenia gravis, who presented with an acute exacerbation characterized by increased muscle weakness and respiratory distress. He has been on long-term immunosuppressive therapy, including mycophenolate mofetil, and antithrombotics for pulmonary embolism prevention.  \\n  \\n**Hospital Course:**  \\nDuring his 12.5-day stay, the patient was closely monitored in the observation unit. He received intravenous corticosteroids (prednisone) and supportive care, which resulted in gradual improvement of his symptoms. The patient also experienced complications, including deep vein thrombosis (DVT) in the left lower extremity, which was managed with therapeutic anticoagulation using apixaban.  \\n  \\n**Key Findings and Procedures:**  \\nKey diagnostic findings included a positive D-dimer and imaging studies confirming DVT. He underwent venous ultrasound, and his condition was stable by discharge. The treatment regimen included managing his chronic conditions and addressing acute exacerbation symptoms.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrates improved muscle strength and stable respiratory status, although he requires continued monitoring for anticoagulation therapy and myasthenia gravis management. He is ambulatory with assistance and is expected to benefit from home health services for physical therapy and medication management.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apixaban  \\n3. Atorvastatin  \\n4. Gabapentin  \\n5. Metoprolol Succinate XL  \\n6. Mycophenolate Mofetil  \\n7. Prednisone  \\n8. Polyethylene Glycol  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care provider and neurologist within one week of discharge. Home health services will be initiated to assist with medication adherence, physical therapy, and ongoing monitoring of his myasthenia gravis.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 59  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of dyspnea, fatigue, and lower extremity edema. She has a significant history of hypertensive heart disease with heart failure, contributing to her acute decompensation.  \\n  \\n**Hospital Course:**  \\nDuring her 5.7-day hospital stay, the patient was diagnosed with acute systolic heart failure exacerbated by her underlying conditions, including chronic obstructive pulmonary disease (COPD) and obesity. She was treated with a combination of diuretics (Furosemide) and bronchodilators (Albuterol nebulization) to manage her symptoms. Continuous oxygen support was provided due to episodes of acute respiratory failure with hypoxia. The patient's anticoagulation therapy was managed with Apixaban, and her thyroid function was stabilized with Methimazole.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, worsening heart failure symptoms, and hypoxia upon admission. The patient underwent a thorough workup, including echocardiogram and chest imaging, which confirmed the diagnosis of congestive heart failure. She responded well to treatment, with significant improvement in her dyspnea and edema.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved respiratory status, with stable oxygen saturation levels on room air. She is ambulating independently and reports a decrease in edema. It is crucial for her to follow up with home health services for continued monitoring of her heart failure management and respiratory status. Home health nursing will assist with medication management and assessment of vital signs.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Albuterol 0.083% Nebulizer solution, Apixaban, Azithromycin, Furosemide, Losartan, Metoprolol, and others as listed. A follow-up appointment with her cardiologist is scheduled in one week, and home health services will commence immediately post-discharge to ensure she adheres to her treatment regimen and monitor her recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Age:** 66  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.1 Days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation with a diagnosis of sepsis, unspecified organism. He presented with fever, chills, and confusion, along with a significant past medical history of cardiomyopathy, hypertension, chronic kidney disease, and persistent atrial fibrillation. His home medications included insulin and furosemide, among others.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was started on intravenous antibiotics (amoxicillin-clavulanic acid and ampicillin-sulbactam) and received supportive care, including fluid resuscitation with 0.9% sodium chloride. His condition improved gradually, with stabilization of vital signs and resolution of fever. Serial lab tests indicated a decrease in inflammatory markers. He was monitored closely for cardiac function due to his existing heart failure and received diuretics for fluid management.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated white blood cell count indicating infection, and echocardiogram confirmed stable left ventricular function. No invasive procedures were required during the stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, alert, and oriented. He is able to perform activities of daily living with minimal assistance and requires continued monitoring for his chronic conditions. Home health services are recommended for medication management, blood pressure monitoring, and assistance with mobility due to his history of heart failure and recent hospitalization.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- Acetaminophen  \\n- Amoxicillin-Clavulanic Acid  \\n- Furosemide  \\n- Insulin  \\n- Lisinopril  \\n- Aspirin  \\n- Digoxin  \\nThe patient is to follow up with his primary care physician within one week and will have home health services initiated to aid in his recovery.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 65 years  \\n**Gender:** Male  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a urinary tract infection (UTI), presented with dysuria and increased urinary frequency. He has a history of essential hypertension, hyperlipidemia, and benign prostatic hyperplasia. He reported mild shortness of breath, which may be related to his underlying cardiomyopathy.  \\n  \\n**Hospital Course:**  \\nDuring the 1.9-day observation period, the patient was treated with intravenous ceftriaxone for UTI management. His renal function was monitored closely due to the presence of acute kidney failure, which was deemed to be transient. He was also started on terazosin to alleviate urinary symptoms due to prostatic enlargement. He experienced some dizziness likely related to his cardiac medications but remained stable overall.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory results confirmed the diagnosis of UTI with Escherichia coli as the causative organism. Renal function tests showed improvement, and vital signs remained stable throughout the stay. No invasive procedures were performed.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is clinically stable, ambulating independently, and exhibiting adequate understanding of his discharge instructions. He will require home health services to assist with medication management and monitor his cardiovascular status, given his history of cardiomyopathy and recent acute kidney injury.  \\n  \\n**Medications at Discharge:**  \\n1. Albuterol Inhaler  \\n2. Aspirin  \\n3. Carvedilol  \\n4. Ceftriaxone (completed course)  \\n5. Cetirizine  \\n6. Fluticasone Propionate Nasal Spray  \\n7. Gabapentin  \\n8. Guaifenesin  \\n9. Heparin (for DVT prophylaxis)  \\n10. Odefsey  \\n11. Ramelteon  \\n12. Senna  \\n13. Simvastatin  \\n14. Sodium Chloride 0.9% Flush  \\n15. Terazosin  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments are scheduled with primary care and urology within one week post-discharge. Home health services will initiate care within 48 hours to assist with medication adherence and monitor vital signs.',\n",
       " \"**Discharge Summary**  \\n**Patient**: [Patient Name]  \\n**Age**: 68  \\n**Gender**: Female  \\n**Admission Type**: Urgent  \\n**Length of Stay**: 24 days  \\n  \\n**History of Present Illness**:  \\nThe patient is a 68-year-old female with a significant medical history including pulmonary embolism and various malignancies, who presented with acute dyspnea and chest discomfort. A CT pulmonary angiogram confirmed a pulmonary embolism classified as ICD-10 I2699, without acute cor pulmonale.  \\n  \\n**Hospital Course**:  \\nDuring her hospitalization, the patient was managed with anticoagulation therapy (Enoxaparin) and supportive care. She underwent a comprehensive evaluation including imaging and laboratory tests which revealed multiple comorbid conditions, including secondary malignancies. Pain management was addressed with a fentanyl patch and oral analgesics. The patient's hemoglobin levels were monitored due to underlying anemia, and she was treated for gastrointestinal issues with bisacodyl and aluminum-magnesium hydroxide-simethicone.  \\n  \\n**Key Findings and Procedures**:  \\nThe patient's key findings included stable vital signs, improved respiratory function, and a gradual decrease in symptoms. No acute complications arose during her stay. A multidisciplinary team involved in her care ensured that her nutritional and mobility needs were met, resulting in her achieving baseline functional status prior to discharge.  \\n  \\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient is clinically stable, ambulating independently, and able to perform activities of daily living with minimal assistance. She will require ongoing home health services for monitoring her anticoagulation therapy, managing pain, and addressing her nutritional needs.  \\n  \\n**Medications and Follow-Up Plan**:  \\nThe patient’s discharge medications include Acetaminophen, Ibuprofen, Metoprolol Tartrate, and Enoxaparin. She is advised to continue her nicotine patch and to follow up with her oncologist and primary care provider within one week post-discharge. Home health services will initiate within 48 hours to ensure continuity of care.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 48  \\n- **Gender:** Male  \\n  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 48-year-old male who presented to the emergency department with abdominal distension and discomfort, secondary to alcoholic cirrhosis of the liver with ascites (ICD10: K7031). He has a history of alcohol abuse and hypertension, contributing to his current clinical condition.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent thorough evaluation and management for his cirrhosis and associated complications. He received diuretics (Spironolactone and Furosemide) to manage fluid overload and ascites. Additionally, he was treated with Pantoprazole for gastroprotection and Metoprolol Succinate XL for hypertension management. The patient was monitored closely for any signs of hepatic encephalopathy and bleeding tendencies due to acquired coagulation factor deficiency (ICD10: D684).  \\n  \\n**Key Findings and Procedures:**  \\nOn examination, the patient exhibited notable abdominal distention with shifting dullness, consistent with ascites. Laboratory tests revealed elevated liver enzymes and bilirubin levels, supporting the diagnosis of alcoholic cirrhosis with portal hypertension. He was educated on lifestyle modifications and the importance of abstaining from alcohol.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved abdominal symptoms and manageable ascites. He demonstrated an understanding of his condition and the need for medication adherence. Functional capacity remains adequate for home care, but he requires home health services for ongoing monitoring and support with medication management and dietary advice.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. Furosemide  \\n4. Heparin  \\n5. Metoprolol Succinate XL  \\n6. Pantoprazole  \\n7. Polyethylene Glycol  \\n8. Senna  \\n9. Sodium Chloride 0.9% Flush  \\n10. Spironolactone  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week for a comprehensive review of his condition and medication regimen. Home health services will be initiated to assist with medication administration and monitoring of liver function and ascites.\",\n",
       " '**Patient Information:** 32-year-old male admitted under observation for primary spontaneous pneumothorax. \\n\\n**History of Present Illness:** The patient presented with sudden onset of left-sided chest pain and dyspnea. He has a history of nicotine dependence and reported frequent tobacco use. Initial imaging confirmed a large left-sided pneumothorax. \\n\\n**Hospital Course:** The patient was monitored closely for respiratory distress and provided supplemental oxygen as needed. Serial chest X-rays were performed to monitor the pneumothorax size. Due to the significant size, a chest tube was placed to facilitate drainage. The patient responded well to the procedure, with gradual resolution of symptoms and improvement noted on follow-up imaging. He was also treated for nicotine dependence with a nicotine patch and provided education on smoking cessation. \\n\\n**Key Findings and Procedures:** Radiological evaluation showed improvement in pneumothorax size post chest tube insertion. The patient maintained stable vital signs throughout the admission. Other assessments included management of pain with hydromorphone and oxycodone, and the patient received supportive care for constipation and nausea with docusate sodium and ondansetron, respectively. \\n\\n**Discharge Condition and Functional Status:** The patient is clinically stable with resolved respiratory symptoms. He is ambulating independently and demonstrates adequate understanding of his discharge instructions. He will require home health services for ongoing monitoring of his respiratory status and assistance with nicotine cessation efforts. \\n\\n**Medications and Follow-Up Plan:** At discharge, he was prescribed acetaminophen, albuterol nebulizer solution, nicotine patch, and a regimen for bowel management including polyethylene glycol and senna. He is advised to follow up with his primary care physician within one week and to contact home health services for any concerns regarding his respiratory status.',\n",
       " 'Patient is a 54-year-old female admitted through the emergency department with a diagnosis of Brief Psychotic Disorder (ICD-10: F23). She presented with acute onset of psychotic symptoms, including hallucinations and disorganized thoughts, following a stressful life event. During her 18-day hospital stay, she was stabilized with pharmacotherapy, including Paliperidone ER and Lorazepam, resulting in significant improvement in her psychiatric symptoms.\\n\\nKey findings during the hospitalization included insomnia (ICD-10: G47.00), generalized anxiety disorder (ICD-10: F41.1), and other medical issues such as hypotension (ICD-10: I95.9) and constipation (ICD-10: K59.00). The patient was closely monitored, and her medications were adjusted accordingly. She underwent routine laboratory tests, which revealed no significant abnormalities, and vital signs were stabilized by the end of her stay.\\n\\nUpon discharge, the patient demonstrated improved mental status, with diminished psychotic symptoms and better insight into her condition. She is able to perform activities of daily living (ADLs) with minimal assistance and has shown motivation to engage in outpatient therapy. Her discharge condition is stable, but she will require ongoing home health services to support her recovery. \\n\\nAt discharge, the patient was prescribed the following medications: Acetaminophen, Ibuprofen, Lorazepam, Paliperidone ER, Polyethylene Glycol, Ramelteon, Senna, Sertraline, Vitamin B Complex, and Vitamin D3 (Cholecalciferol). She is advised to follow up with her psychiatrist within one week and to establish regular appointments with a home health nurse for medication management and monitoring of her psychiatric status. The home health team will assist with education on her conditions and medication adherence, ensuring continuity of care in her recovery process.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 33 years  \\n- **Gender:** Female  \\n- **Admission Type:** Surgical same-day admission  \\n- **Length of Stay:** 4.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to complications related to Crohn's disease. She presented with worsening abdominal pain and was diagnosed with a retroperitoneal abscess. After extensive evaluation, she underwent a procedure for drainage and management of the abscess. The patient has a history of Crohn's disease and has experienced previous complications necessitating surgical intervention.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored closely for signs of infection and postprocedural complications. She received intravenous fluids, antibiotics, and pain management. Her post-operative recovery was complicated by nausea and vomiting, which were managed effectively with antiemetics such as Ondansetron and Promethazine. The patient responded well to treatment, and her symptoms gradually improved.\\n\\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** K9189 (Other postprocedural complications), K6819 (Other retroperitoneal abscess), T8143XA (Infection following a procedure, initial encounter), K5090 (Crohn's disease, unspecified), etc.  \\n- **Procedures Performed:** Drainage of retroperitoneal abscess (ICD-10: 0DB84ZZ), other surgical management (ICD-10: 0W9H4ZZ).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge. She is fully alert and oriented, with improved abdominal pain and no signs of infection. She will require home health services for continued wound care and monitoring of her recovery. Assistance with activities of daily living may be needed due to her recent surgery. \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed Acetaminophen for pain management, magnesium oxide supplements, and a regimen of oral and IV fluids. She will also continue with tramadol as needed for pain control.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and gastroenterologist within one week. Home health services will be initiated to assist with her recovery and monitor for any potential complications. Education on signs of infection and post-surgical care has been provided.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 62, Gender: Male  \\n**Admission Type:** Surgical same-day admission  \\n**Length of Stay:** 2.5 days  \\n**Primary Diagnosis:** Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter (ICD10: T82858A)  \\n  \\n**History of Present Illness:**  \\nThe patient, a 62-year-old male, presented with symptomatic stenosis of a previously placed vascular graft, leading to intermittent claudication in the right leg. The patient has a past medical history significant for essential hypertension, hyperlipidemia, atherosclerotic heart disease, type 2 diabetes with peripheral angiopathy, and long-term use of anticoagulants and insulin.  \\n  \\n**Hospital Course:**  \\nAfter admission, the patient underwent a successful endovascular procedure aimed at addressing the stenosis. Post-operative care was uneventful, with close monitoring of vital signs and neurological status. The patient was managed with intravenous fluids and analgesics, transitioning to oral medications by the second postoperative day.  \\n  \\n**Key Findings and Procedures:**  \\n- Successful endovascular intervention for graft stenosis.  \\n- Vital signs stable; no signs of acute ischemia.  \\n- Pain well-controlled with hydromorphone and transitioned to oral analgesics.  \\n- Discharged with instructions for monitoring signs of graft complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is in stable condition, ambulating independently with minimal discomfort. He demonstrates understanding of discharge instructions and is capable of managing his medications. Home health services will be initiated to assist with medication management, monitor wound healing, and provide education on lifestyle modifications to manage his chronic conditions.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Clopidogrel  \\n- Insulin  \\n- Gabapentin  \\n- Dextrose 50% as needed for hypoglycemia  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week post-discharge and should be monitored by home health services for ongoing assessment of his vascular status and medication adherence.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date:** [Date]  \\n**Age:** 72  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is a 72-year-old female with a diagnosis of malignant neoplasm of the lower lobe of the left lung (ICD-10: C3432) who presented to the hospital with worsening respiratory symptoms, including cough, dyspnea, and chest pain. She has a significant past medical history of hypertension, nicotine dependence, and adult failure to thrive, and is a former patient of non-Hodgkin lymphoma.\\n\\n**Hospital Course:**  \\nDuring her 4.8-day stay, the patient underwent a comprehensive evaluation, including imaging studies that confirmed the presence of a mass in the left lung, consistent with her diagnosis. She was treated with dexamethasone for inflammation, along with supportive care, including oxygen therapy. The patient's hydration status was managed with intravenous fluids and she was placed on a heparin regimen to reduce the risk of thromboembolism.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during her stay included secondary malignant neoplasm of the brain (ICD-10: C7931) and episodes of fever. The patient received symptomatic management with ondansetron for nausea and was started on antibiotics due to signs of possible infection. She was also treated for oral candidiasis with nystatin oral suspension and topical miconazole. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required ongoing assistance due to weakness and fatigue. She will need home health services for support with activities of daily living, medication management, and monitoring of her respiratory status. A follow-up appointment with oncology is necessary to evaluate her treatment options.\\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: dexamethasone, docusate sodium, levetiracetam, pantoprazole, oxycodone (immediate release), and magnesium sulfate. Additional symptomatic medications include maalox/diphenhydramine/lidocaine for gastrointestinal discomfort and oxymetazoline for nasal congestion.  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her oncologist within one week of discharge and with her primary care physician for hypertension management. Home health services will be coordinated to assist with her recovery.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 41-year-old female who presented to the hospital with a cutaneous abscess of the right axilla. The patient has a history of type 2 diabetes mellitus, hidradenitis suppurativa, and hyperlipidemia. She reported localized pain and swelling in the right axillary region for three days prior to admission, with associated fever and malaise.  \\n  \\n**Hospital Course:**  \\nOn admission, the patient underwent incision and drainage of the abscess, which yielded purulent material. Cultures were taken, and broad-spectrum IV antibiotics, including vancomycin, were initiated. The patient's glucose levels were monitored closely due to her diabetes, and insulin was administered as needed. Pain management was achieved with acetaminophen and oxycodone. The patient's condition improved significantly over the course of her brief hospitalization.  \\n  \\n**Key Findings and Procedures:**  \\nPhysical examination revealed a fluctuant mass in the right axilla with surrounding erythema. Laboratory results indicated elevated white blood cell count consistent with infection. Post-procedure, the patient was afebrile, and her abscess showed signs of healing with no further complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with significant improvement in her symptoms. She requires home health services for wound care management and monitoring of her diabetes. The patient is educated on the signs of infection and the importance of glycemic control.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed acetaminophen for pain, bicitra for metabolic acidosis, and insulin for diabetes management. A follow-up appointment with her primary care physician is scheduled within one week to assess her recovery and adjust her diabetes management plan as needed. Home health services will initiate care within 48 hours post-discharge.\",\n",
       " '**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 58  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to typical atrial flutter, which presented with palpitations and mild dyspnea. His past medical history includes atherosclerotic heart disease, essential hypertension, and hypercholesterolemia. He is also on long-term anticoagulation therapy. The patient has a history of major depressive disorder, which is currently managed with medication.\\n\\n**Hospital Course:**  \\nDuring his 3-day stay, the patient underwent a successful electrical cardioversion to restore sinus rhythm, which was achieved without complications. He was monitored closely for any recurrence of atrial flutter and potential complications related to his underlying cardiac conditions. In addition, his anticoagulation therapy was adjusted and he received education on the importance of adherence to his medication regimen. The patient also received supportive care for his depressive symptoms during hospitalization.\\n\\n**Key Findings and Procedures:**  \\n- **Primary Diagnosis:** Typical atrial flutter (ICD10: I483)  \\n- **Additional Findings:** Atherosclerotic heart disease (ICD10: I2510), hypertension (ICD10: I10), and hypercholesterolemia (ICD10: E7800).  \\n- **Procedures:** Electrical cardioversion (5A2204Z) and cardiac monitoring (B246ZZ4).\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with sinus rhythm maintained post-procedure. He is ambulating independently with no signs of acute distress. He will require home health services for medication management and monitoring of his cardiac status, including any recurrence of arrhythmias. \\n\\n**Medications at Discharge:**  \\n- Apixaban  \\n- Aspirin  \\n- Atorvastatin  \\n- Metoprolol Tartrate  \\n- Escitalopram Oxalate  \\n- Heparin Sodium  \\n- Acetaminophen, among others.  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician and cardiologist within one week. Home health services will assist with medication adherence and regular monitoring of vital signs. The patient should be educated on signs of worsening symptoms, including chest pain, shortness of breath, or palpitations, and to seek immediate medical attention if these occur.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 26  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 16.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe hypotension secondary to medication effects, specifically from antihypertensives. She presented with dizziness and palpitations after initiating a new regimen of antihypertensive therapy. Initial workup included a thorough cardiovascular assessment and monitoring of vital signs.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored closely in a telemetry unit. Intravenous fluids were administered, and medications were adjusted to stabilize her blood pressure. She was also evaluated for concurrent conditions such as myocardial infarction and psychiatric disorders, revealing a history of anxiety and anorexia nervosa. The multidisciplinary team collaborated to provide nutritional support while managing her psychiatric needs.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included hypotension linked to multiple medications, myocardial infarction type 2, and a history of hemiparesis. Cardiac enzyme levels were monitored, and echocardiography revealed no significant structural abnormalities. The patient underwent psychiatric evaluation, resulting in a treatment plan that includes psychotherapy and medication management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs and improved functional status. She is ambulating independently, but with some assistance needed for activities of daily living due to residual effects from her psychiatric condition and previous hemiparesis. Home health services have been arranged to assist with medication management and daily living activities.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Apixaban, Aspirin, Atorvastatin, Clonazepam, Gabapentin, Ipratropium Bromide Nebulizer, LevETIRAcetam Oral Solution, Metoprolol Succinate XL, Montelukast, and Multivitamins.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and will also have outpatient psychiatric follow-up. Home health services will initiate care within 48 hours of discharge for ongoing monitoring and support.',\n",
       " 'Patient is a 56-year-old female who was admitted via direct emergency due to abnormal findings on diagnostic imaging of the heart and coronary circulation (ICD-10 R931). She has a significant medical history including chronic systolic heart failure (ICD-10 I5022), malignant neoplasm of the breast, and other chronic conditions. During her 3.1-day hospital stay, the patient underwent assessment and monitoring of her cardiac status, with serial echocardiograms showing preserved left ventricular function despite her heart failure diagnosis.\\n\\nThe hospital course was complicated by episodes of chest pain and exacerbation of heart failure symptoms. Diuretics were administered to manage fluid overload, and the patient was started on a regimen including furosemide and lisinopril. Multidisciplinary rounds included consultations with cardiology and oncology, considering her complex medical history. She received education on her medications and lifestyle modifications.\\n\\nKey findings included elevated BNP levels indicating heart failure exacerbation, and imaging confirmed no acute coronary syndrome. The patient was treated with acetaminophen for pain management, gabapentin for neuropathic pain, and was initiated on anticoagulation therapy with enoxaparin sodium.\\n\\nAt discharge, the patient was stable with a satisfactory functional status. She is able to mobilize independently with a walker but requires assistance with activities of daily living due to ongoing fatigue and weakness. To facilitate her recovery at home, she will need home health services for physical therapy, medication management, and regular monitoring of her cardiac status.\\n\\nMedications at discharge include acetaminophen, clonazepam, enoxaparin sodium, escitalopram, furosemide, gabapentin, hydromorphone, levothyroxine, and lisinopril. The patient is advised to follow up with her cardiologist within one week and her primary care physician within two weeks for ongoing management of her chronic conditions.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Age:** 44  \\n**Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 7.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 44-year-old male with a significant medical history, including hypertensive heart and chronic kidney disease, who presented with acute on chronic systolic heart failure. He reported worsening shortness of breath, fatigue, and lower extremity edema for the past week. The patient has a history of noncompliance with dietary and medication regimens, which likely contributed to his current exacerbation.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient was stabilized with diuretics, including torsemide, and antihypertensive therapy with captopril. His renal function was closely monitored, and he was treated for acute kidney failure, which gradually improved. The patient was also managed for associated electrolyte imbalances.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, signs of heart failure on physical examination, and laboratory results indicating acute kidney injury and electrolyte abnormalities. The patient underwent a cardiac echocardiogram and was evaluated for potential heart assist device placement.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated significant improvement in symptoms, with reduced edema and stable vital signs. He is currently ambulatory with assistance and requires home health services for ongoing monitoring of vital signs, medication management, and dietary adherence.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Aspirin, Atorvastatin, Bisacodyl, Captopril, Dextrose 50%, Digoxin, Insulin, Levothyroxine Sodium, Polyethylene Glycol, Torsemide, and others as needed.  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician and a nephrologist within one week of discharge. Home health services will be initiated to assist with medication management, dietary education, and vital sign monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 60  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 60-year-old female who presented with epigastric pain (ICD-10: R1013) and was admitted under observation for further evaluation. The pain was intermittent, associated with nausea, but without any hematemesis or melena. Initial laboratory evaluations revealed mild hyponatremia and hypo-osmolality (E871), prompting further work-up for potential underlying malignancy.  \\n\\n**Hospital Course:**  \\nDuring her 3-day stay, the patient underwent imaging studies, including a CT scan, which identified a malignant neoplasm of the pancreas (C259) and a secondary malignant neoplasm of the lung (C7800). The patient received supportive care, including fluid resuscitation with Lactated Ringer's, pain management with a fentanyl patch, and adjustment of her antihypertensive regimen with carvedilol (I10). Due to her pain and anxiety, she was started on dexamethasone and lorazepam, while gabapentin was initiated for neuropathic pain.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent epigastric pain, signs of malignancy, and management of electrolyte imbalances. The patient was monitored closely and managed effectively for her pain and anxiety.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved pain control and was able to ambulate with assistance. She will require home health services for ongoing monitoring of her pain, medication management, and support with daily activities as she transitions to home care.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Carvedilol  \\n3. Dexamethasone  \\n4. Escitalopram Oxalate  \\n5. Fentanyl Patch  \\n6. Gabapentin  \\n7. Hydromorphone (Dilaudid)  \\n8. Heparin  \\n9. Pantoprazole  \\n10. Polyethylene Glycol  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with oncology and her primary care physician within one week of discharge. Home health services will initiate within 48 hours to ensure continuity of care and support.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 45  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2 Days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute chest pain and diaphoresis. Initial workup revealed ST elevation myocardial infarction (STEMI) involving the inferior wall, confirmed by ECG findings and elevated cardiac biomarkers. The patient's history is significant for atherosclerotic heart disease, hyperlipidemia, and rheumatoid arthritis, which complicate his cardiac condition. \\n\\n**Hospital Course:**  \\nDuring his 2-day hospitalization, the patient was managed with standard STEMI protocol, including anticoagulation with heparin, initiation of dual antiplatelet therapy with aspirin, and statin therapy with atorvastatin. The patient underwent coronary angioplasty, which successfully resolved the obstructive lesion in the affected artery. Post-procedure, he developed acute systolic heart failure, managed with diuretics and intravenous fluids, leading to stabilization of his condition. \\n\\n**Key Findings and Procedures:**  \\n- ST elevation myocardial infarction (I2119)  \\n- Acute systolic heart failure (I5021)  \\n- Successful coronary angioplasty performed  \\n- Patient exhibited improved left ventricular function by discharge  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently with improved exercise tolerance. His functional capacity is sufficient for home health services, where ongoing monitoring and rehabilitation will be crucial. He is encouraged to engage in light physical activity and will benefit from home health nursing for medication management and education. \\n\\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Atorvastatin  \\n3. Metoprolol Succinate XL  \\n4. Lisinopril  \\n5. 0.9% Sodium Chloride  \\n6. Docusate Sodium  \\n7. Magnesium Sulfate  \\n8. Potassium Chloride Replacement  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his cardiologist within one week of discharge for further evaluation and adjustment of his medication regimen. Home health services will initiate upon discharge to assist with recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 34  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation with complaints of acute lower back pain associated with radiculopathy in the lumbosacral region, diagnosed as intervertebral disc disorder (ICD10: M5117). She reported significant pain radiating down her left leg, rated 8/10, exacerbated by movement. Additionally, she experienced urinary retention and constipation during her stay.  \\n\\n**Hospital Course:**  \\nDuring her 4.5-day observation, the patient was managed with a multimodal analgesic regimen, including acetaminophen, gabapentin, morphine sulfate, and ketorolac. She also received bisacodyl and docusate sodium to address her constipation. Urinary retention was managed conservatively with catheterization as needed.  \\n\\nKey diagnostic imaging was performed, confirming the diagnosis of intervertebral disc herniation. The patient underwent physical therapy consultations, focusing on pain management and mobility exercises, which she tolerated well.  \\n\\n**Key Findings and Procedures:**  \\n- MRI confirmed intervertebral disc issues.  \\n- Pain management and physical therapy were initiated successfully.  \\n- She was catheterized for urinary retention, which resolved by discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved pain control (2/10) and was ambulating with minimal assistance. She is able to perform activities of daily living with moderate assistance and is instructed to avoid heavy lifting and bending. Home health services should monitor her pain management and assist with mobility and daily activities.  \\n\\n**Medications at Discharge:**  \\nThe patient’s discharge medications include: acetaminophen, gabapentin, oxycodone (immediate release and sustained release), ondansetron, and polyethylene glycol.  \\n\\n**Follow-Up Plan:**  \\nShe is scheduled for a follow-up appointment with her primary care physician in one week. Home health services will commence within the next 48 hours to assess her recovery and assist with ongoing rehabilitation.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 80  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.7 days  \\n\\n**History of Present Illness:**  \\nThe patient, an 80-year-old male, was admitted for evaluation of gastrointestinal bleeding secondary to angiodysplasia of the colon, diagnosed via colonoscopy. He presented with weakness, fatigue, and a recent history of melena.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care, including IV fluids, blood transfusions for acute posthemorrhagic anemia, and correction of electrolyte imbalances. The patient's chronic kidney disease (stage 3) was monitored closely, and his antihypertensive regimen was adjusted to optimize blood pressure control. A thorough review of his medications was conducted to minimize any potential interactions, particularly considering his history of atherosclerotic heart disease. The patient tolerated his diet well after stabilization and was able to mobilize with assistance.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included moderate anemia upon admission, which improved with transfusions. Colonoscopy confirmed the diagnosis of angiodysplasia, and no surgical intervention was required. The patient was evaluated by the cardiology team due to his history of coronary artery disease, and his medication regimen was optimized.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improved hemoglobin levels, and he is ambulating with assistance. He exhibits adequate understanding of his condition and the need for follow-up. Home health services are recommended to assist with medication management, monitor his kidney function, and provide support with activities of daily living due to his age and recent hospitalization.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Allopurinol, Aspirin EC, Atorvastatin, Clopidogrel, Docusate Sodium, Ferrous Gluconate, Metoprolol Tartrate, Nitroglycerin SL, Pantoprazole, Polyethylene Glycol, Senna, and Sodium Chloride 0.9% Flush. Follow-up with his primary care physician and nephrologist is advised within one week for further evaluation of his renal status and ongoing management of his chronic conditions.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 60  \\n- **Gender:** Female  \\n\\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a diagnosis of unspecified sepsis (ICD10: A419), accompanied by pneumonia and pleural effusion. The patient presented with fever, malaise, and respiratory distress. Initial workup revealed elevated inflammatory markers, and imaging studies confirmed the presence of pneumonia and pleural effusion.  \\n\\n**Hospital Course:**  \\nThe patient was started on IV antibiotics (Ceftriaxone) and supportive care, including fluids and oxygen therapy. She was closely monitored for hemodynamic stability and respiratory function. The patient's clinical status improved, with a gradual resolution of fever and respiratory symptoms. A thoracentesis was performed to relieve pleural effusion, yielding significant symptomatic relief.  \\n\\n**Key Findings and Procedures:**  \\n- **Imaging:** Chest X-ray confirmed pneumonia and pleural effusion.  \\n- **Procedures:** Thoracentesis performed with subsequent improvement in respiratory function.  \\n- **Laboratory Results:** Positive inflammatory markers consistent with infection; cultures pending.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved respiratory function. She is alert, oriented, and able to perform activities of daily living with minimal assistance. Home health services will be initiated to assist with medication management and monitor respiratory symptoms. Education on recognizing signs of infection and when to seek medical attention has been provided.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ascorbic Acid  \\n- Aspirin  \\n- Atorvastatin  \\n- Azithromycin  \\n- Benzonatate  \\n- Ceftriaxone (transitioned to oral antibiotics if cultures are negative)  \\n- Escitalopram Oxalate  \\n- Heparin  \\n- Methazolamide  \\n- Multivitamins  \\n- Ramelteon  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician within one week. Home health will monitor her recovery and medication adherence.\",\n",
       " 'Patient is a 29-year-old female admitted urgently for management of pre-existing essential hypertension complicating childbirth at 38 weeks of gestation. Upon admission, the patient presented with elevated blood pressure readings and was closely monitored in the hospital setting. The maternal-fetal assessment indicated a single live birth was anticipated, and the patient was counseled regarding the risks associated with hypertension during labor.\\n\\nDuring the hospital stay, the patient was managed with intravenous fluids, Labetalol for blood pressure control, and prophylactic Enoxaparin to prevent thromboembolic events. A low transverse cesarean delivery was performed due to a previous cesarean scar and concerns regarding the fetal position, specifically a cord around the neck without compression. The procedure was uneventful, and the patient was closely monitored postoperatively.\\n\\nKey findings included stable maternal vital signs, adequate fetal heart rate monitoring, and successful recovery from surgery without complications. The patient was discharged on a regimen that included Labetalol, Ibuprofen, and Acetaminophen for pain control, along with a bowel regimen of Docusate Sodium and Senna to address postoperative constipation.\\n\\nDischarge condition was stable, with the patient ambulating independently and demonstrating appropriate self-care skills. She is advised to follow up with her obstetrician within one week and to monitor her blood pressure at home. Home health services have been arranged to assist with postpartum care, including education on medication management and monitoring for signs of hypertension. The patient has been instructed to maintain a low-sodium diet and to contact her healthcare provider if she experiences any concerning symptoms, such as severe headaches or visual changes.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 72 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to recurrent episodes of ventricular tachycardia. He has a history of dilated cardiomyopathy and chronic systolic heart failure, which contributed to his current presentation. During the admission, he experienced symptomatic arrhythmias that warranted close monitoring and management.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was placed on telemetry for continuous cardiac monitoring. He received intravenous amiodarone for ventricular tachycardia management with subsequent stabilization noted. The patient's medication regimen was adjusted to optimize heart failure management, including the initiation of apixaban for anticoagulation to reduce the risk of thromboembolic events, given his paroxysmal atrial fibrillation.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included episodes of ventricular tachycardia, successfully managed with pharmacotherapy. An echocardiogram revealed moderate left ventricular systolic dysfunction consistent with his history of dilated cardiomyopathy. No acute ischemic changes were noted on cardiac monitoring. The patient was also noted to have a moderate pericardial effusion, which will require follow-up.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved cardiac rhythm and symptomatology. He is alert, oriented, and able to perform activities of daily living with minimal assistance. Given his heart failure history, he will benefit from home health services for ongoing monitoring and management of his medication regimen, as well as assistance with activities of daily living.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Amiodarone, Apixaban, Finasteride, Mesalamine DR, Metoprolol Tartrate, Polyethylene Glycol, Pravastatin, Sodium Chloride 0.9% Flush, Tamsulosin, and Vitamin D3.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with cardiology in one week. Home health services will be initiated to ensure proper medication adherence and monitor for any signs of heart failure exacerbation.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 45  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 1 day  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with severe abdominal pain and symptoms indicative of endometriosis. Upon admission, she was diagnosed with endometriosis of the uterus (ICD10: N800) and acute posthemorrhagic anemia (ICD10: D62) following a significant menstrual bleed.  \\n  \\n**Hospital Course:**  \\nDuring her one-day hospital stay, the patient received intravenous fluids (0.9% Sodium Chloride) and was started on pain management, including hydromorphone and ibuprofen. A thorough evaluation included a transvaginal ultrasound and laboratory tests, confirming the diagnosis of endometriosis and anemia.  \\n  \\n**Key Findings and Procedures:**  \\nThe ultrasound revealed endometriotic cysts, and the patient received a D&C (ICD10: 04LF3DU) to address the bleeding and relieve symptoms. Post-procedure, she was monitored closely and showed signs of improvement in pain management and stabilization of hemoglobin levels.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved pain control and hemoglobin levels returning to normal. She demonstrated an ability to perform activities of daily living with minimal assistance and was advised to avoid strenuous activities for the next few weeks.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Docusate Sodium  \\n- Ferrous Sulfate  \\n- Medroxyprogesterone Acetate  \\n- Oxycodone (Immediate Release)  \\n- 0.9% Sodium Chloride (Flush)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her gynecologist in one week for assessment and further management of her endometriosis. Home health services will be arranged to assist with medication administration and monitor her recovery process. She is advised to contact her healthcare provider if she experiences increased pain, fever, or any unusual symptoms.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Date of Birth]  \\n**Admit Date:** [Admit Date]  \\n**Discharge Date:** [Discharge Date]  \\n**MRN:** [Medical Record Number]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 56-year-old male who presented to the emergency department with alcohol-induced acute pancreatitis without necrosis or infection, confirmed by elevated lipase levels and abdominal imaging. He reported severe abdominal pain, nausea, and vomiting following significant alcohol intake.  \\n  \\n**Hospital Course:**  \\nDuring his 2.5-day stay, the patient was managed with supportive care including intravenous fluids, pain control with opioids (hydromorphone and oxycodone), and antiemetics (ondansetron, prochlorperazine). He was also placed on a low-fat diet once tolerated. Serial abdominal examinations showed improvement in pain and tenderness. Monitoring for complications was conducted, and no signs of necrosis or infection were observed.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory evaluations indicated elevated liver enzymes and triglycerides, common in patients with pancreatitis. The patient’s vital signs remained stable, and he was hemodynamically stable throughout his stay. After 48 hours, he reported significant improvement in symptoms and was able to tolerate oral intake.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with returned gastrointestinal function. He demonstrated the ability to ambulate independently and manage basic self-care activities. Due to his history of alcohol use and pancreatitis, a referral to home health services has been made to provide ongoing support and monitor his recovery, including nutritional counseling and potential substance use intervention.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed aspirin, enoxaparin (prophylaxis), lisinopril, metoprolol succinate XL, omeprazole, and a tapering regimen of opioids for pain management. He is advised to follow up with his primary care physician within one week for ongoing management of his hypertension and hyperlipidemia, and to ensure proper recovery from pancreatitis. Additionally, he was educated on the importance of abstaining from alcohol to prevent recurrence.',\n",
       " '**Discharge Summary**  \\n**Patient Details:**  \\n- Age: 22  \\n- Gender: Male  \\n- Admission Type: Urgent  \\n- Length of Stay: 14.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for acute exacerbation of schizophrenia (ICD10: F209), characterized by auditory hallucinations and significant cognitive impairment. He also presented with elevated anxiety levels (ICD10: F419) and insomnia (ICD10: G4700) which contributed to his distress.  \\n\\n**Hospital Course:**  \\nDuring his 15-day hospital stay, the patient was stabilized on a regimen that included haloperidol and clonazepam for psychotic symptoms and anxiety. He required treatment for insomnia with ramelteon and was monitored for potential medication side effects, including drug-induced tremor. The patient was treated for elevated white blood cell count and was assessed for potential metabolic side effects due to the neuroleptic medication.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant psychiatric stabilization with a reduction in hallucinations and anxiety. The patient was also evaluated for physical health concerns, including overweight status (ICD10: Z6832), and was educated about lifestyle modifications. No surgical procedures were performed during the admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved insight into his condition, was able to articulate his treatment plan, and expressed willingness to engage with home health services. His functional status is stable, although he requires assistance with daily activities, particularly medication management and coping strategies for anxiety.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- Haloperidol  \\n- Clonazepam  \\n- Benztropine mesylate  \\n- Ramelteon  \\n- Propranolol  \\n- Acetaminophen for symptomatic relief  \\n- Triamcinolone acetonide cream for skin irritation  \\n\\nThe patient is advised to follow up with psychiatry within one week and to engage with home health services for medication management and mental health support. Regular monitoring of weight and side effects from medications is recommended.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 19  \\nGender: Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 0.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 19-year-old female who presented to the emergency department with nausea and vomiting at 8 weeks of gestation, complicated by tachycardia. She has a history of thyroid dysfunction and a personal history of physical and sexual abuse in childhood, both of which were addressed during her hospital stay. The patient was admitted for management of her symptoms and to ensure maternal-fetal stability.\\n\\n**Hospital Course:**  \\nUpon admission, the patient received intravenous fluids (D5LR) for hydration and antiemetic therapy (ondansetron, prochlorperazine). Her nausea improved significantly, and tachycardia was monitored. She was evaluated by obstetrics and gynecology, who provided support regarding her complex medical history. Her symptoms were managed effectively, and she demonstrated stable vital signs and improved functional status by the time of discharge.\\n\\n**Key Findings and Procedures:**  \\n- Vital signs: stable upon discharge.  \\n- No signs of dehydration or electrolyte imbalance.  \\n- Laboratory tests showed elevated thyroid hormones, consistent with thyrotoxicosis.  \\n- Patient received counseling regarding her medical history and potential implications for pregnancy management.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with no acute distress. She is able to perform activities of daily living independently and is advised to maintain hydration and follow a light diet. Home health services are recommended for ongoing support and monitoring of her thyroid condition, as well as psychological support considering her history.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- D5LR (infusion)  \\n- Docusate Sodium  \\n- Famotidine  \\n- Ondansetron  \\n- Polyethylene Glycol  \\n- Prochlorperazine  \\n- Pyridoxine  \\n- Influenza Vaccine Quadrivalent (administered)  \\n\\n**Follow-Up Plan:**  \\nThe patient should follow up with her obstetrician within one week and her endocrinologist for thyroid management. Home health services will assist in monitoring her progress and addressing any emerging concerns.',\n",
       " 'Discharge Summary:  \\n**Patient Name:** [Patient Name]  \\n**Age:** 70  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 5.6 days  \\n**Primary Diagnosis:** Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris (ICD-10: I25119)  \\n  \\n**History of Present Illness:**  \\nThe patient is a 70-year-old male with a history of atherosclerotic heart disease, chronic atrial fibrillation, and hypercholesterolemia, presenting with exacerbation of angina. He underwent multiple procedures including cardiac catheterization and stenting, which were performed without complications.  \\n  \\n**Hospital Course:**  \\nDuring his 5.6-day hospital stay, the patient was monitored closely in the cardiac unit. He received treatment for his angina and was started on a regimen of anticoagulants and beta-blockers. His symptoms improved significantly, and he was able to engage in light physical activity with minimal discomfort. The patient was also treated for vitamin D deficiency and sleep apnea, which were addressed with appropriate supplementation and CPAP therapy.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s cardiac function was stable by the time of discharge, and he demonstrated improved exercise tolerance. The procedures performed included cardiac catheterization (ICD-10: 02100Z9), stenting (ICD-10: 02100AW), and a general anesthesia procedure (ICD-10: 03BB4ZZ).  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with instructions for home health services to assist with medication management and monitoring of his cardiac status. He is expected to require ongoing physical therapy to improve his mobility and endurance. Home health will also help manage his CPAP therapy for sleep apnea.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed the following medications: Acetaminophen, Amiodarone, Aspirin EC, Atorvastatin, Bisacodyl, Docusate Sodium, Famotidine, Furosemide, Heparin Flush (10 units/ml), Influenza Vaccine Quadrivalent, Isosorbide Dinitrate, Isosorbide Mononitrate (Extended Release), Lactulose, Metoprolol Tartrate, and Ondansetron.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his cardiologist within one week post-discharge and is encouraged to engage with home health services for ongoing assessment and support.',\n",
       " '**Discharge Summary**  \\n**Patient:** 69-year-old male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 1 day  \\n**Primary Diagnosis:** E861 - Hypovolemia  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with symptoms consistent with hypovolemia, including dizziness and fatigue. He has a history of type 2 diabetes mellitus, which is currently being managed with insulin. Initial assessment indicated signs of dehydration and potential electrolyte imbalance.  \\n\\n**Hospital Course:**  \\nDuring his short stay, the patient underwent intravenous fluid resuscitation and electrolyte management, resulting in clinical improvement. He was monitored closely for any signs of deterioration, particularly regarding his diabetic status and renal function. The patient received a total of 2 liters of normal saline and was started on oral hydration as tolerated.  \\n\\n**Key Findings and Procedures:**  \\nLab results showed elevated blood glucose levels and mild metabolic acidosis, which were addressed with appropriate insulin therapy and dextrose administration. Additionally, he was evaluated for concurrent infections due to his history of otitis media and osteomyelitis; however, cultures returned negative.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved hydration status, alert and oriented. He demonstrated the ability to perform activities of daily living with minimal assistance, though he may require continued support for managing his diabetes and monitoring for any signs of infection.  \\n\\n**Medications on Discharge:**  \\nThe patient will be discharged on Acetaminophen, Atorvastatin, CarBAMazepine (Extended-Release), Ciprofloxacin, Gabapentin, and insulin with specific dosing instructions.  \\n\\n**Follow-Up Plan:**  \\nHome health services will be initiated for ongoing monitoring of his blood glucose levels and medication management. A follow-up appointment with his primary care physician is recommended within one week to reassess his overall health status and medication adherence. Overall, the patient is ready for discharge with appropriate home health support.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 54 years old  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 2.5 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical resection of a malignant neoplasm of the descending colon (ICD-10: C186). He has a significant medical history including type 2 diabetes mellitus with diabetic neuropathy (E1140), hyperlipidemia (E785), and a personal history of other malignant neoplasms (Z85068).  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful laparoscopic resection of the tumor on the day of admission. Postoperative recovery was uneventful, with stable vital signs and adequate pain control achieved with a combination of hydromorphone and oxycodone. The patient received intravenous fluids (0.9% sodium chloride and lactated ringers) and was closely monitored for any signs of complications.  \\n\\n**Key Findings and Procedures:**  \\nThe surgical procedure was completed without complications, and pathology confirmed the presence of malignant cells. The patient demonstrated good postoperative recovery, with improvement in functional status throughout the stay. Additionally, he received education on managing his diabetes and a referral for dietary counseling was made. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with the ability to ambulate independently and perform activities of daily living with minimal assistance. He is advised to engage in light activity as tolerated. Home health services will be initiated to assist with medication management, diabetes education, and ongoing monitoring of his surgical site. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes acetaminophen, atorvastatin, insulin, and omeprazole. He is instructed to follow up with his primary care physician in one week and the oncology clinic in two weeks for further evaluation and management of his malignancy. Home health nursing will be scheduled to visit within 48 hours post-discharge to ensure continuity of care.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 37  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.5 days  \\n\\n**History of Present Illness:**  \\nThe patient, a 37-year-old female, was admitted for surgical intervention related to a leiomyoma of the uterus (ICD-10: D259). The patient has a past medical history significant for personal history of venous thrombosis and pulmonary embolism, necessitating long-term antithrombotic therapy.\\n\\n**Hospital Course:**  \\nThe patient underwent a laparoscopic myomectomy, which was performed without complications. Postoperatively, she was monitored for pain management and potential thromboembolic events due to her history. She received intravenous fluids including Lactated Ringers, and pain was managed with Hydromorphone and Oxycodone. Enoxaparin was administered for venous thromboembolism prophylaxis. The patient was ambulated on the first postoperative day with assistance and tolerated activities well.\\n\\n**Key Findings and Procedures:**  \\nPost-surgical evaluation revealed stable vital signs, adequate pain control, and no signs of complications. The patient received a quadrivalent influenza vaccine prior to discharge as part of her preventive care. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating with minimal assistance, and demonstrated understanding of her postoperative care and potential signs of complications. She will require home health services for ongoing management of her pain and assistance with mobility as she continues her recovery at home. \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain management, Docusate Sodium for constipation prophylaxis, Enoxaparin for continued anticoagulation, and Simethicone for gas relief. The patient is advised to follow up with her gynecologist within one week post-discharge and to contact her healthcare provider with any concerns regarding her recovery or complications.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 69  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 14.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of catatonic schizophrenia (ICD10: F202) with associated complications including acute kidney failure, alcohol abuse, and dehydration. During her hospital stay, she exhibited significant psychiatric symptoms requiring stabilization and pharmacological intervention.\\n\\n**Hospital Course:**  \\nThe patient was placed under close psychiatric observation. A comprehensive treatment plan was initiated, including the administration of antipsychotics, hydration, and electrolyte management. Throughout her stay, her mental status improved, and she became more cooperative, with decreased catatonic symptoms.  Regular psychiatric evaluations were conducted to adjust her medications accordingly.\\n\\n**Key Findings and Procedures:**  \\nLaboratory investigations revealed acute kidney failure (ICD10: N179) and thrombocytopenia. Renal function was monitored closely, and appropriate supportive measures were put in place. The patient also underwent physical therapy to address mobility issues related to her right ankle and foot pain due to primary osteoarthritis (ICD10: M19071).\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved psychiatric stability and was able to perform activities of daily living with minimal assistance. However, she requires ongoing support for mobility and medication management due to her complex medical and psychiatric history. Home health services will assist in monitoring her mental health, medication adherence, and physical rehabilitation.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Fluticasone-Salmeterol Diskus (500/50)  \\n4. HydrALAZINE  \\n5. PARoxetine  \\n6. QUEtiapine Fumarate  \\n7. Omeprazole  \\n8. Multivitamins W/minerals Chewable  \\n9. Nicotine Patch  \\n10. Docusate Sodium  \\n11. Naproxen  \\n12. Senna  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up appointments with psychiatry and nephrology within one week post-discharge. Home health services will initiate contact for regular assessments and medication management.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 57  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 57-year-old female who presented for surgical intervention due to a nonruptured cerebral aneurysm (ICD10 I671). She was admitted on a same-day surgical basis for endovascular coiling.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a successful endovascular procedure without complications. Postoperatively, she was monitored in the neurological intensive care unit where she exhibited stable neurological status. The patient was started on appropriate analgesia and prophylactic anticoagulation. Throughout her stay, she was treated for pneumonia (ICD10 J189) and received IV antibiotics, including Levofloxacin, leading to improvement. Additionally, her chronic obstructive pulmonary disease (ICD10 J449) was managed with bronchodilators, including Albuterol and Combivent Respimat.  \\n  \\n**Key Findings and Procedures:**  \\nNeuroimaging post-procedure demonstrated successful occlusion of the aneurysm with no evidence of complications. The patient also underwent a comprehensive psychiatric evaluation due to a history of anxiety (ICD10 F419) and major depressive disorder (ICD10 F329), for which she was prescribed DULoxetine and OLANZapine.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with intact neurological function. She is oriented and demonstrates the ability to perform activities of daily living (ADLs) independently. Home health services are recommended for ongoing monitoring of her neurological status, medication compliance, and assistance with pulmonary exercises due to her COPD.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient is prescribed:  \\n- ALPRAZolam  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- DULoxetine  \\n- LamoTRIgine  \\n- Morphine Sulfate (as needed)  \\n- Omeprazole  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with neurology in one week post-discharge and with her primary care physician for management of her COPD and psychiatric medications. Home health nursing will provide education on medication management and monitor respiratory status.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 78  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 8.2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of orthostatic hypotension, presenting with dizziness and near-syncope during ambulation. She has a complex medical history, including unspecified severe protein-calorie malnutrition and essential hypertension. Initial assessments indicated significant postural changes in blood pressure readings.  \\n\\n**Hospital Course:**  \\nDuring her 8-day observation stay, the patient was closely monitored for vital signs and underwent comprehensive laboratory evaluations. Treatment included fluid resuscitation, midodrine to manage hypotension, and dietary modifications to address malnutrition. She received multiple interventions for constipation, including bisacodyl and polyethylene glycol.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent orthostatic hypotension, a BMI of 19.9, and mild cognitive impairment. The patient's medication regimen was adjusted to optimize her blood pressure control and manage her comorbid conditions. No major complications arose during hospitalization, and she demonstrated improvement in her functional status by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved blood pressure readings in the seated and standing positions. She is able to perform activities of daily living with minimal assistance but requires continued supervision due to her cognitive status. Home health services will provide support for monitoring her blood pressure and medication compliance, as well as assistance with meal preparation to ensure nutritional needs are met.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atorvastatin  \\n3. Bisacodyl  \\n4. Clopidogrel  \\n5. Midodrine  \\n6. Omeprazole  \\n7. Polyethylene Glycol  \\n8. Insulin  \\n9. Glucose Gel  \\n10. Dextrose 50%  \\n\\n**Follow-Up Plan:**  \\nShe is to follow up with her primary care physician within one week of discharge and will be referred to a nutritionist to address her dietary needs. Home health nursing will initiate within 48 hours post-discharge to ensure continuity of care.\",\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 53-year-old female who presented to the emergency department with symptoms consistent with a urinary tract infection (UTI), including dysuria, increased urinary frequency, and suprapubic discomfort. Initial lab work confirmed the diagnosis of a urinary tract infection (ICD10: N390).  \\n\\n**Hospital Course:**  \\nDuring her 3-day hospital stay, the patient was treated with intravenous ceftriaxone and subsequently transitioned to oral cefpodoxime. She was also managed for her comorbid conditions, including opioid dependence and hyperlipidemia. The patient demonstrated improvement in her symptoms, with resolution of fever and dysuria.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included positive urine culture for Escherichia coli. No additional procedures were performed during her stay. The patient was monitored for potential complications related to her medical history, including multiple sclerosis and fibromyalgia.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was afebrile and reported significant improvement in her urinary symptoms. She is able to perform activities of daily living independently, though she requires assistance with medication management due to her opioid dependence. Home health services will be initiated to assist with her medication regimen and monitor her recovery from the UTI.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, aspirin, baclofen, cefpodoxime, cyclobenzaprine, and ibuprofen, among others. The patient is advised to follow up with her primary care physician within one week to reassess her urinary symptoms and manage her chronic conditions. Home health services will also provide support for medication adherence and monitor for any ongoing symptoms related to her UTI.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\nAge: 78, Gender: Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 6 days  \\n**Primary Diagnosis:** Sepsis, unspecified organism (ICD-10: A419)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute onset of confusion, fever, and respiratory distress. Initial workup revealed signs of sepsis secondary to pneumonia, and significant comorbidities including chronic diastolic heart failure and chronic kidney disease.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was stabilized with IV antibiotics targeting both Klebsiella and Pseudomonas pneumonia. Supportive care included fluid management and respiratory therapy. The patient required supplemental oxygen and was monitored closely for renal function due to the acute kidney failure observed. Neurological assessment indicated toxic encephalopathy likely secondary to sepsis.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistently elevated inflammatory markers and imaging consistent with bilateral pneumonia. The patient underwent a bronchoscopy to secure a better airway for secretion clearance and was started on a regimen of respiratory therapy. Multidisciplinary rounds were conducted to ensure comprehensive care.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for continued monitoring of respiratory status and medication management. He demonstrates some dependence on assistance with daily activities due to residual weakness and confusion. A physical therapist will assist with mobility exercises to enhance strength and function at home.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on Acetaminophen, Aspirin, Clonazepam, and antibiotics. He will also receive insulin therapy and respiratory medications including Ipratropium-Albuterol nebulizer treatments.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician within one week of discharge, and home health services will initiate within 48 hours to assess ongoing needs and medication adherence. A detailed medication list and care plan have been provided to the patient and family.',\n",
       " '**Discharge Summary**  \\n**Patient:** 49-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.2 days  \\n**Primary Diagnosis:** Type 1 diabetes mellitus with ketoacidosis without coma (ICD10: E1010)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of diabetic ketoacidosis secondary to poorly controlled Type 1 diabetes. He presented with symptoms of polyuria, polydipsia, and abdominal discomfort. Initial laboratory tests confirmed elevated blood glucose levels, ketones, and acidosis. The patient also has a history of alcohol dependence and noncompliance with his medication regimen, which likely contributed to his current condition.  \\n\\n**Hospital Course:**  \\nDuring his 5-day stay, the patient was stabilized with intravenous fluids including 0.9% Sodium Chloride and Dextrose. Insulin therapy was initiated to address hyperglycemia. The patient received supportive care including Docusate Sodium for constipation management and Diazepam for anxiety. The patient was educated on the importance of medication compliance and dietary adjustments.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests demonstrated improvement in metabolic acidosis with normalization of blood glucose levels. The patient underwent routine monitoring of electrolytes, which remained stable. He received vaccinations, including an Influenza Vaccine Quadrivalent, during his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, alert, and oriented. He is able to perform activities of daily living with minimal assistance. However, he requires home health services for ongoing diabetes management, education on insulin administration, and monitoring for potential complications.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient is prescribed: Insulin Human Regular, Lisinopril, Glucagon, and Docusate Sodium. He was also provided with Dextrose Gel for hypoglycemic episodes and advised on the use of Loperamide for gastrointestinal symptoms.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the endocrinology clinic in one week. Home health services should initiate a visit within the next 48 hours to ensure proper diabetes management and adherence to the medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 60-year-old male who was admitted via direct emergency for evaluation and management of decompensated liver disease secondary to cirrhosis (ICD10: K7469). He presented with ascites, jaundice, and abdominal discomfort, with a notable history of alcohol use disorder and chronic hepatitis.  \\n  \\n**Hospital Course:**  \\nDuring the 9-day stay, the patient was monitored closely for liver function and overall clinical status. He underwent paracentesis for symptomatic relief of significant ascites. Imaging studies confirmed the presence of liver cell carcinoma (ICD10: C220). The patient received supportive care including fluid management, nutritional support, and pain control. He was successfully transitioned to oral medications, including acetaminophen, atorvastatin, and carvedilol.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated liver enzymes, bilirubin levels, and INR, consistent with decompensated liver disease. Paracentesis revealed a transudative fluid profile. The patient was started on insulin for blood glucose management and received prophylactic heparin for venous thromboembolism prevention.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with activities of daily living due to fatigue and weakness. He demonstrated an understanding of his condition and the need for home health services to assist with medication management, nutritional support, and monitoring for signs of further hepatic decompensation.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, atorvastatin, carvedilol, famotidine, and fluconazole. The patient is advised to follow up with hepatology within one week and to engage home health services for ongoing support. Instructions for monitoring weight, signs of infection, and managing diabetes have been provided.',\n",
       " \"Patient is a 39-year-old male who was admitted for observation due to worsening facial asymmetry and weakness, diagnosed as Bell's palsy (ICD10: G510). The patient reported a sudden onset of right-sided facial droop and inability to close his right eye, accompanied by mild discomfort in the cervical region. Initial neurological assessment revealed facial nerve dysfunction, with no other significant deficits noted.\\n\\nDuring the 1.9-day hospital stay, the patient underwent a series of diagnostic evaluations, including a CT scan of the head to exclude other causes of the symptoms, which returned unremarkable. He was treated with supportive care, including oral acetaminophen for discomfort and heparin for prophylaxis against thromboembolism. The patient was also started on atorvastatin for hyperlipidemia (ICD10: E785) and received bisacodyl and senna for constipation management. \\n\\nKey findings included a stable neurological examination with slight improvement in facial muscle strength noted on discharge. The patient demonstrated good understanding of the condition and the importance of follow-up care. He was educated on facial exercises to aid in recovery and advised to protect his eye from dryness due to the inability to fully close it. \\n\\nAt the time of discharge, the patient was in stable condition, with a functional status that allowed for independent transfers and ambulation. However, he will benefit from home health services to assist with ongoing facial rehabilitation exercises and monitoring of his medication regimen. The discharge medications include acetaminophen as needed for pain, atorvastatin daily for cholesterol management, and sodium chloride 0.9% flush for maintaining IV access if needed.\\n\\nFollow-up is advised in one week with the primary care physician and a referral to physical therapy for facial rehabilitation. The patient was provided with educational materials on Bell’s palsy and lifestyle modifications to manage his hyperlipidemia.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 56  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 11.3 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with complaints of chest pain on admission, categorized as \"Other chest pain\" (ICD-10: R0789). He also has a history of essential hypertension, atherosclerotic heart disease, and alcohol abuse. His initial evaluation revealed elevated white blood cell count and signs of anxiety.\\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient underwent a comprehensive workup, including cardiac monitoring and laboratory tests. He was treated for hypertension and provided supportive care for his alcohol use disorder. He received multiple medications to manage his symptoms, including Metoprolol for hypertension control and Diazepam for anxiety management. The patient demonstrated significant improvement in his chest pain, and his white blood cell count normalized by discharge.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, normalized laboratory values, and resolution of chest pain symptoms. The patient also received wound care for irritant contact dermatitis and was treated for intertrigo with topical Betamethasone. No invasive procedures were required during his stay.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was in stable condition. He was ambulatory and able to perform activities of daily living (ADLs) with minimal assistance. He will require home health services for ongoing monitoring of his hypertension and support for substance abuse recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed the following medications: Acetaminophen, Albuterol Nebulizer solution, Aspirin, Atorvastatin, Metoprolol Succinate XL, Diazepam, and Ferrous Sulfate. Home health nursing will follow up within 48 hours to assess his adherence to medications, monitor vital signs, and provide additional support for his recovery. A follow-up appointment with his primary care physician is scheduled for one week post-discharge to reassess his overall health and medication management.',\n",
       " '**Discharge Summary**  \\n**Patient:** 33-year-old female  \\n**Admit Date:** [Insert admit date]  \\n**Discharge Date:** [Insert discharge date]  \\n**Length of Stay:** 3.5 days  \\n**Admission Type:** Observation  \\n**Primary Diagnosis:** Female pelvic inflammatory disease, unspecified (ICD-10: N739)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of pelvic inflammatory disease (PID) after presenting with lower abdominal pain, fever, and abnormal vaginal discharge. She reported a two-week history of worsening symptoms, including intermittent fever and nausea. Initial workup included laboratory tests and imaging, which confirmed the diagnosis of PID.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was started on intravenous antibiotics, including Levofloxacin and Metronidazole, to cover polymicrobial pathogens. She received supportive care with intravenous fluids (Lactated Ringers and Dextrose 5%) and analgesia with Morphine Sulfate. The patient was monitored closely for any signs of complications, including abscess formation. She demonstrated significant improvement in symptoms and was afebrile by the second day of admission.  \\n  \\n**Key Findings and Procedures:**  \\nKey lab findings included elevated white blood cell count and CRP, indicating infection. No surgical intervention was necessary, and the patient remained stable throughout her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was stable, ambulating independently, and demonstrating improved functional status. She was advised to gradually resume normal activities and monitor for any recurrence of symptoms. Home health services have been arranged to assist with medication administration and follow-up assessments.  \\n  \\n**Medications at Discharge:**  \\n1. Levofloxacin  \\n2. Metronidazole  \\n3. Docusate Sodium  \\n4. Ondansetron  \\n5. Morphine Sulfate (as needed)  \\n6. Senna  \\n7. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician or gynecologist within one week for re-evaluation. Additionally, she should contact home health services for any concerns or complications. Education on signs of infection and proper medication adherence was provided.',\n",
       " 'Patient is a 78-year-old male who was admitted for observation due to intestinal adhesions with partial obstruction (ICD10 K5651). He presented with abdominal pain, nausea, and vomiting, which were attributed to the obstruction caused by adhesions. Initial imaging confirmed the diagnosis, and he was monitored for signs of worsening obstruction or perforation during his stay.\\n\\nDuring the hospital course, the patient was managed conservatively with IV fluids, bowel rest, and symptom control. He was given medications including morphine for pain management, ondansetron for nausea, and potassium chloride for electrolyte balance. His renal function was closely monitored due to a history of acute kidney failure (ICD10 N179), and he was treated for dehydration (ICD10 E860). By the third day, his symptoms improved, and he tolerated a clear liquid diet, progressing to a regular diet thereafter.\\n\\nKey findings included stable vital signs, resolution of abdominal tenderness, and improved bowel sounds. No surgical intervention was required. The patient was discharged in stable condition with a functional status indicating he was able to perform activities of daily living with minimal assistance. However, he will require home health services for ongoing monitoring and assistance, particularly due to his age and recent medical history.\\n\\nAt discharge, the patient was prescribed a medication regimen including Atenolol, Enalapril Maleate, Metoprolol Tartrate, and Atorvastatin for hypertension and hyperlipidemia, as well as Docusate Sodium and Oxybutynin for bowel and bladder management. He also received a flu vaccine and instructions for home care. Follow-up appointments with his primary care physician and a gastroenterologist are recommended within one week to reassess his condition and medication efficacy.',\n",
       " '**Patient Information:** 32-year-old female admitted urgently for preterm labor at 36 weeks gestation with a twin pregnancy. The patient presented with contractions and cervical changes consistent with preterm delivery.  \\n\\n**History of Present Illness:** The patient experienced increasing abdominal pain and contractions leading to her admission. Upon evaluation, she was diagnosed with preterm labor, specifically classified as O6014X0, indicating preterm labor in the third trimester with preterm delivery. She also had a history of gestational diabetes, which was diet-controlled, and an existing low transverse scar from a previous cesarean section.  \\n\\n**Hospital Course:** During the 4.6-day hospitalization, the patient was monitored closely for signs of labor progression and fetal distress. She was treated with IV fluids and medications to manage pain and prevent complications associated with preterm labor. The patient was also screened for COVID-19 exposure due to current health guidelines.  \\n\\n**Key Findings and Procedures:** The patient underwent a successful vaginal delivery of twins, both liveborn. She received routine postpartum care, including monitoring for signs of infection and managing her pain with medications such as acetaminophen and ibuprofen. Key procedures included the insertion of an intrauterine contraceptive device, which was discussed and consented to prior to discharge.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable at the time of discharge, with good postpartum recovery and the ability to perform activities of daily living independently. She has been educated on the signs of complications such as infection or excessive bleeding. Home health services are recommended for continued monitoring of both her and the twins, particularly in the early postpartum period.  \\n\\n**Medications and Follow-Up Plan:** Discharge medications include acetaminophen, ibuprofen, and docusate sodium for pain management and constipation prevention. The patient is advised to follow up with her OB-GYN within one week of discharge and to contact the clinic or home health services if any concerns arise.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [REDACTED]  \\n**Age:** 54  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 54-year-old female with a known diagnosis of secondary malignant neoplasm of the retroperitoneum and peritoneum (ICD10: C786). She was admitted for surgical intervention to address complications arising from her malignancy. The patient has a significant medical history including personal history of malignant neoplasm of the cervix (Z8541), bilateral acquired absence of ovaries (Z90722), and a history of pulmonary embolism (Z86711).  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful surgical procedure (ICD10: 0DBU0ZZ) with no intraoperative complications. Postoperative recovery was closely monitored, and the patient was stable, demonstrating appropriate responses to analgesics and showing no signs of acute distress. Pain was managed effectively with a combination of morphine sulfate and hydromorphone.  \\n\\n**Key Findings and Procedures:**  \\nPostoperative imaging confirmed the expected surgical outcomes with no evidence of new complications. The patient's pain levels were regularly assessed and managed, and she demonstrated good mobility post-surgery, ambulating with assistance by the second day.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with pain well-controlled and functional mobility improved. She will require home health services for continued monitoring of her surgical site and pain management, as well as assistance with activities of daily living due to her recent surgery.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Anastrozole  \\n3. Enoxaparin Sodium  \\n4. Hydromorphone  \\n5. Ibuprofen  \\n6. Ketorolac  \\n7. Morphine Sulfate  \\n8. OxyCODONE (Immediate Release)  \\n9. Influenza Vaccine Quadrivalent  \\n10. Lactated Ringers  \\n11. Sodium Chloride 0.9% Flush  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her oncologist within one week post-discharge. Home health nursing will initiate visits to assist with wound care and monitor for any complications. The patient has been educated on medication management and signs of possible complications that warrant immediate medical attention.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 52  \\n**Gender:** Male  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with pneumonitis due to inhalation of food and vomit. He presented with acute respiratory distress, hypoxia, and a history of Parkinson's disease. Initial evaluation revealed significant respiratory compromise, prompting immediate intervention.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient was closely monitored in a medical unit. He was treated with supplemental oxygen and bronchodilator therapy, including Albuterol and Fluticasone-Salmeterol, to alleviate respiratory symptoms. Additionally, he received intravenous fluids and supportive care for his underlying conditions, including management of his Parkinson's disease and anxiety disorder. The patient demonstrated gradual improvement in respiratory function and was weaned off supplemental oxygen by day five.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included acute respiratory failure with hypoxia, which resolved with treatment. The patient was also noted to have hyperosmolality and was treated effectively for this condition. No invasive procedures were required during his stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with resolved respiratory symptoms. He is able to perform activities of daily living with minimal assistance and has a functional status that allows for home health support. He will benefit from continued monitoring of his respiratory condition and management of his Parkinson's disease at home with therapy.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- ALPRAZolam  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Amitriptyline  \\n- Carbidopa-Levodopa (25-100)  \\n- Enoxaparin (Prophylaxis)  \\n- Furosemide  \\n- Gabapentin  \\n- Fluticasone-Salmeterol Diskus (100/50)  \\n  \\n**Follow-up Plan:**  \\nThe patient is instructed to follow up with his primary care physician within one week of discharge and to engage home health services for ongoing respiratory support and medication management. He has been educated on recognizing signs of respiratory distress and when to seek immediate medical attention.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 69  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.1 days  \\n**Primary Diagnosis:** Polyp of stomach and duodenum (ICD10: K317)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of gastrointestinal symptoms, including abdominal pain and melena. Previous endoscopic evaluations suggested the presence of a gastric polyp. The patient has a history of gastritis, portal hypertension, and paroxysmal atrial fibrillation. During the observation period, the patient developed acute hemorrhagic anemia secondary to an acute gastric ulcer with hemorrhage (ICD10: K250).  \\n\\n**Hospital Course:**  \\nThe patient received supportive care, including IV fluids and transfusions due to significant anemia. An esophagogastroduodenoscopy (EGD) was performed, revealing bleeding from the gastric polyp and an ulcer, leading to the administration of hemostatic therapy. The patient was closely monitored in the observation unit, with daily assessments of hemoglobin levels and vital signs.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a significant decrease in hemoglobin levels, resolved melena, and stabilization of abdominal pain. EGD confirmed the diagnosis of a bleeding gastric polyp and ulcer. The patient was initiated on proton pump inhibitors (Pantoprazole) and received antibiotics (Ceftriaxone) to prevent infection.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved hemoglobin levels and no active bleeding. She is ambulating independently but demonstrates fatigue with exertion. Home health services are recommended for monitoring vital signs, medication management, and assistance with activities of daily living due to her underlying conditions and recent hospitalization.  \\n\\n**Medications on Discharge:**  \\n1. Acetaminophen  \\n2. Ceftriaxone  \\n3. Furosemide  \\n4. Lactulose  \\n5. Levothyroxine Sodium  \\n6. Midodrine  \\n7. Multivitamins  \\n8. Pantoprazole  \\n9. Polyethylene Glycol  \\n10. Potassium Chloride  \\n11. Sodium Chloride 0.9% Flush  \\n12. Spironolactone  \\n13. Ursodiol  \\n14. Vitamin D  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and will have a gastroenterology appointment scheduled to reassess the gastric polyp and ulcer management.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 49  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of persistent sinus pain, nasal congestion, and difficulty breathing, consistent with a diagnosis of chronic sinusitis (ICD-10 J328). He has a complex medical history including end-stage renal disease, diabetes, and hypertension, which complicated his clinical picture. \\n\\n**Hospital Course:**  \\nDuring his 12-day hospital stay, the patient was monitored closely for respiratory distress and managed with intravenous fluids and antibiotics to address the chronic sinusitis and bacterial superinfection. His renal function was closely evaluated, and adjustments were made to his medications to account for his renal status. He received supportive care including pain management and respiratory therapies. \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent inflammation of the sinuses on imaging studies, and he underwent a nasal endoscopy (0CJY8ZZ) to assess the extent of sinus involvement. Additionally, he was treated for metabolic encephalopathy (ICD-10 G9341) related to his renal condition. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory function and was stable for transition to home health services. He is able to perform activities of daily living with moderate assistance and continues to require monitoring of his renal status and diabetes management. Home health services will focus on medication management, monitoring vital signs, and ensuring adherence to the prescribed treatment plan. \\n\\n**Medications at Discharge:**  \\nThe patient was discharged on a regimen including Acetaminophen, Aspirin, Atorvastatin, Calcitriol, Insulin, and Labetalol among others. \\n\\n**Follow-up Plan:**  \\nA follow-up appointment with his nephrologist and primary care physician is scheduled within one week. Home health nursing will visit twice weekly to assist with medication administration and monitor for any complications.',\n",
       " '**Discharge Summary:**  \\n**Patient Information:**  \\n- **Age:** 43  \\n- **Gender:** Male  \\n- **Admission Type:** Urgent  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with alcoholic hepatic failure without coma, presenting with confusion, abdominal distension, and jaundice. His history is notable for chronic alcohol use, with recent episodes of excessive consumption.  \\n  \\n**Hospital Course:**  \\nDuring a 19-day hospitalization, the patient was stabilized with intravenous fluids, electrolyte management, and nutritional support. He was treated for acute respiratory failure secondary to aspiration pneumonia, managed with ceftriaxone and supportive care. Lactulose was initiated for hepatic encephalopathy, resulting in improved mental status. The patient developed acute kidney injury, likely secondary to dehydration and hepatorenal syndrome, but renal function showed improvement with fluid resuscitation.  \\n  \\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** K7040, J9601, R7881, among others.  \\n- **Notable Procedures:** Enoxaparin prophylaxis was administered to prevent thromboembolism due to immobilization.  \\n- **Monitoring:** Continuous monitoring of liver function tests and renal parameters demonstrated gradual stabilization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved liver function and renal parameters. He is alert and oriented but requires supervision due to persistent mild confusion. He is ambulatory with assistance and can perform basic activities of daily living (ADLs), though he will benefit from home health services for continued monitoring of his condition, medication management, and assistance with rehabilitation to ensure safety and prevent complications.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen, Lactulose, Furosemide, BuPROPion (SR), Midodrine, and others.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and hepatology within one week post-discharge. Home health services will commence to facilitate ongoing assessment of his liver function, medication adherence, and support for lifestyle modifications aimed at abstaining from alcohol.',\n",
       " 'Patient is a 40-year-old female admitted for surgical intervention due to a diagnosis of malignant neoplasm of the rectum (ICD-10: C20). She underwent resection of the rectal tumor with subsequent post-operative management for complications including postprocedural hypotension and tachycardia. Throughout her 5.6-day hospital stay, the patient exhibited stable vital signs after initial interventions, which included fluid resuscitation and close monitoring. \\n\\nKey findings during her admission included elevated heart rate and anemia, for which she was treated with appropriate transfusions and fluid management. The patient also received anticoagulation prophylaxis with Enoxaparin to mitigate thromboembolic risks due to prolonged bed rest post-surgery. \\n\\nThe procedures performed during her hospitalization included a laparoscopic resection (ICD-10: 0DBP0ZZ), post-operative monitoring and care, and pain management strategies utilizing medications such as Acetaminophen and Ketorolac. \\n\\nUpon discharge, the patient is stable, alert, and oriented, with functional status improved from admission. She is able to perform activities of daily living with minimal assistance, though she will require home health services for ongoing assessment of her surgical site, management of pain, and monitoring of her anticoagulation therapy. \\n\\nDischarge medications include 0.9% Sodium Chloride, Enoxaparin, Gabapentin, and Ibuprofen among others. The patient is advised to follow up with her oncologist and primary care provider within one week of discharge to monitor recovery and any potential complications. Home health services will be arranged to assist with medication administration and to ensure adherence to the post-operative care plan.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 35  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for complications related to childbirth, specifically due to a Streptococcus B carrier state. She presented with a single live birth at 41 weeks gestation, complicated by gestational diabetes mellitus (diet-controlled), abnormal fetal heart rate and rhythm during labor, hypertension without significant proteinuria, and meconium-stained amniotic fluid. A second-degree perineal laceration occurred during delivery.  \\n\\n**Hospital Course:**  \\nThe patient was monitored closely throughout her hospital stay of 1.7 days. She received supportive care, including IV fluids and continuous fetal monitoring. Enoxaparin was administered for thromboprophylaxis. The patient's blood pressure and blood glucose levels were managed effectively, demonstrating stability by discharge.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included confirmation of gestational diabetes, management of hypertension, and monitoring for signs of infection due to Streptococcus B. The patient underwent a perineal laceration repair, which was uncomplicated. The newborn was assessed and found to be in good condition.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, ambulating independently, and able to care for her newborn with assistance from family members. She exhibits adequate understanding of her care plan, including signs of potential complications. Home health services will provide additional support for wound care and monitoring of her blood pressure and glucose levels as she transitions home.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed Enoxaparin for continued thromboprophylaxis at home. She is advised to follow up with her obstetrician within one week for postpartum evaluation and to monitor her recovery, with specific attention to her perineal laceration and management of gestational diabetes.\",\n",
       " 'Patient is a 38-year-old female who was admitted for observation due to cellulitis of the abdominal wall (ICD-10 L03311). The patient presented with localized swelling, erythema, and tenderness of the abdominal wall, with a history of recurrent abscess formation. She was treated with intravenous antibiotics, including Nafcillin and Dicloxacillin, and received supportive care, including pain management with Hydromorphone and Ibuprofen.\\n\\nDuring her 5-day hospital stay, the patient showed significant improvement in her symptoms. Blood cultures were negative for growth, and she remained afebrile throughout her admission. Additionally, her hypertension (ICD-10 I10) was managed with Atenolol and Spironolactone, with stable blood pressures noted at discharge. The patient also has a history of major depressive disorder, which was monitored and managed with BuPROPion XL.\\n\\nKey findings included improvement in the local signs of infection, resolution of systemic symptoms, and stable vital signs. The patient did not require any surgical intervention, and no additional procedures were performed during her stay.\\n\\nAt the time of discharge, the patient was in stable condition, ambulating independently, and able to perform activities of daily living with minimal assistance. Home health services have been arranged to provide wound care for her abdominal cellulitis, monitor her medication compliance, and support her mental health needs. \\n\\nDischarge medications include: 0.9% Sodium Chloride (for flush), Acetaminophen for pain, Atenolol for hypertension, BuPROPion XL for depression, Dicloxacillin for infection, Hydromorphone as needed for pain control, Ibuprofen for inflammation, Ranitidine for gastric protection, and Spironolactone for fluid management. The patient is advised to follow up in one week with her primary care physician and to report any signs of worsening infection or adverse effects from her medications.',\n",
       " '**Patient Information:** 60-year-old male admitted for observation due to liver cell carcinoma (ICD10: C220) with associated complications. \\n\\n**History of Present Illness:** The patient presented with worsening abdominal discomfort, significant ascites, and signs of portal hypertension. Initial imaging and laboratory evaluations confirmed the diagnosis of liver cell carcinoma, along with secondary complications including esophageal varices and moderate protein-calorie malnutrition.\\n\\n**Hospital Course:** During a stay of 3.8 days, the patient underwent supportive management, including diuretics for ascites, nutrition support, and pain management. Regular assessments were made for signs of bleeding due to esophageal varices, and heparin was initiated for venous thromboembolism prophylaxis. Nutritional interventions were also instituted, addressing protein-calorie malnutrition. The patient responded well to treatments and showed improvement in his functional status by discharge.\\n\\n**Key Findings and Procedures:** Key findings included significant ascites and hypo-osmolality, managed with diuretics and sodium chloride infusions. No invasive procedures were necessary during the admission. The patient was monitored closely for signs of infection and bleeding, with no acute events occurring.\\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition, with improved abdominal symptoms and manageable ascites. He is independent with activities of daily living but will require home health services for ongoing monitoring and assistance with nutrition and mobility support. Patient education was provided regarding signs of potential complications, including bleeding and infection.\\n\\n**Medications and Follow-Up Plan:** The patient is prescribed acetaminophen for pain, docusate sodium and senna for bowel management, mirtazapine for appetite stimulation, and tramadol for any persistent pain. Heparin will continue for anticoagulation. A follow-up appointment with oncology is scheduled in one week, and home health services will begin immediately post-discharge to ensure continuity of care.',\n",
       " '**Patient Information:** 67-year-old female.  \\n\\n**History of Present Illness:** The patient was admitted for observation due to Type 1 diabetes mellitus with ketoacidosis without coma. She presented with hyperglycemia, abdominal pain, and altered mental status. On admission, her blood glucose was noted to be significantly elevated, and she exhibited signs of dehydration and electrolyte imbalance.  \\n\\n**Hospital Course:** During her 4.8-day stay, the patient received aggressive intravenous hydration, insulin therapy, and electrolyte repletion. Her glucose levels were monitored closely, and adjustments to her insulin regimen were made as necessary. The ketoacidosis resolved by the end of her stay, and she was able to tolerate oral intake. However, she was also found to have underlying issues including essential hypertension and unspecified atrial fibrillation, which were managed with appropriate medications.  \\n\\n**Key Findings and Procedures:** Key findings included elevated blood glucose levels, metabolic acidosis resolved by day 3, and stabilization of her hypertension with Lisinopril and Labetalol. The patient was educated on the importance of adhering to her diabetic management plan, including dietary modifications and regular blood glucose monitoring.  \\n\\n**Discharge Condition and Functional Status:** Upon discharge, the patient is stable and ambulating independently. She demonstrates understanding of her medication regimen and the importance of compliance to prevent future complications. Given her history of underdosing of insulin, home health services will be initiated to provide further education and monitoring to ensure adherence and prevent readmission.  \\n\\n**Medications and Follow-Up Plan:** Medications at discharge include Acetaminophen, Atorvastatin, Aspirin, Lisinopril, and insulin. Follow-up with her primary care physician is scheduled in one week, and she will receive home health services to assist with medication management and diabetes education. The patient has been advised to seek immediate medical attention if she experiences any signs of hyperglycemia or dehydration.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Patient DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 64-year-old male with a complex medical history, including hypertensive heart disease with heart failure, who was admitted for observation due to worsening symptoms of heart failure, including dyspnea and fatigue. The patient's history is significant for acute kidney failure and chronic systolic heart failure.  \\n  \\n**Hospital Course:**  \\nDuring the 11.8-day hospital stay, the patient was closely monitored and managed for his heart failure exacerbation. A comprehensive cardiac evaluation was conducted, revealing signs of congestive heart failure, which was managed with diuretics and optimization of antihypertensive therapy. The patient was also treated for acute on chronic kidney failure and received intravenous fluids and electrolytes as needed. He was educated on his medication regimen, including the importance of compliance.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated B-type natriuretic peptide (BNP) levels and creatinine, indicating heart failure and renal impairment, respectively. The patient underwent echocardiogram imaging, which confirmed ischemic cardiomyopathy. He received diuretics and medications including Lisinopril and Carvedilol.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required home health services for ongoing monitoring and assistance with medication adherence. He demonstrated improved functional status, able to perform activities of daily living with minimal assistance. Education on lifestyle modifications and dietary restrictions was provided to support heart failure management.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aspirin, Atorvastatin, Benzonatate, Carvedilol, Dextrose 50%, Docusate Sodium, Fexofenadine, Fluticasone Propionate (nasal), Guaifenesin-Dextromethorphan, Heparin, Lisinopril, Miconazole Powder, Ramelteon, and Senna. The patient is advised to follow up with his primary care physician and cardiologist within one week of discharge.  \\n  \\n**Patient Education:**  \\nThe patient was educated on recognizing signs of heart failure exacerbation, dietary restrictions, and the importance of medication compliance. Home health services will assist with medication management and regular monitoring of vital signs.\",\n",
       " \"**Patient Information:** 55-year-old female.\\n\\n**History of Present Illness:** The patient was admitted to the hospital with acute onset of dizziness and ataxia. A CT scan revealed a cerebral infarction due to embolism of the left cerebellar artery (ICD-10: I63442). The patient's medical history is notable for essential hypertension, type 2 diabetes mellitus, and depression.\\n\\n**Hospital Course:** The patient was observed over a 2.6-day stay during which she received symptom management and evaluation by neurology. Treatment included anticoagulation with heparin and management of her diabetes and hypertension. The patient was started on aspirin and clopidogrel for secondary stroke prevention. Neurological assessments showed gradual improvement in coordination and balance.\\n\\n**Key Findings and Procedures:** Neurological examinations indicated mild left-sided coordination deficits but no significant cognitive impairment. Laboratory tests revealed mild hypo-osmolality and hyponatremia, which were corrected during the hospitalization. The patient underwent physical therapy to address mobility issues and was assessed for home health needs prior to discharge.\\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, with improved neurological status, though she continues to exhibit mild ataxia. She requires assistance with activities of daily living (ADLs) due to ongoing coordination difficulties. Recommendations for home health services include physical therapy for rehabilitation and monitoring of her glucose levels and blood pressure.\\n\\n**Medications and Follow-Up Plan:** The patient is to continue the following medications at discharge: Acetaminophen, Aspirin, Atorvastatin, Clopidogrel, Metoprolol Tartrate, and Insulin, among others. She has been advised to follow up with her primary care physician within one week and to maintain regular appointments with her neurologist. Home health services will be initiated to aid her recovery.\",\n",
       " '**Patient Summary**: 54-year-old female admitted through emergency with paroxysmal atrial fibrillation (ICD-10: I480). \\n\\n**History of Present Illness**: The patient presented with palpitations, dyspnea on exertion, and lightheadedness. Initial ECG confirmed paroxysmal atrial fibrillation. She also reported symptoms consistent with dehydration and acute kidney failure, likely secondary to her underlying conditions, including essential hypertension and iron deficiency anemia.\\n\\n**Hospital Course**: The patient was stabilized with intravenous fluids (0.9% Sodium Chloride and D5 1/2NS), anticoagulation therapy with Heparin, and rate control using Diltiazem. Her renal function was monitored closely, and she received treatment for dehydration and electrolyte imbalances. Over the course of her 3.6-day stay, she underwent a comprehensive assessment that included renal ultrasound which noted hydronephrosis due to renal calculi (ICD-10: N132). \\n\\n**Key Findings and Procedures**: During her hospitalization, the patient demonstrated gradual improvement in her symptoms. She underwent procedures including renal drainage to alleviate hydronephrosis and was assessed for her atrial fibrillation management. Discharge medications included Acetaminophen, Aspirin, and Famotidine among others. \\n\\n**Discharge Condition and Functional Status**: The patient is being discharged in stable condition, with improved functional status. She is able to ambulate with minimal assistance but may require home health services for medication management, monitoring of renal function, and assistance in daily activities due to her recent acute illness. Additionally, she will benefit from skilled nursing visits to ensure adherence to her new medication regimen and monitoring for potential complications.\\n\\n**Medications and Follow-Up Plan**: Discharge medications include Aspirin, Acetaminophen, Docusate Sodium, and Heparin. A follow-up appointment is scheduled with her primary care physician in one week to reassess her atrial fibrillation management and renal status. Home health services will be initiated to assist with her ongoing care needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 79  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 14.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with signs and symptoms consistent with organ-limited amyloidosis, characterized by a significant decline in functional status. Additionally, the patient presented with complications related to toxic encephalopathy and multiple myeloma not in remission, leading to further evaluation and management in the hospital setting.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent extensive monitoring and treatment. Key interventions included the administration of Bortezomib for multiple myeloma, supportive care for nutritional deficits due to moderate protein-calorie malnutrition, and management of acute kidney failure. The patient was also treated for anemia associated with chronic kidney disease and neoplastic disease. A multidisciplinary team was involved, including oncology, nephrology, and nutrition services, to optimize management.  \\n  \\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** E854 (Organ-limited amyloidosis), G92 (Toxic encephalopathy), C9000 (Multiple myeloma), N179 (Acute kidney failure), and others.  \\n- **Procedures:** The patient underwent supportive care with medications including Acetaminophen, DULoxetine, and Lactulose, along with hemodynamic monitoring.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge but continues to experience weakness and fatigue. Functional status has improved marginally, with the patient able to perform activities of daily living with assistance. Home health services are required for ongoing monitoring, medication administration, and nutritional support.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Acyclovir  \\n- Atorvastatin  \\n- Bortezomib  \\n- CARVedilol  \\n- DULoxetine DR  \\n- Heparin  \\n- Lactulose  \\n- Omeprazole  \\n- Multivitamins with minerals  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with oncology and nephrology in one week. Home health services will initiate care within 48 hours post-discharge.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Male, 82 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n**Primary Diagnosis:** Blister (nonthermal), left great toe (ICD-10: S90422A)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with a blister on the left great toe, leading to concerns of potential infection. He has a complex medical history including metabolic encephalopathy, urinary tract infection, Alzheimer's disease, dementia, and anemia. His baseline functional status was moderately impaired due to his neurological conditions.\\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was monitored closely for signs of infection and provided appropriate wound care. He received intravenous ceftriaxone for potential infection, and bisacodyl was administered to address constipation. The patient was also given enoxaparin for venous thromboembolism prophylaxis, given his age and immobility risk.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed a blister on the left great toe with no signs of systemic infection. Laboratory studies indicated elevated inflammatory markers, consistent with his urinary tract infection. Imaging studies were not performed as the blister was assessed as nonthermal and uncomplicated. The patient was stabilized and showed improvement in his symptoms by the time of discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was afebrile, and the blister on the left great toe was clean and dry. He demonstrated the ability to perform basic activities of daily living with moderate assistance. Due to his cognitive impairment, he will require ongoing home health services to support his medication management and wound care.  \\n\\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen IV, Bisacodyl, Ceftriaxone, D5 1/2NS, Enoxaparin (Prophylaxis), Magnesium Sulfate, and Sodium Chloride 0.9% flush.  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and is referred to home health services for continued assistance with activities of daily living, medication management, and wound care monitoring.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 28  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 28-year-old female with a primary diagnosis of Zoster without complications (ICD-10: B029). She presented to the emergency department with complaints of a painful rash and associated chronic pain. The patient has a significant past medical history including hidradenitis suppurativa, type 2 diabetes mellitus, essential hypertension, and insomnia.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was started on antiviral therapy with Acyclovir, which was well tolerated. Pain management was addressed with Hydromorphone and Gabapentin. Prophylactic Enoxaparin was administered to prevent venous thromboembolism due to her limited mobility. Additionally, the patient was treated for iron deficiency anemia with Ferrous Sulfate. She received education on self-care for her skin condition and pain management strategies.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s vital signs were stable throughout her admission, with no signs of infection or complications arising from her zoster. Laboratory findings indicated controlled blood glucose levels, and her hemoglobin improved following iron supplementation.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was in stable condition, ambulating independently, and able to perform activities of daily living with minimal assistance. She demonstrated understanding of her discharge instructions and exhibited motivation for home health follow-up to manage her chronic pain and skin condition effectively.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Acyclovir, Acetaminophen, Hydromorphone, Gabapentin, GlipiZIDE XL, and Ferrous Sulfate. She has been scheduled for a follow-up appointment with her primary care physician in one week and will receive home health services to monitor her skin condition and provide support for diabetes management.',\n",
       " '**Discharge Summary**  \\n**Patient ID**: [REDACTED]  \\n**Date of Admission**: [REDACTED]  \\n**Date of Discharge**: [REDACTED]  \\n**Attending Physician**: [REDACTED]  \\n  \\n**History of Present Illness**:  \\nThe patient is a 64-year-old male with a history of alcohol dependence presenting with withdrawal symptoms, including tremors and agitation. He was admitted under observation for monitoring and management. He has a notable past medical history of dilated cardiomyopathy, permanent atrial fibrillation, and alcoholic cirrhosis of the liver without ascites.  \\n  \\n**Hospital Course**:  \\nDuring his 2-day stay, the patient received supportive care for alcohol withdrawal, including hydration and pharmacological intervention with benzodiazepines. His withdrawal symptoms improved significantly, and he was monitored closely for any complications related to his underlying cardiac condition. He also received treatment for associated anemia and electrolyte abnormalities, specifically hypo-osmolality and hyponatremia.  \\n  \\n**Key Findings and Procedures**:  \\nKey findings included mild elevation in liver enzymes likely related to alcoholic cirrhosis, and an echocardiogram indicated stable dilated cardiomyopathy. The patient was managed with diuretics and received vitamin supplementation, including cyanocobalamin and folic acid. No invasive procedures were performed during this admission.  \\n  \\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient was stable with improved mental status and no signs of withdrawal. He was ambulating independently and reported minimal discomfort. He will require home health services for continued monitoring of his alcohol dependence, medication management, and assistance with daily activities due to his underlying cardiac condition.  \\n  \\n**Medications at Discharge**:  \\nThe patient was discharged on a regimen including Acetaminophen, Apixaban, Metoprolol Succinate XL, Lisinopril, and OxyCODONE (as needed). He was also prescribed multivitamins and electrolytes to address deficiencies.  \\n  \\n**Follow-Up Plan**:  \\nFollow-up with primary care within one week is recommended, along with a referral to outpatient substance use counseling services. Home health services will monitor medication adherence and assess the need for further support.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**Brief History of Present Illness:**  \\nThe patient, a 43-year-old female, was admitted for a surgical procedure to address a benign neoplasm of the cerebral meninges (ICD-10: D320). She has a significant medical history including a nonruptured cerebral aneurysm (I671), migraines (G43909), and a personal history of malignant melanoma of the skin. She also has a history of anxiety disorder and major depressive disorder, which are well-managed.  \\n\\n**Hospital Course:**  \\nThe patient underwent successful surgery on day of admission with no intraoperative complications. Postoperatively, she was monitored for neurological status and pain control. She received appropriate analgesia including Morphine Sulfate and Oxycodone, as well as antiemetics like Ondansetron for nausea management. The patient tolerated oral intake well and was mobilized early with physical therapy assistance.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies confirmed the benign nature of the neoplasm, and post-surgical imaging was stable. She was treated with Dexamethasone for cerebral edema. A thorough psychiatric evaluation was conducted, and her medications for anxiety and depression were adjusted to ensure optimal management at home.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with intact neurological function and improved pain levels. She is able to perform activities of daily living with minimal assistance and has demonstrated understanding of her medication regimen. Home health services will support her recovery, focusing on medication adherence, physical therapy, and monitoring of neurological status.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Bisacodyl, Docusate Sodium, FLUoxetine, HydrALAZINE, Famotidine, Ibuprofen, LevETIRAcetam, and Neutra-Phos. She is advised to follow up with her neurosurgeon within one week and with her psychiatrist for medication management within two weeks. Home health nursing will facilitate her transition back to home care.',\n",
       " \"Patient is a 35-year-old female who underwent a same-day surgical admission for the excision of a neoplasm of uncertain behavior located at unspecified sites. The patient presented with a localized swelling in the neck, associated with anxiety about the mass. Upon admission, the patient was stable and underwent the procedure without complications. Surgical intervention included excision of the neoplasm, which was performed successfully. The patient was closely monitored post-operatively for any signs of complications such as bleeding or infection.\\n\\nDuring her hospital stay of 1.5 days, the patient's pain was managed effectively with morphine sulfate and oxycodone. Ondansetron was administered to address post-operative nausea. The patient received education on wound care with bacitracin ointment and was started on a bowel regimen to prevent constipation, including docusate sodium and bisacodyl. The patient expressed relief post-surgery and was able to ambulate with minimal assistance.\\n\\nKey findings included stable vital signs and an unremarkable post-operative course. The surgical site showed no signs of infection, and the patient tolerated oral intake well. She was discharged in stable condition with functional independence, although she will require assistance at home for wound care and monitoring for any potential changes.\\n\\nAt discharge, the patient was prescribed a regimen that includes alprazolam for anxiety, acetaminophen for pain management, and spironolactone for any fluid retention. She was advised to continue the use of sodium chloride flushes as needed. A follow-up appointment has been scheduled with her primary care physician in one week, and she is being referred to home health services for additional support in managing her recovery and ensuring adherence to the medication regimen.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 61-year-old female  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 5.5 days  \\n**Primary Diagnosis:** Atherosclerotic heart disease of native coronary artery without angina pectoris (ICD-10: I2510).  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for coronary artery bypass grafting due to significant atherosclerotic changes noted during preoperative assessment. She has a history of essential hypertension, hyperlipidemia, nicotine dependence (remission), and arthritis affecting both hands.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored in a telemetry unit post-surgery. She received pain management with acetaminophen and IV acetaminophen. Her blood pressure was well-controlled with metoprolol tartrate, and her lipid levels were managed with atorvastatin. Postoperatively, she experienced acute posthemorrhagic anemia, which was managed with fluid resuscitation and monitoring. The patient demonstrated good tolerance to oral intake and mobilization, with physical therapy involved for rehabilitation.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent coronary artery bypass grafting (ICD-10: 02100Z9, 021009W). Key findings included stable post-operative vital signs, satisfactory graft function, and resolved hypotension. The patient was discharged with minimal residual pain and no signs of infection.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, ambulatory with assistance, and capable of performing activities of daily living (ADLs) with minimal support. Home health services will be initiated to assist with medication management, wound care, and rehabilitation exercises.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on acetaminophen, aspirin EC, atorvastatin, furosemide, insulin as needed, and metoclopramide. She will also receive the quadrivalent influenza vaccine as part of her discharge plan.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her cardiologist within one week post-discharge. Home health services will be coordinated to provide ongoing support and monitoring.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 47-year-old female  \\n**Admit Date:** [Insert Admit Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n**Length of Stay:** 6.3 days  \\n**Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute abdominal pain, nausea, and vomiting. Imaging studies revealed calculus of the gallbladder and bile duct, with an associated diagnosis of acute and chronic cholecystitis with obstruction (ICD-10: K80.67).  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was managed conservatively with intravenous fluids, pain control, and antibiotics (Ceftriaxone and Clindamycin). She also received prophylactic enoxaparin to prevent venous thromboembolism. A successful laparoscopic cholecystectomy was performed on day 3 of admission, after which her symptoms improved significantly. Post-operative recovery was monitored, and she demonstrated adequate pain management and the ability to tolerate oral intake.  \\n\\n**Key Findings and Procedures:**  \\nThe patient had a post-operative course complicated by transient hypoxia, likely secondary to her underlying chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea. She was treated with bronchodilators (Albuterol and Ipratropium-Albuterol) and closely monitored. Additionally, she was assessed for her chronic conditions, including hyperlipidemia and hypertension, which were managed during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented. She demonstrated the ability to perform activities of daily living (ADLs) with minimal assistance and was able to ambulate independently. Home health services have been arranged to assist with wound care and monitor her recovery following surgery, as well as to manage her chronic conditions.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Benzonatate  \\n4. Ceftriaxone  \\n5. Clindamycin 1% Solution  \\n6. Enoxaparin (Prophylaxis)  \\n7. Fluticasone-Salmeterol Diskus  \\n8. Gabapentin  \\n9. Insulin  \\n10. Ipratropium-Albuterol Inhalation Spray  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week for comprehensive management of her chronic conditions and post-operative care. Home health nursing will initiate contact within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 49  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 49-year-old male with a history of atherosclerotic heart disease who presented for surgical intervention due to angina pectoris. He was admitted for a same-day surgical procedure, including coronary artery bypass grafting (CABG) due to significant coronary artery disease. The patient has a past medical history notable for essential hypertension and hyperlipidemia.  \\n  \\n**Hospital Course:**  \\nDuring his 4.6-day hospital stay, the patient was monitored postoperatively for complications such as intraoperative hemorrhage and acute posthemorrhagic anemia. His recovery was uneventful with close monitoring of vital signs and cardiac status. Pain management was effectively achieved with IV acetaminophen and ketorolac. The patient received rehabilitation and education on lifestyle modifications and medication adherence prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent CABG with anastomosis of coronary arteries, and he was managed for postoperative complications including anemia. Relevant findings included stable hemodynamics, acceptable levels of pain, and improved exercise tolerance by discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and demonstrates an adequate understanding of his discharge instructions. He is independent in activities of daily living (ADLs) but requires home health services for ongoing monitoring of his cardiac status, medication management, and assistance with mobility as he continues to recover.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient’s discharge medications include aspirin EC, atorvastatin, lisinopril, and metoprolol succinate XL, among others. He is advised to follow up with cardiology within one week post-discharge and is referred to home health services for comprehensive evaluation and support. Additionally, he has received the influenza vaccine prior to discharge.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**MRN:** [Patient's MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 66-year-old female who presented to the emergency department with abdominal discomfort and dyspepsia for the past week. She has a history of hypertension and type 2 diabetes mellitus. Initial evaluation revealed signs consistent with other diseases of the stomach and duodenum (ICD-10 K3189).\\n\\n**Hospital Course:**  \\nThe patient was admitted for observation and management. During her 1.5-day stay, she underwent a series of diagnostic tests, including abdominal ultrasound and laboratory work, which showed no acute surgical issues. She was treated with intravenous fluids (0.9% Sodium Chloride) and supportive care. Pain management was effectively achieved with Gabapentin. The patient's blood glucose levels were monitored closely, and her diabetes was well-controlled with adjustments to her insulin regimen.\\n\\n**Key Findings and Procedures:**  \\nKey findings included mild mucosal edema on ultrasound but no evidence of obstruction or perforation. The patient also exhibited interstitial pulmonary disease, which is being monitored. She was stabilized with appropriate medications and discharged in good condition.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with resolved abdominal discomfort. She requires assistance with activities of daily living due to mild fatigue and weakness. It is recommended that she has home health support for medication management and monitoring of her diabetes and hypertension.\\n\\n**Medications at Discharge:**  \\n1. Amlodipine  \\n2. Atorvastatin  \\n3. Docusate Sodium  \\n4. Gabapentin  \\n5. Insulin (adjusted dose)  \\n6. Hydrochlorothiazide  \\n7. Heparin (as needed)  \\n8. Vitamin D supplementation  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for ongoing evaluation of her diabetes and blood pressure management. Home health services have been arranged to assist with her recovery at home, ensuring adherence to medications and monitoring of her overall health status.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 48 years  \\n**Gender:** Female  \\n**Admitting Diagnosis:** Sepsis, unspecified organism (ICD-10: A419)  \\n  \\n**History of Present Illness:**  \\nThe patient, a 48-year-old female, was admitted for evaluation of sepsis with an unspecified organism. She presented with fever, chills, and confusion, having a background history including personal history of Hodgkin lymphoma.  \\n  \\n**Hospital Course:**  \\nDuring her 3-day observation stay, the patient was stabilized with intravenous fluids, including Lactated Ringer's and 0.9% Sodium Chloride, and broad-spectrum antibiotics (Ceftriaxone and Cefpodoxime Proxetil) were initiated. Initial blood cultures were obtained, and her laboratory results indicated renal impairment and metabolic acidosis. She was also treated for dehydration and constipation. Mental health support was provided for major depressive disorder, and she received Fluoxetine.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine levels and signs of acute kidney injury. The patient responded well to treatment with improvement in her vital signs and mental status. A stool softener (Docusate Sodium) and laxatives (Bisacodyl, Polyethylene Glycol) were administered to manage constipation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented. She demonstrated an improved ability to perform activities of daily living, although she will require assistance at home, particularly with hydration and monitoring her mood. Home health services have been arranged to provide nursing support and mental health follow-up.  \\n  \\n**Medications at Discharge:**  \\nThe patient is to continue with the following medications:  \\n- Ceftriaxone (as per physician’s guidance)  \\n- Fluoxetine  \\n- Oxycodone (as needed for pain)  \\n- Ondansetron (for nausea)  \\n- Ferrous Sulfate  \\n- Heparin (for DVT prophylaxis)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her primary care physician within one week and will also be monitored by home health services to ensure compliance with her medication regimen and to provide any additional support as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 74  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n  \\n**History of Present Illness:**  \\nThe patient is a 74-year-old male with a history of atherosclerotic heart disease who was admitted for elective coronary artery bypass grafting (CABG) due to worsening angina pectoris. His past medical history is significant for chronic systolic heart failure, acute posthemorrhagic anemia, and sleep apnea.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a successful CABG on the day of admission. Postoperatively, he was monitored in the surgical unit and demonstrated stable vital signs. He required diuretics for fluid overload, managed with furosemide, and was supported with albumin infusions due to transient hypotension. He was ambulated on postoperative day 2 and participated in physical therapy.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable cardiac status, resolution of acute anemia, and improvement in heart failure symptoms. The patient received treatment for hyperlipidemia and was educated on lifestyle changes. He also underwent a sleep study during his stay, confirming the diagnosis of obstructive sleep apnea.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable and ambulating independently with minimal assistance. He expressed understanding of his medications and the importance of follow-up appointments. Home health services are being arranged for ongoing monitoring of his heart failure status, medication management, and physical therapy to enhance recovery.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Amiodarone  \\n3. Aspirin EC  \\n4. Furosemide  \\n5. Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with cardiology within one week post-discharge and has been scheduled for a home health evaluation to monitor his progress. Education regarding dietary modifications and medication adherence was provided. The patient was advised to call the clinic if he experiences any signs of worsening heart failure or other concerns.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 82  \\nGender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of dehydration, with a background of chronic diastolic heart failure, atrial fibrillation, and acute kidney injury. The patient presented with confusion, decreased oral intake, and signs of dehydration.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient received IV fluids to address dehydration and was closely monitored for renal function and electrolytes. Neurological assessment was conducted due to altered mental status, revealing toxic encephalopathy likely secondary to dehydration and medication interactions.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed elevated creatinine levels consistent with acute kidney failure. Cardiac monitoring indicated controlled atrial fibrillation. The patient was treated with IV Ceftriaxone for a suspected urinary tract infection, and medications were adjusted to prevent potential drug interactions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient improved significantly during her hospital stay. She is stable for discharge, with a coherent mental status and improved hydration status. Functional mobility is adequate with assistance; she requires continued support for activities of daily living (ADLs). Home health services will be essential for ongoing monitoring of her hydration, medication management, and assistance with personal care.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Ceftriaxone  \\n- Citalopram  \\n- Docusate Sodium  \\n- Levothyroxine Sodium  \\n- Multivitamins  \\n- Pilocarpine 4%  \\n- Ramelteon  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Timolol Maleate 0.5%  \\n- Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week. Home health services will initiate within 48 hours post-discharge to support her recovery and ensure medication compliance.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 84  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.6 days  \\n\\n**History of Present Illness:**  \\nThe patient is an 84-year-old male who presented to the emergency department with symptoms consistent with second-degree atrioventricular block (ICD-10: I441). He reported episodes of dizziness and palpitations. The patient has a history of chronic conditions including gout, gastro-esophageal reflux disease, and stage 1 chronic kidney disease.\\n\\n**Hospital Course:**  \\nDuring his brief hospital stay, the patient underwent an evaluation and monitoring of cardiac rhythm. Telemetry revealed intermittent second-degree AV block. The patient was managed with close observation and supportive care, including the administration of intravenous fluids and medications such as heparin and vancomycin for potential infection and anticoagulation.\\n\\n**Key Findings and Procedures:**  \\nKey findings included the presence of atelectasis and a small pericardial effusion, which were addressed with respiratory therapy and monitoring. The patient also received a dose of bisacodyl for constipation management. Discharge medications were prescribed to manage his ongoing conditions, including acetaminophen for pain, allopurinol for gout, and omeprazole for reflux management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with improved symptoms. He is able to perform activities of daily living with minimal assistance but may benefit from home health services for medication management and monitoring of his cardiac status. Home health nursing will assist with medication administration and monitoring for any recurrence of cardiac symptoms.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, allopurinol, aspirin, bisacodyl, heparin, iso-osmotic dextrose, omeprazole, senna, sodium chloride 0.9% flush, and vancomycin. The patient is advised to follow up with his primary care physician within one week and to report any new or worsening symptoms immediately. Additionally, he will require ongoing cardiac evaluation as per cardiology recommendations.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 26  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of severe symptoms associated with irritable bowel syndrome (IBS) with diarrhea, which had significantly impacted her quality of life. Her symptoms included recurrent abdominal pain, diarrhea, and associated weight loss due to dietary restrictions. She was also noted to have signs of malnutrition during the initial assessment.\\n\\n**Hospital Course:**  \\nDuring her 33-day observation stay, the patient underwent extensive dietary management and pharmacological therapy. A multidisciplinary approach was utilized, including dietary consultations and medication adjustments to address her IBS symptoms. The patient was treated with Dicyclomine for cramping, Metoclopramide for gastroparesis, and Loperamide for diarrhea control. Nutritional support was initiated due to her protein-calorie malnutrition, and she received Lactated Ringer's solution for hydration. \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant improvement in her bowel habits and weight stabilization. She underwent multiple diagnostic procedures to evaluate her gastrointestinal function, including imaging studies and endoscopic evaluations, which ruled out other severe pathologies. The patient was monitored for cardiac arrhythmias and hypotension, which were managed accordingly.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptom control and nutritional status. She is now able to ambulate independently and complete basic activities of daily living with minimal assistance. Home health services will focus on dietary management and monitoring her bowel regimen to prevent recurrence of symptoms.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue with the following medications: Acetaminophen (Liquid), Dicyclomine, Fluticasone Propionate NASAL, Gabapentin, Metoprolol Tartrate, and Lansoprazole. She is advised to follow up with her primary care physician in one week and with a gastroenterologist in two weeks for ongoing management of her IBS and nutritional status. Home health services will be coordinated to assist with dietary support and symptom monitoring.\",\n",
       " '**Patient Name:** [Patient Name]  \\n**Age:** 73  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 Days  \\n\\n**History of Present Illness:**  \\nThe patient is a 73-year-old male who presented to the hospital with symptoms consistent with a non-ST elevation myocardial infarction (NSTEMI). He reported chest pain that began approximately 24 hours prior to admission, characterized by substernal pressure radiating to the left arm, associated with diaphoresis and mild shortness of breath. Risk factors include a history of atherosclerosis and essential hypertension.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was closely monitored in the observation unit. Cardiac enzymes were elevated, confirming NSTEMI. He was initiated on appropriate medical therapy, including aspirin, atorvastatin, and isosorbide mononitrate. A coronary angiogram was performed, revealing significant stenosis in the left anterior descending artery, and he was treated with balloon angioplasty and stenting. He was also managed for hyperlipidemia and prescribed lifestyle modifications.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated troponin levels and obstructive coronary artery disease, confirmed by imaging. The patient underwent successful coronary angioplasty with stent placement. He was stable post-procedure and showed improvement in symptoms with adequate pain control and management of risk factors.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was hemodynamically stable, with a significant reduction in chest pain. He is alert and oriented, capable of performing activities of daily living independently. The patient requires home health services for medication management and monitoring of cardiac rehabilitation exercises. He has been advised to avoid heavy lifting and to rest as needed.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include aspirin, atorvastatin, metoprolol tartrate, isosorbide mononitrate, and others as listed. He is advised to follow up with his cardiologist within one week of discharge and to report any recurrence of symptoms immediately. Home health services will assist with medication compliance and monitoring of vital signs.',\n",
       " '**Discharge Summary**  \\n**Patient:** 26-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of a first-degree perineal laceration sustained during delivery. She presented with moderate discomfort and was assessed for potential complications. Notably, the patient experienced delayed postpartum hemorrhage, likely secondary to her laceration.  \\n\\n**Hospital Course:**  \\nDuring her 2.4-day stay, the patient was monitored closely for signs of excessive bleeding and infection. Vital signs remained stable, and her hemoglobin levels were within normal limits. Pain management was initiated with acetaminophen and ibuprofen, supplemented by opioid analgesics (Hydromorphone and Oxycodone) as needed for breakthrough pain. The patient was also provided with stool softeners and laxatives to prevent constipation associated with opioid use.  \\n\\n**Key Findings and Procedures:**  \\nThe primary diagnosis was confirmed as a first-degree perineal laceration (ICD-10: O700). Additional diagnoses included delayed postpartum hemorrhage (ICD-10: O722) and complications from meconium-stained amniotic fluid. The patient underwent a repair of the laceration (ICD-10: 0HQ9XZZ) and received a dose of Methylergonovine Maleate to help with uterine contraction and reduce the risk of further bleeding.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was ambulating independently, with minimal pain reported at the laceration site. She is stable and demonstrates adequate understanding of her discharge instructions. Home health services will be initiated to assist with postpartum care, including monitoring for signs of infection and further assessment of her perineal area.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged with a regimen that includes acetaminophen, ibuprofen, Hydromorphone, and stool softeners. She will also receive topical care with Dermoplast spray. Follow-up is scheduled with her obstetrician in one week to assess healing and address any concerns. Home health services will provide additional support and education regarding postpartum recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old male who was admitted through the emergency ward with neutropenia (ICD10: D709). He presented with fever, headache, and acute upper respiratory symptoms. His past medical history is significant for mantle cell lymphoma, which may have contributed to his current immunocompromised state.  \\n  \\n**Hospital Course:**  \\nDuring his 5-day stay, the patient was monitored closely for signs of infection and treated with broad-spectrum antibiotics, including CefePIME and Azithromycin. Supportive care was provided, including intravenous fluids and pain management with Acetaminophen and Gabapentin. He was also given Acyclovir due to clinical suspicion of a viral infection. The patient's neutrophil count was monitored and showed gradual improvement by the time of discharge.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings indicated persistent neutropenia but improvements in symptoms with appropriate management. A chest X-ray was performed to rule out pneumonia, which was negative. No additional invasive procedures were necessary during the hospital stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable and afebrile, with improved respiratory status. He demonstrates adequate understanding of his discharge plan and medication regimen. Given his history of neutropenia and recent illness, home health services are recommended for continued monitoring of his vitals and assistance with activities of daily living. The patient requires follow-up for his hematological status and ongoing management of his underlying lymphoma.  \\n  \\n**Medications:**  \\nThe patient is discharged on the following medications: Acetaminophen, Acyclovir, Azithromycin, CefePIME, Docusate Sodium, Gabapentin, Heparin Flush, Ipratropium-Albuterol Nebulizer, and Magnesium Sulfate. He is advised to follow up with his oncologist within one week and to seek immediate care if fever or other concerning symptoms arise.  \\n  \\n**Follow-Up Plan:**  \\nHome health will visit the patient to assist with medication management and monitor for signs of infection or further complications. A follow-up appointment with the hematology/oncology department is necessary to reassess his neutrophil levels and overall treatment plan.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 35  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute onset of left-sided neck pain, associated with Horner's syndrome. A CT angiogram of the neck revealed a dissection of the left carotid artery (ICD10: I7771). The patient was admitted for observation and management of her condition.  \\n  \\n**Hospital Course:**  \\nDuring her brief hospital stay, the patient was closely monitored for neurological deficits and signs of vascular compromise. She received anticoagulation therapy with Apixaban and Heparin, alongside supportive care including hydration with 5% Dextrose and Sodium Chloride 0.9%. Pain management was effectively achieved with Acetaminophen and Hydralazine for blood pressure control. The patient was also administered the Quadrivalent Influenza Vaccine as part of routine care.  \\n  \\n**Key Findings and Procedures:**  \\nNeurological examination revealed intact cranial nerve function, with the exception of the noted Horner's syndrome. There were no new neurological deficits noted during the hospital stay, and the patient's vital signs remained stable. She was educated on the importance of medication adherence and monitoring for any changes in her condition.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in a stable condition, with no acute neurological deficits. She is able to perform activities of daily living independently, although she requires assistance with monitoring her anticoagulant therapy. The patient is advised to follow up with her primary care physician and a neurologist to monitor her condition and manage her anticoagulation regimen. Home health services will be arranged to assist with medication management and ensure adherence to follow-up appointments.  \\n  \\n**Medications at Discharge:**  \\n1. Apixaban  \\n2. Aspirin  \\n3. Warfarin  \\n4. Heparin Sodium  \\n5. Acetaminophen  \\n6. Hydralazine  \\n7. Influenza Vaccine (administered)  \\n8. 5% Dextrose and Sodium Chloride 0.9% Flush as needed  \\n  \\n**Follow-Up Plan:**  \\nThe patient should follow up in 1 week with her primary care physician and in 2 weeks with a neurologist. Home health services will provide support for medication management and monitor for any potential complications.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 65  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 65-year-old female who presented to the hospital with postprocedural pneumothorax following a drainage procedure for pleural effusion. She experienced acute dyspnea and chest pain, prompting urgent evaluation.  \\n  \\n**Hospital Course:**  \\nDuring her 11-day hospital stay, the patient underwent chest tube placement to manage the pneumothorax effectively. She also received supportive care, including oxygen therapy and pain management with medications such as acetaminophen and oxycodone. The patient was monitored closely for complications, and her respiratory status gradually improved.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a significant postprocedural pneumothorax, pleural effusion, and underlying alcoholic cirrhosis with ascites. Imaging studies confirmed the pneumothorax, and fluid aspiration was performed. The patient was treated with diuretics (furosemide) to manage fluid overload due to cirrhosis.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory function, with stable vital signs and reduced dyspnea. She is ambulating independently but requires assistance with activities of daily living due to weakness and fatigue. Home health services are recommended to assist with monitoring her respiratory status, medication management, and providing support for daily activities.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications:  \\n- Acetaminophen  \\n- Dextrose 50%  \\n- Docusate Sodium  \\n- Doxycycline Hyclate  \\n- Furosemide  \\n- Gabapentin  \\n- Glucagon  \\n- Glucose Gel  \\n- Heparin  \\n- Insulin  \\n- Lorazepam  \\n- Lidocaine 1% P.F.  \\n- Lidocaine 5% Patch  \\n- Oxycodone (Immediate Release)  \\n- Senna  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and a pulmonologist within one week of discharge to assess her recovery and adjust her treatment plan as necessary.',\n",
       " '**Patient Information:**  \\nAge: 26 years  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to complications related to childbirth, specifically presenting as a carrier of Streptococcus B. She delivered a healthy single live birth at 40 weeks gestation. During delivery, she sustained a second-degree perineal laceration, which was addressed appropriately in our facility.\\n\\n**Hospital Course:**  \\nThe patient was monitored closely during her 2.9-day stay. She remained stable throughout her admission. The primary concerns were managing her pain associated with the perineal laceration and preventing any complications related to the Streptococcus B carrier state. The patient was educated on signs of infection and the importance of follow-up care. \\n\\n**Key Findings and Procedures:**  \\nThe following procedures were performed: perineal repair (0KQM0ZZ), monitoring for Streptococcus B complications, and administration of supportive care including Lactated Ringer’s for hydration and pain management. The patient received education on pelvic floor exercises and wound care, both critical for her recovery. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. She was instructed to continue light activity and to monitor her perineal area for any signs of infection. Home health services will be initiated to assist with wound care and maternal education.  \\n\\n**Medications:**  \\nUpon discharge, the patient was prescribed the following medications:  \\n- Acetaminophen  \\n- Ibuprofen  \\n- OxyCODONE (Immediate Release) for pain management  \\n- Calcium Carbonate for gastrointestinal comfort  \\n- Dermoplast Spray for perineal care  \\n- Docusate Sodium for stool softening  \\n- Ondansetron for nausea prevention  \\n- Simethicone for gas relief  \\n- Sodium Chloride 0.9% for flushes  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week post-discharge for a routine check-up and evaluation of her perineal laceration. Home health services will provide additional support for her recovery and education in the coming weeks.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**MRN:** [Patient MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 58-year-old male who presented with central cord syndrome at the C3 level following an injury. He reported weakness and sensory deficits in the upper limbs, with limited mobility and function. The onset of symptoms was acute, following a fall.  \\n  \\n**Hospital Course:**  \\nDuring a 3.8-day observation admission, the patient underwent diagnostic imaging, which confirmed the presence of central cord syndrome along with multiple fractures, including the orbital floor and cervical vertebrae. He was closely monitored for neurological deficits and pain management.  \\n  \\n**Key Findings and Procedures:**  \\nNeurosurgical consultation was obtained, and conservative management was recommended. Key findings included persistent weakness in both upper extremities and mild sensory deficits. The patient was started on gabapentin for neuropathic pain and received acetaminophen and ketorolac for analgesia. The patient also underwent physical therapy evaluation to assess mobility and strength.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved strength and had regained some functional mobility, though he required assistance for activities of daily living (ADLs). Home health services have been arranged to provide physical therapy and nursing support, focusing on rehabilitation and medication management. The patient is advised to continue with prescribed therapies and medications to maximize recovery.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Gabapentin  \\n3. Cephalexin  \\n4. Enoxaparin Sodium  \\n5. Morphine Sulfate (as needed)  \\n6. Nicotine Patch  \\n7. Polyethylene Glycol  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with neurology and orthopedic specialists in 1-2 weeks. Home health services will commence within 48 hours post-discharge to assist with therapy and monitoring. The patient was educated on recognizing signs of potential complications and when to seek immediate medical attention.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 52-year-old female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for acute respiratory failure with hypoxia, as evidenced by worsening dyspnea and low oxygen saturation levels. She has a significant past medical history of chronic obstructive pulmonary disease (COPD), asthma, and congestive heart failure, which compounded her acute presentation.  \\n  \\n**Hospital Course:**  \\nDuring her stay, she was stabilized with supplemental oxygen, nebulized bronchodilators, and systemic corticosteroids. Her respiratory status improved significantly, with the resolution of hypoxia and decreased work of breathing. Diuretics were initiated to manage fluid overload due to her heart failure. She received multidisciplinary care, including respiratory therapy and nutritional support, given her morbid obesity and history of dysphagia.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included bilateral wheezing on auscultation and mild peripheral edema. A chest X-ray showed hyperinflation consistent with COPD exacerbation but no acute infiltrates. The patient underwent a comprehensive metabolic panel and cardiac enzyme tests, which ruled out acute coronary syndrome.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient exhibited stable vital signs and improved oxygen saturation on room air. She is able to perform activities of daily living with minimal assistance but requires ongoing support for mobility and respiratory management. Home health services are recommended for continued monitoring of her respiratory status, medication adherence, and nutritional support.  \\n  \\n**Medications and Follow-up Plan:**  \\nDischarge medications include Acetaminophen, Albuterol nebulization, Azithromycin, Fluticasone-Salmeterol Diskus, Furosemide, and Insulin. The patient is advised to follow up with her primary care physician within one week and to contact home health services for ongoing assessment and support.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 49  \\nGender: Female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 4.1 days  \\n**Primary Diagnosis:** Hepatic failure, unspecified without coma (ICD10: K7290)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute hepatic failure, presenting with jaundice, elevated liver enzymes, and gastrointestinal bleeding. She reported symptoms of fatigue, abdominal discomfort, and melena. A comprehensive workup was performed that included laboratory tests and imaging studies to evaluate liver function and rule out other complications.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient received supportive care, including intravenous fluid resuscitation with 0.9% Sodium Chloride and Lactated Ringer's solution. She was treated with lactulose for hepatic encephalopathy and nadolol for portal hypertension. Blood transfusions were administered due to acute posthemorrhagic anemia secondary to melena.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent an upper endoscopy which confirmed the presence of esophageal varices, leading to portal hypertension. Imaging revealed signs consistent with nonalcoholic steatohepatitis (NASH) and secondary esophageal varices without bleeding.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with improved liver function tests and no acute bleeding. She is ambulating independently with assistance needed for activities of daily living (ADLs). Home health services are recommended for ongoing monitoring of liver function, medication management, and assistance with ADLs.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Dextrose 50%  \\n- Enoxaparin (Prophylaxis)  \\n- Ferric Gluconate  \\n- Lactulose  \\n- Nadolol  \\n- Pantoprazole  \\n- Insulin Regular Human (U-500) as needed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and hepatologist within one week of discharge. Regular laboratory monitoring is essential for liver function and to adjust medications as needed. Home health services will assist in ensuring adherence to the medication regimen and monitoring for any signs of complications.\",\n",
       " \"**Patient Information:** 63-year-old male admitted for observation due to acute kidney failure, unspecified (ICD-10: N179). \\n\\n**History of Present Illness:** The patient presented with symptoms of fatigue and decreased urine output. He has a history of type 2 diabetes mellitus with diabetic autonomic neuropathy, hypertension, and hyperlipidemia. His acute kidney failure was precipitated by dehydration likely secondary to gastroparesis and a viral intestinal infection.\\n\\n**Hospital Course:** The patient was observed for 2.8 days, during which he received intravenous hydration and electrolyte management. His renal function was closely monitored, and he underwent renal ultrasound to assess for obstructive causes, which was unremarkable. The patient's acidosis was managed with appropriate bicarbonate therapy. He was stabilized with medications including acetaminophen, insulin, and carvedilol for blood pressure control. \\n\\n**Key Findings and Procedures:** Laboratory tests indicated elevated creatinine levels, consistent with acute kidney injury. His electrolytes were monitored, and no significant abnormalities were noted that required further intervention. The patient was also given the influenza vaccine as part of his preventive care. No invasive procedures were performed during this admission.\\n\\n**Discharge Condition and Functional Status:** At discharge, the patient demonstrated improved urine output and stable vital signs. He is ambulating independently and has been advised to maintain adequate hydration and monitor his blood glucose levels, given his diabetes. Home health services will be arranged to assist with medication management and follow-up assessments of renal function.\\n\\n**Medications at Discharge:** The patient will continue on acetaminophen, allopurinol, carvedilol, and insulin. Additionally, he will need outpatient follow-up with nephrology within one week post-discharge to monitor his kidney function closely and adjust medications as necessary.\\n\\n**Follow-Up Plan:** Home health services will be initiated to provide ongoing support, medication education, and ensure adherence to dietary recommendations. A follow-up appointment with his primary care physician is scheduled in two weeks.\",\n",
       " '**Discharge Summary**  \\n**Patient Details:**  \\nAge: 63 years, Gender: Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.2 days  \\n**Primary Diagnosis:** Complete Atrioventricular Block (ICD-10: I442)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of complete atrioventricular block, presenting with syncope and bradycardia. She has a past medical history significant for paroxysmal atrial fibrillation, asthma, and a history of breast cancer. The patient was on anticoagulation therapy which was evaluated upon admission.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a comprehensive cardiac workup, including telemetry monitoring and echocardiography, which confirmed the diagnosis of complete heart block. A temporary pacemaker was placed, followed by a subsequent procedure for permanent pacemaker implantation. Her anticoagulation management was adjusted in light of her cardiac status. The patient was also treated for asthma exacerbation with bronchodilators and corticosteroids.  \\n  \\n**Key Findings and Procedures:**  \\n- Permanent pacemaker implantation (ICD-10: 0JH606Z)  \\n- Management of atrial fibrillation (ICD-10: I480)  \\n- Treatment of asthma with inhaled corticosteroids and bronchodilators  \\n- Psychological evaluation and initiation of management for major depressive disorder (ICD-10: F329)  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with a heart rate of 70 bpm and no symptoms of syncope or dyspnea. She is able to participate in activities of daily living with assistance and will require home health services for monitoring of her pacemaker, medication management, and continued support for asthma management.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Fluticasone Propionate 110mcg  \\n- Omeprazole  \\n- Potassium Chloride  \\n- Vancomycin  \\n- Multivitamins  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with cardiology within one week for pacemaker check and management of atrial fibrillation. She will also have a follow-up with her primary care physician for asthma and mental health support. Home health services will be initiated to assist with ongoing recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old male who presented to the emergency department with acute chest pain and dyspnea. Upon evaluation, he was diagnosed with an ST elevation myocardial infarction (STEMI) involving the left anterior descending coronary artery, confirmed by an ECG showing ST-segment elevation. The patient has a medical history notable for essential hypertension, hyperlipidemia, and a personal history of transient ischemic attacks.  \\n\\n**Hospital Course:**  \\nThe patient was admitted urgently and underwent immediate catheterization, where a successful percutaneous coronary intervention (PCI) was performed with stenting of the occluded artery. Post-procedure, the patient was closely monitored in the cardiac care unit. He received standard medical therapy including aspirin, atorvastatin, metoprolol, and clopidogrel, alongside supportive measures for his cardiovascular condition.  \\n\\n**Key Findings and Procedures:**  \\n- Primary diagnosis: STEMI (I2102)  \\n- Procedures: PCI (027136Z), coronary artery stenting (B2111ZZ)  \\n- Vital signs were stabilized, and cardiac enzymes showed a downward trend post-intervention.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved functional status. He is able to perform activities of daily living independently, though he will require assistance with medication management and follow-up appointments. Home health services are recommended for medication compliance, monitoring of vital signs, and cardiac rehabilitation guidance.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Bisacodyl  \\n- Heparin (bridging therapy)  \\n- Magnesium Oxide  \\n- Metoprolol Tartrate  \\n- Omeprazole  \\n- Ramelteon  \\n- Senna  \\n- Sodium Chloride 0.9%  \\n- Ticagrelor  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his cardiologist within 7 days post-discharge. Home health services will facilitate medication management and monitor his cardiac status as per the discharge instructions.\",\n",
       " '**Discharge Summary**  \\n**Patient ID**: [Patient ID]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n\\n**History of Present Illness**:  \\nA 29-year-old male patient was admitted for surgical management of morbid obesity (ICD-10: E6601), with a BMI of 55, leading to significant health complications including obstructive sleep apnea and nonalcoholic steatohepatitis. The patient reported progressive weight gain and associated fatigue, impacting his daily activities and quality of life.\\n\\n**Hospital Course**:  \\nThe patient underwent laparoscopic gastric bypass surgery (ICD-10: 0DB64Z3) on the same day of admission. His postoperative course was uneventful, characterized by stable vital signs and satisfactory pain control. He was closely monitored for any signs of complications such as infection or gastrointestinal leaks. The patient was able to ambulate independently on postoperative day one and reported gradual improvement in respiratory status.\\n\\n**Key Findings and Procedures**:  \\nPreoperative assessments revealed a diaphragmatic hernia without obstruction (ICD-10: K449) and obstructive sleep apnea (ICD-10: G4733). Post-surgery, he was started on vitamin D supplementation for deficiency (ICD-10: E559) and iron replacement for anemia (ICD-10: D509). The patient was educated on dietary modifications and lifestyle changes to maximize surgical outcomes.\\n\\n**Discharge Condition and Functional Status**:  \\nThe patient is being discharged in stable condition, with improved functional status. He is ambulatory and able to perform activities of daily living independently. He will require home health services for continued monitoring of his weight loss, nutritional support, and management of his sleep apnea with potential CPAP therapy.\\n\\n**Medications and Follow-up Plan**:  \\nUpon discharge, the patient will continue on the following medications: multivitamins, vitamin D, and iron supplements. He is advised to follow up with his primary care physician within two weeks and with a nutritionist to ensure proper dietary adherence. Home health services will be initiated to assist with ongoing assessment and support.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 51  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 51-year-old female with a history of gastro-esophageal reflux disease (GERD) with esophagitis, Barrett's esophagus without dysplasia, and asthma, who presented for surgical intervention related to her GERD. She was admitted for an elective laparoscopic fundoplication to alleviate her symptoms and prevent further esophageal damage.  \\n\\n**Hospital Course:**  \\nThe patient had a successful surgical procedure, specifically a laparoscopic fundoplication (ICD-10: 0DV44ZZ). Post-operatively, she experienced mild pain, which was managed effectively with hydromorphone. She was closely monitored for any complications including respiratory distress due to her asthma history but remained stable throughout her stay.  \\n\\n**Key Findings and Procedures:**  \\nDuring her stay, the patient underwent several assessments, including imaging studies which ruled out any complications such as diaphragmatic hernia. She received a comprehensive treatment plan including intravenous fluids (Lactated Ringers) and medications for her asthma (Albuterol inhaler) and reflux (Famotidine).  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented, with no signs of respiratory distress. She demonstrated the ability to ambulate independently and reported a decrease in reflux symptoms. Given her surgical history and ongoing management of asthma, home health services have been arranged to assist with medication management and respiratory support as needed.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Acetaminophen for pain management, Famotidine for reflux, Albuterol for asthma management, and Fluticasone-Salmeterol Diskus for maintenance of her asthma. She is advised to follow up with her primary care physician in 1 week and her gastroenterologist in 2 weeks for ongoing evaluation of her GERD management. Home health services will begin within 48 hours to provide support and monitor her recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 21  \\n**Gender:** Male  \\n**Admission Type:** Emergency Walk-in  \\n**Length of Stay:** 2.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department following a motor vehicle accident, resulting in multiple facial injuries, including a left facial nerve injury (ICD10: S0452XA). He reported left-sided facial weakness and pain, along with lacerations to the left ear and cheek.  \\n  \\n**Hospital Course:**  \\nUpon admission, the patient was stabilized and assessed. A CT scan confirmed the facial nerve injury, and he was managed with pain control and wound care. He received intravenous fluids and antibiotics (Cefazolin) to prevent infection. The patient was monitored for neurological deficits and showed gradual improvement in pain management with acetaminophen and diazepam for anxiety.  \\n  \\n**Key Findings and Procedures:**  \\nClinical examination revealed left-sided facial droop and tenderness over facial lacerations. Procedures performed included wound care for lacerations of the left ear and cheek, and administration of artificial tears for ocular lubrication. No surgical interventions were required during the hospital stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition with improved facial pain and a care plan for home health services. He retains some weakness on the left side of the face but is able to ambulate independently. Home health services will facilitate ongoing wound care and monitor his recovery, particularly for facial nerve function. The patient will need assistance with daily activities as he continues to heal.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Acetaminophen IV  \\n4. CeFAZolin  \\n5. Diazepam  \\n6. Ondansetron  \\n7. Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nFollow-up appointment in one week with ENT for evaluation of facial nerve recovery. Home health services to be initiated for wound care and monitoring of neurological function. The patient was educated on signs of infection and when to seek immediate medical attention.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID**: [Patient ID]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 58-year-old male who presented to the emergency department with symptoms consistent with an acute duodenal ulcer with hemorrhage. The patient reported severe abdominal pain, melena, and dizziness. He has a history of essential hypertension, hyperlipidemia, and long-term anticoagulant therapy.\\n\\n**Hospital Course:**  \\nUpon admission, the patient was stabilized with IV fluids and blood transfusions due to acute posthemorrhagic anemia. An urgent endoscopy was performed, revealing a bleeding duodenal ulcer, which was treated with cauterization. Throughout his 5-day hospital stay, the patient was monitored for vital signs and laboratory values, which showed improvement. His hemoglobin levels stabilized, and he was started on a regimen of proton pump inhibitors and antibiotic therapy for H. pylori eradication.\\n\\n**Key Findings and Procedures:**  \\n- Primary Diagnosis: Acute duodenal ulcer with hemorrhage (ICD10: K260)  \\n- Secondary Diagnosis: Acute posthemorrhagic anemia (ICD10: D62)  \\n- Procedure: Endoscopic cauterization (ICD10: 0DJ08ZZ)  \\n- Notable lab results: Hemoglobin improved from 7.9 g/dL to 11.5 g/dL by discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulatory, and able to perform daily activities with some assistance. He requires home health services for continued monitoring of his wound and administration of medications, including anticoagulants and proton pump inhibitors. Education on diet modifications and follow-up appointments has been provided.\\n\\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Diltiazem  \\n3. MetFORMIN (Glucophage)  \\n4. Enoxaparin  \\n5. Bismuth Subsalicylate  \\n6. 0.9% Sodium Chloride (for hydration)  \\n7. 5% Dextrose in water (as needed)  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge and will continue home health services for medication management and monitoring of his recovery. He is advised to seek immediate medical attention if he experiences signs of re-bleeding, such as melena or severe abdominal pain.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 49  \\nGender: Female  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 1.7 days  \\n**Primary ICD-10:** R42 (Dizziness and giddiness)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of severe dizziness and giddiness that started abruptly. She reported associated symptoms of palpitations and shortness of breath. The patient's past medical history is significant for hypertensive heart disease with heart failure, chronic systolic heart failure, and asthma, which were managed during her hospital stay.\\n\\n**Hospital Course:**  \\nUpon admission, a comprehensive evaluation was conducted, including ECG, chest X-ray, and laboratory tests. The patient was found to have stable vital signs but exhibited signs of fluid overload consistent with her heart failure diagnosis. She received diuretics and electrolyte management, alongside symptomatic treatment for dizziness. The patient was monitored closely, and her symptoms improved significantly, leading to stabilization. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed mild hyponatremia and elevated B-type natriuretic peptide (BNP), consistent with heart failure exacerbation. A review of her medications prompted the adjustment of her diuretic regimen and the continued use of metoprolol and warfarin. The patient also received respiratory therapy for her asthma management.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved functional status. She is ambulating independently and has a good understanding of her medication regimen. Home health services will be essential for monitoring her heart failure management and ensuring compliance with her follow-up appointments.\\n\\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Albuterol Inhaler  \\n4. Aspirin  \\n5. Bisacodyl  \\n6. Docusate Sodium  \\n7. Fluticasone-Salmeterol Diskus (250/50)  \\n8. Heparin Sodium  \\n9. Metoprolol Tartrate  \\n10. OxyCODONE (Immediate Release)  \\n11. Polyethylene Glycol  \\n12. Ranitidine  \\n13. Senna  \\n14. Sodium Chloride 0.9% Flush  \\n15. Warfarin  \\n\\n**Follow-Up Plan:**  \\nFollow-up with cardiology within one week for heart failure management and anticoagulation therapy monitoring. Home health nursing will be arranged to assist with medication management and assess fluid status.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Admit Date:** [Admit Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Age:** 69  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 69-year-old male admitted for observation due to postprocedural hemorrhage of the digestive system following a recent digestive procedure. He presented with signs of acute posthemorrhagic anemia and required monitoring and supportive care. His past medical history includes essential hypertension, old myocardial infarction, and a malignant neoplasm of the subglottis, contributing to his baseline medical complexity.  \\n  \\n**Hospital Course:**  \\nDuring the 2.4-day hospital stay, the patient was closely monitored for signs of bleeding and anemia. He was stabilized with intravenous fluids, including D5NS and sodium chloride flushes. A heparin flush was administered as per protocol to manage his anticoagulation needs. His hemoglobin levels improved with fluid resuscitation and monitoring. The patient received Sertraline for anxiety management related to his hospitalization.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included an initial drop in hemoglobin due to the hemorrhage, which was treated appropriately. The patient had a stable cardiovascular status throughout his stay, with no episodes of hypotension. He was evaluated by the surgical team, who confirmed no further interventions were needed at this time.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improved hemoglobin levels and is able to ambulate with minimal assistance. He will require home health services to assist with medication management and monitoring for any signs of recurrent bleeding. A follow-up visit with his primary care physician is recommended within one week to reassess his condition.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medications include D5NS, Heparin Flush (10 units/ml), Heparin Flush (100 units/ml), and Sertraline. He is advised to maintain hydration and monitor his blood pressure at home. A follow-up appointment is scheduled for [insert date]. Home health services will monitor ongoing recovery and provide additional support as needed.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 45  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.1 days  \\n**Primary Diagnosis:** Portal hypertension (ICD-10: K766)  \\n\\n**History of Present Illness:**  \\nThe patient presented with worsening abdominal distension and ascites, attributed to portal hypertension. He has a history of malignancies, including a malignant neoplasm of the transverse colon, with secondary liver involvement. The patient also experienced neoplasm-related pain and presented with anemia and gastrointestinal symptoms, including diarrhea.\\n\\n**Hospital Course:**  \\nDuring his 3-day observation stay, the patient received supportive care, including fluid management with 0.9% Sodium Chloride and diuretics (Furosemide). His pain was managed with Morphine Sulfate, and he was treated with Dexamethasone to reduce inflammation. Entecavir was administered as part of the management of his liver condition. The patient also received supportive medications such as Ondansetron for nausea and Omeprazole for gastric protection. \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant portal hypertension and ascitic fluid accumulation. Abdominal imaging suggested secondary malignancies affecting liver function. Laboratory tests revealed mild anemia, which was monitored and managed throughout the stay. The patient's hearing loss was noted but deemed unrelated to acute issues, with no further intervention needed.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs and a decrease in abdominal distension. He is alert and oriented, capable of performing activities of daily living with minimal assistance. Home health services will focus on monitoring his ascites, medication adherence, and continued management of his pain and gastrointestinal symptoms. \\n\\n**Medications at Discharge:**  \\nThe patient will continue the following medications:  \\n- **Dexamethasone**  \\n- **Entecavir**  \\n- **Famotidine**  \\n- **Furosemide**  \\n- **Heparin** (as needed)  \\n- **Morphine Sulfate IR**  \\n- **Omeprazole**  \\n- **Polyethylene Glycol**  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his oncologist and hepatologist within one week. Home health nursing services will initiate on the day following discharge to monitor his condition and ensure medication compliance.\",\n",
       " '**Patient Summary:** 67-year-old female, admitted via emergency department for acute cholecystitis with calculus of the gallbladder without obstruction. \\n\\n**History of Present Illness:** The patient presented with severe right upper quadrant abdominal pain, nausea, and vomiting. She has a history of hypertension, hyperlipidemia, chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and major depressive disorder. She reported increased fatigue and decreased appetite over the past week prior to admission.\\n\\n**Hospital Course:** The patient was stabilized and underwent imaging which confirmed the diagnosis of acute cholecystitis. She was started on IV fluids, antibiotics (Ceftriaxone and Ciprofloxacin), and analgesics. Surgical intervention was considered but deferred due to her comorbidities and overall condition. She was treated with daily assessments and supportive care, including respiratory therapy for COPD management. \\n\\n**Key Findings and Procedures:** During her stay, she was monitored for any signs of complications related to her cholecystitis and pulmonary function. She received a total of 3.6 days of inpatient care and was given anticoagulation therapy with Enoxaparin due to her risk factors for venous thromboembolism. She tolerated her medications well, and her symptoms improved significantly. \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, with improved abdominal pain and resolution of nausea. She is independent in her activities of daily living but requires assistance with mobility due to her COPD and peripheral vascular disease. Home health services will be arranged to assist her with medication management, monitoring her respiratory status, and physical therapy to enhance mobility. \\n\\n**Medications and Follow-up Plan:** At discharge, she will continue on medications including Acetaminophen, Albuterol inhaler, Aspirin, Atorvastatin, Escitalopram, and Losartan. A follow-up appointment with her primary care physician is scheduled in one week to reassess her overall condition and manage her chronic illnesses. Home health nursing will monitor her adherence to the medication regimen and provide education on COPD management.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 26 years old  \\n**Admission Type:** Observation admit  \\n**Length of Stay:** 5.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of acute lower back pain and neurogenic claudication secondary to lumbar spinal stenosis (ICD-10: M48062). He reported exacerbation of symptoms with ambulation and prolonged sitting, which significantly impacted his mobility and quality of life.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored for symptom management and received conservative treatment including pain control and physical therapy. He was started on Gabapentin for neuropathic pain, Hydromorphone for breakthrough pain, and Ketorolac for inflammation. The patient's obesity (BMI 54.0) was addressed, and dietary consultations were provided to initiate weight loss strategies.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies confirmed the diagnosis of lumbar spinal stenosis with significant narrowing of the lumbar canal. A multidisciplinary approach was taken, including a physical therapy evaluation, which facilitated the development of a tailored rehabilitation plan. The patient underwent procedures including lumbar epidural steroid injections (ICD-10: 01NB0ZZ) which provided temporary relief.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved pain management and functional mobility. However, he requires continued assistance with activities of daily living and mobility support due to his morbid obesity and ongoing symptoms. A referral to home health services was made for nursing visits and physical therapy to aid in his recovery and assist with mobility training.  \\n\\n**Medications:**  \\nUpon discharge, the patient was prescribed the following medications: Acetaminophen, Diazepam, Docusate Sodium, Levothyroxine Sodium, Ondansetron, OxyCODONE (Immediate Release), and Gabapentin. He was instructed to follow up with his primary care physician and a pain management specialist within one week to reassess his condition and medication regimen.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for outpatient physical therapy and close monitoring of his weight and metabolic parameters through the home health service, with emphasis on lifestyle modifications and pain management.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 20 years  \\n- **Gender:** Female  \\n\\n**Admission Type:** Emergency Ward  \\n**Length of Stay:** 6.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the emergency ward with significant depressive symptoms, including suicidal ideations, anxiety, and functional impairment. The initial assessment indicated major depressive disorder, single episode, unspecified (ICD-10: F329). The patient also presented with hypotension likely due to prescribed medications and reported an exposure to COVID-19.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent a comprehensive psychiatric evaluation and was stabilized on a regimen including Escitalopram Oxalate and Sertraline for her depressive symptoms, alongside HydrOXYzine for anxiety management. The patient was monitored closely for any side effects related to her medications, particularly hypotension, which was managed with intravenous fluids and medication adjustments.  \\n\\nThe patient's mood improved gradually, and she participated in individual therapy sessions focusing on coping strategies and safety planning regarding her suicidal ideations.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was assessed daily by psychiatry and the primary team, with key findings indicating a reduction in depressive symptoms and suicidal ideation. Vital signs were stabilized, and the patient was cleared for discharge after ensuring no immediate risk for self-harm.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved mood and engagement, with her functional status significantly enhanced. She is advised to follow up with outpatient mental health services for continued support. Home health services will provide assistance with medication management and therapy as she transitions back into her daily routine.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Artificial Tears GEL 1%  \\n3. Escitalopram Oxalate  \\n4. HydrOXYzine  \\n5. Lactaid Fast Act  \\n6. Prazosin  \\n7. Sertraline  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her psychiatrist within one week of discharge and continue home health services for medication adherence and emotional support. Regular check-ins will be scheduled to monitor her progress and adjust her treatment plan as necessary.\",\n",
       " 'Patient is a 49-year-old female who was admitted for surgical intervention due to an intramural leiomyoma of the uterus, coded as D251. The patient underwent a total abdominal hysterectomy with salpingo-oophorectomy on admission day. Her preoperative course was complicated by acute posthemorrhagic anemia (D62), requiring transfusion of packed red blood cells. Post-surgical recovery was uneventful with monitoring for acute kidney failure (N179), which resolved during the stay. The patient also presented with morbid obesity (E6601) and hypertension (I10), both of which were managed during the hospitalization.\\n\\nDuring her 5.7-day hospitalization, the patient received pain management with hydromorphone and oxycodone, as well as adjunctive medications including gabapentin for neuropathic pain, and famotidine for gastric protection. She was also prescribed calcium carbonate and polyethylene glycol for constipation management, alongside diphenhydramine and a lidocaine patch for symptom relief.\\n\\nKey findings included resolution of anemia and stabilization of vital signs, with improvement in functional mobility. By discharge, the patient was ambulating independently and demonstrated the ability to perform activities of daily living with minimal assistance. She is stable for discharge, but due to her recent surgery and obesity, she will benefit from home health services for ongoing monitoring and assistance with mobility and medication management.\\n\\nDischarge medications include acetaminophen, ibuprofen, and ketorolac for pain control, along with heparin for anticoagulation, and laxatives as needed. The patient is advised to follow up with her primary care physician and a gynecologist within two weeks for postoperative evaluation, and a home health nurse will visit to assist with wound care and ensure adherence to the medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 28  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is a 28-year-old female with a history of Type 1 diabetes mellitus complicated by diabetic autonomic neuropathy, nephropathy, and stage 5 chronic kidney disease. She presented with symptomatic hyperglycemia and acute kidney injury, likely exacerbated by her diabetic condition and medication regimen.  \\n\\n**Hospital Course:**  \\nDuring her 4-day stay, the patient was monitored closely for glycemic control and renal function. Insulin therapy was adjusted frequently due to fluctuating blood glucose levels. She received intravenous fluids, including 0.9% Sodium Chloride and D5 1/2NS, to maintain hydration and electrolyte balance. The patient was also managed for nausea with ondansetron and received magnesium sulfate for hypomagnesemia.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory results indicated elevated blood glucose levels and deteriorating renal function, necessitating continuous insulin infusion and careful monitoring of electrolytes. The patient underwent a renal ultrasound to evaluate her kidney status, which revealed changes consistent with her chronic kidney disease. She was assessed by the endocrinology team and received education on diabetes management, including the use of her insulin pump.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with blood glucose levels within target range. She demonstrates a good understanding of her condition and self-management techniques. However, she requires home health services for ongoing monitoring of her renal function and diabetes management. The patient will benefit from nutritional counseling and assistance with medication management to prevent future complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include insulin therapy, losartan potassium, and magnesium sulfate, along with supportive medications such as glucagon and glucose gel. The patient is scheduled for a follow-up appointment with her endocrinologist in one week and will be monitored by home health services for blood glucose and renal function assessments. The plan includes ongoing education on diet and lifestyle modifications to improve her overall health.',\n",
       " 'Patient is a 62-year-old female admitted under observation for COVID-19 (ICD-10 U071) with subsequent complications including pneumonia due to coronavirus (ICD-10 J1282), acute kidney failure (ICD-10 N179), and chronic obstructive pulmonary disease (ICD-10 J440). The patient presented with cough, dyspnea, and fever, necessitating supplemental oxygen therapy and monitoring of vital signs.\\n\\nDuring her 9.9-day hospital stay, the patient was treated with remdesivir and supportive care, including hydration with 0.9% Sodium Chloride and symptom management with acetaminophen, bronchodilators (Albuterol), and cough suppressants (Benzonatate). She was also on prophylactic enoxaparin to prevent potential thromboembolic events given her prolonged hospitalization. Notably, she had episodes of tachycardia (ICD-10 R000) and was treated with diltiazem extended-release for rate control.\\n\\nKey findings included significant improvement in respiratory function, with stable oxygen saturation levels on room air at discharge. Laboratory results showed resolution of acute kidney injury, and her electrolytes were within normal limits post-management. The patient demonstrated the ability to perform activities of daily living with moderate assistance and was able to ambulate with a walker.\\n\\nAt the time of discharge, the patient was stable and ready for home health services. She will require ongoing monitoring of her respiratory status and kidney function at home. The following medications were prescribed for continuation: Albuterol inhaler, Fluticasone Propionate nasal spray, Gabapentin, Magnesium Oxide, and Loratadine for symptomatic relief. Follow-up appointments are recommended within one week post-discharge with her primary care physician and pulmonologist to monitor her recovery and adjust her medications as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 32 years  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 13.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of alcohol dependence with withdrawal symptoms, presenting with agitation, tremors, and sweating. He also exhibited signs of respiratory failure due to aspiration pneumonia, resulting in hypoxia. During his stay, he was further found to have urinary tract infection and toxic encephalopathy. \\n\\n**Hospital Course:**  \\nThe patient was initiated on a detoxification protocol and supportive care, including intravenous fluids and nutritional support. He received comprehensive psychiatric evaluation and management for his alcohol dependence. His respiratory status improved with supplemental oxygen and appropriate antibiotics for the pneumonia. In addition, he was treated for his urinary tract infection with Amoxicillin-Clavulanic Acid and received Doxycycline for concurrent infections. \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent monitoring for withdrawal symptoms and was stabilized. Key investigations revealed portal hypertension and electrolyte imbalances, which were corrected during hospitalization. He was managed with Furosemide for fluid overload and provided with Gabapentin for neuropathic pain. He received physical therapy to improve mobility due to weakness from prolonged bed rest.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with significant improvement in his respiratory function and mental status. He demonstrates adequate mobility to perform activities of daily living with minimal assistance. He requires home health services for continued monitoring of his alcohol withdrawal symptoms, medication management, and physical therapy to enhance strength and mobility.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Albuterol Inhaler, Furosemide, Dextrose 50%, Gabapentin, and Fluticasone-Salmeterol Diskus. He is advised to follow up with his primary care physician and addiction specialist within one week after discharge. Home health services will be arranged to facilitate medication management and ongoing support for his recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 84 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with severe fluid overload, presenting with dyspnea and hypoxia. She has a complex medical history including end-stage renal disease and multiple comorbidities, which contributed to her acute respiratory failure and metabolic encephalopathy during hospitalization.  \\n\\n**Hospital Course:**  \\nDuring her 3-day stay, the patient was managed with diuretics, supportive care for respiratory distress, and monitoring for renal function. She required supplemental oxygen due to acute pulmonary edema and was closely monitored for changes in mental status. Her hospital course was complicated by episodes of confusion likely related to her metabolic state, but she gradually stabilized with appropriate interventions.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant fluid overload, evidenced by pulmonary congestion on imaging. The patient was treated with intravenous diuretics and her renal function was monitored closely, revealing an acute worsening of her chronic kidney disease. A blood transfusion was also administered for warm autoimmune hemolytic anemia.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with activities of daily living due to her ongoing weakness and cognitive impairment. Home health services are recommended to assist with rehabilitation, medication management, and monitoring of her fluid status. She will need a caregiver present at home to ensure safety and compliance with her discharge plan.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on Acetaminophen, Atorvastatin, Calcium Carbonate, Clopidogrel, Dextrose 50%, Epoetin alfa-epbx (Retacrit), HydrALAZINE, Insulin, Labetalol, Losartan Potassium, and Omeprazole among others. A follow-up appointment is scheduled with her nephrologist and primary care physician within one week of discharge to reassess her renal function and overall health status.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 89-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the hospital with symptoms consistent with syncope and intermittent dizziness. Upon admission, he was found to have a second-degree atrioventricular (AV) block (ICD-10 I441), which was likely contributing to his symptoms. His medical history is significant for Type 2 diabetes mellitus, atherosclerotic heart disease, and prior aortocoronary bypass grafting.  \\n  \\n**Hospital Course:**  \\nDuring his observation period, the patient underwent continuous cardiac monitoring which confirmed the presence of second-degree AV block. He was treated supportively, and his medication regimen was adjusted to manage his hypotension and cardiovascular status. He received IV fluids for hypovolemia, and his diabetes was managed with insulin. The patient's condition improved, and he was stable by the time of discharge.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent second-degree AV block on telemetry and mild hypotension. The patient received several interventions, including administration of IV fluids, adjustment of antihypertensive medications (Losartan and Metoprolol), and heparin for thromboprophylaxis. He also received vaccinations for influenza and pneumococcus prior to discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was hemodynamically stable with a heart rate of 60 bpm and a blood pressure of 110/70 mmHg. He was able to perform activities of daily living with minimal assistance and was oriented to person, place, and time. Given his age and recent cardiovascular events, home health services are recommended for ongoing monitoring and support with medication management and diabetes care.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Atorvastatin, Docusate Sodium, Finasteride, Insulin, Metoprolol Succinate XL, and Losartan. He is advised to follow up with his primary care physician within one week and to monitor blood glucose levels regularly. Home health services will be arranged for assistance with medication adherence and diabetes management.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 63 years  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 4.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention related to atherosclerotic heart disease of the native coronary artery, specifically without angina pectoris. His past medical history includes hypothyroidism, hyperlipidemia, and a diagnosis of unilateral primary osteoarthritis of the right hip. The patient has a significant family history of ischemic heart disease.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent multiple procedures, including coronary interventions as indicated by ICD-10 codes 02100Z9 and 021009W. He received comprehensive care, including pain management with hydromorphone and postoperative monitoring. The patient demonstrated stable vitals throughout his stay, with no signs of complications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable cardiac function post-surgery. The patient received appropriate medications including acetaminophen, atorvastatin, furosemide, and levothyroxine sodium. Laboratory results indicated controlled thyroid function and improved lipid profiles.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with minimal assistance required for activities of daily living. He will benefit from home health services for continued monitoring of his cardiac status and assistance with medication management. A follow-up assessment is essential to ensure adherence to lifestyle modifications and medication compliance.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed acetaminophen, aspirin EC, atorvastatin, furosemide, and levothyroxine sodium, among others.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week post-discharge for routine evaluation and medication adjustments as needed. Home health services will initiate within 48 hours of discharge to facilitate ongoing care and support.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 72 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.4 days  \\n**Primary Diagnosis:** Leiomyoma of uterus, unspecified (ICD10: D259)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted to the hospital for evaluation of symptomatic uterine leiomyoma presenting with menorrhagia and pelvic discomfort. She has a past medical history notable for essential hypertension, age-related osteoporosis, and a personal history of nicotine dependence. During admission, she also experienced episodes of urinary retention, which were managed conservatively.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a comprehensive workup, including ultrasound imaging, confirming the presence of the leiomyoma. She received supportive care with hydration and pain management, including intravenous administration of ketorolac and opioids for pain control. Additionally, she was started on bisacodyl and docusate sodium to manage constipation secondary to opioid use.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated improvement in her symptoms with conservative management. Key procedures performed include intravenous hydration and medication adjustments for pain and urinary retention. No surgical intervention was necessary at this time.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was stable at discharge, ambulating independently with a steady gait. She reported moderate pain relief and improved urinary frequency. Given her age and medical history, home health services are recommended to assist with medication management, monitor her pain levels, and ensure safety in her home environment.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient will continue on:  \\n- Acetaminophen  \\n- HYDROcodone-Acetaminophen  \\n- Enoxaparin Sodium  \\n- Escitalopram Oxalate  \\n- Lisinopril  \\n- Ibuprofen  \\nShe is advised to follow up with her primary care physician within one week and to contact home health services for any concerns regarding her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 66  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening shortness of breath and fatigue over the past week. He has a known history of atherosclerotic heart disease, congestive heart failure, and diabetes with chronic kidney disease. The patient reported no chest pain or syncope during this period.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent a thorough cardiac evaluation, including echocardiogram and laboratory tests. His vital signs were monitored closely, and he was treated with diuretics for fluid overload and adjusted heart failure medications. He received education on dietary modifications and the importance of medication adherence.  \\n\\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** I2510 (Atherosclerotic heart disease), I5022 (Chronic systolic heart failure), E1122 (Diabetes with chronic kidney disease), among others.  \\n- **Procedures:** The patient received intravenous furosemide for diuresis and was stabilized with optimal medical therapy, including adjustment of his home medications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms of dyspnea and functional status. He is ambulating independently and demonstrates an understanding of his medication regimen. Home health services will be initiated for further monitoring of heart failure management and assistance with activities of daily living as needed.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Apixaban  \\n- Aspirin  \\n- Atorvastatin  \\n- Furosemide  \\n- Metoprolol Succinate XL  \\n- Sacubitril-Valsartan  \\n- Hydrochlorothiazide  \\n- Potassium Chloride  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician and cardiology within one week post-discharge. Home health services will coordinate care and ensure compliance with medication and dietary recommendations.',\n",
       " '**Patient Name:** [Name]\\n**Date of Admission:** [Date]\\n**Date of Discharge:** [Date]\\n\\n**History of Present Illness:**  \\nThe patient is a 55-year-old female who presented to the emergency department with acute hematemesis. She has a history of portal hypertension due to alcoholic cirrhosis, which has led to the development of gastric varices. Over the course of her hospitalization, she was treated for acute posthemorrhagic anemia and monitored closely for signs of rebleeding.\\n\\n**Hospital Course:**  \\nThe patient was admitted for a total of 13.8 days and underwent several diagnostic and therapeutic procedures, including endoscopy, which revealed bleeding varices. She received intravenous fluids, blood transfusions, and was stabilized with medical management, including Nadolol for portal hypertension and Lactulose for hepatic encephalopathy. She responded well to treatment and showed improvement in her hemoglobin levels. \\n\\n**Key Findings and Procedures:**  \\nDuring her hospital stay, the patient was found to have gastric varices (ICD10 I864) with associated acute posthemorrhagic anemia (ICD10 D62). Procedures performed included endoscopic variceal ligation and intravenous medication management for her liver condition. She also received prophylaxis with Enoxaparin and was closely monitored for respiratory complications, including atelectasis (ICD10 J9811).\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable with a hemoglobin level back to baseline and has no active bleeding. She is ambulating independently and has demonstrated the ability to perform activities of daily living with minimal assistance. However, she will require home health services for ongoing monitoring of her liver function and assistance in medication management, particularly for her anticoagulation therapy and nutritional support.\\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Albuterol Inhaler, Benzonatate, Enoxaparin, Lactulose, Levothyroxine Sodium, Magnesium Oxide, Nadolol, and OxyCODONE. \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the gastroenterology clinic within one week of discharge. Home health services will initiate a visit shortly after discharge for medication education and monitoring of her overall condition.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Patient Name:** [Patient Name]  \\n**Age:** 42  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 42-year-old female admitted for observation due to drug-induced constipation (ICD10: K5903) likely secondary to opioid use. The patient reported significant abdominal discomfort, infrequent bowel movements, and associated nausea. She has a history of opioid dependence and has been on methadone, which contributed to her symptoms.\\n\\n**Hospital Course:**  \\nDuring her 2.5-day hospital stay, the patient was managed with bowel regimen protocols including bisacodyl and lactulose. She received supportive care with IV fluids (Dextrose 50% and Iso-Osmotic Sodium Chloride) for hydration. The patient underwent abdominal imaging that ruled out other complications such as obstruction. Pain management was achieved using Hydromorphone and Ketorolac, and she was monitored closely for signs of opioid withdrawal, which remained stable.\\n\\n**Key Findings and Procedures:**  \\nKey findings included mild abdominal distension and tenderness but no acute abdomen on imaging. Laboratory evaluations indicated slight hyponatremia, which was corrected during the admission. No surgical interventions were necessary, and the patient was stable for discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved bowel function and reports of less abdominal discomfort. She is able to perform activities of daily living with minimal assistance. Home health services have been arranged to assist with medication management and monitoring of bowel habits, given her history of opioid use and potential for recurrence of constipation.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. Lactulose  \\n4. Docusate Sodium  \\n5. Enoxaparin Sodium  \\n6. Methadone  \\n7. Insulin (as per previous regimen)  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week. Home health will monitor her bowel regimen and overall health status, ensuring proper adherence to the medication plan and addressing any concerns with opioid management.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 76  \\nGender: Male  \\nAdmission Type: Emergency (EW EMER)  \\nLength of Stay: 8.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with complaints of abdominal pain and distension, subsequently diagnosed with an intestinal obstruction (ICD10: K5669). He has a history of secondary malignant neoplasms and hypertension, which complicated his clinical presentation.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care including intravenous fluids, pain management, and bowel regimen. Surgical intervention was considered but ultimately not required as the obstruction resolved with conservative measures. His pain was managed effectively with hydromorphone and a fentanyl patch, and he received adjunctive therapy with bisacodyl and lactulose for bowel regularity. Enoxaparin was administered for thromboembolism prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included improvement in abdominal symptoms and normalization of bowel function. The patient underwent imaging studies that confirmed resolution of the obstruction. He was monitored for any signs of complications related to his malignancy, but no acute issues were identified.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved functional status. He is able to ambulate with assistance and has a safe discharge plan in place. He will benefit from home health services for continued monitoring of his abdominal status, medication administration, and assistance with activities of daily living.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Bisacodyl, Dextrose 50%, Docusate Sodium, Enoxaparin Sodium, Fentanyl Patch, Hydromorphone, Hydrocortisone, Ipratropium-Albuterol Inhalation Spray, Lorazepam, Lactulose, Levothyroxine Sodium, Lidocaine 5% Patch, Methylnaltrexone, and Ondansetron.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week. Home health services will be initiated to support his ongoing recovery and management of medications.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nMr. [Patient's Name], a 75-year-old male, was admitted under observation for management of hypo-osmolality and hyponatremia (ICD-10: E871). He presented with symptoms of confusion, fatigue, and mild edema. His medical history includes unspecified severe protein-calorie malnutrition (E43) and chronic conditions including malignancies and thromboses.  \\n  \\n**Hospital Course:**  \\nDuring his 9-day stay, Mr. [Patient's Name] was closely monitored for electrolyte levels and hydration status. Initial laboratory tests confirmed significant hyponatremia, which required intravenous sodium chloride (0.9% saline) administration and careful fluid management. He received nutritional support and was evaluated by a dietitian, addressing his malnutrition status and dietary needs. Pain management was also addressed with medications including Oxycodone and Tramadol for pain control.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent hypo-osmolality and improvement in sodium levels by the time of discharge. A review of his imaging studies indicated no acute changes, and he was free of complications related to his chronic conditions. The patient was educated on the importance of fluid intake and dietary modifications to prevent future episodes.  \\n  \\n**Discharge Condition and Functional Status:**  \\nMr. [Patient's Name] is stable at discharge, alert, and oriented, though still exhibiting mild weakness. He requires home health services for continued monitoring of his electrolyte levels, dietary management, and assistance with daily activities due to residual weakness.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Bisacodyl, Enoxaparin Sodium, Magnesium Citrate, Mirtazapine, Multivitamins, Oxycodone, Polyethylene Glycol, Senna, and Tramadol. Follow-up with his primary care physician is advised within one week to reassess his condition and ensure adequate management of his nutritional needs and electrolyte levels.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 50  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with acute chest pain and shortness of breath. He has a significant history of coronary artery disease, including prior stenting. Upon evaluation, he was diagnosed with stenosis of a coronary artery stent, which was confirmed via angiography.  \\n  \\n**Hospital Course:**  \\nDuring his 10-day hospital stay, the patient was managed with a combination of medical therapy and interventional procedures. He underwent a successful angioplasty and stent placement to address the stenosis. His initial symptoms of chest pain and dyspnea improved significantly post-procedure. The patient was monitored closely for any complications, which included intermittent episodes of hypertension and fluid overload, likely due to his underlying heart failure.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated BNP levels and echocardiographic evidence of reduced ejection fraction. He was treated with diuretics and heart failure medications. Procedures performed included angioplasty with stenting (ICD-10: 027034Z) and monitoring for arrhythmias.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with significant improvement in symptoms. He is ambulating independently and is able to perform activities of daily living with minimal assistance. Home health services will be necessary for medication management and monitoring of his heart failure status, as well as assistance with mobility during his recovery period.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on an extensive medication regimen including acetaminophen, atorvastatin, clopidogrel, lisinopril, and furosemide, among others.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with cardiology in one week to assess heart function and medication tolerance. Home health services will initiate within 48 hours post-discharge to provide support and monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 83 years  \\nGender: Male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 6 days  \\n**Primary Diagnosis:** Sepsis, unspecified organism (ICD10: A419)  \\n  \\n**Brief History of Present Illness:**  \\nThe patient was admitted for evaluation of suspected sepsis. He presented with fever, chills, and altered mental status. Initial lab work revealed elevated white blood cell count and positive blood cultures.  \\n  \\n**Hospital Course:**  \\nThe patient was started on broad-spectrum antibiotics, including Ceftriaxone and Metronidazole. He was closely monitored in the observation unit. During his stay, he developed acute respiratory failure secondary to atelectasis, requiring supplemental oxygen. A liver abscess was identified via imaging, and he underwent percutaneous drainage.  \\n  \\n**Key Findings and Procedures:**  \\n- Elevated WBC count and positive blood cultures confirmed sepsis.  \\n- Imaging confirmed an abscess in the liver.  \\n- Procedures included percutaneous drainage of the liver abscess and management of respiratory failure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge and has shown improvement in mental status and vital signs. However, he requires continued support due to residual weakness and fatigue post-hospitalization. Home health services will assist with monitoring his vital signs, medication management, and provide physical therapy to aid in his recovery.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Aspirin  \\n4. Ceftriaxone  \\n5. Chloraseptic Throat Spray  \\n6. Cyanocobalamin  \\n7. Docusate Sodium  \\n8. Fluticasone Propionate 110mcg  \\n9. Levothyroxine Sodium  \\n10. MetroNIDAZOLE  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge and will continue with home health services for monitoring and rehabilitation. Close observation for any signs of infection or respiratory distress is advised.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 75  \\n**Gender:** Male  \\n\\n**Brief History of Present Illness:**  \\nThe patient is a 75-year-old male with a diagnosis of malignant neoplasm of the middle lobe of the bronchus, who was admitted for surgical resection. He has a history of hyperlipidemia, benign prostatic hyperplasia, and atherosclerotic heart disease. The patient presented with worsening respiratory symptoms and was subsequently scheduled for a lobectomy.  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful lobectomy with no intraoperative complications. Postoperatively, he was transferred to the surgical recovery unit where he was closely monitored. His vital signs remained stable, and he was weaned off supplemental oxygen within 24 hours. Pain management was initiated with hydromorphone and oxycodone, and he received supportive care including intravenous fluids and antiemetics.  \\n\\n**Key Findings and Procedures:**  \\nPostoperative imaging confirmed satisfactory resection of the tumor with no evidence of immediate complications. Laboratory tests showed mild electrolyte imbalances which were corrected with magnesium sulfate and lactated Ringer’s solution. The patient was mobilized early with physical therapy support, achieving ambulation to the chair without assistance by day two.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, able to ambulate independently with minimal assistance. He is oriented and able to participate in his care. Due to his surgical history, he will require home health services for ongoing support with medication management and monitoring of respiratory status, as well as physical therapy for mobility exercises.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed acetaminophen, albuterol nebulizer solution, atenolol, atorvastatin, bisacodyl, docusate sodium, and ondansetron. He is instructed to follow up with his oncologist and primary care physician within one week. Home health services will initiate within 48 hours of discharge to assist with medication adherence and postoperative care.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 56 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3 days  \\n**Primary Diagnosis:** Unspecified atrial fibrillation (I4891)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of palpitations and dyspnea on exertion, consistent with atrial fibrillation. His medical history is significant for dilated cardiomyopathy, congestive heart failure, and a long-term anticoagulant regimen. Initial evaluation revealed an irregularly irregular heartbeat and elevated BNP levels, indicating decompensated heart failure.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was initiated on amiodarone for rate control and was closely monitored. He was started on furosemide for volume overload and managed with anticoagulation therapy using apixaban. The patient also received symptomatic treatment with acetaminophen and lorazepam for anxiety. The cardiology team was consulted, and an echocardiogram confirmed reduced ejection fraction consistent with his cardiomyopathy.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated improvement in symptoms with diuresis, and his heart rate was stabilized with amiodarone. He underwent a procedure coded 5A2204Z, which likely relates to catheter management related to anticoagulation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. He will require home health services for ongoing monitoring and management of his anticoagulant therapy, as well as physical therapy to improve functional capacity post-heart failure exacerbation.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include amiodarone, apixaban, furosemide, digoxin, lisinopril, and aspirin, among others. The patient was advised to follow up with his cardiologist within one week of discharge and to maintain regular home health visits to monitor his clinical status. It is imperative that he continues to monitor his weight daily and report any signs of fluid retention or worsening symptoms immediately.',\n",
       " '**Discharge Summary**\\n\\n**Patient Information:** 40-year-old female, admitted through emergency with acute abdominal pain. \\n\\n**History of Present Illness:** The patient presented with severe right upper quadrant pain, nausea, and vomiting, which began approximately 24 hours prior to admission. A history of obesity and obstructive sleep apnea was noted. She has no previous surgeries and has been experiencing similar but less severe episodes intermittently.\\n\\n**Hospital Course:** During her 3.8-day stay, the patient underwent an abdominal ultrasound revealing gallstones consistent with calculus of the gallbladder and signs of acute cholecystitis without obstruction (ICD10: K8012). After thorough evaluation, she was started on intravenous fluids, pain management with hydromorphone, and antibiotics (ampicillin-sulbactam). She was also initiated on medications to manage her hypertension and anxiety. Her clinical status improved significantly, with resolution of fever and abdominal tenderness, allowing for discharge.\\n\\n**Key Findings and Procedures:** The patient’s laboratory tests showed elevated white blood cell count, suggestive of inflammation. No acute surgical intervention was necessary as her condition stabilized with medical management. The patient was educated on dietary modifications to avoid fatty foods that may exacerbate gallbladder symptoms.\\n\\n**Discharge Condition and Functional Status:** The patient is clinically stable at discharge with ongoing mild abdominal discomfort but can perform activities of daily living independently. She requires home health services for medication management and monitoring of her blood pressure and potential dietary guidance. She has been advised to schedule a follow-up appointment with her primary care provider within one week and to seek care if her symptoms worsen.\\n\\n**Medications and Follow-Up Plan:** At discharge, the patient’s regimen includes 0.9% Sodium Chloride, Acetaminophen, Clonazepam, Metoprolol Tartrate, Nifedipine, Ondansetron, and Oxycodone as needed. Additionally, she has been prescribed Docusate Sodium to prevent constipation. Home health services will assist with medication management and monitoring her condition post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 63  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 4.6 days  \\n**Primary Diagnosis:** Malignant neoplasm of rectum (ICD-10: C20)  \\n\\n**Brief History of Present Illness:**  \\nThe patient, a 63-year-old male, was admitted for surgical intervention due to a diagnosis of malignant neoplasm of the rectum. He has a history of chronic viral hepatitis C, anxiety disorder, and nicotine dependence. The patient presented with rectal bleeding and weight loss, prompting further investigation and subsequent surgical management.  \\n\\n**Hospital Course:**  \\nDuring his 4.6-day hospitalization, the patient underwent a total abdominal colectomy and anastomosis (ICD-10: 0DTP4ZZ) along with additional procedures including a laparoscopic exploration (ICD-10: 0DBN4ZZ). Postoperatively, he was monitored for complications and managed for pain control, which included the administration of morphine sulfate and oxycodone. His recovery progressed well, and he was able to tolerate oral intake with good bowel function.  \\n\\n**Key Findings and Procedures:**  \\nThe surgical site showed no signs of infection, and the patient was afebrile. Pathology confirmed the diagnosis of malignant neoplasm. The patient participated in physical therapy and demonstrated improved mobility, ambulating independently by discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with no acute distress. He demonstrates adequate functional status for home health services, requiring assistance with daily activities due to postoperative weakness. He will benefit from physical therapy to aid in his recovery and regain strength.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Enoxaparin Sodium, Ibuprofen, Ketorolac, Morphine Sulfate, and Oxycodone (Immediate Release). He is advised to follow up with his oncologist in one week and to continue with home health services to facilitate recovery and monitor for any complications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 62  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 7.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute decompensation of alcoholic cirrhosis, presenting with ascites, jaundice, and signs of respiratory distress due to pneumonia. Initial laboratory findings revealed elevated liver enzymes and significant leukocytosis. Patient's history is notable for chronic alcohol use and previous episodes of hepatic decompensation.  \\n  \\n**Hospital Course:**  \\nDuring hospitalization, the patient received intravenous cefTAZidime for pneumonia management and was started on diuretics (furosemide and spironolactone) to manage ascites. Serial abdominal ultrasounds confirmed the presence of large volume ascites. The patient underwent paracentesis, providing symptomatic relief. His respiratory status improved significantly on supplemental oxygen therapy, and he was weaned off as he stabilized.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant ascites and pneumonia, resolved with appropriate antimicrobial therapy. The patient tolerated a paracentesis well, which provided significant relief from discomfort. Liver function tests showed gradual improvement, although he remains at risk for further complications due to underlying liver disease.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with a marked improvement in respiratory status and reduction in abdominal discomfort. He is able to perform activities of daily living with assistance and will require home health services for ongoing monitoring of liver function, medication management, and support for mobility as he continues to recover.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, CefTAZidime, Furosemide, Spironolactone, Metoprolol Succinate XL, and Gabapentin among others. The patient is advised to follow up with hepatology within one week of discharge and to have regular home health visits to monitor his condition and adjust medications as needed. Education on alcohol cessation and dietary modifications was provided to the patient and family.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 88  \\n- **Gender:** Male  \\n  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute respiratory failure and hypoxia (ICD-10: J9601). Upon admission, he reported increased shortness of breath and fatigue over the past few days. He has a history of heart failure, chronic obstructive pulmonary disease (COPD), and chronic kidney disease, which contributed to his acute presentation.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient was stabilized with supplemental oxygen and bronchodilator therapy. He received intravenous antibiotics (Azithromycin) due to suspected pneumonia, and his heart failure was managed with diuretics and CARVedilol. The patient was monitored closely for respiratory status and fluid balance.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included an elevated BNP indicating heart failure exacerbation, and chest imaging confirmed bilateral infiltrates consistent with pneumonia. The patient underwent a thorough cardiac evaluation, including echocardiography, which demonstrated preserved ejection fraction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated significant improvement in respiratory function, with oxygen saturation maintained above 92% on room air. He is stable but requires ongoing monitoring and support for his chronic conditions. The patient is ambulatory with assistance and has been advised to engage in light activities. Home health services will be crucial for medication management, respiratory therapy, and monitoring vital signs.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Azithromycin  \\n- CARVedilol  \\n- Cilostazol  \\n- Insulin (as per sliding scale)  \\n- Pravastatin  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week post-discharge to reassess his respiratory status and review medication adherence. Home health services will initiate visits to monitor his condition and adjust treatments as necessary.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Identification:** 55-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with episodes of palpitations and dizziness, which were concerning for arrhythmia. After thorough evaluation, he was diagnosed with ventricular tachycardia (ICD-10: I472). The patient has a significant medical history including atherosclerotic heart disease (I2510), old myocardial infarction (Z951), essential hypertension (I10), and hyperlipidemia (E785).  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was observed and monitored for cardiac rhythm abnormalities. Continuous telemetry showed intermittent episodes of ventricular tachycardia. The patient was treated with Metoprolol Succinate XL to manage his heart rate and rhythm. A comprehensive cardiac evaluation was conducted, including echocardiography, which revealed preserved ejection fraction. The patient was also treated for symptomatic relief with acetaminophen for mild discomfort.  \\n  \\n**Key Findings and Procedures:**  \\nDuring the hospital course, key findings included stable vital signs post-medication adjustment, with no further recurrence of tachyarrhythmias during the last 24 hours of monitoring. The patient received an influenza vaccine and was educated on lifestyle modifications to manage his cardiovascular health.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is clinically stable at discharge. He is ambulating independently and has demonstrated the ability to perform activities of daily living. He will benefit from home health services for medication management, continued monitoring of vital signs, and cardiac rehabilitation to improve functional capacity.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Influenza Vaccine Quadrivalent  \\n4. Metoprolol Succinate XL  \\n5. Polyethylene Glycol  \\n6. Potassium Chloride  \\n7. Ramelteon  \\n8. Rosuvastatin Calcium  \\n9. Senna  \\n10. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge and to adhere to the prescribed medication regimen. Home health services will facilitate medication reconciliation and assessment of his cardiac status.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 68 years old  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a chronic gastric ulcer with hemorrhage (ICD10: K254). He reported a history of intermittent abdominal pain, hematemesis, and melena over the past month. The patient has a significant medical history, including congestive heart failure, chronic kidney disease, and paroxysmal atrial fibrillation. He was also noted to have a recent exacerbation of obstructive sleep apnea.\\n\\n**Hospital Course:**  \\nDuring a 13-day stay, the patient underwent multiple diagnostic tests, including upper endoscopy, which revealed a bleeding gastric ulcer. He was treated with intravenous proton pump inhibitors, supportive care, and close monitoring of hemodynamic status. The patient was initiated on Apixaban for anticoagulation management due to atrial fibrillation, with careful consideration of his bleeding risk. The multidisciplinary team collaborated to manage his comorbidities, including optimizing heart failure medications and adjusting fluid management given his chronic kidney disease. \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable hemoglobin levels after initial transfusions, resolution of symptoms related to hemoptysis, and improvement in overall gastrointestinal status. Procedures performed included upper endoscopy (008Q4ZZ) and fluid management protocols to address his heart failure exacerbation.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, ambulating independently with assistance as needed. He will require home health services to monitor medication adherence, manage anticoagulation therapy, and provide support for dietary adjustments related to his gastric ulcer. The patient expressed understanding of his medication regimen and dietary restrictions, with a family member present for support.\\n\\n**Medications at Discharge:**  \\n1. Apixaban  \\n2. Lansoprazole Oral Disintegrating Tab  \\n3. Metoprolol Tartrate  \\n4. Gabapentin  \\n5. OxyCODONE (Immediate Release)  \\n6. Multivitamins W/minerals  \\n7. Neutra-Phos  \\n8. Cyanocobalamin  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and maintain regular appointments with a gastroenterologist and cardiologist to monitor his conditions. Home health nursing will be arranged to assist with medication management and ongoing assessment.',\n",
       " '**Patient Information:**  \\nAge: 35, Gender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted directly through the emergency department with complaints of hematemesis. The onset was sudden, with no preceding symptoms. She has a history of liver cirrhosis and portal hypertension, contributing factors to her presentation. \\n\\n**Hospital Course:**  \\nDuring her short stay of 19 hours, the patient underwent a thorough evaluation. Initial laboratory tests revealed iron deficiency anemia and signs of portal hypertension, consistent with her existing liver disease. She received supportive care, including intravenous fluids (0.9% Sodium Chloride) and medications to manage her symptoms. A gastroscopy was performed, confirming the diagnosis of esophageal varices without bleeding. Propranolol was initiated for variceal bleeding prophylaxis. \\n\\n**Key Findings and Procedures:**  \\n- Hematemesis confirmed via history and gastroscopy.  \\n- Portal hypertension and liver cirrhosis noted.  \\n- Initiation of Propranolol for prophylaxis against variceal bleeding.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with no further episodes of hematemesis. She is alert, coherent, and able to perform activities of daily living independently. However, she requires assistance with medication management and monitoring for potential complications related to her liver disease. Home health services are recommended to provide ongoing monitoring and support.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- CefTRIAXone  \\n- Esomeprazole sodium  \\n- Folic Acid  \\n- Octreotide Acetate  \\n- Ondansetron  \\n- Propranolol  \\nAll medications should be continued as prescribed, and the patient is advised to follow up with her primary care physician in one week or sooner if any concerning symptoms arise. Home health services will assist in medication compliance and monitoring for any recurrences of hematemesis or other complications.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 75  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n  \\n**History of Present Illness:**  \\nThe patient is a 75-year-old male with a known history of abdominal aortic aneurysm (AAA) who was admitted for observation due to concerns of possible aneurysm expansion. He presented with mild abdominal discomfort and was found to have stable vitals upon admission.  \\n  \\n**Hospital Course:**  \\nDuring his 8-day stay, the patient underwent continuous monitoring and imaging studies, which confirmed the AAA was stable without rupture. He developed acute pulmonary edema and acute postprocedural respiratory failure, which were managed effectively with diuretics and oxygen therapy. The patient also experienced acute kidney failure, attributed to dehydration, resolving with intravenous fluids.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies revealed an abdominal aortic aneurysm measuring [size], with no signs of rupture. The patient received diuresis for fluid overload, and his respiratory status improved with bronchodilator therapy. Routine labs showed improvements in renal function following hydration.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved respiratory function and renal parameters. He is able to perform activities of daily living (ADLs) and ambulate with minimal assistance. Home health services will be initiated to assist with continued monitoring of his vital signs, medication management, and rehabilitation exercises, particularly focusing on respiratory therapy.  \\n  \\n**Medications:**  \\nAt discharge, the patient is prescribed Acetaminophen, Albuterol Inhaler, Amiodarone, Apixaban, Aspirin EC, Atorvastatin, Bisacodyl, CARVedilol, Chlorthalidone, Clevidipine, Dextrose 50%, Docusate Sodium, and Escitalopram Oxalate.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up in 1 week with the cardiology and vascular surgery clinics for ongoing management of his AAA and cardiac health. Home health nursing will coordinate care and monitor for any signs of deterioration.',\n",
       " '**Discharge Summary**  \\nPatient is a 64-year-old female admitted under observation for pneumonia, unspecified organism (ICD-10 J189). The patient presented with acute respiratory distress, fever, and cough. Initial evaluation revealed hypoxia and she required supplemental oxygen.  \\n\\n**Hospital Course**  \\nDuring her 9-day stay, the patient received intravenous antibiotics and supportive care, including bronchodilators and steroids. She was monitored for acute respiratory failure with hypoxia (ICD-10 J9601) and showed gradual improvement in respiratory status. The patient experienced episodes of hypokalemia and hypomagnesemia (ICD-10 E872, E876), which were managed with electrolyte replacement. Additionally, she has a history of chronic kidney disease, stage 3 (ICD-10 N1830), which was stable throughout her hospitalization. \\n\\nKey diagnostic findings included chest X-ray confirming pneumonia, and regular assessments of renal function were conducted. The patient underwent a comprehensive medication review. \\n\\n**Discharge Condition and Functional Status**  \\nAt discharge, the patient is stable with improved oxygen saturation and is able to ambulate independently. She requires home health services for continued monitoring of her renal status and respiratory function, as well as assistance with activities of daily living due to mild fatigue. The patient has been advised to engage in light physical activity as tolerated.  \\n\\n**Medications and Follow-Up Plan**  \\nDischarge medications include Acetaminophen for pain, Apixaban for anticoagulation, Benzonatate for cough control, Metoprolol Succinate for blood pressure management, and DULoxetine DR for mood stabilization. The patient has received the Influenza Vaccine High-Dose Quadrivalent prior to discharge.  \\n\\nFollow-up is recommended with her primary care physician within one week, and home health nursing services will initiate within 48 hours for ongoing assessment and support.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 44 years  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an infection following a procedure (ICD-10: T814XXA). She presented with signs of fever, localized abdominal pain, and signs of a cutaneous abscess on the abdominal wall (ICD-10: L02211). She has a past medical history of type 1 diabetes with complications including diabetic neuropathy (ICD-10: E1043) and peripheral angiopathy (ICD-10: E1051).\\n\\n**Hospital Course:**  \\nDuring her 6-day stay, the patient was monitored closely for signs of systemic infection and was started on intravenous antibiotics, including Cefazolin and Ciprofloxacin. Supportive care was provided, and her blood glucose levels were managed throughout her stay. The patient received fluids, including D5 1/2NS and 5% Dextrose, and was treated with Furosemide for fluid management.\\n\\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies which confirmed the presence of an abscess, necessitating a drainage procedure (ICD-10: 0JB80ZZ). Post-procedure, her symptoms improved significantly, and she was afebrile by discharge. Laboratory results indicated stable blood glucose levels and improvement in inflammatory markers.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved wound condition and no signs of systemic infection. She is ambulating independently and requires assistance with daily activities due to her diabetes-related complications.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on a regimen that includes Acetaminophen for pain management, continued antibiotics (Cefazolin and Ciprofloxacin), and Docusate Sodium for constipation. She has been advised to follow up with her endocrinologist for diabetes management and wound care. Home health services will monitor her recovery and provide assistance with activities of daily living and medication management.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 72-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.8 days  \\n**Primary Diagnosis:** Pericardial effusion (noninflammatory) (I313)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of pericardial effusion, which was noted to be noninflammatory on echocardiogram. She presented with symptoms of shortness of breath and mild chest discomfort, with a history of type 2 diabetes mellitus and hyperlipidemia. No acute respiratory distress was observed upon admission, but she did exhibit some signs of fluid overload.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a comprehensive evaluation, including echocardiography confirming a moderate pericardial effusion. The patient was started on diuretics to manage fluid status. She was monitored closely for any signs of cardiac tamponade or worsening symptoms. Additionally, given her diabetic status, her blood glucose levels were closely managed. The patient responded well to diuretics, and her symptoms improved significantly, leading to her readiness for discharge.\\n\\n**Key Findings and Procedures:**  \\nEchocardiogram showed moderate pericardial effusion. Laboratory results indicated controlled glycemic levels post-management. The patient received a pneumococcal vaccine and influenza vaccine during her stay as part of preventive care. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved respiratory symptoms and no signs of fluid overload. She is able to perform activities of daily living with minimal assistance. Home health services are recommended to assist with medication management and ensure continued monitoring of her diabetes and cardiovascular health.\\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on 0.9% Sodium Chloride, Acetaminophen, Aspirin, Insulin, and Docusate Sodium among others.  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and cardiologist within one week. Home health services will be initiated to provide support and education regarding her medications and management of her diabetes.',\n",
       " '**Discharge Summary**  \\n**Patient:** 61-year-old male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute chest pain and elevated cardiac biomarkers, consistent with a Non-ST elevation myocardial infarction (NSTEMI). His medical history is significant for essential hypertension, hyperlipidemia, and a personal history of nicotine dependence.  \\n  \\n**Hospital Course:**  \\nDuring the hospital course, the patient was closely monitored and treated with antithrombotic therapy, including aspirin, clopidogrel, and heparin. He was started on metoprolol tartrate for rate control and atorvastatin for lipid management. Serial troponin levels showed a peak that was consistent with NSTEMI, and the patient was stabilized without the need for invasive cardiac procedures.  \\n  \\n**Key Findings and Procedures:**  \\nAn echocardiogram revealed preserved left ventricular function with no significant wall motion abnormalities. The patient’s blood pressure and heart rate were well controlled with medications. He was educated on lifestyle modifications and the importance of adherence to his medication regimen.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved symptoms. He is capable of performing activities of daily living independently, but will require assistance with medication management and follow-up appointments. Home health services will be initiated to monitor his recovery and ensure adherence to the prescribed regimen.  \\n  \\n**Medications at Discharge:**  \\n1. Aspirin 81 mg daily  \\n2. Atorvastatin 40 mg daily  \\n3. Clopidogrel 75 mg daily  \\n4. Heparin (as directed by home health)  \\n5. Metoprolol Tartrate 25 mg twice daily  \\n6. Amlodipine 5 mg daily  \\n7. Sodium Chloride 0.9% flush as needed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week. Home health services will provide medication education and monitor blood pressure and heart rate. Lifestyle modifications, including dietary changes and smoking cessation, were emphasized during discharge education.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- Age: 25  \\n- Gender: Female  \\n  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 1.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for labor and delivery complicated by meconium-stained amniotic fluid (ICD-10: O770). She was in active labor and presented with concerns due to the presence of meconium.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient underwent continuous monitoring and was managed with oxytocin for augmentation of labor. A vaginal delivery was achieved without major complications. Immediate postpartum, she experienced some hemorrhage, classified as other immediate postpartum hemorrhage (ICD-10: O721), which was effectively managed with fluid resuscitation and medications.  \\n  \\n**Key Findings and Procedures:**  \\n- Delivery of a single live birth.  \\n- Notable finding of a cord around the neck, which was noted but did not cause any compression or fetal distress.  \\n- The patient was monitored closely for signs of infection and postpartum recovery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and has demonstrated adequate recovery. She has been educated on postpartum care, including monitoring for signs of excessive bleeding or infection. She is ambulating independently and is able to care for her newborn with assistance as needed. Home health services will be beneficial to provide support in the coming weeks, particularly for breastfeeding support and postpartum recovery monitoring.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Lactated Ringers  \\n- Oxytocin  \\n- Docusate Sodium  \\n- Bisacodyl  \\n- Senna  \\n- Simethicone  \\n- Calcium Carbonate  \\n- Dibucaine  \\n- Polyethylene Glycol  \\n- Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week to assess her recovery and newborn care. Home health will contact her to arrange postpartum support services.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 19  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following an acute manic episode characterized by severe agitation, psychotic symptoms, and substance use. He presented with increased energy levels, decreased need for sleep, and grandiosity, which led to erratic behavior and potential harm to himself and others. Substance use history included opioids, stimulants, and cannabis which may have exacerbated his psychiatric symptoms.\\n\\n**Hospital Course:**  \\nDuring his 4.9-day stay, the patient was stabilized on a regimen including Risperidone for mood stabilization, along with supportive care. He underwent psychiatric evaluation and was monitored closely for any signs of worsening psychosis or substance withdrawal. His treatment also included nicotine replacement therapy to address tobacco dependence. The patient showed marked improvement and was able to engage in therapeutic activities and psychoeducation sessions.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent manic symptoms with associated psychotic features, as indicated by the primary diagnosis of F302. Psychological assessments ruled out other complicating factors, and he was screened for infections with a sexual mode of transmission (Z202) and other communicable diseases (Z20828). No acute medical issues were identified during his stay.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient's mental status was stable, and he demonstrated insight into his condition. He was able to articulate his treatment plan and expressed willingness to engage in follow-up care. The patient will benefit from home health services to ensure adherence to his medication regimen and ongoing psychiatric support.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain management, a Nicotine Patch for tobacco cessation, Ramelteon for sleep aid, and Risperidone for mood stabilization. The patient is scheduled for follow-up with outpatient psychiatric services within one week. Home health nursing will assist in monitoring mood symptoms, medication compliance, and provide education on substance use management.\",\n",
       " \"**Patient Information:**  \\nAge: 75 years  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms suggestive of a non-ST elevation myocardial infarction (NSTEMI). Upon admission, she reported chest pain and shortness of breath, with risk factors including a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. Initial troponin levels were elevated, confirming NSTEMI.  \\n\\n**Hospital Course:**  \\nDuring her 3.4-day stay, the patient was closely monitored. She received standard medical management for NSTEMI, including antiplatelet therapy with aspirin and clopidogrel, statin therapy with atorvastatin, and beta-blockade with metoprolol succinate. She was also treated for acute kidney failure and received IV fluids, including Lactated Ringer's and sodium chloride. The patient was managed for her diabetes with insulin and monitored for blood glucose levels.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated troponin levels and mild acute kidney injury, likely secondary to dehydration and underlying comorbidities. A cardiac echocardiogram showed left ventricular function within normal limits. No invasive procedures were required during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significant improvement in chest pain and vital signs within normal limits. She is ambulating independently with minor assistance and has been educated regarding her condition and medication management. She will require home health services for continued monitoring of her cardiovascular status and assistance with diabetes management.  \\n\\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient was prescribed acetaminophen for pain, aspirin, clopidogrel, atorvastatin, metoprolol, and insulin. She was also given glucagon and glucose gel for hypoglycemia management. A follow-up appointment with her cardiologist is scheduled in one week to reassess her cardiac status and adjust medications as needed. Home health services will provide ongoing support and education regarding her medications and lifestyle modifications.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 34  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 34-year-old female who was admitted with gestational diabetes mellitus requiring insulin management during childbirth (ICD-10: O24424). She presented with elevated blood glucose levels and required urgent intervention to stabilize her condition prior to delivery.  \\n  \\n**Hospital Course:**  \\nDuring her 2.5-day hospital stay, the patient was monitored closely for blood glucose levels and received insulin therapy to maintain glycemic control. She underwent a vaginal delivery complicated by a first-degree perineal laceration (ICD-10: O700) and experienced abnormal fetal heart rate patterns (ICD-10: O76) during labor. The delivery was successful, resulting in a single live birth at 39 weeks gestation (ICD-10: Z370).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient was managed with a multidisciplinary approach, including obstetrics, nutrition, and nursing. Key procedures performed included the delivery of the infant and repair of the perineal laceration. Postpartum care included monitoring for potential complications associated with gestational diabetes and pain management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs, effective pain management, and the ability to care for herself and her newborn. She has been instructed on monitoring her blood glucose levels and recognizing signs of hyperglycemia or hypoglycemia. She is being referred to home health services for continued support in managing her diabetes and postpartum recovery.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include acetaminophen, ibuprofen, docusate sodium, bisacodyl, and oxycodone (immediate release) for pain management, along with calcium carbonate and simethicone for gastrointestinal comfort. She is also advised to receive the influenza vaccine.  \\n  \\n**Follow-Up Plan:**  \\nThe patient should follow up with her obstetrician within 1 week for a postpartum check and further management of her gestational diabetes. Home health services will assist with diabetes education, monitoring, and support for her recovery process.',\n",
       " '**Discharge Summary**  \\n**Patient:** 72-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute exacerbation of chronic heart failure, with underlying atherosclerotic heart disease and chronic kidney disease. She presented with dyspnea on exertion and peripheral edema. A review of her history revealed a significant cardiovascular profile, including hypertension and type 2 diabetes with associated renal complications.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was stabilized with intravenous fluids and diuretics. Her renal function was closely monitored due to her stage 5 chronic kidney disease. She underwent echocardiography, demonstrating reduced ejection fraction consistent with congestive heart failure. The multidisciplinary team managed her medications, adjusting doses of Metoprolol and initiating Clopidogrel to prevent cardiovascular events. \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated B-type natriuretic peptide (BNP) levels, signs of heart failure on imaging, and acute renal failure, which improved with treatment. The patient received multiple interventions, including diuretics and insulin for glucose management. She was also given an influenza vaccine as preventative care. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was in stable condition, with improved respiratory status and reduced edema. She is able to perform basic activities of daily living, although she requires assistance with ambulation and medication management. Home health services will be initiated to provide nursing support, monitor her heart failure management, and assist with her renal care. \\n\\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Atorvastatin, Clopidogrel, DULoxetine, Metoprolol Succinate XL, and Insulin. \\n\\n**Follow-up Plan:**  \\nShe is instructed to follow up with her primary care physician and a cardiologist within one week post-discharge. Home health services will coordinate care and monitor her progress.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 65  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient, a 65-year-old male, was admitted for observation due to obstructive jaundice secondary to obstruction of the bile duct (ICD-10: K831). He presented with severe abdominal pain, jaundice, and elevated liver enzymes. Initial imaging confirmed the diagnosis of bile duct obstruction.  \\n  \\n**Hospital Course:**  \\nDuring the 14.7-day hospital stay, the patient underwent a series of interventions including endoscopic retrograde cholangiopancreatography (ERCP) to relieve the obstruction. The procedure was successful in decompressing the bile duct. He was monitored for potential complications, including infection and pancreatitis, which were effectively managed. The patient also received nutritional support due to significant protein-calorie malnutrition (ICD-10: E43) and was treated for secondary sepsis.  \\n  \\n**Key Findings and Procedures:**  \\n1. Obstruction of bile duct (K831) with successful ERCP.  \\n2. Management of sepsis (A4159, A4181) with intravenous antibiotics, including Ertapenem.  \\n3. Nutritional intervention for malnutrition and ongoing management of portal hypertension and related complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulatory with assistance, and exhibits improved jaundice. He has been referred to home health services for ongoing nutritional support, monitoring of liver function, and assistance with mobility and daily activities.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Dextrose 50%  \\n3. Ertapenem Sodium  \\n4. Furosemide  \\n5. Insulin and Levothyroxine Sodium  \\n6. Lisinopril  \\n7. Ipratropium-Albuterol Neb  \\n8. Home health nursing to assist with medication management and monitoring.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with Gastroenterology in one week to assess recovery and manage any ongoing issues related to bile duct obstruction and nutritional needs. Home health services will begin within 48 hours post-discharge to ensure continuity of care.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Female, 40 years old  \\n**Admission Type:** Emergency Ward  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with symptoms consistent with a urinary tract infection (UTI), including dysuria, frequency, and flank pain. Initial laboratory tests confirmed the diagnosis of a UTI (ICD-10 N390). The patient also had a history of obesity, hypertension, and obstructive sleep apnea, which were managed during the admission.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient received IV ciprofloxacin for the UTI and was closely monitored for electrolyte imbalances due to underlying conditions. She was administered 5% dextrose with potassium chloride and normal saline to maintain hydration and correct hypo-osmolality and hyponatremia (ICD-10 E871). Additionally, her hypertension (ICD-10 I10) and obesity (ICD-10 Z6843) were addressed, with dietary counseling provided.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient showed improvement in her symptoms with treatment. Vital signs remained stable, and she was able to tolerate oral intake by discharge. Laboratory results indicated resolution of electrolyte abnormalities, and she demonstrated adequate renal function. No additional procedures were necessary during the stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with significant improvement in her urinary symptoms. She is ambulatory, but due to her history of obesity and obstructive sleep apnea, she will require home health services for ongoing monitoring and support, including physical therapy and nutritional counseling.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include IV ciprofloxacin, potassium chloride, and normal saline flushes. The patient is advised to follow up with her primary care physician within one week, and home health services will assist with medication management and monitoring her blood pressure and weight.  \\n**Plan for Follow-Up:**  \\n1. Follow up with primary care physician within 7 days.  \\n2. Home health services for ongoing monitoring of vital signs and medication adherence.  \\n3. Nutritional guidance to manage obesity and hypertension.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 63 years old  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.5 days  \\n**Primary Diagnosis:** Malignant neoplasm of left kidney (ICD-10 C642)  \\n**Additional Diagnoses:** Unspecified atrial fibrillation (I4891), long-term use of antithrombotics/antiplatelets (Z7902), type 2 diabetes mellitus without complications (E119), encounter for immunization (Z23)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical resection of a malignant neoplasm of the left kidney. He has a history of atrial fibrillation, controlled diabetes, and is on chronic anticoagulation therapy.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a left nephrectomy without complications. Post-operatively, he was monitored in the surgical unit and received appropriate pain management, anticoagulation prophylaxis, and management of his diabetes. He was stable throughout his stay, with no signs of infection or other complications.  \\n  \\n**Key Findings and Procedures:**  \\n- Left nephrectomy (ICD-10: 0TB14ZZ) was performed successfully.  \\n- Post-operative imaging showed no immediate complications.  \\n- The patient was educated on signs of infection, importance of medication adherence, and lifestyle modifications related to diabetes management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with intact vital signs and adequate pain control. He is ambulatory with assistance and is capable of self-care. Home health services are recommended to assist with medication management, monitor his recovery, and support diabetes care.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride, Acetaminophen, Dextrose 50%, Diphenhydramine, Docusate Sodium, Glipizide, Glucagon, Glucose Gel, Heparin, Hydrochlorothiazide, Ketorolac, Lisinopril, and Influenza Vaccine Quadrivalent.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his oncologist in one week, and with his primary care physician for diabetes management and anticoagulation therapy. He has been counseled on the importance of consistent follow-up and adherence to prescribed medications.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 35-year-old female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 11.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of localization-related symptomatic epilepsy characterized by simple partial seizures. The patient's seizure activity was noted to have increased in frequency and intensity, which prompted her emergency presentation. \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient was monitored and treated with a regimen that included antiepileptic medications, specifically Clobazam, and symptomatic management for her recurrent migraine and gastrointestinal discomfort. She underwent a thorough evaluation, including neuroimaging, which ruled out any acute intracranial complications. The patient also received psychiatric evaluation and treatment for recurrent major depressive disorder, which was addressed with Brintellix and Nortriptyline. Throughout her stay, her seizure activity was controlled, and she demonstrated stabilization of her mood symptoms. \\n\\n**Key Findings and Procedures:**  \\nNeuroimaging revealed no acute changes. The patient’s seizure frequency decreased significantly during her stay, and she exhibited improved mood stability with pharmacotherapy. She was assessed for discharge with ongoing home health needs, particularly for monitoring her seizure disorder and mental health support. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with a functional status allowing for independent living with some assistance. She is capable of self-care but will benefit from home health services for medication management and regular follow-up for her seizure condition and mental health. The patient was educated on seizure precautions and the importance of adhering to her medication regimen. \\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include Brintellix, Clobazam, and supportive medications such as Calcium Carbonate and DiphenhydrAMINE. The patient is to follow up with her neurologist within one week and maintain regular psychiatric appointments for her mood disorder. Home health services will be initiated to assist in medication compliance and monitoring her seizure activity.\",\n",
       " '**Patient Summary:** 42-year-old female admitted for observation due to acute pulmonary embolism (ICD-10: I2699). \\n\\n**History of Present Illness:** The patient presented with shortness of breath and chest pain. She has a history of recurrent major depressive disorder, obesity (BMI 50.0-59.9), hypertension, asthma, and gastro-esophageal reflux disease. She also has a personal history of venous thrombosis. \\n\\n**Hospital Course:** The patient was admitted for observation over 2.3 days, during which she was started on anticoagulation therapy with Enoxaparin sodium. Her respiratory status improved with nebulized Albuterol and corticosteroids, addressing her asthma exacerbation. A thorough workup, including D-dimer and CT pulmonary angiography, confirmed the diagnosis of pulmonary embolism. In addition, her depression was monitored, and she was placed on an appropriate medication regimen including Fluoxetine and Amitriptyline. \\n\\n**Key Findings and Procedures:** The patient’s vital signs remained stable throughout her stay. Pulmonary function tests indicated moderate obstruction consistent with her history of asthma. She received supportive care, including hydration with 5% Dextrose and symptomatic management with Acetaminophen for discomfort. She was educated on the importance of medication adherence and lifestyle modifications to manage her obesity and hypertension. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable with improved respiratory function and a plan for outpatient follow-up. She is able to ambulate independently but requires assistance with activities of daily living due to obesity-related limitations. Home health services are recommended for medication management and monitoring of her pulmonary status. \\n\\n**Medications at Discharge:** The patient will continue on the following medications: Enoxaparin sodium, Fluoxetine, Amitriptyline, Atenolol, Albuterol inhaler, Omeprazole, and Gabapentin. A follow-up appointment with her primary care physician and a referral to a home health agency for ongoing support and monitoring is advised within one week.',\n",
       " \"**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Patient ID:** [Patient ID]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 26-year-old female who was admitted urgently with complications related to childbirth, primarily liver and biliary tract disorders (ICD-10: O2662) alongside other obstetric and hematologic issues. She presented with symptoms including abdominal pain, nausea, and signs of HELLP syndrome, necessitating immediate evaluation and management.  \\n  \\n**Hospital Course:**  \\nDuring her 10-day hospitalization, the patient was treated for multiple conditions including Hb-SS disease with crisis, acute kidney failure, and acute posthemorrhagic anemia, among others. She underwent supportive care including IV fluids, pain management, and monitoring of vital signs. Key procedures included a laparoscopic cholecystectomy (10D00Z1) and an abdominal ultrasound (04L23DZ) which revealed biliary tract anomalies. The patient's condition stabilized with appropriate interventions, and she was closely monitored for any further complications.  \\n  \\n**Key Findings and Procedures:**  \\n- Laparoscopic cholecystectomy performed successfully.  \\n- Ultrasound indicated biliary tract disorders with no acute findings.  \\n- Laboratory results showed stabilization of liver function tests and hemoglobin levels indicating resolution of critical anemia.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved abdominal pain and other symptoms. She is able to perform activities of daily living (ADLs) with minimal assistance. Home health services will be essential for monitoring her recovery, medication management, and support with mobility as she continues to improve.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Acetaminophen, Bisacodyl, Docusate Sodium, Famotidine, Folic Acid, Hydromorphone, Heparin, Ibuprofen, Metoclopramide, Naloxone, Ondansetron, Sarna Lotion, and Simethicone. A follow-up appointment with her obstetrician and a hematologist is scheduled within one week post-discharge to evaluate her recovery and ensure ongoing management of her conditions.\",\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 78  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.2 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 78-year-old male who presented to the emergency department with accidental poisoning due to insulin and oral hypoglycemic agents. Family members reported confusion and lethargy, prompting them to seek medical attention. Initial blood glucose levels were critically low, necessitating immediate intervention.\\n\\n**Hospital Course:**  \\nUpon admission, the patient received dextrose infusion to stabilize blood glucose levels. Serial glucose monitoring demonstrated improvement, and he regained consciousness with orientation to person, place, and time after several hours. The patient was monitored for any signs of further hypoglycemia and managed with appropriate insulin adjustments. Additionally, a comprehensive evaluation for underlying causes of his diabetes management was conducted.\\n\\n**Key Findings and Procedures:**  \\nThroughout the hospitalization, the patient underwent a thorough assessment, including laboratory tests confirming type 2 diabetes mellitus with hypoglycemic episodes. A fall assessment was also conducted due to his reported fall from the toilet, resulting in a minor abrasion to the head. No significant complications from the fall were noted. The patient was educated on diabetes management, medication adherence, and fall prevention strategies.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, alert, and oriented. He demonstrates the ability to perform activities of daily living with minimal assistance. However, he will require home health services for ongoing diabetes management, medication administration, and monitoring for any potential falls or complications given his recent history.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed acetaminophen, atorvastatin, bisacodyl, insulin, and glucagon among others. He will continue to take his diabetes medications as per the adjusted regimen. A follow-up appointment with his primary care physician is scheduled within one week to reassess his diabetes management plan. Home health services will facilitate medication management and diabetes education to ensure adherence and prevent future incidents.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 91 years  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of abdominal pain and jaundice. Imaging revealed a malignant neoplasm of the head of the pancreas (ICD10: C250) leading to biliary obstruction and gastrointestinal hemorrhage (ICD10: K831). The patient has a significant past medical history including chronic atrial fibrillation, which required anticoagulation therapy, and a history of duodenal ulcer.  \\n\\n**Hospital Course:**  \\nDuring her 10-day hospitalization, the patient was managed with supportive care and underwent several interventions including endoscopic retrograde cholangiopancreatography (ERCP) to relieve biliary obstruction and address the gastrointestinal hemorrhage. She was closely monitored for signs of bleeding and cardiovascular stability due to her atrial fibrillation. The patient's pain was managed effectively with analgesics, and she received appropriate nutritional support.  \\n\\n**Key Findings and Procedures:**  \\n- ERCP performed with successful stenting of the obstructed bile duct.  \\n- No postoperative complications were noted.  \\n- The patient required multiple transfusions for posthemorrhagic anemia.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, although she remains weak due to her prolonged hospitalization and recent illness. She requires assistance with activities of daily living and will benefit from home health services for physical therapy and nursing care. It is important for her to continue monitoring her vital signs and manage her anticoagulation therapy safely at home.  \\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Apixaban  \\n- Atorvastatin  \\n- Insulin  \\n- Levothyroxine Sodium  \\n- Dextrose 50% (as needed)  \\nThe patient is advised to follow up with oncology and her primary care physician within one week of discharge. A home health nurse will visit to assess her condition and ensure proper medication management.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date:** [Insert Date]  \\n**Patient Name:** [Insert Patient Name]  \\n**Age:** 51  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical management related to morbid obesity with alveolar hypoventilation (ICD10 E662). He presented with significant respiratory distress and was at high risk for pulmonary complications due to his obesity and associated comorbidities.  \\n  \\n**Hospital Course:**  \\nDuring his 5.5-day stay, the patient underwent a [specific surgical procedure, e.g., bariatric surgery] (ICD10 0DB64Z3). Postoperatively, he was monitored in the ICU for respiratory support and stabilization. The patient was treated with a combination of oxygen therapy, analgesics including Hydromorphone and Oxycodone, and fluids. He required close monitoring for cardiac rhythm due to a history of ventricular tachycardia (ICD10 I472).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient exhibited improvements in respiratory function, with gradual weaning from supplemental oxygen. He was evaluated for diabetes management due to his Type 2 diabetes mellitus with neuropathy (ICD10 E1140). Cardiac monitoring showed no significant arrhythmias postoperatively.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, able to ambulate with assistance, and demonstrated adequate understanding of his medication regimen. He will require home health services for continued monitoring of respiratory status and diabetes management, as well as assistance with activities of daily living due to his obesity and recent surgery.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen (Liquid)  \\n- Calcium Gluconate  \\n- Dextrose 50%  \\n- Docusate Sodium  \\n- Famotidine  \\n- Glucagon  \\n- Glucose Gel  \\n- Hydromorphone  \\n- Heparin  \\n- Insulin  \\n- Lidocaine Jelly 2%  \\n- Lisinopril  \\n- Magnesium Sulfate  \\n- OxyCODONE (Immediate Release)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in the outpatient clinic in one week for reassessment of surgical site and management of comorbidities. Home health services will initiate within 48 hours post-discharge to monitor his recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 38 years  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention following a right-sided orbital floor fracture sustained from a blunt trauma. The injury involved multiple facial fractures, including nasal bones. She presented with significant periorbital edema and limited ocular movement.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a successful surgical repair of the orbital floor (ICD10 0NSP04Z) and was monitored postoperatively for stable vitals and pain management. She received intravenous antibiotics (Ampicillin-Sulbactam) and analgesics (Hydromorphone) to manage her pain and prevent infection. The patient was also managed for bradycardia, which resolved with monitoring.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed the fracture's extent. During the postoperative period, she was evaluated daily, and her condition improved steadily. Key interventions included ocular assessments and pain control, with her pain levels reducing significantly by discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with intact neurological function and improved visual acuity. She demonstrated the ability to perform activities of daily living independently, though she will require assistance for the first few weeks at home due to mobility restrictions. Home health services will provide support for medication management, wound care, and ongoing monitoring of her recovery.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride (for hydration)  \\n- Acetaminophen (for pain management)  \\n- Dexamethasone (to reduce inflammation)  \\n- Pregabalin (for neuropathic pain)  \\n- Erythromycin Ophthalmic Ointment (for eye care)  \\n- Docusate Sodium (as a stool softener)  \\n- Ondansetron (for nausea management)  \\nA follow-up appointment is scheduled with the orthopedic surgeon in one week to assess recovery and further management.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 83  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted directly through the emergency department with complaints of abdominal pain and jaundice. Laboratory findings revealed elevated bilirubin levels, and an abdominal ultrasound confirmed the presence of a calculus of the bile duct without cholangitis or cholecystitis, resulting in obstruction.  \\n\\n**Hospital Course:**  \\nDuring her two-day stay, the patient underwent an ERCP (Endoscopic Retrograde Cholangiopancreatography) for stone extraction, which was successful. Post-procedure, she was monitored for any complications, including signs of pancreatitis or infections, but remained stable. Her cardiovascular history, including paroxysmal atrial fibrillation and congestive heart failure, was managed with appropriate medications. The patient's heart rate was controlled, and she was hemodynamically stable throughout her hospitalization.  \\n\\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** K8051 (Calculus of bile duct), I5030 (Unspecified diastolic heart failure), I480 (Paroxysmal atrial fibrillation), and others.  \\n- **Procedures:** Successful ERCP performed for stone removal.  \\n- **Key Findings:** Stable vital signs, controlled heart failure symptoms, improved liver function tests post-ERCP.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved abdominal pain and normalized bilirubin levels. She is alert and oriented, able to perform activities of daily living with minimal assistance. Home health services have been arranged to assist with medication management and monitor her cardiovascular status, considering her history of heart failure.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Anastrozole, Apixaban, Aspirin, Atorvastatin, CloNIDine, Diltiazem Extended-Release, HYDROmorphone, Heparin, Influenza Vaccine, Levothyroxine Sodium, Omeprazole, Ondansetron, Triamterene-HCTZ, and ValACYclovir.  \\nA follow-up appointment with her primary care physician is scheduled in one week to reassess her condition and adjust medications as needed.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 71  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation with acute and chronic cholecystitis secondary to gallbladder calculus (ICD10: K8012). He presented with right upper quadrant abdominal pain, nausea, and vomiting. He has a significant past medical history including aortocoronary bypass graft and atherosclerotic heart disease.\\n\\n**Hospital Course:**  \\nDuring his 8.6-day stay, the patient was managed conservatively with IV fluids, analgesics (acetaminophen), and antibiotics. A hepatobiliary scan indicated gallbladder dysfunction, and discussions regarding potential cholecystectomy were held. He showed gradual improvement with symptom resolution and was able to tolerate a regular diet by the end of his stay.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver function tests and imaging confirming gallbladder inflammation. The patient received supportive care including lactated Ringer's solution, heparin for VTE prophylaxis, and potassium chloride supplementation. No surgical intervention was required during this admission.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable, ambulatory, and able to perform activities of daily living (ADLs) with minimal assistance. He has been educated on dietary modifications and signs of potential complications to monitor at home. Home health services will be initiated for nursing support and monitoring of his vital signs as well as medication compliance.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, atenolol, and a regimen of supportive care medications. The patient is advised to follow up with his primary care physician within one week, and to contact the clinic should he experience any concerning symptoms such as abdominal pain, jaundice, or changes in his condition.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 29-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.7 days  \\n**Primary Diagnosis:** Unspecified pre-existing hypertension complicating childbirth (ICD10: O1092)  \\n**Other Diagnoses:** Second degree perineal laceration during delivery (ICD10: O701), Single live birth, 39 weeks gestation (ICD10: Z370), Gestational age 39 weeks (ICD10: Z3A39)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for delivery given her history of pre-existing hypertension. She presented with elevated blood pressure readings and was monitored closely throughout labor.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a vaginal delivery without complications. A second degree perineal laceration was noted and repaired. Post-delivery, her blood pressure was well-managed with careful monitoring, and she was started on oral antihypertensive agents. She received supportive care, including hydration and pain management.  \\n\\n**Key Findings and Procedures:**  \\nThe patient delivered a healthy singleton infant, with Apgar scores of 8 and 9. The perineal laceration was repaired successfully. No additional interventions were required during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with controlled blood pressure, and her pain was managed adequately with oral medications. She demonstrated the ability to ambulate independently and perform activities of daily living with minimal assistance. The patient will benefit from home health services to assist with postpartum care, monitoring of blood pressure, and education on infant care.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Bisacodyl  \\n- Docusate Sodium  \\n- Calcium Carbonate  \\n- Dermoplast Spray  \\n- Milk of Magnesia  \\n- Simethicone  \\n- Influenza Vaccine Quadrivalent  \\n- Lactated Ringers  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for a postpartum evaluation, continued blood pressure monitoring, and further assessment of her perineal recovery. Home health nursing will be arranged to support her transition home.',\n",
       " \"Patient is a 73-year-old male who was admitted via emergency department for evaluation and management of pneumonia, unspecified organism (ICD-10: J189). The patient presented with increased shortness of breath, productive cough, and fever. Initial workup revealed acute respiratory failure with hypoxia, necessitating supplemental oxygen therapy. The hospital stay lasted 5.1 days during which the patient received intravenous antibiotics, including Ceftriaxone and Azithromycin, as well as supportive care for pneumonia and underlying chronic conditions.\\n\\nThroughout the hospitalization, the patient was treated for acute kidney failure (ICD-10: N179) and managed for comorbidities, including hypertension and type 2 diabetes. Key findings included improvement in respiratory status as evidenced by decreased work of breathing and an increased oxygen saturation level. The patient's renal function was closely monitored, with a noted return to baseline levels towards discharge. \\n\\nThe patient underwent chest X-ray and laboratory studies confirming resolution of pneumonia. He was provided with education on the importance of medication adherence, including Aspirin, Atorvastatin, and a new inhaler regimen with Albuterol for ongoing respiratory support. \\n\\nAt the time of discharge, the patient was stable with improved functional status, ambulating independently, and tolerating oral intake. He requires home health services for continued monitoring of respiratory status and medication management. The patient has been advised to follow up with his primary care physician within one week of discharge to assess his recovery and adjust medications as necessary. \\n\\nDischarge medications include Acetaminophen, Albuterol Inhaler, Aspirin, Atorvastatin, Azithromycin, and other supportive medications. Home health services will assist in medication management and monitoring for any potential complications.\",\n",
       " '**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 66  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 66-year-old male with a history of hypertensive heart disease and chronic kidney disease, who presented with exacerbation of heart failure and acute respiratory failure. Upon admission, he was noted to have hypoxia and dyspnea, which required supplemental oxygen. He has a background of Stage 1-4 chronic kidney disease, and his condition was complicated by acute on chronic diastolic heart failure during the hospital stay.  \\n\\n**Hospital Course:**  \\nThe patient was closely monitored in the observation unit for 5 days. His treatment regimen included diuretics (Torsemide) for fluid overload, antihypertensives (Carvedilol, Hydralazine), and supplemental oxygen therapy. His respiratory status improved significantly, and renal function was stabilized with appropriate fluid management. Regular monitoring of vital signs and laboratory parameters was performed, revealing a gradual improvement in his clinical status.  \\n\\n**Key Findings and Procedures:**  \\nKey findings upon discharge include resolution of acute respiratory failure and stabilization of heart failure symptoms. Laboratory results indicated improving renal function and electrolyte balance. No invasive procedures were performed during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function and reduced heart failure symptoms. He is ambulating independently with a walker and can perform activities of daily living with minimal assistance. Home health services are recommended for ongoing monitoring, medication management, and assistance with activities of daily living.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Albuterol Nebulizer, Aspirin, Benzonatate, Carvedilol, Fluticasone-Salmeterol Diskus, Gabapentin, Guaifenesin, Heparin, Hydralazine, Multivitamins, Nicotine Patch, Rosuvastatin, Sodium Chloride 0.9% Flush, Tiotropium Bromide, and Torsemide.  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments with cardiology and nephrology are scheduled within one week post-discharge. Home health services will initiate visits within 48 hours to assess ongoing needs and medication compliance.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Patient DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 76-year-old male who was admitted for observation due to pneumonitis secondary to inhalation of food and vomit. The patient presented with acute respiratory distress, cough, and hypoxia. His medical history includes a myocardial infarction, chronic obstructive pulmonary disease (COPD), hypertension, and chronic kidney disease, which complicate his clinical picture. \\n\\n**Hospital Course:**  \\nDuring his 4-day hospital stay, the patient received aggressive respiratory support, including bronchodilators and antibiotics (Ceftriaxone and Azithromycin) to address potential infection. His respiratory status improved, with oxygen saturation levels stabilizing to above 90% on room air by discharge. He was closely monitored for cardiac complications due to his history of myocardial infarction, and cardiac function was stable throughout his stay. \\n\\n**Key Findings and Procedures:**  \\nKey findings included acute respiratory failure due to pneumonia, confirmed via chest X-ray, which showed infiltrates consistent with aspiration pneumonitis. Laboratory tests revealed stable renal function, and electrolyte levels were corrected. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved respiratory function and is able to ambulate independently, although he requires assistance with activities of daily living due to overall weakness. He will benefit from home health services for skilled nursing care to monitor his respiratory status and medication management. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Acetaminophen, Allopurinol, Atorvastatin, Carvedilol, and Gabapentin among others. He is advised to follow up with his primary care physician within one week and to engage home health services for ongoing support. The patient was educated on recognizing signs of respiratory distress and the importance of medication adherence.  \\n\\n**Conclusion:**  \\nThe patient is discharged in a stable condition with appropriate follow-up and home health services arranged to support recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Details:**  \\n- **Age:** 54  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1 day  \\n\\n**History of Present Illness:**  \\nThe patient, a 54-year-old male, presented with worsening neurological symptoms characterized by weakness and confusion. Imaging studies revealed a secondary malignant neoplasm of the brain (ICD-10: C7931) with accompanying cerebral edema. The patient's medical history includes a personal history of malignant neoplasm of the kidney and a family history of malignant neoplasms of digestive organs.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored in the observation unit. He received dexamethasone for cerebral edema and levetiracetam to manage seizure prophylaxis due to the identified intracranial pathology. The patient's pain was managed with acetaminophen. Serial imaging was performed, which confirmed the presence of a secondary malignant neoplasm of the brain. His overall condition stabilized, although he experienced episodes of weakness and confusion.  \\n\\n**Key Findings and Procedures:**  \\n- **Primary Diagnosis:** Secondary malignant neoplasm of brain (C7931)  \\n- **Additional Diagnoses:** Cerebral edema (G936), nontraumatic intracerebral hemorrhage (I610), and chronic kidney disease, unspecified (N189).  \\n- **Procedures:** No surgical intervention was required during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved stability but continued to experience significant weakness. He will require home health services for rehabilitation to address mobility and strength deficits, as well as ongoing monitoring of his neurological status. A follow-up with neurology is essential within the next week to assess progress and adjust treatment as necessary.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Dexamethasone  \\n- Levetiracetam  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician and neurology within 7 days. Home health services will initiate within 48 hours post-discharge to assist with rehabilitation and monitoring.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 5.7 days  \\n**Primary ICD-10:** F11.14 (Opioid abuse with opioid-induced mood disorder)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted after presenting with acute symptoms consistent with opioid abuse and mood disorder. He reported increased cravings and mood instability, alongside suicidal ideations. During the admission, he also disclosed a history of alcohol abuse with withdrawal symptoms and ongoing anxiety and depressive symptoms.  \\n\\n**Hospital Course:**  \\nThroughout his 5.7-day stay, the patient underwent a comprehensive evaluation and stabilization protocol. He was treated for withdrawal symptoms associated with both opioid and alcohol use. Supportive therapy and pharmacologic interventions were initiated, including Haloperidol for mood stabilization and Propranolol for anxiety management. The patient was monitored closely for any suicidal ideations and received psychiatric consultations for ongoing mental health support.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during his stay included elevated blood pressure, consistent with essential hypertension (I10), and significant mood instability. He received several interventions including hydration, nutritional support with multivitamins and thiamine, and psychiatric management. His mood improved, and he demonstrated insight into his condition by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with a mood significantly improved from admission. He is able to perform basic activities of daily living but requires ongoing support for medication management and mental health maintenance. Home health services are recommended to assist with monitoring medication adherence and provide continued psychiatric support.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Diphenhydramine  \\n3. Haloperidol  \\n4. Hydroxyzine  \\n5. Lisinopril  \\n6. Milk of Magnesia  \\n7. Multivitamins with minerals  \\n8. Nicotine lozenge  \\n9. Propranolol  \\n10. Ramelteon  \\n11. Thiamine  \\n12. Trazodone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and with a psychiatrist for ongoing mental health support. Home health services will be initiated to provide assistance in medication management and monitoring of his mental health status.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 70  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient presented with a diagnosis of abdominal aortic aneurysm (AAA), without rupture, and was admitted under observation for monitoring and management of her condition. She has a history of essential hypertension, hyperlipidemia, and nicotine dependence, which were taken into consideration during her hospital stay.  \\n\\n**Hospital Course:**  \\nThe patient was admitted for 1.2 days. During her stay, she underwent a thorough evaluation including imaging studies which confirmed the AAA. Vital signs were closely monitored, and her blood pressure was managed with labetalol and metoprolol tartrate. She received intravenous fluids (D5 1/2NS) and was started on magnesium sulfate for electrolyte management. The patient was also vaccinated with the pneumococcal 23-valent polysaccharide vaccine prior to discharge.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable AAA on imaging, controlled blood pressure, and a mild elevation in calcium levels. The patient’s laboratory workup showed hypercalcemia; however, no acute intervention was required. She was evaluated for discharge with a plan for home health follow-up.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with no acute distress. She demonstrates the ability to ambulate independently but requires assistance with activities of daily living (ADLs) due to age-related factors. Home health services have been arranged to assist with nursing care and medication management.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Heparin  \\n- Labetalol  \\n- Metoprolol Tartrate  \\n- Magnesium Sulfate  \\n- Pantoprazole  \\n- Pravastatin  \\n- Potassium Chloride  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge for further management of her AAA and to reassess her blood pressure and electrolyte levels. Home health services will contact her within 48 hours for an initial visit.',\n",
       " '**Patient Information:** 61-year-old female admitted via emergency department for evaluation of jaw pain associated with arthritis of the temporomandibular joint (ICD-10: M26649). She has a medical history significant for unspecified adrenocortical insufficiency, hypertrophic cardiomyopathy, myelodysplastic syndrome, and chronic kidney disease. Recent history includes exposure to COVID-19.\\n\\n**Hospital Course:** The patient was admitted for a length of stay of 1.7 days. Initial evaluation confirmed the diagnosis of arthritis of the temporomandibular joint, and she was treated with pain management, including hydromorphone for acute pain relief. Other supportive measures included intravenous fluids and medications to address her underlying medical conditions. \\n\\n**Key Findings and Procedures:** The patient underwent imaging studies that confirmed the presence of degenerative changes in the temporomandibular joint. No acute complications were noted during her hospital stay. She remained stable with no significant changes in her vital signs. Multidisciplinary team input included consultations from pain management and nephrology.\\n\\n**Discharge Condition and Functional Status:** At discharge, the patient demonstrated improved pain control with a reported decrease in jaw pain, although she continues to require assistance with activities of daily living due to her underlying conditions. She is being referred to home health services for ongoing physical therapy and monitoring, as well as assistance with medication management.\\n\\n**Medications and Follow-Up Plan:** The patient is discharged on the following medications: Acyclovir, Entecavir, Metoprolol Succinate XL, Pantoprazole, and others to manage her chronic conditions. She is advised to follow up with her primary care physician within one week of discharge and to continue home health services for evaluation of her functional status and pain management.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 44  \\nGender: Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 11.9 days  \\n**Primary Diagnosis:** Other secondary pulmonary hypertension (ICD-10: I272)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with progressive dyspnea and worsening fatigue over the past month. She has a significant past medical history of chronic obstructive pulmonary disease (COPD), type 2 diabetes, and schizoaffective disorder. Initial workup revealed secondary pulmonary hypertension likely related to her underlying respiratory pathology.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient received oxygen therapy, diuretics, and bronchodilator treatment, which helped manage her respiratory failure and improve her oxygen saturation. She was monitored closely for signs of heart failure, and her fluid status was adjusted appropriately with furosemide.  \\nA transthoracic echocardiogram confirmed diastolic heart failure, and she was initiated on lisinopril for blood pressure control and to manage heart failure symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated significant improvement in her respiratory function, with a decrease in CO2 retention. She was stabilized on a regimen of asenapine for her psychiatric condition and acetazolamide to assist with her pulmonary hypertension. Nebulized treatments with albuterol and ipratropium were continued.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved dyspnea and adequate oxygenation on room air. She is alert and oriented, capable of performing activities of daily living with moderate assistance. Home health services will be arranged to monitor her respiratory status and medication compliance, as well as provide support for her psychiatric needs.  \\n  \\n**Medications at Discharge:**  \\n1. Asenapine  \\n2. Acetazolamide  \\n3. Albuterol Nebulizer solution  \\n4. Furosemide  \\n5. Lisinopril  \\n6. Fluticasone-Salmeterol Diskus  \\n7. Glucose Gel  \\n   \\n**Follow-up Plan:**  \\nThe patient is to follow up with her primary care physician and a pulmonologist within one week of discharge to reassess her pulmonary status and optimize her heart failure management. Home health will initiate services within 48 hours post-discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 85  \\n- **Gender:** Female  \\n- **Length of Stay:** 1.8 days  \\n- **Admission Type:** Observation  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of elevated potassium levels (Hyperkalemia, ICD10: E875). She presented with mild confusion and lethargy, with a reported history of chronic lymphocytic leukemia and essential hypertension.  \\n  \\n**Hospital Course:**  \\nDuring her observation, the patient was monitored closely; lab results confirmed hyperkalemia, which was managed with intravenous sodium chloride and appropriate dietary adjustments. The patient's potassium levels stabilized over the course of her stay. She was assessed by the hematology team for her underlying malignancy, and additional workup revealed no acute complications related to her chronic conditions.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent routine laboratory evaluations which indicated elevated serum potassium levels. ECG monitoring showed no significant arrhythmias. No invasive procedures were required.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented. She demonstrated the ability to ambulate independently with minimal assistance and was able to perform activities of daily living with some support. Her functional status is appropriate for home health services, where she will benefit from assistance with medication management and monitoring of her dietary intake to prevent recurrence of hyperkalemia.  \\n  \\n**Medications at Discharge:**  \\n1. Acyclovir  \\n2. Aspirin  \\n3. Heparin  \\n4. Methylphenidate (Ritalin)  \\n5. Mirtazapine  \\n6. Polyethylene Glycol  \\n7. Sodium Chloride 0.9%  \\n8. Timolol Maleate 0.5%  \\n  \\n**Follow-Up Plan:**  \\nThe patient will require follow-up with her primary care physician within one week of discharge to monitor her potassium levels and overall health status. Home health services will be initiated to assist with medication adherence and routine assessments.\",\n",
       " 'Patient is a 50-year-old male who was admitted for surgical intervention due to cervical spinal stenosis (ICD-10: M4802). The patient presented with symptoms of severe neck pain, radiculopathy, and associated neurological deficits. After comprehensive evaluation, a surgical procedure was performed to decompress the cervical spine, specifically targeting the C6-C7 level.\\n\\nDuring the 3.8-day hospital stay, the patient was closely monitored postoperatively. The hospital course was uncomplicated, with pain management effectively managed using acetaminophen and gabapentin, allowing for early mobilization. The patient demonstrated significant improvement in neurological function and pain reduction, reporting a decrease in radicular symptoms by discharge. Physical therapy was initiated, focusing on strengthening and range of motion exercises to facilitate recovery.\\n\\nKey findings during the hospital stay included improvement in motor strength in the upper extremities and resolution of sensory deficits. The patient underwent a successful laminectomy and discectomy, and imaging confirmed adequate decompression of the affected nerve roots. \\n\\nUpon discharge, the patient is functional at a moderate level, requiring assistance with activities of daily living (ADLs) including dressing and bathing. Home health services are recommended to provide physical therapy for continued rehabilitation and to assist with medication management. The patient will need ongoing monitoring of his diabetes and hypertension, which were stable during hospitalization but require follow-up.\\n\\nDischarge medications include acetaminophen, atorvastatin, gabapentin, and lisinopril, among others. Follow-up appointments are arranged with neurosurgery and primary care within two weeks. The patient is advised to contact the home health agency for any concerns regarding his recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID**: [REDACTED]  \\n**Date of Admission**: [REDACTED]  \\n**Date of Discharge**: [REDACTED]  \\n**Age**: 49 years  \\n**Gender**: Male  \\n**Admission Type**: Urgent  \\n\\n**History of Present Illness**:  \\nThe patient was admitted with symptoms consistent with gammaherpesviral mononucleosis, presenting with fever, fatigue, and lymphadenopathy. He has a complex medical history including hypertension, epilepsy, obstructive sleep apnea, and major depressive disorder.  \\n\\n**Hospital Course**:  \\nDuring a four-day hospitalization, the patient underwent extensive workup including laboratory tests and imaging studies. He was treated with supportive care, including intravenous fluids (Lactated Ringer's solution) and pain management with Hydromorphone and Oxycodone. His acute kidney failure was managed conservatively, and he received Heparin for DVT prophylaxis. The patient's mental health status was monitored, and he received Lamotrigine for his epilepsy.  \\n\\n**Key Findings and Procedures**:  \\nThe patient’s laboratory results confirmed gammaherpesviral mononucleosis without complications. Acute kidney failure resolved during hospitalization, and his blood pressure was stabilized with Diltiazem and Metoprolol. No significant complications arose during his stay, and he demonstrated improvement in energy levels and overall condition by discharge.  \\n\\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient was stable, with no acute distress. He is able to perform daily activities with minimal assistance but will require home health services for medication management and monitoring of his blood pressure and mental health status. A follow-up visit with his primary care physician is recommended within one week.  \\n\\n**Medications at Discharge**:  \\n1. Aspirin  \\n2. Diltiazem Extended-Release  \\n3. Hydromorphone  \\n4. Heparin  \\n5. Lactated Ringers (as needed)  \\n6. Lamotrigine  \\n7. Metoprolol Succinate XL  \\n8. Ondansetron  \\n9. Oxycodone (Immediate Release)  \\n10. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan**:  \\nThe patient is advised to follow up with his primary care provider and the neurology clinic for management of his chronic conditions. Home health services will facilitate medication adherence and monitor for any changes in clinical status.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 60 years  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 60-year-old male with a history of heart transplant, presenting with cytomegaloviral disease (B258). He was admitted for observation due to acute onset of fatigue, low-grade fever, and mild respiratory symptoms.  \\n  \\n**Hospital Course:**  \\nDuring his 4.9-day hospitalization, the patient underwent a thorough evaluation, including laboratory tests and imaging studies. Key findings included elevated liver enzymes and PCR positive for cytomegalovirus. He received antiviral therapy with Atovaquone, hydration, and supportive care. The patient's acute kidney failure (N179) was managed with fluid management and monitoring, resulting in gradual improvement.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient developed transient pancytopenia (D61818), likely secondary to medication effects. He was assessed for potential complications related to his heart transplant status (Z941) and required close monitoring for atrial fibrillation (I4891). A multidisciplinary team was involved in his care, including nephrology and infectious disease specialists.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient remained stable, with resolution of fever and improved energy levels. His functional status has improved; he is able to perform activities of daily living with minimal assistance. He will require continued home health support to monitor renal function and manage ongoing antiviral therapy.  \\n  \\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, Aluminum-Magnesium Hydrox.-Simethicone, Aspirin, Atovaquone, Calcium Carbonate, Levothyroxine Sodium, and multivitamins. Follow-up appointments with nephrology and infectious disease specialists are scheduled within one week to monitor recovery and manage medications. Home health services will initiate nursing visits for medication management and assessment of renal function.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 58 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 4.2 days  \\n**Primary Diagnosis:** Sepsis, unspecified organism (ICD10: A419)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with signs of sepsis, presenting with fever, chills, and right upper limb cellulitis. He reported increasing pain and swelling in the right elbow, along with malaise and decreased appetite over the past 48 hours.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was started on broad-spectrum intravenous antibiotics, including Ceftriaxone and Clindamycin, with subsequent improvement in his clinical status. He was also monitored for acute kidney failure (ICD10: N179), which was resolved with hydration and electrolyte management. Pain control was achieved with Ibuprofen and Acetaminophen. The patient was assessed for underlying conditions contributing to his sepsis, including hyperlipidemia (E785) and essential hypertension (I10).  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed sepsis with leukocytosis and elevated inflammatory markers. Imaging studies ruled out abscess formation. The patient was treated with intravenous fluids (0.9% Sodium Chloride) and phosphorus replacement (Neutra-Phos) due to identified phosphorus metabolism disorders (E8339).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was clinically stable, afebrile, and able to ambulate with minimal assistance. He demonstrated adequate understanding of his discharge medications and home care instructions. Home health services will be arranged to monitor ongoing wound care for cellulitis and assist with medication management, particularly for his chronic conditions.  \\n  \\n**Medications at Discharge:**  \\n1. Ceftriaxone  \\n2. Clindamycin  \\n3. Atorvastatin  \\n4. Dolutegravir  \\n5. Emtricitabine-Tenofovir alafen (DESCOVY)  \\n6. Rilpivirine  \\n7. Ibuprofen  \\n8. Neutra-Phos  \\n9. 0.9% Sodium Chloride Flush  \\n10. Vancomycin  \\n11. Acetaminophen  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician in one week and will be monitored by home health for wound care and medication adherence.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 81 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for treatment of multiple fractures of the left ribs following a fall at home. The incident occurred in the bathroom where she slipped and tripped without striking any objects. She has a history of essential hypertension and unspecified atrial fibrillation, currently managed with anticoagulants.\\n\\n**Hospital Course:**  \\nDuring her 2-day hospital stay, the patient underwent pain management and stabilization. She was treated with intravenous fluids and analgesics, including morphine and oxycodone for pain control. Additionally, she received Docusate Sodium to manage potential constipation from opioid use. Monitoring of her cardiovascular status was performed due to her atrial fibrillation, ensuring no complications arose. A multidisciplinary team was involved in her care, focusing on both her orthopedic and medical needs.\\n\\n**Key Findings and Procedures:**  \\nChest X-rays confirmed multiple rib fractures on the left side. No surgical intervention was necessary at this time, and the fractures were deemed stable. Continuous monitoring revealed no acute complications, and her vital signs remained stable throughout her stay. The patient was assessed for her home environment to ensure safety and appropriate follow-up.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved pain management and was able to ambulate with assistance. She requires home health services for ongoing physical therapy to aid in recovery and ensure safety, particularly in navigating her home environment. Family members have been educated on fall prevention strategies.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Docusate Sodium  \\n3. Lisinopril  \\n4. Oxycodone (Immediate Release)  \\n5. Fluoxetine  \\n6. Heparin  \\n7. Other medications as prescribed  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her primary care physician within one week. Home health services will be initiated for physical therapy and nursing care to monitor her recovery and medication management. Additionally, she will be scheduled for orthopedic follow-up as needed.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 26-year-old female admitted for observation due to phlebitis and thrombophlebitis of the superficial vessels in the right lower extremity. She reported worsening swelling and pain in the affected area over the past week, with no history of trauma. The patient has a complex medical history, including opioid dependence, alcohol dependence, and obesity (BMI 70 or greater).\\n\\n**Hospital Course:**  \\nDuring her 2-day stay, the patient was started on Enoxaparin for deep vein thrombosis prophylaxis and managed with analgesics for pain control. The patient's anticoagulation therapy was adjusted, and her medication regimen was reviewed to minimize polypharmacy risks. She received education on the importance of lifestyle modifications due to her multiple comorbidities.\\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed significant tenderness and swelling in the right lower extremity. Doppler ultrasound confirmed the diagnosis of superficial thrombophlebitis without evidence of deep vein thrombosis. Laboratory tests showed stable hemoglobin and platelet counts, and renal function remained within normal limits. The patient was assessed for discharge readiness with a significant improvement in her symptoms.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with a marked reduction in pain and swelling. She is able to ambulate with assistance and demonstrates understanding of her medication management and follow-up care. Home health services are recommended for continued monitoring of her lower extremity, medication management, and support for her mental health conditions.\\n\\n**Medications at Discharge:**  \\n- Albuterol Inhaler  \\n- Aspirin  \\n- BuPROPion XL (Once Daily)  \\n- Buprenorphine-Naloxone Tablet (8mg-2mg)  \\n- Diazepam (CIWA protocol)  \\n- Dolutegravir  \\n- Emtricitabine-Tenofovir (Truvada)  \\n- Enoxaparin (Prophylaxis)  \\n- Fluticasone Propionate 110mcg  \\n- Gabapentin  \\n- Latuda  \\n- Multivitamins  \\n- Rivaroxaban  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and has been referred to home health for ongoing evaluation and support.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 58, Gender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with exacerbation of Crohn's disease of the small intestine presenting with intestinal obstruction. She reported increasing abdominal pain, bloating, and altered bowel habits over the past week. Prior to admission, she had experienced significant weight loss and decreased appetite, raising concerns for malnutrition.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was managed with intravenous fluids, nutritional support, and medications including infliximab for her Crohn's disease and metronidazole for suspected Clostridium difficile enterocolitis. She received supportive care for acute kidney failure and electrolyte imbalances, particularly hypomagnesemia. Serial abdominal imaging and clinical assessments indicated improvement in bowel function, allowing for gradual reintroduction of oral intake.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated significant clinical improvement; however, she remains at risk for complications due to ongoing Crohn's disease. She was closely monitored for signs of further obstruction and malnutrition, which were effectively managed during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and able to ambulate with minimal assistance. However, she requires ongoing home health services for nutritional support and monitoring due to her protein-calorie malnutrition and Crohn's disease management. She has been educated on recognizing symptoms that warrant immediate medical attention.  \\n  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- 5% Dextrose  \\n- Acetaminophen IV  \\n- Infliximab  \\n- Metronidazole  \\n- Multivitamins W/minerals  \\n- Insulin (Regular) as needed for hyperkalemia  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her gastroenterologist within one week post-discharge and will be monitored by home health for her nutritional needs and medication compliance. Regular lab evaluations are recommended to monitor her renal function and electrolytes.\",\n",
       " \"Patient is a 61-year-old female who was admitted for observation due to an anaphylactic reaction secondary to unknown food products. The initial encounter was marked by severe respiratory distress and urticaria, prompting immediate administration of EPINEPHrine and supportive measures. \\n\\nDuring her 1.6-day hospital stay, she received IV fluids (Lactated Ringer's and Sodium Chloride 0.9%) and was closely monitored. Assessments revealed essential hypertension and hyperlipidemia, which were managed with appropriate medications including HydrALAZINE. The patient demonstrated improvement in respiratory function and was able to ambulate with minimal assistance.\\n\\nKey findings included an elevated blood pressure of 150/90 mmHg and elevated lipids; however, respiratory distress resolved before discharge. A procedure involving IV hydration and monitoring for anaphylaxis was conducted, ensuring the patient's stability before release.\\n\\nAt the time of discharge, the patient was in stable condition with a functional status that allowed her to perform activities of daily living with slight assistance. She will require home health services for continued monitoring of her blood pressure and lipid levels, as well as assistance with medication management.\\n\\nDischarge medications include Acetaminophen for pain management, EpiPen for emergency use, and Ipratropium-Albuterol nebulizer therapy for any respiratory issues. Follow-up appointments with her primary care physician are scheduled within one week to monitor her hypertension and ensure ongoing evaluation of her lipid profile. Home health will also facilitate education on recognizing anaphylaxis symptoms and the importance of dietary restrictions to prevent future reactions.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Discharge:** [Date]  \\n**Admit Date:** [Admit Date]  \\n**Age:** 70  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 70-year-old female who presented to the emergency department with worsening dyspnea, fatigue, and lower extremity edema. Initial evaluation revealed hypertensive heart disease and chronic kidney disease (CKD) exacerbated by acute on chronic diastolic heart failure. The patient has a medical history significant for type 2 diabetes mellitus and morbid obesity.  \\n\\n**Hospital Course:**  \\nDuring her 10-day hospital stay, the patient was managed with diuretics, antihypertensives, and supportive care for her heart failure and renal function. She responded well to treatment, with notable improvement in respiratory status and reduction in edema. Serial laboratory tests indicated stabilization of renal function without the need for dialysis.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, moderate pulmonary congestion on chest X-ray, and lab results indicating CKD stage 2. The patient underwent daily monitoring, dietary counseling, and fluid restriction to manage her heart failure symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with improved functional status and is ambulating independently. She reports reduced shortness of breath at rest and with minimal exertion. However, she will require continued home health support for medication management, dietary adherence, and monitoring of her vital signs and fluid intake.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Atorvastatin  \\n- Aspirin  \\n- Gabapentin  \\n- Docusate Sodium  \\n- Erythromycin Ophthalmic Ointment  \\n- Others as prescribed  \\nThe patient is instructed to follow up with her primary care physician within one week and to maintain appointments with nephrology and cardiology as scheduled. Home health services will be initiated to ensure compliance with medication and dietary restrictions.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 59  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe respiratory distress and a positive COVID-19 test. She presented with pneumonia due to coronavirus disease 2019, along with a history of chronic graft-versus-host disease and common variable immunodeficiency. Symptoms included fever, cough, and shortness of breath, necessitating immediate intervention.\\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was placed on supplemental oxygen due to hypoxemia and received antiviral therapy with Acyclovir and supportive care, including hydration and antibiotics (CefePIME) for secondary bacterial pneumonia. She was closely monitored for respiratory status, and her condition gradually improved. The patient was weaned off supplemental oxygen and exhibited a stable respiratory rate and improved oxygen saturation levels by discharge.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included bilateral infiltrates on chest imaging consistent with pneumonia. Laboratory results indicated leukocytosis, and she was treated for bacteriuria. The patient underwent physical therapy to improve her functional mobility due to weakness from prolonged illness.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented, with improved respiratory function. She demonstrated the ability to ambulate with minimal assistance and was able to perform activities of daily living (ADLs) independently. Home health services are recommended for continued monitoring and assistance with ADLs, as well as rehabilitation support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications: Acyclovir, Escitalopram Oxalate, Fluticasone Propionate NASAL, and Gabapentin. A follow-up appointment is scheduled with her primary care physician and pulmonologist within one week post-discharge. Home health services will provide nursing care for medication management and respiratory therapy as needed. A referral to physical therapy is also indicated to support her recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 72, Gender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of respiratory distress and cough, leading to a diagnosis of other viral pneumonia (ICD-10 J1289). Her past medical history includes acute kidney failure (N179), hypertension (I10), and obesity (E669). She also presented with mild diarrhea (R197) and had a recent history of viral hepatitis (B178).\\n\\n**Hospital Course:**  \\nDuring her 4-day hospital stay, the patient received supportive care, including intravenous fluids, oxygen therapy, and broad-spectrum antibiotics (Ceftriaxone and Doxycycline) due to the concern for secondary bacterial infection. Her renal function was monitored closely, and she was managed with appropriate medications, including Potassium Chloride for electrolyte balance. The patient's respiratory status improved significantly, and she was able to maintain oxygen saturation above 92% on room air by the time of discharge.\\n\\n**Key Findings and Procedures:**  \\nChest imaging demonstrated bilateral infiltrates consistent with viral pneumonia. Laboratory tests showed mild renal impairment, which stabilized during hospitalization. A multidisciplinary team was involved in her care, including nutrition and physical therapy to address her obesity and mobility issues.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented. She demonstrated improved respiratory function with the ability to ambulate short distances with minimal assistance. Home health services will be crucial for ongoing respiratory support, monitoring her renal function, and assisting with mobility and nutritional needs.\\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Atorvastatin, Benzonatate, Ceftriaxone (or oral antibiotics as needed), Doxycycline, GuaiFENesin ER, Heparin, Hydroxychloroquine, Multivitamins, Potassium Chloride, Senna, and Amlodipine.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is recommended within one week with her primary care physician to reassess her respiratory status and renal function. Home health services will coordinate care, including physical therapy and nutritional support.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 60  \\n- **Gender:** Male  \\n- **Admission Type:** Urgent  \\n- **Length of Stay:** 5.2 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with severe lumbar pain radiating to the left lower extremity, consistent with intervertebral disc disorders with radiculopathy (ICD-10: M5116). He reported increased pain intensity over the past week, exacerbated by movement and prolonged sitting. Additionally, the patient has a history of pure hypercholesterolemia and experienced an acute upper respiratory infection during hospitalization.\\n  \\n**Hospital Course:**  \\nDuring the 5-day hospitalization, the patient was managed with a multimodal approach, including pain management and physical therapy. He received intravenous fluids and was started on gabapentin for neuropathic pain. The patient's pain was controlled with oxycodone and adjunct medications, including acetaminophen and diazepam. Physical therapy focused on lumbar stabilization and stretching exercises. The patient demonstrated improvement in mobility and pain responsiveness by discharge.\\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed lumbar disc degeneration with radiculopathy. No surgical intervention was deemed necessary at this time. The patient was monitored closely for adverse effects of medications, particularly regarding benzodiazepines and opioids, which were managed appropriately. Discharge medications included gabapentin, oxycodone, and supportive medications for gastrointestinal health. \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulating with minimal assistance and demonstrating improved functional capacity. He is able to perform activities of daily living with some support and is advised to continue physical therapy at home. Home health services have been arranged to assist with mobility and pain management strategies.\\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include gabapentin, oxycodone, acetaminophen, and bisacodyl for bowel regularity. The patient is advised to follow up with his primary care physician within one week and to contact the home health service for ongoing support. Education regarding pain management and activity modification was provided to the patient and caregiver.\",\n",
       " '**Discharge Summary**  \\n**Patient Information**:  \\n**Name**: [Patient Name]  \\n**Age**: 73  \\n**Gender**: Female  \\n**Admission Type**: Emergency  \\n**Length of Stay**: 5.4 days  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted with acute kidney failure, unspecified (ICD-10: N179), presenting with symptoms of fatigue and decreased urine output. She has a complex medical history including chronic diastolic heart failure, permanent atrial fibrillation, and moderate protein-calorie malnutrition.  \\n  \\n**Hospital Course**:  \\nDuring her hospitalization, the patient was monitored closely and managed with fluid and electrolyte balance. Renal function was assessed daily, and nephrology was consulted, leading to optimization of her medication regimen. Diuretics were administered to manage fluid overload due to heart failure. She was started on insulin therapy for glucose management and received nutritional support to address her malnutrition.  \\n  \\n**Key Findings and Procedures**:  \\nKey findings included persistent acute kidney injury with associated metabolic derangements. A thorough workup, including imaging and laboratory tests, was performed to rule out potential causes. The patient underwent a renal ultrasound which showed no obstructive uropathy.  \\n  \\n**Discharge Condition and Functional Status**:  \\nThe patient is stable at discharge with improved renal function as evidenced by laboratory results. She is alert and oriented but requires assistance with activities of daily living due to weakness from her hospitalization. Home health services will be initiated to assist with monitoring her renal function, medication management, and nutritional support.  \\n  \\n**Medications at Discharge**:  \\n1. Acetaminophen  \\n2. Dextrose 10% in Water (D10W)  \\n3. Enoxaparin (Prophylaxis)  \\n4. Ferrous Sulfate  \\n5. GlipiZIDE  \\n6. Insulin  \\n7. Levothyroxine Sodium  \\n8. Metoprolol Tartrate  \\n9. Ramelteon  \\n10. Rosuvastatin Calcium  \\n11. Sodium Chloride 0.9% Flush  \\n12. Vitamin D3 (Cholecalciferol)  \\n  \\n**Follow-Up Plan**:  \\nThe patient is advised to follow up with her primary care physician within one week post-discharge and to have her renal function reassessed. Home health will coordinate care to ensure adherence to her medication regimen and monitor her nutritional status.',\n",
       " 'Patient is a 40-year-old male who was admitted for surgical intervention related to other pulmonary aspergillosis (ICD10: B441). He underwent a series of procedures, including bronchial lavage and thoracoscopic decortication, over a length of stay of 4.7 days. During the hospital course, he experienced a postprocedural air leak (ICD10: J95812), which was managed conservatively, and he was closely monitored for respiratory distress.\\n\\nKey findings included improvement in respiratory function post-operatively, although the patient demonstrated mild persistent asthma symptoms (ICD10: J45909) necessitating the use of bronchodilators, including Albuterol and Ipratropium Bromide nebulization. The patient also reported symptoms related to lactose intolerance and was educated on dietary modifications to alleviate discomfort. \\n\\nUpon discharge, the patient is stable with ongoing respiratory therapy and has shown satisfactory improvement in lung function. He is ambulating independently and requires home health services for continued respiratory support and monitoring, including nebulizer treatments and medication adherence. The patient will also benefit from physical therapy to enhance pulmonary function and overall mobility. \\n\\nDischarge medications include Acetaminophen for pain management, Fluticasone for asthma control, and Lactulose to manage constipation. The patient is advised to continue taking prescribed medications, including Amitriptyline and Dilaudid for pain, and to follow up with a pulmonologist in one week for further assessment of his respiratory status. He has also been scheduled for a follow-up appointment with a home health nurse to ensure compliance with the discharge plan and address any concerns that may arise.',\n",
       " '**Patient Information**: 67-year-old male admitted under observation for a cerebral infarction due to embolism of the left middle cerebral artery. \\n\\n**History of Present Illness**: The patient presented with sudden onset of right-sided weakness and difficulty speaking, consistent with a cerebrovascular accident. Initial neurological assessment revealed hemiplegia affecting the right dominant side. \\n\\n**Hospital Course**: The patient was monitored in the observation unit for 1.8 days. During this period, neuroimaging confirmed a cerebral infarction. The patient was initiated on appropriate antithrombotic therapy and insulin management for type 2 diabetes mellitus. Neurological status was closely monitored, and he received supportive care including physical therapy evaluation to establish a baseline for rehabilitation. \\n\\n**Key Findings and Procedures**: Neurological examination confirmed right-sided hemiplegia. The patient had a stable course with a gradual improvement in strength and mobility. He was assessed for home health services to facilitate continued rehabilitation.  \\n\\n**Discharge Condition and Functional Status**: The patient is being discharged with residual right-sided weakness but has demonstrated some improvement in mobility and self-care tasks. He requires assistance with activities of daily living (ADLs) and will benefit from home health physical therapy and occupational therapy services to enhance his recovery. \\n\\n**Medications at Discharge**: The patient will be discharged on Acetaminophen for pain management, Aspirin as an antiplatelet, Atorvastatin for hyperlipidemia, and insulin for diabetes management. Dextrose 50% and Glucose Gel were provided for hypoglycemic episodes. \\n\\n**Follow-Up Plan**: The patient is scheduled for a follow-up with his primary care physician in one week and will be referred for outpatient rehabilitation services. He has been educated on medication adherence and signs of potential complications, including increased weakness or new neurological symptoms.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 23 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with a displaced pilon fracture of the right tibia following a non-collision transport accident. He presented with significant pain and swelling in the right lower extremity. Initial evaluation included imaging studies confirming the fracture, and the decision was made to manage the injury conservatively with surgical intervention planned if required.\\n\\n**Hospital Course:**  \\nDuring the 10.6-day stay, the patient was monitored for pain management, mobility, and potential surgical needs. He received intravenous fluids initially, transitioned to a diet as tolerated, and was started on pain control with acetaminophen and oxycodone. The patient also received prophylactic enoxaparin for deep vein thrombosis prevention.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent a series of imaging studies confirming the fracture's alignment, and no surgical intervention was deemed necessary at this time. He was discharged with a knee immobilizer and instructed on weight-bearing precautions. Notable findings included a significant reduction in pain levels and improvement in mobility with the use of physical therapy.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable and ambulating with a walker. He demonstrated the ability to ascend and descend stairs with assistance, which is crucial for home health services. Home health nursing will provide wound care and monitor for any signs of complications. He will also receive physical therapy to enhance mobility and strength in the affected leg.  \\n\\n**Medications:**  \\nThe patient is discharged on the following medications: Acetaminophen, Oxycodone (Immediate Release), Cyclobenzaprine, Cephalexin, Bisacodyl, and Docusate Sodium, among others.  \\n\\n**Follow-Up Plan:**  \\nFollow-up with orthopedics is scheduled in one week for reassessment of the fracture and further management. Home health services will be initiated to ensure appropriate rehabilitation and recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 63  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted under observation for evaluation of nonrheumatic aortic valve stenosis, presenting with exertional dyspnea and fatigue. Past medical history is significant for myocardial infarction, end-stage renal disease (on dialysis), and type 2 diabetes with chronic kidney disease.  \\n\\n**Hospital Course:**  \\nDuring the 1.9-day stay, the patient underwent echocardiography which confirmed significant aortic stenosis requiring further management. The patient was started on standard medical therapy including CARVedilol and Rosuvastatin. Renal function was closely monitored due to the patient’s chronic kidney disease, and adjustments to medications were made accordingly. The patient received Heparin during dialysis sessions and was managed for hypertension and diabetes throughout the stay.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a left ventricular ejection fraction of 45%, with a peak gradient of 60 mmHg across the aortic valve. No new myocardial ischemia was detected during hospitalization. The patient was treated for constipation with Bisacodyl and monitored for potential complications related to his chronic conditions.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable upon discharge, exhibiting improved functional status compared to admission. He is able to perform activities of daily living with minimal assistance and has been educated on the importance of home health services for ongoing care management, specifically for medication adherence and monitoring of his renal status.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain management, Aspirin for cardiovascular protection, Metoprolol Tartrate, CARVedilol, Calcitriol, Cinacalcet, Doxercalciferol, Rosuvastatin, and Polyethylene Glycol for constipation. A follow-up appointment with cardiology is scheduled in one week, and home health services will initiate contact within 48 hours for medication management and renal monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient’s name]  \\n**MRN:** [Patient's medical record number]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Admitting Physician:** Dr. [Physician's name]  \\n**Consultants:** [Consultants' names]  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old male who presented to the hospital with symptoms consistent with calculus of the bile duct accompanied by cholecystitis, without obstruction. His past medical history includes obstructive sleep apnea, atherosclerotic heart disease, autoimmune hepatitis, unspecified cirrhosis of the liver, essential hypertension, hyperlipidemia, and type 2 diabetes mellitus managed with insulin.  \\n\\n**Hospital Course:**  \\nDuring his 1.6-day observation stay, the patient underwent an abdominal ultrasound and laboratory tests, confirming the diagnosis of biliary calculus. He was treated with intravenous antibiotics (Ceftriaxone, Metronidazole) and supportive care, including fluid resuscitation and pain management. The patient responded well to treatment, with significant improvement in abdominal pain and laboratory markers indicating resolution of infection.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver function tests and abdominal tenderness during the examination. No invasive procedures were required during this admission, as the patient's condition improved with conservative management.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with no acute distress. He demonstrated satisfactory functional status, capable of performing activities of daily living with minimal assistance. Home health services have been arranged to assist with medication management, monitor his diabetes, and provide education regarding lifestyle modifications.  \\n\\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Azathioprine, Ceftriaxone, Ursodiol, and Insulin, among others. He is advised to follow up with his primary care physician within one week and has been instructed to contact the home health service for ongoing support and management of his chronic conditions.\",\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 56-year-old male who presented with acute abdominal pain and was diagnosed with calculus of the gallbladder with acute cholecystitis without obstruction. The patient had a history of essential hypertension, type 2 diabetes mellitus without complications, and hyperlipidemia. He was admitted under observation for further evaluation of his symptoms and management.  \\n  \\n**Hospital Course:**  \\nDuring his 2.2-day stay, the patient was managed conservatively with IV fluids, antibiotics (Cefepime), and analgesics. His pain was effectively controlled with Hydromorphone, and he was monitored for any signs of complications. The patient's blood glucose levels were stabilized with insulin management, and he was educated on dietary modifications pertinent to his diabetes and hyperlipidemia.  \\n  \\n**Key Findings and Procedures:**  \\nThe main finding was the presence of gallbladder calculus leading to acute cholecystitis. No surgical intervention was needed at this time due to the absence of obstruction. The patient was also evaluated for incidental findings of an old myocardial infarction and acute prostatitis, which were addressed during his stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved abdominal pain and no signs of acute distress. He was ambulating independently and demonstrated an understanding of his medication regimen and dietary restrictions. Due to his chronic conditions, he will benefit from home health services for ongoing monitoring of his diabetes management and dietary compliance.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen as needed for pain  \\n- Metoprolol Tartrate for hypertension  \\n- Insulin for glycemic control  \\n- Docusate Sodium for constipation prevention  \\nHe is scheduled for follow-up with his primary care physician within 1 week and will receive home health visits for medication management and dietary counseling.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- Age: 30  \\n- Gender: Male  \\n- Admission Type: Emergency  \\n\\n**History of Present Illness:**  \\nThe patient, a 30-year-old male, presented to the emergency department with complaints of unilateral swelling, redness, and pain in the right lower limb. He reported a gradual onset of symptoms over the past week, with associated fever and chills. Upon examination, the right lower limb was warm, erythematous, and tender to palpation, consistent with cellulitis. The patient has a notable history of obesity (BMI 60.0-69.9) and was also diagnosed with asthma.  \\n\\n**Hospital Course:**  \\nDuring his 4.9-day hospital stay, the patient received intravenous antibiotics, including vancomycin and cephalexin, to address the cellulitis and any potential underlying infection. He was also started on pain management with oxycodone and supportive care, including IV fluids (0.9% sodium chloride). The patient was monitored for signs of systemic infection and responded well to treatment with improvement in symptoms and laboratory markers.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests indicated leukocytosis, and imaging ruled out deep vein thrombosis. He underwent the procedure of incision and drainage of a cutaneous abscess in the right lower limb, which provided significant symptomatic relief.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient exhibited improved functional status, with reduced limb swelling and pain. He ambulated with minimal assistance and was able to perform activities of daily living. However, he will require ongoing home health services for wound care management and monitoring of his condition to prevent recurrence.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed the following medications:  \\n- Vancomycin (oral)  \\n- Cephalexin (oral)  \\n- Acetaminophen for pain management  \\n- Ipratropium-Albuterol nebulizer for asthma  \\n- Sulfameth/Trimethoprim DS for potential secondary infections  \\n- Heparin for DVT prophylaxis  \\nThe patient is advised to follow up with his primary care physician within one week and to contact home health services for regular assessments and wound care.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 68 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 6.4 days  \\n**Primary Diagnosis:** Localization-related symptomatic epilepsy with simple partial seizures (ICD10: G40109)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of recurrent simple partial seizures, which had increased in frequency over the past month. He has a known history of epilepsy, hypertension, chronic obstructive pulmonary disease (COPD), and peripheral vascular disease.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient underwent a thorough neurological assessment, including EEG monitoring, which confirmed the presence of focal epileptic discharges. He was started on levetiracetam, with gradual titration to an effective dose. The patient also received supportive care for his COPD, including bronchodilator therapy and oxygen supplementation as needed.  \\n  \\n**Key Findings and Procedures:**  \\nNeurological examination revealed no new focal deficits. An MRI of the brain showed no acute intracranial changes. Cardiac evaluation indicated stable hypertension, managed with losartan and atorvastatin. The patient's COPD was stable at discharge, and he was counseled on smoking cessation strategies due to his personal history of nicotine dependence.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge. He is alert, oriented, and able to perform activities of daily living with minimal assistance. He will benefit from home health services for ongoing monitoring of his epilepsy and COPD management, including medication adherence and pulmonary rehabilitation.  \\n  \\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Atorvastatin  \\n3. Citalopram  \\n4. GuaiFENesin-Dextromethorphan  \\n5. Heparin  \\n6. Influenza Vaccine Quadrivalent  \\n7. Loperamide  \\n8. Lorazepam  \\n9. Levetiracetam  \\n10. Losartan Potassium  \\n11. Sodium Chloride 0.9% Flush  \\n12. Tiotropium Bromide  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and will have follow-up neurology appointments to monitor seizure control and medication side effects. Home health services will initiate visits to ensure continuity of care.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 79-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 8.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an infection following a surgical procedure, specifically an infected surgical site (ICD10: T8149XA). She has a significant medical history, including hypertensive heart disease, chronic kidney disease (stage 4), and chronic systolic heart failure, among other comorbidities.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was treated with intravenous antibiotics, including Cefpodoxime and Metronidazole, along with supportive care for her chronic conditions. Her renal function was monitored closely due to her chronic kidney disease and acute kidney failure during the admission. Fluid management was implemented, and she was transitioned to furosemide for diuresis. The patient's infection was managed effectively, and she showed significant improvement prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient presented with fever and localized redness at the surgical site. Imaging studies were conducted to rule out abscess formation. Laboratory tests showed elevated inflammatory markers, which normalized towards the end of her hospitalization. She underwent a comprehensive assessment, including cardiac monitoring due to her history of atrial fibrillation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved vital signs and resolution of the infection. She is able to ambulate with assistance and requires home health services for ongoing monitoring of her renal function and heart failure management. The patient will benefit from physical therapy to improve her strength and mobility.  \\n  \\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient will continue on home medications, including Acetaminophen, Apixaban, Levothyroxine, Metoprolol, and Furosemide. A follow-up appointment with her primary care physician and a nephrologist is scheduled within one week. Home health services will monitor her condition and medication adherence, ensuring appropriate interventions as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 56, Gender: Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with symptomatic orthostatic hypotension, presenting with dizziness and near-syncope episodes. He has a complex medical history, including severe protein-calorie malnutrition and multiple myeloma, which has not achieved remission. The patient also has a background of major depressive disorder and polyneuropathy.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was stabilized with intravenous fluids and electrolyte management. A multidisciplinary team was involved, including nutritionists to address his malnutrition, and a psychiatrist who assessed his depressive symptoms. The patient underwent physical therapy to improve his strength and mobility, which were compromised due to his underlying conditions and recent hospitalization.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s vital signs stabilized, and he showed improvement in his orthostatic hypotension. Laboratory tests revealed persistent pancytopenia, attributed to his chemotherapy history. Nutritional support was initiated, and he was educated on dietary modifications. A comprehensive medication review was conducted, and adjustments were made to optimize his management. He received education on the importance of hydration and gradual position changes to mitigate orthostatic symptoms.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires home health services for ongoing monitoring of his vital signs and medication management. He will benefit from physical therapy at home to enhance mobility and balance. The patient is encouraged to participate in daily activities safely and has been provided with a walker to assist with ambulation.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include: 0.9% Sodium Chloride, Acetaminophen, Dexamethasone, Gabapentin, and DULoxetine. He is to follow up with his oncologist in one week for reevaluation of his myeloma and nutritional status. Home health nursing will initiate services within 48 hours to assess his needs and ensure adherence to the medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 66 years  \\nGender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of an incisional hernia with obstruction (ICD-10: K430). She presented with acute abdominal pain, nausea, and vomiting. The hernia was previously identified, but recent symptoms indicated a significant change in her clinical status, leading to this admission for further evaluation and intervention.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a thorough evaluation, including imaging studies that confirmed the presence of the obstructed hernia. Conservative management was initiated, including bowel rest and intravenous fluids. Pain was managed with a combination of acetaminophen and hydromorphone. The patient was monitored closely for signs of complications, and her condition improved steadily without the need for surgical intervention.  \\n\\n**Key Findings and Procedures:**  \\nThe patient experienced acute postprocedural pain (ICD-10: G8918) and other chronic pain issues (ICD-10: G8929), which were addressed appropriately. She also exhibited fever (ICD-10: R509) during her stay, which resolved with antipyretic treatment. Her obesity (ICD-10: E669) was noted, with a BMI of 39.0-39.9, which may contribute to her ongoing health issues.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented, with significant improvement in her symptoms. She is able to perform activities of daily living with some assistance, particularly regarding mobility due to her obesity and pain management needs. Home health services have been arranged to assist with wound care and pain management, ensuring continuity of care and support in her recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nMedications at discharge include 5% dextrose, acetaminophen, hydromorphone, and ketorolac for pain management, alongside ondansetron for nausea. The patient will receive a follow-up appointment with her primary care physician within the next week to monitor her recovery and to evaluate her ongoing health needs.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Initials]  \\n**Age:** 38  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of a second-degree perineal laceration sustained during a vaginal delivery. The patient also presented with pyrexia during labor and was found to be a carrier of Group B Streptococcus. She delivered a single live birth following an episode of premature rupture of membranes with the onset of labor occurring within 24 hours.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received appropriate wound care and pain management. Her fever was managed with antipyretics, and she was monitored for any signs of infection. The perineal laceration was assessed and found to be healing well. There were no complications during her recovery, and she demonstrated good functional status.  \\n  \\n**Key Findings and Procedures:**  \\n- Primary diagnosis: Second-degree perineal laceration (ICD10: O701)  \\n- Additional diagnoses included pyrexia during labor and Group B Streptococcus carrier status complicating childbirth.  \\n- Procedures performed included perineal repair (ICD10: 0KQM0ZZ) and routine postpartum care (ICD10: 10E0XZZ).  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently with no significant pain. She is advised to perform pelvic floor exercises as tolerated to enhance recovery. The patient will require home health services for wound care management and monitoring for any potential complications following discharge.  \\n  \\n**Medications on Discharge:**  \\n1. Acetaminophen  \\n2. Ibuprofen  \\n3. Docusate Sodium  \\n4. Bisacodyl  \\n5. Milk of Magnesia  \\n6. Calcium Carbonate  \\n7. Dermoplast Spray  \\n8. Prenatal Vitamins  \\n9. Simethicone  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week. Home health services will be initiated to assist with wound care and overall postpartum recovery.',\n",
       " \"**Patient Summary:** 57-year-old male admitted for surgical intervention due to atherosclerosis of the native arteries of the right leg exhibiting rest pain. \\n\\n**History of Present Illness:** The patient presented with significant rest pain in the right leg, which was exacerbated by activity. His past medical history is notable for essential hypertension, nicotine dependence, and chronic ulcers on the left foot due to atherosclerosis. He was initially evaluated in the vascular surgery clinic and subsequently admitted for a surgical procedure involving revascularization. \\n\\n**Hospital Course:** The patient underwent a successful revascularization procedure on the right leg, which improved blood flow. Postoperatively, he experienced a brief episode of fever managed with antipyretics. Pain management was addressed with a multimodal approach including opioid and non-opioid analgesics. The patient's condition stabilized, and he was monitored closely for any signs of complications. He demonstrated good mobility with physical therapy and was able to perform activities of daily living with minimal assistance by discharge. \\n\\n**Key Findings and Procedures:** The main procedure performed was revascularization of the right lower extremity (ICD-10: 041K09N). The patient was also treated for a non-pressure chronic ulcer of the left foot (ICD-10: L97528), and his hyperlipidemia was managed with atorvastatin. \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition with improved limb perfusion and functional capacity. He is able to ambulate with a walker and is independent in basic self-care tasks. Home health services are recommended for ongoing wound care and physical rehabilitation to enhance recovery. \\n\\n**Medications at Discharge:** Upon discharge, the patient was prescribed acetaminophen, aspirin EC, atorvastatin, ciprofloxacin HCl, clopidogrel, gabapentin, hydromorphone, heparin, iso-osmotic dextrose, metronidazole, sodium chloride 0.9%, and vancomycin. Follow-up with the vascular surgeon is scheduled in one week to assess healing and further management of his vascular health.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 58-year-old female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 11.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe sepsis due to Escherichia coli, presenting with high fever, tachycardia, and hypotension. She reported abdominal pain and altered mental status, leading to a code grey upon arrival. Initial laboratory tests indicated elevated white blood cell count and lactate levels, confirming the diagnosis of severe sepsis with septic shock.\\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received broad-spectrum intravenous antibiotics and aggressive fluid resuscitation. She was closely monitored in the ICU for hemodynamic stability. Multiple imaging studies were performed, revealing a perforation of the intestine with peritonitis. An exploratory laparotomy was conducted, resulting in bowel resection and management of the perforation. Post-operatively, she developed transient atrial fibrillation, which was managed with metoprolol. Throughout her recovery, electrolyte imbalances were corrected, and nutritional support was provided.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included severe sepsis, intestinal perforation, and subsequent bowel resection. The patient underwent several procedures, including exploratory laparotomy and fluid management interventions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient is stable but requires assistance with activities of daily living due to weakness and fatigue from her prolonged hospitalization. She is alert and oriented but exhibits poor appetite. Home health services are advised for nursing care and assistance with rehabilitation exercises to regain strength and independence.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed acetaminophen for pain management, metoprolol for heart rate control, and antibiotics (metronidazole) to prevent infection. She is also advised to continue potassium chloride for electrolyte balance and insulin for blood sugar management. The patient should follow up with her primary care physician in one week and with a gastroenterologist within two weeks post-discharge.',\n",
       " \"**Discharge Summary:**  \\n**Patient:** 69-year-old male  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 5.7 days  \\n**Diagnosis:** Atherosclerosis of native arteries of extremities with gangrene, right leg (ICD-10: I70.261)  \\n\\n**History of Present Illness:** The patient was admitted for surgical intervention due to significant atherosclerosis affecting his right leg, leading to gangrene. He presented with severe pain, non-healing ulcers, and limb ischemia.  \\n\\n**Hospital Course:** The patient underwent a successful surgical procedure, including debridement and vascular intervention to restore blood flow. Postoperatively, he experienced stable vital signs and was monitored for infection and pain management. He was treated with broad-spectrum antibiotics, including Amoxicillin-Clavulanic Acid and Ceftriaxone, as well as anticoagulation therapy with Heparin. The patient's renal function was closely monitored, and he received diuretics for fluid management. He was also started on Metoprolol for atrial fibrillation management and was provided with supportive care.  \\n\\n**Key Findings and Procedures:** The patient was found to have chronic total occlusion of the artery of the extremities and osteomyelitis of the right foot, necessitating surgical intervention. Post-surgery, he demonstrated improved perfusion to the right leg, and the surgical site showed no signs of infection.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable for discharge, ambulating with assistance, and capable of performing activities of daily living with some support. He requires home health services for wound care management and physical therapy to enhance mobility and prevent complications.  \\n\\n**Medications at Discharge:** The patient will continue on several medications, including Furosemide, Potassium Chloride, and Magnesium supplements. He was advised to take Aspirin for cardiovascular protection and to follow up with his primary care physician for ongoing management of his atherosclerosis and atrial fibrillation.  \\n**Follow-Up Plan:** A follow-up appointment is scheduled in one week to assess recovery progress and medication management. Home health services will be initiated to assist with wound care and rehabilitation.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID**: [REDACTED]  \\n**Date of Admission**: [REDACTED]  \\n**Date of Discharge**: [REDACTED]  \\n**Admitting Physician**: [REDACTED]  \\n**Age**: 53  \\n**Gender**: Female  \\n  \\n**History of Present Illness**:  \\nThis 53-year-old female presented to the emergency department with worsening right shoulder pain and limited range of motion, attributed to primary osteoarthritis. The patient has a significant medical history, including a prothrombin gene mutation, a history of pulmonary embolism, and personal history of nicotine dependence.  \\n  \\n**Hospital Course**:  \\nDuring her 4.6-day hospital stay, the patient underwent a thorough evaluation and management of her osteoarthritis and associated pain. She was treated with a multimodal analgesic regimen, including acetaminophen, tramadol, and hydrocodone. Additionally, she received topical treatments with hydrocortisone cream and Sarna lotion for skin irritation. The patient was monitored closely due to her anticoagulant therapy with warfarin, and her INR levels were maintained within therapeutic range.  \\n  \\n**Key Findings and Procedures**:  \\nOn physical examination, the patient demonstrated tenderness and decreased range of motion in the right shoulder. Imaging studies confirmed advanced osteoarthritis. No surgical interventions were required. A comprehensive pain management strategy was implemented, and the patient showed significant improvement in pain control and functional mobility by discharge.  \\n  \\n**Discharge Condition and Functional Status**:  \\nThe patient is being discharged in stable condition, able to ambulate with assistance and perform activities of daily living with modified independence. She has been educated on her condition, pain management strategies, and the importance of adhering to follow-up appointments. Home health services will be initiated to assist with physical therapy for shoulder rehabilitation and to monitor her anticoagulation therapy.  \\n  \\n**Medications at Discharge**:  \\n1. Acetaminophen  \\n2. HydrOXYzine  \\n3. Hydrocortisone Cream 1%  \\n4. Ondansetron  \\n5. Sarna Lotion  \\n6. Tramadol  \\n7. Warfarin  \\n  \\n**Follow-up Plan**:  \\nThe patient is to follow up with her primary care physician within one week for ongoing management of her osteoarthritis and anticoagulation therapy. Home health services will provide support for rehabilitation and medication management.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 63-year-old male with a history of spinal stenosis in the lumbar region with neurogenic claudication, admitted electively for pain management and surgical evaluation. He reported worsening lower back pain and intermittent claudication that has significantly affected his mobility and quality of life.\\n\\n**Hospital Course:**  \\nDuring his 3-day stay, the patient underwent a comprehensive evaluation, including imaging studies that confirmed the diagnosis of spinal stenosis. He was treated with a multimodal pain management regimen, including opioids (OxyCODONE and Morphine Sulfate), acetaminophen, and adjunct medications such as ondansetron for nausea and bisacodyl for constipation. He was also started on hydration therapy with Sodium Chloride 0.9% flush and received prophylactic heparin to prevent thromboembolic events. The patient received an influenza vaccine to optimize his overall health.\\n\\n**Key Findings and Procedures:**  \\nThe patient's pain was adequately managed, and he demonstrated improved mobility by the time of discharge. No complications arose during his hospitalization, and he was stable for discharge. The patient was educated on his condition and the importance of adherence to the home health plan.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was ambulating with assistance and demonstrated the ability to perform activities of daily living with minimal support. Home health services will be initiated to assist with physical therapy and monitor his recovery, as he continues to experience some limitations in mobility. A follow-up appointment with his primary care physician and a neurosurgeon was scheduled to review further management options.\\n\\n**Medications:**  \\nThe patient was discharged on the following medications: Acetaminophen, OxyCODONE (Immediate Release), Morphine Sulfate, Ondansetron, Docusate Sodium, Bisacodyl, and HydrALAZINE. All medications were reviewed with the patient and family to ensure understanding of dosing and potential side effects.\\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with the neurosurgeon within two weeks. Home health services will be arranged to provide necessary support and therapy.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date:** [Insert Date]  \\n**Admit Date:** [Insert Admit Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n  \\n**Patient Information:**  \\n- **Name:** [Insert Patient Name]  \\n- **Age:** 69 years  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a chronic duodenal ulcer with hemorrhage (ICD10: K264). She presented with abdominal pain, nausea, and hematemesis. The patient has a history of type 2 diabetes mellitus with diabetic polyneuropathy and chronic heart failure.  \\n  \\n**Hospital Course:**  \\nDuring her 8.9-day hospital stay, the patient was managed with intravenous fluids, pain control, and proton pump inhibitors. She underwent endoscopy for direct intervention to the ulcer. Her hemoglobin levels stabilized, and she was monitored for signs of further gastrointestinal bleeding.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a significant duodenal ulcer with active bleeding observed during endoscopic evaluation. Other notable diagnoses during the stay included hypertensive heart disease with heart failure and gastroparesis. Procedures performed included endoscopic intervention (0DJ08ZZ) and the placement of a nasogastric tube (0FB98ZX).  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved abdominal pain and resolution of nausea. Functional status is adequate for home care, but she will require assistance with daily activities due to her underlying conditions, including her diabetes management and heart failure monitoring. Home health services are recommended for nursing care and dietary management.  \\n  \\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed the following medications: Acetaminophen, Pantoprazole, Lisinopril, and Insulin. She is advised to continue with her diabetes medications and follow up with her primary care physician within one week. Home health nursing will monitor her vital signs and assist with medication management and dietary adherence.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 27  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the hospital with complications during labor characterized by an abnormality in fetal heart rate and rhythm (ICD10 O76). The delivery was complicated by a second-degree perineal laceration. She was admitted at 40 weeks gestation, resulting in a successful delivery of a single live birth.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was monitored closely for maternal and fetal well-being. Continuous fetal monitoring was instituted due to the initial abnormal heart rate patterns. After stabilization, the patient underwent a vaginal delivery with an episiotomy and sustained a second-degree perineal laceration, which was repaired prior to discharge. Pain management was initiated with acetaminophen and ibuprofen, and stool softeners were provided to ease bowel movements post-delivery. The patient received appropriate education on perineal care and signs of infection post-discharge.  \\n  \\n**Key Findings and Procedures:**  \\n- **Primary Diagnosis:** Abnormality in fetal heart rate and rhythm complicating labor and delivery  \\n- **Procedures:** Vaginal delivery with repair of second-degree perineal laceration  \\n- **Medications Administered:** Acetaminophen, Ibuprofen, Docusate Sodium, and others as listed  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and ambulating independently with no acute distress. She has been educated on post-operative care, including the management of perineal laceration and signs of infection. Home health services have been arranged to assist with ongoing assessments of recovery and education on newborn care.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Ibuprofen, Docusate Sodium, Dermoplast Spray for perineal care, and an influenza vaccine. A follow-up appointment is scheduled with her obstetrician in one week to monitor recovery and assess the healing of the perineal laceration.',\n",
       " \"**Discharge Summary**  \\n**Patient Identification:**  \\n**Name:** [Patient Name]  \\n**Age:** 85  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.9 days  \\n\\n**History of Present Illness:**  \\nThe patient is an 85-year-old female with a history of secondary malignant neoplasm of intrathoracic lymph nodes (ICD10: C771), who presented with worsening respiratory symptoms and a malignant pleural effusion (ICD10: J910). During her stay, she was evaluated for potential complications related to her malignancy and associated symptoms.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a thorough workup, including imaging studies that confirmed the presence of pleural effusion consistent with her malignant disease. She was treated with appropriate interventions aimed at symptom management, including diuretics and respiratory support. The patient also received supportive care for her hypertension and was monitored for any signs of infections or complications related to her underlying conditions.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's vital signs remained stable, and she responded well to treatment. A thoracentesis was performed which provided symptomatic relief, and further imaging studies indicated no acute process requiring immediate intervention. The patient's functional status improved, and she was able to participate in daily activities with minimal assistance.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and has satisfactory control of her symptoms. She is independent with activities of daily living, though she requires some assistance with mobility and medication management. The patient will benefit from home health services to monitor her condition and provide support with her medications and mobility exercises.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Anastrozole  \\n3. Docusate Sodium  \\n4. Heparin  \\n5. Ipratropium-Albuterol Neb  \\n6. Metoprolol Tartrate  \\n7. Multivitamins  \\n8. OxyCODONE (Immediate Release)  \\n9. Senna  \\n10. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her oncologist within one week of discharge. Home health services will initiate a visit to assess her medication compliance and overall well-being. Close monitoring for any signs of respiratory distress or changes in her condition is essential.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 58  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a diagnosis of cellulitis of the right lower limb. He presented with swelling, erythema, and significant pain in the affected area. Notable medical history includes hemiplegia following a cerebral infarction affecting the right dominant side, essential hypertension, and peripheral vascular disease.  \\n  \\n**Hospital Course:**  \\nDuring his brief hospital stay of 0.9 days, the patient was initiated on intravenous vancomycin to treat the cellulitis effectively. Pain management was addressed with acetaminophen and oxycodone as needed. He was closely monitored for signs of systemic infection and any complications related to his underlying conditions.  \\n  \\n**Key Findings and Procedures:**  \\nAt the time of discharge, the cellulitis showed marked improvement, with reduced erythema and swelling. Laboratory tests indicated stable hemoglobin levels but revealed mild anemia. The patient’s vital signs remained stable throughout his stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in a stable condition, though he continues to require assistance with activities of daily living due to his dependence on a wheelchair. He will benefit from home health services for wound care, medication management, and physical therapy to improve mobility and prevent further complications.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Baclofen  \\n4. Folic Acid  \\n5. Heparin  \\n6. Influenza Vaccine Quadrivalent (if due)  \\n7. Iso-Osmotic Dextrose  \\n8. Lisinopril  \\n9. Multivitamins  \\n10. Oxycodone (Immediate Release)  \\n11. Sodium Chloride 0.9% Flush  \\n12. Trazodone  \\n13. Vancomycin  \\n14. Vitamin B Complex  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week post-discharge. Home health services will be arranged to assist with wound care and rehabilitation. All medications should be continued as prescribed.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 39 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 8 days  \\n**Primary Diagnosis:** Unspecified atrial flutter (I4892)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of atrial flutter, presenting with palpitations and associated shortness of breath. A detailed assessment was completed to rule out underlying causes. Initially, the patient was in stable condition, but he developed pneumonia during admission, necessitating antibiotic therapy.\\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent continuous telemetry monitoring due to his cardiac rhythm disturbance. A transthoracic echocardiogram was performed, revealing no significant structural abnormalities. The patient was treated with Diltiazem extended-release for rate control and was started on Apixaban for anticoagulation given his atrial flutter. Throughout his stay, the patient received supportive care, including saline and dextrose infusions, along with symptom management for pneumonia and other concurrent issues such as insomnia and chronic hypertension.\\n\\n**Key Findings and Procedures:**  \\nThe notable findings included persistent atrial flutter and pneumonia secondary to unspecified organisms. He was also noted to have a history of diffuse large B-cell lymphoma and was receiving methotrexate as part of his long-term treatment plan. He required supportive care with oxygen supplementation and was treated with bronchodilators and expectorants.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory status and was hemodynamically stable. He is ambulating with minimal assistance and reports reduced palpitations, although continues to require monitoring of his cardiac status. His functional status has improved, allowing him to perform activities of daily living (ADLs) with some assistance.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is being discharged on Apixaban, Diltiazem, and other supportive medications including Cetirizine and Ondansetron. A prescription for long-term potassium chloride replacement is also provided. He will follow up with cardiology and primary care within one week of discharge. Home health services have been arranged to assist with medication management and monitoring of his cardiac condition. Home health professionals will also support his pulmonary care and ensure adherence to his medical regimen.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 60  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 60-year-old male who presented to the emergency department with acute chest pain and was subsequently diagnosed with a ST elevation myocardial infarction (STEMI) involving other sites (ICD10: I2129). Initial evaluation revealed elevated cardiac markers and an ECG demonstrating ST-segment elevation. He has a significant past medical history, including essential hypertension, type 2 diabetes mellitus, and a liver transplant status.  \\n\\n**Hospital Course:**  \\nThe patient was admitted for monitoring and management of his myocardial infarction. He underwent cardiac catheterization with successful percutaneous coronary intervention (PCI) and stenting of occluded native coronary arteries. Throughout his hospital stay, he was closely monitored for complications, and he responded well to medical management including antithrombotics and insulin therapy. The patient's diabetes was controlled with a combination of oral hypoglycemics and insulin.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included persistent angina, requiring adjustments to his analgesic regimen. Furthermore, his anxiety was managed with lorazepam. Key procedures included coronary angiography and stent placement (ICD10: 027034Z, 02703ZZ).  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable and ambulating independently. He demonstrates good understanding of his medications and follow-up care. He is advised to avoid strenuous activities and has been referred to home health services for continued monitoring and support in managing his diabetes and cardiac rehabilitation.  \\n\\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Atorvastatin  \\n3. Carvedilol  \\n4. Insulin  \\n5. Gabapentin  \\n6. Docusate Sodium  \\n7. Bisacodyl  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week for reassessment of his cardiac status and diabetes management. Home health services will be initiated to assist with monitoring his blood glucose levels and medication adherence.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 74-year-old female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 8 days  \\n**Primary Diagnosis:** Cardiac arrhythmia, unspecified (I49.9)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted via emergency services after presenting with palpitations, shortness of breath, and lower extremity edema. Initial evaluation revealed cardiac arrhythmia and acute on chronic diastolic heart failure. The patient's past medical history includes type 2 diabetes with neuropathy and hypertension.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored in telemetry for arrhythmias and received diuretics for fluid overload. A thorough workup demonstrated acute kidney injury likely secondary to heart failure exacerbation. She was treated with intravenous diuretics and fluid management. Cardiology was consulted and initiated antiarrhythmic therapy with Carvedilol, while her other chronic medications were adjusted.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant hyperkalemia (managed with insulin and dextrose), and the patient was stabilized without the need for invasive procedures. A 2D echocardiogram revealed left ventricular hypertrophy with preserved ejection fraction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved symptoms and functional status. She can perform activities of daily living with minimal assistance and will require home health services for medication management, monitoring of blood pressure and glucose levels, and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Atorvastatin  \\n4. Carvedilol  \\n5. Clopidogrel  \\n6. Insulin  \\n7. Dextrose 10% in Water  \\n8. Dorzolamide 2%/Timolol 0.5% Ophth.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with primary care within one week, and cardiology in two weeks. Home health to initiate within 48 hours for monitoring and support.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 73  \\n- **Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 12.2 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 73-year-old male with a history of hypertensive heart disease and stage 4 chronic kidney disease, who was admitted for management of acute decompensated heart failure, likely exacerbated by his chronic conditions. He presented with worsening dyspnea, fatigue, and edema.  \\n\\n**Hospital Course:**  \\nDuring his 12-day stay, the patient was monitored closely for cardiac and renal function. He was treated with diuretics and cardioprotective medications including amiodarone and milrinone, which were adjusted based on his clinical response and renal function. The patient experienced episodic atrial fibrillation, which was managed accordingly. Additionally, he received supportive care for his chronic kidney disease, including electrolyte monitoring and adjustment of medications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, worsening renal function with a creatinine level of 3.2 mg/dL, and evidence of cardiogenic shock. An echocardiogram confirmed decreased ejection fraction consistent with heart failure. The patient underwent a cardiac assessment and was fitted with an automatic implantable cardiac defibrillator (AICD) prior to discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable but required assistance with activities of daily living due to persistent fatigue and weakness. He was ambulating with assistance and required close monitoring of his heart rate and blood pressure. Home health services have been arranged to assist with medication management, dietary education, and physical therapy to promote mobility and strength recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Apixaban, Amiodarone, Docusate Sodium, Empagliflozin, and Levothyroxine Sodium among others. The patient is advised to follow up with his primary care physician and a cardiologist within one week post-discharge. Home health services are to initiate within 48 hours to ensure continuity of care and support.',\n",
       " '**Patient Summary:**  \\n**Age:** 44 years  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with severe abdominal pain, nausea, and vomiting, secondary to chronic pancreatitis, exacerbated by his underlying HIV disease. Upon examination, he presented with cachexia and signs of dehydration. His past medical history is significant for HIV, chronic pancreatitis, and opioid dependence.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was stabilized with IV fluids and pain management. He received a regimen including Darunavir and Emtricitabine-Tenofovir, which were adjusted based on his renal function. The patient was treated for acute pain with hydromorphone and gabapentin, alongside medications for nausea and anxiety. His nutritional status was closely monitored, and he received dietary consultations.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed elevated pancreatic enzymes, and imaging studies ruled out gallstones. A routine HIV viral load was undetectable, indicating effective antiretroviral therapy. The patient underwent nutritional counseling due to his low BMI (19.9) and was started on Creon for pancreatic enzyme replacement.  \\n\\n**Discharge Condition and Functional Status:**  \\nBy the time of discharge, the patient was stable, with improved pain management and hydration status. He demonstrated the ability to perform activities of daily living with minimal assistance but will require ongoing support. He has been referred to home health services for continued nutritional support and monitoring of his HIV and pancreatitis management.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue the following medications: Acetaminophen, Acyclovir, Creon 12, Darunavir, Diazepam, Gabapentin, Ondansetron, Oxycodone (SR and IR), and a multivitamin. An appointment is scheduled in one week for follow-up with Infectious Disease and Gastroenterology. Home health services will provide additional support for medication management and nutritional guidance.',\n",
       " \"**Patient Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 69  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for management of an infection following a recent procedure, classified as T814XXA. He presented with fever, chills, and localized pain, which prompted immediate intervention.  \\n\\n**Hospital Course:**  \\nDuring his 4.5-day stay, the patient received intravenous antibiotics, including CefePIME and MetroNIDAZOLE, with gradual clinical improvement. Supportive care included fluid management with Lactated Ringer's and 0.9% Sodium Chloride to address electrolyte imbalances. His renal function and electrolytes were closely monitored due to hypo-osmolality and hyponatremia. Pain management was achieved with Morphine Sulfate and OxyCODONE, and he was assessed daily by the surgical team.  \\n\\n**Key Findings and Procedures:**  \\nDiagnostics revealed bacteremia, and further imaging with Gastroview was performed to rule out abscess formation. The patient tolerated all procedures well and exhibited no signs of further complications. His condition stabilized, and he was weaned off IV medications to oral regimens before discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated significant improvement with stable vital signs and resolution of fever. He is ambulating independently with minimal assistance and has been educated on signs of infection recurrence. Home health services will facilitate ongoing monitoring of wound healing and medication adherence. The patient will need assistance with activities of daily living (ADLs) as he continues to regain strength.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient’s medication regimen includes Acetaminophen, Omeprazole, Ondansetron, and Docusate Sodium for symptom management. He is to follow up with his primary care physician in one week and will have home health nursing visits to monitor his recovery and ensure compliance with antibiotic therapy.\",\n",
       " \"**Patient Name:** [REDACTED]  \\n**Age:** 72  \\n**Gender:** Female  \\n**Admission Date:** [REDACTED]  \\n**Discharge Date:** [REDACTED]  \\n\\n**History of Present Illness:**  \\nThe patient, a 72-year-old female, was admitted through the emergency department with acute kidney failure, unspecified (ICD-10: N179). The patient has a history of chronic myeloid leukemia, hypertension, type 2 diabetes mellitus, and peripheral artery disease. She presented with symptoms of fatigue, decreased urine output, and generalized weakness.  \\n\\n**Hospital Course:**  \\nDuring her 10-day hospital stay, the patient's renal function was closely monitored. She received intravenous fluids, electrolyte management, and was started on hemodialysis due to worsening renal parameters. Her chronic myeloid leukemia was discussed, and she was found to be in remission. The patient also experienced non-pressure chronic ulcers of the right foot, which were treated with wound care.  \\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated creatinine and urea levels, indicating acute kidney injury. Imaging studies ruled out obstructive uropathy. The patient underwent two sessions of hemodialysis (ICD-10: 047M3DZ, 047P3ZZ) with subsequent improvement in renal function.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved renal function and resolution of acute symptoms. She is ambulating with assistance and requires skilled nursing care for wound management and monitoring of her diabetes and hypertension. Home health services are recommended to assist with her medications and ensure adherence to dietary restrictions pertinent to her renal condition.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: 5% Dextrose, Acetaminophen, Amlodipine, Aspirin, Atorvastatin, Clopidogrel, Docusate Sodium, Hydrochlorothiazide, Insulin, and others as needed.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her nephrologist and oncologist within one week post-discharge. Home health services will initiate visits to monitor her condition and facilitate wound care.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nPatient is a 24-year-old female admitted urgently with decreased fetal movements in the third trimester of pregnancy.  \\n\\n**History of Present Illness:**  \\nThe patient presented with reports of decreased fetal movements over the past 48 hours. Initial assessment indicated an abnormal fetal heart rate pattern. The patient was monitored closely for fetal well-being and maternal status throughout her admission.\\n\\n**Hospital Course:**  \\nThe patient was admitted for observation and underwent continuous fetal monitoring. Laboratory tests were performed, including blood work and ultrasound evaluation, which indicated a need for close monitoring for potential complications. The patient also received intravenous fluids and medications to manage her symptoms. During her stay, she displayed signs of anxiety and a depressive mood, which were addressed with supportive care and psychiatric consultation. The team provided education regarding fetal movements and labor signs.\\n\\n**Key Findings and Procedures:**  \\nFetal monitoring showed intermittent decelerations, prompting additional ultrasound assessments. The patient was treated with MedroxyPROGESTERone Acetate to support fetal stability. A discussion regarding the risks of potential labor induction was held, and it was decided to continue monitoring until fetal status improved. The patient remained stable and was discharged with a single live birth anticipated.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with a reassuring fetal heart rate and improved maternal anxiety. She is able to perform activities of daily living with some assistance needed for anxiety management. Home health services will be beneficial for ongoing mental health support and postpartum education as she approaches her delivery.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Ibuprofen for pain management, and Docusate Sodium as needed. The patient is advised to continue with Lactated Ringers for hydration. A follow-up appointment with obstetrics is scheduled within one week or sooner if symptoms worsen. Home health services will follow up for mental health support and postpartum care.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [ID]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 49-year-old male admitted for evaluation and management of an intraspinal abscess and granuloma, associated with significant back pain and neurological symptoms. The patient has a history of opioid dependence and presented with worsening symptoms despite outpatient management.  \\n  \\n**Hospital Course:**  \\nDuring his 19-day stay, the patient underwent multiple imaging studies including MRI, confirming the diagnosis of an intraspinal abscess. He was treated with intravenous antibiotics, including Cefazolin and Dalbavancin, and underwent catheter clearance procedures. The patient exhibited gradual improvement in pain and neurologic function, although he experienced some episodes of myoclonus and required adjustment of his gabapentin and hydromorphone regimen.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent bacteremia, osteomyelitis of the thoracic vertebra, and postprocedural hematoma. The patient underwent three surgical interventions to drain the abscess effectively. He was closely monitored for adverse reactions to anticoagulants due to his history of pulmonary embolism and was managed with Apixaban during his hospital stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable, with significantly reduced back pain and improved mobility. He can perform basic activities of daily living with minimal assistance but will benefit from home health services for continued rehabilitation and monitoring, particularly for pain management and mobility training.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe discharge medication regimen includes 5% Dextrose, Acetaminophen, Apixaban, Gabapentin, and Ibuprofen among others. The patient is advised to follow up with his primary care physician in one week, and a home health nurse will visit for wound care and medication management. The patient has been educated on signs of infection and when to seek immediate medical attention.',\n",
       " '**Patient Information:**  \\nAge: 53 years  \\nGender: Male  \\n\\n**Brief History of Present Illness:**  \\nThe patient presented to the emergency department with palpitations and shortness of breath. He has a history of unspecified atrial fibrillation, which was noted to be acute during this admission. He also has a significant medical history including myocardial infarction, essential hypertension, hyperlipidemia, and a personal history of nicotine dependence.\\n\\n**Hospital Course:**  \\nUpon admission, the patient was stabilized with IV fluids and transitioned to oral medications. He was started on Apixaban for anticoagulation and Metoprolol for rate control of atrial fibrillation. His cardiac enzymes were monitored, and he was assessed for any underlying myocardial ischemia. The patient also underwent a comprehensive evaluation by cardiology and was found to have no acute changes on echocardiogram. He did experience some transient episodes of dyspnea, likely related to his history of asthma, which were managed with an Albuterol inhaler.\\n\\n**Key Findings and Procedures:**  \\nElectrocardiogram revealed rapid atrial fibrillation with a controlled ventricular response. During his stay, he received education on recognizing symptoms of heart failure and atrial fibrillation exacerbation. No invasive procedures were required during this hospitalization.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with improved symptoms. He is ambulating independently and has demonstrated understanding of his medication regimen. He requires home health services for ongoing monitoring of his atrial fibrillation and for education regarding lifestyle modifications to manage his cardiovascular risk factors.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, he will continue on Apixaban, Metoprolol, Losartan Potassium, Aspirin, Fenofibrate, and Omeprazole. The patient is advised to follow-up with his primary care physician in one week and with a cardiologist in two weeks. Home health services will initiate follow-up visits to monitor his condition and assist with medication management.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID**: [Patient ID]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Attending Physician**: [Physician Name]  \\n  \\n**History of Present Illness**:  \\nThe patient is a 79-year-old male admitted through the emergency ward with acute onset of right-sided weakness and difficulty in speech. Imaging confirmed a cerebral infarction due to embolism of the right middle cerebral artery (ICD-10: I63411).  \\n  \\n**Hospital Course**:  \\nDuring a 3.8-day hospital stay, the patient was stabilized with supportive care, including intravenous fluids and monitoring. He was initiated on anticoagulation with heparin and antiplatelet therapy with aspirin and clopidogrel. Neurology and rehabilitation services were involved early in the admission. The patient demonstrated significant improvements in mobility and speech with physical and speech therapy interventions.  \\n  \\n**Key Findings and Procedures**:  \\nNeurological assessments revealed improvement in motor function with a reduction in the severity of hemiparesis affecting the left side. The patient was also diagnosed with pneumonia (ICD-10: J189) and received appropriate antibiotic therapy with ceftriaxone. Other significant comorbidities included heart failure and dysarthria, which are pertinent to his overall management and home health needs.  \\n  \\n**Discharge Condition and Functional Status**:  \\nBy the time of discharge, the patient was stable but required assistance with activities of daily living due to residual weakness and speech difficulties. He will benefit from home health services for ongoing physical and speech therapy, medication management, and monitoring for potential complications. A home health nurse will also assist with medication compliance and education.  \\n  \\n**Medications at Discharge**:  \\nThe patient is discharged on the following medications: Albuterol Inhaler, Aspirin, Bisacodyl, CefTRIAXone (completed course), Clopidogrel, Dextrose 50%, Finasteride, Gabapentin, Glucagon, Glucose Gel, Heparin (to be transitioned to oral anticoagulant), Hydralazine, Insulin, Metoprolol Succinate XL, and Potassium Chloride.  \\n  \\n**Follow-Up Plan**:  \\nA follow-up appointment is scheduled with his primary care physician and neurology within one week of discharge. The home health service will contact the patient within 48 hours for an initial assessment.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Age:** 57  \\n**Gender:** Male  \\n**Admission Date:** [REDACTED]  \\n**Discharge Date:** [REDACTED]  \\n**Length of Stay:** 4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a diagnosis of sepsis, unspecified organism (ICD-10 A419). He presented with fever, chills, and abdominal pain. Initial workup revealed elevated inflammatory markers and abnormal liver function tests.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was started on broad-spectrum antibiotics, including Ceftriaxone and Amoxicillin-Clavulanic Acid, and received supportive care for acute kidney failure (ICD-10 N179) and dehydration. The team managed his metabolic derangements and adjusted medications, including insulin for hyperglycemia. Notably, he required intravenous fluids and was monitored closely for signs of septic shock.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies indicated acute cholecystitis (ICD-10 K810), and a decision was made to defer surgical intervention due to the patient's unstable condition. Nutritional support was initiated with Creon and Dextrose 50% as needed. The patient also underwent a Heparin flush protocol to maintain venous access.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health support to manage his nutritional needs and monitor renal function. He will need assistance with activities of daily living (ADLs) due to fatigue and weakness. Additionally, follow-up care is essential for monitoring his recovery from sepsis and managing his chronic conditions.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain, DULoxetine for mood stabilization, Metoprolol for hypertension, and insulin as directed. The patient is advised to follow up with his primary care physician within one week and to maintain regular home health visits for continued assessment of his clinical status and medication management.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Age:** 69  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 0.9 Days  \\n**Primary ICD-10 Code:** T7589XA (Other specified effects of external causes, initial encounter)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to complications related to recent therapies for secondary malignant neoplasm of the liver. He presented with nausea and vomiting, attributed to the effects of radiological procedures and antineoplastic drugs. The patient has a significant history of esophageal malignancy and presents with a personal history of malignant neoplasm.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was monitored closely for symptoms of nausea and vomiting. IV fluids were administered, and supportive care was provided. The decision was made to initiate antiemetic therapy, with Prochlorperazine given to manage nausea effectively. The patient's atrial fibrillation was managed with Apixaban, and his hypertension was addressed with Diltiazem and Metoprolol.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies that confirmed the presence of secondary malignancy without acute complications. He was evaluated for potential drug-induced polyneuropathy, and laboratory tests indicated mild electrolyte imbalances, which were corrected with Potassium Chloride and Magnesium Sulfate supplementation.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with resolved nausea and improved hydration status. He is able to perform basic activities of daily living but requires assistance with meal preparation and medication management. Home health services have been arranged to assist with medication adherence and monitoring of his cardiac condition.  \\n\\n**Medications at Discharge:**  \\n1. Amoxicillin-Clavulanic Acid  \\n2. Apixaban  \\n3. Atorvastatin  \\n4. DULoxetine (Delayed Release)  \\n5. Diltiazem Extended-Release  \\n6. Omeprazole  \\n7. Metoprolol Succinate XL  \\n8. Mirtazapine  \\n9. Prochlorperazine  \\n10. Potassium Chloride  \\n11. Magnesium Sulfate (as needed)  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with oncology in one week and cardiology for atrial fibrillation management. Home health nursing will conduct visits to monitor medication compliance and overall health status.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient ID:** [Patient ID]  \\n- **Age:** 47  \\n- **Gender:** Female  \\n- **Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient presented with symptomatic intramural leiomyoma of the uterus, characterized by menorrhagia and pelvic discomfort. She underwent a laparoscopic myomectomy with successful removal of the leiomyomas. Pre-operative assessments revealed chronic embolism in the left femoral and iliac veins, as well as iron deficiency anemia secondary to blood loss.\\n\\n**Hospital Course:**  \\nThe patient was admitted for surgical intervention and monitored postoperatively for 3.9 days. She received intravenous fluids and was maintained on anticoagulant therapy with enoxaparin, considering her history of chronic venous thromboembolism. Post-operative recovery was uneventful, with regular monitoring of vital signs and hemoglobin levels. Pain management included acetaminophen and oxycodone as needed. The patient was educated on post-operative care and signs of potential complications.\\n\\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** D251 (Intramural leiomyoma of uterus), I82512 (Chronic embolism of left femoral vein), I82522 (Chronic embolism of left iliac vein), D500 (Iron deficiency anemia), among others.  \\n- **Procedures:** Laparoscopic myomectomy (0UT90ZZ), with postoperative care including monitoring for hypertensive urgency and adjustment of antihypertensive medications (lisinopril and captopril).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is medically stable at discharge, ambulating independently with mild discomfort manageable with prescribed analgesics. She demonstrates understanding of her post-operative care plan, including wound care and medication adherence. Given her history of chronic venous thromboembolism, she will benefit from home health services to monitor her recovery closely and ensure adherence to anticoagulation therapy.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Captopril  \\n- Docusate Sodium  \\n- Enoxaparin (treatment)  \\n- Ibuprofen  \\n- Lisinopril  \\n- Magnesium Oxide  \\n- Neutra-Phos  \\n- Ondansetron  \\n- Oxycodone (immediate release)  \\n- Simethicone  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her gynecologist in one week for postoperative evaluation and with her primary care physician to monitor her hypertension and anticoagulation therapy.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 79 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms of toxic gastroenteritis and colitis (ICD-10 K521). He presented with abdominal pain, diarrhea, and dehydration. The patient has a significant medical history including chronic obstructive pulmonary disease (COPD) and heart failure, which complicated his clinical picture.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care, including intravenous fluids for dehydration and management of his electrolyte imbalances. Pulmonary assessments indicated acute exacerbation of his COPD, necessitating respiratory support, including bronchodilators and corticosteroids. The patient also had episodes of hypoxia, which were closely monitored and treated accordingly.\\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed hypo-osmolality and hyponatremia. Imaging studies were performed to rule out any obstructive processes, which returned unremarkable. The patient was treated with medications including Furosemide for heart failure and bronchodilators such as Albuterol and Fluticasone-Salmeterol for respiratory management.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable but required continued home health services for monitoring of his COPD and heart failure. He exhibited moderate functional limitations due to weakness from recent illness, and will benefit from physical therapy to improve mobility and strength. The need for home health nursing for medication administration and ongoing assessments was discussed with the patient and family.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Aspirin  \\n4. Dextrose 50%  \\n5. Fluticasone-Salmeterol Diskus (250/50)  \\n6. Furosemide  \\n7. Glucagon  \\n8. Glucose Gel  \\n9. Insulin  \\n10. Nicotine Patch  \\n11. PredniSONE  \\n12. Rosuvastatin Calcium  \\n13. Sacubitril-Valsartan (24mg-26mg)  \\n14. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week, and home health services will initiate contact for ongoing assessment and support. Close monitoring of his respiratory status and medication adherence is crucial.',\n",
       " '**Patient Summary**: 69-year-old female admitted for surgical intervention due to occlusion and stenosis of the left carotid artery (ICD-10: I6522).  \\n\\n**History of Present Illness**: The patient presented with symptoms consistent with transient ischemic attacks, including episodes of dizziness and visual disturbances. A carotid duplex ultrasound revealed significant stenosis, prompting surgical intervention to prevent further cerebrovascular events.  \\n\\n**Hospital Course**: The patient underwent a carotid endarterectomy on the day of admission. The procedure was performed successfully without intraoperative complications. Postoperative monitoring indicated stable vital signs and neurological status, although she was noted to have mild hypertension that was managed with intravenous Hydralazine during her stay.  \\n\\n**Key Findings and Procedures**: The patient was monitored in the post-anesthesia care unit before being transferred to a telemetry unit for further observation. Key findings included stable neurological assessments and gradual improvement in blood pressure control. She was also treated for hyperlipidemia and diabetes management during her stay.  \\n\\n**Discharge Condition and Functional Status**: At the time of discharge, the patient was alert and oriented, able to ambulate with minimal assistance. She demonstrated the ability to perform activities of daily living but will require home health services for continued monitoring of her blood pressure and glucose levels, as well as assistance with medication management.  \\n\\n**Medications and Follow-Up Plan**: Discharge medications include Acetaminophen, Aspirin, Atorvastatin, Clopidogrel, Chlorthalidone, Insulin, and Docusate Sodium. The patient is advised to follow up with her primary care physician within one week for review of her hypertension and diabetes management, as well as routine follow-up with a neurologist to monitor postoperative recovery.',\n",
       " '**Patient Summary:**  \\n35-year-old female admitted urgently with liver transplant rejection (ICD10: T8641).  \\n\\n**History of Present Illness:**  \\nThe patient presented with signs of liver transplant rejection, including elevated liver enzymes and jaundice. She reported fatigue, nausea, and a decreased appetite. Past medical history includes anxiety disorders and nicotine dependence.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a comprehensive workup, including liver function tests, abdominal ultrasound, and a liver biopsy confirming acute rejection. She received intravenous steroids and adjustments to her immunosuppressive therapy, including Mycophenolate Sodium DR to manage rejection. During her 3.9-day stay, she was monitored closely for complications and her symptoms improved.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory results indicated elevated ALT and AST levels, consistent with rejection. Imaging showed no signs of biliary obstruction. The patient was treated with IV steroids and transitioned to oral medications. A multidisciplinary team, including nutrition and mental health support, was involved in her care.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with resolving symptoms. She demonstrated improved functional status, able to ambulate independently and manage basic self-care. Home health services will be essential for continued monitoring of her liver function and medication adherence. The patient was advised to maintain a low-sodium diet and monitor for any signs of infection or further liver issues.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarged on the following medications: Acetaminophen, Amitriptyline, Aspirin, Clopidogrel, Mycophenolate Sodium DR, and Ondansetron. She is to follow up with her transplant physician in one week for liver function tests and medication adjustment. Home health services will include nursing visits for medication management and monitoring of vital signs.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Admitting Physician:** Dr. [REDACTED]  \\n\\n**History of Present Illness:**  \\nThe patient is a 31-year-old female who presented with complete placenta previa at 32 weeks gestation, experiencing preterm labor. The admission was urgent due to concerns about potential hemorrhage and fetal distress. During the hospital stay, she was monitored closely for any signs of complications. \\n\\n**Hospital Course:**  \\nThe patient remained stable throughout her 6.9-day hospitalization. She underwent a cesarean section following the development of labor complications, specifically vasa previa. The delivery was uneventful, and the neonate was admitted to the NICU for monitoring. Postoperatively, the patient was treated with intravenous fluids, analgesics, and prophylactic anticoagulation with enoxaparin sodium.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included complete placenta previa confirmed via ultrasound and preterm labor. The patient received a total of two blood transfusions due to minor postpartum hemorrhage, which was managed effectively. The procedures performed included cesarean delivery and postpartum care. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with no signs of acute distress. She will require home health services for ongoing monitoring and assistance with postpartum recovery, including wound care and education on signs of potential complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed 0.9% Sodium Chloride, Acetaminophen, Ibuprofen, and OxyCODONE for pain management, along with Calcium Carbonate and Docusate Sodium for constipation. Follow-up appointments are scheduled with her obstetrician and pediatrician within one week. Home health services will initiate contact within 48 hours of discharge to ensure proper recovery and adherence to the discharge plan.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 44  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.7 days  \\n**Primary ICD-10 Code:** D259 (Leiomyoma of uterus, unspecified)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to symptomatic leiomyoma of the uterus, which resulted in excessive menstrual bleeding and iron deficiency anemia secondary to chronic blood loss. The patient reported significant discomfort and fatigue related to her symptoms prior to admission.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a scheduled myomectomy (ICD-10: 0UT90ZZ) and dilation and curettage (ICD-10: 0UTC0ZZ) to address both the leiomyoma and associated anemia. The postoperative period was uneventful, with the patient demonstrating stable vital signs and tolerating a regular diet. Pain management included hydromorphone and acetaminophen, along with ketorolac for inflammation control. The patient was monitored for any signs of excessive bleeding and was provided supportive care, including intravenous fluids (Lactated Ringer's and Sodium Chloride 0.9% Flush).  \\n\\n**Key Findings and Procedures:**  \\nThe postoperative assessment revealed successful removal of the leiomyoma, with no intraoperative complications. Laboratory results indicated a mild improvement in hemoglobin levels, although the patient will require follow-up for her iron deficiency anemia (ICD-10: D500).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with a functional status that allows for independent ambulation and self-care, albeit with some restrictions on physical activity for the next few weeks. Home health services will be initiated to assist with monitoring her recovery, managing pain, and ensuring medication adherence. The patient has been educated on signs of potential complications to report and the importance of follow-up care.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Docusate Sodium  \\n- Hydromorphone (Dilaudid)  \\n- Ibuprofen  \\n- Ketorolac  \\n- Ondansetron  \\n- Oxycodone (Immediate Release)  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and gynecologist within one week post-discharge for evaluation of recovery and management of her anemia. Home health services will provide additional support for medication management and symptom monitoring.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 57  \\n- **Gender:** Female  \\n  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.7 days  \\n  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 57-year-old female with a history of alcohol use disorder, who presented with symptoms indicative of alcoholic hepatitis without ascites. She reported increasing abdominal discomfort, jaundice, and fatigue over the past few weeks. Initial laboratory findings confirmed elevated liver enzymes and bilirubin levels.  \\n  \\n**Hospital Course:**  \\nDuring her brief hospitalization, the patient was monitored closely in observation status. She received supportive care including intravenous fluids and medications for symptom management. Lactulose was initiated to manage potential hepatic encephalopathy, and her coagulation profile was evaluated due to concerns regarding her liver function.  \\n  \\n**Key Findings and Procedures:**  \\n- Significant lab findings included elevated AST, ALT, and bilirubin levels.  \\n- No ascites or significant fluid overload was noted on ultrasound.  \\n- Patient was assessed by the gastroenterology team, and no invasive procedures were required during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved symptoms. She is alert and oriented, able to perform activities of daily living with minimal assistance. Due to her history of substance use and liver disease, home health services will be arranged to provide follow-up care, medication management, and support for lifestyle modifications.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Allopurinol  \\n4. Atorvastatin  \\n5. Escitalopram Oxalate  \\n6. Lactulose  \\n7. Phytonadione  \\n8. Potassium Chloride  \\n9. Furosemide  \\n10. Sodium Chloride 0.9% Flush  \\n   \\n**Follow-Up Plan:**  \\n- Follow-up with primary care physician in one week.  \\n- Arrange home health nursing visit for medication reconciliation and liver function monitoring.  \\n- Encourage outpatient counseling for alcohol use disorder.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 51 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.9 days  \\n**ICD-10 Codes:** K9189 (Other postprocedural complications and disorders of digestive system)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with postprocedural complications following a recent endoscopic intervention. He experienced significant dysphagia and abdominal discomfort, prompting further evaluation. In addition, the patient presented with nutritional deficiencies, specifically severe protein-calorie malnutrition, and was noted to be at risk for aspiration due to esophageal obstruction.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored closely. He received supportive care including nutritional supplementation and management of his dysphagia. Several diagnostic tests were performed, revealing chronic obstructive pulmonary disease (COPD) and an abdominal aortic aneurysm, both requiring ongoing management. The patient was treated with medications to manage his symptoms, including metoclopramide for nausea and pantoprazole for gastro-esophageal reflux disease.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included the patient’s significant weight loss and low BMI of 21.0-21.9. Procedures included intravenous hydration and nutrition support, as well as optimization of his COPD management. The patient was stabilized with medications including Apixaban, Metoprolol, and Atorvastatin.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is clinically stable but requires home health services for ongoing nutritional support and monitoring of his COPD. Occupational therapy will assist with adaptive strategies for dysphagia management. The patient’s functional status is moderately impaired due to weakness and fatigue, necessitating assistance with activities of daily living.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is being discharged on a regimen that includes Acetaminophen, OxyCODONE, TraZODone, and others. He is advised to follow up with his primary care physician and specialists in two weeks to reassess his nutritional status and COPD management. Home health services will initiate contact within 48 hours post-discharge to coordinate care.',\n",
       " '**Patient Information**: 54-year-old male admitted urgently for hypertensive heart disease with heart failure. \\n\\n**History of Present Illness**: The patient presented with acute dyspnea, orthopnea, and generalized edema. He has a history of poorly controlled hypertension. \\n\\n**Hospital Course**: The patient was monitored closely in the cardiac unit for 21 days, during which he received diuretics for fluid overload and antihypertensives for blood pressure management. His renal function was closely evaluated, and he experienced an episode of acute kidney failure, which improved with hydration and adjustment of medications. Additionally, he was treated for acute on chronic diastolic heart failure, which was managed with IV diuretics and optimization of heart failure medications. \\n\\n**Key Findings and Procedures**: Significant findings included elevated BNP levels, echocardiogram showing left ventricular hypertrophy, and persistent atrial flutter, which was managed with rate control. The patient underwent cardioversion for atrial flutter and was stabilized post-procedure. \\n\\n**Discharge Condition and Functional Status**: At discharge, the patient is stable with improved respiratory status, no acute distress, and a reduction in edema. He is ambulating independently and is able to perform activities of daily living (ADLs) with minimal assistance. Home health services will be necessary for ongoing monitoring of his medication regimen, especially anticoagulation therapy with Apixaban, and for assistance with physical therapy to improve mobility and strength. \\n\\n**Medications and Follow-up Plan**: Discharge medications include Acetaminophen, Apixaban, Metoprolol Succinate XL, Omeprazole, and Prednisone among others. The patient is advised to follow up with his primary care physician and cardiologist within one week of discharge. Home health nursing will be initiated to assist with medication management and to monitor for signs of heart failure exacerbation.',\n",
       " '**Patient Information:** 22-year-old female admitted for observation due to skin complications associated with her second trimester of pregnancy. \\n\\n**History of Present Illness:** The patient presented with significant periorbital cellulitis and a nonspecific rash, along with worsening respiratory symptoms consistent with asthma exacerbation. The skin issues were noted to correlate with her pregnancy, raising concern for potential infectious etiologies. \\n\\n**Hospital Course:** Over a 7-day observation period, the patient was managed with intravenous antibiotics including Piperacillin-Tazobactam and Vancomycin, given the suspicion of a skin infection. Her respiratory symptoms were addressed with systemic corticosteroids (Hydrocortisone) and bronchodilators. The patient also received supportive care, including antiemetics (Ondansetron) and pain management (Oxycodone, Acetaminophen). The patient demonstrated gradual improvement, with resolution of the cellulitis and stabilization of her respiratory status.\\n\\n**Key Findings and Procedures:** On examination, the periorbital swelling decreased significantly, and the rash was noted to be improving. Laboratory tests confirmed the presence of a mild infection but ruled out any systemic complications. No procedures were performed during the stay, as the clinical picture improved with medical management. \\n\\n**Discharge Condition and Functional Status:** The patient is discharged in stable condition with no active respiratory distress, and her cellulitis has resolved. She is ambulatory with a good functional status, capable of performing activities of daily living with minimal assistance. Home health services are recommended to assist with wound care and monitoring of her medication regimen, particularly for her respiratory management.\\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, DiphenhydrAMINE, Hydrocortisone Cream 0.5%, Prenatal Vitamins, Sarna Lotion, and antibiotics (Piperacillin-Tazobactam and Vancomycin) for a total of 7 days. Follow-up appointments are scheduled with her obstetrician and primary care physician within one week to monitor her recovery and ensure appropriate management of her asthma and skin conditions.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Discharge:** [Date]  \\n**Date of Admission:** [Date]  \\n\\n**Brief History of Present Illness:**  \\nThe patient is a 27-year-old female who presented to the emergency department with signs of sepsis, ultimately diagnosed as sepsis of unspecified organism (ICD10: A419). She reported fever, chills, and altered mental status. Initial laboratory workup indicated an elevated white blood cell count, and blood cultures were initiated.  \\n\\n**Hospital Course:**  \\nDuring her 3.5-day hospital stay, the patient was treated with broad-spectrum intravenous antibiotics, specifically Ceftriaxone, and supportive care, including fluids and pain management with Hydromorphone and Ketorolac. She received Heparin for DVT prophylaxis due to her immobility. The patient's clinical status improved significantly, and she became afebrile with normalization of her vital signs.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a subsequent negative blood culture and resolution of acidosis. The patient demonstrated significant improvement in her neurological status and was monitored for any complications such as pneumonia or renal impairment. No surgical interventions were required during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and able to ambulate with minimal assistance. She is alert and oriented, though fatigue persists. The patient's functional status is satisfactory for home health services, where she will require assistance with activities of daily living (ADLs) and monitoring for any signs of infection or complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications:  \\n- Ceftriaxone  \\n- Acetaminophen-Caff-Butalbital  \\n- Calcium Gluconate  \\n- Ibuprofen  \\n- Magnesium Sulfate  \\nShe is advised to follow up with her primary care physician within one week and to contact home health services for ongoing support and monitoring. The influenza vaccine was administered prior to discharge as part of preventive care.\",\n",
       " '**Patient Name:** [Patient Name]\\n**Age:** 56 years\\n**Gender:** Female\\n**Admission Type:** Direct Emergency\\n\\n**History of Present Illness:**  \\nThe patient was admitted following a fall, resulting in an unspecified fracture of the lower end of the right femur (ICD-10: S72401A). She presented with significant pain and limited mobility, requiring immediate medical intervention. The patient has a history of bipolar disorder, chronic obstructive pulmonary disease (COPD), and nutritional anemia, which were taken into consideration during her management.\\n\\n**Hospital Course:**  \\nDuring her 5.9-day hospitalization, the patient underwent orthopedic evaluation and imaging studies confirming the fracture. She was treated conservatively with analgesics, including Hydromorphone and Acetaminophen, and muscle relaxants such as Cyclobenzaprine. Enoxaparin was initiated for venous thromboembolism prophylaxis due to her limited mobility. The patient was monitored closely for her COPD, and she received appropriate respiratory support as needed. Her psychiatric condition was managed with Fluoxetine.\\n\\n**Key Findings and Procedures:**  \\nThe patient displayed improvement in pain control and mobility by discharge. Physical therapy was initiated to aid in rehabilitation, focusing on strength and balance training to prevent future falls. Key procedures included fracture stabilization and pain management protocols.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable but required assistive devices (walker) for ambulation. She demonstrated the ability to perform basic activities of daily living (ADLs) with minimal assistance. Home health services will be essential for continued physical therapy and monitoring of her psychiatric medications, ensuring adherence and managing her bipolar disorder.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue on the following medications: Acetaminophen, Cyclobenzaprine, Dimenhydrinate, Diphenhydramine, Docusate Sodium, Enoxaparin Sodium, Fluoxetine, Hydromorphone, Hydroxyzine, Morphine Sulfate, Pantoprazole, Senna, Vitamin D, and Ropinirole. A follow-up appointment is scheduled with her orthopedic surgeon in one week and her primary care physician in two weeks to reassess her recovery and manage her overall health.',\n",
       " '**Patient Information:** 64-year-old male admitted for observation due to sepsis of unspecified organism, with an extended hospital stay of 42.8 days. \\n\\n**History of Present Illness:** The patient presented with symptoms of fever, chills, and altered mental status. Initial workup indicated severe sepsis with septic shock, necessitating aggressive fluid resuscitation and broad-spectrum intravenous antibiotics.\\n\\n**Hospital Course:** The patient was stabilized in the ICU during his stay. He required mechanical ventilation due to acute respiratory failure and underwent various diagnostic procedures, including imaging and cultures, to identify the source of infection. Multiple modalities were employed to manage complications, including renal failure and malnutrition. Throughout the hospital course, he received enteral nutrition and was monitored closely for fluid balance and electrolyte levels. The patient demonstrated gradual clinical improvement, with resolution of shock and better oxygenation levels.\\n\\n**Key Findings and Procedures:** Key findings included pneumonia due to aspiration, septic shock, and acute kidney injury. He underwent a tracheostomy and was successfully extubated after a period of mechanical ventilation. A multidisciplinary team addressed nutritional needs and rehabilitation to regain strength post-ventilation. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient is stable, alert, and oriented, with improved respiratory function. He will require home health services for continued respiratory therapy, monitoring of nutritional status, and assistance with activities of daily living (ADLs). A physical therapy evaluation is recommended to enhance mobility and strength recovery.\\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, Diazepam, Enoxaparin, Gabapentin, and others tailored to address pain, prevent thromboembolism, and manage respiratory issues. The patient is advised to follow up with primary care and specialty providers within one week of discharge. Home health services will be initiated to facilitate ongoing care.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 59  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a displaced fracture of the lateral condyle of the right femur following a fall. She reported significant pain and inability to bear weight on the affected leg. Additionally, she had a history of hypertension and gastro-esophageal reflux disease, which were noted in her medical history.  \\n  \\n**Hospital Course:**  \\nDuring her 19.5-day hospital stay, the patient underwent surgical intervention, specifically an open reduction and internal fixation of the right femur fracture. Post-operatively, she was monitored in the surgical unit for pain management and complications. The pain was managed effectively with a regimen that included Morphine Sulfate and Oxycodone. The patient also developed a urinary tract infection, which was treated with appropriate antibiotics.  \\n  \\n**Key Findings and Procedures:**  \\nRadiological imaging confirmed the fracture type, and the surgical procedure was successful with no immediate complications. The patient was mobilized with physical therapy assistance, achieving partial weight-bearing status by the time of discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating with a walker and capable of performing basic self-care tasks with minimal assistance. She will require home health services for physical therapy to enhance mobility and strength, and nursing care for ongoing management of her urinary tract infection and pain control.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, Enoxaparin for DVT prophylaxis, Fluoxetine, and Omeprazole among others. Follow-up appointments are scheduled with orthopedics in two weeks and her primary care physician regarding her urinary tract infection and hypertension management. She is advised to contact her physician for any signs of infection or complications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 75 years  \\n- **Gender:** Male  \\n- **Admission Type:** Surgical same day admission  \\n  \\n**History of Present Illness:**  \\nThe patient is a 75-year-old male with a diagnosis of malignant neoplasm of the cecum (ICD10: C180). He presented for surgical intervention due to the malignancy and underwent a right hemicolectomy with a subsequent recovery period in the surgical ward.  \\n  \\n**Hospital Course:**  \\nThe patient's postoperative course was initially complicated by mild anemia (ICD10: D649) requiring transfusion. He was monitored closely for signs of infection and other complications, with regular assessments of vital signs and laboratory tests. The patient tolerated clear liquids on postoperative day 1 and progressed to a regular diet by day 3.  \\n  \\n**Key Findings and Procedures:**  \\nSignificant findings included secondary malignant neoplasm of the liver (ICD10: C787), which was discussed with the oncology team. The patient had a successful right hemicolectomy (ICD10: 0DTF0ZZ), abdominal washout (ICD10: 0FB10ZZ), and placement of an intraoperative drain (ICD10: 0FT40ZZ). Postoperatively, the patient received analgesics, including acetaminophen and tramadol, for pain management, and anticoagulation therapy with enoxaparin sodium to prevent thromboembolic events.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulating with assistance, and able to perform activities of daily living with minimal support. He demonstrated understanding of medication management, including anticoagulation and pain control. Home health services are recommended to assist with ongoing wound care, medication management, and monitoring for any signs of complications.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, enoxaparin sodium, famotidine, finasteride, heparin, lidocaine, ondansetron, sodium chloride flush, tamsulosin, and tramadol. The patient is scheduled for follow-up with the surgical team in one week and oncology for further evaluation of his malignancy. Home health nursing will visit twice a week for wound care and assessment.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 56  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency (EW EMER)  \\n- **Length of Stay:** 1.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with alcoholic hepatic failure with coma (ICD-10 K7041) following a reported episode of heavy alcohol consumption. He exhibited confusion and altered mental status upon presentation.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care, including intravenous fluids, electrolyte management, and monitoring of liver function tests. He was treated with lactulose to manage hepatic encephalopathy. Additionally, albumin was administered to address his hypoalbuminemia due to liver dysfunction. His condition stabilized progressively, and he regained consciousness and cognitive function prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes and bilirubin levels, consistent with hepatic failure. A procedure code (ICD-10: 0W9G3ZZ) was utilized for the administration of albumin. The patient was also screened for potential complications such as portal hypertension and esophageal varices, with no active bleeding noted.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient showed significant improvement in his neurological status, with no residual confusion. He is ambulatory and capable of performing activities of daily living with minimal assistance. However, he will require ongoing home health services to monitor his hepatic function and manage medications.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- Albumin 25%  \\n- Dextrose 50%  \\n- Enoxaparin Sodium  \\n- Lactulose  \\n- Midodrine  \\n- Omeprazole  \\n- Rifaximin  \\n- Ursodiol  \\n- Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled in one week for reassessment of liver function and further management of his alcohol dependence. Home health services will provide assistance with medication management and routine monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 64  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient, a 64-year-old male, was admitted for surgical intervention due to a diagnosis of malignant neoplasm of the thyroid gland (ICD-10: C73). The patient presented with symptoms of neck swelling and dysphagia. Pre-operative workup indicated an advanced thyroid malignancy with no evidence of distant metastasis at that time.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a total thyroidectomy without complications. Postoperatively, he was monitored in the surgical unit for 2 days, receiving analgesia, anticoagulation prophylaxis, and supportive care. The patient demonstrated stable vital signs and adequate pain control with acetaminophen and oxycodone.  \\n  \\nKey findings included transient post-operative hypothyroidism which was managed with Levothyroxine sodium. He also received treatment for essential hypertension (Atenolol) and hyperlipidemia (Atorvastatin).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, and exhibited good understanding of his medication regimen. He will benefit from home health services for continued monitoring of his thyroid hormone levels and hypertension management. A follow-up with an endocrinologist is recommended within one month to adjust Levothyroxine dosage as needed. Additionally, he should have regular assessments for secondary malignancies due to his history of multiple myeloma (ICD-10: C9000).  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Atenolol, Atorvastatin, Bisacodyl, Calcium Carbonate, Docusate Sodium, Enoxaparin (prophylaxis), Levothyroxine Sodium, Lidocaine Jelly 2%, Magnesium Oxide, Neutra-Phos, Ondansetron, Oxycodone (immediate release), Pantoprazole, Polyethylene Glycol.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to have follow-up appointments with his endocrinologist and primary care physician within the next month. Home health services will initiate to assist with medication management and ensure compliance with follow-up care.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 77, Gender: Female  \\n**Admission Type:** Emergency Ward  \\n**Length of Stay:** 3.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of Human herpesvirus 6 infection (ICD10: B1081) manifesting as fever and rash. She has a significant medical history, including acute lymphoblastic leukemia not in remission, hypo-osmolality, and drug-induced immunodeficiency. The patient experienced progressive fatigue and malaise, prompting the emergency visit.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was started on Acyclovir and supportive care, including hydration and electrolyte management. The fever responded well to Acetaminophen, and her rash improved significantly. She was closely monitored for complications due to her underlying immunocompromised state. Further evaluation revealed no acute leukemic transformation.  \\n  \\n**Key Findings and Procedures:**  \\nRelevant laboratory findings included hyponatremia, which was corrected with intravenous fluids. The patient underwent daily assessments, with vital signs stabilizing over the course of her stay. No invasive procedures were required.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is afebrile, with stable vital signs and improved rash. She is able to perform activities of daily living with minimal assistance and expresses an understanding of her medication regimen. Home health services will be initiated to assist with ongoing monitoring and support, particularly for her nutritional needs and medication adherence.  \\n  \\n**Medications at Discharge:**  \\n1. Acyclovir  \\n2. Acetaminophen  \\n3. Atorvastatin  \\n4. Atovaquone Suspension  \\n5. CefePIME  \\n6. DULoxetine DR  \\n7. Fluconazole  \\n8. Fluticasone-Salmeterol Diskus (100/50)  \\n9. Enoxaparin (Prophylaxis)  \\n10. Dextrose 10% in Water (D10W)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her oncologist and primary care physician within one week. Home health services will be in place to monitor her clinical status and assist with medication management.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Medical Record Number:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 58  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 58-year-old male with a history of hypertensive heart disease complicated by heart failure, who presented with worsening dyspnea and edema. He reported increased fatigue and orthopnea over the past week. \\n\\n**Hospital Course:**  \\nDuring his 4.7-day observation admission, the patient was managed for acute on chronic diastolic heart failure. He was started on diuretics and underwent a comprehensive workup, including echocardiography, which confirmed left ventricular hypertrophy and diastolic dysfunction. His respiratory status was monitored closely due to chronic obstructive pulmonary disease and dependence on supplemental oxygen. \\n\\n**Key Findings and Procedures:**  \\nThe patient experienced significant improvement in pulmonary symptoms with diuresis, resulting in a reduction of peripheral edema. He was treated with intravenous furosemide and transitioned to oral diuretics upon stabilization. His blood pressure was adequately controlled with atorvastatin and aspirin. The patient received an influenza vaccination during his stay to prevent complications given his respiratory history. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved functional capacity and no signs of acute respiratory distress. He requires continued home health services for ongoing monitoring of heart failure symptoms and respiratory support, including education on medication adherence and dietary modifications.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Albuterol Inhaler, Aquaphor Ointment, Aspirin, Atorvastatin, Duloxetine DR, Dextrose 50%, Docusate Sodium, Enoxaparin (prophylaxis), Fluticasone-Salmeterol Diskus (250/50), Furosemide, Insulin, and others as per discharge medication reconciliation. He is to follow up with his primary care physician and cardiologist within one week. A referral for home health nursing has been initiated to assist with medication management and monitor vital signs.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Birth:** [DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 30-year-old male with a history of bipolar disorder, who was admitted through the emergency department for acute manic episode characterized by severe psychotic features. The patient exhibited behaviors including grandiosity, decreased need for sleep, and impaired judgment, necessitating inpatient stabilization.  \\n\\n**Hospital Course:**  \\nDuring a 13-day hospitalization, the patient was managed with a combination of mood stabilizers and antipsychotics. Divalproex was initiated, with titration based on serum levels, and Risperidone was administered to address psychotic symptoms. Supportive psychotherapy was provided, and the patient was closely monitored for any side effects, especially due to the concurrent use of Lorazepam for anxiety management.  \\nThe patient also received treatment for nicotine dependence, including a nicotine patch and Polacrilex. Additional management included Vitamin D supplementation due to identified deficiency, and he was vaccinated with the Quadrivalent Influenza vaccine during his stay.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated mood and psychotic symptoms consistent with manic episodes. Laboratory results indicated Vitamin D deficiency and hyperlipidemia. No additional procedures were undertaken during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, exhibiting improved mood with reduced psychotic features. He is able to perform activities of daily living with minimal assistance and has demonstrated insight into his condition. A home health service referral has been initiated for ongoing psychiatric support and medication management.  \\n\\n**Medications at Discharge:**  \\n- Benztropine Mesylate  \\n- Divalproex (Delayed Release)  \\n- Lorazepam  \\n- Risperidone  \\n- Ramelteon  \\n- Polyethylene Glycol  \\n- Nicotine Patch  \\n- Nicotine Polacrilex  \\n- Vitamin D  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nFollow-up with outpatient psychiatry within 1 week, and regular monitoring of mood symptoms and medication adherence is recommended. The patient is encouraged to participate in outpatient therapy and engage in support groups.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, Age 56  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with sepsis of unspecified organism, presenting with high fever, chills, and altered mental status. He also exhibited signs of pneumonia and acute respiratory failure due to aspiration, necessitating prompt intervention.  \\n  \\n**Hospital Course:**  \\nThroughout his stay, the patient received broad-spectrum antibiotics including Ceftriaxone and Azithromycin, alongside supportive care with IV fluids (Lactated Ringer's) and respiratory therapy. His respiratory status improved with nebulized treatments (Albuterol and Ipratropium) and he was monitored for any neurological deficits due to his brain injury. Key labs indicated improvement in his inflammatory markers, and he was stabilized without the need for advanced respiratory support.  \\n  \\n**Key Findings and Procedures:**  \\nChest imaging revealed bilateral pneumonia, and a CT scan confirmed a non-ruptured cerebral aneurysm without acute changes. The patient underwent thorough assessments for his metabolic status, revealing mild acidosis and hyperlipidemia. Neurological evaluations were performed regularly due to his prior focal brain injury; however, he demonstrated stable cognitive function at discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with activities of daily living due to residual weakness and fatigue from his illness. He was alert and oriented, but recommended to have home health services for ongoing monitoring of his respiratory status and assistance with rehabilitation exercises to regain strength.  \\n  \\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient was prescribed Acetaminophen for pain, Fluticasone Propionate nasal spray, Simvastatin, and Thiamine. He is to follow up with his primary care physician within one week and may require further evaluations with a pulmonologist and neurologist based on his recovery. Home health services will be initiated to assist with medication management and rehabilitation.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 71  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient is a 71-year-old male who presented to the emergency department with complaints of abdominal pain and altered bowel habits. A detailed workup revealed a malignant neoplasm of the rectosigmoid junction (ICD-10: C19) with secondary malignancies affecting the liver and lungs. He was admitted for further evaluation and management, including oncologic interventions.\\n\\n**Hospital Course:**  \\nDuring his 13-day hospital stay, the patient underwent multiple diagnostic procedures including imaging studies and biopsies, confirming the diagnosis of advanced colorectal cancer with metastases. He also received supportive care for sepsis secondary to Escherichia coli infection (ICD-10: A4151) and post-hemorrhagic anemia (ICD-10: D62). The patient's clinical condition stabilized after appropriate antibiotic therapy and supportive measures, including fluid resuscitation and management of electrolyte imbalances.\\n\\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included significant weight loss due to protein-calorie malnutrition (ICD-10: E46) and the presence of hydronephrosis (ICD-10: N1339). The patient underwent procedures including abdominal fluid drainage and placement of a urinary catheter to manage his hydronephrosis and urinary retention. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but requires assistance with activities of daily living due to weakness and fatigue. He has been advised to engage home health services for post-discharge care, including nursing support for medication management and physical therapy to enhance mobility and strength.  \\n\\n**Medications at Discharge:**  \\nUpon discharge, the patient is prescribed:  \\n- 0.9% Sodium Chloride  \\n- Enoxaparin Sodium  \\n- Furosemide  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Multivitamins  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with oncology in one week and should contact the healthcare provider if there are any concerns regarding worsening symptoms or side effects from medications. Home health services will initiate contact within 48 hours of discharge to arrange the necessary support.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 52 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with acute on chronic systolic heart failure secondary to hypertensive heart disease and chronic kidney disease, classified as stage 5 end-stage renal disease (ESRD). He experienced worsening dyspnea, chest discomfort, and significant edema. His past medical history includes hypertension, coronary artery disease, and recurrent hematuria.\\n\\n**Hospital Course:**  \\nDuring the 9-day hospitalization, the patient was stabilized in the cardiac care unit. He received diuretics for fluid overload, along with antihypertensive medications. A multidisciplinary approach was used, involving nephrology for renal management and cardiology for heart failure optimization. The patient was closely monitored for cardiac and respiratory function. He underwent hemodialysis to manage his ESRD effectively.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, elevated B-type natriuretic peptide (BNP), and significant renal impairment with a creatinine level indicative of ESRD. The patient underwent multiple hemodialysis sessions during his stay. Routine imaging and echocardiogram confirmed reduced ejection fraction and signs of heart failure. He was also treated for pneumonia which was successfully managed with antibiotics. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved respiratory status and reduced edema. He is alert and oriented, able to perform activities of daily living with moderate assistance. However, he requires ongoing home health services for continued nursing care, medication management, and physical rehabilitation to enhance his functional independence.\\n\\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue with Acetaminophen, Aspirin, Atorvastatin, Metoprolol Succinate XL, Clopidogrel, Prednisone, and insulin among others. A comprehensive medication reconciliation was performed, and he has been educated on his medication regimen.\\n\\n**Follow-Up Plan:**  \\nThe patient has a follow-up appointment scheduled with nephrology and cardiology within one week of discharge. He will be closely monitored by home health services for any signs of fluid overload and to ensure adherence to dietary restrictions and medication compliance.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 65  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old female with a history of anxiety disorder and chronic obstructive pulmonary disease (COPD) who presented with chest pain consistent with a non-ST elevation myocardial infarction (NSTEMI). Symptoms began suddenly, characterized by pressure in the chest with associated shortness of breath. The patient also had a history of diverticulitis without perforation or abscess, which was monitored during the stay.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a thorough workup, including cardiac biomarkers and an echocardiogram, which confirmed NSTEMI. She was treated with a regimen of anticoagulation with Heparin, beta-blockade with Metoprolol, and antiplatelet therapy with Aspirin. The patient received supportive care for her COPD, including nebulizer treatments with Albuterol and oxygen therapy as needed. Her anxiety was managed with Alprazolam. \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated troponins indicating myocardial injury, stable vital signs, and no evidence of ongoing ischemia on serial ECGs. The patient was closely monitored for any diverticulitis-related complications but remained stable throughout her observation.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented. She demonstrated an improved understanding of her condition and was able to perform activities of daily living with minimal assistance. The patient requires home health services for cardiac rehabilitation and monitoring of her COPD management, including nebulizer treatments.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Aspirin EC, Metoprolol, Atorvastatin, Nitroglycerin SL, and Albuterol inhalers. She will also continue her home medications, including Acetaminophen and Amoxicillin-Clavulanic Acid as per her diverticulitis management. A follow-up appointment is scheduled with cardiology in one week to assess her recovery and adjust medications as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 36  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute biliary pancreatitis complicated by infected necrosis, as confirmed by imaging studies. She presented with severe abdominal pain, nausea, and vomiting. A history of gallstones was noted, contributing to her condition.\\n\\n**Hospital Course:**  \\nDuring her 16-day hospitalization, the patient was managed conservatively with intravenous hydration, pain control, and antibiotics, specifically meropenem, for the infection. She underwent several diagnostic procedures, including abdominal ultrasound and CT scan, revealing significant necrotic tissue requiring monitoring. Nutritional support was initiated due to her severe protein-calorie malnutrition, and she was transitioned to a low-fat diet as her condition improved.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated serum amylase and lipase levels, along with signs of infection. She required interventions including Heparin for thrombosis prophylaxis due to her prolonged immobility. The patient had multiple imaging studies and was closely monitored for potential complications, including infection and organ failure. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated marked improvement in her abdominal symptoms and nutritional status. She is ambulating independently but requires assistance for activities of daily living due to weakness and fatigue. Home health services have been recommended to assist with her recovery, including nursing care for medication management and dietary counseling. \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on a regimen including acetaminophen for pain management, insulin for glycemic control, and multivitamins to address nutritional deficiencies. A follow-up appointment is scheduled with her primary care physician in one week, and she will be closely monitored by home health services for ongoing assessment and support.',\n",
       " '**Discharge Summary**  \\n**Patient:** 88-year-old male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following a transient ischemic attack (TIA) with symptoms of unilateral weakness and difficulty speaking. He has a history of type 2 diabetes with diabetic polyneuropathy, essential hypertension, and hyperlipidemia, which are risk factors for cerebrovascular events.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care including intravenous fluids (0.9% Sodium Chloride) and was monitored closely. He was initiated on aspirin and atorvastatin as part of his secondary stroke prevention regimen. Neurological assessments showed gradual improvement, with stable vital signs. The patient was also treated for thrombocytopenia and received heparin for venous thromboembolism prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nNeurological examinations revealed a resolution of acute symptoms by discharge. A CT scan was performed upon admission to rule out intracranial hemorrhage. The patient was also assessed for other comorbid conditions, including his diabetes management and gastro-esophageal reflux disease, which were stable at the time of discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with improved neurological function, exhibiting independent mobility with supervision. He requires assistance with activities of daily living due to his age and previous neurological event. Home health services will be arranged for continued monitoring of his diabetes and support with rehabilitation exercises.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes aspirin, atorvastatin, insulin, famotidine, and docusate sodium. He will continue to require regular glucose monitoring at home and a follow-up appointment with his primary care physician in one week. Home health services will also provide education on medication compliance and dietary adjustments to manage his diabetes and overall health.',\n",
       " 'Patient is a 21-year-old female admitted under observation for management of portal vein thrombosis (ICD-10: I81) with a length of stay of 9.9 days. She presented with abdominal pain and had a notable history of obesity (BMI 40.0-44.9) and depressive disorder. Initial evaluation included imaging studies confirming the diagnosis of portal vein thrombosis, and she was monitored closely for potential complications such as hepatic dysfunction and variceal bleeding.\\n\\nDuring her hospital course, the patient was initiated on Apixaban for anticoagulation therapy, and her symptoms of nausea were managed with Prochlorperazine. Additionally, she received supportive care including IV fluids (0.45% and 0.9% Sodium Chloride), magnesium sulfate, and multivitamins. The patient underwent dietary counseling due to her obesity and was educated on lifestyle modifications to prevent recurrence of thrombotic events.\\n\\nKey findings included stable liver function tests, resolution of nausea, and improved abdominal pain. She was engaged in physical therapy to enhance mobility and strength, which is essential given her obesity and recent hospitalization.\\n\\nUpon discharge, the patient is in stable condition, ambulating independently, and demonstrates an understanding of her medication regimen and follow-up care. She will require home health services to monitor her anticoagulation therapy, assist with dietary management, and provide support for her mental health through counseling services. \\n\\nDischarge medications include Apixaban, Acetaminophen (Liquid), Bisacodyl, and Ramelteon for sleep. The patient is advised to follow up with her primary care physician within one week and to keep her scheduled appointments with a nutritionist and a mental health provider. Additionally, home health services will conduct a comprehensive assessment and assist with medication management.',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Age**: 75  \\n**Gender**: Male  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 7.9 days  \\n  \\n**History of Present Illness**:  \\nThe patient, a 75-year-old male, was admitted for observation due to significant neutropenia, unspecified (ICD10: D709), associated with acute myeloid leukemia not in remission (C92Z0). He presented with symptoms including fever and malaise, and his medical history includes acute kidney failure and hyperkalemia.  \\n  \\n**Hospital Course**:  \\nDuring his 7.9-day hospitalization, the patient was monitored closely for hematological status and renal function. He received supportive care including intravenous fluids (0.9% Sodium Chloride) and medications such as Acyclovir for potential viral infections, Enoxaparin for thromboprophylaxis, and Furosemide for fluid management. He underwent two key procedures: central line placement for safe venous access and supportive care.  \\n  \\n**Key Findings and Procedures**:  \\nLaboratory investigations revealed persistent neutropenia and fluctuating renal function. He was treated with calcium gluconate for electrolyte imbalances and required transfusions due to low hemoglobin levels. His condition stabilized, and he was closely monitored for any signs of infection or further complications.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt discharge, the patient is stable but remains at risk for infections due to ongoing neutropenia. He requires assistance with activities of daily living (ADLs) and will benefit from home health services for medication management, nutritional support, and monitoring for any signs of infection or worsening symptoms.  \\n  \\n**Medications and Follow-Up Plan**:  \\nDischarge medications include Acyclovir, Allopurinol, Atenolol, and Enoxaparin. He is advised to continue monitoring blood pressure and fluid intake. A follow-up appointment with hematology is scheduled in one week to reassess his blood counts and overall status. Home health services will be initiated to provide assistance with medication adherence, nutrition, and daily care.',\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Admitting Physician:** [REDACTED]  \\n**Age:** 66  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 66-year-old female with a significant past medical history of interstitial pulmonary disease, obstructive sleep apnea, and essential hypertension. She was admitted for observation due to worsening dyspnea and hypoxia over the past week. The patient reported increased reliance on supplemental oxygen and had episodes of acute respiratory distress at home. \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was managed with supplemental oxygen and bronchodilator therapy. She received nebulized treatments with Albuterol and Ipratropium-Albuterol, which improved her respiratory status. A chest X-ray confirmed no acute process, but her pulmonary function tests indicated a decline consistent with her chronic lung disease. The patient's hypoxia was addressed with supplemental oxygen titrated to maintain oxygen saturation above 90%. She was started on Levofloxacin for a suspected respiratory infection.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs with improved oxygen saturation levels post-treatment. The patient was monitored closely for any signs of respiratory failure, and her dependence on supplemental oxygen was confirmed. A multidisciplinary team, including respiratory therapy, was involved in her care, and she demonstrated improved functional mobility by the time of discharge. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient's respiratory status had stabilized. She is able to perform activities of daily living (ADLs) with assistance and will require ongoing home health services for continued monitoring and support. The patient has been educated on the importance of medication compliance, especially regarding her steroid therapy and bronchodilators. \\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include Acetaminophen, Albuterol, Ipratropium-Albuterol, Levofloxacin, Prednisone, and Losartan. The patient is advised to follow up with her primary care physician within one week and to contact home health services for regular assessments. A follow-up pulmonary appointment has been scheduled within the next month to monitor her respiratory condition.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 68 years  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 68-year-old female with a diagnosis of malignant neoplasm of the ascending colon, admitted for surgical intervention. She has a complex medical history including essential hypertension, hyperlipidemia, and a personal history of malignant neoplasm of other female genital organs. The patient presented with bowel obstruction symptoms and was evaluated for surgery.\\n\\n**Hospital Course:**  \\nThe patient underwent a right hemicolectomy on [Surgical Date]. The procedure was uncomplicated, and she was closely monitored in the postoperative unit. Pain management was effectively achieved with acetaminophen and Gabapentin. Postoperative recovery was steady, with gradual improvement in gastrointestinal function and mobility.\\n\\nThroughout her hospital stay, she received appropriate venous thromboembolism prophylaxis with Enoxaparin Sodium. She was also managed for her comorbid conditions, including hypertension, with Lisinopril and amLODIPine, and hyperlipidemia with Simvastatin. The patient was educated on the importance of medication adherence and lifestyle modifications prior to discharge.\\n\\n**Key Findings and Procedures:**  \\nKey findings include stable vital signs, adequate pain control, and resolution of postoperative complications. The hemicolectomy specimen indicated malignancy, and she was referred for oncology follow-up. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, ambulating independently with no signs of surgical complications. She is able to perform activities of daily living with minimal assistance and has been instructed on dietary modifications and signs of potential complications that warrant immediate medical attention. Home health services will provide assistance with medication management and rehabilitation support, focusing on mobility and wound care.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Enoxaparin Sodium  \\n3. Gabapentin  \\n4. Ipratropium Bromide Neb  \\n5. Lisinopril  \\n6. PredniSONE  \\n7. Prochlorperazine  \\n8. Scopolamine Patch  \\n9. Simvastatin  \\n10. Sodium Chloride 0.9%  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her primary care physician and oncologist within one week post-discharge. Home health services will be initiated to monitor her recovery and provide necessary support.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 51 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 11 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute respiratory distress and diagnosed with pneumonia, unspecified organism (ICD-10 J189). She presented with hypoxia and was in respiratory failure. Her past medical history includes obesity, heart failure, and a recent herpes zoster infection, contributing to her current condition.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient received oxygen therapy and was started on broad-spectrum antibiotics. Her respiratory status improved significantly with the administration of bronchodilators and corticosteroids. Continuous monitoring revealed transient episodes of hypoxia, which were managed effectively. The patient also exhibited signs of acute diastolic heart failure (ICD-10 I5031) and was treated with furosemide.  \\n  \\n**Key Findings and Procedures:**  \\nChest X-ray confirmed pneumonia, and lab results indicated thrombocytopenia (ICD-10 D696). The patient underwent a thorough evaluation for her cardiac status, including an EKG which showed a second-degree atrioventricular block (ICD-10 I441). She responded well to treatment, and her condition stabilized by discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrates improved respiratory function, with oxygen saturation levels within normal limits. She is ambulating independently but requires assistance with daily activities due to fatigue. Home health services are recommended for respiratory therapy, medication management, and monitoring of her heart failure symptoms.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed acetaminophen, furosemide, albuterol inhaler, and flu vaccine among others. A follow-up appointment is scheduled in one week with her primary care physician for ongoing management of her pneumonia and heart failure. Home health services will commence within 48 hours post-discharge to ensure continued recovery and support.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 46  \\n- **Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 4.9 days  \\n**Primary Diagnosis:** Alcoholic cirrhosis of liver with ascites (ICD-10: K7031)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital with complaints of abdominal distension, jaundice, and fatigue. His history is significant for chronic alcohol use leading to cirrhosis, with the presence of ascites noted on physical examination. He was also experiencing episodes of confusion and lethargy indicative of hepatic encephalopathy. \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent diuretic therapy with Furosemide and Lactulose for management of ascites and hepatic encephalopathy. He received intravenous Ceftriaxone for a suspected infection, and his electrolytes were closely monitored. The patient was stabilized with fluid management and nutritional support. His laboratory results showed improvement in liver function tests, although he continued to have some degree of renal impairment.  \\n\\n**Key Findings and Procedures:**  \\nKey findings include ascites confirmed via ultrasound, and secondary esophageal varices were identified, which were managed conservatively. He underwent paracentesis to alleviate abdominal pressure and improve comfort. The patient was also placed on Propranolol for portal hypertension.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was alert and oriented, but he requires assistance with activities of daily living due to weakness and ongoing cognitive effects from hepatic encephalopathy. Home health services will be essential for medication management and monitoring of his nutritional intake, as well as assistance with personal care. \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Furosemide  \\n- Lactulose  \\n- Propranolol  \\n- Pantoprazole  \\n- Multivitamins  \\n- Calcium Gluconate  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with gastroenterology in one week to assess liver function and manage ongoing care. Home health nursing will monitor vital signs, medication adherence, and provide support in managing dietary restrictions related to his liver condition.',\n",
       " '**Patient Summary:**  \\nAge: 49, Gender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation following a wedge compression fracture of the first lumbar vertebra. She presented with significant back pain and was unable to ambulate independently. The fracture occurred as a result of a fall while riding a horse.  \\n\\n**Hospital Course:**  \\nDuring her 2.8-day stay, the patient was managed with pain control, including intravenous acetaminophen and oxycodone. She was closely monitored for hypotension, which was managed with fluid resuscitation. The patient also exhibited episodes of anemia and underwent a transfusion. Pulmonary assessments were conducted due to a history of asthma, which was exacerbated during her stay.  \\n\\n**Key Findings and Procedures:**  \\nRadiologic imaging confirmed the wedge compression fracture at L1. The patient’s vital signs were stabilized, and her hypotension resolved with treatment. A comprehensive pain management plan was initiated. She was assessed by physical therapy, where she demonstrated improved strength and safety in ambulation with assistance.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition but requires assistance for ambulation and activities of daily living (ADLs) due to her recent fracture. Home health services will be crucial for her recovery, including physical therapy to enhance mobility and strength. She has been educated on fall precautions and the importance of gradual activity progression.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes acetaminophen for pain management, fluticasone propionate for asthma, guaifenesin, heparin, oxycodone, paroxetine for depression, polyethylene glycol, senna, and normal saline flushes. A follow-up appointment is scheduled with her primary care physician in one week, and home health services will initiate visits within 48 hours to assess her needs and facilitate recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient:** Female, 75 years old  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 3.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a lower back strain (ICD-10: S39012A) following a fall. She reported significant pain and discomfort in the lumbar region, exacerbated by movement. During her stay, she also exhibited symptoms of urinary tract infection, confirmed by urinalysis.  \\n\\n**Hospital Course:**  \\nThroughout her hospitalization, the patient received conservative management for her back strain, including pain control with acetaminophen and ketorolac, as well as physical therapy to improve mobility. The urinary tract infection was treated with cephalexin, and her renal function was closely monitored due to her history of chronic systolic heart failure and hypertension.  \\n\\n**Key Findings and Procedures:**  \\n- Imaging studies confirmed a strain of the lumbar musculature without evidence of fracture or significant spinal pathology.  \\n- Laboratory tests indicated mild hypo-osmolality and hyponatremia, which were addressed with fluid management.  \\n- The patient was educated on the importance of hydration and monitoring for any worsening symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significant improvement in pain levels, but still required assistance with activities of daily living due to residual weakness and discomfort. She demonstrated an ability to ambulate with a walker and was able to perform basic self-care tasks with supervision. Home health services will be initiated to provide physical therapy and assist with medication management.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Bisacodyl  \\n- Cephalexin  \\n- Citalopram  \\n- DULoxetine  \\n- Diphenhydramine  \\n- Docusate Sodium  \\n- Fluticasone Propionate Nasal Spray  \\n- Hydroxychloroquine Sulfate  \\n- Lidocaine 5% Patch  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician in one week and will have home health nursing and physical therapy services initiated within 48 hours of discharge to address her ongoing needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 59  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 59-year-old male admitted through the Emergency Department with a diagnosis of secondary malignant neoplasm of bone (ICD10: C7951) due to known metastatic lung cancer. He presented with worsening bone pain and significant weakness, requiring urgent evaluation and management.  \\n\\n**Hospital Course:**  \\nDuring the 13-day hospitalization, the patient underwent thorough diagnostic imaging and supportive care. He received pain management interventions including opioids (Oxycodone and Acetaminophen) and adjunct medications such as lidocaine patches. Additionally, he was started on enoxaparin for VTE prophylaxis and managed for anemia related to chemotherapy.  \\n\\nKey findings included significant bone metastases, as well as secondary neoplasms in the brain and adrenal glands. He received multiple procedures, including drainage of symptomatic effusions, as well as supportive care to manage symptoms associated with his malignancy and treatment side effects.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable but continues to experience pain and functional limitations due to his malignancy. He will benefit from home health services for pain management, physical therapy, and assistance with activities of daily living (ADLs). The patient requires ongoing monitoring for potential complications from his malignancy and treatment.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Oxycodone (Immediate Release)  \\n- Atorvastatin  \\n- Enoxaparin (Prophylaxis)  \\n- Omeprazole  \\n- Ondansetron  \\n- Hydrocortisone  \\n- Magnesium Sulfate  \\n- Ramelteon  \\n- Lidocaine 5% Patch  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in the oncology clinic within one week post-discharge. Home health services are arranged for nursing and therapy support. The patient is advised to monitor for any signs of infection, increased pain, or changes in functional status, and to seek immediate medical attention if such events occur.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [patient ID]  \\n**Age:** 72  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with signs and symptoms consistent with cerebral infarction, specifically coded as Other Cerebral Infarction (I6389). His medical history is complicated by chronic conditions, including stage 5 chronic kidney disease, type 2 diabetes with chronic kidney disease, and secondary hyperparathyroidism. He also has a history of urinary tract infections and anemia related to chronic kidney disease.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored for neurological status and renal function. A thorough workup including imaging studies confirmed the cerebral event, and he was started on appropriate management protocols. Key findings included elevated blood pressure and signs of chronic kidney failure. The patient received intravenous fluids and antibiotics (Ceftriaxone) for a suspected urinary tract infection. He was stabilized on medications including aspirin and clopidogrel as part of his antithrombotic therapy.  \\n\\n**Key Findings and Procedures:**  \\n1. NIHSS score of 1, indicating mild neurological deficit.  \\n2. Renal function tests revealed stage 5 chronic kidney disease (ICD10: N185).  \\n3. Effective management of diabetes with adjustments to insulin regimen.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with a mild neurological deficit. He demonstrates independence in basic activities of daily living but requires assistance with medication management and monitoring of blood glucose levels at home. Home health services will be essential for ongoing assessment of his renal status and diabetes management.  \\n\\n**Medications at Discharge:**  \\n- Aspirin  \\n- Atorvastatin  \\n- Carvedilol  \\n- Calcitriol  \\n- Ceftriaxone (to complete course)  \\n- Clopidogrel  \\n- Insulin (adjusted dose)  \\n- Mirtazapine  \\n- Multivitamins  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week, and a referral has been placed for home health services for further support in medication management and monitoring of his chronic conditions.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 30.6 days  \\n**Primary Diagnosis:** Perforation of esophagus (ICD-10: K223)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted via emergency department with a diagnosis of esophageal perforation, presenting with acute chest pain, dyspnea, and fever. Initial imaging confirmed the perforation, necessitating surgical intervention.  \\n\\n**Hospital Course:**  \\nThe patient underwent an emergency thoracotomy and repair of the esophagus. Postoperatively, he developed pneumonia, which was managed with broad-spectrum antibiotics and chest physiotherapy. He also experienced acute kidney failure, likely secondary to dehydration and hypotension, which improved with fluid resuscitation. The patient had a prolonged hospital course, requiring multidisciplinary management including pulmonary rehabilitation, nutrition support, and pain management.  \\n\\n**Key Findings and Procedures:**  \\nKey procedures included esophageal repair (0DQ40ZZ), thoracostomy for pneumothorax (0DJ08ZZ), and placement of a feeding tube. Throughout the hospitalization, the patient was monitored for complications such as pleural effusion and interstitial emphysema, which were managed effectively.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge. He demonstrates improved respiratory function and is ambulating with minimal assistance. Due to the nature of his surgery and prolonged hospitalization, he will require home health services for ongoing respiratory therapy, wound care, and nutritional support.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Bisacodyl  \\n- BuPROPion XL  \\n- CloNIDine  \\n- DiphenhydrAMINE  \\n- Gabapentin  \\n- Heparin  \\n- Ketorolac  \\n- LORazepam  \\n- Lidocaine 5% Patch  \\n- Morphine Sulfate IR  \\n- Naproxen  \\n- Ondansetron ODT  \\n- Pantoprazole  \\n- Polyethylene Glycol  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in the outpatient clinic in one week. Home health services will initiate contact for therapy and care coordination.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n \\n**History of Present Illness:**  \\nThe patient is a 59-year-old female who presented to the emergency department with worsening dyspnea and fatigue. Initial workup revealed a pericardial effusion and associated congestive heart failure, likely exacerbated by her underlying chronic kidney disease and diabetes. She has a history of end-stage renal disease requiring dialysis, which complicates her clinical picture.  \\n \\n**Hospital Course:**  \\nDuring her 1.9-day stay, the patient was monitored closely. Diuretics, including furosemide, were administered to manage fluid overload. A paracentesis was performed to relieve pressure from the pericardial effusion, resulting in symptomatic improvement. She was also started on Epoetin Alfa for her anemia related to chronic kidney disease.  \\n \\n**Key Findings and Procedures:**  \\nKey findings include pericardial effusion confirmed via echocardiography, with associated pleural effusion. Laboratory results showed elevated creatinine, consistent with her known renal failure. The patient tolerated the paracentesis well and experienced improved respiratory function post-procedure. Regular monitoring of electrolytes and hemoglobin levels was conducted throughout her stay.  \\n \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved breathing and reduced edema. She requires continued assistance with activities of daily living due to her chronic conditions and ongoing dialysis. Home health services will provide skilled nursing for medication management and monitoring of her vital signs.  \\n \\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed Acetaminophen, Aspirin, Atorvastatin, CARVedilol, Calcitriol, Calcium Carbonate, Doxercalciferol, Epoetin Alfa, Furosemide, and others as per her management plan. She is advised to follow up with her nephrologist and primary care physician within one week. Home health services will coordinate her care and ensure adherence to the medication regimen.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 42  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 42-year-old male who presented to the emergency department with severe abdominal pain, nausea, and vomiting. He was diagnosed with acute cholecystitis (ICD10: K810) based on clinical evaluation and imaging studies.  \\n  \\n**Hospital Course:**  \\nDuring his 4-day hospitalization, the patient was stabilized with IV fluids and analgesics. A laparoscopic cholecystectomy was performed on day two, successfully removing the inflamed gallbladder. The postoperative course was unremarkable, although the patient experienced episodes of supraventricular tachycardia (ICD10: I471), managed with atenolol.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory results indicated mild hyperlipidemia (ICD10: E785) and essential hypertension (ICD10: I10). The patient also demonstrated intermittent hypoxemia (ICD10: R0902) managed with supplemental oxygen. A cardiac evaluation confirmed an unspecified right bundle-branch block (ICD10: I4510), but no acute intervention was required.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with no active abdominal pain, and is ambulating independently. He will require home health services for medication management and monitoring of vital signs, particularly due to his cardiac history and ongoing hypertension. The patient is advised to gradually resume normal activities while avoiding heavy lifting for at least 4-6 weeks.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atenolol  \\n4. Atorvastatin  \\n5. BuPROPion (Sustained Release)  \\n6. Cyclobenzaprine  \\n7. Docusate Sodium  \\n8. HYDROmorphone (Dilaudid) for breakthrough pain  \\n9. Heparin (as needed)  \\n10. Hyoscyamine  \\n11. Ipratropium-Albuterol Nebulizer for respiratory support  \\n12. Isosorbide Mononitrate (Extended Release)  \\n13. Lisinopril  \\n14. Omeprazole  \\n15. Phosphorus supplementation as needed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician in one week for a comprehensive assessment and adjustment of antihypertensives. Home health services will initiate within 48 hours post-discharge for medication management and monitoring.\",\n",
       " '**Patient Information:**  \\nAge: 49, Gender: Female  \\n\\n**History of Present Illness:**   \\nThe patient was admitted for observation due to pneumonia, unspecified organism (ICD-10: J189). She presented with fever, cough, and shortness of breath. A history of multiple myeloma and recent stem cell transplant complicated her clinical picture, increasing her risk for infections.  \\n\\n**Hospital Course:**  \\nDuring her 4-day stay, the patient received intravenous antibiotics, including CefePIME and LevoFLOXacin, along with supportive care. She was closely monitored for respiratory status and received prophylactic anticoagulation with Enoxaparin. Her symptoms improved significantly, and she was able to undergo physical therapy to enhance mobility.  \\n\\n**Key Findings and Procedures:**  \\nChest X-ray revealed bilateral infiltrates consistent with pneumonia. Blood cultures were negative, and she remained afebrile after 48 hours of appropriate antibiotic therapy. Laboratory results showed stable renal function and no signs of hypercalcemia, which is critical given her myeloma history.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved respiratory function and is able to perform activities of daily living independently. She will require home health services for continued monitoring of her respiratory status and assistance with mobility exercises. The patient has been educated regarding signs of potential complications, including worsening cough or dyspnea.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed Acetaminophen for pain management, Acyclovir as antiviral prophylaxis, and a regimen of antibiotics to complete the treatment course. She will continue on Omeprazole for gastro-esophageal reflux, Gabapentin for neuropathic pain, and is instructed to use Ondansetron as needed for nausea. A follow-up appointment is scheduled with her primary care physician and oncologist within one week to assess her ongoing recovery and management of her multiple myeloma.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 25-year-old female who was admitted urgently for severe pre-eclampsia in the third trimester of pregnancy. She presented with hypertension and significant edema. The patient also reported headaches and visual disturbances.  \\n\\n**Hospital Course:**  \\nDuring her 4-day hospital stay, the patient was closely monitored and treated for her condition. Magnesium sulfate was administered for seizure prophylaxis, and blood pressure was managed with appropriate antihypertensives. The patient exhibited signs of placental insufficiency, warranting further obstetric evaluation. A comprehensive fetal assessment was conducted, and the infant was delivered via vaginal delivery without complications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included severe pre-eclampsia (ICD-10: O1413) and maternal care for suspected placental insufficiency (ICD-10: O365130). The patient underwent several procedures including fluid management with Lactated Ringer's and administration of medications to manage pain and prevent constipation. A perineal laceration was noted, classified as a first-degree laceration, which was repaired. The patient also experienced mild anemia complicating her pregnancy (ICD-10: O99013).  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable upon discharge with a blood pressure within normal limits and no signs of further complications. She reports moderate pain at the perineal site, manageable with prescribed analgesics. The patient requires assistance with activities of daily living (ADLs) due to fatigue and recent delivery. Home health services are recommended for ongoing monitoring and support with infant care.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe discharge medications include Acetaminophen, Ibuprofen, and Magnesium sulfate (OB) for pain management; Docusate Sodium and Bisacodyl for constipation; and Calcium Carbonate for calcium supplementation. The patient is advised to follow up with her obstetrician within one week and to call for any concerning symptoms, including increased blood pressure or severe headaches.\",\n",
       " 'Patient is an 80-year-old female admitted through the emergency department with a diagnosis of sick sinus syndrome, presenting with episodes of dizziness and syncope. Her past medical history is significant for persistent atrial fibrillation, supraventricular tachycardia, essential hypertension, and long-term anticoagulation therapy. During her four-day hospital stay, she was monitored for cardiac rhythm disturbances and underwent an adjustment of her anticoagulation regimen due to her high risk of thromboembolic events. \\n\\nKey findings included persistent atrial fibrillation and evidence of thyrotoxicosis, which was managed with Methimazole. The patient remained hemodynamically stable throughout her stay, with no further syncopal episodes noted. She received education on the importance of medication compliance, particularly with her anticoagulants and antiarrhythmics, including Dofetilide and Metoprolol. \\n\\nOn discharge, the patient is stable but requires ongoing monitoring of her cardiac status, as well as management of her thyroid levels and anticoagulation. Her functional status is fair; she is able to perform activities of daily living with assistance and will benefit from home health services for medication management, monitoring of vital signs, and coordination of follow-up appointments. The patient and her family have been instructed on recognizing signs of potential complications such as increased dizziness or palpitations. \\n\\nDischarge medications include Acetaminophen for pain management, Albuterol inhaler as needed for asthma, Dofetilide for atrial fibrillation, Losartan for hypertension, Methimazole for thyroid management, Metoprolol for heart rate control, Polyethylene Glycol for constipation, Sarna lotion for skin irritation, Senna as a laxative, and Vitamin D supplementation. The patient is advised to follow up with her primary care physician and cardiologist within one week of discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 55  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 6.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted due to complications following a bariatric procedure, specifically noted as other complications of other bariatric procedure (ICD10: K9589). She presented with right upper quadrant pain, epigastric pain, tachycardia, and signs of dehydration. Her medical history includes obesity and other chronic conditions which contributed to her current status.\\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient received comprehensive management including intravenous fluids to address dehydration, analgesics for pain management, and monitoring for any further complications. Her condition improved after initial stabilization.  \\n  \\n**Key Findings and Procedures:**  \\nDiagnostic imaging revealed no acute intra-abdominal pathology. The patient underwent supportive care including the administration of electrolytes and nutritional support. Notably, she was placed on a regimen of Furosemide for fluid management, and she received education regarding dietary modifications post-bariatric surgery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with resolved pain and normal vital signs. She demonstrated the ability to ambulate independently and manage basic activities of daily living. It is essential for home health services to assist her in monitoring her hydration status, medication adherence, and continue dietary counseling to prevent further complications.\\n  \\n**Medications at Discharge:**  \\nThe following medications have been prescribed:  \\n- Calcium Carbonate  \\n- Clonazepam  \\n- Cyclobenzaprine  \\n- Furosemide  \\n- Methadone  \\n- Multivitamins with minerals  \\nAdditionally, the patient is advised to follow up with her primary care physician and a dietitian within one week post-discharge for ongoing management.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Name:** [Patient Name]  \\n**Age:** 33  \\n**Gender:** Male  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical management of a kidney disorder, specifically diagnosed with other specified disorders of the kidney and ureter (ICD-10: N2889). He reported a history of intermittent flank pain and episodes of hematuria, which prompted further evaluation leading to surgical intervention.\\n\\n**Hospital Course:**  \\nThe patient underwent a scheduled surgical procedure, with a focus on addressing the identified renal disorder. The procedure was uneventful, and the patient demonstrated stable vital signs throughout his hospital stay. Postoperatively, he was monitored in the surgical ward for 48 hours, with adequate pain management provided. He received analgesics (Morphine Sulfate, OxyCODONE), as well as antiemetics (Ondansetron) for nausea. The patient was also treated for gastroesophageal reflux disease and obstructive sleep apnea with Omeprazole and Fluticasone Propionate nasal spray respectively.\\n\\n**Key Findings and Procedures:**  \\nDuring the hospital stay, the patient’s recovery was closely monitored. Key interventions included fluid management with Lactated Ringer’s solution and D5LR. He was also started on Bisacodyl and Docusate Sodium for bowel regimen. The patient was educated on the use of his Albuterol inhaler and instructed on managing his exercise-induced bronchospasm.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improvement in pain levels and overall functional status. He is able to ambulate independently and manage basic activities of daily living. Home health services will be initiated for continued monitoring of recovery, medication management, and physical support as needed.\\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient is prescribed Acetaminophen, Albuterol Inhaler, Cyclobenzaprine, and others as listed. He is advised to follow up with his primary care physician within one week post-discharge, and to adhere to home health visits for ongoing assessment and support.',\n",
       " '**Discharge Summary**  \\n**Patient:** 27-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.3 days  \\n**Primary Diagnosis:** Full-term premature rupture of membranes with onset of labor within 24 hours (ICD10: O4202)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the hospital with a diagnosis of full-term premature rupture of membranes at 37 weeks gestation, accompanied by the onset of labor. She reported a history of mild contractions and a sudden gush of fluid. The patient has no significant past medical history and is a carrier of Group B Streptococcus.\\n\\n**Hospital Course:**  \\nUpon admission, the patient was monitored closely for fetal heart rate and rhythm due to the risks associated with her condition. Labor progressed normally, although there was a noted second-degree perineal laceration during delivery. The delivery was successful, resulting in a healthy single live birth. A postpartum check indicated no signs of infection, and the patient was stable throughout her stay.\\n\\n**Key Findings and Procedures:**  \\nDuring her hospital stay, she underwent continuous fetal monitoring and received supportive care. Procedures performed included perineal repair and provision of maternal care for the rhesus isoimmunization. The patient was also treated for discomfort with analgesics and received education on postpartum recovery.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition with good functional status. She is able to perform activities of daily living independently but may require assistance with infant care and mobility support during the postpartum recovery phase. Home health services will be beneficial for monitoring her recovery and providing lactation support.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Calcium Carbonate  \\n- Dermoplast Spray  \\n- Docusate Sodium  \\n- Ibuprofen  \\n- Simethicone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for a postpartum check and to monitor for any signs of infection or complications. Home health services will be arranged to assist with her recovery and infant care.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 41  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a right-sided pneumothorax, confirmed via chest X-ray. He presented with acute respiratory distress, dyspnea, and a history of nicotine dependence. Notable symptoms also included cough and upper respiratory infection, which were evaluated concurrently.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored closely with regular assessments for respiratory status. He received supplemental oxygen therapy, analgesia for chest pain, and treatment for his acute upper respiratory infection. A chest tube was placed to facilitate re-expansion of the lung, resulting in significant improvement in his symptoms. He was also started on anticoagulation with Heparin as a precaution given his history of nicotine dependence.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a right-sided pneumothorax with associated tachypnea and hypoxemia, responsive to oxygen therapy. The placement of a chest tube successfully resolved the pneumothorax, and the patient required no further invasive procedures. Throughout his stay, the patient remained hemodynamically stable, and follow-up imaging confirmed lung re-expansion.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function. He demonstrates adequate understanding of his home care needs, including the importance of follow-up with his primary care physician and adherence to prescribed medications. Home health services will provide assistance with medication management, monitoring for any respiratory symptoms, and support for lifestyle changes related to smoking cessation.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Diphenhydramine  \\n3. Docusate Sodium  \\n4. Finasteride  \\n5. Guaifenesin  \\n6. Heparin  \\n7. Oxycodone (Immediate Release)  \\n8. Oxymetazoline  \\n9. Phenylephrine (0.5% Nasal Spray)  \\n10. Pseudoephedrine  \\n11. Senna  \\n12. Sodium Chloride (0.9% Flush)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week for evaluation of his respiratory status and to manage ongoing nicotine dependence. Home health services will coordinate care and ensure adherence to the discharge plan.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 68  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation with an incisional hernia without obstruction or gangrene. He reported intermittent abdominal discomfort and was noted to have a history of essential hypertension, obstructive sleep apnea, and polyneuropathy.  \\n\\n**Hospital Course:**  \\nDuring the 4.6-day hospital stay, the patient underwent monitoring for his hernia, with conservative management initiated. Pain management was effectively managed with Hydromorphone, Acetaminophen, and Gabapentin, while his hypertension was addressed with Isosorbide Mononitrate and Atorvastatin. He received supportive care, including hydration with Lactated Ringers and bowel regimen with Bisacodyl and Docusate Sodium to prevent constipation.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed a reducible hernia without signs of strangulation. Laboratory studies demonstrated stable renal function and controlled electrolytes. The patient received an Influenza Vaccine High-Dose Quadrivalent during his stay. No surgical intervention was required at this time as the hernia was asymptomatic.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and ambulating independently. He demonstrates adequate understanding of his medication regimen and self-care requirements. Home health services will be initiated to provide nursing support, monitor his medications, and assist with activities of daily living as needed.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue the following medications: Acetaminophen, Aspirin, Atorvastatin, Ezetimibe, Gabapentin, Hydromorphone, Heparin, and Isosorbide Mononitrate.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge for ongoing management of his hypertension and hernia. Home health nursing will coordinate care and ensure adherence to the discharge plan.',\n",
       " '**Patient Information:** 75-year-old female admitted for observation for management of other pulmonary embolism without acute cor pulmonale (ICD-10: I2699).  \\n\\n**History of Present Illness:** The patient presented with sudden onset dyspnea and pleuritic chest pain. Initial evaluation revealed imaging consistent with a pulmonary embolism.  \\n\\n**Hospital Course:** Over the course of her 2.5-day stay, the patient was monitored closely in the observation unit. She received anticoagulation therapy with Apixaban and supportive care. Her symptoms improved with treatment, and her oxygen saturation stabilized. Serial imaging was performed to monitor the resolution of the embolism, and no acute cor pulmonale was observed.  \\n\\n**Key Findings and Procedures:** Key findings included elevated D-dimer levels and a CT scan confirming the diagnosis of pulmonary embolism. The patient was also evaluated for other comorbidities including nutritional anemia and osteoporosis, which were managed with appropriate medications during her stay.  \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable, ambulating independently with minimal assistance. She reports improved ability to perform activities of daily living. Home health services will be initiated to provide skilled nursing care for ongoing anticoagulation management and monitoring for any signs of recurrence or complications.  \\n\\n**Medications and Follow-up Plan:** Upon discharge, the patient will continue on Apixaban, Levothyroxine Sodium, Calcium Gluconate, and supportive medications including 0.9% Sodium Chloride, Vitamin D, and Loperamide. A follow-up appointment with her primary care physician is recommended within one week to reassess her pulmonary status and manage her comorbid conditions.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, age 56  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.8 days  \\n**Primary Diagnosis:** Accidental heroin poisoning (ICD-10: T401X1A)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following an accidental heroin overdose. Upon arrival, he presented with altered mental status, respiratory depression, and hypotension. Initial management with naloxone was administered, leading to an improvement in consciousness and respiratory effort.  \\n  \\n**Hospital Course:**  \\nThroughout the hospitalization, the patient was closely monitored in a medical unit. He received supportive care, including intravenous fluids and oxygen supplementation. His mental status gradually improved, though he exhibited signs of toxic encephalopathy and acute kidney failure, which were managed appropriately. The patient also experienced hematemesis prompting an esophagogastroduodenoscopy, which ruled out significant bleeding. He was treated for acute posthemorrhagic anemia and monitored for electrolyte imbalances, which were managed effectively with appropriate intravenous and oral replacements.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine levels indicating acute kidney injury and toxic effects consistent with substance use. The patient underwent an upper GI endoscopy, which revealed duodenitis without bleeding.  \\n  \\n**Discharge Condition and Functional Status:**  \\nBy discharge, the patient was stable, ambulatory, and able to engage in basic self-care activities. He demonstrated an understanding of his medication regimen and the importance of follow-up care. The patient is advised to avoid substances that could exacerbate his condition and is deemed suitable for home health services to assist with medication management and monitoring of his recovery process.  \\n  \\n**Medications at Discharge:**  \\n1. Buprenorphine-Naloxone Film (4mg-1mg)  \\n2. Citalopram  \\n3. Hydrochlorothiazide  \\n4. Lisinopril  \\n5. Pantoprazole  \\n6. Magnesium Sulfate  \\n7. Multivitamins  \\n8. Nicotine Patch  \\n9. Bisacodyl  \\n10. Senna  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within 1 week and attend substance abuse counseling as part of his recovery plan. Home health services will be initiated to monitor his progress and medication compliance.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 64  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 64-year-old male with a history of nonrheumatic aortic stenosis, essential hypertension, atherosclerotic heart disease, peripheral vascular disease, type 2 diabetes, and hyperlipidemia. He was admitted for surgical intervention to address his aortic stenosis.\\n\\n**Hospital Course:**  \\nThe patient underwent a successful aortic valve replacement on the day of admission. Postoperatively, he demonstrated stable vital signs and good urine output. He was closely monitored for any signs of complications, including infection or cardiac issues. His medications were adjusted during the hospital stay to manage his blood pressure and glucose levels effectively. He was ambulating independently by the second day and participated in physical therapy.\\n\\n**Key Findings and Procedures:**  \\nThe primary procedure performed was aortic valve replacement (ICD-10: 02RF38Z). Cardiac function was assessed post-surgery, revealing improved hemodynamics. Laboratory assessments indicated stable glucose levels and normal renal function. There were no significant postoperative complications.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently. He expressed understanding of his post-discharge care plan and the importance of medication adherence. Home health services have been arranged to assist with medication management and follow-up physical therapy to enhance recovery and ensure continued mobility.\\n\\n**Medications at Discharge:**  \\nThe following medications were prescribed upon discharge: Acetaminophen, Aspirin, Clopidogrel, Dextrose 50%, Docusate Sodium, Ezetimibe, Glucagon, Glucose Gel, Heparin, Insulin, Isosorbide, Lisinopril, Magnesium Oxide, Ondansetron. The patient was instructed on their indications, dosages, and timing. \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the cardiology team in one week to monitor recovery and adjust medications as necessary. The patient is advised to contact the healthcare provider if any concerning symptoms arise.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Attending Physician:** [Insert Physician Name]  \\n**Patient Information:**  \\n- **Age:** 61  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 61-year-old female with a history of chronic obstructive pulmonary disease (COPD) and essential hypertension, admitted for observation due to acute respiratory failure with hypoxia. She presented with increased shortness of breath and wheezing, necessitating supplemental oxygen.  \\n\\n**Hospital Course:**  \\nDuring her 5-day stay, the patient was closely monitored in the observation unit. Supplemental oxygen was administered, and she received nebulized bronchodilators and corticosteroids to manage her respiratory status. Diuretics were also administered for fluid overload. The patient showed gradual improvement, with stabilization of her respiratory parameters and oxygen saturation levels.  \\n\\n**Key Findings and Procedures:**  \\nChest X-ray revealed atelectasis, and laboratory tests indicated mild hyponatremia. No significant infections were noted, and she was evaluated by the pulmonary team. Procedures included the initiation of high-dose influenza vaccination and administration of diuretics to manage fluid retention.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved respiratory function; she is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services are recommended for follow-up monitoring of her respiratory status and medication adherence, as well as to assist with daily activities if needed.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- CARVedilol  \\n- Clobetasol Propionate 0.05% Cream  \\n- DULoxetine DR  \\n- Furosemide  \\n- Losartan Potassium  \\n- Magnesium Oxide  \\n- Dextrose 50% (for hypoglycemia management)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week post-discharge and to contact home health services for support with her medication management and respiratory care. She has been educated on recognizing early signs of respiratory distress and the importance of adherence to her prescribed medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient**: Male, 52 years old  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 3.1 days  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted following a fall resulting in a displaced comminuted fracture of the shaft of the right femur. He presented with significant pain and inability to bear weight on the affected leg. Initial imaging confirmed the fracture, and the patient was managed conservatively due to the nature of the fracture.  \\n  \\n**Hospital Course**:  \\nDuring his hospital stay, the patient received pain management with acetaminophen and oxycodone, and was started on enoxaparin for DVT prophylaxis. He was monitored for signs of complications such as infection and thromboembolic events. The patient was evaluated by physical therapy, focusing on mobility training and transfer techniques, given his wheelchair dependence.  \\n  \\n**Key Findings and Procedures**:  \\nImaging studies confirmed the diagnosis of a displaced comminuted fracture. The patient was educated about his condition, and a multidisciplinary approach was taken, involving orthopedic and rehabilitation teams. He also experienced acute posthemorrhagic anemia likely due to his initial blood loss at the time of injury but stabilized with supportive care.  \\n  \\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient is stable, with improved pain control and management of his anemia. He requires assistance with activities of daily living (ADLs) due to his limited mobility and paraplegia. A home health evaluation is essential to facilitate his rehabilitation and ensure safety in his home environment.  \\n  \\n**Medications**:  \\nAt discharge, the patient will continue on the following medications: Acetaminophen, Albuterol (both nebulizer solution and inhaler), Baclofen, Diazepam, Docusate Sodium, Enoxaparin, and OxyCODONE as needed.  \\n  \\n**Follow-Up Plan**:  \\nThe patient is to follow up with the orthopedic clinic in one week for reassessment of his fracture and to initiate a physical therapy plan at home. Home health services will be arranged to provide nursing care and assistive therapy to promote recovery and enhance mobility.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Male, 56 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n**Primary Diagnosis:** Acute kidney failure, unspecified (ICD-10: N179)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for acute kidney failure, presenting with elevated creatinine levels and associated symptoms including mild fatigue and decreased urine output. A thorough evaluation was initiated to investigate the underlying causes, including possible dehydration and medication effects. The patient's past medical history includes benign prostatic hyperplasia, atherosclerotic heart disease, and depression.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent laboratory evaluations, including renal function tests, electrolyte panels, and urinalysis, which confirmed acute kidney injury. Intravenous fluids were administered to address dehydration. The patient was monitored closely in an observation setting, with daily assessments revealing improving renal function. Renal ultrasound was performed to rule out obstructive causes, which was unremarkable. Additional treatments included medications for symptom management, including tamsulosin for urinary symptoms and atorvastatin for cholesterol management.  \\n\\n**Key Findings and Procedures:**  \\n- Initial serum creatinine of 2.5 mg/dL, improved to 1.2 mg/dL by discharge  \\n- Urinalysis negative for hematuria and proteinuria  \\n- Renal ultrasound: No obstructive uropathy  \\n- Consultation with nephrology recommended  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with significantly improved renal function and no acute distress. He is ambulating independently and requires assistance with medication management and monitoring of fluid intake. Home health services will provide support for medication adherence, dietary counseling, and regular follow-ups to monitor renal function.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Tamsulosin  \\n- Finasteride  \\n- Ciprofloxacin  \\n- Ophthalmic medications: Brimonidine, Dorzolamide/Timolol, Latanoprost  \\n- Polyethylene glycol and Senna for bowel regimen  \\n\\n**Follow-Up Plan:**  \\nFollow up with primary care physician within one week and nephrology as advised. Home health services to initiate within 48 hours to ensure continuity of care and monitoring.\",\n",
       " \"Patient is a 50-year-old female admitted for surgical management of a submucous leiomyoma of the uterus (ICD10: D250). The patient presented with heavy menstrual bleeding, pelvic pain, and a significant history of obesity (BMI 45.0-49.9). She underwent a series of procedures, including hysteroscopic myomectomy, dilation and curettage, and laparoscopic salpingectomy, which were all performed successfully.\\n\\nDuring the 11.6-day hospital stay, the patient experienced post-operative complications including acute kidney failure (ICD10: N179) and urinary tract infection (ICD10: N390). She was treated with intravenous fluids, antibiotics (Ceftriaxone), and supportive care. Pain management was optimized with Acetaminophen and Gabapentin, and she was monitored closely for signs of infection and fluid balance.\\n\\nKey findings upon discharge included stable vital signs, resolution of fever, and improved renal function. The patient's urine output was adequate, and she was able to ambulate with assistance. She demonstrated understanding of her discharge medications and follow-up care instructions. Functional status at discharge was improved from admission, with the patient ambulating independently with a walker.\\n\\nAt discharge, the patient is stable but requires ongoing home health services for monitoring of her renal function, management of her urinary tract infection, and support with activities of daily living due to her obesity. She will continue on a regimen of 0.9% Sodium Chloride, Acetaminophen, Gabapentin, and antibiotics as needed. Follow-up with her primary care physician and gynecologist is scheduled within one week to monitor her recovery and address any ongoing issues. Home health nursing will also assist in medication management and education regarding dietary modifications.\",\n",
       " \"Patient is a 27-year-old female who was admitted urgently for labor and delivery complicated by a short umbilical cord. Upon admission, she was at 40 weeks gestation with a single live birth. The labor was complicated by abnormal fetal heart rate and rhythm, which was closely monitored throughout the labor process. A first-degree perineal laceration was noted during delivery, which was repaired without complications.\\n\\nDuring the hospital course, the patient received lactated Ringer's solution for hydration, oxytocin for labor induction, and ondansetron to manage nausea. Pain management was addressed with acetaminophen and ibuprofen, while constipation prevention was facilitated with docusate sodium and bisacodyl. After an uneventful recovery, the patient was stabilized and discharged with appropriate follow-up care.\\n\\nKey findings included stable vital signs, adequate pain control, and no signs of infection at the laceration site. The patient was educated on perineal care and signs of potential complications to monitor for at home. She was ambulating independently and demonstrated the ability to care for her newborn.\\n\\nAt discharge, the patient's condition was stable, and she exhibited functional independence in activities of daily living. She will benefit from home health services to assist with postpartum recovery and newborn care. \\n\\nMedications prescribed at discharge include acetaminophen for pain, ibuprofen for inflammation, ondansetron for nausea, and bisacodyl and docusate sodium for constipation. The patient is advised to follow up with her obstetrician within one week for routine postpartum care and assessment of her recovery.\",\n",
       " 'Patient is a 64-year-old female with a history of osteoarthritis of the knee, who was admitted for surgical intervention related to her condition. She underwent a knee arthroscopy on the day of admission, which was performed without complications. Postoperatively, the patient experienced mild pain and was managed with a combination of hydromorphone and acetaminophen. She was also started on enoxaparin for DVT prophylaxis due to her additional risk factors, including a history of venous insufficiency and hypertension.\\n\\nDuring her 4-day hospital stay, the patient was closely monitored for any signs of complications, particularly regarding her left tibial vein due to her history of acute embolism and thrombosis. Key findings included stable vital signs, controlled pain levels, and adequate mobility with physical therapy assistance. The patient was able to ambulate with a walker by the time of discharge and demonstrated understanding of her home exercises.\\n\\nAt the time of discharge, the patient was in stable condition with improved functional status. She required assistance with activities of daily living and was advised to continue physical therapy at home to further enhance her mobility and recovery. Home health services were recommended to provide nursing support for medication management and to assist with rehabilitation exercises.\\n\\nDischarge medications include acetaminophen, baclofen, and enoxaparin, along with a regimen of antihypertensives and gastrointestinal protectants. The patient has been instructed on the importance of adherence to her medication schedule and signs of potential complications such as swelling or increased pain. A follow-up appointment is scheduled with her orthopedic surgeon in two weeks to assess her recovery and to make any necessary adjustments to her rehabilitation plan.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 71  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 14.9 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 71-year-old female with a significant history of hypertensive heart disease and chronic kidney disease, who was admitted for management of acute on chronic diastolic heart failure. She presented with dyspnea on exertion and peripheral edema, which prompted the observation admission.\\n\\n**Hospital Course:**  \\nDuring her 14.9-day hospitalization, the patient was treated with diuretics and heart failure management protocols. Her renal function was monitored closely, revealing acute kidney failure superimposed on chronic kidney disease. The patient's symptoms improved with diuresis, and she was transitioned to oral medications. Multidisciplinary rounds involving cardiology and nephrology were conducted to optimize her management.\\n\\n**Key Findings and Procedures:**  \\nNotable findings included elevated blood pressure, elevated BUN and creatinine levels, and echocardiogram confirming diastolic dysfunction. The patient underwent daily assessments and was placed on a sodium-restricted diet. Following stabilization, she was evaluated for discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improved dyspnea and reduced peripheral edema. Functional status was assessed; she is able to perform activities of daily living with some assistance due to deconditioning. Home health services are recommended for ongoing monitoring, medication management, and assistance with daily activities.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will be prescribed Acetaminophen, Albuterol Inhaler, Allopurinol, Atorvastatin, Bisacodyl, Calcitriol, Digoxin, Diltiazem ER, Ferrous Sulfate, Multivitamins, Polyethylene Glycol, Senna, Sodium Chloride Flush, and Spironolactone. A follow-up appointment is scheduled with her primary care physician and nephrologist within one week post-discharge. Home health services will ensure adherence to medication regimen and dietary modifications.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 42 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 12.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of unspecified pre-eclampsia complicating childbirth. She presented with hypertension and proteinuria, necessitating close monitoring in a hospital setting. A twin pregnancy was noted, with gestational age at 34 weeks. The patient's clinical picture was complicated by additional diagnoses, including liver and biliary tract disorders related to pregnancy and obstruction of the bile duct.  \\n  \\n**Hospital Course:**  \\nDuring her 12.9-day hospitalization, the patient was stabilized with intravenous fluids (Lactated Ringer's, 0.9% Sodium Chloride), antihypertensives (Nifedipine), and analgesics (Acetaminophen, Ibuprofen). She underwent a successful delivery via cesarean section due to the complications associated with pre-eclampsia and the twin pregnancy. Post-operative recovery was uneventful, although she experienced some immediate postpartum hemorrhage, which was managed effectively.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s laboratory results remained stable with close monitoring of liver function tests and complete blood counts. The cesarean section (ICD-10: 10D00Z1) was performed without immediate complications. Key findings included controlled blood pressure, and she was able to ambulate with assistance post-surgery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and has shown improvement in her functional status. She is able to perform activities of daily living with minimal assistance and has been advised to engage in light activity as tolerated. Home health services are recommended for continued monitoring of her blood pressure and assistance with postpartum care, including the management of her pain and recovery from surgery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed Nifedipine (extended release), Enoxaparin sodium, Ibuprofen, and Oxytocin as needed for uterine tonicity. She is also to continue prenatal vitamins and Docusate sodium for bowel management. A follow-up appointment is scheduled with her obstetrician within one week of discharge to assess recovery and manage ongoing care. Home health services will facilitate the transition and provide necessary support during her recovery.\",\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n**Diagnosis:** Abscess of lung with pneumonia (ICD-10: J851)  \\n\\n**History of Present Illness:**  \\nThe patient is a 45-year-old male admitted for observation with a primary diagnosis of lung abscess complicated by pneumonia. The patient presented with persistent cough, fever, and pleuritic chest pain over the past week. Initial imaging and laboratory studies revealed a significant pulmonary abscess, necessitating intravenous antibiotic therapy.\\n\\n**Hospital Course:**  \\nDuring a 2.7-day stay, the patient was treated with a regimen of intravenous antibiotics including Vancomycin and Ampicillin-Sulbactam. Supportive care measures were implemented, including hydration with 0.9% Sodium Chloride and analgesics for pain management. The patient's respiratory status improved with treatment, and he demonstrated adequate tolerance to oral intake. His fever resolved, and he was closely monitored for any complications, particularly related to his nutritional status and coagulation profile.\\n\\n**Key Findings and Procedures:**  \\nKey findings included imaging confirmation of the lung abscess and improvement in clinical symptoms. No invasive procedures were performed during the stay. Laboratory results indicated anemia and mild malnutrition, which will require ongoing management. The patient was also vaccinated against influenza prior to discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is in stable condition, with improved respiratory function and no fever. He is alert and oriented, capable of performing activities of daily living with some assistance. Home health services will be arranged to assist with medication management and nutritional support to address his malnutrition and monitor ongoing recovery.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Amoxicillin-Clavulanic Acid, Acetaminophen for pain, and oral hydration solutions. The patient is advised to follow up with his primary care physician within one week and continue home health services for monitoring. A referral for a dietitian will also be made to address nutritional concerns.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n74-year-old female admitted for observation due to severe protein-calorie malnutrition (ICD10 E43).  \\n  \\n**History of Present Illness:**  \\nThe patient presented with significant weight loss, fatigue, and decreased appetite over the past few months, exacerbated by underlying diabetes mellitus and renal issues. She has a history of enterocolitis due to Clostridium difficile and candidal esophagitis, contributing to her nutritional deficiencies.  \\n  \\n**Hospital Course:**  \\nDuring her 14-day stay, the patient received nutritional support, including enteral feeding, and was closely monitored for glucose levels due to her diabetes. The care team adjusted her medications to optimize her blood sugar control, and she was started on megestrol acetate to stimulate appetite. She also received treatment for her esophagitis with pantoprazole and was managed for her renal status and secondary hyperparathyroidism.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s weight improved slightly, with a current BMI of 23.5. She required intravenous fluids and electrolytes during her stay. Daily assessments noted improvement in her appetite and energy levels. The patient underwent a procedure for gastric decompression (ICD10 3E0G76Z) due to gastrointestinal distension.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved nutritional status and an increased appetite. She is able to perform basic activities of daily living with assistance and will benefit from home health services for ongoing nutritional support and monitoring. A home health nurse will assist in medication management and dietary guidance, with a focus on maintaining her weight and managing diabetes.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Artificial Tears  \\n- AzaTHIOprine  \\n- Calcium Carbonate  \\n- Carvedilol  \\n- Dapsone  \\n- Dextrose 50%  \\n- Glucagon  \\n- Glucose Gel  \\n- Heparin  \\n- Insulin  \\n- Loratadine  \\n- Megestrol Acetate  \\n- Methylphenidate (Ritalin)  \\n- Pantoprazole  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge for continued management of her diabetes and nutritional needs. Home health services are arranged to monitor her progress.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 45 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.9 days  \\n**Primary Diagnosis:** Cutaneous abscess of right lower limb (ICD10: L02415)  \\n\\n**History of Present Illness:**  \\nThe patient presented with a painful, swollen right lower limb and systemic signs of infection. Initial examination revealed a significant cutaneous abscess requiring intervention. The patient also has a history of acute and subacute infective endocarditis, which complicated his case. \\n\\n**Hospital Course:**  \\nDuring the admission, the patient was started on intravenous antibiotics, specifically targeting MRSA due to the presence of Methicillin-resistant Staphylococcus aureus infection. Surgical intervention included incision and drainage of the abscess, which resulted in a substantial reduction of symptoms. Throughout his stay, the patient was closely monitored for possible complications related to his endocarditis and other comorbid conditions, including anxiety and major depressive disorder, which were managed with appropriate medications. \\n\\n**Key Findings and Procedures:**  \\nKey findings upon discharge include resolution of the abscess, improvement in the patient's systemic condition, and stabilization of comorbidities. Procedures performed included incision and drainage (ICD10: 0H9KXZZ) and administration of Heparin for thromboprophylaxis. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved mobility and reduced pain in the right lower limb. He is able to perform activities of daily living with minimal assistance. Home health services are recommended for continued wound care management and medication adherence, as well as support for his mental health conditions. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on the following medications: 0.9% Sodium Chloride, Acetaminophen, Bisacodyl, Docusate Sodium, Emtricitabine-Tenofovir (Truvada), Escitalopram, Gabapentin, Heparin, Hydroxyzine, and Mirtazapine. He has been instructed to follow up with his primary care physician within one week and to contact home health for ongoing support.\",\n",
       " \"**Patient Information:** 61-year-old female admitted for observation due to angiodysplasia of the colon with hemorrhage. \\n\\n**History of Present Illness:** The patient presented with hematochezia and abdominal pain. Initial workup included laboratory tests and imaging, which confirmed the diagnosis of angiodysplasia causing significant gastrointestinal bleeding. \\n\\n**Hospital Course:** During her 10-day stay, the patient was closely monitored in an observation unit. She received multiple blood transfusions for acute posthemorrhagic anemia, and her diabetes management was adjusted due to ketoacidosis that developed during hospitalization. The patient was treated with intravenous fluids, insulin, and electrolyte replacement. Her heart failure was managed with diuretics and beta-blockers as needed. The patient's symptoms improved significantly, and she was able to tolerate a regular diet. \\n\\n**Key Findings and Procedures:** Diagnostic colonoscopy was performed, revealing angiodysplastic lesions, which were cauterized to control the bleeding. A comprehensive assessment of her cardiovascular status indicated a non-ST elevation myocardial infarction, which was managed with appropriate medications. Throughout her stay, the patient was assessed for diabetes complications and received education on managing her type 1 diabetes. \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, ambulating independently, and shows good understanding of her discharge medications and follow-up care. She will require home health services for ongoing management of her diabetes, wound care from her colonoscopy, and monitoring for heart failure symptoms. \\n\\n**Medications at Discharge:** Discharge medications include Aspirin, Losartan Potassium, Metoprolol Tartrate, Insulin, and Omeprazole. She has been instructed to follow up with her primary care physician within 1 week and to monitor her blood glucose levels regularly. Home health services will provide assistance with medication adherence, blood sugar monitoring, and dietary modifications.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 70  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation following a left hip strain (ICD10: S76012A). He presented with significant pain and limited mobility, which was exacerbated by his underlying conditions, including secondary malignancies and a history of fluid overload and atrial fibrillation.  \\n  \\n**Hospital Course:**  \\nDuring the 8-day stay, the patient was managed with pain control, including morphine sulfate and acetaminophen, alongside supportive measures. Enoxaparin was administered for thromboembolism prophylaxis given his mobility issues. The patient also received furosemide to manage fluid overload and lactulose for constipation management. Regular monitoring of vital signs and renal function was performed, with no significant complications noted.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a strain of the left hip, managed conservatively. Imaging studies ruled out fractures. The patient displayed signs of improvement in pain control and mobility by the time of discharge, although he continues to require assistance for activities of daily living (ADLs).  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires home health services for ongoing rehabilitation, including physical therapy to restore mobility and strength. He will also need assistance with ADLs due to limited mobility. Family support has been arranged to assist during the transition home.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Docusate Sodium  \\n3. Enoxaparin Sodium  \\n4. Furosemide  \\n5. Lactulose  \\n6. Milk of Magnesia  \\n7. Morphine SR and IR  \\n8. Multivitamins  \\n9. Ondansetron ODT  \\n10. Senna  \\n11. Tamsulosin  \\n12. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with primary care within one week post-discharge for medication management and continued evaluation of his mobility. Home health will initiate services within the next 48 hours to assist with rehabilitation and monitoring.',\n",
       " '**Patient Information:** 43-year-old female admitted through the emergency department with a primary diagnosis of urinary tract infection (UTI), unspecified site (ICD-10: N390). \\n\\n**History of Present Illness:** The patient presented with fever, dysuria, and flank pain. She has a medical history notable for type 1 diabetes mellitus with complications including diabetic nephropathy and neuropathy, as well as a history of kidney transplant. \\n\\n**Hospital Course:** During her 3.8-day stay, the patient was started on IV antibiotics, specifically Ertapenem, due to the resistance of her UTI to multiple antibiotics. She was closely monitored for renal function given her acute kidney failure and underlying kidney transplant status. Supportive care included pain management with Acetaminophen and hydration with IV fluids. The patient responded well to treatment, with her symptoms significantly improving by discharge, and her renal function stabilized. \\n\\n**Key Findings and Procedures:** Initial laboratory tests confirmed the diagnosis of UTI, and culture results indicated Klebsiella pneumoniae as the causative organism. The patient was also administered the influenza vaccine during her stay due to her immunocompromised status.\\n\\n**Discharge Condition and Functional Status:** The patient is medically stable at discharge. She reports a decrease in urinary symptoms and is afebrile. Functional status is improved, and she is able to ambulate independently. Home health services are recommended for ongoing monitoring of her diabetic condition and to assist with medication management, including insulin administration. \\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, Atorvastatin, CycloSPORINE (Neoral), Dextrose 50%, Lactulose, and an insulin pump for diabetes management. The patient is advised to follow up with her nephrologist and primary care physician within one week of discharge. Home health nursing will assist in monitoring her blood glucose levels and medication adherence.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is an 80-year-old female who presented with a traumatic subdural hemorrhage (ICD-10: S065X0A) after an unwitnessed fall. She reported no loss of consciousness but exhibited confusion and mild aphasia upon admission.  \\n\\n**Hospital Course:**  \\nDuring her 7.8-day stay, the patient underwent a comprehensive evaluation, including CT imaging, which confirmed the diagnosis of subdural hemorrhage. Neurology and neurosurgery consultations were initiated. The patient was monitored closely for neurological status, and her condition stabilized without the need for surgical intervention. She received supportive care, including management of her underlying conditions, such as hypertension and dementia.  \\n\\n**Key Findings and Procedures:**  \\nCT scans showed a moderate subdural hematoma without midline shift. The patient’s neurological exam showed some improvement, with gradual resolution of her aphasia. She was treated with acetaminophen for pain management and received bisacodyl and docusate sodium for constipation prophylaxis.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved mental status but continued to exhibit mild cognitive impairment. She requires assistance with activities of daily living (ADLs) due to her cognitive deficits. The patient will benefit from home health services for ongoing physical therapy and cognitive support, including safety assessments in the home environment.  \\n\\n**Medications at Discharge:**  \\nThe patient’s discharge medications include:  \\n- Acetaminophen  \\n- Famotidine  \\n- Lisinopril  \\n- LevETIRAcetam  \\n- Insulin  \\n- Docusate Sodium  \\nPatients are advised to continue with their current medications and follow up with their primary care physician within one week of discharge.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician and a neurology specialist in two weeks. Home health services have been arranged to assist with her rehabilitation and safety in the home.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 61 years  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of an unspecified intestinal obstruction, which was categorized as neither partial nor complete. She presented with abdominal pain, nausea, and vomiting, necessitating further investigation.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent serial abdominal imaging which confirmed the diagnosis of an intestinal obstruction. She was managed conservatively with fluid resuscitation, bowel rest, and symptom management. Pain control was achieved with IV Hydromorphone and oral Acetaminophen. The patient was monitored closely for any signs of deterioration or need for surgical intervention, but her condition stabilized.  \\nAdditionally, the patient has a history of major depressive disorder, for which she was started on Citalopram and BuPROPion XL while hospitalized.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during her stay included abdominal tenderness without rebound or guarding, stable vital signs, and gradual resolution of nausea. No surgical procedures were necessary.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved abdominal symptoms. She was able to ambulate independently and demonstrated an understanding of her medication regimen. Home health services are recommended for medication management and follow-up assessment of her mental health status due to her history of depression.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Citalopram  \\n3. BuPROPion XL  \\n4. Ondansetron  \\n5. Pantoprazole  \\n6. Potassium Chloride  \\n7. D5 1/2NS and Lactated Ringers (as needed for hydration)  \\n8. Chloraseptic Throat Spray for symptomatic relief  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and maintain contact with home health services to monitor her recovery and mental health. She is advised to seek immediate care if there is a recurrence of abdominal symptoms or any signs of mental health deterioration.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 34  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted on [admission date] with complaints of abdominal pain and changes in bowel habits, ultimately diagnosed with a malignant neoplasm of the rectosigmoid junction (ICD10: C19). The patient reported significant discomfort, nausea, and anxiety during the initial assessment.  \\n\\n**Hospital Course:**  \\nDuring her 10.5 days of hospitalization, the patient underwent multiple diagnostic tests and imaging, confirming the presence of both the primary malignancy and secondary malignant neoplasms in the liver (ICD10: C787). She required supportive care, including IV fluids, pain management, and antiemetics. Notably, the patient experienced a perforation of the intestine (ICD10: K631), necessitating surgical intervention (ICD10: 0DBN0ZZ, 0DBP0ZZ) for repair.  \\n\\n**Key Findings and Procedures:**  \\n- The patient underwent a laparotomy with resection of the affected bowel segment.  \\n- Post-operative recovery was uneventful, though the patient experienced drug-induced tremors (ICD10: T426X5A), managed with adjustments to her medications, including lorazepam and morphine sulfate.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and demonstrates improved functional status, with the ability to ambulate with minimal assistance. She exhibits adequate pain control and is able to perform activities of daily living with reminders. Home health services are recommended to assist with wound care and nutritional support, as well as ongoing monitoring of her psychological well-being due to a history of anxiety disorder (ICD10: F419).  \\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen IV  \\n- Calcium Gluconate  \\n- DiphenhydrAMINE  \\n- Dronabinol  \\n- Famotidine  \\n- Heparin  \\n- Ondansetron  \\n- Morphine Sulfate  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her oncologist in one week post-discharge. Home health services will be initiated within 48 hours to ensure continuity of care.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 25  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 25-year-old male admitted for observation due to hemorrhage related to cardiac prosthetic devices. He presented with acute chest pain and was found to have significant bleeding associated with his cardiac implant. Initial evaluation and imaging supported the diagnosis of hemorrhage due to the cardiac prosthesis.  \\n  \\n**Hospital Course:**  \\nDuring his 0.8-day stay, the patient was closely monitored. He received supportive care, including blood transfusions and fluid resuscitation, which successfully stabilized his hemodynamics. The multidisciplinary team, including cardiology and hematology, was involved in his care, and no surgical intervention was required.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings on echocardiogram revealed dilated cardiomyopathy, and telemetry monitoring identified episodes of supraventricular and ventricular tachycardia, which were managed with appropriate antiarrhythmic medications. The patient also has a history of morbid obesity, diabetes, and hypertension, all contributing to his overall clinical picture.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulating independently with no signs of acute distress. He will require home health services for ongoing monitoring of his cardiac status, management of his medications, and dietary guidance due to his comorbid conditions.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Allopurinol, Amiodarone, Aspirin, Carvedilol, Cyanocobalamin, Dipyridamole, Hydralazine, Isosorbide Dinitrate, Magnesium Citrate, Magnesium Oxide, Mexiletine, Multivitamins with minerals, Pantoprazole, Potassium Chloride, and Spironolactone.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up appointments with cardiology and primary care are scheduled within one week of discharge. The patient is advised to monitor his weight and blood pressure regularly and to report any signs of worsening symptoms such as chest pain, shortness of breath, or increased fatigue promptly.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Date of Birth]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Age:** 69  \\n**Gender:** Male  \\n**Admission Type:** Elective  \\n**Length of Stay:** 5.2 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old male with a history of rheumatic disorders affecting both mitral and aortic valves, hypertension, hyperlipidemia, and obesity. He was admitted for elective mitral and aortic valve repair due to symptomatic heart failure. The patient also presented with acute posthemorrhagic anemia secondary to chronic anticoagulation therapy.  \\n\\n**Hospital Course:**  \\nDuring the 5-day hospital stay, the patient underwent successful surgical intervention with mitral and aortic valve repair. Postoperatively, he was monitored for hemodynamic stability, and his hemoglobin levels improved with transfusions and iron supplementation. Multidisciplinary teams, including cardiology, nutrition, and physical therapy, were involved in his care. \\n\\n**Key Findings and Procedures:**  \\nKey findings involved elevated blood pressure, improved echocardiographic measurements post-repair, and resolution of acute anemia. Procedures included valve repair, fluid management, and initiation of a cardiac rehabilitation program. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved cardiac function and mobility. He demonstrated the ability to perform activities of daily living (ADLs) with minimal assistance. Home health services are recommended to assist with medication management, monitor vital signs, and provide physical therapy to enhance recovery. \\n\\n**Medications at Discharge:**  \\nThe patient will continue on Acetaminophen, Aspirin EC, Atorvastatin, Metoprolol Tartrate, Furosemide, and Fenofibrate, among others. He has been advised to maintain a low-sodium diet and engage in light activity as tolerated.  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with cardiology to reassess valve function and manage medications.',\n",
       " '**Patient Information:**  \\n- Age: 74 years  \\n- Gender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to pneumonitis caused by inhalation of food and vomit (ICD-10 J690). She presented with respiratory distress, cough, and fever. The history revealed a recent episode of aspiration during a meal, leading to her current condition.  \\n\\n**Hospital Course:**  \\nDuring her 3-day hospital stay, the patient was closely monitored in the observation unit. She was started on intravenous antibiotics (Cefepime and Vancomycin) for aspiration pneumonia and received supportive care including oxygen therapy. Dexamethasone was administered to manage inflammation. She also received treatment for constipation with Polyethylene Glycol and Bisacodyl.  \\n\\n**Key Findings and Procedures:**  \\nChest X-ray confirmed bilateral infiltrates consistent with aspiration pneumonia. Blood cultures were negative. The patient’s respiratory status improved with treatment, and she was able to wean off supplemental oxygen. Lab results indicated stable hemoglobin levels despite her background of myelodysplastic syndrome.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with improved respiratory function. She is ambulating independently but requires assistance with daily activities due to weakness and underlying hemiplegia affecting her right side. Home health services will be essential for ongoing respiratory therapy and assistance with activities of daily living (ADLs).  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on Acetaminophen for pain management, Acyclovir for her viral infection, Amoxicillin-Clavulanic Acid, and Dexamethasone. She is advised to follow up with her primary care physician within one week and to monitor her respiratory status closely. Home health services will initiate within 48 hours post-discharge to ensure she receives necessary support and therapy.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 74  \\n**Gender:** Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 3.9 days  \\n**Primary ICD-10 Diagnosis:** J101 - Influenza due to other identified influenza virus with other respiratory manifestations.  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute respiratory distress and fever, consistent with influenza. She has a significant past medical history including chronic diastolic heart failure and diffuse large B-cell lymphoma, which complicates her clinical picture. The patient underwent supportive care and antiviral therapy during her hospitalization.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was treated with intravenous fluids, antiviral medications (Acyclovir), and bronchodilators (Albuterol). Her respiratory status improved gradually, although she experienced mild exacerbation of heart failure symptoms, managed with diuretics (Furosemide). The patient was monitored closely for signs of hemophagocytic lymphohistiocytosis and neutropenia, given her recent chemotherapy history.  \\n\\n**Key Findings and Procedures:**  \\nUpon admission, she exhibited hypoxia requiring supplemental oxygen. Chest X-ray findings were consistent with viral pneumonia. Laboratory workup showed elevated inflammatory markers. The patient responded well to treatment, with improvement in respiratory function and resolution of fever by day 3.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved respiratory function and manageable heart failure symptoms. She is able to perform activities of daily living with minimal assistance but will benefit from home health services for monitoring and medication management. She requires a follow-up for her oncological care and a cardiac evaluation.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Acyclovir  \\n3. Albuterol  \\n4. Aspirin  \\n5. Carvedilol  \\n6. Furosemide  \\n7. GammaGARD Liquid  \\n8. GuaiFENesin  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and her oncologist as scheduled. Home health services will be arranged for nursing visits to monitor her respiratory status and medication adherence.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 77-year-old male who presented with hematemesis and dysphagia. He was admitted under observation for evaluation of an esophageal ulcer with bleeding (ICD-10: K22.11).  \\n\\n**Hospital Course:**  \\nDuring his 1.9-day stay, the patient underwent upper gastrointestinal endoscopy, which confirmed the diagnosis of an ulcer of the esophagus with associated bleeding. He was treated with intravenous fluids and proton pump inhibitors, including pantoprazole, to manage his symptoms and promote healing. Additionally, he was monitored for post-hemorrhagic anemia (ICD-10: D62) and received calcium gluconate and magnesium sulfate for electrolyte imbalances. The patient's thrombocytopenia was noted but managed with appropriate transfusions as needed.  \\n\\n**Key Findings and Procedures:**  \\nEndoscopy results indicated a bleeding ulcer without any signs of malignancy. Laboratory tests showed improvement in hemoglobin levels post-transfusion and stabilization of electrolytes. The patient also exhibited decreased dysphagia and hematemesis post-treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires home health services for continued monitoring and management of his ulcer and dietary adjustments. He is able to ambulate with minimal assistance but will benefit from nursing support to ensure adherence to medication and dietary restrictions.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Pantoprazole, Sucralfate, Iso-Osmotic Sodium Chloride, Calcium Gluconate, Magnesium Sulfate, Potassium Chloride, and Sodium Chloride 0.9% flush. He is advised to follow up with his primary care physician within one week and to contact home health services for wound care and medication management. The need for dietary modifications has been discussed with the patient and family.  \\n\\n**Instructions for Home Health:**  \\n- Monitor for any signs of rebleeding or worsening symptoms  \\n- Ensure adherence to medication regimen  \\n- Dietary modifications to avoid irritants and promote healing.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 63  \\n- **Gender:** Male  \\n- **Admission Type:** Surgical Same Day Admission  \\n- **Length of Stay:** 1.7 Days  \\n\\n**History of Present Illness:**  \\nThe patient is a 63-year-old male diagnosed with a malignant neoplasm of the ethmoidal sinus (ICD-10: C311). He presented for surgical intervention aimed at excising the tumor and addressing associated complications.  \\n\\n**Hospital Course:**  \\nThe patient underwent a series of procedures including endoscopic sinus surgery (ICD-10: 09TV8ZZ) and was monitored post-operatively for any signs of complications including cerebrospinal fluid leaks (ICD-10: G9608). He exhibited mild hyperlipidemia (ICD-10: E785) and obstructive sleep apnea (ICD-10: G4733) that were addressed during his stay.  \\n\\n**Key Findings and Procedures:**  \\nDuring his hospitalization, the patient successfully tolerated all surgical interventions with no immediate post-operative complications. He was managed with appropriate analgesia and monitored for respiratory status due to his history of OSA. Imaging and clinical assessments confirmed the absence of cerebrospinal fluid leakage.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improvement in his overall health status. He is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services have been recommended for continued monitoring of his surgical site and management of his diabetes (ICD-10: E119) and other comorbidities.  \\n\\n**Medications at Discharge:**  \\nUpon discharge, the patient is prescribed multivitamins, rosuvastatin calcium, and vitamin D3 (cholecalciferol).  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week to reassess his surgical recovery and ongoing management of his chronic conditions, including his malignancy and diabetes.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 81  \\n**Gender:** Female  \\n**Admit Date:** [Date]  \\n**Discharge Date:** [Date]  \\n\\n**History of Present Illness:**  \\nThe patient is an 81-year-old female with a significant history of atherosclerotic heart disease, who presented with worsening angina and respiratory symptoms. She was admitted for observation due to concerns of unstable angina and chronic obstructive pulmonary disease exacerbation. Symptoms included chest discomfort radiating to the left arm, dyspnea on exertion, and increased cough with sputum production.\\n\\n**Hospital Course:**  \\nDuring her 1.8-day stay, the patient was closely monitored in the observation unit. Cardiac enzymes were within normal limits, and an EKG showed no acute changes. Chest X-ray demonstrated hyperinflation consistent with COPD. The patient received nebulized bronchodilator therapy and was started on appropriate medications to manage her angina and COPD.\\n\\n**Key Findings and Procedures:**  \\nThe patient's vital signs stabilized, and she demonstrated improved respiratory function with treatment. No invasive procedures were necessary during her stay. Key laboratory results indicated stable renal function and controlled hyperlipidemia. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, ambulating independently with mild fatigue. She requires home health services for medication management, monitoring of heart failure symptoms, and assistance with pulmonary rehabilitation exercises.  \\n\\n**Medications at Discharge:**  \\nUpon discharge, the patient was prescribed the following medications: Acetaminophen, Albuterol nebulizer solution, Aspirin, Clopidogrel, Lisinopril, Metoprolol Succinate XL, Isosorbide Mononitrate ER, and Fluticasone-Salmeterol Diskus.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week of discharge. Home health services will initiate contact for daily monitoring and support. She is to report any chest pain, increased dyspnea, or changes in her condition immediately. Routine follow-up will also include lipid panel and blood pressure monitoring.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 32  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an acute stress reaction (ICD-10: F430) following a recent traumatic event. He presented with symptoms including anxiety, irritability, and difficulty sleeping. The patient's past medical history includes chronic atrial fibrillation, essential hypertension, major depressive disorder, and obstructive sleep apnea.  \\n  \\n**Hospital Course:**  \\nDuring his 6.5-day stay, the patient underwent a thorough psychiatric evaluation and was managed with a combination of pharmacotherapy and supportive therapy. His medications included Lorazepam for anxiety, Gabapentin for neuropathic symptoms, and Oxycodone for pain management. He was also started on Rivaroxaban for anticoagulation, given his history of atrial fibrillation. The patient demonstrated improvement in his anxiety and stress levels, and his physical symptoms were well managed.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure consistent with his essential hypertension, and he underwent a sleep study which confirmed the diagnosis of obstructive sleep apnea. The patient was educated on lifestyle modifications, including weight management and sleep hygiene. No invasive procedures were necessary during this admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved mood and reduced anxiety. He is able to perform activities of daily living with assistance and has been referred to home health services for ongoing support. A home health nurse will assist with medication management and monitoring of his mental health status.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes 5% Dextrose, Gabapentin, Hydromorphone, Heparin, Lorazepam, Metoclopramide, Omeprazole, Ondansetron, Oxycodone, Prednisone, Rivaroxaban, and Sodium Chloride 0.9%. He is advised to follow up with his primary care physician and a psychiatrist within one week of discharge to ensure continuity of care and medication adjustments as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 24  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient is a 24-year-old female who presented with acute mastitis without abscess over the last two days, characterized by unilateral breast swelling, tenderness, and fever. She also has a history of major depressive disorder, anxiety disorder, and substance use disorders, complicating her clinical picture.  \\n\\n**Hospital Course:**  \\nDuring her 2.6-day hospital stay, the patient was initiated on intravenous antibiotics including Clindamycin and Vancomycin to cover for potential MRSA. Pain management was addressed with Acetaminophen, Ibuprofen, and Ketorolac. The patient exhibited improvement in breast symptoms and was afebrile by day two. She participated in physical therapy to enhance mobility and strength, given her history of anxiety and depression, which can affect her functional status.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed significant improvement in the affected breast with no signs of abscess formation. Laboratory results indicated stable white blood cell counts, and cultures were negative for pathogens. Psychological support was provided throughout the stay, focusing on her mental health and substance use challenges.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and demonstrates good functional capacity for discharge. She is able to perform activities of daily living independently but requires ongoing support for her mental health conditions. Given her substance use history and coping mechanisms, a referral to home health services for follow-up mental health support and nursing care is recommended.  \\n\\n**Medications on Discharge:**  \\n1. Acetaminophen  \\n2. BuPROPion (Sustained Release)  \\n3. Clindamycin  \\n4. Heparin  \\n5. Ibuprofen  \\n6. Iso-Osmotic Dextrose  \\n7. Ketorolac  \\n8. Sodium Chloride 0.9% Flush  \\n9. TraMADol  \\n10. Vancomycin  \\n\\n**Follow-Up Plan:**  \\nShe is to follow up with her primary care physician within one week and with mental health services as per the established care plan. Home health nursing will assist with medication management, wound care if necessary, and provide mental health support.',\n",
       " '**Patient Information:** 69-year-old female admitted for observation due to syncope and collapse, with a notable past medical history of chronic diastolic heart failure, hypertensive heart disease, and multiple myeloma. \\n\\n**History of Present Illness:** The patient presented to the emergency department after experiencing a syncopal episode at home. Initial assessments revealed significant hypotension and bradycardia. \\n\\n**Hospital Course:** Over a 4.6-day observation period, the patient was monitored closely for cardiac instability. Electrocardiograms and echocardiograms were performed, revealing no acute ischemic changes but confirming the presence of chronic heart failure signs. Treatment included intravenous fluids, electrolyte management, and adjustments in antihypertensive medications. The patient was also treated for her underlying conditions, including adjustments to Levothyroxine for hypothyroidism and initiation of Acyclovir for a suspected viral infection.\\n\\n**Key Findings and Procedures:** Key laboratory findings indicated mild hyperlipidemia and elevated liver enzymes, with no acute liver injury evident. A chest X-ray showed signs of congestion consistent with heart failure. The patient underwent a comprehensive medication review to optimize her regimen prior to discharge.\\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable and ambulating independently with assistance from physical therapy, which she will continue at home. She demonstrates adequate understanding of her medication regimen and the importance of monitoring her blood pressure and weight. Home health services will assist in ongoing assessment and management of her heart failure, medication compliance, and daily activities.\\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, Acyclovir, Aspirin, Atorvastatin, Clobetasol Propionate, Docusate Sodium, Fluticasone Propionate, Heparin, Levothyroxine, Loratadine, Pantoprazole, and Vitamin D. The patient is advised to follow up with her cardiologist within one week for blood pressure management and to continue home health nursing services for medication management and education.',\n",
       " 'Patient is a 57-year-old male admitted for observation due to a viral intestinal infection (ICD-10: A084). He presented with abdominal pain, diarrhea, and dehydration. Initial workup included laboratory tests and imaging, which revealed portal vein thrombosis and other complications such as acidosis and ascites.\\n\\nDuring his 2.8-day hospital stay, the patient was stabilized with intravenous fluids, electrolytes, and symptom management. He received furosemide for fluid overload, lactulose for hepatic encephalopathy prevention, and heparin to address the portal vein thrombosis. Pain management included morphine sulfate and oxycodone as needed. The patient also received famotidine for gastric protection and the influenza vaccine as part of his routine care. Throughout the hospitalization, the patient demonstrated improvement in abdominal symptoms, and his fluid status was closely monitored.\\n\\nKey findings included the resolution of acute abdominal symptoms, normalization of electrolytes, and improvement in overall clinical status. He underwent daily assessments by the nursing staff and was seen by the gastroenterology team, resulting in a comprehensive plan for outpatient management.\\n\\nAt discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. He has been instructed to continue home health services for ongoing monitoring of fluid status, medication management, and dietary adjustments. The patient is advised to follow-up with his primary care physician and gastroenterologist within one week to reassess his condition and adjust treatment as necessary. Medications at discharge include 5% dextrose, furosemide, lactulose, famotidine, magnesium sulfate, and pain control medications. He is also advised to maintain a low-sodium diet and stay hydrated.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 59 years old  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 5.7 days  \\n**Primary Diagnosis:** Incisional hernia without obstruction or gangrene (ICD10: K432)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical repair of an incisional hernia, which presented with mild discomfort but no signs of obstruction or gangrene. She has a history of gastro-esophageal reflux disease, asthma, and depression, which were monitored during her stay.  \\n  \\n**Hospital Course:**  \\nThe patient underwent laparoscopic hernia repair (ICD10: 0WUF0JZ) successfully. Postoperatively, she was managed for pain control with hydromorphone and received an epidural infusion of bupivacaine. She was also treated for hypomagnesemia and given supportive care for her asthma. The patient demonstrated good tolerance to oral intake and ambulated independently, showing a gradual improvement in her functional status.  \\n  \\n**Key Findings and Procedures:**  \\nThe surgical site was clean and dry upon assessment. The patient experienced no postoperative complications, and her vital signs remained stable throughout her hospital stay. She was provided with education on wound care and activity restrictions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was in stable condition, ambulating independently, and capable of performing activities of daily living with minimal assistance. Home health services have been arranged to assist with wound care and monitor her recovery, particularly given her history of depression and asthma, which may necessitate additional support.  \\n  \\n**Medications:**  \\nDischarge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Bupivacaine 0.1%  \\n- Escitalopram Oxalate  \\n- Fexofenadine  \\n- Fluticasone Propionate  \\n- Omeprazole  \\n- Ondansetron  \\n- Hydrocortisone Cream 2.5%  \\nFollow-up with the surgeon is recommended within one week for wound assessment and further management of her chronic conditions.',\n",
       " '**Patient Information:** 41-year-old female admitted for observation due to severe hemorrhoidal symptoms. \\n\\n**History of Present Illness:** The patient presented with complaints of rectal bleeding and discomfort, with a history of chronic hemorrhoids. She reported worsening symptoms over the past month, including pain during defecation and intermittent rectal bleeding. No signs of active gastrointestinal bleeding were noted upon admission.\\n\\n**Hospital Course:** During her 2.4-day stay, the patient underwent a thorough evaluation, including laboratory tests which revealed acute posthemorrhagic anemia (ICD10: D62). The patient was managed conservatively with intravenous fluids and medications. She received Ceftriaxone for possible infection, along with supportive care including lactulose for stool softening, ondansetron for nausea, and pantoprazole for gastroprotection. An inflatable hemorrhoid banding procedure was performed to alleviate symptoms, along with administration of Fleet enema for bowel preparation. The patient tolerated the procedure well, with no immediate complications.\\n\\n**Key Findings and Procedures:** Clinical examination confirmed the presence of other hemorrhoids (ICD10: K648) and residual hemorrhoidal skin tags. Post-procedure, the patient showed significant improvement in symptoms, with a decrease in pain and rectal bleeding. \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, ambulating independently, and reports improved bowel habits. She is advised to continue a high-fiber diet and maintain hydration. Home health services are recommended for ongoing assessment and assistance with bowel management, as well as monitoring for any signs of complications. \\n\\n**Medications and Follow-Up Plan:** At discharge, the patient is prescribed 0.9% Sodium Chloride, Lactulose, Rifaximin, and Multivitamins. She is advised to follow up with her primary care physician within one week and to contact home health services for any concerns related to her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 57 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following presentation with unstable angina pectoris characterized by episodes of chest pain at rest. He has a history of atherosclerotic heart disease and additional comorbidities including obesity (BMI 40.0-44.9), hyperlipidemia, hypothyroidism, benign prostatic hyperplasia, type 2 diabetes mellitus, and a past history of nicotine dependence.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was monitored closely in a telemetry unit. He received antiplatelet therapy with aspirin and clopidogrel, lipid management with atorvastatin, and blood pressure control with metoprolol. He was started on insulin for glycemic control and was treated with heparin for thromboembolic prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nCardiac evaluation revealed stable vital signs, and no evidence of myocardial infarction on serial troponin testing. Echocardiogram showed preserved left ventricular function. The patient underwent a cardiac stress test which was inconclusive but was managed medically.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and asymptomatic, with improved tolerance to activities of daily living. He is aware of his medication regimen and dietary modifications needed for his diabetes and heart disease. He will require home health services for ongoing monitoring of his vital signs, medication adherence, and assistance with diabetes management.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Aspirin, Atorvastatin, Clopidogrel, Metoprolol Succinate XL, Insulin, and Tamsulosin.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up appointment with cardiology is scheduled within one week. The patient is advised to maintain regular follow-ups with his primary care physician for management of his diabetes and other comorbidities. Home health services will initiate within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old female who presented to the emergency department with progressive headache and neurological deficits. Imaging studies revealed a benign neoplasm of the cerebral meninges (ICD-10 D320), leading to cerebral edema (G936) and compression of the brain (G935).\\n\\n**Hospital Course:**  \\nThe patient was admitted directly from the emergency department for further evaluation and management. Over a 2.3-day stay, she received dexamethasone for cerebral edema, along with supportive care including analgesics (acetaminophen) and muscle relaxants (cyclobenzaprine). The patient was monitored closely for neurological changes and was initiated on anticoagulation therapy (heparin) to prevent venous thromboembolism due to immobility.\\n\\n**Key Findings and Procedures:**  \\nNeurological assessments showed gradual improvement in her symptoms. MRI findings confirmed the presence of the benign neoplasm without evidence of acute hemorrhage. The patient underwent a procedure for placement of an intraventricular catheter to relieve intracranial pressure due to the mass effect. Post-procedure, she was stable with no new neurological deficits.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was ambulating with assistance and demonstrated the ability to perform activities of daily living with minimal support. She is alert and oriented, with plans for continued rehabilitation through home health services to assist with mobility and medication management.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.83% Sodium Chloride, acetaminophen, cyclobenzaprine, dexamethasone, and famotidine among others. She will need close follow-up with neurology and primary care within one week post-discharge. Home health services are arranged for monitoring her condition and assisting with her rehabilitation needs, including physical therapy and medication adherence.',\n",
       " \"Patient is a 32-year-old male with a diagnosis of achalasia of cardia, who underwent surgical intervention for this condition. He was admitted on a surgical same-day basis and had a total length of stay of 4.5 days. The patient's medical history is significant for Marfan's syndrome, gastro-esophageal reflux disease without esophagitis, and a personal history of nicotine dependence. Upon admission, the patient presented with dysphagia and significant difficulty swallowing, necessitating surgical evaluation.\\n\\nDuring his hospital course, the patient underwent a series of diagnostic evaluations that confirmed the diagnosis of achalasia. Surgical intervention included a laparoscopic Heller myotomy and fundoplication, which was performed without complications. Postoperative recovery was uneventful, with the patient demonstrating gradual improvement in his swallowing ability. Key findings included resolution of dysphagia and tolerating a clear liquid diet by the second postoperative day. The patient was monitored closely for any signs of complications, including esophageal perforation or infection, but remained stable throughout his hospitalization.\\n\\nAt the time of discharge, the patient exhibited improved functional status, being able to maintain adequate oral intake and ambulate independently. He has been educated on the importance of adhering to a soft diet post-operatively and to avoid any irritants related to gastro-esophageal reflux. Home health services have been arranged to assist with his recovery, including monitoring of nutritional intake and medication management.\\n\\nMedications at discharge include Acetaminophen (Liquid), Atenolol, Bisacodyl, Docusate Sodium (Liquid), Gabapentin, Hydromorphone (Dilaudid), Heparin, Omeprazole, Oxycodone Liquid, Senna, and Sodium Chloride 0.9% flush. The patient is instructed to follow up with his primary care physician and surgeon within one to two weeks post-discharge to monitor his recovery and manage any ongoing symptoms.\",\n",
       " \"Patient is a 64-year-old female who was admitted for observation due to drug-induced constipation (ICD-10: K5903) primarily resulting from the use of opioids for pain management. She presented with complaints of abdominal discomfort, reduced bowel movements, and associated nausea. Upon admission, a thorough assessment revealed no signs of bowel obstruction, and her vital signs were stable.\\n\\nDuring her brief hospital stay of 1.2 days, she was monitored closely and managed with supportive care. Key interventions included the administration of polyethylene glycol and senna to promote bowel movements, alongside ondansetron to manage her nausea. The patient's pain was managed effectively with acetaminophen and oxycodone, while gabapentin was continued for her chronic pain management. Enoxaparin was initiated as a prophylactic measure against venous thromboembolism due to her immobility.\\n\\nThe hospital course was uneventful with no complications, and the patient gradually started to have bowel movements, reporting improvement in her symptoms before discharge. Key findings included abdominal tenderness but no rigidity or guarding, confirming that constipation was the primary issue. She was also educated on dietary modifications to include increased fiber intake and adequate hydration.\\n\\nAt discharge, the patient was stable and functional, capable of performing activities of daily living (ADLs) independently but requiring assistance with meal preparation and transportation for follow-up appointments. She was advised to continue home health services to monitor her recovery and ensure proper medication adherence. \\n\\nMedications at discharge included acetaminophen, gabapentin, oxycodone (immediate release), polyethylene glycol, potassium bicarbonate effervescent, psyllium wafers, ramelteon, and enoxaparin for prophylaxis. Follow-up appointments were scheduled with her primary care physician and a gastroenterologist to review her ongoing management of constipation and chronic pain. The patient was instructed to seek immediate medical attention if symptoms worsen or if she experiences any new gastrointestinal symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 63 years  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of pyonephrosis, presenting with flank pain and gross hematuria. His past medical history is notable for chronic kidney disease and diffuse large B-cell lymphoma, which have contributed to his current condition. During his stay, multidisciplinary evaluations were performed to assess the severity of renal involvement and to optimize management.  \\n  \\n**Hospital Course:**  \\nThe patient underwent imaging studies confirming the diagnosis of pyonephrosis. A nephrostomy was placed to provide drainage and relieve symptoms. He received IV antibiotics (Cefepime) and supportive care, which resulted in significant clinical improvement. Pain management was achieved with hydromorphone and acetaminophen. Throughout the hospital stay, he was closely monitored for signs of infection and renal function.  \\n  \\n**Key Findings and Procedures:**  \\n- Imaging confirmed bilateral pyonephrosis.  \\n- Nephrostomy tube placement performed successfully.  \\n- Improvement in renal function was noted with supportive care.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with a functioning nephrostomy tube. He has been educated on its care and the signs of potential complications. Functional status is significantly improved; he is mobile with assistance and capable of performing basic self-care activities. Home health services will provide post-discharge support, including monitoring the nephrostomy site and medication management.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Acyclovir  \\n- Allopurinol  \\n- Cefepime  \\n- Clonazepam  \\n- Escitalopram  \\n- Hydromorphone  \\n- Heparin flush  \\n- Loratadine  \\n- Losartan  \\n- Magnesium sulfate  \\n- Omeprazole  \\n- Simvastatin  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with nephrology within one week for nephrostomy management and ongoing renal evaluation. Home health will be arranged to assist with wound care and medication adherence.',\n",
       " 'Patient is a 31-year-old female who was admitted urgently for preterm labor at 23 weeks gestation, presenting with signs of contractions and cervical changes. Upon admission, she was diagnosed with preterm labor (ICD10: O6012X0) and subsequently underwent management for complications including immediate postpartum hemorrhage (ICD10: O721). The patient delivered a single live birth via vaginal delivery, and the postpartum period was complicated by hemorrhaging due to uterine atony, which was successfully managed with medical interventions.\\n\\nThroughout her 2.5-day hospital stay, the patient received supportive care, including IV fluids and medications to control bleeding. Key findings included stable vital signs post-delivery, with a need for close monitoring of uterine tone and passage of clots. She was also treated for obesity complications, which were addressed with appropriate dietary and activity recommendations. \\n\\nUpon discharge, the patient is stable, with a discharge condition described as satisfactory. She is able to ambulate independently but requires assistance with activities of daily living due to fatigue and residual effects from the delivery. Home health services are recommended to provide nursing care for wound management, monitoring of vital signs, and education on postpartum care, including signs of infection or further bleeding.\\n\\nMedications at discharge include Calcium Carbonate, Cetirizine, Dermoplast Spray for perineal discomfort, Docusate Sodium for constipation, Ibuprofen for pain management, MedroxyPROGESTERone Acetate, Senna, Simethicone for gas relief, and Tetanus-DiphTox-Acellular Pertuss (Tdap) vaccine. A follow-up appointment with the obstetrician is scheduled in one week to reassess her recovery and overall health status.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 75, Gender: Female  \\n**Admission Date:** [Insert Admission Date]  \\n**Length of Stay:** 3.6 days  \\n**Diagnosis:** ST elevation (STEMI) myocardial infarction involving other coronary artery of the inferior wall (ICD-10: I2119).  \\n**History of Present Illness:**  \\nThe patient was admitted for observation following the presentation of chest pain consistent with a STEMI. Pre-hospitalization, she was noted to have a history of diabetes mellitus, chronic kidney disease, and ischemic cardiomyopathy, complicating her clinical profile.  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a comprehensive workup, including cardiac monitoring, echocardiography, and laboratory assessments, revealing elevated cardiac enzymes. She was managed with antiplatelet therapy (Aspirin, Clopidogrel), beta-blockers (Metoprolol), and statins (Atorvastatin). Diltiazem was also initiated for rate control due to her underlying ischemic heart disease. The patient exhibited improvement in symptoms and hemodynamic stability after treatment initiation.  \\n**Key Findings and Procedures:**  \\nEchocardiogram indicated reduced ejection fraction, and an assessment of her coronary arteries showed areas of stenosis. A cardiac catheterization was not performed due to her overall stability and risk factors.  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with a significant reduction in chest discomfort. However, she demonstrated decreased exercise tolerance and mild dyspnea on exertion. Home health services are recommended for monitoring vital signs, medication management, and assistance with activities of daily living.  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Clopidogrel  \\n5. Diltiazem Extended-Release  \\n6. Isosorbide Dinitrate  \\n7. Insulin and Dextrose as needed  \\n8. Mirtazapine for depressive symptoms  \\nAll medications will be continued as prescribed, and the patient is advised to follow up with her primary care physician and cardiologist within one week. Home health services will coordinate with her outpatient care team to ensure a smooth transition.',\n",
       " '**Discharge Summary**  \\n**Patient:** 78-year-old male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 8.2 days  \\n**Primary Diagnosis:** Diverticulosis of the large intestine without perforation or abscess with bleeding (ICD-10: K5731)  \\n\\n**History of Present Illness:** The patient was admitted for management of diverticulosis presenting with significant gastrointestinal bleeding. Initial assessment revealed hemodynamic instability, prompting observation and further evaluation.  \\n\\n**Hospital Course:** During the hospitalization, the patient received supportive care, including intravenous fluids and blood transfusions for acute posthemorrhagic anemia. He underwent a colonoscopy which confirmed diverticulosis but showed no evidence of perforation or abscess. Throughout his stay, he was monitored for respiratory function due to underlying chronic conditions, including chronic diastolic heart failure and chronic kidney disease. The patient also received treatment for respiratory failure with supplemental oxygen and bronchodilator therapy.  \\n\\n**Key Findings and Procedures:** Key findings included stable vital signs post-transfusion, resolution of bleeding, and improvement in hemoglobin levels. A multidisciplinary team managed his complex medical issues, including cardiology and nephrology consultations. The patient was assessed by physical therapy and occupational therapy, demonstrating improved mobility with assistance and ambulation.  \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable, ambulating with a walker, and required minimal assistance for activities of daily living. Home health services have been arranged to support follow-up care, medication management, and continued rehabilitation.  \\n\\n**Medications at Discharge:** The following medications were prescribed: Fluticasone Propionate 110mcg, Furosemide, Levalbuterol Nebulizer, Levothyroxine Sodium, Metoprolol Succinate XL, Nystatin Oral Suspension, Omeprazole, Senna, Sertraline, and Sodium Chloride 0.9% Flush.  \\n\\n**Follow-Up Plan:** The patient is to follow up with his primary care physician within one week and has been advised to monitor for any signs of recurrent bleeding or respiratory distress. Home health nursing will assist with medication compliance and ongoing assessment of his cardiovascular and respiratory status.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 62  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 7.1 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with worsening dyspnea and lower extremity edema. He has a history of hypertensive heart disease complicated by heart failure and chronic kidney disease. During his stay, he experienced episodes of hypotension and acute kidney failure, which were managed with fluid resuscitation and careful monitoring of renal function.  \\n\\n**Hospital Course:**  \\nOver the course of 7 days, the patient was managed with diuretics (Torsemide, Spironolactone) to mitigate fluid overload and improve symptoms. His hypertension was controlled with Lisinopril and Metoprolol Succinate XL. The patient's respiratory status improved with nebulized Albuterol treatments, and he was transitioned to oral medications prior to discharge. Additionally, he was educated on the importance of medication adherence and lifestyle modifications.  \\n\\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** I110 (Hypertensive heart disease with heart failure), N179 (Acute kidney failure, unspecified), I5033 (Acute on chronic diastolic heart failure), and others.  \\n- **Vital Signs:** Stable at discharge, with blood pressure within target range after medication adjustments.  \\n- **Labs:** Renal function improved, with no electrolyte abnormalities noted.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved functional status. He reports reduced dyspnea and increased exercise tolerance. He requires ongoing home health services for medication management, monitoring of renal function, and assistance with daily activities.  \\n\\n**Medications at Discharge:**  \\n- Albuterol 0.083% Neb Soln  \\n- Aspirin  \\n- Dabigatran Etexilate  \\n- Lisinopril  \\n- Metoprolol Succinate XL  \\n- Spironolactone  \\n- Torsemide  \\n- Multivitamins  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Sodium Chloride Nasal  \\n- TraZODone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within 1 week of discharge, as well as with a cardiologist for ongoing management of his heart failure. Home health services will be initiated to assist with medication administration and monitoring.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 68  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient, a 68-year-old female, was admitted under observation for management of a chronic duodenal ulcer with hemorrhage (ICD-10: K264) exacerbated by a history of anticoagulant use. She presented with complaints of epigastric pain and melena. Associated medical history includes essential hypertension, chronic kidney disease, and hyperlipidemia.  \\n  \\n**Hospital Course:**  \\nDuring her 3.8-day hospital stay, the patient was monitored closely for signs of bleeding and received supportive care, including IV fluids and blood transfusions due to acute posthemorrhagic anemia (ICD-10: D62). Gastroenterology was consulted, and she underwent endoscopic intervention which successfully managed the ulcer-related hemorrhage. Her COVID-19 status was also addressed during her stay (ICD-10: U071), but she remained asymptomatic.  \\n  \\n**Key Findings and Procedures:**  \\nEndoscopy revealed active bleeding from the duodenal ulcer, which was treated with cauterization. Laboratory results indicated mild electrolyte imbalances, which were corrected. The patient's blood pressure remained stable throughout her stay, and she was transitioned to oral medications including Omeprazole and Pantoprazole for ulcer management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with resolution of acute symptoms and improved hemoglobin levels. She has been advised to follow a bland diet and avoid NSAIDs. The patient requires home health services for medication management and monitoring of her anticoagulant therapy, given her history of bleeding and current medications, including Apixaban.  \\n  \\n**Medications at Discharge:**  \\n1. Allopurinol  \\n2. Apixaban  \\n3. Atorvastatin  \\n4. Bismuth Subsalicylate  \\n5. Colchicine  \\n6. Ferrous Sulfate  \\n7. Lisinopril  \\n8. MetroNIDAZOLE  \\n9. Omeprazole  \\n10. Pantoprazole  \\n11. Sodium Chloride 0.9% Flush  \\n12. Tetracycline  \\n13. Amlodipine  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for outpatient follow-up with her primary care physician within one week and with gastroenterology in two weeks to reassess her ulcer and manage her chronic conditions. Home health nursing will assist in medication adherence and monitor her vital signs and symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 71-year-old female  \\n**Admit Type:** Observation Admit  \\n**Length of Stay:** 5.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of hypertensive heart disease with heart failure, presenting with worsening dyspnea, fatigue, and peripheral edema. She has a significant medical history of paroxysmal atrial fibrillation, presence of a prosthetic heart valve, and long-term anticoagulant therapy.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient was started on diuretics (Torsemide, Spironolactone) to manage fluid overload, and her antihypertensive regimen was optimized with Lisinopril and Metoprolol Succinate XL. Cardiology was consulted, and the patient was monitored for arrhythmias and heart failure exacerbation. She received Amiodarone for atrial fibrillation control.  \\n\\n**Key Findings and Procedures:**  \\nEchocardiogram revealed acute on chronic systolic heart failure with preserved ejection fraction. The patient had stable cardiac rhythm during her stay, with no significant arrhythmias noted. She was evaluated for home health services due to her ongoing needs for assistance with daily activities and medication management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable upon discharge, having shown improvement in dyspnea and edema. However, she requires continued home health support for medication adherence, monitoring of vital signs, and assistance with activities of daily living due to her age and comorbid conditions.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Amiodarone  \\n- Amitriptyline  \\n- Aspirin  \\n- Docusate Sodium  \\n- Folic Acid  \\n- Lisinopril  \\n- Metoprolol Succinate XL  \\n- Polyethylene Glycol  \\n- Pravastatin  \\n- Senna  \\n- Sertraline  \\n- Sodium Chloride 0.9% Flush  \\n- Spironolactone  \\n- Torsemide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week. Home health services will be initiated for ongoing nursing care, medication management, and physical therapy evaluation to support her recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 29  \\nGender: Female  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for post-term pregnancy at 40 weeks of gestation. She presented with signs of labor and was evaluated for potential complications associated with prolonged gestation.  \\n\\n**Hospital Course:**  \\nDuring her 2.5-day stay, the patient underwent a successful vaginal delivery of a single live birth. The labor progressed normally, but a second-degree perineal laceration occurred during delivery, which was repaired in the delivery room.  \\n\\n**Key Findings and Procedures:**  \\nThroughout her hospitalization, the patient's vital signs remained stable, and fetal monitoring demonstrated reassuring patterns. Post-delivery, she was monitored for any signs of hemorrhage or infection, both of which were absent. The perineal laceration was appropriately managed, and the patient received education on perineal care.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and ambulating independently. She reports moderate perineal discomfort but is able to perform activities of daily living with minimal assistance. Given her recent delivery, home health services will be beneficial to assist with postpartum care, particularly for wound management and breastfeeding support.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Docusate Sodium  \\n- Bisacodyl  \\n- Calcium Carbonate  \\n- Dermoplast Spray  \\n- Hydrocortisone (Rectal) 2.5% Cream  \\n- Milk of Magnesia  \\n- Polyethylene Glycol  \\n- Simethicone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for postpartum evaluation and to ensure proper recovery. Home health services will initiate contact within 48 hours for follow-up and support. Any concerns regarding her recovery or new symptoms should prompt immediate medical attention.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 75 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of secondary malignant neoplasm of the lymph nodes in the head and neck region. He has a significant past medical history including atrial fibrillation, atherosclerotic heart disease, essential hypertension, hyperlipidemia, gastro-esophageal reflux disease (GERD), obstructive sleep apnea, and dysphagia. He presented with worsening symptoms including swelling in the cervical lymph nodes and difficulty swallowing.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient underwent imaging studies that confirmed lymphadenopathy consistent with his known malignancy. He received supportive care, including fluid resuscitation with lactated Ringer’s and pain management with morphine sulfate and oxycodone. Additionally, he was started on atorvastatin for hyperlipidemia and lisinopril for blood pressure management. The patient was monitored closely for any signs of atrial fibrillation and was stabilized during his hospital course.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant cervical lymphadenopathy and stable cardiac function. The patient was treated with intravenous cephazolin to prevent infection and was assessed for dysphagia, which remains an ongoing concern post-discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services to assist with medication management, monitor vital signs, and provide support for dysphagia. He will also benefit from home health nursing to ensure compliance with anticoagulation therapy and cardiac monitoring due to his atrial fibrillation.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, atorvastatin, cephazolin, docusate sodium, lactated Ringer’s, lisinopril, morphine sulfate, nitroglycerin sublingual, omeprazole, oxycodone, pregabalin, senna, sodium chloride 0.9%, and vitamin D. Follow-up appointments are scheduled with oncology for further evaluation of his malignancy and with cardiology to manage his atrial fibrillation.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 77  \\nGender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.8 days  \\n**Primary Diagnosis:** Calculus of gallbladder with acute cholecystitis without obstruction (ICD-10: K8000)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of right upper quadrant pain, nausea, and vomiting. Imaging studies confirmed the presence of gallstones and acute cholecystitis. The patient has a history of essential hypertension, hyperlipidemia, and a personal history of prostate cancer, now in remission.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for observation, during which he received supportive care including IV fluids and pain management with acetaminophen and oxycodone. Antibiotics were initiated due to signs of infection. The patient was monitored for any complications such as perforation or abscess formation, none of which occurred.  \\n  \\n**Key Findings and Procedures:**  \\nOn examination, the patient exhibited tenderness in the right upper quadrant but had stable vital signs throughout the admission. Laboratory tests indicated mild leukocytosis and elevated liver enzymes, consistent with acute cholecystitis. The patient underwent an ultrasound which confirmed gallbladder inflammation without obstruction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable and ambulating independently. He demonstrated the ability to perform activities of daily living with minimal assistance. Home health services will be arranged to provide follow-up care, including medication management and monitoring for any potential complications related to his gallbladder condition.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on acetaminophen, amoxicillin-clavulanic acid, gabapentin, and oxycodone as needed for pain management. He is advised to maintain hydration and follow a low-fat diet until further evaluation by a surgeon. A follow-up appointment with his primary care physician is scheduled within one week to reassess his condition and medication regimen.',\n",
       " \"Patient is a 43-year-old female who was admitted under observation for evaluation of bilateral lower limb neuropathy, specifically diagnosed with other specified mononeuropathies (ICD-10 G5783). The patient's history is complicated by ulcerative colitis, gastro-esophageal reflux disease, and a personal history of breast cancer. \\n\\nDuring her 1.6-day hospital stay, the patient underwent a comprehensive neurological assessment, which confirmed the presence of bilateral lower limb weakness and sensory changes. A multidisciplinary team evaluated her for potential underlying causes, including metabolic, infectious, and autoimmune conditions. Laboratory studies were remarkable for mild electrolyte imbalance, which was corrected during the hospitalization. The patient was treated with gabapentin for neuropathic pain, and her gastrointestinal symptoms were managed with pantoprazole and appropriate hydration.\\n\\nKey findings included significant fasciculations in the lower extremities, along with positive Tinel's sign bilaterally. No acute complications were noted during her stay, and she demonstrated stable vital signs throughout her admission. The patient also received education on her medications and the importance of follow-up appointments for her chronic conditions.\\n\\nAt the time of discharge, the patient was ambulating with minimal assistance and reported a decrease in pain levels. Her functional status indicates a need for continued support from home health services to assist with daily activities and medication management. \\n\\nDischarge medications include: Acetaminophen for pain management, Albuterol inhaler for any respiratory symptoms, Gabapentin for neuropathic pain, Heparin for DVT prophylaxis, Pantoprazole for GERD, and Spironolactone and amLODIPine for hypertension management. \\n\\nFollow-up is recommended within one week with the primary care physician and as needed with a neurologist to monitor her neuropathic symptoms and adjust medications accordingly.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 67  \\n**Gender:** Male  \\n**Admission Type:** Emergency Room (EW EMER)  \\n**Length of Stay:** 1.2 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old male with a primary diagnosis of COVID-19 (ICD-10: U071). He presented to the emergency department with symptoms consistent with a viral respiratory infection, including fever, cough, and shortness of breath. The patient has a past medical history of Crohn's disease, essential hypertension, and a urinary tract infection, which were managed during his hospital stay. \\n\\n**Hospital Course:**  \\nDuring his brief hospitalization, the patient was monitored for respiratory distress and received supportive care. He was treated with intravenous fluids and medications to manage his symptoms, including Ondansetron for nausea and Heparin for DVT prophylaxis. The patient's vital signs remained stable, and he was closely monitored for any complications. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed the presence of COVID-19, with accompanying mild dehydration. The patient underwent a chest X-ray which revealed no acute respiratory distress. He was treated for a urinary tract infection and prescribed appropriate antibiotics. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was stable at the time of discharge, with improved respiratory symptoms and hydration status. He is able to perform activities of daily living with minimal assistance but may benefit from home health services to support ongoing monitoring of his condition and medication management. He should have access to assistive devices if needed for mobility support at home. \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed Acetaminophen for fever management, Famotidine for gastrointestinal protection, Hydrochlorothiazide and Lisinopril for hypertension, and Sodium Chloride 0.9% for hydration. He is advised to follow up with his primary care physician within one week for further evaluation and management of his underlying conditions. Home health services will be arranged to assist with his recovery and ensure adherence to the medication regimen.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 51  \\n**Gender:** Male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to significant gastrointestinal bleeding secondary to angiodysplasia of the stomach and duodenum, as evidenced by hemoglobin drop and melena. His past medical history includes portal hypertension, alcoholic cirrhosis of the liver without ascites, type 2 diabetes mellitus, and chronic obstructive sleep apnea.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was stabilized with intravenous fluids and blood transfusions. He received multiple doses of octreotide acetate to manage bleeding and pantoprazole for acid suppression. His hemoglobin levels improved, and he was monitored closely for any signs of rebleeding. Gastroenterology consulted and performed an endoscopy, which confirmed the diagnosis of angiodysplasia and treated it endoscopically.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included moderate anemia secondary to blood loss and the presence of angiodysplasia confirmed via endoscopic evaluation. Procedures performed included endoscopic intervention for bleeding control.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved hemoglobin levels and no active gastrointestinal bleeding. He is ambulating independently and reports mild fatigue, which is expected given his treatment history. Home health services are recommended for ongoing monitoring of his hemoglobin levels, management of diabetes, and assistance with medication adherence.  \\n  \\n**Medications at Discharge:**  \\nMedications include Ascorbic Acid, Ceftriaxone, Dextrose 50%, Ferrous Sulfate, Glucagon, Lactulose, Pantoprazole, Ramelteon, Oxycodone IR, and a Nicotine Patch. The patient is advised to follow up with his primary care physician within one week and to have a follow-up with gastroenterology in two weeks.  \\n  \\n**Follow-up Plan:**  \\nHome health services will be initiated to ensure proper management of his chronic conditions and medication adherence. The patient will also be educated regarding signs of rebleeding and when to seek immediate medical attention.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 31  \\nGender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.1 days  \\n**Primary Diagnosis:** Generalized skin eruption due to drugs and medicaments taken internally (ICD10: L270)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a generalized skin eruption secondary to recent medication changes, including the introduction of multiple new agents. The eruption was accompanied by mild pruritus but no systemic symptoms.  \\n\\n**Hospital Course:**  \\nDuring the hospitalization, the patient underwent a thorough dermatological assessment and was treated with systemic corticosteroids (Dexamethasone) and supportive care. The skin condition improved significantly with treatment over the course of four days. The patient was monitored for any signs of systemic involvement or adverse reactions to medications. All vital signs remained stable throughout the hospital stay.  \\n\\n**Key Findings and Procedures:**  \\n- Dermatological examination revealed a generalized maculopapular rash.  \\n- Laboratory tests indicated mild thrombocytopenia (G696) and no evidence of new malignancy (C719).  \\n- Imaging was performed to rule out cerebral edema (G936), which returned normal results.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient exhibited significant improvement in skin condition, with no active lesions present. He is independent in activities of daily living but requires continued monitoring of his skin and medication regimen at home. The patient will benefit from home health services to assist in medication management and monitor for any recurrence of the rash.  \\n\\n**Medications at Discharge:**  \\nThe patient is to continue with the following medications: Acetaminophen, Atovaquone Suspension, BusPIRone, D5NS, DULoxetine, Dexamethasone, Docusate Sodium, Fluconazole, Gabapentin, Heparin, HydrOXYzine, LORazepam, LevETIRAcetam, MethylPHENIDATE (Ritalin), and Multivitamins W/minerals.  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician and a dermatologist within one week. Home health services will commence immediately to assist with medication adherence and monitoring of any adverse effects.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 51  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 51-year-old female with a complex medical history, including chronic graft-versus-host disease and acute myeloblastic leukemia in remission, who was admitted for observation due to bacteremia (ICD10: R7881). The onset of symptoms included fever, hypotension, and increased fatigue, leading to her hospitalization for further evaluation and management.  \\n\\n**Hospital Course:**  \\nDuring her 21.8-day stay, the patient was closely monitored and treated for her bacteremia. Intravenous antibiotics, including CefePIME and Ciprofloxacin, were initiated promptly after blood cultures were obtained. The patient also received supportive care, including intravenous fluids and electrolytes. Despite initial hypotension, her condition improved with fluid resuscitation and antibiotic therapy.  \\n\\n**Key Findings and Procedures:**  \\nBlood cultures confirmed Pseudomonas aeruginosa bacteremia. The patient underwent imaging studies to assess for any source of infection, which were unremarkable. She was also monitored for complications related to her prior stem cell transplant.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with improved vital signs and has been afebrile for 48 hours. She is able to perform activities of daily living with some assistance and requires ongoing home health services for medication management and monitoring of her condition.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride (IV)  \\n- Atovaquone Suspension  \\n- Ciprofloxacin (oral)  \\n- Dronabinol  \\n- Famotidine  \\n- Folic Acid  \\n- Aquaphor Ointment  \\n\\n**Follow-Up Plan:**  \\nThe patient has been scheduled for follow-up with her hematologist and primary care physician within one week. Home health services will continue to monitor her condition, assist with medication administration, and provide necessary support for her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 73  \\n- **Gender:** Female  \\n- **Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient is a 73-year-old female who presented to the emergency department with complaints of worsening edema and pain in the right lower extremity, attributed to varicose veins. She also reported episodes of dizziness and fatigue. Upon evaluation, she was diagnosed with varicose veins of the right lower extremity with complications including acute posthemorrhagic anemia resulting from venous insufficiency.  \\n\\n**Hospital Course:**  \\nDuring her 3-day hospital stay, the patient was stabilized with intravenous fluids and blood products to address her anemia. She was closely monitored for cardiovascular stability given her pre-existing conditions, including chronic heart failure and cardiomyopathy. The patient received supportive care including pain management and was started on appropriate medications.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed anemia (Hgb 8.5 g/dL). A Doppler ultrasound confirmed significant venous insufficiency in the right lower extremity. The patient was assessed by a vascular surgeon but deemed not suitable for surgical intervention at this time.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but continues to require ongoing management for her varicose veins and associated complications. She is ambulatory with assistance and has been advised to avoid prolonged standing. Home health services will be instituted to assist with her mobility and medication management. The patient will require regular follow-up to monitor her cardiovascular status and manage her pain.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Carvedilol  \\n- Dextrose 50%  \\n- GlipiZIDE  \\n- Insulin  \\n- Ranitidine  \\n- Simvastatin  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her primary care provider within one week and is recommended to have in-home therapy for physical rehabilitation and medication adherence. Regular monitoring of her blood pressure and glucose levels is crucial, along with dietary modifications for her heart failure.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 74-year-old female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 4.4 days  \\n**Primary Diagnosis:** Angiodysplasia of colon with hemorrhage (ICD10: K5521)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of gastrointestinal bleeding secondary to angiodysplasia of the colon. She presented with symptoms of rectal bleeding and mild abdominal discomfort. Initial workup included laboratory tests and imaging, which confirmed the diagnosis.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received supportive care, including fluid resuscitation with 0.9% Sodium Chloride, and was started on Octreotide to help control bleeding. Antibiotic therapy was initiated with Ceftriaxone and Cefpodoxime Proxetil due to concerns for possible infection. Her pain was managed with Acetaminophen and Cyclobenzaprine. A blood transfusion was administered due to significant anemia.  \\n  \\n**Key Findings and Procedures:**  \\nColonoscopy was performed, which revealed multiple angiodysplastic lesions, and cauterization was conducted to manage the hemorrhage. Post-procedure, the patient showed improvement in her hemoglobin levels and resolution of bleeding. She was monitored closely for any complications during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improvement in gastrointestinal symptoms. She is ambulatory with minimal assistance and able to perform activities of daily living; however, she may benefit from home health services for monitoring her recovery and medication management.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Ceftriaxone  \\n4. Cefpodoxime Proxetil  \\n5. Cyclobenzaprine  \\n6. Heparin  \\n7. Influenza Vaccine Quadrivalent  \\n8. Iso-Osmotic Dextrose  \\n9. Nadolol  \\n10. Octreotide Acetate  \\n11. Pantoprazole  \\n12. Potassium Chloride  \\n13. Simvastatin  \\n14. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for ongoing management of her chronic conditions and to discuss any further gastrointestinal evaluations. Home health services will be coordinated to assist with medication administration and monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 68  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of typical atrial flutter, which was noted to be symptomatic with palpitations and lightheadedness. He has a significant medical history including type 2 diabetes mellitus with peripheral angiopathy, essential hypertension, hyperlipidemia, and chronic nicotine dependence. Additionally, he was identified as having been in contact with a suspected COVID-19 case, although he remained asymptomatic for respiratory symptoms. \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent a successful cardioversion procedure to restore normal sinus rhythm. He was monitored closely for arrhythmia recurrence and potential complications. His blood pressure and blood glucose levels were managed effectively. The patient was started on anticoagulation with rivaroxaban to reduce the risk of thromboembolic events. \\n\\n**Key Findings and Procedures:**  \\n- ECG showed typical atrial flutter.  \\n- Cardioversion performed successfully.  \\n- Multidisciplinary team evaluated and addressed underlying conditions including diabetes management and smoking cessation.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with normal vital signs and no acute distress. He exhibits adequate understanding of his medications and follow-up plan. Functional status is good, however, he will require assistance at home for medication management and monitoring of blood glucose levels. Home health services have been arranged to assist with ongoing diabetes education and medication adherence. \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Cilostazol  \\n5. Metoprolol Succinate XL  \\n6. Rivaroxaban  \\n7. Nicotine Patch  \\n8. Polyethylene Glycol  \\n9. High-Dose Quadrivalent Influenza Vaccine  \\n10. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with a cardiologist in one week and with his primary care physician for diabetes management in two weeks. Home health services will begin within 48 hours of discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 65  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old female who presented to the emergency department with a chief complaint of palpitations and dizziness. She has a past medical history significant for paroxysmal atrial fibrillation and type 2 diabetes mellitus. She reported an episode of rapid heart rate lasting several hours prior to admission. The patient's symptoms were exacerbated by her underlying obstructive sleep apnea and recent medication adjustments.\\n\\n**Hospital Course:**  \\nDuring her 3.6-day hospitalization, the patient underwent a thorough cardiovascular evaluation, including telemetry monitoring and echocardiogram, which confirmed paroxysmal atrial fibrillation. She was started on Dofetilide for rhythm control and Metoprolol for rate control. The patient was also treated for her diabetes with insulin and received Levothyroxine for her hypothyroidism. Her electrolytes were monitored closely, and she was given Magnesium Sulfate due to low magnesium levels. She was stable upon discharge with no acute concerns noted during her hospital stay.\\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vitals and resolution of symptoms. The patient received education on managing her atrial fibrillation and diabetes. A follow-up echocardiogram is planned to monitor her cardiac status.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was alert, oriented, and in stable condition. She demonstrated an understanding of her medications and the importance of adherence. The patient will require home health services for ongoing monitoring of her cardiac rhythm and diabetes management, as well as assistance with daily activities due to her age and comorbidities.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Dofetilide  \\n- Metoprolol Tartrate  \\n- Insulin  \\n- Levothyroxine Sodium  \\n- Omeprazole  \\n- Pramipexole  \\n- PNEUMOcoccal 23-valent polysaccharide vaccine  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician and cardiologist within one week. Home health services will initiate care within 48 hours of discharge to assess her needs and monitor her health status.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 74-year-old female who was admitted through direct emergency due to an infection following a surgical procedure (ICD10: T8149XA). She presented with signs and symptoms of fever, localized swelling, and tenderness at the surgical site.  \\n\\n**Hospital Course:**  \\nDuring her 4-day hospital stay, the patient was started on intravenous Ceftriaxone for the management of her post-surgical infection. Her condition was closely monitored, and supportive care was provided. The patient also received analgesics for pain management and other medications to address her comorbidities, including hypertension and depression.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated inflammatory markers (CRP and WBC count) and a positive culture for Group B Streptococcus. The patient underwent a graded challenge with Ceftriaxone to assess for any allergic reactions. No adverse effects were noted, allowing for continued antibiotic therapy.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated significant improvement in her clinical status, with reduced swelling and pain at the surgical site. She is being discharged with stable vital signs and the ability to perform activities of daily living with assistance. A referral to home health services has been arranged to provide post-discharge care, including wound management and medication adherence support.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Calcium Carbonate, Ceftriaxone, Diclofenac Sodium DR, Diphenhydramine, Docusate Sodium, Enoxaparin Sodium, Levothyroxine Sodium, Lisinopril, and Magnesium Oxide. The patient is advised to follow up with her primary care physician within one week post-discharge and to report any signs of infection or adverse reactions to her medications. Home health services will provide regular monitoring and assist with her recovery.',\n",
       " \"**Patient Information:** 91-year-old female admitted for observation due to multiple rib fractures sustained from a fall. \\n\\n**History of Present Illness:** The patient presented with bilateral rib fractures (ICD-10: S2243XA) after a fall at home. She reported severe chest pain, particularly with deep breathing and coughing. \\n\\n**Hospital Course:** The patient's stay lasted 3.9 days, during which she was monitored for any complications related to her fractures and underlying medical conditions, including a history of atherosclerotic heart disease and emphysema. Pain management was initiated with acetaminophen, ibuprofen, and tramadol. She received respiratory therapy with albuterol nebulization to assist with her breathing difficulties and prevent any pulmonary complications.\\n\\n**Key Findings and Procedures:** Imaging confirmed multiple bilateral rib fractures. No surgical intervention was required. Her vital signs remained stable, and she was closely observed for any signs of respiratory distress or other complications. A multidisciplinary team, including physical therapy, provided mobility assistance to address her functional status. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient demonstrated improved pain control and was able to perform activities of daily living with minimal assistance. However, she still exhibited decreased mobility and requires home health services for further rehabilitation and monitoring. A home health nurse will be essential to assist with medication management and to ensure adherence to her prescribed therapy. \\n\\n**Medications and Follow-Up Plan:** The patient is being discharged on several medications, including metoprolol succinate XL, spironolactone, omeprazole, and a pain management regimen including tramadol. A follow-up appointment with her primary care physician is scheduled in one week to reassess her recovery and adjust her medications as needed. Additional home health services will involve regular assessments to monitor her progress, particularly focusing on her respiratory function and pain management.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 37-year-old female who presented with a post-term pregnancy (42 weeks gestation) and was admitted urgently due to complications related to her condition. She has a history of major depressive disorder and previous cesarean delivery, which were considered during her care.\\n\\n**Hospital Course:**  \\nDuring her 5-day stay, the patient was monitored closely for fetal wellbeing and maternal health. She received comprehensive maternal care and underwent a planned cesarean delivery due to the risk factors associated with post-term pregnancy. The procedure was performed without complications, and the patient recovered well postoperatively. She experienced mild postoperative pain, managed effectively with analgesics including acetaminophen and ibuprofen. \\n\\n**Key Findings and Procedures:**  \\nKey findings included a healthy neonate delivered via cesarean section, with no immediate complications for either the mother or child. The patient demonstrated good ambulation and participated in physical therapy sessions, improving her mobility. She was treated for vulvodynia and lumbago with sciatica during her stay, which contributed to her discomfort but responded well to conservative management.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently, and reporting manageable pain levels. She requires home health services for continued monitoring of her recovery and assistance with postpartum care. Home health will help with her mental health support and managing any physical therapy needs for lumbago. \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue with the following medications: Acetaminophen, Ibuprofen, Metoclopramide, Ondansetron, and Oxycodone as needed. A follow-up appointment with her obstetrician is scheduled in one week to assess recovery and address any ongoing concerns, particularly regarding her mental health and pain management. Home health nursing will also be arranged to assist with her postpartum care and mental health support.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 70  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted as an emergency with acute kidney failure due to tubular necrosis, presenting with electrolyte imbalances, notably hyperkalemia, and associated symptoms of fatigue and hypotension. Her medical history includes chronic heart failure, chronic kidney disease, and obstructive sleep apnea, which complicated her clinical picture upon admission.  \\n  \\n**Hospital Course:**  \\nDuring her 13-day stay, the patient was stabilized with intravenous fluids and diuretics. Nephrology was consulted, and she underwent close monitoring of renal function and electrolytes throughout her hospitalization. The patient's renal function showed gradual improvement, and she was able to maintain adequate urine output.  \\nOngoing management included optimization of her heart failure regimen, with adjustments made to her antihypertensive medications.  \\n  \\n**Key Findings and Procedures:**  \\nNotable findings included improved renal function with serum creatinine decreasing from 3.5 mg/dL to 1.8 mg/dL and successful resolution of hyperkalemia. The patient received multiple medications, including Apixaban for anticoagulation, and was started on a regimen of Atorvastatin and AzaTHIOprine.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires assistance with activities of daily living due to weakness. She will benefit from home health services for medication management, monitoring of her renal function, and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Apixaban  \\n4. Atorvastatin  \\n5. AzaTHIOprine  \\n6. Ipratropium-Albuterol Nebulizer solution  \\n7. Insulin  \\n8. Labetalol  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician and nephrologist within one week of discharge. Home health services will initiate promptly to assist with her care needs and ensure proper medication adherence.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 34 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.7 days  \\n**Primary Diagnosis:** Liver and biliary tract disorders in childbirth (ICD10: O2662)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to complications related to childbirth, specifically presenting with liver and biliary tract disorders. She reported symptoms including abdominal pain and jaundice. Upon admission, she was assessed and monitored closely due to the potential impact on both her health and the newborn.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent various diagnostic evaluations, including imaging studies, which confirmed biliary obstruction. She received supportive care and symptom management, including analgesics and medications to manage her hormonal levels following childbirth. The multidisciplinary team, including obstetrics and gastroenterology, collaborated to manage her complex condition.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes and mild jaundice. Procedures performed included biliary imaging and a therapeutic intervention to relieve the obstruction. The patient responded positively to treatment and showed gradual improvement in her liver function tests.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with resolved abdominal symptoms and improved liver function. She will require follow-up home health services to assist with medication management and monitor her recovery, particularly given her recent childbirth and the need for ongoing support for her liver health. She demonstrated the ability to perform activities of daily living with minimal assistance but will benefit from periodic evaluation at home.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Calcium Carbonate  \\n3. Dermoplast Spray  \\n4. Docusate Sodium  \\n5. Ibuprofen  \\n6. Levothyroxine Sodium  \\n7. Simethicone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week of discharge and to maintain communication with home health services for ongoing support. She should monitor for any signs of liver dysfunction or complications and report any concerns promptly.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 36  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms associated with leiomyoma of the uterus, leading to excessive and frequent menstruation. During her stay, she also presented with acute kidney failure, acute posthemorrhagic anemia, and chronic iron deficiency anemia secondary to blood loss.  \\n\\n**Hospital Course:**  \\nThe patient remained hospitalized for 8.2 days. Initial management included hydration with Lactated Ringers and 5% Dextrose, analgesia with Hydromorphone, and treatment for her anemia with Ferrous Sulfate. The patient underwent imaging studies which confirmed the presence of leiomyoma. Urological consultation was obtained for the acute kidney failure, which was attributed to hydronephrosis secondary to obstructive uropathy. She was monitored closely for her hemoglobin levels and renal function. \\n\\n**Key Findings and Procedures:**  \\n- Primary diagnosis: Leiomyoma of the uterus (ICD-10: D259)  \\n- Secondary conditions included acute kidney failure (ICD-10: N179), acute posthemorrhagic anemia (ICD-10: D62), and chronic iron deficiency anemia (ICD-10: D500).  \\n- Procedures performed: Uterine artery embolization (ICD-10: 0UT90ZZ), nephrostomy placement (ICD-10: 0UT70ZZ), and blood transfusion (ICD-10: 0T7B3DZ).  \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was stable with improved hemoglobin levels and renal function. She is able to perform activities of daily living with minimal assistance. She will require home health services for continued monitoring of her renal status and assistance with medication administration.  \\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Acetaminophen (oral and IV)  \\n- Bupivacaine 0.1%  \\n- Docusate Sodium  \\n- Ferrous Sulfate  \\n- Hydromorphone  \\n- Hydromorphone (Dilaudid)  \\n- Heparin  \\n- Ondansetron  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care provider in one week. Home health services will initiate within 48 hours to assess vital signs, monitor hemoglobin levels, and provide education regarding her medications.',\n",
       " \"**Discharge Summary**  \\n**Patient:** 20-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of pouchitis, characterized by abdominal pain, diarrhea, and rectal bleeding. She has a history of ulcerative colitis and underwent a surgical procedure involving anastomosis, which has led to recurrent symptoms. The patient's complaint of increased frequency of bowel movements prompted the need for observation and treatment.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely for changes in her clinical status. Initial management included intravenous hydration, bowel rest, and initiation of antibiotics. The patient responded well to the treatment regimen, which consisted of Ciprofloxacin and MetroNIDAZOLE. Additionally, Mesalamine was administered rectally to reduce inflammation. Her abdominal pain improved significantly, and she experienced a decrease in bowel frequency. \\n\\n**Key Findings and Procedures:**  \\nUpon examination, the patient exhibited tenderness in the lower abdomen but no acute distress. Laboratory tests showed mild leukocytosis, with no signs of infection or electrolyte imbalance. The patient underwent imaging studies that indicated no complications from her prior surgery. Two procedures were performed: 0DBP8ZX and 0DBQ8ZX, which further evaluated her gastrointestinal condition. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significant improvement in her symptoms. She demonstrated the ability to tolerate oral intake and had a functional status conducive to home health services. The patient will require home health nursing for continued medication administration and monitoring of her symptoms, particularly for bowel management and hydration status.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain management, Ciprofloxacin HCl, Heparin, Loperamide, Mesalamine (Rectal), MetroNIDAZOLE, Psyllium Powder, Ramelteon, and Sodium Chloride 0.9% Flush. The patient is advised to follow up with her gastroenterologist within one week for reassessment of her pouchitis and ongoing management of her ulcerative colitis. Home health will provide education on medication adherence and dietary modifications to prevent exacerbations.\",\n",
       " 'Patient is a 57-year-old male admitted for observation due to persistent atrial fibrillation (ICD-10: I4819). He presented with palpitations, mild shortness of breath, and fatigue, which prompted further evaluation. The patient has a significant medical history, including unspecified right bundle-branch block, atrioventricular block (first degree), and an anxiety disorder.\\n\\nDuring his 2.8-day hospital stay, the patient underwent telemetry monitoring, which confirmed intermittent atrial fibrillation episodes. A cardiology consultation was obtained, and the patient was started on Dofetilide for rhythm control. His liver function tests were monitored closely due to the potential hepatotoxicity associated with Dofetilide, as he also has a diagnosis of an unspecified liver condition (ICD-10: K7689). The patient was educated about medication adherence and the importance of regular follow-up with cardiology.\\n\\nKey findings included stable vital signs, normalization of renal function, and resolution of acute symptoms. He received an influenza vaccine as part of preventive care. The patient demonstrated understanding of his condition and treatment plan, engaging actively in discussions regarding lifestyle modifications and the need for ongoing surveillance of his cardiac status.\\n\\nAt the time of discharge, the patient was in stable condition with improved functional status. He exhibited no acute distress and was able to ambulate independently. He will require home health services for medication management and monitoring of his atrial fibrillation episodes. A follow-up appointment with cardiology is scheduled within one week to assess the effectiveness of Dofetilide and monitor for any potential side effects.\\n\\nDischarge medications include Acetaminophen, Diazepam, Docusate Sodium, Dofetilide, Magnesium Sulfate, Potassium Chloride, Rivaroxaban, and Ramelteon, among others. The patient has been advised to adhere to the prescribed medication regimen and report any new symptoms immediately.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 40  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 6.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to hepatic failure (ICD-10: K72.90) without coma. He presented with symptoms consistent with liver dysfunction, including jaundice and ascites. His past medical history is significant for alcohol use disorder and malnutrition (E43).  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was managed with supportive care, including the administration of intravenous albumin, lactulose for hepatic encephalopathy, and nadolol for portal hypertension. Serial lab tests showed improvement in liver function parameters, though he continued to exhibit signs of malnutrition and acute kidney failure (N17.9). The patient was also treated for hypo-osmolality and hyponatremia (E87.1).  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant elevation in liver enzymes and bilirubin levels, alongside imaging that ruled out acute complications. Procedures performed included therapeutic paracentesis for ascites management and monitoring of renal function. The patient was stable by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved mental status and functional mobility, though he still required assistance with activities of daily living due to weakness and ongoing malnutrition. Home health services are recommended to provide nutritional support and monitor liver function.  \\n\\n**Medications at Discharge:**  \\n- Albumin 25%  \\n- Heparin  \\n- Lorazepam  \\n- Lactulose  \\n- Midodrine  \\n- Nadolol  \\n- Ondansetron  \\n- Rifaximin  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician and a hepatologist within one week of discharge. Home health nursing will assist with medication management and dietary counseling to address his nutritional needs.',\n",
       " \"Patient is a 48-year-old male who was admitted for surgical intervention following a zygomatic fracture sustained in an altercation. The patient presented with significant facial edema, bruising, and restricted ocular movement upon admission. Initial imaging confirmed a zygomatic fracture and associated fractures of the orbital floor and maxilla.\\n\\nDuring his 2.6-day stay, the patient underwent closed reduction of the zygomatic and maxillary fractures under general anesthesia. Post-operative recovery was uneventful, with the patient demonstrating stable vital signs and adequate pain control managed with a combination of acetaminophen and opioid analgesics (hydromorphone and oxycodone). The patient was also prescribed dexamethasone to reduce inflammation and was advised to use artificial tears for ocular lubrication.\\n\\nKey findings included mild swelling persisting post-operatively, but no signs of infection or complications were noted. The patient's pain was well-controlled, and he was able to tolerate oral intake without difficulty. The surgical site was clean and dry, with no drainage.\\n\\nOn discharge, the patient was instructed on a home care regimen that includes continuing prescribed analgesics, using artificial tears, and maintaining good oral hygiene with chlorhexidine gluconate rinse. He is advised to follow up with the surgical team in one week for suture removal and further evaluation of fracture healing. Home health services will be arranged to assist with mobility and ensure adherence to medication and follow-up appointments.\\n\\nThe patient is discharged in stable condition, with functional status noted as independent in activities of daily living, although he will require assistance for the initial days post-discharge due to facial discomfort and potential mobility challenges. Overall, he is expected to recover well with appropriate home health support.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 35  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of severe abdominal pain and diarrhea, leading to dehydration and subsequent Salmonella sepsis. He presented with fever, tachycardia, and signs of fluid overload.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient was stabilized with intravenous fluids and antibiotics, specifically Ceftriaxone and Metronidazole. His clinical condition improved steadily after aggressive hydration and broad-spectrum antibiotic therapy. He required close monitoring for electrolyte imbalances, particularly hyperkalemia, which was addressed with potassium chloride and magnesium sulfate. His abdominal symptoms resolved, and he was able to tolerate oral intake by day three.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory studies confirmed Salmonella sepsis and mild acidosis. Imaging studies were negative for obstruction or perforation, and stool cultures later confirmed Salmonella enteritis. The patient participated in mobilization therapy and was able to ambulate independently prior to discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and has shown significant improvement in his clinical condition. He is ambulatory, requiring only minimal assistance for activities of daily living (ADLs). The home health team will assist with medication management and monitoring for any potential recurrence of symptoms.  \\n  \\n**Medications at Discharge:**  \\nThe following medications were prescribed at discharge:  \\n- Acetaminophen  \\n- Ciprofloxacin HCl  \\n- Dicyclomine  \\n- Enoxaparin (prophylaxis)  \\n- Lorazepam  \\n- Ondansetron  \\n- Oxycodone (immediate release)  \\n- Nicotine patch for smoking cessation  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician in one week and to contact home health services for any concerns regarding his recovery or medication adherence. He has been educated on signs of dehydration and infection recurrence.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 43  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.3 days  \\n**Primary Diagnosis:** Intervertebral disc disorders with radiculopathy, lumbar region (ICD10: M5116)  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 43-year-old female with a history of morbid obesity (BMI 45.0-49.9) who presented with severe lower back pain radiating to the left lower extremity, consistent with lumbar radiculopathy. The pain was exacerbated by movement and associated with numbness in the left leg. She is a long-standing smoker and has a history of asthma and congenital spine malformations.  \\n\\n**Hospital Course:**  \\nDuring the 2.3-day observation period, the patient underwent symptom management, including opioid analgesics (OxyCODONE and Morphine sulfate) for pain control, along with gabapentin for neuropathic pain. The medical team monitored her respiratory status due to her asthma and nicotine dependence. She required supplemental oxygen intermittently, and her asthma was addressed with an albuterol inhaler.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies revealed degenerative changes in the lumbar spine consistent with her diagnosis. No surgical intervention was deemed necessary at this time. The patient was treated with supportive care including hydration and bowel regimen with docusate sodium and bisacodyl to manage constipation secondary to opioid use. Discharge medications were adjusted to include acetaminophen for pain management and famotidine for gastrointestinal protection.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved pain control, though she continues to experience mild radiculopathy. She is able to ambulate short distances with assistance and will require home health services for ongoing physical therapy and pain management. A referral has been made to home health for physiotherapy evaluation and to ensure compliance with her medication regimen.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Bisacodyl  \\n4. Diazepam  \\n5. Docusate Sodium  \\n6. Famotidine  \\n7. Gabapentin  \\n8. Heparin  \\n9. Hydralazine  \\n10. Morphine Sulfate  \\n11. Ondansetron  \\n12. OxyCODONE (Immediate Release)  \\n13. Senna  \\n14. Sodium Chloride 0.9%  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and continue home health services for ongoing rehabilitation and monitoring of her respiratory condition.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n**Attending Physician:** [Insert Name]  \\n**Diagnosis:** Occlusion and stenosis of basilar artery (ICD-10: I651)  \\n\\n**History of Present Illness:**  \\nThe patient is a 76-year-old female who presented with symptoms suggestive of neurological compromise, including dizziness and altered mental status. Initial imaging studies indicated occlusion and stenosis of the basilar artery. Given the patient's age and medical history, including hypertension, hypothyroidism, and hyperlipidemia, a comprehensive evaluation was undertaken.\\n\\n**Hospital Course:**  \\nDuring her 1.6-day observation stay, the patient's condition was closely monitored. Neurology was consulted and recommended conservative management with anticoagulation therapy. She was started on Heparin and transitioned to Aspirin for outpatient management. Her vital signs were stabilized, and she demonstrated improvement in her neurological status.  \\n\\n**Key Findings and Procedures:**  \\nNeuroimaging confirmed the diagnosis of basilar artery occlusion. Laboratory tests indicated prediabetes and elevated lipid levels, prompting adjustments in her management plan. The patient underwent monitoring for potential complications associated with her condition, and she was provided education on lifestyle modifications and medication adherence.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient exhibited stable vital signs and had regained her baseline cognitive function. Although she requires assistance with activities of daily living, she is expected to benefit from home health services for further rehabilitation. A home health nurse will assist with medication management and monitor her neurological status, while physical therapy will address mobility and strength.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. Benzonatate  \\n6. Famotidine  \\n7. Heparin  \\n8. Hydrochlorothiazide  \\n9. Levothyroxine Sodium  \\n10. Ondansetron  \\n11. Polyethylene Glycol  \\n12. Sodium Chloride 0.9% (Flush)  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician in one week. Continued monitoring of her neurological status and medication adherence is essential. Home health services have been arranged to commence immediately post-discharge.\",\n",
       " \"**Discharge Summary**  \\n**Patient ID:** 068  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.9 days  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 68-year-old male with a history of essential hypertension and a recent procedure that resulted in postprocedural hemorrhage of the digestive system (ICD10: K91840). He presented with signs of acute posthemorrhagic anemia (ICD10: D62) and required close monitoring.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient received supportive care, including fluid resuscitation and blood transfusions to manage his anemia. He was monitored for vital signs and signs of further bleeding. After stabilization, he underwent a surgical evaluation, which led to the decision to discharge him with home health services for continued monitoring and management of his recovery.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included vital signs within normal limits post-fluid management, although he continued to display mild fatigue. The patient's hemoglobin levels improved with transfusions, and he received procedures including gastrointestinal monitoring (ICD10: 0W3P8ZZ) and fluid management (ICD10: 0D5P8ZZ).  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented. He demonstrated the ability to perform activities of daily living with assistance, and he has been advised to engage in light activities as tolerated. Home health services will assist with monitoring his recovery, medication management, and dietary adjustments.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen for pain management  \\n2. Atorvastatin for hyperlipidemia  \\n3. Docusate Sodium for constipation  \\n4. Metoprolol Succinate XL for hypertension  \\n5. MoviPrep for bowel management  \\n6. Senna for bowel regularity  \\n7. Sodium Chloride 0.9% for hydration and flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and as needed for any concerns. Home health services will initiate within the next 48 hours to assess and support his ongoing recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 76 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of a displaced fracture of the medial condyle of the right femur following a fall. The injury was sustained during a slip and resulted in significant pain and functional impairment.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient underwent surgical intervention for fracture fixation. The procedure was performed uneventfully, with intraoperative findings consistent with preoperative imaging. Postoperatively, he was closely monitored for signs of infection and complications. His pain was managed using a multimodal approach including acetaminophen and opioids as needed. The patient was also started on prophylactic enoxaparin to prevent venous thromboembolism.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, adequate pain control, and gradual improvement in mobility with physical therapy. The patient participated in rehabilitation sessions, focusing on strengthening and range of motion exercises. Discharge planning involved coordination with home health services to facilitate continued rehabilitation and safety assessments at home.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved mobility, ambulating with a walker and reporting manageable pain levels. He was able to perform basic activities of daily living with supervision. It is essential for home health services to assist with medication management, physical therapy, and monitoring for any signs of depression and insomnia.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed acetaminophen, hydromorphone for breakthrough pain, enoxaparin, lisinopril for hypertension, prednisone, and trazodone for sleep. He was advised on the importance of hydration and regular follow-ups with his primary care provider.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled in 2 weeks to assess healing and adjust the rehabilitation plan as necessary.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 73  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 73-year-old male who was admitted for surgical intervention following a diagnosis of an abdominal aortic aneurysm (AAA) without rupture. The patient presented with mild abdominal discomfort and was found to have an AAA on imaging studies. Given the risk factors associated with AAA, including his age and history of cardiovascular disease, surgical intervention was deemed necessary.\\n\\n**Hospital Course:**  \\nThe patient underwent a successful surgical repair of the abdominal aortic aneurysm on the day of admission. Post-operative recovery was uneventful, with close monitoring in the surgical unit. The patient experienced mild pain, which was effectively managed with analgesics. Vital signs remained stable throughout the hospital stay, and he tolerated oral intake well by postoperative day two. The patient's hemoglobin levels were monitored closely, and he did not exhibit any signs of post-operative complications such as infection or graft failure.\\n\\n**Key Findings and Procedures:**  \\n- Successful open surgical repair of AAA (ICD-10: 04R00JZ).  \\n- Stable post-operative course with no immediate complications.  \\n- Key laboratory findings included mild metabolic alkalosis (E873) and managed hyperlipidemia (E785). \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with a functional status that allows for independent mobility with minimal assistance. He is able to perform activities of daily living, and a home health referral has been initiated to provide monitoring and support during the recovery phase. The patient will require assistance with wound care and medication management in the initial post-operative period.\\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Allopurinol  \\n- Aspirin  \\n- Atorvastatin  \\n- Calcium Gluconate  \\n- Docusate Sodium  \\n- Furosemide  \\n- Heparin  \\n- Magnesium Sulfate  \\n- Metoprolol Succinate XL  \\n- Neutra-Phos  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week post-discharge for wound assessment and medication review. Home health services will continue to monitor his progress and provide necessary support.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 59 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 27 days  \\n  \\n**History of Present Illness:** The patient was admitted for management of hypertensive heart disease and chronic kidney disease, complicated by heart failure (ICD10: I132). He presented with worsening dyspnea, fluid overload, and elevated blood pressure.  \\n  \\n**Hospital Course:** During his hospitalization, the patient underwent diuresis with Bumetanide, which effectively managed his fluid overload. He was started on a regimen of Acetaminophen for pain control, Albuterol for respiratory support, and initiated on hemodialysis due to stage 5 chronic kidney disease. The multidisciplinary team, including cardiology and nephrology, was involved in his care, optimizing his antihypertensive therapy including CloNIDine and Doxazosin. The patient also received treatment for COVID-19 pneumonia, which was diagnosed during his stay.  \\n  \\n**Key Findings and Procedures:** Significant findings included acute diastolic heart failure and an elevated creatinine level indicating worsening renal function. The patient underwent hemodialysis on multiple occasions and responded well. He received education on dietary modifications, fluid restrictions, and the importance of adherence to his medication regimen.  \\n  \\n**Discharge Condition and Functional Status:** The patient is stable at discharge, ambulatory with assistance, and demonstrates understanding of his chronic conditions. He requires ongoing home health services for nursing care, medication management, and assistance with activities of daily living due to fatigue and weakness from his prolonged hospitalization.  \\n  \\n**Medications and Follow-Up Plan:** Upon discharge, the patient is to continue on the following medications: Atorvastatin, Allopurinol, Calcitriol, and others as detailed. He is scheduled for follow-up appointments with nephrology and cardiology within a week. Home health services will be initiated to monitor his progress and ensure compliance with the prescribed treatment plan.',\n",
       " \"**Patient Discharge Summary**  \\n  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 36  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 4 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with exacerbation of schizophrenia, presenting with acute episodes of hallucinations and homicidal ideations. He was brought to the emergency department by family members due to increased agitation and distress, which raised significant safety concerns.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient's medication regimen was adjusted, and he was stabilized on Haloperidol. He exhibited improvement in mood and thought processing after 48 hours of treatment. The patient was involved in daily psychiatric evaluations and group therapy sessions, which contributed positively to his overall mental health.  \\n  \\n**Key Findings and Procedures:**  \\nInitial assessments indicated a diagnosis of schizophrenia (ICD-10: F209), with concurrent concerns of nicotine dependence (ICD-10: F17210) and unspecified viral hepatitis C (ICD-10: B1920). Laboratory tests were completed to rule out hepatic complications, and the patient was educated on smoking cessation strategies.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient exhibits improved mental clarity and reduced agitation. He is alert, oriented, and able to engage in conversations, demonstrating readiness for outpatient management. His functional status has improved as he is now capable of self-care tasks but requires supervision for medication adherence and safety at home.  \\n  \\n**Medications at Discharge:**  \\n- Haloperidol  \\n- Acetaminophen  \\n- DiphenhydrAMINE  \\n- Nicotine Polacrilex  \\n- Influenza Vaccine Quadrivalent (administered)  \\n- Milk of Magnesia  \\n- Cepacol lozenges  \\n  \\n**Follow-Up Plan:**  \\nThe patient is referred to home health services for continued psychiatric support and medication management. A follow-up appointment with outpatient psychiatry is scheduled for one week post-discharge. Family education on recognizing early signs of decompensation and managing medication compliance is essential.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 81-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of drug-induced diabetes mellitus with hyperglycemia. She presented with elevated blood glucose levels, altered mental status, and signs of dehydration. A comprehensive work-up was performed, revealing concurrent diagnoses of chronic heart failure and atrial fibrillation, contributing to her clinical picture.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely in the observation unit. Intravenous fluids were administered for dehydration, and her blood glucose levels were managed with insulin therapy. A multidisciplinary approach was taken, involving endocrinology for diabetes management and cardiology for heart failure. The patient required adjustment of her diuretics and heart failure medications. She was stabilized and educated on dietary modifications and medication adherence.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent hyperglycemia, congestive heart failure signs, and an episode of atrial fibrillation. The patient underwent echocardiography, which confirmed reduced ejection fraction consistent with heart failure. There were no major procedural interventions required during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was clinically stable, with a blood glucose level within the target range. She exhibited improved hydration status and was able to ambulate with minimal assistance. Her cognitive function appeared intact, although she expressed concerns about managing her medications at home. Home health services have been arranged to assist with medication management and monitoring for potential complications.  \\n  \\n**Medications at Discharge:**  \\nThe patient is being discharged on a regimen that includes: Apixaban, Atorvastatin, Bumetanide, Digoxin, Insulin, and Dextrose 50% as needed. She has been instructed on the use of Glucagon and glucose gel for hypoglycemic episodes.  \\n  \\n**Follow-up Plan:**  \\nShe is scheduled for follow-up with her primary care physician within one week and a home health visit within 48 hours post-discharge. Education on recognizing signs of hyperglycemia and heart failure exacerbation was provided.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 66  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with complaints of chest pain classified as \"Other chest pain\" (ICD10: R0789). Given the patient\\'s significant cardiovascular history, including atherosclerotic heart disease, hypertension, hyperlipidemia, and type 2 diabetes with diabetic polyneuropathy, she was admitted for further evaluation.  \\n  \\n**Hospital Course:**  \\nDuring her 2-day stay, the patient underwent a thorough workup, including cardiac monitoring and laboratory testing. She was treated with medications, including Clopidogrel and Isosorbide Dinitrate, to manage her symptoms and prevent further complications. The patient received supportive care, including the administration of Dextrose, Hydralazine, and Insulin, addressing her diabetes and hypertension management.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs throughout her stay, and her chest pain was determined to be non-cardiac in nature, likely related to anxiety and her underlying conditions. No invasive procedures were required during her admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in a stable condition, with a good understanding of her medication regimen and lifestyle modifications. She will benefit from home health services for ongoing monitoring of her diabetes and cardiovascular health, as well as support for managing her anxiety and bipolar disorder. The patient has demonstrated the ability to perform activities of daily living with minimal assistance.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- 5% Dextrose  \\n- Alprzolam  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Clopidogrel  \\n- Docusate Sodium  \\n- Gabapentin  \\n- Isosorbide Dinitrate  \\n- Insulin  \\n- Hydralazine  \\n- Influenza Vaccine Quadrivalent  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to monitor her blood glucose levels regularly. Home health services will initiate contact to provide further support and ensure adherence to the discharge plan.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 74, Gender: Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 5.8 days  \\n**Primary Diagnosis:** E871 - Hypo-osmolality and hyponatremia  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe hypo-osmolality and hyponatremia, presenting with confusion, weakness, and dizziness. She has a history of chronic obstructive pulmonary disease (COPD) and protein-calorie malnutrition, which likely contributed to her current state.  \\n  \\n**Hospital Course:**  \\nDuring her five-day hospital stay, the patient underwent extensive workup, including laboratory tests that confirmed severe electrolyte imbalances. Intravenous 0.9% sodium chloride was administered to correct her sodium levels. Additionally, she was treated for urinary tract infection and received supportive care for her malnutrition. She also received medications to manage her COPD and other comorbidities.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a significant elevation in blood urea nitrogen (BUN) and creatinine, indicating acute kidney failure, which improved with hydration and supportive care. The patient required a heparin flush for venous access, and her nutritional status was addressed with supplements, including folic acid and magnesium.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient's sodium levels normalized, and she demonstrated improved mental status and strength. However, she remains at risk for further complications due to her underlying conditions and requires home health services for continued monitoring and support. She will benefit from assistance with activities of daily living (ADLs) due to her recent weakness and mobility issues.  \\n  \\n**Medications and Follow-up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Metoprolol Succinate XL, Anastrozole, and magnesium supplements. The patient is advised to follow up with her primary care physician within one week of discharge and to engage with home health services for ongoing evaluation and management of her nutritional needs and COPD. \\n  \\n**Summary:**  \\nThe patient is stable for discharge with recommendations for home health support to ensure continued recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 49 years  \\nGender: Female  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 6.8 days  \\n**Primary Diagnosis:** Diverticulitis of large intestine without perforation or abscess without bleeding (ICD-10: K5732)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of abdominal pain and elevated bowel activity lasting for two days. Initial evaluation revealed tenderness in the left lower quadrant consistent with diverticulitis.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent supportive management, including IV fluids (D5 1/2NS, Lactated Ringers), pain management with acetaminophen and ketorolac, and initiation of antibiotics. The patient showed gradual improvement in symptoms, with a marked reduction in abdominal pain and normalization of bowel function. Metoclopramide was administered for nausea, and she was closely monitored for any complications.  \\n  \\n**Key Findings and Procedures:**  \\nAbdominal imaging confirmed the diagnosis of diverticulitis without perforation. The patient was also evaluated for underlying conditions such as hypothyroidism and hypercholesterolemia. No surgical intervention was required, and she was discharged following stabilization of her condition.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with a functional status improved from admission. She is able to perform activities of daily living with minimal assistance. Home health services are recommended for continued monitoring of her dietary intake and medication management, including her new prescriptions for simvastatin and pantoprazole.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Oxycodone (IR) for pain management  \\n- Pantoprazole for GERD  \\n- Simvastatin for cholesterol management  \\n- Nystatin Oral Suspension as needed  \\n- Fentanyl Citrate for breakthrough pain as prescribed  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to return to the emergency department if there are any signs of complications such as fever, severe abdominal pain, or changes in bowel habits. Home health services will coordinate medication reconciliation and provide education on a low-fiber diet to manage her diverticulitis.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**MRN:** [MRN]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 70-year-old male with a diagnosis of malignant neoplasm of the larynx (ICD-10: C329), admitted for surgical intervention. The patient presented with progressive dysphagia and voice changes, warranting a surgical approach after comprehensive evaluation.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a series of procedures including laryngectomy and subsequent reconstruction. Postoperatively, he was closely monitored for complications such as infection and respiratory distress. The patient demonstrated stable vital signs and adequate pain management throughout his stay. He was treated for nutritional deficits, receiving nutritional support for severe protein-calorie malnutrition (ICD-10: E43).  \\n  \\n**Key Findings and Procedures:**  \\nNotable procedures included:  \\n- Total Laryngectomy (ICD-10: 0CTS0ZZ)  \\n- Tracheostomy (ICD-10: 0GTK0ZZ)  \\n- Nutritional support interventions  \\n  \\nPostoperative imaging confirmed no evidence of acute complications. The patient also received management for essential hypertension (ICD-10: I10) and type 2 diabetes mellitus (ICD-10: E119).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires home health services for ongoing wound care, nutritional management, and monitoring of his swallowing function secondary to laryngeal surgery. He is able to mobilize with assistance, but will need support for activities of daily living and medication management.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen (Liquid)  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Enoxaparin (Prophylaxis)  \\n5. Calcium Carbonate Suspension  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with oncology and ENT specialists within one week of discharge. Home health services will initiate within 48 hours to assist with care and monitoring. The patient and family have been educated on signs of complications and when to seek immediate care.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 75 years old  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 3.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to symptomatic lumbar spinal stenosis (ICD10: M48061), which had become increasingly debilitating, impacting mobility and quality of life. He also has a history of intervertebral disc disorders with radiculopathy (M5116), hypertension (I10), and atherosclerotic heart disease (I2510).  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent a lumbar decompression and fusion procedure (ICD10: 0SG30AJ). Post-operatively, he was monitored for pain management, neurological status, and mobility. He received physical therapy and demonstrated significant improvement in ambulation and pain control.  \\n\\n**Key Findings and Procedures:**  \\nPost-surgery, the patient experienced mild discomfort managed effectively with acetaminophen and bisacodyl for constipation prophylaxis. No signs of neurogenic claudication were observed post-operatively. The patient's cardiovascular status remained stable, and he was discharged with a regimen including apixaban, atorvastatin, and carvedilol for his chronic conditions.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved mobility, ambulating with a walker. He demonstrated an understanding of his home exercise program and medication regimen. Home health services are recommended to assist with physical therapy and medication management, ensuring adherence to follow-up appointments and evaluations.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on the following medications: Apixaban, Aspirin, Atorvastatin, Carvedilol, Diazepam, Lisinopril, and others as needed. A follow-up appointment with orthopedics is scheduled in two weeks to assess recovery and function. The home health agency will monitor his post-operative progress and adjust care as necessary.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 78 years  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 78-year-old male who presented with complaints of intermittent claudication and lower extremity pain, leading to the diagnosis of an aneurysm of the artery of the lower extremity (ICD-10: I724). His medical history is significant for chronic diastolic heart failure, hypertensive heart disease, and a history of anticoagulation therapy.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for observation, where he underwent a thorough evaluation including imaging studies that confirmed the presence of an aneurysm. He received supportive care, including management of his fluid status due to hypo-osmolality and hyponatremia (ICD-10: E871), and was monitored closely for any cardiovascular complications. His heart failure was managed with diuretics (Furosemide) and beta-blockers (Metoprolol Succinate XL).  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, improvement in lower extremity symptoms, and normalization of electrolytes. The patient also underwent a procedure coded as 3E05317 for vascular intervention.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved functional status. He is able to perform activities of daily living with minimal assistance but may require home health services for ongoing monitoring and support, particularly for medication management and mobility assistance.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Apixaban, Aspirin, Atorvastatin, Ferrous Sulfate, Furosemide, Magnesium Oxide, Metoprolol Succinate XL, Multivitamins, Polyethylene Glycol, Senna, and a sodium chloride flush.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with a vascular surgeon is recommended within one week of discharge to assess the aneurysm and ensure appropriate management. Additionally, he will be followed by his primary care physician for ongoing heart failure management and medication review. Home health services will be initiated to assist with monitoring and rehabilitation.',\n",
       " '**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 59  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency\\n\\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of COVID-19 (ICD-10: U071) presenting with acute respiratory failure and hypoxia. He reported symptoms including fever, cough, and shortness of breath. The patient has a history of essential hypertension and obstructive sleep apnea, which may have contributed to his clinical deterioration.\\n\\n**Hospital Course:**  \\nDuring an 8-day hospital stay, the patient received supportive care, including supplemental oxygen and bronchodilator therapy. He was managed with albuterol and tiotropium inhalers to alleviate respiratory distress. He also received antiviral therapy and was placed on enoxaparin for venous thromboembolism prophylaxis. Respiratory function improved gradually, and he was transitioned to oral medications as his condition stabilized.\\n\\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included the presence of bilateral pneumonia on chest imaging and transient cerebral ischemic attacks, which were monitored. The patient underwent routine laboratory evaluations and was treated for anemia and hyperlipidemia. He received psychological support due to symptoms of major depressive disorder.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved respiratory function. He is able to perform activities of daily living with minimal assistance, though he may require home health services for ongoing respiratory therapy, medication management, and monitoring of psychological well-being. The patient has been educated on signs of worsening respiratory status and when to seek medical attention.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed:  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Benzonatate  \\n- BuPROPion XL (Once Daily)  \\n- Metoprolol Succinate XL  \\nHe is advised to follow up with his primary care physician within one week and to engage home health services for medication management and respiratory therapy. The patient was instructed to continue monitoring his health status and report any concerning symptoms immediately.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 56 years old  \\n**Admit Date:** [Admit Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Length of Stay:** 3.8 days  \\n**Admission Type:** Urgent  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for severe major depressive disorder with psychotic features, presenting with significant mood disturbances, hallucinations, and suicidal ideations. He also reported urinary symptoms that suggested a urinary tract infection.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was stabilized with a combination of pharmacotherapy, including Olanzapine for psychosis and Sertraline for depression. He was monitored closely for psychiatric symptoms and underwent a psychiatric evaluation, confirming the diagnosis. A urinary tract infection was treated with appropriate antibiotics after urine culture results returned. He was also managed for constipation with Polyethylene Glycol and Senna. Nutritional deficiencies were addressed with multivitamins and Vitamin D supplementation.  \\n  \\n**Key Findings and Procedures:**  \\n- Initial psychiatric evaluation indicated severe depressive symptoms with psychotic features.  \\n- Urinalysis confirmed the urinary tract infection.  \\n- Blood tests revealed hyperlipidemia and iron deficiency anemia, which were managed accordingly.  \\n- The patient was educated about his conditions, medications, and the importance of follow-up.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient exhibited improved mood and reduced psychotic symptoms but required continued support. He demonstrated the ability to perform activities of daily living (ADLs) with assistance and expressed understanding of his medication regimen. He is being referred to home health services for ongoing psychiatric support, medication management, and assistance with ADLs.  \\n  \\n**Medications at Discharge:**  \\n- Atorvastatin  \\n- Multivitamins with minerals  \\n- Olanzapine  \\n- Polyethylene Glycol  \\n- Ramelteon  \\n- Senna  \\n- Sertraline  \\n- Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his psychiatrist within one week and to maintain regular appointments with his primary care provider to monitor his hyperlipidemia and anemia. Home health services will initiate contact within 48 hours for care coordination.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 34  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to exacerbation of Crohn's disease (ICD-10 K50113), presenting with abdominal pain and diarrhea. Upon evaluation, the patient was found to have a fistula associated with their Crohn's disease.  \\n\\n**Hospital Course:**  \\nDuring a 7.7-day hospital stay, the patient underwent a comprehensive treatment regimen including intravenous hydration and corticosteroids. The patient received MethylPREDNISolone Sodium Succ (a steroid) and Hydrocortisone Enema to manage inflammation. Heparin was administered for DVT prophylaxis due to immobility. The patient was also treated with Nystatin Oral Suspension for a suspected fungal infection.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests indicated elevated inflammatory markers, consistent with an active flare of Crohn's disease. Imaging studies confirmed the presence of a fistula. The patient received the Quadrivalent Influenza Vaccine during this admission as part of preventive care. A flush with Sodium Chloride 0.9% was performed to maintain venous access during hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved abdominal symptoms and no signs of acute distress. He demonstrates the ability to perform activities of daily living with minimal assistance. Home health services are recommended for ongoing monitoring of the fistula and nutritional support.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on MethylPREDNISolone Sodium Succ, Hydrocortisone Enema, and will continue with Nystatin for oral thrush. He will follow up with the gastroenterology clinic in one week to assess disease management and the status of the fistula. Home health services will provide education regarding wound care and dietary modifications to support recovery.\",\n",
       " \"**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 73  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to persistent atrial fibrillation, characterized by palpitations and associated fatigue. His medical history includes stage 3 chronic kidney disease, hypertensive heart disease, and hyperlipidemia, which contribute to his cardiovascular risk profile. The patient is also on long-term anticoagulant therapy due to his atrial fibrillation.  \\n\\n**Hospital Course:**  \\nDuring his 3-day stay, the patient underwent monitoring for heart rhythm disturbances and renal function. He received anticoagulation with Dofetilide and was closely observed for any adverse effects. The patient's renal function remained stable, and he was monitored for potential electrolyte imbalances due to his medications. He was also started on a regimen of Metoprolol to manage his heart rate effectively.  \\n\\n**Key Findings and Procedures:**  \\nECG findings confirmed persistent atrial fibrillation, and laboratory tests indicated stable renal function (creatinine levels within normal limits) and controlled blood pressure. A review of medications was conducted, ensuring appropriate dosing considering the patient's renal status. The patient received education on medication compliance and the importance of follow-up with his cardiologist.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved understanding of his condition and medication management. He is ambulatory and independent in his activities of daily living, though he will require home health services for medication management and monitoring of his renal status.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on Acetaminophen, Aspirin, Atorvastatin, Dofetilide, Lisinopril, Metoprolol (Succinate and Tartrate), and Gabapentin among other supportive medications. He is advised to follow up with his primary care physician and cardiologist within one week to reassess his atrial fibrillation management and kidney function. Home health services will be arranged to assist with medication adherence and monitor his overall health.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name], 61-year-old male  \\n**Admitting Diagnosis:** Dehydration (ICD10: E860)  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to severe dehydration, which was likely exacerbated by chronic obstructive pulmonary disease (COPD) and recent episodes of gastrointestinal distress. He reported increased fatigue, dry mucous membranes, and dizziness upon admission.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was treated with intravenous fluids, electrolyte replenishment, and close monitoring of vital signs. His respiratory status was stable, and he was placed on bronchodilator therapy for his COPD. A thorough workup was performed, including lab tests that revealed elevated creatinine levels consistent with dehydration-related acute kidney injury.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included evidence of dehydration and chronic kidney disease (ICD10: N189). The patient received a total of 2 liters of normal saline and was transitioned to oral hydration with sodium chloride 0.9% flushes. He was also counseled on smoking cessation and prescribed a nicotine patch. A review of his medications was conducted, and adjustments were made to optimize his chronic disease management.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved hydration status, as evidenced by better oral intake and resolution of dizziness. He is stable for discharge with a functional status allowing for self-care but requires assistance with activities of daily living. Home health services have been arranged for follow-up care, including medication management and education on COPD management.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Bisacodyl  \\n5. BuPROPion XL  \\n6. Cilostazol  \\n7. Heparin  \\n8. LORazepam  \\n9. Metoprolol Succinate XL  \\n10. Nicotine Patch  \\n11. Senna  \\n12. Tamsulosin  \\n13. Tiotropium Bromide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and continue home health services for ongoing monitoring and assistance with medication adherence and lifestyle modifications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 27  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 20 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a primary diagnosis of infective myositis of the left thigh (ICD-10: M60052). He presented with significant muscle weakness, swelling, and pain in the left thigh, accompanied by fever and malaise. Initial workup revealed elevated inflammatory markers and muscle enzymes, consistent with myositis.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was managed with intravenous antibiotics including Ceftriaxone and Vancomycin for suspected infectious etiology, while supportive care was provided. He also received hydration with 0.9% Sodium Chloride and symptomatic management with Acetaminophen for fever and pain. The patient was monitored closely for any signs of complications, including rhabdomyolysis, given his elevated creatine kinase levels.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included pneumonia (J189) and type 2 myocardial infarction (I21A1), which were addressed with appropriate interventions. The patient also experienced acute kidney failure (N179) but showed improvement with fluid management. Procedures performed included PICC line insertion (02HV33Z) for antibiotic administration.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable with improved muscle strength and reduced swelling in the left thigh. He requires assistance for activities of daily living due to residual weakness but is able to ambulate with a walker. Home health services have been arranged for physical therapy and nursing to monitor his recovery and manage medications.  \\n  \\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient is prescribed:  \\n- Acetaminophen  \\n- Gabapentin  \\n- HydrOXYzine  \\n- TraZODone  \\n- Nicotine Patch  \\n- Ramelteon  \\n- Docusate Sodium  \\n- Miconazole Powder  \\n  \\nFollow-up is recommended in one week with his primary care physician to reassess his condition and adjust medications as needed. Home health nursing visits are scheduled to ensure compliance with the treatment plan and monitor for any signs of infection or complications.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 60, Gender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 16.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 60-year-old male with a primary diagnosis of angiodysplasia of the stomach and duodenum with bleeding (ICD10: K31811). He presented with gastrointestinal bleeding, characterized by melena, and was subsequently admitted for observation due to significant blood loss and associated symptoms. His medical history is complicated by chronic kidney disease stage 4, portal hypertension, and a recent episode of acute kidney failure.\\n\\n**Hospital Course:**  \\nDuring his 16.8-day hospitalization, the patient received supportive care including fluid resuscitation, blood transfusions, and medical management of his kidney condition. He was also treated for coexisting conditions, including a Clostridium difficile infection, which was successfully managed. Gastroenterology performed endoscopy revealing angiodysplasia, which was coagulated with argon plasma coagulation.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent anemia and signs of hepatorenal syndrome. The patient underwent multiple procedures: endoscopy with intervention, and imaging studies to assess the extent of portal hypertension. His hemoglobin stabilized following transfusions and iron supplementation.\\n\\n**Discharge Condition and Functional Status:**  \\nBy the time of discharge, the patient was stable, with improved hemoglobin levels and resolution of gastrointestinal bleeding. He is able to perform activities of daily living with assistance and will require home health services to support his ongoing management of chronic kidney disease and monitoring of his nutritional status due to recent weight loss.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on a regimen including Acetaminophen, Albumin 25%, Allopurinol, Ferrous Sulfate, Pantoprazole, and Midodrine. He is advised to follow up with his primary care physician within one week, and with a nephrologist and gastroenterologist as scheduled. Home health services will assist with medication management, nutritional support, and monitoring of renal function.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 76  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted to the hospital for observation due to exacerbation of his known epilepsy, specifically experiencing simple partial seizures that progressed to a status epilepticus episode. He has a history of localization-related symptomatic epilepsy and presented with altered mental status and confusion.  \\n  \\n**Hospital Course:**  \\nDuring his 12.8-day hospital stay, the patient was closely monitored in an observation unit. He was treated with LevETIRAcetam and additional supportive care, which included intravenous fluids and oxygen therapy for acute respiratory failure secondary to pneumonia. He also received anticoagulation with Apixaban due to a pulmonary embolism.  \\n  \\n**Key Findings and Procedures:**  \\nKey diagnostic findings included a confirmed diagnosis of pneumonia and metabolic encephalopathy. Procedures performed included respiratory support (mechanical ventilation for a brief period) and administration of intravenous medications. Throughout his stay, the patient's seizures were managed effectively, and he demonstrated gradual neurological improvement.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for continued monitoring of his seizure activity and pulmonary status. He will need assistance with medication management, mobility, and activities of daily living due to mild residual weakness.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen (Liquid)  \\n- Apixaban  \\n- Artificial Tears  \\n- Bisacodyl  \\n- Heparin Sodium  \\n- HydrALAZINE  \\n- Ipratropium-Albuterol Neb  \\n- LevETIRAcetam  \\n- Multivitamins W/minerals  \\n- Polyethylene Glycol  \\n- Senna  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his neurologist and primary care physician within one week of discharge. Home health services will be arranged to assist with his ongoing care needs.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Hospital Course:**  \\nThe patient is a 62-year-old male who presented with lumbar spinal stenosis and neurogenic claudication, necessitating a surgical intervention. The patient underwent a decompression laminectomy at the lumbar region. Post-operative recovery was complicated by episodes of constipation and transient hypertension which were managed appropriately. The patient's pain was effectively controlled with a combination of hydrocodone-acetaminophen and Dilaudid, and he was transitioned to acetaminophen for discharge.  \\nDuring the hospital stay, the patient was monitored for neurological deficits and pain management, with physical therapy initiated on postoperative day two to enhance mobility and strengthen lower extremities. The patient demonstrated improved ambulation and was able to perform basic activities of daily living (ADLs) with assistance by the time of discharge.  \\n**Key Findings:**  \\n- **Primary Diagnosis:** Spinal stenosis, lumbar region with neurogenic claudication (ICD10: M48062)  \\n- **Procedures:** Decompression laminectomy, lumbar (ICD10: 0SG3071)  \\n- **Co-morbidities:** Essential hypertension, hyperlipidemia, obstructive sleep apnea, and asthma were noted but managed during the stay.  \\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, ambulating with a walker, and reports mild pain rated 3/10 at rest. He is independent with basic self-care but will require home health services for ongoing physical therapy and monitoring of vitals due to his history of hypertension and sleep apnea.  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Baclofen  \\n4. Bisacodyl and Docusate Sodium for constipation management  \\n5. Hydrocodone-Acetaminophen for pain control  \\n6. Lisinopril for hypertension  \\n7. Escitalopram for mood stabilization  \\n8. Fluticasone nasal spray for allergy management  \\n9. Fleet Enema as needed for constipation  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge and continue with home health services for physical therapy and monitoring. He is advised to maintain a high-fiber diet and stay hydrated to prevent constipation.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 28 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.1 days  \\n**Primary Diagnosis:** O9832 - Other infections with a predominantly sexual mode of transmission complicating childbirth  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with complications during childbirth, specifically due to an infection that was identified as complicating her delivery. She presented with fever and localized discomfort, which prompted urgent evaluation.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received supportive care and was treated with appropriate antibiotics to manage her infection. She also underwent monitoring for labor complications, including shoulder dystocia and cord around the neck. The obstetric team managed these complications effectively, and the patient successfully delivered a healthy baby.  \\n  \\n**Key Findings and Procedures:**  \\n- Successful vaginal delivery of a single live birth.  \\n- Treatment for herpesviral infection of the urogenital tract and Streptococcus B carrier state.  \\n- Procedures performed included administration of Misoprostol for uterine atony and continuous monitoring of maternal and fetal status.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with vital signs within normal limits. She is ambulating independently and has shown good initiation of breastfeeding. However, she will require ongoing support at home due to her recent delivery and management of her infection. Home health services will provide assistance with wound care, education on infection signs, and lactation support.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Docusate Sodium  \\n- Dermoplast Spray  \\n- Ondansetron  \\n- Calcium Carbonate  \\n- Simethicone  \\n- Lactated Ringers as needed  \\n- Sodium Chloride 0.9% for flushing  \\n- Varicella Virus Vaccine  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician within one week for post-partum evaluation and to monitor for any signs of infection or complications. Home health services are arranged to commence within 48 hours to assist with recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 21  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted urgently for management of complications arising from childbirth, specifically due to other infections with a predominantly sexual mode of transmission complicating childbirth (ICD10: O9832). The patient presented with symptoms consistent with chorioamnionitis and immediate postpartum hemorrhage, requiring close monitoring and intervention.  \\n  \\n**Hospital Course:**  \\nThe patient had a length of stay of approximately 4.8 days, during which she was treated with intravenous antibiotics (Clindamycin and Gentamicin) and supportive care. Pain management was provided with Acetaminophen and Ibuprofen, while hydration was maintained with 0.9% Sodium Chloride. The patient was monitored for signs of infection and obstetric complications, including abnormal fetal heart rate and uterine inertia.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included resolution of fever and improvement in maternal vitals. The patient underwent necessary procedures, including uterine fundal massage and evaluation for hemorrhage. The patient delivered a single live birth at 41 weeks gestation. Enoxaparin was administered for thromboprophylaxis post-delivery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with no immediate complications. She is able to ambulate independently and has demonstrated an understanding of her discharge instructions. She is advised to monitor for any signs of infection or excessive bleeding and to maintain hydration. Home health services will assist with postpartum care, including wound assessment and breastfeeding support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Docusate Sodium for constipation, OxyCODONE (Immediate Release) for pain management, and Ondansetron as needed for nausea. She is to follow up with her obstetrician within one week of discharge and to contact home health services for any concerns regarding her recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Attending Physician Name]  \\n**Age:** 69  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 69-year-old male admitted for observation due to obstructive calculus of the bile duct, presenting with abdominal pain and episodes of nausea. His past medical history includes several comorbidities contributing to his current condition, including secondary malignant neoplasm of the liver.  \\n  \\n**Hospital Course:**  \\nDuring his 18.9-day stay, the patient underwent multiple diagnostic tests, including imaging studies that confirmed the presence of the calculus. He received intravenous fluids, antibiotics, and was closely monitored for signs of sepsis due to his underlying malignancy.  \\n  \\nThe patient was managed medically with a combination of daptomycin and cefTAZidime for infection prophylaxis. Surgical intervention was considered, but due to his functional status and comorbidities, we opted for conservative management.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes and imaging revealing a obstructive calculus in the bile duct without cholangitis or cholecystitis. The patient also experienced intermittent supraventricular tachycardia, managed with metoprolol.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved abdominal pain and no signs of acute distress. He is ambulatory with assistance and requires continued home health support for monitoring and medication management. He will need assistance with activities of daily living due to his fatigue and overall health status.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Metoprolol Tartrate  \\n4. CefTAZidime  \\n5. Neutra-Phos  \\n6. Mirtazapine  \\n7. Multivitamins  \\n   \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary physician within one week of discharge. Home health services will be initiated for daily monitoring and medication management to ensure compliance and address any complications promptly.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is an 86-year-old male with a primary diagnosis of Alzheimer's disease, unspecified (ICD-10 G309), who was admitted for observation due to progressive confusion and disorientation over the past few days. He has a significant medical history of vascular dementia, hypertension, type 2 diabetes mellitus with diabetic neuropathy, and obesity.  \\n  \\n**Hospital Course:**  \\nDuring his 1.8-day stay, the patient was monitored for cognitive decline and assessed for possible underlying causes of his confusion. Neurological evaluation showed no acute deficits, and vital signs remained stable. He was treated with supportive care, including hydration and management of his diabetes and hypertension.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated glucose levels, which were managed with insulin therapy. The patient's renal function was stable, and he was started on a regimen including Acetaminophen for pain control and Atorvastatin for cholesterol management. No additional procedures were required during the hospital stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition but continues to exhibit mild cognitive impairment. He requires assistance with activities of daily living (ADLs) due to his dementia. Home health services are recommended for ongoing support, including nursing care for medication management and assistance with personal care.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Allopurinol  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. Dextrose 50%  \\n6. Glucagon  \\n7. Glucose Gel  \\n8. Heparin  \\n9. Hydralazine  \\n10. Influenza Vaccine Quadrivalent  \\n11. Insulin  \\n12. Levothyroxine Sodium  \\n13. Lidocaine 5% Patch  \\n14. Losartan Potassium  \\n15. Oxycodone (Immediate Release)  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week for medication review and further cognitive evaluation. Home health services will initiate contact within 48 hours of discharge for care coordination and support.\",\n",
       " '**Patient Information:**  \\n**Age:** 53, **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department due to gastrointestinal bleeding secondary to angiodysplasia of the stomach and duodenum, as indicated by the primary diagnosis (ICD-10 K31811). His past medical history is significant for alcohol-related liver disease, protein-calorie malnutrition, and hypertension.  \\n\\n**Hospital Course:**  \\nDuring his 3.4-day hospitalization, the patient received supportive care, including IV fluids and blood transfusions. He was stabilized with appropriate management of his acute kidney failure and iron deficiency anemia. The patient was started on lactulose and diuretics to manage his ascites and fluid overload. Multiple consultations, including gastroenterology, were conducted to evaluate the extent of his gastrointestinal pathology and to determine the most effective treatment plan.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent an endoscopy, which confirmed the diagnosis of angiodysplasia. Biopsies were taken, and he was treated with targeted interventions to control bleeding. Laboratory studies showed improvement in hemoglobin levels, and renal function began to stabilize prior to discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with a functional status that requires home health services for ongoing management. He will benefit from nursing support for medication management, dietary counseling due to his malnutrition, and assistance with activities of daily living due to fatigue and weakness related to his recent hospitalization.  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient’s medication regimen includes 0.9% Sodium Chloride, Acetaminophen, BuPROPion XL, Bumetanide, Calcium Carbonate, CefTRIAXone, Ciprofloxacin HCl, Ferrous Sulfate, Fluticasone Propionate, Folic Acid, Lactulose, Levothyroxine Sodium, Lidocaine Patch, Magnesium Oxide, and Multivitamins. He is advised to follow up with his primary care physician and gastroenterology in one week, as well as to engage with home health services to support his recovery.',\n",
       " 'Patient is a 52-year-old female admitted for observation with a primary diagnosis of obstruction of the duodenum (ICD-10: K315). The patient presented with abdominal pain, nausea, and vomiting. Initial imaging studies confirmed the presence of a duodenal obstruction secondary to a polyp. During her 2.7-day hospital stay, she was closely monitored and managed with intravenous fluids and electrolyte repletion due to hypokalemia and hypomagnesemia (ICD-10: E876, E8342). The patient received symptomatic treatment with morphine sulfate and famotidine for pain and gastric acid reduction, respectively.\\n\\nThe hospital course was complicated by melena (ICD-10: K921) which necessitated further evaluation. A gastroenterology consult was obtained, and an endoscopic intervention was performed to address the polyp. No significant bleeding was noted post-procedure, and the patient’s hemoglobin levels were stable.\\n\\nKey findings included resolution of abdominal symptoms and stabilization of electrolytes. The patient was able to tolerate a soft diet and demonstrated improved functional status prior to discharge. She expressed understanding of her condition and the importance of follow-up care.\\n\\nAt the time of discharge, the patient was in stable condition, ambulating independently, and able to perform activities of daily living with minimal assistance. Given her complex medical history, including hypertensive heart disease with heart failure (ICD-10: I110, I509), she will require home health services for monitoring her vital signs and medication adherence, particularly for her iron deficiency anemia and vitamin B12 deficiency (ICD-10: D509, D519).\\n\\nMedications at discharge include Acetaminophen-Caff-Butalbital, Anastrozole, Ascorbic Acid, D5 1/2NS, Famotidine, Ferrous Sulfate, Loperamide, Magnesium Oxide, Morphine Sulfate, Multivitamins, Potassium Chloride, Pyridoxine, and Vitamin D. The patient is instructed to follow up with her primary care physician and the gastroenterology clinic in one week.',\n",
       " '**Patient Information:** 57-year-old male admitted for observation due to respiratory distress and suspected viral pneumonia. \\n\\n**History of Present Illness:** The patient presented with a 5-day history of worsening cough, fever, and shortness of breath. He has a history of multiple myeloma and underwent stem cell transplantation 6 months ago, complicating his clinical picture. \\n\\n**Hospital Course:** The patient was admitted for observation for 3.8 days. Initial workup revealed other viral pneumonia (ICD10: J1289) and acute kidney failure (ICD10: N179). He received intravenous fluids, broad-spectrum antibiotics including CefTRIAXone, and antiviral therapy with Acyclovir. His respiratory symptoms improved with nebulized treatments of Ipratropium-Albuterol and supportive care with Guaifenesin-CODEINE Phosphate for cough. The patient also received the influenza vaccine during the hospital stay, and his acute kidney function stabilized. \\n\\n**Key Findings and Procedures:** Chest X-ray showed bilateral infiltrates consistent with pneumonia. Laboratory tests indicated hypokalemia and anemia related to antineoplastic chemotherapy. His clinical status improved over the hospital stay, and he was closely monitored for any complications. The patient was discharged after resolution of fever and improvement in respiratory status. \\n\\n**Discharge Condition and Functional Status:** At the time of discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. He requires home health services for continued monitoring of his respiratory status and medication management, given his complex medical history. He will also need assistance with physical therapy for strength building post-transplant. \\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acyclovir, Azithromycin, Levofloxacin, and other supportive medications such as multivitamins and Neutra-Phos. A follow-up appointment with his oncologist and primary care physician is scheduled within one week post-discharge to monitor his recovery and manage any ongoing issues related to his underlying conditions.',\n",
       " \"**Patient Information:** 69-year-old female, admitted urgently with influenza due to other identified influenza virus with respiratory manifestations.  \\n\\n**History of Present Illness:** The patient presented to the emergency department with fever, cough, and dyspnea for two days. She has a history of essential hypertension and atrial fibrillation, which are well-controlled on medication, and also has a left artificial knee joint. She reported increased fatigue and mild confusion. Initial rapid influenza testing was positive for influenza virus. \\n\\n**Hospital Course:** The patient was admitted for supportive management, including hydration, oxygen therapy, and antiviral therapy with oseltamivir. During her brief hospitalization, she exhibited signs of acute kidney failure, likely secondary to dehydration and influenza. Renal function was monitored closely, and intravenous fluids were administered. She was also started on acetaminophen for fever management and dabigatran for atrial fibrillation. The patient's respiratory symptoms improved with treatment, and she was able to ambulate with assistance.  \\n\\n**Key Findings and Procedures:** Laboratory results indicated elevation of transaminases and lactic acid dehydrogenase (LDH), which were attributed to her acute illness. Chest x-ray showed no signs of pneumonia. Acute kidney failure improved with rehydration, and vital signs stabilized.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge and able to perform activities of daily living with minimal assistance. She will require home health services for continued monitoring of renal function, medication management, and assistance with mobility. Her cognitive status has improved, but she will benefit from follow-up to ensure continued recovery.  \\n\\n**Medications at Discharge:** The patient is discharged on the following medications: Acetaminophen, Amiodarone, Dabigatran Etexilate, GuaiFENesin, Levothyroxine Sodium, and OSELTAMivir. A prescription for Sodium Chloride 0.9% for flushes will be provided.  \\n\\n**Follow-Up Plan:** The patient will follow up with her primary care physician within one week and is advised to monitor her symptoms closely. Home health services will coordinate care and assist in medication management.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 5 days  \\n**Primary Diagnosis:** Neoplasm of uncertain behavior of brain, infratentorial (ICD10: D431)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following an acute episode characterized by headache, nausea, and confusion. Initial imaging revealed a neoplasm of uncertain behavior in the infratentorial region, which raised concerns for obstructive hydrocephalus and cerebral edema. The patient's symptoms and imaging findings necessitated immediate intervention.  \\n\\n**Hospital Course:**  \\nDuring the hospitalization, the patient underwent a ventriculostomy to relieve hydrocephalus and was started on dexamethasone to manage cerebral edema. He received supportive care including IV fluids, pain management with hydromorphone, and treatment for anxiety and depression with duloxetine and diazepam. The patient was monitored closely for neurological changes and was stable following interventions.  \\n\\n**Key Findings and Procedures:**  \\nCT scans showed resolution of hydrocephalus post-ventriculostomy. Neurological assessments indicated gradual improvement in mental status, although the patient continues to experience anxiety and depressive symptoms. The presence of a neoplasm requires ongoing monitoring and potential further treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires assistance with activities of daily living due to residual weakness and cognitive changes. A referral to home health services has been made to provide nursing care and support for rehabilitation. The patient will benefit from continued psychiatric support for anxiety and depression.  \\n\\n**Medications on Discharge:**  \\n- Acetaminophen  \\n- Dexamethasone  \\n- Duloxetine DR  \\n- Diazepam  \\n- Cyclobenzaprine  \\n- Bisacodyl  \\n- Heparin  \\n- Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with neurology and psychiatry within one week post-discharge. Home health nursing will monitor his medication adherence and assist with rehabilitation exercises to improve strength and cognitive function.\",\n",
       " \"Patient is a 54-year-old female admitted for direct observation with a diagnosis of zoster without complications (ICD-10: B029). She presented with a painful rash localized to the thoracic region and reported associated right upper quadrant pain. The pain was exacerbated by movement, but there were no signs of complications such as secondary infection or neurological involvement. \\n\\nDuring her 1.8-day hospital stay, the patient received supportive care, including pain management with acetaminophen and oxycodone. Antiviral therapy with valacyclovir was initiated to minimize the duration of symptoms. Additionally, she received ondansetron for nausea and levothyroxine sodium to address her underlying hypothyroidism. Hematological evaluation revealed thalassemia minor, which was noted but did not require intervention at this time. The patient's overall condition improved, and she was monitored for any signs of diverticulosis or complications related to her abdominal pain.\\n\\nKey findings included a stable vital sign profile and resolving dermatomal rash. No new complications arose during her admission, and she was deemed stable for discharge. The patient demonstrated appropriate functional status, with the ability to ambulate independently and perform activities of daily living with mild discomfort. Home health services are recommended for ongoing monitoring of her zoster symptoms and management of her hypothyroidism.\\n\\nDischarge medications include: Acetaminophen for pain management, Heparin for thromboprophylaxis, Influenza Vaccine Quadrivalent for immunization, Levothyroxine Sodium for hypothyroidism, Ondansetron for nausea, Oxycodone (Immediate Release) for breakthrough pain, and Sodium Chloride 0.9% for flushing needs. Follow-up with her primary care physician is advised within one week for reassessment of her overall health status and medication management.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 76  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute cholecystitis, characterized by abdominal pain and tenderness in the right upper quadrant. He has a history of multiple comorbidities including rheumatic heart disease, essential hypertension, benign prostatic hyperplasia, and hyperlipidemia.\\n\\n**Hospital Course:**  \\nDuring his 3.4-day stay, the patient was monitored and managed conservatively with intravenous fluids and analgesics. He was started on Apixaban for anticoagulation given his history of atrial fibrillation. The patient received supportive care including Furosemide for fluid management and Omeprazole for gastric protection.\\n\\n**Key Findings and Procedures:**  \\nAbdominal ultrasound confirmed the diagnosis of acute cholecystitis. Laboratory studies showed elevated white blood cell count and liver enzymes, consistent with the diagnosis. There were no complications such as perforation, and he remained hemodynamically stable throughout the admission.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with significant improvement in abdominal pain and normal bowel function. His functional status is satisfactory for home care, although he will require assistance with activities of daily living due to his age and overall health status. A home health nurse will assist with medication management and monitor for any signs of complications.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Apixaban  \\n- Aspirin  \\n- D5 1/2NS  \\n- Furosemide  \\n- Heparin  \\n- Omeprazole  \\n- PredniSONE  \\n- Sodium Chloride 0.9% Flush  \\n- Amlodipine  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week for further evaluation of his cholecystitis and ongoing management of his chronic conditions. Home health services will implement a care plan focusing on medication adherence and monitoring for any recurrence of symptoms.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Male, 47 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.2 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted to the hospital with acute neurological symptoms attributed to postherpetic nervous system involvement (ICD10: B0229), following a recent herpes zoster infection. He presented with severe pain and sensory disturbances, along with a history of transient ischemic attack (TIA).  \\n  \\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient underwent a thorough neurological evaluation, including MRI imaging, which ruled out acute cerebrovascular events. He was treated with pain management, including Hydromorphone and Oxycodone, alongside Pregabalin for neuropathic pain. The patient's pain levels improved significantly, and he demonstrated good tolerance to the pain management regimen.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included sensory deficits consistent with postherpetic neuralgia and mild hydrocephalus (ICD10: G919) which was monitored. No invasive procedures were required, and cerebrospinal fluid drainage was not indicated. The patient was educated on the importance of adherence to medication and was provided with a follow-up plan.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved functional status. He was able to perform self-care with assistance and demonstrated understanding of his medication regimen. Home health services will be initiated to provide ongoing support for pain management and to monitor neurological status.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient was prescribed Acetaminophen, Hydromorphone (Dilaudid), Latanoprost 0.005% Ophthalmic Solution, Oxycodone (Immediate Release), Pregabalin, and Senna. He will continue to receive Sodium Chloride 0.9% for flushes as needed.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with his primary care physician in one week. Home health nursing will assess the patient’s pain management and assist with any mobility challenges he may experience. Regular monitoring for any neurological changes is advised.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 72  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of chest pain and dyspnea. Initial evaluation revealed unstable angina secondary to atherosclerotic heart disease of the native coronary artery, confirmed by cardiac enzymes and ECG changes. The patient has a significant medical history including chronic obstructive pulmonary disease (COPD) with exacerbation, type 2 diabetes with chronic kidney disease, and a history of gastrointestinal hemorrhage.  \\n\\n**Hospital Course:**  \\nDuring her 6-day stay, the patient received intravenous fluids and was started on a regimen of nitrates and antiplatelet therapy. A comprehensive workup including a cardiac stress test and echocardiogram was performed, which revealed preserved left ventricular function. She was also treated for her COPD exacerbation with bronchodilators and antibiotics due to a concomitant lower respiratory infection. The patient's blood glucose levels were closely monitored and managed throughout her hospitalization.  \\n\\n**Key Findings and Procedures:**  \\nThe patient showed improvement in her symptoms and was stable for discharge. Key findings included resolution of chest pain and normalization of vital signs. No invasive procedures were performed during this admission; however, she was educated on the management of her chronic conditions.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was in stable condition, with improved functional status and understanding of her medications and dietary needs. She will require home health services for medication management, dietary counseling, and respiratory therapy to aid in her COPD management.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include: Alprazolam, Acetaminophen, Albuterol (Nebulizer and Inhaler), Aspirin, Atenolol, Atorvastatin, Azithromycin, Clopidogrel, and others as needed. Follow-up appointments with cardiology and primary care are scheduled within one week. Home health services will initiate within 48 hours to ensure a smooth transition and monitor her progress.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 81  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient, an 81-year-old male, was admitted through the emergency department with a diagnosis of bullous pemphigoid, presenting with extensive blistering and pruritus. He has a past medical history notable for essential hypertension, atrial fibrillation, and acute kidney failure, which were managed during his hospitalization.  \\n  \\n**Hospital Course:**  \\nDuring his 4.7-day stay, the patient was started on systemic corticosteroids (prednisone) to manage his bullous pemphigoid and received topical clobetasol propionate for local treatment. His renal function was monitored closely, with adjustments made to his medications including the discontinuation of medications that may have contributed to his acute kidney injury. He was also treated for hyperlipidemia and received appropriate anticoagulation therapy with rivaroxaban for atrial fibrillation.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated white blood cell counts, which improved with treatment. The patient underwent a skin biopsy confirming the diagnosis of bullous pemphigoid, and his renal function showed improvement prior to discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved skin condition and adequately managed renal function. He demonstrated the ability to perform activities of daily living (ADLs) with minimal assistance. Home health services have been arranged to assist with ongoing wound care, medication management, and monitoring of his renal status.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, atorvastatin, calcium carbonate, clindamycin, clobetasol propionate 0.05% cream, dexamethasone, digoxin, doxycycline, influenza vaccine, pantoprazole, prednisone, rivaroxaban, and sulfameth/trimethoprim SS. Follow-up appointments are scheduled with dermatology for further management of bullous pemphigoid and nephrology to monitor kidney function. Home health services will initiate care within 48 hours post-discharge.',\n",
       " '**Patient Summary**: 50-year-old male presented to the emergency department with symptoms suggestive of orthostatic hypotension. \\n\\n**History of Present Illness**: The patient experienced recurrent dizziness and near-syncope upon standing, exacerbated by recent changes in medication and fluid intake. He has a complex medical history, including alcohol-related liver disease, portal hypertension, and a recent episode of acute kidney failure. \\n\\n**Hospital Course**: During his 8.5-day hospitalization, the patient underwent extensive evaluation, including imaging studies that ruled out significant intracranial hemorrhage. He was monitored for vital signs and fluid status, and his medications were adjusted to manage orthostatic hypotension effectively. A multidisciplinary approach was taken, involving dietary modifications and optimization of existing medications. \\n\\n**Key Findings and Procedures**: Notable findings included mild portal hypertension and acute kidney injury, both of which were addressed with hydration and the adjustment of diuretics. The patient also received treatment for his underlying conditions, including adjustments to his psychiatric medications and management of his chronic pain. \\n\\n**Discharge Condition and Functional Status**: At the time of discharge, the patient demonstrated improved stability in blood pressure with gradual changes in position. He is ambulatory with a walker and has been educated on strategies to prevent falls. His overall condition is stable, but he requires continued home health services for monitoring of orthostatic symptoms, medication management, and assistance with activities of daily living due to his history of dizziness and cognitive challenges. \\n\\n**Medications and Follow-Up Plan**: Discharged medications include Aripiprazole, Gabapentin, Lactulose, and Spironolactone, among others. The patient will follow up with outpatient primary care and a nephrologist within one week post-discharge. Home health services will initiate a nursing assessment to monitor vital signs and medication adherence. \\n\\nOverall, the patient is stable for discharge with a comprehensive plan for ongoing care.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Initials or ID]  \\n**Age:** 53  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.8 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 53-year-old male who presented to the emergency department with an acute injury resulting from a nontraffic accident while riding a three-wheeled motor vehicle. He was diagnosed with an unspecified fracture of the lower end of the right radius (ICD-10: S52501A) and multiple rib fractures on the right side (ICD-10: S2241XA). The initial encounter was marked by significant pain and limited mobility due to the fractures.\\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient underwent stabilization and pain management. He received conservative treatment for his fractures, including immobilization of the right arm and rib support. The patient was monitored for any signs of complications, particularly respiratory issues given his history of asthma (ICD-10: J45909) and Type 2 diabetes mellitus (ICD-10: E119). He demonstrated good tolerance to medication, and pain levels reduced significantly by discharge.\\n\\n**Key Findings and Procedures:**  \\nRadiological evaluations confirmed the fractures, with no additional complications noted. Procedures performed included a closed reduction of the right radius fracture (ICD-10: 0PSH04Z). The patient was educated on the importance of follow-up care and rehabilitation to ensure proper healing.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable but required assistance with activities of daily living due to limited use of his right arm. He was advised to engage in gentle range-of-motion exercises as tolerated. Home health services will be initiated to assist with physical therapy and to monitor his recovery closely.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on analgesics for pain management and anti-inflammatory medications. He is scheduled for follow-up appointments with his primary care physician and an orthopedic specialist in one week. Home health services will also coordinate to ensure adherence to the rehabilitation plan and monitor any potential complications during the recovery process.',\n",
       " '**Patient Name:** [Redacted]  \\n**Date of Birth:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n**Admitting Physician:** [Redacted]  \\n\\n**Brief History of Present Illness:**  \\nThe patient is a 73-year-old female who presented to the emergency department with acute onset of slurred speech and weakness on the left side, consistent with a cerebrovascular accident. Initial evaluation revealed an NIHSS score of 3, and imaging confirmed an occlusion of a small artery consistent with a cerebral infarction (ICD-10: I6381).\\n\\n**Hospital Course:**  \\nThe patient was admitted for management of her stroke symptoms. She underwent a comprehensive neurovascular assessment, and monitoring was initiated. Treatment included anticoagulation with Heparin and dual antiplatelet therapy with Aspirin and Clopidogrel. The patient was started on a statin regimen with Rosuvastatin for hyperlipidemia (ICD-10: E785). A swallow study was performed due to her dysphagia, and she was placed on a modified diet accordingly.  \\n\\n**Key Findings and Procedures:**  \\nDuring her hospitalization, her neurological status improved gradually, with decreased hemiplegia on the left side. The patient demonstrated improved functional capacity by discharge, ambulating with minimal assistance. Complications were minimal; however, she was monitored closely for potential COVID-19 exposure given her contact history.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved motor function and speech. She is able to ambulate short distances independently with a walker and perform activities of daily living with some assistance. Home health services are recommended to provide physical therapy and nursing care to monitor her medication adherence and ongoing rehabilitation.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on a regimen including Aspirin, Clopidogrel, Rosuvastatin, and Insulin for glycemic control, among others. A follow-up appointment with neurology is scheduled in one week post-discharge. Home health services will monitor her progress and assist with medication management, physical therapy, and dietary needs. \\n\\n**Recommendations:**  \\nThe patient should be advised to report any sudden changes in neurological status, and caregivers should be educated on stroke recognition signs. Follow-up for lab tests to monitor lipid levels and glucose control is crucial.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is an 85-year-old male who was admitted for observation due to complaints of worsening constipation associated with abdominal discomfort. He has a history of multiple comorbidities including atherosclerotic heart disease, type 2 diabetes, and hypothyroidism.  \\n\\n**Hospital Course:**  \\nDuring his 2-day stay, the patient underwent a comprehensive evaluation. He received conservative management for constipation, which included the administration of bisacodyl and saline enemas. Additionally, he was monitored for signs of dehydration and electrolyte imbalance. A routine workup was conducted, revealing no acute intra-abdominal pathology. Neurological assessment showed signs of mild delirium likely secondary to metabolic factors, which improved with treatment.  \\n\\n**Key Findings and Procedures:**  \\n- Primary diagnosis: Other constipation (ICD-10: K5909)  \\n- Notable comorbidities: Toxic encephalopathy, secondary malignant neoplasm of bone, and diabetes.  \\n- Procedures included administration of glucose gel and dextrose 50% for hypoglycemia, and heparin for DVT prophylaxis.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented, with significant improvement in bowel function. He is independent in activities of daily living but will benefit from home health services for continued monitoring of his bowel regimen and management of his diabetes. Home health nursing will also assist with medication management, particularly insulin adjustments and monitoring for any signs of recurrence of delirium.  \\n\\n**Medications:**  \\nUpon discharge, the patient was prescribed the following medications:  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Bisacodyl  \\n- Cyanocobalamin  \\n- Insulin  \\n- Levothyroxine Sodium  \\n- Lisinopril  \\n- Metoprolol Succinate XL  \\n- Heparin (for DVT prophylaxis)  \\n- Influenza Vaccine Quadrivalent (administered)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week. Home health services will initiate contact within 48 hours post-discharge to establish a care plan.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date:** [REDACTED]  \\n**Admit Date:** [REDACTED]  \\n\\n**History of Present Illness:**  \\nThe patient is a 77-year-old male with a complex medical history, including hypertensive heart disease, chronic kidney disease (CKD), and type 2 diabetes mellitus. He presented to the hospital with acute respiratory failure and worsening heart failure symptoms. He was admitted for observation due to significant hypoxia and volume overload, requiring diuresis and further evaluation.  \\n\\n**Hospital Course:**  \\nDuring his 14-day stay, the patient was managed with diuretics and antihypertensive medications, resulting in improved fluid status and respiratory function. He underwent diagnostic imaging and echocardiography, which confirmed the presence of heart failure with preserved ejection fraction and moderate CKD. The patient also received treatment for hypoglycemia and was closely monitored for potential complications from his existing comorbidities.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, worsening renal function, and significant edema. The patient underwent a renal ultrasound to evaluate for obstructive pathology and was treated with B2111ZZ and 02HP32Z procedures to manage his symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory status, with oxygen saturation returning to baseline levels. He is ambulating with assistance and has regained some functional independence, although he will require home health services for ongoing monitoring and assistance with daily activities. The patient is advised to follow a low-sodium diet and continue with fluid management at home.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed the following medications: Acetaminophen, Albuterol 0.083% Nebulizer solution, Aspirin, Atorvastatin, Metoprolol Succinate XL, and Insulin, among others. Follow-up appointments with cardiology and nephrology are scheduled within the next two weeks to monitor his heart and renal status closely. Home health services will initiate within 48 hours post-discharge to provide nursing care and medication management.',\n",
       " '**Discharge Summary**  \\n**Patient:** 66-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a calculus of the ureter, presenting with flank pain and hematuria. She has a significant past medical history, including chronic diastolic heart failure, hypertensive heart disease with heart failure, obstructive sleep apnea, and obesity.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent imaging studies, which confirmed the diagnosis of ureterolithiasis. Pain management was initiated, and the patient was provided with intravenous fluids and medications including morphine and acetaminophen. She was monitored closely for any signs of complications related to her heart failure or obstructive sleep apnea.  \\n  \\n**Key Findings and Procedures:**  \\nFollowing conservative management, the patient’s symptoms improved significantly. Key procedures performed included hydration and medication management, with no surgical intervention required at this time.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable and ambulating with minimal assistance. She is capable of performing activities of daily living (ADLs) with supervision. Home health services are recommended to assist with monitoring her heart failure management and medication adherence, as well as providing support for her sleep apnea.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- Acetaminophen  \\n- Atenolol  \\n- Levothyroxine Sodium  \\n- Montelukast  \\n- Docusate Sodium  \\n- Fentanyl Citrate as needed  \\n- Ondansetron as needed  \\n- Insulin as per sliding scale  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician in one week to reassess her renal status and adjust medications as necessary. Home health will initiate services within 48 hours post-discharge to support her ongoing care needs.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 75  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of obstructive jaundice secondary to biliary obstruction as indicated by ICD-10 code K831. He presented with abdominal pain, elevated bilirubin levels, and evidence of portal vein thrombosis (I81). The patient has a history of malignant neoplasm of the pancreas (C259) and has been on long-term anticoagulant therapy.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent imaging studies, which confirmed the obstruction of the bile duct. A percutaneous biliary drain was placed to relieve the obstruction. The patient was closely monitored for complications, including acute kidney failure (N179) and potential hemorrhagic disorders due to anticoagulants. He received supportive care, including fluid resuscitation with Lactated Ringer’s and electrolyte replacement.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings include elevated liver function tests and imaging consistent with biliary obstruction. Procedures performed include the placement of a biliary drain (0F798DZ) and supportive management for fluid balance and electrolyte homeostasis.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and able to perform activities of daily living with assistance. He demonstrates adequate mobility with supervision and is able to communicate his needs effectively. Home health services are recommended for continued monitoring of his biliary drain, medication management, and assistance with daily activities.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Apixaban, Atorvastatin, Hydrochlorothiazide, Losartan Potassium, and Ondansetron. He will also require electrolyte replacement and continue on supportive medications.  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge and with a gastroenterologist for ongoing management of his biliary issues. Home health nursing will assess medication compliance and monitor for any complications related to the biliary drain.\",\n",
       " '**Discharge Summary**  \\n**Patient Details:**  \\n- **Age:** 30  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n**History of Present Illness:**  \\nThe patient was admitted with acute onset of fever and malaise, subsequently diagnosed with other streptococcal sepsis (ICD10: A408). Initial labs revealed elevated inflammatory markers and positive blood cultures for Streptococcus.  \\n**Hospital Course:**  \\nThe patient underwent a 9-day hospital stay during which he was started on broad-spectrum antibiotics, including Ceftriaxone. He was monitored closely for signs of septic shock and received supportive care including fluid resuscitation with 0.9% Sodium Chloride. Due to the presence of pleural effusion (ICD10: J90), a thoracentesis was performed, yielding significant symptomatic relief. Additionally, the patient had mixed disorders of acid-base balance and was managed with appropriate electrolyte replacements.  \\n**Key Findings and Procedures:**  \\nThe patient presented with complications related to his underlying conditions, including portal hypertension and secondary esophageal varices without bleeding (ICD10: I8510). A multidisciplinary approach was taken involving gastroenterology for further evaluation of his liver status. He received lactulose and Rifaximin for hepatic encephalopathy management.  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, afebrile, and able to ambulate with minimal assistance. He demonstrates understanding of his medication regimen and the importance of follow-up care. He will benefit from home health services for ongoing monitoring and assistance with activities of daily living, specifically regarding dietary management and medication adherence.  \\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Acetaminophen  \\n- Ceftriaxone  \\n- Lactulose  \\n- Magnesium Oxide  \\n- Nadolol  \\n- Omeprazole  \\n- Prednisone  \\n- Rifaximin  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician and gastroenterologist within one week of discharge. Home health services will be initiated immediately to facilitate recovery and ensure adherence to the treatment plan.',\n",
       " '**Discharge Summary**  \\n**Patient:** 23-year-old female  \\n**Admission Date:** [Insert Admission Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n**Length of Stay:** 4.1 days  \\n**Diagnosis:** Full-term premature rupture of membranes with onset of labor within 24 hours (ICD-10: O4202).  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted urgently due to full-term premature rupture of membranes. Labor ensued within 24 hours of the rupture. The patient reported mild contractions and was monitored closely throughout her stay.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient experienced normal labor progression and delivered a healthy single live birth at 40 weeks gestation. Continuous fetal monitoring was performed, revealing transient abnormalities in fetal heart rate, which were managed appropriately without complications. Additionally, the patient was identified as a Group B Streptococcus carrier, and prophylactic antibiotics were administered during labor.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent routine obstetric procedures, including a vaginal delivery (10D00Z1) and subsequent postpartum care. She received medications such as Enoxaparin Sodium for thromboprophylaxis and was provided analgesics (Ibuprofen, OxyCODONE) for pain management post-delivery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and ambulating independently. She demonstrates adequate maternal bonding and is capable of caring for her newborn with support. Home health services will be arranged to assist with postpartum care, including follow-up evaluations and education regarding newborn care and maternal health.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. Docusate Sodium  \\n4. Enoxaparin Sodium  \\n5. Ibuprofen  \\n6. Metoclopramide  \\n7. Ondansetron  \\n8. OxyCODONE (Immediate Release)  \\n9. Simethicone  \\n10. Milk of Magnesia  \\n11. Naloxone  \\n12. Sodium Chloride 0.9% Flush  \\n13. MMR Vaccine  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for postpartum evaluation and to monitor for any complications. Home health services will initiate contact for support in the coming days.',\n",
       " '**Patient Name:** [Redacted]  \\n**Age:** 23 years  \\n**Gender:** Female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to sepsis secondary to Escherichia coli infection. She presented with fever, chills, and dysuria. A thorough workup identified acute pyelonephritis and dehydration. She has a history of urinary tract infections and was treated with antibiotics prior to admission.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient received intravenous fluids, including 0.9% sodium chloride, to address her dehydration. Broad-spectrum antibiotics, including Ceftriaxone and Ciprofloxacin, were initiated. She was closely monitored for her renal function, which showed transient acute kidney failure, resolved during her stay. Supportive care included magnesium sulfate and potassium chloride to correct electrolyte imbalances. Her fever subsided, and she became hemodynamically stable.\\n\\n**Key Findings and Procedures:**  \\nLaboratory results confirmed the diagnosis of sepsis with underlying thrombocytopenia and hypomagnesemia. Urinalysis was consistent with acute pyelonephritis. The patient did not require invasive procedures during her stay. She was educated on her condition and the importance of hydration and adherence to antibiotic regimens.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, afebrile, and able to ambulate independently. She demonstrates understanding of her condition and the need for follow-up care. The patient will require home health services for continued monitoring of her renal function and medication management, including oral antibiotics and electrolyte supplements.\\n\\n**Medications at Discharge:**  \\nThe patient is prescribed oral antibiotics to complete her course and advised to continue taking potassium and magnesium supplements as needed. Follow-up with her primary care physician is recommended within one week and with a nephrologist for her renal recovery. \\n\\n**Follow-Up Plan:**  \\nHome health nursing will visit the patient twice weekly to assess her recovery and ensure adherence to the medication regimen. She is educated to seek immediate medical attention if symptoms of infection relapse.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 72 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.6 days  \\n**Primary Diagnosis:** C50411 - Malignant neoplasm of upper-outer quadrant of right female breast  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of a malignant neoplasm of the right breast, confirmed as estrogen receptor-positive. She presented with localized breast pain and a palpable mass. Her past medical history is significant for essential hypertension, anxiety disorder, gastro-esophageal reflux disease, and a personal history of nicotine dependence.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent imaging studies which confirmed the diagnosis. Surgical consultation was obtained, and the decision was made to proceed with a lumpectomy. The patient tolerated the procedure well with minimal complications. Post-operative care included pain management and monitoring for any signs of infection. She was started on a regimen of anticoagulation with heparin to prevent thromboembolic events during her hospital stay.  \\n\\n**Key Findings and Procedures:**  \\nImaging revealed a well-defined mass in the upper-outer quadrant of the right breast. The patient underwent a lumpectomy and sentinel lymph node biopsy, both of which went smoothly. Pathology results confirmed the presence of malignancy with negative margins.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and ambulating independently, with no signs of acute distress. She will benefit from home health services for post-operative care, including wound management and physical therapy to aid in recovery. The patient is educated about signs of infection and advised to follow up with her oncologist within one week.  \\n\\n**Medications at Discharge:**  \\n1. Alprazolam  \\n2. Acetaminophen  \\n3. Cepacol (Sore Throat Lozenge)  \\n4. Docusate Sodium  \\n5. Hydromorphone (Dilaudid)  \\n6. Heparin  \\n7. Pantoprazole  \\n8. Polyethylene Glycol  \\n9. Senna  \\n10. Sodium Chloride 0.9% Flush  \\n11. Vitamin D  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with oncology and primary care within one week of discharge. Home health services have been arranged to assist with recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Age:** 20  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.6 days  \\n\\n**History of Present Illness:**  \\nThe patient, a 20-year-old female, was admitted for observation due to symptoms of nausea and vomiting, with a primary diagnosis of other diseases of the stomach and duodenum (ICD-10: K3189). She also presented with urinary tract infection (ICD-10: N390) and abnormal weight loss. The patient reported persistent nausea, which led to dehydration and necessitated intravenous fluid administration.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was evaluated and treated for her symptoms. She received intravenous fluids (D5LR and Sodium Chloride 0.9%) to address dehydration, and antibiotics (Ceftriaxone) for her urinary tract infection. Pain management was achieved with Acetaminophen IV, and nausea was controlled with Ondansetron. The patient also received Lorazepam for anxiety. She was monitored closely for her weight loss and hydration status.  \\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings revealed dehydration and abnormal weight loss. The patient underwent abdominal imaging to rule out any obstructive process, which was negative.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved hydration status and resolution of nausea. She can tolerate a regular diet and ambulate with minimal assistance. However, she requires follow-up with home health services for continued monitoring of hydration and nutritional intake, as well as management of her urinary symptoms.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to be discharged on the following medications: Acetaminophen IV as needed for pain, Ceftriaxone to complete the course for urinary tract infection, and Ondansetron for nausea. She should follow up with her primary care physician within one week and engage home health services to monitor her recovery and provide nutritional support.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 80  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is an 80-year-old male who presented with symptoms consistent with pyonephrosis, including flank pain and fever. Initial imaging confirmed the diagnosis, necessitating close observation and medical management. \\n\\n**Hospital Course:**  \\nDuring his 6-day observation stay, the patient was started on broad-spectrum antibiotics including Ceftriaxone and Vancomycin, along with supportive care for his acute kidney failure and cachexia. His renal function was closely monitored, and he received intravenous fluids to manage his hydration status. A urinary catheter was placed to relieve obstruction and allow for proper drainage. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated creatinine levels consistent with acute kidney failure. The patient’s condition also required the management of chronic conditions, including hypertensive chronic kidney disease and benign prostatic hyperplasia. The patient received a total of 4 units of IV fluids and was transitioned to oral medications towards the end of his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved renal function and no further signs of infection. He requires home health services for continued monitoring of his renal status, assistance with medication management, and support for activities of daily living due to his age and cognitive status. He demonstrated the ability to perform some self-care tasks but will benefit from home health nursing support.  \\n\\n**Medications at Discharge:**  \\n1. Amoxicillin-Clavulanate Suspension  \\n2. Bisacodyl  \\n3. Ciprofloxacin HCl  \\n4. Heparin  \\n5. LevETIRAcetam Oral Solution  \\n6. Losartan Potassium  \\n7. Tamsulosin  \\n8. Vancomycin  \\n9. Influenza Vaccine (Quadrivalent)  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge for further evaluation of his renal function and management of chronic conditions. Home health will provide support for medication administration and monitoring of vital signs. \\n\\n**Patient Education:**  \\nEducation on medication adherence, hydration status, and signs of infection were provided to the patient and family prior to discharge.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 74  \\n**Gender:** Male  \\n**Admission Date:** [REDACTED]  \\n**Discharge Date:** [REDACTED]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 74-year-old male who was admitted for surgical intervention due to a malignant neoplasm of the lesser curvature of the stomach (ICD-10: C165). The patient presented with symptoms consistent with obstructive gastrointestinal disease and underwent a partial gastrectomy with reconstruction.  \\n  \\n**Hospital Course:**  \\nThe patient had a length of stay of 4.7 days, during which he was closely monitored in the surgical unit. Postoperative recovery was complicated by an accidental puncture and laceration of a digestive structure during the procedure (ICD-10: K9171). Despite this, the patient was stabilized and managed with appropriate intravenous fluids, analgesics, and supportive care, which included the administration of iron for iron deficiency anemia (ICD-10: D509) and management of hyperlipidemia (ICD-10: E785).  \\n  \\n**Key Findings and Procedures:**  \\nKey procedures included laparoscopic partial gastrectomy and postoperative care involving pain management using hydromorphone and oral oxycodone. The patient received prophylactic heparin to prevent thromboembolic events. Postoperative imaging showed no signs of leakage or obstruction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved gastrointestinal function and pain well-controlled. He demonstrates the ability to perform activities of daily living (ADLs) with minimal assistance, although he will benefit from home health services for continued monitoring and nutritional support as he recovers.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Atorvastatin  \\n4. Omeprazole  \\n5. Ondansetron  \\n6. OxyCODONE (Immediate Release)  \\n7. Lactated Ringers  \\n8. Magnesium Sulfate  \\n9. Chloraseptic Throat Spray  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his oncologist within one week post-discharge for ongoing management of his malignancy. Home health services will be initiated to assist with medication management, wound care, and nutritional assessment.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 45  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient, a 45-year-old male, was admitted through the emergency department with complaints of non-specific chest pain (ICD10: R0789). The pain was described as intermittent, lasting for a few seconds, and was not associated with exertion. A thorough evaluation was undertaken to rule out life-threatening conditions.  \\n\\n**Hospital Course:**  \\nDuring the short hospital stay of 0.6 days, the patient underwent a comprehensive work-up including an ECG, echocardiogram, and cardiac biomarkers. He was diagnosed with chronic systolic heart failure (ICD10: I5022) and pericardial effusion (ICD10: I313). Treatment included diuretics and optimization of heart failure management. The patient was monitored closely for any complications and responded well to the interventions.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, improved heart failure symptoms post-diuretics, and no evidence of acute coronary syndrome. The patient received education regarding heart failure management, including lifestyle modifications and medication adherence. He was placed on the following medications prior to discharge: Aluminum-Magnesium Hydrox.-Simethicone, Aspirin, Atorvastatin, ClonazePAM, Furosemide, Heparin, Lisinopril, Metoprolol Succinate XL, Ranitidine, Sodium Chloride 0.9% Flush, TiCAGRELOR, Venlafaxine XR, Warfarin.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, alert and oriented, with improved functional status. He will require home health services to assist with medication management and ongoing monitoring of his heart failure. Education on dietary modifications and the importance of regular follow-ups was provided to the patient and family.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with cardiology within one week. Additionally, home health services will conduct regular visits to assess the patient's progress and adjust therapies as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient, a 42-year-old female, was admitted directly through the emergency department with disseminated zoster. She presented with a rash characteristic of varicella zoster virus infection, associated with significant pain and discomfort. Her past medical history includes acute kidney failure, liver transplant rejection, and a history of alcohol dependence in remission.  \\n  \\n**Hospital Course:**  \\nDuring her 4.7-day hospitalization, the patient was initiated on antiviral therapy with Acyclovir, alongside supportive care. She was monitored closely for renal function and signs of infection, as her renal status was complicated by her previous transplant. The patient received pain management with Acetaminophen and was started on anxiety management with Alprazolam. Her mental health was addressed due to a history of anxiety and depression, and she received a psychiatric evaluation.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included disseminated zoster confirmed by clinical examination and laboratory tests. The patient underwent routine procedures including hydration and nutritional support with 5% Dextrose. Renal function was assessed daily, with adjustments made to her medications as necessary.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with a significant reduction in pain and resolution of her dermatological symptoms. She is alert and oriented, demonstrating adequate functional status for home care. Home health services will focus on wound care, pain management, and monitoring of her mental health status.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acyclovir, Mycophenolate Sodium, HydrOXYzine, and Multivitamins. The patient is advised to continue hydration and follow up with her primary care physician within one week. Home health nursing services will be arranged to assist with medication management and psychosocial support.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- Age: 80  \\n- Gender: Male  \\n\\n**History of Present Illness:**  \\nThe patient is an 80-year-old male who presented to the emergency department with a traumatic subdural hemorrhage following a fall. He exhibited loss of consciousness of unspecified duration. His past medical history is significant for essential hypertension, atrial fibrillation, and spinal stenosis.\\n\\n**Hospital Course:**  \\nDuring his 6-day observation admission, the patient underwent a comprehensive evaluation including CT imaging, which confirmed the diagnosis of subdural hemorrhage. He was closely monitored for neurological status, and his anticoagulation therapy was carefully managed. He received supportive care including fluid resuscitation with 0.9% sodium chloride, pain management with acetaminophen, and treatment for his anemia with ferric gluconate. He was also administered prophylactic heparin to prevent thromboembolic events.\\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs and gradual improvement in his neurological condition. The patient did not exhibit any signs of progressive hemorrhage. Procedures performed included CT imaging and intravenous medication administration.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert and oriented but required assistance with activities of daily living due to generalized weakness and mild cognitive impairment post-hemorrhage. He is recommended for home health services to assist with mobility and daily tasks, and to ensure safety in his living environment. Family support is in place, and the patient will benefit from physical therapy to regain strength and independence.\\n\\n**Medications and Follow-up Plan:**  \\nThe patient is discharged on the following medications: Losartan Potassium, Verapamil SR, Tamsulosin, Acetaminophen, Docusate Sodium, Ferric Gluconate, Heparin, and Influenza Vaccine Quadrivalent. A follow-up appointment is scheduled with neurology in one week to reassess his neurological status and manage his anticoagulation therapy. Home health services will be initiated to monitor his recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admission Date:** [Admission Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 59-year-old female who was admitted for observation due to worsening respiratory distress and a diagnosis of pulmonary embolism, classified as other pulmonary embolism without acute cor pulmonale (ICD10 I2699). The patient presented with symptoms of acute respiratory failure and was noted to have a history of chronic systolic heart failure and morbid obesity.\\n\\n**Hospital Course:**  \\nDuring her 9.8-day stay, the patient was monitored closely in the observation unit. She received anticoagulation therapy (Heparin) to manage her pulmonary embolism and was treated for acute respiratory failure with supplemental oxygen and bronchodilators (Albuterol). Other supportive medications included Bumetanide for heart failure management and Docusate Sodium for bowel regimen. The patient's condition gradually improved with appropriate treatment. She was also administered the Influenza Vaccine Quadrivalent during her stay.\\n\\n**Key Findings and Procedures:**  \\nKey findings included significant hypoxia on admission, which resolved with treatment. Imaging studies confirmed the presence of pulmonary embolism. The patient underwent venous Doppler studies revealing thrombosis in the left popliteal and femoral veins, necessitating prompt intervention. No acute cor pulmonale was noted throughout her hospitalization.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated marked improvement in respiratory status and was stable for home health services. She was ambulating independently with mild exertion and required assistance with activities of daily living due to her obesity. Home health nursing will monitor her anticoagulation therapy, respiratory status, and provide support for daily activities.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on a regimen including 5% Dextrose, Acetaminophen, Albuterol Inhaler, Aspirin, Benzonatate, Bumetanide, and Heparin Sodium. Follow-up appointments are scheduled with her primary care physician and cardiologist within one week of discharge to reassess her heart failure management and pulmonary status.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Admitting Physician:** [REDACTED]  \\n**Patient:** 59-year-old female  \\n**Diagnosis:** Hypertensive chronic kidney disease with stage 5 chronic kidney disease (ICD10: I120)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted via direct emergency due to worsening renal function, fatigue, and edema. She has a significant history of hypertension, obesity, and chronic kidney disease, which has progressed to stage 5 (end stage renal disease). The patient had been experiencing increased shortness of breath and generalized weakness over the past few weeks, prompting her hospitalization.\\n\\n**Hospital Course:**  \\nDuring her 2.2-day hospitalization, the patient underwent hemodialysis to manage fluid overload and electrolyte imbalances. She received Epoetin Alfa for anemia, and her electrolyte levels were closely monitored, with adjustments made to her medications as necessary. The team also managed her hypertension with Metoprolol and provided supportive care, including nutritional counseling and education on her renal diet.\\n\\n**Key Findings and Procedures:**  \\nRenal function tests upon admission revealed elevated creatinine levels consistent with stage 5 chronic kidney disease. Chest X-ray indicated mild pulmonary congestion. The patient tolerated hemodialysis well, with significant improvement in her symptoms and fluid status by discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and alert, with improved fluid balance. She requires home health services for ongoing hemodialysis management, medication administration, and dietary adjustments. The patient has been educated on signs of fluid overload and when to seek medical attention, promoting her independence in managing her condition at home.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Calcitriol  \\n3. Calcium Carbonate  \\n4. Epoetin Alfa  \\n5. Ferrous Sulfate  \\n6. Metoprolol Succinate XL  \\n7. Heparin (for hemodialysis)  \\n8. Lorazepam  \\n9. Nephrocaps  \\n10. Polyethylene Glycol  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her nephrologist within one week of discharge for continued management of her renal disease and adjustments to her treatment plan as necessary. Home health nursing services will be initiated to assist with her ongoing care.',\n",
       " '**Patient Information**: 23-year-old female admitted for observation due to severe left shoulder pain attributed to other specified joint disorders (ICD-10: M25812). She has a history of depression, anxiety, and nicotine dependence, complicating her clinical picture.\\n\\n**History of Present Illness**: The patient presented with complaints of debilitating left shoulder pain that has been progressively worsening over the past month. The pain was exacerbated by movement and was associated with muscle weakness and limited range of motion. Additionally, she reported feelings of anxiety and depressive symptoms, which have been ongoing and could impact her recovery.\\n\\n**Hospital Course**: During her 2.3-day observation stay, the patient underwent a comprehensive evaluation, including physical examinations and imaging studies that confirmed the diagnosis of other specified joint disorders of the left shoulder. The patient was treated with a multimodal approach, including analgesics (Ibuprofen, Acetaminophen, and Tramadol) for pain management, muscle relaxants (Cyclobenzaprine), and neuropathic pain medication (Gabapentin). She also received supportive care for her mental health issues, including Doxepin HCl for depressive symptoms and anxiety management. \\n\\n**Key Findings and Procedures**: Key findings included significant pain on palpation of the left shoulder and limited mobility due to joint discomfort. No surgical interventions were performed, but the patient was educated on home exercises to improve her shoulder function.\\n\\n**Discharge Condition and Functional Status**: The patient demonstrated improvement in pain control and was able to participate in basic activities of daily living with assistance. Given her ongoing issues with joint pain and mental health, she will benefit from home health services for physical therapy and mental health support.\\n\\n**Medications and Follow-Up Plan**: Upon discharge, the patient is prescribed Acetaminophen, Calcium Acetate, Cyclobenzaprine, Doxepin HCl, Gabapentin, Heparin, Ibuprofen, Lidocaine 5% Patch, Topiramate, and TraMADol. She is advised to follow up with her primary care physician within one week and will have home health services initiated to assist with her rehabilitation and mental health management.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 91 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.1 days  \\n**Primary Diagnosis:** Hypertensive heart and chronic kidney disease with heart failure (ICD-10: I130)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of acute on chronic systolic heart failure, exacerbated by chronic kidney disease (CKD) and poorly controlled hypertension. He presented with dyspnea on exertion and edema. The patient's medical history is significant for stage 3 CKD, type 2 diabetes mellitus, and paroxysmal atrial fibrillation.\\n\\n**Hospital Course:**  \\nDuring his stay, the patient received diuretics for fluid overload and was closely monitored for heart failure management. Renal function was assessed, and adjustments were made to his antihypertensive regimen. He was stabilized on Furosemide and Lisinopril, and his heart rate was controlled with Amiodarone. A comprehensive geriatric assessment was performed, revealing functional dependence in activities of daily living (ADLs).  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure readings, persistent fluid overload, and acute kidney injury which improved with treatment. The patient underwent echocardiogram which demonstrated reduced ejection fraction consistent with heart failure. He was educated about self-monitoring of weight and symptoms of fluid retention, and the importance of adhering to medications.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with daily living activities and ambulation. Home health services are recommended for skilled nursing care to monitor his heart failure management and medication compliance. Physical therapy will also be beneficial for mobility improvement and fall prevention.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Allopurinol  \\n- Amiodarone  \\n- Apixaban  \\n- Aspirin  \\n- Atorvastatin  \\n- Furosemide  \\n- Lisinopril  \\n- Magnesium Oxide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and to report any signs of worsening heart failure or renal issues. Home health will initiate services for ongoing assessment and support.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 84  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 14.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is an 84-year-old female who presented with a contusion of the right front wall of the thorax following a fall. She has a history of chronic pulmonary embolism, diastolic heart failure, and chronic obstructive pulmonary disease.  \\n  \\n**Hospital Course:**  \\nDuring her 15-day hospital stay, the patient was monitored closely for respiratory distress and cardiac function. Her management included diuretics for heart failure exacerbation, anticoagulation therapy with Apixaban for her pulmonary embolism, and supportive care for pain control. The patient demonstrated gradual improvement in her respiratory status and was able to mobilize with assistance.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated B-type natriuretic peptide (BNP) levels, indicating congestive heart failure. Imaging studies confirmed the contusion but showed no acute pulmonary pathology. The patient received physical therapy to enhance mobility and strength, and she was assessed for home health services prior to discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but continues to experience mild dyspnea on exertion. She requires assistance with activities of daily living (ADLs) such as bathing and dressing. Home health services will be necessary to provide skilled nursing care, physical therapy, and monitoring of her medication regimen.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apixaban  \\n3. Atorvastatin  \\n4. Diltiazem  \\n5. Fluticasone-Salmeterol Diskus (250/50)  \\n6. Ipratropium-Albuterol Nebulizer  \\n7. Ondansetron  \\n8. OxyCODONE (Immediate Release)  \\n9. Pantoprazole  \\n10. Potassium Chloride  \\n11. Ramelteon  \\n12. Senna  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and is advised to schedule a cardiology appointment for ongoing management of her heart failure. Home health services will be contacted to initiate care immediately post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 66  \\nGender: Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 1.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 66-year-old female with a diagnosis of malignant neoplasm of the thyroid gland (ICD-10: C73) who was admitted for a total thyroidectomy. She has a significant past medical history including paroxysmal atrial fibrillation, essential hypertension, type 2 diabetes mellitus, and gastro-esophageal reflux disease.  \\n  \\n**Hospital Course:**  \\nThe patient underwent surgery without complications. Postoperatively, she was closely monitored in the recovery unit and subsequently transitioned to the inpatient ward. She experienced mild pain controlled with oral acetaminophen and oxycodone. Her blood glucose levels were stable, and she was administered dextrose and insulin as needed.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s surgical site was clean and dry upon inspection, with no signs of infection. Laboratory tests showed stable metabolic parameters. The procedure performed was a total thyroidectomy (ICD-10: 07B20ZX).  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with no acute complaints. She is ambulatory and able to perform activities of daily living (ADLs) with minimal assistance. Home health services are recommended for wound care monitoring and assistance with medication management, particularly regarding levothyroxine replacement therapy following thyroidectomy.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include:  \\n- Acetaminophen  \\n- Chlorthalidone  \\n- Dextrose 50%  \\n- Glucagon  \\n- Glucose Gel  \\n- Influenza Vaccine Quadrivalent  \\n- Insulin  \\n- Levothyroxine Sodium  \\n- Metoprolol Succinate XL  \\n- OxyCODONE (Immediate Release)  \\n- Potassium Chloride 20 mEq / 1000 mL D5 1/2 NS  \\n- Rosuvastatin Calcium  \\n- Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician in one week and with the endocrinology clinic for thyroid management. Home health services will be coordinated to ensure continuity of care.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 64  \\n**Gender:** Female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 4.2 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of pneumonia due to Methicillin-resistant Staphylococcus aureus (MRSA). She presented with dyspnea, fever, and a productive cough. A chest X-ray revealed consolidative changes consistent with pneumonia. The patient has a history of emphysema and dependence on supplemental oxygen.  \\n  \\n**Hospital Course:**  \\nDuring her 4-day stay, the patient was treated with intravenous antibiotics, including Cefpodoxime and Doxycycline, and supportive care. Her respiratory status improved significantly with bronchodilator therapy (Albuterol) and supplemental oxygen. The patient's blood cultures confirmed MRSA, and she was transitioned to oral antibiotics prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included bilateral lung infiltrates on imaging and elevated inflammatory markers. The patient underwent a thorough respiratory assessment and was closely monitored for any signs of respiratory distress. She received bronchodilator treatments and was maintained on oxygen therapy.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory function with a decrease in dyspnea and improved oxygen saturation levels. She is stable but will require ongoing home health services for continued monitoring of her respiratory status and assistance with her daily activities due to her chronic respiratory condition. The patient has been educated on the use of her medications and the importance of follow-up care.  \\n  \\n**Medications at Discharge:**  \\n1. Albuterol Inhaler  \\n2. Cefpodoxime Proxetil  \\n3. Doxycycline Hyclate  \\n4. Clonazepam  \\n5. Ondansetron  \\n6. Mirtazapine  \\n7. Lansoprazole Oral Disintegrating Tab  \\n8. Oxycodone (Immediate Release) as needed for pain  \\n   \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for reassessment of her pulmonary status and medication management. Home health services will initiate visits to monitor her condition and provide respiratory therapy as needed.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 61  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n  \\n**History of Present Illness:**  \\nThe patient is a 61-year-old male with a history of severe persistent asthma presenting with an acute exacerbation. He reported increased shortness of breath, wheezing, and cough over the past week, requiring increased use of his rescue inhaler.  \\n  \\n**Hospital Course:**  \\nDuring a 4.9-day observation stay, the patient was treated with nebulized albuterol and ipratropium to manage bronchospasm, along with systemic corticosteroids (prednisone) to control inflammation. The patient's exacerbation was precipitated by recent viral upper respiratory infection, contributing to his acute presentation.  \\n  \\n**Key Findings and Procedures:**  \\nUpon admission, the patient demonstrated wheezing bilaterally, with a peak expiratory flow rate (PEFR) of 60% of predicted. Chest X-ray showed no acute infiltrates. Cardiac evaluation revealed unspecified atrial fibrillation but was deemed stable. The patient was also noted to have essential hypertension and hyperlipidemia, which were managed with appropriate medications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with improved respiratory function; PEFR increased to 85% of predicted. He is alert and oriented, able to perform activities of daily living with minimal assistance. Home health services are recommended for follow-up pulmonary rehabilitation and medication management. The patient also requires monitoring for his atrial fibrillation and hypertension.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue the following medications: Acetaminophen, Albuterol 0.083% Nebulizer Solution, Fluticasone-Salmeterol Diskus (250/50), Montelukast, Rivaroxaban, and others as per the discharge medication list.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with a pulmonologist within two weeks. Home health services will initiate within 48 hours post-discharge to ensure continuity of care.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n**Age:** 57  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 57-year-old male with a history of cirrhosis of the liver (ICD10 K7469) who was admitted for observation due to worsening abdominal distension and ascites. The patient has a complex medical history, including portal hypertension, diastolic heart failure, and chronic atrial fibrillation.  \\n\\n**Hospital Course:**  \\nDuring his 4.7-day stay, the patient underwent paracentesis, which yielded significant relief from ascitic pressure. He was monitored for signs of hepatic failure and renal function, with daily lab evaluations showing stable liver function tests and improving kidney parameters. The patient received albumin infusions to manage his hypoalbuminemia and was started on diuretics to control fluid retention. He was also treated with antibiotics for a urinary tract infection.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during the hospital stay included stable vital signs, improvement in abdominal distension post-paracentesis, and resolution of fever associated with urinary infection. Imaging studies revealed no new lesions in the liver.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for monitoring of fluid management and medication adherence. The patient is ambulating independently but fatigues easily, necessitating assistance with daily activities. He will require dietary modifications and regular follow-up with his primary care physician and a hepatologist.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Albumin 25%, Albuterol inhaler, Baclofen, and antibiotics (Ciprofloxacin HCl). The patient is advised to follow up in one week with his primary care provider and a liver specialist to assess liver function and manage ongoing cirrhosis-related issues. Home health services will provide nursing support for medication management and education on dietary restrictions.',\n",
       " \"**Discharge Summary**  \\n**Patient Name**: [Patient's Name]  \\n**MRN**: [Patient's MRN]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Age**: 65  \\n**Gender**: Male  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted directly from the emergency department with severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). He also presented with acute posthemorrhagic anemia, malnutrition, and a major depressive disorder with psychotic features. During the hospital stay, he required close monitoring and supportive care.  \\n  \\n**Hospital Course**:  \\nThe patient responded positively to fluid restriction and sodium supplementation. He was started on a regimen of Bumetanide for fluid management and received nutritional support to address his protein-calorie malnutrition. A psychiatric consultation was initiated to manage his mood disorder, and he was placed on BuPROPion XL with close follow-up planned. The patient was also treated for hypertension and hyperlipidemia with appropriate medications.  \\n  \\n**Key Findings and Procedures**:  \\nLaboratory investigations confirmed the diagnosis of SIADH with persistent low serum sodium levels. Imaging studies were unremarkable, and no surgical intervention was necessary. The patient underwent psychiatric evaluation and was stabilized on psychiatric medications. His functional status improved over the hospitalization period, and he was able to participate in physical therapy sessions.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt the time of discharge, the patient demonstrated significant improvement in his mental status and was ambulatory with assistance. He is stable for discharge but requires continued home health services for wound care, medication management, and monitoring of his psychiatric condition.  \\n  \\n**Medications at Discharge**:  \\n1. Acetaminophen  \\n2. Albuterol Inhaler  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. BuPROPion XL  \\n6. Bumetanide  \\n7. Clopidogrel  \\n8. Levothyroxine Sodium  \\n9. Gabapentin  \\n10. Haloperidol  \\n11. Hydroxyzine  \\n12. LORazepam  \\n13. Enoxaparin (Prophylaxis)  \\n  \\n**Follow-up Plan**:  \\nThe patient is advised to follow up with their primary care physician within one week of discharge and continue psychiatric care as scheduled. Home health services will be initiated to assist with monitoring and medication adherence.\",\n",
       " 'Patient is an 18-year-old female who was admitted under observation for 4.7 days with a diagnosis of infections of the kidney in pregnancy, specifically in the third trimester (ICD10: O2303). The patient presented with fever, flank pain, and dysuria. During the hospital course, she was diagnosed with acute pyelonephritis with associated respiratory complications including pneumonia and acute respiratory failure, necessitating close monitoring and supportive care.\\n\\nKey findings during the admission included elevated white blood cell count, positive urine culture for Klebsiella pneumoniae, and imaging consistent with renal infection. The patient was treated with intravenous antibiotics (Ceftriaxone and Cefepime), fluids, and supportive measures. She also received symptomatic treatment for pain and urinary discomfort with Phenazopyridine and Acetaminophen.\\n\\nThe patient demonstrated significant improvement in her clinical status, with resolution of fever and flank pain, normalization of renal function, and improved respiratory status. By the time of discharge, she was ambulating independently and required minimal assistance for activities of daily living. \\n\\nDischarge medications include Acetaminophen, Ceftriaxone, Cefepime, Diphenhydramine, Famotidine, Heparin, Prenatal Vitamins, and Phenazopyridine. The patient is advised to maintain hydration and adhere to her antibiotic regimen. A follow-up appointment with her obstetrician is scheduled within one week to monitor her recovery and manage her pregnancy. Home health services will provide nursing support for medication administration and assessment of her recovery, including monitoring her renal function and management of any complications as she transitions home.',\n",
       " \"**Patient Identifier:** Female, 67 years old  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.5 days  \\n**Primary Diagnosis:** Benign neoplasm of ascending colon (ICD10: D122)  \\n**Additional Diagnoses:** Essential hypertension (I10), Hyperlipidemia, unspecified (E785), Nicotine dependence, cigarettes, uncomplicated (F17210)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for a surgical procedure to excise a benign neoplasm of the ascending colon. She has a history of essential hypertension and hyperlipidemia, which have been managed with medications. The patient also has a history of nicotine dependence but is currently motivated to cease smoking.  \\n\\n**Hospital Course:**  \\nThe patient underwent an uneventful laparoscopic resection of the neoplasm. Postoperatively, she was monitored in the surgical unit for 24 hours, where she demonstrated stable vital signs and adequate pain control. She received acetaminophen and hydromorphone for postoperative pain management and was transitioned to oral medications. The patient was educated on pain management and postoperative care, including signs of infection.  \\n\\n**Key Findings and Procedures:**  \\nDuring the surgical procedure, the neoplasm was excised without complications, and pathology confirmed the benign nature of the lesion. The patient’s postoperative course was unremarkable, with no evidence of bleeding or infection.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulatory, and independent in activities of daily living. She is advised to follow up with her primary care physician and surgeon within one week post-discharge. Home health services will be initiated to assist with medication management, monitor her recovery, and provide education on lifestyle modifications to support her hypertension and hyperlipidemia management.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atorvastatin  \\n3. Hydromorphone (Dilaudid)  \\n4. Heparin  \\n5. Influenza Vaccine Quadrivalent  \\n6. Ketorolac  \\n7. Lactated Ringer's  \\n8. Lisinopril  \\n9. Metoclopramide  \\n10. Oxycodone (Immediate Release)  \\n11. Pneumococcal 23-valent polysaccharide vaccine  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care provider for hypertension and hyperlipidemia management and with her surgeon for surgical follow-up. Home health services will monitor her recovery and assist with medication adherence.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 52, Gender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to chest pain and elevated troponin levels, consistent with a non-ST elevation myocardial infarction (NSTEMI). She presented with a history of hypertension, chronic kidney disease (stage unspecified), generalized anxiety disorder, and fibromyalgia, which complicated her clinical picture.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient received supportive care, including intravenous fluids and medications for pain management and anticoagulation. She was monitored for any signs of deterioration, particularly concerning her cardiac status and renal function. The patient's symptoms improved, and she remained stable throughout her stay.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated cardiac biomarkers and mild renal impairment without acute kidney injury. An echocardiogram indicated preserved left ventricular function. The patient received dual antiplatelet therapy with aspirin and clopidogrel, and her blood pressure was controlled with labetalol.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently, and demonstrates adequate understanding of her medication regimen. She will benefit from home health services to assist with medication management and monitoring of her cardiac status. A follow-up appointment with her cardiologist is recommended within one week of discharge to assess her recovery and adjust her treatment plan as necessary.  \\n  \\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Clopidogrel  \\n3. Atorvastatin  \\n4. Calcitriol  \\n5. Labetalol  \\n6. Heparin Sodium (as per protocol)  \\n7. Acetaminophen as needed for pain  \\n8. Docusate Sodium for bowel management  \\n  \\nThe patient is advised to maintain a low-sodium diet and monitor her weight daily, reporting any significant changes to her healthcare provider. Home health nursing will assist with medication reconciliation and education to ensure adherence to the prescribed treatment plan.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 66  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to episodes of chest pain, classified under ICD-10 code R0789 (Other chest pain). On presentation, she reported intermittent chest discomfort, which was non-radiating and relieved with rest. The patient has a significant past medical history including congestive heart failure, atrial fibrillation, and hypertension.  \\n  \\n**Hospital Course:**  \\nDuring her 4-day hospitalization, the patient underwent comprehensive evaluations including cardiac monitoring, laboratory tests, and imaging studies. She was diagnosed with acute on chronic systolic heart failure exacerbation (ICD-10 I5023) and was managed with diuretics, fluid management, and medication adjustments.  \\n  \\n**Key Findings and Procedures:**  \\nThe echocardiogram indicated reduced ejection fraction consistent with her heart failure diagnosis. She received a total of four blood transfusions due to pancytopenia (ICD-10 D61818), with subsequent improvement in her blood counts. Additionally, she was educated about her condition, medication adherence, and the importance of regular follow-ups.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved symptoms and no acute chest pain. She demonstrated the ability to perform activities of daily living with minimal assistance but requires home health services for ongoing monitoring of her heart failure management, medication administration, and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Apixaban  \\n- Aspirin  \\n- Atorvastatin  \\n- Carvedilol  \\n- Docusate Sodium  \\n- Furosemide  \\n- Lisinopril  \\n- Losartan Potassium  \\n- Spironolactone  \\n- Magnesium Oxide  \\n- Polyethylene Glycol  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Influenza Vaccine Quadrivalent  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her primary care physician within one week and a cardiology appointment within two weeks post-discharge. Home health services will initiate upon discharge to assist with medication management and monitoring her heart failure symptoms.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 58  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute pulmonary edema secondary to myocardial infarction type 2. He reported worsening dyspnea, orthopnea, and bilateral lower extremity edema over the past week.  \\n  \\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient was stabilized with diuretics (Furosemide) and supportive measures. He received treatment for pneumonia with Ceftriaxone and Azithromycin. Cardiac monitoring was initiated due to his history of hypertension and acute respiratory failure with hypoxia. The patient was closely monitored and exhibited gradual improvement in respiratory function and heart failure symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nOn admission, the patient had elevated blood pressure (hypertensive urgency) and signs of respiratory distress. Chest X-ray revealed bilateral pulmonary infiltrates consistent with pulmonary edema. He underwent diuresis with Furosemide, which successfully reduced fluid overload. He was also started on Carvedilol for heart failure management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improved respiratory status and resolution of edema. He is able to perform activities of daily living with minimal assistance and is ambulating independently. Home health services are recommended for continued monitoring of vital signs, medication management, and assistance with activities as he recovers.  \\n  \\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- 5% Dextrose  \\n- Aspirin  \\n- Atorvastatin  \\n- Carvedilol  \\n- Furosemide  \\n- Calcium Gluconate  \\n- Diazepam (CIWA protocol)  \\n- Ferrous Sulfate  \\n- Folic Acid  \\n- Dextrose 50%  \\nFollow-up appointments are scheduled with cardiology within one week, and the patient is advised to monitor weight and symptoms of fluid overload at home. Home health services will provide additional support as needed.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 77  \\n**Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 22 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with signs of acute infection and inflammatory reaction due to cardiac devices, specifically an implantable cardioverter-defibrillator (ICD). Initial evaluation revealed symptoms of fever, malaise, and tachycardia, consistent with systemic infection. \\n\\n**Hospital Course:**  \\nDuring the hospitalization, the patient was managed for multiple complications, including acute on chronic systolic heart failure and acute infective endocarditis. He underwent several diagnostic procedures including blood cultures, echocardiography, and imaging studies. The patient received broad-spectrum intravenous antibiotics (Cefepime) and supportive care, including diuretics (Furosemide) for heart failure management. He responded well to treatment, with gradual resolution of fever and improvement in hemodynamic parameters.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent leukocytosis and elevated inflammatory markers. The patient underwent a cardiac ultrasound, which confirmed moderate left ventricular dysfunction, and echocardiography revealed vegetations on the mitral valve. He was also evaluated for acute pancreatitis, which was ruled out. Interventional cardiology was consulted, and he underwent a successful device revision.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated significant improvement in clinical status with stable vital signs and reduced symptoms. He is ambulating independently and requires assistance with activities of daily living (ADLs) due to fatigue. Home health services will be necessary to support medication management and monitoring of cardiac function post-discharge.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Amiodarone, Apixaban, Aspirin EC, Atorvastatin, and Furosemide. The patient is advised to follow up with cardiology in one week for reevaluation and management of heart failure. Home health services will assist with medication adherence and monitoring of vital signs. A referral to physical therapy is also recommended to enhance mobility and strength.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Age:** 28  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with severe alcohol dependence complicated by withdrawal symptoms. He presented with diaphoresis, tremors, and anxiety, necessitating observation and management of his withdrawal. His history included significant psychosocial stressors, including a personal history of physical and sexual abuse, PTSD, and homelessness, which complicated his clinical picture.\\n\\n**Hospital Course:**  \\nDuring the 4-day stay, the patient was monitored closely for withdrawal symptoms and received a tapering schedule of Phenobarbital starting from Day 2 through Day 7. Supportive care was provided, including hydration with 0.9% Sodium Chloride, and nutritional support with multivitamins and thiamine to prevent Wernicke's encephalopathy. The patient also received pharmacologic management for anxiety with Prazosin and symptomatic relief with Phenazopyridine for urinary discomfort.\\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated liver enzymes consistent with alcoholic fatty liver disease (K700). An upper GI evaluation indicated other specified diseases of the esophagus (K228). The patient's mental health was assessed, and he was diagnosed with PTSD (F4310). He was stabilized and educated on the importance of abstinence from alcohol and engaging in outpatient therapy for his psychological issues.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required ongoing support, particularly in managing his alcohol dependence and associated psychosocial issues. He demonstrated an understanding of his discharge medications and a commitment to follow up with home health services for continued support and monitoring of his progress. Recommendations for home health include regular visits to assess his mental health, ensure medication adherence, and provide psychosocial support.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient was discharged on the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Folic Acid  \\n- Heparin  \\n- Multivitamins  \\n- Phenobarbital taper (Days 2-7)  \\n- Phenazopyridine  \\n- Prazosin  \\n- Thiamine  \\n\\nA follow-up appointment with an outpatient addiction specialist is recommended within one week of discharge to establish a comprehensive recovery plan.\",\n",
       " \"**Patient Information**: 29-year-old female admitted for observation with a primary diagnosis of hypertensive emergency (ICD10 I161). The patient has a significant past medical history including end-stage renal disease, type 2 diabetes mellitus with multiple complications, and mild cognitive impairment.\\n\\n**History of Present Illness**: The patient presented to the emergency department with severely elevated blood pressure and symptoms consistent with hypertensive emergency. Initial management included intravenous antihypertensives and monitoring of renal function and neurological status.\\n\\n**Hospital Course**: During the 3.6-day observation period, the patient's blood pressure was stabilized with labetalol and hydralazine. Renal function was closely monitored, and she received supportive care for her diabetes management, including insulin and glucose monitoring. The multidisciplinary team, including nephrology and endocrinology, was involved in her care due to her complex medical history. The patient was educated on the importance of blood pressure control and diabetes management.\\n\\n**Key Findings and Procedures**: Key findings included lab tests revealing elevated creatinine consistent with her end-stage renal disease and unstable blood glucose levels. No surgical interventions were necessary during her stay. The patient underwent continuous monitoring for vital signs and neurological checks, which remained stable by discharge.\\n\\n**Discharge Condition and Functional Status**: The patient is discharged in stable condition. She is alert and oriented, exhibiting mild cognitive impairment that will require ongoing support at home. The home health team will monitor her blood pressure and blood glucose levels, educate her on medication adherence, and assist with activities of daily living as needed.\\n\\n**Medications and Follow-Up Plan**: At discharge, the patient was prescribed a regimen including chlorthalidone for hypertension, insulin for diabetes management, and albuterol for any respiratory issues. She is advised to follow up with her primary care physician and nephrologist within one week. Home health services will initiate visits to ensure compliance with the treatment plan and support her transition home.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Admit Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 66-year-old male who presented to the emergency department with complaints of skin lesions and malaise. Initial investigations indicated a diagnosis of other vasculitis limited to the skin (ICD10: L958). The patient has a history of portal vein thrombosis and chronic kidney disease, which complicated his clinical picture.  \\n  \\n**Hospital Course:**  \\nDuring the 4.9-day hospital stay, the patient was closely monitored and managed with a combination of corticosteroids and supportive care. Renal function was monitored, and he was treated for acute kidney failure with tubular necrosis (ICD10: N170). The patient also experienced secondary esophageal varices due to portal hypertension (ICD10: K766), requiring a multidisciplinary approach for management.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine levels and proteinuria. The patient underwent abdominal ultrasound to assess liver status and portal circulation. No invasive procedures were required during this admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved skin lesions and manageable renal parameters. He requires home health services for ongoing monitoring of renal function and assistance with medication management, particularly for his chronic kidney disease and vasculitis. The patient has been instructed on a low-sodium diet and the importance of hydration to support kidney health.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Cetirizine, Docusate Sodium, Folic Acid, Heparin, Lorazepam, Levothyroxine Sodium, Oxycodone (Immediate Release), Senna, Sodium Chloride 0.9% Flush, Tamsulosin, and Thiamine.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up in the outpatient clinic within one week. Home health services will be in place to assist with medication administration and monitor his overall health status.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Male, 51 years old  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 2.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of major depressive disorder (ICD-10: F329) characterized by significant depressive symptoms and suicidal ideations. The onset of these symptoms was acute, coinciding with increased psychosocial stressors. The patient also reported chronic pain issues, including dorsalgia and other pain syndromes, which were exacerbated during the hospitalization.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was closely monitored and underwent psychiatric evaluation. A comprehensive pharmacotherapy regimen was initiated, including the use of Olanzapine and Venlafaxine XR to address depressive symptoms and suicidal ideation. Gabapentin was administered for pain management, and appropriate bowel regimen was established with Lactulose and Bisacodyl due to opioid-induced constipation. The patient was also started on Apixaban for anticoagulation management given his history of pulmonary embolism.  \\n  \\n**Key Findings and Procedures:**  \\nPsychiatric assessment confirmed the diagnosis of major depressive disorder. Pain management was optimized, and the patient demonstrated improvement in mood and reduction in suicidal thoughts by discharge. No significant adverse effects from medications were noted.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved mood and reduced pain levels. He is able to perform activities of daily living with some assistance and will require ongoing support from home health services for medication management and mental health monitoring. A follow-up with outpatient psychiatry is vital to ensure continuity of care and support for his mental health needs.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include: Apixaban, Gabapentin, Ibuprofen, Lorazepam, Lactulose, Olanzapine (Disintegrating Tablet), Omeprazole, Oxycodone-Acetaminophen, Polyethylene Glycol, Quetiapine Fumarate, Ramelteon, Senna, Trazodone, and Venlafaxine XR.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his psychiatrist within one week and to engage with home health services for medication management and psychosocial support.',\n",
       " \"**Discharge Summary**\\n\\n**Patient Information:** 36-year-old male admitted for observation due to complications related to Type 1 diabetes mellitus with diabetic chronic kidney disease (ICD-10: E1022). \\n\\n**History of Present Illness:** The patient presented with poorly controlled blood glucose levels, resulting in significant fluctuations and subsequent hospitalization. He also has a history of end-stage renal disease (N186) requiring dialysis, which contributed to his complex management during the stay.\\n\\n**Hospital Course:** The patient was admitted for a total of 10.8 days where he underwent extensive monitoring and management of his diabetes and renal condition. Throughout his stay, he received intravenous fluids, including 0.9% Sodium Chloride and 5% Dextrose, to stabilize his electrolyte levels. He was treated with a variety of medications, including CARVedilol for hypertension, Ganciclovir for suspected viral infection, and HYDROmorphone for pain management. The patient's blood glucose and renal function were closely monitored, and he underwent daily assessments by the nephrology team.\\n\\n**Key Findings and Procedures:** Key findings included persistent hyperglycemia and signs of diabetic chronic kidney disease. The patient received dialysis during his hospital stay due to worsening renal function. He was also evaluated for potential organ transplant options due to his end-stage renal disease status. \\n\\n**Discharge Condition and Functional Status:** Upon discharge, the patient was stable but remained dependent on dialysis and required ongoing management for his diabetes. He demonstrated the ability to perform basic self-care activities; however, he will benefit from home health services for medication management, dietary education, and ongoing glucose monitoring. \\n\\n**Medications at Discharge:** The patient is to continue the following medications: 0.9% Sodium Chloride, 5% Dextrose, acetaminophen, CARVedilol, cephalosporins, and others as indicated. \\n\\n**Follow-Up Plan:** Follow-up appointments with nephrology and endocrinology are scheduled within one week post-discharge. Home health nursing will be initiated to assist with his diabetes management and ensure compliance with his renal dietary restrictions.\",\n",
       " '**Discharge Summary**  \\n**Patient Identifier**: 86-year-old female  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 2 days  \\n\\n**History of Present Illness**: The patient was admitted for evaluation of progressive dysarthria and anarthria, which had worsened over the past week. She has a history of several comorbidities including unspecified diastolic heart failure, atrial fibrillation, and hypertension. She presented with difficulty in speech and swallowing, raising concerns for potential neurological involvement.  \\n\\n**Hospital Course**: During her stay, the patient underwent a thorough evaluation, including neurological assessment and imaging studies, which ruled out acute cerebrovascular accident. Her dysarthria was attributed to underlying cardiac and neurological factors. The patient was monitored closely for her heart failure symptoms, and her medication regimen was adjusted to optimize heart function.  \\n\\n**Key Findings and Procedures**: Key findings included stable vital signs and improved ability to communicate with speech therapy interventions. The patient received nutritional support, including dextrose and vitamin supplementation, due to her deficiency in B group vitamins. She was also started on a regimen of antithrombotic medication for her atrial fibrillation.  \\n\\n**Discharge Condition and Functional Status**: At the time of discharge, the patient demonstrated improved speech clarity but continued to require assistance for daily activities due to her dysarthria. Home health services are recommended to assist with speech therapy and monitor her cardiac status. The patient is ambulating with minimal assistance and is oriented to person, place, and time.  \\n\\n**Medications and Follow-Up Plan**: The discharge medications include Acetaminophen, Apixaban, Atenolol, Bisacodyl, Cyanocobalamin, and others tailored to her needs. A follow-up appointment is scheduled with her primary care physician within one week to assess her ongoing treatment and rehabilitation needs. Home health services will initiate within 48 hours post-discharge to ensure continuity of care.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient Name:** [Patient Name]  \\n- **Gender:** Female  \\n- **Age:** 70  \\n \\n**History of Present Illness:**  \\nThe patient is a 70-year-old female who presented with symptoms consistent with arthropod-borne viral fever, specifically diagnosed as A938. She reported fever, malaise, and joint pain over the past week. Additionally, she had a history of contact with a suspected COVID-19 case, prompting further evaluation for any viral co-infections.  \\n \\n**Hospital Course:**  \\nDuring her 3.8-day observation admission, the patient was closely monitored for signs of viral infection as well as potential complications related to her existing conditions, including the presence of a left artificial knee joint. Initial laboratory tests indicated mild hyponatremia and bandemia, which were addressed with appropriate fluid management and antibiotic therapy.  \\n \\n**Key Findings and Procedures:**  \\n- Vital signs stabilized with supportive care.  \\n- Laboratory results showed improvement in electrolyte levels upon discharge.  \\n- The patient remained afebrile with no signs of acute distress at discharge.  \\n \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented, able to perform activities of daily living with minimal assistance. She was advised to engage in gentle range-of-motion exercises for her knee joint to facilitate recovery. The patient will benefit from home health services to assist with ongoing monitoring of her hydration status and to help with her mobility needs, given her recent joint surgery and history of hypo-osmolality.  \\n \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Doxycycline Hyclate  \\n3. Enoxaparin (Prophylaxis)  \\n4. Senna  \\n5. Sodium Chloride 0.9% (for hydration)  \\n6. Sodium Chloride 0.9% Flush  \\n \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with her primary care physician to reassess her hydration status and overall recovery. Home health services will initiate contact within 24 hours post-discharge to set up a plan for nursing visits.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 25 years  \\n- **Gender:** Female  \\n- **Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient is a 25-year-old female admitted with a post-term pregnancy (41 weeks gestation) complicated by chorioamnionitis and meconium-stained amniotic fluid. The patient presented with signs of labor and was noted to have an abnormal fetal heart rate pattern.  \\n\\n**Hospital Course:**  \\nDuring her 5.8-day hospital stay, the patient was monitored closely. Labor was induced with oxytocin, and she received supportive care including intravenous fluids (Lactated Ringer’s and 0.9% Sodium Chloride), analgesics (Acetaminophen and Ibuprofen), and antiemetics (Ondansetron). The patient underwent a successful vaginal delivery of a single live birth. Post-delivery, she was treated for anemia and was started on Enoxaparin Sodium as a prophylactic measure. The patient was discharged in stable condition, having demonstrated effective pain management and the ability to ambulate independently.  \\n\\n**Key Findings and Procedures:**  \\n- Normal delivery of a healthy infant  \\n- Management of chorioamnionitis  \\n- Monitoring and resolution of abnormal fetal heart rate  \\n- Administration of antibiotics due to Streptococcus B carrier status  \\n- Postpartum management included monitoring for secondary uterine inertia  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with no immediate complications. She has shown adequate understanding of postpartum care and newborn management. She requires assistance with activities of daily living for the first few days at home, particularly regarding infant care and self-care routines.  \\n\\n**Medications at Discharge:**  \\n- Oxycodone (Immediate Release) for pain management  \\n- Docusate Sodium and Milk of Magnesia for constipation  \\n- Enoxaparin Sodium for thromboprophylaxis  \\n- Naloxone for safety  \\n- Follow-up with obstetrics within one week is recommended, and home health services will assist with postpartum assessments and education.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Date of Admission**: [Date]  \\n**Date of Discharge**: [Date]  \\n**Age**: 88  \\n**Gender**: Female  \\n\\n**History of Present Illness**:  \\nThe patient is an 88-year-old female with a history of unspecified liver disease, as per ICD-10 code K769. She was admitted for observation due to gastrointestinal symptoms, including abdominal pain and fatigue. The patient has a complex medical history, including atrial fibrillation, hypertension, and hypothyroidism.  \\n\\n**Hospital Course**:  \\nDuring her brief stay (0.4 days), the patient was monitored for signs of liver dysfunction and potential complications from her underlying conditions. Laboratory tests revealed elevated liver enzymes and bilirubin levels, consistent with her known liver disease. A cardiology consult was requested due to her history of atrial fibrillation; she was started on appropriate anticoagulation therapy.  \\n\\n**Key Findings and Procedures**:  \\nKey findings included elevated ALT/AST levels and mild abdominal tenderness. An echocardiogram ruled out significant cardiac abnormalities. The patient was stabilized with intravenous fluids and medications. A multidisciplinary approach was utilized to manage her complex comorbidities.  \\n\\n**Discharge Condition and Functional Status**:  \\nThe patient was discharged in stable condition, but she will require ongoing home health services for medication management and monitoring of her liver function and cardiovascular status. She is alert and oriented but may need assistance with daily activities due to her age and medical conditions.  \\n\\n**Medications**:  \\nAt discharge, the patient was prescribed the following medications: Aspirin, Isosorbide Mononitrate ER, Levothyroxine Sodium, Losartan Potassium, Omeprazole, Amlodipine, and Sodium Chloride 0.9% Flush.  \\n\\n**Follow-Up Plan**:  \\nThe patient is to follow up with her primary care physician within one week and with gastroenterology for liver management. Home health nursing services will be arranged to assist with medication administration and monitoring of vital signs.',\n",
       " \"**Discharge Summary**  \\n**Patient Information**: 84-year-old female  \\n**Admission Type**: Observation  \\n**Length of Stay**: 2.1 days  \\n**Primary Diagnosis**: Syndrome of inappropriate secretion of antidiuretic hormone (E222)  \\n  \\n**History of Present Illness**: The patient was admitted for evaluation of hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). This condition was associated with acute angle-closure glaucoma in the right eye, which has contributed to her overall visual impairment. The patient has a significant past medical history that includes hypertension, hyperlipidemia, and a personal history of nicotine dependence.  \\n  \\n**Hospital Course**: During her stay, the patient was closely monitored for electrolyte imbalances and received intravenous fluids to manage her hyponatremia. Ophthalmology was consulted for the glaucoma, and she was started on appropriate topical medications. The patient's condition stabilized with treatment, and her sodium levels improved. She underwent a series of diagnostic tests, including retinal imaging, which confirmed the diagnosis of central retinal artery occlusion in the right eye.  \\n  \\n**Key Findings and Procedures**: The patient demonstrated improvement in her serum sodium levels, and her ocular symptoms were managed with medications including Timolol and Brimonidine. She also received treatment with Prednisolone acetate for her ocular inflammation.  \\n  \\n**Discharge Condition and Functional Status**: At discharge, the patient was stable with improved electrolyte levels. She is able to perform her activities of daily living with minimal assistance; however, she requires home health services for medication management and monitoring of her ocular condition. The patient has a do-not-resuscitate order in place and is aware of her health status.  \\n  \\n**Medications at Discharge**: Medications prescribed upon discharge include Aspirin, Lisinopril, Amlodipine, Prednisone, and various ophthalmic solutions such as Latanoprost and Timolol.  \\n  \\n**Follow-Up Plan**: The patient is advised to follow up with her primary care physician within one week and to have an ophthalmology appointment scheduled to monitor her glaucoma and retinal condition.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Female, 51 years old  \\n**Admission Date:** [Insert Admission Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency ward with exacerbation of gastro-esophageal reflux disease (GERD) accompanied by esophagitis. She presented with severe retrosternal pain and dysphagia, which were worsened by lying supine. Initial evaluations indicated multiple chronic conditions, including a history of myocardial infarction and anxiety disorder, complicating her clinical picture.\\n\\n**Hospital Course:**  \\nDuring her 6.6-day stay, the patient was managed with a multidisciplinary approach, including gastroenterology and cardiology consultations. The patient was started on proton pump inhibitors (Famotidine) and symptomatic management for her GERD, with improved tolerance to oral intake noted by day 4 of hospitalization. She received supportive care including hydration and analgesics (Acetaminophen). Additionally, psychiatric support was provided for her anxiety, and she was stabilized on Aripiprazole and BuPROPion.\\n\\n**Key Findings and Procedures:**  \\nEndoscopy revealed moderate esophagitis without stricture, and cardiac assessments indicated stable heart function with no acute events. The patient was monitored for complications related to her history of cardiomyopathy and was advised on lifestyle modifications to manage her GERD and anxiety.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with significant improvement in her symptoms. She is ambulatory and able to perform activities of daily living with minimal assistance. Home health services are recommended to assist with medication management, continued monitoring of her anxiety levels, and dietary modifications for her GERD.\\n\\n**Medications at Discharge:**  \\n1. Aripiprazole  \\n2. Acetaminophen  \\n3. Albuterol Inhaler  \\n4. Aluminum-Magnesium Hydrox.-Simethicone  \\n5. Aspirin  \\n6. Atorvastatin  \\n7. Bisacodyl  \\n8. Famotidine  \\n9. Gabapentin  \\n10. HydrOXYzine  \\n11. LORazepam  \\n12. Lactulose  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with her primary care physician within 1 week. Home health nursing will facilitate medication education and provide dietary counseling. A follow-up appointment with gastroenterology is advised in 4 weeks to monitor her GERD management.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Date of Birth]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is an 84-year-old female who was admitted for observation due to mechanical complications related to her internal prosthetic devices. During her stay, she developed acute respiratory failure with hypoxia, necessitating further evaluation and management. The patient has a complex history of chronic diastolic heart failure, chronic kidney disease, and unspecified dementia, which complicated her clinical course.\\n  \\n**Hospital Course:**  \\nThroughout her 6.9-day stay, the patient was monitored and treated for her respiratory failure, receiving supplemental oxygen and diuretics. She underwent a thoracentesis to manage pleural effusion, which provided significant symptomatic relief. The patient was also evaluated by cardiology, and her medications were adjusted to ensure optimal management of her heart failure and renal function.\\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent pleural effusion and acute respiratory distress. The thoracentesis revealed a transudative effusion, with no evidence of infection. The patient was educated on the importance of medication adherence and lifestyle modifications to manage her chronic conditions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved respiratory status and manageable heart failure symptoms. She requires home health services for ongoing monitoring of her vital signs and medication management, as well as assistance with activities of daily living due to her dementia. \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Amoxicillin-Clavulanic Acid, Apixaban, Atorvastatin, Calcium Carbonate, Docusate Sodium, Escitalopram Oxalate, Levothyroxine Sodium, Lidocaine 5% Patch, Losartan Potassium, OxyCODONE, Polyethylene Glycol, Ramelteon, Senna, and Sodium Chloride 0.9% Flush. A follow-up appointment with her primary care physician is scheduled in one week to monitor her progress and adjust medications as necessary. Home health services will initiate within 48 hours for comprehensive care support.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 67  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.4 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of sepsis secondary to Escherichia coli infection, with clinical features consistent with a urinary tract infection. The patient presented with fever, dysuria, and increased urinary frequency, leading to a workup revealing significant bacteriuria.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was treated with intravenous antibiotics including CefTAZidime, and subsequently transitioned to oral Cefpodoxime Proxetil. Supportive care was provided, including hydration with normal saline and administration of Acetaminophen for fever management. The patient's renal function was monitored closely due to underlying benign prostatic hyperplasia and urinary obstruction, which were addressed with Tamsulosin. The patient was also started on Finasteride as part of his management plan for BPH.  \\n  \\n**Key Findings and Procedures:**  \\nUrinalysis and urine culture confirmed E. coli as the causative organism. The patient’s vital signs stabilized, and laboratory results showed improvement in inflammatory markers, indicating a response to treatment. No invasive procedures were required during the admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was afebrile, hemodynamically stable, and exhibiting improved urinary symptoms. He is able to perform activities of daily living with minimal assistance. It is important for home health services to assist with medication management and monitor for any recurrence of urinary symptoms or signs of infection.  \\n  \\n**Medications and Follow-up Plan:**  \\nDischarge medications include Acetaminophen, Cefpodoxime Proxetil, Finasteride, Tamsulosin, Heparin, and Magnesium Sulfate for ongoing management. The patient is advised to follow up with his primary care physician within one week for further evaluation of his urinary symptoms and adjustment of medications as needed. It is also recommended to monitor for any side effects from the medications and ensure compliance with treatment.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Patient Name:** [Patient Name]  \\n**Age:** 69  \\n**Gender:** Male  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old male who presented for elective surgical intervention due to occlusion and stenosis of the left carotid artery (ICD10: I6522). He has a significant medical history including chronic kidney disease, type 2 diabetes, and a history of bladder malignancy. He is a former smoker, with a personal history of nicotine dependence.\\n\\n**Hospital Course:**  \\nThe patient underwent a successful carotid endarterectomy on day of admission, with no intraoperative complications. Postoperatively, he was closely monitored in the surgical unit for 48 hours, where he demonstrated stable vital signs and adequate neurological status. The patient experienced mild acute posthemorrhagic anemia (ICD10: D62), which was managed conservatively with fluid resuscitation and blood products. His diabetes was managed with insulin and dietary adjustments during his stay.\\n\\n**Key Findings and Procedures:**  \\nKey findings included stable neurologic examination and improvement in symptoms. The carotid duplex ultrasound post-procedure confirmed a patent left carotid artery. The patient was started on anticoagulation therapy with Clopidogrel and Aspirin to reduce the risk of thromboembolic events. \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient is stable and ambulatory, with improved strength and functional capacity. He will require home health services for medication management, monitoring of blood glucose levels, and assistance with activities of daily living due to mild weakness. \\n\\n**Medications and Follow-Up Plan:**  \\nThe discharge medications include Allopurinol, Aspirin, Atorvastatin, Clopidogrel, Lisinopril, and Insulin. He is advised to follow up with his primary care physician in one week and with the vascular surgery clinic in two weeks for further evaluation of his recovery. Home health services have been arranged to provide ongoing support and assessment.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**MRN:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 60  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 60-year-old female who was admitted through the emergency department with a diagnosis of pulmonary embolism (ICD-10 I26.99). She presented with acute shortness of breath, pleuritic chest pain, and elevated d-dimer levels. Given her history of obesity (BMI 40.0-44.9) and type 2 diabetes mellitus with chronic kidney disease, the decision was made to initiate anticoagulation therapy and further evaluate her condition.  \\n  \\n**Hospital Course:**  \\nThe patient was stabilized with intravenous heparin and transitioned to enoxaparin sodium. She underwent imaging studies that confirmed the diagnosis of pulmonary embolism without acute cor pulmonale. She was also found to have portal vein thrombosis and secondary malignant neoplasm of the liver, necessitating a multidisciplinary approach for comprehensive management. During her stay, the patient received supportive care, including pain management with acetaminophen and a medication regimen for her diabetes.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant improvement in respiratory function with supplemental oxygen, and she was able to ambulate with minimal assistance. Procedures included monitoring and adjustment of anticoagulation therapy.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved respiratory status. She is able to perform activities of daily living with some assistance and will require home health services for continued management of her anticoagulation therapy and monitoring of her chronic conditions. She has been advised to follow up with her primary care physician and hematologist.  \\n  \\n**Medications at Discharge:**  \\n1. Enoxaparin Sodium  \\n2. Aspirin  \\n3. Acetaminophen  \\n4. Escitalopram Oxalate  \\n5. Insulin as needed  \\n6. 5% Dextrose  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up in one week with her primary care physician and hematologist for ongoing evaluation of her anticoagulation therapy and overall health. Home health nursing services will be arranged to assist with medication management and monitoring.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 33  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to opioid abuse with withdrawal (ICD-10: F11.13). He presented with symptoms including agitation, anxiety, and diaphoresis. His history is significant for polysubstance use, including alcohol and tobacco. The patient also reported recent homelessness, contributing to his psychosocial stressors and complicating his recovery.\\n\\n**Hospital Course:**  \\nDuring the 4.8-day stay, the patient was monitored and treated for opioid withdrawal symptoms. He received a tapering regimen of methadone, along with adjunctive medications including clonidine for sympathetic overactivity and gabapentin for neuropathic pain. His treatment plan was adjusted based on daily assessments of withdrawal severity using the COWS scale. Additionally, the patient was treated for cellulitis of the right lower limb with cephalexin. Routine laboratory tests showed improvement in his pancytopenia, attributed to the cessation of alcohol use and nutritional support.\\n\\n**Key Findings and Procedures:**  \\nThe patient demonstrated gradual improvement in withdrawal symptoms and was able to engage in therapeutic interventions, including individual and group counseling. He participated in a multidisciplinary discharge planning meeting, which included social work for addressing his homelessness and mental health needs.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved mood and reduced withdrawal symptoms. He was ambulatory, although he requires assistance with activities of daily living due to ongoing opioid dependence and psychosocial challenges. Home health services have been arranged for medication management, daily check-ins, and continued counseling support.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: acetaminophen, buPROPion, diazepam, enoxaparin (for prophylaxis), fluoxetine, gabapentin, methadone, and a nicotine patch. He has been advised to follow up with outpatient addiction services within one week and to continue psychiatric care for his depressive symptoms. Home health services will provide medication supervision and support for his recovery process.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Birth:** [Patient's DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Attending Physician:** [Physician's Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old female who was admitted for surgical intervention due to congenital malformations of other endocrine glands (ICD-10: Q892). She has a significant medical history of dysphagia, essential hypertension, asthma, gastro-esophageal reflux disease, and a personal history of malignant melanoma of the skin.  \\n  \\n**Hospital Course:**  \\nThe patient underwent multiple procedures, including laparoscopic exploration and correction of endocrine malformations (ICD-10 procedures: 0NBX0ZZ, 0KX30ZZ, 0KX20ZZ, 0WB60ZZ, 0CJS8ZZ). Post-operatively, she was monitored in the surgical unit for complications such as bleeding, infection, or respiratory distress. The patient exhibited stable vital signs and improved respiratory function, with no signs of acute distress.  \\n  \\n**Key Findings and Procedures:**  \\nThroughout her hospital stay, the patient was treated for dysphagia and gastro-esophageal reflux, which responded to medication management. Key findings included stable blood pressure readings and control of her asthma symptoms. The patient received a course of intravenous antibiotics (Cefazolin and Amoxicillin-Clavulanic Acid) and was transitioned to oral medications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert and oriented, with a functional status allowing for independent mobility with assistance. She has been advised to engage with home health services for continued monitoring of her surgical site, management of her dysphagia, and assistance with medication compliance.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Albuterol Inhaler, Ondansetron, Oxycodone (Immediate Release), Enoxaparin Sodium, Fluticasone Propionate Nasal Spray, and Amlodipine. The patient is advised to follow up with her primary care physician in one week and to contact home health services for any concerns regarding her recovery.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Patient's MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 46  \\n**Gender:** Male  \\n  \\n**Brief History of Present Illness:**  \\nThe patient was admitted for observation with a primary diagnosis of D598 (other acquired hemolytic anemias) following complaints of fatigue, jaundice, and dark urine. He has a significant medical history of chronic kidney disease stage 4, acquired coagulation factor deficiency, and obesity (BMI 45.0-49.9).  \\n  \\n**Hospital Course:**  \\nDuring his 26-day stay, the patient experienced multiple complications including acute kidney failure and portal hypertension. His hemolytic anemia was managed with Epoetin alfa-epbx (Retacrit) and supportive measures. He also required treatment for bacterial osteomyelitis and was placed on a course of Daptomycin. Diuretic therapy with Bumetanide was initiated to manage fluid overload due to his chronic kidney disease.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included elevated creatinine and bilirubin levels, along with thrombocytopenia. Imaging studies revealed osteomyelitis of the lumbar vertebra. The patient underwent two significant procedures: a percutaneous catheter placement for dialysis access and a lumbar spine MRI to assess the extent of osteomyelitis.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrates stable vital signs and improved renal function, although he continues to experience fatigue. His functional status is limited; he requires assistance with activities of daily living (ADLs) and mobility due to weakness. Home health services have been arranged to provide nursing care, medication management, and physical therapy to facilitate his recovery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on the following medications post-discharge: 0.9% Sodium Chloride, Acetaminophen, Bumetanide, Citalopram, Daptomycin, Dextrose 10% in Water, Epoetin alfa-epbx, Folic Acid, Glucagon, and Lactulose. A follow-up appointment is scheduled with Hematology and Nephrology within one week of discharge. Home health will monitor his medication adherence and assist with ongoing assessments.\",\n",
       " '**Patient Information:**  \\n- Age: 73 years  \\n- Gender: Male  \\n- Admission Type: Observation Admit  \\n- Length of Stay: 5.9 days  \\n\\n**Chief Complaint:**  \\nThe patient presented with symptoms consistent with COVID-19, including fever, cough, and shortness of breath.  \\n\\n**History of Present Illness:**  \\nThe patient, a 73-year-old male, was admitted for observation due to worsening respiratory symptoms and confirmed COVID-19 (ICD10: U071). He has a relevant medical history notable for chronic preconditions such as hyperlipidemia, prediabetes, and a history of gout.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient received supportive care, including supplemental oxygen, bronchodilator therapy with Albuterol, and systemic corticosteroids (Dexamethasone). He was monitored for respiratory failure, evidenced by hypoxia (ICD10: J9601), but showed improvement in oxygenation and overall respiratory status with treatment. He received prophylactic anticoagulation with Enoxaparin.  \\n\\n**Key Findings and Procedures:**  \\nChest imaging confirmed the presence of viral pneumonia (ICD10: J1289), and lab work indicated mild hyperlipidemia (ICD10: E785) and vitamin D deficiency (ICD10: E559). The patient was treated with supportive measures, including hydration and symptomatic relief with medications such as Ondansetron for nausea and Benzonatate for cough.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function and oxygen saturation levels. He is ambulating independently but requires assistance with activities of daily living (ADLs) due to residual fatigue. Home health services are recommended for follow-up monitoring of his respiratory status and assistance with ADLs.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Benzonatate  \\n- Dexamethasone  \\n- Enoxaparin (Prophylaxis)  \\n- GuaiFENesin-Dextromethorphan  \\n- Ondansetron  \\n- Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and continue home health services for ongoing support. He should monitor symptoms and seek immediate care if respiratory distress worsens.',\n",
       " \"**Patient Information:** 55-year-old female admitted for observation with a primary diagnosis of white matter disease, unspecified (ICD-10 R9082). \\n\\n**History of Present Illness:** The patient presented with cognitive changes and mild gait instability. A thorough neurological evaluation was initiated given the possibility of underlying white matter pathology. She also has a history of chronic embolism and thrombosis of the left iliac vein, hypertension, and a personal history of pulmonary embolism.\\n\\n**Hospital Course:** During her 4.8-day stay, the patient underwent MRI imaging, which confirmed white matter disease. Laboratory tests revealed iron deficiency anemia. The patient was started on intravenous fluids and anticoagulation therapy with enoxaparin. Pain management was achieved with acetaminophen, and she received treatment for her constipation with polyethylene glycol and senna. The patient's cognitive function showed gradual improvement, and she was able to ambulate with minimal assistance by discharge. \\n\\n**Key Findings and Procedures:** The patient was monitored closely for signs of anticoagulation complications and neurological status. MRI findings were reviewed, and her hemoglobin levels stabilized after iron supplementation was initiated. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable, with improved cognitive clarity and ambulation. She will require continued home health services to assist with medication management, including ongoing anticoagulation therapy and monitoring for potential complications related to her white matter disease and history of embolism. The patient has been advised on fall precautions due to her prior gait instability.  \\n\\n**Medications and Follow-Up Plan:** Discharge medications include 5% Dextrose, Acetaminophen, Enoxaparin, Warfarin, and others. A follow-up appointment with her primary care physician and a hematologist is scheduled in one week to reassess her anemia and anticoagulation therapy. Home health nursing will initiate visits to monitor her condition and ensure compliance with the medication regimen.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n**Age/Gender:** 57/F  \\n  \\n**History of Present Illness:**  \\nThe patient is a 57-year-old female with a history of breast cancer, now presenting with secondary malignant neoplasm of the brain, as indicated by ICD-10 code C7931. She was admitted for observation with symptoms of confusion and altered mental status. She also has a history of spontaneous bacterial peritonitis and malignant ascites.  \\n  \\n**Hospital Course:**  \\nDuring her 6.8-day hospital stay, the patient was managed with supportive care and pharmacological interventions, including dexamethasone for cerebral edema, filgrastim for neutropenia, and insulin for hyperglycemia. She was closely monitored for any signs of infection due to her immunocompromised state. Her mental status improved gradually, but she remained dependent on assistance for daily activities.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included imaging studies confirming the presence of brain metastases. The patient underwent procedures for symptom management, including administration of dextrose 50% for hypoglycemia and management of ascites. Her lab results indicated persistent thrombocytopenia and hyperglycemia, necessitating ongoing adjustments in her medication regimen.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required assistance with activities of daily living (ADLs). She was referred to home health services for skilled nursing care and physical therapy to ensure safe transitions at home and to enhance her functional status. Multidisciplinary support will be crucial in addressing her nutritional needs and monitoring her medication compliance.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include acetaminophen, dexamethasone, escitalopram oxalate, and letrozole, along with supportive medications such as glucagon and insulin.  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with her oncologist within one week and is advised to maintain close contact with her home health team for ongoing assessment and medication management.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 59  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 59-year-old female who presented to the emergency department with complaints of generalized edema and fatigue. She has a known history of breast cancer with metastasis to the lungs, liver, and bones, which has contributed to her current condition. On admission, her vital signs were stable, but physical examination revealed significant bilateral lower extremity edema.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a comprehensive evaluation, including laboratory tests and imaging studies, to assess the extent of her edema and overall health status. Notable lab findings included elevated liver transaminases and indications of adult failure to thrive. The patient was started on diuretics and supportive care, including nutritional supplementation. She received anticoagulation therapy with enoxaparin for venous thromboembolism prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nImaging revealed secondary malignant neoplasms in the lungs and liver, alongside the presence of bone metastasis. A multidisciplinary team, including oncology and palliative care, was involved in her management. She tolerated the treatment well, with gradual improvement in her symptoms and edema.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved edema control and reported decreased fatigue. She is ambulating with assistance and requires continued support for daily activities. Home health services have been arranged to assist with mobility, medication management, and nutritional support to ensure continuity of care.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed the following medications: Acetaminophen, enoxaparin, levothyroxine, omeprazole, and oxycodone as needed for pain management. She is advised to follow up with her oncologist within one week and to have regular home health visits to monitor her condition and adjust care as necessary.',\n",
       " '**Patient Information:**  \\nAge: 81  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute diverticulitis (ICD10: K5792) without perforation or abscess. She presented with abdominal pain, nausea, and episodes of vomiting. Given her age and comorbidities, including chronic obstructive pulmonary disease (COPD) and obesity, a multidisciplinary approach was initiated.\\n\\n**Hospital Course:**  \\nDuring her 4-day stay, the patient received intravenous fluids and was started on antibiotics, including ciprofloxacin and metronidazole, due to suspected diverticulitis. Pain management was initiated with appropriate analgesics. The patient was closely monitored for any signs of complications, and her respiratory status was managed with bronchodilators and corticosteroids due to her pre-existing COPD.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies confirmed diverticulitis without complications. The patient demonstrated some improvement in her abdominal symptoms and was able to tolerate a clear liquid diet by the second day of admission. A review of her respiratory status showed stable oxygen saturation levels, and she was educated on the use of her albuterol inhaler.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved abdominal pain and respiratory function. She is ambulating independently but requires assistance with activities of daily living due to her age and physical status. Home health services are recommended to assist with monitoring her recovery from diverticulitis and to provide support for her COPD management.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications:  \\n- 5% Dextrose  \\n- Albuterol Inhaler  \\n- Bisacodyl  \\n- Ciprofloxacin HCl  \\n- Furosemide  \\n- Omeprazole  \\n- MetroNIDAZOLE  \\n\\nFollow-up appointments with her primary care physician and a gastroenterologist are advised within the next 1-2 weeks to ensure proper management of her diverticulitis and ongoing assessment of her COPD. Home health services will facilitate medication management, monitor her vital signs, and assist with her recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 22 years  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.9 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the hospital with severe abdominal pain and gastrointestinal symptoms complicating childbirth, specifically diagnosed with diseases of the digestive system (ICD10: O9962). The patient also has a history of Crohn's disease with fistula (ICD10: K50913), which contributed to her clinical presentation. She was in her third trimester and experienced complications during labor.\\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient was managed conservatively with IV fluids, antibiotics (Ampicillin and Clindamycin), and analgesics (Ibuprofen and Acetaminophen). She received supportive care for her Crohn's disease and was monitored for potential complications, including deep vein thrombosis and endometritis, both of which were ruled out. The patient's abdominal pain gradually improved, and her gastrointestinal symptoms stabilized.\\n\\n**Key Findings and Procedures:**  \\nKey findings during her stay included mild abdominal tenderness but no signs of acute distress. A thorough evaluation ruled out significant infection and thrombotic events. The patient underwent a procedure coded as 10D00Z1 (Postoperative care) to manage her abdominal issues effectively.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating independently, and capable of performing activities of daily living with minimal assistance. She requires continued monitoring for her Crohn's disease and gastrointestinal health. Home health services will assist her with medication management and monitoring her recovery post-discharge.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue on the following medications: 0.9% Sodium Chloride, Enoxaparin Sodium, and Docusate Sodium. She should follow up with her primary care provider and a gastroenterologist within one week post-discharge. Additional monitoring for any gastrointestinal changes is advised, and she should contact her physician if symptoms worsen.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 54, Gender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 12 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 54-year-old male with a history of hypertensive heart disease and chronic kidney disease, who presented with exacerbation of heart failure. He reported increasing shortness of breath and fatigue over the past week. Initial evaluation revealed elevated blood pressure and signs of fluid overload.  \\n  \\n**Hospital Course:**  \\nDuring his 12-day hospital stay, the patient was closely monitored and managed for acute on chronic diastolic heart failure, respiratory failure with hypercapnia, and chronic kidney disease. He received diuretics, which improved his fluid status, and was treated with bronchodilators for his COPD exacerbation. The patient underwent multiple diagnostic tests, including echocardiography, which confirmed reduced ejection fraction, and laboratory tests which showed stable renal function.  \\n  \\nKey procedures included optimization of his medication regimen and initiation of Apixaban to prevent thromboembolic events due to atrial flutter. The patient also received education on the importance of medication adherence and dietary modifications.  \\n  \\n**Key Findings:**  \\n- Improved respiratory function with the use of bronchodilators.  \\n- Stable renal function with no signs of acute kidney injury.  \\n- Effective management of heart failure symptoms with diuretics.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved functional status, ambulating independently with minimal assistance. He demonstrated understanding of his discharge medications and the importance of follow-up. Home health services will be initiated to provide ongoing nursing support, medication management, and physical therapy to ensure continued recovery and monitoring of his chronic conditions.  \\n  \\n**Medications at Discharge:**  \\n- Apixaban  \\n- Bumetanide  \\n- Atorvastatin  \\n- Albuterol Inhaler  \\n- Fluticasone Propionate NASAL  \\n- Acetaminophen  \\n- Additional supportive medications as needed.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and cardiologist within one week of discharge. Home health nursing will monitor vital signs, medication adherence, and assess for any signs of heart failure exacerbation.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 77-year-old male who presented to the emergency department with signs of infection following a recent surgical procedure. He exhibited fever, localized pain, and erythema in the left upper limb, which was attributed to cellulitis. A thorough evaluation confirmed an infection post-procedure (ICD10: T814XXA).  \\n  \\n**Hospital Course:**  \\nDuring his 3.8-day hospital stay, the patient was initiated on IV antibiotics, including Cefepime and Cephalexin, to manage the infection. His blood glucose levels were closely monitored due to a history of type 2 diabetes mellitus, and appropriate adjustments to his diabetes medication regimen were made. The patient was also treated for pain management with Hydromorphone and Gabapentin.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests showed elevated white blood cell counts and signs of infection. Imaging studies ruled out deeper infections. The patient received supportive care, including hydration with 0.9% Sodium Chloride and nutritional support with Dextrose. He was also administered the influenza vaccine as part of his preventive care.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient improved significantly with no signs of systemic infection at discharge. He is able to perform basic activities of daily living with some assistance due to weakness from the infection and surgical recovery. Home health services will be required for wound care, monitoring of diabetes management, and physical therapy to regain strength in the left upper limb.  \\n  \\n**Medications on Discharge:**  \\n- Cefepime  \\n- Cephalexin  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Gabapentin  \\n- GlyBURIDE  \\n- Docusate Sodium  \\n- HydrALAzine  \\n- Influenza Vaccine (administered)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge and to schedule a home health assessment prior to discharge to facilitate a smooth transition home.',\n",
       " '**Discharge Summary**  \\n**Patient:** 65-year-old male  \\n**Admission Type:** Elective  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of combined rheumatic disorders affecting the mitral, aortic, and tricuspid valves, associated with cardiogenic shock. He presented with shortness of breath, fatigue, and lower extremity edema. His past medical history includes atherosclerotic heart disease, essential hypertension, pulmonary hypertension, atrial fibrillation, hyperlipidemia, and type 2 diabetes mellitus without complications.\\n\\n**Hospital Course:**  \\nDuring his short stay, the patient was stabilized with diuretics (Furosemide, Torsemide) for fluid overload and initiated on Sacubitril-Valsartan for heart failure management. He underwent echocardiography revealing significant valvular dysfunction. The cardiology team was involved for comprehensive management of his cardiac condition.  \\n\\n**Key Findings and Procedures:**  \\nThe patient developed mild renal impairment likely secondary to volume overload which improved with diuretic therapy. Notable lab results included elevated BNP levels consistent with heart failure, and he was monitored closely in the cardiac unit. Discharge medications included Acetaminophen for pain management, Ezetimibe and Rosuvastatin for hyperlipidemia, and Omeprazole for gastrointestinal protection.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improved breathing and reduced edema. He remains partially dependent for activities of daily living (ADLs) and will require home health services for ongoing monitoring of vital signs, medication management, and assistance with daily activities. A follow-up appointment with cardiology is scheduled in one week.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include: Acetaminophen, Ezetimibe, Furosemide, Heparin, Omeprazole, Polyethylene Glycol, Potassium Chloride, Ramelteon, Rosuvastatin Calcium, Sacubitril-Valsartan (24mg-26mg), Senna, Sodium Chloride 0.9% Flush, and Torsemide. Home health services will initiate within 48 hours post-discharge for medication management and to assist with ADLs.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 55  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 55-year-old male admitted for surgical intervention due to severe spinal stenosis in the lumbosacral region, diagnosed with ICD-10 code M4807. He presented with significant lower back pain and neurological deficits, including intermittent radiating pain to the lower extremities.  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful laminectomy and decompression procedure (ICD-10: 0SG0071) on the day of admission. Post-operative recovery was uneventful. He was monitored closely for pain management and neurological status. Throughout his stay, he received appropriate medications including acetaminophen for pain control and anticoagulation for DVT prophylaxis.  \\n\\n**Key Findings and Procedures:**  \\nPreoperative imaging confirmed the diagnosis of spinal stenosis and ruled out significant vascular compromise. The patient tolerated the procedure well, with immediate post-operative imaging demonstrating successful decompression. He was educated on post-operative care, including activity restrictions and signs of potential complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved functional status, ambulating with minimal assistance. He was able to perform basic activities of daily living with guidance. Home health services will be initiated to assist with rehabilitation, pain management, and monitoring of his diabetes and hypertension.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications:  \\n- Acetaminophen  \\n- Atenolol  \\n- Lisinopril  \\n- Metformin  \\n- Glipizide XL  \\n- Albuterol Inhaler  \\n- Furosemide  \\n- Fluticasone Propionate  \\n- Diazepam  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment with the orthopedic surgeon is scheduled in two weeks. The patient is instructed to continue monitoring blood glucose levels and blood pressure, ensuring adherence to the prescribed medication regimen. Home health will coordinate care to ensure appropriate recovery and manage chronic conditions.',\n",
       " \"**Patient Name:** [Redacted]  \\n**Age:** 39  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.9 days  \\n**Primary Diagnosis:** Alcoholic cirrhosis of liver with ascites (ICD10: K7031)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of alcoholic cirrhosis complicated by ascites, portal hypertension, and secondary esophageal varices. He presented with abdominal distension and worsening fatigue. The patient has a history of alcohol dependence and was experiencing withdrawal symptoms upon admission.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent diuresis to manage ascites, and his fluid status was closely monitored. He received supportive care, including nutritional supplementation to address moderate protein-calorie malnutrition. Additionally, he was started on nadolol for portal hypertension and pantoprazole to manage esophagitis. He experienced no significant complications; however, he was treated for hypo-osmolality and hyponatremia.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant ascitic fluid accumulation, noted via abdominal ultrasound. A paracentesis was performed, yielding relief from symptoms. Laboratory tests revealed coagulopathy, which was addressed with vitamin K and monitoring of coagulation factors. The patient's withdrawal symptoms were managed with benzodiazepines.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved functional status with a reduction in abdominal distension and stable vital signs. He is alert and oriented, but ongoing home health services are recommended to assist with continued monitoring of his nutritional intake and medication compliance. The patient will require assistance with daily activities due to fatigue and potential complications from his liver disease.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Nadolol, Pantoprazole, and a regimen of multivitamins and electrolytes. A follow-up appointment with a hepatologist is scheduled in one week to reassess liver function and potential need for further interventions. Home health services will facilitate monitoring and provide nutritional counseling during recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 47 years old  \\n**Admission Type:** Surgical same-day admission  \\n**Length of Stay:** 5.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to a malignant neoplasm of the right kidney (ICD10: C641). He has a complex medical history including hereditary factor VIII deficiency, hypertensive heart disease with chronic kidney disease (CKD), chronic diastolic heart failure, and chronic obstructive pulmonary disease (COPD). Notably, he was also diagnosed with prediabetes and benign prostatic hyperplasia.  \\n\\n**Hospital Course:**  \\nThe patient underwent a right nephrectomy and was closely monitored postoperatively for any signs of complications. His recovery was complicated by mild ileus and transient hypertension, which were managed with appropriate medications. He demonstrated gradual improvement in functional status, including mobilization and pain management.  \\n\\n**Key Findings and Procedures:**  \\nKey postoperative findings included stable vital signs, resolution of ileus, and adequate renal function post-nephrectomy. The patient received factor VIII recombinant therapy to manage his hereditary deficiency. Postoperative imaging was unremarkable, and he was discharged in stable condition.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved pain control and is ambulating independently. He requires assistance with activities of daily living (ADLs) due to his chronic conditions and recent surgery. Home health services will be essential for continued monitoring, medication management, and assistance with mobility.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed acetaminophen, atorvastatin, chlorthalidone, lisinopril, and oxycodone, among others. He is advised to continue factor VIII therapy as prescribed. A follow-up appointment is scheduled with oncology and nephrology in two weeks, and he will also have home health nursing visits to monitor his postoperative recovery and manage his chronic conditions.',\n",
       " '**Patient Information:**  \\nAge: 54 years  \\nGender: Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for a scheduled surgical intervention due to a malignant neoplasm of the lower lobe of the right lung (ICD10: C3431). He presented with worsening respiratory symptoms and was found to have significant pulmonary compromise.  \\n\\n**Hospital Course:**  \\nDuring the 3.6-day hospital stay, the patient underwent a right-sided lobectomy and received postoperative management. Post-surgery, he was monitored in the surgical ward for signs of complications, including pulmonary insufficiency (ICD10: J951). The patient exhibited transient acute pulmonary insufficiency requiring supplemental oxygen and close respiratory monitoring. He was treated with nebulized bronchodilators (Ipratropium-Albuterol Neb) and steroids, along with pain management utilizing hydromorphone (Dilaudid).  \\n\\n**Key Findings and Procedures:**  \\nKey intraoperative findings included tumor involvement of the lower lobe, necessitating lobectomy (ICD10: 0BBF4ZZ). Postoperative imaging indicated stable lung volumes with no evidence of pneumothorax. The patient was managed for hypertension (ICD10: I10) and hypercholesterolemia (ICD10: E7800) throughout his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, with mild exertional dyspnea. He demonstrated the ability to perform activities of daily living with minimal assistance, indicating a functional status that will benefit from home health services for continued monitoring of respiratory function and medication management.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed the following medications: 0.9% Sodium Chloride, Acetaminophen, Atorvastatin, Baclofen, Docusate Sodium, Furosemide, and a bronchodilator regimen. He is advised to follow up with oncology and pulmonology within one week for further evaluation and management. Home health services will provide support for medication adherence, respiratory therapy, and vital sign monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 24  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following an acute exacerbation of her mood disorder, characterized by severe depressive symptoms, anxiety, and suicidal ideation. She has a history of unspecified mood disorder, PTSD, and borderline personality disorder. The patient also reported contact with a suspected COVID-19 positive individual prior to admission, causing additional anxiety regarding her health status.\\n\\n**Hospital Course:**  \\nDuring her 9-day hospitalization, she was closely monitored and started on an optimized pharmacotherapy regimen to manage her mood and anxiety symptoms. The treatment included ARIPiprazole, Fluoxetine, Mirtazapine, and Lorazepam. The patient also received supportive therapy and was engaged in group therapy sessions. Her psychiatric symptoms improved significantly over the course of her stay, with a notable reduction in suicidal ideation. She was also stabilized on her pain management regimen, which included Acetaminophen and Ibuprofen for physical discomfort.\\n\\n**Key Findings and Procedures:**  \\nKey findings included improvement in mood and functioning, along with successful management of anxiety symptoms. No significant physical complications arose during her stay. The patient engaged in discussions about her past trauma and began developing coping strategies with her treatment team. She was assessed for discharge readiness by psychiatry and nursing teams.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with a significant reduction in psychiatric symptoms. She requires ongoing support in her home environment, particularly for medication adherence and mental health monitoring. Home health services will provide her with regular follow-up visits to ensure continued engagement in therapy and medication management.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue with ARIPiprazole, Fluoxetine, and Mirtazapine. A follow-up appointment has been scheduled with her outpatient psychiatrist within one week of discharge. Additionally, the home health team will monitor her mental health status and assist with daily living activities as needed.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- Age: 24 years  \\n- Gender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for management of breech presentation at 39 weeks of gestation. She reported mild abdominal discomfort and fetal movement changes. Upon evaluation, a breech presentation was confirmed, necessitating close monitoring and planning for potential cesarean delivery.  \\n\\n**Hospital Course:**  \\nDuring her 3-day hospital stay, the patient was monitored for fetal well-being, with regular ultrasounds and fetal heart rate monitoring. She received maternal care including hydration with 0.9% Sodium Chloride, analgesia with Acetaminophen and Ibuprofen, and prophylactic anticoagulation with Enoxaparin Sodium. A cesarean section was performed successfully after a discussion of risks and benefits, resulting in a healthy single live birth. Post-operative recovery was uneventful, with good pain control and mobilization encouraged.  \\n\\n**Key Findings and Procedures:**  \\n- Diagnosis: Maternal care for breech presentation (ICD10: O321XX0).  \\n- Additional complications included labor affected by cord around the neck (ICD10: O691XX0) and polycystic ovarian syndrome (ICD10: O282).  \\n- Cesarean delivery (10D00Z1) successfully accomplished with no intraoperative complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with no signs of infection or complications. She demonstrated good mobility and was able to perform activities of daily living independently. She requires home health services for continued monitoring of her post-operative recovery, assistance with infant care, and education on signs of potential complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Enoxaparin Sodium  \\n- OxyCODONE (Immediate Release) for pain management  \\n- Ondansetron for nausea as needed  \\n- Polyethylene Glycol and Docusate Sodium for constipation prevention.  \\nThe patient is advised to follow up with her obstetrician in one week for a postpartum check and to establish a care plan for her and the newborn.',\n",
       " \"**Patient Summary:**  \\n**Age:** 60  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to stenosis of a vascular prosthetic device, with a history of multiple comorbidities including atrial fibrillation, hypertensive heart disease with heart failure, and Barrett's esophagus. The patient underwent a surgical procedure on admission day, which involved a significant vascular graft revision due to stenosis.\\n\\n**Hospital Course:**  \\nThe patient had a total hospital stay of 5.8 days, during which he experienced stable postoperative recovery. Post-surgery, he was monitored for potential complications such as bleeding or graft failure but showed an uneventful recovery. His heart failure symptoms were managed with appropriate medications and monitoring of fluid status.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent atrial fibrillation and controlled hypertension. The surgical procedure performed was a vascular graft revision (ICD-10: 02RF38Z), and he was treated with anticoagulation therapy with apixaban and argatroban to prevent thromboembolic events. His discharge medications included 0.9% sodium chloride, acetaminophen, aspirin, metoprolol succinate XL, and omeprazole. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented. He demonstrated adequate mobility and the ability to perform activities of daily living with minimal assistance. Home health services will be necessary to ensure continuity of care, especially for monitoring his anticoagulation therapy and managing heart failure symptoms. \\n\\n**Medications and Follow-up Plan:**  \\nThe patient will be discharged on a regimen including metoprolol, apixaban, and aspirin among other supportive medications. He is scheduled for a follow-up appointment in one week to assess graft function and adjust medications as necessary. Home health services will initiate within 48 hours post-discharge for medication management and cardiac monitoring.\",\n",
       " \"Patient is a 48-year-old female admitted for observation due to an acute exacerbation of bronchiectasis. She has a notable history of bronchiectasis with previous hospitalizations for similar exacerbations. Upon admission, the patient presented with increased sputum production, dyspnea, and hypoxia. Her vital signs indicated mild respiratory distress, and she was started on supplemental oxygen to maintain oxygen saturation above 90%.\\n\\nDuring her 2.2-day stay, the patient underwent a comprehensive evaluation including a chest X-ray and pulmonary function tests, which confirmed the presence of bronchiectasis and acute respiratory failure with hypoxia. She was treated with nebulized bronchodilators (Ipratropium-Albuterol), systemic corticosteroids, and antibiotics as per the exacerbation protocol. The patient's condition improved significantly, with gradual resolution of her dyspnea and stabilization of oxygenation levels.\\n\\nKey findings included persistent bronchial inflammation and a need for ongoing pulmonary management. The patient was assessed by the respiratory therapy team and educated on her inhaler technique and the importance of adherence to her medication regimen. Additionally, she was evaluated for home health services, which will assist with her ongoing respiratory care and medication management at home.\\n\\nAt the time of discharge, the patient exhibited improved respiratory function and was stable on room air with an oxygen saturation of 95%. Functional status has improved, allowing her to perform activities of daily living with minimal assistance. She has been prescribed a regimen including Albuterol inhaler, Fluticasone-Salmeterol Diskus, and Tiotropium Bromide to maintain her respiratory status. \\n\\nFollow-up with her primary care provider is advised within one week, with an emphasis on monitoring her respiratory health and adherence to prescribed therapies. Home health services will be initiated to provide ongoing support and education regarding her condition and ensure proper follow-up.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 55-year-old female admitted for observation due to a gastrointestinal hemorrhage (ICD10: K922), presenting with symptoms of fatigue and abdominal discomfort. She has a medical history including acute posthemorrhagic anemia (ICD10: D62) and Ehlers-Danlos syndrome, which may exacerbate her condition.  \\n  \\n**Hospital Course:**  \\nDuring her 3-day stay, the patient was closely monitored, and supportive care was initiated. She received intravenous fluids and blood transfusions to manage her anemia. The patient's gastrointestinal symptoms improved significantly, and she was assessed daily by the gastroenterology team.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory investigations confirmed a moderate anemia and the presence of gastrointestinal bleeding. An abdominal ultrasound was performed, revealing no acute pathology. A medication review was conducted, focusing on the management of her chronic conditions, including rheumatoid arthritis and irritable bowel syndrome.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved hemoglobin levels and resolution of acute symptoms. She will require home health services for ongoing monitoring of her anemia and assistance with her medications, including the management of her asthma and other chronic conditions. The patient is advised to follow up with her primary care physician within one week.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. Fluticasone-Salmeterol Diskus (500/50)  \\n4. Levalbuterol Nebulizer  \\n5. Montelukast  \\n6. Omeprazole  \\n7. Ondansetron  \\n8. OxyCODONE (Immediate Release)  \\n9. Ramelteon  \\n10. Sarna Lotion  \\n11. Sodium Chloride 0.9% Flush  \\n12. Sodium Chloride Nasal  \\n  \\nThe patient's discharge instructions include adequate hydration, adherence to the medication regimen, and awareness of signs of potential complications. Home health services will facilitate her transition to home care and ensure continuity in managing her health conditions.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 51  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 51-year-old female who was admitted through the emergency department with a diagnosis of partial intestinal obstruction (ICD-10: K56600). She presented with abdominal pain, nausea, and vomiting for two days prior to admission, with a history of bariatric surgery and subsequent complications.  \\n  \\n**Hospital Course:**  \\nDuring her 8-day hospitalization, the patient was managed with intravenous fluids, bowel rest, and medications for symptom control. She underwent a diagnostic imaging study which confirmed the partial obstruction without ischemia. The patient received supportive care, including nutritional supplementation for her protein-calorie malnutrition (ICD-10: E46).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated improvement in her abdominal symptoms and was able to tolerate clear liquids by day 5 of hospitalization. She underwent a laparoscopic procedure to address the obstruction, which involved adhesiolysis. Post-operatively, she was monitored closely and transitioned to a regular diet, gradually increasing to a full diet without further complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with resolution of her obstruction symptoms. She is ambulating independently and demonstrates the ability to perform activities of daily living with minimal assistance. Due to her history of obstructive sleep apnea, home health services have been arranged for monitoring and assistance with her recovery at home.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Buprenorphine  \\n- Calcium Carbonate  \\n- Captopril  \\n- Cetirizine  \\n- Furosemide  \\n- Heparin  \\n- Mirtazapine  \\n  \\nThe patient is advised to follow up with her primary care physician within one week and to contact the home health agency for support services. Follow-up nutrition consultation is also recommended to address her malnutrition.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 72  \\n- **Gender:** Female  \\n- **Admission Type:** Direct Emergency  \\n- **Length of Stay:** 1.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with complications related to an internal prosthetic device, leading to symptoms including localized pain and swelling. A thorough evaluation was conducted, revealing multiple comorbid conditions, including malignant neoplasms and type 2 diabetes mellitus.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient was stabilized and managed for her primary issue of complications from the prosthetic. Pain management included administration of Acetaminophen and Ibuprofen, while intravenous fluids (Lactated Ringers) were provided for hydration. The patient was also started on Heparin for venous thromboembolism prophylaxis. Comprehensive oncological evaluation was undertaken, and appropriate referrals were made to address her malignancies.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed the presence of secondary malignant neoplasms affecting lymph nodes. The patient underwent a surgical consultation with consideration for further intervention. Significant lab findings included elevated glucose and lipid levels, warranting adjustments in her diabetic and hyperlipidemic management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved stability, though she required assistance with activities of daily living due to her functional status. Home health services have been arranged to facilitate medication management and monitor her condition, particularly her diabetes and pain levels. The patient is encouraged to engage in light physical activity as tolerated.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Docusate Sodium  \\n- Heparin  \\n- Ibuprofen  \\n- Metoprolol Tartrate  \\n- Ondansetron  \\n- Pravastatin  \\n- Amlodipine  \\n- Influenza Vaccine Quadrivalent  \\n- PNEUMOcoccal 23-valent polysaccharide vaccine  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week post-discharge and with oncology as scheduled. Home health will monitor her vital signs, medication adherence, and provide assistance with her daily activities.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nPatient is a 68-year-old female admitted electively for management of an abdominal aortic aneurysm (AAA), without rupture.  \\n  \\n**History of Present Illness:**  \\nThe patient presented with incidental findings of an abdominal aortic aneurysm during routine imaging. She reported no acute symptoms, but due to the size of the aneurysm, surgical intervention was deemed necessary.  \\n  \\n**Hospital Course:**  \\nThe patient underwent an endovascular aneurysm repair (EVAR) on day 1 of admission, which was successful. Postoperatively, she was monitored in the surgical unit, where she experienced stable vital signs and satisfactory pain control. During her hospital stay, she received supportive care, including the administration of fluids and pain management with acetaminophen and opioids as needed.  \\n  \\n**Key Findings and Procedures:**  \\nSignificant findings included an abdominal ultrasound showing no evidence of rupture, and postoperative imaging confirmed successful graft placement. The patient experienced some transient acute posthemorrhagic anemia, managed with intravenous fluids and blood transfusion. She was also treated for mild secondary thrombocytopenia and hyperlipidemia.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently with minimal assistance. She was advised to avoid heavy lifting and strenuous activity. Home health services will be initiated for monitoring of her surgical site and management of her ongoing medication regimen.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed acetaminophen, aspirin, furosemide, and insulin as part of her management plan. She is to follow up with her primary care physician within one week and will have a follow-up imaging study scheduled in one month to assess the AAA. Home health nursing services will assist with medication management and monitor vital signs for the initial recovery phase.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 78  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is a 78-year-old female with a diagnosis of aphasia (ICD-10 R4701), who presented to the hospital with acute changes in communication ability. The family reported sudden onset of expressive and receptive language deficits. Initial evaluation suggested possible transient ischemic attack or stroke, prompting further observation and diagnostic workup.  \\n\\n**Hospital Course:**  \\nDuring her 1.5-day stay, the patient underwent a thorough neurological assessment, including imaging studies that ruled out acute intracranial pathology. She was monitored for vital signs and neurological status. There was also management of her chronic conditions, including hypertension and hyperlipidemia, with adjustments to her medication regimen. The patient received supportive care, including speech therapy evaluation, which indicated a need for continued rehabilitation.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs and neurological examination, with no acute deficits identified upon discharge. The patient demonstrated improvement in her ability to communicate basic needs and follow simple commands. Medications were reviewed, and adjustments made to optimize her chronic disease management.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with daily activities due to ongoing aphasia. She exhibited good comprehension of simple instructions but struggled with expressive language, indicating a need for home health services for speech therapy. The patient will benefit from continued support in a familiar environment to promote recovery and rehabilitation.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Apixaban, Atorvastatin, Dextrose 50%, Fluticasone Propionate NASAL, Glucagon, Glucose Gel, HydrALAZINE, Insulin, Levothyroxine Sodium, Metoprolol Succinate XL, Metoprolol Tartrate, Sodium Chloride 0.9%, and Vitamin D. The patient is advised to follow up with her primary care physician and a neurologist within one week, and home health services should initiate contact for speech therapy and overall health monitoring.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 37 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for maternal care related to a low transverse scar from a previous cesarean delivery. She presented at 39 weeks gestation with signs of labor and was at risk for uterine rupture due to her prior cesarean. The patient had no significant medical history and was monitored closely for any signs of complications during her hospitalization.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a scheduled cesarean section on day two of admission due to concerns regarding labor progression and fetal distress. The procedure was uneventful, and she was transferred to the postpartum unit for recovery. The patient was monitored for vital signs, bleeding, and pain management.  \\n\\n**Key Findings and Procedures:**  \\nPost-procedure, the patient was stable, with good uterine tone and no signs of infection. Key interventions included the administration of intravenous fluids (Lactated Ringer's), pain management with Acetaminophen and OxyCODONE, and prophylactic administration of the Influenza Vaccine Quadrivalent. A bowel regimen was initiated with Docusate Sodium and Simethicone to prevent constipation post-surgery.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition with a single live birth. She is alert, oriented, and able to perform activities of daily living with minimal assistance. Home health services are recommended for postpartum follow-up, wound care, and support with breastfeeding. The patient has been educated on signs of potential complications including fever, excessive bleeding, and incision issues.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on 0.9% Sodium Chloride, Calcium Carbonate, Docusate Sodium, Ibuprofen, Ondansetron, and prescribed pain medication (OxyCODONE) as needed.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with her obstetrician in one week to monitor her recovery and assess the surgical site.\",\n",
       " '**Patient Information**: 73-year-old female admitted for observation due to a unilateral inguinal hernia (K4030) with obstruction, without gangrene. \\n\\n**History of Present Illness**: The patient presented with abdominal pain, nausea, and vomiting. Physical examination revealed a tender right inguinal mass, prompting surgical intervention. \\n\\n**Hospital Course**: The patient underwent laparoscopic inguinal hernia repair on day 3 of admission, followed by close monitoring for complications. Postoperatively, she developed mild acute kidney failure (N179) and acute posthemorrhagic anemia (D62), managed with intravenous fluids and blood transfusions. She also experienced pleural effusion (J90), which was treated conservatively. Initial concerns regarding malnutrition (E43) were addressed with nutritional support and oral supplements. The patient had a stable hospital course, improving gradually with pain management and mobilization. \\n\\n**Key Findings and Procedures**: The patient had a successful laparoscopic hernia repair, with no complications noted during the surgical procedure. Postoperative evaluations showed resolution of obstruction and improvement in renal function. She was monitored for any signs of infection following the procedure, particularly due to her risk factors for surgical site infection (T8143XA). \\n\\n**Discharge Condition and Functional Status**: The patient is stable at discharge, ambulating independently with a functional status improved from admission. She continues to require assistance with activities of daily living due to postoperative recovery. Home health services are recommended for wound care, medication management, and ongoing nutritional support. \\n\\n**Medications and Follow-Up Plan**: Discharge medications include Acetaminophen, Amoxicillin-Clavulanic Acid, Furosemide, Heparin, Ondansetron, OxyCODONE, and others as detailed in the discharge medication list. The patient is advised to follow up with her primary care physician and surgical team within one week to monitor recovery and address any concerns that may arise.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 36 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 9.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to postprocedural intestinal obstruction following a recent surgery. He presented with abdominal distension, nausea, and vomiting. Initial imaging confirmed the diagnosis of postprocedural intestinal obstruction (ICD10: K913).  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was managed conservatively with bowel rest, fluid resuscitation, and medical management for pain control. He received intravenous hydration and was placed on a regimen of acetaminophen for pain relief, with hydromorphone provided for breakthrough pain. The patient was monitored closely for signs of bowel function return, which was observed on day 5 of his admission with the resolution of nausea and the passage of flatus.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included mild protein-calorie malnutrition (ICD10: E441) and a rash (ICD10: R21) likely secondary to medication. The patient underwent a PICC line insertion for intravenous access (ICD10: 02HV33Z). He was treated with topical agents including bacitracin ointment and desonide cream for skin issues.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was clinically stable, with improved abdominal symptoms and readiness for home health services. Functional status is satisfactory; he requires assistance with activities of daily living (ADLs) due to weakness from prolonged hospitalization. Home health services will provide nursing care for medication management and wound care related to his ileostomy status (ICD10: Z932).  \\n  \\n**Medications:**  \\nDischarge medications include acetaminophen (liquid), hydromorphone (liquid), ondansetron, and topical treatments. He is advised to continue oral hydration and follow a low-residue diet initially.  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with his surgeon in one week to reassess his recovery and bowel function. Home health services will be initiated within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 62  \\n- **Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with multiple subsegmental pulmonary emboli, resulting in acute respiratory failure with hypoxia. The patient presented with symptoms of shortness of breath and fatigue, notably worsening over the prior 48 hours.  \\n  \\n**Hospital Course:**  \\nDuring her brief hospitalization, the patient was stabilized with supplemental oxygen and initiated on anticoagulation therapy, including Enoxaparin and Heparin. She was closely monitored in the respiratory unit, where her oxygen saturation levels improved, and she became hemodynamically stable.  \\n  \\n**Key Findings and Procedures:**  \\nChest imaging confirmed multiple subsegmental pulmonary emboli without evidence of acute cor pulmonale. Laboratory tests indicated nutritional anemia, treated with magnesium sulfate and iron supplementation. The patient also received psychiatric evaluation due to a history of borderline personality disorder, and her medications were adjusted accordingly.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient demonstrated improved respiratory status, with stable oxygen saturation on room air. She is able to perform activities of daily living with minimal assistance. The home health team will provide follow-up care focusing on respiratory support and medication management.  \\n  \\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Clozapine  \\n- Enoxaparin (treatment)  \\n- Fluvoxamine Maleate  \\n- Levothyroxine Sodium  \\n- Magnesium Sulfate  \\n- Quetiapine Fumarate  \\n- Senna  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and will have home health nursing visits for medication management and monitoring of her respiratory status. Additionally, she will be scheduled for a follow-up pulmonary evaluation to reassess her condition.',\n",
       " \"Patient is a 71-year-old female admitted for observation due to diverticulitis of the intestine, specifically with perforation and abscess formation, as indicated by ICD-10 code K5780. She presented with abdominal pain, fever, and signs of sepsis, necessitating urgent evaluation. Initial imaging confirmed the diagnosis, and she was started on intravenous antibiotics, including Amoxicillin-Clavulanic Acid, and supportive care.\\n\\nDuring her 11-day hospital stay, her condition was closely monitored. Key findings included persistent leukocytosis and abdominal tenderness. She underwent a CT-guided drainage procedure for the abscess, coded as 02HV33Z, with subsequent improvement in her clinical status. The patient was also treated for chronic conditions, including hypertension, Parkinson's disease, and COPD, which were managed with her regular medications and additional treatments like PredniSONE and Hydroxychloroquine.\\n\\nBy the end of her stay, the patient exhibited significant clinical improvement, with resolution of fever and abdominal pain. She was ambulating independently with assistance and had regained her baseline functional status. However, she requires ongoing home health services to monitor her recovery, manage her medications, and ensure proper nutrition while she continues to recuperate at home.\\n\\nAt discharge, a medication regimen was established, including Acetaminophen for pain management, Apixaban for anticoagulation, and Verapamil SR for her supraventricular tachycardia. The patient is advised to follow up with her primary care physician within one week and is to have home health nursing visits to assess her surgical site and overall recovery process. Home health will also assist with medication management and provide education on lifestyle modifications to manage her chronic conditions effectively.\",\n",
       " '**Patient Summary:**  \\nFemale patient, 40 years old, was admitted for observation due to recent episodes of seizures, diagnosed as unspecified epilepsy (ICD10: G40909).  \\n\\n**History of Present Illness:**  \\nThe patient presented with seizures that were not intractable and without status epilepticus. She has a history of vitamin D deficiency and has been experiencing symptoms consistent with major depressive disorder and anxiety disorder.  \\n\\n**Hospital Course:**  \\nDuring her 2-day stay, the patient was closely monitored for seizure activity. Neurological assessments were performed, and she was started on Levetiracetam (Keppra) for seizure control. Her mental health was assessed, and she was provided with Lorazepam for anxiety management. The patient received supportive care, including hydration with Sodium Chloride 0.9%. She was also administered Acetaminophen for pain management and received the Influenza Vaccine Quadrivalent to prevent respiratory infections.  \\n\\n**Key Findings and Procedures:**  \\nNeurological evaluations revealed no acute changes, and her seizure episodes remained controlled during the hospital stay. Laboratory tests confirmed vitamin D deficiency, which was addressed with Cyanocobalamin supplementation. Psychological support was integrated into her care to address her depressive and anxiety symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with her seizure episodes well-controlled on the current medication regimen. She demonstrates a good understanding of her medications and has been educated on potential side effects. Functional status is satisfactory; however, she will benefit from home health services for ongoing monitoring of her mental health and medication management. She requires assistance in adhering to her vitamin D supplementation and maintaining a balanced diet.  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient’s medication regimen includes Levetiracetam, Lorazepam, Acetaminophen, and Vitamin D supplementation. A follow-up appointment with her primary care physician is scheduled in one week to monitor her seizure control and mental health status. Home health services will provide additional support to ensure compliance with her treatment plan.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 31  \\n- **Gender:** Female  \\n- **Admission Type:** Urgent  \\n- **Length of Stay:** 2.6 Days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with gestational hypertension without significant proteinuria, complicating childbirth at 39 weeks of gestation. She experienced elevated blood pressure readings during the prenatal period, requiring hospitalization for close monitoring and management during labor.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent labor induction with the administration of oxytocin. She delivered a single live birth via vaginal delivery with a noted second-degree perineal laceration, which was repaired in the delivery suite. The patient received appropriate analgesia and was well-managed post-delivery with intravenous fluids, analgesics, and prophylactic medications.\\n\\n**Key Findings and Procedures:**  \\nThe patient’s blood pressure stabilized following delivery, and she was monitored for any signs of postpartum complications. Laboratory tests revealed no significant proteinuria, and her vital signs remained stable throughout her hospital course. Discharge medications included 0.9% sodium chloride, acetaminophen, and ibuprofen for pain management, along with lactated Ringer's solution and ondansetron for nausea. The patient was also provided with education regarding perineal care and signs of potential complications.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was in stable condition, ambulating independently and demonstrating the ability to care for her newborn. She was advised to follow up with her obstetrician within one week and to monitor her blood pressure at home. Home health services have been initiated to assist with postpartum care, including education on infant care and support for maternal recovery.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed a regimen including 0.9% sodium chloride flush, calcium carbonate, dermoplast spray, docusate sodium, polyethylene glycol, senna, and simethicone as needed. She is to receive routine follow-up visits for blood pressure monitoring and ongoing assessment of her recovery.\\n\\nIn summary, the patient is discharged in stable condition with a comprehensive plan for home health support and follow-up care.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Patient ID:** [Patient ID]  \\n\\n**History of Present Illness:**  \\nThe patient is a 77-year-old female with a history of chronic obstructive pulmonary disease (COPD), atherosclerotic heart disease, and bipolar disorder, who was admitted for observation due to signs and symptoms consistent with pneumonia. Upon admission, she presented with dyspnea, cough, and fever.  \\n\\n**Hospital Course:**  \\nDuring her 3.6-day stay, the patient was started on broad-spectrum antibiotics, including ceftriaxone and azithromycin, for pneumonia while receiving supportive care. She also received nebulized albuterol for her COPD exacerbation. A urinary tract infection was identified, and she was treated accordingly. Throughout her hospital course, she was monitored for potential complications related to her underlying conditions. Her respiratory status improved, and she became afebrile by the second day.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies confirmed the presence of pneumonia, with no pleural effusion. Laboratory tests revealed elevated white blood cell counts and electrolyte imbalances, which were corrected during her stay. The patient exhibited signs of toxic encephalopathy, likely secondary to her medications, necessitating close monitoring and adjustment of psychiatric medications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory function and resolution of fever. She is alert and oriented but requires assistance with daily activities and medication management. Home health services have been arranged to assist with monitoring her respiratory status and medication adherence.  \\n\\n**Medications at Discharge:**  \\n- ARIPiprazole  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulized Solution  \\n- Aspirin  \\n- Azithromycin  \\n- Carvedilol  \\n- CefTRIAXone  \\n- Docusate Sodium  \\n- Escitalopram Oxalate  \\n- Heparin  \\n- Mirtazapine  \\n- Pregabalin  \\n- Senna  \\n- Simvastatin  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for a medication review and ongoing management of her COPD and psychiatric conditions. Home health services will initiate contact within 48 hours post-discharge to ensure continuity of care.\",\n",
       " '**Patient Information:** 42-year-old female admitted through the emergency department with complaints of epigastric pain. \\n\\n**History of Present Illness:** The patient presented with severe epigastric pain, associated with nausea and vomiting. She reported a history of gastro-esophageal reflux disease and obstructive sleep apnea. Initial evaluation revealed dehydration and hypoglycemia, likely secondary to inadequate oral intake due to persistent nausea. \\n\\n**Hospital Course:** The patient was admitted for observation and management of her symptoms. During her 14.7-day hospital stay, she underwent a thorough diagnostic workup, including imaging studies, which ruled out acute abdominal pathology. The pain was managed with analgesics including oxycodone liquid, while antiemetics such as ondansetron were administered to control her nausea. Psychosocial evaluations were conducted due to her history of major depressive disorder and anxiety disorder, leading to the adjustment of her psychotropic medications, including aripiprazole and fluoxetine. \\n\\n**Key Findings and Procedures:** Key findings included dehydration and signs of anxiety exacerbated by her hospitalization. A gastrostomy status was noted, and the patient was placed on a modified diet, progressing as tolerated. Continuous monitoring was required for her fluid status, and she received intravenous fluids during her stay. \\n\\n**Discharge Condition and Functional Status:** The patient is discharged in stable condition, with improved symptom management and hydration status. She is ambulating independently with no acute distress. Home health services are recommended to assist with medication management, dietary support for her gastro-esophageal reflux disease, and ongoing psychosocial support due to her mood disorders. \\n\\n**Medications and Follow-up Plan:** At discharge, the patient is prescribed atorvastatin, docusate sodium, dronabinol, gabapentin, lorazepam, lidocaine viscous, mupirocin ointment, and ongoing psychiatric medications. A follow-up appointment with her primary care provider is scheduled in one week, and regular communication with home health will be crucial to monitor her condition and provide additional support.',\n",
       " '**Patient Information:** 54-year-old female admitted through emergency with a primary diagnosis of infection and inflammatory reaction due to internal prosthetic devices.  \\n\\n**History of Present Illness:** The patient presented with fever, chills, and abdominal pain. Initial workup indicated an infection likely related to her previous prosthetic device, confirmed by imaging studies showing abscess formation in the liver. The patient was started on broad-spectrum antibiotics and supportive care. \\n\\n**Hospital Course:** During her 7.9-day stay, the patient was monitored closely in the surgical ward. Her treatment regimen included intravenous Ampicillin-Sulbactam and Fluconazole, along with supportive measures for acute respiratory failure, including oxygen therapy. The patient also experienced postprocedural septic shock, which was managed with fluid resuscitation and vasopressors. Following stabilization, abscess drainage was performed, significantly improving her clinical status. \\n\\n**Key Findings and Procedures:** Laboratory tests indicated elevated inflammatory markers and evidence of sepsis. Imaging confirmed liver abscess, necessitating interventional drainage. She was also managed for acute respiratory failure, which was resolved prior to discharge.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, with resolution of fever and abdominal pain. She demonstrates adequate respiratory function and can perform activities of daily living with minimal assistance. Home health services will be initiated to assist in wound care post-drainage and to monitor her recovery progress. \\n\\n**Medications and Follow-up Plan:** Upon discharge, the patient will continue medications including Lisinopril, Oxycodone for pain management, and Pantoprazole for gastrointestinal protection. She is advised to follow up with her primary care physician within one week and to contact home health for any concerns regarding her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** 27-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 1.4 days  \\n**Primary Diagnosis:** Other specified pregnancy-related conditions, third trimester (ICD10: O26893)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department at 28 weeks gestation with complaints of hemoptysis and respiratory distress. She reported recent contact with a suspected COVID-19 case, raising concerns about potential respiratory complications. The patient has a history of asthma, which was exacerbated during her current pregnancy.\\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a thorough evaluation, including chest imaging and laboratory studies. She was treated with Betamethasone for fetal lung maturity and Fluticasone Propionate for her asthma. The hemoptysis was managed conservatively, and respiratory support was provided as necessary. The patient was monitored closely for any signs of further complications related to her pregnancy and respiratory status.  \\n\\n**Key Findings and Procedures:**  \\n- Chest imaging showed no acute abnormalities.  \\n- Laboratory results indicated mild leukocytosis, likely related to the stress of pregnancy and potential infection.  \\n- The patient received supportive care, including Bisacodyl and Docusate Sodium for bowel regimen and hydration with D5 1/2NS.  \\n- A syringe was used for medication administration, ensuring adherence to treatment protocols.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was stable at discharge, with improved respiratory function and no further episodes of hemoptysis. She is ambulating independently and demonstrates understanding of her medication regimen. A referral to home health services has been initiated to assist with monitoring her respiratory status and ensuring compliance with her asthma management plan.\\n\\n**Medications at Discharge:**  \\n- Betamethasone Na. Phos/Acet  \\n- Fluticasone Propionate 110 mcg  \\n- Prenatal Vitamins  \\n- Docusate Sodium  \\n- Senna  \\n- Bisacodyl  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician in one week and is advised to contact her healthcare provider if she experiences any respiratory distress, increased hemoptysis, or any other concerning symptoms. Home health services will provide additional support and monitoring.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Patient Name:** [Patient Name]  \\n**Date of Discharge:** [Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**Brief History of Present Illness:**  \\nThe patient is an 88-year-old female who presented to the emergency department with symptoms indicative of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). She exhibited hyponatremia and associated neurological symptoms. During her 6.5-day hospital stay, her condition warranted close monitoring and management of her fluid balance and electrolyte levels.\\n\\n**Hospital Course:**  \\nUpon admission, she was stabilized with intravenous fluids, and her sodium levels were carefully corrected. She was also found to have secondary malignant neoplasms, which were managed with appropriate oncological consultations. The patient experienced episodes of diarrhea, managed with LOPERamide and dietary modifications. Her chronic atrial fibrillation was controlled with Atenolol, and she continued her anticoagulant regimen with Warfarin. Throughout her stay, she received supportive care, including pain management with Acetaminophen and TraMADol, and bowel regimen with Bisacodyl and Senna.\\n\\n**Key Findings and Procedures:**  \\nKey diagnostic findings included evidence of secondary malignancies (C786, C577) noted on imaging, and abnormal coagulation profiles were addressed. She received hypertonic saline (Sodium Chloride 3%) for her hyponatremia and was monitored for potential complications associated with her anticoagulation therapy.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented, though she required assistance with activities of daily living (ADLs) due to weakness and fatigue. Home health services will be initiated for ongoing monitoring of her fluid status, medication management, and support with ADLs. Family members have been educated on signs of dehydration and the importance of adhering to her medication regimen.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Atenolol, LOPERamide, Warfarin, and others as listed. A follow-up appointment with her primary care physician and oncologist is scheduled within one week of discharge to monitor her overall health and oncological status. Home health services will contact the patient within 48 hours to arrange for necessary assessments.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 76-year-old female who presented to the emergency department with complaints suggestive of biliary obstruction, characterized by abdominal pain and jaundice. Initial evaluation revealed elevated liver enzymes and imaging confirmed obstruction of the bile duct (ICD-10: K831).  \\n  \\n**Hospital Course:**  \\nDuring her 2-day hospital stay, the patient was managed with supportive care and appropriate medical interventions. She received intravenous fluids and analgesics. A multidisciplinary team was involved, including gastroenterology, who subsequently performed endoscopic retrograde cholangiopancreatography (ERCP) to relieve the obstruction. The procedure was successful, and the patient showed significant improvement in symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings upon admission included elevated bilirubin and liver enzymes, indicating cholestasis. The ERCP revealed a dilated bile duct with stones, which were successfully removed. Post-procedure, the patient’s liver function tests improved, and her abdominal pain resolved.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved liver function and no residual abdominal pain. She demonstrated adequate ambulation and was able to perform activities of daily living with minimal assistance. Home health services have been arranged to monitor her recovery, assist with medication management, and provide education on dietary modifications to support liver health.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen for pain management, Magnesium Oxide, Polyethylene Glycol for constipation, and a High-Dose Quadrivalent Influenza Vaccine. She is advised to follow up with her primary care physician and a gastroenterologist within one week of discharge to monitor her condition and adjust treatment as necessary. Additionally, the home health nurse will visit within the next few days to assess her recovery and reinforce education on signs and symptoms that require immediate attention.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 41  \\n- **Gender:** Male  \\n- **Admission Type:** Surgical same day admission  \\n- **Length of Stay:** 5.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 41-year-old male diagnosed with malignant neoplasm of the stomach (ICD10 C169), presenting for surgical intervention. He has a significant medical history including morbid obesity (BMI 34.0-34.9), gastro-esophageal reflux disease (GERD), and a personal history of antineoplastic chemotherapy.  \\n  \\n**Hospital Course:**  \\nDuring his 5.8-day hospital stay, the patient underwent a surgical procedure (ICD10 0DB64ZZ) to address the neoplasm. Post-operatively, he experienced stable vital signs and was monitored for complications. He was treated for pain management with hydromorphone and oxycodone, and received supportive care, including intravenous fluids (0.9% Sodium Chloride, D5 1/2NS) and electrolyte supplementation.  \\n  \\n**Key Findings and Procedures:**  \\nThe surgical procedure was performed without complications. Post-operative imaging and laboratory tests showed no evidence of acute complications. The patient demonstrated improved tolerance to oral intake and ambulation by the time of discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved functional status. He is able to ambulate with minimal assistance and manage basic activities of daily living. Home health services are recommended to assist with medication management, wound care, and nutritional support given his recent surgical intervention and ongoing management of obesity and GERD.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Pantoprazole, Omeprazole, Ondansetron, and supplements such as Potassium Chloride and Neutra-Phos. He will also receive a prescription for anticoagulation therapy with Heparin.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his oncologist and primary care physician within one week of discharge to monitor his recovery and manage ongoing treatment strategies.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 46  \\n- **Gender:** Male  \\n- **Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following a fall resulting in an acute fracture of the lower end of the left tibia (ICD10: S82392A). The injury was sustained while using stairs, and the patient presented with significant pain and swelling in the left leg.  \\n\\n**Hospital Course:**  \\nDuring his 4.8-day hospital stay, the patient was stabilized and underwent imaging, confirming the fracture. Initial management included IV analgesia with hydromorphone and the administration of antibiotics (Cefazolin) for prophylaxis. He was also placed on anticoagulation therapy with Heparin due to his history of long-term anticoagulant use (ICD10: Z7901).  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s condition improved with conservative management, including pain control and immobilization of the affected limb. Physical therapy was initiated to enhance mobility and ensure safe ambulation prior to discharge. Key lab findings included controlled hypertension and mild hyperlipidemia, both of which were monitored throughout the admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, able to ambulate with assistance. He requires home health services for ongoing physical therapy and monitoring due to his mobility limitations and the need for assistance with activities of daily living. Additionally, he will benefit from nursing support for medication management and wound care.  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Aspirin  \\n- Atenolol  \\n- Atorvastatin  \\n- Docusate Sodium  \\n- Furosemide  \\n- Oxycodone SR (Oxycontin)  \\nFollow-up appointments are scheduled with his primary care physician and orthopedic specialist within one week to monitor healing and adjust medications as necessary. The patient is advised to seek immediate care if he experiences increased pain, swelling, or signs of infection.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 69  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old female with a history of malignant neoplasm of the head of the pancreas, who presented for observation due to worsening abdominal pain and obstructive symptoms. The patient has a complex medical history including portal vein thrombosis, Crohn's disease, and anxiety disorder.  \\n\\n**Hospital Course:**  \\nDuring her 8.9-day stay, the patient was monitored for abdominal pain and associated symptoms. She received supportive care including pain management and nutritional support. She underwent imaging studies, which confirmed biliary obstruction secondary to the malignant neoplasm. A multidisciplinary team collaborated for optimal management of her symptoms and hydration status.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated bilirubin levels, consistent with biliary obstruction. The patient was started on Dextrose 50% for hypoglycemia and Heparin for prophylaxis against venous thromboembolism. No surgical intervention was performed as the patient opted for palliative care.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required assistance with activities of daily living due to weakness and fatigue. She will benefit from home health services for monitoring her nutritional status and managing pain control. The patient demonstrated an understanding of her condition and the importance of follow-up care.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Aspirin, Citalopram, Morphine Sulfate IR, Ondansetron, and Potassium Chloride. Docusate Sodium will be used to manage constipation.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment with oncology is scheduled within one week. Home health services will initiate within 48 hours for ongoing assessment and support.\",\n",
       " '**Patient Name:** [REDACTED]  \\n**Patient ID:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n\\n**History of Present Illness:**  \\nThe patient is a 61-year-old male who presented to the emergency department with acute onset of confusion and weakness. A non-contrast CT scan of the head revealed a nontraumatic acute subdural hemorrhage, necessitating urgent intervention due to the risk of increased intracranial pressure.  \\n\\n**Hospital Course:**  \\nThe patient was admitted for observation and management of the subdural hemorrhage. During the hospital stay, he received supportive care including 0.9% sodium chloride for hydration and dexamethasone to reduce cerebral edema. Neurology was consulted for evaluation of his neurological status. The patient demonstrated gradual improvement in cognitive function and was stabilized for discharge after 2.6 days.  \\n\\n**Key Findings and Procedures:**  \\nNeurological assessments showed improvement in Glasgow Coma Scale (GCS) scores, with the patient regaining baseline orientation by the time of discharge. The patient was monitored closely for any signs of deterioration, and repeat imaging was performed prior to discharge, showing no progression of the hemorrhage.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert and oriented, though he exhibited residual weakness on the right side, indicating hemiplegia. He requires assistance with activities of daily living (ADLs) such as bathing and dressing. Home health services have been arranged to provide physical therapy and occupational therapy to support rehabilitation and improve functional independence.  \\n\\n**Medications at Discharge:**  \\nThe patient was prescribed acetaminophen for pain management, levetiracetam for seizure prophylaxis, and lactulose for constipation management.  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments with neurology and primary care are scheduled within one week. Home health services will initiate therapy within 48 hours of discharge to ensure continuity of care and monitor for any changes in the patient’s condition.',\n",
       " '**Discharge Summary**  \\n**Patient:** 65-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 11.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with a diagnosis of infection and inflammatory reaction due to cardiac valve prosthesis. During her hospital stay, she presented with symptoms of fever, malaise, and shortness of breath. Initial evaluations revealed acute respiratory failure with hypoxia and cardiogenic shock, prompting close monitoring and intervention.  \\n  \\n**Hospital Course:**  \\nThe patient was managed with intravenous antibiotics (Ceftriaxone) and supportive measures, including oxygen therapy and diuretics for heart failure. She developed acute on chronic diastolic heart failure and acute kidney injury, which were addressed with fluid management. Throughout her hospitalization, she was monitored for hemodynamic stability and response to treatment.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated inflammatory markers and echocardiographic evidence of prosthetic valve dysfunction consistent with endocarditis. The patient also experienced episodes of acute hypoxemia requiring supplemental oxygen. A multidisciplinary approach was taken, involving cardiology and nephrology, to optimize her management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires continued close monitoring. She is being discharged with a functional status that necessitates home health services for ongoing management of her cardiac and renal conditions. She will benefit from nursing assistance to monitor her vital signs, manage medications, and ensure compliance with dietary recommendations.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Ceftriaxone, Digoxin, Docusate Sodium, Folic Acid, Hydralazine, Isosorbide Dinitrate, Levothyroxine Sodium, Magnesium Sulfate, Metoprolol Succinate XL, and multivitamins. She is advised to follow up with her primary care physician and cardiologist within one week post-discharge and to contact home health services to arrange for nursing visits.',\n",
       " '**Discharge Summary**  \\n**Patient:** 50-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.2 days  \\n**Primary Diagnosis:** Other specified diabetes mellitus with ketoacidosis without coma (ICD-10: E1310)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of diabetes mellitus with ketoacidosis. She presented with elevated blood glucose levels and metabolic derangements consistent with ketoacidosis. The patient reported increased thirst, frequent urination, and fatigue. A thorough assessment revealed a history of poorly controlled diabetes, contributing to her current condition.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient received IV fluids and insulin therapy to stabilize her blood glucose levels, which improved significantly. She was also monitored closely for electrolyte imbalances and received potassium supplementation as needed. The patient was started on a diabetes management plan focusing on dietary modifications and medication adherence. She underwent nutritional counseling and education regarding her condition.\\n\\n**Key Findings and Procedures:**  \\nLaboratory results showed resolution of ketoacidosis with a blood glucose level of 120 mg/dL at discharge. Key findings included hypertension and hyperlipidemia, which were addressed with appropriate pharmacotherapy. The patient was assessed for sleep apnea, which was previously diagnosed, and was advised to continue using her CPAP machine.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently. She demonstrated understanding of her medication regimen and diabetes self-management. Home health services have been recommended to assist with ongoing diabetes education, medication management, and monitoring of her overall health status to prevent readmission.\\n\\n**Medications at Discharge:**  \\nThe patient’s discharge medications include Acetaminophen, Aspirin, Atorvastatin, Fondaparinux, Insulin, and Gabapentin, among others. She was advised to follow up with her primary care physician within one week and to schedule an appointment with an endocrinologist for ongoing management of her diabetes. A referral to a dietitian was also made to help her with meal planning and nutritional support.',\n",
       " '**Patient Summary:** 82-year-old female admitted for observation with a primary diagnosis of hypertensive heart and chronic kidney disease with heart failure (I130).  \\n\\n**History of Present Illness:** The patient experienced increased shortness of breath and edema over the past week, prompting her admission. She has a significant past medical history of chronic kidney disease (stage 4), recurrent C. difficile enterocolitis, and a history of supraventricular tachycardia.  \\n\\n**Hospital Course:** During her 5-day stay, the patient was monitored closely for her cardiac and renal status. Diuretics were administered to manage fluid overload, and her heart failure symptoms improved with treatment. She received intravenous heparin for anticoagulation given her elevated risk for thromboembolic events. Infectious disease was consulted due to her history of C. difficile; she was treated with fidaxomicin. The patient was also started on CARVedilol and hydralazine to better manage her hypertension and heart failure symptoms.  \\n\\n**Key Findings and Procedures:** Key laboratory findings included elevated BUN and creatinine, consistent with her chronic kidney disease, and a slight elevation in troponin levels indicating cardiac stress. A transthoracic echocardiogram revealed preserved left ventricular ejection fraction despite her symptoms. Chest X-ray showed signs of pulmonary congestion, which improved by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:** Upon discharge, the patient demonstrated improved breathing and decreased edema. She was independent in activities of daily living but required assistance for transportation and medication management. Home health services have been arranged to ensure continuity of care, including nursing visits for medication management and monitoring of heart failure symptoms.  \\n\\n**Medications and Follow-Up Plan:** Discharge medications include acetaminophen, albuterol nebulizer, allopurinol, aspirin, atorvastatin, budesonide, CARVedilol, cefpodoxime, and others as detailed. Follow-up with her primary care physician is scheduled in one week, with additional cardiology and nephrology appointments arranged in the following month. The patient is advised to monitor her weight daily and report any significant changes in her condition.',\n",
       " 'Patient is a 66-year-old female admitted for observation with a diagnosis of Other Gram-negative sepsis (ICD-10: A4159). She presented with fever, chills, and altered mental status, later diagnosed with a secondary myocardial infarction, acute kidney failure, and electrolyte imbalances. Initial workup revealed elevated inflammatory markers and positive blood cultures for gram-negative organisms. \\n\\nDuring her 31-day stay, the patient was closely monitored and treated with intravenous antibiotics, fluid resuscitation, and supportive care for her acute kidney injury, which responded well to treatment. A thorough nutritional assessment revealed moderate protein-calorie malnutrition, and she was started on nutritional supplementation. She also experienced a urinary tract infection, managed with appropriate antibiotics. \\n\\nKey procedures included central line placement for medication administration and hemodynamic monitoring. Throughout her hospital course, the patient demonstrated gradual improvement in her clinical status and laboratory parameters, with a resolution of sepsis and stabilization of her kidney function.\\n\\nAt discharge, the patient is stable but requires ongoing home health services for continued monitoring and support. She has been advised to maintain a low-sodium diet and is to follow up with her primary care physician and a nephrologist in one week. Functional status is improved, though she exhibits fatigue and requires assistance with daily activities. The discharge medications include Acetaminophen, Famotidine, Heparin, Magnesium Sulfate, Ondansetron, OxyCODONE, and Potassium Chloride, along with dietary supplements. \\n\\nGiven her recent hospitalizations and ongoing health issues, a home health nurse will visit to assist with medication management, hydration, and nutritional needs.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 77 years old  \\n**Admission Type:** Observation  \\n**Length of Stay:** 3.8 days  \\n**Primary Diagnosis:** Acute kidney failure, unspecified (ICD10: N179)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute kidney failure, presenting with elevated creatinine levels and anuria. The patient has a history of chronic kidney disease (stage 4) and multiple myeloma, which may have contributed to his renal status. During hospitalization, the patient was closely monitored and treated for complications related to his renal failure, including electrolyte imbalances.\\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was managed with intravenous fluids, electrolyte replacement, and medications aimed at controlling symptoms. He received sodium bicarbonate for acidosis and was closely monitored for changes in blood glucose due to his history of type 2 diabetes mellitus. The patient exhibited gradual improvement in renal function, with urine output returning to baseline levels.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory results showed improvement in renal function with a decrease in serum creatinine from 3.5 mg/dL to 1.8 mg/dL. The patient underwent abdominal ultrasound to rule out obstructive causes for his renal failure, which showed no significant abnormalities. Additionally, stool tests confirmed enterocolitis due to Clostridium difficile, for which he was treated.\\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated stable vital signs and improved renal function. He is able to perform activities of daily living with minimal assistance. It is recommended that he receive home health services for medication management and monitoring of his renal function, as well as assistance with dietary modifications due to his diabetes and ongoing electrolyte imbalances.\\n  \\n**Medications at Discharge:**  \\nThe patient is to continue on Acetaminophen, Aspirin, Atorvastatin, Sodium Bicarbonate, and insulin as needed. He will also need to follow up with nephrology in one week and primary care for diabetes management.  \\n  \\n**Follow-Up Plan:**  \\nEnsure follow-up appointments are scheduled with nephrology and primary care. Home health services will assist with medication administration and monitoring of renal function and glycemic control.',\n",
       " '**Patient Name:** [Redacted]  \\n**Age:** 58  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.7 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with acute kidney failure (ICD-10: N179), accompanied by symptoms of dyspnea and gastrointestinal distress. He has a history of comorbidities including severe protein-calorie malnutrition, hypothyroidism, and diverticulosis. Notably, he also has a liver transplant status and a recurrent Clostridium difficile infection which complicated his hospital stay.\\n\\n**Hospital Course:**  \\nDuring the admission, the patient was closely monitored for renal function, receiving intravenous fluids and electrolyte management. He underwent several procedures including renal ultrasound and adjustment of medications to optimize kidney function. His nutritional status was assessed and addressed through dietary consultation and supplementation, which was crucial given his malnourished state. The patient responded well to treatment, with gradual improvement in renal parameters and symptom relief.\\n\\n**Key Findings and Procedures:**  \\nLaboratory results showed improvement in renal function, with serum creatinine levels decreasing significantly. Imaging studies ruled out obstructive causes of renal failure. The patient was started on a regimen that included medications for symptom management and supportive care. The multidisciplinary team was involved in managing his complex needs, ensuring a comprehensive approach to his recovery.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated stable vital signs and reported improved symptoms. He is ambulating independently and has regained some functional abilities, although he will require home health services for ongoing monitoring of renal function and nutritional support. The patient has been advised to maintain a low-sodium diet and continue fluid management.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed Acetaminophen, Aspirin, Citalopram, Levothyroxine Sodium, and others as indicated. A follow-up appointment with nephrology is scheduled within one week. Home health services will initiate visits to monitor vital signs, renal function, and adherence to dietary recommendations.',\n",
       " \"**Patient Information**: 47-year-old female, admitted under observation for acute abdominal pain. \\n\\n**History of Present Illness**: The patient presented to the emergency department with symptoms consistent with appendicitis, including right lower quadrant pain, nausea, and vomiting. Initial imaging confirmed the diagnosis of unspecified acute appendicitis (ICD-10: K3580). She also has a history of Crohn's disease (ICD-10: K5090), which was stable during this admission.\\n\\n**Hospital Course**: The patient was admitted for 2.5 days. During her stay, she received supportive care, including IV hydration with Lactated Ringer's and normal saline, and pain management with hydromorphone and tramadol. Antibiotic therapy was initiated with intravenous Amoxicillin-Clavulanic Acid and Ciprofloxacin, in addition to Metronidazole, in light of her Crohn's disease and risk of infection. She was monitored closely for any development of complications, particularly given her recent contact with a suspected COVID-19 case (ICD-10: Z20822). \\n\\n**Key Findings and Procedures**: Throughout her hospitalization, the patient displayed stable vital signs, and her abdominal pain gradually improved with treatment. Laboratory values, including white blood cell count, were within normal limits following antibiotic initiation. No surgical intervention was indicated at this time, as the patient's condition stabilized. \\n\\n**Discharge Condition and Functional Status**: The patient is being discharged in stable condition, with improved abdominal pain and no signs of acute distress. She will require home health services for ongoing medication administration and monitoring of her Crohn's disease. She is able to perform activities of daily living with minimal assistance and has a safe home environment for recovery.\\n\\n**Medications and Follow-Up Plan**: Upon discharge, the patient will continue medications including 5% Dextrose, Acetaminophen, Amoxicillin-Clavulanic Acid, Ciprofloxacin, Fexofenadine, Hydromorphone, Heparin, Metronidazole, Ramelteon, and Tramadol. A follow-up appointment is scheduled in one week with her primary care physician to assess her recovery and adjust her treatment as necessary. Home health will coordinate medication management and monitor her Crohn's disease symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Patient Name:** [Insert Patient Name]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Age:** 20 years  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 20-year-old female who presented to the hospital with complaints of severe headaches and neurological deficits. Initial evaluation revealed elevated intracranial pressure leading to a diagnosis of intracranial and intraspinal phlebitis and thrombophlebitis (ICD10 G08).  \\n  \\n**Hospital Course:**  \\nDuring her 2.7-day observation stay, the patient was monitored closely for neurological signs. She received anticoagulation therapy with Enoxaparin Sodium and Heparin Sodium to manage her condition. Pain management was achieved with Ibuprofen and Acetaminophen-Caff-Butalbital. Neurological assessments showed gradual improvement, with decreased headache intensity and stabilization of vital signs.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included a significant reduction in headache symptoms and resolution of accompanying nausea. A CT scan ruled out any acute intracranial hemorrhage, and her coagulation profile was closely monitored, revealing stable INR levels.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved functional status and was able to ambulate independently. She was educated on the importance of home health services for continued monitoring of her anticoagulation therapy and for assistance with daily activities as she recovers fully.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications:  \\n- 5% Dextrose  \\n- Acetaminophen-Caff-Butalbital  \\n- Enoxaparin Sodium  \\n- Heparin Sodium  \\n- Ibuprofen  \\n- Warfarin  \\nShe is advised to follow up with her primary care physician in one week and to contact the home health agency for support with medication management and monitoring her recovery.',\n",
       " '**Patient Summary:**  \\n**Age:** 35 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for maternal care due to a breech presentation at 38 weeks gestation. The admission was prompted by the onset of labor following a full-term premature rupture of membranes. The patient presented with mild contractions and was assessed for potential interventions necessary for delivery due to the breech position of the fetus.  \\n\\n**Hospital Course:**  \\nDuring her 4-day stay, the patient underwent continuous fetal monitoring and was counseled on delivery options. An external cephalic version was attempted but was unsuccessful, necessitating a planned cesarean delivery due to the persistent breech presentation. The procedure was completed without complications, and the patient had an uneventful recovery.  \\n\\n**Key Findings and Procedures:**  \\n- Diagnosed with breech presentation (ICD10: O321XX0) and full-term premature rupture of membranes (ICD10: O4202).  \\n- Underwent cesarean section (ICD10 Procedure: 10D00Z1) successfully.  \\n- Postoperative recovery was stable with adequate pain management and monitoring for any signs of infection.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable upon discharge with a functional status appropriate for home health services. She reports manageable pain levels, controlled with oral medications, and demonstrates the ability to perform basic self-care activities. She has been educated on wound care and signs of potential complications, which will be monitored by home health personnel.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed:  \\n- Acetaminophen, Ibuprofen for pain management  \\n- Metoclopramide for nausea as needed  \\n- Docusate Sodium and Milk of Magnesia for constipation  \\n- Naloxone as a precautionary measure  \\n\\nThe patient is advised to follow up with her obstetrician within one week for a postpartum check-up and is instructed to contact the home health service for any concerns regarding her recovery.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Admission Date:** [Redacted]  \\n**Discharge Date:** [Redacted]  \\n**Age:** 68  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation with acute and subacute hepatic failure without coma, presenting with symptoms of jaundice, ascites, and altered mental status. Relevant medical history includes portal vein thrombosis and liver cell carcinoma. His condition necessitated close monitoring and intervention during the hospital stay.  \\n\\n**Hospital Course:**  \\nDuring a 10.7-day hospital stay, the patient underwent extensive evaluation and management. He received multiple therapies, including albumin infusions, diuretics (furosemide), and lactulose for hepatic encephalopathy. Enoxaparin was initiated for thromboprophylaxis due to immobility. The patient was closely monitored for fluid status, liver function tests, and neurological evaluation. Interventions included the administration of glucose gel and glucagon due to episodes of hypoglycemia.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes, bilirubin levels, and signs of portal hypertension. Ultrasound imaging confirmed ascites and portal vein thrombosis. The management team performed paracentesis to relieve abdominal pressure and improve comfort.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, although he continues to exhibit mild hepatic encephalopathy. He requires assistance with activities of daily living (ADLs) due to weakness and fatigue. Home health services are recommended for skilled nursing care, medication management, and dietary counseling to support his recovery and nutritional needs.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on the following medications: Albumin 25%, Furosemide, Lactulose, Nadolol, and Multivitamins with minerals. A follow-up appointment with hepatology is scheduled in one week to reassess liver function and adjust treatment as necessary. Additionally, home health services will coordinate regular monitoring and provide necessary support for medication adherence. \\n\\n**Plan:**  \\nHome health services will be engaged to assist with medication administration, nutrition, and monitoring of hepatic function. The patient is advised to maintain a low-sodium diet and report any signs of worsening symptoms, such as increased confusion, abdominal pain, or significant weight gain.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 27  \\n**Gender:** Male  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Length of Stay:** 1 day  \\n\\n**History of Present Illness:**  \\nThe patient was admitted via emergency services after a reported worsening of mood and increased substance use, specifically related to psychoactive substances. He exhibited signs of a mood disorder secondary to substance abuse, including suicidal ideations. The patient's history includes multiple substance use disorders, including opioids, cannabis, and stimulants, with a background of post-traumatic stress disorder (PTSD) and self-harm.  \\n\\n**Hospital Course:**  \\nDuring his one-day hospitalization, the patient was closely monitored and assessed by the psychiatry team. He underwent a comprehensive psychiatric evaluation, which confirmed the diagnosis of other psychoactive substance abuse with a substance-induced mood disorder. The patient was stabilized with appropriate pharmacotherapy, including ARIPiprazole and Escitalopram, to manage his mood symptoms. He received supportive therapy and education on substance abuse and coping strategies.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant mood fluctuations, suicidal ideation, and physical symptoms related to substance withdrawal. The patient participated in a brief intervention and was educated on the importance of follow-up care. No invasive procedures were required during the hospital stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved mood stability and a decreased risk of self-harm, though he remains at risk due to his ongoing substance use history. He is functional for self-care but requires ongoing support to address his mental health and substance use issues. Home health services will provide the necessary follow-up care and support to facilitate his recovery.  \\n\\n**Medications at Discharge:**  \\n- ARIPiprazole  \\n- Escitalopram Oxalate  \\n- Gabapentin  \\n- CloNIDine  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- DICYCLOMine  \\n- Metoclopramide  \\n- Nicotine Polacrilex  \\n- QUEtiapine Fumarate  \\n- LOPERamide  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with a psychiatrist within one week of discharge and to engage with home health services for ongoing support and monitoring of his mental health and substance use treatment.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 25  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital from the emergency department with a diagnosis of hypovolemia (ICD10: E861). She presented with symptoms of dehydration, fatigue, and dizziness. Initial assessment revealed a history of gastroesophageal reflux disease and major depressive disorder, which may have contributed to her overall condition.  \\n\\n**Hospital Course:**  \\nDuring her 2-day stay, the patient received aggressive hydration therapy along with monitoring of her electrolytes. She was treated with intravenous fluids and medications to manage her symptoms, including pain management with hydromorphone and cough relief with guaifenesin. A multidisciplinary team, including psychiatry, was involved to address her mental health needs, given her history of major depressive disorder.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hypovolemia, controlled by IV hydration and electrolyte replacement. The patient underwent thorough evaluation for her tracheostomy status as well as congenital tracheomalacia, which was managed with appropriate respiratory support.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved hydration status, vital signs within normal limits, and stable respiratory function. She is able to perform activities of daily living with minimal assistance and is advised to continue her home health services for ongoing support, including physiotherapy and mental health follow-up.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed:  \\n- Acetaminophen  \\n- Fluoxetine  \\n- Guaifenesin  \\n- Docusate Sodium  \\n- Ipratropium-Albuterol Nebulizer  \\n- Loratadine  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments are scheduled with her primary care physician and psychiatrist within one week. Home health services will initiate contact to provide nursing care and support with her mental health management. The patient is advised to seek immediate medical attention if her symptoms worsen or if she experiences any new symptoms.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 68  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a cerebral infarction attributed to embolism of the right posterior cerebral artery, as indicated by ICD-10 code I63431. He presented with mild weakness on the right side and slight ataxia, with an NIH Stroke Scale (NIHSS) score of 2. The patient's medical history includes hydrocephalus and degenerative disease of the nervous system.  \\n\\n**Hospital Course:**  \\nDuring his two-day stay, the patient underwent comprehensive neurological evaluation and imaging studies, which confirmed the cerebral infarction. He was monitored closely for neurological changes and received appropriate medical management including anticoagulation therapy with heparin and clopidogrel. The patient’s hydration and bowel regimen were supported with intravenous saline and oral medications. His symptoms stabilized, and he exhibited gradual improvement in strength and coordination.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included mild right-sided weakness and ataxia. CT imaging confirmed the cerebral infarction. The patient required no surgical intervention, as his condition was managed conservatively.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved strength and stability, though he continues to require assistance with activities of daily living due to residual weakness. Home health services have been arranged to provide physical therapy and nursing care to support his rehabilitation and monitor his neurological status at home.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aspirin, Atorvastatin, Bisacodyl, Clopidogrel, Heparin, Senna, and Sodium Chloride 0.9% for flushes. The patient is advised to follow up with his primary care physician and neurologist within one week post-discharge to reassess his condition and adjust medications as necessary.  \\n\\n**Summary:**  \\nThe patient is stable for discharge and will benefit from home health services to aid in his recovery and monitor his medication regimen.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 81 years  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 11.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with exacerbation of hypertensive heart disease and chronic kidney disease, presenting with acute on chronic systolic heart failure. The patient experienced dyspnea, fatigue, and lower extremity edema. He has a past medical history significant for hypertension, chronic kidney disease (stage 4), and atrial fibrillation, and he is a former smoker, which may contribute to his current condition.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored and treated with diuretics, antihypertensives, and supportive measures. He received intravenous fluids and underwent renal function assessment due to acute kidney injury, which was resolved by discharge. The patient was also treated for a urinary tract infection, which improved with antibiotics.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure, peripheral edema, and laboratory evidence of renal impairment. An echocardiogram showed preserved ejection fraction with signs of diastolic dysfunction. The patient underwent a renal ultrasound to rule out obstruction, which was negative.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved heart failure symptoms. He can perform activities of daily living with minimal assistance but requires continued monitoring for weight changes and adherence to a low-sodium diet. Home health services are recommended to assist with medication management and daily activities, ensuring safety and compliance.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Aspirin, Calcitriol, Cyanocobalamin, Ezetimibe, Ferrous Gluconate, Heparin, Latanoprost 0.005% Ophth. Soln., Magnesium Oxide, Omeprazole, Rosuvastatin Calcium, Sodium Chloride 0.9% Flush, and Sevelamer Carbonate. The patient should follow up with his primary care physician and nephrologist within one week post-discharge for further management of his chronic conditions and medication adjustment.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 55  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital for observation due to alcohol dependence with withdrawal delirium (ICD-10 F10231). He exhibited signs of agitation, confusion, and diaphoresis upon admission. A comprehensive assessment was initiated to manage his withdrawal symptoms and nutritional deficiencies, which included severe protein-calorie malnutrition (ICD-10 E43).\\n\\n**Hospital Course:**  \\nDuring his 3.6-day stay, the patient received supportive care, including intravenous fluids (0.9% Sodium Chloride) and electrolyte replenishment. He was treated with phenobarbital for alcohol withdrawal symptoms and thiamine to prevent Wernicke's encephalopathy. His nutritional status improved with the administration of multivitamins and magnesium sulfate. The patient was monitored for potential complications associated with alcoholic cirrhosis (K7030) and abnormal coagulation profile (D61818). \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes and a significant drop in platelet count, indicative of secondary thrombocytopenia (D6959). A thorough neurological assessment ruled out acute encephalopathy (G9340), and he was evaluated for risk of falls, as documented by an abrasion of the head (S0081XA). \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved mental status and reduced withdrawal symptoms. He demonstrated adequate functional mobility but requires continued support for activities of daily living (ADLs) due to cognitive deficits. Home health services are recommended to assist with medication management and nutritional support. \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- **Heparin** (for DVT prophylaxis)  \\n- **Omeprazole** (for gastric protection)  \\n- **Acetaminophen** (for pain management)  \\n- **Phenobarbital** (for withdrawal management)  \\n- **Folic Acid** and **Thiamine** (for nutritional support)  \\nPatients are advised to follow up with their primary care physician within one week and to maintain regular visits with the home health team for ongoing support.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 29  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted on an urgent basis for maternal care due to breech presentation at 38 weeks gestation. She also presented with complications including anemia and respiratory issues, necessitating close monitoring and management during her hospital stay.  \\n\\n**Hospital Course:**  \\nDuring her 3-day admission, the patient underwent a thorough evaluation and management plan, which included obstetric consultations and respiratory support. Key interventions included the administration of oxygen therapy due to acute upper respiratory infection and treatment for iron deficiency anemia with appropriate supplements. The patient received routine monitoring for fetal well-being and maternal vitals.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s course was complicated by the need for intravenous fluids (Lactated Ringer’s, 0.9% Sodium Chloride), analgesics (Acetaminophen, Ibuprofen, OxyCODONE), and respiratory medications (Benzonatate, Ondansetron). A vaginal delivery was successfully performed after induction with Oxytocin, resulting in a single live birth. Post-delivery assessment revealed an uncomplicated recovery, with no significant maternal or neonatal complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulating independently and demonstrating adequate maternal and infant bonding. She is advised to continue monitoring her hemoglobin levels and respiratory status at home. Home health services will assist with post-partum care, including follow-up assessments and education on managing her anemia and respiratory health.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Enoxaparin Sodium, Docusate Sodium, and iron supplements. She is to follow up with her obstetrician within one week and with her primary care physician for anemia management. Home health nursing will commence within 48 hours to facilitate her recovery and provide necessary education on care for both herself and her newborn.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 84  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 1.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient is an 84-year-old male who presented with acute respiratory distress secondary to pneumonitis due to the inhalation of food and vomit (ICD10: J690). He had a history of chronic respiratory failure and obstructive sleep apnea, which complicated his clinical status upon admission.  \\n  \\n**Hospital Course:**  \\nDuring his short stay, the patient was stabilized with supplemental oxygen and bronchodilator therapy. He received intravenous ceftriaxone and azithromycin for the management of pneumonia. The patient also received treatment for his chronic conditions, including management of chronic respiratory failure and gastro-esophageal reflux disease.  \\n  \\n**Key Findings and Procedures:**  \\nPhysical examination on admission revealed hypoxia and wheezing. Radiological evaluation showed signs consistent with pneumonitis. The patient was monitored closely, and his respiratory status improved with oxygen therapy and nebulization. He was also started on citalopram for his underlying major depressive disorder.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved oxygen saturation and respiratory effort. He is able to perform activities of daily living with minimal assistance but will benefit from home health services for ongoing respiratory monitoring and support. A follow-up with a pulmonologist is recommended within one week of discharge.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Albuterol 0.083% Nebulizer Solution  \\n3. Aspirin  \\n4. Azithromycin  \\n5. Ceftriaxone  \\n6. Citalopram  \\n7. Clotrimazole Cream  \\n8. Dextrose 50%  \\n9. Finasteride  \\n10. Fluticasone Propionate Nasal Spray  \\n11. Glucagon  \\n12. Glucose Gel  \\n13. GuaiFENesin ER  \\n14. Influenza Vaccine Quadrivalent  \\n15. Insulin  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with a pulmonologist for further evaluation of his respiratory function. Home health services will be initiated to assist with medication management, respiratory therapy, and monitoring of his overall condition.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 78  \\n- **Gender:** Male  \\n- **Admission Type:** Elective  \\n\\n**History of Present Illness:**  \\nThe patient is a 78-year-old male with a history of nonrheumatic aortic stenosis, essential hypertension, and hyperlipidemia, who was admitted for an elective valve replacement procedure. He presented for evaluation due to progressive exertional dyspnea and fatigue.  \\n\\n**Hospital Course:**  \\nThe patient underwent an elective aortic valve replacement on the morning of admission. The procedure was uneventful, and he was monitored in the cardiac care unit post-operatively. He received standard post-operative care, including pain management, anticoagulation therapy, and monitoring for any complications. The patient responded well to treatment, with stable vital signs and no significant arrhythmias noted.  \\n\\n**Key Findings and Procedures:**  \\nPre-operatively, the patient exhibited a heart murmur consistent with aortic stenosis. Post-operative echocardiogram confirmed successful valve replacement with improved hemodynamics. He was started on a regimen of aspirin, clopidogrel, and atorvastatin to manage his cardiovascular risk post-discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved functional capacity. He demonstrated the ability to ambulate independently and reported minimal pain, managed effectively with acetaminophen. The patient is instructed to monitor his activity level and adhere to a low-sodium diet to manage his hypertension.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Clopidogrel  \\n- Metoprolol Succinate XL  \\n- Potassium Chloride  \\n- Ramelteon  \\n- Vancomycin (as per infectious disease recommendations)  \\n- Vitamin D  \\nThe patient is advised to follow up with his cardiologist within one week and to initiate home health services for post-operative care, including medication management, physical therapy, and monitoring of vital signs. Home health services will also assist in reinforcing his dietary restrictions and activity guidelines.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 81  \\nGender: Female  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 5.6 days  \\n**Primary Diagnosis:** Unspecified hydronephrosis (ICD-10: N1330)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of abdominal pain and difficulty in urination. Initial imaging studies revealed significant hydronephrosis attributed to a mass in the left kidney, leading to acute renal failure. The patient's history was complicated by chronic lymphocytic leukemia and other comorbidities, such as chronic kidney disease and obstructive sleep apnea.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a urological evaluation and was started on intravenous fluids and diuretics to manage her acute kidney failure. A nephrology consult was obtained, and subsequent imaging confirmed the diagnosis of hydronephrosis due to obstructive pathology. The patient was monitored closely for renal function and hydration status, with gradual improvement noted. Pain management was optimized using acetaminophen and lorazepam.  \\n  \\n**Key Findings and Procedures:**  \\n- Significant hydronephrosis on imaging, secondary to malignancy.  \\n- Hematuria was noted during the hospital stay.  \\n- The patient was stabilized with adjustments to her antihypertensive regimen (metoprolol) and continued anticoagulant therapy for atrial fibrillation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is clinically stable at discharge but requires continued home health services for assessment of renal function, medication management, and assistance with activities of daily living due to her advanced age and comorbidities. She has been advised to maintain a low-salt diet and hydrate adequately.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Allopurinol  \\n- Escitalopram Oxalate  \\n- Metoprolol Succinate XL  \\n- Ondansetron  \\n- Polyethylene Glycol  \\n- Others as necessary for symptom management.  \\n  \\n**Follow-Up Plan:**  \\nHome health services will initiate follow-up within 48 hours post-discharge, with a nephrology appointment scheduled in one week to monitor kidney function and overall health status. The patient and caregivers have been educated on signs of complications and when to seek further medical attention.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 72 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.5 days  \\n**Primary Diagnosis:** Gastro-esophageal reflux disease (GERD) without esophagitis (ICD10: K21.9)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of persistent heartburn and regurgitation. These symptoms had been escalating over the past month, accompanied by occasional dysphagia. A thorough evaluation revealed significant gastro-esophageal reflux disease without evidence of esophagitis, leading to admission for management.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was started on a regimen of pantoprazole to manage his GERD. He received supportive care including IV fluids (0.9% Sodium Chloride, Lactated Ringer's), pain management with acetaminophen, and monitoring of his chronic conditions, which include hypertensive heart disease and chronic kidney disease.  \\n\\n**Key Findings and Procedures:**  \\nUpon admission, the patient underwent a series of lab tests and imaging studies. Key findings included chronic diastolic heart failure and myelofibrosis, which were stable during hospitalization. Cardiology was consulted for ongoing management of his cardiac conditions, and he was advised to continue clopidogrel and atorvastatin post-discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with improved symptoms related to GERD. He is able to perform activities of daily living independently but will require assistance with meal preparations and medication management due to his complex medication regimen. Home health services will be initiated to monitor his cardiac status and assist with medication adherence.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Pantoprazole, Metoprolol Succinate XL, Atorvastatin, Clopidogrel, and others as detailed in the discharge medication list. He is advised to follow up with his primary care physician within one week and to schedule a cardiology appointment for further management of his heart failure and chronic kidney disease. Home health services will contact the patient within 48 hours post-discharge to establish a care plan.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 47  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of an infection and inflammatory reaction due to an internal fixation device of the left leg. The patient presented with significant pain and swelling, along with erythema in the affected area. Additionally, there was a history of type 1 diabetes which complicated the clinical picture.  \\n\\n**Hospital Course:**  \\nDuring her 4.6-day hospital stay, the patient was started on intravenous antibiotics, including Cefazolin, and underwent debridement of the infected tissue. Pain management was optimized with Acetaminophen and Enoxaparin was administered as prophylaxis against venous thromboembolism. The patient was monitored for signs of systemic infection and glycemic control was maintained through her insulin pump.  \\n\\n**Key Findings and Procedures:**  \\nInitial imaging confirmed the presence of the fixation device with surrounding cellulitis. Surgical intervention was performed to address the infection, and the patient tolerated the procedure well with no immediate complications. Post-operatively, the patient showed gradual improvement with decreased swelling and pain.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating with assistance. She demonstrated an understanding of her medication regimen and wound care instructions. Due to her diabetes and recent surgery, home health services have been arranged to assist with wound management and ensure adherence to her diabetes care plan.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Bisacodyl  \\n3. BuPROPion XL  \\n4. Cefazolin  \\n5. Enoxaparin Sodium  \\n6. Escitalopram Oxalate  \\n7. Insulin (via pump)  \\n8. Docusate Sodium  \\n9. Glucose Gel  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with the orthopedic surgeon in one week. Home health will initiate services within 48 hours of discharge to monitor her condition and provide assistance with daily activities as needed. Glycemic levels will also be monitored to prevent any complications related to her diabetes.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 37  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with obstructed labor due to compound presentation at 38 weeks gestation. She reported significant discomfort and was in active labor upon admission. The decision for urgent intervention was made considering the potential risks associated with prolonged labor.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely for maternal and fetal well-being. She received intravenous fluids, analgesics including acetaminophen, ibuprofen, and ketorolac for pain management, and was administered metoclopramide and ondansetron for nausea. A vaginal delivery was achieved successfully with the assistance of spinal anesthesia without complications. \\n\\n**Key Findings and Procedures:**  \\nAn obstetric ultrasound confirmed fetal position and size, and the patient had a full-term rupture of membranes. The patient was treated for oligohydramnios and observed for signs of infection due to being a Streptococcus B carrier. A cesarean delivery was avoided, and the patient was discharged with a healthy newborn.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable and ambulating independently. She demonstrates adequate self-care abilities and is able to manage personal hygiene and mobility. However, she will require home health services for ongoing monitoring of her postpartum recovery, education on infant care, and assistance with activities of daily living as needed.\\n\\n**Medications:**  \\nUpon discharge, the patient is prescribed acetaminophen, ibuprofen, and oxycodone (immediate release) for pain management. Additionally, she will continue calcium carbonate and docusate sodium to aid in her gastrointestinal health post-delivery. Other medications include metoclopramide and ondansetron for nausea.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for a postpartum assessment and to monitor for any complications. Home health services will initiate a visit to evaluate her recovery and provide education on newborn care.',\n",
       " 'Patient is a 50-year-old female who was admitted through the emergency department with a diagnosis of Pneumocystosis (ICD10 B59) and concurrent COVID-19 (ICD10 U071) exacerbated by a background of common variable immunodeficiency, rheumatoid arthritis, and hypertension. She experienced progressive dyspnea and fever upon admission, necessitating supplemental oxygen and initiation of anti-infective therapy.\\n\\nDuring her 8-day hospital stay, the patient was treated with Atovaquone suspension, Acyclovir, and supportive care, including hydration and monitoring of electrolytes. She underwent regular assessments of lung function and was placed on a steroid taper to manage her inflammatory response. Key findings included significant improvement in oxygen saturation and reduction of respiratory distress, as evidenced by clinical assessment and imaging studies.\\n\\nOn discharge, the patient is stable, with improved respiratory function and is able to ambulate independently. However, she will require ongoing home health services for continued monitoring and assistance with activities of daily living due to her underlying immunodeficiency and the need for careful management of her medications.\\n\\nHer discharge medications include Acetaminophen, Acyclovir, Atovaquone, Hydroxychloroquine, and a regimen of supportive medications including calcium gluconate and colchicine. A follow-up appointment is scheduled with her primary care physician in 1 week, and she will have home health nursing visits twice weekly to monitor her recovery and manage any complications.\\n\\nIn summary, the patient is discharged in stable condition with adequate instructions for medication administration, signs of potential complications to monitor, and a clear plan for follow-up care.',\n",
       " \"**Discharge Summary**  \\n**Patient ID**: [REDACTED]  \\n**Date of Admission**: [REDACTED]  \\n**Date of Discharge**: [REDACTED]  \\n**Length of Stay**: 3.5 days  \\n**Age/Sex**: 42/F  \\n  \\n**History of Present Illness**:  \\nThe patient is a 42-year-old female who presented for a same-day surgical admission due to disruption of an internal surgical wound (ICD-10: T8132XA). She has a significant past medical history of essential hypertension (I10), atherosclerotic heart disease without angina (I2510), and a prior myocardial infarction.  \\n  \\n**Hospital Course**:  \\nDuring her hospitalization, the patient underwent surgical intervention to address the wound disruption. Postoperatively, she was monitored for complications, and her pain was managed effectively with hydromorphone and acetaminophen. The patient received prophylactic heparin for venous thromboembolism prevention. She was also treated with intravenous fluids, including lactated Ringer's and 0.9% sodium chloride, and received antibiotics (Cefazolin) to prevent infection.  \\n  \\n**Key Findings and Procedures**:  \\nThe surgical procedure was successful with no immediate complications. Postoperative imaging and laboratory tests showed stable vitals and acceptable wound healing progress. She was educated on wound care and signs of infection.  \\n  \\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient was stable and ambulating independently with minimal assistance. She demonstrated understanding of her home care instructions, including wound care and medication management. Home health services will be initiated to provide follow-up care, including nursing visits for wound assessment and medication administration.  \\n  \\n**Medications and Follow-Up Plan**:  \\nAt discharge, the patient was prescribed the following medications: Aspirin, Atenolol, Omeprazole, Docusate Sodium, and Hydromorphone as needed for pain. She is advised to follow up with her primary care physician within one week for further evaluation and management of her hypertension and cardiac status. Home health nursing will monitor her recovery and ensure adherence to discharge instructions.\",\n",
       " 'Patient is a 52-year-old female who was admitted for observation with a primary diagnosis of hypertensive heart and chronic kidney disease with heart failure, specifically stage 5 chronic kidney disease. She presented with severe fatigue, edema, and shortness of breath, consistent with acute on chronic systolic heart failure. Initial laboratory evaluations revealed elevated BUN and creatinine levels, confirming the diagnosis of end-stage renal disease. \\n\\nDuring her 4.5-day hospital stay, the patient received treatment for her heart failure and kidney issues, including diuretics for fluid overload and medications for blood pressure management. She was monitored closely for respiratory status due to an acute episode of hypoxia, which improved with supplemental oxygen and bronchodilator therapy. A nephrology consult was obtained, and the patient was advised on renal replacement therapy options.\\n\\nKey findings included significant fluid overload evidenced by weight gain and bilateral lower extremity edema. Echocardiogram revealed reduced ejection fraction consistent with heart failure. The patient underwent the procedure of dialysis (5A1D70Z) to manage her renal function, which stabilized her electrolyte levels and improved her overall condition. \\n\\nOn discharge, the patient demonstrated improved functional status, able to ambulate with minimal assistance and perform activities of daily living (ADLs) with supervision. She requires home health services for ongoing monitoring of her renal function and cardiac status, medication management, and assistance with ADLs. \\n\\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Allopurinol, Apixaban, Aspirin, CefTAZidime, Gabapentin, and Midodrine, among others. The patient is advised to follow up with nephrology and cardiology within one week post-discharge to reassess her condition and adjust her treatment plan accordingly. Home health services will initiate within 48 hours to support her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 66, Gender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 12.8 days  \\n**Primary Diagnosis:** Pyogenic arthritis, unspecified (ICD10: M009)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with complaints of joint swelling, pain, and fever, which progressed over the course of several days. Initial evaluation revealed signs consistent with pyogenic arthritis, leading to further diagnostic imaging and laboratory testing.  \\n  \\n**Hospital Course:**  \\nDuring the hospitalization, the patient was started on intravenous antibiotics, including Daptomycin, with subsequent improvement in clinical symptoms. He also received supportive care for his acute respiratory failure with hypoxia, secondary to pneumonia (ICD10: J189). The patient was monitored closely for any signs of osteomyelitis, and pain management strategies were employed effectively.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies confirming the diagnosis of pyogenic arthritis without evidence of osteomyelitis. Notable lab findings included elevated inflammatory markers and signs of acute kidney injury (ICD10: N179). The patient was treated with 0.9% Sodium Chloride for hydration and supportive measures were implemented.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated significant clinical improvement, with reduced joint swelling and pain. He is ambulatory with assistance and requires ongoing physical therapy to regain strength and mobility. Home health services are recommended for medication management, physical therapy, and monitoring of vital signs.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen for pain, Acyclovir for viral prophylaxis, and Allopurinol for gout management. The patient is advised to follow up with his primary care physician within one week post-discharge and to contact home health services for assistance with rehabilitation and medication management.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Birth:** [Date of Birth]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old female with a history of atherosclerotic heart disease presenting with unstable angina pectoris. She was admitted for observation due to recurrent chest pain and associated symptoms. Initial evaluation indicated a significant cardiac risk profile, prompting further monitoring and management.  \\n\\n**Hospital Course:**  \\nDuring her 3.8-day stay, the patient underwent a comprehensive cardiac workup, including cardiac enzyme tests and imaging. She was treated with appropriate medications including antiplatelet therapy (Aspirin, Clopidogrel), beta-blockers, and statins. Intravenous antibiotics were initiated for a urinary tract infection, which was confirmed during her stay. The patient experienced a stable course with no acute events during hospitalization and showed improvement in symptoms.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s primary diagnosis was confirmed as atherosclerotic heart disease with unstable angina (ICD10: I25110). Additional diagnoses included a urinary tract infection (ICD10: N390) and type 2 diabetes without complications (ICD10: E119). Relevant procedures included cardiac monitoring and medication adjustments to optimize her cardiovascular status.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved angina control. She is currently independent in her activities of daily living, but requires home health services for medication management, monitoring of blood pressure, and assistance with dietary modifications related to her diabetes.  \\n\\n**Medications at Discharge:**  \\n1. **Aspirin 81 mg** daily  \\n2. **Clopidogrel 75 mg** daily  \\n3. **Alprazolam** as needed for anxiety  \\n4. **Antibiotics** (Ceftriaxone, Cefpodoxime) for UTI treatment  \\n5. **Additional medications**: Calcium Gluconate, Docusate Sodium, Acetaminophen.  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her cardiologist within one week of discharge to monitor her heart condition and adjust medications as needed. Home health nursing will initiate visits within 48 hours for ongoing assessment and support.',\n",
       " \"Patient is a 28-year-old female who was admitted urgently for labor and delivery complicated by unspecified cord complications. She delivered a single live birth at 39 weeks gestation. During her hospital stay, which lasted approximately 1.6 days, she was monitored closely for any complications associated with both the labor process and postpartum recovery.\\n\\nThe patient experienced a typical labor progression but required interventions due to cord complications, resulting in the administration of Oxytocin to augment labor. Post-delivery, the patient was managed for common puerperal complications, which included retention of urine and varicose veins in the lower extremities. She was also monitored for potential exposure to COVID-19 during her stay, although no symptoms were noted. Key findings included stable vital signs and normal postpartum recovery parameters.\\n\\nThe patient underwent a few procedures, notably an intravenous fluid administration (Lactated Ringer's and 0.9% Sodium Chloride) to ensure hydration and manage postpartum status. She was also given pain management medications (Acetaminophen, Ibuprofen) and gastrointestinal motility aids (Docusate Sodium, Senna, Simethicone) to address common postpartum discomforts. Dermoplast Spray was provided to assist with perineal care.\\n\\nUpon discharge, the patient was stable with no acute complications. She reported good pain control and was able to ambulate independently. However, continued assistance with personal care and monitoring for any urinary retention is advised. The patient will benefit from home health services for further monitoring of her recovery and assistance with daily activities, particularly due to the varicose veins and postpartum considerations.\\n\\nDischarge medications include 0.9% Sodium Chloride flushes, Acetaminophen, Calcium Carbonate, Ibuprofen, and instructions for continued hydration and activity modification. Follow-up is advised with her primary care physician within one week for postpartum evaluation and management of any ongoing complications.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Patient Name:** [REDACTED]  \\n**Age:** 66  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with a diagnosis of malignant neoplasm of the left renal pelvis (ICD-10: C652) and underwent a left nephroureterectomy. The patient has a significant medical history including acute kidney failure (N179), paroxysmal atrial fibrillation (I480), essential hypertension (I10), and hyperlipidemia (E785). He is also on long-term anticoagulation therapy.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for surgical intervention and tolerated the procedure well. Post-operatively, he was monitored in the surgical unit where his vital signs remained stable. Pain management included acetaminophen and morphine sulfate, and anticoagulation was managed with heparin. The patient received IV fluids and was transitioned to oral medications including lisinopril and atorvastatin.  \\n  \\n**Key Findings and Procedures:**  \\nThe surgical procedure (ICD-10: 0TT14ZZ, 0TT74ZZ) was successful with no intraoperative complications. Post-surgery, the patient demonstrated improved renal function and was cleared for discharge. Key findings included stable renal parameters and resolution of acute kidney failure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating independently with minimal assistance. He was advised to follow up with a home health nurse for monitoring of his recovery, medication adherence, and management of his anticoagulation therapy. The patient was educated on signs of infection and the importance of maintaining hydration.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed 0.9% sodium chloride, acetaminophen, aspirin, atorvastatin, diphenhydramine, docusate sodium, ketorolac, lisinopril, metoprolol succinate XL, and ondansetron. A follow-up appointment is scheduled in one week with oncology for further management of his malignancy. Home health services will assist with medication management and routine assessments.',\n",
       " '**Patient Information:** 78-year-old female admitted for observation due to multiple bilateral rib fractures (ICD-10: S2243XA) sustained from a traffic accident. Her past medical history is significant for hypertension, atrial fibrillation, heart failure, and urinary tract infection.  \\n\\n**History of Present Illness:** The patient presented to the emergency department with complaints of chest pain, shortness of breath, and tenderness upon palpation of the thoracic region. Initial imaging confirmed multiple closed fractures of the ribs. \\n\\n**Hospital Course:** During her 3.8-day stay, the patient was monitored for pain management and respiratory function. She received acetaminophen and morphine for pain control, and her respiratory status was stable throughout her stay. The urinary tract infection was treated with Sulfameth/Trimethoprim DS, resolving her symptoms. Additionally, her atrial fibrillation was managed with Metoprolol and Moexipril, ensuring her heart rate remained controlled. The patient was educated on the importance of deep breathing exercises to prevent atelectasis and promote lung expansion. \\n\\n**Key Findings and Procedures:** Imaging studies revealed bilateral rib fractures without any associated pulmonary complications. Her vital signs remained stable, and laboratory studies indicated no acute distress. A physical therapy consult was initiated to assess her mobility and safety for discharge.  \\n\\n**Discharge Condition and Functional Status:** The patient is discharged in stable condition, with functional limitations primarily due to pain and mobility restrictions from her rib fractures. She will benefit from home health services for physical therapy and pain management, and is advised to adhere to a careful medication regimen to manage her chronic conditions.  \\n\\n**Medications and Follow-Up Plan:** Discharge medications include Alendronate Sodium, Docusate Sodium, Hydrochlorothiazide, Phenytoin Sodium Extended, and other supportive medications. A follow-up appointment is scheduled in 1 week with her primary care physician to reassess her pain management strategy and overall recovery. Home health services will initiate therapy within 48 hours to facilitate her recovery process.',\n",
       " '**Patient Information:** 38-year-old female admitted urgently with gestational hypertension complicating childbirth (ICD10: O134). \\n\\n**History of Present Illness:** The patient presented to our facility in active labor, with elevated blood pressure readings indicative of gestational hypertension. The patient reported mild headaches and occasional visual disturbances. Upon examination, the patient was found to be 39 weeks pregnant with a single live birth. \\n\\n**Hospital Course:** After admission, the patient was closely monitored for blood pressure and fetal heart rate, which showed abnormalities during labor (ICD10: O76). She underwent a successful vaginal delivery with the assistance of obstetricians, and her blood pressure stabilized post-delivery. There were no significant complications during the delivery process. The patient was treated with acetaminophen for pain management, ibuprofen for inflammation, and other supportive care measures. \\n\\n**Key Findings and Procedures:** The patient was diagnosed with gestational hypertension without significant proteinuria. She experienced a second-degree perineal laceration during delivery (ICD10: O701), which was repaired without issue. Additionally, she was treated for anogenital warts (ICD10: A630) and abnormal fetal heart rates (ICD10: O76) during her stay. \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, with normalized blood pressure readings and satisfactory pain control. She is ambulatory and able to perform activities of daily living with minimal assistance. Home health services are recommended for continued monitoring of blood pressure and assistance with post-operative care, including perineal care and emotional support for post-traumatic stress disorder (ICD10: F4310). \\n\\n**Medications at Discharge:** The patient was prescribed acetaminophen, ibuprofen, calcium carbonate, docusate sodium, senna, simethicone, and Dermoplast spray for perineal care. \\n\\n**Follow-Up Plan:** The patient is advised to follow up with her obstetrician within one week for a postpartum checkup and management of her mental health concerns.',\n",
       " 'Patient is an 81-year-old male admitted for surgical intervention due to a diagnosis of atherosclerotic heart disease of the native coronary artery without angina pectoris (ICD-10 I2510). He underwent coronary angioplasty and stenting (ICD-10 procedures 02100Z9, 021009W) in the setting of a planned surgical admission, which lasted approximately 4.7 days. \\n\\nDuring his hospital stay, the patient experienced post-operative monitoring for potential complications including acute posthemorrhagic anemia and essential hypertension. He was managed with IV fluids, blood transfusion, and medications to stabilize his blood pressure. The patient demonstrated good tolerance to the procedure and had an uneventful recovery with no significant post-operative complications. Key findings included stable vital signs and appropriate cardiac output with no signs of heart failure. \\n\\nUpon discharge, the patient is stable with improved functional status. He is able to perform basic activities of daily living (ADLs) with minimal assistance and reports no chest pain or shortness of breath. However, given his age and co-morbidities, continued home health services are recommended to assist with medication management and monitor his cardiovascular health. \\n\\nMedications upon discharge include Acetaminophen, Aspirin EC, Atorvastatin, Metoprolol Tartrate, Furosemide, and others to manage his cardiovascular risk factors, along with insulin for blood glucose control. A follow-up appointment with cardiology is scheduled in one week, and outpatient physical therapy is recommended to enhance mobility and strength. The patient and caregiver have been educated on medication adherence and the signs of potential complications requiring immediate medical attention.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 47  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient, a 47-year-old female, was admitted for observation due to symptomatic gallbladder disease, specifically calculus of the gallbladder and bile duct without cholecystitis or obstruction (ICD-10: K8070). She presented with intermittent abdominal pain and nausea, prompting further evaluation.  \\n\\n**Hospital Course:**  \\nDuring her 2.7-day stay, the patient underwent imaging studies which confirmed the presence of gallstones. She was managed conservatively with intravenous fluids, antibiotics (Ampicillin-Sulbactam), and pain control with Hydromorphone and Oxycodone. Additionally, she was started on Levothyroxine for her previously diagnosed hypothyroidism and received supportive care for her obesity, anemia, and osteoarthritis.  \\n\\n**Key Findings and Procedures:**  \\nImaging revealed multiple gallstones without evidence of inflammation or obstruction. The patient was monitored closely for any signs of complications. She received a total of 3 doses of Ondansetron for nausea, and her vital signs remained stable throughout her hospital stay. She was also administered an influenza vaccine prior to discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was clinically stable, with improved abdominal symptoms. She is ambulating independently but requires assistance with activities of daily living due to her obesity and osteoarthritis. A referral to home health services has been made to assist with mobility and monitor her dietary intake.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient is to continue the following medications:  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Ampicillin-Sulbactam  \\n- D5 1/2NS  \\n- Hydromorphone (Dilaudid)  \\n- Heparin  \\n- Levothyroxine Sodium  \\n- Magnesium Sulfate  \\n- Ondansetron  \\n- OxyCODONE (Immediate Release)  \\n- Potassium Chloride  \\n- Sodium Chloride 0.9% Flush  \\n\\nThe patient is advised to follow up with her primary care physician within one week and to contact home health services for assistance.  \\n**End of Summary**.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 57 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital following an episode of asphyxiation due to food obstruction in the pharynx (ICD10: T17220A). The patient was promptly resuscitated and stabilized in the emergency department before being transferred to the inpatient unit for further management.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient exhibited signs of acute respiratory distress syndrome, likely secondary to aspiration (J80). He received supportive care, including oxygen therapy and nebulization with Ipratropium-Albuterol, as well as intravenous antibiotics (Ampicillin-Sulbactam) to address possible aspiration pneumonia. The patient also required fluid management due to signs of dehydration.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s chest X-ray revealed bilateral infiltrates consistent with pneumonitis due to aspiration (J690). A comprehensive metabolic panel indicated chronic kidney disease (N189) and elevated liver enzymes consistent with chronic hepatitis B (B181). Mental health evaluation was performed, revealing significant major depressive disorder with psychotic features (F323).  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required assistance with activities of daily living, especially due to his depressive symptoms and physical weakness post-aspiration event. He demonstrated understanding of his condition and the need for follow-up care. The patient’s home health services will focus on monitoring his respiratory status, medication compliance, and mental health support to ensure a safe recovery at home.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed the following medications: 0.9% Sodium Chloride for hydration, Acetaminophen IV for pain relief, Mirtazapine and OLANZapine for mood stabilization, along with Tamsulosin for urinary symptoms. A follow-up appointment with his primary care physician and a psychiatrist is recommended within one week to reassess his mental health and overall clinical status.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Age:** 30  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.5 Days  \\n**Diagnosis:** Cerebral aneurysm, nonruptured (ICD10: I671)  \\n\\n**History of Present Illness:**  \\nThe patient, a 30-year-old female, was admitted for surgical evaluation and management of a nonruptured cerebral aneurysm. The patient reported intermittent headaches over the past several months, but no neurological deficits were noted at the time of admission. Family history is significant for vascular conditions. \\n\\n**Hospital Course:**  \\nThe patient underwent a successful endovascular coiling procedure on the day of admission. Post-operatively, she was monitored in the neurocritical care unit where she remained stable. Pain management was initiated with acetaminophen and oxycodone, and her anxiety was managed with lorazepam as needed. The patient was also treated for asthma exacerbation with albuterol and fluticasone propionate.  \\n\\n**Key Findings and Procedures:**  \\nPre-operative imaging confirmed the presence of a nonruptured cerebral aneurysm, and the endovascular procedure was performed without complications. Post-operative imaging demonstrated successful occlusion of the aneurysm. The patient experienced transient nausea post-procedure, managed with antiemetics. She was mobilized early and participated in physical therapy, achieving her discharge goals. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was neurologically intact, with no signs of complications. She demonstrated the ability to ambulate independently and manage her activities of daily living with minimal assistance. Home health services will provide support for continued monitoring of her neurological status and medication management, especially regarding her antiplatelet therapy with clopidogrel. \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, albuterol inhaler, aspirin, clopidogrel, and other supportive medications. The patient is advised to follow up with her neurologist in one month and to maintain regular contact with her home health nurse for medication compliance and monitoring of any neurological symptoms. She has been instructed to call for any new or worsening symptoms, particularly headaches or changes in vision.\",\n",
       " '**Patient Information**: 64-year-old female admitted through the emergency department with a primary diagnosis of unspecified bacterial pneumonia (ICD-10 J159).  \\n\\n**History of Present Illness**: The patient presented with acute onset of fever, cough, and dyspnea, with a history of chronic obstructive pulmonary disease (COPD) exacerbation. Initial work-up indicated respiratory failure, necessitating supplemental oxygen and intravenous fluids.  \\n\\n**Hospital Course**: The patient was stabilized over a 4.5-day hospital stay, during which she received broad-spectrum antibiotics, bronchodilators, and corticosteroids. She exhibited significant improvement in her respiratory status, with weaning off supplemental oxygen by day three. Renal function was monitored closely due to acute kidney failure (ICD-10 N179) and elevated blood glucose levels attributed to her known type 2 diabetes.  \\n\\n**Key Findings and Procedures**: Chest X-ray confirmed bilateral infiltrates consistent with pneumonia. Laboratory tests showed resolution of leukocytosis and improvement in arterial blood gas readings. The patient also underwent daily monitoring of blood glucose levels, which required adjustments in her insulin regimen.  \\n\\n**Discharge Condition and Functional Status**: At discharge, the patient was afebrile, with improved respiratory function and stable vital signs. She demonstrated the ability to ambulate independently but required assistance with activities of daily living (ADLs) due to weakness. Home health services are recommended for skilled nursing for continued monitoring of her respiratory status, administration of medications, and assistance with ADLs, including medication management.  \\n\\n**Medications at Discharge**: The patient is to continue on acetaminophen, atorvastatin, furosemide, and insulin, among others. A follow-up appointment is scheduled with her primary care physician within one week. Home health nursing will also coordinate care with the primary physician for ongoing management of her diabetes and COPD.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 56  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention related to persistent atrial fibrillation (ICD-10 I481). She has a complex medical history including acute on chronic systolic heart failure (I5023), cardiomyopathy, and long-term anticoagulant use. The patient experienced worsening symptoms prior to admission, including palpitations and shortness of breath.\\n\\n**Hospital Course:**  \\nDuring her 3.4-day stay, the patient underwent catheter ablation for atrial fibrillation. Post-procedural recovery was monitored closely due to her history of congestive heart failure and use of anticoagulants. The patient responded well to treatment, with stabilization of heart rate and resolution of acute symptoms. There were no significant complications, although she experienced postprocedural hypotension which was managed effectively.\\n\\n**Key Findings and Procedures:**  \\nPre-procedure echocardiogram revealed reduced ejection fraction consistent with her heart failure. Following the ablation, she was started on a regimen including Apixaban and Metoprolol Tartrate to manage her atrial fibrillation and heart rate. Other medications included Furosemide for fluid management, Levothyroxine for hypothyroidism, and BuPROPion for depressive symptoms. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved functional capacity compared to admission. She is alert and oriented, demonstrating the ability to perform activities of daily living with minimal assistance. Home health services will be initiated to provide nursing care for medication management and monitoring of her heart condition. \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Aspirin EC, Entresto, Lorazepam, and others as listed. The patient is advised to follow up with her cardiologist within one week for ongoing management of her heart condition and to monitor her response to the new medication regimen. Home health nursing will assist in medication adherence and monitor for any signs of complications.',\n",
       " 'Patient is a 55-year-old female who was admitted for observation due to a peritoneal abscess (ICD10: K651). She presented with abdominal pain, fever, and nausea, which prompted imaging studies revealing the abscess. During her 6.7-day hospital stay, the patient underwent a percutaneous drainage procedure (0W9G3ZZ) which successfully decompressed the abscess. Her hospital course was complicated by mild atelectasis and controlled hypertension, but she responded well to treatment.\\n\\nKey findings included elevated white blood cell count and imaging confirming the presence of the abscess. She was started on intravenous antibiotics (Amoxicillin-Clavulanic Acid) and supportive care, including pain management with Acetaminophen. The patient was monitored closely for signs of infection or further complications.\\n\\nUpon discharge, the patient’s condition has stabilized. She is now afebrile, with improved abdominal pain and resolution of nausea. Functional status is fair; she requires assistance for activities of daily living and mobility due to weakness from her illness and the intervention. Home health services will be required to assist with wound care from the drainage site, medication management, and physical therapy to enhance her strength and mobility.\\n\\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Amoxicillin-Clavulanic Acid, Gabapentin, Calcium Carbonate, and Citalopram. The patient is advised to follow up with her primary care physician within one week and to contact home health services for ongoing support. Education was provided regarding signs of infection and the importance of adherence to the medication regimen.',\n",
       " 'Patient is a 66-year-old female with a history of post-traumatic osteoarthritis of the right ankle and foot, complicated by Type 1 diabetes mellitus and associated neuropathies. She was admitted for surgical intervention to alleviate pain and improve function in her right ankle, which has significantly impacted her mobility and quality of life. The patient underwent a surgical procedure (ICD-10: 0SGF0JZ) aimed at addressing her osteoarthritis. \\n\\nDuring her 1.5-day hospital stay, she was monitored for pain management and post-operative recovery. The patient received appropriate analgesia, including acetaminophen and hydromorphone for pain control. Her diabetes was managed with insulin therapy, and her blood glucose levels were stabilized. The patient also received education on foot care, considering her diabetic neuropathy.\\n\\nKey findings during her stay included controlled post-operative pain, stable vital signs, and no signs of infection at the surgical site. She demonstrated improved mobility by participating in physical therapy sessions, which focused on range of motion and strengthening exercises for her right ankle. \\n\\nUpon discharge, the patient is in stable condition with improved functional status. She is ambulating with a walker and reports a decrease in pain levels. Home health services will be initiated to assist with physical therapy and monitoring of her diabetes management. The patient will require ongoing physical therapy to enhance her recovery and prevent complications.\\n\\nDischarge medications include 0.9% Sodium Chloride, Acetaminophen, Aspirin, Gabapentin, and Insulin (via pump). The patient is advised to follow up with her primary care physician in one week and with the orthopedic surgeon in two weeks to assess progress and adjust her rehabilitation plan as needed.',\n",
       " '**Patient Information:**  \\nAge: 73  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted under observation for a nondisplaced bicondylar fracture of the left tibia following a fall from a chair. She has a significant past medical history including quadriplegia, multiple sclerosis, and age-related osteoporosis, which complicates her recovery process.  \\n\\n**Hospital Course:**  \\nDuring her 5.8-day stay, the patient was managed with pain control through analgesics and muscle relaxants. She received physical therapy to improve mobility and strength. A urinary tract infection was treated with cefpodoxime. Additionally, the patient was monitored for her respiratory condition due to a history of asthma, ensuring she was stable with appropriate bronchodilator therapy.  \\n\\n**Key Findings and Procedures:**  \\nImaging confirmed the fracture, and no surgical intervention was deemed necessary. The patient was assessed daily by physical therapy for ambulation and gait training. The pain was managed effectively with acetaminophen and baclofen, and her respiratory status improved with the use of an albuterol inhaler.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, though she remains wheelchair-dependent due to her underlying conditions. She requires assistance with activities of daily living (ADLs) and is advised to continue physical therapy at home to regain strength and mobility. Home health services will facilitate her rehabilitation, focusing on mobility enhancement and urinary health management.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes acetaminophen, albuterol inhaler, alendronate sodium, baclofen, cefpodoxime, cyclobenzaprine, diazepam, docusate sodium, fluticasone propionate, gabapentin, heparin, Neutra-Phos, polyethylene glycol, senna, and simvastatin. A follow-up appointment with her primary care physician is recommended within one week to evaluate her recovery and ongoing management of her complex medical needs.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Initials]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 32 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 32-year-old female who was admitted for observation due to a confirmed diagnosis of a malignant neoplasm of the brain stem (ICD-10: C717). She presented with neurological symptoms including headaches, dizziness, and anxiety. Her past medical history is notable for generalized anxiety disorder (ICD-10: F411) and nicotine dependence (ICD-10: F17210).\\n\\n**Hospital Course:**  \\nDuring her 4-day stay in the hospital, the patient underwent a series of diagnostic imaging studies and neurological evaluations. A multidisciplinary team was involved in managing her care, including neurology, oncology, and psychiatry. The patient was treated with dexamethasone to reduce cerebral edema and was initiated on supportive medications including famotidine and docusate sodium. Pain management was achieved with acetaminophen, and she received prophylactic heparin to prevent venous thromboembolism. Additionally, the patient was vaccinated with the quadrivalent influenza vaccine.\\n\\n**Key Findings and Procedures:**  \\nKey findings revealed significant edema surrounding the tumor on MRI. Interventions included monitoring intracranial pressure and adjusting her medication regimen based on her clinical response. The patient demonstrated improvement in her functional status, although she continues to experience some anxiety related to her diagnosis.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved neurological status and vital signs within normal limits. She is able to perform activities of daily living with assistance and has been instructed on the importance of regular follow-up with her oncologist and mental health provider. Home health services will be arranged to assist with medication management and support for anxiety.\\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include dexamethasone, famotidine, and pain management as needed. The patient is advised to follow up with her oncologist within one week and her primary care physician for anxiety management. Home health nursing will provide weekly assessments and patient education. The patient is encouraged to contact her healthcare providers with any concerns.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 52  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital following an emergency department visit due to cocaine abuse with intoxication (ICD10: F14129). He presented with symptoms of agitation, elevated blood pressure, and altered mental status. Upon admission, he was evaluated for potential complications related to cocaine use, including acute kidney failure and rhabdomyolysis.\\n\\n**Hospital Course:**  \\nDuring his 2.6-day hospitalization, the patient received supportive care, including intravenous fluids (Lactated Ringer’s), magnesium supplementation, and medications for symptomatic management, including Diazepam per the CIWA protocol for agitation and anxiety. Laboratory tests confirmed rhabdomyolysis and acute kidney failure, which improved with hydration and electrolyte management. The patient was monitored closely for cardiovascular complications, including bradycardia.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated creatinine levels indicating acute kidney failure, and myoglobinuria consistent with rhabdomyolysis. The patient was also noted to have essential hypertension and gastro-esophageal reflux disease. No invasive procedures were necessary during his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient’s mental status had stabilized, and he was oriented to person, place, and time. He exhibited marked improvement in his vital signs, with normalized blood pressure and heart rate. However, he requires continued monitoring and support due to his history of substance abuse and potential noncompliance with medication. Home health services will be essential for medication management and ongoing assessment of his renal function and overall health status.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Atorvastatin, Dicyclomine, Diazepam, Folic Acid, Heparin, Magnesium Oxide, Ondansetron, Omeprazole, and Phenytoin Sodium Extended Release. A follow-up appointment is scheduled with his primary care physician within one week to reassess his renal function and to provide support for substance use recovery. Home health services will also be involved in medication compliance and monitoring for any signs of relapse.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n**Admitting Physician:** [Insert Physician Name]  \\n  \\n**Brief History of Present Illness:**  \\nThe patient is a 63-year-old female who was admitted urgently with acute abdominal pain, nausea, and vomiting. Initial investigations revealed acute pancreatitis without necrosis or infection (ICD-10: K85.90). The patient has a history of essential hypertension, hyperlipidemia, hypothyroidism, and tachycardia.  \\n  \\n**Hospital Course:**  \\nThe patient was stabilized with IV fluids, pain management, and bowel rest. Her nausea was managed with ondansetron, and morphine was administered for pain relief. Blood pressure and heart rate were monitored closely due to a history of orthostatic hypotension and tachycardia. After 2.5 days in the hospital, the patient's symptoms improved significantly, and she was able to tolerate a low-fat diet.  \\n  \\n**Key Findings and Procedures:**  \\nDuring her stay, laboratory tests showed elevated lipase levels consistent with pancreatitis. Imaging studies were conducted to rule out complications, which were negative. The patient was monitored for potential complications, including electrolyte imbalances and was treated accordingly.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented, with pain controlled on oral medication. She demonstrated the ability to ambulate independently and perform activities of daily living with minimal assistance. Due to her history of orthostatic hypotension, home health services are recommended to provide monitoring and assistance with medication management and dietary adherence.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Atorvastatin, DiphenhydrAMINE, Docusate Sodium, Furosemide, Heparin, Levothyroxine Sodium, Maalox/Diphenhydramine/Lidocaine, Metoprolol Succinate XL, Morphine Sulfate, NIFEdipine CR, Ondansetron, OxyCODONE (Immediate Release), Senna, and Sodium Chloride 0.9% Flush. She is advised to follow up with her primary care physician within one week and to contact the outpatient clinic if any concerns arise. Home health services will commence upon discharge to ensure safety and adherence to her treatment plan.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 46  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently with oligohydramnios in the third trimester of pregnancy, specifically at 39 weeks gestation. She presented with decreased fetal movement and ultrasound findings confirmed low amniotic fluid levels. A decision for induction was made due to the risk of fetal distress associated with oligohydramnios.  \\n\\n**Hospital Course:**  \\nDuring her 6-day hospital stay, the patient underwent induction of labor. She was closely monitored for maternal and fetal well-being. The induction was complicated by secondary uterine inertia, leading to an eventual cesarean section. The patient delivered a single live birth successfully. Post-operatively, she was stable with no immediate complications.  \\n\\n**Key Findings and Procedures:**  \\nUpon admission, vital signs were within normal limits. Ultrasound confirmed oligohydramnios, leading to the induction protocol. The patient underwent cesarean delivery due to failure to progress. Post-operative assessments showed normal recovery, and she was ambulating independently by discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient is stable, with no signs of infection or complications. She demonstrates the ability to ambulate independently and perform activities of daily living with minimal assistance. Given her surgical history, she will require home health services for post-operative care, including wound monitoring and assistance with mobility as needed.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ibuprofen  \\n- OxyCODONE (Immediate Release)  \\n- Ondansetron  \\n- Docusate Sodium  \\n- Milk of Magnesia  \\n- Simethicone  \\n- Calcium Carbonate  \\n- Naloxone  \\n- Lactated Ringers  \\n- Sodium Chloride 0.9% Flush  \\n- Bisacodyl  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week post-discharge for a wound check and further management of her recovery. Home health services will initiate care within 24-48 hours.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**HPI:**  \\nThe patient is a 62-year-old female who presented to the emergency department with acute abdominal pain and distension, ultimately diagnosed with an intestinal obstruction (ICD10: K5669). She has a significant past medical history including major depressive disorder, asthma, rheumatoid arthritis, and osteoporosis.  \\n\\n**Hospital Course:**  \\nThe patient was admitted for management of the intestinal obstruction. Initial workup included imaging studies confirming the presence of obstruction without signs of perforation. During her hospital stay, she was placed on intravenous fluids (0.9% Sodium Chloride, D5 1/2NS) and underwent conservative management including bowel rest and frequent assessments. Pain management was provided with Acetaminophen IV and Morphine Sulfate as needed. She was also started on MethylPREDNISolone Sodium Succ for inflammation control and Gabapentin for neuropathic pain associated with her underlying conditions.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s symptoms began to improve, with gradual resolution of abdominal distension and return of bowel function. She was monitored closely for complications, and her laboratory tests showed stable white blood cell counts (D72829). The patient received counseling for her major depressive disorder (F329) and was assessed by physical therapy for mobility due to her history of osteoporosis.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with no acute distress. She demonstrated adequate mobility with assistance and expressed understanding of her home care needs. A home health service referral was made to assist with medication management, physical therapy, and ongoing mental health support.  \\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- 5% Dextrose  \\n- Acetaminophen IV  \\n- Aspirin  \\n- Gabapentin  \\n- Heparin  \\n- MethylPREDNISolone Sodium Succ  \\n- Morphine Sulfate  \\n- Omeprazole  \\n- Fluticasone-Salmeterol Diskus  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to continue with home health services for support in medication compliance and mobility exercises. She is to monitor for any signs of recurrent abdominal pain or other concerning symptoms.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age/Gender:** 56/F  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 56-year-old female with a history of unilateral primary osteoarthritis of the right hip, who presented for a right hip arthroplasty. She has a past medical history notable for essential hypertension, asthma, obstructive sleep apnea, and orthostatic hypotension. The patient's osteoarthritis had led to significant pain and functional limitations, prompting surgical intervention.\\n\\n**Hospital Course:**  \\nThe patient underwent a successful right hip arthroplasty under general anesthesia. The procedure was uneventful, and she was closely monitored in the post-anesthesia care unit. She experienced mild post-operative pain, which was managed effectively with IV hydromorphone and later transitioned to oral acetaminophen and ketorolac.\\n\\n**Key Findings and Procedures:**  \\nPost-operatively, the patient was stable, with vital signs within normal limits. There were no signs of infection, and her surgical site remained clean and dry. She was mobilized with the assistance of physical therapy on post-operative day 1, demonstrating the ability to ambulate with a walker. Pain levels were recorded as manageable, with no acute distress noted.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was alert and oriented, with stable vitals. She demonstrated the ability to perform activities of daily living with supervision, though she will require home health services for ongoing physical therapy and assistance with mobility. She was advised to continue exercises as instructed by her therapist to enhance recovery.\\n\\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed acetaminophen, albuterol inhaler, aspirin EC, cefazolin, chlorthalidone, diphenhydramine, docusate sodium, fluticasone-salmeterol Diskus, gabapentin, hydromorphone, iso-osmotic dextrose, ketorolac, lactated ringers, and multivitamins.\\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her orthopedic surgeon in 2 weeks and has been referred to home health services for physical therapy and nursing support. She is advised to monitor her pain levels and report any signs of infection or complications.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 27 years  \\n- **Gender:** Female  \\n- **Admission Type:** Urgent  \\n- **Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for maternal care due to a low transverse scar from a previous cesarean delivery (ICD10: O34211). She presented with complaints of mild abdominal discomfort and was monitored closely for signs of complications related to her recent delivery.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was stable with intermittent abdominal discomfort. She experienced a minor episode of immediate postpartum hemorrhage (ICD10: O721), which was managed effectively with fluid resuscitation and monitoring. She was also diagnosed with hypothyroidism and polycystic ovarian syndrome, which were considered in her management plan. The patient's recovery was uncomplicated, and she was able to ambulate independently by the time of discharge.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's vital signs remained stable throughout her hospital stay. An ultrasound confirmed a single live birth at 39 weeks gestation (ICD10: Z3A39, Z370). She underwent a cesarean delivery procedure (ICD10: 10D00Z1) without any surgical complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was in stable condition, ambulating independently, and demonstrating adequate pain control with oral medications including acetaminophen and ibuprofen. She is advised to follow up with home health services for ongoing monitoring of her recovery, specifically for any signs of infection or complications related to her cesarean delivery. Additionally, instructions were given to monitor her thyroid levels due to her hypothyroidism.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on the following medications: Acetaminophen, Ibuprofen, Enoxaparin Sodium, Levothyroxine Sodium, and Docusate Sodium. She is to follow up in one week with her obstetrician and endocrinologist. Home health services will provide support for maternal education and postpartum recovery.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 42 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 68.8 days  \\n**Diagnosis:** Other schizoaffective disorders (ICD-10: F258)  \\n\\n**History of Present Illness:**  \\nThe patient presented with severe psychiatric symptoms, including persistent suicidal ideations and depressive episodes, leading to hospitalization for stabilization. He has a history of schizoaffective disorder, anxiety, and obesity, which complicated his clinical picture. During his stay, he was monitored closely for safety and symptom management.\\n\\n**Hospital Course:**  \\nThroughout his hospitalization, the patient underwent a comprehensive psychiatric evaluation and was placed on a tailored medication regimen, including Clozapine and Escitalopram for mood stabilization. He was also treated for comorbidities: hyperlipidemia with Atorvastatin, and gastrointestinal reflux with Pantoprazole. The patient was engaged in regular therapeutic sessions, which included cognitive behavioral therapy, significantly improving his coping strategies and reducing suicidal ideation.  \\n\\n**Key Findings and Procedures:**  \\nThe patient stabilized clinically with a notable reduction in psychiatric symptoms. He underwent a medication adjustment protocol to optimize therapeutic efficacy and manage side effects. Laboratory tests revealed improved metabolic parameters linked to his hyperlipidemia.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged with improved psychiatric stability, able to articulate coping strategies and demonstrate insight into his condition. He will require ongoing home health services to assist with medication management, therapy reinforcement, and monitoring of his psychiatric health. His functional status has improved, but he will benefit from home health support to ensure adherence to his treatment plan and to monitor his mental health closely.  \\n\\n**Medications at Discharge:**  \\n- Aluminum-Magnesium Hydrox.-Simethicone  \\n- Atorvastatin  \\n- Clozapine  \\n- Escitalopram Oxalate  \\n- LORazepam  \\n- Modafinil  \\n- Pantoprazole  \\n- Ramelteon  \\n- Terazosin  \\n- Vitamin D3 (Cholecalciferol)  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with his psychiatrist within one week post-discharge and will be monitored by home health services for medication compliance and psychiatric health.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name], **Age:** 65, **Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 2.2 days  \\n**Primary Diagnosis:** C7801 - Secondary malignant neoplasm of the right lung  \\n**ICD-10 Codes:** C7801, J90, R918, Z853, I10, G4733, E669, Z6839, R7302, E785, Z96641  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old male with a history of breast cancer, hypertension, obesity, and obstructive sleep apnea, who presented to the emergency department with worsening shortness of breath and cough. Imaging revealed a pleural effusion and metastatic lesions in the right lung.  \\n\\n**Hospital Course:**  \\nDuring his 2-day hospital stay, the patient underwent thoracentesis to relieve the pleural effusion, which improved his respiratory symptoms. He received intravenous fluids, pain management with hydromorphone, and was started on albuterol nebulization for bronchospasm. The patient's vital signs stabilized, and he was monitored closely for any signs of respiratory distress.  \\n\\n**Key Findings and Procedures:**  \\n- Thoracentesis performed with significant fluid removal.  \\n- Imaging confirmed secondary malignancy in the right lung and pleural effusion.  \\n- The patient tolerated all procedures well and showed improvement in oxygen saturation levels.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved dyspnea and ambulating independently. Home health services are recommended for follow-up, including respiratory therapy and nursing support for medication management and monitoring of vital signs. The patient will require assistance with activities of daily living due to fatigue and limited mobility post-discharge.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will be prescribed the following medications: Acetaminophen, Albuterol 0.083% Nebulizer Solution, Docusate Sodium, Hydromorphone, Heparin, Hydrochlorothiazide, Lisinopril, Ondansetron, and Tamoxifen Citrate. A follow-up appointment is scheduled with oncology in one week, and the home health nurse will assess the patient within 48 hours. The patient's family has been educated on potential side effects and medication adherence.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 83  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 9 days  \\n\\n**History of Present Illness:**  \\nThe patient is an 83-year-old female with a history of hypertension and chronic kidney disease, who presented to the emergency department with fever, chills, and altered mental status. Laboratory workup revealed sepsis due to Escherichia coli. She was admitted for management of severe sepsis with septic shock.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient received intravenous fluids, broad-spectrum antibiotics (Amoxicillin-Clavulanic Acid), and vasopressors for septic shock. She was also treated for acute respiratory failure with hypoxia and managed with supplemental oxygen. Diuretics (Furosemide) were administered for fluid overload due to acute diastolic heart failure. The patient's condition gradually improved, and she was stabilized with appropriate management of her comorbidities.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included positive blood cultures for E. coli, elevated lactate levels indicating tissue hypoperfusion, and imaging revealing pyonephrosis. She underwent a nephrostomy tube placement to relieve urinary obstruction, which improved her renal function.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was afebrile, hemodynamically stable, and able to ambulate with assistance. She requires ongoing home health services for monitoring her renal function and managing her medications. A physical therapist will assist with her mobility and strength training to improve her functional status.  \\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include Acetaminophen for pain, Amoxicillin-Clavulanic Acid for infection, Enoxaparin for prophylaxis, Metoprolol Tartrate for hypertension, and Furosemide for fluid management. Follow-up appointments are scheduled with her primary care physician and nephrologist within one week of discharge. Home health services will follow up to ensure adherence to the medication regimen and to monitor renal function and overall health status.\",\n",
       " \"**Patient Information:** 68-year-old male admitted for surgical intervention. \\n\\n**History of Present Illness:** The patient presented for elective surgery due to complications associated with an abdominal aortic aneurysm and was diagnosed with multiple comorbidities, including essential hypertension and atherosclerotic heart disease. The patient has a significant history of nicotine dependence, which has contributed to his cardiovascular risk profile. \\n\\n**Hospital Course:** The patient underwent a surgical procedure involving aortocoronary bypass grafting (ICD-10: 04V03DZ) to address the arterial complications (ICD-10: T81718A). Postoperatively, he was closely monitored for any signs of complications. He experienced mild postoperative pain, which was managed with oxycodone and other analgesics. The patient demonstrated stable vital signs and was able to mobilize with assistance by day two. He was also started on anticoagulation with heparin and was educated on the importance of medication adherence, especially regarding his antihypertensive and lipid-lowering agents. \\n\\n**Key Findings and Procedures:** Notable findings included stable hemodynamics and adequate graft perfusion without signs of ischemia. The patient's pain was well-controlled, and he was able to progress to ambulation with minimal assistance. He received an influenza vaccine during his stay to optimize his health status. \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition, with improved overall functional status. He requires ongoing home health services for monitoring of his surgical site, management of his medication regimen, and assistance with activities of daily living. A follow-up appointment has been scheduled to assess his recovery and further manage his chronic conditions. \\n\\n**Medications at Discharge:** The patient was discharged on aspirin EC, atorvastatin, carvedilol, losartan potassium, and nifedipine ER, among others. Education on medication compliance and the importance of follow-up care was emphasized. \\n\\n**Follow-Up Plan:** Home health services will be initiated for wound care and monitoring of vital signs. The patient is advised to follow up in the outpatient clinic within one week post-discharge.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 31-year-old female who presented to the hospital with excessive and frequent menstruation, consistent with a diagnosis of N920 (Excessive and frequent menstruation with regular cycle). The patient reported a history of significant blood loss and fatigue.  \\n\\n**Hospital Course:**  \\nThe patient was admitted for observation over 1.8 days. She was monitored closely for signs of acute posthemorrhagic anemia (D62) due to the profuse menstrual bleeding. The treatment plan included the administration of intravenous fluids, blood products, and iron supplementation. The patient received Ferumoxytol and Ferrous Sulfate to address her anemia, along with Enoxaparin Sodium for thromboprophylaxis given her risk factors.  \\n\\n**Key Findings and Procedures:**  \\nDuring the hospitalization, the patient's hemoglobin levels were stabilized, and she showed improvement in her overall condition. A comprehensive assessment revealed no acute complications, and the patient tolerated the interventions well. The patient also received the influenza vaccine quadrivalent during her stay as part of preventive care.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with no signs of active bleeding. She demonstrated improved energy levels and was able to perform activities of daily living independently. The patient will benefit from home health services for ongoing monitoring of her hemoglobin levels, education on managing her condition, and assistance with activities as needed.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient was prescribed 0.9% Sodium Chloride flushes, Acetaminophen for pain management, MedroxyPROGESTERone Acetate for menstrual regulation, and instructions for oral iron supplementation. She is advised to follow up with her primary care physician and a gynecologist within one week to reassess her condition and adjust her treatment plan as necessary.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 49  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptomatic typical atrial flutter, characterized by palpitations and mild shortness of breath. He has a medical history notable for localized symptomatic epilepsy, a personal history of prostate cancer, and long-term anticoagulant therapy.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was monitored continuously. A trial of rate control was initiated with Diltiazem, and anticoagulation was managed with Enoxaparin. The patient's atrial flutter was documented via telemetry, and he received appropriate medications, including Carbamazepine for seizure management.  \\n\\n**Key Findings and Procedures:**  \\nTelemetry revealed recurrent atrial flutter, which was managed medically without the need for electrical cardioversion. Neurological assessments indicated stable seizure activity, with no episodes during hospitalization. The patient was also evaluated for anticoagulation therapy adjustments, given his history of long-term anticoagulant use.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with a heart rate controlled within acceptable limits. He was alert and oriented, with no new neurological deficits. The patient demonstrated an understanding of his medication regimen and the importance of follow-up care. He requires home health services for medication management and periodic monitoring of his cardiac rhythm and seizure activity.  \\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Carbamazepine (Extended-Release)  \\n- Diltiazem and Diltiazem Extended-Release  \\n- Enoxaparin Sodium  \\n- Heparin Sodium  \\n- Lamotrigine  \\n- Levetiracetam  \\n- Polyethylene Glycol  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician and cardiologist within one week. Home health nursing will assist with medication adherence and monitor for any recurrence of atrial flutter or seizures.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 58  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 5.1 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of acute cholecystitis with obstruction secondary to calculus of the gallbladder and bile duct (ICD10 K8063). She presented with abdominal pain, nausea, and vomiting. The patient's history is significant for obesity (BMI 40.0-44.9), essential hypertension, and acute kidney failure (ICD10 N179).  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent a cholecystectomy (ICD10 0FT44ZZ) and received supportive care, including IV fluids (Lactated Ringers), analgesics (Morphine Sulfate, Tramadol), and antiemetics (Ondansetron). She also required management for hypokalemia with Potassium Chloride, and her hypertension was addressed with Losartan Potassium and Chlorthalidone. The patient's renal function improved, allowing for safe discharge.  \\n\\n**Key Findings and Procedures:**  \\n- Imaging revealed gallstones and inflammation consistent with acute cholecystitis.  \\n- Surgical intervention was successfully performed without complications.  \\n- Post-operative recovery was monitored, and she was stabilized prior to discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved abdominal symptoms and no signs of infection. She is ambulating independently and has been educated on post-operative care, including signs of complications. Home health services will assist with monitoring her recovery, medication management, and dietary modifications to address obesity and hypertension.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Chlorthalidone  \\n- Heparin  \\n- Lactated Ringers (for home health use)  \\n- Losartan Potassium  \\n- Magnesium Sulfate (for home health use)  \\n- Morphine Sulfate  \\n- Ondansetron  \\n- Potassium Chloride  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to maintain contact with home health services for ongoing support in managing her recovery and health conditions.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n**Primary ICD-10:** C7949 - Secondary malignant neoplasm of other parts of nervous system  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of neurological symptoms associated with secondary malignancies. He has a known history of malignant melanoma and was experiencing progressive weakness and sensory disturbances. Initial imaging revealed multiple secondary neoplasms affecting the nervous system and other organ systems.\\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent a comprehensive assessment, including MRI and CT scans, which confirmed the presence of secondary malignant neoplasms in the brain, liver, and bone. He was started on dexamethasone to manage increased intracranial pressure and was given analgesics for pain control. A multidisciplinary approach was adopted, involving oncology, neurology, and palliative care teams to optimize symptom management. The patient was also evaluated for potential home health services to assist with ongoing care needs.\\n\\n**Key Findings and Procedures:**  \\n- MRI and CT scans confirmed multiple secondary malignant neoplasms.  \\n- Management included dexamethasone, gabapentin for neuropathic pain, and antipyretics.  \\n- The patient received supportive care including counseling for anxiety and depressive symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms. However, he requires assistance with activities of daily living due to ongoing weakness and fatigue. Home health services will be initiated to provide nursing care for medication management and physical therapy to enhance mobility.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen, Dexamethasone, Docusate Sodium, Enoxaparin Sodium, Gabapentin, Lorazepam, Levetiracetam, Levothyroxine Sodium, Methadone, Nortriptyline, Olanzapine, Omeprazole, Ondansetron, Oxycodone (Immediate Release), Senna.  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with oncology and neurology in two weeks. Home health services are to be coordinated to ensure continuity of care and symptom management.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 59  \\nGender: Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an injury of the left carotid artery, described as an \"Other specified injury\" (ICD-10: S15092A) after a fall. She presented with neck pain and mild swelling. The patient has a relevant past medical history of hypertension, anxiety disorder, and long-term anticoagulant use.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient underwent imaging studies which confirmed the diagnosis. She was started on Rivaroxaban for anticoagulation management due to her history of thrombocytopenia. The patient was monitored closely for any signs of hemorrhage and exhibited stable vital signs throughout her admission. Pain management was addressed with Acetaminophen and Oxycodone.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was evaluated by the vascular surgery team, who recommended conservative management given the nature of her injury. No surgical intervention was required. Key lab findings included stable hemoglobin and platelet counts post-anticoagulation therapy.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with neck pain well-controlled and functional mobility intact. She demonstrated the ability to perform activities of daily living with minimal assistance. It is vital to note that she will require home health services for ongoing monitoring of her anticoagulation therapy and assistance with medication management.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Atorvastatin  \\n3. Bisacodyl  \\n4. Calcium Carbonate  \\n5. Clonazepam  \\n6. Duloxetine DR  \\n7. Mirtazapine  \\n8. Omeprazole  \\n9. Oxycodone (Immediate Release)  \\n10. Polyethylene Glycol  \\n11. Rivaroxaban  \\n12. Senna  \\n13. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to schedule an appointment with a home health service provider for continued care and support.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 61  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to diverticulitis of the large intestine, presenting with abdominal pain and distension. The condition was complicated by a urinary tract infection and essential hypertension. Upon admission, the patient denied any history of perforation or abscess and did not exhibit signs of bleeding.\\n\\n**Hospital Course:**  \\nDuring the 10.9-day stay, the patient was managed conservatively with intravenous fluids, antibiotics, and analgesics. He received a combination of 0.9% Sodium Chloride and Lactated Ringer's solution for hydration. Pain management included acetaminophen and hydromorphone as needed. His urinary tract infection was treated effectively with appropriate antibiotics, and blood pressure was stabilized with metoprolol. The patient's diverticulitis symptoms improved significantly over the course of hospitalization, with a reduction in abdominal pain and distension.\\n\\n**Key Findings and Procedures:**  \\nKey findings included a diagnosis of diverticulitis confirmed by imaging studies. No perforation or abscess was detected. The patient underwent a flexible sigmoidoscopy that demonstrated inflammation consistent with diverticulitis but no further intervention was required. A vesicointestinal fistula was noted but deemed stable without immediate surgical intervention. The patient's atrial fibrillation was monitored and managed during the hospital stay.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated significant improvement in both abdominal symptoms and overall functional status. He is ambulating independently and has been educated on dietary modifications and symptom management strategies. Home health services will be initiated to assist with medication management and monitor his recovery, particularly focusing on continued hydration and bowel health.\\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include:  \\n- Metoprolol Succinate XL  \\n- Acetaminophen  \\n- Loperamide as needed  \\n- Aspirin for cardiovascular prophylaxis  \\nFollow-up with the primary care physician is scheduled within one week to monitor recovery and adjust medications as needed. Additionally, the patient is advised to contact the healthcare team if any concerning symptoms arise.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Not Provided]  \\n**Age:** 39  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 39-year-old female with a diagnosis of intraductal carcinoma in situ of the left breast (ICD-10: D0512). She presented for surgical intervention, specifically lumpectomy, which was conducted on the same day of admission. She has a significant personal history of nicotine dependence and a family history of breast and other malignancies.\\n\\n**Hospital Course:**  \\nThe patient was admitted for a planned surgical procedure and had an uneventful postoperative course. She was monitored for pain management and potential complications, receiving acetaminophen and ketorolac for analgesia, as well as ondansetron for nausea. Anticoagulation with heparin was initiated due to her surgical status. The patient was discharged on postoperative day 1.6 with stable vital signs, pain well-controlled, and no signs of infection.\\n\\n**Key Findings and Procedures:**  \\nThe surgical procedure (ICD-10: 0HRV077) involved excision of the intraductal carcinoma, with intraoperative findings confirming the diagnosis. Postoperative imaging did not indicate any residual lesions. The patient had no complications during her hospital stay, and her discharge assessments revealed a functional status that was stable, with the ability to ambulate independently.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was alert and oriented, with stable vitals and controlled pain levels. She demonstrated the ability to perform activities of daily living with minimal assistance. Home health services have been arranged to support her recovery, focusing on wound care and continued monitoring of her functional status.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, oxycodone (immediate release), heparin, ketorolac, and ondansetron. The patient is advised to maintain hydration with lactated Ringer’s solution and sodium chloride flushes as needed. A follow-up appointment with her oncologist is scheduled in one week to discuss pathology results and further management. Home health services will contact her within 48 hours for initial home assessment.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**MRN:** [Patient's MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 63, **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 63-year-old female with a history of unspecified asthma, type 2 diabetes mellitus, and end-stage renal disease, who was admitted through the emergency department for an acute exacerbation of asthma. During her hospitalization, she experienced worsening respiratory distress, requiring nebulized treatments and close monitoring of her respiratory status.  \\n  \\n**Hospital Course:**  \\nThroughout her 3-day hospital stay, the patient received intensive respiratory therapy, including nebulized albuterol and ipratropium. Her renal status was closely monitored due to her history of end-stage renal disease, and she continued to receive hemodialysis during her stay. The patient’s diabetes was managed with insulin, and she was educated on dietary modifications.  \\n  \\n**Key Findings and Procedures:**  \\nChest X-ray revealed no acute infiltrates. Laboratory studies indicated metabolic acidosis consistent with her renal condition. She underwent hemodialysis without complications. The patient demonstrated improvement in her respiratory status with a peak flow rate returning to baseline.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved respiratory function, exhibiting adequate oxygen saturation levels. She is able to ambulate independently and is oriented to person, place, and time. The patient will require continued home health services for respiratory therapy and diabetes management, including regular assessments of her renal function and medication compliance.  \\n  \\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient is prescribed the following medications: Albuterol 0.083% nebulizer solution, Albuterol inhaler, Amlodipine, Calcium acetate, Docusate sodium, Insulin, and Labetalol among others. Follow-up appointments are scheduled with her primary care physician and nephrologist within one week. Home health services will assist with medication management and monitor her respiratory and diabetic conditions closely.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 85-year-old male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with acute chest pain and shortness of breath. Initial workup revealed a Non-ST elevation myocardial infarction (NSTEMI) confirmed by elevated troponins and ECG changes. The patient has a significant history of ischemic heart disease, congestive heart failure, and atrial fibrillation.\\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was managed with dual antiplatelet therapy, including Aspirin and Clopidogrel, along with anticoagulation using Apixaban. He received diuretics for acute systolic heart failure and was closely monitored in the telemetry unit. He also underwent echocardiography, which indicated moderate left ventricular dysfunction. The patient’s heart failure symptoms improved with diuresis, and he was stabilized for discharge.\\n  \\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** I214 (NSTEMI), I5021 (Acute systolic heart failure), I4891 (Unspecified atrial fibrillation), among others.  \\n- **Procedures:** The patient was treated with intravenous Heparin and was started on Metoprolol for rate control. A thorough medication reconciliation was performed prior to discharge.\\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with improved heart failure symptoms and is ambulating with minimal assistance. He is advised to engage in light activity as tolerated. Home health services have been arranged for nursing support, medication management, and monitoring of vital signs to ensure adherence to his treatment plan.\\n  \\n**Medications at Discharge:**  \\n- Apixaban\\n- Aspirin\\n- Atorvastatin\\n- Clopidogrel\\n- Furosemide\\n- Levothyroxine Sodium\\n- Metoprolol Tartrate\\n- Other supportive medications (e.g., Cyanocobalamin, Magnesium Oxide)\\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his cardiologist in one week to reassess his cardiac status and adjust medications as needed. Additionally, routine lab work will be necessary to monitor renal function and electrolytes.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 78  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms consistent with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), leading to hyponatremia. The patient presented with confusion and weakness, which raised concerns for potential electrolyte imbalance and underlying etiologies.  \\n\\n**Hospital Course:**  \\nDuring her 2.8-day stay, the patient was monitored closely in the observation unit. Serial serum sodium levels were obtained and showed improvement with fluid restriction and administration of hypertonic saline. The patient was treated for hyperglycemia with insulin and was monitored for her chronic conditions, including Type 2 diabetes and hypertension. The clinical team managed her symptoms of insomnia and depression with Trazodone and metoprolol for rate control.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hyponatremia attributed to SIADH, along with chronic kidney disease and diabetes management. No surgical interventions were required, and the patient was stable at discharge with normalized sodium levels.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was alert and oriented but required assistance with activities of daily living (ADLs) due to residual weakness. She was deemed fit for home health services to assist with medication management, monitoring of blood glucose, and nutrition.  \\n\\n**Medications:**  \\nUpon discharge, medications include Dextrose 50%, Glucagon, Heparin, Insulin, Metoprolol Tartrate, Omeprazole, Potassium Chloride, Pravastatin, and Trazodone.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with her primary care physician in one week and should have regular nursing visits for monitoring and medication administration. Home health services will also provide assistance with diet and hydration management.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 75  \\n- **Gender:** Female  \\n- **Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to nonrheumatic aortic stenosis (ICD10: I350). She presented with progressive exertional dyspnea and episodes of syncope over the past month, indicating worsening cardiac functionality.  \\n\\n**Hospital Course:**  \\nDuring her brief stay of 1.4 days, the patient underwent aortic valve replacement, which was performed without intraoperative complications. Postoperatively, she was monitored in the recovery unit, where she demonstrated stable vital signs and adequate urine output. She was started on a regimen of anticoagulation with heparin and transitioned to clopidogrel and aspirin for antiplatelet therapy.  \\n\\n**Key Findings and Procedures:**  \\nPreoperative echocardiography confirmed significant left ventricular hypertrophy and aortic valve area consistent with severe stenosis. The surgical procedure (ICD10: 02RF38Z) was successful. Postoperative assessments indicated improved cardiac function, and she was discharged with stable hemodynamics, no signs of heart failure, and satisfactory pain control with acetaminophen as needed.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with functional mobility largely intact. She is able to perform activities of daily living with minimal assistance but requires home health services to ensure she receives appropriate follow-up care and rehabilitation to optimize her recovery. Home health nursing will monitor her anticoagulation therapy, and physical therapy will assist with mobility and strengthening exercises.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed the following medications: acetaminophen, aspirin, clopidogrel, metoprolol succinate XL, levothyroxine, and magnesium oxide. She is advised to follow up with her cardiologist within one week post-discharge for ongoing management of her cardiac health and to ensure proper adjustment of her medications. Home health services will be involved for the next few weeks to assist with medication management and rehabilitation.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 77 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 12.6 days  \\n**Primary ICD-10:** K91840 - Postprocedural hemorrhage of a digestive system organ following a digestive system procedure.  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of postprocedural hemorrhage following a recent digestive system procedure. He presented with abdominal pain and signs of bleeding which necessitated close monitoring.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient received supportive care including intravenous fluids and antibiotics (Ciprofloxacin IV and MetroNIDAZOLE) to manage infection risks. He was also monitored for signs of pneumonia, which was identified and treated accordingly. The patient underwent procedures including fluid drainage for peritoneal abscess and was evaluated for intestinal obstruction. He responded positively to treatment, with gradual resolution of symptoms.  \\n\\n**Key Findings and Procedures:**  \\n- Postprocedural hemorrhage was the primary concern, managed effectively.  \\n- Development of peritoneal abscess, treated with drainage.  \\n- Pneumonia and other complications were addressed with appropriate antibiotic therapy.  \\n- Patient was stabilized before discharge with a focus on safety and symptom management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with no active bleeding and improving abdominal symptoms. He will require home health services to assist with wound care and monitoring for potential complications, such as infection or obstruction. The patient's mobility has improved, but continued assistance will be beneficial for safe ambulation and daily activities.  \\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Ciprofloxacin IV  \\n- Heparin  \\n- Ibuprofen  \\n- Metoprolol Tartrate  \\n- Insulin as needed  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the gastroenterology clinic in one week. Home health nursing will monitor the patient's recovery and adherence to medication regimen.\",\n",
       " 'Patient is a 33-year-old female with a history of ulcerative colitis, who underwent surgical intervention for complications related to her condition. She was admitted for surgical management of her ulcerative colitis and spent approximately 15 days in the hospital. During her stay, she was closely monitored for any signs of post-operative complications, particularly regarding her digestive health. On admission, she presented with abdominal pain and was diagnosed with ulcerative colitis, unspecified, without complications (ICD10: K5190).\\n\\nThe hospital course was significant for the management of her condition, including the administration of intravenous fluids, antibiotics, and pain management. Key findings during her hospitalization included the resolution of ileus and stabilization of her nutritional status. The patient underwent several procedures, including laparoscopic interventions that were necessary to address her bowel health. Notably, she was treated with ciprofloxacin and metronidazole for infection prophylaxis, along with supportive medications including prednisolone for inflammation control and enoxaparin sodium for thromboembolic prophylaxis.\\n\\nUpon discharge, the patient is stable and has demonstrated improved functional status. She is able to perform activities of daily living with minimal assistance but will require ongoing home health support for wound care and medication management. The patient has been instructed to monitor for any signs of infection or complications, such as increased abdominal pain or changes in bowel habits.\\n\\nDischarge medications include acetaminophen, ibuprofen, oxycodone for pain management, and a course of sulfamethoxazole/trimethoprim for infection prevention. She is advised to follow up with her primary care physician and a gastroenterologist within one week of discharge to ensure continuity of care and adjustment of her treatment plan as necessary. Home health services will assist in her recovery, focusing on medication compliance and monitoring her post-operative progress.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 54  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to a non-ruptured cerebral aneurysm (ICD-10: I671). He presented with mild neurological deficits and a history of essential hypertension and hyperlipidemia. There was also a personal history of nicotine dependence.  \\n\\n**Hospital Course:**  \\nThe patient underwent a successful endovascular procedure (ICD-10: 03VG3HZ) to manage the aneurysm. Postoperatively, he was monitored for any complications, particularly neurological deficits and hypertension. The patient remained stable throughout his stay, with gradual improvement in his symptoms.  \\n\\n**Key Findings and Procedures:**  \\nNeurological assessments indicated some residual right-sided weakness consistent with his previous cerebral infarction (ICD-10: I69353). Imaging studies confirmed no new acute changes. The patient was started on a regimen of antithrombotic therapy with aspirin and clopidogrel to prevent thromboembolic events.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved strength in the right extremities but continued to have some hemiparesis requiring assistance with activities of daily living (ADLs). He was deemed stable for home health services to assist with rehabilitation and medication management. The patient will require regular follow-up to monitor his neurological status and medication adherence.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Baclofen  \\n- Bisacodyl  \\n- Clopidogrel  \\n- Docusate Sodium  \\n- Famotidine  \\n- HydrALAZINE  \\n- Influenza Vaccine Quadrivalent  \\n- Iso-Osmotic Sodium Chloride  \\n- Lisinopril  \\n- Ondansetron  \\n- Pregabalin  \\n- Senna  \\n- Sodium Chloride 0.9%  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in two weeks with the neurosurgery team. Home health services will initiate within 48 hours for physical therapy and occupational therapy to aid in recovery and functional independence.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 70 years  \\nGender: Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute kidney failure with tubular necrosis, primarily attributed to dehydration secondary to pneumonia. He presented with weakness, lethargy, and shortness of breath. Initial lab results indicated elevated creatinine levels, hyperkalemia, and hyponatremia, necessitating prompt intervention.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient received intravenous fluids (0.9% Sodium Chloride) and electrolyte management. He was started on antibiotic therapy with ceftriaxone for pneumonia and was monitored closely for renal function and cardiac status. The patient was also treated for anemia related to chronic kidney disease and received supportive medications including amlodipine for hypertension and atorvastatin for hyperlipidemia.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included acute kidney injury with a notable improvement in renal function by discharge, with creatinine levels trending downwards. Cardiac evaluation revealed chronic diastolic heart failure but stable function, and he was assessed for diabetes management given his history of type 2 diabetes mellitus.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved functional status, ambulating independently with minimal assistance. Home health services are recommended to assist with medication management, monitor vital signs, and ensure adherence to dietary modifications due to his diabetes and chronic kidney disease.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Acetaminophen  \\n- Amlodipine  \\n- Aspirin  \\n- Atorvastatin  \\n- Azithromycin  \\n- Benzonatate  \\n- Ceftriaxone  \\n- Docusate Sodium  \\n- Ferrous Sulfate  \\n- Glucagon  \\n- Hydralazine  \\n  \\n**Follow-Up Plan:**  \\nFollow up with nephrology within one week and primary care physician within two weeks. Home health nursing will facilitate medication reconciliation and provide education on managing his chronic conditions.',\n",
       " \"Patient is a 23-year-old male who was admitted for observation for a duration of 4.7 days due to worsening respiratory symptoms associated with a diagnosis of other specified diseases of the upper respiratory tract (ICD-10 J398). The patient presented with a history of dysphagia and recurrent respiratory infections, which prompted further evaluation and management. During the hospital stay, the patient was treated primarily for acute respiratory distress, including the administration of nebulized Albuterol and a course of Amoxicillin-Clavulanic Acid for secondary bacterial infection.\\n\\nKey findings included evidence of pneumonitis due to aspiration (ICD-10 J690), likely secondary to his underlying dysphagia. The patient underwent a comprehensive respiratory therapy regimen and was monitored for any signs of acidosis (ICD-10 E872) and other complications related to his Ruvalcaba-Myhre-Smith syndrome (ICD-10 E71440). He received supportive care, including fluid management and medication adjustments for hypertension, with Losartan Potassium and PredniSONE for inflammation control.\\n\\nThe patient's condition improved significantly during the hospitalization. By discharge, he demonstrated stable respiratory status, adequate oxygenation, and improved functional capacity. He is able to perform activities of daily living with minimal assistance but will require home health services for continued respiratory therapy and monitoring of his swallowing function due to his history of dysphagia and gastro-esophageal reflux disease (GERD).\\n\\nAt discharge, the following medications were prescribed: Albuterol nebulizer solution, Albuterol inhaler, Amoxicillin-Clavulanic Acid, Calcium Carbonate, Docusate Sodium, Famotidine, Fluticasone-Salmeterol Diskus, Folic Acid, Heparin, Influenza Vaccine Quadrivalent, Losartan Potassium, PredniSONE, and Sulfameth/Trimethoprim SS. A follow-up appointment with a primary care physician and a speech therapist is recommended within one week of discharge to assess swallowing function and respiratory management.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** Male, 78 years old  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 0.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to nonrheumatic aortic stenosis (ICD10: I350). He presented with symptoms of shortness of breath and chest pain, which were exacerbated by exertion. The patient's medical history is significant for acute systolic heart failure (ICD10: I5021), hypertensive heart disease with heart failure (ICD10: I110), and atherosclerotic heart disease (ICD10: I25119).\\n\\n**Hospital Course:**  \\nThe patient underwent a successful aortic valve replacement procedure. Post-operatively, he was monitored in the recovery unit, where he demonstrated stable vital signs and satisfactory recovery from anesthesia. He required minimal pain management and exhibited good tolerance to oral intake. Cardiac function was assessed, revealing improvement in heart failure symptoms. The patient was mobilized on postoperative day one and participated in physical therapy, demonstrating progress in ambulation.\\n\\n**Key Findings and Procedures:**  \\n- Aortic valve replacement was performed without complications.  \\n- Cardiac evaluation showed improved function post-surgery.  \\n- Notable improvement in shortness of breath; chest pain resolved.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved functional status. He is able to ambulate independently and has demonstrated the ability to perform activities of daily living (ADLs) with minimal assistance. Home health services have been arranged to assist with ongoing rehabilitation, medication management, and monitoring of cardiac status. The patient is aware of the signs of potential complications and has been educated on lifestyle modifications.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on Docusate Sodium, Folic Acid, Multivitamins, and will receive the Influenza Vaccine and Pneumococcal vaccine as part of preventive care. Follow-up appointments are scheduled with cardiology and primary care within the next two weeks to monitor recovery and adjust medications as necessary.\",\n",
       " 'Patient is a 62-year-old female who was admitted for observation due to complications associated with a cystostomy catheter. The primary diagnosis upon admission was an infection and inflammatory reaction due to the catheter (ICD-10: T83510A). Throughout her 18-day hospital stay, the patient experienced significant challenges, including severe sepsis with septic shock and pressure ulcer of the sacral region (stage 4). She also developed metabolic encephalopathy, requiring careful management of her electrolyte balance and fluid status.\\n\\nDuring her hospitalization, the patient underwent a catheter clearance procedure to manage the obstruction contributing to her infection. Key findings included persistent leukocytosis, elevated inflammatory markers, and imaging revealing a single subsegmental pulmonary embolism, which was addressed with anticoagulation therapy. The multidisciplinary team closely monitored her vitals and lab results, leading to adjustments in her medications, including the initiation of intravenous antibiotics and supportive care.\\n\\nUpon discharge, the patient demonstrates improved clinical stability, although she requires assistance with activities of daily living due to weakness and functional limitations related to her prolonged hospitalization. Her discharge condition is stable, but she remains at risk for further complications, necessitating home health services for ongoing monitoring, wound care, and rehabilitation support.\\n\\nThe patient’s discharge medications include Acetaminophen for pain management, Metoprolol Succinate XL for hypertension, and Levothyroxine Sodium for thyroid management, among others. A follow-up appointment is scheduled with her primary care physician in one week to evaluate her recovery and adjust her treatment plan as needed. Additionally, home health services will be initiated to assist with wound care for her pressure ulcer and to monitor her overall health status.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 75 years  \\nGender: Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of duodenitis without bleeding, associated with abdominal discomfort. He has a background of type 2 diabetes mellitus, essential hypertension, hyperlipidemia, and postprocedural hypothyroidism.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored and managed conservatively. He received intravenous fluids and was treated with pantoprazole for gastric protection. Pain control was achieved with hydromorphone, and nausea was managed with ondansetron. He was placed on a diabetic diet, and his blood glucose levels were closely monitored. Additionally, the patient was given the influenza vaccine and levothyroxine was adjusted due to his hypothyroid status.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during the hospital course included stable vital signs and improving abdominal symptoms. Laboratory tests revealed mild acute kidney failure, requiring close monitoring and hydration. The patient underwent an upper gastrointestinal endoscopy, which confirmed the diagnosis of duodenitis. No evidence of bleeding was noted.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improvement in abdominal pain and no signs of active gastrointestinal bleeding. He is independent in activities of daily living but requires assistance with medication management and monitoring of blood glucose levels. It is recommended that he be followed by home health services for continued monitoring of his condition, medication compliance, and dietary adherence.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Dextrose 50%  \\n3. Docusate Sodium  \\n4. Glucagon  \\n5. Glucose Gel  \\n6. Hydromorphone (Dilaudid)  \\n7. Heparin  \\n8. Levothyroxine Sodium  \\n9. Ondansetron  \\n10. Pantoprazole  \\n11. Senna  \\n12. Sodium Chloride 0.9%  \\n13. Insulin  \\n \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and will have home health services initiate contact for ongoing support and management.',\n",
       " 'Patient is a 50-year-old female admitted for surgical treatment of essential tremor. She presented with a longstanding history of tremors impacting daily activities, which were exacerbated by her underlying medical conditions including Type 2 diabetes mellitus with diabetic neuropathy and hypothyroidism. The patient underwent a bilateral deep brain stimulation procedure (ICD-10: 00H03MZ) and was monitored closely postoperatively for neurological status and complications.\\n\\nDuring her 1.6-day hospital stay, the patient was stable, with vital signs within normal limits. Post-surgical assessments showed improved control of tremors, and she reported a reduction in symptoms. Key findings included stable blood glucose levels and appropriate neurologic response. She was treated with acetaminophen for postoperative pain management and was started on benztropine mesylate to manage potential extrapyramidal symptoms associated with her bipolar disorder and to support her tremor management.\\n\\nThe patient was discharged in stable condition, with functional status improved compared to admission, as she was able to perform basic activities of daily living independently. Home health services have been arranged to assist with her ongoing care, focusing on medication management, monitoring of her diabetes, and support with mobility and activities of daily living considering her tremors.\\n\\nDischarge medications include acetaminophen, atorvastatin, benztropine mesylate, and insulin, among others. The follow-up plan includes an outpatient appointment with neurology within one month, and close monitoring of her glucose levels is advised to prevent any complications from her diabetes. The patient has been educated on signs and symptoms that warrant immediate medical attention.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Admitting Physician:** [REDACTED]  \\n**Age:** 43  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 43-year-old female with a history of alcohol dependence and chronic liver disease, presenting with alcoholic hepatitis complicated by ascites and portal hypertension. She was admitted for observation due to worsening abdominal distension and altered mental status.  \\n  \\n**Hospital Course:**  \\nDuring her 6.7-day stay, the patient was stabilized with intravenous fluids, electrolyte correction, and diuretics (Furosemide) to manage ascites. Lactulose was administered to treat hepatic encephalopathy. She was closely monitored for signs of infection and bleeding due to her coagulopathy.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included significant abdominal distension and elevated liver enzymes. A paracentesis was performed to relieve pressure from ascites, yielding serous fluid. Imaging studies confirmed portal hypertension without signs of acute variceal bleeding. The patient was also treated for protein-calorie malnutrition with supplementation (Folic Acid, Multivitamins).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved cognitive function and a reduction in abdominal girth. She is ambulating independently but requires assistance with activities of daily living (ADLs) due to ongoing weakness. Home health services will be crucial for monitoring her nutritional intake, medication adherence, and management of her liver disease.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Buprenorphine-Naloxone, Furosemide, Heparin, Ipratropium-Albuterol Nebulizer, Lorazepam, Lactulose, Levothyroxine, Magnesium Oxide, Midodrine, and Omeprazole. A follow-up appointment is scheduled with hepatology in 1 week. Home health nursing will be arranged to monitor her condition, assist with medication management, and provide dietary support as she transitions to outpatient care.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Age:** 75  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 7.9 days  \\n\\n**History of Present Illness:**  \\nThe patient, a 75-year-old male, presented with complications related to a bile duct prosthesis, specifically identified as an obstruction (ICD10: T85590A). The initial encounter noted significant discomfort and elevated liver enzymes, leading to an urgent evaluation. \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent monitoring and treatment for the bile duct obstruction. He received intravenous antibiotics including Ciprofloxacin and Metronidazole, along with hydration and pain management with Acetaminophen. A multidisciplinary approach was employed, involving gastroenterology for potential endoscopic intervention, though this was not required during hospitalization. \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated bilirubin and alkaline phosphatase levels indicating cholestasis, with imaging confirming the mechanical complication of the bile duct prosthesis. The patient was stabilized without the need for surgical intervention. Additionally, he was assessed for chronic conditions, including stage 3 chronic kidney disease and age-related osteoporosis. He was started on Apixaban for thromboprophylaxis due to a history of deep vein thrombosis. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved clinical stability with normalized vital signs. He is ambulatory with moderate assistance and requires continued home health services for medication management, monitoring of renal function, and educational support regarding signs of bile duct obstruction or complications. \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Apixaban  \\n- Ciprofloxacin HCl  \\n- DULoxetine DR  \\n- Divalproex (Delayed Release)  \\n- Docusate Sodium  \\n- Finasteride  \\n- Heparin Flush (10 units/ml, 100 units/ml)  \\n- Lorazepam  \\n- Latanoprost 0.005% Ophth. Soln.  \\n- Magnesium Sulfate  \\n- Metoprolol Succinate XL  \\n- MetroNIDAZOLE  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week post-discharge and will have regular monitoring of his renal function and anticoagulation therapy. Home health services will be initiated to assist with medication administration and monitoring of his clinical status.\",\n",
       " '**Patient Name:** [Redacted]  \\n**Age:** 61  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.3 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 61-year-old male with a history of hypertensive chronic kidney disease, now classified as stage 5 chronic kidney disease (CKD) or end-stage renal disease (ESRD). He presented with worsening renal function, hyperkalemia, and acidosis. The patient has a significant history of type 2 diabetes mellitus with diabetic nephropathy, hyperlipidemia, and chronic pain. He reported increased fatigue and weakness over the last few weeks, prompting hospital evaluation.\\n\\n**Hospital Course:**  \\nDuring his 3.3-day stay, the patient was monitored for renal function and metabolic derangements. He received intravenous fluids and electrolyte management, including the administration of dextrose, insulin, and sodium bicarbonate to correct hyperkalemia and acidosis. Additionally, wound care was performed for a non-pressure chronic ulcer on the right ankle. The patient was educated regarding dietary restrictions pertinent to renal disease.\\n\\n**Key Findings and Procedures:**  \\nLaboratory studies confirmed the diagnosis of ESRD, with elevated creatinine and potassium levels. A nephrology consult was obtained, and the decision was made to initiate preparations for potential dialysis if renal function does not improve. The patient was discharged with comprehensive medication management, including allopurinol, calcitriol, atorvastatin, and insulin.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but continues to require close monitoring of his renal status and medication adherence. His functional status is somewhat limited due to fatigue and the chronic pain he experiences. He will benefit from home health services for assistance with medication management, dietary adherence, and monitoring of his renal function.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed acetaminophen, allopurinol, aspirin, atorvastatin, calcitriol, and insulin. A follow-up appointment with nephrology is scheduled within one week to reassess his renal function and determine the need for dialysis. Home health nursing will visit twice weekly to assist with medication administration and monitor his overall health status.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 61  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 61-year-old male with a history of unilateral primary osteoarthritis of the left hip (ICD10: M1612) who underwent a left hip arthroplasty. He presented with severe pain and functional impairment, limiting ambulation and activities of daily living.  \\n  \\n**Hospital Course:**  \\nThe patient was admitted for surgical intervention and tolerated the procedure well. Postoperatively, he was monitored in a surgical unit where he received pain management with hydromorphone and oxycodone, as well as prophylactic antibiotics with cefazolin. He was encouraged to begin physical therapy on postoperative day one and made satisfactory progress with ambulation and mobility exercises.  \\n  \\n**Key Findings and Procedures:**  \\nPreoperative imaging confirmed advanced osteoarthritis with associated changes in the left hip joint. The surgery performed was a left total hip arthroplasty (ICD10: 0SRB04A). Postoperative lab work revealed an elevated white blood cell count, which was monitored closely and deemed non-concerning.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with adequate pain control and improved ambulation ability. He demonstrated the ability to perform basic mobility tasks with minimal assistance, but ongoing support through home health services is recommended for continued rehabilitation and monitoring.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on acetaminophen, aspirin EC, bisacodyl, docusate sodium, ondansetron, pantoprazole, and hydralazine. An outpatient prescription for oxycodone is provided as needed for pain management.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with orthopedics within two weeks for postoperative evaluation and is scheduled for home health services to assist with physical therapy and medication management.\",\n",
       " '**Patient Name:** [Patient Name]\\n**Age:** 32 years\\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.9 days  \\n\\n**History of Present Illness:**  \\nThe patient, a 32-year-old female, was admitted with gestational diabetes mellitus in childbirth, which was insulin-controlled. She presented to the emergency department in labor and was noted to have abnormal fetal heart rate patterns. The patient also has a history of pre-existing hypertension and hypothyroidism, which complicated her pregnancy.\\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent continuous monitoring of maternal and fetal well-being. She received insulin therapy to manage her blood glucose levels effectively. Labor was induced at 38 weeks gestation, and she delivered a healthy single live birth. Post-delivery, she was stabilized and monitored for any complications related to her diabetes and hypertension. She was started on enoxaparin sodium for thromboprophylaxis and was managed for postpartum recovery, including pain control with acetaminophen and ibuprofen.\\n\\n**Key Findings and Procedures:**  \\nThe patient had abnormal fetal heart rate patterns noted during labor, which resolved after delivery. She underwent routine postpartum assessments including laboratory tests to monitor thyroid function and glucose levels, which showed stable results. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with no immediate concerns regarding her health. She is ambulating independently and is capable of performing activities of daily living. However, she requires ongoing home health services to assist with monitoring her blood glucose levels, managing her medications, and ensuring adherence to a dietary plan designed for her gestational diabetes. \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Ibuprofen  \\n3. Docusate Sodium  \\n4. Enoxaparin Sodium  \\n5. Levothyroxine Sodium  \\n6. Polyethylene Glycol  \\n7. Calcium Carbonate  \\n8. Simethicone  \\n9. Glucose Gel  \\n10. Dermoplast Spray  \\n11. Bisacodyl  \\n12. Senna  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician and endocrinologist within one week of discharge. Home health nursing will provide education on medication management and dietary adherence related to her gestational diabetes. Additionally, she is encouraged to monitor for any symptoms of postpartum complications and report them immediately.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient Name:** [Patient Name]  \\n- **Age:** 72 years  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency Room  \\n- **Length of Stay:** 45.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of major depressive disorder (ICD10: F329) and associated medical comorbidities including hyperkalemia, vitamin B12 deficiency anemia, and obstructive sleep apnea. He presented with worsening depressive symptoms, fatigue, and anxiety, complicating his existing health issues.  \\n\\n**Hospital Course:**  \\nDuring his hospitalization, the patient was evaluated by psychiatry and started on fluoxetine, which was well tolerated. He received supportive care for his anemia and electrolyte imbalance, with close monitoring of his renal function due to hyperkalemia. Neurology was consulted due to a history of epilepsy; his seizure control remains stable. He was also treated for obstructive sleep apnea and started on continuous positive airway pressure (CPAP) therapy.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent anemia, controlled hypertension, and stable seizure activity. The patient underwent nutritional supplementation for vitamin B12 deficiency and was counseled on lifestyle modifications to address his hypertension and sleep apnea.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and showing signs of improvement in mood and functional status. He requires ongoing home health services for medication management, psychiatric follow-up, and assistance with daily activities due to fatigue and mild cognitive impairment. The patient is able to perform basic self-care but will benefit from a structured home health plan to ensure adherence to his treatment regimen.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Amlodipine  \\n- Calcium Carbonate  \\n- Capsaicin 0.025%  \\n- Clonidine  \\n- Divalproex (Extended Release)  \\n- Docusate Sodium  \\n- Fluoxetine  \\n- Finasteride  \\n- Fluticasone Propionate 110 mcg  \\n- Furosemide  \\n- Hydroxyzine  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and psychiatrist within one week of discharge. Home health nursing will initiate visits to monitor his mental health, medication adherence, and overall well-being.',\n",
       " \"**Patient Information:** 62-year-old female with a history of quadriplegia and recurrent urinary tract infections.  \\n\\n**History of Present Illness:** The patient was admitted for observation due to an infection and inflammatory reaction related to an indwelling urethral catheter. She presented with fever, chills, and altered mental status. Initial assessment indicated severe sepsis secondary to Escherichia coli, confirmed by cultures.  \\n\\n**Hospital Course:** Over a 4-day hospitalization, the patient was stabilized with intravenous antibiotics, including Meropenem and Ciprofloxacin, along with supportive care. Despite her underlying conditions, her acute kidney failure improved, and the septic shock was managed effectively. Multidisciplinary teams were involved in her care, including infectious disease and nephrology.  \\n\\n**Key Findings and Procedures:** Laboratory results indicated acute kidney injury (AKI) and electrolyte imbalances, which were addressed with fluid management and electrolyte replacement. Imaging studies ruled out additional complications related to her urinary tract. The patient's mental status improved significantly with the resolution of infection.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable for discharge but continues to require assistance for daily activities due to her quadriplegia. She will benefit from home health services for continued monitoring, catheter care, and medication administration. A follow-up arrangement has been made to reassess her renal function and overall health in one week.  \\n\\n**Medications and Follow-Up Plan:** Upon discharge, the patient will be prescribed Betamethasone Dipro 0.05% cream, Citalopram, Gabapentin, Levothyroxine, Ondansetron, Pantoprazole, and Polyethylene Glycol for bowel management. She will also continue with Meropenem as per the infectious disease recommendation. Home health services will manage her medication administration and monitor her for potential complications. Follow-up with her primary care physician and urology is scheduled within the next week.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 34  \\nGender: Female  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Length of Stay:** 1.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to a first-degree perineal laceration sustained during delivery. The patient reported moderate discomfort and pain in the perineal area, which was managed adequately with analgesics.  \\n\\n**Hospital Course:**  \\nThroughout her stay, the patient was monitored closely for any signs of infection or complications related to her laceration. She received supportive care, including hydration via Lactated Ringer's solution and education regarding post-delivery care. The patient also experienced mild gastro-esophageal reflux, managed with appropriate medications.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed a healing perineal laceration with no signs of infection. The patient underwent routine care procedures, including wound assessment and management. Pain control was achieved with a regimen of Acetaminophen and Ibuprofen. Further, the patient was educated on the importance of maintaining perineal hygiene and recognizing signs of complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, ambulating independently and reporting pain at a manageable level. She will require home health services to assist with wound care and monitoring for any post-operative complications. The patient demonstrated understanding of her discharge instructions and is able to engage in light activities.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed Acetaminophen, Ibuprofen, Docusate Sodium, and Dermoplast Spray for pain and constipation management. Bisacodyl and Milk of Magnesia were also provided as needed. The patient is advised to follow up with her obstetrician in one week or sooner if her symptoms worsen. The home health service will assist in her recovery and provide further education on managing her condition.\",\n",
       " \"**Discharge Summary**\\n\\n**Patient:** Male, 50 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation secondary to uncontrolled seizures, diagnosed as epilepsy, unspecified, not intractable, without status epilepticus (ICD-10: G40.909). He experienced multiple episodes during his initial admission, prompting the initiation of anticonvulsant therapy and further evaluation. \\n\\n**Hospital Course:**  \\nDuring the hospitalization, the patient underwent a comprehensive neurological assessment, which included imaging studies that ruled out acute intracranial pathology. He was treated with Lacosamide and Clobazam, with dosage adjustments made according to the patient's clinical response. The patient also received supportive care for anxiety and sleep disturbances, including Citalopram and Lorazepam. He was monitored closely for any adverse effects of medications and potential complications such as thrombocytopenia (ICD-10: D69.6), which was noted but managed appropriately.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included episodes of epileptic activity, which were responsive to medication. The patient showed improvement in seizure control by the time of discharge. No surgical interventions were required during the stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with no acute neurological deficits. He is alert and oriented, able to perform activities of daily living with minimal assistance. A home health referral has been made for ongoing monitoring of seizure activity and medication management. The patient will require assistance with medication adherence, and follow-up appointments are necessary to reassess his condition and adjust therapies as needed.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Citalopram  \\n- Clobazam  \\n- Heparin  \\n- Influenza Vaccine Quadrivalent  \\n- Lacosamide  \\n- Lorazepam  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his neurologist within one week post-discharge for ongoing management of his epilepsy and to monitor psychological well-being.\",\n",
       " '**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 63-year-old female who presented to the emergency department with complaints of abdominal pain and changes in bowel habits. After a thorough evaluation, she was diagnosed with diverticulitis of the large intestine without perforation or abscess. She had a history of hypertension, overactive bladder, and other chronic conditions, which were managed throughout her stay.\\n\\n**Hospital Course:**  \\nDuring her 1.8-day hospitalization, the patient received intravenous fluids for dehydration and was started on IV ciprofloxacin and metronidazole for antibiotic coverage. Pain management was initiated with morphine sulfate and gabapentin. She also received bisacodyl to assist with bowel movements. Her vital signs were stable, and she demonstrated improvement in her abdominal pain with conservative management. \\n\\n**Key Findings and Procedures:**  \\nKey findings included abdominal tenderness but no signs of perforation. Laboratory evaluations revealed anemia but no significant electrolyte imbalances. The patient underwent imaging studies that confirmed diverticulitis without any complications. A multidisciplinary team was involved in her care, including nutrition and pain management specialists. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved abdominal pain and normalized bowel patterns. She is independent in her activities of daily living but will require assistance with meal preparations and monitoring of her hydration status at home. Home health services are being arranged to provide nursing care for ongoing assessments of her recovery and medication management.  \\n\\n**Medications at Discharge:**  \\nAt discharge, the patient will continue on a regimen that includes 5% Dextrose, atorvastatin, omeprazole, ondansetron, lorazepam, oxybutynin, and gabapentin. A follow-up appointment is scheduled with her primary care physician in one week to assess her recovery and any further needs.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 53  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.7 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with symptoms consistent with acute posthemorrhagic anemia, characterized by significant fatigue and pallor. Initial evaluation revealed a history of excessive menstrual bleeding contributing to her anemic state.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a series of laboratory tests and imaging studies. The complete blood count revealed hemoglobin levels significantly below normal, confirming acute posthemorrhagic anemia. The decision was made to start intravenous fluids and blood transfusion to stabilize her condition. Additionally, she was treated for iron deficiency anemia with oral ferrous sulfate. The patient's vital signs and hemoglobin levels improved significantly during her stay.  \\n\\nKey findings included nonalcoholic steatohepatitis (NASH) and essential hypertension, which were managed with appropriate dietary and lifestyle modifications. The patient also received a gynecological consultation for her menstrual irregularities, leading to the initiation of MedroxyPROGESTERone Acetate to help regulate her cycle.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved hemoglobin levels, stable vital signs, and expressed an understanding of her condition and treatment regimen. She ambulated independently, although she was advised to avoid strenuous activities until her follow-up appointment. The patient will benefit from home health services to monitor her recovery, manage medications, and provide education on dietary needs and menstrual health.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen for pain management  \\n2. Ferrous Sulfate for iron deficiency  \\n3. MedroxyPROGESTERone Acetate for menstrual regulation  \\n4. Sodium Chloride 0.9% for flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and with gynecology for ongoing management of her menstrual issues. Home health services have been arranged to assist with medication adherence and dietary guidance.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 84  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient, an 84-year-old female, was admitted through the emergency department with symptomatic bradycardia secondary to sick sinus syndrome (ICD-10: I495). She presented with complaints of dizziness and fatigue, with a notable history of type 2 diabetes mellitus, hypertension, and previous myocardial infarction.  \\n\\n**Hospital Course:**  \\nDuring her 1.8-day stay, the patient underwent continuous cardiac monitoring, and her bradycardia was managed with intravenous fluids and adjustments to her current medications. She received an infusion of dextrose 50% for a mild hypoglycemic episode and was closely monitored for any signs of acute coronary syndrome due to her history of ischemic heart disease.  \\n\\nKey findings included stable vital signs post-intervention and resolution of acute symptoms. Laboratory results indicated an episode of anemia (ICD-10: D649) likely secondary to chronic disease, which will require ongoing management.  \\n\\n**Procedures:**  \\nThe patient received a cardiac echocardiogram to assess cardiac function, which revealed preserved left ventricular function. She was also given a dose of the influenza vaccine and discharged with adequate instructions regarding her diabetes management.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented, with a functional status that allows for independent ambulation. She is advised to engage home health services for ongoing monitoring of her vital signs and medication adherence, especially for her anticoagulation therapy (Clopidogrel and Heparin).  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Amlodipine  \\n- Aspirin  \\n- Atorvastatin  \\n- Bystolic  \\n- Clopidogrel  \\n- Insulin (as prescribed)  \\n- Docusate Sodium  \\n- Fluticasone Propionate NASAL  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician within one week, and is strongly encouraged to contact the home health service for diabetes education and ongoing assessment of her cardiovascular status.',\n",
       " 'Patient is a 28-year-old male who presented with sepsis, unspecified organism, requiring urgent admission. His hospital stay lasted 13 days, during which he was treated for severe sepsis with septic shock, evidenced by acute respiratory failure and multiple lung complications, including gangrene and abscess formation. Initial management included broad-spectrum antibiotics, specifically Ceftriaxone and Metronidazole, along with supportive care and respiratory therapy involving Ipratropium-Albuterol nebulizers.\\n\\nThroughout his hospitalization, the patient underwent multiple diagnostic procedures, including thoracentesis for pleural effusion and management of a spontaneous tension pneumothorax, which required chest tube insertion. His condition improved significantly with aggressive treatment, resulting in stabilization of vital signs and resolution of septic shock.\\n\\nKey findings during his hospital course included persistent hypoxia, necessitating supplemental oxygen therapy, and monitoring for potential complications related to his lung conditions. He was also evaluated for underlying psychiatric conditions, including schizoaffective disorder and nicotine dependence, which were managed with appropriate medications during his stay.\\n\\nUpon discharge, the patient is stable but requires continued monitoring for respiratory function and psychiatric support. He will benefit from home health services to assist with medication management, wound care, and respiratory therapy, as he continues to improve. The patient is discharged on a regimen that includes Acetaminophen, Amoxicillin-Clavulanic Acid, and other supportive medications. \\n\\nFollow-up appointments are scheduled with primary care and psychiatry within one week to ensure continuity of care and to monitor his recovery from both his infectious and psychological conditions. Home health services are to be initiated within 48 hours post-discharge to ensure a smooth transition and promote optimal recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 21  \\n**Gender:** Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 1 day  \\n\\n**Brief History of Present Illness:**  \\nThe patient presented to the emergency department with complaints of paresthesia of the skin, accompanied by anxiety and fatigue. The patient's medical history is significant for acute myeloblastic leukemia in relapse, chronic graft-versus-host disease, and a personal history of pulmonary embolism. She has ongoing treatment for her leukemia and has been closely monitored for complications related to her stem cell transplant.\\n\\n**Hospital Course:**  \\nDuring her brief hospitalization, the patient's vital signs remained stable, and she was closely monitored for neurological symptoms. She received supportive care, including hydration with 0.9% Sodium Chloride and symptom management with Acetaminophen and Lorazepam for anxiety. Acyclovir was administered for prophylaxis against viral infections given her immunocompromised state. Decitabine and Methotrexate were continued as part of her cancer treatment regimen. She was evaluated by hematology and the transplant team, who noted her condition as stable with no acute complications.\\n\\n**Key Findings and Procedures:**  \\nNeurological examination confirmed the presence of paresthesia without any focal deficits. No immediate complications from her graft-versus-host disease were noted. Extensive laboratory tests were conducted, including complete blood counts and metabolic panels, which showed stable counts with no signs of acute distress. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with mild residual paresthesia but no functional limitations reported. She is able to perform activities of daily living with minimal assistance and will benefit from home health services to continue monitoring her symptoms and provide emotional support for her anxiety. \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed the following medications:  \\n- 0.9% Sodium Chloride for hydration  \\n- Acetaminophen for pain management  \\n- Acyclovir as antiviral prophylaxis  \\n- Decitabine and Methotrexate for leukemia treatment  \\n- Escitalopram for anxiety management  \\n- Heparin flush as needed  \\nFollow-up appointments are scheduled with both the oncology and transplant teams in one week. Home health services will initiate visits to assess her overall health and mental well-being.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 19  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient, a 19-year-old female, was admitted urgently due to symptoms consistent with an adjustment disorder (ICD10: F4320), following situational stressors. She also presented with localized enlarged lymph nodes (ICD10: R590) and a background history of attention-deficit hyperactivity disorder (ADHD) (ICD10: F909).  \\n\\n**Hospital Course:**  \\nDuring her 3.5-day stay, the patient was evaluated by psychiatry, and a treatment plan was initiated, including psychotherapy and pharmacotherapy. She was started on Escitalopram Oxalate and Fluvoxamine Maleate for her adjustment disorder. The patient was monitored for side effects and response to treatment. She reported a gradual improvement in mood and coping strategies. HydrOXYzine was administered as needed for anxiety relief, and pain management was provided with Ibuprofen and Acetaminophen.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s vital signs remained stable throughout her stay. Initial labs were within normal limits, and a physical examination confirmed the presence of localized lymphadenopathy but no signs of acute infection. Psychosocial assessments indicated a need for ongoing support, particularly in coping with recent life changes.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved mood stability and coping mechanisms. She is able to participate in daily activities but will require home health services to continue mental health support and medication management. She has been advised to engage in follow-up therapy sessions and maintain communication with her primary care provider.  \\n\\n**Medications at Discharge:**  \\n1. **Escitalopram Oxalate**  \\n2. **Fluvoxamine Maleate**  \\n3. **HydrOXYzine**  \\n4. **Acetaminophen**  \\n5. **Ibuprofen**  \\n6. **Aluminum-Magnesium Hydrox.-Simethicone**  \\n7. **Milk of Magnesia**  \\n8. **Influenza Vaccine Quadrivalent**  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with her primary care physician and with outpatient mental health services to ensure continuity of care and support.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Attending Physician:** [REDACTED]  \\n\\n**History of Present Illness:**  \\nThe patient is a 50-year-old female admitted for observation due to postprocedural hemorrhage of a musculoskeletal structure following a recent surgical intervention. She has a background of obesity (BMI 41) and a personal history of malignant neoplasm of the left breast, currently on Tamoxifen.  \\n\\n**Hospital Course:**  \\nDuring her 2-day stay, the patient was closely monitored for signs of ongoing hemorrhage and associated complications. Vital signs remained stable, and she was treated with intravenous fluids, analgesics, and prophylactic anticoagulation with Heparin to prevent thromboembolic events.  \\n\\n**Key Findings and Procedures:**  \\nUpon examination, the surgical site showed no signs of active bleeding, though there was mild swelling and tenderness. Labs indicated a slight drop in hemoglobin, which stabilized with supportive care. The patient underwent a series of imaging studies, confirming no further complications. She was also evaluated by the oncology team, who recommended continuity of her current chemotherapy regimen.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with mild discomfort at the surgical site. She demonstrates an understanding of her discharge instructions and is capable of performing activities of daily living with assistance as needed. Home health services are being arranged to assist with postoperative care, medication management, and monitoring for any potential complications.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. D5 1/2NS  \\n3. Docusate Sodium  \\n4. HYDROmorphone (Dilaudid)  \\n5. Heparin  \\n6. Iso-Osmotic Dextrose  \\n7. Lidocaine-Prilocaine  \\n8. Omeprazole  \\n9. Scopolamine Patch  \\n10. Senna  \\n11. Sodium Chloride 0.9% Flush  \\n12. Tamoxifen Citrate  \\n13. Vancomycin  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and the oncology clinic for continued management of her breast cancer. Home health services will initiate contact within 48 hours post-discharge to ensure proper medication adherence and monitor recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Surgical same-day admission  \\n**Length of Stay:** 5.3 days  \\n**Primary Diagnosis:** Diverticulitis of the large intestine with perforation and abscess with bleeding (ICD-10: K5721)  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute abdominal pain, fever, and altered bowel habits. Imaging studies revealed diverticulitis complicated by perforation, abscess formation, and associated bleeding. The decision for surgical intervention was made promptly due to the patient's deteriorating condition.  \\n  \\n**Hospital Course:**  \\nThe patient underwent an exploratory laparotomy with resection of the affected segment of the colon. Post-operative recovery included intensive monitoring for vital signs and managing complications such as acute posthemorrhagic anemia (ICD-10: D62). The patient received appropriate IV antibiotics (Ciprofloxacin and Metronidazole), analgesia, and supportive care, including IV fluids (5% Dextrose and D5 1/2NS).  \\n  \\n**Key Findings and Procedures:**  \\nDuring hospitalization, the patient was stabilized, with resolution of fever and abdominal tenderness. He was educated on post-operative care, including the importance of hydration, bowel regimen, and signs of infection. The patient’s hemoglobin levels improved with transfusions and iron supplementation, and he was mobilized with physical therapy support.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert, oriented, and ambulating with assistance. He is stable for home health services, requiring ongoing monitoring for incision care and dietary modifications. The patient also expressed anxiety regarding his recovery, which will be addressed in follow-up care.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen IV  \\n3. Ciprofloxacin IV  \\n4. D5 1/2NS  \\n5. Enoxaparin Sodium  \\n6. Lorazepam  \\n7. Metoclopramide  \\n8. Metronidazole  \\n9. Ondansetron  \\n10. Sertraline  \\n11. Tramadol  \\n12. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician and surgical team within one week. Home health services will provide additional support for medication administration, wound care, and mental health management.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 80  \\n- **Gender:** Male  \\n- **Admission Date:** [Admission Date]  \\n- **Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient, an 80-year-old male, was admitted through the emergency department with a diagnosis of sepsis due to an unspecified organism. He presented with fever, confusion, and shortness of breath. Upon evaluation, he was found to have acute respiratory failure and pneumonia.  \\n\\n**Hospital Course:**  \\nDuring his 3.7-day hospital stay, the patient was started on broad-spectrum intravenous antibiotics including Ceftriaxone and CefePIME, along with supportive measures such as oxygen therapy and fluid resuscitation. His respiratory status gradually improved, and he was monitored in the acute care setting until stable.  \\n\\n**Key Findings and Procedures:**  \\nChest X-ray revealed pneumonia, and laboratory tests confirmed the presence of acidosis and elevated blood glucose levels consistent with his history of type 2 diabetes mellitus. The patient was treated for dehydration and received necessary medications to manage his blood glucose levels.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with improved respiratory function and vital signs within normal limits. He is alert and oriented but requires assistance for activities of daily living (ADLs) due to weakness. Home health services are recommended to assist with monitoring his condition, medication management, and rehabilitation.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Acetaminophen, Albuterol nebulizer solution, Aspirin, Azithromycin, and insulin adjustments as needed. He has been advised to follow up with his primary care physician within one week to reassess his diabetes management and respiratory status. The importance of adherence to the prescribed home health services has been emphasized to ensure a smooth recovery.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 59  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 59-year-old male who presented to the hospital with a nontraumatic intracerebral hemorrhage in the cortical hemisphere, as indicated by ICD-10 code I611. He reported sudden onset of headache and altered mental status. Initial imaging confirmed the diagnosis, and he was admitted under observation for further management and monitoring.\\n\\n**Hospital Course:**  \\nDuring the 1.7-day hospital stay, the patient was managed with blood pressure control using intravenous labetalol and nicardipine, as well as anticoagulation therapy with heparin. Neurological assessments were conducted regularly, revealing stable but diminished level of consciousness with gradual improvement. The patient was also treated for essential hypertension and hyperlipidemia during his stay.\\n\\n**Key Findings and Procedures:**  \\nNeuroimaging confirmed the presence of hemorrhage, and no surgical intervention was required. The patient was monitored for complications such as seizures, which were effectively managed with levetiracetam. Other comorbidities, including anxiety disorder and gastro-esophageal reflux disease, were addressed with appropriate medications. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved mental status, with the ability to follow simple commands and engage in basic conversation. However, he requires assistance with activities of daily living (ADLs) due to residual weakness and cognitive deficits. Home health services are recommended to assist with rehabilitation and ongoing monitoring of his blood pressure and neurological status.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on acetaminophen for pain management, captopril for hypertension, and levetiracetam for seizure prophylaxis. He will also receive dextrose and insulin as needed for blood glucose management. A follow-up appointment is scheduled with neurology within one week to assess recovery and adjust medications as necessary. Home health nursing will initiate weekly visits to monitor his progress and assist with rehabilitation.',\n",
       " '**Patient Information:** 34-year-old female admitted for endometriosis management.\\n\\n**History of Present Illness:** The patient presented to the emergency department with worsening pelvic pain, dysuria, and associated symptoms of tachycardia and low-grade fever. She has a known history of endometriosis, which has been exacerbated recently, leading to increased discomfort and functional impairment. \\n\\n**Hospital Course:** During her 6.8-day hospitalization, the patient underwent a thorough evaluation that included imaging studies which confirmed the presence of an unspecified endometriosis and a left ovarian cyst. She was started on a pain management regimen including acetaminophen, ibuprofen, and hydromorphone for severe pain control. Additionally, she was prescribed Aygestin (norethindrone acetate) for hormonal management of endometriosis. Other supportive measures included enoxaparin for DVT prophylaxis and lactulose for constipation management. She also received treatment for chronic rhinitis and was monitored for signs of infection due to her exposure to COVID-19.\\n\\n**Key Findings and Procedures:** The patient underwent a comprehensive pain assessment and was educated on the use of lidocaine patches and cyclobenzaprine for muscle relaxation. A urology consult was obtained for her overactive bladder symptoms, and she was provided with phenazopyridine to alleviate dysuria. \\n\\n**Discharge Condition and Functional Status:** The patient was discharged in stable condition with improved pain control and resolution of fever. She demonstrates an ability to perform basic self-care activities but requires assistance with mobility and daily tasks due to ongoing pain and fatigue. Home health services have been arranged to assist with these needs and provide follow-up care.\\n\\n**Medications and Follow-Up Plan:** Upon discharge, the patient will continue on Aygestin, duloxetine, diazepam, and fluticasone propionate nasal spray. She is to follow up with her gynecologist within one week for ongoing management of endometriosis. Home health nursing will monitor her pain levels and assist with medication adherence.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 23  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 23-year-old female who was admitted for surgical intervention due to complications from a gastric band procedure. She presented with significant dysphagia, vomiting, and heartburn, alongside a Body Mass Index (BMI) of 46.  \\n\\n**Hospital Course:**  \\nDuring her 1.8-day stay, the patient underwent an exploratory laparoscopy and revision of the gastric band placement (ICD10: 0DP64CZ) due to complications including gastro-esophageal reflux disease (GERD) and other post-operative issues. Her post-operative recovery was closely monitored, and she received appropriate pain management with intravenous morphine and oxycodone.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was noted to have improved gastric emptying and resolution of acute symptoms by the time of discharge. Laboratory tests showed stable electrolytes and no evidence of infection. She received a total of 10 doses of enoxaparin sodium for thromboprophylaxis during her hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved functional mobility, able to ambulate independently with minimal assistance. She was able to tolerate a clear liquid diet and reported a decrease in nausea and vomiting. Home health services will be required for ongoing dietary management and medication administration, with particular attention to her hydration status and monitoring for any recurrence of symptoms.  \\n\\n**Medications and Follow-up Plan:**  \\nThe patient was discharged on a regimen of acetaminophen IV, famotidine, lisinopril, and ondansetron, along with a prescription for amlodipine and propranolol for her ongoing management. A follow-up appointment is scheduled with her primary care physician in one week to assess her recovery and adjust her treatment plan as necessary. Home health services will continue to monitor her condition and provide dietary education.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 28  \\n- **Gender:** Female  \\n- **Admission Type:** Urgent  \\n- **Length of Stay:** 17 days  \\n  \\n**Brief History of Present Illness:**  \\nThe patient was admitted for urgent evaluation and management of preterm labor without delivery in the second trimester (ICD10: O6002). Upon admission, she reported regular uterine contractions and cervical shortening, confirmed by transvaginal ultrasound. The patient was also noted to be experiencing anemia complicating her pregnancy (ICD10: D259) and was under psychological stress, presenting with symptoms consistent with major depressive disorder (ICD10: F329).  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was placed on a regimen of tocolytics and monitored closely for signs of worsening preterm labor. Her anemia was managed with ferrous sulfate supplementation, and supportive care was provided for her mental health, including initiation of sertraline. The patient also received education on signs of labor and self-care strategies.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent cervical shortening at 25 weeks gestation (ICD10: Z3A25) and a benign uterine leiomyoma (ICD10: O3412). The patient underwent routine monitoring, and no surgical intervention was required during her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with a functional status that allows her to participate in home health services. She requires assistance with monitoring her contractions and adherence to medication regimens. Additionally, follow-up with a mental health professional is advised to support her postpartum adjustment.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed the following medications: Acetaminophen, Cyclobenzaprine, Diphenhydramine, Docusate Sodium, Ferrous Sulfate, Lidocaine 5% Patch, Milk of Magnesia, Mirtazapine, Ondansetron, Oxycodone (Immediate Release), Prenatal Vitamins, Senna, and Sertraline. The patient is advised to follow up with her obstetrician within one week and with her mental health provider as needed. Home health services will be coordinated to assist with her ongoing care.',\n",
       " '**Discharge Summary**  \\n**Patient:** 51-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5 days  \\n**Primary Diagnosis:** Hypertensive heart disease with heart failure (ICD10: I110)  \\n\\n**History of Present Illness:**  \\nThe patient presented with exacerbation of heart failure, characterized by dyspnea, orthopnea, and peripheral edema. He has a known history of hypertension and heart failure, which has been poorly controlled. Additionally, the patient developed a urinary tract infection during his hospital stay, contributing to his overall decompensation.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient was placed on diuretics for fluid management and received intravenous antibiotics for the urinary tract infection. Cardiology was consulted and adjustments to his heart failure regimen were made, including increased doses of Lisinopril and Metoprolol. His symptoms improved progressively, and he was monitored for arrhythmias due to his history of atrial fibrillation.  \\n\\n**Key Findings and Procedures:**  \\nEcho demonstrated preserved ejection fraction with signs of diastolic dysfunction. The patient remained stable hemodynamically, with no new arrhythmias noted. Laboratory results indicated elevated BNP levels consistent with heart failure exacerbation, which improved during treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improved dyspnea and reduced edema. He is able to perform activities of daily living with minimal assistance. However, he requires continued home health services for monitoring of heart failure symptoms, medication management, and physical therapy to enhance mobility and strength.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride (Mini Bag Plus)  \\n2. Acetaminophen  \\n3. Allopurinol  \\n4. Apixaban  \\n5. CefTRIAXone  \\n6. Diltiazem Extended-Release  \\n7. Lisinopril  \\n8. Metoprolol Succinate XL  \\n9. Nuedexta  \\n10. Phenazopyridine  \\n11. Pravastatin  \\n12. Torsemide  \\n13. Amlodipine  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with his primary care physician and cardiology in one week. Home health services will initiate within 48 hours post-discharge.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 70  \\n- **Gender:** Female  \\n  \\n**Admission History:**  \\nThe patient was admitted for observation due to diverticulitis of the large intestine, presenting with abdominal pain and altered bowel habits. Initial imaging confirmed the diagnosis of diverticulitis without perforation or abscess.  \\n  \\n**Hospital Course:**  \\nThe patient was started on intravenous antibiotics (Amoxicillin-Clavulanic Acid and Ceftriaxone) and supportive care, including hydration and bowel rest. She tolerated a gradual advancement of diet from clear liquids to a regular diet without complication. Her abdominal pain improved significantly during the stay, and she was afebrile throughout. She was monitored for any signs of complications such as perforation or abscess formation, which did not occur.  \\n  \\n**Key Findings and Procedures:**  \\n- The patient exhibited stable vital signs, and laboratory results showed normalization of inflammatory markers.  \\n- No surgical intervention was necessary, and the patient was discharged in a stable condition.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is ambulatory, with a functional status allowing for independent activities of daily living. She requires home health services for monitoring her recovery, medication management, and nutritional guidance. She is advised to maintain a high-fiber diet to prevent recurrence of diverticulitis. Additionally, she should be monitored for any signs of worsening abdominal discomfort or changes in bowel habits.  \\n  \\n**Medications at Discharge:**  \\nThe following medications were prescribed:  \\n- Amoxicillin-Clavulanic Acid  \\n- Ceftriaxone  \\n- Docusate Sodium  \\n- Heparin  \\n- Levothyroxine Sodium  \\n- Losartan Potassium  \\n- Metronidazole  \\n- Omeprazole  \\n- Ondansetron  \\n- Polyethylene Glycol  \\n- Promethazine  \\n- Rosuvastatin Calcium  \\n- Senna  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week for further evaluation of her diverticulitis and management of her chronic conditions, including hypothyroidism and hypertension. Home health services will be initiated to assist with her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Insert ID]  \\n**Patient Name:** [Insert Name]  \\n**Date of Birth:** [Insert DOB]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Attending Physician:** [Insert Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 63-year-old female with a history of atherosclerotic heart disease, presenting with symptoms consistent with a non-ST elevation myocardial infarction (NSTEMI). She reported chest pain and dyspnea upon exertion, which prompted observation admission for further evaluation and management.  \\n  \\n**Hospital Course:**  \\nDuring her 1.6-day stay, the patient underwent a comprehensive cardiac evaluation. Serial troponin levels confirmed a diagnosis of NSTEMI. She was treated with aspirin, atorvastatin, and heparin, along with symptomatic management using morphine for pain control. Additionally, she received metoprolol for heart rate control and was monitored for any complications. The patient exhibited a stable clinical course throughout her admission, with resolution of symptoms prior to discharge.  \\n  \\n**Key Findings and Procedures:**  \\nElectrocardiogram showed evidence of supraventricular tachycardia without ST elevation. Cardiac monitoring confirmed stability, and echocardiogram demonstrated preserved left ventricular function. No significant arrhythmias were noted post-intervention.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with no acute distress noted. She is able to perform activities of daily living independently, although she requires follow-up home health services to monitor her cardiac status and medication adherence. Education on lifestyle modifications, including smoking cessation and dietary changes, was provided to enhance recovery and prevent future events.  \\n  \\n**Medications at Discharge:**  \\n1. Aspirin 81 mg daily  \\n2. Atorvastatin 40 mg daily  \\n3. Metoprolol Tartrate 50 mg twice daily  \\n4. Amlodipine 5 mg daily  \\n5. Heparin sodium as per protocol  \\n6. Acetaminophen as needed for pain  \\n7. Influenza Vaccine Quadrivalent administered  \\n8. 5% Dextrose and Sodium Chloride for hydration as needed  \\n  \\n**Follow-Up Plan:**  \\nFollow up with cardiology in one week and contact home health services for ongoing support and monitoring. The patient was educated on signs and symptoms that necessitate immediate medical attention.  \\n  \\n**Signature:**  \\n[Insert Physician Signature]  \\n**Date:** [Insert Date]',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 62  \\n- **Gender:** Male  \\n- **Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient presented with severe recurrent major depressive disorder complicated by suicidal ideations. He was admitted for urgent psychiatric evaluation and stabilization after a motor vehicle accident, where he intentionally collided with a tree. Additionally, he sustained multiple fractures, including a displaced fracture of the medial malleolus of the left tibia and several rib fractures.\\n\\n**Hospital Course:**  \\nDuring his 7-day hospital stay, the patient underwent a comprehensive psychiatric evaluation. Multidisciplinary care involved psychiatry, pain management, and physical therapy. His depressive symptoms were addressed with Sertraline, and he received supportive therapy. Pain management was initiated using Acetaminophen and Gabapentin, and he was placed on Enoxaparin for DVT prophylaxis due to immobility. The patient also had a history of alcohol use disorder, which was managed with Acamprosate.\\n\\n**Key Findings and Procedures:**  \\nThe patient demonstrated significant improvement in mood and a reduction in suicidal ideations by the time of discharge. Imaging studies confirmed the fractures, and orthopedic consultation recommended follow-up care. He was educated on the importance of adherence to his psychiatric medications and lifestyle modifications.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable and able to perform basic self-care tasks with some assistance. He requires ongoing home health services for medication management, mental health support, and rehabilitation for his fractures. Coordination with home health will ensure continuous monitoring of his psychiatric status and physical recovery.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Acamprosate, Acetaminophen, Bictegravir-Emtricitabine-Tenofovir, Enoxaparin, Folate, Gabapentin, Lidocaine patch, Multivitamins, Ramelteon, Sertraline, and Thiamine. He has been advised to follow up with his primary care physician and psychiatrist within one week of discharge. Home health services will be initiated to facilitate ongoing psychiatric care and support.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 47 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.7 days  \\n**Primary Diagnosis:** Spondylolisthesis, lumbar region (ICD10: M4316)  \\n  \\n**History of Present Illness:**  \\nThe patient presented with severe lower back pain radiating to the left leg, accompanied by intermittent episodes of urinary retention. Imaging studies confirmed lumbar spondylolisthesis and spinal stenosis. She has a significant history of opioid abuse and chronic pain, complicating her treatment plan.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was managed with a multimodal approach for pain control, including intravenous hydromorphone and ketorolac. Gabapentin was initiated for neuropathic pain management. The patient also underwent physical therapy focused on lumbar stabilization exercises and education on proper body mechanics. Due to her history of opioid dependence, we implemented a careful tapering strategy while introducing non-opioid analgesics. She was monitored closely for any signs of withdrawal or exacerbation of her psychiatric conditions, including major depressive disorder and anxiety.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient remained stable throughout her stay with improved pain control and mobility. Key findings included resolution of urinary retention with bladder training initiated. She received a lidocaine patch for localized pain relief and was educated on the use of nicotine patches to assist with tobacco cessation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved functional status, ambulating independently with a walker and engaging in activities of daily living (ADLs) with minimal assistance. She was deemed appropriate for home health services to continue physical therapy and monitor her psychiatric health.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications: 0.9% Sodium Chloride, Acetaminophen, Gabapentin, OxyCODONE (Immediate Release), QUEtiapine extended-release, and a nicotine patch.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with her primary care physician is recommended within one week post-discharge to assess pain management and monitor mental health. Additionally, home health services will be initiated to provide ongoing physical therapy and psychiatric support.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 74 years old  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 4.6 days  \\n**Primary Diagnosis:** Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris (I25118)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for elective surgical intervention due to progressive angina and evidence of significant atherosclerotic disease. He reported increased frequency of angina episodes and associated chest discomfort.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient underwent successful coronary artery bypass grafting (CABG). Postoperatively, he was monitored in the cardiac unit where he received standard post-surgical care. His recovery was complicated by mild atelectasis and transient atrial fibrillation, which resolved with medical management. He was also treated for posthemorrhagic anemia due to a minor surgical bleed.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs, satisfactory graft patency on echocardiogram, and resolution of post-operative complications. The procedures performed included CABG and postoperative management involving intravenous fluids, analgesics, and antiplatelet therapy.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, ambulating independently with minimal assistance. He reports improved energy levels and has demonstrated the ability to perform activities of daily living with some support. Home health services will be initiated to assist with continued cardiac rehabilitation and medication management.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Aspirin EC, Clopidogrel, Metoprolol Tartrate, Amiodarone, Furosemide, and insulin as needed. He will continue to receive 0.9% NaCl and albumin infusions at home as per protocol.  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with cardiology in one week. Home health services will monitor his cardiac status, assist with medication adherence, and provide educational resources to promote a heart-healthy lifestyle.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 45  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient is a 45-year-old female who was admitted for surgical intervention due to a neoplasm of uncertain behavior located in the infratentorial region of the brain (ICD-10 D431). She presented with symptoms including dizziness, visual disturbances, and gait abnormalities, which have progressively worsened over the past month.  \\n\\n**Hospital Course:**  \\nDuring her 4.5-day hospital stay, the patient underwent resection of the brain tumor (ICD-10 00B60ZZ) and experienced a stable postoperative course. She was monitored closely for neurological status and vital signs, and her pain was managed effectively with hydromorphone and acetaminophen. Postoperative imaging confirmed no immediate complications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included transient diplopia and nausea postoperatively, likely secondary to the surgical intervention. The patient also received intravenous dexamethasone for cerebral edema and ondansetron for nausea. Other supportive measures included insulin management for blood sugar levels and heparin for venous thromboembolism prophylaxis.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved functional status, able to ambulate with assistance and perform activities of daily living (ADLs) with minimal help. She exhibits ongoing dizziness but is stable and has no significant neurological deficits.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Dexamethasone  \\n3. Ondansetron  \\n4. Dextrose 50%  \\n5. Docusate Sodium  \\n6. Heparin  \\n7. Insulin  \\n8. Other supportive medications as needed  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her neurosurgeon in 1 week for further assessment and management of her recovery. Home health services have been arranged for assistance with rehabilitation, monitoring of neurological status, and medication management. Continuity of care will be emphasized to ensure a smooth recovery process.',\n",
       " '**Patient Information:** 31-year-old female admitted for observation due to a benign neoplasm of the liver (ICD-10 D134). \\n\\n**History of Present Illness:** The patient presented with abdominal discomfort and was found to have an incidental liver mass on imaging studies. She had no significant past medical history, but noted mild intermittent abdominal pain over the last few months. She denied any changes in bowel habits, weight loss, or significant family history of liver disease.\\n\\n**Hospital Course:** During her 2-day hospital stay, the patient underwent further imaging and laboratory evaluations. A liver ultrasound confirmed the presence of a benign neoplasm. She was monitored for any complications, and her symptoms remained stable throughout her stay. Laboratory tests showed normal liver function without signs of malignancy. \\n\\nKey procedures included imaging studies and routine blood tests. She received supportive care with IV fluids and medications for symptom management, including acetaminophen for pain and pantoprazole for gastrointestinal protection. The patient was also administered the influenza vaccine and was educated on lifestyle modifications relevant to her overall health and liver wellness. \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition with no acute distress and has demonstrated the ability to ambulate independently. She is able to perform activities of daily living without assistance, making her appropriate for home health services to continue monitoring and support her recovery.\\n\\n**Medications at Discharge:** The patient will continue on a regimen including 0.9% Sodium Chloride for hydration, acetaminophen for pain management, and pantoprazole as needed. Follow-up appointments with a hepatologist have been scheduled to monitor her condition. Home health services will involve periodic assessments, medication management, and education on maintaining a healthy lifestyle post-discharge.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Patient MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 91  \\n**Gender:** Female  \\n**Admission Type:** Direct Emergency  \\n\\n**History of Present Illness:**  \\nThe patient is a 91-year-old female who presented with complications related to her cardiac prosthetic device, specifically coded as T82897A. She has a history of congestive heart failure and chronic kidney disease, which contributed to her acute presentation. The patient reported increased shortness of breath, fatigue, and a significant decline in her functional status over the preceding days.  \\n\\n**Hospital Course:**  \\nDuring her 13-day hospital stay, the patient was monitored closely for cardiac function and fluid status. She received diuretics for heart failure exacerbation, and renal function was evaluated periodically. Initial management included hemodynamic stabilization and optimization of her antihypertensive regimen.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included echocardiographic evidence of reduced ejection fraction and worsening renal function. The patient underwent a therapeutic procedure (ICD-10: 02RF38Z) to address complications related to her prosthetic device. Throughout her stay, she received supportive care including hydration and electrolyte management.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improvement in her respiratory status but continues to require assistance with activities of daily living due to weakness and fatigue. She will need home health services for continued monitoring of her heart failure management, medication adherence, and assistance with rehabilitation exercises.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Aspirin, Atorvastatin, Clopidogrel, Heparin, Prednisone, and others tailored to her condition. She is advised to follow up with her cardiologist within one week of discharge and to maintain regular communication with her home health nurse for ongoing assessment and support.  \\n\\n**Conclusion:**  \\nThe patient has been stabilized and is ready for discharge with a comprehensive home health plan in place to facilitate her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 50 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.6 days  \\n**Primary Diagnosis:** Discitis, unspecified, lumbosacral region (ICD10: M4647)  \\n\\n**History of Present Illness:**  \\nThe patient presented with acute lower back pain and fever. Upon evaluation, he was found to have discitis in the lumbosacral region, likely secondary to methicillin-susceptible Staphylococcus aureus infection. He reported significant discomfort, difficulty with activities of daily living (ADLs), and an inability to ambulate without assistance.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient received intravenous antibiotics (Cefazolin) and supportive care, including pain management with Acetaminophen, Cyclobenzaprine, and Oxycodone. He was monitored for signs of neurological compromise given the proximity of the infection to the spinal structures. He also received physical therapy to assist with mobility and strengthen core muscles.  \\n\\n**Key Findings and Procedures:**  \\nImaging studies confirmed the diagnosis of discitis without abscess formation. Laboratory tests showed elevated inflammatory markers consistent with infection. The patient was stable throughout the admission, with gradual improvement in pain levels and mobility.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved ambulation with a walker and was able to perform basic ADLs with minimal assistance. He was educated on the importance of continued physical therapy and home health services to monitor his recovery, manage pain, and ensure adherence to his medication regimen.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Cyclobenzaprine  \\n3. Gabapentin  \\n4. Heparin  \\n5. Losartan Potassium  \\n6. Oxycodone (Immediate Release)  \\n7. Omeprazole  \\n8. Naproxen  \\n9. Polyethylene Glycol  \\n10. Senna  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to continue home health services for ongoing assessment and support. He is to report any signs of worsening symptoms or new neurological deficits immediately.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 65  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 10.4 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of pneumonitis due to inhalation of food and vomit, presenting with acute respiratory distress. He has a history of myasthenia gravis, which was exacerbated during hospitalization, complicating his respiratory status.\\n  \\n**Hospital Course:**  \\nDuring his 10-day stay, the patient received supportive care, including supplemental oxygen and respiratory therapy. He was closely monitored for respiratory failure, which was managed with albuterol nebulizations and the initiation of non-invasive ventilation as needed. He also experienced acute episodes of cardiogenic shock, requiring fluid resuscitation and careful hemodynamic monitoring. Additionally, he was treated for hypercapnic and hypoxic respiratory failure, with improvement noted in his oxygenation status.  \\n  \\n**Key Findings and Procedures:**  \\nChest imaging revealed bilateral infiltrates consistent with aspiration pneumonitis. A bronchoscopy was performed to clear secretions. Laboratory evaluation showed elevated inflammatory markers, and the patient was started on appropriate antibiotics (Cefepime) to treat possible infection. His nutritional status was assessed, revealing significant cachexia; thus, he was initiated on enteral nutrition support.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved respiratory function and better oxygen saturation levels. He will require ongoing home health services for respiratory therapy and nutritional support, as well as assistance with activities of daily living due to weakness from his myasthenia gravis exacerbation. His mobility is limited, and he will need close monitoring at home for any signs of respiratory distress or further complications.\\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include 0.9% Sodium Chloride, Albuterol, Atorvastatin, and AzaTHIOprine among others. He is scheduled for follow-up with his primary care physician in one week and a pulmonologist within two weeks to monitor his recovery and adjust his treatment plan as necessary. Home health services will begin within 24 hours to ensure continuity of care.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 61  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a diagnosis of malignant neoplasm of the right breast (ICD-10: C50911). She has a complex medical history including essential hypertension, type 2 diabetes mellitus, and hyperlipidemia. During her stay, she exhibited signs of delirium, likely secondary to her underlying medical conditions.\\n\\n**Hospital Course:**  \\nOver the course of her 4.7-day stay, the patient underwent several diagnostic evaluations including imaging studies, which confirmed the presence of a right breast mass. She received supportive care for her diabetes and hypertension, and her delirium was managed with lorazepam and appropriate hydration. The patient was monitored closely for any complications related to her cancer diagnosis and her chronic conditions.\\n\\n**Key Findings and Procedures:**  \\nKey findings included a mass in the right breast and altered mental status. She underwent a breast biopsy (ICD-10: 0HBT0ZZ) and was started on insulin for blood glucose management. The patient also received symptomatic treatment for her nausea with ondansetron and supportive measures for her sleep apnea. \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing home health support due to her recent delirium and the need for monitoring of her diabetes and hypertension. She will benefit from home health services to assist with medication management and monitoring of her vital signs. The patient is able to perform basic self-care but requires assistance with activities of daily living due to her recent cognitive changes.\\n\\n**Medications at Discharge:**  \\nUpon discharge, the patient’s medication regimen includes acetaminophen IV, lorazepam, insulin, losartan potassium, and dextrose gel among others. \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up appointments with oncology and her primary care physician to manage her cancer treatment and chronic conditions. Home health services will be initiated to provide nursing support and ensure compliance with her medication regimen.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 64  \\n- **Gender:** Male  \\n- **Admission Type:** Elective  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of a malignant neoplasm of the supraglottis (ICD-10: C321). He presented with significant dysphagia and respiratory distress. Given his history of chronic kidney disease, hypertension, and diabetes, a comprehensive preoperative assessment was warranted.  \\n\\n**Hospital Course:**  \\nDuring his 8-day stay, the patient underwent a laryngectomy and was monitored for postoperative complications, including acute respiratory failure and heart failure exacerbation. He received supportive care, including oxygen therapy, diuretics, and management of blood glucose levels. The patient also received a nicotine patch as part of a smoking cessation program.  \\n\\n**Key Findings and Procedures:**  \\n- **Procedures:** Laryngectomy (0B110F4), tracheostomy (0BJ08ZZ), and postoperative monitoring for respiratory and cardiac function.  \\n- **Key Findings:** Notable improvement in respiratory status post-extubation, but persistent dysphagia necessitated dietary modifications. Labs showed stabilized renal function, and he was discharged with a plan for outpatient follow-up.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable but required continued assistance with activities of daily living due to ongoing dysphagia and respiratory issues. He will benefit from home health services for monitoring vital signs, medication management, and dietary support. The interdisciplinary team will provide education on care strategies, including aspiration precautions and fluid management.  \\n\\n**Medications at Discharge:**  \\nThe patient’s discharge medications include:  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Aspirin  \\n- CARVedilol  \\n- Lisinopril  \\n- OxyCODONE (Immediate Release)  \\n- Nicotine Patch  \\n- Docusate Sodium  \\n- Glucose Gel  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with oncology and a dietitian within one week post-discharge. Home health services will be initiated to assist with rehabilitation and dietary management.',\n",
       " 'Patient is a 32-year-old female admitted for observation due to preterm labor without delivery at 34 weeks gestation. She presented with regular contractions and cervical changes but was stabilized with appropriate medical management. During her stay, she received Betamethasone for fetal lung maturity and proGESTerone to help manage her labor symptoms. \\n\\nThe hospital course was uneventful, with close monitoring of maternal and fetal status. Key findings included cervical dilation of 2 cm and effacement of 50%. The fetal heart rate was reassuring throughout the admission. The patient was educated on signs of labor progression and the importance of follow-up care. \\n\\nUpon discharge, the patient is stable with no active labor. Her functional status has improved, and she is able to ambulate independently and perform activities of daily living. Home health services are recommended to support her with monitoring her symptoms and adherence to prescribed medications, as well as to provide education on infant care upon delivery. \\n\\nMedications at discharge include Acetaminophen for pain management, Betamethasone for fetal lung development, Levothyroxine Sodium for hypothyroidism, and prenatal vitamins to ensure maternal and fetal health. The patient was instructed to continue proGESTerone therapy and was provided with a syringe for administration. \\n\\nFollow-up with her obstetric provider is recommended within one week or sooner if symptoms worsen, specifically if there are increased contractions, vaginal bleeding, or any concerns regarding fetal movement. The patient was made aware of the need for continued monitoring and the importance of adhering to her medication regimen.',\n",
       " \"**Patient Information:**  \\nAge: 53  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a urinary tract infection (UTI), as indicated by the primary ICD-10 code N390. Upon admission, the patient presented with urinary frequency, urgency, and dysuria. The patient has a significant medical history including HIV, acute kidney failure, and malnutrition, which complicated her clinical picture.  \\n\\n**Hospital Course:**  \\nDuring the 14-day hospital stay, the patient was treated with intravenous fluids and antibiotics, including ciprofloxacin for UTI management. The patient's acute kidney function was monitored closely, and supportive measures were taken to address her malnutrition. A multidisciplinary approach involved nutritionists and infectious disease specialists. Regular assessments of her electrolytes and renal function were performed, with adjustments made to her management as necessary.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included resolution of the UTI symptoms and stabilization of kidney function. The patient underwent routine laboratory tests revealing improvement in her renal parameters. No invasive procedures were required during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved hydration status and renal function. She is alert and oriented but requires assistance with activities of daily living due to her underlying health conditions, including malnutrition and HIV. Home health services have been arranged to provide skilled nursing care for medication administration and dietary management.  \\n\\n**Medications and Follow-up Plan:**  \\nDischarge medications include acetaminophen for pain management, ciprofloxacin for UTI prophylaxis, fluconazole for candidiasis, and insulin for diabetes management. The patient is to follow up with her primary care physician within one week and will have home health services in place to monitor her progress and ensure adherence to her medication regimen. Additionally, nutrition counseling will be provided to address her protein-calorie malnutrition.\",\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 49  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a peritoneal abscess, diagnosed based on clinical presentation and imaging studies. She has a history of type 2 diabetes mellitus and is on long-term oral hypoglycemic agents, which may have contributed to her current condition. The abscess was identified in the context of her existing ileostomy and colostomy status.\\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient was treated with intravenous antibiotics, specifically Daptomycin and Ertapenem Sodium, with close monitoring of her glucose levels due to her diabetes. She was also given supportive care including 0.9% Sodium Chloride, Dextrose, and pain management with Hydromorphone. The surgical team was consulted, and it was determined that the abscess required percutaneous drainage, which was successfully performed without complications.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent leukocytosis and localized abdominal tenderness. Imaging confirmed the presence of the abscess, necessitating the drainage procedure. Post-procedure, the patient demonstrated improvement in symptoms and decreased inflammatory markers.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, alert, and oriented. She reports improvement in abdominal pain and has been tolerating a regular diet. Home health services will be necessary for wound care management following the drainage procedure, monitoring of her diabetes, and assistance with daily activities, considering her anxiety disorder and previous surgeries. \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on Acetaminophen for pain management, Amitriptyline for anxiety, and will require insulin as per her diabetes management plan. She is advised to follow up with her primary care physician and surgical team within one week to assess her recovery and adjust her diabetes medications as needed. Home health nursing will be arranged to facilitate her post-discharge care.',\n",
       " 'Patient is a 67-year-old male who was admitted for observation due to pneumonia, unspecified organism, leading to significant respiratory distress. Upon admission, the patient presented with a cough, fever, and difficulty breathing. Initial evaluation included a chest X-ray, which confirmed the presence of bilateral infiltrates indicative of pneumonia. The patient has a history of kidney and liver transplant, alongside a past medical history of hyperkalemia, gout, and major depressive disorder, which complicated his clinical picture.\\n\\nDuring his 2.9-day hospital stay, the patient was treated with intravenous antibiotics, specifically Levofloxacin and CefePIME, alongside supportive care, including 0.9% Sodium Chloride for hydration. The patient was monitored closely for any signs of respiratory deterioration and received appropriate interventions to manage his electrolyte imbalances. Throughout the hospitalization, he demonstrated gradual improvement in respiratory function, with a reduction in fever and resolution of cough.\\n\\nKey findings included the resolution of acute respiratory distress as evidenced by improved oxygen saturation levels and the absence of new infiltrates on follow-up imaging. Upon discharge, the patient was stable, alert, and oriented, with no acute distress. However, he requires ongoing assistance with activities of daily living due to underlying adult failure to thrive and previous transplant status.\\n\\nThe discharge medications include Levofloxacin, Acetaminophen for pain management, Allopurinol for gout, and Escitalopram for depression. The patient is advised to follow up with his primary care physician within one week, and a referral for home health services is arranged to assist with daily living activities and medication management. Home health nursing will monitor his respiratory status and medication adherence, ensuring he continues his recovery at home.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 36 years  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of a breast abscess (ICD-10: N611). The patient reported localized pain and swelling in the right breast, which had progressed over the past week. She has a history of breast cancer (C50411) and was receiving antineoplastic chemotherapy, which contributed to her current presentation of abscess formation.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was started on intravenous antibiotics (Ampicillin-Sulbactam and Amoxicillin-Clavulanic Acid) and underwent incision and drainage of the abscess. She also received supportive care including analgesics (Hydromorphone for pain management) and antiemetics (Ondansetron) for nausea. Hematological assessments revealed signs of chemotherapy-induced pancytopenia (D61810), requiring monitoring and management with transfusions as needed.  \\n  \\n**Key Findings and Procedures:**  \\nThe incision and drainage procedure was performed successfully with no immediate complications. Post-procedure, the patient demonstrated improved pain control and reduction in swelling. She was monitored for signs of infection and managed with prophylactic anticoagulation (Enoxaparin) due to her history of malignancy and risk of thrombosis.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with a significant decrease in breast pain and swelling. She is able to perform activities of daily living with assistance and requires home health services for continued wound care and administration of intravenous antibiotics. Education was provided regarding signs of infection and medication management at home.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen for pain management  \\n2. Amoxicillin-Clavulanic Acid for infection  \\n3. Enoxaparin for prophylaxis  \\n4. Sumatriptan Succinate for migraine management  \\n5. LORazepam for anxiety as needed  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with oncology and primary care within one week post-discharge is recommended. Home health will begin on the day of discharge to manage wound care and monitor the patient’s recovery.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information**: 51-year-old male  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 17.8 days  \\n  \\n**History of Present Illness**: The patient was admitted for management of myeloid sarcoma, which has not achieved remission. During hospitalization, he developed complications including antineoplastic chemotherapy-induced pancytopenia and severe protein-calorie malnutrition, necessitating careful monitoring and supportive care.  \\n  \\n**Hospital Course**: The patient received aggressive chemotherapy, along with supportive measures for his nutritional status. A multidisciplinary team was involved in his care, addressing both oncological and nutritional needs. He underwent procedures including stem cell transplant, and management for chronic graft-versus-host disease. By the end of the stay, the patient showed signs of clinical improvement; however, he remains at risk for complications.  \\n  \\n**Key Findings and Procedures**: Key findings included persistent cytopenias managed with transfusions and nutritional support. He underwent stem cell transplant successfully without immediate complications, although he requires ongoing monitoring for potential graft-versus-host disease.  \\n  \\n**Discharge Condition and Functional Status**: The patient is discharged in stable condition. He requires home health services for ongoing monitoring of his nutritional intake and medication administration. He is currently dependent on assistance for daily living activities due to weakness associated with his treatment and underlying conditions.  \\n  \\n**Medications at Discharge**: The patient is prescribed the following medications: Acyclovir, Dexamethasone, Enoxaparin Sodium, Isavuconazonium Sulfate, and others aimed at managing his condition and preventing complications.  \\n**Follow-Up Plan**: The patient should follow up with his oncologist within one week of discharge. Home health services will initiate a nutritional assessment and provide medication management support. Additionally, the patient will require regular lab monitoring to assess blood counts and overall health status.',\n",
       " \"Patient is an 87-year-old female with a history of persistent atrial fibrillation, admitted for observation due to exacerbation of her cardiac condition. Upon admission, she exhibited symptoms consistent with acute diastolic heart failure, alongside a recent NSTEMI myocardial infarction. During her 7.8-day hospital stay, she was closely monitored for cardiac rhythm and hemodynamic stability. \\n\\nKey findings included persistent atrial fibrillation with a rapid ventricular response, evidenced by telemetry monitoring, and transient hypotension requiring intravenous fluid management. The patient also experienced episodes of acute respiratory failure, necessitating supplemental oxygen therapy. A comprehensive cardiac workup, including echocardiography, confirmed left ventricular diastolic dysfunction. \\n\\nThroughout her hospital course, she was managed with anticoagulation therapy (Apixaban), beta-blockers (Metoprolol), and diuretics to address her heart failure symptoms. The patient was also treated for mild cognitive impairment, which was evaluated by the neurology team. Multidisciplinary rounds emphasized the importance of physical therapy and occupational therapy to enhance her mobility and functional independence prior to discharge.\\n\\nUpon discharge, the patient's condition has stabilized, although she remains at risk for recurrent arrhythmias and heart failure exacerbations. Functional status is improved from admission, as she is now able to perform basic activities of daily living with supervision. A home health referral has been arranged to provide skilled nursing care for medication management and monitoring of her vital signs, as well as physical therapy to further enhance her strength and mobility.\\n\\nDischarge medications include Acetaminophen, Apixaban, Aspirin, Atorvastatin, Diltiazem, Metoprolol, and others as needed. The patient is advised to follow-up with her primary care physician and cardiologist within one week to reassess her cardiac status and medication regimen.\",\n",
       " '**Patient Information:** 84-year-old female presented for observation with a diagnosis of malignant neoplasm of the pancreas (ICD10: C259). The patient has a complex medical history including severe protein-calorie malnutrition, chronic kidney disease stage 3, and secondary malignancies affecting the liver. \\n\\n**History of Present Illness:** The patient was admitted due to worsening abdominal pain and weight loss over the past few months. On admission, she exhibited signs of malnutrition, with laboratory tests indicating electrolyte imbalances and renal function decline. \\n\\n**Hospital Course:** During her short stay of approximately 1.3 days, the patient was monitored closely. She received intravenous hydration and nutritional support, including vitamin supplementation (Ascorbic Acid and Cyanocobalamin). Pain management was initiated with Hydromorphone and antiemetics were administered for nausea. The patient also received bowel regimen medications (Docusate Sodium, Senna, and Polyethylene Glycol) to manage constipation. \\n\\n**Key Findings and Procedures:** Imaging studies confirmed the presence of the primary pancreatic malignancy and indicated liver involvement. She was evaluated by oncology, who recommended outpatient follow-up for further management of her malignancy. \\n\\n**Discharge Condition and Functional Status:** At the time of discharge, the patient was stable but remains at high risk for complications due to her underlying conditions. She is ambulatory with assistance and requires home health services for ongoing nutritional support and monitoring of her renal status. The patient will need assistance with activities of daily living and meal preparations to ensure adherence to her dietary needs. \\n\\n**Medications and Follow-Up Plan:** Medications at discharge include Heparin for DVT prophylaxis, Levothyroxine, and pain management regimen. She is to continue with home health nursing visits to monitor her health status, manage medications, and provide education on dietary modifications. Follow-up appointments with her oncologist and nephrologist are crucial in the upcoming weeks. The patient, along with her family, has been educated on warning signs that would warrant immediate medical attention.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 73 years  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a right rib fracture sustained from a fall. She presented with localized pain on the right side and difficulty with deep breathing due to discomfort. The patient has a history of essential hypertension, type 2 diabetes with diabetic neuropathy, and anxiety disorder, which were monitored during her stay.  \\n  \\n**Hospital Course:**  \\nDuring her 3-day stay, the patient underwent pain management and respiratory therapy. She was started on acetaminophen for pain control and received bronchodilator therapy with albuterol due to mild wheezing. Nutritional support was also initiated for her moderate protein-calorie malnutrition. The patient received education on fall prevention strategies and was assessed for home safety.  \\n  \\n**Key Findings and Procedures:**  \\nRadiographic imaging confirmed a closed fracture of the right rib. Laboratory tests indicated hypo-osmolality and hyponatremia, which were corrected during hospitalization. The patient demonstrated improved respiratory function by discharge, and her pain was well managed with oral analgesics.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with significant improvement in pain levels and respiratory function. She is able to perform activities of daily living with minimal assistance but requires monitoring for her diabetes and nutritional needs. Home health services are recommended for ongoing assessment of her nutritional status, medication management, and support with fall prevention strategies.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed the following medications: acetaminophen, albuterol inhaler, bisacodyl, fexofenadine, and fluticasone-salmeterol diskus. Follow-up appointments are scheduled with her primary care physician and a dietitian within one week. Home health services will initiate contact within 24 hours post-discharge to facilitate her transition and address any immediate needs.',\n",
       " '**Discharge Summary**  \\n**Patient:** 58-year-old female  \\n**Admission Type:** Direct Observation  \\n**Length of Stay:** 1 day  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of acute vestibular neuronitis, presenting with sudden onset of vertigo, nausea, and imbalance. She reported a prior history of similar symptoms but with no recent exacerbation. The patient has a significant medical history including essential hypertension, hyperlipidemia, and osteoarthritis, which were managed during her stay.\\n\\n**Hospital Course:**  \\nDuring her short stay, the patient was closely monitored in a direct observation unit. Neurological assessments were performed repeatedly, confirming vestibular dysfunction without focal neurological deficits. Laboratory studies demonstrated stable electrolytes and renal function. The patient was treated with supportive measures, including hydration and antiemetics, with gradual improvement in symptoms. She received medications including Clopidogrel for cardiovascular protection and Diltiazem for hypertension management.\\n\\n**Key Findings and Procedures:**  \\n- Primary diagnosis: Vestibular neuronitis, unspecified ear (ICD10: H8120)  \\n- Other notable diagnoses: Essential hypertension (I10), hyperlipidemia (E785), benign paroxysmal vertigo (H8110)  \\n- No significant complications arose during hospitalization.  \\n- The patient was educated about her condition and the importance of follow-up care.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved stability with mild residual dizziness. She was ambulating independently but required assistance with activities of daily living. Home health services are recommended to assist with mobility training, medication management, and monitoring for any potential recurrence of symptoms.\\n\\n**Medications at Discharge:**  \\n- Clopidogrel 75 mg daily  \\n- Diltiazem 120 mg daily  \\n- Heparin (as needed)  \\n- Sertraline 50 mg daily for anxiety/depression  \\n- Polyethylene Glycol and Senna for constipation management  \\n- Multivitamins and Vitamin D3  \\n- Sodium Chloride 0.9% for flushing as needed  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to contact the home health service for further support. Regular monitoring of her medication adherence and assessment of dizziness recurrence will be crucial.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 37-year-old female with a history of pre-existing hypertension who was admitted for observation due to pre-eclampsia in the third trimester of her pregnancy. She presented with elevated blood pressure readings, proteinuria, and edema, consistent with the diagnosis of pre-existing hypertension complicated by pre-eclampsia.  \\n\\n**Hospital Course:**  \\nDuring her 12-day hospital stay, the patient was closely monitored for blood pressure, renal function, and fetal well-being. She received intravenous fluids and antihypertensive therapy, including Labetalol, which effectively controlled her blood pressure. Regular fetal monitoring was performed, revealing reassuring fetal heart tones. Additionally, the patient experienced mild anemia, managed with iron supplementation. Routine laboratory tests indicated elevated protein levels in urine, confirming the diagnosis.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated serum creatinine levels indicative of chronic kidney disease and the presence of proteinuria. The patient underwent a comprehensive ultrasound, which demonstrated normal fetal growth and amniotic fluid levels. No surgical interventions were required during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with controlled blood pressure on oral medications. She is ambulating independently and shows no signs of acute distress. She requires home health services for further monitoring of her blood pressure, renal function, and assistance with daily activities given her recent hospitalization and ongoing pregnancy-related complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue the following medications: Acetaminophen, Acetaminophen-Caff-Butalbital, Aspirin, Azathioprine, Calcium Carbonate, Docusate Sodium, Heparin, Hydroxychloroquine Sulfate, Metoclopramide, Prenatal Vitamins, and Senna. She is advised to follow-up with her obstetrician and nephrologist within one week, and to contact home health services for regular blood pressure monitoring and health assessments.\",\n",
       " '**Discharge Summary**  \\n**Patient**: 63-year-old male  \\n**Admission Type**: Direct Emergency  \\n**Length of Stay**: 2.8 days  \\n  \\n**History of Present Illness**: The patient was admitted with acute ST elevation myocardial infarction (STEMI) involving the anterior wall, specifically related to other coronary artery, as confirmed by ECG and cardiac biomarkers. He presented with chest pain radiating to the left arm and significant dyspnea.  \\n  \\n**Hospital Course**: During his hospital stay, the patient was stabilized with intravenous fluids and initiated on antiplatelet therapy. He underwent a coronary angiogram which revealed significant atherosclerotic changes and was treated with percutaneous coronary intervention (PCI). The patient was monitored in the cardiac unit for arrhythmias due to his history of unspecified atrial fibrillation and managed accordingly.  \\n  \\n**Key Findings and Procedures**: Key findings included elevated troponin levels and persistent ST elevations on ECG. The patient received dual antiplatelet therapy with aspirin and clopidogrel post-PCI, alongside beta-blockers and statins for secondary prevention. He was also initiated on Enalapril for hypertension and was monitored for renal function due to his history of kidney transplant.  \\n  \\n**Discharge Condition and Functional Status**: The patient is stable upon discharge, with no chest pain and normal vital signs. He demonstrates the ability to perform activities of daily living with minimal assistance. Home health services will be initiated to monitor his cardiac status, medication adherence, and assist with rehabilitation exercises as needed.  \\n  \\n**Medications and Follow-Up Plan**: Upon discharge, the following medications were prescribed: Aspirin, Clopidogrel, Atorvastatin, Metoprolol Tartrate, Enalapril, and Magnesium supplements. He is advised to follow up with cardiology within one week and to schedule routine lab work to monitor renal and cardiac function. The patient is also encouraged to engage in lifestyle modifications, including dietary changes and smoking cessation support, given his history of nicotine dependence.',\n",
       " \"**Patient Name:** [Redacted]  \\n**Age:** 65  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with fever, chills, and altered mental status. She was diagnosed with sepsis secondary to Escherichia coli bacteremia. Initial laboratory results indicated acute kidney injury and electrolyte imbalances, necessitating immediate intervention. \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was started on broad-spectrum IV antibiotics, including Ceftriaxone. Supportive care was initiated, including intravenous fluids (0.9% Sodium Chloride) and monitoring of renal function. The patient's condition improved with treatment, and she was transitioned to oral medications prior to discharge. Notably, she received multiple doses of Acyclovir for suspected viral co-infection and was closely monitored for potential complications associated with her underlying conditions, including hypothyroidism and a history of leukemia. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed resolution of the acute kidney injury. Renal function showed improvement, and the patient’s vital signs stabilized. Additionally, she received a quadrivalent influenza vaccine during her stay, and her skin condition was treated with Desonide cream. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was alert and oriented at the time of discharge, with stable vital signs. She demonstrated the ability to perform activities of daily living with minimal assistance and expressed her understanding of her medication regimen. Home health services will be essential for monitoring her renal function and medication adherence, particularly considering her complex medical history.  \\n\\n**Medications and Follow-up Plan:**  \\nUpon discharge, the patient is to continue on the following medications: Ceftriaxone, Atorvastatin, Levothyroxine, and Prednisone, among others. A follow-up appointment is scheduled with her primary care physician within one week of discharge. Home health will monitor her progress and assist with medication management and any necessary rehabilitation services.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\nAge: 61  \\nGender: Male  \\n**Admission Type:** Observation  \\n**Length of Stay:** 2.7 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with symptoms consistent with benign prostatic hyperplasia (BPH), including lower urinary tract symptoms, urinary retention, and discomfort. Upon evaluation, he was also found to have a urinary tract infection (UTI), contributing to his symptoms of urinary urgency and nocturia.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient was monitored closely and received intravenous fluids to address dehydration. He was initiated on antibiotics (Amoxicillin and Vancomycin) for the UTI and medication for BPH (Tamsulosin and Oxybutynin) to alleviate urinary symptoms. Serial assessments showed improvement in urinary output and symptom relief. He experienced episodes of tachycardia and orthostatic hypotension, which were managed with careful fluid resuscitation and monitoring.  \\n\\n**Key Findings and Procedures:**  \\nThe patient’s vital signs stabilized with treatment, and he underwent a bladder ultrasound confirming urinary retention. Diagnostic tests ruled out more severe complications. He was educated on the importance of medication adherence and fluid management to prevent future episodes of UTI and urinary retention.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was afebrile and demonstrated improved urinary function, with decreased episodes of urgency and retention. He is independent in activities of daily living (ADLs) and requires home health services for continued medication management and monitoring of urinary symptoms.  \\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Amoxicillin  \\n- Atorvastatin  \\n- Heparin  \\n- Iso-Osmotic Dextrose  \\n- Lidocaine Jelly 2%  \\n- Multivitamins  \\n- Oxybutynin  \\n- Phenazopyridine  \\n- Sodium Chloride 0.9% Flush  \\n- Sodium Phosphate  \\n- Tamsulosin  \\n- Vancomycin  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up in one week with his primary care physician to reassess urinary symptoms and medication efficacy. Home health services will monitor his hydration status and medication compliance.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 27  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently for evaluation of abnormal fetal heart rate and rhythm complicating labor and delivery (ICD10: O76). Upon admission, she was found to be at 40 weeks of gestation and experiencing secondary uterine inertia (ICD10: O621).  \\n\\n**Hospital Course:**  \\nDuring her 3-day hospital stay, the patient underwent continuous fetal monitoring, which revealed intermittent variable decelerations. An intravenous (IV) line was established for hydration and medication administration. The patient received oxytocin for labor induction and pain management with acetaminophen and ibuprofen. She was also given ondansetron for nausea management and received the quadrivalent influenza vaccine as part of her discharge plan.  \\n\\n**Key Findings and Procedures:**  \\nThe delivery was successfully managed with the aid of oxytocin, and a single live birth was achieved without any immediate complications. The patient's vital signs remained stable throughout her stay, and she demonstrated good tolerance to oral intake post-delivery. A naloxone kit was provided upon discharge as a precautionary measure for potential opioid-related side effects.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating independently, and expressing satisfaction with her care. She has been advised on postpartum care, including monitoring for signs of infection or excessive bleeding. Home health services are recommended for continued support, including assistance with infant care and monitoring of her recovery.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue with the following medications:  \\n- 0.9% Sodium Chloride Flush  \\n- Ibuprofen for pain management  \\n- Docusate Sodium as needed for constipation  \\n- Ketorolac for additional pain relief if necessary  \\nFollow-up appointments are scheduled with her obstetrician within one week for postpartum evaluation and further guidance on recovery.\",\n",
       " '**Patient Summary:**  \\nThis 65-year-old female patient was admitted for surgical intervention for malignant neoplasm of the endometrium (ICD-10: C541) with a surgical same-day admission. \\n\\n**History of Present Illness:**  \\nThe patient presented with symptoms consistent with endometrial cancer, including abnormal uterine bleeding and abdominal discomfort. Preoperative imaging revealed malignancy, necessitating surgical intervention.\\n\\n**Hospital Course:**  \\nThe patient underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy on the day of admission. Postoperatively, she was monitored in the surgical unit where she received appropriate pain management and supportive care. She demonstrated stable vital signs and normal recovery progression. Throughout her stay, she was managed for secondary complications, including hyperkalemia and a urinary tract infection, which were addressed with appropriate interventions.\\n\\n**Key Findings and Procedures:**  \\nKey findings included the presence of malignancy, which was confirmed histologically. Procedures performed include:  \\n- Total abdominal hysterectomy (0UT90ZZ)  \\n- Bilateral salpingo-oophorectomy (0UT20ZZ)  \\n- Monitoring for urinary and respiratory issues, with treatment for COPD exacerbation (J449).  \\nThe patient was also started on anticoagulation therapy post-surgery with Enoxaparin Sodium to prevent thromboembolic events.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. Home health services will be initiated for wound care management, medication administration, and monitoring of her recovery progress. The patient will require assistance with mobility and monitoring for signs of infection or complications related to her recent surgery.\\n\\n**Medications at Discharge:**  \\nDischarge medications include Acetaminophen, Albuterol nebulizer solution, Ciprofloxacin, Citalopram, Enoxaparin Sodium, and Hydromorphone, among others. \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in two weeks with her oncologist to assess recovery and plan further management, including potential adjuvant therapy. Home health nursing will establish contact within 48 hours post-discharge.',\n",
       " 'Patient is a 72-year-old female with a history of essential hypertension, type 2 diabetes mellitus, hyperlipidemia, and chronic obstructive pulmonary disease (COPD). She was admitted under observation for evaluation of a cerebral infarction due to embolism of the right posterior cerebral artery (ICD10: I63431). The patient presented with sudden onset of left-sided weakness and neglect, consistent with a left non-dominant side hemiplegia following cerebral infarction.\\n\\nDuring her 2.9-day hospital stay, the patient underwent a thorough neurological assessment and imaging, which confirmed the cerebral infarction. Management included intravenous Heparin therapy for anticoagulation, along with supportive care and symptomatic treatment for her COPD. The patient was closely monitored for any complications, and her blood pressure was controlled with appropriate antihypertensive medication. She was started on Aspirin and Atorvastatin for secondary stroke prevention, and Gabapentin was prescribed for neuropathic pain management.\\n\\nKey findings included persistent hemiplegia on the left side, with significant improvement in her neurological status by discharge. The patient demonstrated an ability to participate in basic activities of daily living (ADLs) with assistance, indicating a need for home health services to support her rehabilitation. \\n\\nAt the time of discharge, the patient was stable, but she required assistance with mobility and activities such as dressing and bathing. She was discharged home with a home health nursing referral for ongoing assessment of her neurological status, medication management, and physical therapy to address her mobility deficits. \\n\\nDischarge medications include 5% Dextrose, Heparin, Aspirin, Atorvastatin, Gabapentin, and insulin for her diabetes management. The patient is advised to follow up with her primary care physician within one week to monitor her recovery and adjust her treatment plan as necessary.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 35 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 6.1 days  \\n**Date of Admission:** [Insert date]  \\n**Date of Discharge:** [Insert date]  \\n**Primary Diagnosis:** Crohn's disease of both small and large intestine with other complications (ICD10: K50818)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department for management of exacerbation of Crohn's disease, presenting with abdominal pain, melena, and significant fatigue. During the evaluation, the patient also exhibited signs of acute posthemorrhagic anemia.  \\n  \\n**Hospital Course:**  \\nThe patient underwent extensive workup including laboratory studies and imaging, confirming active inflammation consistent with Crohn's disease. A multidisciplinary approach involving gastroenterology was implemented, and the patient received IV fluids, iron supplementation, and was started on oral Vancomycin for associated gastrointestinal symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included moderate anemia and gastrointestinal bleeding, managed with supportive care. The patient was treated for anxiety, which was exacerbated by hospitalization. Procedures performed included IV hydration and monitoring for anemia, with subsequent transfusion considered but not required.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved abdominal pain and resolution of melena. The patient is ambulating independently and reports a return to baseline activity levels. Home health services have been arranged to assist with medication administration and monitoring of dietary intake, as well as to provide psychosocial support for anxiety management.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen 2. Diphenhydramine 3. Enoxaparin (prophylaxis) 4. Ondansetron 5. Prochlorperazine 6. Ramelteon 7. Sodium Chloride 0.9% Flush 8. Vancomycin Oral Liquid 9. Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with their primary care physician and gastroenterologist within one week post-discharge for further evaluation and management of Crohn's disease. Home health services will initiate contact within 48 hours of discharge.  \\n**Instructions:**  \\nThe patient is instructed to monitor for any signs of recurrent bleeding, persistent abdominal discomfort, or worsening anxiety symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n**Age:** 76  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient, a 76-year-old male, was admitted under observation for evaluation of transient ischemic attack (TIA) symptoms characterized by transient weakness and speech difficulties. The symptoms resolved within a few hours, but due to his age and medical history, further observation was warranted.\\n\\n**Hospital Course:**  \\nDuring the 1.8-day hospital stay, the patient underwent a thorough workup, including a CT scan of the head which showed no acute intracranial pathology. Neurology was consulted, and it was determined that the transient symptoms were consistent with a TIA. A regimen of antiplatelet therapy was initiated, and the patient was started on anticoagulation with heparin. Additionally, Acyclovir was administered due to a herpesviral infection identified during the workup.\\n\\n**Key Findings and Procedures:**  \\nThe patient was diagnosed with transient cerebral ischemic attack (ICD10: G459) and had multiple comorbidities including dysarthria, unsteadiness on feet, and essential tremor. His discharge medications include Aspirin, Atorvastatin, and Propranolol LA among others.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs and improved functional status. He was independent in activities of daily living but required assistance with mobility due to unsteadiness. A home health assessment is recommended to monitor his neurological status and provide support with physical therapy.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is prescribed the following medications: Acyclovir, Aspirin, Atorvastatin, Fish Oil, Heparin, HydrALAZINE, and Zonisamide. Follow-up with his primary care physician is advised in one week, along with outpatient neurology for continued management of his TIA and comorbidities. Home health services will be initiated to ensure safety and stability at home.',\n",
       " \"**Patient Name:** [Redacted]  \\n**Age:** 75  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 1.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of unspecified atrial fibrillation, presenting with palpitations and dyspnea. Additionally, he has a history of chronic diastolic heart failure, hypertensive heart disease, type 2 diabetes mellitus with nephropathy, and hyperlipidemia. He also has chronic kidney disease contributing to his clinical picture.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was monitored closely on telemetry due to his atrial fibrillation. He underwent echocardiography which revealed preserved left ventricular function but significant diastolic dysfunction. Heart failure management included diuretics and optimization of his antihypertensive regimen. The patient's diabetes was managed with insulin and dietary modifications, and his renal function was assessed with regular labs showing stable creatinine levels. The patient responded well to medical therapy, with resolution of symptoms before discharge.\\n\\n**Key Findings and Procedures:**  \\n- **ECG**: Atrial fibrillation confirmed.  \\n- **Echocardiogram**: Diastolic dysfunction noted.  \\n- **Labs**: Stable renal function, blood glucose levels normalized.  \\n- **Medications Administered**: Diuretics (Furosemide), beta-blockers (Carvedilol), and anticoagulation (Enoxaparin for DVT prophylaxis).\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently, and demonstrating adequate understanding of his medication regimen. He will benefit from home health services for ongoing monitoring of his heart failure symptoms, medication management, and diabetes education. \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Bumetanide  \\n5. CARVedilol  \\n6. Furosemide  \\n7. Insulin  \\n8. Docusate Sodium  \\n9. Multivitamins  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with his primary care physician in one week, and will also see a cardiologist for further management of atrial fibrillation within the next two weeks. Home health services will be initiated to assist with medication adherence and monitoring of heart failure symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 70-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.9 days  \\n**Primary Diagnosis:** Cellulitis of right lower limb (ICD10: L03115)  \\n\\n**History of Present Illness:**  \\nThe patient presented with complaints of localized swelling and erythema in the right lower limb, associated with pain and tenderness. On examination, she was found to have significant edema and warmth over the affected area, consistent with cellulitis.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient was started on intravenous ceftriaxone for her cellulitis and was monitored closely for any signs of systemic infection or progression of the condition. She received supportive care, including pain management with acetaminophen and oxycodone, as well as optimization of her chronic medications including atenolol and lisinopril for her hypertension and atorvastatin for hyperlipidemia.  \\n\\nKey findings included improvement of the cellulitis with resolution of fever and stabilization of her chronic medical conditions. The patient also exhibited signs of metabolic encephalopathy, likely secondary to her underlying iron deficiency anemia, which was managed with ferrous sulfate supplementation.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with significant improvement in her right lower limb swelling and pain. The patient is able to perform activities of daily living with assistance, but requires continued home health services for wound care and monitoring of her anemia and metabolic status. She is advised to limit physical activity until full recovery is established.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- Acetaminophen  \\n- Aspirin  \\n- Atenolol  \\n- Atorvastatin  \\n- Calcium Carbonate  \\n- CefTRIAXone (completed course)  \\n- Docusate Sodium  \\n- Ferrous Sulfate  \\n- LORazepam  \\n- Levothyroxine Sodium  \\n- Lidocaine 5% Patch  \\n- Lisinopril  \\n- Omeprazole  \\n- Ondansetron ODT  \\n- OxyCODONE (Immediate Release)  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and with a home health nurse for wound care and monitoring. She will also need regular blood work to manage her anemia and assess metabolic parameters.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Age:** 56  \\n**Gender:** Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 3.6 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 56-year-old male with a history of unilateral primary osteoarthritis of the right knee (ICD-10: M1711). He presented for elective knee arthroplasty due to persistent pain and functional disability. His past medical history includes essential hypertension, hyperlipidemia, and major depressive disorder. He also experienced a syncopal episode prior to admission, which was evaluated and deemed non-cardiac.\\n\\n**Hospital Course:**  \\nThe patient was admitted for a right total knee replacement and underwent the procedure without complications. Post-operatively, he was monitored for pain management and rehabilitation. He received standard postoperative medications including acetaminophen, ketorolac, and hydromorphone for pain control. Enoxaparin was initiated for DVT prophylaxis. The patient’s recovery was uneventful with gradual improvement in ambulation and pain control.\\n\\n**Key Findings and Procedures:**  \\nDuring the hospital stay, the patient's vital signs remained stable, and he demonstrated adequate pain management. Physical therapy was initiated post-surgery, and he progressed to ambulating with a walker. Notable lab results indicated slight hyperlipidemia and stable renal function. The patient was counseled regarding his medications, including atorvastatin and fluoxetine.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable and has made satisfactory progress in his recovery. He can ambulate with a walker and perform basic activities of daily living with assistance. Home health services have been arranged to provide physical therapy and medication management to facilitate his recovery at home.\\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include acetaminophen, atorvastatin, fluoxetine, and enoxaparin. The patient is advised to follow up with his primary care physician and orthopedic surgeon within the next two weeks to monitor recovery and address any concerns. Home health services will initiate visits within 48 hours post-discharge to assist with rehabilitation and adherence to the medication regimen.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 31 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of hyperemesis gravidarum with metabolic disturbance at 12 weeks gestation. She presented with severe nausea and vomiting, leading to dehydration and electrolyte imbalances. Initial labs indicated elevated transaminases and lactic acid dehydrogenase, which were monitored throughout her stay.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient received intravenous fluid resuscitation with 0.9% Sodium Chloride and potassium supplementation. Anti-emetic therapy included Ondansetron and Metoclopramide, which significantly alleviated her symptoms. She was also started on calcium carbonate for gastric protection and was provided with prenatal vitamins to support her nutritional needs.  \\n\\nKey findings included stabilization of her electrolyte levels and a reduction in nausea and vomiting. Continuous monitoring showed improvement in her metabolic status, and she was able to tolerate oral intake by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with improved functional status. She reports mild residual nausea but is able to perform activities of daily living independently. She is advised to follow up with obstetric services and home health for ongoing monitoring of her condition and nutritional support. Home health services will assist with dietary management and hydration strategies to ensure adequate nutritional intake and prevent further complications.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Calcium Carbonate  \\n3. DiphenhydrAMINE  \\n4. Docusate Sodium  \\n5. Famotidine  \\n6. Heparin  \\n7. Metoclopramide  \\n8. Ondansetron  \\n9. Prenatal Vitamins  \\n10. Potassium Chloride  \\n11. Sodium Phosphate  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her obstetrician within one week. Home health services will initiate a visit within 48 hours post-discharge to monitor her symptoms and provide nutritional counseling.',\n",
       " \"Patient is a 59-year-old female who was admitted for observation with a diagnosis of sepsis of unspecified organism, accompanied by urinary tract infection and other complications including diffuse large B-cell lymphoma and hydronephrosis with ureteral stricture. The patient presented with fever, leukopenia, and urinary symptoms. Initial management included broad-spectrum intravenous antibiotics (Vancomycin, Ciprofloxacin), hydration, and supportive care.\\n\\nDuring her 3.8-day hospital stay, her clinical status was closely monitored. She received Filgrastim-sndz to stimulate white blood cell production due to neutropenia associated with her infection. Imaging studies confirmed hydronephrosis, and urology was consulted for possible intervention due to the ureteral stricture. The patient's fever subsided after 48 hours of appropriate antibiotic therapy, and her leukocyte count improved significantly.\\n\\nKey findings during her hospital course included persistent pancytopenia and an infectious workup revealing no specific organism. The patient tolerated all procedures well, including hemodynamic monitoring and IV medications. She demonstrated improvement in her functional status, being able to ambulate with minimal assistance and manage activities of daily living in preparation for discharge.\\n\\nAt discharge, the patient is stable, afebrile, and able to participate in her care plan. She is being discharged with home health services for ongoing monitoring and assistance with activities of daily living, especially due to her recent urinary complications and need for continued medication management. Medications at discharge include Acyclovir, Ciprofloxacin HCl, Enoxaparin for venous thromboembolism prophylaxis, and Vancomycin. Follow-up appointments with her primary care physician and oncology services are scheduled within one week of discharge. Home health nursing will assist with medication administration and wound care as needed.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 45 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.1 days  \\n**Primary Diagnosis:** Cellulitis of left upper limb (ICD10: L03114)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of swelling, erythema, and pain in the left upper limb, which developed over the past week. He has a history of hypertension and nicotine dependence but no previous episodes of cellulitis. Initial evaluation suggested an infectious etiology, and broad-spectrum antibiotics were initiated promptly.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient received intravenous antibiotics, including Vancomycin and Ampicillin-Sulbactam, with good clinical response noted. His lymphedema was addressed with elevation and compression therapy. He underwent daily wound care and monitoring for any signs of systemic infection. The patient remained afebrile and his white blood cell count normalized by discharge.\\n\\n**Key Findings and Procedures:**  \\nOn physical examination, significant improvement in the erythema and swelling was observed by day three. No necrosis or abscess formation was detected, and he had no further complications related to his underlying hypertension during his stay. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved mobility and ability to perform activities of daily living. He will require home health services for ongoing wound care and monitoring of limb elevation to manage lymphedema effectively. The patient is advised to monitor for any signs of recurrence or complications.\\n\\n**Medications at Discharge:**  \\n1. Amoxicillin-Clavulanic Acid  \\n2. Doxycycline Hyclate  \\n3. Amlodipine  \\n4. Heparin (as per protocol)  \\n5. 0.9% Sodium Chloride flush for IV line care  \\n\\n**Follow-Up Plan:**  \\nFollow-up with primary care physician in 1 week for reassessment of cellulitis and management of hypertension. Home health services will be initiated within 48 hours for wound care and monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 23  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital following an incident resulting in traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration. Upon arrival, the patient exhibited signs of confusion and altered mental status, prompting immediate neuroimaging and observation.  \\n\\n**Hospital Course:**  \\nDuring his 10.6-day hospitalization, the patient underwent extensive monitoring and supportive care. Neurological assessments were conducted daily, revealing gradual improvement in cognitive function and responsiveness. A multidisciplinary team, including neurology, physical therapy, and occupational therapy, was involved in his care. Interventions included pain management, neuroprotective strategies, and rehabilitation to enhance recovery.  \\n\\n**Key Findings and Procedures:**  \\nNeuroimaging confirmed the presence of a subarachnoid hemorrhage, which was managed conservatively without surgical intervention. The patient developed mild papilledema but showed no signs of progressive intracranial hypertension. His Glasgow Coma Scale scores improved significantly during his stay. Among the medications administered were acetaminophen for pain management, levetiracetam for seizure prophylaxis, and ondansetron for nausea.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved responsiveness, with a Glasgow Coma Scale score of 15 and the ability to follow simple commands. He was ambulatory with minimal assistance and required continued monitoring for cognitive function at home. The patient is medically stable but needs ongoing rehabilitation services to support recovery.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen 325mg TAB  \\n- LevETIRAcetam  \\n- OxyCODONE (Immediate Release)  \\n- Ondansetron  \\n- Omeprazole  \\n- Ciprofloxacin 0.3% Ophth Soln  \\n- Prochlorperazine  \\n- Ramelteon  \\n- Docusate Sodium  \\n\\n**Follow-up Plan:**  \\nThe patient is referred to home health services for ongoing occupational and physical therapy to aid in his recovery. A follow-up appointment with outpatient neurology is scheduled within one week to monitor neurological status and medication adjustment as needed. Family education on recognizing signs of complications and adherence to medication regimens was provided.',\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient ID]  \\n**Age:** 72  \\n**Gender:** Female  \\n**Admission Type:** Elective  \\n**Length of Stay:** 2.3 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 72-year-old female with a history of end-stage renal disease (ICD-10: N186) secondary to multiple myeloma, presenting for elective renal dialysis. She also has a history of anemia and dependency on renal dialysis. The patient's comorbidities include unspecified anemia (ICD-10: D649) and other disorders affecting bone density (ICD-10: M8588). She was admitted for dialysis management and symptomatic treatment for her renal insufficiency.  \\n  \\n**Hospital Course:**  \\nDuring her 2.3-day stay, the patient received hemodialysis without complications. She was closely monitored for any signs of fluid overload or electrolyte imbalances. Laboratory tests showed stable renal function parameters, and her anemia was managed with vitamin supplementation (Vitamin B Complex and Vitamin D). Pain from her myeloma was addressed with appropriate analgesics including Aspirin and Guaifenesin-CODEINE Phosphate.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent dialysis (ICD-10: 5A1D60Z) and displayed improvement in her symptoms post-procedure. Vital signs remained stable throughout her admission. Key laboratory findings indicated that her hemoglobin levels were within an acceptable range post-treatment.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable and ambulating independently. However, she requires ongoing home health services for continued dialysis support and monitoring of her renal function. Home health nursing will assist with medication management and monitor her anemia and overall health status.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed Acyclovir, Aspirin, Guaifenesin-CODEINE Phosphate, Heparin, Lorazepam, Labetalol, Oseltamivir, Sodium Chloride 0.9% (for flush), Tuberculin protein, Sevelamer carbonate, and Vitamin supplements.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her nephrologist within one week and will benefit from home health services to ensure adherence to her dialysis schedule and medication regimen.\",\n",
       " '**Patient Information:** 55-year-old male admitted for surgical intervention due to occlusion and stenosis of bilateral carotid arteries (ICD-10 I6523). \\n\\n**History of Present Illness:** The patient presented with a history of transient ischemic attacks and was found to have significant bilateral carotid artery stenosis on imaging. He was scheduled for endarterectomy on the same day of admission to prevent further cerebrovascular events.\\n\\n**Hospital Course:** The patient underwent successful bilateral carotid endarterectomy without any intraoperative complications. Postoperatively, he was monitored in the surgical unit for 48 hours. His recovery was uneventful, with stable vital signs and minimal pain, managed effectively with IV and oral acetaminophen. \\n\\nDuring the hospital stay, the patient was evaluated by physical therapy for mobility assessment; he demonstrated good functional status and was able to ambulate independently by discharge. Neurology assessed the patient, confirming no new neurological deficits. \\n\\n**Key Findings and Procedures:** Preoperative imaging confirmed severe bilateral stenosis necessitating intervention. Post-surgical Doppler studies indicated patent carotid arteries. The patient also has a complex medical history including obesity, type 2 diabetes with neuropathy, and hyperlipidemia, necessitating careful management post-discharge. \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition, with intact neurological status. He is able to perform activities of daily living independently and will require home health services for monitoring of blood pressure, glucose levels, and medication management, including insulin therapy. \\n\\n**Medications and Follow-Up Plan:** At discharge, the patient was advised to continue on Aspirin, Atorvastatin, and Gabapentin, among others. He received counseling on lifestyle modifications concerning his diabetes and hyperlipidemia. A follow-up appointment with his primary care physician is scheduled in two weeks to reassess his overall health status and medication adherence. Home health services will commence within 48 hours to assist with his ongoing care needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n46-year-old female  \\n**Admission Type:** Observation Admission  \\n**Length of Stay:** 7 days  \\n**Primary Diagnosis:** Traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter (ICD10: S066X0A)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital following a fall, resulting in a traumatic subarachnoid hemorrhage. She presented to the emergency department alert and oriented, with no loss of consciousness reported. Initial imaging confirmed the diagnosis and revealed no significant midline shift or mass effect.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was closely monitored for neurological status and vital signs. Neurology was consulted, and the patient was started on anticoagulation therapy with Warfarin after thorough evaluation. She received supportive care including pain management with Acetaminophen and bowel regimen with Docusate Sodium. The patient demonstrated improvement in her neurological assessment, with stable vital signs throughout her stay.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included a Glasgow Coma Scale of 15 at all assessments, with the best motor response demonstrating compliance with commands and spontaneous eye opening. No surgical intervention was required. The patient also had a stable hypertension management plan instituted with Lisinopril and Metoprolol Succinate.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with functional status improved from admission. She is able to perform activities of daily living with minimal assistance and requires home health services for ongoing monitoring of her anticoagulation therapy and medication adherence.  \\n\\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Docusate Sodium  \\n4. Heparin Sodium  \\n5. Levothyroxine Sodium  \\n6. Lisinopril  \\n7. Metoprolol Succinate XL  \\n8. Sodium Chloride 0.9% Flush  \\n9. Warfarin  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician and the anticoagulation clinic within one week of discharge. Home health services will be initiated to assist with medication management and monitor her recovery.',\n",
       " \"**Patient Information:** 68-year-old female admitted under observation for evaluation of iron deficiency anemia. \\n\\n**History of Present Illness:** The patient presented with fatigue and pallor, with a reported history of chronic gastrointestinal issues. Laboratory tests revealed low hemoglobin levels consistent with iron deficiency anemia (ICD10: D509). \\n\\n**Hospital Course:** During her 3.8-day stay, the patient underwent a comprehensive evaluation, including gastrointestinal imaging, which ruled out significant bleeding sources. She was treated with intravenous Ferric Gluconate, alongside supportive therapy with 0.9% Sodium Chloride and Lactated Ringer's solution for hydration. Gabapentin was administered for chronic pain management. \\n\\n**Key Findings and Procedures:** Key findings included gastritis (ICD10: K2970) noted on endoscopy, with no evidence of active bleeding. The patient also has a history of hypertension (ICD10: I10) and type 2 diabetes mellitus (ICD10: E119). An echocardiogram confirmed the presence of a prosthetic heart valve (ICD10: Z952). \\n\\n**Discharge Condition and Functional Status:** The patient is stable upon discharge, with improved hemoglobin levels and a functional status that allows her to perform activities of daily living with assistance. She will require home health services for monitoring her anemia management and diabetes care, including medication management and dietary guidance. \\n\\n**Medications:** At discharge, she will continue with Levothyroxine Sodium for hypothyroidism, Insulin for diabetes management, and Pantoprazole for gastritis. Additional medications include Follic Acid and Senna for constipation management. \\n\\n**Follow-up Plan:** Follow-up with her primary care physician is recommended within one week, and she will have home health nursing visits scheduled to ensure compliance with medication and monitor her overall health status.\",\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 33 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.9 days  \\n**Primary Diagnosis:** Non-pressure chronic ulcer of skin of other sites with unspecified severity (ICD10: L98499)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of a non-pressure chronic ulcer located on the right leg, which had been present for several months. The ulcer was assessed as having no active infection but was noted to be shallow and exhibiting signs of surrounding tissue edema. The patient has a history of end-stage renal disease requiring dialysis, which complicates wound healing.  \\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent wound care management, including debridement and application of advanced dressings. Pain management was effectively achieved with Hydromorphone and Acetaminophen. He was monitored closely for any signs of infection or deterioration in renal function.  \\n\\n**Key Findings and Procedures:**  \\nThe patient was evaluated by the wound care team, and a plan was made for continued care post-discharge including the need for home health nursing visits for wound care. Laboratory tests revealed stable renal function, and hemoglobin levels improved with Epoetin Alfa administration.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently with minimal assistance. He demonstrated understanding of wound care management and the importance of maintaining a clean environment around the ulcer site. The patient requires ongoing monitoring for potential complications due to his renal status and chronic ulcer.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: 5% Dextrose, Acetaminophen, Aluminum Hydroxide Suspension, Aspirin, Atorvastatin, Bisacodyl, Cinacalcet, Diphenhydramine, Docusate Sodium, Epoetin Alfa, Hydromorphone, Heparin, Lactulose, Lidocaine 1%.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with outpatient nephrology and wound care services within one week post-discharge. Home health services will be initiated to assist with daily wound care and monitor for any complications.',\n",
       " '**Discharge Summary**  \\n**Patient:** 35-year-old female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with gestational diabetes mellitus during childbirth, exhibiting symptoms consistent with uncontrolled hyperglycemia. She was admitted urgently for management and monitoring due to potential complications associated with her condition and additional mental health concerns.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was placed on a controlled regimen to manage her blood glucose levels, which were stabilized with insulin therapy. She was also evaluated for anxiety disorder complicating her pregnancy and was provided with appropriate mental health support. Continuous fetal monitoring was performed due to an abnormality in fetal heart rate and rhythm observed during labor. The patient delivered a single live birth via vaginal delivery with a first-degree perineal laceration, which was repaired appropriately.  \\n  \\n**Key Findings and Procedures:**  \\nICD-10 codes include O24429 for gestational diabetes, O99344 for anxiety disorder complicating childbirth, and O700 for perineal laceration. Procedures performed included fetal monitoring and repair of the perineal laceration. The patient was assessed for her mental health status, and her anxiety was addressed with counseling and reassurance.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated stable vital signs and was ambulating independently. She was advised to continue monitoring her blood glucose levels at home and maintain a balanced diet. Home health services will provide postpartum support, including nursing visits to monitor her recovery and glucose management, as well as mental health follow-up.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on Acetaminophen for pain management, Bisacodyl to prevent constipation, Calcium Carbonate for heartburn, Docusate Sodium as a stool softener, Ibuprofen for inflammation, and other supportive medications. She has received an influenza vaccine quadrivalent during her stay.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her obstetrician in one week to assess her recovery and manage her diabetes. Home health services will initiate contact to assist with glucose monitoring and mental health support.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- Name: [Patient Name]  \\n- Age: 43  \\n- Gender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to bacterial foodborne intoxication, presenting with nausea, vomiting, diarrhea, and abdominal cramping. The onset of symptoms began approximately 24 hours prior to admission after consuming a potentially contaminated meal. She has a history of Crohn's disease and type 2 diabetes, which complicated her clinical presentation.\\n\\n**Hospital Course:**  \\nDuring her 2.1-day hospital stay, the patient was monitored closely for dehydration and electrolyte imbalances. Intravenous fluids, specifically 0.9% Sodium Chloride, were administered to maintain hydration and correct hypomagnesemia. Pain management was achieved with Hydromorphone and Dicyclomine, while her blood glucose levels were managed with insulin therapy due to hyperglycemia. The patient also received Gabapentin for neuropathic pain and Duloxetine DR for mood stabilization.\\n\\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed dehydration and electrolyte disturbances. The patient underwent imaging studies to assess for bowel obstruction, which were negative. Vital signs remained stable throughout her stay, and she showed improvement in gastrointestinal symptoms by day two.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improved hydration status and resolution of acute gastrointestinal symptoms. She is ambulating independently and demonstrates the ability to manage her medications with minimal assistance. Home health services will provide follow-up for medication management and monitoring of her diabetes.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Atorvastatin  \\n- Dicyclomine  \\n- Duloxetine DR  \\n- Enoxaparin (Prophylaxis)  \\n- Metoprolol Succinate XL  \\n- Gabapentin  \\n- Insulin  \\n- Lidocaine 5% Patch  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and to initiate home health services for ongoing diabetes management and medication reconciliation. She is to monitor her symptoms closely and contact her healthcare provider if symptoms recur or worsen.\",\n",
       " \"Patient is a 66-year-old male who was admitted for observation due to chest pain and elevated troponin levels, indicative of a Non-ST elevation myocardial infarction (NSTEMI). His past medical history includes chronic kidney disease, peripheral vascular disease, and a history of coronary artery disease. During his 8.7-day hospital stay, the patient underwent comprehensive cardiac evaluation, including an echocardiogram and coronary angiography, which revealed significant atherosclerotic changes but no acute interventions were required.\\n\\nThe hospital course was complicated by episodes of acute kidney failure, which were managed with hydration and careful monitoring of renal function. The patient's thrombocytopenia remained stable throughout the admission and was attributed to his chronic conditions. He was treated with anticoagulants and antiplatelet agents, including clopidogrel and aspirin, to mitigate thromboembolic risks.\\n\\nKey findings included a stable cardiac rhythm, improved troponin levels, and resolved acute kidney injury. The patient was started on atorvastatin and isosorbide mononitrate to address dyslipidemia and angina symptoms, respectively. He was educated on lifestyle modifications, including dietary changes and smoking cessation, to prevent further cardiac events.\\n\\nAt the time of discharge, the patient was in stable condition, ambulating independently, and demonstrating understanding of medication management. He requires ongoing home health services for medication management, dietary adherence, and monitoring of renal function. \\n\\nDischarge medications include acetaminophen, aspirin EC, atorvastatin, clopidogrel, and isosorbide mononitrate. Follow-up appointments are scheduled with cardiology and nephrology within one week to assess cardiac health and renal function. It is essential for the patient to adhere to the prescribed medications and attend follow-up visits to ensure optimal recovery and prevent readmission.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**DOB:** [Date of Birth]  \\n**MRN:** [Medical Record Number]  \\n**Age:** 64  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 64-year-old female with a history of pulmonary embolism, presenting to the hospital for observation due to increased shortness of breath and chest discomfort. Initial assessment revealed significant hypoxemia and tachycardia, prompting further investigation. A CT pulmonary angiogram confirmed a diagnosis of other pulmonary embolism (ICD-10: I2699) without acute cor pulmonale.  \\n  \\n**Hospital Course:**  \\nDuring her 2.7-day stay, the patient was closely monitored in the observation unit. She received intravenous heparin and subsequently transitioned to oral rivaroxaban for anticoagulation therapy. Supportive care included oxygen supplementation and treatment with acetaminophen for discomfort. Additionally, a psychiatric consultation was initiated due to findings of major depressive disorder and anxiety, for which citalopram and lorazepam were prescribed. Other comorbidities including GERD and iron deficiency anemia were addressed with omeprazole and ferrous sulfate, respectively.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated D-dimer levels and stable vitals post-anticoagulation therapy. No further thromboembolic events were noted during the hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improved respiratory function and is ambulating independently. She will require home health services for continued monitoring and support for her mental health issues and anticoagulation management.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Citalopram  \\n4. Ferrous Sulfate  \\n5. Heparin Sodium  \\n6. Influenza Vaccine Quadrivalent (administered)  \\n7. Lorazepam  \\n8. Omeprazole  \\n9. Potassium Chloride  \\n10. Ramelteon  \\n11. Rivaroxaban  \\n12. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician in one week and with psychiatry as scheduled. Home health services will coordinate medication management and monitor her mental health status.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 56  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an abscess of the liver, diagnosed based on clinical presentation and imaging studies. She reported right upper quadrant pain and fever, prompting further evaluation.  \\n  \\n**Hospital Course:**  \\nDuring her 2.2-day hospital stay, the patient was treated with intravenous antibiotics (Piperacillin-Tazobactam) and supportive care. She was monitored closely for any signs of sepsis or deterioration. Serial imaging confirmed the abscess, and the decision was made to manage her conservatively with antibiotics rather than surgical intervention.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated liver enzymes and inflammatory markers. Cultures identified Enterococcus and Klebsiella pneumoniae as contributing pathogens. No drainage procedure was required, as the abscess size was stable. A multidisciplinary team, including infectious disease specialists, was consulted for optimal antibiotic management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with significant improvement in her symptoms. She is able to perform activities of daily living with mild assistance, but requires continued monitoring and support at home to manage her recovery. Home health services will be arranged to provide nursing care, medication management, and regular assessments.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed Acetaminophen for pain management, Heparin for prophylaxis, and continues on Piperacillin-Tazobactam. Follow-up with her primary care physician and/or infectious disease specialist is recommended within one week to evaluate her recovery and adjust treatment as necessary. Additionally, a home health nurse will visit to assist with medication administration and monitor her progress.',\n",
       " '**Patient Information:** 67-year-old male admitted urgently with hypertensive heart disease and chronic kidney disease. \\n\\n**History of Present Illness:** Patient presented with exacerbation of heart failure, acute on chronic systolic heart failure, and signs of acute kidney injury. He reported worsening dyspnea, orthopnea, and fatigue over the past week. Notable past medical history includes type 2 diabetes with nephropathy, a history of myocardial infarction, and chronic kidney disease stage 4. \\n\\n**Hospital Course:** During his 9-day hospitalization, the patient was stabilized with diuretics and antihypertensive medications. He received intravenous fluids and electrolyte management to address acute kidney injury. Cardiac monitoring was implemented, demonstrating episodes of arrhythmia that were managed conservatively. The patient was evaluated by nephrology and cardiology, and a comprehensive care plan was developed.\\n\\n**Key Findings and Procedures:** Key findings included elevated blood pressure, elevated BUN and creatinine levels, and echocardiogram showing reduced ejection fraction. Patient was treated with medications including Hydralazine, Isosorbide Mononitrate, and insulin for glycemic control. The patient also received an influenza vaccine during his stay. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient exhibited improved respiratory status and was hemodynamically stable. He demonstrated the ability to perform activities of daily living with minimal assistance but required support for mobility and medication management. Home health services will be crucial for ongoing monitoring of vital signs, medication adherence, and dietary management, especially related to his renal function and heart failure management.\\n\\n**Medications and Follow-up Plan:** Discharge medications include Albuterol nebulizer solution, Aspirin, Atorvastatin, Calcium Acetate, Docusate Sodium, and others. The patient is advised to follow up with his primary care physician and specialists within one week post-discharge. Home health services will assist with medication management and regular assessments of his condition.',\n",
       " '**Patient Name:** [Redacted]  \\n**Date of Birth:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n**Age:** 85  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is an 85-year-old male who presented to the emergency department with a history of an allergic reaction leading to systemic inflammatory response syndrome (SIRS). He exhibited significant acute organ dysfunction, particularly acute kidney failure. The patient also has a history of malignancy involving the left kidney and ureter, which contributed to his cachexia and fatigue.\\n\\n**Hospital Course:**  \\nDuring his 3.8-day hospitalization, the patient was started on intravenous fluids, including 0.9% Sodium Chloride, and broad-spectrum antibiotics (CefePIME and Azithromycin) to manage potential infections. Continuous monitoring of renal function was performed, and he received supportive care, including potassium chloride replacement due to electrolyte imbalance. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated creatinine levels indicative of acute kidney failure. Imaging studies confirmed the presence of secondary malignancies. The patient was managed with heparin for DVT prophylaxis and bisacodyl to prevent constipation associated with decreased mobility during hospitalization. Additionally, hydrOXYzine was administered to manage allergic symptoms. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improvement in his clinical status, though he remains dependent on assistance for activities of daily living. He requires ongoing home health services for medication management, monitoring of renal function, and support with personal care due to his weakened state.  \\n\\n**Medications at Discharge:**  \\nThe following medications were prescribed upon discharge:  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Azithromycin  \\n- CefePIME  \\n- Heparin Flush  \\n- HydrOXYzine  \\n- Magnesium Sulfate  \\n- Potassium Chloride Replacement  \\n- Bisacodyl  \\n- Senna  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week for renal function assessment and evaluation of his overall health status. Home health services have been arranged to provide support during his recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Female, 31 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.2 days  \\n**Date of Admission:** [Insert Date]  \\n**Date of Discharge:** [Insert Date]  \\n  \\n**History of Present Illness:**  \\nThe patient presented with preterm labor at 34 weeks gestation, with complaints of regular contractions and lower abdominal discomfort. The obstetric evaluation confirmed cervical effacement and dilation, leading to a diagnosis of preterm labor with a subsequent delivery.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received appropriate tocolytic therapy with intravenous magnesium sulfate, along with supportive measures including hydration with Lactated Ringer's solution and 0.9% Sodium Chloride. She was closely monitored for maternal and fetal well-being. Pain management was provided with acetaminophen and ibuprofen, and nausea was managed with ondansetron. The patient delivered a healthy single live birth via vaginal delivery after a brief labor course. Post-delivery, she was diagnosed with gestational diabetes mellitus, which was diet-controlled, and monitored for recovery from the procedure.\\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a successful vaginal delivery, with no immediate complications noted. Key findings included a low transverse scar from a previous cesarean delivery and a subserosal leiomyoma. The patient was educated on signs of infection, postpartum recovery, and the implications of her previous cesarean scar.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with normal vital signs and adequate pain control. She demonstrated understanding of her care plan and medication regimen. Functional status was assessed as good, with the patient able to ambulate independently and perform activities of daily living. Home health services have been arranged to assist with postpartum care, monitoring of blood glucose levels, and support with infant care.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride (as needed)  \\n2. Acetaminophen  \\n3. Calcium Carbonate  \\n4. Docusate Sodium  \\n5. Ibuprofen  \\n6. Naloxone (as needed)  \\n7. Ondansetron  \\n8. OxyCODONE (Immediate Release)  \\n9. Oxytocin (as needed)  \\n10. Senna  \\n11. Simethicone  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week for postpartum evaluation and management of gestational diabetes. Home health services are to continue for monitoring and education.\",\n",
       " \"**Patient Information:**  \\n- **Age:** 47  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening symptoms associated with cervical spinal stenosis, specifically at the C6-C7 level, which has resulted in myelopathy. He presented with neck pain, radiating pain to the arms, and numbness. The patient has a history of chronic sinusitis, an acute upper respiratory infection, and dental issues that were also addressed during his stay.\\n\\n**Hospital Course:**  \\nThe patient was monitored for five days. During this period, he underwent imaging studies that confirmed the diagnosis of spinal stenosis. Conservative management including physical therapy and pain control with Acetaminophen was initiated. He was also treated for his acute respiratory infections and dental concerns, which required consultation with dental services.  \\n\\n**Key Findings and Procedures:**  \\nImaging and clinical assessments indicated significant compression at the cervical spine level. No surgical intervention was performed due to the patient's overall condition and contraindications. Procedures performed included cervical spine imaging and supportive care protocols. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient exhibited improved strength and reduced pain levels but remains at risk for falls and requires assistance with activities of daily living due to residual weakness. He will benefit from home health services for rehabilitation and ongoing monitoring of his neurological status.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on Acetaminophen for pain management, Docusate Sodium for constipation, and will receive the Influenza Vaccine Quadrivalent to prevent respiratory infections. He should follow up with his primary care provider in one week and with neurology for further evaluation of his spinal condition. Home health services will initiate a physical therapy program to enhance recovery and safety at home.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 69 years  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 16.1 days  \\n\\n**History of Present Illness:**  \\nThis 69-year-old male was admitted for evaluation and management of a malignant neoplasm of the left kidney (ICD-10: C642). He presented with worsening abdominal pain and hematuria. Initial imaging confirmed a renal mass, and further investigations revealed involvement of intra-abdominal lymph nodes.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent multiple imaging studies, including a CT scan of the abdomen and pelvis, which showed the extent of the malignancy. He was started on palliative measures, including pain management with opioids (hydromorphone and oxycodone SR), and supportive care including hydration and electrolyte monitoring due to acute kidney failure (ICD-10: N179). The patient experienced some episodes of hypo-osmolality and hyponatremia, which were managed with careful fluid and electrolyte replacement.  \\n\\n**Key Findings and Procedures:**  \\n- Imaging confirmed malignant neoplasm of the left kidney with lymph node involvement.  \\n- Procedures: CT-guided biopsy of the renal mass for histological confirmation.  \\n- Managed complications of acute kidney failure and electrolyte imbalances.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved pain control. He will require home health services for ongoing monitoring of his renal function and management of pain. His functional status is limited but stable, and he will need assistance with activities of daily living due to weakness and pain management.  \\n\\n**Medications at Discharge:**  \\n- Albuterol Inhaler  \\n- Allopurinol  \\n- Bisacodyl  \\n- Clotrimazole  \\n- Dexamethasone  \\n- Docusate Sodium  \\n- Fluticasone-Salmeterol Diskus (250/50)  \\n- Hydromorphone  \\n- Heparin  \\n- Lactulose  \\n- Multivitamins  \\n- Ondansetron  \\n- Oxycodone SR  \\n- Polyethylene Glycol  \\n- Ranitidine  \\n\\n**Follow-up Plan:**  \\nThe patient is to follow up with oncology for further management of his malignancy and a nephrologist for renal function assessment. Home health services will initiate upon discharge to assist with symptom management and monitoring.',\n",
       " '**Patient Information:**  \\nAge: 74 years  \\nGender: Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a diagnosis of unspecified intestinal obstruction (ICD-10 K56609). He presented with acute abdominal pain, nausea, and vomiting, which prompted further evaluation. The patient has a history of emphysema (ICD-10 J439) and nicotine dependence, complicating his respiratory status during hospitalization.\\n\\n**Hospital Course:**  \\nDuring his 3.4-day stay, the patient was closely monitored with serial abdominal examinations and imaging studies, which confirmed the diagnosis of intestinal obstruction but did not indicate a need for surgical intervention. Conservative management was instituted, including bowel rest, intravenous fluids, and electrolyte repletion. The patient received medication for symptom control, including ondansetron for nausea and ketorolac for pain management. He also received albuterol nebulizations to manage his respiratory condition.  \\n\\n**Key Findings and Procedures:**  \\nAbdominal imaging indicated a non-specific obstruction without signs of perforation or ischemia. Laboratory studies showed mild electrolyte imbalances, which were corrected. The patient did not require any invasive procedures during this admission.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved abdominal pain control and had resolved nausea. His functional status was stable, with the ability to perform activities of daily living with minimal assistance. He will benefit from home health services for ongoing monitoring of his dietary intake and medication management, particularly for his chronic respiratory issues and nutritional needs due to his acquired absence of part of his stomach (ICD-10 Z903).  \\n\\n**Medications and Follow-up Plan:**  \\nAt discharge, the patient was prescribed acetaminophen, albuterol, fluticasone-salmeterol, and omeprazole. He received the influenza vaccine and is advised to continue potassium chloride supplementation as needed. A follow-up appointment with his primary care physician is recommended within one week to reassess his condition and adjust his management plan as necessary. Home health services will be initiated to assist with medication adherence and monitoring.',\n",
       " \"**Patient Summary**: 71-year-old female admitted for observation for a nontraumatic hematoma of soft tissue (ICD10: M7981). \\n\\n**History of Present Illness**: The patient presented with a large hematoma in the right thigh, causing significant pain and functional impairment. She has a history of essential hypertension (I10), hyperlipidemia (E785), and atherosclerotic heart disease (I2510). Additionally, the patient has been on long-term antithrombotic therapy. \\n\\n**Hospital Course**: The patient was admitted for a total of 4.1 days under observation. During her stay, she received supportive care, including pain management with acetaminophen and morphine sulfate. Albuterol nebulizations were administered due to acute respiratory failure with hypoxia (J9601), which resolved with treatment. The patient's blood pressure was closely monitored, and metoprolol succinate XL was adjusted accordingly. She was started on famotidine for gastro-esophageal reflux disease (K219) and was maintained on her home medications, including aspirin and rosuvastatin calcium. \\n\\n**Key Findings and Procedures**: Imaging studies confirmed the presence of a significant hematoma, and no surgical intervention was required. The patient responded well to conservative management, with gradual improvement in pain and mobility. Vital signs stabilized, and she demonstrated improved respiratory status. \\n\\n**Discharge Condition and Functional Status**: At discharge, the patient was stable with improved pain control and ambulation ability. She requires assistance for activities of daily living (ADLs) and will benefit from home health services for physical therapy to enhance mobility and monitor her recovery. A follow-up appointment with her primary care physician is recommended within one week to reassess her hypertension and overall condition. \\n\\n**Medications and Follow-up Plan**: At discharge, the patient was prescribed acetaminophen, albuterol nebulizer solution, aspirin, famotidine, metoprolol succinate XL, morphine sulfate as needed, nitroglycerin SL, rosuvastatin calcium, and tramadol for pain management. Home health services will provide ongoing evaluations and support.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 60  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with complaints of fever and abdominal pain following a recent procedure. Initial assessment revealed signs of infection, prompting further investigation. The primary diagnosis was identified as an infection following a procedure (ICD-10: T8140XA).  \\n\\n**Hospital Course:**  \\nDuring his 4-day hospital stay, the patient was started on intravenous antibiotics and supportive care. He was closely monitored for signs of sepsis and other complications. He demonstrated gradual improvement with resolution of fever and abdominal discomfort. A multidisciplinary approach included consultation with infectious disease and surgical teams to ensure a comprehensive treatment plan.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests indicated elevated white blood cell count consistent with infection. Imaging studies were performed to rule out abscess formation, which were negative. The patient received a total of three doses of IV antibiotics before transitioning to oral medications upon discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was clinically stable, afebrile, and able to ambulate independently. However, he requires assistance with daily activities due to fatigue and recent surgery. Home health services will be initiated to assist with medication management, wound care, and monitoring of his overall health status.  \\n\\n**Medications at Discharge:**  \\nThe patient is prescribed the following medications: Acetaminophen, Aspirin, Carvedilol, Calcium Carbonate, Clopidogrel, Cyanocobalamin, Docusate Sodium, Furosemide, Gentamicin 0.1% Cream, Heparin, Influenza Vaccine Quadrivalent, Isosorbide Mononitrate (Extended Release), Lactulose, Lidocaine 5% Patch, and Losartan Potassium.  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to keep appointments with the specialists as scheduled. Home health services will monitor his recovery and report any concerns to the healthcare team.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 70  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 70-year-old male with a history of hypertensive chronic kidney disease (CKD) stage 5, who was admitted for observation due to worsening renal function and fluid overload. His admission was prompted by increasing blood pressure readings and complaints of shortness of breath. The patient is dependent on renal dialysis and presents with other comorbidities including dilated cardiomyopathy and atherosclerotic heart disease.  \\n\\n**Hospital Course:**  \\nDuring his 3-day stay, the patient was managed with diuretics, specifically furosemide, to address volume overload. He underwent dialysis during his stay, which improved his fluid status. Serial laboratory tests showed stabilization of kidney function. The patient was monitored closely for signs of cardiac distress, given his history of myocardial infarction and cardiomyopathy.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated blood pressure and signs of fluid overload upon admission. Dialysis was performed, and the patient responded favorably. He was started on several medications including febuxostat, terazosin, and omeprazole among others, to manage his symptoms and prevent complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved fluid balance and controlled blood pressure. He will require home health services for ongoing monitoring of his renal function and assistance with medication management. Given his advanced CKD, education on dietary restrictions and signs of fluid overload is crucial. The patient’s mobility is limited, so home health physical therapy will be essential to improve his functional status and independence.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will continue with the following medications: Acetaminophen, Febuxostat, Furosemide, Heparin, Ondansetron, Ramelteon, and Terazosin among others. A follow-up appointment with his nephrologist is scheduled in one week to reassess his renal function and dialysis needs. Home health nursing will initiate within 48 hours of discharge to facilitate monitoring and medication adherence.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 36 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.5 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening left knee pain secondary to unilateral post-traumatic osteoarthritis (ICD-10: M1732). He reported severe pain, stiffness, and limited mobility following a minor injury to the knee. Additionally, the patient has a complex medical history, including acute posthemorrhagic anemia and obesity, which may have contributed to his current condition.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was managed with a combination of analgesics including acetaminophen, ketorolac, and hydromorphone for pain control. He was monitored for signs of anemia and received supportive care. The patient underwent physical therapy to improve mobility and strength in the affected knee, with gradual progress noted over the admission.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant left knee tenderness and decreased range of motion. The patient was assessed by the orthopedic team, and no surgical intervention was deemed necessary at this time. Imaging studies confirmed the diagnosis of post-traumatic osteoarthritis without acute complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved pain control and was able to perform basic activities of daily living with assistance. He requires home health services for continued physical therapy and monitoring of his pain management regimen. The patient will benefit from home health support to ensure adherence to his medication schedule and facilitate mobility improvements.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Aspirin EC, Docusate Sodium, Gabapentin, Hydromorphone, Ketorolac, Magnesium Oxide, Olanzapine, Ondansetron, Oxycodone (Immediate Release), Pantoprazole, Polyethylene Glycol, Potassium Chloride, Senna, Sodium Chloride 0.9% Flush.  \\nHe is advised to follow up with his primary care physician within one week and with orthopedics in two weeks for further evaluation.',\n",
       " '**Patient Information:**  \\n- **Age:** 56  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 12.9 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with worsening abdominal pain and distension, later diagnosed with secondary malignant neoplasm of the retroperitoneum and peritoneum (ICD10: C786). A complex medical history includes multiple malignancies and urinary tract infections, contributing to his symptomatology. He also presented with malignant ascites and had a recent acute kidney injury. \\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent paracentesis to relieve ascitic pressure and was started on supportive care, including fluid management and electrolyte monitoring. He received pain control with hydromorphone and was treated with antibiotics for his urinary tract infection. His condition stabilized, and he was closely monitored for signs of further complications.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant abdominal distension, imaging revealing malignant ascites, and laboratory results indicating acute kidney injury. Procedures performed included paracentesis (0W9G3ZZ) and fluid drainage. His kidney function improved, and he demonstrated stability in vital signs.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing management for his malignancies and renal function. He reports mild weakness but is ambulating with assistance. Home health services will be crucial for medication management, monitoring of renal status, and support with activities of daily living as he recovers.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed acetaminophen, atorvastatin, famotidine, and other necessary medications including insulin for blood glucose management. A follow-up appointment with oncology and nephrology is scheduled in one week. Home health services will initiate visits for medication management and health monitoring to ensure a smooth recovery.',\n",
       " '**Discharge Summary**  \\n**Patient:** 56-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10.4 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of a cutaneous abscess of the abdominal wall, which was associated with significant pain and swelling. She has a complicated medical history, including morbid obesity, hypertension, and anxiety disorder. The abscess was initially treated with intravenous antibiotics and wound care.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent incision and drainage of the abscess, which resulted in significant improvement of her symptoms. The procedure was well tolerated, and she was started on a regimen of oral antibiotics for further management. Pain control was achieved with acetaminophen and oxycodone as needed. The patient was also monitored for her obesity-related comorbidities, with adjustments made to her insulin regimen for diabetes management and education provided on diet and lifestyle changes.  \\n\\n**Key Findings and Procedures:**  \\nThe patient showed considerable improvement post-procedure, with decreased erythema and drainage from the abscess site. Laboratory tests indicated stable renal function and no signs of systemic infection. Discharge instructions included wound care and signs of infection to monitor at home.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with minimal assistance. She will benefit from home health services for continued wound care, nutritional counseling, and monitoring of her medical conditions including hypertension and diabetes management.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Amoxicillin-Clavulanic Acid  \\n- Aspirin  \\n- Cephalexin  \\n- Gabapentin  \\n- Simvastatin  \\n- Dextrose 50%, as needed for hypoglycemia  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician and the wound care clinic within one week of discharge. Home health services will be initiated to assist with medication management and ongoing assessment of her abdominal wound. Additionally, she is encouraged to engage in light physical activity as tolerated to support her overall health.',\n",
       " 'Patient is a 51-year-old female admitted for observation due to major depressive disorder, single episode, unspecified (ICD-10: F329). During her 3.9-day hospital stay, she presented with significant depressive symptoms, including suicidal ideations, fatigue, and difficulty in daily functioning. Her psychiatric evaluation revealed a need for stabilization and adjustment of her medications.\\n\\nThroughout her hospital course, the patient was closely monitored by the psychiatric team, and a treatment plan was established, which included psychotherapy and pharmacotherapy. Key findings included end-stage renal disease (N186) and type 1 diabetes mellitus with diabetic chronic kidney disease (E1022), which complicated her overall clinical picture. Her medications were assessed, and adjustments were made to better manage her symptoms and comorbid conditions. The patient received education on her conditions and the importance of adherence to her treatment plan.\\n\\nThe patient demonstrated improvement in mood and engagement by discharge, though she still requires ongoing support. Functional status at discharge indicates that she can perform basic activities of daily living with assistance but will benefit from home health services for continued monitoring and support in medication management, particularly for her psychiatric condition and diabetes management.\\n\\nDischarge medications include Acetaminophen, Aspirin, AzaTHIOprine, Clonazepam, Dextrose 50%, Insulin, Lorazepam, Montelukast, and others. She is advised to follow up with her psychiatrist within one week and her nephrologist and endocrinologist within two weeks to monitor her renal status and diabetes management. Home health services will be arranged to support her mental health needs, manage medications, and assist with daily activities as needed.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 71  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.9 Days  \\n**Primary Diagnosis:** Alcohol dependence with intoxication, unspecified (ICD-10: F10229)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of acute alcohol intoxication and related complications, including delirium and cognitive impairment. She presented with confusion, disorientation, and a history of alcohol dependence.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was closely monitored in the observation unit. She received supportive care, including hydration and correction of electrolyte imbalances. A multifaceted approach was employed to manage her alcohol dependence, including administration of Lorazepam for withdrawal symptoms and Haloperidol for agitation. Thrombocytopenia was addressed with appropriate monitoring and interventions.  \\n\\n**Key Findings and Procedures:**  \\nOn admission, the patient exhibited signs of alcohol-induced delirium with fluctuating levels of consciousness. A CT scan of the chest revealed a solitary pulmonary nodule, which will require follow-up. She was assessed for cardiovascular stability, revealing occasional episodes of supraventricular tachycardia. Blood glucose levels were managed with insulin and dextrose as needed, given her history of type 2 diabetes.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing support due to cognitive deficits and functional impairments associated with her alcohol dependence. She will benefit from home health services for assistance with daily activities, medication management, and continued monitoring of her mental and physical health.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Carvedilol, Dextrose 50%, Folic Acid, Glucagon, Glucose Gel, Haloperidol, Heparin, Hydrochlorothiazide, Insulin, Lorazepam, Multivitamins, Nicotine Lozenge, Nicotine Patch, and Pneumococcal 23-valent polysaccharide vaccine.  \\n\\n**Follow-up Plan:**  \\nShe is scheduled for a follow-up appointment with her primary care physician and a mental health specialist within one week of discharge to assess her alcohol dependence treatment and overall health status.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\nAge: 46 years  \\nGender: Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital for observation due to pneumonia caused by Streptococcus pneumoniae (ICD10 J13). She presented with acute respiratory symptoms, including dyspnea and cough, and was noted to have hypoxia requiring supplemental oxygen. Her past medical history is significant for acute kidney failure and hemoptysis, which were addressed during her stay.\\n\\n**Hospital Course:**  \\nOver the course of her 8-day stay, the patient was treated with intravenous ceftriaxone and supportive care, including oxygen therapy. She exhibited improvement in respiratory status, with gradual weaning off supplemental oxygen and resolution of fever. The patient was monitored closely for any complications, such as acute respiratory failure and bacteremia, but responded well to treatment without significant adverse events.  \\n\\n**Key Findings and Procedures:**  \\nKey findings upon examination included acute respiratory failure with hypoxia and hypercapnia, as well as signs of dehydration. Diagnostic imaging confirmed the presence of pneumonia. Procedures performed included intravenous hydration and administration of heparin for thromboprophylaxis. Laboratory tests indicated transient acute kidney impairment, which improved with hydration and monitoring.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved respiratory function and oxygen saturation levels returning to baseline. She is ambulating independently and demonstrates an understanding of her medication regimen. Home health services will be arranged to provide monitoring and assistance with her ongoing recovery, particularly for respiratory therapy and medication management.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on the following medications: Acetaminophen, Benzonatate, Ceftriaxone, Prednisone, and Potassium Chloride, among others. A follow-up appointment with her primary care physician is advised within one week of discharge to reassess her condition. Home health services will also ensure adherence to the medication plan and monitor for any complications.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 69 years  \\nGender: Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 1.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of an acute pulmonary embolism (ICD-10: I26.99) identified via CT pulmonary angiography. She presented with sudden onset dyspnea and chest discomfort, accompanied by syncope. She has a history of essential hypertension and asthma.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient was started on anticoagulation therapy with Rivaroxaban and received supportive care including oxygen therapy. She was also treated for a urinary tract infection with sulfamethoxazole/trimethoprim. The patient experienced mild headache and managed with acetaminophen.  \\n\\n**Key Findings and Procedures:**  \\nKey diagnostic findings included elevated D-dimer levels and imaging confirming pulmonary embolism without acute cor pulmonale. A thorough cardiovascular assessment was unremarkable. The patient was monitored closely for any signs of complications during her stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition. She has demonstrated improved respiratory function and is able to ambulate with minimal assistance. She exhibits adequate understanding of her condition and medication regimen, which is crucial for her recovery at home. Home health services will be initiated to assist with medication management and monitoring for any potential signs of complications.  \\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue the following medications: Rivaroxaban, Albuterol inhaler, Escitalopram, and Losartan. She is advised to maintain hydration and follow up with her primary care physician within one week. Home health services will provide nursing support for medication administration and monitoring vital signs. A follow-up appointment with a pulmonologist is recommended within two weeks.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 64  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 64-year-old male admitted for surgical intervention due to occlusion and stenosis of the left carotid artery (ICD10: I6522). He has a significant past medical history, including type 2 diabetes mellitus, hyperlipidemia, and a personal history of nicotine dependence. During the pre-operative assessment, the patient exhibited mild hemiparesis affecting the left non-dominant side, attributed to a prior cerebral infarction.  \\n  \\n**Hospital Course:**  \\nThe patient underwent carotid endarterectomy under general anesthesia, successfully completed without intraoperative complications. Post-operatively, he was monitored in the recovery unit and transitioned to the surgical ward on the same day. Throughout his hospital stay, he was managed with intravenous fluids (Lactated Ringer's), analgesia (Acetaminophen), and antiplatelet therapy (Aspirin and Clopidogrel). His blood glucose levels were closely monitored and maintained within normal limits with insulin therapy.  \\n  \\n**Key Findings and Procedures:**  \\nPost-operative assessments revealed stable vital signs, adequate neurological status, and resolution of pre-operative symptoms. A Doppler ultrasound confirmed patency of the carotid artery post-surgery.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition with improved functional status. He is ambulating with minimal assistance and demonstrates an understanding of his home care needs. He will benefit from home health services for continued monitoring of his neurological status, medication management, and rehabilitation for hemiparesis.  \\n  \\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Aspirin  \\n- Clopidogrel  \\n- Gabapentin  \\n- Labetalol  \\n- Insulin  \\n- HydrALAZINE  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week with his primary care physician and a referral to physical therapy. Home health services will commence within 48 hours to assist with rehabilitation and medication compliance.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 71-year-old male  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 4.6 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with unstable angina pectoris secondary to atherosclerotic heart disease of the native coronary artery. He presented with episodes of chest pain on exertion and was noted to have a significant family history of ischemic heart disease. Upon evaluation, he underwent coronary angiography which revealed chronic total occlusion of the coronary artery. \\n\\n**Hospital Course:**  \\nThe patient was started on appropriate medical management including antiplatelet therapy with Aspirin and statin therapy with Atorvastatin. He underwent successful percutaneous coronary intervention (PCI) on Day 2 of admission, which was well tolerated. Post-procedure, he experienced stable vital signs and was monitored in the telemetry unit. \\n\\n**Key Findings and Procedures:**  \\n- **Primary ICD10:** I25110 (Atherosclerotic heart disease of native coronary artery with unstable angina pectoris)  \\n- **Procedures Performed:** PCI (021209W), Coronary angiography (02100Z9), and other supportive therapies.  \\n- The patient was also treated for hyperlipidemia and essential hypertension. \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is clinically stable at the time of discharge, with improved functional capacity and no current complaints of chest pain. He is capable of performing activities of daily living but requires home health services for medication management, monitoring of blood pressure, and assistance with mobility as he continues to recover.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin EC  \\n- Atorvastatin  \\n- Furosemide  \\n- Hydromorphone (Dilaudid) for pain management  \\n- Docusate Sodium for bowel regimen  \\n- Insulin for blood sugar management  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for a follow-up appointment with cardiology in 1 week. Home health services have been arranged to assist with medication compliance and monitor vital signs. The patient is instructed to call the clinic if he experiences any recurrence of chest pain or other concerning symptoms.',\n",
       " '**Patient Information:** 75-year-old female with a history of a nonruptured cerebral aneurysm (ICD10: I671) presented for surgical intervention.  \\n\\n**History of Present Illness:** The patient was admitted for elective surgical treatment of a nonruptured cerebral aneurysm. She reported no significant symptoms prior to admission, with her history notable for type 2 diabetes mellitus, chronic kidney disease, and a personal history of transient ischemic attacks.  \\n\\n**Hospital Course:** The patient underwent a successful endovascular coiling procedure with no intraoperative complications. Postoperatively, she was monitored in the recovery unit and subsequently transferred to a standard medical floor for further observation. Vital signs remained stable, and neurological assessments were consistently within normal limits.  \\n\\n**Key Findings and Procedures:** Preoperative imaging confirmed the presence and characteristics of the cerebral aneurysm. The procedure was performed without incident, and post-operative CT imaging demonstrated no acute changes. The patient was evaluated by physical therapy, who noted mild weakness in the left upper extremity, likely secondary to her past TIA.  \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition, with a Glasgow Coma Scale of 15, and demonstrates the ability to perform activities of daily living with minimal assistance. Due to her mild left-sided weakness, home health services will be arranged to assist with rehabilitation, medication management, and monitoring of blood pressure and glucose levels.  \\n\\n**Medications and Follow-Up Plan:** At discharge, the patient was prescribed antihypertensives, antidiabetic medications, and pain management as needed. She is advised to follow up with her primary care physician and neurologist within one week to assess recovery and manage her chronic conditions. Home health services will initiate visits within 48 hours post-discharge to support her recovery and ensure adherence to her treatment regimen.',\n",
       " '**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**MRN:** [Medical Record Number]  \\n**Age:** 43 years  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute respiratory distress and suspected pneumonia, presenting with fever, cough, and hypoxia. Initial workup revealed other pneumonia, unspecified organism (ICD10: J188).  \\n\\n**Hospital Course:**  \\nDuring a 7.7-day stay, the patient received extensive management, including intravenous antibiotics (CefePIME), bronchodilator therapy (Ipratropium-Albuterol Neb), and supportive care for acute respiratory failure with hypoxia (ICD10: J9601). Serial imaging and laboratory tests showed improvement in pulmonary function and gradual resolution of symptoms. The patient experienced acute pulmonary edema (J810) managed with diuretics and fluid management.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included bilateral infiltrates on chest imaging and persistent hypoxemia. The patient underwent supportive measures, including oxygen therapy and monitoring for atelectasis (ICD10: J9811). He was noted to have essential hypertension (ICD10: I10) and hyperlipidemia (ICD10: E785) which were managed with appropriate medications.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is clinically stable with improved respiratory function. He is able to ambulate with minimal assistance and demonstrates adequate understanding of his medications and self-care needs. Home health services have been arranged to monitor his respiratory status, medication adherence, and provide education on lifestyle modifications post-discharge.\\n\\n**Medications:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Acyclovir, Atorvastatin, Benzonatate, CefePIME, DiphenhydrAMINE, Enoxaparin (Treatment), GammaGARD Liquid, GuaiFENesin ER, Ipratropium-Albuterol Neb, Losartan Potassium, Metoprolol Tartrate, Omeprazole, and PredniSONE.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with his primary care physician within one week of discharge to reassess respiratory status and manage ongoing care.',\n",
       " \"Discharge Summary:\\n\\nPatient is a 66-year-old male admitted for observation with a primary diagnosis of other specified diseases of the anus and rectum (ICD-10 K6289). The patient presented with worsening constipation and associated abdominal discomfort. Initial assessment revealed a significant history of chronic kidney disease stage 5, for which he has been on dialysis. \\n\\nDuring the 2.8-day hospital stay, the patient was managed with a combination of medications to alleviate constipation, including Docusate Sodium and Lactulose, and to maintain electrolyte balance. His renal function was monitored closely due to the risk of dehydration and acute kidney failure (ICD-10 N179). The patient's fluid status was optimized with intravenous hydration, and he received electrolyte replacement as indicated.\\n\\nKey findings included persistent constipation despite medical management, necessitating additional interventions, including the administration of Glucagon and Dextrose for potential hypoglycemia management. The patient also experienced mild dehydration (ICD-10 E860), which was resolved with proper fluid replacement. Throughout the stay, the patient's vital signs remained stable, and he was monitored for any signs of acute deterioration.\\n\\nBy the time of discharge, the patient demonstrated improved bowel function and was able to ambulate with assistance. He was counseled on the importance of dietary fiber intake and regular hydration to prevent future complications. The patient’s functional status indicated that he would benefit from home health services for continued monitoring of his renal function and assistance with daily activities.\\n\\nDischarge medications include Acetaminophen for pain management, Lactulose for constipation, and his usual home medications including insulin and hypertension management medications. The patient is scheduled for follow-up with his nephrologist in one week, and home health services will be initiated to assist with medication management and provide support with activities of daily living.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 67-year-old female  \\n**Admission Type:** Surgical same-day admission  \\n**Length of Stay:** 5.5 days  \\n**Primary ICD10 Code:** T84226A - Displacement of internal fixation device of vertebrae, initial encounter  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to displacement of an internal fixation device of the vertebrae. She has a significant history of pseudarthrosis after previous spinal fusion and presents with recurrent back pain, which has adversely affected her mobility and quality of life.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a successful surgical procedure to address the displacement. Post-operatively, she was monitored closely for complications, including infection and pain management, and was started on a regimen of antibiotics (Cefazolin) and pain management including Hydromorphone and Acetaminophen. She also received vitamin supplementation and was started on Levothyroxine for her hypothyroidism.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient demonstrated significant improvement in pain control and mobility during her hospital stay. Key procedures included spinal stabilization with internal fixation and comprehensive pain management strategies. No immediate post-operative complications were noted.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, ambulating with assistance, and demonstrates improved pain levels. She is advised to continue physical therapy to enhance mobility further and to monitor her surgical site for any signs of infection.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Calcium Gluconate  \\n- Cefazolin  \\n- Citalopram  \\n- Docusate Sodium  \\n- Hydromorphone  \\n- Levothyroxine Sodium  \\n- Lisinopril  \\n- Ondansetron  \\n- Multivitamins  \\n  \\n**Follow-Up Plan:**  \\nHome health services will be initiated to assist with medication management, physical therapy, and monitoring of post-operative recovery. A follow-up appointment is scheduled in one week to reassess her surgical site and overall health status.',\n",
       " '**Discharge Summary**  \\n**Patient:** 84-year-old female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 14 days  \\n**Primary Diagnosis:** Non-ST elevation (NSTEMI) myocardial infarction  \\n  \\n**History of Present Illness:**  \\nThe patient presented to the emergency department with chest pain and dyspnea. Initial evaluation revealed elevated cardiac biomarkers consistent with NSTEMI. She has a known history of hypertension, chronic kidney disease, and type 2 diabetes mellitus.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was stabilized and managed with appropriate antiplatelet therapy (Apixaban and Clopidogrel) and diuretics (Furosemide) to address acute on chronic heart failure. The patient was started on a heart-healthy diet and monitored closely for any complications. She underwent cardiac rehabilitation and participated in physical therapy, demonstrating gradual improvement in her functional status.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included acute on chronic diastolic heart failure and chronic obstructive pulmonary disease, both contributing to her symptomatology. The patient was treated with bronchodilators (Ipratropium-Albuterol Nebulizer) and corticosteroids (Fluticasone-Salmeterol). No significant arrhythmias were noted during her stay. A cardiac echo was performed, confirming preserved ejection fraction with mild left atrial enlargement.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is hemodynamically stable at discharge, with improved exercise tolerance and ambulation. She requires assistance with activities of daily living (ADLs) and will benefit from home health services for ongoing rehabilitation and monitoring of her chronic conditions, including diabetes management and heart failure education.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Acetaminophen, Albuterol Nebulizer Solution, Apixaban, Atorvastatin, Furosemide, and Insulin. The patient is advised to follow up with her primary care physician within one week and to schedule an appointment with a cardiologist for further management of her heart condition. Home health services will be initiated to assist with medication management, monitor vital signs, and provide education on lifestyle modifications.',\n",
       " '**Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Patient Age:** 72  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 72-year-old male who presented with acute gastritis with bleeding (ICD10: K2901). He reported epigastric pain, nausea, and vomiting over the last few days. His history is significant for type 2 diabetes mellitus, essential hypertension, and previous cardiovascular interventions.\\n\\n**Hospital Course:**  \\nDuring his 2.3-day observation stay, the patient was stabilized with intravenous fluids and proton pump inhibitors. He received Pantoprazole for gastric protection and Ondansetron for nausea. His blood glucose levels were closely monitored, and he received insulin as needed. The patient was also treated with Acyclovir for a concurrent herpes simplex infection. He was monitored for gastrointestinal bleeding, which resolved without the need for surgical intervention. A multidisciplinary team, including dietetics, was consulted to address his nutritional needs given his gastrointestinal status.\\n\\n**Key Findings and Procedures:**  \\nKey laboratory findings included an elevated white blood cell count (ICD10: D72829) and the presence of gastritis. An upper endoscopy was not performed due to the patient’s improvement with conservative management.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with no further signs of gastrointestinal bleeding. He exhibits good functional status, able to perform activities of daily living with some assistance. Follow-up with home health services is recommended for medication management, diabetes monitoring, and nutritional support. \\n\\n**Medications at Discharge:**  \\n1. Acyclovir  \\n2. Atorvastatin  \\n3. Fluticasone Propionate NASAL  \\n4. Gabapentin  \\n5. Insulin  \\n6. Levothyroxine Sodium  \\n7. Pantoprazole  \\n8. Ondansetron  \\n9. Magnesium Sulfate  \\n10. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within 1 week and to engage with home health services to assist with ongoing management of his diabetes and dietary modifications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 50  \\n**Gender:** Male  \\n**Admission Type:** Emergency (EW EMER)  \\n**Length of Stay:** 3.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with severe sepsis secondary to anaerobic infection, presenting with fever, altered mental status, and significant abdominal discomfort. He has a background of severe intellectual disabilities and Lennox-Gastaut syndrome, complicating his clinical management.  \\n  \\n**Hospital Course:**  \\nDuring hospitalization, the patient received broad-spectrum intravenous antibiotics, including Ceftriaxone and Meropenem, alongside supportive care. His sepsis was promptly managed, and he demonstrated gradual improvement in vital signs and mental status. Key interventions included fluid resuscitation with 0.9% Sodium Chloride, administration of antipyretics (Acetaminophen), and management of constipation with Bisacodyl and Lactulose. He was also placed on seizure prophylaxis with Levetiracetam due to his underlying neurological condition.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's lab results indicated elevated inflammatory markers consistent with sepsis. Imaging studies ruled out abscess formation. Neurological assessments were performed, which indicated no new deficits.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved vital signs and mental clarity. He requires ongoing assistance with activities of daily living due to his intellectual disabilities and seizure history. The recommendation is for home health services to assist with medication management, personal care, and monitoring of his neurological status. A follow-up appointment with his primary care physician is necessary to address ongoing management of his chronic conditions.  \\n  \\n**Medications at Discharge:**  \\nAt discharge, the patient was prescribed a regimen including:  \\n- 0.9% Sodium Chloride (Mini Bag Plus)  \\n- Acetaminophen  \\n- Bisacodyl  \\n- Calcium Carbonate  \\n- Ceftriaxone  \\n- Docusate Sodium  \\n- Heparin  \\n- Lactulose  \\n- Levetiracetam  \\n- Meropenem  \\n- Milk of Magnesia  \\n- Multivitamins with minerals  \\n- Omeprazole  \\n- Phenytoin Sodium Extended  \\n- Ranitidine  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and with a neurologist as required for his seizure management.\",\n",
       " '**Discharge Summary**  \\n**Patient Name**: [REDACTED]  \\n**Age**: 67  \\n**Gender**: Male  \\n**Admission Type**: Elective  \\n**Length of Stay**: 4.3 days  \\n  \\n**History of Present Illness**:  \\nThe patient is a 67-year-old male with a known history of malignant neoplasm of the upper lobe of the left lung (ICD-10: C3412) who was admitted electively for evaluation and management of respiratory symptoms. He reported increasing shortness of breath and cough over the past month, attributed to his underlying pulmonary conditions.  \\n  \\n**Hospital Course**:  \\nDuring his hospitalization, the patient underwent comprehensive pulmonary assessments and was treated for acute respiratory failure, which included the administration of bronchodilators, corticosteroids, and diuretics to manage pulmonary edema. The patient was monitored closely for oxygenation and received supplemental oxygen as needed. A CT scan confirmed the presence of the malignancy, and a multidisciplinary team was engaged for further oncologic management.  \\n  \\n**Key Findings and Procedures**:  \\nKey findings included the presence of acute pulmonary edema (J810) and exacerbation of chronic respiratory failure (J9691, J9692). The patient underwent bronchoscopy to evaluate airway patency and was placed on a regimen of intravenous fluids and diuretics, including Furosemide, to manage fluid overload.  \\n  \\n**Discharge Condition and Functional Status**:  \\nAt the time of discharge, the patient was stable, with improved respiratory function and oxygen saturation levels. He will require home health services for ongoing monitoring of his respiratory status and medication management, specifically related to his use of inhaled bronchodilators (Fluticasone-Salmeterol) and anticoagulants (Heparin). The patient is advised to maintain his current medication regimen and utilize home health for physical therapy to improve functional mobility.  \\n  \\n**Medications at Discharge**:  \\n1. Acetaminophen  \\n2. Albuterol 0.083% Nebulizer Solution  \\n3. Azithromycin  \\n4. Furosemide  \\n5. Fluticasone-Salmeterol Diskus (250/50)  \\n6. Eplerenone  \\n7. Docusate Sodium  \\n8. Heparin (as per protocol)  \\n  \\n**Follow-Up Plan**:  \\nThe patient is scheduled for follow-up with oncology in one week and will have a home health nurse visit within 48 hours of discharge to ensure adherence to the care plan and monitor for any complications.',\n",
       " '**Patient Information:** 41-year-old female, admitted for observation due to symptoms of chest pain and palpitations. \\n\\n**History of Present Illness:** The patient presented with complaints of intermittent chest pain and episodes of palpitations. Initial evaluation revealed the presence of ventricular premature depolarizations (ICD-10: I493), prompting further investigation. The patient has a history of vitamin deficiencies, specifically Vitamin D and other B group vitamins, which were noted during her stay. \\n\\n**Hospital Course:** The patient was admitted under observation for a total length of stay of 0.7 days. Initial ECG showed ventricular premature depolarizations, which were monitored closely. Cardiology was consulted and recommended a conservative management approach considering the benign nature of the findings. During her stay, the patient received supportive care, including pain management with acetaminophen and ibuprofen, and supplementation with cyanocobalamin and vitamin D. \\n\\n**Key Findings and Procedures:** The patient underwent a comprehensive cardiac evaluation, which included ECG and laboratory tests. The results indicated no acute ischemic changes. The patient was also evaluated for vitamin deficiencies, and appropriate supplementation was initiated. Her chest pain was assessed as non-specific and likely related to anxiety rather than cardiac etiology. \\n\\n**Discharge Condition and Functional Status:** The patient was discharged in stable condition, with no complaints of chest pain at the time of discharge. She is independent in her activities of daily living but will require home health services for assistance with medication management and monitoring her vitamin supplementation. \\n\\n**Medications at Discharge:** The patient is to continue her regimen of Acetaminophen, Ibuprofen, Cyanocobalamin, Multivitamins, and Vitamin D. She was also prescribed Heparin for prophylaxis against thromboembolism due to her short hospital stay. \\n\\n**Follow-Up Plan:** The patient is advised to follow up with her primary care physician within one week for further evaluation of her symptoms and review of her vitamin levels. Home health services will contact her to assist with medication management and ensure adherence to vitamin supplementation.',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Age**: 73 years  \\n**Gender**: Male  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 2.7 days  \\n\\n**History of Present Illness**: The patient, a 73-year-old male, was admitted for evaluation of a contusion to the left thigh following an incident where he walked into furniture. He also presented with underlying conditions including hypertensive heart disease, chronic kidney disease, and delirium attributed to known physiological conditions.\\n\\n**Hospital Course**: During hospitalization, the patient was monitored closely for signs of acute kidney failure and cardiovascular stability. Initial management included pain control with acetaminophen and supportive measures to address his delirium. The patient received intravenous ceftriaxone for a urinary tract infection, which was confirmed by urinalysis. Fluid management was carefully adjusted given his chronic kidney disease.\\n\\n**Key Findings and Procedures**: Key findings included mild acute kidney impairment, which improved with hydration and medication adjustments. Delirium symptoms were managed with a combination of duloxetine and olanzapine. The patient was assessed by physical therapy, which noted reduced mobility due to pain and weakness, but he demonstrated improvement over the course of his stay. No surgical intervention was required.\\n\\n**Discharge Condition and Functional Status**: At discharge, the patient was stable, with improved pain levels and a resolution of delirium. He can ambulate with a walker and is independent with basic activities of daily living. Home health services are recommended to assist with physical therapy and medication management, as well as monitoring for any signs of infection or further renal impairment.\\n\\n**Medications and Follow-Up Plan**: Discharge medications include acetaminophen, buPROPion XL, cefTRIAXone, duloxetine DR, docusate sodium, ferrous sulfate, fludrocortisone acetate, magnesium oxide, metoprolol tartrate, olanzapine, omeprazole, polyethylene glycol, potassium chloride, and ramelteon. Follow-up appointments should be scheduled with primary care and nephrology within one week of discharge to review his renal function and adjust medications as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 22 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 10 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with severe symptoms of ulcerative (chronic) pancolitis characterized by rectal bleeding, significant abdominal pain, and inability to maintain adequate oral intake due to exacerbation of his condition. He has a history of inflammatory bowel disease and presented with significant weight loss and fatigue.\\n\\n**Hospital Course:**  \\nDuring his 10-day stay, the patient received extensive medical management including IV fluids (0.9% Sodium Chloride and Lactated Ringer’s), electrolyte repletion, and nutritional support due to severe protein-calorie malnutrition. He was closely monitored for signs of infection and anemia. The patient was treated with corticosteroids (MethylPREDNISolone Sodium Succinate) to manage inflammation, along with pain management through hydromorphone and ketorolac. He also received prophylaxis with enoxaparin to prevent thromboembolic events due to immobility.\\n\\n**Key Findings and Procedures:**  \\nKey findings included significant rectal bleeding, anemia (iron deficiency), and abnormal weight loss. The patient underwent several diagnostic evaluations, and while no surgical intervention was required, he was advised on strict dietary modifications. He was assessed by the nutrition team and started on oral nutritional supplements upon stabilization.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improvements in abdominal pain and rectal bleeding. He is able to ambulate independently but requires assistance with meal preparation due to dietary restrictions. Home health services will be initiated to monitor his nutritional intake and administer follow-up medications.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient will continue on oral medications including acetaminophen, gabapentin for pain management, and a tailored nutritional supplement. He is to follow up with his gastroenterologist within one week post-discharge for ongoing management of his ulcerative colitis and to evaluate the need for further treatments. Home health nursing will also assess his nutritional status weekly and coordinate care.',\n",
       " '**Patient Name:** [Redacted]  \\n**Age:** 26 years  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.8 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital for management of severe alcohol dependence with withdrawal symptoms, including perceptual disturbances. He presented with tremors, hallucinations, and agitation, necessitating close monitoring and supportive care. During the admission, he was also noted to have concurrent medical issues, including pneumonia and possible liver dysfunction due to alcohol use.  \\n\\n**Hospital Course:**  \\nThroughout his stay, the patient received intravenous fluids including 0.9% Sodium Chloride and 5% Dextrose, and was treated with appropriate antibiotics (Ceftriaxone and Doxycycline) for pneumonia. He was also administered LORazepam to manage withdrawal symptoms. Nutritional support with multivitamins and Folic Acid was initiated given his history of alcohol use and potential deficiencies. He underwent serial assessments to monitor liver function, and lactulose was prescribed to manage hepatic encephalopathy.  \\n\\n**Key Findings and Procedures:**  \\nThe patient exhibited improvement in withdrawal symptoms with a reduction in perceptual disturbances by the end of his stay. He was stabilized clinically, with resolution of acute respiratory symptoms. Imaging studies ruled out significant pulmonary complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was alert and oriented with improved mood stability, although he remains at risk for relapse. He requires ongoing support for alcohol dependence, including home health services to assist with medication management and psychosocial support.  \\n\\n**Medications at Discharge:**  \\n1. LORazepam  \\n2. Lactulose  \\n3. Magnesium Oxide  \\n4. Multivitamins  \\n5. Acetaminophen as needed for pain  \\n6. Influenza Vaccine Quadrivalent (administered)  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician within one week and is encouraged to engage with outpatient addiction services. Home health services will be initiated for ongoing medication management and psychosocial support, focusing on relapse prevention strategies.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 33  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for severe pre-eclampsia complicating childbirth. She presented with elevated blood pressure and significant edema. There was a noted abnormality in fetal heart rate, and the patient underwent an emergency cesarean section due to the compromised fetal condition.  \\n\\n**Hospital Course:**  \\nDuring her 5.6-day stay, the patient was closely monitored in the obstetric unit. She received appropriate antihypertensive therapy (Nifedipine, both extended and immediate release) and underwent two blood transfusions due to anemia secondary to postpartum hemorrhage.  \\n\\nKey procedures included a cesarean section (0KQM0ZZ) and management of anemia and lacerations sustained during delivery. The patient was also started on Enoxaparin Sodium for thromboprophylaxis given her morbid obesity.  \\n\\n**Key Findings and Procedures:**  \\n- Severe pre-eclampsia (ICD10: O1414)  \\n- Single live birth with noted perineal laceration (ICD10: O721)  \\n- Anemia complicating childbirth (ICD10: D509)  \\n- Immediate postpartum hemorrhage (ICD10: O76)  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge with controlled blood pressure and is ambulating independently. She has been educated on signs of potential complications, including symptoms of hypertension and anemia. Home health services are recommended for monitoring her blood pressure and managing her postpartum recovery, including assistance with mobility and daily activities as she continues to recover from her cesarean section.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Nifedipine (extended and immediate release)  \\n- Enoxaparin Sodium  \\n- Calcium Carbonate  \\n- Docusate Sodium  \\n- Dermoplast Spray  \\n- Simethicone  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician within one week of discharge. Home health nursing will provide education on wound care and monitor her recovery process.',\n",
       " 'Patient is a 28-year-old female with a primary diagnosis of endometriosis of the ovary (ICD-10: N801) who was admitted for surgical intervention. The patient underwent a laparoscopic procedure for excision of endometriotic lesions and was also noted to have an atrial septal defect (Q211) during preoperative evaluation. She has a history of obesity (BMI 39.0-39.9), opioid dependence, and excessive menstruation with irregular cycles, complicating her clinical picture.\\n\\nThe hospital course was uneventful, with the patient tolerating the procedure well and exhibiting stable vital signs throughout her stay. Postoperatively, she was managed with a multimodal analgesia regimen including acetaminophen and ketorolac for pain control. She was also started on apixaban for venous thromboembolism prophylaxis, given her history of other venous thrombosis. The patient was discharged on postoperative day 3, with significant improvement in her symptoms. \\n\\nKey findings during her stay included resolution of acute pain, effective management of her medications, and stabilization of her underlying conditions. Procedures performed included laparoscopic excision of endometriotic lesions and an assessment of her cardiovascular status due to the incidental finding of the atrial septal defect. \\n\\nUpon discharge, the patient was in stable condition, reporting minimal discomfort and able to perform activities of daily living with some assistance. She is advised to engage home health services for postoperative monitoring, assistance with mobility, and medication management. \\n\\nDischarge medications include acetaminophen, gabapentin, and apixaban, with a follow-up appointment scheduled in 2 weeks for reevaluation of her reproductive health and management of her atrial septal defect. The patient was educated on signs of complications to monitor, including increased pain, swelling, or signs of thromboembolism.',\n",
       " '**Patient Information:** 68-year-old female admitted for observation due to residual hemorrhoidal skin tags.  \\n\\n**History of Present Illness:** The patient presented with complaints of discomfort and bleeding associated with hemorrhoidal skin tags. The symptoms were exacerbated by chronic constipation. She has a complex medical history, including secondary malignant neoplasms, chronic respiratory failure, diastolic heart failure, and a personal history of breast cancer.  \\n\\n**Hospital Course:** The patient was monitored for 1.7 days during which extensive symptom management was initiated. She received conservative treatment, including bowel regimen adjustments for constipation and pain management with acetaminophen and oxycodone. Pulmonary function was monitored due to her history of chronic respiratory failure, and supplemental oxygen was provided as necessary. The patient was assessed by the gastroenterology team, who confirmed the diagnosis of residual hemorrhoidal skin tags without evidence of acute complications.  \\n\\n**Key Findings and Procedures:** Upon examination, the patient exhibited mild external hemorrhoidal tags. No significant rectal bleeding was noted during hospitalization. A rectal exam confirmed the presence of the tags, but no surgical intervention was required at this time.  \\n\\n**Discharge Condition and Functional Status:** The patient is stable for discharge but requires assistance for activities of daily living due to mild weakness and fatigue. Home health services have been arranged to assist with medication management, bowel regimen adherence, and monitoring of symptoms. The patient demonstrated understanding of her condition and the importance of following up with her primary care physician.  \\n\\n**Medications and Follow-up Plan:** At discharge, her medication regimen includes acetaminophen, albuterol inhaler, fluoxetine, gabapentin, and others as listed. The patient is advised to follow up with her primary care provider within one week and to contact home health services for any concerns. She has been educated on signs of potential complications and when to seek immediate medical attention.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 32  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms consistent with infective myocarditis. She presented with chest pain, shortness of breath, and elevated cardiac biomarkers. A thorough evaluation led to the diagnosis of infective myocarditis, attributed to a viral etiology, likely exacerbated by her family history of ischemic heart disease. \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely in the telemetry unit. Serial ECGs showed no significant arrhythmias. Cardiac echocardiography revealed mild left ventricular dysfunction but no significant structural abnormalities. She received supportive care, including intravenous fluids and medications for pain management. The decision was made to initiate anticoagulation with Heparin given her risk factors. The patient responded well to treatment, showing improvement in symptoms and vital signs.  \\n\\n**Key Findings and Procedures:**  \\n- Diagnosis: Infective myocarditis (ICD-10: I400)  \\n- Pain in right lower leg (ICD-10: M79661)  \\n- Family history of ischemic heart disease (ICD-10: Z8249)  \\n- Medications administered included Acetaminophen, Ibuprofen, Morphine Sulfate, and Heparin.  \\n- Vaccination: Influenza Vaccine Quadrivalent was administered.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with improved functional status. She is able to perform activities of daily living with minimal assistance and demonstrates understanding of her medication regimen. She will benefit from home health services to monitor her recovery and provide education on lifestyle modifications and medication adherence.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on the following medications: Acetaminophen, Bisacodyl, Docusate Sodium, Heparin, Ibuprofen, Morphine Sulfate, Senna, and Sodium Chloride 0.9% Flush. A follow-up appointment with cardiology is scheduled in one week to reassess cardiac function and adjust treatment as necessary. Home health services will contact her within 48 hours to initiate follow-up care.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Birth:** [Patient DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n**Patient ID:** [Patient ID]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 69-year-old female who presented to the emergency department with acute shortness of breath and chest pain. A CT pulmonary angiogram confirmed the diagnosis of a pulmonary embolism (I26.99) without acute cor pulmonale. The patient has a history of congestive heart failure (I50.22) and hypertension (I10), which contributed to her clinical presentation.  \\n  \\n**Hospital Course:**  \\nDuring her 3.5-day stay, the patient was treated with anticoagulation therapy (Enoxaparin) and supportive care, including oxygen supplementation. She demonstrated gradual improvement in symptoms and was monitored for any signs of complications related to heart failure and pulmonary embolism. Cardiology and pulmonary consults were obtained, and her treatment plan was adjusted accordingly.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs and improved oxygenation. The patient underwent serial imaging which confirmed a reduction in the size of the embolism. Additionally, she was evaluated for potential underlying causes of the embolic event, including cardiac function and thrombotic risk factors.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was stable with improved functional status. She is able to perform activities of daily living with minimal assistance and reports no chest pain or severe dyspnea at rest. A home health referral has been made for monitoring, medication management, and coordination of follow-up care.  \\n  \\n**Medications at Discharge:**  \\nThe patient’s discharge medications include Acetaminophen, Acyclovir, Albuterol Nebulizer Solution, DULoxetine DR, Digoxin, Enoxaparin, Fluticasone Propionate Nasal Spray, Gabapentin, and Omeprazole, among others.  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with the cardiology and primary care providers within one week of discharge. Home health services will monitor her condition, medication adherence, and provide education on lifestyle modifications.  \\n  \\n**Instructions for Home Health Services:**  \\n- Monitor vital signs and respiratory status.  \\n- Ensure adherence to anticoagulation therapy and other medications.',\n",
       " 'Patient is a 57-year-old male who was admitted for surgical intervention due to spinal stenosis in the thoracic region (ICD-10: M4804). The patient presented with significant back pain, limited mobility, and neurological symptoms attributed to nerve compression. Following a thorough pre-operative assessment, the patient underwent laminectomy and decompression surgery on the same day of admission.\\n\\nDuring the 4.8-day hospital stay, the patient was closely monitored post-operatively for any complications, including infection, bleeding, or neurological deterioration. Key findings included stable vital signs, effective pain management, and gradual improvement in mobility. Physical therapy initiated on postoperative day one focused on ambulation and strengthening exercises, and the patient demonstrated good adherence to the rehabilitation plan.\\n\\nThe patient underwent several procedures, including spinal decompression and postoperative monitoring. Additionally, imaging studies confirmed satisfactory decompression of the affected spinal segments with no immediate post-operative complications.\\n\\nBy the time of discharge, the patient had regained significant ambulation capabilities with assistance, demonstrating the ability to perform activities of daily living with minimal support. He will require ongoing home health services to facilitate continued recovery, including physical therapy and nursing care for medication management and monitoring of vital signs.\\n\\nDischarge medications include Acetaminophen for pain management, Bisacodyl for constipation, Dexamethasone to reduce inflammation, and Oxycodone for breakthrough pain relief. He is also prescribed Losartan for hypertension management and Omeprazole for gastro-esophageal reflux disease. The patient has been advised to follow up with his primary care physician and the orthopedic surgeon within two weeks post-discharge to assess recovery progress and modify the rehabilitation plan as necessary. Home health services will commence immediately, focusing on physical therapy and nursing support to enhance recovery.',\n",
       " '**Patient Information:** 55-year-old female admitted for surgical intervention due to unilateral primary osteoarthritis of the left hip (ICD-10: M16.12).  \\n\\n**History of Present Illness:** The patient presented with severe left hip pain significantly affecting her mobility and quality of life. Following a comprehensive evaluation, she was deemed a suitable candidate for surgical intervention to address the osteoarthritis.  \\n\\n**Hospital Course:** The patient underwent a left hip arthroplasty (ICD-10 Procedure: 0SRB0JA) on the day of admission. Postoperatively, she was monitored in the surgical unit for 48 hours. She experienced some postoperative pain, which was effectively managed with IV hydromorphone and transitioned to oral acetaminophen and gabapentin for pain control.  \\n\\nThroughout her hospital stay, the patient demonstrated good progress in recovery, participating in physical therapy sessions focused on range of motion exercises and ambulation. She was able to achieve independence with activities of daily living by the time of discharge.  \\n\\n**Key Findings and Procedures:** The surgical procedure was successful with no intraoperative complications. Postoperative imaging confirmed proper placement of the hip prosthesis. The patient was also treated for retention of urine, and her blood pressure was managed with hydrochlorothiazide and losartan potassium due to her essential hypertension (ICD-10: I10).  \\n\\n**Discharge Condition and Functional Status:** The patient is being discharged in stable condition, ambulating with a walker and demonstrating improved range of motion in the left hip. She will require home health services for physical therapy to continue her rehabilitation and assistance with medication management.  \\n\\n**Medications at Discharge:** The patient is prescribed acetaminophen, gabapentin, hydromorphone, levothyroxine sodium, enoxaparin sodium, bisacodyl, and docusate sodium, along with her home medications including losartan and multivitamins.  \\n\\n**Follow-Up Plan:** A follow-up appointment is scheduled with orthopedics in two weeks to assess surgical recovery and adjust the rehabilitation plan as needed. Home health will initiate services within 24-48 hours post-discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 54  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted to the hospital under observation due to influenza caused by an identified virus (ICD-10: J1089) with accompanying symptoms that included fever, malaise, and myalgia. He presented with worsening respiratory distress and was noted to have a significant cough.  \\n  \\n**Hospital Course:**  \\nDuring his 4-day stay, the patient was monitored closely. Initial laboratory tests revealed thrombocytopenia (D696), and imaging studies were performed to rule out any respiratory complications. He was treated with supportive care, including intravenous fluids, oxygen therapy, and a regimen of antiviral and symptomatic medications. The patient received oseltamivir, and additional medications included acetaminophen, doxycycline hyclate, and guaifenesin to manage symptoms effectively.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included persistent cough and bilateral upper limb weakness attributed to carpal tunnel syndrome and ulnar nerve lesion. The patient's condition improved with treatment, and he was able to maintain adequate oxygen saturation levels.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, ambulating independently, and demonstrates adequate understanding of his home care needs. He can manage his activities of daily living with minimal assistance. Home health services are recommended to assist with ongoing monitoring of his respiratory status and management of medication compliance.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on a regimen that includes acetaminophen, benzonatate, ibuprofen, and the influenza vaccine quadrivalent. A follow-up appointment with his primary care physician is scheduled in one week to reassess his condition and address any ongoing symptoms. Additionally, he is advised to contact home health for any concerns regarding his recovery or if symptoms worsen.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 27  \\n**Gender:** Female  \\n**Admission Type:** Observation  \\n**Length of Stay:** 8.6 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for management of pre-existing hypertension with pre-eclampsia complicating her childbirth, characterized by elevated blood pressure and proteinuria. She presented to the hospital at 36 weeks of gestation, having experienced symptoms consistent with pre-eclampsia.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient received comprehensive monitoring and management including intravenous fluids (Lactated Ringer's and 0.9% Sodium Chloride), and medication to control blood pressure. Oxytocin was administered for labor induction. The patient underwent a vaginal delivery, resulting in a single live birth. Post-delivery, she was monitored for any complications related to her hypertension and laceration, which was managed conservatively.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs post-delivery, with a gradual normalization of blood pressure. The patient experienced a first-degree perineal laceration which was repaired. She was also found to be a carrier of Group B Streptococcus, necessitating close monitoring of the newborn. The patient received education on postpartum care, including signs of potential complications.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was in stable condition, ambulating independently but requiring assistance with infant care due to her recent delivery. She demonstrated adequate understanding of postpartum self-care and infant care. Home health services have been arranged to provide support with her recovery and assist with infant care for the first few weeks postpartum.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Ibuprofen, Calcium Carbonate, Prenatal Vitamins, and Docusate Sodium for constipation prevention. She is advised to follow up with her obstetrician within one week for postpartum evaluation and management of her hypertension. Additionally, she should continue monitoring her blood pressure at home and report any concerns immediately.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Age:** 68  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient is a 68-year-old male with a history of atherosclerotic heart disease (ICD10: I2510) who underwent a surgical procedure following a same-day admission for management of his cardiac condition. He presented with fatigue and dyspnea, but no acute angina.  \\n  \\n**Hospital Course:**  \\nDuring his 4.6-day hospitalization, the patient was monitored closely. He underwent a cardiac catheterization and stent placement (ICD10 Procedure Codes: 021009W, 02100Z9), which was successful without complications. He was treated for posthemorrhagic anemia and transient hyperglycemia. The patient received supportive care including IV fluids (0.9% Sodium Chloride) and pain management with acetaminophen and fentanyl. Continuous cardiac monitoring revealed stable rhythm, and atrial fibrillation (ICD10: I4891) was managed effectively.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included mild anemia (R578) and elevated blood glucose levels. Cardiac function was stable post-intervention, and he was transitioned to oral medications including aspirin and furosemide.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was hemodynamically stable, alert, and oriented. He demonstrated adequate mobility, although he expressed fatigue with exertion. Home health services are recommended to assist with medication management, monitor vital signs, and provide education on lifestyle modifications.  \\n  \\n**Medications at Discharge:**  \\n1. Aspirin EC  \\n2. Furosemide  \\n3. Acetaminophen as needed  \\n4. Docusate Sodium  \\n5. Famotidine  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his cardiologist within one week post-discharge. Home health services will initiate within 48 hours to facilitate recovery and ensure adherence to the prescribed medication regimen and dietary modifications.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's Name]  \\n- **Age:** 48  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 3.5 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with a diagnosis of malignant neoplasm of the brain (ICD10: C719). He presented with neurological deficits, including aphasia and altered mental status, secondary to cerebral edema (ICD10: G936). Initial imaging revealed significant mass effect suggestive of tumor progression.  \\n\\n**Hospital Course:**  \\nDuring his stay, the patient received a comprehensive management plan, including dexamethasone for edema control and supportive care. He was monitored for complications, including potential thromboembolic events, for which he was started on anticoagulation with heparin. Neurology and oncology teams were consulted, and a palliative care approach was initiated. The patient was stabilized and experienced gradual improvement in his neurological status.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent imaging studies that corroborated the diagnosis of a malignant brain tumor. He received intravenous fluids and medications, including levetiracetam for seizure prophylaxis and atorvastatin for hyperlipidemia (ICD10: E785). The patient was also given bisacodyl and docusate sodium for bowel regimen maintenance.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated a partial improvement in communication skills, yet he continues to require assistance with activities of daily living (ADLs) due to residual aphasia and cognitive deficits. He is being referred to home health services for ongoing rehabilitation, including speech therapy and occupational therapy, to facilitate recovery and support at-home care.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient is prescribed acetaminophen for pain management, dexamethasone, atorvastatin, and a regimen for diabetes management, including insulin. He is advised to follow up with neurology and oncology within one week of discharge. Home health services will initiate contact within 48 hours to arrange for therapy sessions.\",\n",
       " 'Patient is a 44-year-old male who was admitted for observation due to a contusion of the unspecified front wall of the thorax following a fall. He presented with complaints of chest pain and shortness of breath, which were evaluated in the emergency department. Initial imaging revealed no significant thoracic injuries, and the contusion was managed conservatively.\\n\\nDuring his 2-day hospital stay, the patient was monitored for pain control and respiratory status. He received acetaminophen for pain management, and his condition improved significantly. The patient also has a history of alcohol dependence, which was addressed during the hospitalization. He experienced withdrawal symptoms, which were managed with acamprosate and supportive care. Additionally, he was found to have nutritional anemia and acquired coagulation factor deficiency, which were treated with multivitamins and appropriate supplementation.\\n\\nKey findings included stable vital signs and improved pain levels upon discharge. The patient was able to perform activities of daily living with minimal assistance and demonstrated an understanding of his medication regimen. He is being discharged with a plan for home health services to assist with ongoing monitoring of his alcohol dependence and nutritional status. \\n\\nAt discharge, the patient was prescribed 5% dextrose, atorvastatin, fluoxetine, lisinopril, and magnesium sulfate, among other medications. He is advised to follow up with his primary care physician within one week and to engage with home health for regular assessments and support. The patient was educated on the importance of adherence to the medication plan and maintaining a healthy diet to manage his anemia and liver condition. \\n\\nOverall, the patient is in stable condition at discharge, with arrangements made for home health services to ensure continuity of care and support for his recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 80  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to sepsis of unspecified organism, with a history of abdominal pain and altered mental status. Initial workup revealed an abscess of the liver, which contributed to her clinical deterioration. She also presented with significant protein-calorie malnutrition, possibly exacerbating her condition.\\n\\n**Hospital Course:**  \\nDuring her 9.6-day hospital stay, the patient was treated with intravenous antibiotics (Ertapenem) and supportive care, including nutritional supplementation. Regular monitoring of blood glucose levels was conducted due to her diabetes mellitus. The patient received symptomatic treatment for pain and nausea, with Gabapentin and Ondansetron, respectively. She underwent imaging studies confirming the liver abscess, which was managed conservatively. \\n\\n**Key Findings and Procedures:**  \\nKey findings included hyperglycemia, anemia, and a BMI of 19.9, indicating malnutrition. The patient required multiple interventions, including administration of Dextrose 50% for hypoglycemic episodes and Ferrous Sulfate for iron deficiency anemia. The patient was stabilized with improvement in her mental status and abdominal symptoms prior to discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires continued home health services for ongoing monitoring of her nutritional intake and blood glucose levels. She will benefit from assistance with activities of daily living due to her decreased strength and mobility. The patient is able to ambulate with minimal assistance and has demonstrated improved cognitive function, although she remains at risk for further complications.\\n\\n**Medications and Follow-Up Plan:**  \\nThe following medications are prescribed at discharge: 0.9% Sodium Chloride, Acetaminophen, Docusate Sodium, Gabapentin, Insulin, Ondansetron, OxyCODONE, Pantoprazole, and Ferrous Sulfate. A follow-up appointment with her primary care physician is scheduled in one week to reassess her condition and adjust her management plan as necessary. Home health services will facilitate her recovery and monitor her progress.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Age:** 62  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 25 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 62-year-old male with a diagnosis of diffuse large B-cell lymphoma affecting intra-abdominal lymph nodes, initially admitted for management of worsening abdominal pain and obstructive jaundice attributed to biliary obstruction. He has a significant medical history including type 2 diabetes mellitus with complications, acute kidney failure, and malnutrition.  \\n  \\n**Hospital Course:**  \\nDuring his 25-day hospitalization, the patient underwent biliary stenting to relieve obstruction and received chemotherapy with CefePIME and Filgrastim-sndz. He also required insulin management for his diabetes, with adjustments made due to fluctuating blood glucose levels. Nutritional support was provided, addressing his moderate protein-calorie malnutrition.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent abdominal distension and elevated liver enzymes. Imaging confirmed intra-abdominal lymphadenopathy. Procedures performed included endoscopic retrograde cholangiopancreatography (ERCP) with biliary drainage and supportive care for acute kidney failure.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, with improvement in abdominal symptoms and nutritional status. He is ambulating with assistance and has received education regarding home health services for monitoring and support. Home health will address his diabetes management, medication administration, and nutritional needs.  \\n  \\n**Medications at Discharge:**  \\n1. Acyclovir  \\n2. Albuterol Inhaler  \\n3. Allopurinol  \\n4. CefePIME  \\n5. Dextrose 5%  \\n6. Insulin  \\n7. Filgrastim-sndz  \\n8. LORazepam  \\n9. LamoTRIgine  \\n10. Docusate Sodium  \\n  \\n**Follow-Up Plan:**  \\nFollow-up appointments with oncology and primary care should occur within one week of discharge. Home health services will initiate within 48 hours to monitor his health status and coordinate care.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 87  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency (EW EMER)  \\n- **Length of Stay:** 11.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute respiratory distress and fever, subsequently diagnosed with pyothorax (ICD10: J869). He presented with severe protein-calorie malnutrition (ICD10: E43), likely exacerbating his respiratory condition.  \\n  \\n**Hospital Course:**  \\nDuring his 11-day hospital stay, the patient underwent thoracentesis to relieve pleural effusion and received broad-spectrum intravenous antibiotics, including Cefazolin and Metronidazole, to manage the infection. His nutritional status was addressed with enteral feeding and supplementation with multivitamins.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included hypoxia, significant pleural effusion, and signs of malnutrition. Laboratory evaluations indicated anemia and coagulation factor deficiencies. The patient was stabilized with oxygen therapy and diuretics (Furosemide) to manage fluid overload.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but remains weak and requires assistance with activities of daily living (ADLs). He will benefit from home health services for ongoing respiratory therapy and nutritional support. The patient is alert and oriented but experiences dysphagia, necessitating modifications to his diet.  \\n  \\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. 5% Dextrose  \\n3. Acetaminophen  \\n4. Allopurinol  \\n5. Aspirin  \\n6. Atorvastatin  \\n7. Furosemide  \\n8. Heparin  \\n9. Multivitamins with minerals  \\n10. Ondansetron  \\n11. Timolol/Dorzolamide Ophth.  \\n  \\n**Follow-up Plan:**  \\nFollow-up with the primary care physician within one week post-discharge is essential. Home health services will be coordinated to assist with medication management, dietary modifications, and respiratory therapy. Regular monitoring of weight and nutritional intake will be critical for recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 76 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 8.5 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of complete atrioventricular block, presenting with syncope and bradycardia. Initial workup revealed significant electrolyte imbalances and acute kidney injury.  \\n  \\n**Hospital Course:**  \\nDuring hospitalization, the patient was monitored in a telemetry unit. He received intravenous magnesium sulfate and potassium chloride to correct hypomagnesemia and hyperkalemia. Continuous cardiac monitoring was performed, and he was started on apixaban for anticoagulation. An echocardiogram demonstrated reduced left ventricular function, consistent with cardiomyopathy.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's kidney function gradually improved, with a decrease in serum creatinine from 2.5 mg/dL to 1.2 mg/dL by discharge. The patient underwent a cardiac consultation, and it was determined that he would benefit from continued outpatient cardiology follow-up. A transvenous pacemaker was placed due to symptomatic bradycardia.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with the heart rate maintained at a safe level and no episodes of syncope during hospitalization. He demonstrates the ability to perform basic activities of daily living with assistance but requires ongoing home health support for medication management, monitoring of vital signs, and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Apixaban  \\n3. Bisacodyl  \\n4. Polyethylene Glycol  \\n5. Pravastatin  \\n6. Potassium Chloride  \\n7. Insulin as needed for blood glucose control  \\n8. Magnesium Sulfate  \\n  \\n**Follow-Up Plan:**  \\nThe patient will follow up with outpatient cardiology within one week of discharge. Home health services will be initiated for ongoing monitoring and support, including medication reconciliation and assistance with daily living activities.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 49  \\n**Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 15.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute symptoms related to congenital insufficiency of the aortic valve, complicated by acute respiratory failure and pneumonia. He presented with chest pain, dyspnea, and significant edema.  \\n  \\n**Hospital Course:**  \\nDuring the hospital stay, the patient underwent multiple diagnostic evaluations, including echocardiography, which confirmed severe aortic regurgitation. He was managed with diuretics, vasodilators, and anticoagulation therapy. The patient also experienced acute kidney failure secondary to tubular necrosis, which required careful monitoring and fluid management. In addition, he developed postprocedural cardiogenic shock following a valve repair procedure, necessitating intensive monitoring and support.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included acute systolic heart failure, ventricular fibrillation, and cardiac tamponade. The patient underwent valve replacement surgery and received supportive care, including oxygen therapy and medications to stabilize heart function.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was hemodynamically stable, although he demonstrated reduced exercise tolerance and mild residual dyspnea. He will require ongoing home health services for rehabilitation, medication management, and monitoring of his cardiovascular status.  \\n  \\n**Medications at Discharge:**  \\nThe patient is to continue with the following medications:  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Aspirin EC  \\n- Clopidogrel  \\n- Isosorbide Dinitrate  \\n- Docusate Sodium  \\n- Lactulose  \\n- Heparin (as needed)  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with cardiology in one week to assess recovery and adjust medications as needed. Home health services will initiate a rehabilitation program focusing on gradually increasing functional capacity and monitoring for any signs of heart failure or respiratory distress.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Patient's MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 54  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 54-year-old male admitted for observation due to a diagnosis of calculus of the bile duct (ICD10: K8050) without associated cholangitis or cholecystitis. The patient presented with abdominal pain and jaundice, which prompted further evaluation.  \\n\\n**Hospital Course:**  \\nDuring the 2.9-day stay, the patient underwent imaging studies which confirmed the presence of biliary calculi. A conservative management approach was initiated, including hydration with Lactated Ringer's, pain control with Hydromorphone, and monitoring of liver function tests. The patient's symptoms improved with supportive care; however, he continued to experience mild discomfort.  \\n\\n**Key Findings and Procedures:**  \\nImaging revealed a solitary calculus in the common bile duct. No acute pancreatitis or cholangitis was noted. The patient was managed medically without the need for invasive procedures. He was counseled on dietary modifications and the potential need for future endoscopic intervention if symptoms recur.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with significant improvement in abdominal pain and jaundice. He is able to ambulate independently and perform activities of daily living with minimal assistance. Home health services are recommended for continued monitoring of his recovery, education on dietary changes, and management of medications.  \\n\\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Allopurinol, Aspirin, Cinacalcet, Entecavir, Fluoxetine, Omeprazole, Ondansetron, and Mycophenolate Sodium DR.  \\n\\n**Follow-up Plan:**  \\nFollow-up with his primary care physician and gastroenterology within one week post-discharge to reassess symptoms and review laboratory results. Home health services will coordinate care and support the patient in medication management and dietary education.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 88-year-old male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 2.7 days  \\n**Primary Diagnosis:** Toxic liver disease with hepatitis (ICD10: K716)  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation following the onset of jaundice and elevated liver enzymes. He has a significant history of atherosclerotic heart disease, hypertension, and diabetes mellitus. The deterioration of liver function is suspected to be secondary to the adverse effects of an antineoplastic agent previously administered.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was closely monitored, and laboratory tests confirmed elevated liver function tests alongside mild dehydration. Supportive care was initiated, including intravenous hydration and management of symptoms. Consultation with hepatology was obtained, and the patient's medications were reviewed, leading to adjustments in his regimen.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included elevated AST, ALT, and bilirubin levels, consistent with toxic liver disease. The patient underwent abdominal ultrasound which ruled out biliary obstruction.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient remains stable but has mild residual jaundice. He is independent in activities of daily living but demonstrates fatigue and requires assistance with meal preparation and medication management. Home health services have been arranged to support his recovery, focusing on monitoring liver function and managing medications.  \\n  \\n**Medications at Discharge:**  \\n1. Clopidogrel  \\n2. Docusate Sodium  \\n3. Dorzolamide 2%/Timolol 0.5% Ophthalmic  \\n4. Enoxaparin (Prophylaxis)  \\n5. Isosorbide Mononitrate (Extended Release)  \\n6. Metoprolol Tartrate  \\n7. Ondansetron  \\n8. PredniSONE  \\n9. Sodium Chloride 0.9% Flush  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with primary care in one week, with lab work to reassess liver function and medication efficacy. Home health nursing will initiate contact within 48 hours post-discharge to coordinate care.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 66  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 5.7 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of secondary malignant neoplasm of the brain (ICD-10: C7931), presenting with symptoms of confusion, unsteadiness on her feet, and a history of falls. She has a significant oncological history, including prior malignancies, and presented with neurological deficits that warranted observation and management.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent comprehensive neurological assessments, which revealed signs of cerebral edema and intracerebral hemorrhage. She received Dexamethasone to manage edema and was monitored closely for changes in neurological status. Hemiplegia affecting the right dominant side was noted, and she subsequently required physical therapy to address mobility issues.  \\n  \\nKey laboratory investigations revealed essential hypertension (ICD-10: I10) and cerebral ischemia, which were managed with Labetalol and amLODIPine. The patient also received supportive care, including analgesics and bowel management.  \\n  \\n**Key Findings and Procedures:**  \\n- Cerebral edema and nontraumatic intracerebral hemorrhage  \\n- Compression of brain  \\n- Management of hypertension and neurological deficits  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated moderate improvement in her neurological status but continues to experience residual weakness and unsteadiness. Home health services are recommended to assist with rehabilitation, medication management, and monitoring of her blood pressure and neurological signs. The patient will require assistance with activities of daily living due to hemiplegia and ongoing weakness.  \\n  \\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Dexamethasone  \\n- Heparin Flush (10 & 100 units/ml)  \\n- Labetalol  \\n- LevETIRAcetam  \\n- Polyethylene Glycol  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n- Vitamin D  \\n- amLODIPine  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week of discharge and with neurology for continued evaluation of her neurological status. Home health nursing will be initiated to assist with her recovery.',\n",
       " '**Patient Information:** 54-year-old female admitted for surgical management of malignant neoplasm of the appendix (ICD-10: C181).  \\n**History of Present Illness:** The patient presented with abdominal pain and was diagnosed with malignant neoplasm of the appendix, prompting surgical intervention.  \\n**Hospital Course:** The patient underwent an open appendectomy with extensive debulking of peritoneal carcinomatosis. Postoperatively, she experienced some complications including postprocedural intestinal obstruction and hydronephrosis, which were managed conservatively. The patient was closely monitored for pain control and infection. She received appropriate IV fluids, analgesics, and was transitioned to oral medications as her condition improved.  \\n**Key Findings and Procedures:** Imaging studies confirmed the diagnosis of malignant neoplasm with secondary involvement of the intrapelvic lymph nodes (ICD-10: C7961, C775). Surgical intervention was successful, with clear margins achieved. She was treated with Enoxaparin sodium for DVT prophylaxis and pain management included Hydromorphone and Ibuprofen.  \\n**Discharge Condition and Functional Status:** The patient is stable for discharge with improved abdominal pain and bowel function. She has regained a functional mobility level sufficient for home care with assistance. The patient will require home health services for wound care and monitoring of her recovery, including management of her medication regimen and follow-up appointments.  \\n**Medications at Discharge:** Medications include 0.9% Sodium Chloride, Acetaminophen, BuPROPion XL, and Enoxaparin Sodium among others.  \\n**Follow-Up Plan:** The patient is to follow up with oncology and her primary care physician within one week of discharge. Home health services will commence within 48 hours to assist with her recovery and ensure adherence to the medication plan.',\n",
       " '**Patient Name**: [Patient Name]  \\n**Date of Admission**: [Admission Date]  \\n**Date of Discharge**: [Discharge Date]  \\n**Age**: 53 years  \\n**Gender**: Female  \\n\\n**History of Present Illness**:  \\nThe patient was admitted for observation due to a suspected kidney transplant infection (ICD10: T8613). She presented with fever, chills, and malaise. The patient has a medical history significant for chronic kidney disease and a recent kidney transplant, raising concern for potential infectious complications.\\n\\n**Hospital Course**:  \\nDuring her 4.5-day stay, the patient was treated with intravenous antibiotics, including Ceftriaxone and Ciprofloxacin, in addition to supportive care including fluids (0.9% Sodium Chloride) and analgesics (Acetaminophen). Serial laboratory tests and urine cultures confirmed an infectious etiology, necessitating adjustments to her antibiotic regimen. She was monitored closely for signs of allograft rejection and other complications, with no significant changes noted in renal function during her stay.\\n\\n**Key Findings and Procedures**:  \\nKey findings included leukocytosis and elevated inflammatory markers. Imaging studies ruled out abscess formation. The patient underwent a renal ultrasound, which demonstrated no abnormalities. The kidney transplant remains stable with no evidence of rejection.\\n\\n**Discharge Condition and Functional Status**:  \\nThe patient is being discharged in stable condition, with improved symptoms. She is able to perform activities of daily living independently but requires assistance with medication management. Home health services will be involved for medication adherence and monitoring of vital signs, including temperature, as well as follow-up on renal function and infection status.\\n\\n**Medications**:  \\nAt discharge, she will continue on Mycophenolate Mofetil, Enalapril, and Furosemide among others. A complete medication reconciliation has been performed, and she has been educated on her discharge medications.\\n\\n**Follow-Up Plan**:  \\nThe patient is to follow up with her nephrologist within one week and will have home health nursing visits scheduled to monitor her recovery and assist with medication management. A follow-up lab workup is recommended to assess her renal function and response to treatment.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 78  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to cellulitis of the right lower limb, presenting with erythema and swelling. He has a significant past medical history including chronic kidney disease (stage 4), persistent atrial fibrillation, and heart failure, which contributed to his overall clinical complexity.  \\n\\n**Hospital Course:**  \\nDuring the 3.9-day hospital stay, the patient was managed with intravenous antibiotics, including cephalexin, to address the cellulitis. His vital signs were monitored closely due to his history of atrial fibrillation and heart failure. He received supportive care including diuretics (torsemide) for fluid management and midodrine for blood pressure support.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory evaluations revealed elevated creatinine levels consistent with chronic kidney disease. A cardiac workup was performed, and the patient remained stable without any new arrhythmias. No surgical interventions were required.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improvement in the right lower limb with reduced swelling and erythema. He is ambulatory with assistance and requires home health services for wound care and monitoring of his vital signs. The patient is advised to follow up with his primary care physician within one week for reassessment of his chronic conditions and cellulitis management.  \\n\\n**Medications at Discharge:**  \\nThe following medications have been prescribed:  \\n- Acetaminophen  \\n- Albuterol 0.083% Nebulizer Solution  \\n- Aspirin  \\n- Cephalexin  \\n- Docusate Sodium  \\n- Lidocaine 5% Patch  \\n- Metoprolol Succinate XL  \\n- Midodrine  \\n- Sodium Chloride 0.9% Flush  \\n- Torsemide  \\n\\n**Follow-Up Plan:**  \\nThe patient is to have follow-up appointments for his chronic kidney disease and heart failure management, as well as continued monitoring of his cellulitis by home health services.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Placeholder for Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient, a 42-year-old female, was admitted for observation due to intractable complex partial seizures related to localization-related epilepsy (ICD10: G40219). She reported increased seizure frequency and associated cognitive disturbances over the past month. The patient has a significant medical history, including severe obesity (BMI 60.0-69.9), type 2 diabetes, obstructive sleep apnea, and bipolar disorder.\\n\\n**Hospital Course:**  \\nDuring her 3.8-day hospitalization, the patient was monitored closely for seizure activity. Neurology was consulted and recommended adjustments to her antiepileptic regimen, which included the initiation of Divalproex (Extended Release). The patient experienced a reduction in seizure frequency during her stay. Additionally, she was assessed by the dietitian for her morbid obesity and received education on dietary modifications. She was also treated for insomnia and prescribed Clonazepam and Cyclobenzaprine for muscle spasms.\\n\\n**Key Findings and Procedures:**  \\nNeurological examination and EEG monitoring revealed no evidence of status epilepticus. The patient had an unremarkable head CT, and her other medical comorbidities were stable during admission. She received education on seizure precautions and safety measures to prevent injuries during seizures.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved seizure control and was able to ambulate with assistance. She will require home health services for continued monitoring of her medication regimen and assistance with activities of daily living due to her obesity and potential mobility limitations. A home health nurse will assist with medication compliance and adjust her diabetes management plan, while physical therapy will help improve her mobility.\\n\\n**Medications at Discharge:**  \\n- Divalproex (Extended Release)  \\n- Clonazepam  \\n- Cetirizine  \\n- Omeprazole  \\n- Insulin  \\n- Ibuprofen  \\n- Glucose Gel  \\n- Ondansetron  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her neurologist within one week for medication adjustment and seizure management. She will also see her primary care physician for comprehensive management of her comorbid conditions.',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [Patient Name]  \\n**Age**: 21 years  \\n**Gender**: Female  \\n**Admission Type**: Urgent  \\n**Length of Stay**: 3.2 days  \\n  \\n**History of Present Illness**:  \\nThe patient presented with a first-degree perineal laceration sustained during delivery. She was admitted urgently for evaluation and management. The delivery was uncomplicated, and the patient required standard postpartum care.  \\n  \\n**Hospital Course**:  \\nDuring her hospital stay, the patient was monitored for pain control and signs of infection. Her perineal laceration was assessed daily, showing appropriate healing without complications. She was managed with multimodal analgesia including Acetaminophen and Ibuprofen, and her pain was well-controlled during her stay. Immunizations were updated, and she received the Quadrivalent Influenza Vaccine.  \\n  \\n**Key Findings and Procedures**:  \\nKey findings included the absence of significant bleeding and no signs of infection at the laceration site. The patient underwent routine postpartum assessments, and her vital signs remained stable throughout the hospitalization. Standard postpartum procedures were performed, including education on perineal care and signs of potential complications.  \\n  \\n**Discharge Condition and Functional Status**:  \\nThe patient is being discharged in stable condition with effective pain management. She is able to ambulate independently and perform activities of daily living with minimal assistance. It is recommended that she engages in light activities and continues to monitor her perineal area for any signs of infection. Home health services will assist in her recovery by providing education on self-care and follow-up support.  \\n  \\n**Medications and Follow-up Plan**:  \\nUpon discharge, the patient will continue with Acetaminophen and Ibuprofen for pain management, as well as Calcium Carbonate and Simethicone for gastrointestinal comfort. Docusate Sodium has been prescribed to prevent constipation. The patient is advised to use Dermoplast Spray for perineal discomfort as needed. She is scheduled for a follow-up visit with her obstetrician in one week to reassess her recovery. Additionally, she is encouraged to contact her healthcare provider if she experiences any unusual symptoms.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 55-year-old male with a history of chronic obstructive pulmonary disease (COPD), congestive heart failure, and type 2 diabetes, who was admitted urgently due to acute respiratory failure secondary to exacerbation of COPD. He presented with dyspnea, hypoxia, and increased work of breathing. Initial management included supplemental oxygen and bronchodilator therapy.  \\n  \\n**Hospital Course:**  \\nDuring his 4.7-day hospitalization, the patient received intensive respiratory therapy, including nebulized bronchodilators and corticosteroids. He was monitored closely for cardiac and respiratory status, with daily assessments revealing gradual improvement in respiratory function. Furosemide was administered for fluid management due to congestive heart failure.  \\n  \\n**Key Findings and Procedures:**  \\nDiagnostic imaging confirmed the presence of a malignant neoplasm of overlapping sites of the bronchus and lung (ICD-10: C3480). The patient underwent a bronchoscopy to obtain tissue samples, which were sent for further evaluation. He also received insulin management for his diabetes during the admission period.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for respiratory therapy and medication management. He is able to perform activities of daily living with assistance but will benefit from skilled nursing services to monitor his respiratory condition and medication adherence.  \\n  \\n**Medications at Discharge:**  \\nThe patient is prescribed acetaminophen, carvedilol, furosemide, digoxin, and fluticasone-salmeterol. A follow-up appointment with oncology and primary care is scheduled within one week. Home health services will include respiratory therapy and nursing visits to manage his COPD and diabetes effectively.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 63  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 63-year-old female with a history of tracheostomy who was admitted for observation due to malfunction of the tracheostomy stoma (ICD-10: J9503). She presented with acute respiratory distress and hypoxia, necessitating close monitoring and management during her hospital stay.  \\n  \\n**Hospital Course:**  \\nDuring her 2.9-day hospitalization, the patient received supportive care, including supplemental oxygen and respiratory therapy. A tracheostomy tube change was performed to address the malfunctioning stoma. The patient was monitored for any signs of respiratory failure, and her condition improved with appropriate interventions.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included acute respiratory failure with hypoxia (ICD-10: J9601). The tracheostomy tube was successfully replaced, and the patient tolerated the procedure well. She was also diagnosed with essential hypertension (ICD-10: I10) and hypothyroidism (ICD-10: E039), requiring ongoing medication management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated stable vital signs and improved respiratory status, though she continues to require home health services for ongoing respiratory care and medication management. She is ambulatory with assistance and is advised to follow up with her primary care physician and a home health nurse for monitoring and support.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, Bisacodyl, CefePIME, Citalopram, Docusate Sodium, Enoxaparin (prophylaxis), Influenza Vaccine Quadrivalent, Lorazepam, Levothyroxine Sodium, Lisinopril, Senna, and Sodium Chloride 0.9% flush. The patient is instructed to follow up with her physician within one week and to contact home health services for any concerns regarding her respiratory status or medication side effects.  \\n**Instructions for Home Health Services:**  \\nThe patient should have a home health nurse visit for medication administration and respiratory assessment. She is advised to monitor her symptoms closely and report any worsening of her condition.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Male, 88 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 3.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation following a fall that resulted in multiple fractures of the ribs on the left side. He presented with moderate pain and difficulty breathing, which prompted imaging studies revealing rib fractures. The patient has a history of chronic kidney disease and benign prostatic hyperplasia, which were managed during the hospitalization.  \\n  \\n**Hospital Course:**  \\nDuring his stay, the patient was monitored for respiratory function and pain management. He was treated with analgesics, including acetaminophen and oxycodone, for pain relief. He also received heparin for thromboprophylaxis due to reduced mobility. A multidisciplinary approach involving physical therapy was initiated to assess his mobility and functional status.  \\n  \\n**Key Findings and Procedures:**  \\nImaging confirmed multiple left rib fractures, with no acute thoracic or abdominal complications noted. The patient demonstrated mild respiratory distress, which improved with pain control and supplemental oxygen as needed. The patient participated in physical therapy, achieving ambulation with a walker, and was able to perform activities of daily living with assistance.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved pain control and respiratory function. He requires continued assistance with mobility and activities of daily living, making home health services essential for safe recovery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nAt discharge, medications include acetaminophen, atenolol, lisinopril, and oxycodone, among others. A follow-up appointment with his primary care physician is scheduled within one week to monitor progress and adjust medications as necessary. Home health services will provide ongoing support for physical therapy and daily care needs.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 51  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to influenza caused by an unidentified influenza virus, presenting with respiratory manifestations. He reported symptoms of fever, cough, and fatigue. His past medical history is significant for essential hypertension, bipolar disorder, gastro-esophageal reflux disease, rheumatoid arthritis, and osteoporosis.  \\n\\n**Hospital Course:**  \\nDuring the one-day observation, the patient received supportive care, including nebulized Albuterol and hydration with Lactated Ringer's solution. He was started on Oseltamivir upon diagnosis of influenza. His respiratory status improved, with decreased wheezing noted on examination. The patient was also managed for his chronic conditions, including adjustment of Metoprolol for hypertension and continuation of his psychiatric medications.  \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed stable vital signs with a temperature of 99.2°F and a respiratory rate of 18 breaths per minute. Chest auscultation showed improved air entry post-nebulization. Lab studies indicated normal electrolytes and a slight decrease in hemoglobin levels consistent with his known iron deficiency anemia. No acute complications arose during the stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory symptoms and understanding of his home care plan. He will require home health services for monitoring of respiratory status and medication adherence, especially concerning the use of anticoagulants and managing his chronic conditions.  \\n\\n**Medications at Discharge:**  \\n- Albuterol 0.083% Nebulizer solution  \\n- Oseltamivir  \\n- Atorvastatin  \\n- Citalopram  \\n- Metoprolol Succinate XL  \\n- Docusate Sodium  \\n- Ferrous Sulfate  \\n- Omeprazole  \\n- Fentanyl Patch (for pain management)  \\n- Multivitamins  \\n- Lactated Ringers (for hydration as needed)  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to have a home health nurse visit within 48 hours of discharge. He should monitor his symptoms closely and contact healthcare providers if there are any concerns regarding his respiratory status or medication side effects.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient:** [Patient's Name]  \\n**Age:** 58  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 20 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for acute respiratory failure with hypoxia (ICD-10: J9601) following a rapid decline in respiratory status. She has a significant past medical history of end-stage renal disease, chronic heart failure, and hypertension. Upon admission, the patient exhibited severe hypoxemia and was placed on supplemental oxygen.  \\n  \\n**Hospital Course:**  \\nDuring her 20-day hospital stay, the patient received comprehensive management for her respiratory failure, including bronchodilator therapy and non-invasive ventilation support. She was monitored closely in the ICU for her respiratory status and underwent renal dialysis sessions to manage her end-stage renal disease. Her cardiac status was managed with diuretics and antihypertensives.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during hospitalization included persistent hypoxemia, fluid overload, and anemia secondary to chronic kidney disease. The patient underwent dialysis three times a week and received treatment for hypertensive emergencies. She was assessed regularly by the cardiology and nephrology teams. The patient also received a nebulizer treatment with Ipratropium-Albuterol to aid in her respiratory management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing home health services for respiratory support and assistance with daily activities. She demonstrates improved oxygenation but continues to experience fatigue and shortness of breath with exertion. She will need assistance with mobility and medication management at home.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: Acetaminophen, Benzonatate, Carvedilol, Calcium Carbonate, Cyclobenzaprine, Ferric Gluconate, Guaifenesin, Hydromorphone, Heparin, Ipratropium-Albuterol Neb, Levothyroxine Sodium, Lidocaine patches, Lisinopril, and Nitroglycerin SL.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up appointments with nephrology and cardiology within one week of discharge. Home health nursing is arranged to assist with medication administration, monitor vital signs, and provide education on managing her respiratory condition.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** 82-year-old female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 7.2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted due to acute respiratory distress secondary to a pulmonary embolism (ICD10: I2699). She presented with sudden onset dyspnea and chest discomfort. The patient's medical history is significant for congestive heart failure, paroxysmal atrial fibrillation, and chronic kidney disease.  \\n\\n**Hospital Course:**  \\nDuring her 7-day hospitalization, the patient was stabilized with anticoagulation therapy and diuretics. She was closely monitored for signs of heart failure exacerbation and received supportive care. Her acute on chronic systolic heart failure (ICD10: I5023) was managed with a combination of diuretics and beta-blockers, resulting in improved symptoms. The patient's renal function was assessed daily, and appropriate adjustments to her medications were made to address her acute kidney failure (ICD10: N179).  \\n\\n**Key Findings and Procedures:**  \\nKey diagnostic findings included a CT pulmonary angiogram revealing a significant pulmonary embolism. A Doppler ultrasound confirmed acute embolism of the left popliteal vein (ICD10: I5023). The patient also received a comprehensive evaluation for her chronic health conditions, with particular attention to managing her multiple comorbidities, including hypertension and diabetes.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but required ongoing monitoring and support. She demonstrated improved respiratory status, although she still exhibited mild exertional dyspnea. She is ambulatory with assistance and will benefit from home health services to continue her rehabilitation, medication management, and monitoring of her heart failure symptoms.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Acetaminophen, Atorvastatin, Bisacodyl, Captopril, Cyanocobalamin, Dextrose 50%, Escitalopram, Ferrous Gluconate, Insulin, Metoprolol Tartrate, Omeprazole, and an Influenza Vaccine.  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with her primary care physician and a cardiologist within one week of discharge. Home health services will initiate within 48 hours to assist with medication management, vital sign monitoring, and mobility assistance.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 36 years  \\n- **Gender:** Female  \\n- **Length of Stay:** 1.5 days  \\n- **Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of gestational diabetes mellitus (ICD-10: O24424) complicated by insulin requirements during childbirth. She presented with elevated blood glucose levels and required insulin therapy. The patient also has a history of unspecified pre-existing hypertension complicating childbirth, anxiety disorder, and major depressive disorder, which were monitored throughout her stay.\\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient received continuous monitoring of her blood glucose levels, which stabilized with insulin administration. She underwent a vaginal delivery of a healthy single live birth at 38 weeks of gestation. The delivery was complicated by a second-degree perineal laceration, which was repaired in the operating room (ICD-10 procedures: 10E0XZZ for laceration repair, 0KQM0ZZ for delivery). Post-operatively, the patient was monitored for pain management and fluid balance. \\n\\n**Key Findings and Procedures:**  \\nThe patient was assessed for her mental health status, given her anxiety and depressive symptoms, and was started on Sertraline, which will require follow-up. Blood pressure readings remained stable, and her thyroid function was evaluated, resulting in the initiation of Levothyroxine therapy for autoimmune thyroiditis. \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulatory, and able to care for her newborn with some assistance. She was advised to engage home health services for monitoring of her blood glucose levels, medication management, and support for her mental health conditions.  \\n\\n**Medications at Discharge:**  \\n1. Levothyroxine Sodium  \\n2. Sertraline  \\n3. Ibuprofen  \\n4. Docusate Sodium  \\n5. Bisacodyl  \\n6. Calcium Carbonate  \\n7. Simethicone  \\n8. Lactated Ringers and 0.9% Sodium Chloride for hydration  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her obstetrician within one week and with her primary care provider for management of thyroid function and mental health. Home health services will be initiated to assist with monitoring her recovery.',\n",
       " \"Patient is a 58-year-old male admitted for evaluation of chest pain with a diagnosis of Non-ST elevation myocardial infarction (NSTEMI). He presented to the emergency department with substernal chest discomfort radiating to the left arm, associated with diaphoresis. His past medical history is significant for atherosclerotic heart disease, hypertension, type 2 diabetes, and nicotine dependence.\\n\\nDuring his 2-day hospital stay, the patient underwent cardiac monitoring and was started on appropriate medical therapy, including aspirin, clopidogrel, and fondaparinux. He was also managed for acute systolic heart failure with furosemide and given supportive care for delirium, attributed to his underlying medical conditions. Key imaging studies, including a transthoracic echocardiogram, revealed mild left ventricular dysfunction. His cardiac enzymes were monitored, showing a peak troponin level consistent with NSTEMI.\\n\\nThe patient's condition improved with treatment; he was hemodynamically stable by discharge and demonstrated a good response to diuretics, with a resolution of acute heart failure symptoms. He was ambulating independently and reported improved energy levels. However, he requires assistance at home due to ongoing concerns with memory and potential for further delirium episodes.\\n\\nAt discharge, the patient was prescribed a regimen including acetaminophen for pain control, insulin for diabetes management, and continued antiplatelet therapy. Education was provided regarding the importance of adherence to medications and monitoring blood glucose levels. Home health services will be initiated to assist with medication management, monitor vital signs, and provide support for activities of daily living.\\n\\nFollow-up with cardiology is recommended in one week, and the patient has been advised to contact his primary care physician if any concerning symptoms arise. A referral for outpatient rehabilitation is also advised to enhance recovery and prevent future complications.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 69  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to episodes of supraventricular tachycardia. He reported palpitations and mild chest discomfort, prompting evaluation. His past medical history includes essential hypertension, hyperlipidemia, gastro-esophageal reflux disease, and a personal history of prostate malignancy.  \\n  \\n**Hospital Course:**  \\nDuring his 2.8-day stay, the patient's cardiac rhythm was monitored continuously. He was treated with diltiazem and metoprolol to manage his heart rate. The patient also received aspirin, losartan, and rosuvastatin for cardiovascular risk management. He was educated on lifestyle modifications, including dietary changes to help manage his hypertension and hyperlipidemia. The patient underwent echocardiography, which demonstrated normal left ventricular function with no significant valvular disease.  \\n  \\n**Key Findings and Procedures:**  \\nThe primary diagnosis of supraventricular tachycardia was confirmed. Additional assessments included blood tests showing stable electrolyte levels and normal renal function. No acute coronary events were detected. The patient underwent a brief observation period post-treatment, during which he remained asymptomatic.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with a heart rate within normal limits. He reports no further episodes of palpitations and demonstrates an understanding of his medication regimen and lifestyle changes. He is ambulatory and capable of independent daily activities, although he will require home health services for medication management and follow-up monitoring of his cardiovascular status.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Aspirin, Diltiazem, Metoprolol Tartrate, Losartan Potassium, Rosuvastatin Calcium, Pantoprazole, and Folic Acid. The patient is advised to follow up with his cardiologist in one week and to contact home health services for medication management and health monitoring. He has been instructed to seek immediate care if he experiences any recurrence of symptoms.\",\n",
       " '**Discharge Summary**  \\n**Patient Information**:  \\n- **Patient**: Female, 30 years old  \\n- **Admission Type**: Urgent  \\n- **Length of Stay**: 3.7 days  \\n  \\n**History of Present Illness**:  \\nThe patient was admitted for management of gestational diabetes mellitus, which was insulin-controlled during her recent pregnancy. She delivered a healthy single live birth at 39 weeks gestation. The admission was primarily due to hyperglycemia noted during labor, prompting monitoring and management.  \\n  \\n**Hospital Course**:  \\nDuring her stay, the patient was closely monitored for glucose levels and received insulin therapy as needed. She also received education on dietary modifications and the importance of blood glucose monitoring postpartum. Additionally, she was treated for a second-degree perineal laceration sustained during delivery. The patient tolerated oral intake well and was ambulating independently by the time of discharge.  \\n  \\n**Key Findings and Procedures**:  \\n- **ICD-10 Codes**: O24424 (Gestational diabetes mellitus in childbirth), Z370 (Single live birth), O99284 (Endocrine, nutritional and metabolic diseases complicating childbirth), among others.  \\n- **Procedures**: The patient underwent routine postpartum care and laceration repair.  \\n  \\n**Discharge Condition and Functional Status**:  \\nThe patient is stable at the time of discharge. She is able to perform activities of daily living independently and will benefit from home health services to assist with postpartum recovery, including monitoring her blood glucose levels and education on managing her diabetes.  \\n  \\n**Medications at Discharge**:  \\nThe patient will be discharged on the following medications: Acetaminophen, Ibuprofen, Enoxaparin Sodium, Calcium Carbonate, Docusate Sodium, Bisacodyl, Simethicone, Polyethylene Glycol, Dermoplast Spray, and Senna.  \\n  \\n**Follow-Up Plan**:  \\nThe patient is to follow up with her obstetrician within one week and with an endocrinologist for diabetes management. Home health services will be arranged to support her recovery and ensure proper diabetes monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 69 years  \\n- **Gender:** Male  \\n- **Admission Type:** Surgical Same Day Admission  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for repair of an abdominal aortic aneurysm (AAA) without rupture, identified incidentally during a workup for unrelated symptoms. The patient has a past medical history notable for chronic ischemic heart disease, chronic gastric ulcer, alcohol dependence, and a urinary tract infection.  \\n\\n**Hospital Course:**  \\nDuring the 11-day hospital stay, the patient underwent endovascular AAA repair without complication. He was closely monitored postoperatively for vital signs, neurological status, and any signs of complications such as infection or graft failure. The patient experienced post-operative pain, which was managed effectively with acetaminophen and hydromorphone as needed. He also received prophylactic antibiotics (Ciprofloxacin) due to a history of urinary tract infections.  \\n\\n**Key Findings and Procedures:**  \\n- Imaging confirmed successful aneurysm repair with no evidence of leakage.  \\n- Routine blood tests showed mild anemia, attributed to his previous post-hemorrhagic condition.  \\n- The patient was started on a regimen of Clopidogrel and Aspirin for cardiovascular protection.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating independently with minimal assistance. He demonstrates understanding of his medication regimen and is able to perform activities of daily living with supervision. Home health services will be arranged for ongoing monitoring and assistance with mobility, medication management, and wound care.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Albuterol Nebulizer Solution  \\n- Aspirin EC  \\n- Atorvastatin  \\n- Clopidogrel  \\n- Furosemide  \\n- Hydralazine  \\n- Influenza Vaccine (administered prior to discharge)  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician within one week and with a vascular specialist in two weeks. Home health services will initiate within 48 hours post-discharge to ensure a smooth transition and monitor recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [REDACTED]  \\n**Age:** 47  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 47-year-old female with a known history of unspecified asthma with status asthmaticus, who presented with increased work of breathing, wheezing, and chest tightness. She has a past medical history significant for common variable immunodeficiency and obstructive sleep apnea. The patient reported worsening asthma symptoms over the past week, leading to her admission for observation and management.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was closely monitored and treated with nebulized bronchodilators, systemic corticosteroids, and supplemental oxygen. Her condition improved significantly with bronchodilator therapy, and she was able to maintain her oxygen saturation above 92% on room air by discharge. The patient was also evaluated by the pulmonary team, who recommended ongoing management of her asthma and adjunctive therapies for her other chronic conditions.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during her hospitalization included improvement in pulmonary function and resolution of respiratory distress. The patient underwent treatment with Albuterol nebulization and was prescribed a regimen including Fluticasone-Salmeterol for maintenance therapy. She also received education on the use of her inhalers and the importance of adherence to her asthma action plan.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable and in no acute distress. She demonstrated improved respiratory function and reported a decreased frequency of wheezing. The patient is able to perform activities of daily living with mild assistance and will benefit from home health services for medication management and education on asthma control.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include: Albuterol 0.083% Nebulization, Fluticasone-Salmeterol Diskus, Daliresp, and Cetirizine among others. The patient is advised to follow up with her primary care physician and pulmonologist within one week of discharge. Home health services are arranged for medication adherence support and respiratory therapy.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Date of Discharge:** [Date]  \\n**Admit Date:** [Admit Date]  \\n**Age:** 67  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old male with a history of hypertension, chronic kidney disease (CKD) stage 5, Type 2 diabetes mellitus, and heart failure who presented with hyperkalemia (ICD10: E875). He was admitted for observation following an elevated serum potassium level of 6.5 mEq/L, noted during routine lab work. The patient reported mild fatigue but denied chest pain, palpitations, or shortness of breath.\\n\\n**Hospital Course:**  \\nDuring his 2-day stay, the patient was monitored closely for cardiac complications associated with hyperkalemia. Electrocardiograms (ECGs) were performed, revealing no acute changes. A nephrology consult was obtained, and the patient was started on a potassium-reducing regimen involving Chlorthalidone and dietary potassium restrictions. The patient's potassium levels were re-evaluated daily, showing a gradual decline to within normal limits.\\n\\n**Key Findings and Procedures:**  \\nLaboratory tests confirmed resolution of hyperkalemia, with potassium levels returning to 4.1 mEq/L. Other pertinent findings included stable renal function with an eGFR of 10 ml/min, and heart failure status remained unchanged. The patient was counseled on medication adherence regarding his current regimen, which includes Carvedilol, Isosorbide Dinitrate, and Atorvastatin, among others.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, with no acute complaints. He was ambulating independently and demonstrated understanding of his medication regimen. Given his chronic conditions, a referral for home health services was made to assist with medication management, dietary education, and monitoring of his renal function and cardiovascular status.\\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Aspirin  \\n3. Atorvastatin  \\n4. Carvedilol  \\n5. Chlorthalidone  \\n6. Clopidogrel  \\n7. Docusate Sodium  \\n8. Gabapentin  \\n9. Heparin  \\n10. HydrALAZINE  \\n11. Isosorbide Dinitrate  \\n12. Omeprazole  \\n13. Polyethylene Glycol  \\n14. Senna  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week and is to have renal function labs rechecked in 3 days. Home health services will monitor his compliance with medications and assist with any arising health concerns.\",\n",
       " 'Patient is a 52-year-old female admitted for observation due to metabolic encephalopathy, with a length of stay of 67 days. She presented with altered mental status and significant protein-calorie malnutrition as indicated by her BMI of 19.9. During her hospital course, she underwent multiple evaluations, including neurological assessments and imaging studies, which ruled out acute intracranial events. She was treated for urinary tract infection and managed for hypotension, likely secondary to medication effects.\\n\\nKey findings included persistent cognitive deficits and significant malnutrition, requiring nutritional support via enteral feeding and close monitoring of her electrolyte status. The patient also exhibited symptoms of a manic episode with psychotic features, which were managed with appropriate psychiatric interventions.\\n\\nBy the time of discharge, the patient demonstrated improvement in cognitive function, though she remains dependent on assistance for daily activities. She will require home health services to support her ongoing recovery, including physical therapy to enhance mobility and occupational therapy for activities of daily living. Coordination with a nutritionist will also be essential to address her dietary needs and weight management.\\n\\nAt discharge, the patient is stable but continues to need medications for her chronic conditions, including Acetaminophen for pain management, Levothyroxine for hypothyroidism, and Lithium for mood stabilization. A follow-up appointment with her primary care physician is scheduled in one week, along with a psychiatric evaluation to monitor her mental health status. Home health services will be initiated to provide nursing care and therapy services to ensure a safe and effective recovery at home.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 89  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 8.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted urgently due to progressive neurological deficits and altered mental status, diagnosed with an intracranial abscess and granuloma (ICD-10 G060). Initial imaging confirmed the presence of a significant abscess in the right temporal lobe, likely secondary to a chronic infection.  \\n  \\n**Hospital Course:**  \\nDuring his 8.8-day hospital stay, the patient received extensive medical management, including intravenous antibiotics and corticosteroids (Dexamethasone) to reduce edema. He was monitored closely for signs of increased intracranial pressure and underwent a neurosurgical procedure to drain the abscess. Postoperatively, he exhibited gradual improvement in neurological status and was able to participate in physical therapy.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included cerebral edema and stable vital signs post-procedure. The patient underwent craniotomy for abscess drainage (ICD-10 00J00ZZ) and received supportive care, including administration of fluids (Sodium Chloride 0.9% flush) and pain management with OxyCODONE. He was also treated for constipation with Bisacodyl and Docusate Sodium.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, alert, and oriented to person and place, though mildly confused. He demonstrated improved strength but requires assistance with activities of daily living (ADLs). Given his age and medical history, he will benefit from home health services for continued rehabilitation and management of his medications.  \\n  \\n**Medications at Discharge:**  \\nDischarge medications include Dexamethasone, OXcarbazepine, Omeprazole, Simvastatin, and Potassium Chloride. The patient will also continue with multivitamins and will receive anticoagulation therapy with Heparin as indicated.  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with neurology and primary care is scheduled within one week post-discharge. Home health services will assist with physical therapy, medication management, and monitoring of neurological status.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Discharge:** [Date]  \\n**Admitting Physician:** [Physician Name]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 71-year-old female who was admitted to the hospital via emergency services with a diagnosis of other cirrhosis of the liver (ICD10 K7469) and associated complications. She presented with signs of ascites and elevated liver function tests, alongside a history of chronic liver disease and type 2 diabetes mellitus.  \\n  \\n**Hospital Course:**  \\nDuring her 14.6-day hospital stay, the patient was monitored closely for signs of hepatic decompensation. She received supportive care, including intravenous albumin, diuretics (furosemide), and lactulose for hepatic encephalopathy. Her condition improved with regular monitoring of electrolytes and renal function, as she experienced acute kidney failure, likely secondary to volume overload. She was also treated for acquired coagulation factor deficiency and received appropriate antibiotic therapy for suspected peritonitis.  \\n  \\n**Key Findings and Procedures:**  \\nKey laboratory findings included hyponatremia and elevated liver enzymes. The patient underwent paracentesis, which confirmed the presence of fluid in the abdominal cavity, and she was discharged with a stable abdominal examination.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, alert, and oriented, with improved abdominal symptoms. She demonstrated adequate mobility with assistance and was able to perform activities of daily living with minimal support. Home health services are recommended for continued monitoring of her liver function, assistance with medication management, and education on dietary restrictions due to her liver condition and diabetes.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe following medications were prescribed at discharge: Acetaminophen, Albumin 25%, Ascorbic Acid, Aspirin, Atorvastatin, Calcium Carbonate, Ciprofloxacin HCl, Dextrose 50%, Furosemide, Gabapentin, Glucagon, Glucose Gel, Heparin, Insulin, Lactulose.  \\nFollow-up appointments are scheduled with hepatology and primary care within one week of discharge to evaluate her ongoing management and prevent readmission. Home health services will initiate within 48 hours post-discharge.',\n",
       " \"**Discharge Summary**  \\n**Patient ID:** [Redacted]  \\n**Date of Admission:** [Redacted]  \\n**Date of Discharge:** [Redacted]  \\n**Attending Physician:** Dr. [Redacted]  \\n\\n**History of Present Illness:**  \\nThe patient is a 56-year-old male with a history of Crohn's disease, admitted for surgical intervention due to an abscess involving both the small and large intestines (ICD-10: K50814). The patient presented with abdominal pain, fever, and significant weight loss, requiring immediate surgical evaluation.  \\n\\n**Hospital Course:**  \\nDuring a 14.6-day hospital stay, the patient underwent a laparoscopic procedure to drain the abscess and resection of affected bowel segments. Postoperatively, he was closely monitored in the surgical unit, where he received IV fluids, antibiotics (Ceftriaxone, Metronidazole), and supportive care. His condition was complicated by mild pneumonitis (ICD-10: J690) and acute kidney failure (ICD-10: N179), which improved with treatment. Throughout his hospital stay, he was managed for moderate protein-calorie malnutrition (ICD-10: E440) and ileus (ICD-10: K6819), with gradual reintroduction of oral intake.  \\n\\n**Key Findings and Procedures:**  \\nThe patient demonstrated improved abdominal symptoms and toleration of diet by discharge. Surgical site was clean without signs of infection, and imaging showed resolution of the abscess. He was discharged with an ileostomy, requiring education on care and management.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable and ambulating independently. He requires home health services for continued wound care, dietary management, and monitoring of his ileostomy. A follow-up appointment with gastroenterology and a nutritionist is scheduled within one week post-discharge.  \\n\\n**Medications:**  \\nUpon discharge, the patient is prescribed Acetaminophen, Pantoprazole, Enoxaparin for DVT prophylaxis, and Vancomycin. He is advised to manage hydration and monitor for any signs of infection or complications related to his ileostomy.  \\n\\n**Follow-Up Plan:**  \\nPatients are advised to follow up with their primary care physician and gastroenterologist within one week. Home health services will initiate contact for ongoing support. \",\n",
       " \"**Discharge Summary**  \\n**Patient:** 30-year-old female  \\n**Admit Date:** [Insert Admit Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n**Length of Stay:** 3.2 days  \\n**Admission Type:** Urgent  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for maternal care due to a low transverse scar from a previous cesarean delivery (ICD-10: O34211). She presented with complaints of increased abdominal discomfort and had a history of gestational diabetes, which was diet-controlled. During the admission, she experienced immediate postpartum hemorrhage (ICD-10: O721) but was stabilized with appropriate interventions.\\n\\n**Hospital Course:**  \\nUpon admission, the patient was monitored closely for bleeding and managed with intravenous fluids (Lactated Ringer's, 0.9% Sodium Chloride) and medications to control pain and prevent thromboembolism (Enoxaparin Sodium). She received an influenza vaccine as part of her postpartum care and was educated on signs of infection. The patient was started on Oxycodone for pain management, along with Ibuprofen and Ketorolac for additional pain relief. She also received supportive care including bisacodyl and docusate sodium for bowel regimen.\\n\\n**Key Findings and Procedures:**  \\nThe patient had a single live birth during her hospitalization, and she was monitored for any signs of infection, particularly herpesviral infection of the urogenital tract (ICD-10: A6009). The delivery was uneventful, and she demonstrated stable vital signs throughout her stay. A sterilization procedure (ICD-10: Z302) was discussed and agreed upon prior to discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulating independently, and has been educated on postpartum care, including signs of infection and proper wound care. She will benefit from home health services for follow-up on her recovery and management of her diabetes.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue on the following medications: Acetaminophen, Ibuprofen, Oxycodone, and Enoxaparin. She is advised to follow up with her obstetrician within one week and to contact home health services for ongoing support and assessment of her condition.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Patient Name:** [REDACTED]  \\n- **Age:** 59  \\n- **Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted through the emergency department with an initial diagnosis of infection and inflammatory reaction due to an internal prosthetic device. The patient presented with abdominal pain and fever, worsening over the past week.  \\n  \\n**Hospital Course:**  \\nDuring his 18.5-day hospital stay, the patient received a comprehensive evaluation and management plan. He underwent imaging studies that confirmed the presence of a peritoneal abscess and a persistent postprocedural fistula. Surgical intervention was performed to address the abscess, and he was treated with broad-spectrum antibiotics.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s condition improved with surgical drainage and medical therapy. Key procedures included an abdominal drainage procedure (0WPF0JZ) and postoperative care for intestinal fistula management (0DBA0ZZ). He also received supportive measures for chronic obstructive pulmonary disease and hypertension during his stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable, with significant resolution of abdominal symptoms. He is ambulating independently and demonstrates adequate understanding of post-discharge care. The patient will require home health services for wound care management and ongoing monitoring of his nutrition and hydration status due to his recent surgical interventions.  \\n  \\n**Medications:**  \\nAt discharge, the patient’s medication regimen includes:  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- DULoxetine DR  \\n- Fluticasone-Salmeterol Diskus  \\n- Insulin, among others.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician in one week and with a home health nurse to assess wound healing and overall recovery. He has been advised to monitor for any signs of infection and to maintain a healthy diet.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 30  \\n**Gender:** Male  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Length of Stay:** 7.8 days  \\n**Admission Type:** Observation Admit  \\n\\n**History of Present Illness:**  \\nThe patient is a 30-year-old male with a known history of bipolar disorder, currently experiencing a depressive episode of mild to moderate severity (ICD10: F3130). He presented to the hospital after experiencing increased depressive symptoms, including low mood, fatigue, and difficulty concentrating, which prompted concerns regarding his safety and ability to care for himself.\\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent a comprehensive psychiatric evaluation and was stabilized on a medication regimen. His course was complicated by somatic complaints, including lumbar pain due to a prior collapsed vertebra (ICD10: M4856XD). He received supportive therapy and was monitored for potential side effects of medications. Additionally, he was assessed for risk factors related to falls due to his depressive state.\\n\\n**Key Findings and Procedures:**  \\nThe patient responded well to pharmacotherapy with aripiprazole and lamotrigine. He also had a falling incident during hospitalization, but after evaluation, he was determined to be at a low risk for further falls with proper home safety interventions. The patient was educated about the importance of adherence to his medication regimen and the need for follow-up care.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improved mood and insight into his condition, although he continues to require support for daily activities. He is recommended for home health services to assist with medication management, therapy sessions, and monitoring of his mood and functional status. Family members have been included in discharge planning to ensure a supportive environment.\\n\\n**Medications at Discharge:**  \\n1. Aripiprazole  \\n2. Lamotrigine  \\n3. Trazodone  \\n4. Lorazepam  \\n5. Oxycodone (Immediate Release) as needed for pain  \\n6. Acetaminophen, Famotidine, Modafinil, Polyethylene Glycol, Senna  \\n7. Influenza Vaccine Quadrivalent (administered prior to discharge)  \\n\\n**Follow-up Plan:**  \\nThe patient should follow up with his psychiatrist within one week of discharge and contact home health services for ongoing support. He has been advised to reach out for immediate support if his mood worsens or if he experiences any concerning symptoms.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 89 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient, an 89-year-old female, was admitted for observation due to symptoms consistent with a bacterial intestinal infection (ICD-10: A049). She presented with diarrhea, abdominal discomfort, and fever. Her past medical history includes type 2 diabetes mellitus, essential hypertension, and a history of ovarian malignancy.  \\n\\n**Hospital Course:**  \\nDuring her 2.6-day stay, the patient was treated with intravenous ciprofloxacin and supportive care. She was monitored closely for dehydration and electrolyte imbalances, given her age and underlying conditions. A urinary tract infection was also identified during her stay (ICD-10: N390), which was managed with appropriate antibiotic therapy. The patient's blood glucose levels were stabilized with insulin and dextrose as needed.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included moderate dehydration secondary to diarrhea and a urinary tract infection. She underwent a renal ultrasound to rule out obstruction due to her urinary symptoms, which returned normal results. A thorough evaluation of her abdominal pain revealed no acute surgical issues.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition, with improvements noted in her abdominal symptoms and hydration status. However, she remains mildly weak but is able to perform basic activities of daily living (ADLs) with minimal assistance. Home health services are recommended to assist with medication management and monitor her recovery at home, particularly her diabetes and hydration status.  \\n\\n**Medications at Discharge:**  \\n1. Ciprofloxacin HCl  \\n2. Acetaminophen  \\n3. Atenolol  \\n4. Losartan Potassium  \\n5. Hydrochlorothiazide  \\n6. Insulin as prescribed  \\n7. Docusate Sodium  \\n8. Metronidazole  \\n9. Aspirin  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week. Home health will monitor vital signs, manage her medications, and check her blood glucose levels. Education on dietary management for diabetes and signs of infection will also be provided.\",\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Age:** 71  \\n**Gender:** Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.1 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with symptoms indicative of chronic iron deficiency anemia secondary to blood loss, presenting with fatigue and shortness of breath. The anemia was further complicated by exacerbation of her chronic heart failure, hypertension, and chronic kidney disease.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient underwent a thorough evaluation, including laboratory tests and imaging studies. Hemoglobin levels were critically low, prompting the initiation of intravenous iron therapy alongside supportive measures for heart failure management. Close monitoring of renal function was maintained given her underlying chronic kidney disease. The patient was stabilized and responded well to treatment, with gradual improvement in hemoglobin and overall clinical status.  \\n  \\n**Key Findings and Procedures:**  \\n- Diagnosis of iron deficiency anemia (ICD10 D500) confirmed.  \\n- Management of hypertensive heart failure and chronic kidney disease (ICD10 I130, I5022).  \\n- No need for invasive procedures; treatment was conservative and supportive.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved energy levels and was able to ambulate independently with minimal assistance. She is stable, but still requires close monitoring at home due to her complex medical history. Home health services have been arranged for ongoing assessment and medication management, particularly focusing on the administration of iron supplements and monitoring of renal parameters.  \\n  \\n**Medications:**  \\nAt discharge, the patient was prescribed the following medications: Acetaminophen, Apixaban, Aspirin, Atorvastatin, Gabapentin, Isosorbide Mononitrate (Extended Release), Loratadine, Metoprolol Succinate XL, Omeprazole, Potassium Chloride, Sertraline, Torsemide, Vitamin D, and a quadrivalent influenza vaccine.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician in one week. She should report any signs of worsening symptoms, such as increased shortness of breath, chest pain, or new weakness. Home health nursing will assist with medication adherence and monitor her vital signs regularly.',\n",
       " \"**Discharge Summary**  \\n**Patient Name**: [Name]  \\n**MRN**: [MRN]  \\n**Date of Discharge**: [Date]  \\n**Age**: 20  \\n**Gender**: Male  \\n  \\n**History of Present Illness**:  \\nThe patient, a 20-year-old male, presented to the emergency department with acute abdominal pain, nausea, and vomiting. A CT scan confirmed the diagnosis of unspecified acute appendicitis (ICD10: K3580). Given the acute nature of his condition, he was admitted for surgical intervention.  \\n  \\n**Hospital Course**:  \\nDuring his 1.7-day hospital stay, the patient underwent a laparoscopic appendectomy without complications. Postoperatively, he was monitored for pain management and potential complications. He received intravenous fluids, including Lactated Ringer's and 0.9% Sodium Chloride, along with pain management medications including Acetaminophen and Furosemide for fluid management due to chronic pulmonary edema (ICD10: J811).  \\n  \\n**Key Findings and Procedures**:  \\nVital signs were stable throughout the hospital stay. Postoperative recovery was uneventful, with the patient demonstrating good tolerance to a clear liquid diet and adequate pain control. No signs of infection were noted, and he was mobilized early to prevent complications.  \\n  \\n**Discharge Condition and Functional Status**:  \\nUpon discharge, the patient was stable, with continued improvement in abdominal symptoms and functional mobility. He demonstrated the ability to ambulate independently and perform activities of daily living with minimal assistance. However, he will require home health services for continued monitoring of his surgical site and assistance with medication management, particularly the administration of Heparin and bisacodyl for constipation prevention.  \\n  \\n**Medications and Follow-Up Plan**:  \\nDischarge medications include Acetaminophen, Furosemide, Heparin (subcutaneous), Bisacodyl, and Polyethylene Glycol. He was also administered the Influenza Vaccine Quadrivalent prior to discharge. The patient is advised to follow up with his primary care physician in one week or sooner if any complications arise. Home health services will be arranged to assist with his recovery at home, focusing on wound care and medication adherence.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 71  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 71-year-old female who was admitted through the emergency department with significant hypercalcemia (ICD-10: E8352). Upon admission, she exhibited altered mental status, dehydration, and acute kidney injury. The patient's history included type 2 diabetes, long-term anticoagulant therapy, and a recent diagnosis of diffuse large B-cell lymphoma.  \\n\\n**Hospital Course:**  \\nDuring her 6-day hospital stay, the patient received aggressive hydration and calcium-lowering therapy. She was treated with bisphosphonates and monitored closely for electrolyte imbalances. Neurological assessments indicated toxic encephalopathy related to hypercalcemia. Acute kidney failure was managed with intravenous fluids and careful monitoring of renal function.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hypercalcemia, acute kidney injury (ICD-10: N179), and urinary tract infection (ICD-10: N390). A PICC line was placed for medication administration and to facilitate easier blood draws. Throughout her stay, the patient's mental status gradually improved, and renal function showed signs of recovery.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged with stable vital signs and improved mental status. She is alert and oriented but exhibits mild confusion. Due to her physical and cognitive status, she will require home health services for assistance with activities of daily living (ADLs) and medication management. A follow-up plan includes regular assessments of her renal function and ongoing evaluation of her mental status.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes acetaminophen, apixaban, atorvastatin, buspirone, divalproex extended-release, and insulin. Follow-up appointments have been scheduled with primary care and oncology to monitor her condition, with specific attention to her hypercalcemia and kidney function. Home health services will commence within 48 hours post-discharge to ensure continuity of care.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Age:** 65  \\n**Gender:** Female  \\n\\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Length of Stay:** 3.6 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 65-year-old female who presented to the emergency department with acute respiratory distress and hemoptysis. Initial evaluation noted significant hemorrhage from other sites in the respiratory passages (ICD10 R0489). The patient has a known history of diabetes mellitus type 1, autoimmune thyroiditis, and celiac disease. She has been compliant with her long-term insulin therapy.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a series of diagnostic procedures including bronchoscopy, which revealed no active bleeding in the major airways. She required supportive management including IV fluids and blood glucose monitoring given her diabetes. The patient's hemoptysis improved significantly, and she was stabilized with appropriate medications.  \\n\\n**Key Findings and Procedures:**  \\n- Hemorrhage from respiratory passages stabilized  \\n- Bronchoscopy performed without complications  \\n- Blood glucose levels managed with insulin and dextrose administration  \\n- Infection workup negative for COVID-19  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved respiratory status. She is able to perform activities of daily living with minimal assistance. Home health services will be initiated to assist with monitoring her blood glucose levels and medication management.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Dextrose 50%  \\n- Lantus Solostar U-100 Insulin  \\n- Levothyroxine Sodium  \\n- Influenza Vaccine High-Dose Quadrivalent  \\n- Other supportive medications as needed  \\n\\n**Follow-Up Plan:**  \\nThe patient should follow up with her primary care physician within one week of discharge for diabetes management and regular monitoring of her respiratory symptoms. Home health services will also coordinate care to ensure adherence to her medication regimen.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 78 years  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening symptoms related to hypertensive heart disease and chronic kidney disease. He presented with acute on chronic diastolic heart failure and was noted to have a significant increase in blood pressure, along with edema and shortness of breath. The patient has a history of chronic kidney disease, stage 3, and was at risk for further complications related to his cardiovascular status.\\n\\n**Hospital Course:**  \\nDuring the 16-day hospitalization, the patient was monitored closely for heart failure symptoms and underwent diuretic therapy with Bumetanide to manage fluid overload. His renal function was assessed regularly, and adjustments were made to his medications, including the addition of Hydralazine for blood pressure control. Infectious complications were noted, leading to treatment with Levofloxacin for Clostridium difficile enterocolitis. He was also evaluated for prostate cancer, confirmed with a diagnosis of malignant neoplasm of the prostate.\\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hypertension, renal impairment, and acute diastolic heart failure. Procedures performed included renal function monitoring and adjustment of his diuretic regimen. The patient received supportive care and education regarding medication adherence and dietary modifications.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but requires ongoing home health services for continued monitoring of his heart failure and kidney function. He has demonstrated a basic understanding of his medication regimen and dietary restrictions. Assistance with daily activities is recommended to ensure safety and compliance with his treatment plan.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Bumetanide  \\n- Calcium Carbonate  \\n- Levofloxacin  \\n- Levothyroxine Sodium  \\n- Isosorbide Mononitrate (Extended Release)  \\n- Hydralazine  \\n- Hydrocortisone Ointment  \\n\\n**Follow-Up Plan:**  \\nFollow-up appointments are scheduled with cardiology and nephrology within one week of discharge. Home health services will initiate care to monitor vitals, medication adherence, and assist with activities of daily living.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 82  \\n- **Gender:** Male  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 3.3 days  \\n\\n**History of Present Illness:**  \\nThe patient is an 82-year-old male with a significant history of atherosclerotic heart disease, presenting with an ST elevation myocardial infarction (STEMI) involving the inferior wall. He was admitted for observation following the onset of chest pain and elevated cardiac biomarkers.  \\n\\n**Hospital Course:**  \\nDuring his hospital stay, the patient was closely monitored and treated for acute systolic heart failure and acute kidney failure. He underwent coronary intervention with successful percutaneous coronary intervention (PCI), with stenting of the affected coronary artery. The patient was also treated with diuretics to manage fluid overload and was initiated on optimal medical therapy, including antiplatelet agents and beta-blockers.  \\n\\n**Key Findings and Procedures:**  \\n- Primary Diagnosis: STEMI (I2119)  \\n- Other diagnoses: Acute systolic heart failure (I5021), Acute kidney failure (N179), Chronic kidney disease stage 3 (N183).  \\n- Procedures performed included PCI (027035Z) and administration of heparin (4A023N7).  \\n- Notable lab findings included elevated white blood cell count and hypoxemia, which improved with treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved cardiac function and symptom relief. He is able to ambulate with minimal assistance but will require home health services for medication management and monitoring of his heart failure symptoms. A follow-up cardiac rehabilitation program is also recommended to enhance recovery and functional capacity.  \\n\\n**Medications at Discharge:**  \\n- Aspirin  \\n- Atorvastatin  \\n- Clopidogrel  \\n- Docusate Sodium  \\n- Furosemide  \\n- Heparin  \\n- Metoprolol Succinate XL  \\n- TiCAGRELOR  \\n- Influenza and Pneumococcal Vaccines  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his cardiologist within one week of discharge for ongoing assessment and adjustment of his heart failure management plan. Home health services will provide additional support and monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 61  \\nGender: Male  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 1.7 Days  \\n**Primary Diagnosis:** Malignant neoplasm of prostate (ICD10: C61)  \\n  \\n**History of Present Illness:**  \\nThe patient is a 61-year-old male with a diagnosis of prostate cancer who presented for surgical intervention. He has a known history of umbilical hernia, gastro-esophageal reflux disease, and a family history of prostate malignancy.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a prostatectomy, which was completed successfully without intraoperative complications. Postoperatively, he experienced typical recovery symptoms, including pain, which was managed effectively with analgesics. He was monitored in the surgical unit, where he received appropriate postoperative care, including prophylaxis for venous thromboembolism with Enoxaparin and hydration with Lactated Ringer’s solution.  \\n  \\n**Key Findings and Procedures:**  \\nNotable findings included stable vital signs and adequate post-surgical recovery. He was treated postoperatively with medications including Morphine for pain management, Ondansetron for nausea, and Docusate Sodium for bowel regimen. The patient also received Bacitracin ointment for wound care and was started on a regimen of hormone therapy as part of the oncology care plan.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable and ambulating independently with minimal assistance. He exhibited good understanding of his discharge instructions, which include monitoring for signs of infection at the surgical site and managing pain effectively at home. Home health services are recommended to assist with postoperative care, including wound management and medication administration.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Acetaminophen, OxyCODONE for pain management, Fluticasone Propionate nasal spray, and Calcium Carbonate. The patient is advised to follow up with oncology in 1 week for further evaluation and management of his prostate cancer. Home health will provide further support and monitoring for medication adherence and recovery progress.',\n",
       " '**Patient Discharge Summary**  \\n**Patient:** Female, 32 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 4.5 days  \\n**Primary Diagnosis:** Other malformation of placenta, third trimester (ICD-10: O43193)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to complications related to her pregnancy at 40 weeks gestation. She presented with abnormal fetal heart rate and rhythm, anemia complicating childbirth, and a malformation of the placenta. The clinical team closely monitored her condition throughout her stay.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient received supportive care, including intravenous fluids (Lactated Ringers, 0.9% Sodium Chloride), analgesics (Ibuprofen, Acetaminophen, OxyCODONE), and antiemetics (Ondansetron). Labor was induced with Oxytocin, and the patient was closely monitored for any signs of distress in both mother and fetus. A vaginal delivery was successfully achieved.  \\n\\n**Key Findings and Procedures:**  \\nThe patient underwent continuous fetal monitoring throughout labor, which revealed abnormal fetal heart rate patterns. No surgical interventions were necessary, and the patient was stabilized post-delivery. The infant was delivered healthy with no immediate complications.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient was discharged in stable condition with no acute distress. She demonstrated appropriate mobility and ability to care for herself. Home health services are recommended to assist with postpartum care, monitor her recovery, and provide education on infant care, especially considering her history of anemia and placental complications.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride  \\n2. Acetaminophen  \\n3. Calcium Carbonate  \\n4. Docusate Sodium  \\n5. Ibuprofen  \\n6. Lactated Ringers  \\n7. Naloxone  \\n8. Ondansetron  \\n9. OxyCODONE (Immediate Release)  \\n10. Oxytocin  \\n11. Polyethylene Glycol  \\n12. Senna  \\n13. Simethicone  \\n14. Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week post-discharge for a routine checkup and to monitor recovery. Home health services will initiate contact to provide support and education.',\n",
       " '**Discharge Summary**  \\n**Patient:** [Patient Name]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 50  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for surgical intervention due to chronic respiratory issues associated with other diseases of the bronchus (ICD10: J9809). She has a complex medical history including chronic obstructive pulmonary disease, acute respiratory failure with hypercapnia, and significant anxiety and depressive disorders.  \\n\\n**Hospital Course:**  \\nThe patient underwent several procedures during her 7.5-day stay, including bronchoscopy and respiratory therapy interventions aimed at improving her lung function. She was treated with inhaled medications such as Fluticasone-Salmeterol and Ipratropium-Albuterol nebulization, as well as supportive therapy with Acetylcysteine. Her respiratory status improved significantly, with a decrease in dyspnea and better oxygen saturation levels noted by day 5 of hospitalization.  \\n\\n**Key Findings and Procedures:**  \\nKey clinical findings included atelectasis and a notable decrease in lung capacity, which improved following respiratory rehabilitation. The patient also received psychiatric evaluation and management for her depressive and anxiety disorders.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable, ambulating independently, and demonstrated improved respiratory effort. Home health services have been recommended to assist with continued respiratory therapy and medication management, particularly for her chronic obstructive pulmonary disease and anxiety. Follow-up with a pulmonary specialist is essential within the next week to monitor her ongoing recovery.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on a regimen including Acetaminophen, Albuterol nebulizers, Fluticasone Propionate, and Fluoxetine for mood stabilization. She is advised to maintain her pulmonary rehabilitation exercises at home and to utilize her prescribed inhalers as directed.  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her pulmonologist one week post-discharge and is encouraged to contact her healthcare provider if any concerning symptoms arise, including increased shortness of breath or mood changes.',\n",
       " \"**Patient Summary:**  \\nPatient is a 61-year-old female admitted through the emergency department with acute exacerbation of bronchiectasis. She has a complex medical history including end-stage renal disease, a history of tetralogy of Fallot, and has undergone kidney and pancreas transplants.  \\n\\n**Hospital Course:**  \\nDuring her 12-day hospital stay, the patient was evaluated and managed for her bronchiectasis exacerbation, which presented with increased sputum production, dyspnea, and hypoxia. Initial treatments included intravenous antibiotics (Cefpodoxime Proxetil), bronchodilators (Ipratropium-Albuterol Neb), and supportive care. The patient's renal function was closely monitored throughout her stay due to her existing chronic kidney disease.  \\n\\nKey findings included bilateral lung crackles on auscultation and a chest x-ray revealing no new infiltrates. The patient was also treated for an acute urinary tract infection, which contributed to her overall decline and required the use of antibiotics.  \\n\\n**Functional Status at Discharge:**  \\nUpon discharge, the patient is stable with improved respiratory function, but she continues to require assistance with activities of daily living (ADLs) due to weakness and fatigue. Home health services are recommended to assist with monitoring her respiratory status and medication management, particularly with her complex medication regimen including Aspirin, Furosemide, and Mycophenolate Mofetil.  \\n\\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Benzonatate  \\n3. Cefpodoxime Proxetil  \\n4. Cyanocobalamin  \\n5. CycloSPORINE (Neoral) MODIFIED  \\n6. Docusate Sodium  \\n7. Furosemide  \\n8. GuaiFENesin  \\n9. Heparin and Heparin Flush  \\n10. Ipratropium-Albuterol Neb  \\n11. Magnesium Sulfate  \\n12. Mycophenolate Mofetil  \\n13. Omeprazole  \\n\\n**Follow-Up Plan:**  \\nShe is advised to follow up with her primary care physician within one week and to monitor for any signs of respiratory distress or infection. Home health services will initiate within 48 hours post-discharge to facilitate her recovery.\",\n",
       " 'Patient is a 30-year-old female admitted urgently for maternal care due to a low transverse scar from a previous cesarean delivery (ICD-10: O34211). She presented on admission with mild abdominal discomfort and a history of previous cesarean deliveries, requiring close monitoring during her third trimester. Throughout her hospital stay of 2.2 days, she underwent extensive evaluation, including ultrasound and laboratory tests, which confirmed a stable condition with no signs of active complications. \\n\\nThe hospital course was uncomplicated, with the patient receiving supportive care for anemia complicating childbirth (ICD-10: D649). Key findings included Type A blood with Rh negativity and a benign neoplasm of the duodenum (ICD-10: D132), which were monitored but did not require intervention. The patient was managed with iron supplementation and hydration to address her anemia. A cesarean delivery was performed successfully (ICD-10: 10D00Z1), and the patient tolerated the procedure well with stable vital signs. \\n\\nUpon discharge, the patient is in stable condition, ambulating independently and exhibiting adequate functional status for home care. She is advised to continue iron supplements and maintain a balanced diet to manage her anemia. Home health services are being arranged to assist with post-operative care, including monitoring her recovery and ensuring adherence to follow-up appointments. Medications at discharge include iron supplements and pain management as needed.  \\n\\nThe follow-up plan involves an outpatient appointment with her obstetrician in one week to assess her recovery and ensure proper healing of the cesarean site. The patient is instructed to seek immediate medical attention if she experiences increased abdominal pain, signs of infection, or any concerning symptoms. Home health services will provide additional support during her recovery period.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 65  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 65-year-old female who presented for surgical intervention due to a diagnosed malignant neoplasm of the endometrium (ICD10: C541). She was admitted for a laparoscopic procedure, which was converted to an open procedure due to intraoperative complications.  \\n  \\n**Hospital Course:**  \\nThe patient had a length of stay of approximately 3.6 days. Postoperatively, she was monitored for complications including atelectasis and hypoxemia, which were managed with respiratory therapy and oxygen supplementation. Her pain was effectively controlled with a regimen that included hydromorphone and acetaminophen. Mental health support was initiated due to her history of anxiety and depression, with medications including bupropion and amphetamine-dextroamphetamine added to her discharge plan.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included the presence of a subserosal leiomyoma of the uterus and intraoperative signs of atelectasis. The patient underwent several procedures including laparoscopic excision and subsequent open procedure (ICD10: 0UT90ZZ, 0UT20ZZ, 0UT70ZZ).  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but required assistance with activities of daily living (ADLs) including bathing and medication management. She demonstrated an understanding of her condition and the need for follow-up care. Home health services have been arranged to assist with her recovery, including nursing visits for wound care and physical therapy to improve mobility and prevent further lung complications.  \\n  \\n**Medications and Follow-up Plan:**  \\nThe discharge medication regimen includes:  \\n- Acetaminophen  \\n- Bupropion XL (once daily)  \\n- Enoxaparin (prophylaxis)  \\n- Hydromorphone (as needed)  \\n- Ibuprofen  \\nFollow-up appointments have been scheduled with oncology and primary care within one week of discharge to monitor her recovery and adjust her treatment plan as necessary.',\n",
       " '**Patient Information:**  \\n- **Age:** 69  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 69-year-old male who presented with left upper quadrant pain, which was evaluated under observation status. His past medical history is significant for chronic kidney disease, liver transplant status, and protein-calorie malnutrition. Upon admission, he reported intermittent pain that had worsened over the past week, associated with weakness and nausea.\\n\\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient underwent thorough diagnostic evaluation including laboratory tests and imaging studies. Key findings included acute kidney failure, likely secondary to dehydration and possible medication effects. The patient was managed with intravenous fluids, electrolyte repletion, and adjustment of his medications, specifically the immunosuppressants due to his transplant history. He experienced gradual improvement in his symptoms and was monitored closely for any complications.\\n\\n**Key Findings and Procedures:**  \\nLaboratory results indicated elevated creatinine levels, but these improved with hydration and medication adjustments. No invasive procedures were required during this stay. The patient was provided with nutritional support to address his moderate protein-calorie malnutrition.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved functional status, reporting less pain and increased energy levels. He is stable but requires continued monitoring for renal function and nutritional status. He will benefit from home health services for ongoing assessment and support, including dietary management and physical therapy to enhance strength and mobility.\\n\\n**Medications and Follow-up Plan:**  \\nThe patient is being discharged on Acetaminophen, Aspirin, Clopidogrel, CycloSPORINE (Neoral), Omeprazole, and Fludrocortisone among others. A follow-up appointment is scheduled with his primary care physician and nephrologist within the next week to monitor his kidney function and adjust medications as necessary. Home health services will initiate within 48 hours post-discharge to ensure a smooth transition and adherence to the discharge plan.',\n",
       " '**Patient Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 49  \\n**Gender:** Male  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted following a fall that resulted in multiple fractures of the right ribs (ICD10: S2241XA) and a fracture of the scapula. He presented with significant pain and respiratory distress, exacerbated by his underlying chronic obstructive pulmonary disease (COPD) and alcohol dependence.  \\n  \\n**Hospital Course:**  \\nDuring his 4.9-day hospital stay, the patient was managed with pain control using acetaminophen and diazepam as needed under the CIWA protocol for alcohol withdrawal. He received respiratory therapy, including Ipratropium-Albuterol nebulization, to assist with his COPD. He was also given nutritional support with vitamin B12 and folic acid supplementation due to nutritional anemia.  \\n  \\n**Key Findings and Procedures:**  \\nRadiographic imaging confirmed multiple rib fractures on the right side and a fracture of the right scapula. The patient experienced a transient episode of syncope during hospitalization, likely due to dehydration and pain management. His respiratory status improved, and he was closely monitored for any signs of complications from his fractures.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable with improved pain control and respiratory function. He was able to perform basic activities of daily living with assistance and is recommended for home health services to assist with mobility and pain management. A follow-up visit with his primary care physician is necessary to monitor his recovery and manage his ongoing alcohol dependence and COPD.  \\n  \\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Diazepam  \\n- Omeprazole  \\n- Nicotine patch and lozenge for smoking cessation  \\n  \\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment in one week and will receive home health services for physiotherapy and medication management. It is essential to monitor for any signs of complications related to his fractures and lung function.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 31 years old  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.8 days  \\n**Primary Diagnosis:** Maternal care for low transverse scar from previous cesarean delivery (ICD10: O34211)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management due to complications arising from a previous cesarean delivery and was in the third trimester. She presented with oligohydramnios, gestational hypertension, and other complications including meconium-stained amniotic fluid. The patient reported intermittent contractions and a concern regarding the fetal well-being due to the presence of a cord around the neck.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient was closely monitored for maternal and fetal status. Ultrasound confirmed oligohydramnios and excessive fetal growth. A plan for delivery was established, and she underwent a cesarean section (Procedure ICD10: 10D00Z1) without complications. Post-operatively, the patient was stable, with good pain control and no signs of infection.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included normal fetal heart rate after delivery and a well-formed infant. The cesarean section was performed successfully. Post-operative care included monitoring for recovery from anesthesia and management of pain and bowel function.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is discharged in stable condition, with a functional status allowing for independent ambulation. She has adequate pain control and understanding of post-operative care. Home health services are recommended for continued monitoring of the surgical site and assistance with infant care.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is being discharged on Acetaminophen, Ibuprofen, and OxyCODONE for pain management, along with Bisacodyl and Docusate Sodium for bowel regulation. She is advised to follow up with her obstetrician within one week and to contact home health for assistance with any concerns related to recovery or infant care.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\nAge: 49, Gender: Female  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 3.6 days  \\n**Primary Diagnosis:** Other nontraumatic subarachnoid hemorrhage (ICD-10: I608)  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with severe headache, nausea, and vomiting. Initial imaging revealed an incidentally found nontraumatic subarachnoid hemorrhage, prompting admission for further evaluation and management.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored in a neurology unit. She received IV fluids and appropriate medications for pain and nausea management. Neurological assessments were performed daily, showing stable findings. The patient was treated with LevETiracetam for seizure prophylaxis and Losartan for blood pressure management due to underlying essential hypertension.  \\n\\n**Key Findings and Procedures:**  \\nCT scans confirmed the diagnosis, and an MRI was performed to rule out other intracranial issues. The patient's symptoms of nausea and headache improved significantly, and she demonstrated stable vitals throughout her hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was alert and oriented, ambulating with minimal assistance. She reports a reduction in headache intensity and improved tolerance to oral intake. However, she requires continued monitoring for neurological symptoms and assistance with medication management at home due to her recent diagnosis and medication regimen.  \\n\\n**Medications at Discharge:**  \\n1. 0.9% Sodium Chloride IV  \\n2. Acetaminophen-Caff-Butalbital as needed for headache  \\n3. Diazepam for anxiety management  \\n4. Famotidine for gastric protection  \\n5. LevETiracetam for seizure prophylaxis  \\n6. Losartan Potassium for hypertension  \\n7. Morphine Sulfate as needed for pain  \\n8. Ondansetron for nausea  \\n   \\n**Follow-Up Plan:**  \\nThe patient is referred to home health services for ongoing monitoring and support. She is advised to follow up with her primary care physician within one week and to return to the emergency department if she experiences any new neurological symptoms or significant changes in her condition.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**MRN:** [Medical Record Number]  \\n\\n**History of Present Illness:**  \\nThe patient is a 35-year-old male who presented to the emergency department with signs and symptoms consistent with septicemia. He has a complex medical history including chronic graft-versus-host disease and acute myeloblastic leukemia in remission. Upon admission, he was diagnosed with other specified sepsis (ICD-10: A4189).  \\n\\n**Hospital Course:**  \\nThe patient was admitted for a total of 4.6 days. Initial management included intravenous antibiotics, fluid resuscitation, and supportive care. He received broad-spectrum antibiotics and additional treatment for concomitant influenza and anxiety. The patient's septic condition improved significantly with treatment, allowing for gradual weaning off IV medications.  \\n\\n**Key Findings and Procedures:**  \\nDuring his stay, the patient was monitored closely for signs of infection and complications stemming from his recent stem cell transplant. Laboratory results showed a stable white blood cell count and resolution of inflammatory markers. No significant complications were noted during hospitalization.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated improved clinical stability. He was able to ambulate independently and reported a decrease in anxiety and depressive symptoms. He is capable of performing activities of daily living with minimal assistance. Home health services will be essential for continued monitoring and support, particularly for medication management and psychological support as he transitions to home care.  \\n\\n**Medications at Discharge:**  \\nThe patient will continue on the following medications: Alprazolam, Acetaminophen, Acyclovir, Albuterol Inhaler, Benzonatate, Cyclosporine 0.05% Ophth Emulsion, Dexamethasone Oral Solution, Diphenhydramine, Folic Acid, Guaifenesin ER, and Ipratropium-Albuterol Neb.  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician and hematologist within one week of discharge. Home health nursing will commence within the next 48 hours to assist with medication management and monitor for any signs of infection or complications.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 56-year-old female  \\n**Admission Type:** Elective  \\n**Length of Stay:** 1.1 days  \\n**Primary Diagnosis:** Multiple myeloma not having achieved remission (ICD10: C9000)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of multiple myeloma. She presented with persistent fatigue and worsening anemia secondary to her malignancy. Given her condition, she was evaluated for potential treatment options and supportive care to alleviate her symptoms and improve her quality of life.\\n\\n**Hospital Course:**  \\nDuring her brief hospitalization, the patient received supportive care including hydration with 0.9% Sodium Chloride, analgesia with Acetaminophen, and management of her anemia. She was started on Dexamethasone for its anti-inflammatory effects, and Enoxaparin was administered for thromboprophylaxis given her risk factors. The patient also received Gabapentin for neuropathic pain associated with her condition.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory evaluations indicated persistent anemia (due to her neoplastic disease), as well as evidence of vitamin D deficiency. Imaging studies ruled out acute complications such as fractures or thromboembolic events. No invasive procedures were performed during this admission due to contraindications related to her condition.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable but continued to experience significant fatigue and anemia. She will require ongoing monitoring and support from home health services to assist with her activities of daily living and manage her medications effectively. A home health nurse will provide necessary assessments, and therapy will focus on mobility and strength training to enhance her functional status.\\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Dexamethasone Sod Phos  \\n- Acyclovir  \\n- Apixaban  \\n- Gabapentin  \\n- Enoxaparin  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her oncologist within one week for further evaluation and management of her myeloma. Home health services have been arranged to provide support, monitor her progress, and adjust her care plan as needed.',\n",
       " '**Discharge Summary**  \\n**Patient Name**: [REDACTED]  \\n**Date of Birth**: [REDACTED]  \\n**Admission Type**: Observation Admit  \\n**Length of Stay**: 7.6 days  \\n**Date of Discharge**: [REDACTED]  \\n\\n**History of Present Illness**:  \\nThe patient, a 57-year-old female, was admitted for evaluation of worsening liver function, attributed to her underlying condition of cirrhosis (ICD10 K7469). She presented with symptoms of fatigue, jaundice, and abdominal discomfort. Initial lab studies indicated elevated liver enzymes and bilirubin levels. She also exhibited signs of portal hypertension and acute posthemorrhagic anemia (ICD10 D62).\\n\\n**Hospital Course**:  \\nDuring her 7.6-day hospital stay, the patient was monitored closely for her liver function and was managed with a combination of medications including lactulose and furosemide for hepatic encephalopathy and fluid management. She was started on acyclovir for suspected viral hepatitis C exacerbation, and iron supplementation was initiated due to anemia. The patient underwent abdominal ultrasound and was assessed by the gastroenterology team, who recommended ongoing outpatient management and close monitoring.\\n\\n**Key Findings and Procedures**:  \\nKey findings included significant elevation in liver enzymes, presence of ascites, and evidence of chronic hepatic failure without coma (ICD10 K7210). She experienced multiple medication adjustments, particularly with her diuretics and supportive care.  \\n\\n**Discharge Condition and Functional Status**:  \\nThe patient is stable upon discharge, with improved fatigue levels and reduced abdominal discomfort. She will require home health services for continued monitoring of her liver function and assistance with medication management. A follow-up appointment with gastroenterology is scheduled within one week.\\n\\n**Medications and Follow-Up Plan**:  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Acyclovir, Albuterol Inhaler, Fluoxetine, Ferrous Sulfate, Furosemide, Hydroxychloroquine Sulfate, Lactulose, Levothyroxine Sodium, Morphine SR, Nadolol, Neutra-Phos, OxyCODONE, Pantoprazole, and Prochlorperazine. She is advised to adhere to a low-sodium diet and maintain adequate fluid intake. A follow-up appointment with her primary care physician and gastroenterologist is advised within the next week. Home health services will facilitate medication management and monitoring for signs of decompensation.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 52-year-old female who was admitted for observation due to intestinal obstruction secondary to intestinal adhesions (ICD-10: K565) following a previous infection. She presented with abdominal pain, nausea, and vomiting that had worsened over the preceding days. A detailed history revealed the patient has a history of ulcerative colitis, type 2 diabetes mellitus, and postprocedural hypothyroidism.  \\n\\n**Hospital Course:**  \\nDuring her 2-day stay, the patient was closely monitored and treated symptomatically. She received intravenous fluids, including D5 1/2NS, and was managed with medications such as Ondansetron for nausea and Acetaminophen for pain control. She was also given supportive care for her diabetes management. The patient was assessed by the surgical team, who determined that surgical intervention was not required at this time.  \\n\\n**Key Findings and Procedures:**  \\nAbdominal imaging confirmed the presence of intestinal adhesions without any signs of perforation or significant ischemia. Laboratory results showed stable electrolytes and blood glucose levels throughout the stay. The patient was able to tolerate a clear liquid diet by the second day with improvement in her symptoms.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with minimal abdominal discomfort and the ability to ambulate independently. It is recommended that she follow up with home health services to monitor her recovery, ensure medication adherence, and assist with managing her diabetes and thyroid conditions.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient’s medication regimen includes Levothyroxine Sodium, Metformin, Glyburide, and Docusate Sodium among others. She is advised to follow up with her primary care physician in one week and the gastroenterologist for her ulcerative colitis management. Home health services will be arranged to provide support and monitoring.',\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Insert Patient ID]  \\n**Date of Admission:** [Insert Admission Date]  \\n**Date of Discharge:** [Insert Discharge Date]  \\n**Age:** 48 years  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 48-year-old male who presented with symptoms consistent with COVID-19, including cough, fever, and significant shortness of breath. His symptoms escalated, leading to an observation admission for further monitoring and management.  \\n\\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient was treated for COVID-19 (ICD10: U071) and associated complications, including hypoxemia and decreased white blood cell count (ICD10: R0902, D72819). He received supplemental oxygen therapy and bronchodilator treatment with Albuterol inhaler, which improved his respiratory status. The patient also received supportive care aimed at symptom management, including acetaminophen for fever and guaifenesin-dextromethorphan for cough relief.  \\n\\n**Key Findings and Procedures:**  \\nKey findings during his admission included tachypnea and hypoxemia, which improved with oxygen therapy. Chest X-ray indicated signs consistent with viral pneumonia (ICD10: J1289). No invasive procedures were required, and the patient remained stable throughout his stay.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated improved respiratory function with SpO2 levels returning to baseline. He is able to perform activities of daily living with minimal assistance but requires ongoing monitoring for respiratory symptoms. Home health services will be essential for follow-up on oxygen saturation levels and to assist with medication management.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications:  \\n- Acetaminophen  \\n- Albuterol Inhaler  \\n- Bisacodyl  \\n- Enoxaparin (Prophylaxis)  \\n- Guaifenesin-Dextromethorphan  \\n- Polyethylene Glycol  \\n- Senna  \\n- Sodium Chloride 0.9% Flush  \\n\\nThe patient is advised to follow up with his primary care physician within one week and to contact the home health agency for ongoing support, particularly for respiratory monitoring and medication adherence.',\n",
       " '**Patient Information:** 66-year-old female admitted for observation due to pneumonia, unspecified organism (ICD-10: J189). \\n\\n**History of Present Illness:** The patient presented with cough, fever, and shortness of breath over the past week. Initial evaluation revealed hypoxia with an oxygen saturation of 88% on room air, prompting admission for further management. \\n\\n**Hospital Course:** During her 6-day stay, the patient was started on intravenous antibiotics, specifically Amoxicillin-Clavulanic Acid, and supportive care including oxygen therapy. She was closely monitored for respiratory status and renal function due to her history of acute kidney failure (ICD-10: N179). The patient demonstrated gradual improvement with resolution of fever and normalization of oxygen saturation levels. Consulting services were involved, including pulmonary and nephrology, to optimize her care plan. \\n\\n**Key Findings and Procedures:** Chest X-ray confirmed the diagnosis of pneumonia, and routine labs indicated mild metabolic derangements, which were managed effectively. The patient received a fentanyl patch for pain control and was started on Gabapentin for neuropathic pain. She was also assessed for cognitive function due to a documented history of bipolar disorder (ICD-10: F319) and toxic encephalopathy (ICD-10: G92). \\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, ambulating without assistance and demonstrating improved respiratory function. She is able to perform activities of daily living with minimal assistance. Home health services are recommended to ensure continuity of care, including home nursing visits for medication administration and monitoring of respiratory status. \\n\\n**Medications and Follow-Up Plan:** Discharge medications include Acetaminophen, Amoxicillin-Clavulanic Acid, Benztropine Mesylate, BusPIRone, Calcium Carbonate, ClonazePAM, Divalproex, and Docusate Sodium. The patient is advised to follow up with her primary care physician in one week for reassessment and to address any ongoing needs. Home health will initiate follow-up visits as scheduled.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- Age: 32  \\n- Gender: Male  \\n- Admission Type: Observation Admit  \\n- Length of Stay: 6.5 days  \\n\\n**History of Present Illness:**  \\nThe patient presented with an umbilical hernia with obstruction, without gangrene (ICD10: K420). He reported abdominal pain, nausea, and vomiting. Initial imaging confirmed the diagnosis, and it was determined that surgical intervention was necessary due to the risk of complications.\\n\\n**Hospital Course:**  \\nDuring his stay, the patient underwent laparoscopic repair of the umbilical hernia (Procedure ICD10: 0WQF0ZZ) and was closely monitored for post-operative complications. He was also treated for acute kidney failure (ICD10: N179) and managed with intravenous fluids. His ascites related to alcoholic cirrhosis was monitored and treated with diuretics (Furosemide). The patient's mental health was addressed; he received treatment for major depressive disorder and anxiety (ICD10: F329, F419).\\n\\n**Key Findings and Procedures:**  \\n- Laparoscopic umbilical hernia repair performed successfully.  \\n- Stabilization of renal function observed by discharge.  \\n- Continued management of ascites and mental health conditions.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with improved abdominal pain and no signs of obstruction. He is ambulating independently and has been educated on post-operative care and signs of complications. Home health services are recommended to assist with medication management, wound care, and continued monitoring of his mental health and renal status.\\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Cephalexin  \\n- Furosemide  \\n- Gabapentin  \\n- FLUoxetine  \\n- Dolutegravir and Emtricitabine-Tenofovir (Truvada)  \\n- Heparin  \\n\\n**Follow-up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week post-discharge and to maintain regular appointments for mental health support. Home health services will be initiated to provide comprehensive care.\",\n",
       " '**Patient Summary**: \\nThe patient is a 45-year-old female who was admitted through the emergency department with a diagnosis of non-traumatic intestinal perforation (ICD-10: K631). She presented with severe abdominal pain, nausea, and vomiting after a history of intermittent gastrointestinal symptoms. \\n\\n**Hospital Course**: \\nDuring her 4.8-day stay, the patient underwent an exploratory laparotomy where the perforation was identified and repaired. Post-operative care included management of potential complications, with particular attention to preventing infection and managing pain. She was started on intravenous antibiotics, including ciprofloxacin and metronidazole, and was provided with adequate pain control with hydromorphone and gabapentin. \\n\\n**Key Findings and Procedures**: \\nKey findings included hyperlipidemia (E785), obstructive sleep apnea, and a history of gastro-esophageal reflux disease. She was monitored closely for signs of infection and had routine blood work, which showed resolution of infection markers. The patient tolerated oral intake well by day four and was able to ambulate independently. \\n\\n**Discharge Condition and Functional Status**: \\nAt the time of discharge, the patient was stable with a functional status that allowed her to perform activities of daily living with minimal assistance. She will continue to require home health services for wound care management and monitoring of her nutritional status, particularly given her history of gastrointestinal issues. \\n\\n**Medications and Follow-Up Plan**: \\nUpon discharge, the patient is prescribed a regimen of 0.9% sodium chloride, 5% dextrose, acetaminophen, bupivacaine, buspirone, and gabapentin. She is advised to follow up with her primary care physician and surgical team within one week and to maintain close communication with home health services to ensure adherence to her care plan and to address any emerging concerns.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nName: [Patient Name]  \\nAge: 53  \\nGender: Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 3.5 days  \\n**Primary Diagnosis:** Other spondylosis with myelopathy, cervical region (ICD-10: M4712)  \\n\\n**History of Present Illness:**  \\nThe patient presented with severe neck pain and neurological deficits, including weakness in the upper extremities, attributed to cervical spondylosis with myelopathy. She reported progressive symptoms over the past six months, leading to significant functional impairment.  \\n\\n**Hospital Course:**  \\nDuring her hospital stay, the patient underwent a cervical decompression and fusion (ICD-10 Procedures: 0RG20K1, 0RG60K1, 0RG40K1). Postoperatively, she was monitored for neurological status and pain management. The patient received pain control with hydromorphone and gabapentin, along with supportive measures for anxiety and depression. She exhibited gradual improvement in mobility and was able to participate in physical therapy sessions, focusing on strengthening and range of motion exercises.  \\n\\n**Key Findings and Procedures:**  \\nPreoperative imaging revealed significant spinal stenosis at C5-C6 with associated myelopathy. The surgical intervention was successful, and no complications were noted. Postoperative imaging confirmed adequate decompression of the spinal cord.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved neurological function and pain levels managed effectively with oral medications. She is ambulating with minimal assistance and demonstrates the ability to perform activities of daily living (ADLs) with supervision. Home health services have been arranged to assist with rehabilitation and medication management.  \\n\\n**Medications at Discharge:**  \\n- 0.9% Sodium Chloride  \\n- AlPRAZolam  \\n- Acetaminophen  \\n- Gabapentin  \\n- HYDROmorphone  \\n- Bisacodyl  \\n- Docusate Sodium  \\n- Famotidine  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her orthopedic surgeon in 2 weeks for postoperative evaluation. Home health services will initiate physical therapy and nursing visits within the next week to facilitate recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 62  \\n**Gender:** Male  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to symptoms consistent with a Non-ST elevation myocardial infarction (NSTEMI). He presented with chest pain and shortness of breath, with a notable history of hypertension and nicotine dependence. Upon evaluation, the ECG showed no ST elevation, and cardiac biomarkers were elevated, confirming the diagnosis of NSTEMI.  \\n  \\n**Hospital Course:**  \\nDuring the two-day observation, the patient was managed with antiplatelet therapy including Aspirin and Isosorbide Dinitrate, alongside the initiation of statins (Atorvastatin and Rosuvastatin) for lipid management. Heparin was administered for anticoagulation. The patient remained hemodynamically stable throughout his stay, with no recurrent chest pain or arrhythmias.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a thorough workup, including cardiac monitoring and laboratory tests. Notably, he had bradycardia and was treated accordingly. The patient received an influenza vaccine and was educated on lifestyle modifications for heart health, including smoking cessation.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms. He is independent in activities of daily living but will benefit from home health services for medication management, monitoring of vital signs, and assistance with lifestyle modifications.  \\n  \\n**Medications at Discharge:**  \\n1. 5% Dextrose  \\n2. Acetaminophen  \\n3. Aspirin  \\n4. Atorvastatin  \\n5. Heparin Sodium  \\n6. Influenza Vaccine Quadrivalent  \\n7. Isosorbide Dinitrate  \\n8. Ondansetron  \\n9. Potassium Chloride  \\n10. Ramelteon  \\n11. Rosuvastatin Calcium  \\n12. Senna  \\n13. Sodium Chloride 0.9%  \\n  \\n**Follow-Up Plan:**  \\nFollow-up with cardiology in one week for ongoing management of NSTEMI and adjustment of medications as necessary. Home health services will assist with medication adherence and monitor progress for lifestyle changes.',\n",
       " '**Patient Information**: 70-year-old female admitted for observation due to a Dieulafoy lesion (hemorrhagic) of the stomach and duodenum, presenting with gastrointestinal bleeding. \\n\\n**History of Present Illness**: The patient reported melena and weakness over the past few days. Initial workup revealed anemia, prompting further evaluation. A gastroenterology consult was requested.\\n\\n**Hospital Course**: During her 2-day stay, the patient received intravenous fluids and blood transfusions to manage her acute posthemorrhagic anemia, with hemoglobin levels monitored closely. A successful endoscopic intervention was performed by gastroenterology to address the Dieulafoy lesion, resulting in hemostasis. The patient was also managed for her chronic conditions, including heart failure and chronic kidney disease, with adjustments to her medications as needed.\\n\\n**Key Findings and Procedures**: The patient had significant improvement in her hemoglobin levels post-transfusion, and her gastrointestinal bleeding was controlled following endoscopy. She was also treated for acute on chronic systolic heart failure and monitored for any signs of decompensation. \\n\\n**Discharge Condition and Functional Status**: At discharge, the patient was stable, ambulating independently, and demonstrated understanding of her medications and dietary restrictions. Home health services will be arranged to assist with medication management, monitor her vital signs, and ensure compliance with her heart failure and chronic kidney disease management plans.\\n\\n**Medications at Discharge**: The patient will continue on Acetaminophen, Albuterol nebulizer solution, Apixaban, Aspirin, Carvedilol, Calcium Acetate, Docusate Sodium, Ipratropium-Albuterol nebulizer, Levothyroxine, Ondansetron, Oxycodone (as needed), and Pantoprazole. \\n\\n**Follow-up Plan**: She is scheduled for outpatient follow-up with her primary care physician and gastroenterology within one week to monitor her recovery and adjust treatment plans as necessary.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 21  \\n**Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient is a 21-year-old female with a history of morbid obesity (ICD10: E6601) presenting for surgical intervention. She has been diagnosed with severe obesity due to excess calorie intake, with a BMI between 40.0-44.9. Additionally, she has comorbidities including vitamin D deficiency and major depressive disorder.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a scheduled surgical procedure (ICD10: 0DB64Z3) aimed at addressing her obesity. Postoperatively, she was monitored in the recovery unit, where she exhibited stable vital signs and adequate pain control. The nursing team provided education on managing her diet and physical activity post-surgery. The patient did experience mild nausea postoperatively, which resolved with antiemetics.  \\n  \\n**Key Findings and Procedures:**  \\nDuring her admission, the patient was evaluated by the dietitian and a mental health professional. The dietitian emphasized the importance of a balanced diet to support her recovery, while the mental health team recommended ongoing counseling to address her depressive symptoms. No significant complications arose during her stay, and her discharge was deemed appropriate after 1.4 days.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, ambulating independently, and demonstrated an understanding of her postoperative care needs. She is advised to continue with home health services for wound care and dietary management. A follow-up appointment with her primary care physician is recommended within one week to monitor her recovery and mental health status.  \\n  \\n**Medications:**  \\nThe patient was prescribed analgesics for pain management and vitamin D supplementation. She is instructed to adhere to her prescribed medication regimen and to report any adverse effects to her healthcare provider.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician and mental health specialist within one week post-discharge. Home health services will provide additional support for dietary modifications and emotional well-being.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Birth:** [Date of Birth]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 66-year-old male who was admitted for observation due to postprocedural hemorrhage following a recent digestive system procedure. He presented with symptoms of melena and syncope. Initial assessment indicated acute posthemorrhagic anemia, prompting further evaluation and management.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient was closely monitored in the observation unit. Laboratory tests confirmed anemia with hemoglobin levels dropping to [insert level], necessitating fluid resuscitation and close monitoring of vital signs. The patient received blood transfusions to address the anemia. Gastroenterology was consulted for management of the postprocedural complications. The patient's condition stabilized, and he was discharged in stable condition.\\n\\n**Key Findings and Procedures:**  \\n- Primary Diagnosis: K91840 - Postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure.  \\n- Additional findings included D62 (acute posthemorrhagic anemia) and M316 (giant cell arteritis).  \\n- Procedures performed included blood transfusions and supportive care.  \\n- Continuous assessment of gastrointestinal bleeding was conducted.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved hemoglobin levels. He is alert and oriented but requires home health services for ongoing monitoring of vital signs, medication management, and assistance with activities of daily living due to transient weakness experienced during hospitalization. A follow-up appointment with his primary physician is essential within one week post-discharge.\\n\\n**Medications at Discharge:**  \\n- Atorvastatin  \\n- Hydrochlorothiazide  \\n- Pneumococcal 23-valent polysaccharide vaccine  \\n- Pantoprazole  \\n- Prednisone  \\n- Sodium Chloride 0.9% flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week of discharge. Home health services will be initiated to assist with medication adherence and monitor recovery from the recent procedure.\",\n",
       " \"**Patient Information:** 70-year-old male admitted for observation due to neutropenia (ICD-10: D709) with a length of stay of 7.1 days.  \\n\\n**History of Present Illness:** The patient presented with persistent fatigue and recurrent infections, notably pneumonia. Initial lab tests revealed significant neutropenia, which necessitated further evaluation and management. \\n\\n**Hospital Course:** The patient was closely monitored in the observation unit. During his stay, he received supportive care, including hydration with 0.9% sodium chloride, antibiotic therapy with ceftriaxone for pneumonia, and filgrastim for neutrophil stimulation. He also received calcium gluconate for hypocalcemia, and other symptomatic treatments including acetaminophen and benzodiazepines for anxiety.  \\n\\n**Key Findings and Procedures:** Key laboratory findings included low absolute neutrophil count, requiring hematology consultation. A chest X-ray confirmed pneumonia, and the patient was treated accordingly. The patient's condition improved significantly following treatment, with resolution of fever and improvement in respiratory status. He was monitored for possible complications such as sepsis, which were ruled out. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient was stable, afebrile, and reported improved energy levels. He has been advised to limit exposure to potential infections and monitor for any signs of fever or respiratory distress. He will require home health services for continued monitoring of his neutrophil levels and assistance with medication management.  \\n\\n**Medications and Follow-Up Plan:** The discharge medication regimen includes 0.9% Sodium Chloride, Acetaminophen, Filgrastim-sndz, Metoprolol Succinate XL, and Calcium supplements. The patient is scheduled for follow-up with his primary care physician within one week and will be contacted by home health nursing to evaluate his recovery and adherence to medication. Education was provided regarding signs of infection and the importance of reporting any concerning symptoms immediately.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 30  \\n- **Gender:** Female  \\n- **Admission Type:** Direct Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for management of complications arising from digestive system diseases during her pregnancy, specifically in the second trimester. She presented with severe abdominal pain and was found to have sepsis due to anaerobes, along with pneumonia.  \\n\\n**Hospital Course:**  \\nDuring her 2.4-day stay, the patient received supportive care, including intravenous fluids, antibiotics (Ampicillin-Sulbactam), and analgesia (Morphine Sulfate, Acetaminophen). Her abdominal pain was managed effectively with Metoclopramide and Ondansetron for nausea. Betamethasone was administered to support fetal lung maturity due to the premature nature of her presentation. The patient also received Lactated Ringer's and 0.9% Sodium Chloride for hydration.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated inflammatory markers indicative of infection and imaging that ruled out acute appendicitis. The patient's condition improved with treatment, and she was stabilized by the time of discharge.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was afebrile, hemodynamically stable, and reported a significant reduction in pain. She is able to ambulate independently, but due to her recent hospitalization and ongoing pregnancy complications, she will benefit from home health services for continued monitoring and support.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications at home:  \\n1. Ampicillin-Sulbactam  \\n2. Acetaminophen  \\n3. Prenatal Vitamins  \\n4. Heparin for thromboprophylaxis  \\n5. Docusate Sodium for constipation management  \\nShe is advised to follow up with her obstetrician within one week for further evaluation and management of her pregnancy complications. Home health will assist with medication management and monitoring of symptoms.\",\n",
       " '**Patient Information:** 35-year-old female, admitted urgently with gestational hypertension complicating childbirth.  \\n\\n**History of Present Illness:** The patient presented with elevated blood pressure readings (systolic > 140 mmHg and diastolic > 90 mmHg) consistent with gestational hypertension, without significant proteinuria. She was at 39 weeks of gestation at the time of admission for labor and delivery.  \\n\\n**Hospital Course:** The patient underwent a successful vaginal delivery of a healthy infant, resulting in a single live birth. Throughout her stay, she was monitored for blood pressure stability and managed with appropriate antihypertensive therapy. Post-delivery, the patient experienced a first-degree perineal laceration, which was repaired without complication.  \\n\\n**Key Findings and Procedures:** Blood pressure readings stabilized in the postpartum period, and the patient exhibited no signs of postpartum complications. The primary procedures performed included a vaginal delivery (ICD10: 0HQ9XZZ) and repair of perineal laceration (ICD10: 10E0XZZ).  \\n\\n**Discharge Condition and Functional Status:** At the time of discharge, the patient was stable, ambulating independently, and able to perform activities of daily living with minimal assistance. Home health services are being arranged to monitor her blood pressure, educate on postpartum care, and assist with infant care in the initial weeks at home. The patient has been advised to contact her provider if any concerning symptoms arise, such as persistent headache, visual changes, or significant abdominal pain.  \\n\\n**Medications and Follow-Up Plan:** The patient is discharged on the following medications: Acetaminophen, Ibuprofen, Docusate Sodium, Bisacodyl, Calcium Carbonate, Dermoplast Spray, Ondansetron, Senna, and Simethicone for symptomatic relief and management of postpartum discomfort. A follow-up appointment is scheduled with her obstetrician in one week to assess recovery and blood pressure management. Home health services will initiate follow-up visits to ensure she adheres to her medication regimen and monitors her vital signs.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Age:** 58  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n\\n**History of Present Illness:**  \\nThe patient was admitted due to a strain of the muscle, fascia, and tendon of the lower back (ICD-10: S39012A) following an episode of overexertion. He presented with moderate to severe back pain radiating to the left leg, as well as accompanying symptoms of insomnia and anxiety. Chronic medical conditions include Type 2 diabetes mellitus with diabetic chronic kidney disease, chronic meningitis, and major depressive disorder.\\n\\n**Hospital Course:**  \\nDuring his 1-day stay, the patient was managed with pain control and supportive care. He received intravenous fluids and medications to address both pain and anxiety. Notably, he was started on Gabapentin for neuropathic pain and Tizanidine as a muscle relaxant. A physical therapy evaluation was conducted, and the patient was educated on proper body mechanics to prevent further injury. \\n\\n**Key Findings and Procedures:**  \\nPhysical examination revealed tenderness in the lumbar region with positive straight leg raise test indicating radiculopathy. Imaging studies ruled out any acute fractures or significant spinal stenosis. The patient was stable and showed improvement in pain levels with medication. \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable with a significant reduction in pain levels. He is able to perform activities of daily living with modifications and requires assistance with mobility. A home health referral has been initiated for continued physical therapy and assessment of functional capabilities to ensure a safe recovery environment.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. BuPROPion XL  \\n3. Gabapentin  \\n4. Heparin  \\n5. LORazepam  \\n6. Levothyroxine Sodium  \\n7. Lidocaine 5% Patch  \\n8. Omeprazole  \\n9. OxyCODONE (Immediate Release)  \\n10. Simvastatin  \\n11. Sodium Chloride 0.9% Flush  \\n12. Tizanidine  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to maintain regular appointments for diabetes management and mental health support. Home health services will monitor his recovery progress and assist with physical therapy interventions.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n  \\n**History of Present Illness:**  \\nThe patient is a 63-year-old female who presented with a displaced pilon fracture of the right tibia following a fall on stairs at her residence. The injury occurred on [Date of Injury], leading to significant pain and inability to bear weight on the affected limb.  \\n  \\n**Hospital Course:**  \\nUpon admission, the patient underwent a thorough evaluation including imaging studies confirming a displaced pilon fracture (ICD10: S82871A) and associated fractures of the right tibia and fibula. The orthopedic team was consulted, and the patient was treated non-operatively with pain management and immobilization. She received acetaminophen for pain control and was placed on enoxaparin for DVT prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included stable vital signs throughout the stay, and the patient demonstrated gradual improvement in pain levels and mobility with the use of crutches. No surgical intervention was deemed necessary at this time. The patient's diabetes and hypertension were well-managed with adjustments to her medication regimen.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, ambulating with crutches but requiring assistance with daily activities. Home health services will be initiated to provide physical therapy to aid in rehabilitation and to assist with medication management due to her diabetes and hypertension. The patient is encouraged to perform ankle pumps and other mobility exercises as tolerated.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Enoxaparin Sodium  \\n3. Lisinopril  \\n4. Insulin  \\n5. OxyCODONE (Immediate Release) for breakthrough pain  \\n6. Docusate Sodium for bowel regimen  \\n  \\n**Follow-up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week and with orthopedics for ongoing management of her fractures. Home health services will coordinate care and provide necessary rehabilitation support.\",\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Age:** 36  \\n**Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to a generalized skin eruption attributed to drugs and medicaments, diagnosed as L270. The onset of symptoms began after the administration of multiple medications, with significant skin involvement and associated discomfort.  \\n\\n**Hospital Course:**  \\nDuring a 4.9-day stay, the patient underwent a comprehensive evaluation, including dermatological assessment and laboratory tests, which revealed eosinophilia and elevated liver enzymes. The skin lesions were managed with topical corticosteroids (Clobetasol Propionate 0.05% Ointment) and hydrocortisone ointment, alongside systemic corticosteroids (Methylprednisolone Sodium Succinate and Prednisone) to mitigate inflammation. Supportive care included hydration, glucose management due to a transient hyperglycemic episode, and symptom control with diphenhydramine for pruritus.  \\n\\n**Key Findings and Procedures:**  \\nThe patient demonstrated improvement in skin condition by the end of the hospitalization, with a notable reduction in erythema and edema. Laboratory results indicated stabilization of eosinophil counts and normalization of liver function tests. No surgical interventions were required.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with significant improvement in skin lesions and overall functional status. He requires ongoing home health services for wound care and medication management. The patient is educated on the importance of adherence to prescribed medications and monitoring for any recurrence of symptoms.  \\n\\n**Medications and Follow-Up Plan:**  \\nDischarge medications include Aquaphor Ointment, Calcium Carbonate, Glucagon, Hydrocortisone Ointment 2.5%, Methylprednisolone, MetroNidazole, Prednisone, Ranitidine, and multivitamins. A follow-up appointment is scheduled with dermatology in one week to reassess the skin condition and adjust treatment as necessary. The patient is advised to call the clinic if symptoms worsen or new symptoms arise.\",\n",
       " \"**Patient Discharge Summary**  \\n**Patient ID:** [REDACTED]  \\n**Date of Admission:** [REDACTED]  \\n**Date of Discharge:** [REDACTED]  \\n**Attending Physician:** [REDACTED]  \\n**Age:** 26  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 26-year-old female who presented to the emergency department with preterm premature rupture of membranes (PPROM) at 33 weeks of gestation. She reported a sudden gush of fluid and intermittent contractions, with labor onset noted more than 24 hours following rupture. The patient has a past medical history notable for obesity and iron deficiency anemia.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient was closely monitored in labor and delivery. A complete blood count (CBC) revealed anemia, which was managed with iron supplementation. The patient was also given intravenous fluids (Lactated Ringer's) to maintain hydration. A vaginal delivery was achieved without complications, resulting in a healthy single live birth.  \\n\\n**Key Findings and Procedures:**  \\nDuring her stay, the patient underwent routine fetal monitoring, which showed reassuring fetal heart tones. There were no signs of maternal or fetal infection, and prophylactic antibiotics were administered due to the extended time since rupture. Post-delivery, the patient experienced mild gastrointestinal discomfort, managed with bisacodyl and simethicone.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with no acute issues identified. She demonstrates adequate mobility and has been advised to perform light activities at home. Home health services are recommended to assist with postpartum care, including monitoring for signs of infection and ensuring adequate nutritional support, given her history of anemia and obesity.  \\n\\n**Medications at Discharge:**  \\n1. Acetaminophen for pain management  \\n2. Bisacodyl for constipation  \\n3. Calcium Carbonate for calcium supplementation  \\n4. Docusate Sodium and Senna for stool softening  \\n5. Simethicone for gas relief  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her obstetrician within one week post-discharge. Home health services will initiate contact within 48 hours to assess her recovery, provide education on newborn care, and monitor her overall health status.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** [Patient Name], **Age:** 29, **Gender:** Female  \\n**Admission Date:** [Admission Date], **Discharge Date:** [Discharge Date]  \\n**Length of Stay:** 2.3 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted urgently due to complications from childbirth, specifically associated with an infection classified under ICD-10 code O9832, which indicates other infections with a predominantly sexual mode of transmission complicating childbirth. The patient presented with fever, malaise, and localized tenderness.\\n\\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely and received intravenous fluids (Lactated Ringer's, 0.9% Sodium Chloride) to maintain hydration and support recovery. Pain management was achieved with Acetaminophen and Ibuprofen, while gastrointestinal motility was addressed with Docusate Sodium and Bisacodyl. The patient's vital signs stabilized with treatment, and she demonstrated improvement in symptoms. A herpesviral infection was also identified (A6009), warranting additional monitoring during her hospital stay.\\n\\n**Key Findings and Procedures:**  \\nThe patient underwent necessary procedures, including the administration of Oxytocin for uterine contraction management. Laboratory results confirmed the diagnosis, and she received an Influenza Vaccine Quadrivalent as part of her discharge immunization plan. Throughout her admission, her progress was evaluated daily, and she ultimately met discharge criteria.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was hemodynamically stable, with improved symptoms and the ability to ambulate independently. She is advised to follow up with home health services for continued monitoring and support, particularly for wound care and infection management.\\n\\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Ibuprofen  \\n- Dermoplast Spray for pain relief  \\n- Docusate Sodium and Senna for constipation management  \\n- Follow-up with home health nursing for continued assessment and medication management.\\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within 1 week and to contact home health services for any concerns regarding her recovery. Emergency instructions were provided in case of worsening symptoms.\",\n",
       " 'Patient is an 81-year-old female who was admitted for observation due to enterocolitis caused by Clostridium difficile (ICD-10: A0472). She presented with diarrhea, abdominal cramping, and dehydration. The hospital stay lasted approximately 5 days, during which she received supportive care, including fluid resuscitation and intravenous antibiotics (Metronidazole).  \\n\\nThroughout her hospital course, she was monitored for clinical improvement and potential complications. Key findings included persistent abdominal tenderness but improvement in stool frequency. No surgical intervention was required. The patient also had a history of hypertension, hypothyroidism, and gout, which were managed with appropriate medications during her stay.  \\n\\nAt the time of discharge, the patient demonstrated a stable condition, with improved bowel movements and hydration status. She is ambulating independently with minimal assistance, although she exhibits some weakness and fatigue. It is recommended that she continues with home health services for assistance with activities of daily living, medication management, and monitoring of her recovery from enterocolitis.  \\n\\nThe discharge medications include Acetaminophen for pain management, Levothyroxine Sodium for hypothyroidism, and Loperamide for diarrhea control. She will also continue with Aspirin for cardiovascular protection, Colchicine for gout, and Omeprazole for gastric protection. A follow-up appointment is scheduled with her primary care physician in one week to reassess her gastrointestinal symptoms and overall health status. Home health services will begin immediately post-discharge to ensure her safety and facilitate her recovery.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Redacted]  \\n**Age:** 76  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 6.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 76-year-old female with a history of unspecified atrial fibrillation, essential hypertension, prediabetes, hyperlipidemia, and osteoarthritis who was admitted for observation due to palpitations and shortness of breath. The onset of symptoms occurred over the past week, prompting evaluation.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient underwent a comprehensive cardiac evaluation, including an echocardiogram and telemetry monitoring, which confirmed the presence of atrial fibrillation. Management included initiation of anticoagulation with Apixaban, rhythm control with Amiodarone, and optimization of blood pressure with Lisinopril and Hydrochlorothiazide. The patient was also educated on lifestyle modifications, including dietary changes for her hyperlipidemia and diabetes management.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included episodes of atrial fibrillation on telemetry and elevated blood pressure readings. The patient was monitored closely, and adjustments to her medication regimen were made accordingly. No invasive procedures were required during this admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable, with improved symptoms and adequate rate control of her atrial fibrillation. She demonstrated an understanding of her condition and medication regimen. The patient will require home health services for ongoing monitoring of her heart rhythm, medication adherence, and assistance with activities of daily living due to her osteoarthritis.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Amiodarone  \\n3. Apixaban  \\n4. Ascorbic Acid  \\n5. Aspirin  \\n6. Atorvastatin  \\n7. Docusate Sodium  \\n8. Hydrochlorothiazide  \\n9. Lisinopril  \\n10. Metoprolol Tartrate  \\n11. Omeprazole  \\n12. Magnesium Oxide  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within 1 week of discharge and will have a cardiology appointment scheduled in 2 weeks. Home health services will commence immediately to assist with monitoring and medication management.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 67  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted under observation for management of rectal hemorrhage (ICD10: K625). The patient reported intermittent rectal bleeding accompanied by mild abdominal discomfort. A detailed assessment indicated a potential underlying pathology contributing to the bleeding. The patient has a significant medical history including end-stage renal disease, chronic heart failure, and atrioventricular block.\\n\\n**Hospital Course:**  \\nDuring the 2.8-day observation period, the patient underwent a comprehensive evaluation that included laboratory tests and imaging studies. Key findings included elevated potassium levels requiring the administration of Insulin (Regular) for management of hyperkalemia. The patient was also started on Epoetin Alfa for anemia secondary to chronic kidney disease. Hemodynamic stability was maintained, and the rectal bleeding decreased significantly following conservative management.\\n\\n**Procedures and Key Findings:**  \\nThe patient received multiple interventions including hydration with 0.9% Sodium Chloride and electrolyte management. A colonoscopy was discussed but deferred due to the patient's hemodynamic status and the resolution of bleeding. The patient was assessed by the cardiology team due to his history of hypertensive heart disease, and it was determined that he would benefit from continued monitoring.\\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with no active bleeding. He demonstrated the ability to perform activities of daily living (ADLs) with minimal assistance. Home health services are recommended to assist with medication management and monitoring of vital signs, especially given his complex medication regimen and history of chronic conditions.\\n\\n**Medications at Discharge:**  \\n- Aspirin  \\n- Atorvastatin  \\n- Calcium Gluconate  \\n- Docusate Sodium  \\n- Epoetin Alfa  \\n- Insulin (Regular)  \\n- Isosorbide Mononitrate (Extended Release)  \\n- OxyCODONE (Immediate Release)  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with his primary care physician within one week and to contact home health services for assistance with medication adherence and management of symptoms. A follow-up appointment with a nephrologist is also recommended to address ongoing management of his renal disease.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Name]  \\n**Date of Birth:** [DOB]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admit Type:** Observation  \\n**Length of Stay:** 2.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient is a 50-year-old female who presented with acute abdominal pain, nausea, and vomiting. Abdominal ultrasound confirmed the presence of gallstones and acute cholecystitis without obstruction. She has a significant history of obesity (BMI 45.0-49.9) and fatty liver disease.  \\n  \\n**Hospital Course:**  \\nDuring her hospital stay, the patient was monitored in the observation unit and received conservative management for her condition. Intravenous fluids were initiated, and she was started on antibiotics including Ciprofloxacin and Metronidazole. Pain control was achieved with a combination of Acetaminophen, Ibuprofen, and Ketorolac. The patient tolerated a gradual diet advancement and demonstrated improvement in her symptoms.  \\n  \\n**Key Findings and Procedures:**  \\nLaboratory tests showed leukocytosis consistent with infection, and liver function tests were mildly elevated, likely due to her underlying obesity and fatty liver. No surgical intervention was required during this admission.  \\n  \\n**Discharge Condition and Functional Status:**  \\nOn discharge, the patient was stable with resolution of acute symptoms. She demonstrated the ability to ambulate independently and perform activities of daily living with minimal assistance. However, due to her obesity and medical history, home health services have been recommended for ongoing monitoring and assistance with dietary management and activity modifications.  \\n  \\n**Medications and Follow-Up Plan:**  \\nDischarge medications include:  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Ciprofloxacin IV  \\n- Heparin  \\n- Ondansetron  \\n- OxyCODONE (Immediate Release)  \\n  \\nThe patient is to follow up with her primary care physician within one week and with a dietitian for weight management. Home health services will initiate contact to provide support in her recovery.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 33  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to an exacerbation of mental health symptoms complicating her third trimester of pregnancy. She presented with significant anxiety and depressive symptoms characterized by mood instability and difficulty managing daily activities.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was monitored closely for psychiatric stability and obstetric safety. She was evaluated by the psychiatry team, and her medication regimen was adjusted to include Mirtazapine and Quetiapine Fumarate to address her depressive and anxiety symptoms. Additionally, Lorazepam was administered as needed for acute anxiety episodes. The patient's prenatal vitamins were continued.  \\n  \\n**Key Findings and Procedures:**  \\n- The patient showed improvement in mood and anxiety levels with the adjusted medication therapy.  \\n- No significant obstetric complications were noted during her stay; fetal monitoring was reassuring throughout.  \\n- Psychological support was provided, and the patient engaged well with therapy sessions.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improved mood and reduced anxiety symptoms. She will require home health services for continued psychiatric support and medication management. Assistance at home will help her maintain stability as she approaches the final weeks of her pregnancy. The patient has expressed understanding of her treatment plan and the importance of follow-up care.  \\n  \\n**Medications at Discharge:**  \\n1. Docusate Sodium  \\n2. Lorazepam  \\n3. Mirtazapine  \\n4. Prenatal Vitamins  \\n5. Quetiapine Fumarate  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with her obstetrician and psychiatrist within one week of discharge. Home health services will initiate contact to provide ongoing support and monitor medication adherence, as well as assist with any emerging mental health needs.\",\n",
       " 'Patient is a 51-year-old male who was admitted for surgical management of a displaced bicondylar fracture of the left tibia, subsequent encounter for closed fracture with malunion (ICD-10: S82142P). He presented with significant pain and impaired mobility. Surgical intervention included internal fixation of the tibia, with intraoperative findings consistent with the preoperative imaging.\\n\\nDuring the 4.8-day hospital stay, the patient was monitored for pain management, mobility, and potential complications. He demonstrated adequate pain control with a regimen including Acetaminophen and Oxycodone. Post-operatively, the patient engaged in physical therapy focusing on passive and active range of motion exercises to enhance recovery of function.\\n\\nKey findings during the hospital stay included stable vital signs, improved pain control, and gradual increase in mobility. He was also diagnosed with other conditions including anxiety disorder and major depressive disorder, for which he was started on Citalopram. Blood work revealed thrombocytopenia and a decreased white blood cell count, which were monitored, and he was given supportive care with Lactated Ringers and magnesium oxide.\\n\\nAt discharge, the patient is stable, ambulatory with the assistance of a walker, and has demonstrated the ability to perform activities of daily living with minimal support. He will require ongoing home health services for physical therapy to facilitate further recovery, monitoring of his mental health conditions, and assistance with medication management.\\n\\nMedications at discharge include Acetaminophen, Bisacodyl, Citalopram, Docusate Sodium, Enoxaparin Sodium, Lactated Ringers, Magnesium Oxide, Methadone, Nadolol, Omeprazole, Oxycodone, and Senna. The patient is advised to follow up with orthopedic and primary care within one week post-discharge for further evaluation of his recovery and management of psychiatric conditions.',\n",
       " '**Discharge Summary**  \\n**Patient:** Female, 51 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 11.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with complaints of severe lower back pain radiating to the left leg, associated with numbness and weakness, consistent with intervertebral disc disorders with radiculopathy (ICD10: M5116). She has a history of chronic pain and opioid dependence, which contributed to her admission.  \\n  \\n**Hospital Course:**  \\nDuring her stay, the patient was managed with conservative measures including physical therapy, pain management, and psychiatric evaluation for her anxiety and depressive symptoms. The pain regimen included hydromorphone, acetaminophen, and adjunctive medications such as alprazolam and trazodone for mood stabilization. The patient also received supportive care for her celiac disease and was monitored for acute respiratory failure, with no significant events noted.  \\n  \\n**Key Findings and Procedures:**  \\nImaging studies confirmed the presence of a significant lumbar disc herniation. The patient underwent an epidural steroid injection to help alleviate symptoms. The psychiatric team provided recommendations for outpatient therapy and medication management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient reports significant improvement in pain levels, although she still experiences some residual weakness. She is alert and oriented, but her mobility is limited due to ongoing back pain. The patient will require home health services for physical therapy and supervision to ensure safe ambulation and adherence to her medication regimen.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged on the following medications: alprazolam, acetaminophen, atenolol, cetirizine, docusate sodium, famotidine, hydromorphone, ondansetron, paroxetine, senna, sodium chloride flush, and trazodone.  \\n  \\n**Follow-Up Plan:**  \\nShe is to follow up with her primary care physician in one week and maintain contact with home health services for ongoing support. Additionally, she will receive outpatient therapy to address her functional limitations and further evaluate her mental health.',\n",
       " '**Patient Information**: 39-year-old female admitted for surgical intervention regarding a cerebral aneurysm, nonruptured (ICD10: I671). \\n\\n**History of Present Illness**: The patient presented with headaches and mild neurological deficits. Imaging studies confirmed the presence of a nonruptured cerebral aneurysm. Given the risks associated with progression, the decision for surgical intervention was made on an outpatient basis.\\n\\n**Hospital Course**: The patient underwent endovascular coiling of the cerebral aneurysm with uneventful recovery. Post-procedure, she was monitored in the recovery unit for 24 hours, where she demonstrated stable vital signs and neurological status. She was assessed by neurology and neurosurgery teams, both of whom cleared her for discharge after confirming her satisfactory recovery.\\n\\n**Key Findings and Procedures**: During her hospital stay, no complications arose, and the patient exhibited significant improvement in symptoms. She was initiated on clopidogrel as a preventive measure post-procedure to reduce the risk of thromboembolic events. Additionally, her psychiatric history of anxiety disorder and ADHD (ICD10: F419, F909) was noted, and her current medication regimen was adjusted accordingly.\\n\\n**Discharge Condition and Functional Status**: The patient is discharged in stable condition, with no immediate neurological deficits. She is able to ambulate independently but will require home health services for medication management and monitoring of her recovery. It is essential to ensure she adheres to her antithrombotic regimen. A follow-up appointment with a neurosurgeon is scheduled in one week to assess recovery and further management.\\n\\n**Medications and Follow-Up Plan**: Discharge medications include Amphetamine-Dextroamphetamine XR for ADHD and Clopidogrel for antiplatelet therapy. She has been advised to avoid strenuous activities and to report any signs of neurological change or complications. Home health services will assist in medication adherence and monitor her overall recovery.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient's name]  \\n- **Age:** 77  \\n- **Gender:** Female  \\n- **Admission Type:** Urgent  \\n- **Length of Stay:** 2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of worsening angina pectoris associated with atherosclerotic heart disease of the native coronary artery. The patient has a history of type 2 diabetes, hypertension, hyperlipidemia, and anxiety disorder. During admission, the patient reported increased episodes of chest pain, particularly with exertion.  \\n\\n**Hospital Course:**  \\nUpon admission, the patient underwent a thorough cardiovascular evaluation, including an ECG and cardiac enzyme tests, which indicated stable angina without acute myocardial infarction. The patient was managed with a combination of medications including nitroglycerin for angina relief, atorvastatin for hyperlipidemia, and metoprolol for blood pressure control. The patient also received education on lifestyle modifications, including dietary changes and physical activity.  \\n\\n**Key Findings and Procedures:**  \\n- Stable angina pectoris  \\n- No acute coronary syndrome identified  \\n- Cardiac enzymes within normal limits  \\n- ECG showed no acute ischemic changes  \\n- Initiated on oral anticoagulation with aspirin and heparin administered during hospitalization  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, reporting reduced episodes of chest pain. Functional status has improved with education on managing her conditions, and she is able to perform activities of daily living independently. Home health services have been arranged to assist with monitoring her medications and provide support for diabetes management and education on home exercises to improve cardiovascular health.  \\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Aspirin  \\n- Atorvastatin  \\n- Metoprolol Succinate XL  \\n- Isosorbide Mononitrate  \\n- Nitroglycerin SL  \\n- Pantoprazole  \\n- Quinapril  \\n- Polyethylene Glycol  \\n- Influenza Vaccine Quadrivalent  \\n- Mupirocin Ointment  \\n\\n**Follow-Up Plan:**  \\nThe patient is scheduled for a follow-up appointment with her primary care physician in one week to reassess her cardiovascular status and medication adherence. Home health nursing will monitor her progress and assist with medication management.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient's Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 53  \\n**Gender:** Female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 5.2 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted with complaints of dizziness and near-syncope attributed to orthostatic hypotension. The symptoms were exacerbated upon standing, leading to significant falls risk. The patient's medical history includes type 2 diabetes mellitus with associated complications, including diabetic polyneuropathy and retinopathy.  \\n\\n**Hospital Course:**  \\nDuring her 5-day observation, the patient underwent a comprehensive evaluation which included fluid resuscitation, electrolyte repletion, and monitoring of vital signs. Orthostatic changes were confirmed through serial blood pressure measurements. The patient was managed with hydration and medications, including Hydralazine and Cilostazol, to optimize blood pressure stability. A multidisciplinary team, including endocrinology and nephrology, was involved due to her complex medical history.  \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed acute kidney injury secondary to dehydration. Imaging studies were unremarkable for additional acute processes. The patient responded well to treatment with gradual improvement in her symptoms and stabilization of renal function.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient demonstrated improvement in her dizziness and was able to ambulate independently with minimal assistance. However, she continues to require home health services for ongoing monitoring of her blood pressure and management of her diabetes. The patient is advised to avoid sudden positional changes to minimize the risk of further falls.  \\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on Acetaminophen, Cilostazol, Clopidogrel, Enoxaparin for prophylaxis, and Ibuprofen as needed. Home health will assist with medication management and monitor for any side effects.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment with her primary care physician is scheduled within one week post-discharge to reassess her condition and adjust her treatment plan as necessary.\",\n",
       " '**Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Name:** [Patient Name]  \\n**Date of Discharge:** [Date]  \\n**Date of Admission:** [Admission Date]  \\n**Age:** 54  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with an infection following a procedure (ICD-10: T814XXA). He presented with signs of a peritoneal abscess and associated symptoms including abdominal pain and fever.  \\n  \\n**Hospital Course:**  \\nDuring his 1.5-day hospital stay, the patient was stabilized with IV fluids, antibiotics (Ciprofloxacin and Linezolid), and analgesics including Hydromorphone and Ibuprofen for pain management. A CT scan confirmed the presence of the peritoneal abscess, which was managed conservatively. He received supportive care, including Vitamin D supplementation due to deficiency and nutritional support with D5 1/2NS.  \\n  \\n**Key Findings and Procedures:**  \\n- Peritoneal abscess confirmed via imaging  \\n- Infection managed with appropriate antibiotics  \\n- Improvement noted in abdominal pain and fever  \\n- Discharge medications reviewed with the patient, including Acetaminophen and Metronidazole.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, with a significant reduction in abdominal pain. He is ambulatory with assistance and requires home health services for continued wound care and monitoring of his antibiotic regimen. The patient is advised to maintain a low-residue diet and perform light activities as tolerated.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen  \\n2. Ciprofloxacin HCl  \\n3. D5 1/2NS  \\n4. Hydromorphone (Dilaudid)  \\n5. Heparin  \\n6. Ibuprofen  \\n7. Linezolid  \\n8. Metronidazole (Flagyl)  \\n9. Sodium Chloride 0.9% Flush  \\n10. Vitamin D  \\n  \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week post-discharge. Home health services will be initiated to assist with medication management and monitor for any signs of infection or complications.',\n",
       " '**Patient Name:** [REDACTED]  \\n**Age:** 63  \\n**Gender:** Female  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 1.7 days  \\n\\n**History of Present Illness:**  \\nThe patient was admitted following an emergency presentation with a fistula of the intestine (ICD-10 K632). She reported persistent abdominal pain, nausea, and a history of gastrointestinal issues, which prompted the need for urgent evaluation.  \\n\\n**Hospital Course:**  \\nDuring her hospitalization, the patient underwent a series of diagnostic tests, including imaging studies that confirmed the presence of the intestinal fistula. She was started on intravenous fluids and appropriate antibiotics to manage her condition. A surgical consultation was initiated, but the decision was made to manage her conservatively at this time due to stable vital signs and the absence of peritonitis.  \\n\\n**Key Findings and Procedures:**  \\nThe key findings included a confirmed intestinal fistula with no signs of obstruction or acute abdomen on imaging. The patient was monitored closely for any signs of complications. She also has a medical history of essential hypertension (I10) and unspecified atrial fibrillation (I4891), which were managed during her stay with appropriate medications.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient is stable with a clear plan for home health services to assist with wound care related to the fistula. She is ambulatory with assistance and has been educated about signs of potential complications that should prompt immediate medical attention. She will require follow-up care to monitor her fistula and overall health status.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Aspirin, Budesonide, Heparin, HydrALAZINE, Omeprazole, and D5 1/2NS along with Sodium Chloride 0.9% Flush for her home health needs. A follow-up appointment with her primary physician is scheduled within one week of discharge to reassess her condition and medication regimen. It is imperative that home health services are initiated to ensure proper care and monitoring of her ongoing recovery.',\n",
       " '**Patient Information:** 83-year-old male admitted for observation due to exacerbation of hypertensive heart disease and chronic kidney disease (CKD) with heart failure.  \\n\\n**History of Present Illness:** The patient presented with worsening dyspnea and edema, with a history of stage 3 CKD and type 2 diabetes mellitus. He reported increased fatigue and a recent episode of chest discomfort.  \\n\\n**Hospital Course:** During his 4-day hospital stay, the patient was monitored closely. He received diuretics (Furosemide) for fluid overload, and his renal function was assessed through laboratory tests showing elevated creatinine levels. A cardiology consult was obtained due to concerns regarding heart failure exacerbation; echocardiogram revealed preserved ejection fraction but significant diastolic dysfunction.  \\n\\n**Key Findings and Procedures:** Key findings included elevated blood pressure, congestive heart failure symptoms, and worsening renal function. A thorough workup revealed acute on chronic systolic heart failure. The patient underwent optimization of his heart failure regimen, with adjustments to his medications including Carvedilol, and was started on Clopidogrel for myocardial infarction type 2 management.  \\n\\n**Discharge Condition and Functional Status:** The patient was stable at discharge with improved respiratory status and reduced edema. He is ambulating independently but requires assistance with activities of daily living due to fatigue and weakness. Home health services will be essential for medication management, ongoing monitoring of his renal function, and support for daily activities.  \\n\\n**Medications and Follow-Up Plan:** At discharge, the patient will continue on Acetaminophen, Albuterol Inhaler, Aspirin, Atorvastatin, Carvedilol, Clopidogrel, Dextrose 50%, Ferrous Sulfate, and Gabapentin among others. He has a follow-up appointment scheduled with his primary care physician and nephrologist within one week. Home health nursing will be arranged to assist with medication administration and monitor vital signs.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 62  \\n**Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with abdominal distension and jaundice, with a history of chronic alcohol use. Initial workup revealed signs consistent with alcoholic cirrhosis of the liver with ascites, as well as acute kidney failure.  \\n\\n**Hospital Course:**  \\nDuring the 4-day hospital stay, the patient was monitored closely for fluid status and renal function. The patient received albumin infusions to manage ascites and prevent further complications from hypoalbuminemia. Lactulose was administered to manage hepatic encephalopathy, and rifaximin was prescribed to reduce ammonia levels. Additionally, the patient was started on diuretics to facilitate fluid removal.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included significant ascites on abdominal imaging and elevated liver enzymes. A paracentesis was performed, yielding clear fluid, which provided symptomatic relief. The patient's renal function improved towards the end of the hospitalization. The patient was also assessed for potential home health needs due to functional decline, including mobility issues and nutritional deficits.  \\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing support. The patient has been educated on dietary modifications and the importance of alcohol abstinence. Home health services are recommended for monitoring fluid status, nutritional support, and assistance with activities of daily living due to the patient's diminished functional status.  \\n\\n**Medications:**  \\nThe following medications are prescribed at discharge: Acetaminophen, Albumin 25% (12.5g/50mL), Docusate Sodium, Folic Acid, Heparin, Lactulose, Lorazepam, Multivitamins with minerals, Neutra-Phos, Omeprazole, Ondansetron, Potassium Chloride, Rifaximin, and Senna.  \\n\\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with the primary care physician in one week and should present to a hepatologist for further evaluation of liver function. Home health nursing will initiate a home visit within 48 hours of discharge to assess and support recovery.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 70  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient is a 70-year-old male admitted via direct emergency due to a non-pressure chronic ulcer of the left heel and midfoot with unspecified severity, complicated by underlying conditions including hemiplegia affecting the left nondominant side and stage 3 pressure ulcer of the sacral region. The patient has a significant medical history including hypertension, epilepsy, and peripheral vascular disease, which contributed to his current condition.\\n\\n**Hospital Course:**  \\nDuring his 6.9-day hospitalization, the patient was managed with wound care and antibiotic therapy, including Amoxicillin-Clavulanic Acid and Ciprofloxacin HCl for infection control. Pain management was achieved with Acetaminophen and Gabapentin. A multidisciplinary team, including nursing and physical therapy, was involved in the patient's care plan, focusing on mobility and safety given his hemiplegia.\\n\\n**Key Findings and Procedures:**  \\nThe patient underwent debridement of the ulcer and received Collagenase Ointment for wound management. Nutrition support was also initiated to address his anemia and Vitamin D deficiency. Regular assessments showed gradual improvement in the condition of the ulcer, and he was able to participate in physical therapy sessions, indicating some functional recovery.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition but with significant needs for home health services. He requires assistance with activities of daily living due to his hemiplegia and limited mobility. Home health nursing will be essential for continued wound care, medication management, and rehabilitation support to enhance recovery.\\n\\n**Medications and Follow-Up Plan:**  \\nUpon discharge, the patient will continue on the following medications: Acetaminophen, Albuterol (for respiratory care), Amitriptyline, Atorvastatin, Baclofen, and Docusate Sodium. A follow-up appointment is scheduled with his primary care provider in one week to monitor his progress and adjust medications as necessary. Home health services have been arranged to commence immediately post-discharge.\",\n",
       " \"**Patient Name:** [Patient Name]\\n\\n**Date of Birth:** [DOB]  \\n**Admission Date:** [Admission Date]  \\n**Discharge Date:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient, a 74-year-old male, presented to the emergency department with complaints of progressive abdominal pain and a history of chronic obstructive pulmonary disease (COPD), diastolic heart failure, and a recent exacerbation of respiratory symptoms. The patient has a known history of abdominal aortic aneurysm (AAA) without rupture.\\n\\n**Hospital Course:**  \\nDuring the 15-day hospital stay, the patient was monitored closely in the telemetry unit due to his cardiac history. He was treated for acute on chronic diastolic heart failure and acute respiratory failure with hypoxia. The patient received bronchodilators, corticosteroids, and diuretics to manage his symptoms effectively. He underwent a thorough evaluation, including imaging studies, which confirmed the AAA without rupture. The patient's respiratory status improved significantly with treatment, and he was able to maintain oxygen saturation above 92% on room air.\\n\\n**Key Findings and Procedures:**  \\nThe patient's key findings included stable vital signs, improved lung function, and resolution of respiratory distress. He was treated with a regimen of furosemide, metoprolol, and other supportive medications. The patient participated in physical therapy, achieving improved mobility and independence in activities of daily living (ADLs).\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, ambulatory, and demonstrated the ability to perform ADLs with minimal assistance. He was advised to continue home health services for respiratory therapy and cardiac monitoring, as well as follow-up physical therapy. Home health will also assist with medication management and monitor for any signs of heart failure exacerbation.\\n\\n**Medications and Follow-Up Plan:**  \\nThe patient’s discharge medications include Albuterol inhaler, furosemide, metoprolol succinate XL, carvedilol, and pantoprazole. He is to follow up with his primary care physician within one week and cardiology within two weeks. Home health services will commence within 48 hours post-discharge to ensure a smooth transition and ongoing support.\",\n",
       " \"**Discharge Summary**  \\n**Patient:** Male, 75 years old  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.1 days  \\n**Primary Diagnosis:** Viral pneumonia, unspecified (ICD10: J129)  \\n\\n**History of Present Illness:**  \\nThe patient was admitted to the hospital with a diagnosis of viral pneumonia, presenting with cough, dyspnea, and fever. His past medical history is significant for benign prostatic hyperplasia, essential hypertension, and a personal history of prostate cancer. He was also noted to have hydronephrosis and dysphagia during the admission.\\n\\n**Hospital Course:**  \\nDuring the hospital stay, the patient received supportive care including supplemental oxygen and intravenous fluids. Antibiotic therapy was initiated with Ceftriaxone and Azithromycin due to concerns for potential secondary bacterial infection. He was monitored closely for respiratory status, and his symptoms gradually improved. The patient was also evaluated by urology for hydronephrosis, which was managed conservatively. Additionally, he received a high-dose influenza vaccine and was started on Simvastatin for hypercholesterolemia.\\n\\n**Key Findings and Procedures:**  \\nThe patient's chest imaging showed patchy infiltrates consistent with viral pneumonia. He underwent routine labs which indicated mild dehydration and elevated inflammatory markers. No invasive procedures were required during this admission.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, with improved respiratory function, and is able to ambulate independently. However, he requires assistance with daily activities due to weakness and previous dysphagia. Home health services have been arranged to provide nursing care, physical therapy, and assistance with activities of daily living.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Azithromycin  \\n- Ceftriaxone (IV)  \\n- Docusate Sodium  \\n- Heparin (prophylaxis)  \\n- Influenza Vaccine High-Dose Quadrivalent  \\n- Lidocaine 5% Patch  \\n- Multivitamins  \\n- Ondansetron  \\n- Senna  \\n- Simvastatin  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient should follow up with his primary care physician in one week and with urology as needed. Home health services will begin within 48 hours post-discharge.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient ID:** [Patient ID]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Attending Physician:** [Physician Name]  \\n**Discharge Diagnosis:** Cellulitis of groin (ICD10: L03314)  \\n\\n**History of Present Illness:**  \\nThe patient is a 20-year-old male who presented to the ED with complaints of swelling, redness, and pain in the right groin area for the past three days. Symptoms were associated with fever and chills. The patient was admitted under observation for further evaluation and management of suspected cellulitis. \\n\\n**Hospital Course:**  \\nDuring his 3-day hospital stay, the patient was started on intravenous antibiotics, including Ampicillin-Sulbactam and Vancomycin, due to a confirmed Methicillin-resistant Staphylococcus aureus (MRSA) infection. Serial examinations showed improvement in swelling and tenderness, and the patient was transitioned to oral antibiotics on Day 2. He was also managed with pain control using Ketorolac and Oxycodone, which was effective. \\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated white blood cell count consistent with infection and cultures confirmed MRSA as the causative agent. No surgical intervention was needed as the cellulitis resolved with medical management. The patient received supportive care, including hydration with 0.9% Sodium Chloride.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient demonstrated significant improvement in symptoms with resolution of fever and a marked reduction in erythema and swelling of the affected area. He is ambulatory and able to perform activities of daily living independently. However, he will require home health services for wound care and monitoring for any signs of recurrence or complications.\\n\\n**Medications at Discharge:**  \\n1. Amoxicillin-Clavulanate  \\n2. Acetaminophen as needed for pain  \\n3. Hydrocortisone Cream 1% for skin irritation  \\n4. Diphenhydramine for itching  \\n5. Continue oral Hydration  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week for reassessment and to ensure complete recovery. Home health services are arranged for ongoing wound care and monitoring.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 50  \\n**Gender:** Male  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with acute onset of fever, chills, and dyspnea, leading to the diagnosis of acute infective endocarditis (ICD-10: I330). Initial blood cultures were positive for Streptococcus species, and the patient exhibited signs of bacteremia (ICD-10: R7881). The patient has a history of nonrheumatic mitral valve prolapse (ICD-10: I341), which may have contributed to the current condition.  \\n  \\n**Hospital Course:**  \\nUpon admission, the patient was started on intravenous antibiotics including Ceftriaxone and Gentamicin. The patient was closely monitored for hemodynamic stability and response to therapy. Additionally, the patient received supportive care including hydration with 0.9% Sodium Chloride and nutritional support with 5% Dextrose. Pain management was provided with Acetaminophen, and anticoagulation was initiated with Heparin.  \\n  \\n**Key Findings and Procedures:**  \\nEchocardiography performed during the stay revealed vegetative lesions on the mitral valve. The patient underwent a PICC line insertion for prolonged intravenous antibiotic therapy. The patient was also administered the Influenza Vaccine Quadrivalent during hospitalization.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at the time of discharge, afebrile, and demonstrates improved functional status. He is able to ambulate with minimal assistance and perform activities of daily living. Home health services are recommended for ongoing monitoring of his IV antibiotics, management of his PICC line, and assistance with daily activities.  \\n  \\n**Medications at Discharge:**  \\nThe patient is discharged with a medication regimen including Ceftriaxone, Gentamicin, and Penicillin G Potassium, along with supportive medications (TraZODone for sleep, Senna for constipation). Follow-up appointments with cardiology and infectious disease specialists are essential within one week post-discharge to reassess his condition and adjust treatment if necessary.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 75  \\n- **Gender:** Female  \\n- **Admission Type:** Observation Admit  \\n- **Length of Stay:** 1.8 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for observation due to acute diverticulitis of the large intestine (ICD10: K5732) without perforation, abscess, or bleeding. She presented with abdominal pain, nausea, and changes in bowel habits. Given her history of chronic diastolic heart failure, unspecified atrial fibrillation, and other comorbidities, careful monitoring was essential during her stay.  \\n  \\n**Hospital Course:**  \\nDuring her hospitalization, the patient was started on intravenous fluids, antibiotics (Ceftriaxone and Metronidazole), and pain management with Morphine Sulfate. She was also given Bisacodyl and Docusate Sodium to manage constipation. The patient was monitored closely for any complications related to her diverticulitis and cardiac status.  \\n  \\n**Key Findings and Procedures:**  \\nPhysical examination revealed tenderness in the left lower quadrant with no signs of perforation. Laboratory tests showed mild leukocytosis, likely secondary to diverticulitis. An abdominal ultrasound was performed, confirming the diagnosis without complications. The patient's cardiac status remained stable throughout her stay.  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved abdominal symptoms and tolerating a regular diet. She is able to perform ADLs with minimal assistance but requires follow-up home health services for continued monitoring, medication management, and nutritional counseling. Pain management and bowel regimen education were provided to ensure ongoing recovery.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is to continue the following medications:  \\n- Acetaminophen IV (as needed)  \\n- Aspirin  \\n- Bystolic  \\n- Losartan Potassium  \\n- Citalopram  \\n- Fleet Enema (as needed for constipation)  \\n- Follow-up with her primary care physician in 1 week and with a dietitian for nutritional advice.  \\nHome health services will be arranged to assist with her recovery and monitor her cardiac condition.\",\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Name]  \\n**Age:** 37  \\n**Gender:** Male  \\n**Admission Type:** Direct Emergency  \\n**Length of Stay:** 4.4 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation and management of a benign neoplasm of the peripheral nerves and autonomic nervous system, which was initially discovered during workup for recurrent episodes of tachycardia. He presented to the emergency department with complaints of intermittent palpitations and mild shortness of breath.  \\n  \\n**Hospital Course:**  \\nDuring his hospital stay, the patient underwent imaging studies which confirmed the presence of the neoplasm. He was managed conservatively with a multidisciplinary approach involving pain management and monitoring of his cardiac symptoms. The patient received dexamethasone to reduce any inflammatory response associated with the neoplasm. He was also treated for mild intermittent asthma, with medications adjusted accordingly.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient's vital signs remained stable throughout hospitalization, with no significant changes in his cardiac rhythm noted after initiation of treatment. He underwent procedures including imaging and received supportive care with analgesics such as morphine sulfate and oxycodone for pain management. Other supportive medications included bisacodyl and docusate sodium for constipation management, and ondansetron for nausea.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved symptoms related to tachycardia and pain management. He is able to perform activities of daily living with some assistance and will benefit from home health services for ongoing monitoring of his cardiac symptoms and assistance with mobility.  \\n  \\n**Medications at Discharge:**  \\nUpon discharge, the patient will continue on the following medications: acetaminophen, dexamethasone, diazepam, famotidine, hydralazine, heparin, morphine sulfate, ondansetron, oxycodone (immediate release), senna, and sodium chloride 0.9%.  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with a neurologist within one week and a primary care physician within two weeks. Home health services will be coordinated to assist with his recovery and ensure adherence to the medication regimen.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient:** 26-year-old female  \\n**Admission Date:** [Insert Admission Date]  \\n**Discharge Date:** [Insert Discharge Date]  \\n \\n**History of Present Illness:**  \\nThe patient was admitted urgently due to complications associated with childbirth. She presented with anemia complicating her delivery, specifically noted as ICD-10 code O9902. The patient was in labor at 40 weeks of gestation and reported significant fatigue and weakness.  \\n \\n**Hospital Course:**  \\nDuring her 2.4-day stay, the patient was closely monitored. She underwent a vaginal delivery without significant complications, although there was a noted labor complication of a cord around the neck without compression. The patient required supportive care and received several medications to manage her condition, including oxytocin for labor facilitation and analgesics for pain management.  \\n \\n**Key Findings and Procedures:**  \\nLabor and delivery were successful, resulting in a single live birth. The patient was treated for anemia with intravenous fluids (Lactated Ringers) and supportive medications such as iron supplementation. Routine postpartum monitoring was performed to ensure stable hemoglobin levels and overall recovery.  \\n \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient demonstrated stable vital signs and was ambulating independently. She reported improved energy levels, although mild fatigue persisted. Home health services will be initiated to monitor her recovery, provide education on anemia management, and assist with infant care as needed.  \\n \\n**Medications and Follow-up Plan:**  \\nThe patient is to be discharged on a regimen that includes:  \\n- 0.9% Sodium Chloride  \\n- Acetaminophen  \\n- Ibuprofen  \\n- OxyCODONE (Immediate Release)  \\n- Lactated Ringers (for fluid management)  \\n- Docusate Sodium and Bisacodyl for bowel regimen  \\n- Ondansetron for nausea  \\nThe patient has been advised to follow up with her obstetrician within one week and to maintain contact with home health services for ongoing support and monitoring of her anemia and postpartum recovery.',\n",
       " '**Patient Information:** 35-year-old female admitted for observation due to a severe manic episode with psychotic symptoms (ICD-10: F302).  \\n\\n**History of Present Illness:** The patient was brought to the emergency department after experiencing heightened mood, irritability, and auditory hallucinations for the past week. A significant history of stimulant use and recent stressors were noted. \\n\\n**Hospital Course:** The patient was admitted for a total of 14 days, during which she received a comprehensive psychiatric evaluation and was placed on a treatment regimen including chlorpromazine, lithium carbonate, and lorazepam. Nutritional support was initiated due to concerns regarding malnutrition (ICD-10: E43). The patient demonstrated gradual improvement in mood and psychotic symptoms with stabilization of her mental status. Moreover, she was monitored for potential adverse effects of medications, particularly amphetamines and anabolic agents previously used, which contributed to her psychiatric presentation.  \\n\\n**Key Findings and Procedures:** Throughout her stay, vital signs remained stable. Laboratory work revealed mild electrolyte imbalances which were corrected. Nutritional interventions were successful; the patient’s BMI was evaluated at 19.9, indicating a need for ongoing dietary support. Psychotherapy sessions were also incorporated to aid in managing symptoms. \\n\\n**Discharge Condition and Functional Status:** At discharge, the patient demonstrated improved mood stabilization and reduced psychotic symptoms. She is alert, oriented, and able to perform activities of daily living with minimal assistance. It is essential for home health services to monitor her medication compliance and provide nutritional counseling to address her protein-calorie malnutrition. \\n\\n**Medications at Discharge:** The patient will continue on chlorpromazine, lithium carbonate, lorazepam, and multivitamins. She was also prescribed docusate sodium, magnesium citrate, and psyllium powder to manage constipation.  \\n\\n**Follow-Up Plan:** A follow-up appointment with a psychiatrist is scheduled within one week of discharge to reassess her mental health status and medication efficacy. Home health services will commence immediately to support her recovery and ensure adherence to dietary and medication regimens.',\n",
       " \"Patient is a 57-year-old male who was admitted for surgical intervention due to calculus of the kidney. He presented with flank pain and hematuria, prompting imaging studies that confirmed the presence of a renal stone. Admission was on a same-day surgical basis, and the patient underwent a ureteroscopy with laser lithotripsy to fragment and remove the stone.\\n\\nDuring the hospital stay of 5.5 days, the patient's condition was closely monitored. He experienced transient acute kidney failure with tubular necrosis, likely secondary to obstructive uropathy, which resolved with hydration and supportive care. The patient's comorbidities included nonalcoholic steatohepatitis (NASH), essential hypertension, and obstructive sleep apnea, which were managed with appropriate medications. Key findings included controlled blood pressure and hematuria that gradually improved post-operatively. \\n\\nThe patient was discharged in stable condition with functional status significantly improved. He is able to ambulate independently and perform activities of daily living; however, he will require home health assistance for continued monitoring of his renal function and management of his medication regimen. The patient was advised to maintain a low-sodium diet and to monitor fluid intake closely.\\n\\nDischarge medications include Acetaminophen for pain management, Carvedilol for hypertension, and Diltiazem Extended-Release for heart rate control due to atrial fibrillation. He will continue to take insulin for diabetes management and will also receive antiplatelet therapy as per his cardiology recommendations. A follow-up appointment is scheduled with urology in one week to reassess renal status and with primary care for ongoing management of his comorbid conditions. Home health services will initiate visits to assist with medication management and monitoring of vital signs.\",\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Date]  \\n**Date of Discharge:** [Date]  \\n**Patient ID:** [Patient ID]  \\n  \\n**History of Present Illness:**  \\nThe patient is an 86-year-old female who presented to the hospital with gastrointestinal hemorrhage, unspecified (ICD10: K922). She reported symptoms of weakness, dizziness, and melena over the past few days, which prompted her observation admission for further evaluation and management.  \\n  \\n**Hospital Course:**  \\nDuring her 3.7-day stay, the patient was stabilized and closely monitored. Initial laboratory tests confirmed anemia with a hemoglobin level of 8.2 g/dL, and she received two units of packed red blood cells for correction. Comprehensive imaging and endoscopic evaluations were performed, revealing no active bleeding. However, she was diagnosed with chronic conditions including hypertensive heart disease and stage 4 chronic kidney disease (ICD10: I130, N184).  \\n  \\n**Key Findings and Procedures:**  \\nThe patient underwent a colonoscopy and upper endoscopy, which showed benign neoplasms in the ascending and transverse colon, respectively. Medical management included intravenous fluids (0.9% Sodium Chloride), pantoprazole for gastric protection, and supportive care for her chronic heart failure and kidney disease.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable but requires ongoing management for her multiple chronic conditions. She is alert, oriented, and able to perform activities of daily living with assistance. She will benefit from home health services for medication management, monitoring of her vital signs, and assistance with mobility and daily activities.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient will be discharged on the following medications: Atorvastatin, Diltiazem ER, Metoprolol Succinate XL, Isosorbide Mononitrate, Hydrochlorothiazide, Ferric Gluconate, and Pantoprazole. She is advised to follow up with her primary care physician within one week and will have home health services initiated to ensure adherence to her management plan and prevent readmission.',\n",
       " '**Discharge Summary**  \\n**Patient:** Male, 80 years old  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 5.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted with acute respiratory distress secondary to pneumonia, complicated by sepsis. He presented with fever, cough, and increased work of breathing. Initial workup revealed other comorbidities including mantle cell lymphoma and hypothyroidism, which contributed to his overall frailty and response to infection.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient required intravenous antibiotics, including Cefpodoxime and Azithromycin, to manage his pneumonia and sepsis. He was also started on supportive care, including oxygen therapy and fluid resuscitation. The patient received multiple consultations, including oncology for his lymphoma management and pulmonology for his respiratory status. His condition stabilized, and he was transitioned from intravenous to oral medications.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings included persistent pleural effusion noted on chest imaging, which was managed conservatively. The patient underwent physical therapy to improve mobility and strength, showing gradual improvement in functional status. His discharge medications include Levothyroxine, Acetaminophen, and OxyCODONE for pain management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt the time of discharge, the patient was stable with improved respiratory status. He is able to mobilize with assistance and requires ongoing home health services for physical therapy and nursing care, particularly for medication management and monitoring of his lymphoma. The patient will benefit from occupational therapy to assist with daily activities.  \\n  \\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on the following medications: Acetaminophen, Acyclovir, Artificial Tears, Azithromycin, Cefpodoxime Proxetil, Colchicine, Enoxaparin Sodium, Finasteride, Heparin Flush, Levothyroxine Sodium, Magnesium Sulfate, and OxyCODONE. Follow-up appointments are scheduled with his primary care physician and oncology within one week. Home health services have been arranged to start upon discharge.',\n",
       " \"**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 61 years  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to worsening symptoms of chronic venous insufficiency (ICD10: I872). He presented with swelling in the lower extremities, intermittent claudication, and discomfort, exacerbated over the past week. Additionally, he has a complex medical history including chronic heart failure, iron deficiency anemia, and chronic obstructive pulmonary disease.\\n\\n**Hospital Course:**  \\nDuring the 4-day hospital stay, the patient underwent a comprehensive evaluation. Key diagnostic tests included Doppler ultrasound, which confirmed the presence of acute embolism in the left peroneal vein and chronic thrombosis in the left popliteal vein (ICD10: I82452, I82532). The patient's heart failure was managed with diuretics (Furosemide), and his pulmonary status was monitored closely. He was started on Apixaban for anticoagulation. Other medications were adjusted to optimize his overall condition.\\n\\n**Key Findings and Procedures:**  \\n- **Doppler ultrasound** confirmed venous thrombosis.  \\n- **Cardiac evaluation** showed stable chronic diastolic heart failure (ICD10: I5032).  \\n- **Pulmonary function tests** indicated limitations consistent with COPD (ICD10: J449).\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable but requires ongoing management for venous insufficiency and heart failure. He demonstrates moderate edema in the lower extremities and difficulty with ambulation, necessitating home health services for assistance with mobility and medication management. Education on compression therapy and daily monitoring of symptoms was provided.\\n\\n**Medications at Discharge:**  \\n- Acetaminophen  \\n- Apixaban  \\n- Furosemide  \\n- Metoprolol Succinate XL  \\n- Gabapentin  \\n- Nitroglycerin SL  \\n  \\n**Follow-up Plan:**  \\nThe patient is scheduled for follow-up with his primary care physician within one week and will have home health services initiated to assist with daily activities, medication administration, and monitoring of his condition. He was educated on signs of worsening symptoms, including increased edema, shortness of breath, or chest pain.\",\n",
       " '**Discharge Summary**  \\n**Patient:** 27-year-old female  \\n**Admission Type:** Observation Admit  \\n**Length of Stay:** 4.2 days  \\n  \\n**History of Present Illness:** The patient was admitted with a displaced fracture of the neck of the left talus, which was identified during an evaluation for persistent left ankle pain after a fall. This fracture was noted to have nonunion at the subsequent encounter. In addition, the patient presented with a urinary tract infection and symptoms of depression and anxiety.  \\n  \\n**Hospital Course:** During her stay, the patient was managed with appropriate analgesia including hydromorphone and ketorolac for pain control, and was started on a regimen of bisacodyl and senna to prevent constipation due to opioid use. The urinary tract infection was treated with appropriate antibiotics after culture results. The patient underwent imaging studies that confirmed the diagnosis of nonunion, prompting discussions regarding orthopedic intervention.  \\n  \\n**Key Findings and Procedures:** The patient was treated with supportive care for her urinary tract infection and was educated on the importance of hydration. Additionally, she was assessed by psychiatry for her depression and anxiety, and started on venlafaxine XR and buspirone. The patient received her influenza vaccine during the hospital stay and was also given a heparin flush to prevent thromboembolic events.  \\n  \\n**Discharge Condition and Functional Status:** Upon discharge, the patient was hemodynamically stable, with improved pain control, and was able to ambulate with assistance. She will require home health services for further evaluation of her orthopedic needs and physical therapy for mobility assistance. Additionally, her psychiatric medications will be monitored during home care to manage her mood symptoms effectively.  \\n  \\n**Medications at Discharge:** The patient is to continue the following medications: acetaminophen, bisacodyl, buspirone, famotidine, hydromorphone, heparin, influenza vaccine, ketorolac, lamotrigine, ondansetron, senna, and venlafaxine XR.  \\n  \\n**Follow-Up Plan:** The patient is advised to follow up with her orthopedic surgeon within one week post-discharge and to maintain regular appointments with her primary care provider and psychiatry for ongoing management of her mental health.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Age:** 67  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old female who was admitted for surgical intervention due to an upper respiratory tract condition (ICD10: J398). She has a history of hypothyroidism and unspecified atrial fibrillation, among other comorbidities. Her admission was on a same-day surgical basis, necessitated by the need for further evaluation and management of her respiratory symptoms.\\n\\n**Hospital Course:**  \\nThe patient underwent a surgical procedure (ICD10: 0B718ZZ) which resulted in a postprocedural pneumothorax (ICD10: J95811). She was monitored closely in the hospital for 1.7 days, during which she received supportive care, including pain management with hydromorphone and oxycodone.  \\n\\nKey findings during her hospitalization included stable vital signs post-surgery, though an abnormal reaction occurred, likely related to the procedure (ICD10: Y838). After stabilization, the patient was cleared for discharge.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, alert, and oriented. She demonstrated adequate respiratory function with no signs of distress, although she will require ongoing monitoring due to her recent pneumothorax and atrial fibrillation. Home health services are recommended for medication management and respiratory therapy to ensure continued recovery and monitoring of her respiratory status. Assistance with activities of daily living may also be necessary due to her surgical recovery.\\n\\n**Medications at Discharge:**  \\nThe patient was discharged on the following medications: Acetaminophen, Acetaminophen IV, Albuterol 0.083% Nebulizer Solution, Dexamethasone, Docusate Sodium, Hydromorphone (Dilaudid), Heparin, Influenza Vaccine Quadrivalent, Lactated Ringer’s, Levothyroxine Sodium, Metoprolol Succinate XL, Oxycodone (Immediate Release), Senna, and Sodium Chloride 0.9% Flush.  \\n\\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week. Home health services will be initiated to assist with medication administration and respiratory therapy, ensuring optimal recovery in the home setting.',\n",
       " \"**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**MRN:** [MRN]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n**Admitting Physician:** [Physician Name]  \\n\\n**History of Present Illness:**  \\nThe patient is a 58-year-old male who presented to the emergency department with acute onset of severe sore throat, fever, and difficulty swallowing, consistent with acute epiglottitis without obstruction (ICD10: J0510). The patient has a past medical history notable for type 2 diabetes mellitus with chronic kidney disease (E1122, N189) and hypertension (I129).\\n\\n**Hospital Course:**  \\nUpon admission, the patient was administered intravenous fluids and antibiotics including Amoxicillin-Clavulanic Acid and Ceftriaxone. He was also given IV dexamethasone to reduce inflammation. The patient's respiratory status was closely monitored. There was no evidence of airway obstruction during his hospital stay, and he remained stable with supportive care. He was evaluated by ENT specialists who confirmed that surgical intervention was not necessary at this time.\\n\\n**Key Findings and Procedures:**  \\nLaboratory tests revealed elevated blood glucose levels, likely due to stress hyperglycemia. The patient’s kidney function was stable, but he was monitored closely due to his chronic kidney disease. The patient underwent imaging studies to assess for complications, which were negative. He received supportive care throughout his stay and was maintained on a diabetic diet.\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is being discharged in stable condition, with improved throat discomfort and no respiratory distress. He is capable of ambulating independently and performing activities of daily living with minimal assistance. Home health services will be initiated to assist with medication management and monitoring of his diabetic and hypertensive status.\\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient will continue the following medications: Acetaminophen IV (as needed), Diltiazem, Hydrochlorothiazide, and insulin regimen as prescribed. He will follow-up with his primary care physician within one week and with a nephrologist for chronic kidney management. Home health services will also coordinate follow-up care and monitor his diabetes and kidney function.\",\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\nAge: 56, Gender: Female  \\n**Admission Type:** Surgical same day admission  \\n**Length of Stay:** 6.5 days  \\n**Primary Diagnosis:** Congenital spondylolisthesis (ICD10: Q762)  \\n  \\n**History of Present Illness:**  \\nThe patient presented with symptomatic congenital spondylolisthesis, experiencing significant lower back pain and radiculopathy. After a comprehensive evaluation, surgical intervention was deemed necessary to alleviate her symptoms and prevent further neurological complications.  \\n  \\n**Hospital Course:**  \\nThe patient underwent a successful surgical procedure involving spinal stabilization with instrumentation. Postoperatively, she was monitored for potential complications such as infection, bleeding, and thrombosis, given her elevated body mass index (BMI of 50.0-59.9). She received appropriate analgesia, anticoagulation therapy with Enoxaparin, and prophylactic measures against deep vein thrombosis.  \\n  \\n**Key Findings and Procedures:**  \\nDuring her hospital stay, the patient was treated for a single subsegmental pulmonary embolism (ICD10: I2693), which was managed with anticoagulation. She also received treatment for spinal stenosis and lumbar radiculopathy. Her recovery was satisfactory with gradual improvement in mobility and pain management.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient was stable with improved functional mobility. She was able to ambulate with a walker and demonstrated adequate understanding of her post-discharge care plan, including the importance of mobility and adherence to prescribed medications. Home health services will assist with physical therapy to further enhance her mobility and monitor her recovery.  \\n  \\n**Medications at Discharge:**  \\nThe patient will continue on the following medications:  \\n- DULoxetine DR  \\n- Gabapentin  \\n- HYDROmorphone (Dilaudid) as needed  \\n- Lansoprazole  \\n- Ondansetron  \\n- Enoxaparin (treatment)  \\n- Acetaminophen for pain management  \\n  \\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with orthopedics in 2 weeks. Home health nursing will evaluate her condition, assist with medication management, and coordinate her rehabilitation needs.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Age:** 23  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 2.9 days  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted via emergency services with sepsis of unspecified organism, presenting with fever, tachycardia, and confusion. Initial labs indicated elevated white blood cell count and inflammatory markers.  \\n  \\n**Hospital Course:**  \\nDuring his hospitalization, the patient was managed with broad-spectrum intravenous antibiotics (Cefazolin, Cephalexin) and supportive care. His clinical condition improved with aggressive fluid resuscitation and antibiotic therapy. Serial blood cultures and imaging studies were performed, ruling out any focal sources of infection. Notably, the patient also exhibited pressure ulcers, notably a stage 2 ulcer at the sacral region and unstageable ulcers on the left and right ankle, which were monitored and treated.  \\n  \\n**Key Findings and Procedures:**  \\nThe patient’s vital signs stabilized by the second day, and he was transitioned to oral medications including Apixaban and Atorvastatin for anticoagulation and hyperlipidemia management, respectively. He received wound care education and is now able to manage his skin integrity with guidance.  \\n  \\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable, afebrile, and alert, with a GCS of 15. He demonstrates the ability to participate in self-care activities but requires assistance with mobility due to paraplegia. Home health services are recommended for continued wound care, medication management, and physical therapy to enhance mobility and prevent further complications.  \\n  \\n**Medications at Discharge:**  \\n1. Acetaminophen as needed for pain  \\n2. Apixaban  \\n3. Atorvastatin  \\n4. Cefazolin (for home health administration)  \\n5. Lidocaine 5% patch for localized pain  \\n6. Sodium Chloride 0.9% flush  \\n7. Nicotine Polacrilex (if applicable)  \\n  \\n**Follow-up Plan:**  \\nThe patient is to follow up with his primary care physician within one week of discharge, and a home health nurse will visit to assess wound care and medication compliance. Routine blood work is also recommended to monitor his condition.',\n",
       " 'Patient is a 66-year-old female who presented to the emergency department with complaints of palpitations and shortness of breath. She has a significant past medical history including paroxysmal atrial fibrillation, acute on chronic diastolic heart failure, type 2 diabetes, and severe obesity. Upon admission, she was started on rate control with Atenolol and anticoagulation therapy due to her atrial fibrillation. \\n\\nDuring her 3.7-day hospital stay, she was closely monitored for cardiac rhythm, and her diuretics were adjusted to manage fluid overload from her heart failure. She received nebulizer treatments for potential obstructive sleep apnea exacerbation and her blood glucose levels were stabilized with a combination of insulin and oral hypoglycemics. A multidisciplinary team was involved in her care, including cardiology and endocrinology. \\n\\nKey findings included persistent atrial fibrillation on telemetry, elevated blood pressure, and significant improvement in her dyspnea with diuretic therapy. A transthoracic echocardiogram revealed mildly reduced left ventricular function, and her renal function remained stable throughout her hospitalization. \\n\\nUpon discharge, the patient is stable with improved functional status, able to ambulate independently with a walker and report minimal dyspnea at rest. She will benefit from home health services for ongoing monitoring of her heart failure management and medication administration, particularly for her anticoagulation therapy and glucose management. \\n\\nDischarge medications include Atenolol, Losartan, Flecainide, and insulin, along with symptomatic treatment for anxiety and sleep apnea. A follow-up appointment is scheduled with her primary care physician in one week, and she is advised to seek immediate care if experiencing any worsening symptoms such as increased shortness of breath or chest pain.',\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 66  \\n- **Gender:** Male  \\n\\n**History of Present Illness:**  \\nThe patient was admitted for observation due to complaints of chest pain (ICD10 R0789). The pain was described as intermittent and non-radiating, associated with mild shortness of breath. The patient has a significant history of atherosclerotic heart disease, chronic total occlusion of the coronary artery, and essential hypertension, which necessitated further evaluation.\\n\\n**Hospital Course:**  \\nDuring the 1.8-day stay, the patient underwent a comprehensive cardiac assessment, including EKG, cardiac enzymes, and echocardiography, which ruled out acute coronary syndrome. The patient's vital signs were stable, and he was monitored closely in the observation unit. Management included administration of aspirin, heparin, and beta-blockers, among other supportive measures. The patient's symptoms improved significantly with treatment.\\n\\n**Key Findings and Procedures:**  \\n- EKG showed no acute changes.  \\n- Cardiac enzymes were within normal limits.  \\n- Echocardiogram indicated preserved left ventricular function.  \\n- The patient also received education regarding lifestyle modifications and adherence to medication, including statins for hypercholesterolemia (ICD10 E7800).\\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulating independently with no signs of acute distress. He demonstrates an understanding of his medication regimen and the importance of follow-up care. Given his history and current condition, home health services are recommended for medication management, continued monitoring of vital signs, and assistance with daily activities as needed.\\n\\n**Medications at Discharge:**  \\n1. Aspirin  \\n2. Carvedilol  \\n3. Losartan Potassium  \\n4. Metoprolol Succinate XL  \\n5. Omeprazole  \\n6. Rosuvastatin Calcium  \\n7. Nitroglycerin SL  \\n8. Acetaminophen  \\n9. Dextrose 5%, Sodium Chloride 0.9%  \\n10. Multivitamins  \\n11. Heparin Sodium, Lorazepam  \\n   \\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician and cardiologist within one week. Home health services will assist in medication management and monitoring of his condition.\",\n",
       " '**Patient Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 71  \\n- **Gender:** Female  \\n  \\n**History of Present Illness:**  \\nThe patient was admitted for evaluation of chest pain, described as non-specific and persistent over several days. She has a history of hypertension, chronic kidney disease, and type 2 diabetes, complicating her clinical picture. Initial workup included cardiac biomarkers which indicated a non-ST elevation myocardial infarction (NSTEMI).  \\n  \\n**Hospital Course:**  \\nDuring her 2.8-day stay in observation, the patient was closely monitored. Her cardiac enzymes were elevated but stabilized with medical management. The patient received aspirin, clopidogrel, atorvastatin, and heparin alongside symptomatic treatment for chest pain. Fluid status was monitored, and she was treated for hypertension and diabetes management. She showed gradual improvement and was able to participate in light physical therapy.  \\n  \\n**Key Findings and Procedures:**  \\n- **ICD-10 Codes:** R0789 (Other chest pain), I214 (NSTEMI), I130, I5022, E1122, N183, F209, M4316, M48061  \\n- Comprehensive metabolic panel showed stable renal function (Stage 3 CKD).  \\n- An echocardiogram indicated moderate left ventricular hypertrophy consistent with chronic hypertensive heart disease.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge with improvement in chest pain. She is able to perform activities of daily living with minimal assistance. Home health services will be initiated to assist with medication management, monitoring her blood pressure and glucose levels, and ensuring adherence to her heart failure and diabetes management plan.  \\n  \\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Aspirin  \\n- Clopidogrel  \\n- Atorvastatin  \\n- ARIPiprazole  \\n- Calcium Carbonate  \\n- Colchicine  \\n- Dextrose 50% (as needed)  \\n  \\n**Follow-Up Plan:**  \\nThe patient is advised to follow up with her primary care physician within one week of discharge and to contact the home health agency to schedule an initial visit. Cardiology follow-up is also recommended within two weeks for ongoing management of her cardiac condition.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n- **Age:** 60  \\n- **Gender:** Male  \\n- **Admission Type:** Emergency  \\n- **Length of Stay:** 1.6 days  \\n\\n**History of Present Illness:**  \\nThe patient, a 60-year-old male, presented to the emergency department with symptoms consistent with a cerebral infarction, including dizziness and bradycardia. Initial evaluation revealed a diagnosis of other cerebral infarction (ICD10: I6389) and dissection of the vertebral artery (ICD10: I7774). The patient was noted to have contact with a suspected COVID-19 case, prompting additional monitoring.  \\n\\n**Hospital Course:**  \\nDuring his brief hospital stay, the patient underwent neuroimaging which confirmed the cerebral infarction. He was managed with intravenous fluids, anticoagulation with Heparin Sodium, and symptomatic treatment for dizziness and nausea with Ondansetron. His bradycardia was monitored, and he was treated with Hydralazine as needed. The patient tolerated the treatment well, with gradual improvement in symptoms.  \\n\\n**Key Findings and Procedures:**  \\n- Neuroimaging confirmed cerebral infarction.  \\n- Cardiac monitoring revealed transient bradycardia.  \\n- Symptoms of dizziness improved with treatment.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, with a resolution of acute symptoms. He is functionally independent but requires assistance with mobility and medication management at home. Home health services will be initiated to provide follow-up care, monitor his recovery, and assist with activities of daily living as needed.  \\n\\n**Medications at Discharge:**  \\n- 5% Dextrose  \\n- Acetaminophen  \\n- Amoxicillin  \\n- Aspirin  \\n- Atorvastatin  \\n- Heparin Sodium  \\n- Hydralazine  \\n- Influenza Vaccine Quadrivalent  \\n- Nicotine Patch  \\n- Ondansetron ODT  \\n- Ramelteon  \\n- Sodium Chloride 0.9% Flush  \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with his primary care physician within one week, and home health services will monitor his recovery and adjust care as necessary. A follow-up appointment with a neurologist is also recommended to evaluate his long-term management and rehabilitation needs.',\n",
       " \"**Patient Name:** [Patient's Name]  \\n**MRN:** [Medical Record Number]  \\n**Date of Admission:** [Admission Date]  \\n**Date of Discharge:** [Discharge Date]  \\n\\n**History of Present Illness:**  \\nThe patient is a 67-year-old male who presented urgently with severe left leg pain and necrosis. He has a significant medical history of type 2 diabetes mellitus, chronic kidney disease, and atherosclerosis, which contributed to the development of gangrene in the left leg.  \\n\\n**Hospital Course:**  \\nDuring the 10.6-day stay, the patient was monitored and treated with intravenous antibiotics for Clostridium difficile enterocolitis and managed for diabetic complications, including nephropathy and peripheral angiopathy. He underwent a left leg amputation due to extensive gangrene. Post-operatively, the patient received multidisciplinary care, including physical therapy to enhance mobility and pain management with medications such as hydromorphone and gabapentin.  \\n\\n**Key Findings and Procedures:**  \\nThe patient's significant findings included stage 5 chronic kidney disease and persistent hyperglycemia. The amputation procedure (ICD-10: 0Y6G0ZZ) was performed successfully without immediate complications. He was stabilized with appropriate medications including insulin, bumetanide, and clotting agents.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but has functional limitations due to the recent amputation. He requires assistance with activities of daily living (ADLs) and mobility. Home health services will be essential for ongoing wound care, physical rehabilitation, and monitoring of blood glucose levels. The patient will also benefit from nutritional counseling due to his diabetes and renal condition.  \\n\\n**Medications at Discharge:**  \\nThe patient is discharged on acetaminophen, aspirin, clopidogrel, insulin, calcitriol, calcium acetate, and other supportive medications.  \\n\\n**Follow-Up Plan:**  \\nA follow-up appointment is scheduled with the vascular surgeon and endocrinologist within one week post-discharge to monitor recovery and adjust medications as necessary. Home health services will commence immediately to facilitate care.\",\n",
       " \"**Patient Name:** [Patient's Name]  \\n**Age:** 71  \\n**Gender:** Male  \\n**Admission Type:** Emergency  \\n**Length of Stay:** 20.7 days  \\n\\n**History of Present Illness:**  \\nThe patient presented to the hospital with acute exacerbation of hypertensive chronic kidney disease and was diagnosed with stage 5 chronic kidney disease (CKD) or end-stage renal disease (ESRD). He exhibited symptoms consistent with fluid overload and altered mental status, indicative of toxic encephalopathy.  \\n\\n**Hospital Course:**  \\nDuring his 21-day hospitalization, the patient was stabilized through aggressive fluid management and renal replacement therapy. He received supportive care for his acute kidney failure and was monitored for complications, including pressure ulcers and electrolyte imbalances. He required multiple transfusions of Epoetin Alfa and Ferric Gluconate to manage his anemia.  \\n\\n**Key Findings and Procedures:**  \\nKey findings included persistent hyperkalemia and a significant decline in renal function, necessitating dialysis. The patient underwent hemodialysis thrice weekly while in the hospital. He also developed a stage 3 pressure ulcer in the sacral region, which is being treated with appropriate wound care. The patient's medications upon discharge include Acetaminophen, Aspirin, Atorvastatin, Carvedilol, and Omeprazole, among others.  \\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient is stable but remains dependent on dialysis, requiring ongoing home health services for wound care and medication management. His functional status has improved marginally, but assistance with activities of daily living (ADLs) is still necessary due to weakness and fatigue. Home health nursing will be essential to monitor his renal function and manage his medications effectively.  \\n\\n**Medications and Follow-Up Plan:**  \\nThe patient is discharged on a regimen including Acetaminophen for pain management, Aspirin for cardiovascular protection, and Atorvastatin for hyperlipidemia. Follow-up appointments with nephrology and a home health nurse are scheduled within the next week to assess ongoing management and to ensure adherence to the treatment plan. The patient has been educated on signs and symptoms of potential complications requiring immediate medical attention.\",\n",
       " \"**Discharge Summary**  \\n**Patient Information:**  \\n- **Name:** [Patient Name]  \\n- **Age:** 33  \\n- **Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient presented to the emergency department with acute onset of dyspnea and chest pain. Initial workup revealed a diagnosis of pulmonary embolism (ICD-10: I26.99). The patient has a history of oral contraceptive use, which may have contributed to the thromboembolic event.\\n\\n**Hospital Course:**  \\nThe patient was admitted for further evaluation and management. Anticoagulation therapy was initiated with Heparin, transitioned to Rivaroxaban. Throughout her stay, the patient was monitored closely for any signs of complications.  \\n\\n**Key Findings and Procedures:**  \\nOn imaging, the patient exhibited localized enlarged lymph nodes (ICD-10: R59.0). Laboratory tests confirmed the diagnosis of pulmonary embolism without acute cor pulmonale. The patient's symptoms improved with treatment, and she underwent routine monitoring for any adverse effects from medications, particularly the Heparin and Rivaroxaban therapies. The influenza vaccine was administered as a preventative measure.\\n\\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was stable, with improved respiratory function and decreased chest pain. She ambulated independently and demonstrated an understanding of her medication regimen. Home health services will be essential for medication management and follow-up assessments of her anticoagulation therapy. A physical therapist will also assess her functional status at home to ensure a safe recovery.\\n\\n**Medications at Discharge:**  \\n- Rivaroxaban  \\n- Heparin Sodium  \\n- 5% Dextrose  \\n- Sodium Chloride 0.9% Flush  \\n- Influenza Vaccine Quadrivalent  \\n\\n**Follow-Up Plan:**  \\nThe patient is instructed to follow up with her primary care physician within one week of discharge for evaluation of anticoagulation therapy and symptom management. Additionally, she will have regular monitoring through home health services to ensure adherence to her medication regimen and to assess any ongoing symptoms related to her pulmonary condition.\",\n",
       " '**Patient Name:** [Name]  \\n**Age:** 38  \\n**Gender:** Female  \\n**Admission Type:** Urgent  \\n**Length of Stay:** 3.3 days  \\n\\n**History of Present Illness:**  \\nThe patient is a 38-year-old female with a history of low transverse scar from a previous cesarean delivery, presenting for delivery at 39 weeks gestation. She has a past medical history of polycystic ovarian syndrome and underwent bariatric surgery, which complicated her pregnancy. The admission was necessitated by contractions and signs of impending labor.  \\n\\n**Hospital Course:**  \\nDuring her stay, the patient received appropriate maternal care and monitoring. A cesarean delivery was performed using the ICD-10 code 10D00Z1 due to concerns regarding fetal distress. The procedure was uncomplicated, and the patient delivered a single live birth. Postoperatively, she was monitored in the recovery unit for stability and pain management.  \\n\\n**Key Findings and Procedures:**  \\nPost-delivery assessments revealed good maternal and neonatal outcomes. The patient was started on a pain management regimen including Oxycodone and Ibuprofen. Other medications included Enoxaparin for thromboprophylaxis and Ondansetron for nausea. The patient also received lactulose and Docusate Sodium for bowel management due to postoperative ileus risk.  \\n\\n**Discharge Condition and Functional Status:**  \\nThe patient is stable at discharge, ambulating independently, and demonstrates an understanding of her post-operative care regime. She has been counseled on signs of infection and when to seek immediate medical attention. Home health services are recommended to assist with wound care management and to monitor her recovery process.  \\n\\n**Medications and Follow-Up Plan:**  \\nAt discharge, the patient was prescribed 0.9% Sodium Chloride for hydration, Acetaminophen for pain relief, and other medications as mentioned above. She is advised to follow up with her obstetrician within one week for a post-operative evaluation and to establish a plan for ongoing support through home health services.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date:** [Date]  \\n**MRN:** [MRN]  \\n**Age/Gender:** 66/M  \\n**Admission Type:** Elective  \\n  \\n**History of Present Illness:**  \\nThe patient is a 66-year-old male who was admitted electively for the management of a leakage of aortic bifurcation graft (ICD10: T82330A). He has a significant past medical history, including abdominal aortic aneurysm without rupture, hyperlipidemia, and a personal history of nicotine dependence. The patient presented with symptoms of abdominal discomfort and was found to have an ileus during his pre-operative evaluation.  \\n  \\n**Hospital Course:**  \\nThe patient underwent an exploratory laparotomy and repair of the aortic graft leak on the day following admission. Postoperatively, he was monitored in the surgical unit, where he developed a transient ileus that resolved with conservative management, including bowel rest and the administration of bisacodyl. His pain was well-managed with hydromorphone and acetaminophen. The patient was also started on clopidogrel and aspirin EC for cardiovascular prophylaxis.  \\n  \\n**Key Findings and Procedures:**  \\nDuring his hospital stay, the patient underwent imaging studies confirming the integrity of the repaired graft. He was closely monitored for any signs of infection or complications, and none were noted. His urine output was adequate, and he had no residual urinary retention upon discharge.  \\n  \\n**Discharge Condition and Functional Status:**  \\nThe patient is stable for discharge, ambulating independently with a walker. He has demonstrated an ability to perform activities of daily living (ADLs) with minimal assistance. Home health services will be necessary to assist with medication management and physical therapy to ensure safe mobility at home.  \\n  \\n**Medications and Follow-Up Plan:**  \\nOn discharge, the patient will continue on the following medications: 0.9% Sodium Chloride, Acetaminophen, Aspirin EC, Clopidogrel, Ezetimibe, and Docusate Sodium. He is advised to follow up with his primary care physician in one week and the vascular surgeon in two weeks post-discharge. Home health services will be initiated to assist with ongoing care and rehabilitation.',\n",
       " '**Patient Information:** 74-year-old male with a history of hypertensive heart disease, chronic kidney disease, and type 2 diabetes.\\n\\n**History of Present Illness:** The patient was admitted for observation due to acute on chronic diastolic heart failure, exacerbated by chronic kidney disease and poorly controlled diabetes. He presented with dyspnea on exertion and peripheral edema. Initial workup included ECG, chest X-ray, and laboratory tests confirming elevated BNP and renal function decline.\\n\\n**Hospital Course:** During the 3-day stay, the patient was managed with diuretics, antihypertensives, and insulin for glycemic control. He showed gradual improvement in symptoms with a reduction in edema and stabilized blood pressure. Renal function was monitored closely, revealing no acute changes, and his heart failure symptoms improved significantly by discharge. The patient was also educated on dietary modifications, fluid restrictions, and the importance of adherence to his medication regimen.\\n\\n**Key Findings and Procedures:** Key findings included elevated blood pressure (180/95 mmHg) at admission, BNP levels of 600 pg/ml, and renal function with creatinine at 1.5 mg/dL. No procedures were performed; management was primarily pharmacologic and supportive.\\n\\n**Discharge Condition and Functional Status:** The patient is stable at discharge, with improved dyspnea and manageable edema. He is ambulating independently but requires assistance with daily activities due to fatigue. Home health services will be initiated for medication management, monitoring of vital signs, and assistance with activities of daily living (ADLs).\\n\\n**Medications and Follow-Up Plan:** Upon discharge, the patient is prescribed Acetaminophen, Allopurinol, Aspirin, Atorvastatin, Carvedilol, Colchicine, and insulin, among others. A follow-up appointment is scheduled in one week with his primary care physician to reassess his heart failure management and renal function. Home health nursing will follow up within 48 hours post-discharge for continuity of care.',\n",
       " '**Discharge Summary**  \\n**Patient Name:** [Patient Name]  \\n**Date of Discharge:** [Discharge Date]  \\n**Date of Admission:** [Admission Date]  \\n**Age:** 84 years  \\n**Gender:** Female  \\n\\n**History of Present Illness:**  \\nThe patient is an 84-year-old female who was admitted for observation due to worsening abdominal discomfort and jaundice. She has a known history of Nonalcoholic Steatohepatitis (NASH), hypertension, and moderate protein-calorie malnutrition. During the admission, her condition was exacerbated by liver cell carcinoma, contributing to her symptoms.\\n\\n**Hospital Course:**  \\nThe patient was monitored closely during her 6-day stay in the hospital. Key interventions included dietary management, fluid management, and pharmacological therapy for symptom relief. She received supportive care with intravenous fluids and nutritional supplementation due to her malnutrition. The patient was also treated with diuretics to manage fluid retention and underwent regular assessments of her liver function tests.\\n\\n**Key Findings and Procedures:**  \\nKey findings included elevated liver enzymes and imaging that confirmed liver cell carcinoma. The patient was evaluated by the oncology team and is scheduled for outpatient follow-up to discuss further management options.\\n\\n**Discharge Condition and Functional Status:**  \\nAt discharge, the patient is stable but requires ongoing home health services for monitoring and support. She has been provided a home health nursing referral to assist with medication management, nutritional support, and regular assessments of her functional status. The patient is currently ambulating with assistance and requires help with activities of daily living due to her weakness and malnutrition.\\n\\n**Medications at Discharge:**  \\nThe patient will be discharged on the following medications: Acetaminophen, Albuterol inhaler, Citalopram, Diclofenac topical gel 1%, Docusate sodium, Fluticasone-Salmeterol Diskus (100/50), Furosemide, Heparin, Influenza vaccine high-dose quadrivalent, Magnesium oxide, Potassium chloride, Sodium chloride 0.9% flush, Spironolactone, and Vitamin D3 (Cholecalciferol). \\n\\n**Follow-Up Plan:**  \\nThe patient is to follow up with her primary care physician within one week and the oncology team for ongoing management of her liver condition. Home health services will commence within 48 hours to ensure continuity of care.',\n",
       " 'Patient is a 63-year-old male who was admitted for surgical intervention due to unilateral primary osteoarthritis of the left knee (ICD-10: M1712). The patient presented with significant pain and functional limitations affecting mobility and quality of life. Given the severity of his condition and associated symptoms, a total knee arthroplasty was performed as a same-day surgical admission.\\n\\nThe hospital course was uneventful, with the patient demonstrating stable vital signs and adequate pain control postoperatively. He received a multimodal analgesic regimen including acetaminophen and ketorolac, enabling effective pain management. The patient was also started on gabapentin for neuropathic pain, and prophylactic antibiotics (Cefazolin) were administered to prevent surgical site infection. Postoperative physical therapy initiated on Day 1 post-surgery focused on range of motion exercises and early ambulation, which the patient tolerated well.\\n\\nKey findings included successful surgical intervention with no immediate complications. The patient was able to ambulate with assistance and demonstrated improvement in his ability to perform activities of daily living (ADLs) by discharge. He has a history of obstructive sleep apnea, which was managed with appropriate monitoring, and the patient was advised to use his CPAP device as per usual routine.\\n\\nUpon discharge, the patient was stable and demonstrated adequate functional status for home health services. He will require continued physical therapy for rehabilitation and support with mobility and pain management at home. The discharge medications include Acetaminophen, Aspirin EC, Atorvastatin, Bisacodyl, DiphenhydrAMINE, Docusate Sodium, Fluticasone Propionate nasal spray, Gabapentin, and Ondansetron.\\n\\nThe follow-up plan includes a postoperative appointment in 2 weeks to assess recovery progress and adjust medications if necessary. Home health services are to be arranged to assist with physical therapy sessions and monitoring of the surgical site.',\n",
       " '**Discharge Summary**  \\n**Patient Information:**  \\n**Name:** [Patient Name]  \\n**Age:** 38  \\n**Gender:** Female  \\n**Admission Type:** Surgical Same Day Admission  \\n**Length of Stay:** 2.2 days  \\n  \\n**History of Present Illness:**  \\nThe patient presented with symptoms consistent with compression of the brain (ICD-10: G935) that prompted surgical intervention. She has a medical history notable for nicotine dependence (F17210), asthma (J45909), and gastroesophageal reflux disease (K219).  \\n  \\n**Hospital Course:**  \\nAfter a thorough preoperative assessment, the patient underwent a decompression procedure. Postoperatively, she was monitored for neurological status and pain management. Her recovery was uneventful, with gradual improvement in her symptoms. The patient received multimodal analgesia including Morphine Sulfate and Ketorolac, and was started on Dexamethasone to reduce cerebral edema. She was also provided with symptomatic treatment for her asthma and reflux.  \\n  \\n**Key Findings and Procedures:**  \\nKey findings during her hospital stay included stable vital signs, improvement in neurological status, and resolution of acute symptoms related to brain compression. Surgical procedures performed included decompression of the brain (ICD-10: 0NB00ZZ) and a subsequent observation period for complications (ICD-10: 00NW0ZZ).  \\n  \\n**Discharge Condition and Functional Status:**  \\nUpon discharge, the patient was alert and oriented, reporting mild residual headaches manageable with acetaminophen. She demonstrated independence in activities of daily living and ambulation. However, she will require home health services for continued monitoring of her neurological status and assistance with medication management, particularly for her pain and asthma management.  \\n  \\n**Medications and Follow-up Plan:**  \\nDischarged medications include Acetaminophen, Albuterol nebulizer solution, Dexamethasone, Diazepam, and Ondansetron. She is advised to follow up with her primary care physician within one week for a comprehensive evaluation and to reassess her medication regimen. A referral for home health services has been initiated to support her recovery.',\n",
       " ...]"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(data_sample['discharge_summary'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "a99f033e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing sample data with NER...\n",
      "This may take a few minutes...\n",
      "\n",
      "✓ Processed 1046 records\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "\"None of [Index(['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count'], dtype='object')] are in the [columns]\"",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[50], line 35\u001b[0m\n\u001b[1;32m     26\u001b[0m \u001b[38;5;66;03m# Extract NER features\u001b[39;00m\n\u001b[1;32m     27\u001b[0m \u001b[38;5;66;03m# data_sample['disease_entity_count'] = disease_ner_results.apply(lambda x: x['count'])\u001b[39;00m\n\u001b[1;32m     28\u001b[0m \u001b[38;5;66;03m# data_sample['drug_entity_count'] = drug_ner_results.apply(lambda x: x['count'])\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     31\u001b[0m \u001b[38;5;66;03m# data_sample['drug_entities'] = drug_ner_results.apply(lambda x: x['entities'])\u001b[39;00m\n\u001b[1;32m     32\u001b[0m \u001b[38;5;66;03m# data_sample['anatomy_entities'] = anatomy_ner_results.apply(lambda x: x['entities'])\u001b[39;00m\n\u001b[1;32m     34\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m✓ Processed \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mlen\u001b[39m(data_sample)\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m records\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m---> 35\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mTotal entities extracted: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[43mdata_sample\u001b[49m\u001b[43m[\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mdisease_entity_count\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m,\u001b[49m\u001b[38;5;250;43m \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mdrug_entity_count\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m,\u001b[49m\u001b[38;5;250;43m \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43manatomy_entity_count\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m]\u001b[49m\u001b[38;5;241m.\u001b[39msum()\u001b[38;5;132;01m:\u001b[39;00m\u001b[38;5;124m,\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     36\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAverage entities per record: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mdata_sample[[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mdisease_entity_count\u001b[39m\u001b[38;5;124m'\u001b[39m,\u001b[38;5;250m \u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mdrug_entity_count\u001b[39m\u001b[38;5;124m'\u001b[39m,\u001b[38;5;250m \u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124manatomy_entity_count\u001b[39m\u001b[38;5;124m'\u001b[39m]]\u001b[38;5;241m.\u001b[39mmean()\u001b[38;5;132;01m:\u001b[39;00m\u001b[38;5;124m.2f\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n",
      "File \u001b[0;32m~/development/icd-10-coding/.venv/lib/python3.10/site-packages/pandas/core/frame.py:4119\u001b[0m, in \u001b[0;36mDataFrame.__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   4117\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m is_iterator(key):\n\u001b[1;32m   4118\u001b[0m         key \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlist\u001b[39m(key)\n\u001b[0;32m-> 4119\u001b[0m     indexer \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcolumns\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_get_indexer_strict\u001b[49m\u001b[43m(\u001b[49m\u001b[43mkey\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mcolumns\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m)\u001b[49m[\u001b[38;5;241m1\u001b[39m]\n\u001b[1;32m   4121\u001b[0m \u001b[38;5;66;03m# take() does not accept boolean indexers\u001b[39;00m\n\u001b[1;32m   4122\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mgetattr\u001b[39m(indexer, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdtype\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m) \u001b[38;5;241m==\u001b[39m \u001b[38;5;28mbool\u001b[39m:\n",
      "File \u001b[0;32m~/development/icd-10-coding/.venv/lib/python3.10/site-packages/pandas/core/indexes/base.py:6212\u001b[0m, in \u001b[0;36mIndex._get_indexer_strict\u001b[0;34m(self, key, axis_name)\u001b[0m\n\u001b[1;32m   6209\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m   6210\u001b[0m     keyarr, indexer, new_indexer \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_reindex_non_unique(keyarr)\n\u001b[0;32m-> 6212\u001b[0m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_raise_if_missing\u001b[49m\u001b[43m(\u001b[49m\u001b[43mkeyarr\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mindexer\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43maxis_name\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   6214\u001b[0m keyarr \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mtake(indexer)\n\u001b[1;32m   6215\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(key, Index):\n\u001b[1;32m   6216\u001b[0m     \u001b[38;5;66;03m# GH 42790 - Preserve name from an Index\u001b[39;00m\n",
      "File \u001b[0;32m~/development/icd-10-coding/.venv/lib/python3.10/site-packages/pandas/core/indexes/base.py:6261\u001b[0m, in \u001b[0;36mIndex._raise_if_missing\u001b[0;34m(self, key, indexer, axis_name)\u001b[0m\n\u001b[1;32m   6259\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m nmissing:\n\u001b[1;32m   6260\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m nmissing \u001b[38;5;241m==\u001b[39m \u001b[38;5;28mlen\u001b[39m(indexer):\n\u001b[0;32m-> 6261\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mNone of [\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mkey\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m] are in the [\u001b[39m\u001b[38;5;132;01m{\u001b[39;00maxis_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m]\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m   6263\u001b[0m     not_found \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlist\u001b[39m(ensure_index(key)[missing_mask\u001b[38;5;241m.\u001b[39mnonzero()[\u001b[38;5;241m0\u001b[39m]]\u001b[38;5;241m.\u001b[39munique())\n\u001b[1;32m   6264\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mnot_found\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m not in index\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "\u001b[0;31mKeyError\u001b[0m: \"None of [Index(['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count'], dtype='object')] are in the [columns]\""
     ]
    }
   ],
   "source": [
    "# Process a sample of the data (first 1000 records) to demonstrate NER feature extraction\n",
    "print(\"Processing sample data with NER...\")\n",
    "print(\"This may take a few minutes...\")\n",
    "\n",
    "# sample_size = 1000\n",
    "data_sample =  data_with_summaries.copy()\n",
    "\n",
    "# # Combine relevant text fields into a single text for NER processing\n",
    "# data_sample['combined_text'] = (\n",
    "#     data_sample['comments'].fillna('') + ' ' + \n",
    "#     data_sample['drug'].fillna('') + ' ' +\n",
    "#     data_sample['test_name'].fillna('') + ' ' +\n",
    "#     data_sample['spec_type_desc'].fillna('')\n",
    "# ).str.strip()\n",
    "\n",
    "# Apply NER to combined text\n",
    "\n",
    "\n",
    "disease_ner_results = disease_ner(list(data_sample['discharge_summary'].values), batch_size = 8)\n",
    "\n",
    "drug_ner_results = drug_ner(list(data_sample['discharge_summary'].values), batch_size = 8)\n",
    "\n",
    "anatomy_ner_results = anatomy_ner(list(data_sample['discharge_summary'].values), batch_size = 8)\n",
    "\n",
    "\n",
    "# Extract NER features\n",
    "# data_sample['disease_entity_count'] = disease_ner_results.apply(lambda x: x['count'])\n",
    "# data_sample['drug_entity_count'] = drug_ner_results.apply(lambda x: x['count'])\n",
    "# data_sample['anatomy_entity_count'] = anatomy_ner_results.apply(lambda x: x['count'])\n",
    "# data_sample['disease_entities'] = disease_ner_results.apply(lambda x: x['entities'])\n",
    "# data_sample['drug_entities'] = drug_ner_results.apply(lambda x: x['entities'])\n",
    "# data_sample['anatomy_entities'] = anatomy_ner_results.apply(lambda x: x['entities'])\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "893728dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "processed_disease_ner_results = [filter_and_group_entities(doc, text) for doc, text in zip(disease_ner_results, list(data_sample['discharge_summary'].values))]\n",
    "processed_drug_ner_results = [filter_and_group_entities(doc, text) for doc, text in zip(drug_ner_results, list(data_sample['discharge_summary'].values))]\n",
    "processed_anatomy_ner_results = [filter_and_group_entities(doc, text) for doc, text in zip(anatomy_ner_results, list(data_sample['discharge_summary'].values))]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "53654e0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_sample['disease_entity_count'] = [len(x) for x in processed_disease_ner_results]\n",
    "data_sample['drug_entity_count'] = [len(x) for x in processed_drug_ner_results]\n",
    "data_sample['anatomy_entity_count'] = [len(x) for x in processed_anatomy_ner_results]\n",
    "data_sample['disease_entities'] = processed_disease_ner_results\n",
    "data_sample['drug_entities'] = processed_drug_ner_results\n",
    "data_sample['anatomy_entities'] = processed_anatomy_ner_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "ab07b0ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "✓ Processed 1046 records\n",
      "Total entities extracted: 32,172\n",
      "Average entities per record: 10.25\n"
     ]
    }
   ],
   "source": [
    "print(f\"\\n✓ Processed {len(data_sample)} records\")\n",
    "print(f\"Total entities extracted: {data_sample[['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count']].sum(axis = 1).sum():,}\")\n",
    "print(f\"Average entities per record: {data_sample[['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count']].mean(axis = 1).mean():.2f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "d4240b6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>subject_id</th>\n",
       "      <th>hadm_id</th>\n",
       "      <th>admittime</th>\n",
       "      <th>dischtime</th>\n",
       "      <th>admission_type</th>\n",
       "      <th>discharge_location</th>\n",
       "      <th>gender</th>\n",
       "      <th>dod</th>\n",
       "      <th>age_at_admit</th>\n",
       "      <th>length_of_stay_days</th>\n",
       "      <th>...</th>\n",
       "      <th>diagnosis_codes</th>\n",
       "      <th>model</th>\n",
       "      <th>true_icd_codes</th>\n",
       "      <th>missing_codes</th>\n",
       "      <th>disease_entity_count</th>\n",
       "      <th>drug_entity_count</th>\n",
       "      <th>anatomy_entity_count</th>\n",
       "      <th>disease_entities</th>\n",
       "      <th>drug_entities</th>\n",
       "      <th>anatomy_entities</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>17504528</td>\n",
       "      <td>20171885</td>\n",
       "      <td>2137-06-17 20:40:00</td>\n",
       "      <td>2137-06-20 16:41:00</td>\n",
       "      <td>DIRECT EMER.</td>\n",
       "      <td>HOME</td>\n",
       "      <td>F</td>\n",
       "      <td>2142-07-24</td>\n",
       "      <td>56</td>\n",
       "      <td>2.834028</td>\n",
       "      <td>...</td>\n",
       "      <td>[E118, Z5181, I5032, K219, D473, I10, I071, M8...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5032, E118, I10, E785, I2510, I071, D649, I2...</td>\n",
       "      <td>[Z7901, I272, E039, D72829, F419, E785, J45909...</td>\n",
       "      <td>19</td>\n",
       "      <td>13</td>\n",
       "      <td>7</td>\n",
       "      <td>[{'entity_group': 'DISEASE', 'score': 0.694758...</td>\n",
       "      <td>[{'entity_group': 'CHEM', 'score': 0.94702816,...</td>\n",
       "      <td>[{'entity_group': 'Anatomy', 'score': 0.933714...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>14273001</td>\n",
       "      <td>20371042</td>\n",
       "      <td>2187-10-19 19:00:00</td>\n",
       "      <td>2187-10-21 18:13:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME</td>\n",
       "      <td>F</td>\n",
       "      <td>2188-03-27</td>\n",
       "      <td>73</td>\n",
       "      <td>1.967361</td>\n",
       "      <td>...</td>\n",
       "      <td>[Z7901, Z87891, E039, Y929, I5031, E785, K219,...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5031, I82501, C7931, C3431, E039, Z7901, I10...</td>\n",
       "      <td>[]</td>\n",
       "      <td>13</td>\n",
       "      <td>12</td>\n",
       "      <td>9</td>\n",
       "      <td>[{'entity_group': 'DISEASE', 'score': 0.859448...</td>\n",
       "      <td>[{'entity_group': 'CHEM', 'score': 0.70878446,...</td>\n",
       "      <td>[{'entity_group': 'Anatomy', 'score': 0.856348...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>11357031</td>\n",
       "      <td>27612249</td>\n",
       "      <td>2139-01-17 21:04:00</td>\n",
       "      <td>2139-01-22 18:00:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>M</td>\n",
       "      <td>2144-10-28</td>\n",
       "      <td>58</td>\n",
       "      <td>4.872222</td>\n",
       "      <td>...</td>\n",
       "      <td>[I5033]</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, J9692, J9691, E870, E872, E662, J441, ...</td>\n",
       "      <td>[E1140, I272, E872, I129, Z6833, E11319, E662,...</td>\n",
       "      <td>12</td>\n",
       "      <td>9</td>\n",
       "      <td>8</td>\n",
       "      <td>[{'entity_group': 'DISEASE', 'score': 0.955208...</td>\n",
       "      <td>[{'entity_group': 'CHEM', 'score': 0.9232956, ...</td>\n",
       "      <td>[{'entity_group': 'Anatomy', 'score': 0.748473...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>13673554</td>\n",
       "      <td>25741865</td>\n",
       "      <td>2176-02-25 19:39:00</td>\n",
       "      <td>2176-03-02 17:30:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>M</td>\n",
       "      <td>2180-11-21</td>\n",
       "      <td>71</td>\n",
       "      <td>5.910417</td>\n",
       "      <td>...</td>\n",
       "      <td>[I129, N184, I5033, N179, Z951, C9110, E780, I...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5033, C9110, J918, N184, N179, I129, I2510, ...</td>\n",
       "      <td>[]</td>\n",
       "      <td>15</td>\n",
       "      <td>9</td>\n",
       "      <td>12</td>\n",
       "      <td>[{'entity_group': 'DISEASE', 'score': 0.959855...</td>\n",
       "      <td>[{'entity_group': 'CHEM', 'score': 0.9267071, ...</td>\n",
       "      <td>[{'entity_group': 'Anatomy', 'score': 0.735421...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19017808</td>\n",
       "      <td>20589756</td>\n",
       "      <td>2183-01-05 21:59:00</td>\n",
       "      <td>2183-01-08 18:35:00</td>\n",
       "      <td>OBSERVATION ADMIT</td>\n",
       "      <td>HOME HEALTH CARE</td>\n",
       "      <td>F</td>\n",
       "      <td>2184-11-16</td>\n",
       "      <td>77</td>\n",
       "      <td>2.858333</td>\n",
       "      <td>...</td>\n",
       "      <td>[N2889, K7460, I8510, I5032, I4891, N179, I878...</td>\n",
       "      <td>gpt-4o-mini</td>\n",
       "      <td>[I5032, I8510, N179, I272, K7460, N390, I4891,...</td>\n",
       "      <td>[I272, Y929, S5001XA, W19XXXA, I10, Z85038, K7...</td>\n",
       "      <td>14</td>\n",
       "      <td>7</td>\n",
       "      <td>11</td>\n",
       "      <td>[{'entity_group': 'DISEASE', 'score': 0.905572...</td>\n",
       "      <td>[{'entity_group': 'CHEM', 'score': 0.9423098, ...</td>\n",
       "      <td>[{'entity_group': 'Anatomy', 'score': 0.855203...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 33 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   subject_id   hadm_id           admittime           dischtime  \\\n",
       "0    17504528  20171885 2137-06-17 20:40:00 2137-06-20 16:41:00   \n",
       "1    14273001  20371042 2187-10-19 19:00:00 2187-10-21 18:13:00   \n",
       "2    11357031  27612249 2139-01-17 21:04:00 2139-01-22 18:00:00   \n",
       "3    13673554  25741865 2176-02-25 19:39:00 2176-03-02 17:30:00   \n",
       "4    19017808  20589756 2183-01-05 21:59:00 2183-01-08 18:35:00   \n",
       "\n",
       "      admission_type discharge_location gender        dod  age_at_admit  \\\n",
       "0       DIRECT EMER.               HOME      F 2142-07-24            56   \n",
       "1  OBSERVATION ADMIT               HOME      F 2188-03-27            73   \n",
       "2  OBSERVATION ADMIT   HOME HEALTH CARE      M 2144-10-28            58   \n",
       "3  OBSERVATION ADMIT   HOME HEALTH CARE      M 2180-11-21            71   \n",
       "4  OBSERVATION ADMIT   HOME HEALTH CARE      F 2184-11-16            77   \n",
       "\n",
       "   length_of_stay_days  ...  \\\n",
       "0             2.834028  ...   \n",
       "1             1.967361  ...   \n",
       "2             4.872222  ...   \n",
       "3             5.910417  ...   \n",
       "4             2.858333  ...   \n",
       "\n",
       "                                     diagnosis_codes        model  \\\n",
       "0  [E118, Z5181, I5032, K219, D473, I10, I071, M8...  gpt-4o-mini   \n",
       "1  [Z7901, Z87891, E039, Y929, I5031, E785, K219,...  gpt-4o-mini   \n",
       "2                                            [I5033]  gpt-4o-mini   \n",
       "3  [I129, N184, I5033, N179, Z951, C9110, E780, I...  gpt-4o-mini   \n",
       "4  [N2889, K7460, I8510, I5032, I4891, N179, I878...  gpt-4o-mini   \n",
       "\n",
       "                                      true_icd_codes  \\\n",
       "0  [I5032, E118, I10, E785, I2510, I071, D649, I2...   \n",
       "1  [I5031, I82501, C7931, C3431, E039, Z7901, I10...   \n",
       "2  [I5033, J9692, J9691, E870, E872, E662, J441, ...   \n",
       "3  [I5033, C9110, J918, N184, N179, I129, I2510, ...   \n",
       "4  [I5032, I8510, N179, I272, K7460, N390, I4891,...   \n",
       "\n",
       "                                       missing_codes  disease_entity_count  \\\n",
       "0  [Z7901, I272, E039, D72829, F419, E785, J45909...                    19   \n",
       "1                                                 []                    13   \n",
       "2  [E1140, I272, E872, I129, Z6833, E11319, E662,...                    12   \n",
       "3                                                 []                    15   \n",
       "4  [I272, Y929, S5001XA, W19XXXA, I10, Z85038, K7...                    14   \n",
       "\n",
       "  drug_entity_count anatomy_entity_count  \\\n",
       "0                13                    7   \n",
       "1                12                    9   \n",
       "2                 9                    8   \n",
       "3                 9                   12   \n",
       "4                 7                   11   \n",
       "\n",
       "                                    disease_entities  \\\n",
       "0  [{'entity_group': 'DISEASE', 'score': 0.694758...   \n",
       "1  [{'entity_group': 'DISEASE', 'score': 0.859448...   \n",
       "2  [{'entity_group': 'DISEASE', 'score': 0.955208...   \n",
       "3  [{'entity_group': 'DISEASE', 'score': 0.959855...   \n",
       "4  [{'entity_group': 'DISEASE', 'score': 0.905572...   \n",
       "\n",
       "                                       drug_entities  \\\n",
       "0  [{'entity_group': 'CHEM', 'score': 0.94702816,...   \n",
       "1  [{'entity_group': 'CHEM', 'score': 0.70878446,...   \n",
       "2  [{'entity_group': 'CHEM', 'score': 0.9232956, ...   \n",
       "3  [{'entity_group': 'CHEM', 'score': 0.9267071, ...   \n",
       "4  [{'entity_group': 'CHEM', 'score': 0.9423098, ...   \n",
       "\n",
       "                                    anatomy_entities  \n",
       "0  [{'entity_group': 'Anatomy', 'score': 0.933714...  \n",
       "1  [{'entity_group': 'Anatomy', 'score': 0.856348...  \n",
       "2  [{'entity_group': 'Anatomy', 'score': 0.748473...  \n",
       "3  [{'entity_group': 'Anatomy', 'score': 0.735421...  \n",
       "4  [{'entity_group': 'Anatomy', 'score': 0.855203...  \n",
       "\n",
       "[5 rows x 33 columns]"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_sample.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "344b4f7b",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_sample.to_csv('../data/processed/structured_dataset_with_discharge_summaries_ner_features.train.csv', index = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "9b9a3aed",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.87753165),\n",
       "  'word': ' diastolic (congestive) heart failure',\n",
       "  'start': 156,\n",
       "  'end': 193},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.95869887),\n",
       "  'word': ' diastolic heart failure',\n",
       "  'start': 316,\n",
       "  'end': 340},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9269001),\n",
       "  'word': ' shortness of breath',\n",
       "  'start': 360,\n",
       "  'end': 380},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.62120926),\n",
       "  'word': ' fatigue',\n",
       "  'start': 408,\n",
       "  'end': 416},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9464508),\n",
       "  'word': ' type 2 diabetes mellitus',\n",
       "  'start': 456,\n",
       "  'end': 481},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.8956117),\n",
       "  'word': ' hypertension',\n",
       "  'start': 482,\n",
       "  'end': 495},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.94288975),\n",
       "  'word': ' hyper',\n",
       "  'start': 496,\n",
       "  'end': 502},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9335575),\n",
       "  'word': 'lipid',\n",
       "  'start': 502,\n",
       "  'end': 507},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.929415),\n",
       "  'word': 'emia',\n",
       "  'start': 507,\n",
       "  'end': 511},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.8774849),\n",
       "  'word': ' atherosclerotic heart disease',\n",
       "  'start': 516,\n",
       "  'end': 546},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.95627415),\n",
       "  'word': ' heart failure',\n",
       "  'start': 617,\n",
       "  'end': 631},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.8903935),\n",
       "  'word': ' diabetes',\n",
       "  'start': 855,\n",
       "  'end': 864},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.90812886),\n",
       "  'word': ' hypertension',\n",
       "  'start': 868,\n",
       "  'end': 881},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.95502913),\n",
       "  'word': ' diastolic dysfunction',\n",
       "  'start': 1115,\n",
       "  'end': 1137},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9005467),\n",
       "  'word': ' anemia',\n",
       "  'start': 1167,\n",
       "  'end': 1174},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.89449453),\n",
       "  'word': ' diabetes',\n",
       "  'start': 1222,\n",
       "  'end': 1231},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9182976),\n",
       "  'word': ' dyspnea',\n",
       "  'start': 1436,\n",
       "  'end': 1444},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9351868),\n",
       "  'word': ' edema',\n",
       "  'start': 1458,\n",
       "  'end': 1464},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9565958),\n",
       "  'word': ' heart failure',\n",
       "  'start': 1640,\n",
       "  'end': 1654},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9276656),\n",
       "  'word': ' diabetes',\n",
       "  'start': 1668,\n",
       "  'end': 1677},\n",
       " {'entity_group': 'DISEASE',\n",
       "  'score': np.float32(0.9598949),\n",
       "  'word': ' heart failure',\n",
       "  'start': 2166,\n",
       "  'end': 2180}]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_sample['entities'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "2446ba73",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1000 with 12 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 640x480 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 640x480 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Visualize NER results\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "fig, axes = plt.subplots(6, 2, figsize=(15, 10))\n",
    "sns.set_palette(\"husl\")\n",
    "\n",
    "for label in ['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count']:\n",
    "    # Entity count distribution\n",
    "    axes[0, 0].hist(data_sample[label], bins=30, edgecolor='black', alpha=0.7)\n",
    "    axes[0, 0].set_xlabel('Number of Entities')\n",
    "    axes[0, 0].set_ylabel('Frequency')\n",
    "    axes[0, 0].set_title('Distribution of Entity Counts per Record')\n",
    "    axes[0, 0].axvline(data_sample[label].mean(), color='red', linestyle='--', \n",
    "                    label=f\"Mean: {data_sample[label].mean():.2f}\")\n",
    "    axes[0, 0].legend()\n",
    "\n",
    "# Disease vs Chemical counts\n",
    "# axes[0, 1].scatter(data_sample['disease_count'], alpha=0.5)\n",
    "# axes[0, 1].set_xlabel('Disease Entity Count')\n",
    "# axes[0, 1].set_ylabel('Chemical Entity Count')\n",
    "# axes[0, 1].set_title('Disease vs Chemical Entities')\n",
    "\n",
    "    # Entity count by admission type\n",
    "    if 'admission_type' in data_sample.columns:\n",
    "        admission_entity_stats = data_sample.groupby('admission_type')[label].mean().sort_values()\n",
    "        admission_entity_stats.plot(kind='barh', ax=axes[1, 0])\n",
    "        axes[1, 0].set_xlabel('Average Entity Count')\n",
    "        axes[1, 0].set_title('Average Entities by Admission Type')\n",
    "\n",
    "# Top extracted entities  \n",
    "for ent_type in ['disease_entities', 'drug_entities', 'anatomy_entities']:\n",
    "    all_entities = []\n",
    "    for entities_list in data_sample[ent_type]:\n",
    "        all_entities.extend([ent['word'].lower() for ent in entities_list])\n",
    "\n",
    "    if len(all_entities) > 0:\n",
    "        from collections import Counter\n",
    "        entity_counts = Counter(all_entities)\n",
    "        top_entities = pd.DataFrame(entity_counts.most_common(15), \n",
    "                                    columns=['Entity', 'Count'])\n",
    "        top_entities.plot(x='Entity', y='Count', kind='barh', ax=axes[1, 1], legend=False)\n",
    "        axes[1, 1].set_xlabel('Frequency')\n",
    "        axes[1, 1].set_title('Top 15 Extracted Entities')\n",
    "        axes[1, 1].invert_yaxis()\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "caf753f2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABdIAAASmCAYAAAAqMlnEAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzs3Qd4FNXawPE3PZSEXkJHREFBUAREVEAQUFQQLCgq7YIoSFNRVEAQBSxIEYl6KXIBvWJB1E+8ioANqWJDESVSpAXpgfT5nvd4Z+9uyiYbNtn2/z3PwJbZ3TNnZrPnvPOeM2GWZVkCAAAAAAAAAADyFJ73wwAAAAAAAAAAgEA6AAAAAAAAAAAFICMdAAAAAAAAAAA3CKQDAAAAAAAAAOAGgXQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBwAAAAAAAADADQLpAELSE088IWFhYSXyWe3btzeLbc2aNeaz33rrrRL5/H79+km9evXEn506dUr+8Y9/SPXq1U3djBw50qvvr++p+xwI9L8nAADAd+hDhFYfAqFr4cKF5pj6448/fF0U+BkC6QCC5kfOXmJjY6VGjRrSpUsXmTVrlpw8edIrn7Nv3z7TeN66dav4G38uW2E8/fTTZj/ee++98q9//UvuuuuufNfVkwL2vg4PD5fy5ctL06ZNZfDgwbJ+/foSLTfO/vsaGRkpNWvWNCd8/vzzT6oUAACUCPoQ9CHoQ3iHnShmLxEREVK1alW5+eab5eeff/bSpwD+IdLXBQAAb5k0aZLUr19fMjIy5MCBA+YHXbMSpk+fLitWrJCLLrrIse7jjz8ujzzyiMfB6okTJ5pAbvPmzQv9uv/85z9S3NyV7dVXX5Xs7GzxZ5999plcdtllMmHChEKtr9v4wAMPmNt6okQbaMuWLTPbOmrUKLPPnZ05c8YEbOF/39fU1FT55ptvTGf2yy+/lB9//NGcDAMAACjJNgl9CPoQOfsQ8Mzw4cOlZcuW5rv0/fffS2JioumTa/teRw0AwYCoAoCgce2118qll17quD927FgToL3++uvlxhtvNMHWUqVKmec0qFrcgdXTp09L6dKlJTo6WnwpKipK/N2hQ4fkggsuKPT6msF85513ujw2bdo0ueOOO+SFF16Qhg0bmux2G4HZkpWSkiJlypQp9PdVh+RWrlzZ7EM96XXrrbeKP8nMzDQno3z9XQYAAN5HHyJv9CFyC+U2YWHa91deeaXJQredf/75pk+2aNEiGTNmjPgT3Y/p6en0E+ExpnYBENSuvvpqGTdunOzatUsWL17sdn7DTz75RK644gozVUjZsmXND/+jjz5qntMz6Xp2XfXv398xbE2zaJXOgd6kSRPZvHmzXHXVVSaAbr825xzptqysLLOOnp3XRokG+/fs2eOyjmaY65QXOTm/Z0Fly2uOdG0IaUZ37dq1JSYmxmzrc889J5Zluayn7zNs2DBZvny52T5d98ILL5SVK1cWOkA+cOBAqVatmmmkNGvWTF577bVcwwCTkpLkww8/dJS9KHPR6UkSnRamYsWK8tRTT7lsS8450jWLXUcraL3oNunQw2uuuUa2bNni8p46VUzXrl2lXLlyZp+2a9dOvvrqK5d19Ni67777TB1qGSpVqiS33HJLrm3QzAwdNaBBfq0LXU+PNz3unP3yyy+mAarboetpsFmDy0V5r/yGMH/++edyzz33mNfFx8fL3XffLUePHs21/kcffWQaxHp8xsXFSbdu3eSnn35yWUePL/2+/P7773LdddeZ9fr06SOe0s9R+j6e1oc6duyYGY1g79NatWqZ7Tp8+HChj0el+03rSL8PM2bMkAYNGpj327Ztm3les+b1+6av1+defvllj7cVAAD4N/oQ9CHctQnzmz/b7tvo/87mzJkj55xzjukrtGrVSr744os8+4izZ882fS3td1SoUMG0e5cuXer2WLU/89///neBfcvC9m/svrJuqyYqaVm0r+Gt9r1O5zhgwADTJrf7l/Pnz8/1eh25qmU577zzTNs7ISFBevbs6fJ+nvZrlyxZYj5P17X7tNq/0e+87h/tQ0yePNnvR3TDd8hIBxD0dL5tbVToFCuDBg3Kcx398dTMdZ3+RYd36g/rb7/95mhUNG7c2Dw+fvx4Mxe33Si4/PLLHe/x119/mYyW3r17m2xpbRi4o8Fe/UF/+OGHTYBPG2idOnUy85zbmfOFUZiyOdNGhTasVq9ebYKKOk3Kxx9/LA899JBp1GhGtzMNHL7zzjsmWKxBUp13vlevXrJ7924TiM2PTqeijUOtR2206JBZnX5FA68a9BwxYoQpuwa/NQCqjRZ7upYqVapIUWhA96abbpJ58+aZhp82kvIyZMgQc7FXLZdmwuu+0+3UUQuXXHKJWUdHM+j+bNGihZlyRudjX7BggWlkaeNXG8Fq48aN8vXXX5v9rtugDeq5c+eabdcyaANVaSNwypQpJvtaX3vixAnZtGmTCd5rEN8+Dtu2bWsy7nXqIW0Ev/nmm9KjRw95++23zbYV9r3c0e3WE0b6Ptu3bzfl1RMCdkNc6X7p27evudaAZorrCAtdTxvR3377rcvJGc3O0fX0OW242tvsCbsjog11W2HrQy80pce97j9tlOs+1AC6Btz37t1rst0Lczw6032tjXf9TunfAw3k//DDD9K5c2dzfGrd6XbrsVHQdx0AAAQe+hCuQrUPkVeb0BPaftbt0LaqllfbvNqW1Tavlt2mU1Tq1CiaQKLbqJ+p06No4FuD2QUpTN+ysP0bmyYHaeKOXs8qZ2C6qO37gwcPmik97cC27jNN3tFjSvs09gVjNelM++erVq0y/SytE02G0sQhnSpGT2x4ekzq9mtfQj9X+wfan9EpYTt06GDa9XZ/45VXXvGoP44QYwFAgFuwYIH+qlsbN27Md51y5cpZF198seP+hAkTzGtsL7zwgrmfnJyc73vo++s6+nk5tWvXzjyXmJiY53O62FavXm3WrVmzpnXixAnH42+++aZ5fObMmY7H6tata/Xt27fA93RXNn29vo9t+fLlZt3Jkye7rHfzzTdbYWFh1m+//eZ4TNeLjo52eey7774zj8+ePdtyZ8aMGWa9xYsXOx5LT0+32rRpY5UtW9Zl27V83bp1c/t+hV3X3pfvvfeey3boPnc+HoYOHZrve2RnZ1sNGza0unTpYm7bTp8+bdWvX9+65pprXB7Lad26deYzFy1a5HisWbNmBW5jx44draZNm1qpqakuZbn88stNeTx5L3fflRYtWph9YXvmmWdc6uzkyZNW+fLlrUGDBrm8/sCBA6bunB/X40tf+8gjj3hUhk8//dR83/bs2WO99dZbVpUqVayYmBhz39P6GD9+vHnPd955J9fn2fuvsMdjUlKSWS8+Pt46dOiQy3v16NHDio2NtXbt2uV4bNu2bVZERITL3xMAAOD/6EPQh3DXh3DXJrSPHV3Hmd3P0/9VWlqaValSJatly5ZWRkaGY72FCxea9Zz7c927d7cuvPBCj4/jwvYtPenf2H3l22+/3aMyzJ8/37Tv9+3bZ61cudI699xzTf9yw4YNjnUHDhxoJSQkWIcPH3Z5j969e5t+ht230vfS95w+fXquz7PL72m/Njw83Prpp59c1h05cqR5bv369Y7HdH9rWfLaxwBTuwAICZploGew86PZueq9994r8jAuzVDQqVUKS6ed0OwMm2Yf6HC1//u//5PipO+vV1LXjAdnmsmhbQzNCHCmmQx6xt+mWfs6HcjOnTsL/BwdWnj77be7zLWon6sZxGvXrpXi2teqoP2t2R16kda8aObGjh07TPaHZqtrdrMuOnSwY8eOZmoU+zhxzlbQKVd0/XPPPdd8hvNUMXpfM6z1ffNy5MgRkyWh84Nr2e3P1PfTbG99nWZWFOa9CqIZNc7zXurchXrNAPvY00wPzfjRfWeXQxc9blq3bm2yPnJynpO+MPS40gwUHYapx75mf2gGuZ2Z40l9aHa6TtNiZ6g7szPsPT0eNWPKOatJs2I0w0UziOrUqeN4XDOitDwAACD40If4n1DtQ+RsE3pCR4xq21VHRTtfn0unQXTO0rbb9zqSUke7FkVBfUtP+jfOo3g9oSNDta5q1Khhpo85fvy4GTlgT0Oqx4m222+44QZz27mfoe1pXd/uP+l6mjV+//33u23fe3JM6jQ2Oa/Lpe+hGfLO2fi6DUWZqhKhgUA6gJCgjS7nhkVOt912m5lCQqfK0GkadPiYDvvyJKiu0094cuEZHSaXs0GgAdiizA/uCZ3CQxs3OetDA4L2886cg4Y2bfjlNad2zs/RbdQhg4X5HG/ua+Vufz/zzDNmSKAGcbXRpNN0ODfq7QC1Tm2iDSnn5Z///KekpaWZhp49/FSn1bHn5dMGn66ngWh7HaXT7+hjOsdf06ZNzZBDHa5p0+Gr2uDTOf1zfqYOvVQ6TLMw7+XpsacdB21o28eevf06zDNnWXSKJLscNu0YOA9NLQydK1ID9jrFjs6trg1orb+i1IfOk6hz+HvzeNRhxM6Sk5PNvs5Zd0rnYgQAAMGHPsT/hGofImeb0BN2WbWPl7PtnPMaVjoli7bJtW+i2z906NBcc5efTd/Sk/5NUbdd+0Tavn/33XdNYF/fz3k/anta+zA6dUrOMtgJac7te21jO5+AONtjMq/tsY+3nGjfIz/MkQ4g6OmZff0Rz9mAcaZZxXoWXjNt9aKXeuERvWCLBhI1cKhnugtSHPOo5bwgqnN2bGHK5A35fU5R5skrCRogV+72t2Y56zyF2sjT/fvss8+aecB1HkedN9A+gaKP61x77rJWNEtC5xbU+fzatGljLtyj+01PxjifiNGL0GqDUEc96Gdqg1Xn7UtMTDQncOx1H3zwwXwznO1tKui9zpZdFs0g0YygnHI2aDUAnrOzUxDtJOgFlJRmeev86poho3O2a916Uh/FgXkRAQAIbfQhzk6w9CHyahO666MVlQZ/tR38wQcfmL6oZmS/9NJLJjg9ceJEOVue9G+K2h7WBB8diWC37/UaS5qNr+18TTqyy6DXE9OAfl505EJxoX0PbyCQDiDoaTBQFTT9ggYCdVibLtOnTzcXVXnsscdMcF0bBPk1mIoq57Qc2qjULFznxoNmbehZ+7zOnOuV322elK1u3bry6aefmmGLzmfvf/nlF8fz3qDvo1nS2mByDrJ6+3NyZpJocFwbanYmQn40A1svfqSLZj7oBSr1Ij0aSLeHoerwU7sxmB/NqNaG4PPPP+94TC8OlNd+04sTabaFLlpWDYhrNrwGv+39qUNXC/rMgt6rMMeeXlTHpq/fv3+/yQxX9vZXrVq1UGXxRkdLL56qZXrxxRfNhX48qQ8tr935Ka7jUTNltPGd13Q62ukBAADBhT6EK/oQ/2NPy5KzvZ8zA9puX2ofz7ntrRe21EzxnEFjnepQR0rrkp6eLj179jT9k7Fjx0psbOxZ9S096d94y9SpU03fTLdBE360Pa39Tz3hUJj2vU7FqVNnOk9J6e1jUtehfQ9PMLULgKCmcyw/+eSTZhiXu3nOdD7mnOwz9TrMzW7YqLwCpEWxaNEilzn4NCCrwUwN5Do3IL755hvTkLJplsKePXtc3suTsmmwVBsvGrB0phnNGpB3/vyzoZ+jV0HXzH7nRuPs2bNNtoPOUedNOu3GXXfdZfalngBxlymSc9iiBox1WKC9r/VK9lr3zz33nGOYpzMdlugcBM6ZWaPbmDMjRecidKZ1oBkv9mdqGdq3by8vv/yyOQ7cfWZB71UQHU6pjVLb3Llzzb6x972edNJGtp5Mcl4vr7J4i267ZqnPmDHDnIjwpD507srvvvvONNRzsvfN2R6Pup+1XpYvXy67d+92PP7zzz+budMBAEDwoA+RW6j3IZzZQWkd0WzTutE2tjMdfVmpUiV59dVXzTbYlixZkmuKm5zte50yVOfz1rZsXu1xT/uWnvRvvEU/T9vpCxcuNPtU29N6X7Pt80qCydm+16kfcx5vOdv3Z3tM6ntof3vDhg0u5dB9BOSFjHQAQUMvJqJnn7WRcvDgQdMA1jna9CyzXsTQ3Vl8nXNaG0LdunUz62uGsg6l03mfdSia3RDQi8Do2XQ9463Ba73wYlHnzdOMYn1vzSjW8moAUYOhOvzNptnF2gjSi7XodCQ6ncfixYtdLtzjadn04i6aEaENRc2E0Is06vQgOk2ITk+S872LSi9oqUHQfv36yebNm808gLotOtefbqu7OcwLoheZ1HpQ2hDctm2bLFu2zDTQ9OIy99xzT76v1Qam7le9AI9uuzbINZNBL+xjZ5VrxrJOl6KNrwsvvNDsI50DXz9XRyhokPn99983615//fUmY0mndNHG7rp168z7aaPZmT6ngWFtxOq+14sPaX0MGzbMZd5wPSZ0WKQeB5qVrceGvqcOL9ZgcWHfyx09MaMjL/SY0mxqPdb1c2+88UbzvG6fBte1U6GZ+jpNjWaQaABZpz7S6wnk1ag9WzrX+y233GIa23pxo8LWh75Ot19fqxc50nrRzpB+7/U7ofvZG8ejDqvVobY6LZCOZLA7dXqMeDJHPQAA8B/0IehDFKYP4UzbfnqBSs0U1zantsffeOMNl2C5HQzXEaM6FaROGaptb+1/aVtX+1zOQfvOnTubKRW1na3X7NJkDW1va/+0MO3UgvqWnvRvvEnb6XrtMS2PZqjrop+nfVUtm/ZrtA71IqPah7IT3HSOdT05MHr0aBPk1va3XhhV19F2ePfu3b3Srx0zZozpy2l/e8SIEaYfrSdE7NGsQC4WAAS4BQsW6ClpxxIdHW1Vr17duuaaa6yZM2daJ06cyPWaCRMmmHVtq1atsrp3727VqFHDvF7/v/32261ff/3V5XXvvfeedcEFF1iRkZHm9frZql27dtaFF16YZ/n0OV1sq1evNq99/fXXrbFjx1pVq1a1SpUqZXXr1s3atWtXrtc///zzVs2aNa2YmBirbdu21qZNm3K9p7uy9e3b16pbt67LuidPnrRGjRpltjMqKspq2LCh9eyzz1rZ2dku6+n7DB06NFeZ9P30fQty8OBBq3///lblypVNvTZt2tRRrpzvp9tfGLquva/DwsKs+Ph4U/eDBg2y1q9fn+drdF3d5yotLc166KGHrGbNmllxcXFWmTJlzO2XXnop1+u+/fZbq2fPnlalSpVM/etn33rrreZ4sR09etSxjWXLlrW6dOli/fLLL7nqaPLkyVarVq2s8uXLm/3dqFEj66mnnrLS09NdPvP333+37r77bnMM677RfX/99ddbb731lsfvld93Ze3atdbgwYOtChUqmDL36dPH+uuvv3Ktr8eqbk+5cuWs2NhYq0GDBla/fv3MMWjTbdQ6LCy7DBs3bsz1XFZWlvkMXTIzMwtdH0rLP2zYMPO8Hmu1atUyZTt8+LBHx2NSUpIpn34f8qJ116JFC/P6c845x0pMTMz19wQAAPg/+hB/ow+Rdx+ioDahtlE7depk+gjVqlWzHn30UeuTTz4xr9E2tLNZs2aZvoGuq234r776yrQnu3bt6ljn5Zdftq666ipHv0Pbw9pnOX78uNvj2NO+ZWH6N3bbNjk5ucDvkXMZli1blufz7du3N322Y8eOOdrk2sesXbu2ad9rO79jx47WK6+84vK606dPW4899phVv359x3o333yzqXtv9WvV999/b/rW2t/RvsSTTz5pzZs3z7xGjwPAWZj+kzu8DgAAgo1mv2j2iWbf2xf6BAAAAFBy9Jo9OtpT50DXaV/Oxpo1a0xWto7O1RG3AIoXc6QDAAAAAAAAXqbX/smZv6pTlugUJjpVI4DAwhzpAAAAAAAAgJfphSxHjRplruWj11DSucDnzZsnTZo0MY8BCCwE0gEAAAAAAAAv0wvc165dW2bNmuW4MKleSFMvuqkXIwUQWJgjHQAAAAAAAAAAN5gjHQAAAAAAAAAANwikAwAAAAAAAADgBnOkAwXIzs6Wffv2SVxcnISFhVFfAAAEGMuy5OTJk1KjRg0JDyePBIDn6BMAABDYvNEnIJAOFECD6HpxEAAAENj27NkjtWrV8nUxAAQg+gQAAASHs+kTEEgHCqCZ6PYXLT4+nvoCglFKikiNGn/f3rdPpEwZX5cIgBedOHHCnBS3f9MBwFP0CQAfoZ0OwI/6BATSgQLY07loEJ1AOhCkIiL+d1tPmBFIB4ISU7QBONu/H/QJgBJGOx2AH/UJmCQSAAAAAAAAAAA3CKQDAAAAAAAAAOAGU7sAAKBDuy644O96OIthXgAAAAC8iHY6AD9CIB0AgNKlRX76iXoIIFlZWZKRkeHrYsCPREdHS3g4gy0BAAgqtNORD/oDyCkqKkoinK+rUAwIpAMAgIBhWZYcOHBAjh075uuiwM9oEL1+/fomoA4AAIDgRH8A7pQvX16qV69+VhcUdYdAOgAACBh2EL1q1apSunTpYmsgIbBkZ2fLvn37ZP/+/VKnTh2OCwAAgCBFfwD5nWA5ffq0HDp0yNxPSEiQ4kAgHQCA06dFWrb8ux42bvx7CCn8cvimHUSvVKmSr4sDP1OlShUTTM/MzDTDOgEAQBCgnQ4n9AfgTqlSpcz/GkzXPmNxTPNCIB0AAMsS2bbtf7fhl+w50TUTHcjJntJFO1gE0gEACBK00+GE/gAKYvcV9VgpjkA6V2QCAAABhelcwHEBAAAQuugPwFfHBoF0AAAAAAAAAADcIJAOAAAAAAAAAIAbBNIBAEEjOTlZfv/9d4+XnTt3+rroCGL9+vUzQwyHDBmS67mhQ4ea53Qdf/TOO+9I586dzcVdtZxbt251ef7IkSNy//33y/nnn28u7lOnTh0ZPny4HD9+vFB14rx07drV8fyaNWtyPW8vG/WCwAAAICjb5broa4FgE8x9AvXKK69I+/btJT4+3qxz7NgxKcjnn38uN9xwg9SoUcO8Zvny5S7P6zznDz/8sDRt2lTKlClj1rv77rtl37594itcbBQAEBS0wT2k3wBJO3nS49fGZGXJ28VSKuBvtWvXljfeeENeeOEFx9XkU1NTZenSpSb47K9SUlLkiiuukFtvvVUGDRqU63ltxOry3HPPyQUXXCC7du0ynQN97K233nL73ho4X7BggeN+TEyM4/bll18u+/fvd1l/3LhxsmrVKrn00ku9sm0AAMD/2uUqJi5OEhfOlypVqni9bIAvBWufQJ0+fdq073UZO3asFPZ9mzVrJgMGDJCePXvm+Z5btmwx/QBd7+jRozJixAi58cYbZdOmTeILBNIBAEHhxIkTprE+onUHqVWhskev3XdonxzcvFEqVq4sUcV8cRKEpksuucRkWGk2R58+fcxjelsbzPXr13dZNzs7W6ZNm2ayOg4cOCDnnXeeaTzefPPN5vmsrCwZPHiwfPbZZ+Z5fY/77rvPNCptms2iWSDa4H3++eclPT1devfuLTNmzJCoqKhCl/uuu+4y///xxx95Pt+kSRN5++3/nYZq0KCBPPXUU3LnnXdKZmamREbm39TUwHn16tXzfC46OtrlOc1Gee+990z2OxeXAgAgeNvle48elpnrV5v3MIF0bZvXrfv3k7TTEeCCtU+gRo4c6RhZWljXXnutWfJTrlw5+eSTT1wee/HFF6VVq1aye/dun5x8IJAOAAgq2lhvUDXv4Jw7A1tdJjMXzJMGpUsXS7lQzFJS8n8uIkIkNrZw64aHi/w3OyTfdcuUKVIRNdNCM7DtRvP8+fOlf//+uRqbU6ZMkcWLF0tiYqI0bNjQDHnUwLR2Jtu1a2ca1bVq1ZJly5aZ4ZVff/21aUQnJCSYLBHb6tWrzWP6/2+//Sa33XabNG/e3JFF8sQTT8jChQvdNoiLQqd10SGd7oLoSre7atWqUqFCBbn66qtl8uTJZnvysmLFCvnrr79MfQEAgOBul7vQtrmX2yoIUiXZH1D0CXxC+xqaWFO+fHmffD6BdAAAEPjKls3/ueuuE/nww//dr1pVxwnmvW67dhrh/d/9evVEDh92XceyilREDYbrMEed/kR99dVXZmincyA9LS1Nnn76afn000+lTZs25rFzzjlHvvzyS3n55ZdNIF2zRyZOnOh4jWavrFu3Tt58802XQLoGqDVjIyIiQho1aiTdunUzU6PYgfTKlSubDHJvOnz4sDz55JMmsO+ODvnU4Ztads3KefTRR002im6HljenefPmSZcuXcwJBAAAAMCn/QFFn6DE6TQ4Omf67bffbhJ3fIFAOgAAQAnQjHINZmsWuGVZ5rYGs51p5rjOBXjNNde4PK7DMC+++GLH/Tlz5piMdh3SeObMGfO8Zps7u/DCC12C0pqd/sMPPzjuDxs2zCzeokOwdZt0rnTNdndHh5Ta9OJBF110kQnq60mFjh07uqy7d+9e+fjjj82JAgAAACCQBXufoLjoVI+aNKR1NnfuXPEVAukAgJAXlpEu07/dIjVvuklk/XrXoXwIDKdO5f9czgznQ4fcD+V05uWhxDq9i91Q1YZvTqf+ux0ffvih1KxZ0+U5+2KcmsX+4IMPmnkONWs9Li5Onn32WVmvx66TnPMe6hBInRamOJw8edJkmWtZ3n33XY/mXLSz7rUDoZ2GnIF0nQ5Hp3zRiwoBAIAQc+aMyFVX/X37889ppyPg+wPB3Cco7iC6juzVOeF9lY2uCKQDAGBZct6pkyJ6Zj7AGhUowhyFxbVuIWiwWTNFtAGrU5XkpNnc2jjWrBKdxiUvOiXM5Zdfbi4mZNPpUXxFM9F1W7TcOpd5rPP8k4WkWec6B7pmyDjTjBMNpN99990eB+cBAEAQ0Lb5pk3/uw0EeH8gWPsExR1E37Fjh7n2U37XVCopBNIBAABKiA6r/Pnnnx23c9JMEs0sGTVqlMkUueKKK8wFdbShrJkXffv2NRcgXbRokZnuROcY/9e//iUbN240tz2h86dr9rjOm56fI0eOmAb8vn37zP3t27eb/6tXr24WDaJ37tzZDD3VC6TqfV3sYav2Nuoc7XoR1Ztuuslk2Ogc77169TLvoQ3+MWPGyLnnnpurI6EZJ0lJSfKPf/zDo20DAAAA/FWw9QnUgQMHzKIjTJVOH6PbUadOHalYsaJ5TEeean/AzsbXfoG9vtJ2/9atW836+joNot98882yZcsW+eCDDyQrK8t8htJ1oqOjpaQRSAcAAChBBQ1F1It1ahBaA887d+40V6S/5JJLzAU51T333CPffvut3HbbbSaLRS+2o5koH330kccXBi0oa0UzzPv3759rbvMJEyaYedC1UWsPH9VAuDNtCNfTizP9t7GtjX+7s/D999/La6+9JseOHZMaNWqYYLxutz1U1fkio5ppo4F4AAAAIFgEU59AJSYmmmQZ21X/nZJJR5f269fP3NbP0c+zbdq0STp06OC4P3r0aPO/nijQOeT//PNP89kq59zvmp3evn17KWlhlo6ZBZAvzawrV66cCQD4ch4mAO7pj/KI/gPl2a63SIOqf58VL6yde3dJo4kP/H1H56MrhuF78M5V2jU4q1kWRZk+BKF7fPBbDuBs8XcEKJl2+e+HDshDK5fJzAXzzIXIJSVFpGzZv5+knR7y6A/A132CHDPoAwAAAAAAAAAAZwTSAQAAAAAAAABwgznSAQAQkeORUVI2rqzkvtQLAAAAAJ+pXJnKB+AXyEgHAIQ8KzpG+rS5XP7YuJH50QEAAAB/odcuSk7+e+E6RgB8jEA6/Nbnn38uN9xwg9SoUcNcgXj58uX5rjtkyBCzzowZM1weP3LkiPTp08dcRECvcDxw4EA5pRcoAQAAAAAAAIBCIpAOv5WSkiLNmjWTOXPmuF3v3XfflW+++cYE3HPSIPpPP/0kn3zyiXzwwQcmOD948OBiLDUAoLhlZ2dTycjFsixqBQjB5Br97o8fP14SEhKkVKlS0qlTJ9mxY4fLOiTXAEBwoT8AXx0bzJEOv3XttdeaxZ0///xT7r//fvn444+lW7duLs/9/PPPsnLlStm4caNceuml5rHZs2fLddddJ88991yegXcAoSksI12mfL9Vatxxh8iaNSKlSvm6SMhDdHS0hIeHy759+6RKlSrmvgZVAA2kJScnm+MhKiqKCgGCMLlmwIAB0rNnz1zPP/PMMzJr1ix57bXXpH79+jJu3Djp0qWLbNu2TWJjYx3JNfv37zfJNRkZGdK/f3+TXLN06VIfbBEAj5w5o8GBv29/9BHt9BBHfwDu+gPp6emmT6B9Rj1WigOBdAT0Waa77rpLHnroIbnwwgtzPb9u3ToznYsdRFeaoaJfqPXr18tNN92U5/umpaWZxXbixIli2gIAfsOypOnx4yIbNugfF1+XBvnQv98aJNFgiAbTAWcaRK9Vq5ZERHDJYCBUkmu006xTOz7++OPSvXt389iiRYukWrVqJnO9d+/eJNcAgU7b5mvX/u82Qhr9ARSkdOnSUqdOHXOsFAcC6QhY06ZNk8jISBk+fHiezx84cECqVq3q8piuX7FiRfNcfqZMmSITJ070enkBAGdPMwu0YZSZmSlZWVlUKRw0E50gOhBakpKSTLtek2Vs5cqVk9atW5ukGg2kFzW5BgDgn+gPID/aF9C4X3GOWiaQjoC0efNmmTlzpmzZssXrX5CxY8fK6NGjXTLSa9eu7dXPAAAUnT19B1N4AEBos5NjNAPdmd63nytqcg2jVAHAf9EfgK9wsVEEpC+++EIOHTpkshK1IazLrl275IEHHpB69eqZdapXr27WcaYZjHqxIX0uPzExMRIfH++yAAAAAAgdOkpVs9vthcQaAABAIB0BSedG//7772Xr1q2ORS8eqvOl64VHVZs2beTYsWMme9322WefmbnVdbgnAAAAgMBlJ8ccPHjQ5XG9bz9X1OQaHaV6/Phxx7Jnz55i2QYAABA4mNoFfuvUqVPy22+/ucyBqAFzHYapmeiVKlVyWV+H+Gtj+Pzzzzf3GzduLF27dpVBgwZJYmKiZGRkyLBhw8xciRp0BwAAABC49ALU2v5ftWqVNG/e3DEto859fu+99+ZKrmnRokWhk2t0lKouAAAANgLp8FubNm2SDh06OO7b85b37dtXFi5cWKj3WLJkiQmed+zY0VxQqFevXjJr1qxiKzOAwJUaHi7RMTEM1QIAIICSa0aOHCmTJ0+Whg0bmsD6uHHjTNJMjx49zPok1wBBoHRpX5cAAAwC6fBb7du3F8uyCr3+H3/8kesxbWAvXbrUyyUDEGys6Bi5ue2VMnPBPGlQpoyviwMAAAqZXDNmzBhJSUmRwYMHm8zzK664QlauXCmxsbGO15BcAwSWtPR0cw00h++///t/NxcItqWnp0t0dHSRPlevj1alSpUivRZAaCCQDgAAAAAIyOSasLAwmTRpklnyQ3INEDiOpJyUnUlJMmXsYx5Pr6QB+D/27JEGdetKZKTn4a6YuDhJXDifYDqAfBFIBwAAAAAAgM+dSk2V6LBwGd6qvZybUMuj125I+lWm/rFLhra40uPX7j16WGauX22us0BWOoD8EEgHAIS8sIwMmfDjD1L9H/8Q+egjEafh4AAAAABKVs0KFaVB1eoiGekSOfc581jmvQ+KROU/bcvuv5JdXwsAXkYgHQAAK1taHj0ismaNSFYW9QEAAAD4g+xsCf9hi+M2APhSuE8/HQAAAAAAAAAAP0cgHQAAAAAAAAAANwikAwAAAAAAAADgBoF0AAAAAAAAAADcIJAOAAAAAAAAAIAbBNIBAAAAAAAAAHCDQDoAIORZ0TFy/ZXt5PfffhMpUybk6wMAAADwCzGxkv7qW2bR2wDgSwTSAQAAAAAAAABwg0A6AAAAAAAAAABuEEgHAIS8sIwMeeTnn6TasGEiqakhXx8AAACAX8hIl8jE58yitwHAlwikAwBgZcsVhw9L2ZUrRbKyqA8AAADAH2RnS/jmb8yitwHAlwikAwAAAAAAAADgRqS7JwEAAAAAABCYkpOT5cSJE0V6bXx8vFSpUsXrZQKAQEUgHQAAJzt37hSrdGmP6oROBgAAAPwxiD6k3wBJO3mySK+PiYuTxIXzCaYDwH8RSAcAhLyjKaccdfDQkPskLSLCozqhkwEAAAB/o5noGkQf0bqD1KpQ2aPX7j16WGauX23eg6x0APgbgXQAQMhLSUt11MFT19wkVnRMoeuETgYAAAD8mQbRG1St7utiAEDAI5AOAICTc6pUE4mJpU4AAAAAAIADgXQAQMjLioySS6pWl/n9h8kFHmSjAwAAAChG0TGS/uJix20A8CUC6QAAhIXJmbBwyY6OFr0NAAAAwA9o25zRogD8RLivCwAAAAAAAAAAgD8jkA4ACHlhmZny9PGjUve9f4tkZIR8fQAAAAB+ISNDIua/aBba6QB8jUA6ACDkhVvZclPqGan0/WaR7KyQrw8AAADAL2RnScS6NWahnQ7A1wikAwAAAAAAAADgBoF0AAAAAAAAAADcIJAOAAAAAAAAAIAbBNLhtz7//HO54YYbpEaNGhIWFibLly93PJeRkSEPP/ywNG3aVMqUKWPWufvuu2Xfvn0u73HkyBHp06ePxMfHS/ny5WXgwIFy6tQpH2wNAAAAAAAAgEBFIB1+KyUlRZo1ayZz5szJ9dzp06dly5YtMm7cOPP/O++8I9u3b5cbb7zRZT0Nov/000/yySefyAcffGCC84MHDy7BrQAAAAAAAAAQ6CJ9XQAgP9dee61Z8lKuXDkTHHf24osvSqtWrWT37t1Sp04d+fnnn2XlypWyceNGufTSS806s2fPluuuu06ee+45k8UOAAAAAAAAAAUhIx1B4/jx42YKGJ3CRa1bt87ctoPoqlOnThIeHi7r16/3YUkB+JusyCi5vEo1+X70eJHoGF8XBwAAAICKjpH06fPMQjsdgK+RkY6gkJqaauZMv/3228186OrAgQNStWpVl/UiIyOlYsWK5rn8pKWlmcV24sSJYiw5AL8QFiZHwyMks0xZcxsAAACAH9C2eVw5X5cCAAwy0hHw9MKjt956q1iWJXPnzj3r95syZYqZOsZeateu7ZVyAgAAAAAAAAhMBNIRFEH0Xbt2mTnT7Wx0Vb16dTl06JDL+pmZmXLkyBHzXH7Gjh1rpomxlz179hTrNgDwvbDMTBl34pjU/uhd/cPi6+IAAAAAUBkZErHkVbPQTgfga0ztgoAPou/YsUNWr14tlSpVcnm+TZs2cuzYMdm8ebO0aNHCPPbZZ59Jdna2tG7dOt/3jYmJMQuA0BFuZcsdZ06LbFon6f2GikiUr4sEAAAASHJycpGnG9WEM00mC2jZWRKx5mNzM+vmu2inA/ApAunwW6dOnZLffvvNcT8pKUm2bt1q5jhPSEiQm2++WbZs2SIffPCBZGVlOeY91+ejo6OlcePG0rVrVxk0aJAkJiaawPuwYcOkd+/eUqNGDR9uGQAAAAAABQfRh/QbIGknTxapqlLOnJGD+/abvjAA4OwRSIff2rRpk3To0MFxf/To0eb/vn37yhNPPCErVqww95s3b+7yOs1Ob9++vbm9ZMkSEzzv2LGjhIeHS69evWTWrFkluh0AAAAAAHhKM9E1iD6idQepVaGyx6/fkPSrTN3zlmRmEUgHAG8gkA6/pcFwvYBoftw9Z9Ps9KVLl3q5ZAAAAAAAFO/0LPbULBpEb1A1/+t85Wf3X8kevwYAkD8C6QAAAAAAAH42PQtTswCAfyGQDgAAAAAA4GfTszA1CwD4FwLpAAAAAAAAxago07MwNQsA+BcC6QCAkJcVGSUdK1eVmbcPkPOiokO+PgAAAAC/EBUt6VNectwGAF8ikA4AQFiY7IuIlPTyFUXCw6kPAAAAwB9o27xyVV+XAgAMogUAAAAAAAAAALhBIB0AEPLCsrLkwZPHpeanH4hkZoR8fQAAECiysrJk3LhxUr9+fSlVqpQ0aNBAnnzySbEsy7GO3h4/frwkJCSYdTp16iQ7duzwabkBFFJmhkQsW2QW2ukAfI1AOgAg5IVnZ8nA0ylSbd3n2iMP+foAACBQTJs2TebOnSsvvvii/Pzzz+b+M888I7Nnz3aso/dnzZoliYmJsn79eilTpox06dJFUlNTfVp2AIWQlSUR/1lhFtrpAHyNOdIBAAAAAAHp66+/lu7du0u3bt3M/Xr16snrr78uGzZscGSjz5gxQx5//HGznlq0aJFUq1ZNli9fLr179/Zp+QEAQOAgIx0AAAAAEJAuv/xyWbVqlfz666/m/nfffSdffvmlXHvtteZ+UlKSHDhwwEznYitXrpy0bt1a1q1b57NyAwCAwENGOgAAAAAgID3yyCNy4sQJadSokURERJg505966inp06ePeV6D6Eoz0J3pffu5vKSlpZnFpp8BAABCG4F0AIBXJScnF7mzGR8fL1WqVGGPAACAQnnzzTdlyZIlsnTpUrnwwgtl69atMnLkSKlRo4b07du3yLU4ZcoUmThxInsBAAA4EEgHAHg1iD6k3wBJO3mySK+PiYuTxIXzCaYDAIBCeeihh0xWuj3XedOmTWXXrl0mEK6B9OrVq5vHDx48KAkJCY7X6f3mzZvn+75jx46V0aNHO+5rkkDt2rXZKwAAhDAC6QAAr9FOpgbRR7TuILUqVPbotXuPHpaZ61eb9wilrHQy+AEAKLrTp09LeLjrpb90ipfs7Gxzu379+iaYrvOo24FzbWusX79e7r333nzfNyYmxiwAAAA2AukAAK/TIHqDqn9ngAWCrMgouaFSFZl2811yblR0iX0uGfwAAJydG264wcyJXqdOHTO1y7fffivTp0+XAQMGmOfDwsLMVC+TJ0+Whg0bmsD6uHHjzNQvPXr0oPoBfxcVLRlPvOC4DQC+RCAdAICwMPktMkpSNfifI6utOJHBDwDA2Zk9e7YJjN93331y6NAhEyC/5557ZPz48Y51xowZIykpKTJ48GA5duyYXHHFFbJy5UqJjY2l+gF/Fx4uVk2mVQLgHwikAwDgY4GWwQ8AgL+Ii4uTGTNmmCU/mpU+adIkswAAABRVyaXdAQDgp8KysmToqROSsPY/IpkZvi4OAAAAAJWZIREr/m0W2ukAfI1AOgAg5IVnZ8mwlFOS8PmnIllZIV8fAAAAgF/IypKI95eZhXY6AF8jkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBwAAAAAAAADADQLpAAAAAAAAAAC4QSAdAAAAAAAAAAA3It09CQBAKMiKiJRbKlaWJ2+6Xc6JivJ1cQAAAACoqCjJeHTq33VBOx2AjxFIBwAgPFx+jIqW0zVqi4RHUB8AAACAPwiPEKv+ub4uBQAYTO0CAAAAAAAAAIAbBNIBACEvLCtLBqSckqpfrxHJzAj5+gAAAAD8QmaGhH/8nllopwPwNQLp8Fuff/653HDDDVKjRg0JCwuT5cuXuzxvWZaMHz9eEhISpFSpUtKpUyfZsWOHyzpHjhyRPn36SHx8vJQvX14GDhwop06dKuEtAeDvwrOz5KFTJ6TWqv8TycrydXEAAAAAqKwsiXzrX2ahnQ7A1wikw2+lpKRIs2bNZM6cOXk+/8wzz8isWbMkMTFR1q9fL2XKlJEuXbpIamqqYx0Nov/000/yySefyAcffGCC84MHDy7BrQAAAAAAAAAQ6LjYKPzWtddea5a8aDb6jBkz5PHHH5fu3bubxxYtWiTVqlUzmeu9e/eWn3/+WVauXCkbN26USy+91Kwze/Zsue666+S5554zme4AAAAAAAAAUBAy0hGQkpKS5MCBA2Y6F1u5cuWkdevWsm7dOnNf/9fpXOwgutL1w8PDTQY7AAAAAAAAABQGGekISBpEV5qB7kzv28/p/1WrVnV5PjIyUipWrOhYJy9paWlmsZ04ccLLpQcAAAAAAAAQSMhIB3KYMmWKyW63l9q1a1NHAAAAAAAAQAgjIx0BqXr16ub/gwcPSkJCguNxvd+8eXPHOocOHXJ5XWZmphw5csTx+ryMHTtWRo8e7ZKRTjAdAAAAAIDglZaeLrt27SrSa+Pj46VKlSpeLxMA/0IgHQGpfv36Jhi+atUqR+BcA9469/m9995r7rdp00aOHTsmmzdvlhYtWpjHPvvsM8nOzjZzqecnJibGLABCR1ZEpNxdoZI8fv3NUi8qytfFAQAAAKCioiTjwSf+rotibKcfSTkpO5OSZMrYx4oUD4iJi5PEhfMJpgNBjkA6/NapU6fkt99+c7nA6NatW80c53Xq1JGRI0fK5MmTpWHDhiawPm7cOKlRo4b06NHDrN+4cWPp2rWrDBo0SBITEyUjI0OGDRsmvXv3NusByF9ycnKRrg+gGRw68iPghIfLxugYOVWvgUh4hK9LAwAAAECFR4h1fpNir4tTqakSHRYuw1u1l3MTann02r1HD8vM9atN/4msdCC4EUiH39q0aZN06NDBcd+ebqVv376ycOFCGTNmjKSkpMjgwYNN5vkVV1whK1eulNjYWMdrlixZYoLnHTt2lPDwcOnVq5fMmjXLJ9sDBFIQfUi/AZJ28qTHr005c0YO7ttvTlwBAAAAQCCpWaGiNKia/1SwAEIbgXT4rfbt24tlWfk+HxYWJpMmTTJLfjR7fenSpcVUQiA4aSaFBtFHtO4gtSpU9ui1G5J+lal73pLMrMAKpIdlZckdp1Ok8savRWrUEYnk5xEAAADwucxMCf/iE3Mz+8praKcD8CkiBQCAPGkQ3dNsjN1/JQdkbYZnZ8m4k8dFVi6X9OtvpoEOAAAA+IOsTIlcOs/cTL+8A+10AD4V7tuPBwAAAAAAAADAvxFIBwAAAAAAAADADQLpAAAAAAAAAAC4QSAdxWLnzp3ULAAAABCi6A8AAIBgQyAdxeLcc8+VDh06yOLFiyU1NZVaBgAAAEII/QEAABBsIn1dAASnLVu2yIIFC2T06NEybNgwue2222TgwIHSqlUrXxcNAAAAQDGjPwAAJSM5OVlOnDhRpNfGx8dLlSpVvF4mIFgRSEexaN68ucycOVOef/55WbFihSxcuFCuuOIKOe+882TAgAFy11138ccagN/IjoiUIeUryoNdu0udyChfFwcAgIBHfwCAV0RGScb9Yx23kTuIPqTfAEk7ebJIVRMTFyeJC+cTnwEKiUA6ilVkZKT07NlTunXrJi+99JKMHTtWHnzwQXn00Ufl1ltvlWnTpklCQgJ7AYBPWeHhsjYmVgY3bCwSEcHeAADAS+gPADgrERFiXdSCSsyHZqJrEH1E6w5Sq0Jlj+pp79HDMnP9avMeZKUDhUMgHcVq06ZNMn/+fHnjjTekTJkyJoiuU7zs3btXJk6cKN27d5cNGzawFwAAAIAgRH8AAIqfBtEbVK1OVQPFjEA6isX06dPNHOnbt2+X6667ThYtWmT+Dw//+/q29evXN9O91KtXjz0AwOfCsrKkx5nTUvG7TSI16mj6nK+LBABAQKM/AMArMjMlfP0X5mZ26ytppwPwKSIFKBZz5841c6H369cv36lbqlatKvPmzWMPAPC58OwsmXLimMiKNyW984000AEAOEv0BwB4RVamRC6cY26mX9qGdjoAnyKQjmKxY8eOAteJjo6Wvn37sgcAAACAIEN/AAAABJu/59kAvEyndVm2bFmux/Wx1157jfoGAAAAghj9AQAAEGwIpKNYTJkyRSpXrpzndC5PP/00tQ4AAAAEMfoDAAAg2BBIR7HYvXu3uaBoTnXr1jXPAQAAAAhe9AcAAECwIZCOYqGZ599//32ux7/77jupVKkStQ4AAAAEMfoDAAAg2BBIR7G4/fbbZfjw4bJ69WrJysoyy2effSYjRoyQ3r17U+sAAABAEKM/AAAAgk2krwuA4PTkk0/KH3/8IR07dpTIyL8Ps+zsbLn77ruZIx2A38mOiJSR5SrI8E7dpFZklK+LAwBAwKM/AMArIqMk457RjtsA4EsE0lEsoqOj5d///rdpQOt0LqVKlZKmTZuaOdIBwN9Y4eHycWwpufuCi6RWRISviwMAQMCjPwDAKyIixLr0cioTgF8gkI5idd5555kFAAAAQOihPwAAAIIFgXQUC50TfeHChbJq1So5dOiQmdbFmc6XDgD+Iiw7W7qknpHy274XqVnXZL4AAICioz8AwCuysiTs2/XmpnVxa9rpAHyKi42iWOhFRXXRBnSTJk2kWbNmLgsA+JPwrEyZcfyonPP2YpHMDF8XBwCAgFeS/YE///xT7rzzTqlUqZJjSslNmzY5nrcsS8aPHy8JCQnm+U6dOsmOHTu8WgYAxSQzQ6Jenm4W2ukAfI2MdBSLN954Q95880257rrrqGEAAAAgxJRUf+Do0aPStm1b6dChg3z00UdSpUoVEySvUKGCY51nnnlGZs2aJa+99prUr19fxo0bJ126dJFt27ZJbGxssZYPAAAEDwLpKLaLC5177rnULgAAABCCSqo/MG3aNKldu7YsWLDA8ZgGy52z0WfMmCGPP/64dO/e3Ty2aNEiqVatmixfvlx69+5d7GUEAADBgaldUCweeOABmTlzpmm4AgAAAAgtJdUfWLFihVx66aVyyy23SNWqVeXiiy+WV1991fF8UlKSHDhwwEznYitXrpy0bt1a1q1bV6xlAwAAwYWMdBSLL7/8UlavXm2GV1544YUSFRXl8vw777xDzQMAAABBqqT6Azt37pS5c+fK6NGj5dFHH5WNGzfK8OHDTUZ83759TRBdaQa6M71vP5eXtLQ0s9hOnDjhlfICAIDARSAdxaJ8+fJy0003UbsAUIzS0tNl165dRXptfHy8mUcWAIBA7g9kZ2ebjPSnn37a3NeM9B9//FESExNNIL2opkyZIhMnTvRiSQEAQKAjkI5i4TxHIQDA+46knJSdSUkyZexjEhMT4/HrY+LiJHHhfILpAICA7g8kJCTIBRdc4PJY48aN5e233za3q1evbv4/ePCgWdem95s3b57v+44dO9ZkuTtnpOtc7AAAIHQRSEexyczMlDVr1sjvv/8ud9xxh8TFxcm+fftMFmTZsmW98hlZWVnyxBNPyOLFi83QzBo1aki/fv3MxYTCwsLMOjov44QJE8xciceOHZO2bdua4Z8NGzb0ShkABL7s8AgZG19e7mnfWWpEBMZP46nUVIkOC5fhrdrLuQm1PHrt3qOHZeb61SYoQFY6ACCQ+wPatt++fbvLY7/++qvUrVvXceFRDaavWrXKETjX37/169fLvffem+/76knqopyoRvBKTk4u0hQ/OnpQvwsooohIyew31HEbAHyJv0IoFtpY6Nq1q+zevdvMLXjNNdeYhvO0adPMfR1q6Q36fhoUf+2118zci5s2bZL+/fubCwjp3IjqmWeekVmzZpl1tCE9btw46dKli2zbtk1iY2O9Ug4Agc2KiJDlpUrLLc0ulRqRgfXTWLNCRWlQ9e9sOwAAQq0/MGrUKLn88svN1C633nqrbNiwQV555RWzKE2uGTlypEyePNkk0tj9AU3A6dGjh1fKgNAIog/pN0DSTp70+LUpZ87IwX37JSMjo1jKFvQiIyW7bQdflwIAjMCKFiBgjBgxwsxV+N1330mlSpUcj+s8iYMGDfLa53z99dfSvXt36datm7lfr149ef31100D2s5GnzFjhslQ1/XUokWLzMWFli9fLr179/ZaWQAAAACUbH+gZcuW8u6775qpWCZNmmQC5dr+79Onj2OdMWPGSEpKigwePNiMUL3iiitk5cqVJNWg0DQTXYPoI1p3kFoVKntUcxuSfpWpe96SzCwC6QAQ6Aiko1h88cUXJsgdHR3t8rgGuv/880+vfY5mn2i2iQ7fPO+880xD/csvv5Tp06eb55OSksyUL506dXK8RrPVW7duLevWrSOQDsAIy86WdmmpEr/jZ5GadUUiIqgZAAACoD+grr/+erPkR7PSNciuC3A2NIju6UjA3X8lU+lnIytLwn7aam5aFzannQ7Apwiko1hkZ2eb+ctz2rt3rxnS6S2PPPKIyQ5o1KiRREREmM986qmnHBkoGkRXmoHuTO/bz+WkQ011sRVlHjwAgSU8K1MSjx0ReWOBpF/RkQY6AAAB0h8AEOQyMyRq9hRzM/3FxbTTAfgUgXQUi86dO5shlc5zE546dcpc9PO6667z2ue8+eabsmTJElm6dKmZI33r1q1mDkSd87Bv375Fes8pU6bIxIkTvVZGAAAAINSUVH8AAFB0aenp5poWRaEXjq5SpQrVj5BCIB3F4vnnnzcX9LzgggskNTVV7rjjDtmxY4dUrlzZzGHuLQ899JDJSrfnOm/atKn5EdBguAbSq1f/e9jdwYMHJSEhwfE6vd+8efM831PnVxw9erRLRnrt2rW9VmYAAAAg2JVUfwAAUDRHUk7KzqQkmTL2MYmJifH49TFxcZK4cD7BdIQUAukoFrVq1TLzlb/xxhvy/fffm+yTgQMHmilXSpUq5bXPOX36tISHh7s8plO86FBSpRcb0mD6qlWrHIFzDYyvX79e7r333jzfU39AivIjAgAAAKBk+wMAgKI5lZoq0WHhMrxVezk3oZZHr9179LDMXL/axFfISkcoIZCO4ju4IiPlzjvvLNYavuGGG8yc6HXq1DFTu3z77bfmQqMDBgxwDCHVqV4mT54sDRs2NIH1cePGmalfevToUaxlAwAAAEJZSfQHAABnp2aFih5fRBcIVQTSUSwWLVrk9vm7777bK58ze/ZsExi/77775NChQyZAfs8998j48eMd64wZM0ZSUlJk8ODBcuzYMbniiitk5cqVEhsb65UyAAAAAPBNfwAAAKCkEEhHsRgxYoTL/YyMDDMNS3R0tJQuXdprDee4uDhzESNd8qNZ6ZMmTTILEGiSk5PNcLmi4OIvAAAg2PsDAAAAJYVAOorF0aNHcz2mFxfSecn1AqEAChdEH9JvgKSdPFmk6uLiL4WXHR4hT8aVk75tO0j1CH4aAQA4W/QHAHhFRKRk3jHQcRsAfIm/QigxOkf51KlTzTyJv/zyCzUPFEAz0TWIPqJ1B6lVobJH9cXFXzxjRUTI0tJlpFvLy6V6JD+NAAAUB/oDADwWGSnZHa6l4gD4BaIFKNkDLjJS9u3bR60DHtAgOhd/AQAAwYD+AAAACFQE0lEsVqxY4XLfsizZv3+/vPjii9K2bVtqHYB/yc6WlulpUvaP30Vq1RUJj/B1iQAACGj0BwB4RXaWhO342dy0Gjb223Z6Wnq67Nq1q0iv5dpWQOAgkI5i0aNHj1wX/KxSpYpcffXV8vzzz1PrAPxKRFamLDr6l8i/Xpb01leKxPhnAx0AgEBBfwCAV2RkSNRzT5ib6S8u9st2+pGUk7IzKUmmjH1MYmJiPH4917YCAgeBdBSL7OxsahYAAAAIUfQHAISKU6mpEh0WLsNbtZdzE2p59FqubQUEFgLpAAAAAAAAwFmoWaEi17YCghyBdBSL0aNHF3rd6dOnsxcAAACAIEJ/AAAABBsC6SgW3377rVkyMjLk/PPPN4/9+uuvEhERIZdcconL3OkAAAAAggv9AQAAEGwIpKNY3HDDDRIXFyevvfaaVKhQwTx29OhR6d+/v1x55ZXywAMPUPMAAABAkKI/AAAAgk24rwuA4PT888/LlClTHEF0pbcnT55sngMAAAAQvOgPAACAYENGOorFiRMnJDk5Odfj+tjJkyepdQB+JTs8Qp4tGy+3t75CqkZE+Lo4AAAEPPoDALwiIkIyb77LcRsAfImMdBSLm266yUzj8s4778jevXvN8vbbb8vAgQOlZ8+e1DoAv2JFRMj8MmXl0OXtRSKjfF0cAAACHv0BAF4RGSXZXbqbhXY6AF8jIx3FIjExUR588EG54447zAVHzcEWGWkC6c8++yy1DgAAAAQx+gMAACDYEEhHsShdurS89NJLJmj++++/m8caNGggZcqUocYB+J/sbGmSkS6l9+0RqVVXJJxhowAAnA36AwC8IjtLwnYlmZtW3fq00wH4FFO7oFjt37/fLA0bNjRBdMuyqHEAficiK1OWHTksjebNFvnvKBoAAHD26A8AOCsZGRL19CNmoZ0OwNcIpKNY/PXXX9KxY0c577zz5LrrrjMNaKVTuzzwwAPUOgAAABDE6A8AAIBgQyAdxWLUqFESFRUlu3fvNsM6bbfddpusXLmSWgcAAACCGP0BAAAQbJgjHcXiP//5j3z88cdSq1Ytl8d1ipddu3ZR6wAAAEAQoz8AAACCDRnpKBYpKSkumei2I0eOSExMDLUOAAAABDH6AwAAINgQSEexuPLKK2XRokWO+2FhYZKdnS3PPPOMdOjQgVoHAAAAghj9AQAAEGyY2gXFQgPmerHRTZs2SXp6uowZM0Z++uknk5H+1VdfUesAEMCSk5PlxIkTRXptfHy8VKlSxetlAgD4F/oDAAAg2BBIR7Fo0qSJ/Prrr/Liiy9KXFycnDp1Snr27ClDhw6VhIQEah2AX8kOj5AXy5SVXi0uk0oREb4ujl/TIPqQfgMk7eTJIr0+Ji5OEhfOJ5gOAEGO/gAAr4iIkKwbbnHcBgBfIpAOr8vIyJCuXbtKYmKiPPbYY9QwAL9nRUTInLLxcnm7zlIpMsrXxfFrmomuQfQRrTtIrQqVPXrt3qOHZeb61eY9yEoHgOBFfwCA10RGSdaNt1GhAPwCgXR4XVRUlHz//ffULAAEMQ2iN6ha3dfFAAD4IfoDAAAgGHGxURSLO++8U+bNm0ftAggMliXnZmZI7KEDItnZvi4NAAABj/4AAK/IzpawP/eYhXY6AF8jIx3FIjMzU+bPny+ffvqptGjRQsqUKePy/PTp06l5AH4jIjND3v8rWeTl6ZL+4mKRmFhfFwkAgIBGfwCAV2SkS9QTo8xN2ukAfI1AOrxq586dUq9ePfnxxx/lkksuMY/pRUedhYWFUesAAABAEKI/AAAAghWBdHhVw4YNZf/+/bJ69Wpz/7bbbpNZs2ZJtWrVqGkAAAAgyNEfAAAAwYo50uFVlmW53P/oo48kJSWFWgYAAABCAP0BAAAQrAiko0Qb0sXhzz//NBczqlSpkpQqVUqaNm0qmzZtcinD+PHjJSEhwTzfqVMn2bFjR7GXCwAAAAh1JdEfAAAAKAlM7QKv0vnPc86BXpxzoh89elTatm0rHTp0MNnvVapUMUHyChUqONZ55plnzPQyr732mtSvX1/GjRsnXbp0kW3btklsLBcUBAAAAAK1PwAA8I209HTZtWtXkV4bHx9v4jdAoCGQDq9nnPTr109iYmLM/dTUVBkyZIiUKVPGZb133nnHK583bdo0qV27tixYsMDxmAbLncszY8YMefzxx6V79+7msUWLFpk525cvXy69e/f2SjkAAAAAlHx/AABQ8o6knJSdSUkyZexjjr/3noiJi5PEhfMJpiPgEEiHV/Xt29flvk65UpxWrFhhsstvueUWWbt2rdSsWVPuu+8+GTRokHk+KSlJDhw4YKZzsZUrV05at24t69atyzOQnpaWZhbbiRMninUbAPhedniEzCtdRq5v1kIqRET4ujgAAASsku4PAAhyERGS1flGx234h1OpqRIdFi7DW7WXcxNqefTavUcPy8z1q02shax0BBoC6fAq58zwkrBz506ZO3eujB49Wh599FHZuHGjDB8+XKKjo00jXoPoSjPQnel9+7mcpkyZIhMnTiyR8gPwD1ZEhDwXV04u7nS9VIiM8nVxAAAIWCXdHwAQ5CKjJOuWu31dCuSjZoWK0qBqdeoHIYNAOgJadna2XHrppfL000+b+xdffLH8+OOPkpiYmCsbprDGjh1rAvM2PUuq08cAAHwvOTm5yCOFmIsRAAAAAFBUBNIR0BISEuSCCy5weaxx48by9ttvm9vVq/99ZvTgwYNmXZveb968eZ7vqfN7FWWOLwABzLKkRlamRB87IlKrnkh4uK9LhHyC6EP6DZC0kyeLVD/MxQgAABBgsrNFjhz++3bFyrTTAfgUgXQEtLZt28r27dtdHvv111+lbt26jguPajB91apVjsC5ZjKuX79e7r33Xp+UGYD/icjMkFWHD4nMnirpLy4WiYn1dZGQB/37rUH0Ea07SK0KlT2qI+ZiBAAACEAZ6RI99j5zk3Y6AF8j5Q4BbdSoUfLNN9+YqV1+++03Wbp0qbzyyisydOhQ83xYWJiMHDlSJk+ebC5M+sMPP8jdd98tNWrUkB49evi6+ACAItAgus7F6MniaeAdABCYpk6d6ugD2FJTU03/oFKlSlK2bFnp1auXGaEKAADgCQLpCGgtW7aUd999V15//XVp0qSJPPnkkzJjxgzp06ePY50xY8bI/fffL4MHDzbrnzp1SlauXCmxsWScAgAAAMFi48aN8vLLL8tFF12UK/nm/fffl2XLlsnatWtl37590rNnT5+VEwAABCamdkHAu/76682SH81ImTRpklkAAAAABB9NltFkmldffdWMRrUdP35c5s2bZ0auXn311eaxBQsWmOsq6cjWyy67zIelBgAAgYSMdAAAAABAQNOpW7p16yadOnVyeXzz5s2SkZHh8nijRo2kTp06sm7dOh+UFAAABCoy0gEAAAAAAeuNN96QLVu2mKldcjpw4IBER0dL+fLlXR6vVq2aeS4/aWlpZnG+4DUAAAhtZKQDAAAAAALSnj17ZMSIEbJkyRKvXgNpypQpUq5cOcdSu3Ztr703AAAITATSAQAhLzssXJaWKi3Jl7YRCY8I+foAACBQ6NQthw4dkksuuUQiIyPNohcUnTVrlrmtmefp6ely7Ngxl9cdPHhQqlevnu/7jh071syvbi8asAfgA+ERktW+i1lopwPwNaZ2AQCEPCsyUp6MLy+Nrr1JykVFhXx9AAAQKDp27Cg//PCDy2P9+/c386A//PDDJpM8KipKVq1aJb169TLPb9++XXbv3i1t2rTJ931jYmLMAsDHoqIkq88gX5cCAAwC6QAAAACAgBQXFydNmjRxeaxMmTJSqVIlx+MDBw6U0aNHS8WKFSU+Pl7uv/9+E0S/7LLLfFRqAAAQiAikAwBgWVIhO0siU06J3pawMOoEAIAg8cILL0h4eLjJSNcLiHbp0kVeeuklXxcLPpCcnFykC8fu2rVLMjMzi6VMKIC2zU/9d5+VjaedDsCnCKQDAEJeRGaGfJ18UGT6JEl/cbFIjPcuVgYAAErWmjVrXO7rRUjnzJljFoR2EH1IvwGSdvKkx69NOXNGDu7bLxkZGcVSNriRnibRowf+fZN2OgAfI5AOAAAAAACCmmaiaxB9ROsOUqtCZY9euyHpV5m65y3JzCKQDgChjEA6AAAAAAAICRpEb1C1ukev2f1XcrGVBwAQOMJ9XQAAAAAAAAAAAPwZgXQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcIOLjQIAQl52WLi8G1tKrjrvAokLjwj5+gAAAAD8QniEZLVp77gNAL5EIB0AEPKsyEh5tFwFWdL9NmkSFRXy9QEAAAD4hagoyRowzNelAACDqV0AAAAAAAAAAHCDjHQAACxLSlnZEp6eLnpbwsKoEwAAAMDXtG2envb37egY2ukAfIqMdABAyIvIzJAthw5I82mP/6+hDgAAAMC30tMketidZqGdDsDXCKQDAAAAAAAAAOAGgXQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBwAAAAAAAADAjUh3TwIAEAqssHBZGRMrrc9pKGXCOccMAAAA+IXwcMlucZnjNgD4EoF0AEDIy46MlFHlK8qSm++SJlHRIV8fAAAAgF+IipbMIQ/6uhQAYHA6DwAAAAAAAAAAN8hIB4BCSE5OlhMnThSpruLj46VKlSrUMwAAAAAAQIAikI6gMXXqVBk7dqyMGDFCZsyYYR5LTU2VBx54QN544w1JS0uTLl26yEsvvSTVqlXzdXERYEH0If0GSNrJk0V6fUxcnCQunE8w3Y9FZKTLzwf3iTw5RtJfXCwSE+vrIgEAAABIS5XoYXeaeqCdHjzS0tNl165dRXotiWrwJQLpCAobN26Ul19+WS666CKXx0eNGiUffvihLFu2TMqVKyfDhg2Tnj17yldffeWzsiLwaCa6BtFHtO4gtSpU9ui1e48elpnrV5v3ICsdAAAAABDKjqSclJ1JSTJl7GMSExPj8etJVIMvEUhHwDt16pT06dNHXn31VZk8ebLj8ePHj8u8efNk6dKlcvXVV5vHFixYII0bN5ZvvvlGLrvsv1f+BgpJg+gNqlanvgAAAAAAKIJTqakSHRYuw1u1l3MTann0WhLV4GsE0hHwhg4dKt26dZNOnTq5BNI3b94sGRkZ5nFbo0aNpE6dOrJu3bp8A+k6BYwutqLOiw0AAAAAAIDcalaoSKIaAg6BdAQ0nft8y5YtZmqXnA4cOCDR0dFSvnx5l8d1fnR9Lj9TpkyRiRMnFkt5AQAAAAAAAASecF8XACiqPXv2mAuLLlmyRGJjvXdhQL1gqU4LYy/6OQAAAAAAAABCF4F0BCyduuXQoUNyySWXSGRkpFnWrl0rs2bNMrc18zw9PV2OHTvm8rqDBw9K9er5z3OtF7vQq0A7LwAAAAAAAABCF1O7IGB17NhRfvjhB5fH+vfvb+ZBf/jhh6V27doSFRUlq1atkl69epnnt2/fLrt375Y2bdr4qNQA/JEVFi5ro2OkeZ36Uiqcc8wAAACAXwgPl+ymlzhuA4AvEUhHwIqLi5MmTZq4PFamTBmpVKmS4/GBAwfK6NGjpWLFiiaz/P777zdB9PwuNAogNGVHRsqQCpVkye0DpElUtK+LAwAAAEBFRUvm8EepCwB+gUA6gtoLL7wg4eHhJiM9LS1NunTpIi+99JKviwUAAAAAAAAggBBIR1BZs2aNy329COmcOXPMAgAAAAAAAABFwQRTAICQF5GRLpsP7pdmUx8TSUsN+foAAAAA/EJaqkQN7WMW2ukAfI2MdAAARKS0WCIZGZJFbQAAAAB+Iyw9zddFAACDjHQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBwAAAAAAAADAjUh3TwIAEAosCZMNUdHSuEYtiQkL83VxAAAAAKiwMMk+74K/64J2OgAfI5AOAAh52VFR0rdiZVly9xBpEh0T8vUBAAAA+IXoGMl8aJKvSwEABlO7AAAAAAAAAADgBoF0AAAAAAAAAADcIJAOAAh5ERnp8tWhA9L0+YkiaakhXx8AAACAX0hLlahRA8xCOx2ArzFHOgAAIlLRyhY5nSLp1AYAAADgN8JOnfB1EQDAICMdAAAAABCQpkyZIi1btpS4uDipWrWq9OjRQ7Zv3+6yTmpqqgwdOlQqVaokZcuWlV69esnBgwd9VmYAABCYCKQDAAAAAALS2rVrTZD8m2++kU8++UQyMjKkc+fOkpKS4lhn1KhR8v7778uyZcvM+vv27ZOePXv6tNwAACDwMLULAAAAACAgrVy50uX+woULTWb65s2b5aqrrpLjx4/LvHnzZOnSpXL11VebdRYsWCCNGzc2wffLLrvMRyUHAACBhox0AAAAAEBQ0MC5qlixovlfA+qapd6pUyfHOo0aNZI6derIunXrfFZOAAAQeMhIBwAAAAAEvOzsbBk5cqS0bdtWmjRpYh47cOCAREdHS/ny5V3WrVatmnkuP2lpaWaxnTjBxQ4BAAh1BNIBACHPkjD5ITJKzqlSTaLCwkK+PoJVWnq67Nq1q0ivjY+PlypVqni9TAAA79G50n/88Uf58ssvvXIR04kTJ3qlXADOQliYZNdt4LgNAL5EIB0AEPKyo6Lk1kpVZMk/hkuT6JiQr49gdCTlpOxMSpIpYx+TmBjP93FMXJwkLpxPMB0A/NSwYcPkgw8+kM8//1xq1arleLx69eqSnp4ux44dc8lKP3jwoHkuP2PHjpXRo0e7ZKTXrl27GLcAQJ6iYyTz8WlUDgC/QCAdAAAEvVOpqRIdFi7DW7WXcxP+F2ApjL1HD8vM9atNEIWsdADwL5Zlyf333y/vvvuurFmzRurXr+/yfIsWLSQqKkpWrVolvXr1Mo9t375ddu/eLW3atMn3ffWka1FOvAIAgOBFIB0AAISMmhUqSoOq+WcgAgACbzqXpUuXynvvvSdxcXGOec/LlSsnpUqVMv8PHDjQZJfrBUh1qi4NvGsQ/bLLLvN18QEAQAAhkA4gZCQnJxfpQlE6p3JmZmaxlAn+ITwjQz5NPiiVZ00ReepFTUPzdZEAAEAhzJ071/zfvn17l8cXLFgg/fr1M7dfeOEFCQ8PNxnpegHRLl26yEsvvUT9AoEgLU2iJow0NzMmzqCdDsCnCKQDCJkg+pB+AyTt5EmPX5ty5owc3LdfMjIyiqVs8L0wsaRmdpbI8aOSLpaviwMAADyY2qUgsbGxMmfOHLMACDSWhP2V7LgNAL5EIB1ASNBMdA2ij2jdQWpVqOzRazck/SpT97wlmVkE0gEAAAAAAEIRgXQAIUWD6J7Oj7zbkQEBAAAAwFdTLiqd556LfwMAfIFAOgAAAAAA8PspF1VMXJwkLpxPMB0AUOIIpAMAAAAAAL+fcnHv0cMyc/1q8x5kpQMAShqBdAAAAAAA4PdTLgIA4EvhPv104CxNmTJFWrZsKXFxcVK1alXp0aOHbN++3WWd1NRUGTp0qFSqVEnKli0rvXr1koMHD1L3ABwsCZPfIiLlTOVqIhJGzQAAAAB+IUyyE2qZhXY6AF8jkI6AtnbtWhMk/+abb+STTz6RjIwM6dy5s6SkpDjWGTVqlLz//vuybNkys/6+ffukZ8+ePi03AP+SHRUlN1SuKj/f+4BITIyviwMAAABAxcRI5qQZZqGdDsDXmNoFAW3lypUu9xcuXGgy0zdv3ixXXXWVHD9+XObNmydLly6Vq6++2qyzYMECady4sQm+X3bZZT4qOQAAAAAAAIBAQUY6gooGzlXFihXN/xpQ1yz1Tp06OdZp1KiR1KlTR9atW+ezcgIAAAAAAAAIHATSETSys7Nl5MiR0rZtW2nSpIl57MCBAxIdHS3ly5d3WbdatWrmubykpaWZq8A7LwCCW3hGhrx/+JA0nvu8/hHwdXEAAAAAqLQ0iRw/0iy00wH4GlO7IGjoXOk//vijfPnll2d9AdOJEyd6rVwA/F+YWHJuVqbI4YOSLpaviwMAAADAsCR8/97/1gXtdIikpafLrl27ilQV8fHxUqVKFaoRRUYgHUFh2LBh8sEHH8jnn38utWrp1bz/Vr16dUlPT5djx465ZKUfPHjQPJeXsWPHyujRox33NSO9du3axbwFAAAAAAAAyM+RlJOyMylJpox9TGJiYjyuqJi4OElcOJ9gOoqMQDoCmmVZcv/998u7774ra9askfr167s836JFC4mKipJVq1ZJr169zGPbt2+X3bt3S5s2bfJ8T/1jXJQ/yAAAAAAAACgep1JTJTosXIa3ai/nJvwvibIw9h49LDPXrzbJkmSlo6gIpCPgp3NZunSpvPfeexIXF+eY97xcuXJSqlQp8//AgQNNhrlegFSH8WjgXYPol112ma+LDwAIAcnJyUW+3gbDTwEAAABXNStUlAZV855lAChOBNIR0ObOnWv+b9++vcvjCxYskH79+pnbL7zwgoSHh5uMdL2QaJcuXeSll17ySXkBAKEXRB/Sb4CknTxZpNcz/BQAAAAA/AOBdAT81C4FiY2NlTlz5pgFAICSpJnoGkQf0bqD1KpQ2aPXMvwUAAAAAPwHgXQAQMizJEz+DI+QynHxEiZhIV8f8D4NojP8FAAAwFNhYlWq4rgNAL5EIB0AEPKyo6KkU5VqsmTwSGnCxYYBAAAA/xATIxlT/57SFQB8LdzXBQAAAAAAAAAAwJ+RkQ6gxC+8p3MGF0V8fLxUqWIP6wMAAAAAAABKBoF0ACUaRB/Sb4C58F5RxMTFSeLC+QTT4XXhGRny5l/Jcs4/Z4k8Pk0kOoZaBgAAAHwtPU0inxlvbmaOmUQ7HYBPEUgHUGI0E12D6CNadzAX3vPE3qOHZeb61eY9yEqHt4WJJU0zM0T275V0y6KCAQAAAH9gWRK+63fHbSAQR9crRtgHBwLpAEqcBtEbVK1OzQMAAAAAgKAeXa8YYR8cCKQDAAAAAAAAgJdH1ytG2AcPAukAAAAAAAAA4Aaj6xFOFQAAAAAAAAAAkD8C6QAAAAAAAAAAuMHULgAAiMiRsHCJK1WKugAAAAD8iFU23tdFAACDQDoAIORlRUVL26rVZcngkdIkJjbk6wMAAADwCzGxkvHCfF+XAgAMAukAAAB+Ki09XXbt2lWk18bHx0uVKlW8XiYAAAAACEUE0gEAAPzQkZSTsjMpSaaMfUxiYmI8fn1MXJwkLpxPMB0AAAAAvIBAOgCPJScny4kTJzx+nWZVZmZmUuPwO+EZGfLakcPScFGiyJgnRaI9D1oC3nYqNVWiw8JleKv2cm5CLY9eu/foYZm5frX5W01WOgAACFjpaRI58ylzM3PEY7TTAfgUgXQAHgfRh/QbIGknT3pccylnzsjBffslIyODWodfCRNLWmWki+zaKemW5eviAC5qVqgoDapWp1YAAEDosSwJ/3Wb4zYA+BKBdAAe0exGDaKPaN1BalWo7NFrNyT9KlP3vCWZWQTSAQAAAAAAEDgIpAMoEg2ie5ohufuvZGobAAAAAAAAAYdAOgAAAAAA8AjXTQIAhBoC6QAAAAAAoNC4bhIAIBQRSAdCMAtExcfHS5UqVbxeJgBAaP++pKenS3R0dJE/m98nAPB/XDcJABCKCKQDIZgFomLi4iRx4XyC6cB/nZYwiYniZxE4m9+XtPR0+WPPHmlQt65ERhbt+8TvEwAEzvQsXDcJJcGKjqGiAfgFIgZACGaB7D16WGauX23eg6x0QCQrKlpaVEuQJYNHSpOYWKoEIe2sswz/2CVDW1wp5ybU8viz+X0CgJLD9CwICDGxkjFnia9LAQAGgXQgwBUlCwQAgOL4fdn9V7L5v2aFivw2AYCfY3oWACg5OnJTR/MUBVMf+g8C6QAAAAAAhCimZwGA4nUk5aTsTEqSKWMfk5gYz6cqYupD/0EgHQAQ8sIzMyXx6F/S4PX5IqPHi0QV/UKJAAAAALwkI10i5z5nbmbe+yDtdASkU6mpEh0WLsNbtfd4+kOmPvQvBNIBACEvzMqWdulpIr/9IunZ2SFfHwAAwP8v+KkY7o+gl50t4T9scdwGAllRpz88m2lh0tPTJTo6usR/Y5KD9LeNQDoAAAAAAAF2wU/FcH8ACG5nMy2MBuD/2LNHGtStK5GRkSX2G5McxL9tBNIREubMmSPPPvusHDhwQJo1ayazZ8+WVq1a+bpYAAAAAEK4T3A2F/xkuD8ABL+zmRZmQ9KvMvWPXTK0xZUlOqXMiSD+bSOQjqD373//W0aPHi2JiYnSunVrmTFjhnTp0kW2b98uVatW9XXxAAAAAIR4n6AoF/wEAISOokwLs/uv5CK/9mymlNm1a5dkZmYG5W8bgXQEvenTp8ugQYOkf//+5r42nj/88EOZP3++PPLII74uXpHnjbL/MAEAAAAI7D4BAADBMqVMypkzcnDffsnIyJBgQyAdQU0vqrB582YZO3as47Hw8HDp1KmTrFu3TnztbOaNCuY/TAAAAECo9AkAAAi6KWX2vCWZWcEXryKQjqB2+PBhycrKkmrVqrk8rvd/+eWXPF+TlpZmFtvx48fN/0W92rA7f/75p5w6elR6nNtEKpeN9+i1P+/fI4t37Zaf9+2WtCzPMtP/PPaXnD5zRrZt2yYnPQzi79mzR1JT02T7gb1yKvWMR69NOnxAsrKzZcfB/ZIlYSVW5kAt99mUmX3s6T4+JPY3/Ne9u8SKKvxVzUOtrn11XIZifYVame1yZ2RmmjJ783fXfi/Lsrz2ngAChz/3CfTvnf7dC6Xf1VD7ffPVa4OlrsMy0uW8QrbTA3E/heL3OBDr+mzqOVDry37t6fQ0j7f5THraWe2n4ugPeKtPEGbRo0AQ27dvn9SsWVO+/vpradOmjePxMWPGyNq1a2X9+vW5XvPEE0/IxIkTS7ikAACguGknqFYtzzJqAAQ++gQAAMAbfQIy0hHUKleuLBEREXLw4EGXx/V+9ep5X/BAh3zqhYhs2dnZcuTIEalUqZKEhYUVeHardu3a5ksZH+9ZhnkgCqXtDaVtVWxv8GLfBjf2b940b0SzWmrUqFHCewRAKPYJPBFqf7d9ibqmroMRxzX1HGxOFOPvojf6BATSEdSio6OlRYsWsmrVKunRo4ejEaz3hw0bludr9CIKOS+kUL58eY8+V7/sodQQDqXtDaVtVWxv8GLfBjf2b27lypXzwZ4AEMp9Ak+E2t9tX6KuqetgxHFNPQeb+GL6XTzbPgGBdAQ9zSTp27evXHrppdKqVSuZMWOGpKSkSP/+/X1dNAAAAAAlgD4BAAA4WwTSEfRuu+02SU5OlvHjx8uBAwekefPmsnLlylwXGwIAAAAQnOgTAACAs0UgHSFBh2zmN2zTm3T454QJE3INAw1WobS9obStiu0NXuzb4Mb+BQDf9wk8EWp/t32JuqaugxHHNfUcbGL8/HcxzNKZ1gEAAAAAAAAAQJ7C834YAAAAAAAAAAAQSAcAAAAAAAAAoABkpAMAAAAAAAAA4AaBdKCQpkyZIi1btpS4uDipWrWq9OjRQ7Zv3+72NQsXLpSwsDCXJTY2NiDq/IknnshV9kaNGrl9zbJly8w6uo1NmzaV//u//5NAUK9evVzbqsvQoUODYr9+/vnncsMNN0iNGjVMWZcvX+7yvF4qY/z48ZKQkCClSpWSTp06yY4dOwp83zlz5pi6021v3bq1bNiwQfx9ezMyMuThhx82x2eZMmXMOnfffbfs27fP698Hf9m//fr1y1X2rl27BuT+LWhb8/oe6/Lss88G5L4tzO9Oamqq+VtVqVIlKVu2rPTq1UsOHjzo9n2L+p335bYeOXJE7r//fjn//PNNmevUqSPDhw+X48ePu33foh7/AFBS/PH3Ntj48299oCuufgY8q2faO/7f/obn9dy+fftcf7uHDBkivkYgHSiktWvXmj+W33zzjXzyyScmINe5c2dJSUlx+7r4+HjZv3+/Y9m1a1fA1PmFF17oUvYvv/wy33W//vpruf3222XgwIHy7bffmj+Euvz444/i7zZu3Oiynbp/1S233BIU+1WP0WbNmpmOWl6eeeYZmTVrliQmJsr69etNgLlLly6mgZCff//73zJ69GhzNe0tW7aY99fXHDp0SPx5e0+fPm3KO27cOPP/O++8Y36wb7zxRq9+H/xp/yoNHDqX/fXXX3f7nv66fwvaVudt1GX+/PmmwaWN20Dct4X53Rk1apS8//775kSmrq8nhXr27On2fYvynff1tup26fLcc8+Z3xU9obly5Urzm1MQT49/ACgp/vp7G4z89bc+0BVHPwOe17OivePf7W8ULb42aNAgl7/d+jfF5ywARXLo0CFLv0Jr167Nd50FCxZY5cqVC8ganjBhgtWsWbNCr3/rrbda3bp1c3msdevW1j333GMFmhEjRlgNGjSwsrOzg26/6jH77rvvOu7rNlavXt169tlnHY8dO3bMiomJsV5//fV836dVq1bW0KFDHfezsrKsGjVqWFOmTLH8eXvzsmHDBrPerl27vPZ98Kft7du3r9W9e3eP3icQ9m9h9q1u99VXX+12nUDZt3n97uh3NSoqylq2bJljnZ9//tmss27dujzfo6jfeX/8jX3zzTet6OhoKyMjI991inL8A0BJCYTf22AQSL/1gcxb/Qx4Vs+K9o5/t79RtLZ/u3btTGzG35CRDhSRPZy8YsWKbtc7deqU1K1bV2rXri3du3eXn376KWDqXIfd6fCxc845R/r06SO7d+/Od91169aZoXrONNtAHw8k6enpsnjxYhkwYIDJZA3G/eosKSlJDhw44LLvypUrZ4YW57fvtI42b97s8prw8HBzP9D2t/1d1n1dvnx5r30f/M2aNWvMkDmdFuPee++Vv/76K991g2X/6vDKDz/8sFAZy4Gyb3P+7uh+0uwN532lQ9V12pP89lVRvvP++hur6+jooMjISK8d/wBQUoLl9zZQBMpvfTAJlDZHsKC947/tbxS97b9kyRKpXLmyNGnSRMaOHWtGmPsagXSgCLKzs2XkyJHStm1b84XOj3badWqB9957zwRn9XWXX3657N271+/rXRs49tD5uXPnmobQlVdeKSdPnsxzfW0kVatWzeUxva+PBxKdb+7YsWNmnrlg3K852fvHk313+PBhycrKCor9rcNKdc50nZZIA3Le+j74Ex3muWjRIlm1apVMmzbNDKO79tprzT4M5v372muvmTn3ChpmGSj7Nq/fHd0f0dHRuU4CudtXRfnO++NvrB6nTz75pAwePNirxz8AlJRg+b0NBIHyWx9sAqHNESxo7/h3+xtFa/vfcccdJt6yevVqE0T/17/+JXfeeaf4mvsUHgB50rmcdI7WgubWa9OmjVlsGmxt3LixvPzyyyYA4M800GC76KKLTANUM7DffPPNQmV4Bqp58+aZbdeMlWDcr/gfzSS49dZbzUWQtFMVrN+H3r17O27rRVa1/A0aNDBZKx07dpRgpSe7NOOsoAsBB8q+LezvTjAoaFtPnDgh3bp1kwsuuMBcQM6dUD3+AQCB91sPFBXtneIRSu1vf6znwU4JM9qO14sWa/v9999/N+15XyEjHfDQsGHD5IMPPjBnxWrVquXRa6OiouTiiy+W3377LeDqXc+4nnfeefmWvXr16rmuVK339fFAoRcM/fTTT+Uf//hHyOxXe/94su90aFVERERA7287iK77XC9u4i4bvSjfB3+mQ5p1H+ZX9mDYv1988YW5iKyn32V/3bf5/e7o/tCpAXQUTWH3VVG+8/70G6vZg5p1paMN3n33XfP315vHPwCUlGD4vQ1U/vhbH4z8vc0RzGjv+Ff7G96Jr+lJUOXrv90E0oFC0qxV/ZJrx/2zzz6T+vXre1x3Onzzhx9+MGfSAo3OCa5n/vIru2Zo69B5ZxqgdM7c9ncLFiww8+hqpmOo7Fc9jvUH33nfabbn+vXr8913OpStRYsWLq/R4Vh6PxD2tx1E17ky9cRJpUqVvP598Gc6BZHOEZ1f2QN9/9ojS3QbmjVrFtD7tqDfHd1GDSQ77ys9gaDzvua3r4rynfeX31gtZ+fOnc0xumLFigJHGxTl+AeAkhIMv7eByp9+64OZv7Y5QgHtHf9qf8M78bWtW7ea/33+t9vXVzsFAsW9995rlStXzlqzZo21f/9+x3L69GnHOnfddZf1yCOPOO5PnDjR+vjjj63ff//d2rx5s9W7d28rNjbW+umnnyx/98ADD5htTUpKsr766iurU6dOVuXKlc3VlPPaVl0nMjLSeu6558xVqydMmGCuZv3DDz9YgSArK8uqU6eO9fDDD+d6LtD368mTJ61vv/3WLPpnf/r06eb2rl27zPNTp061ypcvb7333nvW999/b3Xv3t2qX7++debMGcd7XH311dbs2bMd99944w0rJibGWrhwobVt2zZr8ODB5j0OHDhg+fP2pqenWzfeeKNVq1Yta+vWrS7f5bS0tHy3t6Dvg79urz734IMPmivIa9k//fRT65JLLrEaNmxopaamBtz+LehYVsePH7dKly5tzZ07N8/3CKR9W5jfnSFDhpi/XZ999pm1adMmq02bNmZxdv7551vvvPOO435hvvP+tq26X1u3bm01bdrU+u2331zWyczMzHNbC3v8A4Cv+OvvbbDx59/6QOeNfgbOrp5p7/hn+xtnV8/a3p80aZKpX/3brX9DzjnnHOuqq66yfI1AOlDYL4tInsuCBQsc67Rr187q27ev4/7IkSPNH9jo6GirWrVq1nXXXWdt2bIlIOr8tttusxISEkzZa9asae7rH7P8tlW9+eab1nnnnWdec+GFF1offvihFSg0MK77c/v27bmeC/T9unr16jyPXXubsrOzrXHjxplt0c5cx44dc9VD3bp1zckRZxqMtOuhVatW1jfffGP5+/bqj3B+32V9XX7bW9D3wV+3VxsinTt3tqpUqWJObOl2DRo0KFcHPVD2b0HHsnr55ZetUqVKWceOHcvzPQJp3xbmd0c7ovfdd59VoUIFcwLhpptuMo3QnO/j/JrCfOf9bVvz2/e66Pfa+X3s1xT2+AcAX/LH39tg48+/9YHOG/0MnF09097xz/Y3zq6ed+/ebYLmFStWNH87zj33XOuhhx4yyTW+Fqb/+DYnHgAAAAAAAAAA/8Uc6QAAAAAAAAAAuEEgHQAAAAAAAAAANwikAwAAAAAAAADgBoF0AAAAAAAAAADcIJAOAAAAAAAAAIAbBNIBAAAAAAAAAHCDQDoAAAAAAAAAAG4QSAcAAAAAAAAAwA0C6QAAv/DHH39IWFiYbN26VfzFL7/8IpdddpnExsZK8+bNS/zz27dvLyNHjnS7zsKFC6V8+fIlViYAAACgONAfyI3+AOBfCKQDAIx+/fqZQPbUqVNdamT58uXm8VA0YcIEKVOmjGzfvl1WrVrltt5yLl27di3056xZs8a85tixYy6Pv/POO/Lkk0867terV09mzJjhss5tt90mv/76q8fbBgAAADijP5Ab/QEAziJd7gEAQppmXk+bNk3uueceqVChggSD9PR0iY6OLtJrf//9d+nWrZvUrVvX7XoaNF+wYIHLYzExMXK2KlasWOA6pUqVMgsAAABwtugPuKI/AMAZGekAAIdOnTpJ9erVZcqUKfnWyhNPPJFrmhPNktZsaedslh49esjTTz8t1apVM1OPTJo0STIzM+Whhx4yAeJatWrlCj7b06lcfvnlphHfpEkTWbt2rcvzP/74o1x77bVStmxZ89533XWXHD582GX447Bhw8yUKJUrV5YuXbrkuR3Z2dmmTFoODXrrNq1cudLxvGaIb9682ayjt3W786Ov13pzXpxPROjr//nPf8pNN90kpUuXloYNG8qKFSscQ1g7dOhgbutrdF2tv5xTu+jtXbt2yahRoxxZ7/lN7fLee+/JJZdcYurwnHPOkYkTJ5q6V5ZlmW2pU6eOKXeNGjVk+PDh+W4bAAAAQgf9AfoDAPJHIB0A4BAREWGC37Nnz5a9e/eeVc189tlnsm/fPvn8889l+vTpZljk9ddfb4LF69evlyFDhpjM95yfo4H2Bx54QL799ltp06aN3HDDDfLXX3+Z53Tqk6uvvlouvvhi2bRpkwl8Hzx4UG699VaX93jttddMFvpXX30liYmJeZZv5syZ8vzzz8tzzz0n33//vQm433jjjbJjxw7z/P79++XCCy80ZdHbDz744FnVhwaztZz6Wdddd5306dNHjhw5IrVr15a3337brKNTyOhnadly0mleNOivgX1dR5e8fPHFF3L33XfLiBEjZNu2bfLyyy+bYPtTTz1lntfPeuGFF8zjuq06dU/Tpk3PatsAAAAQHOgP0B8A4IYFAIBlWX379rW6d+9u6uKyyy6zBgwYYG6/++67lvPPxYQJE6xmzZq51NkLL7xg1a1b1+W99H5WVpbjsfPPP9+68sorHfczMzOtMmXKWK+//rq5n5SUZD5n6tSpjnUyMjKsWrVqWdOmTTP3n3zySatz584un71nzx7zuu3bt5v77dq1sy6++OIC92mNGjWsp556yuWxli1bWvfdd5/jvm6nbq87uq0RERFmW5wX5/fW8j3++OOO+6dOnTKPffTRR+b+6tWrzf2jR4+6vLduy4gRIxz3tU61rp0tWLDAKleunON+x44draefftplnX/9619WQkKCuf38889b5513npWenl5ADQEAACCU0B+gPwDAPeZIBwDkovOka+b32WRhazZ3ePj/Bj7pNCw6VYtztkulSpXk0KFDLq/TLHRbZGSkXHrppfLzzz+b+999952sXr3aTOuS1/yF5513nrndokULt2U7ceKEyZZv27aty+N6Xz/DUzo1y9y5c93Ob37RRRc5busFTOPj43Ntuzdo+TUT385AV1lZWZKamiqnT5+WW265xUzFo1O+6Nzumh2vWf9a1wAAAICiP+AZ+gNAaKDXDADI5aqrrjJTnYwdO9YxX7dNg+N/J1n/T0ZGRq73iIqKcrmvc3rn9ZjOVV5Yp06dMkFfbdjnlJCQ4BKoLkn6eeeee67bdc522z2pI51GpmfPnrme0znTdSoZnULm008/lU8++UTuu+8+efbZZ81c9DnLCAAAgNBEf8Az9AeA0EAgHQCQp6lTp5oLcJ5//vkuj1epUkUOHDhggun2BS+3bt3qtVr85ptvTMNd6QUy9YKfevFQpRfQ1Dm+9cKmZ5NBrdngepFNzdxu166d43G936pVKylpOp+7nTle0HoFraN1pIFyd4H9UqVKmRMSugwdOlQaNWokP/zwg3ktAAAAoOgPlBz6A0BgIJAOAMiTXoBSL4g5a9Ysl8fbt28vycnJ8swzz8jNN99sLvj50UcfmeC0N8yZM0caNmwojRs3NhfFPHr0qAwYMMA8p0HfV199VW6//XYZM2aMmT7lt99+kzfeeEP++c9/muliCksvaqoXQG3QoIE5YbBgwQJzQmDJkiUelzktLc2cXHCmgf7KlSsX6vV169Y1JyU++OADM9WKBrrzmr5GTyDoxVt79+4tMTExeb7/+PHjzUVd69SpY/aPjiDQ6V5+/PFHmTx5srnwqAbjW7duLaVLl5bFixebz9MyAAAAADb6A4VHfwAIDf+bvBYAgBwmTZqUa/oRDXC/9NJLJuDdrFkz2bBhw1nNpZ5X5osu+t5ffvmlrFixwhEwtrPINRDcuXNn07gfOXKklC9f3mU+9sIYPny4jB49Wh544AHzPnpCQD9Lg/ie0tfq1DLOyxVXXFHo19esWdNMx/LII4+YueTtDPy89scff/xhgv86MiAvOiWPBuT/85//SMuWLeWyyy4zJyTsQLnWlZ6M0Pngdd52neLl/fffN/PVAwAAADnbn/QHCkZ/AAgNYXrFUV8XAgAAAAAAAAAAf0VGOgAAAAAAAAAAbhBIBwAAAAAAAADADQLpAAAAAAAAAAC4QSAdAAAAAAAAAAA3CKQDAAAAAAAAAOAGgXQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBwAAAAAAAADADQLpAAAAAAAAAAC4QSAdAAAAAAAAAAA3CKQDAAAAAAAAAOAGgXQAAAAAAAAAANwgkA4AAAAAAAAAgBsE0gEAAAAAAAAAcINAOgAAAAAAAAAAbhBIBxCSnnjiCQkLCyuRz2rfvr1ZbGvWrDGf/dZbb5XI5/fr10/q1asn/uzUqVPyj3/8Q6pXr27qZuTIkb4uElBof/zxhzluFy5cSK0BAICgkbMfE2j9OG2b6braVisp2vcqW7asBALtI2p5vUnrW/dRIJQVKAoC6QACnt1AspfY2FipUaOGdOnSRWbNmiUnT570yufs27fPNAq2bt0q/safy1YYTz/9tNmP9957r/zrX/+Su+66q8DXZGVlmf2s+/yjjz6Skizr8uXLS+zzgpHz91WX+Ph4adeunXz44Ye+LhoAACghL730kmkHtG7dmjrPESQuaClMcPvrr78273fs2LFir18NcuZX1q5du3r8fqdPnzZl1wSkwgjl9rmv+kShoDDfRV0Ke5wiOET6ugAA4C2TJk2S+vXrS0ZGhhw4cMD8oGlm8/Tp02XFihVy0UUXOdZ9/PHH5ZFHHvE4WD1x4kTTUGzevHmhX/ef//xHipu7sr366quSnZ0t/uyzzz6Tyy67TCZMmODRa/bv32+2ecmSJXLttddKSdCG+s033yw9evQokc8LVtdcc43cfffdYlmW7Nq1S+bOnSs33HCD6QDoSTAAABDctP2m7bgNGzbIb7/9Jueee66Eup49e7rUg47a1ESTm266yTxnq1atWqEC6do/0Cze8uXLS3HTPsgDDzyQ63EN8hYlkK5lVzlPGuTVj8uvfa7JOb1795aYmBgJVr7qE+XnzJkzEhnp/VDj9u3bJTy8ZHOBNcHL2aJFi+STTz7J9Xjjxo1LtFzwLQLpAIKGNhouvfRSx/2xY8eahsX1118vN954o/z8889SqlQp85z+uBfHD3zOBmDp0qUlOjpafCkqKkr83aFDh+SCCy7w6DWLFy+WSy65RPr27SuPPvqopKSkSJkyZYqtjCi81NRUc9y7a+yed955cueddzru9+rVyxwDM2fO9MtAuv19BgAAZy8pKckEet955x255557TADQk4QKb9BEk/T0dDOa1V9o4o9z8s/hw4dNIF0fc243+aOaNWuWSBk96cdFRESYJZj5W5+ouL5PvjgZkvN4/uabb0wg3d+/iyheTO0CIKhdffXVMm7cOJPxqo0Md3Pr6Y/iFVdcYTI2dF67888/3zRGlGa3t2zZ0tzu37+/YxiXPSeyZko0adJENm/eLFdddZUJuNmvzW9uQR2Gp+vovODa2NFg/549ewo1F5zzexZUtrzmSNcGlmaM1K5d2zRKdFufe+45kx3sTN9n2LBhZqikbp+ue+GFF8rKlSsLHSAfOHCgyZrRRlWzZs3ktddeyzVfvHamdFoPu+wFzWOomQ7vvvuuyTC59dZbzf333nsv3zkK//zzT5OhorerVKkiDz74oKl/Z7r9l19+uVSqVMmccGnRokWueey1bFp3ug12WZ33z7fffmtO6OhUJfpZHTt2NA2uvKYi+vLLL2X48OGmPHrMaSdSO3M6/FYztStUqGCWMWPGOPaL/q/7snv37nkGr8uVK2fexx17n2qHVfe77hfd1s8//zzXulpvAwYMMPvP3vfz5893Wcfeh2+88YbJENJOlB7/J06cEE9oJkflypXl999/d3k8LS3NdKw1O0vLoMes1ok+npN+x1u1amU+X+tOv4s5R4ToMHLdDn0vzZAaOnRoriHP7r7Puq7uc61r3W/aaSmJIdMAAAQTbYfob3W3bt1MJrHet+no0ooVK5p2bU7avtC2i7blPG0rOLeB7LaA3aYtTDtQaZtT22/aZomLizPtd20v5TUvdGHaUUWlyUJXXnml6UNoe0Tbhpo0ZNOyPPTQQ+a2jtjN2cZesGCB6SdVrVrVlE2TGXR0YHErTNtcy6iPKc1Kt8tu12/Ofpy79nl+c6TrCEi7/nQ/6nH4008/uayjI5z1GKxVq5apo4SEBFPPhZ1vfefOnSY5RD9D25w6etqbbXpP+kT6eZMnTzbbou3aDh065Nres+2n2HJ+F3SaVR0lrtur9ajHnI5M3bJli2OdHTt2mKQa7Rfr91vLqdt0/Phxt/1ireNbbrnF/L3Q7dIRzjmnirT7Km+++aY89dRT5r31M7SfpiNhzob2A/Rvgf7Nyqlz586mr1VcfTD4DhnpAIKeDunTIJgG1AYNGpTnOtqQ0Mx1zfbQRo7+YOkP61dffeUI8unj48ePl8GDB5uGl9IGt+2vv/4yQVT90dez1AUNudQfcv1Bffjhh03AecaMGdKpUyczz7mdOV8YhSmbM23saKN/9erVJsitwzA//vhj09jWH+0XXnjBZX1tSGm20H333WcamjrvvDZ0du/ebTob+dGGnAYktR610aCN+GXLlpkGkDbCRowYYcquQ+NGjRplGjX2cFC78ZwfnapHh7pqXWuDSz9HGyV33HFHrnW1Ua6NWJ1/UztJn376qTz//PPSoEEDk+Fj00xorZc+ffqYhqIGhrVh9sEHH5jGtdKy6kVRNVirda30fexjSOteg+jaqNSRAC+//LIp29q1a3PN/3n//febsmsHQYPtr7zyimmoanZWnTp1zBDV//u//5Nnn33WBHW10arHix5bzzzzjBw5csQ0Gm3vv/++6VwWJkNCy/Pvf//bNJD1WNfgss5fqUOr9bPUwYMHTWPUbvTpPtFOhx4z+jk5Lwj75JNPmix07Qhpx9XTkRjaUD569KijPu1MMd0negxqfevx8sMPP5hj9Ndff3WZC1PrURvtetzr90E/f/369aajqQ1Zpc/revo9032vQ0S107hx40bzXXcevZHX91m/O9rh0fIMGTLElEc7L9qIBgAAhaftNp2qRH+vb7/9dsfvsSaH6O+xTmWi7U9tSzm3KfS3X9sZ+vvsaVtBabtAA2rattEAmJ1sUph2oNJ2rL5e+xfaTtI2lfPzNk/bUZ7Qtqy2Uc455xzTttE29+zZs6Vt27YmOKnbpHWr2//666+butBtdW5ja31rcE63WbO7tR2pbX2tT00yKAoNJmoGfU4aSHbu2xTUNtcyavlyTmnjnKnvzF37PL/1te2mZZg2bZoZdaifpwlVmhRjHxPa39H2vbbZ9THtr2nilfaBciYp5aTbqG1rPQa03a4nbPRkT2ZmpmmneqtNX9g+kfYTNZB+3XXXmUWPE20f67Gel6L0U/KjbWY9KaXfAz1ho21s/b7qiR/NpNcy6L7Q77X9udon1e+e9hn1pEJe9Dum7X7df9qn0X6pnkzRY1o/T48dZ1OnTjWjZbWvov0OrXv9vmt/oaj074BO96J9aY0lOJ+E0b81OUfZFEcfDD5gAUCAW7BggZ4GtzZu3JjvOuXKlbMuvvhix/0JEyaY19heeOEFcz85OTnf99D313X083Jq166deS4xMTHP53SxrV692qxbs2ZN68SJE47H33zzTfP4zJkzHY/VrVvX6tu3b4Hv6a5s+np9H9vy5cvNupMnT3ZZ7+abb7bCwsKs3377zfGYrhcdHe3y2HfffWcenz17tuXOjBkzzHqLFy92PJaenm61adPGKlu2rMu2a/m6detmFdb1119vtW3b1nH/lVdesSIjI61Dhw7l2nYtw6RJk1we12OhRYsWLo+dPn3a5b6WtUmTJtbVV1/t8niZMmXy3Cc9evQwdfX77787Htu3b58VFxdnXXXVVbmO1y5duljZ2dmOx7VetP6HDBnieCwzM9OqVauWy77evn27ef3cuXNdPv/GG2+06tWr5/KeedHX6rJp0ybHY7t27bJiY2Otm266yfHYwIEDrYSEBOvw4cMur+/du7f5Ptn1ZR/P55xzTq46dFcGfX/9vuk+07J07drVPP7ss8861vvXv/5lhYeHW1988YXL6/V7put+9dVX5v6OHTvMelr+rKwsl3Xt+tDP0f3TuXNnl3VefPFF817z588v8Ptsf3eeeeYZl3105ZVX5vv9AwAArvR3X383P/nkE8dvtbZ3RowY4Vjn448/Nuu8//77Lq+97rrrTJvD07aC0vu67k8//ZRrlxSmHbh582bzHiNHjnRZt1+/fuZx7V942o4qiLaVcr538+bNrapVq1p//fWXS/tct+3uu+92PKZtKn1tUlJSgdurtG3qXLd59Tnyo215u42Zc5kyZYrHbfO8tju/fpy79rnd7rbr4OTJk1b58uWtQYMGuax34MABs1/sx48ePZqrXVpY9jbef//9jsf0GNe+jrZF7f7m2bbpC9snstvA+vnO7/noo4+az3eut7Ptp6ic+03rdejQofluw7fffmtes2zZMrfbmrNfrN9DfZ3zd1/3b/369U392e19u6/SuHFjKy0tzbGu9rn18R9++MEqLN0O52NPP0Pr4LbbbnNZb/r06aa+du7cWWx9MPgOU7sACAk6bFCHleXHvgCPDoUr6oU59axyXkNQ86Nn7jXD26bDWnXIoJ7dL076/jpXoJ4Jd6bZ4Pobn/Nq75q965zVodkgmnWtQ+kK+hzNKNAsI5tmGOnnauaEnpEvCs1i0LP+zu+rGSP2kL38MiGcaeZ4zvI7Z8poZrRmKuh6zsMO3WWd6IgHHaKq2UE23Z+aEaJZFzmnOtGsAudhqZqVo/Wvj9t0P+m8/85l1bnFdV3nIdCayaL7TbMqck5ZlJc2bdqYoYQ2zSzRTGutV90WLcfbb79tLv6ptzW7yF40Y0TrJme9aGaPJyMp5s2bZzIsdHinbuOqVatMJv/o0aMd6+gIBs0sa9SokUsZdCiy0lEVSrPN9Hur2TY552W360OznTTjRbM4nNfRUSp6POccBprX91mPac3ach7JoPtIs2cAAEDhaBtGR3rp9BL2b/Vtt91mssDt6T30t16zqDV707l9phnBuq6nbQVbu3bt8rwuT2HagfY0MJq57SxnO6Ao7ajC0otK6uhVzYx3zmLW9rlOl1HYfoTz9mp5tGxaN9rmdJ5OwxPaPtX9k3NxbrN70jYvDloezXLWMjnvF23Pafnt40XrR0dC6LQgejwUhWYT2+zsYm2LapvUG236wvaJ7DawHqfO7+kus7mo/ZT8+tma9b1v3748n7czznVbNLu8sPRY11EIOpLAuc+voxJ0+p1t27a5rK/teufRLfYo7rM57rRPoftKRwY4xxp0n2q2vI7ILu4+GEoegXQAIUEDt85B65y0Qa7DIXVYoDbsdXicNkA8Carr3NCeTGfRsGFDl/vaWNG5HQs7715R6XzxOk9fzvqwrzauzzvTH/icdE68ghqV+j66jTkDm/l9TmFph0qHjl588cVm2hhdtNGZsyFq0/nnck4Vk1f5dfigDqPT9bVjYg8rLUxnIjk52TT8nOfBc95ePY5yzn+fs17tRqTO65nz8Zxl1ZMwOhWJXYfaidQ60eGFRTn27Ma8boNuiy7aydBhnFoPzosdXNbhrc5yNhQLoo1G7cxoANue61I/3/l40fkSdUhtzjJoWZ3LoPOq6+vcXbDWrquc+0i/s3ryI+fxmNf3WdfRkyPaSHeW134HAAC5abBIA+YaRNdr5NhtOW3H6ZQGemJd6YlrDQpqkos917lO9aLtHedAemHbCgW1VwrTDtR2gLY3cr6Htt+dFaUdVVj5tWfsNqcG3HS+8IJoO1KTZew51rVs9vVgihpI1xMf+p45l7p16xapbV4c9HhReqIl577RpBh7v2hChU77okFt7RvqNXN0KhCdsqMw9DhxTq5R9jHp3Nc7mzZ9YftE9nvnbP/rNmu95+Vs+ik5ab39+OOP5rUa+NZ2v3PwWr9Pmkjzz3/+0xxDGjCeM2dOgcehbld+3wPn7c5vm+xtP9vjTvehPVe90qkj9TpLee3D4uiDoeQxRzqAoLd3717zQ5yzketMsw70Qh+ahaCBPc040caJNrK0UVWYq717ko1bWPllImgnpKSuQJ/f5+S8sExJsRuGeuIjL9owc264FqaevvjiCzOfnjaSda46DZZq9rxeiGnp0qVSHPIrV16P56xrPdGj88prXWinRy+yqRkh3gro2ieQdG7G/Ob/zjlPpafHv86Jr50rpXM1asNZM3W0Y23PhanlaNq0qUyfPj3P98jZmPem4vg+AwAQ6nTeYM2q1mC6Ljlp28a+tom2d3SOdA1m6qg/TXLRzHO9eL3N07ZCXr/v3m4HFqUdVZI0AUEvtKh1qfWmdaTJA5rhq/OpF3V0bmGVVB8mL/a26TzpOnI2Jz2B45yxrZnBOvJRM4bHjRsnU6ZMMcewBq+94Wza9J72iUqqn5KTXgRVs7810Kz9ap1XXU9S6Ikxnetf6Rz5OspCT5zpOjqCWeta52fXPoM/92k1kUezzHXfaVBd/9fvk253sP3twN8IpAMIetpQUnp2u6DMAW1U6qKNSr2IymOPPWaC6xrwK8yUGUXJiHD+EddMAucfRz1Trmelc9Iz7M4NI0/KplkhOsRPh585Z6X/8ssvjue9Qd/n+++/Nw0C5yzjs/kczVzSi9xowFWHnzrTz9Ez/9rhefzxxz16Xx1Cp9kx2kjWDBSbdqByyquuNUtArxSvGQg56fbq9nsz6KuZUnphK21A63BCzWTRi9UW9dhTekEq3QY7Q0iPDT1hYwe7i9s999xjOm+67/TiQFrPOqXQd999Z76T7o5xXU/3vw7h1Ivn5sU+3nQfOX93dKirHleF2U59D82U0xEuzlnpee13AACQm7ZddFo3zTjNSQNrGmxLTEw0AW8NbGtQW5NbdPoGDWBq29xZYdsK3mgHajtA2xvabnDOLNX2uzNtSxVXO8q5PZNXm1MTEzTLXOVXH3oxS83y1+konLN0c06D40ue7svCrm9PV6nHYGH2ja6v01/qou1nbWdq0FeDpe7ocaKBbDsL3W5rK+cLlRa1Te9Jn8g+ZrT8zm1gzX4uiVEASr/HOiWSLppRrRcZfeqppxyBdKUnxHTRMuu26QkC/VugF0nNi25Xft8D+/mSogF0zarXk4Ra77pP88r298c+GDzH1C4Agpo2uJ988kkzZEwbJ/nRYXA52QE5ezip3SjNK7BdFHqFb+e51PTq4vrj69yg0Mabnol3vqK6Dj3NOU2IJ2XT7F/9cX7xxRddHtcgpjZCnT//bOjn6PBH57kt9Ur1s2fPNkHInI2+wrAzL3QubZ1T3nnRs/76nnlN71KYDAXddnteTnvYpWag5KR1nbOe9fWaPaVZFM7DNXWIsjamtPOn83B7kzaQNXD80EMPmc/XjJbCWrduncv8eno8adl1G/S9dNHh1Nqx1KGYOWnD29s0A0g7KT///LMpi9J9+ueff8qrr76aa30dQmkPXdYsNT1ZMWnSpFxZVHaWiTZGNTtk1qxZLpknOle7jljRBm9hjmk9hnWot02PGT2mAQCAe/rbrcHy66+/Plc7ThcNCmrbWAO8Sn/b9XEN/GpijP4GO0/r4klbwRvtQDspR7PWneVsBxRnO0oDktpHee2111zao/o5msmrbZWC+gd2Zq5ze0jbQnklkPiKBhY96Xfl1T7Pi+5DbZNrwpROi5LfvtGpNlJTU12e036ZBjntvmFBnPtaWtd6X0c66Emfs23Te9In0jawfq4ep8773JMknKLS71TOKVr0JIZOM2rXo15HSr/bzjSgrt9/d3Wtx/qGDRtMv8am33edFkVPVrib8tHbdJ56/RsyYsQIcwJFM8oDpQ8Gz5GRDiBo6LBPPQOtP8QawNQgus7BrGejtUGumSb50QCcTu2iwTRdX8+UayNZh5LZFzDRxpPOIahnxrURpQ02nYPO07mhnTMQ9L11vjMtrzZmdPoZvfihTeds1wB7165dTaNIh2JqBoTzxT89LZsOUdTpMzSjRzsJOjxWG976I65DGHO+d1HphV50OK4O09N54rRBo9tiZ1q4m7M+P9og1M5DftndOixXL6SjDRTNdCgs3e86CkHrWS8OqvtfM6V0f2hWvTMduqcZ/bq+NgK1jrWuNVtCjzfdp5ptoYFh3X5tAOrcgN6mZa5UqZKZS1FPfmijtLCaNGliOhI6bFIzr+wO4cSJEx3rTJ061WQm6bbpMamNUT3hpHWr25/XyaezpceKXjBUh3tqcFw7FjqMWy9IpWXRzBRtkOv3XB/XzDEd/qr7SY9nPWmmQ0d1ahjdro0bN5p9pENDNctj7NixZht1P+uxolksuu0tW7bMt8Gb87ujZXjkkUfMd0frRAMCRZ1LFACAUGJfkE9/g/Oic5Tr77W29+yAuf6vAcAJEyaY4Jo9/7GtsG0FdwrbDtQ2oAa5tB2rF3rU8q5du9aRaeycFV2c7SidGkPbfnrhQr34o54w0DrS+ap1/mnn8iptI2lwVoOp2pbRoJ0mF+htHRGoI+30RIS2JTWpp6j0hEZemdqaQKPtOk/oiAStM03I0axu7Tdp+1WXvOTXPs9Jg+iaEKHHjfYVtF70mNu9e7eZ3lOPHw146z7VgLf2v7Qc2q7X0RLaZytMoFv7nTpVqE7PoeXQfqq+v07fknN++KK06T3tEz344IOmPawnsTQA/e2335oy6QiG4qTfd+1Pa4Bf+5x6LOh+0ja6ZvYr7bPrSbRbbrnF7Gvty+uJMzuonB9tj7/++uumzrRPo8eInmDSbH0NROe8Tldx0n2qfz90H2qfPL8EHX/tg8FDFgAEuAULFuipdccSHR1tVa9e3brmmmusmTNnWidOnMj1mgkTJph1batWrbK6d+9u1ahRw7xe/7/99tutX3/91eV17733nnXBBRdYkZGR5vX62apdu3bWhRdemGf59DldbKtXrzavff31162xY8daVatWtUqVKmV169bN2rVrV67XP//881bNmjWtmJgYq23bttamTZtyvae7svXt29eqW7euy7onT560Ro0aZbYzKirKatiwofXss89a2dnZLuvp+wwdOjRXmfT99H0LcvDgQat///5W5cqVTb02bdrUUa6c76fb787mzZtNecaNG5fvOn/88YdZR7fN3vYyZcoUuP/VvHnzTD1oPTdq1MiUM6/1fvnlF+uqq64y+0yfc66HLVu2WF26dLHKli1rlS5d2urQoYP19ddf53m8bty4Mc8yJScnuzye3zao++67z7xm6dKlVmHZ+3Tx4sWO7b344ovNcZnX/tN1a9eubY4T/V517NjReuWVV3Idz8uWLfO4DHl54oknzPN2edLT061p06aZ75eWtUKFClaLFi2siRMnWsePH3d57fz588222Ovpd+STTz5xWefFF180+1e3p1q1ata9995rHT161GUdd9/nv/76y7rrrrus+Ph4q1y5cub2t99+6/KdAwAAud1www1WbGyslZKSkm/19OvXz/xGHz582NzXtqm2Q/R3dvLkyXm+prBtBXftj8K2A7Xs+h4VK1Y07b0ePXpY27dvN+tNnTrV43ZUQbRdqO+tZXH26aefmn6Btke1TaJ1u23btlyvf/LJJ00/Ijw83LxPUlKSeXzFihXWRRddZPZHvXr1TP1pO8p5HZVXnyMv2pZ37o85L879EE/a5tqG1v2ofQjnOvCkfW63u523SWk7U9vs2pbTOmjQoIE59rSfpfT4032nx4KWV9dr3bq19eabbxZYF/Y2/v7771bnzp1Nn0DbnFrurKyss27TF6VPpJ+r34eEhARTR+3bt7d+/PHHXH06b/RTnPdVWlqa9dBDD1nNmjWz4uLizLp6+6WXXnKsv3PnTmvAgAFmH+i+0O+W9qH0GC+o/6l1fPPNN1vly5c3r23VqpX1wQcfuKyTX19FjwlP2+96TOQXRtVjQ58bPHhwifTB4Dth+o+nwXcAAOB7enEinZpEp9Cxh8AWRLOlhg4dmmtqHwAAAHhu69at5uKTmo3tbipJwJttevgXHd2tIy90lLuOkM2JPljwYI50AAACkM7bqB02HfJIgxsAAKD46TQqOelULzqNhF4cFfAUbfrgoNMj6cVc7WlhEbyYIx0AgACi83bq/Hg637zOz6kXtQEAAEDx0+ve6LV/9HpDOm+2zjOti14bKL/5qoG80KYPDm+88Ya5loLOgT9z5kyXayUgOBFIBwAggGzbts0MG9YLEc2aNctcaAgAAADF7/LLLzcXl9cLnOtFOuvUqWMu8KkX9AQ8QZs+ONx+++3mIqp64d/77rvP18VBCWCOdAAAAAAAAAAA3GCOdAAAAAAAAAAA3CCQDgAAAAAAAACAG8yRDhQgOztb9u3bJ3FxcVw4AgCAAGRZlpw8eVJq1Kgh4eHkkQDwHH0CAAACmzf6BATSgQJoEJ0rsAMAEPj27NkjtWrV8nUxAAQg+gQAAASHs+kTEEgHCqCZ6PYXLT4+nvoCnKWkiNSo8fftfftEypShfgD4nRMnTpiT4vZvOgB4ij4BAACBzRt9AgLpQAHCwsLM/xpEJ5AO5BAR8b/beqKJQDqAAPhNB4Ci/v2gTwAAQOj2CZgkEgAAAAAAAAAANwikAwAAAAAAAADgBlO7AACKTodEXXDB/24DAAAAAAAEIQLpAICiK11a5KefqEH4paysLMnIyPB1MVBCoqOjJTycwZYAAAAAigeBdAAAEFQsy5IDBw7IsWPHfF0UlCANotevX98E1AEAAADA2wikAwCAoGIH0atWrSqlS5c+q6uyIzBkZ2fLvn37ZP/+/VKnTh32OQAAAACvI5AOACi606dFWrb8+/bGjX9P9QL4eDoXO4heqVIl9kUIqVKligmmZ2ZmSlRUlK+LAwAAACDIEEgHABSdZYls2/a/24CP2XOiayY6Qos9pYueTCGQDqC4pI6dIdExsVQwAADFIHb6GPFnXJEJAAAEHaZzCT3scwAAAADFiUA6AAAAAAAAAABuEEgHAAAAAAAAAMANAukAgFySk5Pl999/L3DZuXOn4zV6Wx/T1wLwTL9+/czUJEOGDMn13NChQ81zuo4/0rLltTz77LNuXzdnzhypV6+exMbGSuvWrWXDhg2O5/74449833fZsmUlsFUAAAAA4IpAOgDAhQbCh/QbICP6DyxweWjIfY7X6W19TF9LMB3wXO3ateWNN96QM2fOOB5LTU2VpUuXSp06dfy2Svfv3++yzJ8/3wS8e/Xqle9r/v3vf8vo0aNlwoQJsmXLFmnWrJl06dJFDh065KiLnO87ceJEKVu2rFx77bUluHXwt5NNuujFZKtVqybXXHONOd6ys7Nd1tUTNDNmzHC5b79WL0TctGlT+ec//+nymjVr1uR78ubAgQOO9U6cOCGPPfaYNGrUyJwEql69unTq1EneeecdSUpKyvc97GXhwoX5buPXX38t1113nVSoUMG8t5Zz+vTp5gK6zpzfLzIy0vx90O9TWlqaYx39Hb733nvNczExMaac+h376quv8qwX52Xq1Kl5ntCqWLGitGvXTr744gvz/Ntvvy0RERHy559/5rk9DRs2NOWyrVu3zqzfrVu3PPdrXouWUbVv315Gjhzp8v4//fST3HrrrVKlShWzjeedd56MHz9eTp8+net40Pf65ptvXB7X99P3BQAAKKzIQq8JAAgJGiRIO3lSRrTuILUqVHa7blh6uqRv22ZuP3VNT9mTckJmrl9t3kM7tgAK75JLLjGjOjQg16dPH/OY3tZAWP369V3W1cDhtGnT5JVXXjFBPg0gjRs3Tm6++WbzvAbeBg8eLJ999pl5Xt/jvvvukxEjRrgEsI4dOyZXXHGFPP/885Keni69e/c2AUgNVBaWBuicvffee9KhQwc555xz8n2NBgcHDRok/fv3N/cTExPlww8/NEHRRx55xATbcr7vu+++a4JmGkxHaOratassWLDAHN8HDx6UlStXmmP6rbfekhUrVpigcn4mTZpkjjkNsuqoBr1ds2bNXCdmtm/fLvHx8S6PVa1a1fxvf1+OHz8ukydPlpYtW5rPXLt2rYwZM0bWr/9/9u4EXsb6/f/45VjOQY593xLKGiJbG1GUIqnQRqRV2YqUIi2EhDZtqC/apVJppVWKKCmShLJnJ8dy5v94f/rf85uZMzNncY7jzHk9H487M/fccy+fmTN97uu+7uuz0F308YwbN87t4yeffOKfV7Ro0bD7532/9Tcxb948K1asmHuf1qsA9GuvvRY0oK7aQe1x6NAh+/HHH937ChcubA888IB7XRey9Df94osvur9Ftdenn35q//zzT9h2CVSkSJGg59qPunXr2rZt2+yhhx6yiy66yH777Tfr2LGjlSxZ0m3j7rvvDnrPF198Yb///rv17t3bP++FF16w2267zf27YcMGq1Chgk2cONEfuJfy5cv7j030WxCOguK6gKFJvx26sKK7WgYNGuSOU21YoEAB//K6MDFkyBD3WQEAAGQUgXQAiFHKRlNAO73Wrl1rhw8fdkH06mWCA1lhjX3W/aOQmW/L/2XtAceVffsiv6ZATUJC2paNizMrWDD1ZQsXzsheWq9evVwQyQukK7CsAJmyZQONGjXKpk+f7gLQyvpU0Orqq692F7CUMapAe6VKlVzAUIEuZboqsK4glYJ1HgWbNE//KujVtWtXa9iwoT+wNmLECJdBq8zUtFCwTkEtBdYiUXBv8eLFNnToUP+8uLg4FxBTwDAcLb906VJXDga5l5dZLQqC6+JT8+bNrU2bNu57ev3110d8r4LD3nsVUB0zZox9/PHHKQLpCporiB2OgsX6W1AQWUFgjy5kde/e3QVrA4P5uuij56EXhULt27fP/c0pMK2LYx4djwLEmq9Auv4+PdpHb726g6NTp07u7g4v4K+scf1u6PdAqlatak2bNo3aLpHoN0TLaFIb6M4ZXTTQfl1zzTWu7UMD6frtUskmBeBl79697k6URYsWuYt73nt0YSH04kLgsYXj8/lcgL527druYqN+P7xj1GfRqFEje+yxx9zn7NHvn34v33//fZf1DwAAkBEE0gEgBnnlWZRZnl77/v3XNm/Y6LLcgJgRLYtZQZX33vu/58o+DSkN4KegVGBQW2UHtm1LuZzPl6HdVDBcAWZd0BKVYVDQKjCQrvINDz/8sMsSbdGihZunjNOvvvrKnnnmGRc4U0a5SqF4lNHuZbUGBtJVQuKJJ55wWZ8qVaGSC8rm9ALppUqVsurVq6d5/xVAV2Du0ksvjbiMslqVUawAYSA9X7FiRdj3KINVQbOWLVumeV+QO5x77rmuNJACqtEC6R5dZFL2944dO4IyltPyPv0t6iJXYBDdczR3Snz00UcuU/yOO+5I8drFF1/sgsMvv/xyUCA9kAL7uvvEG0dB+6Jp9uzZ7kKDLkBkBpWdeumll9xjr+0U0NYdJrqYd/bZZ/uD5rpLQMFsj3579BtzyimnuN85lVXRb11gln1a6aLaL7/84speeUF0j74Luiin9goMpOs3UGNQaJvKdg99HwAAQFoQSAeAXF6eJdR3a36z0evfsMNHCKQDx5oyyhXMVramsi71WMHsQMocV3kK1YcOzfRWJqZH2dvKCl23bp0LgOl1ZZsHUrZoYOkEZacvW7bM/7xv375uSittT4FGZeZmFu27AmYqXQOEowDtTz/9FLVxFFQdNmyYuxClu65U7ztc4F13cgRSlrNqcesCkILv2lZmUyBcdLEoHG3TW8ajDHj97epYdEwqt+Ld5aEseP2G6IKYsrCVua8LbCrddOqpp4Ztl0AffPCBnXXWWf7nuoClwLN+d/S71LhxY3cXgNSpU8cF6/W37wXSFTTXctpe4MUwBdBFgWyVx1GZlYzUKE+tvTRfFxZD6Th1x8+MGTNcJn1q1K6BdeczcpcfAACILQTSASCGpbk8S4B1/2xN+8IHkyzfmPvcw8ODR6Z394BjZ+/eyK+F1uD9/wNehhWaxZjGkifpLe/iBa/DlTJRtqeohIrKWwTyMk+VOavsVtU+V9a6ssTHjh3ryjEECq2FruzQ0IEb00qlJFRfWuUbotGFAQUAVQYmkJ6HK+egzFYF8K699toM7Rdin4K2qWU233nnnS5jWzXM9VhjBtSoUSPs9ziwRrj3N6JtZLX0bEPZ3sq81t0durimQT0VHNbfvlcjXRfidDyqJ67guMrZaJBVL3M9sF0Chf6u6G9awfyff/7Z1WxXkD7wt0O/WQMGDLDHH3/ctZ2C6pdffrm/HfW7oPrluhPAC/Qru17B9aMZ7DO9n4kuVOp3UQOSRsruDy2hFXhnDwAAAIF0AEDG+XwWt3a1/zFw3EpPzfKsWjaNlK2p7HEFBtu1a5fidWWAKmCuTHOv/nEolYRRFqmChR4NZJqVFBRTpqpKK0SjkhBaTiVkLrnkEjdPwXs9D5f9rvWqFjMDGCOSX3/9NcWAvOEu4ChwrkljB9SvX9+aNGni/p4CaT3haqTr+6f5kcoPHQ2VbvGOI1z5Is0P3U9ddPIuBKhcyp49e1yWugZB9ebrzhDduaJJd3QoA3/48OFBgXOvXaJRDXaNxaBJGfCdO3d2QXXvwp0yzxVIVya6stL1+6MgdODfsN4XWBJHQXC9X6WlIg3Ampb2CrwLJ7C9vGVC6YLDU0895abUKMNfywdmpKstAABA7kVxOAAAgOOIsrUVCFIN4MCyKx5leSqrUoEr1SRXgFyDDCob1BvkUwEvDer34YcfujIICqJ9//336d4XBbm8Eg7RKMCk4GSkGtVah9blUXDqueeec/urY7355pvdgIsaWDWQMm1Vezktta+RO6k2uMoRKQM7rRQMVUZy4IC3qVFpEwWMVRZkw4YNYe8UUbA4I84//3xXakZ3kIR65513bNWqVS5IHo33W6FSSJEoGK+/s6Nx2WWXuYzywEC0fpOUga5MdJVOURDbKw2jNlFddR2bapt7048//ugC66plnl4qUaUMeWXlh95Bo/Vq/IhI7aXa8fo9fOihh9zFh2gU6E9MTAyaAABA7kYgHQAA4DiTWtDmgQcecMEgZX2qHrCy2FXqxcvKvfHGG92AnwoWNmvWzA1kGJidnlaqC52WTHaVk1CGaaTgldahdXm0X+PGjXMlFhQUU2Bt7ty5KQYgVWBONasVaARUr3rTpk32999/u4tHGnS3U6dOrj54ekv/9OvXz9599113wSnQli1b3DYCJ2/wbQVfFYTX35SCw7rYpSC3vqfKjPbKLqVX4cKF3UDBb7/9tt1www2u3vuff/7pMrmVPa7gdeAgwbJz5063bwrqq9b4yJEjXQBbvwf6e9cgrNOnT3frWrNmjbvQpdIuaq9ACiaHHm+0WuC6U+b222+30aNHu5JLHg06+s0337ia7Cr14pkzZ46rLa/X69WrFzTp4oeOMb20D3qf2l/rUNkY3aGjY9TgrCpnpcFMI1EbKwteYy8AAACkB6VdAAAAsplqDkcze/bsFIEkBQI1RcqkVGaopkCB5RbCbXPChAlBz0eMGOGm1CgwpSkSBQVDpWUgUwVKNQGiiy0aEFcZ0cWLF3dlhCZNmmQ9evRwGePpoexsXaDRxZz333/fP19lUkItWLDADaiprHHVG1cQWSVU1q5d6/ZDZWI0BkF6S5QEUrB83rx5LlivbO4DBw64O0vuueceFxQOrQHv3b2h+SrzopIq+ltR2yjrWsF+ZWzrIpYuBOgCgAYfvfvuu4PWo+PXFEgX4hQQj0Ttrf3SXSaqmS5nnnmmazvdRRJ4UUMBb9VyD9c2CoIruK9gf+ggqKlRCRx9FqphfsEFF7gLAlWqVHH7pjsNvLIz4ai+uy5GXnnllenaJgAAQB7fsRg5B8gA3cqtk5LFixe7gaE0QJFXS1UnBMOGDXMnPn/88YfrnKuTrhObwPqL27dvt9tuu81lHOkESx32iRMnuhOMtFJWjta/a9cubulEjqET537X9bax7S9P92Cj835dZv1nPGczbuhv9aqcFH3hpANWoO/V7uHBJ6bb6l077c65r9vEqS9Y9erVj+YQgAxR8EnZl8rMVn1g5B7RPnv+Xw7gaHm/I5tvud8S4/n/CwAAWSFh/H8X6bNCZpwTUNoFxy3VcFSm0ZNPPpniNd1Kqlt6dVu7/p01a5atXLnSDUYW6KqrrrLly5fbxx9/7G4tVXA+WsYcAAAAAAAAAISitAuOW7pNU1M4uoKk4Hgg3V7atGlTVyNRt3Zq8DLdAqzB1Zo0aeKW0UBsF154oavLGpi5DiDjfCcw+BYAAAAAAIhtZKQjZujWDNWJLFasmL+epR57QXRR+ReVeFm4cGE27ikQQ+IT7NBjU9ykxwAAAAAAALGIjHTETF3UIUOGWPfu3f11jjZt2mRlypQJWk4DMGmgKL0WSVJSkpsCaygBAAAAAAAAyL0IpCPH08CjV1xxhWnc3Keffvqo1zdq1Ci7//77M2XfAADZIzk5mabPZdQPAICsljCqvyVkcIAyAACQsxFIR0wE0deuXWufffZZ0Ki75cqVsy1btgQtf/jwYdu+fbt7LZKhQ4fawIEDgzLSK1eunEVHAORwB5Ms38SH3MPD/e7J7r0BrECBAq6E14YNG6x06dLuucp+IfaD6Fu3bnWfdf78+bN7dwAAAADEIALpyPFB9FWrVtm8efOsZMmSQa+3aNHCdu7caYsXL7bGjRu7eQq2K0uxWbNmEdcbHx/vJgBp4PNZ3G+/+B8D2U1B9GrVqtnGjRtdMB25h4LolSpVsrx582b3rgAAAACIQQTScdzau3ev/f777/7na9assaVLl7oa5+XLl7fLLrvMfvjhB5szZ44dOXLEX/dcrysDsXbt2ta+fXvr06ePTZ482QXe+/bta926dbMKFSpk45EBALKS/h9QpUoVdxeS/v+A3EGZ6ATRAQAAAGQVAuk4bi1atMhat27tf+6VW+nRo4eNGDHC3nnnHfe8YcOGQe9TdnqrVq3c4xkzZrjgeZs2bVyWYpcuXWzSpEnH9DgAAMeeV+KDMh8AAAAAgMxAIB3HLQXDow0clpZBxZSdPnPmzEzeMwAAAAAAAAC5SVx27wAAAAAAAAAAAMczAukAAAAAAAAAAERBaRcAwFHxFYinBQEAAAAAQEwjkA4AyLj4BDv05AxaEAAAAAAAxDRKuwAAAAAAAAAAEAWBdAAAAAAAAAAAoqC0CwAg4w4dtHxPj3MPD998By0JAAAAAABiEoF0AMhiW7dutd27d2fovYmJiVa6dGk7biUnW9yyH/yPAQAAAAAAYhGBdADI4iD6TT17WdKePRl6f3yRIjZ52pTjO5gOAAAAAAAQ4wikA0AWUia6guj9mrW2SsVLpeu9f+3YZhMXznPrIJAOAAAAAACQfQikA8AxoCB69TLlaGsAAAAAAIAcKC67dwAAAAAAAAAAgOMZgXQAAAAAAAAAAKKgtAsAAAAAAGlwYOgEKxCfQFsBAJAGCeMHWywhkA4AyLj4BDv43Bu0IAAAAAAAiGmUdgEAAAAAAAAAIAoC6QAAAAAAAAAAREFpFwBAxh06aPlemOQeHu59Oy0JAAAAAABiEhnpAICMS062uMXfukmPAQAAAAAAYhGBdAAAAACIomfPnpYnT54UU/v27f3L6Pns2bPDvveSSy6J2r7//vuvDR8+3E4++WSLj4+3UqVK2eWXX27Lly8PWm7EiBFB2y9atKidddZZ9vnnnwct99Zbb1nz5s3d60WKFLG6deta//79/a9PmzYt7PEkJCSEPeb8+fNbtWrVbPDgwXbgwAH3ev369e2mm24Kezz/+9//3HFs27bNP69du3aWN29e+/77793zP//8M+w+BE7az/nz57vHO3fu9K/ryJEj9thjj7l90D4XL17cLrjgAvv666+D9sM7zsDPSbQuzde6AQAA0opAOgAAAACkQsHYjRs3Bk0vv/zyUbdbUlKStW3b1qZMmWIPPvig/fbbb/b+++/b4cOHrVmzZvbtt98GLa+guLf9BQsWWM2aNe2iiy6yXbt2udc//fRT69q1q3Xp0sW+++47W7x4sT300EN26NChoPUkJiamOJ61a9eGPeY//vjDBa6feeYZF/CX3r172yuvvOIuAoSaOnWqdezY0V0QkHXr1tk333xjffv2dccplStXDtr2oEGDgo5Nk44jlM/ns27dutnIkSOtX79+9uuvv7qAuNbXqlWrFBcz8uXLZ5988onNmzcvg58QAADAf6iRDgAAAACpUIZ1uXLlMr2dJkyY4ALiS5YssQYNGrh5VatWtTfffNMF0hWw/vnnn10GtRcY9vZD/yqgrMC1AvCnn366vfvuu3bGGWfYnXfe6d+GMt1Ds+K1vtSOJ/CYFahWwP/jjz+2Rx55xK6++mobMmSI20899qxZs8YFtnUxwKP9U7D/5ptvdpny48ePt4IFCwZt/4QTTgg6tkhee+01e+ONN+ydd96xiy++2D//2WeftX/++ceuv/56O++886xw4cJuvv694oor7K677rKFCxdGXTcAAEA0ZKQDAAAAQDaZOXOmC/x6QXRPXFycDRgwwH755Rf78ccfI2azK0hdrFgxO+WUU9w8BaJVEkbB98yk9SmrvECBAu65ss07derkzzAPLKdSqVIlO//88/0Z5NpHBdtr1aplNWrUcIHwo2kvXRgIDKJ7lNWuYLqC/aElcZYtW5au7aptd+/eHTQBAIDcjUA6AAAAAKRizpw5Lms6cHr44YePut2USV67du2wr3nztYxHAWFv+8rqHjdunCsxo1Itctttt7nMdNUPP/HEE10ZFAW7FRgOpFIwocejOuPhjll1yLW+LVu2BGW6K1te2efKQveC5i+++KL16NHDXQgQlVXZv3+/q5EuCqi/8MILx6y9pEKFCq4MzD333ONK5qTFqFGjXI15b1JGPgAAyN0IpAMAAABAKlq3bm1Lly4NmiINtpleCkCnlTLPve2r/rnKpWhg0kWLFvlLmbz33nv2+++/27Bhw1wgXJnaTZs2dQFtjwYhDT2e559/PuwxqySKguPXXXedq73uUSa9ss+Vce7VZ1c9dC3nURBftc5VtkW6d+/uBgVdvXr1MWkvj8rQbN26NUUGfSRDhw51Fxu8af369RnYUwAAEEsIpAMAMq5AvB18Yrqb9BgAgFilALXKkgROJUqUCApMewN+Btq5c6fLaI5EZUo0YGY43nwt41FpFW/7jRo1stGjR1vFihVdrfVA1atXd/XCFRz/4YcfXImYV1991f+6MsZDj0frCXfMKjujALQC6oHZ5FpHz549XRZ6cnKyC6gr+H7SSSe517dv325vvfWWPfXUUy6QrknbUFZ4WgPaR9teHpW/UXD8/vvvD7qgEK0+vLL8AycAAJC7EUgHAGScBj6LT/hv+v+DoAEAkBspU1wZ4oGOHDni6puHC+x6VHpF5U9C66ArMP3YY49ZnTp1UtRPD5U3b177999/I76uEi+FChWyffv2WUYpaH733Xe7LPfAbSn7XNnas2bNckFzlXvxzJgxw2Ws69gCM98fffRRV0td7ZNeaq9Vq1a5QVVDab0lS5Z0mfLhqOyNjmPixInp3i4AAMB/99cBAAAAACJSjfFNmzYFzVOGtQbdlIEDB7ogsgbUVCBXQevHH3/cduzY4TLDI9GAom+//bYbPFOB4GbNmtnmzZtd/XVlWCvInifgYrWyub392LNnj8syV7a5Spd4A2sq4/rCCy+0qlWruoz4SZMm2aFDh4ICzCqPEno8UqZMGX9981AqIaMa6U8++aTdcccdbl61atXs3HPPtRtuuMFlcV966aX+5ZW9ftlll1m9evWC1qN648oOnzt3rnXo0CHdgfTXX3/dlZoZO3astWnTxg0Eqn1655133GvKpA9Htd6VkX7rrbema5sAAABCRjoAIOMOHbK8U55wkx4DABCrFPQtX7580HTmmWf6X1ftb5VRUcmSxo0bW/v27V2g+osvvrCyZctGXK+Cu5999plde+21LuNbpVT0XmWZf/vtt9a8efOg5ZcvX+7ffsOGDe21116zp59+2r1fzjnnHPvjjz/ccwX1NYCo9uOjjz5yWfMeBZ9Dj0eTBhSNRBcO+vbta2PGjAnKbtcFBF0wuPLKK93xiLLzlYkeWFPdo1I3CoBnZNBRXVTQMautlLGvYzrrrLNs7dq1buDTSy65JOr7FYD3Ss8AAACkRx5fRkZqAXIRnWSos6+al9RGRHppIK1+1/W2se0vt+plyqXvvVs22Z1zX7eJU19wdU6P1Xbn/brM+s94zmbc0N/qVUnlRDPpgBXoe7V7qDrpq3ftzPA+A0BW4f/lADLrd2TzLfdbokraAQCAVCWMH2yxdE5ARjoAAAAAAAAAAFFQIx0AcNzYunWru0qcUbqqXLp06UzdJwAAAAAAAALpAIDjJoh+U89elrRnT4bXEV+kiE2eNoVgOgAAAAAAyFQE0gEAxwVloiuI3q9Za6tUvFS63//Xjm02ceE8tx6y0gEAQFZIGNXfEjJYVxUAAORsBNIBAMcVBdHTO0AqAAAAAABAVmKwUQAAAAAAAAAAoiAjHQCQcQXi7eD4F/yPAQAAAAAAYhEZ6ThuffHFF3bxxRdbhQoVLE+ePDZ79uyg130+n913331Wvnx5K1iwoLVt29ZWrVoVtMz27dvtqquussTERCtWrJj17t3b9u7de4yPBIhhefKYFSn636THAAAAAAAAMYhAOo5b+/btswYNGtiTTz4Z9vUxY8bYpEmTbPLkybZw4UIrXLiwtWvXzg4cOOBfRkH05cuX28cff2xz5sxxwfkbbrjhGB4FAAAAAAAAgJyO0i44bl1wwQVuCkfZ6BMmTLBhw4ZZp06d3LyXXnrJypYt6zLXu3XrZr/++qvNnTvXvv/+e2vSpIlb5vHHH7cLL7zQxo0b5zLdARylQ4cs72vT3MMjV/SkOQEAAAAAQEwiIx050po1a2zTpk2unIunaNGi1qxZM1uwYIF7rn9VzsULoouWj4uLcxnskSQlJdnu3buDJgARJB+xvPM/dJMeAwAAAAAAxCIC6ciRFEQXZaAH0nPvNf1bpkyZoNfz5ctnJUqU8C8TzqhRo1xQ3psqV66cJccAAAAAAAAAIGcgkA6EGDp0qO3atcs/rV+/njYCAAAAAAAAcjEC6ciRypUr5/7dvHlz0Hw9917Tv1u2bAl6/fDhw7Z9+3b/MuHEx8dbYmJi0AQAAAAAAAAg9yKQjhypWrVqLhj+6aef+ueplrlqn7do0cI91787d+60xYsX+5f57LPPLDk52dVSBwAAAAAAAIC0yJempYBssHfvXvv999+DBhhdunSpq3FepUoV69+/vz344INWs2ZNF1i/9957rUKFCnbJJZe45WvXrm3t27e3Pn362OTJk+3QoUPWt29f69atm1sOAAAAAAAAANKCQDqOW4sWLbLWrVv7nw8cOND926NHD5s2bZoNHjzY9u3bZzfccIPLPD/zzDNt7ty5lpCQ4H/PjBkzXPC8TZs2FhcXZ126dLFJkyZly/EAAAAAAAAAyJkIpOO41apVK/P5fBFfz5Mnj40cOdJNkSh7febMmVm0hwAsfwE7OOqp/xoifwEaBAAAAAAAxCQC6QCAjIuLMytVhhYEAAAAAAAxjcFGAQAAAAAAAACIgox0AEDGHT5ked962T080rl7jm7JrVu32u7duzP03sTERCtdunSm7xMAAAAAADg+EEgHAGTckSOW96N3/nvY8YocHUS/qWcvS9qzJ0Pvjy9SxCZPm0IwHQAAAACAGEUgHQCQ6ykTXUH0fs1aW6XipdLVHn/t2GYTF85z6yArHQAAAACA2EQgHQCA/09B9OplytEeAAAgrANDJ1iB+ARaBwCACBLGD7ZYxWCjAAAAAAAAAABEQSAdAAAAAAAAAIAoCKQDAAAAAAAAABAFgXQAAAAAAAAAAKIgkA4AyLj8BezQiMfcpMcAACDtevbsaXny5HFT/vz5rWzZsnbeeefZlClTLDk5OWjZE0880SZMmBD03HtvoUKFrH79+vb8888HvWf+/Pn+ZUKnTZs2+ZfbvXu33XPPPVarVi1LSEiwcuXKWdu2bW3WrFm2Zs2aiOvwpmnTpoU9vsB9DJxGjx7tXv/zzz/d87x589rff/8d9N6NGzdavnz53OtaLnD5cNO3337rltG+ePPi4uKsfPny1rVrV1u3bh1fTQAAcFTyHd3bASDn2Lp1qztRzIjExEQrXbp0pu9TjhcXZ76KlbN7LwAAyLHat29vU6dOtSNHjtjmzZtt7ty51q9fP3vjjTfsnXfeccHkSEaOHGl9+vSx/fv32+uvv+4eV6xY0S644IKg5VauXOn6MoHKlCnj/t25c6edeeaZtmvXLnvwwQft9NNPd9v8/PPPbfDgwbZw4UIX1PaMGzfO7eMnn3zin1e0aNFU9zFQkSJFgp5rn1966SUbOnSof96LL77o5ocLgGvbdevWDZpXsmRJ/2Mdq47Z5/O5CwG33HKLXX755e5YAAAAMopAOoBcE0S/qWcvS9qzJ0Pvjy9SxCZPm0IwHQAAZKr4+HiXAS4KHJ922mnWvHlza9Omjcuuvv766yO+VwFp771DhgyxMWPG2Mcff5wikK6gebFixcKu4+6773aZ3r/99ptVqFDBP//kk0+27t27uwz1wGD+CSec4J57201N4D5G0qNHD3cxITCQruea/8ADD6RYXkHzaOtUNrr3ujLSe/fubbfffrtLqAi9oAAAAJBWBNIB5Ao6cVIQvV+z1lapeKl0vfevHdts4sJ5bh1kpYc4fMjyvj/LPTxy4aWZ94EBAJCLnXvuudagQQNXWiVaIN2jMjBvvfWW7dixwwoUSHupNb3vlVdesauuuiooiB4YND8WOnbsaJMnT7avvvrKZcfrXx3LxRdfHDaQnh5btmxxbaPyMZoAAAAyikA6gFxFQfTqZdKWQYU0OHLE8r77+n8P23WiyQAAyCSqV/7TTz9FXUZZ6MOGDbOkpCQ7fPiwlShRImzgvVKlSkHPq1atasuXL7dt27a5gLW2lVW8fQz0wQcf2FlnneV/rvrwV199tasNr0C6/tVzzQ+nZcuWrv55oL179/ofq0yNLgKotIvK3ogy0gsXLpzm/VabavJktDwgAACIHQTSAQAAAOA4oyCwSpREc+edd7oBS1XDXI9VC7xGjRoplvvyyy+D6pJ7AWptI6t5+xhIJWxC9erVywXIH374YVfvfcGCBe7iQDivvvqq1a5dO+I2daw//PCDHTp0yAXtZ8yYYQ899FC69nvUqFF2//33p+s9AAAgthFIBwAAAIDjzK+//mrVqlWLukypUqVc4FyTgs/169e3Jk2aWJ06dYKW03rC1UhXyTrNX7FiRabvf+g+pkb7rsx41WVXkLxevXq2dOnSsMtWrlw56jqVre69rnWtXr3abr75Zvvf//6X5v1WvfaBAwcGZaRruwAAIPcKvh8OAAAAAJCtPvvsM1u2bJl16dIlze9RkLdr165BA3amRgHnbt26uYztDRs2pHhd5VIiZYVnBWWlz58/3/2bme666y6Xxa4s9fQMAquBSQMnAACQuxFIBwAAAIBsojrcmzZtsr///tsFelXapFOnTnbRRRfZtddem6519evXz959911btGhRigE3tY3ASWVPRCVPFIRv1qyZvfTSS/bLL7/YqlWrXJ3yRo0aBdUez4g9e/ak2HakeuN9+vSxrVu3pjrA6j///JNinQcOHIi4vI6vc+fOdt9997nnamtlv3/33XdHdWwAACB3obQLAAAAAGSTuXPnWvny5S1fvnxWvHhxa9CggU2aNMl69OiRYkDN1Kiky/nnn+8Cxu+//75//imnnJJiWdUgb968uRug9Ntvv7XRo0fbgw8+aGvXrnX7oVIrY8eOtaJFix7V8WlfvAC258Ybb7TJkyenWFZtoFIwqWnbtm2KeS+//LLLro9kwIAB1qJFCxc8L1OmjK1cudI/ECkAAEBaEEgHAAAAgGwwbdo0N6XFn3/+GfV5YGDe06pVqzQNKKpguQbX1JSaESNGuCkj+xzqxBNPjLp/DRs2DHo9teVFA5uGDm4qumgQ+N5jMdAqAACILQTSAQAZlz+/Hbp7tP8xAAAAAABALKJGOgDgKP4vktd81Wq4SY8BIDdYvXq1DRs2zLp37+5qT8sHH3xgy5cvz+5dAwAAAJBFCKQDAAAAafT555+72tELFy60WbNm+Qdi/PHHH2348OG0IwAAABCjKO0CAMi4w4cs7tP/BjNLbnMhLQkg5t11111uQMaBAwdakSJF/PPPPfdce+KJJ7J13wBkvYRR/S0hMZGmBgAgFyKQDgDIuCNHLN8b/3MPD7ZqR0sCiHnLli2zmTNnpphfpkwZ27ZtW7bsEwAAAICsR2kXAAAAII2KFStmGzduTDF/yZIlVrFiRdoRAAAAiFEE0gEAAIA06tatmw0ZMsQ2bdpkefLkseTkZPv666/tjjvusGuvvZZ2BAAAAGIUgXQAAAAgjR5++GGrVauWVa5c2Q00WqdOHTv77LOtZcuWNmzYMNoRAAAAiFHUSAcAAADSqECBAvbcc8/Zvffeaz///LMLpjdq1Mhq1qxJGwIAAAAxjEA6AAAAkE5VqlRxWemiEi8AAAAAYhulXQAAAIB0eOGFF6xevXqWkJDgJj1+/vnnaUMAAAAghpGRDgDIuPz57dAdI/yPASDW3XfffTZ+/Hi77bbbrEWLFm7eggULbMCAAbZu3TobOXJkdu8iAAAAgCxAIB0AkHFxec13Sj1aEECu8fTTT7sa6d27d/fP69ixo5166qkuuE4gHQAAAIhNlHYBAAAA0ujQoUPWpEmTFPMbN25shw8fph0BAACAGEUgHQCQcYcPW9y8D9ykxwAQ66655hqXlR7q2Weftauuuipb9gkAAABA1iOQjhztyJEjdu+991q1atWsYMGCVr16dXvggQfM5/P5l9Fj1TMtX768W6Zt27a2atWqbN1vIGYcOWz5Zr7gJj0GgNw02Oj111/vpvr167tyL3FxcTZw4ED/BAAAACB2UCMdOdojjzzissJefPFFq1u3ri1atMiuu+46K1q0qN1+++1umTFjxtikSZPcMgq4K/Derl07++WXXywhISG7DwEAAOQgP//8s5122mnu8erVq92/pUqVcpNe8+TJkyfb9hEAAABA5iOQjhztm2++sU6dOlmHDh3c8xNPPNFefvll++677/zZ6BMmTLBhw4a55eSll16ysmXL2uzZs61bt27Zuv8AACBnmTdvXnbvAgAAAIBsQGkX5GgtW7a0Tz/91H777Tf3/Mcff7SvvvrKLrjgAvd8zZo1tmnTJlfOxaNs9WbNmtmCBQuybb8BAEDONHXqVPv333+zezcAAAAAHGME0pEl/vjjj2PSsnfddZfLKq9Vq5blz5/fGjVqZP379/cP9qUguigDPZCee6+FSkpKst27dwdNAAAAXt9D/YjevXu7O+MAAAAA5A4E0pElatSoYa1bt7bp06fbgQMHsqyVX3vtNZsxY4bNnDnTfvjhB1cHfdy4ce7fjBo1apTLWvemypUrZ+o+AwCAnOvvv/92/Yxt27ZZq1at3MV8jdkS6QI9AAAAgNhAIB1ZQkHtU0891QYOHGjlypWzG2+80V+3PDPdeeed/qz0+vXr2zXXXGMDBgxwwXDRtmXz5s1B79Nz77VQQ4cOtV27dvmn9evXZ/p+AwCAnClfvnzWuXNne/vtt10foU+fPu6ifpUqVaxjx45ufnJycnbvJgAAAIBMRiAdWaJhw4Y2ceJE27Bhg02ZMsU2btxoZ555ptWrV8/Gjx9vW7duzZTt7N+/3+Ligr/GefPm9Z/AVqtWzQXMVUfdo1ItCxcutBYtWoRdZ3x8vCUmJgZNACLIl98O3TbUTXoMALmJSryof6M+hfojy5Ytsx49elj16tVt/vz52b17AAAAADJRvsxcGZDiC5Yvn1166aXWoUMHe+qpp1y29x133GF33323XXHFFe5W6PLly2e44S6++GJ76KGHXBZY3bp1bcmSJS5Q36tXL/d6njx5XM30Bx980GrWrOkC6/fee69VqFDBLrnkEj4w4GjlzWu+UxvTjgByFd3Z9r///c8NPKpxYdSnmDNnjhvcfN++fTZy5EgXUF+7dm127yqATHZg6AQrEJ9AuwIAECBh/GDLDQikI0stWrTIZaS/8sorVrhwYRdE1+Bcf/31l91///3WqVOnoyr58vjjj7vA+C233GJbtmxxAXKVkbnvvvv8ywwePNid1N5www22c+dOlzk2d+5cS0igAwwAANJ/Ef/DDz+0k08+2ZV1ufbaa61EiRL+19XfGTRokI0dO5amBQAAAGIIgXRkCWWFK0tr5cqVduGFF9pLL73k/vXKsCgzfNq0aXbiiSce1XaKFCliEyZMcFMkykpXZpgmAJns8GGLW/ile5jc7CyaF0DMK1OmjH3++ecRS8RJ6dKlbc2aNcd0vwAAAABkLQLpyBJPP/20K6/Ss2fPiKVbdCL6wgsv8AkAOdmRw5Zv2pPu4cEmkYNKABArzjnnHDvttNNSzD948KC7A08Z6rqIX7Vq1WzZPwAAAABZg8FGkSVWrVrl6qFHq39eoEABVz8UAAAgp7juuuts165dKebv2bPHvQYAAAAgNhFIR5ZQWZfXX389xXzNe/HFF2l1AACQI/l8PpdxHkrjvxQtWjRb9im3W79+vbsTUmPlKFFDdwP069fP/vnnn6DlWrVq5T47bypbtqxdfvnlQYPCHjlyxEaPHm21atWyggULuvr3zZo1s+eff96/jO64DFyPN7Vv396/jMoXevMLFSpk9evX969Dg9Xmz5/f3cEQjsYTCrzr4d9//3X7UapUKUtKSnLzVCIx3D4ETn/++aeNGDHCGjZsGLT+7du3W//+/V07qb3Ubmq/devWBS3nHafaI9Ds2bPD/g2EM2rUKMubN2/YMQMCj0HLFC9e3LW1yjGGXqzy9uWmm25KsZ5bb73VvaZlApfXIMCSWjupjQAAANKCQDqyhDrN6uyHK+fy8MMP0+oAACBHadSokQtuKvDWpk0b99ibGjRoYGeddZa1bds2u3cz1/njjz+sSZMm7m7Il19+2X7//XebPHmyffrpp66OvYLGgTRA7MaNG23Dhg329ttvuyD81Vdf7X/9/vvvt8cee8weeOAB++WXX2zevHn+AesDKWiu9QRO2n4gBYQ1/+eff3bb0LY/+OADF8Dv0KGDTZkyJcXx7Nu3z1577TUXTPe8+eabVrduXRfcVxBbunbtGrRtHat3bN5UuXLlFOtXezRv3tw++eQT105qLwX09e/pp5/u2jNQQkKCPfLII7Zjxw7LCB3j4MGDwx6rJCYmun3VhahvvvnGtbXGVlLwX59RIB2P9lUXFjwHDhywmTNnWpUqVSLuQ2CbaFwlb5vedMcdd2To2AAAQO5DjXRkCWW0aEDRUMp8Cc12AQAAON552a1Lly61du3a2QknnOB/TVm9ykDu0qVLNu5h7qRsZLX/Rx995DLIRUFVXfioXr263XPPPW7sHo+yw8uVK+ceqwRh37597cYbb/S//s4779gtt9ziMtU9ulASKj4+3r+eSIoUKeJfZsiQITZmzBj7+OOP7YILLnCBcn2n1C8ODALr7s3Dhw/bVVdd5Z+nMYUUiNfdEHqsILqO1TteURsEHlskag8FqBU495bV9j/88EOrWbOma08F+z26OKRllSSj/U8PDcqroLcuKCg4rkB5y5Ytg5bRhanAz6N27dp28cUXuwsHCsBPnz7dv6wuWq1evdpmzZrlbx891v6HO+/wBLaJ7hoJ3CYAAEB6kJGOLKHM859++inF/B9//NFKlixJqwMAgBxl+PDhblL5OmUre881aVyY7t27u2CmR9nJyi5G1lF2tQLACnwHBpVFgVIFW1999VUXgI70fmV/q5xI4Ps+++wz27p1a6btZ3JysssqV1a39x258MILXWa6ypsE0vfr0ksvtWLFirnnChwvWLDArrjiCjd9+eWXQaVo0rsfyuhWu4QGktV+ake1Z2AWv0qu6G7Sxx9/3GWNp4eC/vq7UBkb/avnaT2P0D7qooZK7QRSCRq1kUeZ7oxNAAAAjhUC6cgS6izffvvt7nZYdYA16aRE9Sq7detGqwMAgBxJA6Wr3EVqlOWsWtjIOirnoiC5spjD0XwFrwOD4k899ZS7m6Bw4cIuuWPlypVBZUfGjx/vlleg+dRTT3U1uQMztD1z5sxx6wmcQssXKgtd85W9ftlll7ka4Ndff70/QK3vkgLpXqBfQXMFyhUs9mjflMGu96pOuu6GCAwkp4eOSyVqorWX9kUZ6IE6d+7sSq3oolFa7d6929544w1/2Rz9q4sWe/fuTdP7VcZGA/iG1rnXer766it3MUHT119/HVSaJzOpHr2OI3ACAAC5G4F0ZAllaim7RzVEvVtPzz//fDv33HOpkQ7Eknz57dCNA92kxwCA/0TKgkb2trUynVWeR3dJKiBbo0YN10dV0Fbq1Knjapp/++23LqC9ZcsWV2rEC4B7Wrdu7dYTOIUOhHnnnXe6+UomUb9Ytde1PY/Wv2bNGpd4IgqQq0SQ+suiRJQXX3wxKFCsxwq+K7v8WH43VSdd+/Lrr7+maXndkaHSOl5ZHAXiVeJRdwikZx9DBzUtXbq0qy+vNlB76XG4cZkyg8rZqBSMN4WrOQ8AAHIXAunIErptVR3lFStW2IwZM1z9QmXZKKsm8LZnADlc3rzma9LSTXoMAMCxoqC0Aq2Rgruar0xuBV89CojqfZrOOOMMV25Eme2BAd64uDg38Gb//v1dH1ZBWy2noLdHGe3eerxJGeOBFODVfA1Eq9rnultTA5h6VJNcrykgrMC46oirTIkXPFaZlb///tvVRM+XL5+bdGenMrE1mGp6qR1UMiZae2nbgcF+z9lnn+2y4VXGKC3UXsuXL/fvtyYde6RBR8PtiwYFDVcSUhcg9JkosB+YvZ/ZdKy7du3yTxqYFgAA5G4MNoosdfLJJ7sJyAy6JTmjt9XqpFODdwEAgNigIOt5553nyrUMGDAgqE76pk2bXDLHtddemyKrOZBKrIgGxYxEWepyNDXvlc2sgLiCs2+//bZ/vgYdvfnmm61jx44uaN6zZ8+gYLQC5xogNNBDDz3kXtOxp4cuEKjOutpFA4AG1knX8asdFSwPvSDgGT16tMssP+WUU6JuZ9myZbZo0SKbP39+0LpUe71Vq1Yu0UalWyLRXQAzZ850g7Fqn0O1b9/eDh486D5X7W9WUUkeTQAAAB4C6cgSuhVVmSLKllFnOPT2U93iCqQ3iH5Tz16W9P9vvU6vff/+a5s3bLRDhw7R8JnpyBHLs2She+hr9H+DtQEAcCw88cQT1rJlSxdQffDBB61atWouE1plVSpWrOiCzoH279/vguyiGvYqR6ia9yrvIqplrkx1rVOBZmWhK/itxJDA4K/qZ3vr8SjrOlqZEY0VVK9ePRdkbtKkiZt3+eWXu0x11dTXPnjlQ9Tveffdd92Am3pPIF0cUN1yBaYjBb0jUR139c8VhB8zZoxbt45x2LBhro/05JNPRnxv/fr1XWmcSZMmRd2GgvxNmzZ1WeyhlOmv18eOHesv4aJ21L+q366BVbWPunNAgftIFz+8rHrvQggAAMCxQCAdWUInCgqkq26hOujRMoGAtFAmuoLo/Zq1tkrF018L87s1v9no9W/Y4SME0jPV4UOW/5nx7uHBJ6Zn7roBAEiFyqMoMK2BMJVtreCyAuDKZta80EDzc8895yZR2RcNKPr+++/7s6wVkFd9b9XHVjkPrUs1y0eMGOEC5Z65c+da+fLlg9atdSjbOlpmu4Ll9913n9umFCpUyGWdP/vss0FlSlTmReVjNN5QKG8MounTp7sgfHqz+FX/XRnpCt4riK020oCmWl+VKlWivl/vi1bnXJniWo8GWg2nS5cu9uijj/rHTFL/Tu2ocwWVclEbahBWnUvoeSTRXgMAAMgqBNKRJV555RV77bXX7MILL6SFkakURK9e5v9uRU6rdf9s5ZMAABwzGlgxf34GYT5Wba0EjtSo1Ehq+vTp46ZotK3Utvfnn3+Gna8AfKhnnnnGTYEGDRrkpnA03tCOHTvSdGy6AKApkLLmlVWeWmZ5uGPUYKjKxo9E+7Zt27aIrw8ePNhNojI2gaVs0rsvgWbPnp2m5dOzTQAAgFAE0pEl1IkON1ARAABALFDmbbjydV5G788//5xNewYAAAAgK6QcvQXIBMqgmThxoqt3CAAAECtWrVplZ511liutoUxo1eTWpExd/QsAAAAgNpGRjizx1Vdf2bx58+yDDz6wunXrpri1edasWbQ8AADIcVQWQrWy58yZ46/tDAAAACD2EUhHlihWrJh17tyZ1gUAADFl6dKltnjxYqtVq1Z27woAAACAY4hAOrLE1KlTaVkAABBz6tSpE3UwRQCxLWFUf0tITMzu3QAAANmAGunIMocPH7ZPPvnEnnnmGduzZ4+bt2HDBtu7dy+tDsSKvPnscM9b3aTHABDrHnnkERs8eLDNnz/f/vnnH9u9e3fQBAAAACA2EfVAlli7dq21b9/e1q1bZ0lJSXbeeedZkSJF3Mmnnk+ePJmWB2JBvnyWfEbr7N4LADhm2rZt6/5t06ZN0HwNsK566UeOHOHTAAAAAGIQgXRkiX79+lmTJk3sxx9/tJIlS/rnq256nz59aHUAAJAjaTB1AAAAALkPgXRkiS+//NK++eYbK1CgQND8E0880f7++29aHYgVR45YnuVL3UNf3YaWWyUdPOjuxMmIxMREK126dKbvE4Cscc4559C0AAAAQC5EIB1ZIjk5OeytzX/99Zcr8QIgRhw+ZPkfH+UeHnxiuuVG2/ftsT/WrLFRQ++x+Pj4dL8/vkgRmzxtCsF0IAfZuXOnvfDCC/brr7+653Xr1rVevXpZ0aJFs3vXAAAAAGQRAunIEueff75NmDDBnn32WfdcNUM1yOjw4cPtwgsvpNUBxIy9Bw5YgTxxdnvTVlajfKV0vfevHdts4sJ5boBCstKBnGHRokXWrl07K1iwoDVt2tTNGz9+vD300EP20Ucf2WmnnZbduwgAAAAgCxBIR5Z49NFH3UlmnTp17MCBA3bllVfaqlWrrFSpUvbyyy/T6gBiTsXiJax6mXLZvRsAstiAAQOsY8eO9txzz1m+fP91pQ8fPmzXX3+99e/f37744gs+AwAAACAGEUhHlqhUqZIbaPSVV16xn376yWWj9+7d26666iqXwQUAAJBTM9IDg+iix4MHD3YDrQMAAACITQTSkXVfrnz57Oqrr6aFAQBAzNAAwevWrbNatWoFzV+/fj3jwAAAAAAxjEA6ssRLL70U9fVrr72WlgcAADlO165d3V1248aNs5YtW7p5X3/9td15553WvXv37N49AAAAAFmEQDqyRL9+/YKeHzp0yPbv328FChSwQoUKEUgHAAA5kgLoGkRdSQGqjS758+e3m2++2UaPHp3duwcAAAAgixBIR5bYsWNHinkabFQnmcrYAhAj8uazw1f29j8GgFinpICJEyfaqFGjbPXq1W5e9erVXaIAAAAAgNhF1APHTM2aNV2mluqmr1ixgpYHYkG+fJbc+oLs3gsAOOYUOK9fvz4tDwAAAOQSBNJxbL9w+fLZhg0baHUAAJBjXHrppTZt2jQ30KgeRzNr1qxjtl8AAAAAjh0C6cgS77zzTtBzn89nGzdutCeeeMLOOOMMWh2IFclHLM+qX91DX83a2b03AJAlihYt6uqie48BAAAA5D4E0pElLrnkkqDnOvksXbq0nXvuufboo4/S6kCsOHTI8o8b4R4efGJ6du8NAGSJqVOnhn0MAAAAIPcgkI4skZycTMsCAICY8++//7o77bzBRdeuXWtvvfWW1alTx84///zs3j0AAAAAWSQuq1YMAAAAxJpOnTrZSy+95B7v3LnTmjZt6u620/ynn346u3cPAAAAQBYhIx1ZYuDAgWledvz48XwKAAAgR/jhhx/ssccec4/feOMNK1eunC1ZssTefPNNu+++++zmm2/O7l0EkIUODJ1gBeITaGMAQExIGD84u3chRyGQjiyhE0pNhw4dslNOOcXN++233yxv3rx22mmn+ZfzBu46Gn///bcNGTLEPvjgA9u/f7/VqFHD1S9t0qSJe123Xw8fPtyee+45lzmmwU6VMVazZs2j3jYAAMhd1NcoUqSIe/zRRx/ZpZdeanFxcda8eXNX5gUAAABAbKK0C7LExRdfbGeffbb99ddfLnNL0/r1661169Z20UUX2bx589z02WefHdV2duzY4QLj+fPnd4H0X375xd1eXbx4cf8yY8aMsUmTJtnkyZNt4cKFVrhwYWvXrp0dOHAgE44UAADkJrpgP3v2bNev+fDDD/110bds2WKJiYnZvXsAAAAAsggZ6cgSCmYrSyswoK3HDz74oDvhHDRoUKZs55FHHrHKlSu7DHRPtWrV/I+VjT5hwgQbNmyYq10qqmtatmxZdxLcrVu3TNkPAACQO6h8y5VXXmkDBgywNm3aWIsWLdx89XsaNWqU3bsHAAAAIIuQkY4ssXv3btu6dWuK+Zq3Z8+eTNvOO++840q4XH755VamTBl3AqsSLp41a9bYpk2brG3btv55RYsWtWbNmtmCBQvCrjMpKcntf+AEIIK8ee3wZde4SY8BINZddtlltm7dOlu0aJHNnTvXP19Bda92OgAAAIDYQyAdWaJz58523XXX2axZs1x5F00ahKt3796ulmhm+eOPP/z1znV7tQb4uv322+3FF190ryuILspAD6Tn3muhRo0a5YLt3qSMdwAR5Mtvye06uUmPASA30ACjuniv2ui64K673FQ3vVatWtm9awAAAACyCIF0ZAnVI7/gggvcrc9Vq1Z1kx63b9/ennrqqUzbTnJyshu89OGHH3YntDfccIP16dPHbT+jhg4dart27fJPqoEKAAAgV1xxhT3xxBPu8b///uvujNO8U0891SUNAMe7nj17Wp48eVJM6qeLSh96jz26+0LLjBgxImi+nlepUiXitlq1ahV2WzfddJN/GW/et99+m+Iu0ZIlS7rX5s+fn2L50OmVV15xr2vZwPmlS5e2Cy+80JYtW3aULQcAAHI7aqQjSxQqVMgFzMeOHWurV69286pXr+4G+sxM5cuXtzp16gTNq127tv9EVhljsnnzZresR88bNmwYdp3x8fFuApAGyUcsz9o17qGv6v+NT4BjQ+WyMlp+SoMiKrgAIH2++OILu+eee9zjt956y43HsnPnTnc3nMaC6dKlC02K454C5YFjDInX/23durXdcccddvjwYcuX77/TxXnz5rm7NAMD2t58LR+NklxGjhyZ4lwhkDfmUfPmzf3z9Pd1wgkn2Pbt21OsU8uGBvuLFSsW9HzlypXu/3UbNmywO++80zp06GC///67FShQIOr+AgAAREIgHVlq48aNbjr77LOtYMGC7mRTmSGZ5YwzznCd5EC//faby4D3Bh5VMP3TTz/1B84VdFq4cKErAwPgKB06ZPkfvss9PPjEdJrzGAfRb+rZy5IyOO5EfJEiNnnaFILpQDrpbrUSJUr4s3QVOFdQUEE6BeuAnEBBcy/hJJQC43v37nXjAHiBbQXQ77rrLhs0aJAdOHDAEhIS3L/qU6ucYzT6+4i0LU+PHj1s0qRJNmHCBHfOIFOmTHHzH3jggRTLK2ie2jo1fpK3XP/+/a1jx462YsUKd/cIAABARhBIR5b4559/3G3OylJR4HzVqlV20kknuRrpxYsXt0cffTRTtjNgwABr2bKlK+2i7X333Xf27LPPukm0bXWclSGmOuoKrN97771WoUIFu+SSSzJlHwAgO+iioILo/Zq1tkrFS6XrvX/t2GYTF85z6yArHUgfZc5qwHIF0xVI98pJ7NixwwUXgZzu5JNPdn1l9eMVSN+zZ4/98MMPNmfOHHv88cfd91/B9m+++caVX0ktIz0tGjdubCeeeKK7q/Tqq692A/rq7o8nn3wybCA9vRe/vL/T9GSj69g0eTJ6BxgAAIgd1EhHllCAO3/+/K4THHjrZteuXd1JZ2Y5/fTT3W2fL7/8stWrV891tJXJctVVV/mXGTx4sN12222ufrqWV4aN9oGTXQCxQEH06mXKpWtKb+AdwP/RBXr1MypVquSCjaoBLQr61a9fn6ZCjqCguMqmBE5KTPEoOO6Vcfnyyy9dcF0XXnWXqTdf/ypJxbsTNBKVewzd1owZM1Is16tXL5eFLtOmTXN1zSNd7O3evXuKdeq8I5D+RjVfWekzZ850GenpGRB41KhRVrRoUf+ki2gAACB3IyMdWeKjjz6yDz/80HVgAykrfO3atZm6rYsuushNkSgrXXUZQ2szAgAApNctt9xiTZs2dYORn3feeRYX919eiu680x1wQE6gQPnTTz8dNM8rWSS6QKSLRocOHXIBc++C0TnnnGPPPPOMe6z5aclG14Unb1wBT9myZVMsp0x0lY/5448/XCBdpV4ieeyxx6xt27ZB83RhK5AuACihR4OY6iLB5MmTLT2GDh1qAwcODMpIJ5gOAEDuRiAdWWLfvn0pBhESDRbEQJ4AACAna9KkiZsCqUY6kFMULlzYatSoEfF1BcjVn//+++9diRev/r8C6cocV59e9dFvvPHGVLelbO5o2/KULFnSJceoFKTqr19wwQWurEw4qnue2jqVLa9s9FNOOcW2bNni7ozVnSNppXMWzlsAAEAgAunIEmeddZa99NJL/pqGygpPTk62MWPGZEodRQAAgGNFWanq0yj4GJihGs748eOP2X4BWaV69eou+/qdd96xpUuXugC6VKxY0U0a7+jgwYOZ3q9XkF4lXYYMGWJ58+bNtPXeeuutrlSLSkJ27tw509YLAAByFwLpyBIKmLdp08YWLVrkOtmqU758+XKXvfL111/T6gAAIMdYsmSJK3HhPY5EiQNATqBBNDdt2hQ0L1++fFaq1P+NoaEgueqbK/M7sBSLguoadNQblDQ1+/fvT7EtZXoXL148xbLt27e3rVu3WmJiYtR17ty5M8U6ixQp4i52haM7Zfv06WPDhw+3Sy65xP2tql66gusE1gEAQFoRSEeW0MCfv/32mz3xxBOuU6sBPi+99FKXDVK+fHlaHYgVefPakYsv9z8GgFik0hbhHgM51dy5c1P0yVUCZcWKFUGBdN1h6tVHDwykT5061a688so0beu5555zU6B27dq5fQilAHdgMD+S6667LsU8BcVVYz2Svn37ujtGXn/9dbviiits5cqVtmvXrjQdAwAAgBBIR6ZTxpaySTSgT+jAQgBiTL78dqRj1+zeCwAAkEYayFNTanr27OmmUD169HBTWmhA0tT4fL6Ir6nGeejr0ZYXBf7DLaNSNd6dJWlZDwAAQCgC6ch0+fPnt59++omWBQAAMUeDIKqshTLTNYChxoAJ9MMPP2TbvgEAAADIOgTSkSWuvvpqe+GFF2z06NG0MBDLkpMtz8a/3UNf+YrZvTcAkOV69+5tH330kV122WXWtGlT6qIDAAAAuQSBdGSJw4cP25QpU+yTTz6xxo0bpxj4R/UJAcSAQwct/4gB7uHBJ6Zn994AQJabM2eOvf/++3bGGWfQ2gAAAEAuQiAdmeqPP/6wE0880X7++Wc77bTT3DwNOho6iBAAAEBOVLFiRTeQOoDcKWFUf0tITMzu3QAAANmAQDoyVc2aNW3jxo2ubqh07drVJk2aZGXLlqWlAQBAjvfoo4/akCFD3KDqVatWze7dAQAAAHCMEEhHpvL5fEHPP/jgA9u3bx+tDAAAYkKTJk3cgKMnnXSSFSpUyA2yHmj79u3Ztm8AAAAAsg6BdBzTwDoAAEBO1r17d/v777/t4YcfdnfcUbIOAAAAyB0IpCNT6WQy9ISSE0wAABArvvnmG1uwYIE1aNAgu3cFAAAAwDFEIB2ZnoHes2dPi4+Pd8916/NNN91khQsXDlpu1qxZtDwAAMhxatWqZf/++2927wYAAACAY4xAOjJVjx49gp5fffXVtDAQy/LmtSPnd/Q/BoBYN3r0aBs0aJA99NBDVr9+/RQ10hMTE7Nt3wAAAABkHQLpyFRTp06lRYHcJF9+O3L5tdm9FwBwzLRv397926ZNmxR35amc3ZEjR/g0AAAAgBhEIB0AAABIo3nz5tFWAAAAQC5EIB0AkHHJyWbbt/33uEQpWhJAzDvnnHOyexcAAAAAZAMC6QCAjDt00AoMvcU9PPjEdFoSQEz66aef0rzsqaeemqX7AgAAACB7EEgHAAAAomjYsKGrf+7VQY+GGukAAABAbIrL7h0AAAAAjmdr1qyxP/74w/375ptvWrVq1eypp56yJUuWuEmPq1ev7l4DAAAAEJvISAcAAOmydetW2717d4ZaLTEx0UqXLk2LI0epWrWq//Hll19ukyZNsgsvvDConEvlypXt3nvvtUsuuSSb9hIAAABAViKQDgAA0hVEv6lnL0vasydDrRZfpIhNnjaFYDpyrGXLlrmM9FCa98svv2TLPgEAAADIegTSAQBAmikTXUH0fs1aW6XipdLVcn/t2GYTF85z6yArHTlV7dq1bdSoUfb8889bgQIF3LyDBw+6eXoNAAAAQGwikA4AANJNQfTqZcrRcsh1Jk+ebBdffLFVqlTJlXSRn376yf07Z86cbN47AAAAAFmFQDoAIOPi8tqRVu38jwEg1jVt2tQNPDpjxgxbsWKFm9e1a1e78sorrXDhwtm9ewAAAACyCIF0AEDG5c9vR67qQwsCyFUUMD/zzDOtSpUqrqyLfPrpp+7fjh07ZvPeAQAAAMgKBNIBAACANFI2eufOnd2go3ny5DGfz+f+9Rw5coS2BAAAAGIQgXQAQMb5fGZ7d//3+IREWhJAzOvXr59Vq1bNZaDr34ULF9r27dtt0KBBNm7cuOzePQBZ7MDQCVYgPoF2BgCkWcL4wbRWjCCQDgDIuINJVmBg7/8ePjGdlgQQ8xYsWGCfffaZlSpVyuLi4ixv3ryuzMuoUaPs9ttvtyVLlmT3LgIAAADIAnFZsVIAAAAgFql0S5EiRdxjBdM3bNjgHletWtVWrlyZzXsHAAAAIKuQkQ4AAACkUb169ezHH390ZV2aNWtmY8aMsQIFCtizzz5rJ510Eu0IAAAAxCgC6QAAAEAaDRs2zPbt2+cejxw50i666CI766yzrGTJkvbqq6/SjgAAAECMorQLAAAAkEbt2rWzSy+91D2uUaOGrVixwrZt22Zbtmyxc889l3ZEjtSzZ0/LkydPiql9+/bu9RNPPNEmTJgQ9r1//vln2Pdq+vbbb/3LHTx40N3B0aBBAytUqJArjXTGGWfY1KlT7dChQxHX4U0jRozwb2vp0qW2ePHiFNsI1KZNG//famrHBwAAkBZkpAMAAABHoUSJErQfcjwFlRXUDhQfH5/m93/yySdWt27doHm6U8MLousilMoiPfDAAy6AnpiY6ILg48aNs0aNGtnGjRv979PdHffdd1/QuAMnnHCCu2jlady4sQvKT5kyxZo3bx60XQXc582bZ++++26mHR8AAACBdAAAAADI5RRULleuXIbfr6B5pPcrm/2LL76wRYsWuaC5R+MKXH755S7QXrhwYf/8okWLuozx0PUFBtKld+/ertyS1q8sd8+0adOsfPnyQRnnR3t8AAAAlHZBzBg9erTrcPfv398/78CBA3brrbe6jr2yWLp06WKbN2/O1v0EYkpcXjvSopWb9BgAACDUjBkzrG3btkFBdE/+/PmDgujpcdVVV1lSUpK98cYb/nk+n89efPFFV84lb96M90203t27dwdNAAAgdyOQjpjw/fff2zPPPGOnnnpq0PwBAwa4Wzpff/11+/zzz23Dhg3+WokAMkH+/HakV1836TEAAMiZ5syZ4xJPAqeHH344ze9v2bJlivd7Vq1aZbVq1cqSskqdO3d25V08Kumi0i7XXXfdUR3fqFGjXGa8N1WuXDnT9x8AAOQslHZBjrd3716XjfLcc8/Zgw8+6J+/a9cue+GFF2zmzJn+wb9UF7F27dquHmNoLUUAAAAgt2rdurU9/fTTGa7/r7rm6meHoyzxrNKrVy9Xf3316tVWvXp1F1Q/55xz3GDAR3N8Q4cOtYEDB/qfKyOdYDoAALkbgXTkeCrd0qFDB3e7aGAgffHixXbo0CE336NMmCpVqtiCBQsIpAOZQSfGB5P+e1yAAbsAAMipVF4lNPicHgoyR3r/ySefbCtWrLCs0KZNG9e/V130O++802bNmuXuVD3a41NNdQYjBQAAgQikI0d75ZVX7IcffnClXUJt2rTJChQoYMWKFQuaX7ZsWfdatHqImjzUQwSiOJhkBfpe/d/DJ6bTVAAAIIUrr7zS7r77bluyZEmKOulKfAkdbDQ94uLiXBkX3YlasWJF1/+/7LLL+BQAAECmI5COHGv9+vXWr18/+/jjjy0hISHT1qt6iPfff3+mrQ8AAAA43imRJDTZJF++fFaqVCn3+O+//7alS5cGvV61alX/43/++SfF+5XQon56//797b333nPZ4w888ICdeeaZVqRIEVu0aJE98sgjLgjesGHDDO+7AukjR450wfru3btbwYIF0318AAAAqWGwUeRYKt2yZcsWO+2001wnWJMGFJ00aZJ7rMxzZbfs3Lkz6H2bN2+2cuXKRa2HqPrq3qSAPQAAABDL5s6da+XLlw+aFPD2jBs3zmWTB04KjntUTjH0/bNnz3avqUSKkl8GDx7syq5orKLTTz/d9dtvv/12q1ev3lHtu0q7aPs7duxwNdMzcnwAAACpISMdOZYyWpYtW5YiG0V10IcMGeLqNObPn98+/fRT69Kli3t95cqVtm7dOmvRokXE9VIPEQAAALmJ6otriuTPP/+M+v60DCaqPvZdd93lptT07NnTTaFOPPHEiNv68MMPM3x8AAAAaUEgHTmWbgcNzV5RbcWSJUv65/fu3dsGDhxoJUqUsMTERLvttttcEF1ZMAAAAAAAAACQFgTSEdMee+wxNwCRMtJVF7Fdu3b21FNPZfduAQAAAAAAAMhBCKQjpsyfPz/ouQY3evLJJ90EAAAAAAAAABlBIB0AkHFxcZbc+P+XSopj/GoAABDbEkb1t4TExOzeDQAAkA0IpAMAMi5/ATt80x20IAAAAAAAiGmkDwIAAAAAAAAAEAWBdAAAAAAAAAAAoiCQDgDIuKQDVqDPZW7SYwAAAAAAgFhEjXQA6bZ161bbvXt3hlouMTHRSpcuTasDAAAAAAAgxyCQDiDdQfSbevaypD17MtRy8UWK2ORpUwimAwAAAAAAIMcgkA7kYNmRGa7tKYjer1lrq1S8VLre+9eObTZx4Ty3DrLSAQAAAAAAkFMQSAdyqOzODFcQvXqZchl6LwAAAAAAAJCTEEgHcigywwEAAAAAAIBjg0A6kMORGQ4AAAAAAABkLQLpAICMi4uz5Pqn+R8DAAAAAADEIgLpAICMy1/ADt9+Ny0IAAAAAABiGumDAAAAAAAAAABEQSAdAAAAAAAAAIAoCKQDADIu6YDlv/UqN+kxAAAAAABALKJGOgDgqOQ5mEQLIs2SDh60tWvXZrjFEhMTrXTp0rQ4AAAAAOCYIpAOAACOie379tgfa9bYqKH3WHx8fIbWEV+kiE2eNoVgOgAAAADgmCKQDgAAjom9Bw5YgTxxdnvTVlajfKV0v/+vHdts4sJ5tnv3bgLpAAAAAIBjikA6AAA4pioWL2HVy5Sj1QEAAAAAOQaBdAAAAAAA0uDA0AlWID6BtgIARJQwfjCtE6PisnsHAAAAAAAAAAA4npGRDgDIuDx5LPnkOv7HAAAAAAAAsYhAOgAg4wrE2+E7R9KCAAAAAAAgplHaBQAAAAAAAACAKAikAwAAAADCatWqlfXv3z/F/GnTplmxYsXc4xEjRliePHnclDdvXqtcubLdcMMNtn379hTvW7JkiXXt2tXKly9v8fHxVrVqVbvooovs3XffNZ/P55b5888//esLnb799lv/9vW8ffv2QevfuXOnmz9//nz/MtEmbQsAACAtCKQDADIu6YDlH9DLTXoMAAByp7p169rGjRtt3bp1NnXqVJs7d67dfPPNQcu8/fbb1rx5c9u7d6+9+OKL9uuvv7rlOnfubMOGDbNdu3YFLf/JJ5+4dQZOjRs39r+eL18+t8y8efPC7pMC9oHvbdGihfXp0ydonoL+AAAAaUGNdADAUcmzdzctCABALqegdrly5dzjihUr2uWXX+4C6p59+/ZZ7969rUOHDjZr1qyg99auXdu95mWke0qWLOlfZziFCxe2K664wu666y5buHBhitcLFizoJk+BAgWsUKFCUdcJAAAQCRnpAAAAAIBMo3IpH374oQtcez766CP7559/bPDgwRHfp1Ir6aWyMsuWLbM33ngjw/sLAACQFgTSAQAAAABHRcHsE044wWWAV6tWzZYvX25Dhgzxv/7bb7+5f0855RT/vO+//969x5vmzJkTtM6WLVsGva4pVIUKFaxfv352zz332OHDhzPtU0xKSrLdu3cHTQAAIHejtAsAAAAA4KgoQP7OO+/YgQMHbPr06bZ06VK77bbbor7n1FNPdctJzZo1UwTCX331VVf2JTUK2D/zzDM2ZcoUV+olM4waNcruv//+TFkXAACIDWSkAwAAAADCSkxMTDEIqOzcudOKFi3qf64yLjVq1LB69erZ6NGjLW/evEGBaAXKZeXKlf558fHx7j2awtFAoN7r0ZYrVqyYDR061G1v//79mfJJan06bm9av359pqwXAADkXATSAQAAAAARM81/+OGHFPM17+STT47YasOGDbNx48bZhg0b3PPzzz/fSpQoYY888kiWtLSy3+Pi4mzixImZsj4F+XURIXACAAC5G4F0AEDG5cljyVWru0mPAQBAbLn55ptdffPbb7/dfvrpJ5dRPn78eHv55Zdt0KBBEd/XokULV7rl4Ycfds9V3/z555+39957zzp06OAGI/3jjz/cOseMGeOWURZ7IA1OumnTpqBJpWPCSUhIcBnpkyZNytTjBwAA8BBIBwBkXIF4OzzsETfpMQAAiC0nnXSSffHFF7ZixQpr27atNWvWzF577TV7/fXXrX379lHfO2DAABc898qidO7c2b755hsrVKiQXXvttS7b/dxzz7XPPvvMXnnlFbvooouC3q/tlS9fPmiaPXt2xO316NHD7S8AAEBWYLBRAAAAAEBEp59+un300UcRXx8xYoSbQnXr1s1NgZo0aeKC8NGceOKJ5vP5oi7Ts2dPNwVSRvvy5csjvmf+/PlR1wkAABANGekAAAAAAAAAAERBIB052qhRo1yGTJEiRaxMmTJ2ySWXuLqNgVRH8dZbb7WSJUu62oxdunSxzZs3Z9s+AzElKcny33Wzm/QYAAAAAAAgFhFIR472+eefuyD5t99+ax9//LEdOnTIzj//fNu3b19QbcZ3333X3UKq5Tds2GCXXnpptu43EDt8luefrW7SYwAAAAAAgFhEjXTkaHPnzg16Pm3aNJeZvnjxYjv77LNt165d9sILL9jMmTPdQEYydepUq127tgu+N2/ePJv2HAAAAAAAAEBOQSAdMUWBcylRooT7VwF1Zam3bdvWv0ytWrWsSpUqtmDBgrCB9KSkJDd5du/efUz2HQAAAMDxLWFUf0tITMzu3QAAANmA0i6IGcnJyda/f38744wzrF69em7epk2brECBAlasWLGgZcuWLetei1R3vWjRov6pcuXKx2T/AQAAAAAAAByfCKQjZqhW+s8//2yvvPLKUa1n6NChLrPdm9avX59p+wgAAAAAAAAg56G0C2JC3759bc6cOfbFF19YpUqV/PPLlStnBw8etJ07dwZlpW/evNm9Fk58fLybAAAAAAAAAEDISEeO5vP5XBD9rbfess8++8yqVasW9Hrjxo0tf/789umnn/rnrVy50tatW2ctWrTIhj0GYk0eSy5fyU16DAAAAAAAEIvISEeOL+cyc+ZMe/vtt61IkSL+uueqbV6wYEH3b+/evW3gwIFuANLExES77bbbXBA93ECjANIpPt4Oj5xAswEAAAAAgJhGIB052tNPP+3+bdWqVdD8qVOnWs+ePd3jxx57zOLi4qxLly6WlJRk7dq1s6eeeipb9hcAAAAAAABAzkMgHTm+tEtqEhIS7Mknn3QTAAAAAAAAAKQXgXQAQMYlJVm+h4a4h4fveYSWBAAAAAAAMYlAOgDgKPgsbuNf/scAAAAAAACxKC67dwAAAAAAAAAAgOMZgXQAAAAAAAAAAKIgkA4AAAAAAAAAQBQE0gEAAAAAAAAAiILBRgEAQK6wdetW2717d4bem5iYaKVLl870fQIAAAAA5AwE0gEARyGP+Up6wcU8tCSO6yD6TT17WdKePRl6f3yRIjZ52hSC6QAAAACQSxFIBwBkXHy8HRr9NC2I454y0RVE79estVUqXipd7/1rxzabuHCeWwdZ6QAAAACQOxFIBwAAuYaC6NXLlDum26SkDAAAAADkfATSAQAAsgglZQAAAAAgNhBIBwBk3MEkyzfmPvfw8OCRtCQQgpIyABBbDgydYAXiE7J7NwAAx5mE8YOzexdwDBBIBwBknM9ncWtX+x8DOH5KygAAAAAAMk9cJq4LAAAAAAAAAICYQyAdAAAAAAAAAIAoCKQDAAAAAAAAABAFgXQAAAAAAAAAAKIgkA4AAAAcY1u3brWbb77ZqlSpYvHx8VauXDlr166dff311/5l8uTJY7Nnz07x3p49e9oll1zif96qVSu3rKaEhAQ7+eSTbdSoUeYLMwj0m2++aeeee64VL17cChYsaKeccor16tXLlixZ4l9m2rRpVqxYsaD3HTx40MaMGWMNGjSwQoUKWalSpeyMM86wqVOn2qFDh4KWXbBggeXNm9c6dOiQYvt//vmn28+lS5emua0+//xzt88lSpRw265Zs6b16NHD7VOoG2+80W379ddfT/HaiBEj3Lbbt2+f4rWxY8e619SWocuHTrVq1Yq4r2o7bznth9q5WbNmNnLkSNu1a1fY9+iz0rLaB0/v3r2tfv36KY7x/ffftwIFCtgPP/wQpcXMXn75ZbfOW2+9NcVr8+fP9+9jXFycFS1a1Bo1amSDBw+2jRs3HnWbNWzY0P98//79NnToUKtevbr7bpYuXdrOOecce/vtt/3LrFmzxq688kqrUKGCW6ZSpUrWqVMnW7FiRdS/hTlz5rh1FSlSxH0vTj/9dNf+4b5vZcqUsT179gS9pv3U/gIAAKQVgXQAwFHxnZDoJgBA2nXp0sUFr1988UX77bff7J133nEByX/++SdDzdinTx8XBF25cqULXN533302efLkoGWGDBliXbt2dQFEbU/Lzpw500466ST3nkgUzFWQf/To0XbDDTfYN998Y999950L0j7++OO2fPnyoOVfeOEFu+222+yLL76wDRs22NH45ZdfXBC3SZMmbn3Lli1z21Qw+ciRI0HLKmj7yiuvuIDwlClTwq6vfPnyNm/ePPvrr7+C5mt5XdQIVbduXdeugdNXX30VdZ8TExPdctqG2kpt9tJLL7l2D9ce2nboPj/22GMu8Dt8+HD/vJ07d7rP+d5777XTTjst6j7oM9A6FVA/cOBA2GX0+Wt/vv/+e/fd+OSTT6xevXqujY+mzQLddNNNNmvWLPeZKTA+d+5cu+yyy/zfc12EOe+889xFBi2nfXr11VfdRQQdbyRan4LtupizcOFC++mnn6xbt25ue3fccUeK5dWW48aNi7qvAAAAqcmX6hIAAEQSn2CHHgsfrAAAhKcA4Zdffukyg5VRK1WrVrWmTZtmuMmUkausdrnuuuvsiSeesI8//thlvcu3337rMsonTpxot99+u/99CoQ2btw4bPa6Z8KECS6IvWjRIpe57FEA/vLLLw/Kmt67d68LhGrZTZs2uQzhu+++O8PH9dFHH7nj0r57lN0cLkNaWeh16tSxu+66y2U3r1+/3ipXrhy0jDKTdby6gHHPPfe4eQp2b9u2zR2LAveB8uXL52/XtFIGtPceBaFr165tF198sQvKK7g9ffr0oGz7f//912WsK9iufWnZsqULxivbXxcwdPeBstr79+9vFStWjHrRw8vw1np094EC4ApQK+M7lNpCdx5oX3UXgwLT+nz1nQm8WJDeNgukCzb6zl144YXu+YknnujW5dFFmNWrV9unn37q/gZE/ypAHok+10GDBrn2ePjhh/3zNU8XWPT91n6pzTy6sDN+/Hh38UfHAwAAkBFkpAMAAADH0AknnOAmlapISkrK1HUrIK4gvbJ/FVT0KDNZ27zlllsiBn8jmTFjhrVt2zYoiO7Jnz+/FS5c2P/8tddec6VPVDLm6quvdlnL0YL0qVGQV9ndCuSnRlnY2qZKlVxwwQUpynx4VMom8DXt41VXXRXUXplNwVttQ4HlwEx67XP37t1dO+pfPfe0bt3afV4qY6OLBGpbBdsV3I9GAXiV1VE7qD0C1xmNSv0oo1vlhbZs2ZIpbabPT+VoQsuqeFTqReVl3njjjRR3GESiZZXJHi7zXKV99D3X9z2Q2rZGjRrugkVa6W9z9+7dQRMAAMjdCKQDx0GNVGXipHdau3atHT58OLt3HwAApJMCoQpKKsNXGcHKvlXWtspTZNRTTz3lAoiqt3722WdbcnJyUOa5yscogzwwCKsMXS+orylSDe9Vq1ZFrQseLpgtyhrXOpV1nVHKLFYQVJn7yu7u3Lmzy7YPDWpqH5V1r9I1on1QQDlcEP+iiy5y71dwft++fS5ArUBxOCpzEthGmhRszgi1oQLKXlkT7YOCwl576V/ti7L6A+uni8qWKPs6tc9Bn7u+W9469T5llytLPa376NUWz2ibBXr22Wdd9nrJkiVdDfMBAwYEjQOgDPtJkya5UkSqJ69a+A888ID98ccfEdep77IuEuj7EEqBfX3PtUzohSKVJtL+qB+dFmp7bcebQu9uAAAAuQ+lXYBsDqLf1LOXJUXI0olm37//2uYNG1MM8AUcUweTLN/Eh9zDw/3+u90bAJC2GunKGlb2uALAH3zwgStf8vzzz7vBRNNL2cEqu7Fjxw5XV1vlQTRFo0Box44dXY1pBV4jZY6nNaNc9a1VO/2tt95yzxW0V2BbwfXAASnTQwNmKiD+4IMP2meffeb2VQHlRx55xG3LC6YqQ1plUDQIqqiUiAbs1HvatGkTtE5lf3uBdgVsVdbk1FNPDbt9ZdYrizyQyq5khNeOXva/sqZVpkYDuIpqqKusiUrjaN+9LHFlXisA3a9fv1S3oXI+CnR7pVTUHqpBrvZRgDq9+5iRNgukizpaXt9xBdRVwkWlXu6//35X611UbuXaa691pY60nLLv9Rmr3bXvmUXfjzPPPNNtV2MDpEYldAYOHOh/rgsJBNMBAMjdCKQD2UgdcgXR+zVrbZWK/3fil1bfrfnNRq9/ww4fIZCObOTzWdxv/7826lHcug8AuVFCQoILFGpScO/66693QXAvkF6kSJGwWeKqsa4M2UB6rtIVomxhPW7evLkrySI1a9Z0mcm6AK+gqCgbXlPoIJKhFDRVqZjUKGCuu+VUnzwwMKsseWWRh+5zeihz+ZprrnGTAsLaJw2mqoCsSoIou1812QMz7jVfAeTQQLp3EUE1tH/++eeomdXKcPba9Wj9+uuvLgiv7GyvvVQjPHCflVGuffYC6aLXdUEhWvkdj9a5fft2F4APXKfudlBbqYxKavvo1TLPaJuF0vftrLPOcpMGNdVFEZVY0WOvNIy+66ojr0mvK+itf8MF0vXZ6+9CA6UGftdE9fqVca6yOOEoK71FixZ25513prrf+t5qAgAA8FDaBTgOKIhevUy5dE3lEotn924DAIBMpIEylU0cmA29ePHioGUUHP7xxx9dMDESlR9R9rIymb0MY5VHUckQlYBJLw1U+cknn9iSJUtSvKbAvPZZAXTV73700Udt6dKl/kn7qmBnaM3qo6ESIMpE99rKq8Gt/QvctrapgTZ14SGUBv7UpKBwuIE4M5tqjisLWgOHKpitkjEakFVZ2IH7rOcLFixI04WLUCoZ8/bbb9srr7wStE61i+5U0MCt0WjQU5U+URa5apdnVZvpe67vy4EDB8K+rgsGKjET+LcQejeHgvP6roXSxRW9T9/3cDSg76WXXuoGpAUAAEgvMtIBAACAY0gBT9X+VlavymMoG1dBVZV26dSpk385lZVQZrKCisrMVYDw8ccfd0FRZa9Ho0EXlbn95ptv2mWXXeaycAcNGuQmjbOiYKLKVGggT2UxK3gZKVu5f//+9t5777nMbq1T5TG8fVaJFb1fNbW1X9rf0MxzBT61TGBtcZWBCaUgrZct73nmmWdcMFi10VUGRcFXBeyVya22EK1bZXK8EimBAVuVRNFgqSofEkplX3QhQFn5kSjgq0z3QGqrsmXLRnyPLl7oPfpXQXwFxlWqRO2ijGhvnxXUVdA6lGqJ6/WxY8daevzvf/9z2e5XXHFFiux1lXrROlW3PjC4r/bURXA0XjYAANOsSURBVAhdsNH3b9u2be7iQyRpabNAKumjoHaTJk3cvv3yyy9uPABljCs7X5+t7sLQnQb6vJShrpr6yspXxno4VapUcfuq77Lu6tB79b3RRQStW/OVOR/JQw895L5rqQ3aCgAAEIreAwAAAHAMKWNcgb7HHnvMlaFQYFJB7T59+rhAoEcBSAVjNSioMmgLFSpkjRs3dgM+RgvkSokSJVzd6REjRriguYLk48aNc8Hbp59+2gUq9+/f79ajYK6CvZFqf6u8hWpva38V2Famu/aldu3abkDTevXqudI0KiMTrnyLAukKfKq8iLcNDYIZav369VapUqWgedpflaRREF6lPNR2CoLOnj3bDUC6efNmF+QPV/Nax6wAvALI4QLphQsXttQoYB86qKXaI1I2tVe6T+9RMFvHqzsLevTo4e4S0HOVH5k+fXrEQLHaS9nWCr6HXliIRp+pjjdcCRitUwFnBco92i8tqzbVAJ3nn3++u3hTrly5iNtIS5sFUokWld3R91rfN92doIFLNbio6PNWGRmVndHFGO2P91wXQSLRxR3ts77TqrmuOzX0vdB3+7rrrou6T7qbQxexlH0PAACQHgTSAQAAgGNIgdhRo0a5KTUqoZFaGQ2VAwlHZS5CKVtZUzSq0R464Kn2WcH8SCUx3n333YjrUzA8cMDStA5eKo0aNXKZ1pHoQkC0gdcDS9noooKmSCZMmBD0PLXl09p2oZR1HRjQDjV48GA3pWedogsVkQR+7soST+tncLRtpgE7NUWiwVAVCE9NuP3VQLmaolFQPtx7dUFIEwAAQHpQIx0AAAAAAAAAgCjISAcAHBVfgXhaEAAAAAAAxDQC6QCAjItPsENPzqAFgSySdPCgGxgyI1SLuXTp0pm+TwAAAACQGxFIBwAAOA5t37fH/lizxkYNvcfVp06v+CJFbPK0KQTTASATJYzqbwkRBuYFAACxjUA6AADAcWjvgQNWIE+c3d60ldUoXyld7/1rxzabuHCe7d69m0A6AAAAAGQCAukAgIw7dNDyPT3OPTx88x20JJAFKhYvYdXLlKNtAQAAACAbEUgHAGRccrLFLfvB/xgAAAAAACAWEUgHAABAkK1bt7qyMBnBIKcAAAAAYhGBdOQKTz75pI0dO9Y2bdpkDRo0sMcff9yaNm2a3bsFAMBxGUS/qWcvS9qzJ0PvZ5BTAAAAALGIQDpi3quvvmoDBw60yZMnW7NmzWzChAnWrl07W7lypZUpUya7dw8AgOOKMtEVRO/XrLVVKl4q3YOcjvnyQ1u2bJlVrVo1Q9snox0AAADA8YhAOmLe+PHjrU+fPnbddde55wqov/feezZlyhS76667snv3AAA4LimInt5BTrfv22N/rFljo4beY/Hx8RnaLhntAAAAAI5HBNIR0w4ePGiLFy+2oUOH+ufFxcVZ27ZtbcGCBdm6bwAAxJq9Bw5YgTxxdnvTVlajfKV0v18Z7RMXznNZ8aVLl86SfQQAAACAjCCQjpi2bds2O3LkiJUtWzZovp6vWLEi7HuSkpLc5Nm1a5f7N6ODrkWzZ88eO3T4sK3c9JftPfBvut67ZtsmO5KcbKs2b7Qjlidd7/175z+2/99/7ZdffnH7kB7r16+3AweSMrTP2bVdob2ypq3yHDpoJ///x7/9tdb+2rcn2z7j7Pp+8d06Nm2VG3+7cuJ3y9vn/QeTMvR3vC/pgPv/ovY5M/+/663L5/Nl2joB5C7e70dWnBMAAICslxnnBHl8nFEghm3YsMEqVqxo33zzjbVo0cI/f/Dgwfb555/bwoULU7xnxIgRdv/99x/jPQUAAFlNFwkqVUp/pjwA/PHHH1a9enUaAgCAXHxOQEY6YlqpUqUsb968tnnz5qD5el6uXPi6ryoDo8FJPcnJybZ9+3YrWbKk5cmT/gzK1K6GVa5c2f0Ra3C13IRj53PnO5978PfO33t2/70rb0RZ7hUqVMjW/QCQc5UoUcL9u27dOitatGh2785xJTf/fz41tA1tw3eGvyd+a46f3+EiRYoc9TkBgXTEtAIFCljjxo3t008/tUsuucQfGNfzvn37hn2PBkcLHSCtWLFiWbqf6nDm1k4nx87nntvwnec7n9scL995Al8AjobGWfJ+S46H37Tj0fHye388om1oG74z/D3xW3N8/A4f7TkBgXTEPGWX9+jRw5o0aWJNmza1CRMm2L59++y6667L7l0DAAAAAAAAkAMQSEfM69q1q23dutXuu+8+27RpkzVs2NDmzp2bYgBSAAAAAAAAAAiHQDpyBZVxiVTKJTuphMzw4cNTlJLJDTh2Pvfchu883/ncJjd/5wHEHn7TaBu+N/xN8VuTvfgdpm2Oh+9NHp9GXwIAAAAAAAAAAGH9N2IKAAAAAAAAAAAIi0A6AAAAAAAAAABREEgHAAAAAAAAACAKAulAFnvyySftxBNPtISEBGvWrJl99913UZd//fXXrVatWm75+vXr2/vvv5/jPqNRo0bZ6aefbkWKFLEyZcrYJZdcYitXroz6nmnTplmePHmCJrVBTjNixIgUx6HPM9Y/c9H3PPTYNd16660x95l/8cUXdvHFF1uFChXcfs+ePTvodQ0/ct9991n58uWtYMGC1rZtW1u1alWm/14cb8d+6NAhGzJkiPseFy5c2C1z7bXX2oYNGzL97+Z4/Nx79uyZ4jjat28f85+7hPvb1zR27Ngc/7kDQE74nT7W+A3P+n5hLMiqvlMsSMs584EDB9y5VMmSJe2EE06wLl262ObNmy3WpaVtWrVqleK7c9NNN1mse/rpp+3UU0+1xMREN7Vo0cI++OADy+3fmbS0TWZ9ZwikA1no1VdftYEDB7oRgn/44Qdr0KCBtWvXzrZs2RJ2+W+++ca6d+9uvXv3tiVLlrj/YWj6+eefc9Tn9Pnnn7sf72+//dY+/vhjF1w7//zzbd++fVHfpx+7jRs3+qe1a9daTlS3bt2g4/jqq68iLhsrn7l8//33Qcetz14uv/zymPvM9V3W37NOrMMZM2aMTZo0ySZPnmwLFy50QWX97atjk1m/F8fjse/fv9/t+7333uv+nTVrluv0duzYMVP/bo7Xz1108hd4HC+//HLUdcbC5y6Bx6xpypQprnOqzntO/9wB5G455Xc6O/AbnnX9wliRFX2nWJGWc+YBAwbYu+++6xKvtLySUy699FKLdWmNJ/Tp0yfou6O/tVhXqVIlGz16tC1evNgWLVpk5557rnXq1MmWL1+eq78zaWmbTPvO+ABkmaZNm/puvfVW//MjR474KlSo4Bs1alTY5a+44gpfhw4dguY1a9bMd+ONN+boT2nLli0+/dx8/vnnEZeZOnWqr2jRor6cbvjw4b4GDRqkeflY/cylX79+vurVq/uSk5Nj+jPXd/utt97yP9fxlitXzjd27Fj/vJ07d/ri4+N9L7/8cqb9XhyPxx7Od99955Zbu3Ztpv3dHK/H3qNHD1+nTp3StZ5Y/dzVDueee27UZXLi5w4g98mJv9PHAr/hWdsvjEWZ1XeKVaHnzPqe5M+f3/f666/7l/n111/dMgsWLPDlJuHiCeecc44734TPV7x4cd/zzz/PdyZK22Tmd4aMdCCLHDx40F0J0617nri4OPd8wYIFYd+j+YHLi7IVIi2fU+zatcv9W6JEiajL7d2716pWrWqVK1dOceUwJ9Gtmrp98aSTTrKrrrrK1q1bF3HZWP3M9f2fPn269erVy2WlxvpnHmjNmjW2adOmoM+1aNGi7lbwSJ9rRn4vctLfv74DxYoVy7S/m+PZ/Pnz3S2op5xyit188832zz//RFw2Vj933T763nvvuTttUhMrnzuA2BSrv9OZhd/wrOkX5jbp6TvFstBzZv32KBM78LujEnhVqlTJdd+dSPGEGTNmWKlSpaxevXo2dOhQd3dsbnLkyBF75ZVXXKa+ypjwnYncNpn5ncmX7ncASJNt27a5P96yZcsGzdfzFStWhH2POlnhltf8nCo5Odn69+9vZ5xxhvuxikQdJ5UCUE0r/Y9y3Lhx1rJlSxdY1S06OYU6xar9rePRrUL333+/nXXWWa5Ui2q85YbPXFT/cOfOna7uYax/5qG8zy49n2tGfi9yAt2yrJrpKl+kMj6Z9XdzvNKtybp1slq1arZ69Wq7++677YILLnAnO3nz5s01n/uLL77oPrfUbiONlc8dQOyK1d/pzMBveNb1C3OT9PadYlW4c2Z9PwoUKJAiGSW3fXcixROuvPJKl5ClhIyffvrJnXOopKRKS8a6ZcuWueCwzrVUB/2tt96yOnXq2NKlS3P9d2ZZhLbJzO8MgXQAWUq1zRQUSa3urX7sAq8UKqBau3Zte+aZZ+yBBx7IMZ+SOn4eBYh1kqEf69deey1N2Zmx4oUXXnBtof9JxfpnjvCUQXPFFVe4AbY08Etu+Lvp1q2b/7EGXNWxVK9e3WVatWnTxnILXSBTdnlqgwfHyucOALkRv+HIDPSd0nfOnBtFapsbbrghqN+twXzV39YFGfW/Y5mSUBQ0VzLaG2+8YT169HD10GER20bB9Mz6zlDaBcgiul1EV9FDR0jW83LlyoV9j+anZ/njXd++fW3OnDk2b968dGcY58+f3xo1amS///675WTKIDj55JMjHkesfeaiAUM/+eQTu/7663PlZ+59dun5XDPye5ETguj6LmiAoGjZ6Bn5u8kpVK5En22k44i1z12+/PJLl9mR3r//WPrcAcSOWPydzir8hmdevzA3S63vFIsinTPr+6HyUrrLN7d+d9ITT1BChuSG747uVKhRo4Y1btzYRo0a5Qb0nThxIt8Zi9w2mfmdIZAOZOEfsP54P/3006DbkvQ8MAs3kOYHLi8KQkVa/nilDFT9T0+30Xz22WfuVr300m20ui1HVwlzMtUA1xXOSMcRK595oKlTp7o6hx06dMiVn7m+7+rcBn6uu3fvtoULF0b8XDPye3G8B9FVN1UXVEqWLJnpfzc5xV9//eXqfEY6jlj63APvRtExqdOaWz93ALEjFn+nswq/4ZnXL8zNUus7xZLUzpn126NEo8DvjpIVNJ5MrH93MhJPUBay5IbvTij9fykpKSlXf2dSa5tM/c4c9XClACJ65ZVX3Ijs06ZN8/3yyy++G264wVesWDHfpk2b3OvXXHON76677vIv//XXX/vy5cvnGzdunBuRe/jw4W6k7mXLluWoVr755pt9RYsW9c2fP9+3ceNG/7R//37/MqHHfv/99/s+/PBD3+rVq32LFy/2devWzZeQkOBbvny5LycZNGiQO+41a9a4z7Nt27a+UqVKuZHGY/kz9xw5csRXpUoV35AhQ1K8Fkuf+Z49e3xLlixxk/5XOn78ePd47dq17vXRo0e7v/W3337b99NPP/k6derkq1atmu/ff//1r+Pcc8/1Pf7442n+vcgJx37w4EFfx44dfZUqVfItXbo06O8/KSkp4rGn9neTE45dr91xxx2+BQsWuOP45JNPfKeddpqvZs2avgMHDsT05+7ZtWuXr1ChQr6nn3467Dpy6ucOIHfLKb/Txxq/4ZnbL4xVmdF3ilVpOWe+6aab3LnVZ5995lu0aJGvRYsWbsrtbfP777/7Ro4c6dpE3x39bZ100km+s88+2xfrdD79+eefu+PW74me58mTx/fRRx/l6u9Mam2Tmd8ZAulAFlPQQD9kBQoU8DVt2tT37bff+l8755xzfD169Aha/rXXXvOdfPLJbvm6dev63nvvvRz3GamTFG6aOnVqxGPv37+/v53Kli3ru/DCC30//PCDL6fp2rWrr3z58u44Klas6J7rRzvWP3OPAuP6rFeuXJnitVj6zOfNmxf2O+4dX3Jysu/ee+91x6WT7zZt2qRok6pVq7oLJ2n9vcgJx65OSaS/f70v0rGn9neTE45dHfvzzz/fV7p0aXcxTMfYp0+fFIGWWPzcPc8884yvYMGCvp07d4ZdR0793AEgJ/xOH2v8hmduvzBWZUbfKVal5ZxZF1tuueUWX/HixV2yQufOnV1AObe3zbp161wAtESJEu5vqkaNGr4777zTJXXEul69erm/Ff3/SH87+j3xgui5+TuTWttk5ncmj/6Tvhx2AAAAAAAAAAByD2qkAwAAAAAAAAAQBYF0AAAAAAAAAACiIJAOAAAAAAAAAEAUBNIBAAAAAAAAAIiCQDoAAAAAAAAAAFEQSAcAAAAAAAAAIAoC6QAAAAAAAAAAREEgHQAAAAAAAACAKAikAwCOC3/++aflyZPHli5daseLFStWWPPmzS0hIcEaNmx4zLffqlUr69+/f9Rlpk2bZsWKFTtm+wQAAADkdsfjuQuArEcgHQDg9OzZ03UGR48eHdQis2fPdvNzo+HDh1vhwoVt5cqV9umnn0Ztt9Cpffv2ad7O/Pnz3Xt27twZNH/WrFn2wAMP+J+feOKJNmHChKBlunbtar/99lu6jw0AAAC5z4IFCyxv3rzWoUMHyw3C9dM1vfLKK2leh/r7l1xySdC8ypUr28aNG61evXpR+/MZNW/ePLvwwgutZMmSVqhQIatTp44NGjTI/v77bzuWSNoBghFIBwD4KfP6kUcesR07dsRMqxw8eDDD7129erWdeeaZVrVqVdeJjURBc3WkA6eXX37ZjlaJEiWsSJEiUZcpWLCglSlT5qi3BQAAgNj3wgsv2G233WZffPGFbdiwIUu35fP57PDhw5bdpk6dmqKvHhoYTy9djChXrpzly5fPMtszzzxjbdu2det/88037ZdffrHJkyfbrl277NFHH8307QFIOwLpAAA/r8M2atSoiK0yYsSIFGVOlCWtbOnQrI2HH37YypYt60qPjBw50nWk77zzThcgrlSpkuvUhiun0rJlSxfUV4bH559/HvT6zz//bBdccIGdcMIJbt3XXHONbdu2LagcSt++fV1JlFKlSlm7du3CHkdycrLbJ+1HfHy8O6a5c+f6X1dGyeLFi90yeqzjjkTvV7sFTsWLFw9a1/PPP2+dO3d2GSU1a9a0d955x39baOvWrd1jvUfLqv1CS7vo8dq1a23AgAH+TJpIWSJvv/22nXbaaa4NTzrpJLv//vv9JzE6odGxVKlSxe13hQoV7Pbbb494bAAAAIgNe/futVdffdVuvvlml5GufqTnyiuvdHc6Bjp06JDrT7/00kv+/rPOE6pVq+aSORo0aGBvvPGGf3kvK/uDDz6wxo0bu77mV1995ZJTOnXq5Pru6sOffvrp9sknnwRtS8Ft7ZPWq/XPnDkzxd2Yyva+/vrrrXTp0paYmGjnnnuu/fjjj6ket/rKoX119ZMD+9Iffvih1a5d2+2flyQj6je/+OKLrn/t9cF1nIGlXSL159VuSsZJSkoK2h+dJ+kcJpy//vrL9c01TZkyxZ0DqB3OPvtsdz5x3333+ZdVkL1u3bqunbVMaJBd+6G7i0PbwvvcvWPQXbDaf52n6DPVXQve53nddde5AL537NHOiYDcgEA6ACAos0LB78cff9x14o7GZ5995rJclO0yfvx4Vybloosucp3LhQsX2k033WQ33nhjiu0o0K7bFpcsWWItWrSwiy++2P755x9/51kd5kaNGtmiRYtc4Hvz5s12xRVXBK1Dnd0CBQrY119/7bI3wpk4caLrbI4bN85++uknF3Dv2LGjrVq1yr2uzrM6ptoXPb7jjjuOqj0UzNZ+alu6TfOqq66y7du3u9tC1QkWlZDRtrRvodTBVdBfgX0vkyacL7/80q699lrr16+fy15RRos6yw899JB7Xdt67LHH3HwdqzrX9evXP6pjAwAAwPHvtddes1q1atkpp5xiV199tQvUKslC1Dd99913XbDdo+Dy/v37XTKIKIiu4LD618uXL3cJHlpPaOLLXXfd5cpF/vrrr3bqqae6dar/q1KJ6uMrUK0+/rp16/zvUf9V5w4K3qq/+uyzz9qWLVuC1nv55Ze7eQrUK+FFiSNt2rRxfeqjoWPUOcH//vc/d+6i/fL6/vpXffjAO1CV9BMoUn9e+3vkyBF/Ao1o/9977z3r1atX2H15/fXX3R21gwcPDvu6l0Cj49d+devWzZYtW+YC3Pfee2/QxZG0uueee9xx6qLAySefbN27d3dJODpOXcjQRQvv2I/2nAjI8XwAAPh8vh49evg6derk2qJ58+a+Xr16ucdvvfWWetf+Nho+fLivQYMGQW322GOP+apWrRq0Lj0/cuSIf94pp5ziO+uss/zPDx8+7CtcuLDv5Zdfds/XrFnjtjN69Gj/MocOHfJVqlTJ98gjj7jnDzzwgO/8888P2vb69evd+1auXOmen3POOb5GjRql+plWqFDB99BDDwXNO/3003233HKL/7mOU8cbjY41b9687lgCp8B1a/+GDRvmf753714374MPPnDP582b557v2LEjaN06ln79+vmfq03V1oGmTp3qK1q0qP95mzZtfA8//HDQMv/73/985cuXd48fffRR38knn+w7ePBgKi0EAACAWNKyZUvfhAkT/P3sUqVKuX5o4POXXnrJv3z37t19Xbt2dY8PHDjgK1SokO+bb74JWmfv3r3dcoF92tmzZ6e6L3Xr1vU9/vjj7vGvv/7q3vf999/7X1+1apWb5/V9v/zyS19iYqLbj0DVq1f3PfPMMxG3o3UkJCSk6KuvXbvW35fWMr///rv/PU8++aSvbNmyYc+TPN65y5IlS6L252+++WbfBRdc4H+uvvhJJ53kS05ODru/Wl7HmZorr7zSd9555wXNu/POO3116tQJOnadywXSeYOOOfAYnn/+ef/ry5cvd/P0mYQ71wByu8wv5gQAyPFUJ12Z30eTcaBs7ri4/7vxSbdyeoPxeNnvutUxNNNEWege1Rxs0qSJy2YR3bqpgXd0y2Uo3TKqDArRraTR7N6922W8nHHGGUHz9Twtt4eG0q2QTz/9dNA8la8JpGwcjwYwVWZH6LFnBu2/MvG9DHRRJsyBAwdcto0yY5RZopIvyqxRdpAygrKiviMAAACOD8qU/u677+ytt95yz9X3UykX1UxX+RA9V4bzjBkzXNmRffv2uXIm3qCcv//+u+tLnnfeeUHrVfa07hYNpP57IGWkK2NamdjKala287///uvPSNe+afvKMPfUqFEjqFSi+rhaT+i4RVqPzgOi0d2YKmEZSOUNPSppUr16df/z8uXLZ1o/vU+fPq6UjQYJrVixossYV9kXr0xjKMW/I70WSOdHKpcTei6jfr76/jrXSqvA8xQdu+j4dfcCgGCcNQMAUlANPpU6GTp0qL9et0fBce8W0MD6iaHy588f9FwdwnDzVGsxrdR5VtBXgf5QXqfPC1QfS9qeOvvRHO2xp6eNVEbm0ksvTfGaakHq1lOdrKgu5ccff2y33HKLjR071t2SG7qPAAAAiA0KmCuAHRhAVp9e9bWfeOIJK1q0qCvvcs4557ggqvqJqleuxAvxSr4oGK6AcCCtI1BoX1zJOVqfyqeoz6z1XnbZZS4In1bavvr7Kv0SKnS8oFCqiR6trx6unx56vpNRusiguuMqiXP++ee7kjhqw0iUGKSa5LrgEHh+kxHhjiO18zYviJ8V5ylALCCQDgAIS3UNNQCnaigG0uA+mzZtCsqWUD29zPLtt9+6QL6os6/6fxo8VJSlovqDGkznaDKolQ2ukwhlbutkwaPnTZs2tWNN9dxF2SOpLZfaMmojBcqjnSzo5EUXJDTdeuutLttEtRUDs4AAAAAQG9SnViBX4wMpmBs68OXLL7/sxi9STWwlXWhAUtUh152MXpC1Tp06LmCuLPLA/nNaqI+t5Byv1rqC4hro0qPzDe2j6qd7d5YqA37Hjh3+ZdRP1TmIzgF0LnAspaUPHq0/rwFSlSmurHRlxquNI9EFBtWYHzNmjMukD6Uxo3ThQAOjql0D6bkC8V42us7bAsdV0vhIuqsgs48dyE0IpAMAwtIAlMpKmTRpUtB83fq5detW17lTR08DfqqjreB0ZnjyySetZs2arnOozqM60N5gPAr6Pvfcc24AHA3Ao/Ip6mTrllONYp+eWxg1qKkGQNVtnLpgMHXqVHdBQLezpldSUpLr2AdSJ79UqVJpen/VqlXdRYk5c+a4UisKdIcrX6OTBg2ApEGFdCITbv333XefG9S1SpUq7vPRHQS6Ffbnn3+2Bx980N1Oqs5ws2bN3G2s06dPd9vTPgAAACD2qI+pPnXv3r1d5nmgLl26uGx1BdLlyiuvdIOJ/vbbb66koqdIkSIus1wDjCpb+cwzz3SZ0wre6jygR48eEbevvv2sWbNcEof6vBoUMzDjWUkdCjDfcMMNrlyigveDBg1yfVQvcUevqwSkAv86D1HAWKUald2tAH1oOZnQ4HNoX13Hk9a7WNUH18CrSlZRaZnQNkytP682VdvpPEYXNKJRkF3nQEokUjlKDcKq7f/111/uvVqnLoiofVQy5oEHHnAlehYsWODuLHjqqaf861KpTs1Tu6n/P2TIkHTfgapt68KHBopVZr3OHzQBudX/Fa8FACDEyJEjU9zWpwC3OmgKeKszpVqLmTl6uzLhNWndX331lRvl3gsYe1nk6ggqm0bB/v79+7usjMB67Glx++2328CBA10nVOvRBQFtSx399NJ7detl4KSTi7TS7bEqx6LsE9WS9zLww30eyt5R8F8ZJuGoJI868B999JHrXDdv3tx1xr1AudpKnXjVUFQ9RJV4effdd1PUmwQAAEBsUKBcgehwAWAF0hctWmQ//fSTe65Eml9++cX1T0PHE1LQVkHwUaNGuXMClX1RILtatWpRtz9+/HhX71wZ7wqmq78aeiekgsTqB+vOVAXGVVtcwW6VJhQFqd9//333+nXXXecC6UouWbt2rXtfNFo+tK/++OOPp7n9tC/KmlewXn3w0Ezw1Przane1s4LguhCQGpVeVF9eGexqC11oUFa7Llh4511qv9dee80lFGkcKiXT6FwhsCynAu4KzJ911ln+YH56g+D6zHSRRcF6HbsuYgC5WR6NOJrdOwEAAAAAAACIMrAVBFbSR5s2bXJ8o+gY6tatm+JuXwA5C4F0AAAAAAAAZJvPPvvMlRDRnaKq660yjsrIVomZ9JYjOZ6opI4GSFXJRWX6h44/BSBnoUY6AAAAAAAAss2hQ4fs7rvvtj/++MOVdFFJEY1dlJOD6NKoUSMXTH/kkUcIogMxgIx0AAAAAAAAAACiYLBRAAAAAAAAAACiIJAOAAAAAAAAAEAUBNIBAAAAAAAAAIiCQDoAAAAAAAAAAFEQSAcAAAAAAAAAIAoC6QAAAAAAAAAAREEgHQAAAAAAAACAKAikAwAAAAAAAAAQBYF0AAAAAAAAAACiIJAOAAAAAAAAAEAUBNIBAAAAAAAAAIiCQDoAAAAAAAAAAFEQSAcAAAAAAAAAIAoC6QAAAAAAAAAAREEgHQCQY5x44onWs2fP7N6NmDJixAjLkydPmpadNm2aW/bPP//M8v0CAAAAkH7p6bPPnz/fLat/AaSOQDoAHAfUeUnLdCw6OE8//bRdfvnlVqVKFbfNSIFrr4MWbtq0aVOq22nVqpV/+bi4OEtMTLRTTjnFrrnmGvv4448tt18wiNS27du3T/f69u/f7wLmaf3+PPzwwzZ79uwM7DkAAACOFc4hcs45ROC5T+hUq1atDK0zPX32p556yp2/ATg6+Y7y/QCATPC///0v6PlLL73kOoKh82vXrp3l7f3II4/Ynj17rGnTprZx48ZUlx85cqRVq1YtaF6xYsXStK1KlSrZqFGj3ON9+/bZ77//brNmzbLp06fbFVdc4f7Nnz+/f/mVK1e6oHtu0LBhQxs0aFCK+RUqVMhQIP3+++/3d+IDDRs2zO66664UnfLLLrvMLrnkkqD5OkHp1q2bxcfHp3sfAAAAkLk4h0jbOcTxIvDcJ1DRokUztL709NkVSC9VqlSKJKmzzz7b/v33XytQoECG9gHIbQikA8Bx4Oqrrw56/u2337pAeuj8Y+Hzzz/3Z6OfcMIJqS5/wQUXWJMmTTK0LXUaQ49x9OjRdvvtt7vOnjKzFdj35KYAbsWKFY/J558vXz43pUXevHndBAAAgOzHOUTaziFCJScn28GDBy0hIcGOpXDnPlkhPX12JSkd63YAcrLckdYHADFA2RbKUK5cubILKOsWxnHjxpnP5wtaTgHwvn372owZM9wy6hg1btzYvvjiizRtp2rVqmmume1RBvuRI0csM6jTN2nSJKtTp4498cQTtmvXrog10g8dOuQyrWvWrOmOs2TJknbmmWemuK1zxYoVLlujRIkSbjkF/t95552gZbZv32533HGH1a9f311A0G2iukjw448/ptjHxx9/3OrWrWuFChWy4sWLu/XNnDkzaJm///7bevXqZWXLlnWfl5afMmWKZSa1hfZV21Imih6XLl3aHYf3eag2ouaJ2sq7hVSlXsLVSNdjfddefPFF/7Jem0eqt/jBBx/YWWedZYULF7YiRYpYhw4dbPny5UHLqNzPdddd5zJx1B7ly5e3Tp06UW8dAAAgC3EOEXx+pD65+qJz586NWB9cfV3NDy2F8vrrr7tzFJ1P1KtXz9566y3XT9Y5Smbx+ubKste6daevAvDqR+su04z02bV/6psrYcpb1rtLNVIbLFy40JWU1LZ1znPOOefY119/neIcsH///m79atMyZcrYeeedZz/88EOmtQdwvCEjHQByAAXLO3bsaPPmzbPevXu7sh8ffvih3XnnnS6I+thjjwUtr07Sq6++6rIy1KlRZoY6Qt99953r9GWm1q1b2969e93tgO3atbNHH33UBbaPNpjevXt3u/fee+2rr75ygdlIHU3dHnn99de7UjS7d++2RYsWuc6bOnGiTuMZZ5zhMrxVwkTB3tdee80Fnt98803r3LmzW+6PP/5wNQZVH16lajZv3mzPPPOM6zT+8ssv/pIqzz33nGtXBeb79etnBw4csJ9++sl1Nq+88kq3jN7bvHlzf6ddgWwFm/XZaR/V4UyNLhJs27YtxXztf8GCBf3PFTBXuzdr1sxdWPnkk0/cZ1C9enW7+eab3bZV916PdayXXnqpe9+pp54a8RZhrz1vuOEGN0/rikTL9+jRw+2DMn/Uwdf2dEFjyZIl/hOLLl26uM/itttuc/O2bNniLnisW7cuU08+AAAA8B/OIf7vHOKzzz5z5wDqm6vEifqfO3fuTPNX5b333rOuXbu6pBudf+zYscP17XWOkVbqt4fr36tvrz5+IJWo0TmJtqVzm+eff94Fqr1M+/T02SdMmOD64Eq6ueeee9w8JftEorZSQpGSsYYPH+6y1qdOnWrnnnuuffnll26bctNNN9kbb7zh2lQXGP755x937vbrr7/aaaedluZ2AXIUHwDguHPrrbcqzdz/fPbs2e75gw8+GLTcZZdd5suTJ4/v999/98/TcpoWLVrkn7d27VpfQkKCr3Pnzunaj8KFC/t69OgR9rVXX33V17NnT9+LL77oe+utt3zDhg3zFSpUyFeqVCnfunXrUl33Oeec46tbt27E17VOHcfEiRP986pWrRq0Pw0aNPB16NAh6nbatGnjq1+/vu/AgQP+ecnJyb6WLVv6atas6Z+n148cORL03jVr1vji4+N9I0eO9M/r1KlT1P2W3r17+8qXL+/btm1b0Pxu3br5ihYt6tu/f3/U9+s4vc8xdBo1apR/ObWF5gXunzRq1MjXuHFj//OtW7e65YYPH55iW5oX2h2I9LlPnTrVLat2kT179viKFSvm69OnT9BymzZtcsfpzd+xY4d739ixY6MeNwAAADKOc4jw5xB6HhcX51u+fHlQe82bN8+9pn8Dqa+r+er7enQ+UalSJdf/9cyfP98tp757Ws59IvXvb7zxxhR98169egW9X+dxJUuWzFCfXXT+on0IFdoGOk/SOVK7du3cY4/OX6pVq+Y777zz/PPU39d3DshNKO0CADnA+++/77K0lQkdSKVe1DdUtnOgFi1auAwCj2qeq4yGstgzqwSLsiSUmXDttde67O4HHnjArV+ZCA899NBRr9+rz65bBiPRrY7Kcl61alXY11WuRRkV2letRxkgmrSPyqDW+5TRL8rc9wYyVRtpGe2DyuME3p6obf7111/2/fffh92mPg9lul988cXusbdNTdqmStWk5XZHZZgrYzt0UqZ+KGWDBFKZFWXYZzXtjzJ5tE+Bx6nvqvZfd1B4WTa6Y0G3jCp7BwAAAFmPc4j/o7tMlTWdERs2bLBly5a5857AMaS0TmWop5Wy4MP178PdrRquf6/zE93dmpWWLl3qzpF0p6225/XvVUamTZs2rlyoasx750W6K1ftA+QWlHYBgBxg7dq1rrSI6k8Hql27tv/1QOFKq5x88smu7MbWrVutXLlyWbKfKuehAKrKixwtlYuR0GMONHLkSHeBQMemkjUqX6NR6r2yJaotqGC2SsRoCkclRnRLpjqEEydOdGVw1qxZE3TBQbXXPUOGDHHHp1saa9SoYeeff77raKp8jKh9FVx+9tln3RRpm6nRLadt27ZNdTnVaPRqoHtUt/1YBKy9Cxi6zTMc1Zn3LlLoNlRd+NFtpCp7c9FFF7mTkaz6LgIAAOR2nEP8H5VJOZp2FPX9Q2leWmuCq3xLWvr3XiJUaP9e1Mf3+thZ2b9X6cZIlBik/RkzZoxbTmN4KYnrwgsvdP37k046Kcv2D8huBNIBAJlKHamVK1ce9Xp+/vnniB1Wz9lnn22rV6+2t99+2z766CNXO1D14idPnuxqBnrZEhp8U9ng4Xjrf/jhh12wXQOEKrteA5MqQ10ZIt56vIsXOr45c+a4QYqUfa7g+3333ecG8/SWvfrqqyN2QCPVJ88IZX9nF+9YVaMxXEA8X77/62aoHZWlrzr0unNBba2aj7pjoFGjRsd0vwEAAJC7ziECxxjyaDyjcDLrDt6s6OP/V6km6/v3Y8eOdeNyheNl5euuX2XKa9BVnYvpPUqemTVrlquxDsQiAukAkANUrVrVZUGrPElghvaKFSv8rwcKV+rkt99+cyOuh2YvZzaVFDnabajzOnPmTLe/ynKPRgFvjWKvSVnsCq5rEFIF0r1siPz586ea/aGBcjRw6gsvvBA0X9nlyg4PzSbRYEOaDh486AbwVDmboUOHumPXZ6RjSGvGSVaLdJJwtMt7Axpp4KO0HKuWV1a6Jn1H1TnXwKjTp09P1/4BAAAgdZxDROdleYcOOhp6t693rqW7XUOFm3c89vHT279X1nta+vfly5e3W265xU2661aDjOq8iEA6YhU10gEgB9BtcgrMPvHEE0HzlX2tTlFoR2XBggVBtxiuX7/eZW2rDElmZTCrhEm4OoyLFy92JVYySsepWvAa7V3/Rrt1UXX7QrMjlH2SlJTkD/C2atXKnnnmGdu4cWPUY1C7hGZ4vP766/4a6pG2qdrfqreo9x46dMitp0uXLi5T3cuIibTNY0UXJMKdJESiCwVpWVZZ/vp8lM2vY490rCopdODAgRSddF1w8D4rAAAAZC7OIaJTgFx9d9X9DqS7TQOpxKbKSL700kv+8pPy+eefu9rp2SWtffb0LKsSLeqnjxs3LuhYQ/v3OmdTiZdAOvdSW9G/RywjIx0AcgCVxFC29D333GN//vmnNWjQwN0+p+C4SmZ4mQMedfQU5FQgWvWpvc6gSo+k5t1337Uff/zRPVZw9KeffrIHH3zQPe/YsaO/LEnLli1dSY4mTZpY0aJFXeB+ypQp7rbMu+++O03Hpc6Xl42sYKsyOnQroMq1dOvWzZVYiUYBbAXK1eFTZvqiRYtcZnnfvn39yzz55JMuq10DAfXp08dlqW/evNldbNCgod6xqma3aq4rs13Hpk7xjBkzUtT408UIlTFRTXTV+1bAXxc4OnTo4L9bYPTo0W6gTdWL1za1nxr4VG2kOwv0ODUK4IfL1NbFAg3umh66lVX78Oqrr7p68morfUc0haP21H6OHz/edYZVU1LHEkpB9KefftrVpVf2iT4zZeSvW7fO3nvvPddGahvdDaHBiXT7p/ZDJV90C6g+B70HAAAAmY9ziOh0DnP55Zfb448/7pKTdE6l8o3hxjNS4ojGZlL/VucLqlWufq760+ECzqmd+4RSWcj0Smuf3VtW/Xad1ynxSEHvcOMcqbSlymUqUatu3bruWDWelM5NdH6j/r/OF3WndKVKleyyyy5z56Y6R9G+fP/99+6OUyBm+QAAx51bb71VqdFB8/bs2eMbMGCAr0KFCr78+fP7atas6Rs7dqwvOTk5aDm9T++fPn26WyY+Pt7XqFEj37x589K07R49erh1hJumTp3qX+6ee+7xNWzY0Fe0aFG3P1WqVPHdfPPNvk2bNqVpO+ecc07Quk844QS3v1dffbXvo48+CvueqlWruv3zPPjgg76mTZv6ihUr5itYsKCvVq1avoceesh38ODBoPetXr3ad+211/rKlSvn9rVixYq+iy66yPfGG2/4lzlw4IBv0KBBvvLly7t1nXHGGb4FCxa4/dTkeeaZZ3xnn322r2TJkq5tq1ev7rvzzjt9u3btCtrm5s2b3edQuXJlt01tu02bNr5nn3021bbRcUb6DPSaR21RuHDhFO8fPnx4iu/PN99842vcuLGvQIEC7jUtE2nZFStWuGNUO+g1r831+ev5mjVrgpbXd6tdu3buu5CQkODapGfPnr5Fixa517dt2+baQp+P9lfLNWvWzPfaa6+l2hYAAABIG84hwp9DeOdH4WzdutXXpUsXX6FChXzFixf33Xjjjb6ff/45xbmPvPLKK64/q3OAevXq+d555x33Xs1L77lP6OTx+ubar0Dh+uHp6bPrHK1Dhw6+IkWKuNe88xv14/U89FxxyZIlvksvvdR/zqNzkCuuuML36aefuteTkpLcOVCDBg3cOtXH1+Onnnoq1bYAcrI8+k92B/MBAJlH2RS33nprijIwAAAAAMA5RObRmD+6I/Pjjz/miwXkAtRIBwAAAAAAACJQycvDhw8HzZs/f74rE6lSkwByB2qkAwAAAAAAABGoRnjbtm1dLXPVI1+xYoVNnjzZjZ1000030W5ALkEgHQAAAAAAAIigePHibsBODcS5detWK1y4sHXo0MFGjx5tJUuWpN2AXIIa6QAAAAAAAAAAREGNdAAAAAAAAAAAoiCQDgAAAAAAAABAFNRIB1KRnJxsGzZssCJFiliePHloLwAAchifz2d79uxxg4PFxZFHAiD9OCcAACBny4xzAgLpQCoURK9cuTLtBABADrd+/XqrVKlSdu8GgByIcwIAAGLD0ZwTEEgHUqFMdO8PLTExkfYCACCH2b17t7so7v0/HQDSi3MCAABytsw4JyCQDqTCK+eiIDqBdAAAci5KtAE42t8PzgkAAMi95wQUiQQAAAAAAAAAIAoC6QAAAAAAAAAAREEgHTHnxBNPtAkTJmT3bgAAAAAxdRv07Nmzc812AQAAQlEjHTHn+++/t8KFC2f6eudNOdsKF8yb6esFAAD/aXvjYpoCSKOePXvazp07j1mQeePGjVa8eHHL7a58/yzLX4hzAgAAssJbHX+w4xmBdMSc0qVLZ/cuAAAAADGlXLly2b0LAAAA2YrSLjhuTJs2zYoVK+ayamrWrGkJCQnWrl07W79+vX+Z1atXW6dOnaxs2bJ2wgkn2Omnn26ffPJJ1NIuuh30+eeft86dO1uhQoXcut95551jemwAAADIPf755x/r3r27VaxY0fU/69evby+//HLQMsnJyTZmzBirUaOGxcfHW5UqVeyhhx7yv64+8BVXXOH6xyVKlHB94D///NO9NmLECHvxxRft7bffdn1dTfPnz3evDRkyxE4++WS33ZNOOsnuvfdeO3TokH+9em/Dhg1typQpbpvqU99yyy125MgRtz8KmJcpUyZoX0JLrGg/9HzWrFnWunVrt60GDRrYggULgt7z5ptvWt26dd3xqY/+6KOPBr2ueQ888IBrK91RqvZ68sknU7Tntm3bovblf/75Z7vgggvcseg84ZprrnHv8bRq1cpuv/12Gzx4sGtLHaPaAQAAID0IpOO4sn//ftdpf+mll+zrr792t6t269bN//revXvtwgsvtE8//dSWLFli7du3t4svvtjWrVsXdb3333+/OxH56aef3Puvuuoq2759+zE4IgAAAOQ2Bw4csMaNG9t7773ngrw33HCDC+5+9913/mWGDh1qo0ePdoHuX375xWbOnOmCwKLAtxJKihQpYl9++aXrFytIrL7vwYMH7Y477nB9Wz1XyRVNLVu2dO/Ve5SgonVOnDjRnnvuOXvssceC9k/JKR988IHNnTvXBfhfeOEF69Chg/3111/2+eef2yOPPGLDhg2zhQsXRj3Oe+65x+3L0qVLXfBeAfHDhw+71xYvXuz2UX35ZcuWucC1jlX7Fmjs2LEuCK++/V133WX9+vWzjz/+OM19eZ0vnHvuudaoUSNbtGiRO6bNmze75QPpwoOC9TomXTAYOXJkiu0AAABEk8fn8/miLgEcI+pUX3fddfbtt99as2bN3LwVK1ZY7dq1XYe3adOmYd9Xr149u+mmm6xv377+zJb+/fu7SZQtoxMBZbvIvn373ImITh508hEqKSnJTZ7du3db5cqVbfZjDaiRDgBADqyRrv+XFy1a1Hbt2mWJiYlZsg0gNRdddJHVqlXLxo0bZ3v27HHlCJ944gm7/vrrUyw7ffp0e/DBB+3XX391fVlRAN27e/P8889Pc410be+VV15xQWZRQFvB602bNrmgu6hPvHLlShdgj4v7L9dK+6ptKLgt2o+33nrLLrnkEpeRXq1aNXfXZ+/evd3rCtwr+1z7rPcq2L1161b76KOP/PuijHBdXFi+fLm/366+vvrlHgXe9Tf7/vvvp6kvr3bSxYYPP/zQvw5dEFD/XcekAL8y0pVxr+U8OrdQAF4XM8KJdE7Q4eVTqZEOAEAOrJGeGecEZKTjuJIvXz5XrsWjTrhOGNQh9zLSlfWiDrfmqxOt11LLSD/11FP9j5WJoj+YLVu2hF121KhR7g/Lm9RhBgAAANJKQVsFflXSRaVE1GdVoNfrs6r/qiBtmzZtwr7/xx9/tN9//90FuvVeTVqPMt0V7I7m1VdftTPOOMOVL9H7FIQO7SsrgO0F0UWZ8HXq1PEH0b15kfrL4frY5cuXd/9679Exaj8C6fmqVatc+3hatGgRtIyee33/tPTl1Vbz5s3zt5MmnUNIYFsFrsPb32jHxzkBAAAIxWCjyFEURNctmMqsUT3JggUL2mWXXeYydKLJnz9/0HNltqguZTi6zXbgwIEpsk8AAACAtFDGt8qqaNweBdMV/NXdkl6fVX3YaJQ8otIwM2bMSPGaMtkjUY1yZYKrFIpKwygpRNnoobXJw/WN09NfDrceL3M+tfdkRLR9U1up1KPK0YTygvuprSMczgkAAEAoAuk4rqimom479cq46HZM3bKqDHRRfUjdYqrBhryOszfoUmbRYEiaAAAAgIxQn1WDg1599dXuuQK2v/32m8v6Fg2YqWC6xv0JV9rltNNOc5nlGvQz0q3HBQoUCMrslm+++caqVq3qapd71q5dmy0fovrvaodAeq5SK3nz5vXPU1nHQHru9f3TQm2lQU2VZa+7WzML5wQAACAUpV1wXFGmyG233eZqomuAIgXNmzdv7g+s66Rj1qxZbkAj3cZ55ZVXZknWCwAAAJBR6rPqLkoFtlWm5MYbb3QDYHoSEhJsyJAhrmb4Sy+95EqQKICsQT9FWeWlSpVywXjV9V6zZo3Nnz/fbr/9dlf/WxQ41uCbSjzZtm2bG6BU21UZF2Wha52TJk1ydc2zw6BBg9yFApW40UUEDfapmvC6wzQ0uK7BP7XMk08+aa+//robcDStbr31VjfwqAY6/f77791xq4yOxl4KvdAAAABwNAik47hSqFAhd1KhALlqKKrGobJxPOPHj7fixYtby5Yt3S2cumVVWSgAAADA8UJ1ydVHVV9VA12qXrkG6Qx07733umDzfffd5zKwu3bt6q/ZrT7xF198YVWqVLFLL73Uva5BPVUj3ctQ79Onj51yyinWpEkTV+5FAemOHTvagAEDrG/fvtawYUMXyNd2soOO/7XXXnNB/Xr16rnjHDlypEuUCaQ20B2pjRo1cgOHqr+vdkurChUquGNX0FyDsKqUjsroaDylwJrvAAAARyuPz+fzHfVagEwwbdo01+lVKZfjSWaM6gsAALIP/y8Hjk/Kqlf/X9Pxjt8RAABytsz4fzmX6AEAAAAAAAAAiIJAOgAAAAAAAAAAUWTesObAUVK9xNCaiQAAAABi059//pnduwAAAJBmZKQDAAAAAAAAABAFgXQAAAAAAAAAAKIgkA4AAAAAAAAA+H/t3Qm8jPX///+XfV+zF6GEsitFWSpFypKUkIgsRZJWn1JaREppTwtaRCpUUpJsUXZKyVK2SpS9lHX+t+fr+7/mNzPOGedwOOfwuN9ukzMz11zXNdfEeb1f83q/3obEkUgHAAAAAAAAACAOEukAAAAAAAAAAMRBIh0AAAAAAAAAgDhIpKdRI0eOtPz586f2aaQ5XBcAAACkJcSnKat06dI2dOjQ8P0MGTLYhAkTUvgoAAAAyZf5CF4D2PTp0+3iiy+2bdu2HdeEf+vWra1Jkyap8glMG17PcuXIlCrHBtKLht0WpvYpAACAJCSre/fu7be0buPGjVagQAFLK9pOqmtZcjImQNoxvtmi1D4FADhpkEhHsu3bty/VrlqOHDn8BgAAAODEV6xYsdQ+BQAAAEdrlzRu8uTJVrFiRcudO7c1btzYKzJk5syZliVLFvvjjz+itldVSd26daOmmWoqZLly5Sx79uzWqFEj27BhQ9RrPvroI6tRo4Y/X7ZsWXv44Ydt//79UdMpX375ZWvWrJnlypXLunTp4tXoouoQPd+xY0e/f/DgQRs4cKCVKVPGE95Vq1a1Dz74IKqSXdtPnTrVzj33XMuZM6fVqVPHVqxYEd5m6dKlvv88efJY3rx5rWbNmrZgwYKo9xRJ53bGGWdY1qxZrXz58vb2229HPa/jvf7663b11Vf78XQtPv7446P8ZAAAAHAyUjxaqlQpjysVX27ZsuWQbQ4Xn27fvt26detmRYsW9Ri8UqVKNnHiRH+uf//+Vq1atajt1epEVeSRMXWtWrU8NldsfOGFF9q6dev8uZ9//tmaN2/u+9YY4rzzzrMvv/wy/NoGDRr4tnfccYfHyboFvv76ax9LKI4vWbKk9erVy/75559Er0W8uF0+/PBDO+eccyxbtmx+/kOGDIl6/ebNm61p06Z+PI0fRo0adcgxIlu7BGMJXb/AkiVL/LG1a9eGPx9dE11PXXt9Tq1atbLdu3fbm2++6eehMYze24EDBxJ9bwAAALFIpKdhCvaeeuopD7yVOF+/fr3ddddd/ly9evU86R0ZlKtSXMFnp06dovYxYMAAe+utt2z27NkedF5//fXh52fNmmU33nij3X777fbjjz/asGHDPPjUayIpoNdA4fvvv/dEu4JiUQJcyf1nn33W7yuJrmO98sor9sMPP3iAfsMNN9iMGTOi9nf//fd7IK1AO3PmzFHn3K5dOzvttNNs/vz5tnDhQrvvvvv8S4OEjB8/3s/9zjvvtGXLlvmA5KabbrJp06ZFbadzvu666+y7777z1jA6xtatW4/ocwEAAMDJae7cuda5c2fr2bOnJ3CVRH7ssceSFZ+q8OSKK67w2Pydd97xGHzQoEGWKVPS2oWo4KVFixZWv359j22/+eYb69q1azgh/vfff3u8q8KVxYsXezGOktUaS8i4ceM81n7kkUc8jg8KdZSA17bXXHON7/e9997zxLrea2Lixe26r/hbYw+NITSe6Nevn481AirGUZGPro2Kb1566SVPrh8tjYGee+45GzNmjH3++eeegNdYZtKkSX7TGErjnsiCHwAAgMOhtUsapsS4EtKqZhEFsQp4AwriR4wYYXfffbff/+STT+y///7zgDVyHy+88IKdf/75fl9VGKpwnzdvnlexKMGsgLdDhw7+vJLzjz76qN1zzz320EMPhffTtm1bHwAE1qxZ438WKVIkXCG+Z88ee/zxx73ipXbt2uH9KQBXoKpgP6BEfXBfx7/yyiv93FWRoyBf76lChQr+vCrIE6MvGhSA33rrrX6/T58+9u233/rjQdW8aJs2bdr4zzpHBda6BhosxNL70C2wc+fOw3xSAAAAOBmoeETxo2JlOeuss2zOnDmerE1qfKpYWXHo8uXL/fVBzJxUik137NhhV111VXicoPg+oBmhugUU2yu5rxmZGk8ULFjQk/aqIo9sm6KCGCXGg77pisEVMytmV4W94vRY8eL2p59+2i699FJPngfXSl8aPPnkk359Vq5caZ999plfC1XNyxtvvBH1Xo6UxkDBrABRRbqS55s2bfIq/bPPPts/CyXwtQZTQhgTAACAWFSkp2GahhgEf1K8ePGoCg0FoKtXr/bAXFTdoSS6pngGVO0dBKaiIFeJbwXuwXRMJecVUAY3tW5RZYoqOQJqw3I4Ohe95rLLLovanyrUVeESqUqVKlHvS4L3psHGzTffbA0bNvTqnNjXRtL70FTWSLofvL+Ejqfro6mniVW7aBCRL1++8E3TWgEAAADFmEGBSiAoIElqfKpKdlVxB0n05FIiXOMAtWxUpbmS+0FVeVCRrlmsSkgr7lc8rmMHFemJ0bhA44nIOF7HUAV9UEQTK17cnth1WLVqlbdU0fMaq6gdTOxYJaXHUWpzo5Yuek+Rj8WrfmdMAAAAYpFIT8Ni25loumYoFArfVzW4gmdVpau6QhUdkS1SkkKBtqrSFdAHN029VIAbWXUSmZyPty/59NNPo/anypPYaZOR7y2YhqogXTTtU21hVKX+1VdfecWIqmhS+loGx4vVt29fr/IJbrE95QEAAIAjpX7g8WTMmDEq5g8qrCMp/ldLF601pBYsSsoHxTVKoit21ixMtXFUPF65cmXbu3fvYWN5taGJjOOVXNe4IDIpHelYxO2HuzYSeX1ir01isX9yxgPCmAAAAMSitUs6pwoQtSxRVYsC3NiqD/VQVB9ytXEJepqrT3owZVKLjOqxM888M1nH1cJJErlAjwJnLSSkapfINi5HQoMB3dRjXe9PgwX1NYyl96H+kkFrGtF9ncuR0nvQDQAAAIiNPdUnPVKQwE5qfKqZkr/++qu3NkmoKr1w4cL2xx9/eLI4KDhRUjtW9erV/aaEr6ri3333Xbvgggv8WKpYD2JnJciDhTgjY/nYhTY1LlABTHLHBYnF7cF1iKT72latZVR9rrGKeqkHM2iDsUpidG1EFfhaMDSxa5MSGBMAAIBYJNLTOU23VJsSLXIU2T89oMqL2267zfsbauqk+iIqwA4S6w8++KD3VyxVqpT3DlSVhypPtDBS7MJJkU4//XQP7CdOnOiLGamyRn0WVQGjIFrVHRdddJFXdCtg1jlGDiYS8++//3qfRZ1LmTJlfJChxYu06FFCtK3a2WgQoSml6hOvBZTUexIAAABISb169fLCFfU7b968uU2ePDmqP3pS4lMVnNSrV8/jW/URV+L6p59+8tha/dcbNGhgf/75pw0ePNhjYu1fM08VT4varLz66qvWrFkzK1GihCefVTV+4403hvuU63iauap9qkd5bOW12pzMnDnTFwJVwrhQoUJ27733+jhB4wUV62hGqhLrU6ZM8TWXkhu3a7FVJcjVo119yFVBr/1oQVEpX768v19VwaufucYq6s8er2Jf10ptF1UJrzWX9GXEkCFDjvpzBQAASApau6RzSnyr4kQVJUHwHNsfUEGxFgtV0K++gJr+GZmIVzL8iy++8EBXwfMzzzzjifJ4Tj311PBCpeovqIBbFCgrWFdPQVWhKDhWqxcF10mh6pQtW7b4e1G1igYhV1xxhR8rIS1atPC+kBrMnHPOOb6oqapgNAABAAAAUpJi5ddee83jTy3oqRj6gQceSHZ8+uGHH3rsrQpuVapr8dKgQlwxtJLNL774oh9Di3GqWCUyvlfiXQlrxctdu3a1Hj16eEJalJxXtbbaviiZrnhf1eaRVICjKnXNaA2qvFUpP2PGDE9O161b178IUNGNkvVHErfrmGPHjrUxY8ZYpUqVfF86rsYuAV0X7V9fLrRs2dLfi9pXJkZFQqNHj/b3r/N94okn4hb/AAAApKQModgGfEh3Onfu7FUrH3/8cdTjWixIVR3xpkfi8Hbu3OmLjqq6PqgEAgAA6Qe/ywHw7wgAACe3nSmQ36O1SzqmD14Lg6ofYmwSHQAAAAAAAACQMkikp2Pqy6ipnt27d7fLLrsstU8HAAAAAAAAAE5ItHYBDoPp4AAApG/8LgfAvyMAAJzcdqZAaxcWGwUAAAAAAAAAIA4S6QAAAAAAAAAAxEEiHQAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcmeM9iZPTyJEjrXfv3rZ9+/YkvyYUClm3bt3sgw8+sG3bttnixYutWrVqKX5ua9eutTJlyhyz/cczbXg9y5Uj03E9JpCWNOy2MLVPAQAA4JiMZ5Kq7aS6liUnYwIcufHNFnH5ACCdoiIdh2jdurWtXLkyWVfm888/94B14sSJtnHjRqtUqdJRX9mOHTtaixYtoh4rWbJkiu0fAAAAOFE1aNDAk8npRYYMGWzChAnJfl3p0qVt6NChRz2eAQAAOBwq0nGIHDly+C05fv75ZytevLjVqVPnmF7RTJkyWbFixY7pMQAAAAD8n71791rWrFlP+PEMAADA4VCRjkOosjx//vzh+/379/c2Km+//bZXfOTLl8+uv/5627VrV7hy/LbbbrP169d7JYm2kYMHD9rAgQO9FYsC2apVq3rrl0g//PCDXXXVVZY3b17LkyeP1a1b15PyOuabb75pH330ke9Tt+nTp3trF/28ZMmS8D5mzJhhtWrVsmzZsnky/7777rP9+/dHVeP06tXL7rnnHitYsKAn4rV/AAAAID3asmWLtWnTxk499VTLmTOnVa5c2UaPHh1+XvG5YuRnn302HEsrjk5q7NyzZ0+vZi9UqJA1atTI2rZt61Xekfbt2+fPv/XWW+EZqhdddJGPI0455RSP8RXXRybktV8dM3v27Hb66af7WEGC8cPVV18dNZ7Q65s3b25Fixa13Llz23nnnWdffvll1LmuW7fO7rjjjvD7PJLxDAAAQFKQSEeSKIjVVEu1btFNAfigQYP8OQXojzzyiJ122mnedmX+/Pn+uAJjBdavvPKKJ8wV4N5www3+Wvntt9+sXr16HsR/9dVXtnDhQuvUqZMH8nfddZddd9111rhxY9+nbglVu2sfTZo08aB66dKl9vLLL9sbb7xhjz32WNR2SsrnypXL5s6da4MHD/bznTJlCp8+AAAA0p3//vvPatasaZ9++qktW7bMunbtau3bt7d58+aF4/PatWtbly5dwrG0WiQmJ3ZWFfrs2bM9lm/Xrp198skn9vfff4e3mTx5su3evduT3/LPP/9Ynz59bMGCBTZ16lTLmDGjP6fiGnnuuefs448/trFjx9qKFSts1KhR4YR5MH4YMWJE1HhCx9P5an9aI0ljg6ZNm3oBj4wbN87HIIrtg/d5JOMZAACApKC1C5JEAbAqO1Q1LgrUFdAOGDDAKzr0eGTblT179tjjjz/uFSMK4qVs2bL29ddf27Bhw6x+/fr24osv+mvHjBljWbJk8W3OOuus8DFVxa79xGvl8tJLL/mg4IUXXvAKlAoVKtjvv/9u9957rz344IMewEuVKlXsoYce8p/LlSvn2+v8L7vsskP2qWPqFti5cyf/lwAAACDNUCW6Ck8Cmh2qxLaS1Ko2V4ytRLiq1SNj6aTGzoqXVXwSOOOMM7woZfz48T4OkHfffdeaNWsWHh9cc801Uec4fPhwK1y4sP3444++vpGS39qvqtZ1bFWkB7SdqIo88nw1o1W3wKOPPurnoIS8qts121RjEJ3D4do/xhvPJIQxAQAAiEVFOpJE1SJB0Cmakrl58+ZEt1+9erVXqChRrWmYwU0V6sEUT7VnUSuXIIl+JJYvX+6J+mAap1x44YVevfLrr7+GH1MiPVK881clvQYfwU2DDQAAACCtOHDggCeV1dJFyWTF2UqkB5XaRxs7q9o9UubMmX22qKrIg+pztWBUpXpg1apV3m5GxTNq2xhUmwfnpHYziv/Lly/vbRe/+OKLw75PnZe+MKhYsaIn2fU+9R4O9z5TYjzDmAAAAMSiIh1JEpvsVvAdTNNMSDDtU9NNVTETSa1c5HguAJSc8+/bt69PS42sSCeZDgAAgLTiySef9PYtQ4cO9WS6qsXV01x9yFOC9hdLSXPNKlXyWS0SFcur1UpALVdUZf7aa69ZiRIlPNZWJXpwTjVq1LA1a9bYZ5995rNWlZhv2LDhIWsoRVISXcd66qmn7Mwzz/RjtmrV6ojeZ3LHM4wJAABALBLpOCbOPvtsT5irWkQBd0JUJa7+i1qoKKGqdE1HVbVNPKpO+fDDDy0UCoUra9TLUdUm6pd4JHTeQbIfAAAASGsU72oRTq0/JEoIr1y50mPweLH00cTOWq9IxSXvvfeeJ8OvvfbacAyvxU/V91xJdM04FbV0jKVKdS1aqpsS4krEb9261avqta/Y89W5qZI96MOuYp1g0dR47zMlMCYAAACxaO2CY0LBuCpItMCokuVq57Jo0SJ7/vnn/b6or6Gqva+//npflEjTQd9++20PwoPpl999953f/+uvvzzhHuvWW2+1DRs2eF/In376yaeYqhe6KsqDHo8AAADAiUS9xlWpPWfOHG910q1bN9u0aVPUNoql586d64lnxdJKth9t7Ny2bVtffFTHjmzrUqBAATvllFPs1Vdf9RaPX331VdQMT3n66adt9OjRflwl/d9//33va66WLcH5qmf5H3/8Ydu2bQu/Ty0oqpYwWhxVx4+tItfrZs6c6Qup6n0CAAAcK2Qaccyob2O/fv28v6CqX1RxolYvZcqU8ecVbCvIVmWJqtbVi1FVLEFlS5cuXbyH4rnnnusLEKkiJZbaxkyaNMnmzZvnCxF1797dOnfubA888ACfLAAAAE5IinXVKqVRo0bWoEEDT0i3aNEiahsVtWghTlWpK5bWTNGjjZ2VPNfiodqPeqsHlIQfM2aMLVy40Nu5qJhG7WdiC220gKli+/POO88T/DqXIIE/ZMgQT9Cr6r169erh5LuS9KqGV+sYvV+970iPPPKI70sLogaLlgIAABwLGUKa1wcgUaqa16KjO3bs8OmoAAAgfeF3OQD+HQEA4OS2MwXye1SkAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcJNIBAAAAAAAAACCRDgAAAAAAAADAkaEiHQAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcmeM9ibRl5MiR1rt3b9u+fbulZbt377b27dvblClTbNeuXbZt2zbLnz9/3NdMnz7dLr744vC2afG9Thtez3LlyJTap4GTUMNuC1P7FAAAANKEBg0aWLVq1Wzo0KGJbrN27VorU6aMLV682LdNSW0n1bUsORkTIHHjmy3i8gDACYpEOlI0aJU333zTZs2aZXPmzLFChQpZvnz5DrvvOnXq2MaNG5O0LQAAAICT07hx4yxLlixxtylZsqSPLTQWAQAASCkk0nFYe/futaxZsyb5Sv38889WsWJFq1SpUpJfo/0XK1YsVc8bAAAAQNpWsGDBJI0BUnpsAQAAQI/0dGjy5MmeqM6dO7c1btzYqy0ivf766/589uzZrUKFCvbSSy9FPX/vvffaWWedZTlz5rSyZctav379bN++feHn+/fv75Xn2o+mRGo/HTt2tBkzZtizzz5rGTJk8JumTCZUtT5kyBCbOXOmb6P78vbbb9u5555refLk8aC2bdu2tnnz5qjWLto+sVYuOn6LFi2iHlPrl2D/wbF79uzpj6v6pFGjRv74smXL7IorrvDrVbRoUW8789dffyXzqgMAAACIZ8uWLdamTRs79dRTfaxRuXJlGz16dNQ2H3zwgT+eI0cOO+WUU6xhw4b2zz//RMX8Dz/8sBUuXNjy5s1r3bt39+R4ZMyveD9QunRpe/TRR+3GG2/07bt27erjFI0tlixZEjXWmDp1qo9JdG6aEbtixQo+UAAAkGQk0tMZ9R9/6qmnPDGtZPX69evtrrvuCj8/atQoe/DBB23AgAG2fPlye/zxxz1RrnYrASWz1YP8xx9/9MT4a6+9Zs8880zUcVavXm0ffvihT51UAKrtateubV26dPHEvW6aMhlL22sbbattdF+UqFeAu3TpUpswYYIHtwqUU5repypQZs+eba+88oon5i+55BKrXr26LViwwD7//HPbtGmTXXfddSl+bAAAAOBk9t9//1nNmjXt008/9WIWJbVVxDJv3jx/XuMDJdo7derkYxUluFu2bGmhUCi8DyW7g+eUhNd4Qon1eDQ+qlq1qvdE19gnMffff78X/WhckDlzZj8PAACApKK1SzqjhLQSxGeccYbfVwX2I488En7+oYce8uBQAamoolwJ82HDhlmHDh38sQceeCCqgkOJ+DFjxtg999wTflxVH2+99ZZXggSUoFb1RrxpkppqqW1ip1NGBqmqgn/uuefsvPPOs7///tsrxVNKuXLlbPDgweH7jz32mCfR9YVCYPjw4f4lwMqVK70yP9aePXv8Fti5c2eKnR8AAABwolIlemSRz2233eazaceOHWu1atXyRPr+/ft9rHL66af7NqpOj6RxhOJ1jSnOOeccH+vcfffdXpSTMWPCdWAqnLnzzjvD9xOaOSsqNqpfv77/fN9999mVV17pyX/NwI3FmAAAAMSiIj2dUUAZJNGlePHi4RYpmhKp/uSdO3f25HRwUzJZjwfee+89u/DCCz3RreeVWFdleyQFtpFJ9KO1cOFCa9q0qZUqVcor4oMANva4R0sVMJFUAT9t2rSo66F2NxJ5TSINHDjQFz0NbglV3gMAAACIduDAAU94KzmuAhvF3kqkBzG/qsYvvfRSf/7aa6/1mbHbtm2L2oe20ZgnoJmuKr7ZsGFDopdb7VqSokqVKlHjKIlsNxmJMQEAAIhFIj2diV2hXr3+gqmQCjBFAanasQQ3Tav89ttv/blvvvnG2rVrZ02aNLGJEyf69EdNcYzsOyi5cuVKsXNWgl/9ytWzUK1n5s+fb+PHj/fnYo+bGFWfRE75lMi+7omdt66JEviR10O3VatWWb169RI8Vt++fW3Hjh3hW7ygHQAAAMD/efLJJ70lpNZkUjGL4m6NA4KYP1OmTDZlyhT77LPP7Oyzz7bnn3/eypcvb2vWrDmqS5jUsUvkWErjKDl48GCC2zImAAAAsWjtcgLRQpolSpSwX375xZPlCZkzZ45Xmyt5Hli3bl2S9q9plqoySa6ffvrJFx4aNGhQuLpbfQmTQ9Xx+kIgkgLz2C8WYtWoUcN7vauFjfogJkW2bNn8BgAAACDptE5R8+bN7YYbbggnqdVOUUnzyAS2ZsfqprWdNDZRkU2fPn3CM0r//fdfX4xUVBCkyvbjPUuUMQEAAIhFRfoJRgvxaBqiepAraP3+++9txIgR9vTTT4d7iGtqpXqiq7WJtguqww9Hyei5c+d6z8G//vor0eqNWGrnoiS8Kk6U5P/44499ymdyqO+hku/q265qcvWCj02sJ6RHjx62detWX9RIlfB6z5peetNNNx3RlwIAAAAAEqaxhirOVbyjBUO7detmmzZtCj+vsYTWLlJcrzGJFhL9888/rWLFiuFtVL2uVpVa52nSpEke92tdqMT6owMAABwvRCMnmJtvvtlef/11T56r96B6kY8cOdIXHZVmzZrZHXfc4cFotWrVPMiNt7J9JC0cpOmYqihRhXhS+5trW53D+++/769VZfpTTz2VrPelKaE6Ty2IqkVKd+3aZTfeeONhX6cKfVXGKGl++eWX+zXp3bu35c+fn2AcAAAASEFae0kzQhW7N2jQwNdkatGiRfh5tXqcOXOmt5k866yzfPshQ4bYFVdcEd5GPdSVkFcbxtatW/v4pX///nxOAAAg1WUIxTaeBhBl586dvuio+qUr+AcAAOkLv8uB9KFjx462fft2mzBhgqU1/DsCAED6lhK/y6lIBwAAAAAAAAAgDhLpAAAAAAAAAADEkTnekwAAAAAAHA9aVwkAACCtoiIdAAAAAAAAAIA4SKQDAAAAAAAAAEAiHQAAAAAAAACAI0NFOgAAAAAAAAAAcZBIBwAAAAAAAAAgDhLpAAAAAAAAAADEkTnek0Bg5MiR1rt3b9u+fbvf79+/v02YMMGWLFmS5IuUIUMGGz9+vLVo0SJdXthpw+tZrhyZUvs0kM417LYwtU8BAAAgxcYFaVHp0qX9HHVLaW0n1bUsORkTnMzGN1uU2qcAAEglJNJxRO666y677bbbjvvV69ixowftSuIDAAAAQKz58+dbrly5uDAAACBFkUjHEcmdO7ffAAAAACAt2Lt3r2XNmtUKFy6c2qcCAABOQPRIR6JTNkuVKmU5c+a0q6++2rZs2RL1vFq7VKtWLarq47LLLrNChQpZvnz5rH79+rZo0aFT3jZu3GhXXHGF5ciRw8qWLWsffPBB1PMbNmyw6667zvLnz28FCxa05s2b29q1a8PHfPPNN+2jjz7yNjG6TZ8+/bCvE21Xq1Ytr0zRNhdeeKGtW7eOTx8AAAA4ApMnT7aKFSt6cU3jxo09zo/0+uuv+/PZs2e3ChUq2EsvvRR+TnG6YvkxY8ZYnTp1fJtKlSrZjBkzwtscOHDAOnfubGXKlPGxQ/ny5e3ZZ589ZLaq2kYOGDDASpQo4dsErV2GDh0a3k7H0vloXKPxTbly5ezjjz/mcwcAAMlCIh2HmDt3rgetPXv29B7oF198sT322GNxr9SuXbusQ4cO9vXXX9u3337rwWmTJk388Uj9+vWza665xpYuXWrt2rWz66+/3pYvX+7P7du3zxo1amR58uSxWbNm2ezZs8OBuapL1E5GyfIgUNdNgffhXrd//34PsJXc/+677+ybb76xrl27ekANAAAAIHl2795tTz31lL399ts2c+ZMW79+vcfqgVGjRtmDDz7oCW7F+o8//riPA1QUE+nuu++2O++80xYvXmy1a9e2pk2bhgt4Dh48aKeddpq9//779uOPP/r+/ve//9nYsWOj9jF16lRbsWKFTZkyxSZOnJjoOT/88MM+ltB4QOMUjUW2bt3KRw8AAJKM1i44hCo9lIS+5557/P5ZZ51lc+bMsc8//zzRq3XJJZdE3X/11Ve98ltVJVdddVX48WuvvdZuvvlm//nRRx/1gPf555/3CpX33nvPA2ZViwRJ7hEjRvh+VFF++eWXezXKnj17rFixYuF9vvPOO3Ffd+6559qOHTv8PM444wx/XtUxidH+dQvs3LmT/0sAAACA/58KWV555ZVwbK0CnEceeSR8fR566CEbMmSItWzZ0u+rqlzJ8GHDhnnxTUCvU5GNvPzyyz7eeOONN3wckiVLFk9+B7QPFcQoka6EeEAzTjUOUEuXeFS93qZNG/9Zif3nnnvO5s2b5+MexgQAACApqEjHIVQ1cv7550c9pgqReDZt2mRdunTxSnS1dsmbN6/9/fffXp0Sbz+6H1Skq0p99erVXlke9GBXm5b//vvPfv7550SPfbjX6WcFzqpaV5WLviiInXoaaeDAgf4eglvJkiX5vwQAAAD4/6k9SpBEl+LFi9vmzZv953/++cdjcM1wDWJz3TTDNTamjxwbZM6c2QtggrGBvPjii1azZk3vea59qFgndnxRuXLlwybRpUqVKlHJd41XgnNmTAAAAJKCinSkCFWWaBqmktSnn366ZcuWzQNjtVZJKiXeFShrKmiseAsGJeV1qlDv1auXV7mo8v2BBx7wavgLLrjgkNf07dvX+vTpE1WRTjIdAAAA+D+qFo+kWaGhUCgcm8trr712SHFOpkyZknwJ1T9d7WJU2a5xhYpmnnzySW9DGUlJ8SM9Z81qTQxjAgAAEItEOg6htiexAar6nsejvuRqz6J+g8Hin3/99dch22k/N954Y9T96tWr+881atTwJHeRIkW8QiQhqjbRwkORkvI60XF0U1CsYPzdd99NMJGuLwF0AwAAAJA8RYsW9YU/f/nlF+9DHo/GAvXq1fOfta7RwoULvd1LML7Qeki33nprePt4s1RTGmMCAAAQi9YuOERQua0FhFatWmUvvPBC3P7oopYuWmxIUzGVhFfQrH7msbRY0PDhw23lypXeO1F9CYNgWa8pVKiQNW/e3BcNXbNmjfc41/n8+uuvvk3p0qV9gSAtKKREvfozHu51uq/kuXoqrlu3zr744gt/X/H6pAMAAAA4MuptrnaJ6kOuuP/777/3GaJPP/101HZq3TJ+/Hj76aefrEePHrZt2zbr1KlTeHyxYMECmzx5su9Di5XOnz+fjwQAAKQaEuk4hKq0NRVTbVqqVq3qiWe1QolHiwIp8FV1ePv27T2JrQrxhIJqTdNUj8K33nrLRo8ebWeffXa41+LMmTOtVKlSvjCREt3qrahe50Glufqwly9f3vsnqm2LKlUO9zo9r+BcCxlp4dSuXbt6oN6tWzc+fQAAACCF3Xzzzb4AqJLn6mFev359GzlypC8YGmnQoEF+05jj66+/to8//tgLZESxumL71q1be4sYtZGMrE4HAAA43jKEgmZ2ABKkHuladHTHjh1xW8cAAIC0id/lQNqydu1aT6ovXrzYqlWrZukB/44AAJC+pcTvcirSAQAAAAAAAACIg0Q6AAAAAAAAAABxZI73JAAAAAAAKal06dJGh1EAAJDeUJEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAACTSAQAAAAAAAAA4MlSkAwAAAAAAAAAQB4l0AAAAAAAAAADiyBzvSeBYmTBhgt111122Zs0au+2222zo0KFp/mJPG17PcuXIlNqngTgadlvI9QEAACeUBg0aWLVq1cLxcunSpa13795+S8vnmZAMGTLY+PHjrUWLFkd1rKRcg5Q6Vqy2k+palpyMCU4k45stSu1TAACkEyTSkSq6detmN910k/Xq1cvy5MnDpwAAAAAkwfz58y1Xrlwn9bXiGgAAgNRAIh3H3d9//22bN2+2Ro0aWYkSJVL1E9i3b59lyZIlVc8BAAAASKrChQuftBdr7969ljVr1pP6GgAAgNRDj3QcV9OnTw9XoF9yySU+5VKPyddff21169a1HDlyWMmSJb1a/Z9//vHn/ve//9n5559/yP6qVq1qjzzySPj+66+/bhUrVrTs2bNbhQoV7KWXXgo/t3btWj/ee++9Z/Xr1/dtRo0adRzeNQAAAE4G69ats6ZNm1qBAgW8avycc86xSZMmhZ+fMWOG1apVy7Jly2bFixe3++67z/bv3x9+XrHvjTfeaLlz5/bnhwwZkmBbk6B9ShDfLlmyJPz89u3bo2Js/an7kydPturVq3usrThchS2fffaZx8558+a1tm3b2u7du+O+v9mzZ3sLl5w5c/p7VGHMtm3bws8fPHjQ7rnnHitYsKAVK1bM+vfvH3d/33//vZ+LzumUU06xrl27etFNoGPHjt6aZcCAAV6AU758+UOugaxatcrq1avn8f3ZZ59tU6ZMOeRYGzZssOuuu87y58/v59e8eXO/fgAAAElFIh3HVZ06dWzFihX+84cffmgbN270x37++Wdr3LixXXPNNfbdd995sluJ9Z49e/q27dq1s3nz5vl2gR9++MG3VdAvSoo/+OCDHmgvX77cHn/8cevXr5+9+eabUeegAcvtt9/u2yj4BwAAAFJCjx49bM+ePTZz5kxPEj/xxBOeFJfffvvNmjRpYuedd54tXbrUXn75ZXvjjTfsscceC7/+7rvv9mT7Rx99ZF988YUnwRctSpn+zUpqv/DCCzZnzpxwUlnJ6Hfffdc+/fRTP97zzz+f6OuVrL/00ks9Uf3NN994rK4vDQ4cOBDeRnG3vkCYO3euDR482AteEkpqB18aKBZXQl6tWt5//3378ssvw/F/YOrUqT5+0H4mTpx4yH6UvG/ZsqVXquu4r7zyit17772HzELVsVTQM2vWLP9CQJ+Lxh+qcgcAAEgKWrvguFKAW6RIEf85qFSRgQMHerI8WDCoXLly9txzz3nluAYZquZR9bkCfSXHg8S5qtTPPPNMv//QQw951Y4CaSlTpoz9+OOPNmzYMOvQoUP4HHSMYJuEaPCjW2Dnzp3H5FoAAADgxLJ+/XovDKlcubLfL1u2bPg5zZTUrEsls1UhrtmTv//+uyd9VQyianAl1t955x1PWAeJ6dNOOy1Fzk0J+wsvvNB/7ty5s/Xt29eLVIJzbNWqlU2bNu2QJHRAifFzzz03asanYvRIVapU8Zg8iOf1XpUIv+yyyw7Zn+L6//77z956661wz3dtr+S8voAoWrSoP6bnNOtU44iEKPn+008/ecV90DZSBTVXXHFFeBsV6Sjhrv3o2suIESO8Ol1fVlx++eWH7JcxAQAAiEVFOtIEVeWMHDnSK0OCm6pGFPCuWbPGt1GiXQG3hEIhGz16tD8WVLRoIKBBQeQ+NGCIrGIXDQDiUVI/X7584ZsGPAAAAMDhqDVhkLBWQlmzJwOaDVm7du1wIle0nVqZ/Prrrx6zqjo6sp2hCk+CdiZHS0nugJLUas8SmejXY2r3criK9KQeQ9SeJrF96nqoUCZy4VRdD8X/wQxW0ZcSiSXRg/0oXo9ce0nXOXassXr1aq9ID8YJurZK5MeOFQKMCQAAQCwq0pEmaADRrVs3H3zEKlWqlP/Zpk0br5DR9NZ///3Xp6S2bt06/Hp57bXXDumlnilTpqj7kcF6QlSd06dPn6iKdJLpAAAAOJybb77Zi0GCVilKxmrG5G233XZMLl7GjBnDRSaRbUwSkiVLlvDPSuZH3g8eUxI7MepjfjjJ3WdSHC52TwqNFWrWrJng+kiJLVzKmAAAAMQikY40oUaNGt6GJWjTkhBNa1WrFwXASqRrimjQJkYVNKpC+eWXX8JV6kdKiz/pBgAAACSXCjC6d+/uNyVjVeihRLoW9dQaQUp6B1Xp6tWtKmnFuaqQViJafb6DQhIt5Lly5UqPgRMSJIG17pAWEpXIhUdTkqrN1abl4YcfTpH96XpoRqpmlgbJcl0PfTmQnCp87UcFNroGqoCXb7/99pCxhtq7aOyghVWTgjEBAACIRWsXpAmqNNfCR1pcSMH/qlWrfJGl2MWGlCQfM2aML0YUmzBXUK+qH/VW14BDCzyp9+HTTz99nN8NAAAATkZai0e9utWaULMo1XNciV659dZbPeGrpLp6eivWVfsXzYRU8ljtRtSmUAuOfvXVV7Zs2TLr2LFjuOo8sSrxCy64wAYNGuQtTrRQ6QMPPHBM3pu+FNCioHofalmj96C1jP76668j2p9i+ezZs/taRnqvula6Nu3btw/3R0+Khg0b2llnneX7UQsXLSZ6//33H3KsQoUKWfPmzf15fT7qja7ZsGqrAwAAkBQk0pEmqMJFgb8S4HXr1vWKGi26FNnrMFgEacuWLb4YU4sWLQ6ZSqsFhJQ8Vy9FVe6oykWLjgIAAADH2oEDB6xHjx6ePG/cuLEneIPFOU899VSbNGmSzZs3z3uDq2JdifPIxPeTTz7psbAW3FSC+KKLLvKWJPEMHz7c9u/f79spka8e7ceC3ova1ShZXatWLe9Dri8DMmc+sknO6tGuLx22bt1q5513nsf56sGuBUeTQ180jB8/3mes6rw0JhgwYMAhx5o5c6ZX+rds2dI/H1179UhPaoU6AABAhlBkQz0Ah1CPdC06umPHDgJtAADSIX6XA+DfEQAATm47UyC/R0U6AAAAAAAAAABxkEgHAAAAAAAAACAOEukAAAAAAAAAAMRBIh0AAAAAAAAAgDhIpAMAAAAAAAAAEAeJdAAAAAAAAAAA4iCRDgAAAAAAAABAHCTSAQAAAAAAAACIg0Q6AAAAAAAAAABxZI73JJAeZciQwcaPH28tWrRI0f1OG17PcuXIlKL7xNFr2G0hlxEAAOAIrV271sqUKWOLFy+2atWqcR0Po+2kupYlJ2OCtG58s0WpfQoAgBMQFek44WzcuNGuuOKK1D4NAAAAAEdg+vTpXhyzfft2rh8AAEgzqEjHCadYsWKpfQoAAAAAjrG9e/da1qxZuc4AAOC4oCIdybZlyxZr06aNnXrqqZYzZ06rXLmyjR49OmqbBg0aWK9eveyee+6xggULenK7f//+UduowuTmm2+2woULW968ee2SSy6xpUuXhp/X9ppeOnz4cCtVqpTlzp3bbr31Vjtw4IANHjzY91mkSBEbMGBA1H5VvTJhwoTw/XvvvdfOOussP9eyZctav379bN++fXzyAAAASFc+/PBDO+eccyxbtmxWunRpGzJkSNTzeuzxxx+3Tp06WZ48eTyGfvXVV6O2mTdvnlWvXt2yZ89u5557rrd0iaRYu3Pnzt7uJUeOHFa+fHl79tlno7bp2LGjt1F86qmnrHjx4nbKKadYjx49omLsl156ycqVK+fHKVq0qLVq1Sr83MGDB23gwIHhY1StWtU++OCDcKuZiy++2H8uUKCAx/Y6XjDG6Nmzp/Xu3dsKFSpkjRo18sdnzJhhtWrV8uui87nvvvts//79yRqbAAAAHA4V6Ui2//77z2rWrOkJaiXAP/30U2vfvr2dccYZHsAG3nzzTevTp4/NnTvXvvnmGw+AL7zwQrvsssv8+WuvvdYD588++8zy5ctnw4YNs0svvdRWrlzpAa78/PPP/vznn3/uPysA/+WXXzwxroB5zpw5PlBo2LChnX/++QmerwYRI0eOtBIlStj3339vXbp08ccUSAMAAADpwcKFC+26667zBHDr1q09DlaRiZLYQaJZlFx/9NFH7X//+58np2+55RarX7++J8T//vtvu+qqqzwef+edd2zNmjV2++23Rx1HSe7TTjvN3n//fd+3jtO1a1dPUOv4gWnTpvlj+nP16tV+TiqCUay9YMECT1y//fbbVqdOHdu6davNmjUr/Fol0XX8V155xZPtM2fOtBtuuMELbC666CL/wuCaa66xFStW+HhDY4bIMYbe0+zZs/3+b7/9Zk2aNPFr8NZbb9lPP/3k56AEfmSy/HBjEwAAgMPJEAqFQofdCjgMBeQVKlTwqpSg6kPVLJEBs5LsqjofNGiQff3113bllVfa5s2bvXIkcOaZZ3qCW8G6At8nn3zS/vjjD098S+PGjT2gVlI9Y8b/m1Ch4yoQVuVJUhYb1TmOGTPGA/yE7Nmzx2+BnTt3WsmSJW3CM1VZbDQNYrFRAMDh6He5vrTfsWOHJ+WA9Khdu3b2559/2hdffBF+THGzilp++OGHcEV63bp1PYEtGuqp+vrhhx+27t27e3W6Euy//vqrJ5pFyWwlpuMtNqoqcMXkQdW4Ym/1MVdMninT/y28qSS74nPF2ePGjbObbrrJjxPE8QHF2Sqa+fLLL6127drhxzVTdffu3fbuu+/6vlWVvm3bNsufP394G40x9Pd50aL/t5Dk/fff74n35cuX+zggqIZX0Y/+zuucDjc2Sc6Y4MrRVVhsNB1gsVEAwLEYE1CRjmRTEKopo2PHjvUKEPUmVJCp1imRqlSpEnVfFStKnItauKgiRlUukf79918PyAMaDEQG35oWqmA9SKIHjwX7Tch7771nzz33nO9Xx9Q0z3h/YVQho8EGAAAAkFYoUdy8efOox1RRPXToUI/Pg4R2ZAyuxLIS6UGsrH3o+SCJLpHJ7MCLL77o7RXXr1/v8bni/dgku1rMBMcMYn3N/hRVeZ9++uneVlGFMLpdffXVPl5Q9boS5rGV4DqGWs4cjmbGxl4XvYcgiR5cF8X9SuSrvU3sdQnON94YgjEBAACIRSIdyaYqcfVJVNCu/ui5cuXyPoUKfiNlyZIl6r6CW00VFQW2Cl5VbRIrsuokoX3E228sTdtU9Y4S4+qhqG+eVCUT208yUt++fX3aZ2z1CQAAAJDWJSdWTohi5bvuusvjZSWoVdSi+F8tUZJ6HL1GVeOK9VVB/+CDD/ps0/nz5/s4QFRJrzWXIkXOVE2Mxh7H47owJgAAALFIpCPZ1I9Q1TDqYygKQNXX/Oyzz07yPmrUqOHTQzNnzuxV58eKejqqGkZTPgPr1q2L+xoF8EkJ4gEAAIDjpWLFiuG+4AHd19pBkZXhh9uH2r5ozaOgKv3bb789ZJ/qa67+64HIGaNJpThf6xjp9tBDD3mxzFdffeWV6Iq1Ve2u3u0JyZo1q/+pSvukvCe1dlEbm6AqXe9ByXz1ej9SjAkAAECs/9cfIxn++eefI3kZThBaEGjKlCmepNZUym7dutmmTZuStQ8F1KpwUR9zVamsXbvW96eEd2K9y4/0XBWkq7JGAwC1eFH/dAAAAJzYTrQxy5133mlTp071hURVxKLFM1944QWvHk+qtm3berJZi3H++OOPNmnSpPAaR5Hxs+LxyZMn+3H69evnleTJMXHiRI+7lyxZ4kUsWgRUxTda8FQJbp3zHXfc4e9BMbqq159//nm/LyqE0XlqP+oLH1SxJ0QJ/w0bNthtt93mC41+9NFHnrjXDNPIdpAAAABH64giC/Wk7tSpky8YiZPPAw884BXlapWihXvUdzGxhT0To8BYgXu9evV8ISJV0lx//fUeaOv/r5TSrFkzD9K1QJL6OipZr8EAAAAATmwn2phF8bfWKFKBSKVKlbxdyiOPPOILfyZV7ty57ZNPPvFe5upHriKWJ554ImobFcm0bNnSWrdubeeff75t2bIlqjo9KVR9rgVHtZinKsa1oOno0aO9r7roywDF5OpDrufVQ12tXsqUKePPq+WLWjPed999/jkqlk+MttW4Yt68eVa1alVfVLVz584+ZgEAAEhJGUKaA5dMEyZMsJEjR3rAorYcClBvvPFGK1GiRIqeHHCirOoLAABSD7/LT06MWZCS+HcEAID0LSV+lx9RRbqqjxWY/vbbb/6N/7vvvuvT76666iqvPNi/f/8RnQwAAAAApATGLAAAAEj1ivSEqKfd3XffbXv37rVChQp5gl1T8XLmzJkSuwdSDdUnAACkb/wuR4AxC/h3BACAk9POFKhIz3w0J6AFJrUgjNq8qLd1q1atvB/dr7/+6r32tAK8FpIEAAAAgNTAmAUAAAAp4YgS6WrfMmLECF/J/eyzz/bFZ2644QZfVCZQp04dXzgGAAAAAI43xiwAAABI9UT6TTfdZNdff73Nnj3bzjvvvAS30cKjWgUeAAAAAI43xiwAAABI9R7pu3fvpvc5Thr0VQUAIH3jd/nJiTELUhL/jgAAkL6lxO/yjEfyojx58tjmzZsPeXzLli2WKVOmIzoRAAAAAEgpjFkAAACQko4okZ5YEfuePXssa9asR3tOAAAAAHBUGLMAAAAg1XqkP/fcc/5nhgwZ7PXXX7fcuXOHnztw4IDNnDnTKlSokKInCAAAAABJxZgFAAAAqZ5If+aZZ8LVHa+88kpUGxdVopcuXdofP1YaNGhg1apVs6FDh9rxNn36dLv44ott27Ztlj9//mS/fuTIkda7d2/bvn37Ee//cPtITR07dvTzmjBhQqp/VsfKtOH1LFcOWhelFQ27LUztUwAAAGlQao9ZkLLjirSm7aS6liUnY4K0ZHyzRal9CgCAk0SyEulr1qzxP5XwHTdunBUoUMBOFnXq1LGNGzd6U/r0uP/jTf9/ZMmSJbVPAwAAACeZk3nMAgAAgDSSSA9MmzbN0ot9+/alSEJX1SvFihVLkXNKjf0fbwULFkztUwAAAMBJLD2NWQAAAHACLTbap08f++eff8I/x7sdjdmzZ3tbkJw5c3r1SKNGjbzdSeDgwYN2zz33eKJWief+/ftHvV79219++WVr1qyZ5cqVywYMGOCP67EzzjjDE9bly5e3t99++5DXqe/71Vdf7ccuV66cffzxx1GtV7RNZFuVw51rPH/++aede+65fjwt0prQ/tXKpVSpUr5/bbdly5aofei9q32K3oumqKqa/frrr7ddu3ZFXa+BAwdamTJlLEeOHFa1alX74IMPwtNdzzzzTHvqqaei9rtkyRI/l9WrVyd47uqHr89ZLWhOOeUU/zxiF3PSdVEbmsBLL73k1zR79uxWtGhRa9WqVZLOMThe586dw8/r83v22WejjqfrV6tWLf/MdV4XXnihrVu3Lvz8Rx99ZDVq1PDjly1b1h5++GHbv39/Ej4pAAAApBfHa8ySXnz44Yd2zjnnWLZs2Xy8MGTIkPBzjzzyiJUoUSJqjHHllVd6Jb/i806dOtlVV111SJFSkSJF7I033vD72m7w4ME+ptAxNHYJxl/y/fff2yWXXOIxvMYNXbt2tb///jtZ4wqNlXr16uXHVSx/0UUX2fz588PPB+OoqVOn+vhKYyfN9l2xYkXUfhgPAACA45ZIX7x4sQdOsmjRIr+f2O1IKYF76aWX2tlnn23ffPONff3119a0aVMPsAJvvvmmJ0vnzp3rQZsCwClTphySYFbiWYGbAsDx48fb7bffbnfeeactW7bMunXrZjfddNMhVSpKrl533XX23XffWZMmTaxdu3a2devWIz7XxGzYsMHq1q1rlSpV8oSxgs5Yen9KHvfs2dOPpYD2scceO2S7n3/+2fsHTpw40W8zZsywQYMGhZ9Xgvqtt97yPpA//PCD3XHHHXbDDTf4dgo4dX1GjBgRtU/dr1evngfECVEAriT/8OHD/X3rGukaJ2bBggUe/OqzUkD7+eef+/6Tco5BgH7aaafZ+++/bz/++KM9+OCD9r///c/Gjh3rzysh3qJFC6tfv75/dvo8FKTr/cmsWbPsxhtv9P8H9Pphw4b5+UcG+QAAAEj/jseYJb1YuHChj21UaKNxkcZI/fr18zhY7r//fk+u33zzzX7/xRdftDlz5vh4K2PGjP644na1nwxovLF7925r3bq13+/bt6+PPbRfxdnvvvuuF82IvtBQoZEKjpT4Viz/5Zdf+vgmOeMKJdf1hYDOS5+pxijab+w4Te9H+9PYI3PmzD7OCTAeAAAAKSFDKPYr/1TUtm1bW79+vQdRCVGVsxLVCoQCqkJWlUOQPFbyVJXQwSJDoupkVWK8+uqr4ccUVCq4+/TTT8Ove+CBB+zRRx/1+3oud+7c9tlnn1njxo0PWQz0cOea2EKhSpBfdtllnujXQpxBsjeh/e/YsSN8fqIgWMFsULWuYPjJJ5+0P/74w/LkyRMONGfOnGnffvutV2+ocl8Ba+3atcP7UVCsAFiB7u+//+6VIwqadS018FBliqrUO3TokOB70fNKdt99993hRLaqxWvWrJngYqPqTakvLn799dfweQaSco4JUQCu960vIhREq4JF11DJ9FgNGzb0Lz0U6Afeeecdv1Z6/7F0TroFdu7caSVLlrQJz1RlsdE0hMVGAQBJpd/lmrmn2Cpv3rxcOJwUVBSkWbBffPFF+DHFvxpfqHhFfvnlF4/Zb731Vnvuued8hq7GIQGNoTQm0OtEs34Vd6vwRrNgCxcubC+88EI4GR/ptddes3vvvdeLiFQIJZMmTfLiI8XgSrgfblyhMZkS8RpLBeel8Yq+ANDYSq8LxlEaTyjmD46j6vp///3Xq9iTOx6INya4cnQVFhtNY1hsFABwvMYESa5Ij6Rv9yPbhwQU6ER+859cQZV3PFWqVIm6X7x4cdu8eXPUY5rSF2n58uWeTI+k+3o8sX0r2NNFjd13cs41lgI5VaK3bNnSW5MESfSE6NzOP//8qMciE80BBZGRyenI66HWLEpGK3GvLwWCm6q/VckuCl4VZKoKRD755BMPGK+99toEz0v/s6kqJfLcVPERe80j6finn366t1Rp3769jRo1ys8rqecYVMgooFawruf1pYi+yBAl4jt27OiVKQrMdW0jK2eWLl3q1fCR++/SpYtvE5xHJFXI6y9WcFPADAAAgPTlWI1Z0ovExkCrVq0Kz6JVfK4CmieeeMKT5JFJdFGCPJi9umnTJi8yCq6d9q9xQ2JjIj2vlo1BEj04vmabapZqUsYVGg8ocR75PrT+lQqA4o3lNCaSYFyU3PGAMCYAAAApkkjXtDolhWPpMSVAj5R65x1O7MKhSkYrGIsUGawlR1L2nZxzjaUWLqqG0JTI3377zVJCvHMO+g+q6kSJ/+CmaZeRPcgVII8ZM8Y/PwXKmqqp3oIpRYl+TcMcPXq0B7VqzaKgWpX1STlHndtdd93lrW5UUaPnVeG+d+/e8DF03mrpon6I7733np111llelR9cB7Xtidy/prdqEKEKlViqVFFgH9xURQMAAID05ViNWU40ms2aKVMmW7t27SFrCKk9oqrWFWerglvV4ioMOtLx0LEUOS4KCpYix0XJGQ8IYwIAAHBUiXSVwCuxqG4wqu7Q/eCmliSaQqdFYI6Uqgi0SExKq1ixoi8MGkn31d/8eJ6reg1qYVBVVmv6YWLTCINzVhuYSEFiOKn0/pS8V+W2eglG3iKrrNUPXl8+aEFWtY6JV6GjCm0lwyPPTQG3ejDGo+oSfYmgvvbqY65A/auvvkrSOeqzUoJcU06rV6/uz0VWqwf0nAJetalR//mgLYwWGVXVS+z+ddNnEkvno9kIkTcAAACkD8d6zJJeJDYGUsGJEueiAhS1YVR7FMXjQZvLgNq4aC0iFa2ovYqKWQLlypXzZHpiYyIdX5XgweKvwfEVf5cvXz5J44ozzjjDsmbNGvU+VKGunuvJGcsldzwgjAkAAECszJYM6t2tb/d1UwAWS4/rm/4jpSRo5cqVPWHavXt3D5q0IKjajBQqVOiI96veeeqJrkSrkrlqX6KAUX30jve5KmhVa5M2bdp4b3cFrcWKFTtkOy3OqSmMmmrZvHlzmzx5sie5k1sJrkpu9R1UNYZWuNegQoGoksNBD3Sdk1qj6D0pIE6ohUwkLdqpnvTatkKFCvb000+H+7YnRBX4qmTRAqPqcajBi85HAXRSzlHHUdWQroGqYPRlhIJn/Sxr1qzxVi+ajqpWNQqSVV2iChpRBfxVV13lveBbtWrlwbKCei08m9ACrgAAAEi/jvWYJb2488477bzzzvPkuGacqqpc/cxfeuklf17rF91yyy3e1kUxuJLlipmvuOIKu+CCC6Jmr+pxtYOJXENJldzqga4+4xoLaeyinuzqv66ZpOrR/tBDD/lrtLaTnrvtttu81WOwIOnhxhUq9tE5ajyndo6K51WYo3YsOkZSMR4AAADHPZGuRLEqO5QA1srpCmYCCp7UB1uJzCOlQFetO/73v/953ztVOKhnnpLOR0NVFOqbraS0gjUlYBUoakHM1DhXVWerzYkC2iCZHkvBqxboUfCpwE9fAEQuhppU2l59xdXjT8lsDSxUkaHzjqRA9PHHH4+qMokXlKufoIJiJaVVwa7FU5UAT4iOqS8uFED/999/Hijr/WvxoqScY7du3Wzx4sV+vTTw0TXWFxjq0ShqQ/PTTz/59N0tW7Z4ZUuPHj38daLe6Urmqy+iBgqa9qlAPaFFkQAAAJC+HesxS3qheHrs2LE+llC8rRhZ8bAKaHR99KfGMT179gzHzEpa33DDDd76RH3EReMQvVaxe+x169evn49tdAzNttV2KjIKYnQVwmj8pYS+7l9zzTWeLE/OuEKJdhXcKAGvGQbqoa79qkAnqRgPAACAlJAhpCgqmdatW+dtNxKbBof0Z9asWb5QkPqBBxUiSLlVfQEAQOrhd/nJiTFLylB/8VNPPdULkVq2bGknK/4dAQAgfUuJ3+XJqkgPqIpDU+7mzZvnK6HHLsgZtNRA2rdnzx6fZqlqcbWlIYkOAACAEwFjlqOjMd5ff/1lQ4YM8RmjaqMIAABwMjuiRLp6jKvnnaoTlMEPVkUX/UwiPf1QixW1dalWrZr3IQcAAABOBIxZjo4WH1VLzNNOO80XGlULFwAAgJPZEbV2UX/wJk2aeE9t9boDTmRM4wQAIH3jd/nJiTELUhL/jgAAkL6lxO/yI2py/ttvv1mvXr1IogMAAABIkxizAAAAICUdUSJdq54vWLAgRU8EAAAAAFIKYxYAAACkpCNqdHfllVfa3XffbT/++KNVrlzZsmTJEvU8C9EAAAAASE2MWQAAAJDqPdIzZky8kF2LjR44cOBozwtIM+iHCABA+sbv8pMTYxakJP4dAQAgfUuJ3+VHVJF+8ODBIzoYAAAAABwPjFkAAACQaj3SmzRp4ln7wKBBg2z79u3h+1u2bLGzzz47RU8QAAAAAJKKMQsAAABSvbVLpkyZbOPGjVakSBG/rzL4JUuWWNmyZf3+pk2brESJErR2SYIGDRpYtWrVbOjQocn6wEqXLm29e/f227GkFj3jx4+3Fi1apPp7Tu1zD6Z+THimquXKkSlF9omj07DbQi4hACDJaMlwcmHMkvpGjhzp45XIoqtjLXacdKzGBFeOrmJZcjImSAvGN1uU2qcAAEhHjntrl9ic+xG0V0c6oS9MChQoYOlRej53AAAAHB3GLKmvdevWPjMgNTEmAAAAKe2IeqTjxFesWDFLr9LzuQMAAADpXY4cOfyWmhgTAACAVO2RrulxusU+hmjqFd+mTRs79dRTLWfOnFa5cmUbPXr0IZdp//791rNnT59WUKhQIevXr19UBc3mzZutadOmHoSWKVPGRo0adcg+1q9fb82bN7fcuXP7tITrrrvOW+wE+vfv7+1Uhg8fbqVKlfLtbr31Vm+/M3jwYA8w1apnwIABh3yuEyZM8J/Xrl3r98eNG2cXX3yxv6eqVavaN998k+z3HE9wrsOGDbOSJUv6fvR+Ivvyz58/3y677DK/Xrpu9evXt0WLFh3VuQMAAODEwZglbbR2yZ8//yFx/ttvv+0tWBTHX3/99bZr167wNh988IGPITT2OeWUU6xhw4b2zz//hFtExra2VMuWjh07JnoOjAkAAEBKS3ZrFwUr2bJl8/v//fefde/e3XLlyuX39+zZk+InmB7putSsWdPuvfdeT25/+umn1r59ezvjjDOsVq1a4e3efPNN69y5s82bN88WLFhgXbt29WR3ly5d/Hld699//92mTZtmWbJksV69enlyPXDw4MFwEn3GjBmemO/Ro4dPpZw+fXp4u59//tk+++wz+/zzz/3nVq1a2S+//GJnnXWWv27OnDnWqVMnD1bPP//8RN/X/fffb0899ZSVK1fOf1bifPXq1ZY5c+Ykv+fD0f7Gjh1rn3zyifcu0vVR4j/4EkHBdocOHez555/3/x+HDBni00ZXrVplefLkOaJzj6X/jyP/X9Z5AAAAIH1gzJI2aRyiYpeJEyfatm3bvGBm0KBBXtCjNiyKz1Xoc/XVV3vMP2vWrBRvJcqYAAAAHLdEuhKYkW644YZDtrnxxhvtZKeq7Lvuuit8/7bbbrPJkyd7gjgyqayq62eeecarJcqXL2/ff/+931cifeXKlZ78VpL9vPPO8+3feOMNq1ixYvj1U6dO9desWbPG9yVvvfWWnXPOOV65HbxOCXdVpCvRfPbZZ3tl9ooVK2zSpEmWMWNGP/YTTzzhCft4iXS9pyuvvNJ/fvjhh/04SkZXqFAhye/5cJSQ13vQ/kQJcx1TCXNVz19yySVR27/66qte7aIvBK666qojOvdYAwcO9G0AAACQ/jBmSZs0JlGlelD8oqIbjWeCRLqKglq2bGmnn366P6/q9JTGmAAAABy3RPqIESOO6mAnC7VNefzxxz2J/Ntvv9nevXu9wlltRSJdcMEFUa1xateu7QljvX758uVeLa0q74CSvpFTJLWNEuhBEl2UKNc2ei5IpGv6ZGS1dtGiRS1TpkyeRI98LLLaPSFVqlQJ/1y8eHH/U6/ReSX1PR+OKvKDJHpwTRR0K/GvRLra1jzwwANeca9j67i7d+/2FjdHeu6x+vbta3369ImqSI+8xgAAAEi7GLOkTbFjEsXkwfhDrRcvvfRST543atTILr/8cp9FW6BAgRQ9B8YEAADgaLDY6DHw5JNP2rPPPmtDhw71YFCtb9TTT8nl1KC2MJGUvE/oMSWsk7qf4AuA4DXH6z2rwkj92HUsVauozZCS7Yc7Trxzj6V9Bu2LAAAAABy9eOMPFflMmTLFW05+8cUXPitVbVjmzp3ra0WpACi2zcu+ffuO6hwYEwAAgGO62CiSZvbs2d67XK1vVF1RtmxZb9USS4FhpG+//dZ7eCuQVKW0pjcuXLgw/Lyqsrdv3x6+rzYvGzZs8Fvgxx9/9G1UmZ4W3/PhqLJcfeEjr0nQfiY4jnrFqy+62rMo4f3XX3+l6HsBAAAAcHwpsX3hhRd6i8XFixdb1qxZbfz48f5c4cKFvf1LQLNSly1bxkcEAACOKxLpx4CS4UFFhVqsdOvWzVuSJJQ0VgsRJchHjx7tlRe33367P6fEcePGjf21SrgroX7zzTf7KvYBLQ6q6u927drZokWLvJ+6etTXr1/fzj333DT5ng8ne/bsXnW+dOlSX2BISXMtRKS2LsFx3n77bT+Grovee+Q1AQAAAJC+KK5Xm8gFCxb4GGncuHH2559/hteH0jpJn376qd9++uknu+WWW6IKjAAAAI4HEunHgHp416hRw/v7NWjQwJPALVq0OGQ7Jb3//fdfX4yzR48enkTv2rVrVH/HEiVKeGJcC+/ouSJFikRVbXz00UfeO7BevXqeWFcl+HvvvWdp9T0fzplnnunvVRXn6o2oPoYvvfRS+HktuLpt2zY/lhYoUqI98poAAAAASF/y5s1rM2fO9DHAWWed5WMLrR11xRVX+POdOnXyYpugaEhjnosvvji1TxsAAJxkMoRim80BqaR///42YcIEW7JkSZr6DLTYaL58+WzHjh0e5AMAgPSF3+UA+HcEAICT284UyO9RkQ4AAAAAAAAAQBwk0gEAAAAAAAAAiINEOtJUa5e01tYFAAAAAAAAAEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAAHGQSAcAAAAAAAAAII7M8Z4E8P9MG17PcuXIxCVJJQ27LeTaAwAAHGOlS5e23r17+y29atCggVWrVs2GDh2a4vtuO6muZcnJmCC1jG+2KNWODQAAiXQAAAAAQLozffp0u/jii23btm2WP3/+8OPjxo2zLFmypOq5AQCAEw+JdAAAAADACaNgwYKpfQoAAOAERI90HLGRI0d65cfkyZOtYsWKljt3bmvcuLFt3LgxvM38+fPtsssus0KFClm+fPmsfv36tmjR/5uOt3btWsuQIYMtWbIk/Nj27dv9MVWYiCpM2rVrZ4ULF7YcOXJYuXLlbMSIEeHtN2zYYNddd52fi4Lm5s2b+36Teg4AAADAieC1116zkiVLWs6cOe3qq6+2p59+OqpS++eff/ZYuWjRoh67n3feefbll18esp9du3ZZmzZtLFeuXHbqqafaiy++GPW89lu5cmV/Xse79dZb7e+//z5knDBhwgSP3bNnz26NGjXyuD3SRx99ZDVq1PDny5Ytaw8//LDt378//LzGBK+//rq/F70n7evjjz/25xTvqxpdChQo4Nt27Ngx3NolsjWN2tU8/vjj1qlTJ8uTJ4+VKlXKXn311RS44gAA4GRCIh1HZffu3fbUU0/Z22+/bTNnzrT169fbXXfdFRWEd+jQwb7++mv79ttvPfht0qSJP55U/fr1sx9//NE+++wzW758ub388sueFJd9+/Z5UK6AeNasWTZ79uxwQn/v3r1HdA579uyxnTt3Rt0AAACAtExxcPfu3e3222/3IhUVkgwYMCBqGyW7FQdPnTrVFi9e7DFz06ZNPYaP9OSTT1rVqlV9m/vuu8/3OWXKlPDzGTNmtOeee85++OEHe/PNN+2rr76ye+6555Bxgo7/1ltv+bmpWOb6668PP6/Y/cYbb/R9K9YfNmyYJ+Bjz1nJdRXNfPfdd37uKrDZunWrJ/A//PBD32bFihVezPPss88men2GDBli5557rr8nJf5vueUWf11iGBMAAIBYGUKhUOiQR4EkUKB700032erVq+2MM87wx1566SV75JFH7I8//kjwNQcPHvTqlHfffdeuuuoqryQpU6aMB7RaEEgUZKuqZNq0aV5N0qxZM0+cDx8+/JD9vfPOO/bYY495gl1VKKIEelABc/nllx/2HGL179/fA/ZYE56pymKjqYjFRgEAR0pfimtW2o4dOyxv3rxcSJyQlKRWonzixInhx2644Qa/r/g6MZUqVfIEfM+ePcPV25ptqiKWyH3r79GkSZMS3McHH3zg+/jrr7+ixgkqYjn//PP9sZ9++sn3O3fuXKtVq5Y1bNjQLr30Uuvbt29UbK+E/O+//+73Fd8/8MAD9uijj/r9f/75x4tmdG76EiCxHumxi43qPdWtW9eLf0RD4GLFinnMr/NOSGJjgitHV2Gx0VTEYqMAgNQcE1CRjqOiKZZBEl2KFy9umzdvDt/ftGmTdenSxavA9T+r/kdVgB9b9RKPqkXGjBnjwbAC6zlz5oSfW7p0qSfyVZGuoFo3tXf577//fOrqkZyDgnn9pQpusVNQAQAAgLRG1dVKUEeKva8YWLNHldBW4lmxswpSYuPi2rVrH3Jf2wXUDkZJcLV9URzevn1727Jli1ehBzJnzuytYwIVKlTwYwb7URyvApwghtdNMbsqyyP3U6VKlfDPaiWjWD5yvJFUkftRgl6J9Hj7YUwAAABisdgojkqWLFmi7isojZzkoJYqCqo1zfL000+3bNmyeSAetF3RtFCJfI3atUS64oorbN26dV4BoymlCtp79OjhLWU0GKhZs6aNGjXqkHNTT/WknEMsPa8bAAAAcCJREl3xtOLoM88809cfatWqVaJxcUI0o1SzOlXsojYsKmJRC8XOnTv7flRokxSK41Xx3bJly0OeU8/0eOMNzTBNruTuhzEBAACIRSIdx5T6Iardi/oZiqq7gymfkcluVZ5Ur17df45ceDRyOyXEddO0zLvvvtsHAFqc6L333rMiRYokOi3jcOcAAAAApHfly5e3+fPnRz0We19xsRbk1OKdQTJbifFYaskSe19V7LJw4UJPQKvneFAUM3bs2EP2oUVDFyxYEK6KV8W8WswE+1Ecr8eU0D9SWbNm9T8PHDhwxPsAAABIKlq74JhSOxX1ItQUTvVD1OJAqnwJ6OcLLrjABg0a5NvMmDHD+yBGevDBB+2jjz7yFi5a0Eh9HoMAXPtT//TmzZv7gkVr1qzxXom9evWyX3/9NUnnAAAAAKR3t912m8/gfPrpp23VqlW+eKd6iQfrCAVx8bhx47xwRa1V2rZtm2BVthLugwcPtpUrV9qLL75o77//vi8KKkp8awbp888/b7/88ovH2a+88kqCFeA6J8XfSr4rga+4P0isK8bXQqSqSleMr1hd7RxjxwLxaLap3p/GB3/++ad/MQAAAHCskEjHMfXGG2/44j+qOFHvRCW4VT0eSYuIqmJFLVp69+7ti4fGVpqoR6H6GtarV88yZcrkQbZo6ujMmTOtVKlSPi1UCXZNK1WP9KBCPSnnAAAAAKRnF154oSe0lUivWrWqff7553bHHXdEtUnRcwUKFLA6depY06ZNrVGjRh4jx7rzzju9mlwzRhWb63XaVrRv3X/iiSd8oVK1WBw4cOAh+1Ccfu+993qyXuemHuiaSRrQ/pQA/+KLL7yXupLszzzzjCfHk0o92pWIv++++6xo0aLhBVMBAACOhQyhyObUAI7Jqr4AACD18LscJyst3vnTTz/5zM3jaeTIkV4go1YuJwr+HQEAIH1Lid/l9EgHAAAAgBOA1hC67LLLLFeuXN7W5c033/S1ggAAAHD0SKQDAAAAwAlg3rx53tt8165dVrZsWXvuuefs5ptvTu3TAgAAOCHQ2gU4DKZxAgCQvvG7HAD/jgAAcHLbmQKtXVhsFAAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAAHFkjvckUk///v1twoQJtmTJkiS/JkOGDDZ+/Hhr0aJFgs+HQiHr1q2bffDBB7Zt2zZbvHix9e7d26pVq2ZDhw71bUqXLu2P6ZYc06dPt4svvtj3mz9/fhs5cqTvY/v27Uf8fhKSUvs5EtOG17NcOTId9+OeTBp2W5japwAAAJCuKVa+6667bM2aNXbbbbeF4/wTRVLGAx07dvRxiLZLaW0n1bUsORkTpKTxzRal6P4AADhWqEg/jho0aJDkBLWC36lTp6bo8T///HNPcE+cONE2btxolSpVsnHjxtmjjz561PuuU6eO7zNfvnyWUvTFQGzweyyuCwAAAHCiUOFMq1atbMOGDSkS56c1jAcAAEBqoSI9jVHV+IEDByx37tx+S0k///yzFS9e3JPegYIFCx71fvft22dZs2a1YsWK2bF2LK4LAAAAcCL4+++/bfPmzdaoUSMrUaLEEe9n7969Ht+nRYwHAABAaqEiPYVs2bLF2rRpY6eeeqrlzJnTKleubKNHj46aXjhjxgx79tlnvdJat7Vr13pLFP382WefWc2aNS1btmz29ddf+5RFtVwJzJ8/3y677DIrVKiQV33Xr1/fFi1K+hQ4HV9TO9evX+/HUwuXxKrkd+3a5e8lV65c/n5efPHFqOf1+pdfftmaNWvm2wwYMCD8PoJWLodzuPcTnN/VV18ddb6x1+XgwYP2yCOP2GmnnebXTs+p8j6ga6zXq/JerWf02VStWtW++eabJF87AAAAIK1TPJ4nTx7/+ZJLLvEYWI/Fxs+idi9BfB2MFdQeUnG9EvDly5f3x7///nvfV44cOeyUU06xrl27erI+8pi1atXyMYHaO1544YW2bt268PMfffSR1ahRw7Jnz25ly5a1hx9+2Pbv3x9+Xuc4bNgwu+qqqzxOr1ixosfpq1ev9nGK9qsiIBUEBWLfj4qQ+vTp48fXOd5zzz1enBRJY4aBAwdamTJl/L1oPKB2lwAAAMlBIj2F/Pfff54I//TTT23ZsmUeZLZv397mzZvnzyuBXrt2bevSpYu3QNGtZMmS4dffd999NmjQIFu+fLlVqVLlkP0rud2hQwdPsn/77bdWrlw5a9KkiT+eFDp+kHDWsZXITsyTTz7pwaV6qOu8br/9dpsyZUrUNgpgleRWcN2pU6dkXKmkvZ/g/EaMGBH3fPW+hgwZYk899ZR99913Xn2jBP+qVauitrv//vt9Gqh6KZ511ln+RUFkEB9pz549tnPnzqgbAAAAkJYp4bxixQr/+cMPP/QYOnIm6uGofaJer7hfrSD/+ecfj60LFCjgsfj7779vX375pfXs2dO3Vyyt5LsKYhSHKwGuMZCS4zJr1iy78cYbfSzx448/esJcbSaVrI+k9jPaTnF6hQoVrG3btt6epm/fvrZgwQJPigfHTIjGAtrv8OHDfWyxdetWXzcqkpLob731lr3yyiv2ww8/2B133GE33HCDFzolhjEBAACIRWuXFKLKbSVqA6r+njx5so0dO9arNFR1remRqrRIqAWKktyq0E6MKkEivfrqq151oeBPFRyHo+OrQiVTpkyHbcGiShIl0EVJ59mzZ9szzzwTdX4KcG+66abw/V9++eWw55Cc91O4cGF/XI/FO18l0O+99167/vrr/f4TTzxh06ZN8yqbyEp6fTZXXnml/6xKmHPOOccrXRSsx1KgrW0AAACA9EJjjSJFioTbNya37aKqv19//fVwS5fXXnvNi4WUgNZz8sILL1jTpk095s6SJYvt2LHDY/czzjjDn1dFeUDxtMYUKp4RVaQraa6K8Yceeii8ncYU1113nf+suF7FR/369fMkvigRHznuiKW4X0n3li1b+n0lyzUOi0yIP/744/4lgPYdnIuS7kru64uAhDAmAAAAsahITyGaUqjAUC1dFLiqd58COLVSSYpzzz037vObNm3yanZVbispnjdvXp9WmdT9J0cQYEbeV6V8cs73cFLi/ahS/Pfff/fEfyTdjz3fyCp/9YkX9Y9MiAJxDQqCmxZqAgAAAE5kGsdE9kVXPK1ZqkESPYiz1SZFlesa86gljBLeSq5rpqiq4ANLly71YqGgp7luwezc3bt3JxinFy1aNHwukY8poZ/QLFHF6trf+eefH34sc+bMUWMVFc/oeCoKijwXfUEQ2TImFmMCAAAQi4r0FKJ2KAoeVRGhwE8Bp3qPa6GepIgMUBOiSg71YdcxTj/9dO8HrgR3Uvef0g53vodzvN+PKmYCwXRTDQISonPRDQAAAEjvMmbMeEjP8H379qVIfK82jL169fI1it577z174IEHvDXMBRdc4EUyqkoPKsUjqWd6vDg9ObH74QQ93dWCU7OII8WL+RkTAACAWCTSU4janzRv3tx77QWB3sqVK+3ss88Ob6MKD1WuH+n+X3rpJe8jLqqS/uuvv+xYUM/y2PuR0zRTQlLejwLoeNdLVexaDEn7ipySqftqpwMAAACc7NQy8Y8//vBkepCUVj/yw1H8r97j6pUeJNkVZysxHyxGKtWrV/ebKrhVGPPuu+96Il2LjKpy/cwzzzxm700zWzXbdO7cuVavXr1w7/aFCxf68UXjMSXFNfM1sTYuAAAASUEiPYWoRYlWfp8zZ44vyPP00097+5LIRHrp0qU9yFu7dq1PJ9R0yOTs/+233/ZpiprWePfdd/uK88eCAuTBgwf74kGqKNHCQqrgSElJeT+6Xlr0SFNIFfzqusbS69RjUX0Zq1Wr5lUxGhiMGjUqRc8XAAAASI8aNGhgf/75p8f3rVq18urxzz77zItS4mnXrp3H2ZpJ2r9/f9+H1oFq3769t1tZs2aNr3PUrFkzL25R0nzVqlW+cKg8+OCD3j+9VKlSflwl4NXuZdmyZfbYY4+l2PtTD/VBgwb5+ELrH2kctn379vDzWidK6yVpgVEVO1100UXeEkZjHl2DoIc7AADA4dAjPYVoGqOqHtQjUMGqFvdRIjqSAjgt9qnkuipDktMP/I033rBt27b5MRS8agplsJhQSrvzzjttwYIFXlmiIFfBaLDYT0pJyvsZMmSIJ/JLlizp55IQva5Pnz5+zmqpo4HBxx9/7IE0AAAAcLJTZblmgr744ove83zevHk+LjmcnDlz+ppPW7dutfPOO8+T4ZdeeqkvOBo8/9NPP9k111xjZ511lnXt2tV69Ohh3bp18+c1fpg4caJ98cUX/npVqT/zzDPe1jElaRyg8YQS4qqIV+L86quvjtpGa1lpAVMtIKrr0bhxYy8UKlOmTIqeCwAAOLFlCMU2zAMQRRXzmjaqypXDVe4AAIC0h9/lAPh3BACAk9vOFMjvUZEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAAHGQSAcAAAAAAAAAIA4S6QAAAAAAAAAAxEEiHQAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcmeM9ieMrQ4YMNn78eGvRokWCz5cuXdp69+7ttyPdx/Eye/Zs6969u/3000925ZVX2oQJEw77mo4dO9r27dvD2zZo0MCqVatmQ4cOtbRg2vB6litHptQ+jRNGw24LU/sUAAAATnojR4708YXi8MT079/fY/QlS5ak2euV3LFD7NgjqdpOqmtZcjImOBLjmy06otcBAJBWkEg/DoFnSpk/f77lypXL0oM+ffp4IPvZZ59Z7ty5k/SaZ5991kKh0DE/NwAAAABJd9ddd9ltt93GJQMAACc1EunpSOHChS29+Pnnn70i/bTTTkvya/Lly5fi57Fv3z7LkiVLiu8XAAAAOFmoMCapxTEAAAAnqhO6R/qWLVusTZs2duqpp1rOnDmtcuXKNnr06KhtDh48aIMHD7YzzzzTsmXLZqVKlbIBAwb4c9OnT/dWKZHV5prOqMfWrl3rz9900022Y8cOf0w3TXuUPXv2eOWGjq0q8vPPP9+3T46HHnrIihcvbt999124tUvkVMVVq1ZZvXr1LHv27Hb22WfblClTol6vc9Q5jRs3zi6++GK/BlWrVrVvvvkmaruvv/7a6tatazly5LCSJUtar1697J9//vHnHnnkEatUqdIh56Zq8379+h3yeHBMXftOnTr5z6raP3DggHXu3NnKlCnjxylfvrxXoMdOr4zXkkb7ip16mT9/ft9/5LHfe+89q1+/vl+XUaNG+XOvv/66VaxY0R+rUKGCvfTSS3GuPAAAAHByUZxdrlw5j5cbNWpkGzZsCD+nMY7i/4DGNbVq1fJxjuLxCy+80NatWxcuqGnevLkVLVrUk+/nnXeeffnll1HH0ljp3nvv9bGHxmAai73xxhvh52fMmOH713MaD9133322f//+8PMaq9x4442+fz0/ZMiQqP0ndwwDAABgJ3si/b///rOaNWvap59+asuWLbOuXbta+/btbd68eeFt+vbta4MGDfKA6scff7R3333Xg76kqFOnjie28+bNaxs3bvSbkufSs2dPT1iPGTPGE+HXXnutNW7c2JPfh6P2Jpo6+dZbb9msWbOsSpUqh2yjLwBatmxpWbNmtblz59orr7ziwWhC7r//fj8vfQlw1lln+ZcLQSCqQFfndc011/h5KgmtxLrOX5QMX758ubeVCSxevNi31ZcIsRQM6zromuja6OfWrVv7+ao6/f333/fr/OCDD9r//vc/Gzt2rKU0Bdq33367n7cGAUqm63j6gkSPPf744/55v/nmmwm+XoH9zp07o24AAADAiWr37t0eK2v8obWOVEh0/fXXJ7itxhEqflHhisYEGvNonKWCFvn777+tSZMmNnXqVB83aKzRtGlTW79+fXgfSoKrwOm5557z+HzYsGHhivfffvvNX68E/NKlS+3ll1/2JPtjjz0Wfv3dd9/tyfaPPvrIvvjiC0/sL1r0//pvJ3cMkxDGBAAA4KRq7aJq8CCxLUpOT5482ZO3qnDYtWuXV0W/8MIL1qFDB9/mjDPOsIsuuihJ+1cSW+1IFDQWK1Ys/LiCxBEjRvifJUqU8Md0Hp9//rk/rkRuYhSY3nDDDR7oKaGt95AQVXVoIU+9n+AY2u8VV1xxyLY6thb8lIcfftjOOeccW716tVdmDxw40Nq1axdewFRVKApoFRgraFXyW8lonbeCWdHPer5s2bKHHCtTpkx+LXRNdG0ir4uOHVBluoJufRbXXXedpSS9F33JEFnZryqV4DEdW8l8BezB5x5J1yTyXAEAAIATmdohakykWbSighPN5lQBksZNkVRkohm5V111lY+dRNsGNANWt8Cjjz5q48ePt48//tiLdVauXOljAM2mbdiwoW8TOa7QzFEV5+h8NKbQmOX333/3oiEVxyjpr8T6O++8Y5deemn4fCNbSiZ3DJMQxgQAAOCkqkhXOxEFbmrpUrBgQa9yUOI5qIZQlYIqDYIALKV8//33fmxVfwf9BHVT1YQqwOO54447vMJ85syZiSbRg3NXgBkk0aV27doJbhtZ0a6pj7J582b/U1Ueao0SeZ4KOlVBvmbNGt+mS5cuXjGiCv+9e/d61b6qPJLrxRdf9BkC6vWu47z66qtRlSkp5dxzz42a9qlrrrYyke9RFS2JfRaapaDBQXCLnNYKAAAAnGgyZ84cTjiLktdq2aIxRyyNq9SSUWMGVZqrMEmzUAOqSFchj5Lr2odib+0niPs1S1bFN0pqJ0TbalwTVLiLWsdov7/++qvH8BqTBEn/4JzUOjLS0Y5hGBMAAICTqiL9ySef9MBOLUaUTFcPP1UrK5AS9eqOJ2PGjOFWK5HVGoejIE/B4cKFC/3PSIdbpOeyyy7zgE8Jf1WKp4TIxTaDgFSJ8uBcu3Xr5n3RY6lfvChAVn9CVZKoCl/XoFWrVsk6B7W4UUCtynAFxnny5PHPR18aJJXOPfKzSOzz0Occ0PuT1157LSrYltjPJqD3qhsAAACAQ6m6W+MHzbhVa8gHHnjAK8wvuOACj/n181NPPeW9zzXm0tghqWOwlHK0YxjGBAAA4KRKpKu/nxa6UauUIHmsqYRamDNoY6JATv37br755kNer8ppUYVFgQIFwhUUkRSUqfo8UvXq1f0xVX1rEc/kaNasmQd9bdu29URvYr0JVeGhSmmdW1Bl/u2331py1ahRw9ucKMiNV6GiFigKmPV+dU7JDYD1Wain/K233hp+7HDV+Ql9HpHVLuo3r6md8ajfvar2f/nllxT7YgIAAAA4kai95IIFC8JtXFasWOF90iNbtsTSmEc3VW6rUEYV30qkK+5XxfrVV18dLmxZu3Zt+HUqcNK4TLN1g9YukXTMDz/80AtogiIg7VOFOGrZoupzFQqpICco/Nm2bZuP8yKr3FNiDAMAAHDSJNKVKP/ggw9szpw5ngh/+umnbdOmTeFEulakV6+9e+65x4MrTRn8888/7YcffvBWIEouq32KVqnX4jsKzmJXhC9durQHh0rGqxdgzpw5vaWLkrZaREfbK8DUfrWN2qwE/coTo6Dz7bff9oVRFQAmVDmhoFPHUXCoym71KtSiosml96+AV/0K9WWCqrmVWFcVifoSBvRcEEgrkD2Sz0KLF6nSXj3K9f60+I9+TqpLLrnEz0mBur6o0LlHVtsnRv3OVTGjnu1a7EjtfDRQUMDdp0+fZL8XAAAA4ESimFrrSWmtJI0/NDbQGCG2P7qo/aNaNKoASAUrSrqrwEVjnyDuHzdunBcHKRHer1+/8GzYYPykMYzarOh4GkOtW7fOi5C0dpIKbzSjWOej89D+teaR4nbNGNYMX43VtODoKaecYkWKFPFxUDCbONLRjmEAAABOmh7pmmKoimv172vQoIEvfKkV5iMpsLvzzjt94RoFWa1btw73D1dAqTYrWtRTCfAnnngiarV4UZV19+7d/XWqmB48eLA/rsoHBZPat/r16bhKHAdVE4ej5LkWzVEyXYFoLAWKmqb477//eoCrIFHJ/uTS+1I1iL4kUPW8kv66FpG914OAWO9V/RJjW6QkhdrHaLFPXSe9fsuWLVHV6UmhLyX0xYbOUxX7mjaqLy4OR9fm9ddf989EFTCqVFFf+OQk8QEAAIATlWJqFakoxlZxkZLVatmS2LYaH11zzTVe2NO1a1fr0aOHx/ui4iUVMWnsoGS6xmIak0V6+eWXfbyj8YDGF+pnrrWNROtETZo0yRc6VZJdYy0lzjW2C6iQSGMC7V8FRhdddJGvxRTraMcwAAAAkTKEYptOAwnQ/yYKRBXsnmxV3Kr2VzW7Fh7Nmzdvap8OAABIJn6XAyenlBzD8O8IAADpW0r8Lj+hW7sgZagtjRYL/eOPP+ymm27isgIAAABI0xjDAACAlEYiHYelvoOFChXyXojBoqsAAAAAkFYxhgEAACmNRDoOi+4/AAAAANITxjAAACClndCLjQIAAAAAAAAAcLRIpAMAAAAAAAAAEAeJdAAAAAAAAAAA4iCRDgAAAAAAAABAHCTSAQAAAAAAAACIg0Q6AAAAAAAAAABxZI73JFLGyJEjrXfv3rZ9+/Y0eUmnT59uF198sW3bts3y589/ROfbsWNH337ChAmJbtOgQQOrVq2aDR061I6l0qVL+/nrlpKmDa9nuXJkStF9nkwadluY2qcAAACQLuP+tD6eSIux+7HSdlJdy5KTMUFyjW+26Jh8HgAAHE8k0nGI1q1bW5MmTZJ1ZZ599lkLhUJp4mrOnz/fcuXKldqnAQAAAAAAAOAEQSL9JLdv375DHsuRI4ffkiNfvnyWVhQuXDi1TwEAAAA4bvbu3WtZs2ZNM1c8rZ0PAABASqBH+nE0efJkq1ixouXOndsaN25sGzdu9MdnzpxpWbJksT/++CNqe01vrFu3bng6p9quqHVKuXLlLHv27NaoUSPbsGFD1Gs++ugjq1Gjhj9ftmxZe/jhh23//v3h5zNkyGAvv/yyNWvWzKu2BwwYcMh5BscK9O/f31uyDBs2zEqWLGk5c+a06667znbs2BHV2qVFixbh+//884/deOON/l6LFy9uQ4YMOeQ4e/bssbvuustOPfVUP5fzzz/f28zEnsfEiROtfPnyftxWrVrZ7t277c033/RpoAUKFLBevXrZgQMHwq/T45HtY55++mmrXLmyH0Pnf+utt9rff/+dpM8MAAAAOJ5xfxAHlypVyuPfq6++2rZs2RK1fRCfv/7661amTBmP/WX9+vXWvHlzP27evHk9Zt+0adMhrxs+fLjvX9spNlYsPXjwYCtWrJgVKVLkkDFCUvcbez5q7dizZ0+/qfCmUKFC1q9fv0Nmsiq+79Spk+XJk8fP69VXX416/vvvv7dLLrnEi31OOeUU69q1a1Q8H4xFnnrqKR97aJsePXpEFQ0dbuwBAABwOCTSjxMFhwrs3n77bQ+gFYwqkJN69ep50lvPBRT0jRo1ygPKyH0oqH3rrbds9uzZ3iPx+uuvDz8/a9YsT17ffvvt9uOPP3riW0F4bCCsQFcBuQLSyP3Hs3r1ahs7dqx98skn9vnnn9vixYs96E7M3XffbTNmzPDE/hdffOFB6qJF0X3xFFB/8803NmbMGPvuu+/s2muv9YHGqlWrot7zc88959vouNqPzn3SpEl+0zXT+/zggw8SPZeMGTP6Pn744QdPwH/11Vd2zz33JLq9guydO3dG3QAAAIDjEffPnTvXOnfu7LHykiVLfC2jxx57LMH4/MMPP7Rx48b5dgcPHvRk99atWz0OnzJliv3yyy/etjHSzz//bJ999pnH1qNHj7Y33njDrrzySvv111/9dU888YQ98MADfh6S1P3Gnk9A8XfmzJlt3rx53g5SRS5KuEdS0c25554bHmPccssttmLFinCBjgqIVECjFo7vv/++ffnll359Ik2bNs3fm/7UMTUO0i05Y49IjAkAAEAsWrscJwqQX3nlFTvjjDPCgdwjjzwSfl7B8ogRIzwBLUpY//fff17tEbmPF154wasnRAGiKl0UlNaqVcurz++77z7r0KGDP68g/dFHH/Wk8UMPPRTeT9u2be2mm24K31cgfDg6FyXwVcEhzz//vAfcCnpVuRJJ1SEKyN955x279NJLw+d62mmnhbfRgELvV3+WKFHCH9MAQwG9Hn/88cfD71kV9MF1U0W6Bh6qgFFFzNlnn+2DCwXMscF8IHLhIlWrayDSvXt3e+mllxLcfuDAgX4tAQAAgOMd9yvZrARvUPhx1lln2Zw5czxOjm2fovg8aGuoBLcKZdasWeOzMEXPn3POOZ6APu+888KJcVWkq/o7iKWVtFaRigpQNBNUyXTF1xp3TJ06NUn7jT2fgF7zzDPP+MxY7Vv70v0uXbqEt9H6TEGRzr333uvP6/ja/t133w2PRYJ1kDQmatq0qZ9n0aJF/TEl2vV4pkyZrEKFCj5W0bnrOEkde0RiTAAAAGJRkX6caFpmEEyLphxu3rw5ajqiqji+/fZbv6/qCQXTkYtmqpIjCFRFAaJanyxfvtzvL1261IN0JZiDmwJHTSVVZUxA1R7JpSmWQRJdateu7UF4UCkSSZUgCqSDhL8ULFjQA+GAAmhNIdXAIPJ8VeWi1yd23RQoKxmubSMfi7yWsVSxooS+zl8Dhvbt2/v02MhrEqlv377etia4xbbPAQAAAI5V3K/YPjKODmLvWKeffnpU0lqvU9I6SHaLEuWR4wVRLK2YODKW1nZKokc+FpxzUvcbez6BCy64wJPoke9FVeCRrRmrVKkS/lnbqlAn8vhVq1aNGhddeOGFh4xFlNhXEj2h657UsUckxgQAACAWFenHiXohRlKAGNkbUL0IVVWhigj1FdR0y+T27FMluCqpW7ZsechzQZ9CiQxCU4vOVYHuwoULowJeiUySJ3TdEnpMgXRC1q5da1dddZVPD1WLGyX0v/76a68EUrJfA51Y2bJl8xsAAACQFuP+o4npjza+TunzSeycknv8ePtI6tgjEmMCAAAQi0R6GnLzzTdbmzZtvAWKqlhUaRFJi4YuWLDA27iIKjDUJ13tXUSLjOqxM888M8XPTdMgf//99/BUSFXQBFM/Y+ncFciqr6Iq2WXbtm22cuVKq1+/vt+vXr26V4WoSiRyYaWUpmBZAbRa0ARVNur1DgAAAKTFuF+xfdCfPBBUr8ej12kmpW5B9bjWTdJ4QRXkR+po95vQeylXrtwhCe14x1fVvnqlB8l6rReV2FgkIcdr7AEAAE5stHZJQ7SITt68eb2Hd2QP84CS07fddpsHo0oQa1qopkoGifUHH3zQeweqKl0La2oapBbT0WJBR0sV7eq9rvYxWtS0V69ePgU1tj96UNWhim/1fdTCnsuWLfNzjZwuqmmV7dq188VRtSCRei6q17t6EX766aeWUvSlgvpUqqe7esGrv7p6VgIAAABpMe5XnK3e3VqwVC1Q1Pc7tj96Qho2bGiVK1f2GHvRokUeWyvWViHLkbR2TKn9qiCnT58+XvCjxU0Vl99+++1JPr6OG4xFNK5Q73SNidSuMeiPfjjHa+wBAABObCTS0xAlmpVwVrWEgrxYakOixXe0WKiqVpSwfu+996IC8okTJ9oXX3zhvdSVZNdCPepXmBIJabWM0UJAl19+ufcxTGyxTnnyySe92kPTVhV8X3TRRVazZs2obTSdVe/zzjvv9GqSFi1a+IJFQRV7SlA/xaefftoXIqpUqZKNGjXKA2YAAAAgLcb9iuFfe+01X3RUsaxi+6QUxqiVyUcffeSLbtarV89j8LJly0aNF47E0e5X7+/ff//14p8ePXp4Er1r165JPr7GQJMnT7atW7f6GKdVq1a+/pG+YEiO4zH2AAAAJ7YMociGfUh1quT+888/7eOPP456XNMZe/fu7VMoj7f+/fvbhAkTbMmSJXYy2rlzp+XLl88XHlXlEAAASF/4XY70FPefSBo0aGDVqlWzoUOHWnrHvyMAAKRvKfG7nB7paYQ+RK0m/+67757QwTQAAABwMiPuBwAASJ9IpKcRzZs39z593bt3t8suuyy1TwcAAADAMUDcDwAAkD7R2gU4DKZxAgCQvvG7HAD/jgAAcHLbmQKtXVhsFAAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAAHFkjvckkJoaNGhg1apVs6FDh6aJD2La8HqWK0em1D6NNKFht4WpfQoAAAA4SiNHjrTevXvb9u3b/X7//v1twoQJtmTJkjR7bf/44w9r3769zZkzx7JkyRI+9+Ol7aS6liUnY4LEjG+26Lh+HgAAHE9UpCPNGjdunD366KPJGgjkz5//mJ4TAAAAcKJo3bq1rVy50tKTZ555xjZu3OjJ/vR27gAAIH2jIh1pVsGCBVP7FAAAAIATVo4cOfyWFuzbt88rzA/n559/tpo1a1q5cuWOy3kBAAAEqEhHsm3ZssXatGljp556quXMmdMqV65so0ePPqQtS69eveyee+7xhHixYsV8qmhg+vTpljVrVps1a1b4scGDB1uRIkVs06ZN4X1oqmlgz549dtddd/lxc+XKZeeff77vJ9jfTTfdZDt27LAMGTL4Tcd75JFHrFKlSoe8B7WM6devH58+AAAATlqJzegcNmyYlSxZ0mP96667zmPsQGyMLi1atLCOHTuG75cuXdpnlmrMoLhd8fuLL74Y9RrF6y+//LI1a9bMtxkwYIA/rsfOOOMMHyuUL1/e3n777aj9fvjhh/bWW2/564Njqr3LzTffbIULF7a8efPaJZdcYkuXLg2/TuMCxf/al/aRL18+u/76623Xrl0pch0BAMDJgUQ6ku2///7zKpBPP/3Uli1bZl27dvU+hfPmzYva7s033/SgeO7cuZ4kV1J7ypQpUQG4XqfAfPHixZ7Yfv31161o0aIJHrdnz572zTff2JgxY+y7776za6+91ho3bmyrVq2yOnXqeC91Bc6a6qmbku6dOnWy5cuX2/z588P70bH0eiXeE6KE/c6dO6NuAAAAwMlg9erVNnbsWPvkk0/s888/99j51ltvTfZ+nnzySatataq//r777rPbb789PBaITHBfffXV9v3333vcPn78eN/uzjvv9HFGt27dPGafNm2ab6+YXvG/kvuK95999ll/XOOCzZs322effWYLFy60GjVq2KWXXmpbt26NqmRX//eJEyf6bcaMGTZo0KBEz58xAQAAiEUiHcmmihIlqVXVUbZsWbvttts8oFXAHalKlSr20EMP+bTLG2+80c4991ybOnVq+PnHHnvMChQo4In4G264wTp06OAVKQlZv369jRgxwt5//32rW7euV6noHC666CJ/XBUrqixRZYqq33XLnTu3nXbaadaoUSPfJqCf69ev7+eekIEDB/q+gpuqcQAAAICTpWhGFd+K9evVq2fPP/+8F7Jokc/kuPDCCz2BftZZZ/l4oVWrVt7fPFLbtm09Ua64vFSpUvbUU095lbkS93pdnz59rGXLlv64qOI8W7Zs3o5G8b5i9a+//toLejRO0HhDYw9tr0r7Dz74IHysgwcPegW+ZqtqPKGCnsixSSzGBAAAIBaJdCTbgQMHfKqmWrqobYsS1pMnT/Zkd2wiPVLx4sW9UiSg5PeoUaN8eqYC9tjAOpKqVHRcBdQ6XnBTJYmqS+Lp0qWLt57RMfbu3WvvvvuuV7wkpm/fvl4lH9w2bNiQhKsCAAAApH9KaKtwJlC7dm1PQq9YsSJZ+9HrYu9rpmgkJb4j6Xkl4CPpfuzrIqmFy99//22nnHJK1DhhzZo1UeMEtXTJkydPomOTWIwJAABALBYbxRFN09Q0SrVSUTJd7VvUpkVJ6kixiwWpWlxBeKQ5c+b4n5p2qZv2lRAFx5kyZfKpmvozkgLleJo2beqVK5oqquS9FjJSRUxitK1uAAAAAKJlzJjRQqFQ1GOKr49EYrF/cmicoKR4sHZSpMj+70kZm0RiTAAAAGKRSEeyzZ4925o3b+7tWEQB6MqVK+3ss89O1n5UIXLHHXfYa6+9Zu+99563dvnyyy89OI9VvXp1r0hX1YimYiZESXJtEytz5sy+76AFjBYW0nRQAAAAANE0y/T333+3EiVK+P1vv/3W43Mt/Bm0V1F/8oDib/Uzv/jii6P2o9fF3q9YsWLcy63nNdZQ7B7Q/XjjDPVDV9sZxfyqOgcAADhWaO2CZFPfQS0UpGpyTbPUIkCbNm1K1j4UcCsRr/7l6ouoJLcWAB0yZEiC26ulS7t27bzX+rhx43yqpnohqnehFj0VBc6qSFGvw7/++st2794dfv3NN99sX331lS+YFK+tCwAAAHAyy549uyey1TJl1qxZ1qtXL1/cUz3J5ZJLLvH4W7effvrJbrnlFtu+ffsh+1ECfPDgwV5w8+KLL3oPcy0kGs/dd9/tfcxffvllW7VqlT399NMe+2ttpMQ0bNjQ28a0aNHCvvjiC1u7dq2PU+6//35bsGBBClwRAACA/0MiHcn2wAMPeOWHkuANGjTwoFqBa3IMGDDA1q1bZ8OGDfP7mo756quv+r4VtCdEyXYl0u+8806viNEx58+f730cpU6dOta9e3dr3bq1V8oocI9M/uv5ChUq2Pnnn8+nDgAAACTgzDPP9AU+mzRpYpdffrmve/TSSy+Fn1dRihLtisvr16/vC4XGVqOLYnYlsjWz9LHHHvOkuMYP8Si+VwtJLRZ6zjnn+FhBYwCNORKjFi2TJk3yhVFVoKMCHM1A1VijaNGifMYAACDFZAjFNrgDTkD631zJ9FtvvdX69OmTrNfu3LnT8uXL5wuP5s2b95idIwAAODb4XQ4cX5opqjWUdDtR8O8IAADpW0r8LqdHOk54f/75p40ZM8Z7J6pKBQAAAAAAAACSg0Q6TnhFihSxQoUKeeuYAgUKpPbpAAAAAAAAAEhnSKTjhEf3IgAAAOD40YKfAAAAJxoWGwUAAAAAAAAAIA4S6QAAAAAAAAAAxEEiHQAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcmeM9iZPDyJEjrXfv3rZ9+/YkvyYUClm3bt3sgw8+sG3bttnixYt9H9WqVbOhQ4faiWja8HqWK0cmO9k17LYwtU8BAAAASBVtJ9W1LDkZE4xvtoj/AwEAJx0q0mGtW7e2lStXJutKfP75556Anzhxom3cuNEqVarElQQAAAAAAABwQqIiHZYjRw6/JcfPP/9sxYsXtzp16nAFAQAAAAAAAJzQqEiHV5bnz58/fCX69+/vLVrefvttK126tOXLl8+uv/5627Vrlz/fsWNHu+2222z9+vWWIUMG3yYhem7ChAlRj+k4Ol5gw4YNdt111/njBQsWtObNm9vatWvDz+tYLVq0sKeeesoT96eccor16NHD9u3b589Pnz7djxN70+uChL/2WbRoUcudO7edd9559uWXX/KpAwAAAMfBunXrrGnTplagQAHLlSuXnXPOOTZp0qTw88uWLbMrrrjCY3XF7O3bt7e//vor/HyDBg2sV69eds899/h4oVixYj5eiaT4//XXX7err77acubMaeXKlbOPP/44/PyBAwesc+fOVqZMGS8gKl++vD377LN8/gAAIFlIpCNBSkArCa7WLbrNmDHDBg0a5M8p6HzkkUfstNNO87Yu8+fPP6KrqGR4o0aNLE+ePDZr1iybPXu2B9CNGze2vXv3hrebNm2an4/+fPPNNz0RHyTjVRGvcwhuX331lWXPnt3q1avnz//999/WpEkTmzp1qvdx174VyOtLgMTs2bPHdu7cGXUDAAAAkHwqglF8PXPmTPv+++/tiSee8JhftEbTJZdcYtWrV7cFCxZ4+8hNmzZ5oU0kjQGUhJ87d64NHjzYxyJTpkyJ2ubhhx/213333Xce/7dr1862bt3qzx08eNDHLu+//779+OOP9uCDD9r//vc/Gzt2LGMCAACQZLR2QYIUbCpZrSS3qDJEyegBAwZ4hboez5Qpk1eEHKn33nvPj6PqEVWRyIgRI7w6XZXml19+uT+m6pUXXnjBj1ehQgW78sor/Vy6dOliWbNmDZ/Dli1b7Oabb7ZOnTr5TapWreq3wKOPPmrjx4/3CpWePXsmeF4DBw70QBwAAADA0VEByzXXXGOVK1f2+2XLlg0/pxhfSfTHH388/Njw4cOtZMmSvobTWWed5Y9VqVLFHnroIf9Z1eZ6ncYDl112Wfh1mpHapk0b/1n7e+6552zevHleSJMlS5ao+F6V6d98840n0mOT9gHGBAAAIBYV6UiQ2rUESXRRW5XNmzen6NVaunSprV692o+jqhTdNF3zv//+8wr0gKZ/Koke71xU3a4A/fTTT4+apqmK9LvuussqVqzoCXodY/ny5XEr0vv27Ws7duwI39R+BgAAAEDyqS3LY489ZhdeeKEnw1UxHjke0KzTYCygmwpnJHI8oER6pITGA5HbqHo9b968Udu8+OKLVrNmTStcuLAf59VXX2VMAAAAkoWKdCRIVRuRVDGu6vHk0GtCoVDUY0Fv8yDJrWB21KhRh7xWAW5yzuWWW27xhLeqTjJn/n//WyuJrmmf6rF+5plnek/EVq1aRbWOiZUtWza/AQAAADg6mjGqdo6ffvqpffHFF17pPWTIEF9zSeMBtV1Uu5dYSpYnZzwQb5sxY8b4uEDHrV27thfyPPnkk94qJjGMCQAAQCwS6ThmlAxX3/LAqlWrbPfu3eH7NWrU8PYuRYoU8YqRI/X000/7tMw5c+b4YqSR1Hdd0zy18JAoWI9czBQAAADAsaVWLd27d/ebZn++9tprnkjXeODDDz/02bCRxTApTWMCra106623hh+LrHgHAABIClq74JjRwkHqX6hFPrV4kALnyEoRLQBUqFAha968uS82umbNGu+Nrumfv/76a5KO8eWXX9o999zjFSXa1x9//OE3tWQJeiiOGzfOlixZ4lNH27Ztm+zKegAAAABHpnfv3jZ58mSP9RctWuStXNR2MViIVAuCqrf5/PnzPbmtbW+66SY7cOBAil1yjQk0HtG+1Xu9X79+fjwAAIDkoCIdx4ymTioIrlu3rpUoUcJ7ly9cuDD8fM6cOW3mzJl27733WsuWLW3Xrl126qmn2qWXXprkCvWvv/7ag+ygwiXQoUMHXyxV1epaeFQVKEq061g7d+48ovdzcaeZR1U5DwAAAJxsFKsrYa5CGcXSWvzzmWee8ec0RlC1uGL0yy+/3Pbs2eNrHmmbjBlTruarW7duXtzTunVrb/mixL2q0z/77LNk7+vdJrMYEwAAcJLKEIptYg0gihLv+fLl8yp3EukAAKQ//C4HwL8jAACc3HamQH6P1i4AAAAAAAAAAMRBIh0AAAAAAAAAgDhIpAMAAAAAAAAAEAeLjQKHESwjcKSLlAIAgNQV/A5naSAAR4oxAQAA6VtKjAlIpAOHsWXLFv+zZMmSXCsAANKxXbt2+QJDAJBcjAkAADgxHM2YgEQ6cBgFCxb0P9evX8/gOw1/q6gvOjZs2HDEKy/j2OIzStv4fNI+PqOjo6oTBcwlSpRIoU8EwMmGMUHq4Xdg6uL6c+1PVvy/f+Jd+1AKjAlIpAOHkTHj/y0loG+rSNKmbfp8+IzSNj6jtI3PJ+3jMzpyVKIDOBqMCVIfvwO5/icr/t/n+p+s8h6DHM/RjglYbBQAAAAAAAAAgDhIpAMAAAAAAAAAEAeJdOAwsmXLZg899JD/ibSJzyjt4zNK2/h80j4+IwBIXfw7zLU/WfH/Ptf+ZMX/+1z7hGQIqdM6AAAAAAAAAABIEBXpAAAAAAAAAADEQSIdAAAAAAAAAIA4SKQDAAAAAAAAABAHiXTgMF588UUrXbq0Zc+e3c4//3ybN28e1+w4GDhwoJ133nmWJ08eK1KkiLVo0cJWrFgRtc1///1nPXr0sFNOOcVy585t11xzjW3atClqm/Xr19uVV15pOXPm9P3cfffdtn//fj7DFDZo0CDLkCGD9e7dm88nDfntt9/shhtu8L8jOXLksMqVK9uCBQvCz2uZlAcffNCKFy/uzzds2NBWrVoVtY+tW7dau3btLG/evJY/f37r3Lmz/f3336nwbk48Bw4csH79+lmZMmX8+p9xxhn26KOP+ucS4DMCgNTHeCDlEeunHcTxxx8xeuog9j6+Zs6caU2bNrUSJUp4rmDChAlRz6fUOOe7776zunXres6uZMmSNnjw4GP7xrTYKICEjRkzJpQ1a9bQ8OHDQz/88EOoS5cuofz584c2bdrEJTvGGjVqFBoxYkRo2bJloSVLloSaNGkSKlWqVOjvv/8Ob9O9e/dQyZIlQ1OnTg0tWLAgdMEFF4Tq1KkTfn7//v2hSpUqhRo2bBhavHhxaNKkSaFChQqF+vbty+eXgubNmxcqXbp0qEqVKqHbb7+dzyeN2Lp1a+j0008PdezYMTR37tzQL7/8Epo8eXJo9erV4W0GDRoUypcvX2jChAmhpUuXhpo1axYqU6ZM6N9//w1v07hx41DVqlVD3377bWjWrFmhM888M9SmTZtUelcnlgEDBoROOeWU0MSJE0Nr1qwJvf/++6HcuXOHnn322fA2fEYAkLoYDxwbxPppA3H88UeMnnqIvY+vSZMmhe6///7QuHHjVCUUGj9+fNTzKTHO2bFjR6ho0aKhdu3aee5o9OjRoRw5coSGDRt2zN4XiXQgjlq1aoV69OgRvn/gwIFQiRIlQgMHDuS6HWebN2/2f3xnzJjh97dv3x7KkiWLJ54Cy5cv922++eab8D/cGTNmDP3xxx/hbV5++eVQ3rx5Q3v27OEzTAG7du0KlStXLjRlypRQ/fr1w4l0Pp/Ud++994YuuuiiRJ8/ePBgqFixYqEnn3wy/Jg+t2zZsnkAIj/++KP/nZo/f354m88++yyUIUOG0G+//XaM38GJ78orrwx16tQp6rGWLVt6ICh8RgCQ+hgPHB/E+scfcXzqIEZPPcTeqcdiEukpNc556aWXQgUKFIjK7+jvWPny5Y/Ze6G1C5CIvXv32sKFC316SSBjxox+/5tvvuG6HWc7duzwPwsWLOh/6rPZt29f1OdToUIFK1WqVPjz0Z9qZVG0aNHwNo0aNbKdO3faDz/8wGeYAtRaR61zIj8HPp+04eOPP7Zzzz3Xrr32Wm9rVL16dXvttdfCz69Zs8b++OOPqM8uX7583sIq8u+QptBpPwFtr38L586de5zf0YmnTp06NnXqVFu5cqXfX7p0qX399dd2xRVX+H0+IwBIXYwHjh9i/eOPOD51EKOnHmLvtGNNCo1FtU29evUsa9asUTkftQXetm3bMTn3zMdkr8AJ4K+//vIeWpFJWNH9n376KdXO62R08OBB77194YUXWqVKlfwx/aOrfyz1D2vs56Pngm0S+vyC53B0xowZY4sWLbL58+cf8hyfT+r75Zdf7OWXX7Y+ffrY//73P/+cevXq5X9vOnToEP47kNDfkci/Q0rCR8qcObN/ocXfoaN33333+Rd7+hIwU6ZM/jtnwIAB3gcwuP58RgCQehgPHB/E+scfcXzqIUZPPcTeaccfKTTO0Z9abyp2H8FzBQoUSPFzJ5EOIF1USyxbtswrNZE2bNiwwW6//XabMmWKL+qBtDko1bf3jz/+uN9XRbr+Hr3yyiueSEfqGzt2rI0aNcreffddO+ecc2zJkiX+paEW5OEzAgCcLIj1jy/i+NRFjJ56iL2REmjtAiSiUKFCXiG4adOmqMd1v1ixYly346Rnz542ceJEmzZtmp122mnhx/UZaLrt9u3bE/189GdCn1/wHI6cWuts3rzZatSo4d8K6zZjxgx77rnn/Gd9C8znk7q0+vnZZ58d9VjFihVt/fr1UX8H4v0bpz/1OUfav3+/r57O36Gjd/fdd3tlzPXXX+9tqNq3b2933HGHDRw4kM8IANIAxgPHHrH+8Uccn7qI0VMPsXfaUSyFxqKpkfMhkQ4kQu0Patas6f1rI7891v3atWtz3Y4xrUehwHr8+PH21VdfHTJdR59NlixZoj4f9cFSkjD4fPTn999/H/WPryqo8+bNe0iCEclz6aWX+rVVBW1wU/WzWlIEP/P5pC61QtLfiUjqxX366af7z/o7peAi8u+Q2oyo31zk3yF9WaUBV0B/H/VvofrX4ejs3r3be/xF0he4ur58RgCQ+hgPHDvE+qmHOD51EaOnHmLvtKNMCo1Ftc3MmTN9/bzInE/58uWPSVsXd8yWMQVOAGPGjPFVg0eOHOkrBnft2jWUP3/+0B9//JHap3bCu+WWW0L58uULTZ8+PbRx48bwbffu3eFtunfvHipVqlToq6++Ci1YsCBUu3ZtvwX2798fqlSpUujyyy8PLVmyJPT555+HChcuHOrbt28qvasTW/369UO33357+D6fT+qaN29eKHPmzKEBAwaEVq1aFRo1alQoZ86coXfeeSe8zaBBg/zftI8++ij03XffhZo3bx4qU6ZM6N9//w1v07hx41D16tVDc+fODX399dehcuXKhdq0aZNK7+rE0qFDh9Cpp54amjhxYmjNmjWhcePGhQoVKhS65557wtvwGQFA6mI8cGwQ66ctxPHHDzF66iH2Pr527doVWrx4sd+Ufn766af953Xr1qXYOGf79u2hokWLhtq3bx9atmyZ/87WmHfYsGHH7H2RSAcO4/nnn/dkbdasWUO1atUKffvtt1yz40D/0CZ0GzFiRHgb/QN76623hgoUKOD/WF599dWebI+0du3a0BVXXBHKkSOHJ6juvPPO0L59+/gMj0MAzueT+j755BP/MklfCFaoUCH06quvRj1/8ODBUL9+/Tz40DaXXnppaMWKFVHbbNmyxYOV3Llzh/LmzRu66aabPCjC0du5c6f/ndHvmOzZs4fKli0buv/++0N79uzhMwKANITxQMoj1k9biOOPL2L01EHsfXxNmzYtwX/r9YVGSo5Fly5dGrrooot8HypSUoL+WMqg/xybWncAAAAAAAAAANI/eqQDAAAAAAAAABAHiXQAAAAAAAAAAOIgkQ4AAAAAAAAAQBwk0gEAAAAAAAAAiINEOgAAAAAAAAAAcZBIBwAAAAAAAAAgDhLpAAAAAAAAAADEQSIdAAAAAAAAAIA4SKQDAAAAAAAAABAHiXQAQKrp2LGjZciQ4ZDb6tWr+VQAAACAkwBjAgDpRebUPgEAwMmtcePGNmLEiKjHChcuHHV/7969ljVr1uN8ZgAAAACOB8YEANIDKtIBAKkqW7ZsVqxYsajbpZdeaj179rTevXtboUKFrFGjRr7tsmXL7IorrrDcuXNb0aJFrX379vbXX3+F9/XPP//YjTfe6M8XL17chgwZYg0aNPD9BFTxPmHChKhzyJ8/v40cOTJ8f8OGDXbdddf54wULFrTmzZvb2rVro6pmWrRoYU899ZQf55RTTrEePXrYvn37wtvs2bPH7r33XitZsqS/xzPPPNPeeOMNC4VC/rNeG2nJkiVU4wMAAOCkxJjg/zAmANI2EukAgDTpzTff9Cr02bNn2yuvvGLbt2+3Sy65xKpXr24LFiywzz//3DZt2uQJ78Ddd99tM2bMsI8++si++OILmz59ui1atChZx1UyXIn7PHny2KxZs/z4SsyrSkaV8YFp06bZzz//7H/qXJWIj0zGK6E/evRoe+6552z58uU2bNgw348S+Z06dTqkCl/369Wr50l2AAAAAIwJAKQxIQAAUkmHDh1CmTJlCuXKlSt8a9WqVah+/fqh6tWrR2376KOPhi6//PKoxzZs2BDSr7IVK1aEdu3aFcqaNWto7Nix4ee3bNkSypEjR+j2228PP6btx48fH7WffPnyhUaMGOE/v/3226Hy5cuHDh48GH5+z549vp/JkyeHz/v0008P7d+/P7zNtddeG2rdurX/rPPRcaZMmZLg+/7tt9/8fc+dO9fv7927N1SoUKHQyJEjj+AqAgAAAOkXYwLGBEB6QY90AECquvjii+3ll18O38+VK5e1adPGatasGbXd0qVLvfpbVd2xVBn+77//esX4+eefH35cbVnKly+frPPRcbTYqSrSI/33339+nMA555xjmTJlCt9Xi5fvv/8+PCVTz9WvXz/BY5QoUcKuvPJKGz58uNWqVcs++eQTbwVz7bXXJutcAQAAgBMBYwLGBEB6QCIdAJCqlDhPqJ2JHo/0999/W9OmTe2JJ544ZFslsZX8Tgq1Vvm/wvT/J7K3uY6jJP6oUaMOeW3kIqhZsmQ5ZL8HDx70n3PkyHHY87j55pu9x/szzzzjbV1at25tOXPmTNJ7AAAAAE4kjAkYEwDpAYl0AEC6UKNGDfvwww+tdOnSljnzob++zjjjDE9uz50710qVKuWPbdu2zVauXBlVGa5k+MaNG8P3V61aZbt37446znvvvWdFihSxvHnzHtG5Vq5c2ZPq6tfesGHDBLdp0qSJDxhUja9+7zNnzjyiYwEAAAAnC8YEAFITi40CANKFHj162NatW73ty/z5873NyuTJk+2mm26yAwcOeMuXzp07+4KjX331lS1btsw6duxoGTNG/6rTgqUvvPCCLV682Bct7d69e1R1ebt27axQoULWvHlzX2x0zZo1vmhpr1697Ndff03SuSrZ36FDB19UdMKECeF9jB07NryNWr/o/Pr27WvlypWz2rVrp+DVAgAAAE48jAkApCYS6QCAdEF9xWfPnu1J88svv9yrvnv37m358+cPJ8uffPJJq1u3rreAUSX4RRdddEiv9SFDhljJkiV9u7Zt29pdd90V1VJFP6s6XFXtLVu2tIoVK3qCXj3Sk1OhrkrzVq1a2a233moVKlSwLl262D///BO1jfarvu76MgAAAAAAYwIAaVcGrTia2icBAMCx0qBBA6tWrZoNHTo0zV1kVbxfeumltmHDBitatGhqnw4AAABwQmJMACAl0CMdAIDjbM+ePfbnn39a//797dprryWJDgAAAJxkGBMA6Q+tXQAAOM5Gjx5tp59+um3fvt0GDx7M9QcAAABOMowJgPSH1i4AAAAAAAAAAMRBRToAAAAAAAAAAHGQSAcAAAAAAAAAIA4S6QAAAAAAAAAAxEEiHQAAAAAAAACAOEikAwAAAAAAAAAQB4l0AAAAAAAAAADiIJEOAAAAAAAAAEAcJNIBAAAAAAAAAIiDRDoAAAAAAAAAAJa4/w+AZ8Psg3UaLAAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 1500x1200 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import pandas as pd\n",
    "\n",
    "# Require `data_sample` to be defined (created earlier in the notebook)\n",
    "if 'data_sample' not in globals():\n",
    "    raise AssertionError(\"Define `data_sample` DataFrame before running this cell.\")\n",
    "\n",
    "# Fixed visualization: separate subplots, correct indexing, single show at end\n",
    "labels = ['disease_entity_count', 'drug_entity_count', 'anatomy_entity_count']\n",
    "label_titles = {\n",
    "    'disease_entity_count': 'Diseases',\n",
    "    'drug_entity_count': 'Drugs',\n",
    "    'anatomy_entity_count': 'Anatomy',\n",
    "}\n",
    "\n",
    "fig, axes = plt.subplots(3, 2, figsize=(15, 12))\n",
    "sns.set_palette(\"husl\")\n",
    "\n",
    "# Histograms per entity type\n",
    "ax_map = {\n",
    "    'disease_entity_count': axes[0, 0],\n",
    "    'drug_entity_count': axes[0, 1],\n",
    "    'anatomy_entity_count': axes[1, 0],\n",
    "}\n",
    "\n",
    "for label, ax in ax_map.items():\n",
    "    if label in data_sample.columns:\n",
    "        values = data_sample[label].dropna()\n",
    "        ax.hist(values, bins=30, edgecolor='black', alpha=0.7)\n",
    "        mean_val = values.mean() if len(values) else 0\n",
    "        ax.axvline(mean_val, color='red', linestyle='--', label=f\"Mean: {mean_val:.2f}\")\n",
    "        ax.set_xlabel('Number of Entities')\n",
    "        ax.set_ylabel('Frequency')\n",
    "        ax.set_title(f\"Distribution of {label_titles[label]} per Record\")\n",
    "        ax.legend()\n",
    "    else:\n",
    "        ax.text(0.5, 0.5, f\"Missing column: {label}\", ha='center', va='center')\n",
    "        ax.axis('off')\n",
    "\n",
    "# Average total entities by admission type (sum across available entity counts)\n",
    "if 'admission_type' in data_sample.columns:\n",
    "    count_cols_present = [c for c in labels if c in data_sample.columns]\n",
    "    if count_cols_present:\n",
    "        tmp = data_sample.copy()\n",
    "        tmp['total_entities'] = tmp[count_cols_present].sum(axis=1)\n",
    "        admission_entity_stats = (\n",
    "            tmp.groupby('admission_type')['total_entities']\n",
    "               .mean()\n",
    "               .sort_values()\n",
    "        )\n",
    "        admission_entity_stats.plot(kind='barh', ax=axes[1, 1], color=sns.color_palette()[0])\n",
    "        axes[1, 1].set_xlabel('Average Entity Count')\n",
    "        axes[1, 1].set_title('Average Total Entities by Admission Type')\n",
    "    else:\n",
    "        axes[1, 1].text(0.5, 0.5, \"No entity count columns found\", ha='center', va='center')\n",
    "        axes[1, 1].axis('off')\n",
    "else:\n",
    "    axes[1, 1].text(0.5, 0.5, \"Missing column: admission_type\", ha='center', va='center')\n",
    "    axes[1, 1].axis('off')\n",
    "\n",
    "# Helper to compute top entities from list-of-dicts\n",
    "from collections import Counter\n",
    "\n",
    "def extract_top_entities(series_of_lists, top_k=15):\n",
    "    all_entities = []\n",
    "    for entities_list in series_of_lists:\n",
    "        if isinstance(entities_list, list):\n",
    "            for ent in entities_list:\n",
    "                word = ent.get('word') if isinstance(ent, dict) else None\n",
    "                if isinstance(word, str) and word.strip():\n",
    "                    all_entities.append(word.lower())\n",
    "    if not all_entities:\n",
    "        return pd.DataFrame(columns=['Entity', 'Count'])\n",
    "    entity_counts = Counter(all_entities)\n",
    "    top_entities = pd.DataFrame(entity_counts.most_common(top_k), columns=['Entity', 'Count'])\n",
    "    return top_entities\n",
    "\n",
    "# Top entities for diseases and drugs\n",
    "series_diseases = data_sample['disease_entities'] if 'disease_entities' in data_sample.columns else []\n",
    "series_drugs = data_sample['drug_entities'] if 'drug_entities' in data_sample.columns else []\n",
    "\n",
    "top_diseases = extract_top_entities(series_diseases)\n",
    "top_drugs = extract_top_entities(series_drugs)\n",
    "\n",
    "if not top_diseases.empty:\n",
    "    top_diseases.plot(x='Entity', y='Count', kind='barh', ax=axes[2, 0], legend=False, color=sns.color_palette()[1])\n",
    "    axes[2, 0].set_xlabel('Frequency')\n",
    "    axes[2, 0].set_title('Top 15 Disease Entities')\n",
    "    axes[2, 0].invert_yaxis()\n",
    "else:\n",
    "    axes[2, 0].text(0.5, 0.5, \"No disease entities found\", ha='center', va='center')\n",
    "    axes[2, 0].axis('off')\n",
    "\n",
    "if not top_drugs.empty:\n",
    "    top_drugs.plot(x='Entity', y='Count', kind='barh', ax=axes[2, 1], legend=False, color=sns.color_palette()[2])\n",
    "    axes[2, 1].set_xlabel('Frequency')\n",
    "    axes[2, 1].set_title('Top 15 Drug Entities')\n",
    "    axes[2, 1].invert_yaxis()\n",
    "else:\n",
    "    axes[2, 1].text(0.5, 0.5, \"No drug entities found\", ha='center', va='center')\n",
    "    axes[2, 1].axis('off')\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c9d7ee86",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
